PATIENT_ID	SAMPLE_ID	SAMPLE_COLLECTION_SOURCE	SPECIMEN_PRESERVATION_TYPE	SPECIMEN_TYPE	DNA_INPUT	SAMPLE_COVERAGE	TUMOR_PURITY	MATCHED_STATUS	SAMPLE_TYPE	PRIMARY_SITE	METASTATIC_SITE	SAMPLE_CLASS	ONCOTREE_CODE	CANCER_TYPE	CANCER_TYPE_DETAILED	LEVEL_1	LEVEL_2	LEVEL_3A	LEVEL_3B	LEVEL_4	LEVEL_R1	LEVEL_R2	LEVEL_R3	HIGHEST_LEVEL	oncogenic_mutations	#actionable_mutations	#oncogenic_mutations
P-0000004	P-0000004-T01-IM3	Outside	FFPE	Biopsy	250	428	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.A138Cfs*27;RAC1 Amplification	1	3
P-0000015	P-0000015-T01-IM3	In-House	FFPE	Biopsy	198	281	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.L536H)						LEVEL_1	PIK3CA p.E545K;ESR1 p.L536H;TP53 p.R248W;GATA3 p.D335Gfs*17;KIT Amplification;PDGFRA Amplification	3	6
P-0000023	P-0000023-T01-IM3	In-House	FFPE	Biopsy	250	454	30	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										LATS1 p.R63*;BAP1 p.P328Lfs*7;LATS2 p.N847*;BCOR Deletion	0	4
P-0000024	P-0000024-T01-IM3	In-House	FFPE	Resection	250	1016	40	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.R130G);GSK2636771,AZD8186(PTEN p.N292Kfs*6)				LEVEL_4	CTNNB1 p.S37Y;PTEN p.R130G;BCOR p.N1459S;ARID1A p.K1830Mfs*52;PIK3R1 p.X582_splice;PTEN p.N292Kfs*6;AKT3 Amplification	2	7
P-0000025	P-0000025-T02-IM5	In-House	FFPE	Biopsy	250	1147	30	Matched	Metastasis	Uterus	Peritoneum	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P104L);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.P104L;FGFR1 Amplification	2	3
P-0000025	P-0000025-T01-IM3	In-House	FFPE	Resection	250	1161	NA	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.R248Q	0	1
P-0000026	P-0000026-T01-IM3	In-House	FFPE	Cytology	250	1222	10	Matched	Metastasis	Uterus	Pelvis	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.Q546K;CCNE1 Amplification;ERBB2 Amplification	2	4
P-0000027	P-0000027-T01-IM3	Outside	FFPE	Biopsy	250	668	NA	Matched	Primary	Lung	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type											0	0
P-0000030	P-0000030-T01-IM3	Outside	FFPE	Biopsy	250	757	40	Unmatched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R173C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.R173C;TP53 p.R209Kfs*6;FOXL2 p.E118K;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0000034	P-0000034-T01-IM3	In-House	FFPE	Resection	250	461	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(KDM6A p.E1370Kfs*6)				LEVEL_3B	ARID1A p.S138*;FAT1 p.R2556*;BLM p.Q83*;BLM p.S106*;KDM6A p.E1370Kfs*6;AMER1 Deletion;CDK4 Amplification;MCL1 Amplification;MDM2 Amplification	3	9
P-0000036	P-0000036-T01-IM3	In-House	FFPE	Biopsy	50	380	30	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 SLC34A2-ROS1 fusion);Crizotinib,Entrectinib(SLC34A2 SLC34A2-ROS1 fusion)								LEVEL_1	TP53 p.Q331*;ROS1 SLC34A2-ROS1 fusion;SLC34A2 SLC34A2-ROS1 fusion	2	3
P-0000037	P-0000037-T01-IM3	In-House	FFPE	Resection	250	761	90	Matched	Metastasis	Liver	Liver	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.R249S	0	1
P-0000037	P-0000037-T02-IM3	In-House	FFPE	Resection	250	201	90	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										ARID2 p.E1511*	0	1
P-0000039	P-0000039-T01-IM3	In-House	FFPE	Resection	250	387	40	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										CREBBP Deletion	0	1
P-0000041	P-0000041-T01-IM3	Outside	FFPE	Biopsy	144	401	30	Unmatched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.X125_splice;NF2 p.P135Lfs*39	2	3
P-0000042	P-0000042-T01-IM3	Outside	FFPE	Biopsy	250	538	40	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 Deletion	0	1
P-0000043	P-0000043-T02-IM3	In-House	FFPE	Biopsy	250	833	50	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;PTPRD p.W1440*;CCNE1 Amplification;MITF Amplification;MYCN Amplification	1	5
P-0000047	P-0000047-T01-IM3	In-House	FFPE	Resection	250	571	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type				Crizotinib,Entrectinib(ROS1 TMEM181-ROS1 fusion);Crizotinib,Entrectinib(TMEM181 TMEM181-ROS1 fusion)					LEVEL_3B	BAP1 p.D34Rfs*32;AMER1 Deletion;ATRX Deletion;BCOR Deletion;KDM5C Deletion;MED12 Deletion;NF2 Deletion;SH2D1A Deletion;ROS1 TMEM181-ROS1 fusion;TMEM181 TMEM181-ROS1 fusion	2	10
P-0000053	P-0000053-T01-IM3	In-House	FFPE	Resection	250	842	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type											0	0
P-0000055	P-0000055-T01-IM3	In-House	FFPE	Resection	250	910	80	Matched	Primary	Uterus	Not Applicable	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma										TP53 p.R273H;PIK3R1 p.L449Ifs*3	0	2
P-0000056	P-0000056-T01-IM3	In-House	FFPE	Biopsy	250	1004	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN1A p.E66*;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	2	4
P-0000057	P-0000057-T01-IM3	Outside	FFPE	Resection	250	835	25	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.R342*	2	2
P-0000058	P-0000058-T01-IM3	In-House	FFPE	Biopsy	144	799	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK DDX11L2-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(DDX11L2 DDX11L2-ALK fusion)					LEVEL_1	TP53 p.I195T;ERBB2 Amplification;MAPK1 Amplification;ALK DDX11L2-ALK fusion;DDX11L2 DDX11L2-ALK fusion	4	5
P-0000059	P-0000059-T01-IM3	In-House	FFPE	Biopsy	234	971	20	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0000060	P-0000060-T01-IM3	Outside	FFPE	Biopsy	250	731	30	Matched	Metastasis	Uterus	Omentum	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.H1047R	1	2
P-0000061	P-0000061-T01-IM3	In-House	FFPE	Resection	250	921	60	Matched	Primary	Uterus	Not Applicable	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R)					LEVEL_3B	PIK3CA p.G1049R;SMARCA4 p.R1243G	1	2
P-0000062	P-0000062-T01-IM3	In-House	FFPE	Biopsy	250	1176	30	Matched	Primary	Esophagus	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R248W;CCNE1 Amplification;ERBB2 Amplification;GRIN2A Deletion;MCL1 Amplification;PTPRT Deletion	2	6
P-0000063	P-0000063-T01-IM3	In-House	FFPE	Resection	250	900	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108N)				LEVEL_3B	KMT2C p.Q528*;TP53 p.R175H;CDKN2A p.D108N;ERBB2 Amplification;RICTOR Amplification	2	5
P-0000064	P-0000064-T02-IM3	In-House	FFPE	Resection	151.58	552	35	Matched	Metastasis	Uterus	Lung	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma				Olaparib(ATM p.S1601Ffs*7)					LEVEL_3B	SMAD4 p.X436_splice;PPP2R1A p.S219L;ATM p.S1601Ffs*7	1	3
P-0000065	P-0000065-T01-IM3	In-House	FFPE	Resection	250	810	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Trametinib,Cobimetinib(MAP2K1 p.C121S)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;MAP2K1 p.C121S;NCOR1 p.E382*	2	3
P-0000066	P-0000066-T01-IM3	In-House	FFPE	Biopsy	250	922	NA	Matched	Metastasis	Breast	Parasternal Mass	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.L536H);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.L536H;ESR1 p.D538G;TP53 p.R213*;CCND1 Amplification;MYC Amplification	2	5
P-0000066	P-0000066-T02-IM5	In-House	DNA	Biopsy	236.6	677	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537C)						LEVEL_3A	ESR1 p.Y537C;KMT2C p.S3213*;CCND1 Amplification	1	3
P-0000067	P-0000067-T01-IM3	In-House	FFPE	Resection	250	923	NA	Matched	Metastasis	Ovary	Cervix	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	RB1 p.L389*;TP53 p.Y163C;NF1 Deletion	1	3
P-0000067	P-0000067-T02-IM5	In-House	FFPE	Resection	250	952	80	Matched	Metastasis	Ovary	Pelvis	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	RB1 p.L389*;TP53 p.Y163C;BCL2L11 Deletion;CARD11 Amplification;EED Deletion;ETV1 Amplification;GATA3 Deletion;NF1 Deletion;RAC1 Amplification	1	9
P-0000068	P-0000068-T01-IM3	In-House	FFPE	Resection	250	973	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.G266E	0	1
P-0000069	P-0000069-T01-IM3	In-House	FFPE	Resection	250	735	60	Matched	Metastasis	Uterus	Rectosigmoid Colon	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(ATM p.X1370_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.K267Rfs*9);GSK2636771,AZD8186(PTEN p.N323Mfs*21)				LEVEL_3B	KRAS p.G12D;PIK3CA p.H1047R;ARID1A p.G2087R;FBXW7 p.R465H;CCND1 p.E279*;ATM p.X1370_splice;ARID1A p.D641Ifs*6;JAK1 p.K860Nfs*16;SOX17 p.S208Efs*157;PTEN p.K267Rfs*9;PTEN p.N323Mfs*21	5	11
P-0000071	P-0000071-T01-IM3	In-House	FFPE	Resection	250	795	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.R1279*)				LEVEL_4	RB1 p.S834*;TP53 p.C275*;NCOR1 p.S2084*;PTPRT p.X781_splice;KDM6A p.R1279*;KDM5A Amplification	1	6
P-0000073	P-0000073-T01-IM3	In-House	FFPE	Resection	250	687	60	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer										ARID1A p.K1021Rfs*18	0	1
P-0000075	P-0000075-T01-IM3	In-House	FFPE	Resection	250	782	NA	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Tipifarnib(HRAS p.G13R)					LEVEL_1	PIK3CA p.H1047R;SF3B1 p.K700E;HRAS p.G13R;POLE p.P286T;RB1 p.S838*;TP53 p.E204Wfs*44;B2M Deletion;CDKN1B Deletion	3	8
P-0000076	P-0000076-T01-IM3	Outside	FFPE	Resection	250	1514	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	RHOA p.R5W;TP53 p.C135G;ERBB2 Amplification	2	3
P-0000077	P-0000077-T01-IM3	In-House	FFPE	Cytology	250	1053	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MCL1 Amplification;PAK1 Amplification	2	5
P-0000079	P-0000079-T01-IM3	Outside	FFPE	Biopsy	195	84	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.E271K;RB1 Deletion	0	2
P-0000080	P-0000080-T01-IM3	In-House	FFPE	Resection	250	974	70	Matched	Primary	Uterus	Not Applicable	Tumor	UUC	Endometrial Cancer	Uterine Undifferentiated Carcinoma										TP53 p.R175H;RB1 p.Q471*;RB1 p.R787*;MEF2B Amplification;MYC Amplification	0	5
P-0000081	P-0000081-T01-IM3	Outside	FFPE	Biopsy	250	1186	20	Unmatched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;ARID2 p.K35*;MAP3K1 p.N1125Sfs*24;MAP3K1 p.R1385Kfs*35	2	4
P-0000082	P-0000082-T01-IM3	In-House	FFPE	Resection	250	905	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.H179R;NOTCH1 p.S852_F853delinsRS;NKX2-1 Amplification	2	4
P-0000083	P-0000083-T01-IM3	In-House	FFPE	Resection	250	605	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	NOTCH1 p.Q2123*;KRAS p.G12A;CTCF p.E230*;TP53 p.X307_splice;TP53 p.E180D;TP53 p.Q100*;EP300 p.X541_splice;SUFU p.A25Gfs*23	1	8
P-0000084	P-0000084-T01-IM3	In-House	FFPE	Resection	250	684	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A Deletion)				LEVEL_4	ERBB3 p.V104L;RB1 p.R556*;CDKN1A p.D62Tfs*86;CDKN1A p.G85*;TP53 p.C124Wfs*25;DNMT3B Amplification;JUN Amplification;KDM6A Deletion	1	8
P-0000085	P-0000085-T02-IM3	In-House	FFPE	Biopsy	250	757	30	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q)					LEVEL_3B	PIK3CA p.E545Q;ARID1A p.D2133Tfs*2	1	2
P-0000086	P-0000086-T01-IM3	Outside	FFPE	Biopsy	250	914	20	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	ERBB4 p.L798R;EGFR Amplification;ERBB2 Amplification	2	3
P-0000088	P-0000088-T01-IM3	In-House	FFPE	Resection	250	783	60	Matched	Metastasis	Upper Tract	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.R110Vfs*13;STAG2 p.Q1029*;ARID1A p.Q1519Pfs*13;ERBB2 Amplification	1	4
P-0000092	P-0000092-T01-IM3	Outside	FFPE	Resection	250	1065	90	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										MED12 p.G44A;TP53 Deletion	0	2
P-0000093	P-0000093-T01-IM3	In-House	FFPE	Resection	250	1051	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.N329Kfs*14);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R273H;PTEN p.N329Kfs*14;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MYC Amplification	2	7
P-0000095	P-0000095-T01-IM3	In-House	FFPE	Biopsy	250	513	50	Matched	Primary	Mediastinum	Not Applicable	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor				Olaparib(PALB2 p.X999_splice);Olaparib(RAD51B Deletion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.K117R)				LEVEL_3B	KRAS p.K117R;PALB2 p.X999_splice;TP53 p.X307_splice;RAD51B Deletion	3	4
P-0000096	P-0000096-T01-IM3	In-House	FFPE	Resection	250	1084	70	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.R424Nfs*17)	Tazemetostat(KDM6A p.N855Efs*11);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	RHOA p.E47K;FGFR3 p.S249C;TSC1 p.R424Nfs*17;KDM6A p.N855Efs*11;CDKN2A Deletion;CDKN2B Deletion;FGFR3 Amplification	5	7
P-0000098	P-0000098-T01-IM3	Outside	FFPE	Biopsy	250	684	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TNFAIP3 p.T292Ifs*6	0	1
P-0000100	P-0000100-T02-IM3	In-House	FFPE	Resection	250	638	25	Matched	Metastasis	Testis	Pelvis	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										TP53 p.I255del	0	1
P-0000102	P-0000102-T02-IM3	In-House	FFPE	Biopsy	125	755	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.Q171*)				LEVEL_3B	TP53 p.N239D;PTEN p.Q171*;FGFR1 Amplification	2	3
P-0000103	P-0000103-T01-IM3	Outside	FFPE	Biopsy	250	997	50	Matched	Metastasis	Esophagus	Lymph Node	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					GSK2636771,AZD8186(PTEN p.L146*)				LEVEL_4	PTEN p.L146*;TP53 p.W91*;BMPR1A Deletion;CCND1 Amplification;EGFR Amplification;FGF19 Amplification;FGFR2 Amplification;MYC Amplification	1	8
P-0000104	P-0000104-T01-IM3	Outside	FFPE	Biopsy	250	817	60	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.L23V);GSK2636771,AZD8186(PTEN p.C124S)				LEVEL_4	PTEN p.L23V;PTEN p.C124S;FOXA1 p.S250F;CDH1 p.E310*;KMT2A p.R736Kfs*7;IKBKE Amplification;MDM4 Amplification	2	7
P-0000105	P-0000105-T01-IM3	In-House	FFPE	Biopsy	250	750	80	Matched	Metastasis	Uterus	Kidney	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.I1058L)					LEVEL_3B	PPP2R1A p.P179R;TP53 p.I255T	1	2
P-0000106	P-0000106-T01-IM3	In-House	FFPE	Biopsy	130.9	625	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.N239Tfs*8;MYC Amplification;PAK1 Amplification	0	3
P-0000107	P-0000107-T01-IM3	In-House	FFPE	Resection	250	818	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.D1017E);Fulvestrant+Alpelisib(PIK3CA p.I1019V);Fulvestrant+Alpelisib(PIK3CA p.Y1021H)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D1017E);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.I1019V);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Y1021H)		Trametinib,Cobimetinib(NF1 p.M1162Nfs*33)				LEVEL_1	PIK3CA p.Y1021H;NF1 p.M1162Nfs*33	7	2
P-0000108	P-0000108-T01-IM3	In-House	FFPE	Resection	250	772	90	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R)				LEVEL_4	KRAS p.G12V;FGFR2 p.C382R	2	2
P-0000110	P-0000110-T01-IM3	In-House	FFPE	Resection	250	866	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.G244Afs*3;CARD11 Amplification;EGFR Amplification;ETV1 Amplification;RAC1 Amplification	0	5
P-0000112	P-0000112-T01-IM3	In-House	FFPE	Biopsy	250	743	NA	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.Q100*;EIF1AX p.R13L;SOX9 p.W335Lfs*243;SMAD4 p.A456Sfs*38;CDK6 Amplification;CDKN2A Deletion;MAP2K4 Deletion;MET Amplification	2	8
P-0000113	P-0000113-T01-IM3	In-House	FFPE	Resection	250	635	80	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R175H;RASA1 p.R709*;RB1 p.X474_splice;PTPRT p.E61*;PTPRT p.Q131Kfs*17;FOXL2 p.P116Qfs*121;EPHA3 Deletion;INPP4B Deletion;RASA1 Deletion;TGFBR2 Deletion	0	10
P-0000114	P-0000114-T01-IM3	In-House	FFPE	Biopsy	250	938	60	Matched	Metastasis	Liver	Lymph Node	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	FBXW7 p.R505C;IDH1 p.R132C;BAP1 Deletion	1	3
P-0000114	P-0000114-T02-IM3	In-House	FFPE	Biopsy	250	409	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Everolimus(TSC1 p.Q851*)					LEVEL_3A	FBXW7 p.R505C;IDH1 p.R132C;TSC1 p.Q851*;KMT2C p.N2587*;BAP1 Deletion	2	5
P-0000115	P-0000115-T01-IM3	Outside	FFPE	Biopsy	240	987	50	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.G105D;ERBB2 Amplification	2	2
P-0000116	P-0000116-T01-IM3	In-House	FFPE	Resection	250	490	90	Matched	Metastasis	Uterus	Diaphragm	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PIK3R1 Deletion;PTEN Deletion;RB1 Deletion	1	3
P-0000117	P-0000117-T01-IM3	Outside	FFPE	Biopsy	54.4	482	15	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.D1217*)				LEVEL_4	CDKN2C p.E8*;NF1 p.D1217*	1	2
P-0000118	P-0000118-T01-IM3	In-House	FFPE	Resection	250	884	90	Matched	Metastasis	Ovary	Kidney	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W;GNAS p.Q227K	0	2
P-0000119	P-0000119-T01-IM3	In-House	FFPE	Resection	250	610	70	Matched	Metastasis	Cecum	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.I112_L113del)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	APC p.E1097*;KRAS p.A146T;SMAD4 p.P91L;PIK3CA p.I112_L113del;APC p.T1438Yfs*35;MYC Amplification	2	6
P-0000120	P-0000120-T01-IM3	In-House	FFPE	Biopsy	225.4	336	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ARID1A p.S744*;ASXL2 p.X211_splice;SMAD4 p.A118V;FOXA1 Amplification	0	4
P-0000121	P-0000121-T01-IM3	Outside	FFPE	Biopsy	115.6	506	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Olaparib(CDK12 p.S283*);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S283*)				LEVEL_1	TP53 p.X125_splice;CDK12 p.S283*;ERBB2 Amplification	4	3
P-0000122	P-0000122-T01-IM3	Outside	FFPE	Resection	250	841	90	Matched	Primary	Uterus	Not Applicable	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.P301Qfs*44;MED12 p.E1556Gfs*20;BRCA2 Deletion;PTEN Deletion;RB1 Deletion	2	5
P-0000123	P-0000123-T01-IM3	In-House	FFPE	Biopsy	90	678	50	Matched	Metastasis	Testis	Chest Wall	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0000125	P-0000125-T01-IM3	In-House	FFPE	Cytology	94.8	545	90	Unmatched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0000126	P-0000126-T01-IM3	In-House	FFPE	Biopsy	65	588	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)		GSK2636771,AZD8186(PTEN p.C136R)				LEVEL_1	SF3B1 p.K700E;PIK3CA p.C420R;PTEN p.C136R;TP53 p.M246V;KMT2C p.T3607Kfs*23;AKT3 Amplification;IKBKE Amplification;MDM4 Amplification	3	8
P-0000127	P-0000127-T01-IM3	In-House	FFPE	Biopsy	174.3	623	30	Matched	Metastasis	Liver	Lymph Node	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										TP53 p.Y234C;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	0	4
P-0000127	P-0000127-T02-IM3	In-House	FFPE	Cytology	212.5	255	NA	Matched	Metastasis	Liver	Lymph Node	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										TP53 p.Y234C;CCND1 Amplification;FGF19 Amplification	0	3
P-0000129	P-0000129-T01-IM3	In-House	FFPE	Biopsy	250	940	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.R130*)				LEVEL_4	PTEN p.R130*;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	1	4
P-0000130	P-0000130-T01-IM3	Outside	FFPE	Biopsy	250	203	NA	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RB1 p.Q850*;TP53 p.R158L;AXIN2 p.G214Dfs*5;PTEN Deletion	1	4
P-0000131	P-0000131-T01-IM3	In-House	FFPE	Biopsy	250	2610	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.T319Kfs*24)				LEVEL_1	PTEN p.T319Kfs*24;TP53 p.H178Tfs*69;CD274 Amplification;ERBB2 Amplification;FGFR2 Amplification;JAK2 Amplification	3	6
P-0000132	P-0000132-T01-IM3	In-House	FFPE	Cytology	75	809	30	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.Q136P;RB1 p.L670Cfs*7;ARID5B Deletion;BCL6 Amplification;GATA3 Deletion;PIK3CA Amplification;TGFBR2 Deletion	0	7
P-0000133	P-0000133-T01-IM3	In-House	FFPE	Biopsy	90	529	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P539R)					LEVEL_3B	PIK3CA p.P539R;PMS2 p.R20Q;TP53 p.K139N	1	3
P-0000134	P-0000134-T02-IM3	Outside	FFPE	Biopsy	250	661	NA	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										TP53 p.V216M;RB1 p.C438Vfs*19	0	2
P-0000134	P-0000134-T01-IM3	Outside	FFPE	Resection	250	761	90	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.N822K)	Sorafenib(KIT p.N822K)					Imatinib,Sunitinib(KIT p.N822K)		LEVEL_1	KIT p.N822K;TP53 p.V216M;RB1 p.C438Vfs*19;FGF19 Amplification	2	4
P-0000135	P-0000135-T01-IM3	In-House	FFPE	Resection	250	610	90	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor			AZD5363(AKT1 p.E17K)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345I);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	AKT1 p.E17K;PIK3CA p.N345I;TP53 p.X332_splice;MAP3K1 p.R405Lfs*2;FGFR1 Amplification	3	5
P-0000136	P-0000136-T01-IM3	Outside	FFPE	Resection	250	558	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;SPEN p.T3461Nfs*17;GATA3 p.A394Lfs*110;CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;MCL1 Amplification	2	7
P-0000137	P-0000137-T01-IM3	In-House	FFPE	Biopsy	250	796	50	Matched	Metastasis	Cervix	Pelvis	Tumor	GCEMU	Cervical Cancer	Gastric Type Mucinous Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;EPCAM p.X186_splice	1	2
P-0000138	P-0000138-T01-IM3	In-House	FFPE	Biopsy	250	1313	60	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E453K);Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		Trametinib,Cobimetinib(NF1 p.E648*);Trametinib,Cobimetinib(NF1 p.S2670*)				LEVEL_1	PIK3CA p.E453K;PIK3CA p.E542K;GATA3 p.R364T;MSH2 p.E853*;FGFR4 p.V550M;DIS3 p.E429*;NF1 p.E648*;NF1 p.S2670*;KMT2C p.P2955Lfs*4;TBX3 p.W113*;DDR2 Amplification	6	11
P-0000138	P-0000138-T02-IM3	In-House	FFPE	Biopsy	250	1102	60	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E453K);Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E453K;PIK3CA p.E542K;TET2 p.D1412H;FGFR4 p.V550L;PTPN11 p.E69K	4	5
P-0000140	P-0000140-T01-IM3	In-House	FFPE	Biopsy	84	629	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion;RB1 Deletion;TP53 Deletion	1	3
P-0000141	P-0000141-T01-IM3	In-House	FFPE	Resection	250	740	20	Matched	Metastasis	Ovary	Abdomen	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ARID2 p.L327*;SMAD4 p.D537V;GNAS p.R201H	1	4
P-0000142	P-0000142-T01-IM3	In-House	FFPE	Resection	250	639	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TP53 p.R213*;CDK4 Amplification;MCL1 Amplification	2	4
P-0000143	P-0000143-T01-IM3	In-House	FFPE	Resection	250	797	70	Matched	Metastasis	Testis	Pelvis	Tumor	TMESO	Mesothelioma	Testicular Mesothelioma											0	0
P-0000144	P-0000144-T01-IM3	Outside	FFPE	Resection	250	711	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.G266R	2	2
P-0000145	P-0000145-T01-IM3	In-House	FFPE	Resection	250	737	90	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)					LEVEL_3B	PIK3CA p.H1047L;TP53 p.L257Rfs*6	1	2
P-0000146	P-0000146-T01-IM3	In-House	FFPE	Resection	107	557	90	Matched	Primary	Retroperitoneum	Small Bowel	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0000147	P-0000147-T01-IM3	In-House	FFPE	Resection	250	1051	80	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0000148	P-0000148-T01-IM3	In-House	FFPE	Resection	114.24	378	70	Matched	Metastasis	Ovary	Spleen	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;CCND1 p.Q261*;EIF1AX p.G9V	1	3
P-0000148	P-0000148-T02-IM3	In-House	FFPE	Resection	221.1	1291	50	Matched	Metastasis	Ovary	Liver	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;EIF1AX p.G9V	1	2
P-0000149	P-0000149-T01-IM3	In-House	FFPE	Biopsy	250	883	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)	Neratinib(ERBB2 p.G778_P780dup)	Sonidegib,Vismodegib(PTCH1 p.X249_splice)					LEVEL_2	PTCH1 p.X249_splice;ATR p.G1795Efs*29;ERBB2 p.G778_P780dup;CCNE1 Amplification;FOXA1 Amplification;NKX2-1 Amplification	3	6
P-0000149	P-0000149-T02-IM3	In-House	FFPE	Cytology	54	164	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)	Neratinib(ERBB2 p.G778_P780dup)						LEVEL_2	ATR p.G1795Efs*29;ERBB2 p.G778_P780dup;CCNE1 Amplification;KDM5A Amplification	2	4
P-0000151	P-0000151-T01-IM3	In-House	FFPE	Biopsy	250	797	80	Matched	Metastasis	Testis	Kidney	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	BRCA2 Deletion;FAT1 Deletion;LATS2 Deletion;MAPK1 Amplification;MDM2 Amplification;RB1 Deletion	2	6
P-0000152	P-0000152-T01-IM3	Outside	FFPE	Biopsy	250	889	80	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MAP2K4 p.X131_splice;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	0	4
P-0000152	P-0000152-T02-IM5	Outside	FFPE	Resection	250	732	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;MAP2K4 p.X131_splice;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	1	5
P-0000153	P-0000153-T02-IM3	In-House	FFPE	Biopsy	250	690	25	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0000153	P-0000153-T01-IM3	Outside	FFPE	Biopsy	250	803	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0000154	P-0000154-T01-IM3	In-House	FFPE	Biopsy	250	767	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132G)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;IDH1 p.R132G	2	2
P-0000155	P-0000155-T01-IM3	Outside	FFPE	Biopsy	250	301	60	Matched	Metastasis	Breast	Chest Wall	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.D350N)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D350N)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.D350N;MAP3K1 p.T304Qfs*8;CDH1 p.L466Hfs*16	4	4
P-0000156	P-0000156-T01-IM3	In-House	FFPE	Resection	250	735	60	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;KMT2D p.Q3811*;TP53 p.D281G;CREBBP Deletion;RB1 Deletion	1	5
P-0000157	P-0000157-T01-IM3	In-House	FFPE	Biopsy	250	1196	40	Matched	Metastasis	Uterus	Lymph Node	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111N);Everolimus(TSC1 p.L191I)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;EP300 p.M1470Cfs*26;FBXW7 p.R465H;RIT1 p.A77T;PIK3CA p.K111N;ARID1B p.Y1527*;TSC1 p.L191I;KMT2D p.Q3651*;ARID1A p.D1850Tfs*33;ARID1A p.P1898Hfs*25;MLH1 p.R659Dfs*2;TBX3 p.G529Afs*103;NCOR1 p.R572Efs*18	3	13
P-0000158	P-0000158-T01-IM3	In-House	FFPE	Cytology	172.5	827	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	KMT2D p.G1864Afs*12;ERBB2 Amplification	2	2
P-0000159	P-0000159-T01-IM3	Outside	FFPE	Cytology	245	224	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										BAP1 p.V162Gfs*24	0	1
P-0000160	P-0000160-T01-IM3	In-House	FFPE	Biopsy	250	715	70	Matched	Metastasis	Breast	Chest Wall	Tumor	IMMC	Breast Cancer	Breast Invasive Mixed Mucinous Carcinoma										GATA3 p.P408Afs*99;CCND1 Amplification;FGF19 Amplification	0	3
P-0000161	P-0000161-T01-IM3	In-House	FFPE	Resection	250	653	70	Matched	Metastasis	Testis	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										MAPK1 Amplification	0	1
P-0000162	P-0000162-T01-IM3	In-House	FFPE	Biopsy	250	965	40	Matched	Metastasis	Testis	Stomach	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0000163	P-0000163-T02-IM3	Outside	FFPE	Cytology	50	439	80	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	TP53 p.R248W;ERBB2 p.Y772_A775dup;FOXA1 Amplification;NKX2-1 Amplification;RB1 Deletion	2	5
P-0000165	P-0000165-T01-IM3	In-House	FFPE	Biopsy	250	795	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)								LEVEL_1	EGFR p.L861Q;TP53 p.C176F;SMAD4 p.D351Y;MYC Amplification	1	4
P-0000167	P-0000167-T02-IM3	In-House	FFPE	Biopsy	90	677	70	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Fulvestrant+Alpelisib(PIK3CA p.K111E)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111E)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.E542K;PIK3CA p.K111E;CDH1 p.V475Gfs*6;NFE2L2 p.G31E;SETD2 p.S831*;SOX9 p.E148*;SMAD4 p.R361C;SMAD4 p.W524C;SPEN p.K2911Nfs*19;MDM2 Amplification	5	10
P-0000167	P-0000167-T01-IM3	Outside	FFPE	Biopsy	250	733	80	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.K111E)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111E)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.K111E;CDH1 p.V475Gfs*6;MDM2 Amplification	3	3
P-0000168	P-0000168-T01-IM3	In-House	FFPE	Biopsy	250	904	70	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;PBRM1 p.X239_splice	1	2
P-0000170	P-0000170-T01-IM3	In-House	FFPE	Resection	250	570	80	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0000171	P-0000171-T01-IM3	In-House	FFPE	Resection	250	591	80	Matched	Metastasis	Vulva	Lymph Node	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	SMARCB1 Deletion	1	1
P-0000174	P-0000174-T01-IM3	In-House	FFPE	Resection	250	801	NA	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;NKX2-1 Amplification	2	2
P-0000175	P-0000175-T03-IM3	Outside	FFPE	Resection	250	455	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N1044K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1044K)						LEVEL_1	PIK3CA p.N1044K	2	1
P-0000178	P-0000178-T01-IM3	Outside	FFPE	Resection	250	985	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	EPHB1 p.D762N;TP53 p.G154V;PTPRT p.X162_splice;CCNE1 Amplification;ERBB2 Amplification	2	5
P-0000180	P-0000180-T01-IM3	In-House	FFPE	Biopsy	191.2	711	20	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.C141Y	0	1
P-0000180	P-0000180-T02-IM3	Outside	FFPE	Biopsy	250	621	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.C141Y;CDH1 p.D257Y	0	2
P-0000181	P-0000181-T01-IM3	In-House	FFPE	Biopsy	250	1335	20	Matched	Metastasis	Testis	Retroperitoneum	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0000182	P-0000182-T01-IM3	In-House	FFPE	Biopsy	250	1345	80	Matched	Metastasis	Liver	Peritoneum	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										WT1 p.L408*;CCND1 Amplification;FGF19 Amplification	0	3
P-0000183	P-0000183-T01-IM3	In-House	FFPE	Biopsy	250	1099	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		GSK2636771,AZD8186(PTEN p.D331Tfs*13)				LEVEL_1	PIK3CA p.H1047R;SF3B1 p.K700E;MAP3K1 p.E484Tfs*8;PTEN p.D331Tfs*13;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	3	7
P-0000184	P-0000184-T01-IM3	In-House	FFPE	Biopsy	250	1249	90	Matched	Primary	Urethra	Not Applicable	Tumor	USCC	Bladder Cancer	Urethral Squamous Cell Carcinoma										KMT2C p.X3151_splice	0	1
P-0000185	P-0000185-T01-IM3	In-House	FFPE	Resection	250	1117	90	Matched	Primary	Ovary	Not Applicable	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;TP53 p.R248Q;CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification	2	5
P-0000186	P-0000186-T01-IM3	Outside	FFPE	Biopsy	250	1207	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R248W;TP53 p.P278Lfs*67;EGFR Amplification;KRAS Amplification;MYC Amplification	0	5
P-0000187	P-0000187-T01-IM3	In-House	FFPE	Biopsy	250	1135	70	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										TP53 p.S241Pfs*6;CD274 Amplification;JAK2 Amplification;RB1 TGFB2-RB1 fusion;TGFB2 TGFB2-RB1 fusion	0	5
P-0000188	P-0000188-T01-IM3	Outside	FFPE	Resection	250	788	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_4	TP53 p.R213*;PTEN p.X70_splice;RB1 p.R320*;BAP1 p.R385Qfs*45;MRE11 p.Q482Afs*4;CCND2 Amplification	1	6
P-0000189	P-0000189-T01-IM3	In-House	FFPE	Biopsy	250	766	80	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										SF3B1 p.K700E;PIK3CB p.E1051G	0	2
P-0000190	P-0000190-T01-IM3	Outside	FFPE	Biopsy	250	1216	90	Matched	Metastasis	Lung	Brain	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										SETD2 p.X1572_splice;RB1 p.N854*;TP53 Deletion	0	3
P-0000191	P-0000191-T01-IM3	Outside	FFPE	Resection	250	1359	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	TP53 p.R249G;CCND1 Amplification;FGF19 Amplification;MDM4 Amplification;NF1 Deletion;PAK1 Amplification	1	6
P-0000192	P-0000192-T02-IM3	In-House	FFPE	Biopsy	250	744	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0000193	P-0000193-T01-IM3	In-House	FFPE	Resection	250	941	70	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;ARID1A p.P1898Hfs*25;CTNNB1 p.D32V;ARID1A p.Q588Ifs*27;CTCF p.Y386*;CDH1 p.G354Qfs*4	1	6
P-0000195	P-0000195-T01-IM3	In-House	FFPE	Resection	250	873	90	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.X187_splice;BRD4 Amplification;SDHA Deletion	0	3
P-0000196	P-0000196-T01-IM3	Outside	FFPE	Resection	250	1126	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)	Olaparib(CDK12 p.S320Rfs*31)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S320Rfs*31)				LEVEL_3A	AKT1 p.E17K;TP53 p.R175H;MAP3K1 p.W376*;CDK12 p.S320Rfs*31;RUNX1 p.P98Qfs*8	3	5
P-0000197	P-0000197-T01-IM3	In-House	FFPE	Biopsy	240	1188	30	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.I232F	0	1
P-0000199	P-0000199-T01-IM3	In-House	FFPE	Resection	250	531	80	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib(NF1 p.P890Qfs*13)				LEVEL_4	NF1 p.P890Qfs*13	1	1
P-0000201	P-0000201-T01-IM3	In-House	FFPE	Biopsy	200	985	70	Matched	Metastasis	Breast	Neck	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.I33del)				LEVEL_3B	MSH2 p.S269*;KMT2C p.S187*;CDH1 p.X278_splice;PTEN p.I33del;TBX3 p.D66Ifs*22;AKT3 Amplification;DDR2 Amplification;FGFR1 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	2	12
P-0000202	P-0000202-T01-IM3	In-House	FFPE	Resection	250	939	90	Matched	Metastasis	Major Salivary Gland	Lymph Node	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										KMT2D p.S3373*;KDM6A p.Q208Ffs*33;SUFU Deletion	0	3
P-0000203	P-0000203-T01-IM3	Outside	FFPE	Resection	250	1149	90	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	MEN1 p.X224_splice;KRAS p.Q61R	1	2
P-0000204	P-0000204-T01-IM3	In-House	FFPE	Biopsy	250	1235	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;PIK3CA Amplification	2	5
P-0000204	P-0000204-T02-IM3	In-House	FFPE	Biopsy	250	878	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Neratinib(ERBB2 p.I767M)	Ado-Trastuzumab Emtansine(ERBB2 p.I767M)					LEVEL_1	PIK3CA p.H1047R;ERBB2 p.I767M;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;PIK3CA Amplification	4	6
P-0000205	P-0000205-T01-IM3	In-House	FFPE	Resection	250	1214	90	Unmatched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	EGFR p.L858R;FH p.K477dup;CCNE1 Amplification;ERBB2 Amplification	2	4
P-0000206	P-0000206-T01-IM3	In-House	FFPE	Biopsy	160	1165	50	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R;ATP1B2 TP53-ATP1B2 fusion;TP53 TP53-ATP1B2 fusion	1	3
P-0000207	P-0000207-T01-IM3	Outside	FFPE	Resection	250	958	70	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.K111E);Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111E);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.K111E;PIK3CA p.N345K;CDH1 p.Q765*	4	3
P-0000208	P-0000208-T01-IM3	In-House	FFPE	Biopsy	250	1346	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)		Everolimus,Temsirolimus(MTOR p.S2215F)				LEVEL_1	MTOR p.S2215F;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	7	3
P-0000208	P-0000208-T02-IM5	In-House	DNA	Biopsy	250	442	40	Matched	Metastasis	Lung	Subcutaneous Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)		Everolimus,Temsirolimus(MTOR p.S2215F)				LEVEL_1	MTOR p.S2215F;EGFR Amplification;FOXA1 Amplification;NKX2-1 Amplification;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	7	6
P-0000209	P-0000209-T02-IM3	In-House	FFPE	Resection	250	798	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.R130G);Trametinib,Cobimetinib(NF1 p.Q950*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.R130G;NF1 p.Q950*;PIK3R1 p.E468_E469insGEYDRLYE;TP53 p.N345Pfs*17;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0000210	P-0000210-T01-IM3	Outside	FFPE	Biopsy	250	716	70	Matched	Primary	Cervix	Not Applicable	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ERBB2 Amplification	1	1
P-0000211	P-0000211-T01-IM3	In-House	FFPE	Biopsy	250	1251	30	Matched	Metastasis	Liver	Chest Wall	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										TP53 p.G244S	0	1
P-0000212	P-0000212-T01-IM3	In-House	FFPE	Biopsy	185	1212	50	Matched	Metastasis	Ovary	Bowel	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.Y220C;TGFBR2 p.S409Lfs*22	1	3
P-0000214	P-0000214-T01-IM3	In-House	FFPE	Biopsy	125	997	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y220C;RB1 p.R467*	0	2
P-0000215	P-0000215-T01-IM3	In-House	FFPE	Biopsy	250	1476	80	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;ERBB2 Amplification	4	2
P-0000216	P-0000216-T01-IM3	In-House	FFPE	Biopsy	250	1344	80	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)	Olaparib,Talazoparib(BRCA2 p.S1013*)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Rucaparib,Niraparib(BRCA2 p.S1013*)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.K659N);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K)				LEVEL_1	PIK3CA p.E545K;FGFR2 p.K659N;FGFR2 p.N549K;BRCA2 p.S1013*	6	4
P-0000216	P-0000216-T02-IM3	In-House	FFPE	Biopsy	250	990	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)	Olaparib,Talazoparib(BRCA2 p.S1013*)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Rucaparib,Niraparib(BRCA2 p.S1013*)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.K659N);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K)				LEVEL_1	PIK3CA p.E545K;FGFR2 p.K659N;FGFR2 p.N549K;BRCA2 p.S1013*	6	4
P-0000217	P-0000217-T01-IM3	In-House	FFPE	Biopsy	250	315	80	Matched	Metastasis	Anus	Lung	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;KMT2C p.X197_splice;KMT2C p.R56*;KDM6A p.Q301*	1	4
P-0000218	P-0000218-T01-IM3	In-House	FFPE	Biopsy	62.4	918	80	Matched	Metastasis	Liver	Liver	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0000219	P-0000219-T01-IM3	In-House	FFPE	Resection	250	1033	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	BRAF p.V459L;SMAD4 p.G352E;EGFR p.E746_A750del	1	3
P-0000220	P-0000220-T01-IM3	Outside	FFPE	Resection	250	1774	90	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;MAP3K1 p.D1164Vfs*8;CDH1 p.R492Kfs*30;AKT3 Amplification;IKBKE Amplification;MDM4 Amplification	2	6
P-0000221	P-0000221-T01-IM3	Outside	FFPE	Biopsy	250	1302	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.G245S;CCNE1 Amplification;ERBB2 Amplification	2	3
P-0000222	P-0000222-T01-IM3	In-House	FFPE	Resection	250	1101	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										KMT2C p.S2663*;RBM10 p.Q649*	0	2
P-0000223	P-0000223-T01-IM3	In-House	FFPE	Biopsy	250	1064	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132S)					LEVEL_3B	IDH1 p.R132S;TP53 p.H214R;ATRX p.T1821Qfs*7	1	3
P-0000224	P-0000224-T01-IM3	Outside	FFPE	Biopsy	250	1218	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537S)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	ESR1 p.Y537S;AR Amplification;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;GATA3 Amplification	2	6
P-0000225	P-0000225-T01-IM3	Outside	FFPE	Biopsy	250	1635	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.G35_A36del);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H123Ifs*23);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	TP53 p.E285K;CDKN2A p.G35_A36del;CDKN2A p.H123Ifs*23;CDKN2A p.R58*;KRAS Amplification;PAK1 Amplification	3	6
P-0000226	P-0000226-T01-IM3	Outside	FFPE	Biopsy	250	1298	60	Matched	Primary	Not available	Not available	Tumor	ARMS	Soft Tissue Sarcoma	Alveolar Rhabdomyosarcoma											0	0
P-0000227	P-0000227-T01-IM3	In-House	FFPE	Resection	250	1069	90	Matched	Primary	Maxilla	Not Applicable	Tumor	CCOC	Head and Neck Cancer	Clear Cell Odontogenic Carcinoma										EWSR1 ATF1-EWSR1 fusion;ATF1 ATF1-EWSR1 fusion	0	2
P-0000228	P-0000228-T03-IM5	In-House	DNA	Biopsy	250	697	20	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										ZFHX3 p.Q3333*	0	1
P-0000228	P-0000228-T01-IM3	Outside	FFPE	Biopsy	197.2	1308	90	Matched	Metastasis	Liver	Bone	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										BRD4 Amplification;MCL1 Amplification	0	2
P-0000230	P-0000230-T01-IM3	Outside	FFPE	Resection	250	1056	60	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93Q)					LEVEL_3B	TP53 p.G266E;PPP2R1A p.P179R;PIK3CA p.R93Q	1	3
P-0000231	P-0000231-T01-IM3	In-House	FFPE	Biopsy	110	1003	40	Matched	Metastasis	Lung	Mediastinum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Y163C	0	1
P-0000232	P-0000232-T01-IM3	In-House	FFPE	Resection	250	1835	NA	Matched	Primary	Chest Wall	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0000233	P-0000233-T01-IM3	Outside	FFPE	Resection	250	747	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0000234	P-0000234-T02-IM5	In-House	FFPE	Cytology	133	578	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Fulvestrant+Alpelisib(PIK3CA p.M1043I)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)						LEVEL_1	PIK3CA p.E542K;PIK3CA p.M1043I;TP53 p.N239H;TP53 p.G244Afs*3;CCND1 Amplification;FGF19 Amplification	4	6
P-0000234	P-0000234-T01-IM3	Outside	FFPE	Resection	250	696	60	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Fulvestrant+Alpelisib(PIK3CA p.M1043I)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)						LEVEL_1	PIK3CA p.E542K;PIK3CA p.M1043I;TP53 p.N239H;TP53 p.G244Afs*3;FOXA1 Amplification	4	5
P-0000235	P-0000235-T01-IM3	In-House	FFPE	Resection	250	618	70	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.L35Sfs*9;PIK3CA Amplification	1	3
P-0000236	P-0000236-T01-IM3	In-House	FFPE	Resection	250	642	60	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.H178D	0	1
P-0000237	P-0000237-T01-IM3	In-House	FFPE	Biopsy	250	613	60	Matched	Metastasis	Skin	Orbital Floor	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	TP53 p.R213*;TP53 p.R282W;DNMT3A p.Q182*;FAT1 p.Q1160*;PRKN p.Q282*;TET1 p.L52*;EPHA3 p.L616Ifs*9;SETD2 p.H1035*;ASXL1 p.W1037*;CDKN2A p.R58*	1	10
P-0000238	P-0000238-T01-IM3	In-House	FFPE	Resection	250	564	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;BAP1 p.K286Sfs*49	1	2
P-0000239	P-0000239-T01-IM3	In-House	FFPE	Biopsy	250	970	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E808*)					LEVEL_3B	BRCA2 p.E808*;RBM10 p.X387_splice	1	2
P-0000240	P-0000240-T01-IM3	Outside	FFPE	Resection	250	402	90	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0000241	P-0000241-T01-IM3	In-House	FFPE	Biopsy	250	902	60	Matched	Metastasis	Ascending Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;ERBB3 p.A232V;TP53 p.R158H;APC p.D1134Efs*3;APC p.S1465Wfs*3	2	5
P-0000242	P-0000242-T01-IM3	In-House	FFPE	Resection	250	498	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.V274G;RUNX1 p.A107P;KMT2C p.K3401*;FGFR1 Amplification	1	4
P-0000242	P-0000242-T02-IM3	Outside	FFPE	Biopsy	110	231	50	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.V274G;RUNX1 p.A107P;KMT2C p.K3401*;FGFR1 Amplification;TGFBR1 Deletion	1	5
P-0000244	P-0000244-T01-IM3	In-House	FFPE	Resection	250	678	70	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.X1237_splice)				LEVEL_1	TP53 p.E326*;NF1 p.X1237_splice;ERBB2 Amplification;MAP2K4 Deletion;PRDM1 Deletion;RICTOR Amplification;SH2D1A Deletion;STAG2 Deletion;TERT Amplification	3	9
P-0000245	P-0000245-T01-IM3	In-House	FFPE	Resection	250	735	80	Matched	Metastasis	Liver	Lymph Node	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.D1990Cfs*12)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3B	RASA1 p.R711*;ERBB3 p.D297Y;TP53 p.S106R;SMARCA4 p.M781I;BRCA2 p.D1990Cfs*12;CDKN2A p.H83Y	2	6
P-0000246	P-0000246-T01-IM3	Outside	FFPE	Cytology	250	441	NA	Matched	Metastasis	Ovary	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Ivosidenib(IDH1 p.R132C);Imatinib,Sunitinib,Regorafenib,Sorafenib,Avapritinib,Ripretinib(KIT p.D816H)	Trametinib,Cobimetinib,Binimetinib(KRAS p.L19F)				LEVEL_3B	IDH1 p.R132C;KIT p.D816H;KRAS p.L19F	3	3
P-0000247	P-0000247-T02-IM5	In-House	DNA	Biopsy	250	660	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545A)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545A)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.E545A;NOTCH4 p.E1836*;TBX3 p.Q115*;EGFR Amplification;FGFR1 Amplification;KRAS Amplification;PPM1D Amplification	3	7
P-0000247	P-0000247-T03-IM5	In-House	FFPE	Biopsy	250	1301	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	MGA p.E1064*;FGFR1 Amplification;PPM1D Amplification	1	3
P-0000247	P-0000247-T01-IM3	Outside	FFPE	Biopsy	175	967	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MSH6 p.S154*;SOX17 p.N95Ifs*67	0	2
P-0000249	P-0000249-T02-IM3	Outside	FFPE	Biopsy	225	347	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.S37Cfs*7	0	1
P-0000250	P-0000250-T01-IM3	Outside	FFPE	Resection	250	665	40	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0000252	P-0000252-T01-IM3	In-House	FFPE	Biopsy	72.2	502	20	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(CUBN RET-CUBN fusion);Selpercatinib(RET RET-CUBN fusion);Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(CUBN RET-CUBN fusion);Cabozantinib,Vandetanib(RET RET-CUBN fusion);Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(CUBN RET-CUBN fusion);BLU-667(RET RET-CUBN fusion);BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R213*;CDKN2A Deletion;CDKN2B Deletion;CUBN RET-CUBN fusion;RET RET-CUBN fusion;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	13	7
P-0000253	P-0000253-T02-IM5	In-House	FFPE	Biopsy	250	683	50	Unmatched	Metastasis	Bone	Lung	Tumor	ES	Bone Cancer	Ewing Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	CDKN2A Deletion;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	3	3
P-0000257	P-0000257-T01-IM3	In-House	FFPE	Biopsy	250	829	50	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor											0	0
P-0000258	P-0000258-T02-IM5	In-House	FFPE	Biopsy	250	745	90	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										PPP6C p.W256*;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	3
P-0000259	P-0000259-T01-IM3	Outside	FFPE	Biopsy	250	697	30	Matched	Metastasis	Breast	Chest Wall	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;RASA1 p.W568*;FOXA1 p.N397_F400del	2	3
P-0000260	P-0000260-T01-IM3	In-House	FFPE	Biopsy	250	521	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										BAP1 PHF7-BAP1 fusion;PHF7 PHF7-BAP1 fusion	0	2
P-0000261	P-0000261-T01-IM3	Outside	FFPE	Resection	250	470	20	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0000263	P-0000263-T01-IM3	In-House	FFPE	Biopsy	105	482	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R342*	0	1
P-0000266	P-0000266-T01-IM3	Outside	FFPE	Biopsy	250	714	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	CCND1 Amplification;CDK4 Amplification;MCL1 Amplification;MDM4 Amplification;MYC Amplification;PIK3CA Amplification	1	6
P-0000267	P-0000267-T01-IM3	Outside	FFPE	Resection	250	179	20	Unmatched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.S241C	0	1
P-0000268	P-0000268-T01-IM3	Outside	FFPE	Biopsy	128.52	795	20	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										KMT2A p.E1600*;TP53 p.R213G	0	2
P-0000269	P-0000269-T01-IM3	Outside	FFPE	Resection	250	186	90	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;PPP2R1A p.R183Q	1	2
P-0000270	P-0000270-T01-IM3	Outside	FFPE	Biopsy	150	404	50	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.M53I)				LEVEL_4	ARID1A p.S103*;TP53 p.G108Vfs*15;CDKN2A p.M53I;FOXA1 Amplification;MCL1 Amplification;PRKN Deletion	1	6
P-0000271	P-0000271-T01-IM3	In-House	FFPE	Resection	250	596	90	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN p.L320S)				LEVEL_4	PTEN p.L320S;EZH2 p.I626Dfs*11;ATRX p.K1646Rfs*2;RB1 Deletion;SUFU Deletion;TP53 Deletion	1	6
P-0000272	P-0000272-T01-IM3	In-House	FFPE	Biopsy	124	442	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.N78S;MLH1 p.L576*;BAP1 p.S63Yfs*5;PBRM1 p.P1584Lfs*12	0	4
P-0000273	P-0000273-T01-IM3	In-House	FFPE	Biopsy	250	1382	50	Matched	Metastasis	Cancer of Unknown Primary	Muscle	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	NF2 p.X149_splice;CDK4 Amplification;MDM2 Amplification	2	3
P-0000274	P-0000274-T01-IM3	In-House	FFPE	Resection	250	159	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.L188Pfs*19;AURKA Amplification	2	3
P-0000275	P-0000275-T01-IM3	Outside	FFPE	Resection	250	690	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.W91*;BCL6 Amplification;PIK3CA Amplification;PTEN Deletion	1	4
P-0000276	P-0000276-T01-IM3	Outside	FFPE	Resection	250	357	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;CDH1 p.W20*;FOXA1 p.K267dup;RUNX1 p.M341Hfs*232;FGFR1 Amplification;PAK1 Amplification;SDHAF2 Deletion	3	7
P-0000277	P-0000277-T01-IM3	In-House	FFPE	Biopsy	250	455	90	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0000278	P-0000278-T01-IM3	Outside	FFPE	Resection	250	940	70	Matched	Metastasis	Breast	Uterus	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.R93W)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93W)						LEVEL_1	PIK3CA p.R93W	2	1
P-0000280	P-0000280-T01-IM3	In-House	FFPE	Resection	250	397	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;NKX2-1 Amplification	1	2
P-0000281	P-0000281-T01-IM3	In-House	FFPE	Biopsy	250	453	30	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.Y772_A775dup)	Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)					LEVEL_3A	ERBB2 p.Y772_A775dup	2	1
P-0000281	P-0000281-T02-IM3	In-House	FFPE	Biopsy	211.5	581	50	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		Neratinib(ERBB2 p.Y772_A775dup)	Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 p.Y772_A775dup;ERBB2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification	4	5
P-0000282	P-0000282-T02-IM5	In-House	FFPE	Resection	250	1197	30	Matched	Metastasis	Stomach	Ovary	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R342*;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;MET Amplification;PPM1D Amplification	4	6
P-0000282	P-0000282-T01-IM3	Outside	FFPE	Biopsy	250	783	50	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R342*;ERBB2 Amplification	2	2
P-0000283	P-0000283-T01-IM3	Outside	FFPE	Resection	250	443	60	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma										TP53 p.Q317*;MYC Amplification	0	2
P-0000284	P-0000284-T01-IM3	In-House	FFPE	Resection	250	316	70	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.C176F;FAT1 p.R2726*;DICER1 p.Q1198*;FAT1 p.P941*;DICER1 p.Q1198delinsLC*;TGFBR2 Deletion	0	6
P-0000285	P-0000285-T01-IM3	Outside	FFPE	Resection	250	752	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer				Everolimus(TSC2 p.N187Qfs*2)	GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_3B	ARID1A p.D1850Tfs*33;PTEN p.X70_splice;MLH1 p.E13Rfs*4;DAXX p.L98Vfs*13;MEN1 p.P498Rfs*66;TSC2 p.N187Qfs*2;TP53 p.P152Rfs*18;FAT1 Deletion	2	8
P-0000286	P-0000286-T01-IM3	Outside	FFPE	Resection	250	172	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 p.V603Rfs*32;LATS1 p.N402Mfs*8	0	2
P-0000287	P-0000287-T01-IM3	In-House	FFPE	Biopsy	233	195	90	Matched	Metastasis	Testis	Brain	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MCL1 Amplification;PRKN Deletion	0	5
P-0000288	P-0000288-T01-IM3	In-House	FFPE	Biopsy	250	1971	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_1	PIK3CA p.E545K;ESR1 p.Y537S;ARID1A p.Q581*;GATA3 p.M293K;MAP3K1 S696fs;MAP3K1 p.I1347Yfs*2	3	6
P-0000289	P-0000289-T01-IM3	Outside	FFPE	Resection	250	393	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1006_splice)	Crizotinib(MET p.X1006_splice)	Cabozantinib(MET p.X1006_splice)	Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_1	MET p.X1006_splice;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	5	3
P-0000290	P-0000290-T01-IM3	In-House	FFPE	Biopsy	250	615	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Tazemetostat(KDM6A p.E999*)				LEVEL_3B	ARID1A p.Q944*;LATS1 p.Q435*;CREBBP p.E1243*;KDM6A p.E999*;RBM10 p.Q64*;ERBB2 Amplification	2	6
P-0000291	P-0000291-T01-IM3	In-House	FFPE	Resection	250	368	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0000292	P-0000292-T01-IM3	Outside	FFPE	Resection	250	444	70	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;MAX p.Q83*;CCND1 Amplification;MCL1 Amplification	2	4
P-0000293	P-0000293-T01-IM3	In-House	FFPE	Resection	250	469	60	Matched	Primary	Skin	Not Applicable	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.Q576*)						LEVEL_3A	MYCN p.P44L;CCND3 p.T283I;PTCH1 p.Q576*;KMT2D p.E5038*;KMT2D p.R2099Pfs*56;TP53 p.L344Rfs*8	1	6
P-0000295	P-0000295-T01-IM3	Outside	FFPE	Resection	250	435	80	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.E258K	2	2
P-0000296	P-0000296-T01-IM3	Outside	FFPE	Resection	250	407	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	TP53 p.X187_splice;AKT1 Amplification;ERBB2 Amplification;FGFR1 Amplification;TERT Amplification	3	5
P-0000298	P-0000298-T01-IM3	In-House	FFPE	Resection	250	318	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										ARID1A p.N1341Ifs*140	0	1
P-0000299	P-0000299-T01-IM3	Outside	FFPE	Biopsy	250	699	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.H174D	2	2
P-0000300	P-0000300-T01-IM3	Outside	FFPE	Resection	250	635	50	Matched	Metastasis	Stomach	Colon	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;BCOR p.G1622Rfs*7	1	2
P-0000301	P-0000301-T01-IM3	In-House	FFPE	Biopsy	250	658	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)								LEVEL_1	TP53 p.E287*;EGFR p.L747_P753delinsS	1	2
P-0000302	P-0000302-T01-IM3	Outside	FFPE	Cytology	250	739	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A	1	1
P-0000303	P-0000303-T01-IM3	Outside	FFPE	Biopsy	250	664	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0000306	P-0000306-T01-IM3	In-House	FFPE	Resection	250	212	90	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557R)								LEVEL_1	KIT p.W557R;KIT Amplification	1	2
P-0000307	P-0000307-T01-IM3	Outside	FFPE	Biopsy	250	789	40	Matched	Primary	Upper Tract	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										KMT2D p.E1680*;TP53 p.E204*;RBM10 p.Y596*;NOTCH3 p.D139Mfs*97;CCND1 Amplification	0	5
P-0000308	P-0000308-T01-IM3	Outside	FFPE	Biopsy	250	835	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D277H);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)	Tazemetostat(KDM6A p.S821*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ERCC4 p.E210*;ERBB2 p.D277H;ERBB2 p.S310F;KDM6A p.S821*;ARID1A p.G1543Lfs*19;CDKN2A Deletion;CDKN2B Deletion	4	7
P-0000309	P-0000309-T01-IM3	In-House	FFPE	Resection	250	769	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	MDM2 Amplification;NF1 Deletion;SDHA Deletion;SUZ12 Deletion	2	4
P-0000309	P-0000309-T03-IM5	In-House	DNA	Resection	250	893	80	Matched	Metastasis	Stomach	Lung	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification);Olaparib(RAD51D Deletion)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	CDK4 Amplification;MDM2 Amplification;NF1 Deletion;RAD51D Deletion;SDHA Deletion;SUZ12 Deletion	4	6
P-0000313	P-0000313-T01-IM3	In-House	FFPE	Resection	250	152	80	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	ACCC	Salivary Gland Cancer	Acinic Cell Carcinoma											0	0
P-0000314	P-0000314-T01-IM3	In-House	FFPE	Resection	250	883	90	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Olaparib(BARD1 p.R150*)					LEVEL_3B	BARD1 p.R150*;FAT1 p.Q1441*;BCOR p.E1372Sfs*8	1	3
P-0000315	P-0000315-T01-IM3	In-House	FFPE	Biopsy	250	820	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TET2 p.E524*;FAT1 p.Q16*;TP53 p.F113C;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification;PAK1 Amplification;PIK3CA Amplification	0	8
P-0000316	P-0000316-T01-IM3	In-House	FFPE	Biopsy	250	982	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.V274L;EGFR p.M277E;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;PTEN Deletion	2	7
P-0000317	P-0000317-T01-IM3	Outside	FFPE	Biopsy	250	452	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;CCND1 Amplification;FGF19 Amplification	1	3
P-0000318	P-0000318-T01-IM3	In-House	FFPE	Biopsy	250	782	60	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	BMPR1A Deletion;CCND1 Amplification;FOXA1 Amplification;LATS1 Deletion;MDM2 Amplification;MYC Amplification;PIK3CB Amplification;PTEN Deletion;RICTOR Amplification	2	9
P-0000319	P-0000319-T01-IM3	Outside	FFPE	Resection	250	205	50	Matched	Primary	Larynx	Not Applicable	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.R173P)				LEVEL_4	NFE2L2 p.R34Q;PTEN p.R173P;FAT1 p.P2506Sfs*29;FAT1 p.S76Kfs*17	1	4
P-0000320	P-0000320-T02-IM3	In-House	FFPE	Resection	250	587	NA	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.R280K;NF2 p.X122_splice	2	3
P-0000320	P-0000320-T01-IM3	Outside	FFPE	Resection	250	154	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0000321	P-0000321-T02-IM3	Outside	FFPE	Resection	250	551	70	Matched	Primary	Uterus	Not Applicable	Tumor	UUC	Endometrial Cancer	Uterine Undifferentiated Carcinoma										TP53 p.R273C;MED12 p.X68_splice;PIK3R1 p.N564D;PIK3R1 p.M563Yfs*5;RB1 Deletion	0	5
P-0000322	P-0000322-T01-IM3	In-House	FFPE	Resection	250	630	60	Matched	Metastasis	Uterus	Lung	Tumor	BCCA	Germ Cell Tumor	Choriocarcinoma										TP53 p.Q192*	0	1
P-0000323	P-0000323-T01-IM3	In-House	FFPE	Biopsy	250	997	80	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Olaparib(CDK12 p.K152Rfs*10)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K152Rfs*10)				LEVEL_3B	RB1 p.C706Y;CREBBP p.W1502L;TP53 p.E286G;ATRX p.X2109_splice;CDK12 p.K152Rfs*10;TOP1 p.L629Ffs*16;CD274 Amplification;JAK2 Amplification;MYCL Amplification;RB1 Deletion	2	10
P-0000324	P-0000324-T01-IM3	Outside	FFPE	Biopsy	70.85	383	60	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib(NF1 p.D618Efs*12)				LEVEL_4	NBN p.X615_splice;NF1 p.D618Efs*12	1	2
P-0000325	P-0000325-T01-IM3	In-House	FFPE	Cytology	118.8	371	50	Matched	Metastasis	Anus	Liver	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										KMT2D p.R2830*	0	1
P-0000326	P-0000326-T01-IM3	Outside	FFPE	Cytology	250	861	30	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.R158H;TGFBR1 p.W273*;RBM10 p.S622*	0	3
P-0000327	P-0000327-T01-IM3	In-House	FFPE	Biopsy	250	479	80	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	IDH1 p.R132C;CDKN2A Deletion	2	2
P-0000328	P-0000328-T01-IM3	Outside	FFPE	Resection	250	900	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib(NF1 p.X1477_splice)				LEVEL_4	NF1 p.X1477_splice;SMAD4 p.X483_splice	1	2
P-0000329	P-0000329-T01-IM3	Outside	FFPE	Biopsy	250	1079	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Olaparib(ATM p.R1466Q)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ATM p.R1466Q;TP53 p.D281H;ARID1A Deletion;CDKN2A Deletion;PIK3CA Amplification	2	5
P-0000332	P-0000332-T01-IM3	In-House	FFPE	Resection	250	426	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLSMESO	Mesothelioma	Pleural Mesothelioma, Sarcomatoid Type										BAP1 p.Q684*;LATS1 p.Q170*	0	2
P-0000333	P-0000333-T01-IM3	In-House	FFPE	Resection	250	594	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0000334	P-0000334-T01-IM3	In-House	FFPE	Biopsy	250	994	80	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.K132Rfs*38;MYC Amplification	0	2
P-0000335	P-0000335-T02-IM3	Outside	FFPE	Biopsy	250	806	30	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.X125_splice;GATA3 Amplification;PTEN Deletion	1	3
P-0000335	P-0000335-T01-IM3	Outside	FFPE	Resection	250	676	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.X125_splice	0	1
P-0000336	P-0000336-T01-IM3	In-House	FFPE	Biopsy	250	757	70	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	TP53 p.R158H;ERBB2 p.S310F;SPOP p.W36*;ARID1A p.P225Afs*175;RB1 p.P28Lfs*37	1	5
P-0000337	P-0000337-T01-IM3	In-House	FFPE	Biopsy	250	841	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.S401Ffs*106;MCL1 Amplification	0	2
P-0000337	P-0000337-T02-IM5	In-House	FFPE	Biopsy	250	936	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	GATA3 p.S401Ffs*106;MCL1 Amplification;MDM2 Amplification;PPM1D Amplification	1	4
P-0000339	P-0000339-T01-IM3	Outside	FFPE	Biopsy	250	906	90	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R342*;RB1 p.P732Lfs*12;CREBBP Deletion;FOXA1 Amplification;PIK3CA Amplification	0	5
P-0000340	P-0000340-T01-IM3	Outside	FFPE	Resection	250	394	70	Matched	Primary	Minor Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										NOTCH1 p.C456Y;ARID1A p.Q1327Afs*11	0	2
P-0000341	P-0000341-T01-IM3	Outside	FFPE	Biopsy	250	625	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.X187_splice;ROS1 Amplification	0	2
P-0000342	P-0000342-T01-IM3	Outside	FFPE	Biopsy	250	581	30	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction										ERBB3 p.Q809R;TP53 p.P278S;NF2 p.Q320*;SOX9 p.S405Qfs*173;CDK6 Amplification	0	5
P-0000343	P-0000343-T01-IM3	Outside	FFPE	Resection	250	445	15	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.R273H;PPP2R1A p.P179R;TP53 p.N239K	0	3
P-0000344	P-0000344-T01-IM3	In-House	FFPE	Resection	250	526	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;KEAP1 p.R601W;STK11 p.G279Afs*8	2	3
P-0000345	P-0000345-T01-IM3	Outside	FFPE	Resection	250	960	60	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										PIK3R1 p.D560Y;JAK1 p.Y422Ifs*11;TP53 p.G108_F109del;EP300 p.T1101Yfs*3;CD274 Amplification;JAK2 Amplification;MCL1 Amplification	0	7
P-0000346	P-0000346-T01-IM3	Outside	FFPE	Biopsy	250	700	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ERBB3 p.V104L;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification;SRC Amplification	1	6
P-0000347	P-0000347-T01-IM3	In-House	FFPE	Resection	250	679	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;RB1 p.X463_splice;TP53 p.E271*;TP53 p.R156G;EGFR Amplification	2	6
P-0000348	P-0000348-T01-IM3	In-House	FFPE	Resection	250	689	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Afatinib(EGFR p.L747P)				LEVEL_4	TP53 p.R213*;EGFR p.L747P;EGFR Amplification	1	3
P-0000349	P-0000349-T01-IM3	In-House	FFPE	Cytology	73.6	443	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;KDR p.P1105T	1	2
P-0000350	P-0000350-T01-IM3	In-House	FFPE	Biopsy	250	731	40	Matched	Metastasis	Kidney	Lung	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0000350	P-0000350-T02-IM3	In-House	FFPE	Resection	250	841	30	Matched	Metastasis	Kidney	Ovary	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0000351	P-0000351-T01-IM3	In-House	FFPE	Biopsy	89.32	423	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W15Lfs*29);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.Q331*;NFE2L2 p.E79K;CDKN2A p.W15Lfs*29;BCL6 Amplification;FBXW7 Deletion;PTEN Deletion;PTPRD Deletion	2	7
P-0000352	P-0000352-T01-IM3	Outside	FFPE	Biopsy	250	777	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y129*)				LEVEL_1	EGFR p.L858R;CTNNB1 p.S45P;EGFR p.L833V;CDKN2A p.Y129*;MDM2 Amplification	3	5
P-0000353	P-0000353-T01-IM3	Outside	FFPE	Biopsy	250	1061	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.V73Rfs*76;FGFR1 Amplification;MYC Amplification	1	3
P-0000354	P-0000354-T01-IM3	Outside	FFPE	Resection	250	340	20	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0000355	P-0000355-T01-IM3	In-House	FFPE	Biopsy	250	816	80	Matched	Metastasis	Uterus	Chest Wall	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib(RAD51B Deletion)					LEVEL_3B	TP53 p.G262V;ATRX p.K1001Nfs*3;EPCAM Deletion;RAD51B Deletion;RB1 Deletion	1	5
P-0000356	P-0000356-T01-IM3	Outside	FFPE	Biopsy	250	828	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.E453K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.E453K;SPOP p.R240*;MAP2K4 p.S240Kfs*5;CCND1 Amplification	4	5
P-0000357	P-0000357-T01-IM3	In-House	FFPE	Biopsy	250	955	70	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0000358	P-0000358-T01-IM3	In-House	FFPE	Resection	231.88	466	NA	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	CDH1 p.Q23*;AKT3 Amplification;ERBB2 Amplification	2	3
P-0000359	P-0000359-T01-IM3	In-House	FFPE	Biopsy	250	649	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	KRAS p.Q61R	1	1
P-0000360	P-0000360-T01-IM3	In-House	FFPE	Resection	250	785	80	Matched	Metastasis	Liver	Chest Wall	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	IDH1 p.R132C;CDKN2A Deletion;CDKN2B Deletion;EP300 Deletion;MAPK1 Amplification	2	5
P-0000361	P-0000361-T01-IM3	In-House	FFPE	Resection	250	336	90	Matched	Metastasis	Thyroid	Larynx	Tumor	OFMT	Soft Tissue Sarcoma	Ossifying Fibromyxoid Tumor											0	0
P-0000362	P-0000362-T01-IM3	In-House	FFPE	Resection	131.44	515	80	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	PBRM1 p.E1128*;ERBB2 Amplification	1	2
P-0000363	P-0000363-T01-IM3	In-House	FFPE	Biopsy	78.54	418	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R280K;TP53 p.R209K;TP53 p.N310Tfs*35;TP53 p.X307_splice;DDR2 Amplification	0	5
P-0000364	P-0000364-T01-IM3	Outside	FFPE	Resection	250	800	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.G266R;CDKN1A p.S98*;RB1 p.R661W;RB1 p.D156Efs*19	0	4
P-0000365	P-0000365-T01-IM3	In-House	FFPE	Resection	250	933	90	Matched	Metastasis	Pelvis	Liver	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma										TP53 p.Y220C	0	1
P-0000366	P-0000366-T01-IM3	In-House	FFPE	Biopsy	250	899	60	Matched	Metastasis	Ovary	Vagina	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Cabozantinib,Crizotinib(MET Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.A84Pfs*39;AKT3 Amplification;MET Amplification;PTEN Deletion	2	4
P-0000367	P-0000367-T01-IM3	In-House	FFPE	Resection	250	688	80	Matched	Metastasis	Uterus	Lung	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	TP53 p.R273H;KRAS p.G12A;SPOP p.S80R	1	3
P-0000368	P-0000368-T01-IM3	Outside	FFPE	Biopsy	250	877	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PBRM1 p.N258Kfs*6;BAP1 Deletion;CDKN2A Deletion	1	3
P-0000369	P-0000369-T01-IM3	Outside	FFPE	Biopsy	208	588	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	ARID1A p.Q806*;MET Amplification	1	2
P-0000370	P-0000370-T01-IM3	In-House	FFPE	Biopsy	250	59	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.R337L;EGFR p.MD277IY;CDK4 Amplification;FLT3 Amplification	2	5
P-0000372	P-0000372-T01-IM3	Outside	FFPE	Resection	250	732	80	Matched	Primary	Testis	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib(NF1 p.S1078*)				LEVEL_3B	PIK3CA p.E542K;PBRM1 p.X239_splice;TET2 p.T1257M;NF1 p.S1078*;EP300 p.Q190*;KDM5C p.E1505*;JUN Amplification	2	7
P-0000373	P-0000373-T02-IM5	In-House	FFPE	Biopsy	250	865	30	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	AR Amplification;PIK3R1 Deletion;PTEN Deletion;TCF3 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0000373	P-0000373-T01-IM3	In-House	FFPE	Resection	250	708	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0000374	P-0000374-T01-IM3	Outside	FFPE	Biopsy	116.6	430	60	Matched	Metastasis	Minor Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										NOTCH1 p.A1701P;NOTCH1 p.S2439Cfs*34	0	2
P-0000375	P-0000375-T02-IM5	Outside	FFPE	Resection	250	866	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	NF1 Deletion	1	1
P-0000376	P-0000376-T01-IM3	In-House	FFPE	Biopsy	250	553	60	Matched	Metastasis	Ovary	Abdomen	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor										TP53 p.L188Wfs*59	0	1
P-0000376	P-0000376-T02-IM3	In-House	FFPE	Resection	250	1063	80	Matched	Metastasis	Ovary	Abdomen	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	TP53 p.L188Wfs*59;NF1 NF1-intragenic	1	2
P-0000377	P-0000377-T01-IM3	In-House	FFPE	Biopsy	117.7	706	70	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.G105C	0	1
P-0000377	P-0000377-T03-IM3	In-House	FFPE	Biopsy	250	805	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.G105C;APC p.S1970*	0	2
P-0000377	P-0000377-T04-IM5	In-House	DNA	Biopsy	250	834	30	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.G105C;ZFHX3 p.S2515*;MIPOL1 FOXA1-MIPOL1 fusion;FOXA1 FOXA1-MIPOL1 fusion	0	4
P-0000377	P-0000377-T05-IM5	In-House	FFPE	Biopsy	250	1049	30	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.G105C	0	1
P-0000377	P-0000377-T02-IM3	Outside	FFPE	Resection	250	564	60	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.G105C	0	1
P-0000378	P-0000378-T01-IM3	In-House	FFPE	Resection	250	626	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	SETD2 p.Q198*;EGFR Amplification;PTEN Deletion	2	3
P-0000379	P-0000379-T02-IM3	In-House	FFPE	Biopsy	137.5	468	80	Matched	Metastasis	Soft Tissue	Bone	Tumor	MYCHS	Bone Cancer	Myxoid Chondrosarcoma										EWSR1 NR4A3-EWSR1 fusion;NR4A3 NR4A3-EWSR1 fusion	0	2
P-0000380	P-0000380-T01-IM3	In-House	FFPE	Biopsy	250	1188	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.C176Y	0	1
P-0000381	P-0000381-T01-IM3	Outside	FFPE	Resection	250	875	60	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.R175H;AKT2 p.I289M	2	3
P-0000382	P-0000382-T01-IM3	In-House	FFPE	Resection	250	383	90	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.V173L;MED12 p.P22H;BRCA2 Deletion;PTEN Deletion;RB1 Deletion	2	5
P-0000383	P-0000383-T01-IM3	Outside	FFPE	Biopsy	250	615	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Tazemetostat(SMARCB1 p.R377H)				LEVEL_4	TP53 p.G245D;SMARCB1 p.R377H;CCND1 Amplification;FGF19 Amplification;PAX5 Amplification	1	5
P-0000384	P-0000384-T01-IM3	In-House	FFPE	Cytology	250	883	40	Matched	Metastasis	Upper Tract	Lymph Node	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(SMARCB1 p.X121_splice)				LEVEL_3B	SMARCB1 p.X121_splice;MCL1 Amplification;MDM2 Amplification	2	3
P-0000386	P-0000386-T02-IM5	In-House	FFPE	Biopsy	182	169	70	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(MARVELD3 FGFR2-MARVELD3 fusion);Erdafitinib(FGFR2 FGFR2-MARVELD3 fusion)		Debio1347,BGJ398,AZD4547(MARVELD3 FGFR2-MARVELD3 fusion);Debio1347,BGJ398,AZD4547(FGFR2 FGFR2-MARVELD3 fusion)	Pemigatinib(MARVELD3 FGFR2-MARVELD3 fusion);Pemigatinib(FGFR2 FGFR2-MARVELD3 fusion)	Tazemetostat(KDM6A p.D125Lfs*56);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KDM6A p.D125Lfs*56;KMT2D p.S5341*;ARID1A p.L2238Afs*39;CDKN2A Deletion;CDKN2B Deletion;CREBBP Deletion;MARVELD3 FGFR2-MARVELD3 fusion;FGFR2 FGFR2-MARVELD3 fusion	8	8
P-0000386	P-0000386-T01-IM3	In-House	FFPE	Resection	250	432	70	Matched	Primary	Upper Tract	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.D125Lfs*56);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CASP8 p.E56*;CREBBP p.E1626*;KDM6A p.D125Lfs*56;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0000387	P-0000387-T01-IM3	Outside	FFPE	Biopsy	250	900	90	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.A138P;RB1 p.P250Afs*16	0	2
P-0000388	P-0000388-T01-IM3	Outside	FFPE	Cytology	133.56	468	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.G2481Vfs*8);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	ERCC4 p.E17*;TP53 p.A78Qfs*45;NF1 p.G2481Vfs*8;SMAD4 p.G231Afs*10;KRAS p.G13D	2	5
P-0000390	P-0000390-T01-IM3	In-House	FFPE	Resection	250	92	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.E298*;TP53 p.S241Y;RB1 Deletion	1	4
P-0000391	P-0000391-T01-IM3	In-House	FFPE	Resection	250	704	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000392	P-0000392-T01-IM3	Outside	FFPE	Cytology	250	817	40	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.M133R;STAG2 p.E490*;PAK1 Amplification	0	3
P-0000394	P-0000394-T01-IM3	In-House	FFPE	Biopsy	250	1025	60	Matched	Metastasis	Upper Tract	Lymph Node	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma										EP300 p.X1224_splice	0	1
P-0000395	P-0000395-T01-IM3	In-House	FFPE	Biopsy	250	1149	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.G245S;TP53 p.E271*;CDK4 Amplification;MCL1 Amplification	1	4
P-0000396	P-0000396-T01-IM3	In-House	FFPE	Biopsy	250	645	60	Matched	Metastasis	Oropharynx	Brain	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										TP53 p.H178Tfs*69;CCND1 p.P287L;CREBBP p.R1672*;AMER1 Deletion;ATRX Deletion;BCL6 Amplification;BCOR Deletion;KDM6A Deletion;MED12 Deletion;PIK3CA Amplification;STAG2 Deletion	0	11
P-0000397	P-0000397-T01-IM3	In-House	FFPE	Biopsy	250	925	20	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E453K);Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		Trametinib,Cobimetinib(NF1 p.X355_splice)				LEVEL_1	TP53 p.Q331*;PIK3CA p.E453K;PIK3CA p.E542K;RASA1 p.E155*;NF1 p.X355_splice;SMAD2 p.S464*;CDH1 p.H233Qfs*11	5	7
P-0000398	P-0000398-T01-IM3	Outside	FFPE	Biopsy	238.68	562	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G245S	0	1
P-0000399	P-0000399-T01-IM3	Outside	FFPE	Resection	250	291	NA	Matched	Primary	Skin	Not Applicable	Tumor	SKAC	Skin Cancer, Non-Melanoma	Skin Adnexal Carcinoma			Sonidegib,Vismodegib(PTCH1 p.H634Kfs*59)						LEVEL_3A	DICER1 p.R509*;PBRM1 p.P132Lfs*42;KMT2D p.Q4079*;TP53 p.W53*;TP53 p.P278F;PTCH1 p.H634Kfs*59;MYCN Amplification	1	7
P-0000400	P-0000400-T01-IM3	In-House	FFPE	Resection	250	680	60	Matched	Primary	Urethra	Not Applicable	Tumor	UAD	Bladder Cancer	Urethral Adenocarcinoma										FBXW7 p.R222*;TP53 p.R158_A159dup	0	2
P-0000401	P-0000401-T01-IM3	In-House	FFPE	Biopsy	60.5	552	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000402	P-0000402-T01-IM3	In-House	FFPE	Resection	250	606	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0000403	P-0000403-T01-IM3	In-House	FFPE	Resection	250	232	70	Matched	Metastasis	Ovary	Bowel	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.K164Sfs*6;AXIN1 Deletion;CCND3 Amplification;CDKN2A Deletion;FGFR3 Amplification;LATS2 Deletion;PAX5 Deletion;PIK3CA Amplification	1	8
P-0000404	P-0000404-T01-IM3	In-House	FFPE	Resection	250	647	80	Matched	Metastasis	Uterus	Lymph Node	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P449R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN p.S170Vfs*13)				LEVEL_3B	KRAS p.G12A;PIK3CA p.K111E;PIK3CA p.P449R;PTEN p.S170Vfs*13;ARID1A p.N106Kfs*5	4	5
P-0000405	P-0000405-T01-IM3	In-House	FFPE	Resection	250	808	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										PTPRD p.L503H;TP53 p.X261_splice;NF2 p.X80_splice;SMARCA4 p.L1161Sfs*3	0	4
P-0000406	P-0000406-T01-IM3	Outside	FFPE	Biopsy	113	203	40	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction											0	0
P-0000407	P-0000407-T01-IM3	In-House	FFPE	Cytology	121.8	671	NA	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.C141Y;SMAD3 p.R287Q;CIC p.G136*;STAG2 p.R766*;AKT2 Amplification;CCNE1 Amplification	0	6
P-0000408	P-0000408-T01-IM3	In-House	FFPE	Resection	250	688	80	Matched	Metastasis	Stomach	Brain	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.V45Yfs*9)				LEVEL_1	TP53 p.G245D;TGFBR2 p.X152_splice;PTEN p.V45Yfs*9;ERBB2 Amplification	3	4
P-0000409	P-0000409-T01-IM3	In-House	FFPE	Biopsy	250	805	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Talazoparib,Olaparib(BRCA1 Deletion)		Niraparib,Rucaparib(BRCA1 Deletion)					LEVEL_2	TP53 p.P278T;BRCA1 Deletion;FOXA1 Amplification	2	3
P-0000410	P-0000410-T01-IM3	In-House	FFPE	Biopsy	250	597	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										FBXW7 p.W425C;RB1 p.Q736*;CDKN1A p.D87Gfs*2;YAP1 Amplification	0	4
P-0000411	P-0000411-T01-IM3	In-House	FFPE	Biopsy	250	887	70	Matched	Metastasis	Breast	Soft Tissue	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3R1 p.R465dup;ERBB2 Amplification	2	2
P-0000412	P-0000412-T01-IM3	In-House	FFPE	Resection	250	640	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G302Rfs*4	0	1
P-0000413	P-0000413-T01-IM3	In-House	FFPE	Biopsy	250	724	40	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R248W;EGFR Amplification	0	2
P-0000414	P-0000414-T01-IM3	In-House	FFPE	Biopsy	136	206	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K	2	1
P-0000415	P-0000415-T01-IM3	Outside	FFPE	Resection	250	267	70	Matched	Metastasis	Thyroid	Bone	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;MEN1 p.W126Afs*23	2	2
P-0000416	P-0000416-T01-IM3	Outside	FFPE	Resection	250	454	60	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.R280G	0	1
P-0000417	P-0000417-T01-IM3	In-House	FFPE	Biopsy	250	620	50	Matched	Metastasis	Stomach	Soft Tissue	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0000418	P-0000418-T01-IM3	Outside	FFPE	Cytology	103.68	361	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R175H;KMT2D p.X4839_splice;CCND2 Amplification;CDKN2A Deletion;CDKN2B Deletion;KDM5A Amplification	1	6
P-0000419	P-0000419-T01-IM3	In-House	FFPE	Biopsy	250	573	30	Matched	Metastasis	Liver	Liver	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0000420	P-0000420-T01-IM3	In-House	FFPE	Resection	250	424	70	Matched	Metastasis	Anus	Lymph Node	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma											0	0
P-0000421	P-0000421-T01-IM3	In-House	FFPE	Cytology	87.98	452	20	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma											0	0
P-0000422	P-0000422-T02-IM3	In-House	FFPE	Biopsy	250	823	70	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		AZD9496,Fulvestrant(ESR1 p.D538G);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)		GSK2636771,AZD8186(PTEN p.A126S);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	ESR1 p.D538G;PIK3CA p.H1047L;PTEN p.A126S;CDH1 p.Y827*;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification;PTEN Deletion	5	8
P-0000422	P-0000422-T01-IM3	In-House	FFPE	Resection	250	572	80	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)		GSK2636771,AZD8186(PTEN p.A126S)				LEVEL_1	PIK3CA p.H1047L;PTEN p.A126S;CDH1 p.Y827*;CCND1 Amplification;FGF19 Amplification	3	5
P-0000423	P-0000423-T01-IM3	In-House	FFPE	Biopsy	250	679	70	Matched	Primary	Bladder	Not Applicable	Tumor	SRCBC	Bladder Cancer	Plasmacytoid/Signet Ring Cell Bladder Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453Q)	Trametinib,Cobimetinib(NF1 p.Q1086*)				LEVEL_3B	PIK3CA p.E545K;TP53 p.R280K;PIK3CA p.E453Q;TET2 p.S794*;CREBBP p.Q1073*;CDH1 p.E247*;NF1 p.Q1086*	3	7
P-0000423	P-0000423-T02-IM3	In-House	FFPE	Biopsy	158.08	430	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CARD11 Amplification;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	5
P-0000425	P-0000425-T01-IM3	In-House	FFPE	Biopsy	250	568	50	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion)			BLU-667,Cabozantinib,Vandetanib(RET CCDC6-RET fusion);BLU-667,Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion)					LEVEL_1	TP53 p.P27Lfs*17;RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	4	3
P-0000426	P-0000426-T01-IM3	Outside	FFPE	Resection	250	467	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;KEAP1 p.E496*	1	2
P-0000427	P-0000427-T01-IM3	Outside	FFPE	Resection	250	749	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										BRAF p.D594N;KEAP1 p.E542Dfs*31	0	2
P-0000428	P-0000428-T01-IM3	In-House	FFPE	Biopsy	249.6	533	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.X343_splice);GSK2636771,AZD8186(PTEN p.X25_splice)				LEVEL_4	PTEN p.X343_splice;PTEN p.X25_splice	2	2
P-0000429	P-0000429-T01-IM3	In-House	FFPE	Resection	250	208	70	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;CCND2 Amplification;MYCN Amplification	1	3
P-0000431	P-0000431-T01-IM3	In-House	FFPE	Resection	250	530	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	PTEN p.T319*	1	1
P-0000432	P-0000432-T01-IM3	In-House	FFPE	Resection	215.8	453	NA	Matched	Metastasis	Breast	Ovary	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										RUNX1 p.L134Pfs*52	0	1
P-0000433	P-0000433-T01-IM3	In-House	FFPE	Resection	143.04	509	80	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;RB1 p.S634*	1	2
P-0000434	P-0000434-T01-IM3	Outside	FFPE	Resection	250	365	70	Matched	Primary	Minor Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										SETD2 p.Q2127*;MAX p.X99_splice;RUNX1 p.E61Gfs*50	0	3
P-0000435	P-0000435-T01-IM3	In-House	FFPE	Resection	250	535	NA	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;GATA3 p.P408Afs*99;EGFR p.L833M;CDK8 Amplification;DNMT3A Deletion	1	5
P-0000436	P-0000436-T01-IM3	In-House	FFPE	Biopsy	250	706	40	Matched	Metastasis	Esophagus	Lymph Node	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R282W;SMAD4 p.Q245*;ERBB2 Amplification	2	3
P-0000438	P-0000438-T01-IM3	Outside	FFPE	Resection	250	934	30	Unmatched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma		Olaparib,Talazoparib(BRCA2 p.S1630*)		Rucaparib,Niraparib(BRCA2 p.S1630*)					LEVEL_2	BRCA2 p.S1630*	2	1
P-0000439	P-0000439-T01-IM3	In-House	FFPE	Resection	250	421	90	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0000440	P-0000440-T01-IM3	In-House	FFPE	Biopsy	250	926	50	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.R175H;MAP3K1 p.Y773Lfs*8;ERBB2 Amplification	4	4
P-0000441	P-0000441-T01-IM3	In-House	FFPE	Biopsy	250	734	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.L2362Cfs*5)			Talazoparib,Niraparib(BRCA2 p.L2362Cfs*5)					LEVEL_1	AR p.L702H;SPEN p.D1322Efs*3;BRCA2 p.L2362Cfs*5;AXIN1 p.R266Dfs*10	2	4
P-0000441	P-0000441-T02-IM5	In-House	FFPE	Biopsy	118	356	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.L2362Cfs*5)			Talazoparib,Niraparib(BRCA2 p.L2362Cfs*5)					LEVEL_1	AR p.L702H;SPEN p.D1322Efs*3;BRCA2 p.L2362Cfs*5;FOXL2 FOXL2-intragenic	2	4
P-0000442	P-0000442-T01-IM3	In-House	FFPE	Biopsy	250	922	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.N63Kfs*11)				LEVEL_4	PTEN p.N63Kfs*11	1	1
P-0000443	P-0000443-T01-IM3	In-House	FFPE	Biopsy	250	742	40	Matched	Metastasis	Testis	Brain	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										RUNX1 p.Y380*	0	1
P-0000444	P-0000444-T01-IM3	In-House	FFPE	Biopsy	250	929	30	Matched	Metastasis	Esophagus	Liver	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.V157_R158del;ERBB2 Amplification	2	2
P-0000444	P-0000444-T02-IM5	In-House	DNA	Biopsy	250	889	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.V157_R158del;JAK1 p.R174*;KMT2D p.X3411_splice	1	4
P-0000445	P-0000445-T01-IM3	In-House	FFPE	Biopsy	250	850	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K	2	1
P-0000446	P-0000446-T01-IM3	In-House	FFPE	Biopsy	250	955	80	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R342*;ARID1A p.X1708_splice;PAX5 p.V26G;EGFR Amplification	0	4
P-0000447	P-0000447-T01-IM3	Outside	FFPE	Resection	250	815	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN PTEN-intragenic)				LEVEL_4	TP53 p.N288Kfs*18;PTEN PTEN-intragenic	1	2
P-0000448	P-0000448-T01-IM3	In-House	FFPE	Biopsy	250	587	70	Matched	Metastasis	Uterus	Rectum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L755S);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344M);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.T1025A);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q);Olaparib(BRIP1 p.N1147Mfs*3)					LEVEL_3B	FBXW7 p.R465H;ERBB2 p.L755S;TP53 p.R273C;SPEN p.Q3294*;ARID1A p.R693*;ARID1A p.W1498*;JAK1 p.R724H;SHQ1 p.R254*;PIK3CA p.V344M;PIK3CA p.T1025A;FAT1 p.E2602*;KMT2C p.R2066*;FLT3 p.R849H;DICER1 p.X1031_splice;CTCF p.Q484*;ERBB2 p.R678Q;RPTOR p.R139H;NOTCH3 p.X651_splice;CASP8 p.L474Tfs*6;PTPRD p.S596Ffs*8;BRIP1 p.N1147Mfs*3	5	21
P-0000449	P-0000449-T01-IM3	In-House	FFPE	Biopsy	250	919	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.D268Gfs*30)				LEVEL_4	SMAD2 p.W132*;JAK1 p.L431Vfs*22;APC p.T1556Nfs*3;TET1 p.T62Nfs*4;PTEN p.D268Gfs*30;AR Amplification;CDK6 Amplification	1	7
P-0000449	P-0000449-T02-IM5	In-House	FFPE	Biopsy	250	873	80	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Tazemetostat(SMARCB1 Deletion)	GSK2636771,AZD8186(PTEN p.D268Gfs*30);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	SMAD2 p.W132*;JAK1 p.L431Vfs*22;APC p.T1556Nfs*3;TET1 p.T62Nfs*4;PTEN p.D268Gfs*30;NCOR1 p.E529Rfs*7;AR Amplification;BMPR1A Deletion;CDK6 Amplification;DIS3 Deletion;PTEN Deletion;SMARCB1 Deletion	3	12
P-0000450	P-0000450-T01-IM3	In-House	FFPE	Resection	212	583	20	Matched	Metastasis	Testis	Liver	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	AXIN1 p.W564*;MDM2 Amplification	1	2
P-0000451	P-0000451-T01-IM3	Outside	FFPE	Resection	250	475	90	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										RB1 p.X654_splice	0	1
P-0000452	P-0000452-T01-IM3	Outside	FFPE	Biopsy	250	867	80	Matched	Primary	Cervix	Not Applicable	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;CASP8 p.L474Tfs*6;BAP1 p.E201*;FBXW7 p.R479P	1	4
P-0000453	P-0000453-T01-IM3	In-House	FFPE	Resection	250	653	50	Matched	Metastasis	Cervix	Lymph Node	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310Y);Olaparib(BRIP1 p.Y1131Lfs*18)					LEVEL_3B	ERBB2 p.S310Y;SMAD4 p.S178*;BRIP1 p.Y1131Lfs*18;FOXA1 Amplification	2	4
P-0000454	P-0000454-T01-IM3	In-House	FFPE	Biopsy	250	1066	30	Matched	Metastasis	Oropharynx	Abdomen	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										SPEN p.R229*;TP63 p.Q523*	0	2
P-0000455	P-0000455-T01-IM3	In-House	FFPE	Biopsy	63.6	364	70	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.Y234C;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification	1	4
P-0000456	P-0000456-T01-IM3	In-House	FFPE	Resection	250	795	20	Matched	Metastasis	Testis	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										FLT3 p.G679R	0	1
P-0000457	P-0000457-T01-IM3	In-House	FFPE	Biopsy	250	828	30	Matched	Metastasis	Upper Tract	Adrenal Gland	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ARID1A p.Q1363*;BCOR Deletion;CDKN2A Deletion;CDKN2B Deletion;KMT2A Deletion	1	5
P-0000458	P-0000458-T01-IM3	In-House	FFPE	Biopsy	104.4	1201	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										KDM5C p.L394Afs*11	0	1
P-0000459	P-0000459-T01-IM3	In-House	FFPE	Resection	250	172	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X574_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E120*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	VHL p.M1?;FANCA p.R880*;KEAP1 p.E535*;STK11 p.P281Rfs*6;NF1 p.X574_splice;CDKN2A p.E120*;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	3	9
P-0000460	P-0000460-T01-IM3	In-House	FFPE	Cytology	247	602	80	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										PIK3R1 p.W583del	0	1
P-0000461	P-0000461-T01-IM3	In-House	FFPE	Resection	155	500	40	Matched	Primary	Mediastinum	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557G)					LEVEL_3B	TP53 p.R248W;KIT p.W557G;AKT1 Amplification	1	3
P-0000462	P-0000462-T01-IM3	Outside	FFPE	Resection	250	538	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.Q219*);GSK2636771,AZD8186(PTEN p.P103Tfs*4)				LEVEL_4	PTEN p.Q219*;PTEN p.P103Tfs*4;MEN1 p.S606Vfs*78	2	3
P-0000463	P-0000463-T01-IM3	In-House	FFPE	Resection	250	826	70	Matched	Metastasis	Lung	Brain	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R282W;NFE2L2 p.Q26K;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;INPP4B Deletion	2	6
P-0000464	P-0000464-T01-IM3	In-House	FFPE	Biopsy	250	899	20	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.P151H	0	1
P-0000465	P-0000465-T01-IM3	In-House	FFPE	Resection	250	582	70	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;SPOP p.M117V	2	2
P-0000466	P-0000466-T01-IM3	In-House	FFPE	Resection	250	699	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CDH1 p.Q23*;RUNX1 p.S362Rfs*203	0	2
P-0000467	P-0000467-T01-IM3	In-House	FFPE	Resection	250	524	80	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.R273H;ARID2 Deletion;CCND1 Amplification;EGFR Amplification;FGF19 Amplification;PMAIP1 Deletion	0	6
P-0000468	P-0000468-T01-IM3	In-House	FFPE	Biopsy	250	397	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;DNMT3B p.Y474Ifs*116	1	2
P-0000469	P-0000469-T01-IM3	In-House	FFPE	Biopsy	250	618	70	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Olaparib(PALB2 p.I1035Mfs*6)					LEVEL_1	PIK3CA p.E545K;TP53 p.S183*;PALB2 p.I1035Mfs*6	3	3
P-0000470	P-0000470-T02-IM5	In-House	FFPE	Resection	250	569	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.R175H;ERBB2 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	4	6
P-0000471	P-0000471-T01-IM3	Outside	FFPE	Resection	250	956	90	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;CCND1 Amplification;FGF19 Amplification	1	3
P-0000472	P-0000472-T01-IM3	Outside	FFPE	Resection	250	1079	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	SOX17 p.R273*;TP53 p.V157G;PTEN Deletion	1	3
P-0000473	P-0000473-T01-IM3	In-House	FFPE	Biopsy	185.6	778	60	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.W274*)				LEVEL_3B	PTEN p.W274*;TP53 p.V216E;FGFR1 Amplification;GATA3 Amplification	2	4
P-0000474	P-0000474-T01-IM3	Outside	FFPE	Biopsy	250	704	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0000475	P-0000475-T01-IM3	In-House	FFPE	Resection	250	505	90	Matched	Metastasis	Testis	Lung	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	LATS2 p.E780*;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MDM2 Amplification	1	5
P-0000476	P-0000476-T01-IM3	In-House	FFPE	Resection	250	610	70	Matched	Primary	Brain	Not Applicable	Tumor	APE	CNS Cancer	Anaplastic Ependymoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_4	CDKN2A p.Y44*	1	1
P-0000477	P-0000477-T01-IM3	Outside	FFPE	Biopsy	250	753	60	Matched	Metastasis	Lung	Liver	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										EGFR Amplification;FANCA Deletion	0	2
P-0000478	P-0000478-T01-IM3	In-House	FFPE	Biopsy	63.8	481	20	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.F134C;CCND1 Amplification;ERBB2 Amplification	2	3
P-0000479	P-0000479-T01-IM3	In-House	FFPE	Resection	250	537	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										MCL1 Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0000480	P-0000480-T01-IM3	Outside	FFPE	Resection	250	1665	60	Matched	Metastasis	Skin	Lymph Node	Tumor	AECA	Skin Cancer, Non-Melanoma	Sweat Gland Carcinoma/Apocrine Eccrine Carcinoma										ARID1A p.Q840*;ARID1A p.Y1052Lfs*53;KDM6A p.R1054Kfs*5	0	3
P-0000481	P-0000481-T01-IM3	In-House	FFPE	Biopsy	250	768	60	Matched	Metastasis	Stomach	Bowel	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0000482	P-0000482-T01-IM3	In-House	FFPE	Biopsy	250	802	80	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.C275R;ATRX p.K562*	0	2
P-0000483	P-0000483-T01-IM3	In-House	FFPE	Biopsy	250	574	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CDKN1B p.T170Mfs*52;SMAD2 Deletion	0	2
P-0000484	P-0000484-T01-IM3	In-House	FFPE	Resection	250	571	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000485	P-0000485-T01-IM3	In-House	FFPE	Biopsy	250	575	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.C242Y	0	1
P-0000486	P-0000486-T01-IM3	In-House	FFPE	Biopsy	250	651	80	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ARID1B p.P916Qfs*10	1	2
P-0000488	P-0000488-T01-IM3	Outside	FFPE	Biopsy	250	705	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R175H	0	1
P-0000489	P-0000489-T01-IM3	In-House	FFPE	Resection	250	138	90	Matched	Metastasis	Minor Salivary Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;ERBB3 p.A232V	1	2
P-0000490	P-0000490-T01-IM3	Outside	FFPE	Resection	250	519	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MAP3K1 p.A594Gfs*52;GATA3 p.M356Nfs*15	0	2
P-0000491	P-0000491-T01-IM3	In-House	FFPE	Biopsy	72	491	40	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X244_splice)				LEVEL_4	PBRM1 p.X434_splice;TET2 p.G1235A;TP53 p.R282G;NF1 p.X244_splice;SMARCA4 p.X873_splice;CREBBP p.S1066Vfs*34;AXIN2 p.E415Gfs*43;MAPK1 Amplification	1	8
P-0000493	P-0000493-T01-IM3	In-House	FFPE	Biopsy	174.24	678	30	Unmatched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C901F);Sonidegib,Vismodegib(PTCH1 p.E992*)					LEVEL_3B	TP53 p.R248W;PIK3CA p.C901F;APC p.K1165*;PTCH1 p.E992*	2	4
P-0000494	P-0000494-T01-IM3	In-House	FFPE	Biopsy	250	919	10	Matched	Metastasis	Cancer of Unknown Primary	Neck	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.Y220*;ERBB2 Amplification	1	2
P-0000495	P-0000495-T01-IM3	In-House	FFPE	Cytology	161.2	637	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.Q317Sfs*28;AURKA Amplification;FOXA1 Amplification	2	4
P-0000497	P-0000497-T01-IM3	In-House	FFPE	Resection	250	775	90	Matched	Primary	Not available	Not available	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	CBFB Deletion;NF1 Deletion	1	2
P-0000499	P-0000499-T01-IM3	In-House	FFPE	Resection	250	713	90	Matched	Metastasis	Uterus	Abdomen	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)					LEVEL_3B	PIK3CA p.H1047L;TP53 p.M243*;DAXX Deletion;RB1 Deletion;SDHA Deletion	1	5
P-0000500	P-0000500-T01-IM3	In-House	FFPE	Resection	250	824	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib(RAD51B p.X1_splice);Everolimus(TSC2 p.V705M);Olaparib(BRIP1 p.E636K)	GSK2636771,AZD8186(PTEN p.M35V)				LEVEL_3B	PIK3CA p.E545K;PIK3CA p.E542K;TP53 p.G266R;FH p.X246_splice;MSH6 p.Q1048*;PMS1 p.X195_splice;TGFBR2 p.X88_splice;BAP1 p.W52*;FOXP1 p.X140_splice;EPHA3 p.Q386*;RAD50 p.X1068_splice;PTEN p.M35V;EED p.Q292*;RB1 p.R251*;RAD51B p.X1_splice;TSC2 p.V705M;BRIP1 p.E636K;RB1 p.R698Afs*22	6	18
P-0000501	P-0000501-T01-IM3	In-House	FFPE	Biopsy	250	972	40	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Everolimus,Temsirolimus(MTOR p.A1459D)				LEVEL_4	MTOR p.A1459D;SDHB p.R46*	1	2
P-0000501	P-0000501-T02-IM3	Outside	FFPE	Resection	250	811	60	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Everolimus,Temsirolimus(MTOR p.A1459D)				LEVEL_4	MTOR p.A1459D;SDHB p.R46*	1	2
P-0000502	P-0000502-T01-IM3	In-House	FFPE	Resection	250	684	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Tazemetostat(KDM6A p.Y362*)				LEVEL_1	TP53 p.R273H;PIK3CA p.E545K;FGFR3 p.S249C;RBM10 p.Q349*;STK11 p.N181Tfs*106;KDM6A p.Y362*	4	6
P-0000503	P-0000503-T01-IM3	In-House	FFPE	Resection	250	720	80	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0000504	P-0000504-T01-IM3	In-House	FFPE	Resection	250	655	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000505	P-0000505-T01-IM3	In-House	FFPE	Resection	250	698	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.K418Sfs*17)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K418Sfs*17)				LEVEL_1	SPOP p.F125C;CDK12 p.K418Sfs*17	2	2
P-0000506	P-0000506-T01-IM3	In-House	FFPE	Resection	250	489	90	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										KMT2A p.T548Kfs*17;AKT2 Amplification;NKX2-1 Amplification;TP53 Deletion	0	4
P-0000507	P-0000507-T01-IM3	In-House	FFPE	Biopsy	250	945	60	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										FOXP1 p.E644*;PIK3R1 p.H385Ifs*11;KDM6A p.F289Sfs*36	0	3
P-0000508	P-0000508-T01-IM3	Outside	FFPE	Resection	250	463	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MAP2K4 Deletion	0	1
P-0000509	P-0000509-T02-IM5	In-House	FFPE	Biopsy	250	1022	70	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPEN p.L3646Qfs*20	0	1
P-0000509	P-0000509-T01-IM3	In-House	FFPE	Resection	250	651	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000510	P-0000510-T01-IM3	In-House	FFPE	Resection	250	1062	90	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										BCL2L1 Amplification;PIK3R2 Amplification	0	2
P-0000511	P-0000511-T01-IM3	In-House	FFPE	Biopsy	242	963	20	Matched	Metastasis	Sigmoid Colon	Chest Wall	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	TP53 p.R248Q;APC p.T1556Nfs*3;BRAF p.K601E	2	3
P-0000512	P-0000512-T01-IM3	In-House	FFPE	Resection	250	588	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.M918T)		BLU-667(RET p.M918T)						LEVEL_1	RET p.M918T	2	1
P-0000513	P-0000513-T01-IM3	In-House	FFPE	Resection	250	507	40	Matched	Primary	Urethra	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R282W;DIS3 p.X586_splice;NOTCH3 p.X536_splice	0	3
P-0000514	P-0000514-T02-IM5	In-House	DNA	Biopsy	137.8	102	10	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;SF3B1 p.K700E;CDH1 p.M1?	2	3
P-0000514	P-0000514-T01-IM3	In-House	FFPE	Resection	80	460	60	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;SF3B1 p.K700E;CDH1 p.M1?	2	3
P-0000515	P-0000515-T01-IM3	Outside	FFPE	Resection	250	254	70	Matched	Metastasis	Cancer of Unknown Primary	Uterus	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K)	GSK2636771,AZD8186(PTEN p.A126S);GSK2636771,AZD8186(PTEN p.K183Rfs*16)				LEVEL_3B	BCOR p.N1459S;PIK3CA p.E453K;PTEN p.A126S;CTNNB1 p.S33C;ARID1A p.R110Efs*3;ARID1A p.W1073Mfs*32;PTEN p.K183Rfs*16	3	7
P-0000516	P-0000516-T01-IM3	Outside	FFPE	Biopsy	77	375	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Y)				LEVEL_4	TP53 p.R273L;NFE2L2 p.E79Q;EPHA3 p.X897_splice;TET2 p.E1477*;CDKN2A p.D108Y	1	5
P-0000517	P-0000517-T01-IM3	In-House	FFPE	Biopsy	250	605	80	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	ARID1A p.E1764*;MSH6 p.L655*;CDH1 p.D291Y;TP53 p.R306*;PTEN Deletion;TNFAIP3 Deletion	1	6
P-0000519	P-0000519-T01-IM3	In-House	FFPE	Biopsy	250	952	70	Matched	Metastasis	Breast	Retroperitoneum	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification;PAK1 Amplification	1	2
P-0000520	P-0000520-T01-IM3	In-House	FFPE	Resection	250	618	60	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;APC p.Y935*;SOX9 p.Q412*;APC p.V1320Efs*11	1	4
P-0000521	P-0000521-T01-IM3	In-House	FFPE	Biopsy	250	919	80	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification;KMT2C PAXIP1-MLL3 fusion;PAXIP1 PAXIP1-MLL3 fusion	0	3
P-0000522	P-0000522-T01-IM3	Outside	FFPE	Biopsy	250	940	60	Matched	Metastasis	Breast	Scalp	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM p.V2119*)					LEVEL_3B	GATA3 p.S436Pfs*39;ATM p.V2119*	1	2
P-0000523	P-0000523-T01-IM3	In-House	FFPE	Biopsy	250	711	70	Matched	Metastasis	Stomach	Adrenal Gland	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.M237I;GNAS p.R201C;ARID2 p.V960Sfs*8	0	3
P-0000524	P-0000524-T01-IM3	Outside	FFPE	Cytology	250	292	70	Matched	Metastasis	Minor Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										NOTCH1 p.S2439Rfs*37	0	1
P-0000525	P-0000525-T03-IM5	In-House	DNA	Biopsy	250	1008	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.R280K;RUNX1 p.N69Tfs*26;POLE p.E18K;RB1 p.S463*;MYC Amplification	1	6
P-0000525	P-0000525-T01-IM3	Outside	FFPE	Biopsy	114	364	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.R248Q;TP53 p.R175H;RUNX1 p.N69Tfs*26	1	4
P-0000525	P-0000525-T02-IM3	Outside	FFPE	Biopsy	250	771	20	Matched	Metastasis	Breast	Cervix	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.R280K;RUNX1 p.N69Tfs*26;POLE p.E18K;EP300 p.Q813*	1	5
P-0000526	P-0000526-T01-IM3	Outside	FFPE	Resection	250	688	60	Matched	Metastasis	Sigmoid Colon	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R1875*);Cabozantinib,Crizotinib(MET Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;APC p.K534*;ATM p.R1875*;MET Amplification	3	4
P-0000527	P-0000527-T01-IM3	Outside	FFPE	Biopsy	250	659	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										NFE2L2 p.R34L;CREBBP p.Q517*;RB1 p.R418Sfs*9;TP53 p.K120Sfs*3	0	4
P-0000530	P-0000530-T01-IM3	Outside	FFPE	Resection	243.8	176	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.M1043V)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.M1043V;CDK4 Amplification;MDM2 Amplification	4	3
P-0000531	P-0000531-T01-IM3	Outside	FFPE	Biopsy	250	596	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0000532	P-0000532-T02-IM5	In-House	DNA	Biopsy	250	688	50	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										TP53 p.P278T;DNMT3B p.W834*;PDE1C FH-PDE1C fusion;FH FH-PDE1C fusion	0	4
P-0000532	P-0000532-T01-IM3	In-House	FFPE	Resection	250	332	35	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										TP53 p.P278T	0	1
P-0000533	P-0000533-T01-IM3	Outside	FFPE	Resection	250	541	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.N323Kfs*2)				LEVEL_3B	BRAF p.V600E;PTEN p.N323Kfs*2;NKX2-1 Amplification	2	3
P-0000535	P-0000535-T01-IM3	Outside	FFPE	Resection	250	769	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252L);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_3B	BRAF p.D594N;KMT2C p.K411*;FGFR2 p.S252L;ARID2 p.Q1031*;KMT2D p.R1615*;NCOR1 p.E1436*;KMT2C p.P4041Lfs*42;CDKN2A p.Y44*;MDM2 Amplification	3	9
P-0000536	P-0000536-T01-IM3	Outside	FFPE	Resection	250	716	70	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Olaparib(ATM p.Y2019C)					LEVEL_3B	ATM p.Y2019C;CCND2 Amplification;KDM5A Amplification	1	3
P-0000538	P-0000538-T01-IM3	Outside	FFPE	Biopsy	245.3	245	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	APC p.R1450*;TP53 p.R174W;ERBB2 Amplification	2	3
P-0000539	P-0000539-T02-IM3	In-House	FFPE	Biopsy	244.2	618	65	Matched	Metastasis	Thyroid	Liver	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer										IKBKE Amplification;MDM4 Amplification	0	2
P-0000541	P-0000541-T02-IM5	In-House	FFPE	Biopsy	112.9	717	10	Matched	Metastasis	Prostate	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.F266Lfs*7;MEN1 MEN1-intragenic	0	2
P-0000541	P-0000541-T01-IM3	In-House	FFPE	Resection	250	515	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ETV1 Amplification	0	1
P-0000542	P-0000542-T01-IM3	In-House	FFPE	Resection	250	481	60	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(BARD1 p.C108Vfs*16)	GSK2636771,AZD8186(PTEN p.K344*)				LEVEL_3B	TP53 p.C242Y;PTEN p.K344*;BARD1 p.C108Vfs*16	2	3
P-0000543	P-0000543-T01-IM3	In-House	FFPE	Resection	250	739	35	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										TP53 p.G266R;DNMT3A p.R882H	0	2
P-0000544	P-0000544-T01-IM3	In-House	FFPE	Resection	250	601	20	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma											0	0
P-0000546	P-0000546-T01-IM3	In-House	FFPE	Resection	250	477	65	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										CREBBP p.R1446H	0	1
P-0000547	P-0000547-T01-IM3	In-House	FFPE	Biopsy	250	711	85	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_1	PIK3CA p.E542K;ERBB2 p.L755S;FOXA1 p.M253K;CDH1 p.X722_splice;CCND1 Amplification;FGF19 Amplification;MYC Amplification;PAK1 Amplification	4	8
P-0000550	P-0000550-T05-IM3	Outside	FFPE	Biopsy	250	679	30	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.E285K;ERBB2 Amplification	2	2
P-0000552	P-0000552-T01-IM3	In-House	FFPE	Biopsy	250	756	70	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)		Cetuximab,Panitumumab(NRAS p.Q61L)			LEVEL_3B	APC p.Q1338*;NRAS p.Q61L;TP53 p.S127F;SMAD4 p.W99C;FLT3 Amplification	1	5
P-0000553	P-0000553-T02-IM5	In-House	DNA	Biopsy	250	813	20	Unmatched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R273H;EGFR Amplification;MYC Amplification	0	3
P-0000553	P-0000553-T01-IM3	In-House	FFPE	Cytology	250	585	90	Matched	Metastasis	Stomach	Lymph Node	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R273H;GNAS p.R201H;GNAS p.R201C;FGFR2 Amplification	0	4
P-0000554	P-0000554-T01-IM3	In-House	FFPE	Biopsy	250	962	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Sorafenib(ARAF p.S214Y)						LEVEL_3A	TP53 p.P278T;CARD11 p.T112I;ARAF p.S214Y	1	3
P-0000555	P-0000555-T01-IM3	In-House	FFPE	Biopsy	250	637	95	Matched	Metastasis	Thyroid	Trachea	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										RB1 p.L769Cfs*41;BCOR Deletion;TP53 Deletion	0	3
P-0000557	P-0000557-T01-IM3	In-House	FFPE	Biopsy	96.2	391	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	TP53 p.C242G;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	3
P-0000558	P-0000558-T01-IM3	Outside	FFPE	Resection	250	594	35	Matched	Metastasis	Uterus	Lymph Node	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Everolimus(TSC2 p.G654Lfs*2)	GSK2636771,AZD8186(PTEN p.T319*);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252W)				LEVEL_3B	FBXW7 p.S668Vfs*39;PTEN p.T319*;PIK3R1 p.Y580N;FGFR2 p.S252W;SMAD3 p.R373H;CDH1 p.X129_splice;ARID1A p.G889Afs*2;JAK1 p.P430Rfs*2;JAK1 p.K142Rfs*26;ARID1B p.R372Pfs*163;SOX17 p.Y296Lfs*68;TSC2 p.G654Lfs*2	3	12
P-0000560	P-0000560-T01-IM3	In-House	FFPE	Biopsy	112.36	560	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000561	P-0000561-T01-IM3	In-House	FFPE	Resection	250	384	60	Matched	Primary	Transverse Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(CDK12 p.Q937Kfs*9)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q937Kfs*9);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PTCH1 p.S1203Afs*52;PIK3CA p.H1047R;APC p.E761*;APC p.S1465Rfs*9;CDK12 p.Q937Kfs*9;KRAS p.G13D	5	6
P-0000562	P-0000562-T01-IM3	In-House	FFPE	Resection	250	435	30	Matched	Metastasis	Ascending Colon	Abdomen	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	TP53 p.R248Q;KRAS p.G12A;GNAS p.R201H;AKT1 p.E40K;SMAD4 p.D537G;FAT1 p.G3953Wfs*19	1	6
P-0000563	P-0000563-T01-IM3	In-House	FFPE	Resection	250	369	45	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.A159V	0	1
P-0000564	P-0000564-T01-IM3	In-House	FFPE	Resection	250	541	90	Matched	Metastasis	Soft Tissue	Retroperitoneum	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0000566	P-0000566-T01-IM3	Outside	FFPE	Biopsy	250	617	15	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma										FBXW7 p.R479Q	0	1
P-0000569	P-0000569-T01-IM3	In-House	FFPE	Cytology	250	482	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	2
P-0000570	P-0000570-T01-IM3	In-House	FFPE	Biopsy	250	580	30	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.E339*;SOX9 p.S405Afs*67;ERBB2 Amplification	2	3
P-0000571	P-0000571-T01-IM3	In-House	FFPE	Cytology	95.76	406	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.N771_H773dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.N771_H773dup)			LEVEL_3A	TP53 p.R337G;EGFR p.N771_H773dup;EGFR Amplification;RB1 Deletion	1	4
P-0000572	P-0000572-T01-IM3	In-House	FFPE	Biopsy	250	907	80	Unmatched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R282W;ARID1A p.M1154Wfs*7;ARID1A p.S1985Qfs*13;STAG2 p.X399_splice;CDKN2B Deletion;EGFR Amplification;PTEN Deletion	2	7
P-0000573	P-0000573-T01-IM3	In-House	FFPE	Biopsy	234	917	60	Matched	Metastasis	Oral Cavity	Tongue	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_4	TP53 p.Y220C;TP53 p.P278S;BMPR1A p.X112_splice;FAT1 p.T2054Rfs*4;NSD1 p.A1837Lfs*12;KMT2C p.S2816Ifs*6;CREBBP p.T1574Pfs*61;CDKN2A p.W110*	1	8
P-0000574	P-0000574-T01-IM3	Outside	FFPE	Biopsy	182	251	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0000575	P-0000575-T01-IM3	Outside	FFPE	Biopsy	250	986	40	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E110_K111dup)	GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_3B	TP53 p.R273C;PTEN p.R130Q;EP300 p.D1399N;PIK3CA p.E110_K111dup	2	4
P-0000576	P-0000576-T01-IM3	In-House	FFPE	Resection	250	1211	90	Matched	Metastasis	Uterus	Bowel	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.G106R;ATRX Deletion;CDKN2A Deletion;CDKN2B Deletion;RB1 Deletion	2	5
P-0000578	P-0000578-T01-IM3	In-House	FFPE	Resection	250	974	30	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.R248W	0	1
P-0000579	P-0000579-T01-IM3	In-House	FFPE	Resection	250	897	70	Matched	Primary	Not available	Not available	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma											0	0
P-0000580	P-0000580-T01-IM3	In-House	FFPE	Biopsy	250	1320	85	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.N131I;SMARCA4 p.E512*;NKX2-1 Amplification	2	5
P-0000581	P-0000581-T01-IM3	In-House	FFPE	Biopsy	250	934	90	Matched	Primary	Pleura	Not Applicable	Tumor	PLBMESO	Mesothelioma	Pleural Mesothelioma, Biphasic Type					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF2 p.G161*;MEN1 p.V189Gfs*5;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0000582	P-0000582-T01-IM3	In-House	FFPE	Biopsy	250	700	90	Matched	Metastasis	Skin	Orbit	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Olaparib(CDK12 p.R1242*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R1242*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110_G111delins*)				LEVEL_3B	TP53 p.Y236C;NOTCH2 p.X561_splice;NFE2L2 p.D77G;CASP8 p.Q227*;TET2 p.Q758*;RAC1 p.P29L;ARID2 p.Q1411*;TP53 p.E287K;CDK12 p.R1242*;EP300 p.Q1648*;TP53 p.R249Kfs*15;KDM5C p.V826Gfs*22;CDKN2A p.W110_G111delins*;CD274 Amplification;EGFR Amplification;JAK2 Amplification	3	16
P-0000583	P-0000583-T01-IM3	In-House	FFPE	Biopsy	250	1146	60	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Afatinib(EGFR p.L861Q)			Olaparib(ATM p.Q91*)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L861Q;TP53 p.V173L;HIST1H3B p.E106Q;ATM p.Q91*;ETV1 Amplification	3	6
P-0000584	P-0000584-T01-IM3	Outside	FFPE	Biopsy	250	912	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 p.S1982Rfs*22)		Rucaparib,Niraparib(BRCA2 p.S1982Rfs*22);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_2	DNMT3A p.R882C;TGFBR2 p.S295*;GATA3 p.P408Afs*99;BRCA2 p.S1982Rfs*22;CCND1 Amplification;MDM2 Amplification	3	6
P-0000585	P-0000585-T01-IM3	Outside	FFPE	Resection	210	260	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0000586	P-0000586-T01-IM3	In-House	FFPE	Cytology	250	284	NA	Matched	Primary	Oropharynx	Not Applicable	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										TP53 p.X187_splice	0	1
P-0000587	P-0000587-T01-IM3	Outside	FFPE	Biopsy	250	566	80	Matched	Metastasis	Liver	Bone	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										GNAS p.R201C;RB1 p.X203_splice;RB1 p.E204Kfs*10	0	3
P-0000588	P-0000588-T01-IM3	Outside	FFPE	Biopsy	250	264	90	Unmatched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.G266R;IDH1 p.R132H;TP53 p.S215I	1	3
P-0000589	P-0000589-T01-IM3	Outside	FFPE	Biopsy	250	755	90	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	PTEN p.R130Q	1	1
P-0000590	P-0000590-T01-IM3	In-House	FFPE	Resection	250	715	80	Unmatched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	AURKA Amplification;BCL2L1 Amplification;FGFR1 Amplification;SRC Amplification	1	4
P-0000591	P-0000591-T01-IM3	Outside	FFPE	Resection	150.3	758	30	Matched	Metastasis	Cancer of Unknown Primary	Heart	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12S)					LEVEL_3B	ARID1A p.R1276*;NRAS p.G12S;RHOA p.E40V;KDM6A p.R393*	1	4
P-0000592	P-0000592-T01-IM3	Outside	FFPE	Biopsy	250	649	65	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.M1043I)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)						LEVEL_1	PIK3CA p.E545K;PIK3CA p.M1043I;CDH1 p.N181Tfs*34	4	3
P-0000593	P-0000593-T01-IM3	Outside	FFPE	Resection	250	662	25	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type											0	0
P-0000594	P-0000594-T01-IM3	In-House	FFPE	Cytology	106	526	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)	Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	TP53 p.R213*;ERBB2 p.Y772_A775dup;CBL p.Y735*;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;TERT Amplification	4	7
P-0000595	P-0000595-T01-IM3	In-House	FFPE	Biopsy	250	876	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.S436Pfs*39;CCND1 Amplification;FGF19 Amplification;MAP2K4 Deletion	0	4
P-0000595	P-0000595-T02-IM5	In-House	FFPE	Biopsy	250	592	60	Matched	Metastasis	Breast	Axilla	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.S436Pfs*39;CCND1 Amplification;EPHA7 Deletion;FGF19 Amplification;MAP2K4 Deletion;PAK1 Amplification	0	6
P-0000596	P-0000596-T01-IM3	In-House	FFPE	Resection	250	612	70	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Trametinib,Cobimetinib(NF1 p.X1066_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice)				LEVEL_4	RAC1 p.P29S;GRIN2A p.R52*;TP53 p.X331_splice;TP53 p.X125_splice;NF1 p.X1066_splice;CDKN2A p.X51_splice	2	6
P-0000597	P-0000597-T01-IM3	In-House	FFPE	Biopsy	250	683	60	Unmatched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 p.L1491Kfs*12)		Rucaparib,Niraparib(BRCA2 p.L1491Kfs*12)					LEVEL_2	BRCA2 p.L1491Kfs*12;AKT3 Amplification;IKBKE Amplification;MDM4 Amplification	2	4
P-0000598	P-0000598-T01-IM3	Outside	FFPE	Resection	250	748	40	Matched	Primary	Mediastinum	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										TP53 p.K132N;MAPK1 Amplification	0	2
P-0000599	P-0000599-T01-IM3	In-House	FFPE	Resection	250	736	70	Matched	Metastasis	Liver	Lymph Node	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3A	IDH1 p.R132C;PIK3CA p.E542K;MDM2 Amplification	3	3
P-0000600	P-0000600-T01-IM3	In-House	FFPE	Cytology	250	814	50	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification	0	1
P-0000602	P-0000602-T01-IM3	In-House	FFPE	Biopsy	161.2	897	80	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X2281_splice);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3B	PIK3CA p.E545K;TP53 p.R209Kfs*6;ATR p.X1242_splice;BRCA2 p.X2281_splice;KEAP1 p.E198*;PTPRT p.L464Cfs*27;CDKN2A p.H83Y;ERBB2 Amplification	4	8
P-0000603	P-0000603-T01-IM3	In-House	FFPE	Resection	250	729	75	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000604	P-0000604-T01-IM3	In-House	FFPE	Biopsy	207	990	25	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0000605	P-0000605-T01-IM3	Outside	FFPE	Biopsy	209	897	40	Unmatched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0000606	P-0000606-T01-IM3	In-House	FFPE	Biopsy	145.6	1057	75	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545K;SF3B1 p.K741N;KMT2C p.S2090*;TP53 p.P278R;PTPRS p.W401*;ERBB2 Amplification	4	6
P-0000607	P-0000607-T01-IM3	In-House	FFPE	Biopsy	244.8	728	60	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L);Fulvestrant+Alpelisib(PIK3CA p.E545Q)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q);AZD9496,Fulvestrant(ESR1 p.L536Q)						LEVEL_1	PIK3CA p.H1047L;PIK3CA p.E545Q;SPEN p.R1470*;CDH1 p.T330Gfs*21;ESR1 p.L536Q	5	5
P-0000609	P-0000609-T01-IM3	In-House	FFPE	Biopsy	250	1040	80	Matched	Metastasis	Soft Tissue	Bladder	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0000610	P-0000610-T01-IM3	In-House	FFPE	Resection	250	308	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.P278S;APC p.K2689Rfs*34;PTEN Deletion	1	3
P-0000611	P-0000611-T01-IM3	Outside	FFPE	Resection	250	1102	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H);Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.N659K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN p.L70I);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	KRAS p.G12A;IDH1 p.R132H;PDGFRA p.N659K;PTEN p.L70I;TP53 p.M237I;ATRX p.S1101*;NOTCH1 p.V324Qfs*6;ARID5B Deletion;BMPR1A Deletion;CCND2 Amplification;CDKN2A Deletion;CDKN2B Deletion;KDM5A Amplification;KDR Amplification;KIT Amplification;NPM1 Deletion;PDGFRA Amplification;PTEN Deletion;RAD50 Deletion	6	19
P-0000612	P-0000612-T01-IM3	In-House	FFPE	Biopsy	250	992	75	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	ESR1 p.D538G;CDH1 p.I650Hfs*12;NCOR1 p.M2290Yfs*17;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification	2	7
P-0000613	P-0000613-T01-IM3	In-House	FFPE	Cytology	225	1096	20	Unmatched	Metastasis	Breast	Pleura	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545K;TP53 p.Q192*;ERBB2 Amplification	4	3
P-0000614	P-0000614-T01-IM3	Outside	FFPE	Resection	250	634	75	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R);GSK2636771,AZD8186(PTEN p.N323Kfs*2);Everolimus,Temsirolimus(MTOR p.M2327V);Trametinib,Cobimetinib(NF1 p.N78Kfs*29)				LEVEL_4	FGFR2 p.C382R;JAK1 p.L431Vfs*22;PTEN p.N323Kfs*2;MTOR p.M2327V;ARID1A p.R1461*;NOTCH2 p.X1927_splice;PMS2 p.X236_splice;SMAD4 p.R361H;MED12 p.Q1939*;SPEN p.I1159Lfs*28;SPEN p.A2105Gfs*18;ARID1A p.Q802Sfs*15;ARID1A p.F2141Ifs*9;PIK3R1 p.K459del;PMS2 p.X236_splice;KMT2D p.F2494Vfs*12;CTCF p.T204Nfs*26;NF1 p.N78Kfs*29	4	18
P-0000615	P-0000615-T01-IM3	In-House	FFPE	Resection	250	796	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133C	0	1
P-0000616	P-0000616-T01-IM3	In-House	FFPE	Biopsy	250	851	80	Matched	Metastasis	Ascending Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;CTNNB1 p.K335I;TP53 p.G199_E204del;RNF43 p.P660Sfs*87;CDKN2A Deletion;CDKN2B Deletion;MET Amplification;PTPRD Deletion	5	8
P-0000616	P-0000616-T02-IM3	In-House	FFPE	Resection	250	434	40	Matched	Metastasis	Ascending Colon	Skin	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;CTNNB1 p.K335I;TP53 p.G199_E204del;RNF43 p.P660Sfs*87;BRAF Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MET Amplification;PTPRD Deletion	5	10
P-0000617	P-0000617-T01-IM3	In-House	FFPE	Biopsy	250	882	90	Matched	Metastasis	Breast	Peritoneum	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	GATA3 p.P408Afs*99;ATRX p.X2283_splice;CDH1 p.E463*;FGFR1 Amplification	1	4
P-0000618	P-0000618-T01-IM3	In-House	FFPE	Resection	250	559	70	Matched	Primary	Minor Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ARID1A p.S11Afs*91;NOTCH1 p.S2467Rfs*10;KDM6A p.G1215Efs*6;CDK4 Amplification;ERBB2 Amplification;MCL1 Amplification	2	6
P-0000619	P-0000619-T01-IM3	Outside	FFPE	Biopsy	250	670	90	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										NOTCH2 p.Q1865*;MDM4 Amplification	0	2
P-0000620	P-0000620-T01-IM3	Outside	FFPE	Biopsy	212	402	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										PPP2R1A p.R183W	0	1
P-0000621	P-0000621-T01-IM3	In-House	FFPE	Biopsy	140	605	40	Matched	Metastasis	Oral Cavity	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	TP53 p.R342*;CDKN2A p.H83Y;EGFR Amplification	1	3
P-0000622	P-0000622-T01-IM3	Outside	FFPE	Biopsy	250	965	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0000623	P-0000623-T02-IM5	Outside	FFPE	Biopsy	246.8	402	70	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										ARID1A p.L2056Afs*43;MYCN Amplification	0	2
P-0000623	P-0000623-T01-IM3	Outside	FFPE	Resection	250	421	80	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										ARID1A p.L2056Afs*43;MYCN Amplification	0	2
P-0000624	P-0000624-T02-IM5	In-House	DNA	Biopsy	250	1435	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.D335Gfs*17;MAX p.R75*;ARID1A p.D1850Gfs*4;FOXA1 Amplification;NKX2-1 Amplification;NOVA1 NFKBIA-NOVA1 fusion;NFKBIA NFKBIA-NOVA1 fusion	0	7
P-0000624	P-0000624-T01-IM3	Outside	FFPE	Resection	250	201	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	GATA3 p.D335Gfs*17;PIK3CA p.H1047R;MAX p.R75*;ARID1A p.D1850Gfs*4	2	4
P-0000625	P-0000625-T01-IM3	Outside	FFPE	Biopsy	250	605	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.T1556Nfs*3;APC p.E268*;TP53 p.X126_splice	1	4
P-0000626	P-0000626-T01-IM3	Outside	FFPE	Biopsy	182	523	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.R175H;PBRM1 p.R534*	2	3
P-0000627	P-0000627-T01-IM3	In-House	FFPE	Biopsy	250	753	35	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X1477_splice);Trametinib,Cobimetinib(NF1 p.X2272_splice)				LEVEL_4	TP53 p.R249S;ARID1A p.Q780*;TP63 p.R643*;KMT2D p.E3081*;FANCA p.Q956*;NF1 p.X1477_splice;KMT2C p.R1351Gfs*23;NF1 p.X2272_splice	2	8
P-0000628	P-0000628-T02-IM5	In-House	FFPE	Biopsy	250	971	NA	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L747_P753delinsS;TP53 p.E298*;SETD2 p.N1643Dfs*25;EGFR Amplification;ERBB2 Amplification;MYC Amplification;RB1 Deletion;RICTOR Amplification;TERT Amplification	3	10
P-0000628	P-0000628-T01-IM3	Outside	FFPE	Cytology	250	869	75	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)								LEVEL_1	EGFR p.L747_P753delinsS;TP53 p.E298*;SETD2 p.N1643Dfs*25;EGFR Amplification;MYC Amplification;RB1 Deletion	1	6
P-0000629	P-0000629-T01-IM3	In-House	FFPE	Biopsy	250	1106	90	Matched	Primary	Pelvis	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	1	3
P-0000630	P-0000630-T01-IM3	In-House	FFPE	Biopsy	100.65	614	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719S)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	EGFR p.G719S;PIK3CA p.E545K;EGFR p.E709K;SETD2 p.L2512Afs*8	2	4
P-0000632	P-0000632-T01-IM3	Outside	FFPE	Biopsy	250	957	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	TP53 p.G302Rfs*4;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	3
P-0000633	P-0000633-T01-IM3	In-House	FFPE	Resection	250	880	75	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										NF2 p.R262*;TP53 p.A83Rfs*40;PAK1 Amplification	0	3
P-0000635	P-0000635-T01-IM3	In-House	FFPE	Biopsy	250	1231	25	Matched	Metastasis	Rectosigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)	Cetuximab,Panitumumab(KRAS p.G13C)			LEVEL_4	APC p.E1408*;KRAS p.G13C	1	2
P-0000636	P-0000636-T01-IM3	In-House	FFPE	Biopsy	63.6	507	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.E746_A750del;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0000637	P-0000637-T01-IM3	In-House	FFPE	Resection	250	803	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;PBRM1 p.S1278*;BAP1 p.F678Sfs*12;KMT2A p.S774Vfs*12	1	4
P-0000638	P-0000638-T01-IM3	Outside	FFPE	Resection	250	850	30	Matched	Metastasis	Breast	Heart	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification	2	1
P-0000639	P-0000639-T01-IM3	In-House	FFPE	Biopsy	74.8	415	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Everolimus(TBL3 TSC2-TBL3 fusion);Everolimus(TSC2 TSC2-TBL3 fusion)					LEVEL_3B	TP53 p.I162N;KDM5C p.A663Cfs*98;TBL3 TSC2-TBL3 fusion;TSC2 TSC2-TBL3 fusion	2	4
P-0000640	P-0000640-T03-IM5	In-House	FFPE	Biopsy	219.1	404	70	Matched	Metastasis	Prostate	Spine	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000640	P-0000640-T01-IM3	Outside	FFPE	Biopsy	250	879	65	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000640	P-0000640-T02-IM5	Outside	DNA	Biopsy	250	695	30	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM Deletion);Olaparib(CHEK2 Deletion)			Tazemetostat(SMARCB1 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	AR Amplification;ATM Deletion;BCL10 Deletion;BIRC3 Deletion;BMPR1A Deletion;CBL Deletion;CHEK2 Deletion;EP300 Deletion;EPHA7 Deletion;KMT2A Deletion;MRE11 Deletion;NF2 Deletion;PTEN Deletion;RAD21 Deletion;SDHAF2 Deletion;SDHD Deletion;SMARCB1 Deletion;SUFU Deletion;TCF7L2 Deletion	4	19
P-0000641	P-0000641-T01-IM3	In-House	FFPE	Biopsy	114.4	611	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0000642	P-0000642-T01-IM3	In-House	FFPE	Biopsy	203.5	876	25	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.H773dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.H773dup)			LEVEL_3A	RB1 p.X46_splice;EGFR p.H773dup;TP53 p.C135Afs*35;KDM5C p.E1338Afs*19;EGFR Amplification	1	5
P-0000643	P-0000643-T01-IM3	In-House	FFPE	Resection	250	828	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0000644	P-0000644-T01-IM3	Outside	FFPE	Biopsy	250	587	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(FGFR2 AHCYL1-FGFR2 fusion);Pemigatinib(AHCYL1 AHCYL1-FGFR2 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 AHCYL1-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(AHCYL1 AHCYL1-FGFR2 fusion)						LEVEL_1	FGFR2 AHCYL1-FGFR2 fusion;AHCYL1 AHCYL1-FGFR2 fusion	4	2
P-0000645	P-0000645-T01-IM3	In-House	FFPE	Resection	250	767	60	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Everolimus,Temsirolimus(MTOR p.M2327I)				LEVEL_1	FGFR3 p.S249C;PIK3CA p.E542K;MTOR p.M2327I	4	3
P-0000646	P-0000646-T02-IM3	In-House	FFPE	Resection	250	425	50	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib(BRAF p.K601E)		PLX8394(BRAF p.K601E)				LEVEL_3A	BRAF p.K601E;EPHB1 p.R743W;BRAF p.P367L;FLT3 p.M908I;PTPRT p.R470*;FUBP1 p.I301Nfs*4;MITF Amplification	2	7
P-0000647	P-0000647-T01-IM3	In-House	FFPE	Resection	250	805	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.V216L	0	1
P-0000648	P-0000648-T01-IM3	In-House	FFPE	Resection	250	999	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	TT	Germ Cell Tumor	Teratoma					GSK2636771,AZD8186(PTEN p.G127V)				LEVEL_4	PTEN p.G127V;TP53 p.G105V	1	2
P-0000649	P-0000649-T01-IM3	In-House	FFPE	Resection	250	405	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	SETD2 p.E1528*;LATS1 p.W268*;KMT2C p.K2386*;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	5
P-0000650	P-0000650-T01-IM3	In-House	FFPE	Resection	250	946	20	Matched	Metastasis	Testis	Brain	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.E542K;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	1	5
P-0000651	P-0000651-T01-IM3	In-House	FFPE	Resection	250	755	99	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)	Lapatinib(EGFR Amplification)				LEVEL_3B	TP53 p.R248Q;IDH1 p.R132H;FAT1 p.T1516Ffs*2;ATRX p.K1583Nfs*22;CDK6 Amplification;EGFR Amplification;SH2D1A Deletion;STAG2 Deletion;TNFAIP3 Deletion	2	9
P-0000652	P-0000652-T01-IM3	In-House	FFPE	Resection	250	829	90	Matched	Metastasis	Lower Extremity	Lung	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										EP300 p.R1462*	0	1
P-0000653	P-0000653-T01-IM3	In-House	FFPE	Resection	250	1016	80	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.X268_splice);GSK2636771,AZD8186(PTEN p.X268_splice);GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_3B	PIK3CA p.H1047R;PTEN p.X268_splice;EED p.W152*;PTPN11 p.N308D;PTEN p.X268_splice;PTEN p.X268_splice	4	6
P-0000654	P-0000654-T01-IM3	In-House	FFPE	Resection	250	1173	80	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822K);Olaparib(CDK12 p.X643_splice)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.X643_splice)				LEVEL_3B	KIT p.N822K;CDK12 p.X643_splice;CCND2 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification;PTPRD Deletion	3	7
P-0000655	P-0000655-T01-IM3	In-House	FFPE	Biopsy	81.6	614	70	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(PALB2 Deletion)				Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K)				LEVEL_1	CTNNB1 p.S37F;KRAS p.Q61K;PALB2 Deletion	2	3
P-0000655	P-0000655-T03-IM5	In-House	FFPE	Biopsy	250	989	10	Matched	Metastasis	Prostate	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K)				LEVEL_4	KRAS p.Q61K	1	1
P-0000655	P-0000655-T02-IM3	In-House	FFPE	Resection	250	290	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(PALB2 Deletion)				Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KRAS p.Q61K;CDKN2A Deletion;CDKN2B Deletion;FOXA1 Amplification;PALB2 Deletion	3	5
P-0000656	P-0000656-T01-IM3	Outside	FFPE	Biopsy	210.1	711	80	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB3 p.K329T;TP53 p.Q165*;ERBB2 Amplification	2	3
P-0000657	P-0000657-T02-IM5	In-House	DNA	Biopsy	250	802	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(PALB2 Deletion)	GSK2636771,AZD8186(PTEN p.T319*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PTEN p.T319*;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PALB2 Deletion	4	5
P-0000657	P-0000657-T01-IM3	In-House	FFPE	Resection	250	648	NA	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.T319*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.T319*;EGFR p.D587N;SDHA p.L639V;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ETV1 Amplification	3	7
P-0000658	P-0000658-T01-IM3	Outside	FFPE	Biopsy	250	580	85	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;KMT2C p.X2481_splice;TP53 p.F212Sfs*3;NCOR1 p.E354Tfs*21;CCND1 Amplification;FGF19 Amplification	2	6
P-0000659	P-0000659-T01-IM3	In-House	FFPE	Biopsy	250	1267	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.K57N)					LEVEL_3B	MAP2K1 p.K57N;KDM6A p.R1054Afs*29	1	2
P-0000660	P-0000660-T01-IM3	Outside	FFPE	Resection	250	787	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	FDCS	Soft Tissue Sarcoma	Follicular Dendritic Cell Sarcoma										KMT2A p.P1359Tfs*12	0	1
P-0000661	P-0000661-T01-IM3	In-House	FFPE	Resection	250	223	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.R213*;AKT1 p.F55Y;NOTCH2 p.L2199Ifs*4;MCL1 Amplification	2	5
P-0000662	P-0000662-T01-IM3	In-House	FFPE	Resection	250	645	75	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.C634R)		BLU-667(RET p.C634R)						LEVEL_1	RET p.C634R	2	1
P-0000663	P-0000663-T01-IM3	Outside	FFPE	Cytology	250	1014	20	Matched	Metastasis	Retroperitoneum	Liver	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0000664	P-0000664-T01-IM3	Outside	FFPE	Biopsy	250	1103	75	Matched	Metastasis	Testis	Retroperitoneum	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										KRAS Amplification	0	1
P-0000665	P-0000665-T01-IM3	Outside	FFPE	Biopsy	250	771	40	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	KRAS Amplification;MDM2 Amplification	1	2
P-0000666	P-0000666-T01-IM3	In-House	FFPE	Resection	250	227	90	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R156Afs*14	0	1
P-0000667	P-0000667-T01-IM3	In-House	FFPE	Resection	250	570	65	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer	Olaparib,Rucaparib,Niraparib(BRCA2 Deletion)			Talazoparib(BRCA2 Deletion)					LEVEL_1	TP53 p.R213*;AKT2 Amplification;BRCA2 Deletion;CCND3 Amplification;CCNE1 Amplification;DDR2 Amplification	2	6
P-0000668	P-0000668-T01-IM3	Outside	FFPE	Biopsy	250	557	60	Matched	Primary	Nasopharynx	Not Applicable	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma										TP53 p.E271K	0	1
P-0000669	P-0000669-T01-IM3	In-House	FFPE	Biopsy	250	679	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G112Vfs*10	0	1
P-0000670	P-0000670-T01-IM3	In-House	FFPE	Biopsy	209.76	438	35	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.P772_H773dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A36_N39delinsD)	Erlotinib,Gefitinib,Afatinib(EGFR p.P772_H773dup)			LEVEL_3A	TP53 p.Y236C;EGFR p.P772_H773dup;CDKN2A p.A36_N39delinsD	2	3
P-0000671	P-0000671-T01-IM3	In-House	FFPE	Biopsy	250	729	65	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.G67C)				LEVEL_3B	KEAP1 p.G333C;TP53 p.V157F;PIK3CA p.E542K;NOTCH2 p.E2258*;PBRM1 p.E796*;SMARCA4 p.E535*;ARID1A p.G922Afs*2;AXIN1 p.Q559Rfs*146;CDKN2A p.G67C	2	9
P-0000672	P-0000672-T01-IM3	Outside	FFPE	Biopsy	250	603	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.Y949Lfs*10)			Talazoparib,Niraparib(BRCA2 p.Y949Lfs*10)					LEVEL_1	BRCA2 p.Y949Lfs*10	2	1
P-0000673	P-0000673-T01-IM3	In-House	FFPE	Resection	250	913	90	Matched	Metastasis	Lower Extremity	Diaphragm	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	MET Amplification;TP53 Deletion;LRCH1 RB1-LRCH1 fusion;RB1 RB1-LRCH1 fusion	1	4
P-0000674	P-0000674-T01-IM3	Outside	FFPE	Biopsy	250	664	65	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;APC p.R564*;APC p.E1397*;TP53 p.Q167*;FGFR1 Amplification;PRKN Deletion;SMAD4 Deletion	2	7
P-0000675	P-0000675-T01-IM3	Outside	FFPE	Biopsy	181.5	616	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										KMT2C p.R1861Gfs*78	0	1
P-0000675	P-0000675-T02-IM3	Outside	FFPE	Resection	250	638	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R273H;APC p.R499*;APC p.E1322*	0	3
P-0000676	P-0000676-T01-IM3	Outside	FFPE	Cytology	112.2	591	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.C238W	0	1
P-0000677	P-0000677-T01-IM3	Outside	FFPE	Resection	250	860	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	RB1 p.N522Ifs*2;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;GATA3 Deletion;PAX5 Deletion	2	6
P-0000678	P-0000678-T01-IM3	In-House	FFPE	Resection	106	218	40	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.H1047R;APC p.R332*;APC p.L954*;APC p.E1521*;TP53 p.V173L;KRAS p.G13D;MAP2K4 Deletion	2	7
P-0000679	P-0000679-T01-IM3	In-House	FFPE	Resection	250	709	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					GSK2636771,AZD8186(PTEN p.D331Sfs*10);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.P191del;PTPN11 p.T507K;PTEN p.D331Sfs*10;CDKN2A Deletion	2	4
P-0000680	P-0000680-T01-IM3	In-House	FFPE	Resection	250	670	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFS	Soft Tissue Sarcoma	Myxofibrosarcoma											0	0
P-0000681	P-0000681-T01-IM3	In-House	FFPE	Biopsy	250	834	75	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719A)			Olaparib(BRIP1 p.EA636DS)					LEVEL_1	TP53 p.S215I;MUTYH p.X309_splice;EGFR p.G719A;RBM10 p.E355*;BRIP1 p.EA636DS	2	5
P-0000681	P-0000681-T02-IM5	In-House	FFPE	Resection	250	817	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719A)			Olaparib(BRIP1 p.EA636DS)					LEVEL_1	TP53 p.S215I;MUTYH p.X309_splice;EGFR p.G719A;RBM10 p.E355*;BRIP1 p.EA636DS;FGFR4 Amplification;TERT Amplification	2	7
P-0000682	P-0000682-T01-IM3	Outside	FFPE	Resection	250	609	20	Matched	Metastasis	Cecum	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;GNAS p.R201H;PIK3CA p.E542K;JAK1 p.E609*;APC p.Q1429*;RBM10 p.R5*;APC p.R856Nfs*6;TBX3 p.T483Nfs*209	2	8
P-0000683	P-0000683-T01-IM3	In-House	FFPE	Biopsy	190.3	256	30	Matched	Metastasis	Prostate	Urethra	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.D207Mfs*40;AR Amplification;FANCA Deletion;MAP3K1 Deletion;MYC Amplification;PTEN Deletion	1	6
P-0000684	P-0000684-T01-IM3	Outside	FFPE	Resection	250	1074	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R337L;RASA1 p.R512*;NOTCH3 p.P42Lfs*194	0	3
P-0000685	P-0000685-T01-IM3	In-House	FFPE	Biopsy	250	761	90	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										FAT1 p.E2874*;CCND2 Amplification;FOXA1 Deletion;KRAS Amplification;PRKN Deletion;YAP1 Amplification	0	6
P-0000686	P-0000686-T01-IM3	In-House	FFPE	Biopsy	243.1	563	70	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Olaparib(ATM p.R2832C)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.P250S);Trametinib,Cobimetinib(NF1 p.Q1822*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P81L)				LEVEL_3B	RAC1 p.P29S;TP53 p.R213*;MSH6 p.W1047*;MSH6 p.X1186_splice;FGFR3 p.P250S;TET2 p.Q1624*;PIK3R1 p.R386*;NSD1 p.C1435*;ATM p.R2832C;CBL p.E894*;LATS2 p.Q35*;DICER1 p.S1344L;GRIN2A p.X375_splice;NF1 p.Q1822*;NOTCH3 p.E657*;MED12 p.A59T;CDKN2A p.P81L	4	17
P-0000687	P-0000687-T01-IM3	In-House	FFPE	Resection	250	1141	60	Matched	Metastasis	Rectosigmoid Colon	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	APC p.R213*;APC p.L1488Yfs*19;TP53 p.C275Lfs*31;ERBB2 Amplification	2	4
P-0000688	P-0000688-T01-IM3	In-House	FFPE	Resection	250	642	50	Matched	Metastasis	Cervix	Ovary	Tumor	GCEMU	Cervical Cancer	Gastric Type Mucinous Carcinoma										TP53 p.R282W;KMT2A p.P280Sfs*4;CCND1 Amplification;FGF19 Amplification	0	4
P-0000689	P-0000689-T01-IM3	In-House	FFPE	Biopsy	130.9	458	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0000689	P-0000689-T02-IM5	In-House	FFPE	Biopsy	250	966	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.X245_splice	0	1
P-0000690	P-0000690-T03-IM5	In-House	DNA	Biopsy	250	748	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;TP53 p.H179R;PIK3R2 Amplification;BTC FAT1-BTC fusion;FAT1 FAT1-BTC fusion	2	5
P-0000690	P-0000690-T02-IM5	In-House	DNA	Resection	250	650	40	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;TP53 p.H179R;PIK3R2 Amplification;PODNL1 BRD4-PODNL1 fusion;BRD4 BRD4-PODNL1 fusion	2	5
P-0000690	P-0000690-T01-IM3	Outside	FFPE	Biopsy	56.5	856	90	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;TP53 p.H179R;PIK3R2 Amplification	2	3
P-0000691	P-0000691-T01-IM3	In-House	FFPE	Resection	250	92	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000692	P-0000692-T01-IM3	Outside	FFPE	Resection	250	257	NA	Matched	Primary	Testis	Not Applicable	Tumor	SCST	Sex Cord Stromal Tumor	Sex Cord Stromal Tumor				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CTNNB1 p.T41I;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MDM2 Amplification	1	5
P-0000693	P-0000693-T01-IM3	In-House	FFPE	Biopsy	147.4	636	50	Matched	Metastasis	Small Bowel	Liver	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0000694	P-0000694-T01-IM3	In-House	FFPE	Resection	137.5	284	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	PIK3CA p.H1047R;CDK4 Amplification	3	2
P-0000695	P-0000695-T01-IM3	Outside	FFPE	Resection	250	145	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R213*;APC p.Q1406*;TP53 p.L130V	0	3
P-0000696	P-0000696-T01-IM3	Outside	FFPE	Resection	250	582	NA	Unmatched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559D)								LEVEL_1	KIT p.V559D	1	1
P-0000697	P-0000697-T01-IM3	In-House	FFPE	Resection	250	202	80	Matched	Metastasis	Skin	Lymph Node, Non-Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.X751_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	B2M p.L7S;B2M p.E94*;NF1 p.X751_splice;CDKN2A Deletion;CDKN2B Deletion;PAK1 Amplification;YAP1 Amplification	2	7
P-0000698	P-0000698-T01-IM3	Outside	FFPE	Resection	250	412	50	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.M1043I;PIK3R1 p.K447Nfs*31	1	3
P-0000699	P-0000699-T01-IM3	In-House	FFPE	Resection	250	593	80	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.K534*;ERBB3 p.S846I;DICER1 p.E1813G	0	3
P-0000700	P-0000700-T01-IM3	Outside	FFPE	Resection	250	540	90	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.M918T)		BLU-667(RET p.M918T)						LEVEL_1	RET p.M918T;EPHA3 Deletion;WT1 Deletion	2	3
P-0000702	P-0000702-T01-IM3	In-House	FFPE	Biopsy	250	605	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A;HIST1H3B p.E106Q	1	2
P-0000703	P-0000703-T01-IM3	In-House	FFPE	Resection	250	531	50	Matched	Metastasis	Cecum	Omentum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V173L;RHOA p.G62E;NCOR1 p.R414*;SOX9 p.E159Gfs*25;SMAD4 p.Q248Sfs*88	0	5
P-0000704	P-0000704-T01-IM3	In-House	FFPE	Biopsy	250	477	80	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		GSK2636771,AZD8186(PTEN p.D92H)				LEVEL_1	PIK3CA p.E542K;PTEN p.D92H;KMT2D p.Q3913*;TP53 p.G245V;IKBKE Amplification;MAP2K4 Deletion;NCOR1 Deletion;ROS1 Amplification	3	8
P-0000705	P-0000705-T01-IM3	In-House	FFPE	Resection	250	526	30	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.G380R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A148Gfs*45)				LEVEL_3B	MSH6 p.C1003*;MSH6 p.Q1314*;PIK3CA p.R108H;FGFR3 p.G380R;KMT2D p.R2685*;KMT2D p.P2354Lfs*30;TP53 p.D48Tfs*75;ASXL1 p.G1376Vfs*74;ASXL2 p.R2Tfs*4;NOTCH1 p.X481_splice;KMT2C p.R193*;TP53 p.V272K;CDKN2A p.A148Gfs*45	3	13
P-0000706	P-0000706-T01-IM3	Outside	FFPE	Biopsy	225	379	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.D194Y;FOXA1 Amplification;NKX2-1 Amplification	2	4
P-0000707	P-0000707-T01-IM3	In-House	FFPE	Biopsy	140	506	10	Matched	Metastasis	Testis	Adrenal Gland	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0000708	P-0000708-T01-IM3	In-House	FFPE	Resection	250	260	90	Matched	Primary	Bone	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ARID2 p.X258_splice;ATRX Deletion;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;MDM2 Amplification	3	7
P-0000709	P-0000709-T01-IM3	In-House	FFPE	Resection	250	1071	40	Matched	Metastasis	Cancer of Unknown Primary	Ovary	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TGFBR1 p.X377_splice;ARID1A p.S1645Cfs*2;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0000710	P-0000710-T01-IM3	In-House	FFPE	Biopsy	250	364	80	Matched	Primary	Bone	Not Applicable	Tumor	CHBL	Bone Cancer	Chondroblastoma											0	0
P-0000711	P-0000711-T01-IM3	Outside	FFPE	Resection	250	393	60	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										RB1 p.W563Lfs*7;TP53 Deletion	0	2
P-0000713	P-0000713-T01-IM3	Outside	FFPE	Biopsy	60.5	141	30	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C	1	1
P-0000714	P-0000714-T01-IM3	In-House	FFPE	Resection	250	470	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;APC p.E574*;APC p.K1561Rfs*4;TP53 p.N30Kfs*13;MAPK1 Amplification;MYC Amplification	3	6
P-0000715	P-0000715-T03-IM3	In-House	FFPE	Biopsy	250	609	50	Matched	Metastasis	Thyroid	Liver	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;RBM10 p.D681Efs*36	2	2
P-0000716	P-0000716-T01-IM3	Outside	FFPE	Biopsy	121	403	70	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X153_splice)				LEVEL_1	TP53 p.R282W;AXIN1 p.R723*;KMT2A p.P1767Sfs*15;CDKN2A p.X153_splice;ERBB2 Amplification	3	5
P-0000717	P-0000717-T01-IM3	In-House	FFPE	Resection	250	492	70	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0000718	P-0000718-T01-IM3	In-House	FFPE	Resection	250	651	90	Matched	Primary	Buttock	Not Applicable	Tumor	MYCHS	Bone Cancer	Myxoid Chondrosarcoma											0	0
P-0000719	P-0000719-T01-IM3	Outside	FFPE	Biopsy	250	609	90	Matched	Primary	Not available	Not available	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0000720	P-0000720-T01-IM3	Outside	FFPE	Resection	250	366	90	Matched	Primary	Uterus	Not Applicable	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	ATRX p.G1567Vfs*13;BRCA2 Deletion;SMAD3 Deletion;TP53 Deletion	1	4
P-0000721	P-0000721-T01-IM3	In-House	FFPE	Resection	250	669	50	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_2	KRAS p.G12D;APC p.R1450*;APC p.R1114*;ERBB3 p.V104L;ERBB2 Amplification	3	5
P-0000722	P-0000722-T01-IM3	Outside	FFPE	Biopsy	250	462	15	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;CDK6 Amplification;MDM2 Amplification	2	3
P-0000723	P-0000723-T01-IM3	Outside	FFPE	Biopsy	250	448	60	Matched	Primary	Not available	Not available	Tumor	ES	Bone Cancer	Ewing Sarcoma											0	0
P-0000724	P-0000724-T01-IM3	In-House	FFPE	Biopsy	91	200	40	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLAD	Bladder Cancer	Bladder Adenocarcinoma										SMAD4 p.R361C;APC p.S837*;TP53 p.Q167_M169dup;KRAS Amplification;RICTOR Amplification;TERT Amplification	0	6
P-0000725	P-0000725-T01-IM3	Outside	FFPE	Resection	250	586	65	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.D32Y;FOXA1 p.F254_N256delinsY;FOXA1 Amplification;MYC Amplification	0	4
P-0000726	P-0000726-T01-IM3	Outside	FFPE	Biopsy	143.5	413	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Tipifarnib(HRAS p.G13V)	Trametinib,Cobimetinib(NF1 p.E1220*);Tazemetostat(SMARCB1 p.X167_splice)				LEVEL_3B	INPP4B p.R818*;HRAS p.G13V;TP53 p.R175L;NF1 p.E1220*;PRKN p.V330Cfs*105;MAX p.D41Tfs*24;B2M p.S16Afs*27;EP300 p.T992Nfs*10;SMARCB1 p.X167_splice	3	9
P-0000728	P-0000728-T01-IM3	Outside	FFPE	Resection	250	496	10	Matched	Metastasis	Skin	Liver	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma					GSK2636771,AZD8186(PTEN p.T131Kfs*52)				LEVEL_4	PTEN p.T131Kfs*52	1	1
P-0000729	P-0000729-T01-IM3	Outside	FFPE	Resection	250	540	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.V157F;KMT2D p.Q2553*;KMT2D p.S2312*;TP53 p.K101*;KEAP1 p.I137Mfs*33;BCL6 Amplification;PIK3CA Amplification	0	7
P-0000730	P-0000730-T01-IM3	Outside	FFPE	Biopsy	250	712	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					GSK2636771,AZD8186(PTEN p.G36R)				LEVEL_4	PTEN p.G36R;TP53 p.V73Wfs*50	1	2
P-0000731	P-0000731-T01-IM3	Outside	FFPE	Biopsy	250	549	80	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)						LEVEL_1	TP53 p.C135F;ATRX p.E1159*;MET p.X963_splice;MYC Amplification	3	4
P-0000732	P-0000732-T01-IM3	In-House	FFPE	Resection	250	382	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ATR p.L318*;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	3
P-0000733	P-0000733-T01-IM3	Outside	FFPE	Resection	250	297	50	Matched	Metastasis	Blood Vessel	Lung	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;MDM2 Amplification	2	4
P-0000735	P-0000735-T01-IM3	In-House	FFPE	Resection	250	481	80	Matched	Metastasis	Thymus	Lymph Node	Tumor	THYC	Thymic Tumor	Thymic Carcinoma											0	0
P-0000736	P-0000736-T01-IM3	In-House	FFPE	Resection	250	398	60	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.R203H)				LEVEL_4	TP53 p.G266E;FBXW7 p.R658*;APC p.S596*;FGFR2 p.R203H;APC p.Y1376Cfs*9;SOX9 p.D290Mfs*93;CDK8 Amplification;FLT3 Amplification;NKX3-1 Deletion	1	9
P-0000737	P-0000737-T01-IM3	In-House	FFPE	Resection	250	260	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.Q1429*;TP53 p.Y126C	1	3
P-0000738	P-0000738-T01-IM3	In-House	FFPE	Resection	250	329	70	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V217Gfs*30	0	1
P-0000739	P-0000739-T02-IM5	In-House	FFPE	Biopsy	250	936	25	Matched	Metastasis	Sigmoid Colon	Brain	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;PIK3CA p.E545K;APC p.S457*;APC p.T1301Nfs*14;CDK8 Amplification;FLT3 Amplification;EIF3H RAD21-EIF3H fusion;RAD21 RAD21-EIF3H fusion	3	8
P-0000739	P-0000739-T01-IM3	In-House	FFPE	Resection	250	498	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.S457*;APC p.T1301Nfs*14;CDK8 Amplification;FLT3 Amplification;PMAIP1 Deletion	2	6
P-0000740	P-0000740-T01-IM3	In-House	FFPE	Resection	250	555	60	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma					GSK2636771,AZD8186(PTEN p.L25S)				LEVEL_4	TP53 p.R273H;PTEN p.L25S;KMT2D p.Q3963*;TP53 p.C176R	1	4
P-0000741	P-0000741-T01-IM3	In-House	FFPE	Resection	250	269	60	Matched	Metastasis	Pleura	Diaphragm	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 p.M681Afs*35	0	1
P-0000742	P-0000742-T01-IM3	In-House	FFPE	Resection	250	615	40	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248Q;APC p.S1315*	0	2
P-0000743	P-0000743-T01-IM3	Outside	FFPE	Resection	250	430	40	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	SMAD4 p.R361C;CTNNB1 p.S45P;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0000744	P-0000744-T01-IM3	In-House	FFPE	Resection	250	436	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.C420R;SMAD4 p.R361H;APC p.S245*	2	4
P-0000745	P-0000745-T01-IM3	In-House	FFPE	Resection	250	407	30	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R175H;SMAD4 p.R361H;APC p.Q1367*	1	4
P-0000746	P-0000746-T01-IM3	In-House	FFPE	Resection	250	397	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.E687*);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(KDM6A p.C562Afs*15)				LEVEL_3B	TSC1 p.E687*;DOT1L p.S118L;RUNX1 p.L55Cfs*41;KDM6A p.C562Afs*15;STK11 p.V66Sfs*98;MDM2 Amplification	3	6
P-0000747	P-0000747-T01-IM3	In-House	FFPE	Resection	250	493	60	Matched	Metastasis	Testis	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0000748	P-0000748-T01-IM3	In-House	FFPE	Biopsy	147.4	352	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.K650E)					LEVEL_3B	FGFR3 p.K650E	1	1
P-0000749	P-0000749-T01-IM3	In-House	FFPE	Resection	250	328	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R273H;TP53 p.S183*;IDH1 p.R132H;PIK3R1 p.N564D;ATRX p.Q1691*;CDKN2A Deletion;CDKN2B Deletion;KDM5A Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	2	11
P-0000750	P-0000750-T01-IM3	In-House	FFPE	Resection	250	406	80	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										NF2 p.E166*;NF2 p.E270*;BAP1 p.X577_splice	0	3
P-0000751	P-0000751-T01-IM3	In-House	FFPE	Biopsy	71.5	372	30	Matched	Metastasis	Esophagus	Liver	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										MSH6 p.F1088Lfs*5;TP53 p.R213*;APC p.T1556Nfs*3;STK11 p.X288_splice	0	4
P-0000754	P-0000754-T01-IM3	In-House	FFPE	Resection	250	858	25	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.I767M)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;TP53 p.V272L;ERBB2 p.I767M;APC p.P1427Qfs*40	2	4
P-0000755	P-0000755-T01-IM3	In-House	FFPE	Biopsy	115.2	513	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(PALB2 p.R414*);Olaparib(CHEK1 p.T226Hfs*14)			Trametinib(BRAF p.K601E)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);PLX8394(BRAF p.K601E)				LEVEL_1	JAK1 p.K860Nfs*16;PTEN p.K267Rfs*9;BRAF p.K601E;MSH2 p.R621*;PALB2 p.R414*;AR p.W742C;AR p.T878A;JAK1 p.N136Mfs*32;MLH1 p.R497Gfs*11;NBN p.R551Gfs*8;PAX5 p.V26Gfs*49;KLF4 p.P56Qfs*58;CHEK1 p.T226Hfs*14	5	13
P-0000756	P-0000756-T01-IM3	In-House	FFPE	Cytology	63.25	257	65	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.G245V	2	2
P-0000757	P-0000757-T01-IM3	In-House	FFPE	Biopsy	250	983	35	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R213*;STK11 p.P221L;KRAS p.G13D	1	3
P-0000758	P-0000758-T01-IM3	In-House	FFPE	Biopsy	250	243	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	PIK3CA p.E545K;TP53 p.Q136E;CCND1 Amplification;CDK4 Amplification;ETV1 Amplification;FGF19 Amplification;PTEN Deletion	3	7
P-0000758	P-0000758-T02-IM5	In-House	FFPE	Biopsy	250	454	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.R282G;CDK4 Amplification;KIT Amplification;MET Amplification;PDGFRA Amplification	2	5
P-0000759	P-0000759-T01-IM3	In-House	FFPE	Resection	250	520	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.R130*);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN p.R130*;TP53 p.M237I;CUL3 p.M299V;TP53 p.R267Gfs*78;CCNE1 Amplification;PTEN Deletion	2	6
P-0000760	P-0000760-T01-IM3	In-House	FFPE	Resection	250	334	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.T319*);Trametinib,Cobimetinib(NF1 p.S2543Ffs*2);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.T319*;NF1 p.S2543Ffs*2;STAG2 p.D515Gfs*6;BCOR Deletion;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0000761	P-0000761-T01-IM3	In-House	FFPE	Biopsy	64.2	124	90	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	IDH1 p.R132H;TP53 p.S90Pfs*33;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0000762	P-0000762-T01-IM3	In-House	FFPE	Resection	250	412	50	Matched	Metastasis	Cecum	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.R1450*;TP53 p.X224_splice;APC p.N741Ifs*20	1	4
P-0000763	P-0000763-T01-IM3	In-House	FFPE	Resection	250	595	70	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	TP53 p.R248W;KRAS p.A146T;PIK3CA p.E542K;BRAF p.H574Y;TET1 p.R107*;CTNNB1 p.W25_D32del;CDK8 Amplification;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	2	10
P-0000764	P-0000764-T01-IM3	In-House	FFPE	Resection	250	597	90	Matched	Metastasis	Soft Tissue	Chest Wall	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma					Tazemetostat(SMARCB1 p.R377H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CREBBP p.I1084Sfs*15;RB1 p.R320*;SMARCB1 p.R377H;KMT2D p.P2354Lfs*30;NOTCH2 p.R2036*;PMS1 p.Q437*;MLH1 p.X152_splice;FBXW7 p.Q275*;KMT2D p.R2734*;MAPK1 p.E322A;ARID1A p.K1072Nfs*21;BAP1 p.S489Afs*82;INPP4B p.N406Tfs*19;TP53 p.R248Q;TP53 p.X125_splice;RASA1 p.X444_splice;CDKN2A Deletion;EPHA3 Deletion	2	18
P-0000765	P-0000765-T01-IM3	In-House	FFPE	Biopsy	250	533	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3R1 p.E469*;PRKN p.E310*;PTPN11 p.E76Q;TP53 p.R248L;PTPRT p.E1105*;ATRX p.E2281*	2	7
P-0000766	P-0000766-T01-IM3	In-House	FFPE	Biopsy	250	638	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C	2	1
P-0000767	P-0000767-T01-IM3	In-House	FFPE	Resection	54.57	52	20	Matched	Primary	Cervix	Not Applicable	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.G245S	1	2
P-0000768	P-0000768-T01-IM3	In-House	FFPE	Resection	250	434	50	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										KMT2C p.Q166*;ATR p.N1135*;PIK3R1 p.R577Vfs*19;DNMT3B Amplification	0	4
P-0000769	P-0000769-T01-IM3	In-House	FFPE	Resection	250	573	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.Q1406*;APC p.Q789*;TP53 p.L194F	0	3
P-0000770	P-0000770-T01-IM3	Outside	FFPE	Resection	159.6	442	40	Matched	Metastasis	Breast	Chest Wall	Tumor	MBC	Breast Cancer	Metaplastic Breast Cancer				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.R248Q;CDK4 Amplification	1	2
P-0000771	P-0000771-T01-IM3	In-House	FFPE	Resection	250	494	70	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61P)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)				LEVEL_3B	NRAS p.Q61P;KRAS p.A146V	2	2
P-0000772	P-0000772-T01-IM3	In-House	FFPE	Biopsy	250	669	15	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)	GSK2636771,AZD8186(PTEN p.K330*)				LEVEL_3B	TP53 p.R248Q;APC p.S1276*;PTEN p.K330*;APC p.R1435Kfs*38;MET Amplification	2	5
P-0000774	P-0000774-T01-IM3	In-House	FFPE	Biopsy	250	926	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;PIK3CA p.E545K;EGFR p.E746_A750del;TET1 p.Q1169*;STK11 p.E165K;RUNX1 p.D255Vfs*316;CDKN2A Deletion;CDKN2B Deletion	4	8
P-0000775	P-0000775-T01-IM3	In-House	FFPE	Resection	250	562	NA	Matched	Metastasis	Major Salivary Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.Y16*)				LEVEL_3B	TP53 p.Y220C;PTEN p.Y16*;AR Amplification;ERBB2 Amplification	2	4
P-0000776	P-0000776-T01-IM3	Outside	FFPE	Biopsy	250	898	80	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R248Q;CCND1 Amplification;EGFR Amplification;FGF19 Amplification;FGFR2 Amplification;KRAS Amplification;MCL1 Amplification	0	7
P-0000777	P-0000777-T01-IM3	In-House	FFPE	Resection	250	352	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.Y163C;APC p.W685*;APC p.I1307Nfs*8;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;PTEN Deletion;SRC Amplification	1	8
P-0000778	P-0000778-T01-IM3	In-House	FFPE	Resection	250	650	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	MAP2K4 p.X297_splice;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	5
P-0000779	P-0000779-T01-IM3	Outside	FFPE	Resection	250	1012	40	Matched	Primary	Back	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor				Tazemetostat(SMARCB1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CBL p.R420Q;CDKN2A Deletion;RAD51 Deletion;SMARCB1 Deletion	2	4
P-0000780	P-0000780-T01-IM3	Outside	FFPE	Resection	250	574	75	Matched	Metastasis	Uterus	Omentum	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										TP53 p.C238Y	0	1
P-0000782	P-0000782-T01-IM3	Outside	FFPE	Resection	250	759	80	Matched	Metastasis	Testis	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3B	NRAS p.Q61K	1	1
P-0000783	P-0000783-T01-IM3	Outside	FFPE	Resection	250	399	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.Q2157Ifs*18)	Talazoparib,Niraparib(BRCA2 p.Q2157Ifs*18)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12R;BRCA2 p.Q2157Ifs*18;CDKN2A Deletion;SMAD4 Deletion	4	4
P-0000784	P-0000784-T01-IM3	Outside	FFPE	Resection	250	726	75	Matched	Primary	Mediastinum	Not Applicable	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor										BRAF p.D594N	0	1
P-0000785	P-0000785-T01-IM3	In-House	FFPE	Biopsy	189	777	75	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.R280I;PIK3R2 p.X520_splice;CDK4 Amplification;FOXA1 Amplification;MDM2 Amplification;NKX2-1 Amplification	3	7
P-0000786	P-0000786-T01-IM3	In-House	FFPE	Biopsy	250	832	75	Matched	Metastasis	Breast	Skin	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;ARID1A p.S11Afs*91;FOXA1 p.A323Pfs*22;RUNX1 p.R142Kfs*44	2	4
P-0000787	P-0000787-T01-IM3	Outside	FFPE	Biopsy	250	853	75	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CTNNB1 p.S45F;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0000788	P-0000788-T01-IM3	Outside	FFPE	Biopsy	250	420	30	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Afatinib(EGFR p.L861Q);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1010I)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.E542K;EGFR p.L861Q;APC p.E1521*;SETD2 p.X1572_splice;APC p.Q541*;SMAD3 p.R368*;SMAD2 p.D300G;SETD2 p.T305Nfs*4;AXIN2 p.A643Gfs*64;KRAS p.G13D	4	10
P-0000789	P-0000789-T01-IM3	In-House	FFPE	Cytology	82.8	422	25	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.K132N;STK11 p.W332*;KEAP1 p.F546Lfs*2;ETV1 Amplification;MYC Amplification;PRDM1 Deletion	0	6
P-0000790	P-0000790-T01-IM3	In-House	FFPE	Resection	70.8	374	85	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										RB1 p.Y606C;RUNX1 p.T219Qfs*13	0	2
P-0000791	P-0000791-T01-IM3	Outside	FFPE	Biopsy	250	345	80	Matched	Metastasis	Testis	Abdomen	Tumor	SEM	Germ Cell Tumor	Seminoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;BRAF p.D594G;ETV1 Amplification;MAPK1 Amplification	1	4
P-0000792	P-0000792-T01-IM3	Outside	FFPE	Biopsy	250	821	60	Matched	Primary	Minor Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										KDM6A p.S700Ffs*30	0	1
P-0000793	P-0000793-T02-IM5	In-House	FFPE	Biopsy	250	578	60	Matched	Metastasis	Esophagus	Liver	Tumor	EPDCA	Esophagogastric Cancer	Esophageal Poorly Differentiated Carcinoma										TP53 p.R175H;KDM5A Amplification;KRAS Amplification;MYC Amplification	0	4
P-0000795	P-0000795-T01-IM3	In-House	FFPE	Biopsy	250	959	75	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ARID2 p.X638_splice	0	1
P-0000796	P-0000796-T01-IM3	In-House	FFPE	Resection	250	635	50	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0000797	P-0000797-T01-IM3	In-House	FFPE	Biopsy	102.6	661	15	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R196*	0	1
P-0000797	P-0000797-T02-IM3	In-House	FFPE	Biopsy	64	549	50	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R196*	0	1
P-0000798	P-0000798-T01-IM3	In-House	FFPE	Resection	250	706	50	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.Q1367*;TP53 p.V173M	2	3
P-0000799	P-0000799-T01-IM3	Outside	FFPE	Resection	250	844	75	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										RAC1 p.G12R;MAX p.H28R	0	2
P-0000800	P-0000800-T01-IM3	Outside	FFPE	Resection	250	633	70	Matched	Metastasis	Thyroid	Mediastinum	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer					Tazemetostat(SMARCB1 p.L166Ffs*10)				LEVEL_4	APC p.Q1529*;KEAP1 p.R320L;PIK3R2 p.E338*;TBX3 p.A440Pfs*192;TP53 p.N310Tfs*35;SMARCB1 p.L166Ffs*10	1	6
P-0000802	P-0000802-T01-IM3	In-House	FFPE	Resection	250	584	90	Matched	Metastasis	Sigmoid Colon	Pelvis	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.N1037Tfs*19;SOX9 p.W143Lfs*109;RUNX1 p.X143_splice;MAX Deletion	1	5
P-0000803	P-0000803-T01-IM3	In-House	FFPE	Resection	250	126	75	Matched	Primary	Testis	Pelvis	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0000804	P-0000804-T01-IM3	In-House	FFPE	Resection	250	384	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.P153Afs*28	0	1
P-0000805	P-0000805-T01-IM3	In-House	FFPE	Biopsy	250	732	70	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.C136R)				LEVEL_4	PTEN p.C136R;CCND1 Amplification	1	2
P-0000806	P-0000806-T01-IM3	In-House	FFPE	Biopsy	141.6	667	50	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;FOXA1 Amplification;PAK1 Amplification	2	5
P-0000807	P-0000807-T01-IM3	In-House	FFPE	Biopsy	99	355	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KEAP1 p.G333C;TP53 p.P278S;TP53 p.S127F;KRAS p.G13D	1	4
P-0000808	P-0000808-T01-IM3	In-House	FFPE	Biopsy	250	459	25	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0000809	P-0000809-T01-IM3	Outside	FFPE	Biopsy	250	717	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.Y2285Tfs*5)				LEVEL_4	NF1 p.Y2285Tfs*5;CCNE1 Amplification;CDKN1B Deletion;FOXA1 Amplification;NKX2-1 Amplification	1	5
P-0000811	P-0000811-T01-IM3	In-House	FFPE	Biopsy	250	389	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R175H	0	1
P-0000812	P-0000812-T01-IM3	Outside	FFPE	Resection	250	1054	80	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma											0	0
P-0000813	P-0000813-T01-IM3	In-House	FFPE	Biopsy	250	671	85	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma											0	0
P-0000814	P-0000814-T01-IM3	In-House	FFPE	Biopsy	250	460	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R273H;RHOA p.G62V	0	2
P-0000815	P-0000815-T01-IM3	In-House	FFPE	Resection	250	536	50	Matched	Primary	Not available	Not available	Tumor	CHOS	Bone Cancer	Chondroblastic Osteosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	RYBP p.X233_splice;ASXL2 Deletion;CDKN2A Deletion;CDKN2B Deletion;PRKN Deletion;TP53 Deletion	1	6
P-0000816	P-0000816-T01-IM3	Outside	FFPE	Resection	250	592	85	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 p.L142*)				LEVEL_4	NF1 p.L142*;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	1	4
P-0000817	P-0000817-T01-IM3	In-House	FFPE	Resection	250	431	65	Matched	Metastasis	Back	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 p.C135R	0	1
P-0000818	P-0000818-T01-IM3	In-House	FFPE	Resection	250	617	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.R130Q);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN p.R130Q;TP53 p.V272L;RB1 p.X474_splice;ARID5B Deletion;PTEN Deletion	2	5
P-0000819	P-0000819-T01-IM3	Outside	FFPE	Resection	250	326	90	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	PTPRD p.A494S;RBM10 p.Q200*;ARID2 p.P1095Lfs*61;TP53 p.N263_N268del;DNMT3B p.Y477*;ERBB2 Amplification;KRAS Amplification;MET Amplification	3	8
P-0000820	P-0000820-T01-IM3	In-House	FFPE	Biopsy	250	905	20	Matched	Metastasis	Breast	Pelvis	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_3A	ERBB2 p.L755S;RUNX1 p.D96Gfs*15;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	5
P-0000820	P-0000820-T02-IM3	Outside	FFPE	Resection	250	475	75	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_3A	ERBB2 p.L755S;RUNX1 p.D96Gfs*15;SPEN p.E694*;CBFB Deletion;CCND1 Amplification;FGF19 Amplification;MEN1 Deletion;NTRK1 Amplification;PAK1 Amplification;TNFRSF14 Deletion	2	10
P-0000821	P-0000821-T01-IM3	In-House	FFPE	Resection	250	494	50	Matched	Metastasis	Skin	Lung	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.X449_splice)						LEVEL_3A	FAT1 p.X1441_splice;FAT1 p.Q843*;PTCH1 p.X449_splice;MYCN p.P44F;TP53 p.E285K	1	5
P-0000822	P-0000822-T01-IM3	In-House	FFPE	Resection	250	516	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	CDK4 Amplification;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ETV1 Amplification;FOXA1 Deletion;PTEN Deletion;TBX3 Deletion	4	9
P-0000824	P-0000824-T01-IM3	In-House	FFPE	Biopsy	250	407	25	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										TP53 p.I195N;SETD2 p.P1854Hfs*3;BAP1 p.E693Sfs*43	0	3
P-0000825	P-0000825-T01-IM3	In-House	FFPE	Resection	84.6	143	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R158L;PBRM1 p.S413*;STK11 p.Y246*;KEAP1 p.Q82*	0	4
P-0000826	P-0000826-T01-IM3	In-House	FFPE	Resection	250	433	15	Matched	Metastasis	Skin	Chest Wall	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.R130*)				LEVEL_4	PTEN p.R130*;TP53 p.G262V	1	2
P-0000827	P-0000827-T01-IM3	In-House	FFPE	Resection	250	511	15	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.K292*;TP53 p.P190L;SMAD2 p.S296*	0	3
P-0000828	P-0000828-T02-IM3	Outside	FFPE	Resection	250	482	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	SMAD2 p.R182*;B2M Deletion;PTEN Deletion	1	3
P-0000829	P-0000829-T01-IM3	In-House	FFPE	Biopsy	250	1154	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.R249S;PMS1 p.X234_splice;PBRM1 p.Q1400*	0	3
P-0000830	P-0000830-T01-IM3	In-House	FFPE	Resection	250	503	75	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;FOXA1 Amplification	2	2
P-0000831	P-0000831-T01-IM3	In-House	FFPE	Resection	250	544	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(CHEK2 p.V314Wfs*6);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	FOXP1 p.Q71*;TP53 p.P151T;PIK3R2 p.N561D;DNMT3B p.I575Ffs*15;CHEK2 p.V314Wfs*6;SMARCA4 p.R654Sfs*120;MDM2 Amplification	2	7
P-0000835	P-0000835-T01-IM3	In-House	FFPE	Biopsy	250	170	NA	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma											0	0
P-0000835	P-0000835-T02-IM3	Outside	FFPE	Resection	250	334	40	Matched	Primary	Lower Extremity	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										PIK3R1 p.Y390Efs*6	0	1
P-0000836	P-0000836-T01-IM3	In-House	FFPE	Biopsy	250	658	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.M918T)		BLU-667(RET p.M918T)						LEVEL_1	RET p.M918T	2	1
P-0000837	P-0000837-T01-IM3	In-House	FFPE	Resection	75.9	223	85	Matched	Primary	Breast	Not Applicable	Tumor	BA	Breast Sarcoma	Breast Angiosarcoma										MYC Amplification	0	1
P-0000838	P-0000838-T01-IM3	Outside	FFPE	Resection	250	514	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)		Trametinib,Cobimetinib(NF1 p.L2755Sfs*2)				LEVEL_1	MET p.X1010_splice;NF1 p.L2755Sfs*2	4	2
P-0000839	P-0000839-T02-IM5	In-House	DNA	Biopsy	250	1311	80	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;CTNNB1 p.S37F	1	2
P-0000839	P-0000839-T01-IM3	In-House	FFPE	Resection	250	823	50	Matched	Metastasis	Uterus	Abdomen	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)	Temsirolimus(MTOR p.L2427Q)	Everolimus(MTOR p.L2427Q)				LEVEL_3A	AKT1 p.E17K;CTNNB1 p.S37F;MTOR p.L2427Q	3	3
P-0000840	P-0000840-T01-IM3	In-House	FFPE	Resection	250	303	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	2
P-0000841	P-0000841-T01-IM3	Outside	FFPE	Resection	250	523	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;CDKN2B Deletion;MET Amplification	2	3
P-0000842	P-0000842-T02-IM5	In-House	DNA	Biopsy	250	395	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.R93*)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R93*)				LEVEL_1	CDK12 p.R93*;AR Amplification;TIGD7 CREBBP-TIGD7 fusion;CREBBP CREBBP-TIGD7 fusion	2	4
P-0000842	P-0000842-T01-IM3	Outside	FFPE	Biopsy	108	242	75	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.R93*)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R93*)				LEVEL_1	CDK12 p.R93*	2	1
P-0000843	P-0000843-T01-IM3	In-House	FFPE	Resection	250	510	40	Matched	Metastasis	Transverse Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.Q1338*;TP53 p.R282W;BCL2L1 Amplification;DNMT3B Amplification;EGFR Amplification;MYC Amplification;PIK3R2 Deletion;SRC Amplification	0	8
P-0000845	P-0000845-T01-IM3	Outside	FFPE	Resection	250	447	70	Matched	Metastasis	Unknown	Lung	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										AR Amplification	0	1
P-0000846	P-0000846-T01-IM3	In-House	FFPE	Resection	250	472	50	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0000847	P-0000847-T01-IM3	In-House	FFPE	Resection	250	585	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.R261C	0	1
P-0000848	P-0000848-T01-IM3	Outside	FFPE	Resection	250	364	75	Matched	Metastasis	Clivus	Forehead	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0000849	P-0000849-T01-IM3	In-House	FFPE	Resection	250	415	50	Matched	Metastasis	Bowel	Peritoneum	Tumor	CCS	Soft Tissue Sarcoma	Clear Cell Sarcoma											0	0
P-0000850	P-0000850-T01-IM3	In-House	FFPE	Resection	250	358	50	Matched	Metastasis	Breast	Axilla	Tumor	BA	Breast Sarcoma	Breast Angiosarcoma											0	0
P-0000851	P-0000851-T01-IM3	In-House	FFPE	Resection	250	262	90	Matched	Primary	Neck	Not Applicable	Tumor	ASPS	Soft Tissue Sarcoma	Alveolar Soft Part Sarcoma											0	0
P-0000852	P-0000852-T01-IM3	In-House	FFPE	Biopsy	224.4	331	80	Matched	Metastasis	Eye	Lung	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;EIF1AX p.R13C	0	2
P-0000853	P-0000853-T01-IM3	In-House	FFPE	Resection	250	271	70	Matched	Primary	Liver	Not Applicable	Tumor	HCCIHCH	Hepatobiliary Cancer	Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma											0	0
P-0000854	P-0000854-T01-IM3	In-House	FFPE	Resection	250	438	35	Matched	Primary	Ascending Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	APC p.Y935*;APC p.Q1429*;RHOA p.Y34F;SOX9 p.Q393Sfs*10;PTEN Deletion	1	5
P-0000855	P-0000855-T01-IM3	In-House	FFPE	Resection	250	377	30	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 p.R273H;ATRX p.K2036*	0	2
P-0000856	P-0000856-T01-IM3	In-House	FFPE	Resection	250	662	80	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TNFRSF14 Deletion	0	1
P-0000857	P-0000857-T01-IM3	In-House	FFPE	Resection	250	579	NA	Matched	Metastasis	Bone	Soft Tissue	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										PRDM1 Deletion	0	1
P-0000858	P-0000858-T01-IM3	In-House	FFPE	Resection	250	281	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0000859	P-0000859-T01-IM3	In-House	FFPE	Resection	250	363	50	Matched	Primary	Chest Wall	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma											0	0
P-0000860	P-0000860-T01-IM3	In-House	FFPE	Resection	250	401	15	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.I1307Nfs*8;TP53 p.L111P	0	3
P-0000861	P-0000861-T01-IM3	In-House	FFPE	Resection	250	501	70	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G	1	1
P-0000862	P-0000862-T01-IM3	Outside	FFPE	Biopsy	250	453	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R38C)					LEVEL_3B	TP53 p.R273C;CTNNB1 p.S45P;CTCF p.T204Nfs*26;MLH1 p.Q327*;PIK3CA p.R38C;ARID1B p.R885*;KMT2D p.X3481_splice;ARID1A p.G276Efs*87;ARID1A p.Q1519Rfs*8;CASP8 p.K353Sfs*11;TGFBR2 p.K128Afs*3;SETD2 p.D2064Pfs*8;FAT1 p.G2825Efs*4;SOX17 p.P328Rfs*59;BMPR1A p.L59*;NCOR1 p.T525Qfs*30;ATRX p.K1357Rfs*18	1	17
P-0000863	P-0000863-T01-IM3	In-House	FFPE	Biopsy	176	636	30	Matched	Metastasis	Soft Tissue	Lung	Tumor	ASPS	Soft Tissue Sarcoma	Alveolar Soft Part Sarcoma											0	0
P-0000864	P-0000864-T01-IM3	Outside	FFPE	Biopsy	250	613	40	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;MAP3K1 p.R405Vfs*31;MAP3K1 p.T457Sfs*3	1	3
P-0000865	P-0000865-T01-IM3	In-House	FFPE	Resection	250	481	80	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;ARID2 p.Q1313*;ARID2 p.Q961Hfs*14;B2M Deletion;RAD51 Deletion	1	5
P-0000866	P-0000866-T01-IM3	In-House	FFPE	Biopsy	250	779	80	Matched	Primary	Buttock	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0000867	P-0000867-T01-IM3	In-House	FFPE	Resection	250	364	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	BRAF p.D594N;PIK3CB p.D1067V;CDK4 Amplification;MDM2 Amplification;TERT Amplification	2	5
P-0000868	P-0000868-T01-IM3	In-House	FFPE	Resection	250	514	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V272M;APC p.R232*;BCL2L1 Amplification;DNMT3B Amplification;PIK3CB Amplification;SRC Amplification	0	6
P-0000869	P-0000869-T01-IM3	In-House	FFPE	Resection	250	587	50	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R273C;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;MAPK1 Amplification;SRC Amplification	0	6
P-0000870	P-0000870-T01-IM3	In-House	FFPE	Biopsy	250	508	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.X187_splice;EGFR Amplification	0	2
P-0000871	P-0000871-T01-IM3	Outside	FFPE	Biopsy	250	658	90	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ARID1B p.M1?;SPEN p.E1695Nfs*6	0	2
P-0000872	P-0000872-T01-IM3	In-House	FFPE	Resection	250	338	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma											0	0
P-0000873	P-0000873-T01-IM3	Outside	FFPE	Resection	250	631	75	Matched	Metastasis	Lung	Pancreas	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.L282Afs*3	0	1
P-0000874	P-0000874-T01-IM3	Outside	FFPE	Resection	250	444	35	Matched	Metastasis	Rectosigmoid Colon	Brain	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R213L;KRAS p.G13D	1	2
P-0000875	P-0000875-T01-IM3	In-House	FFPE	Resection	250	697	25	Matched	Metastasis	Upper Tract	Lymph Node	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.H878Y)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TP53 p.E285K;TP53 p.R280K;KMT2D p.Q2800*;ERBB2 p.H878Y	2	5
P-0000876	P-0000876-T01-IM3	In-House	FFPE	Cytology	59.22	154	60	Matched	Metastasis	Thyroid	Bone	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										STK11 p.K84*	0	1
P-0000877	P-0000877-T01-IM3	Outside	FFPE	Biopsy	250	538	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										U2AF1 p.S34F;RB1 p.X500_splice;TP53 p.E258*;KMT2D p.S4948Hfs*47;KRAS Amplification	0	5
P-0000878	P-0000878-T01-IM3	Outside	FFPE	Resection	250	1020	60	Matched	Primary	Uterus	Not Applicable	Tumor	UNEC	Endometrial Cancer	Uterine Neuroendocrine Carcinoma										TP53 p.D281N;AKT2 Amplification;RB1 Deletion	0	3
P-0000879	P-0000879-T01-IM3	In-House	FFPE	Biopsy	250	708	40	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0000879	P-0000879-T02-IM5	In-House	DNA	Biopsy	250	573	40	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0000879	P-0000879-T03-IM5	In-House	FFPE	Biopsy	250	1027	60	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;NRAS p.Q61R;CDKN2A Deletion;CDKN2B Deletion;SPOP Deletion	3	5
P-0000880	P-0000880-T01-IM3	In-House	FFPE	Biopsy	250	567	30	Matched	Metastasis	Bladder	Colon	Tumor	SRCBC	Bladder Cancer	Plasmacytoid/Signet Ring Cell Bladder Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;RB1 p.R251*;RB1 p.E97*;CDH1 p.R598*;TP53 p.R213Q;TP53 p.R248Q	1	6
P-0000881	P-0000881-T01-IM3	In-House	FFPE	Resection	250	519	85	Matched	Metastasis	Lower Extremity	Kidney	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0000883	P-0000883-T01-IM3	Outside	FFPE	Biopsy	75.6	409	10	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106V)					LEVEL_3B	PIK3CA p.G106V;PTPN11 p.A72G	1	2
P-0000883	P-0000883-T02-IM5	Outside	DNA	Resection	250	783	20	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106V);Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)	Trametinib,Cobimetinib(NF1 p.X751_splice);Trametinib,Cobimetinib(NF1 p.X1526_splice);Trametinib,Cobimetinib(NF1 p.F358Lfs*18);Trametinib,Cobimetinib(NF1 p.S2484Ffs*3)				LEVEL_3B	PIK3CA p.G106V;NRAS p.G12D;NF1 p.X751_splice;MSH2 p.X71_splice;AKT1 p.R370H;NF1 p.X1526_splice;NF1 p.F358Lfs*18;NF1 p.S2484Ffs*3	6	8
P-0000884	P-0000884-T01-IM3	In-House	FFPE	Biopsy	112.5	645	10	Matched	Primary	Eyelid	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease											0	0
P-0000885	P-0000885-T01-IM3	In-House	FFPE	Resection	250	390	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.T1556Nfs*3;MAP3K1 p.X434_splice;APC p.R405*;SMAD3 p.R373C;APC p.N627Tfs*3	1	6
P-0000887	P-0000887-T01-IM3	In-House	FFPE	Biopsy	250	597	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.R342Efs*3;CTCF p.X259_splice	1	3
P-0000888	P-0000888-T01-IM3	In-House	FFPE	Biopsy	250	902	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RB1 p.X605_splice;APC Deletion;PTEN Deletion;TP53 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0000889	P-0000889-T01-IM3	In-House	FFPE	Resection	250	971	70	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion)			BLU-667,Cabozantinib,Vandetanib(RET CCDC6-RET fusion);BLU-667,Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion)					LEVEL_1	RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	4	2
P-0000890	P-0000890-T01-IM3	Outside	FFPE	Resection	250	477	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	KRAS p.Q61R;CDKN2C p.Q93*;EIF1AX p.X113_splice	1	3
P-0000891	P-0000891-T01-IM3	In-House	FFPE	Biopsy	250	711	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	PIK3CA p.E545K;FGFR3 p.S249C;KMT2C p.E3199*;KMT2D p.Q3793*;CDKN1A p.V25Rfs*13;CREBBP p.V2012Sfs*28;SH2D1A Deletion;STAG2 Deletion	3	8
P-0000892	P-0000892-T01-IM3	Outside	FFPE	Resection	250	1065	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib(ATM p.E38*);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	PIK3CA p.E545K;CDKN1A p.C13*;ATM p.E38*;RB1 p.Q395*;ARID1A p.N1986Qfs*13;ERBB2 Amplification;MEF2B Amplification	3	7
P-0000893	P-0000893-T01-IM3	Outside	FFPE	Biopsy	58.85	142	80	Matched	Metastasis	Skin	Lymph Node, Non-Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(MAP2K1 p.E102_I103del)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R112P)				LEVEL_3A	PIK3CD p.N334K;MAP2K1 p.E102_I103del;CDKN2A p.R112P	2	3
P-0000894	P-0000894-T01-IM3	In-House	FFPE	Resection	250	532	85	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;MDM2 Amplification;MYC Amplification;PAK1 Amplification;RAC1 Amplification	2	5
P-0000895	P-0000895-T01-IM3	In-House	FFPE	Biopsy	250	857	70	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)		GSK2636771,AZD8186(PTEN p.N292Kfs*6)				LEVEL_3A	RAC1 p.P29S;PTEN p.N292Kfs*6;NRAS p.Q61L;B2M p.A6Pfs*2;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	7
P-0000896	P-0000896-T01-IM3	In-House	FFPE	Resection	250	526	90	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;FUBP1 p.X569_splice;ARID1A p.Y551Lfs*72	1	3
P-0000897	P-0000897-T01-IM3	Outside	FFPE	Resection	250	355	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.X224_splice;STK11 p.Q214*;FOXA1 Amplification;NKX2-1 Amplification	2	5
P-0000898	P-0000898-T01-IM3	In-House	FFPE	Resection	61.6	130	80	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L32Q)				LEVEL_1	BRAF p.V600E;CDKN2A p.L32Q	3	2
P-0000899	P-0000899-T01-IM3	Outside	FFPE	Biopsy	135.3	315	35	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.P278R;RASA1 p.X593_splice;CIC p.P911Cfs*6	0	3
P-0000900	P-0000900-T01-IM3	In-House	FFPE	Resection	250	570	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR Amplification	1	2
P-0000901	P-0000901-T01-IM3	In-House	FFPE	Biopsy	211	728	20	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.H1047R;TP53 p.X126_splice;PIK3R2 Amplification	2	4
P-0000902	P-0000902-T01-IM3	In-House	FFPE	Resection	250	628	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;ARID1A p.S1791*;NKX2-1 Amplification	2	3
P-0000903	P-0000903-T02-IM3	Outside	FFPE	Biopsy	250	1112	60	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;NFE2L2 p.R34G;TP53 p.E258V	1	3
P-0000903	P-0000903-T01-IM3	Outside	FFPE	Resection	250	650	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;NFE2L2 p.R34G;TP53 p.E258V	1	3
P-0000904	P-0000904-T01-IM3	In-House	FFPE	Resection	250	1064	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer					GSK2636771,AZD8186(PTEN p.W111*)				LEVEL_4	PTEN p.W111*	1	1
P-0000905	P-0000905-T01-IM3	In-House	FFPE	Resection	226.6	400	70	Matched	Primary	Not available	Not available	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma					GSK2636771,AZD8186(PTEN p.V9Afs*14)				LEVEL_4	PTEN p.V9Afs*14;BMPR1A Deletion	1	2
P-0000906	P-0000906-T01-IM3	In-House	FFPE	Biopsy	250	725	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.X212_splice)				LEVEL_3B	TP53 p.R273C;EGFR p.H304Y;PTEN p.X212_splice;CDK8 p.S62L;SETD2 p.V1427Efs*4;CDK4 Amplification;MYCN Amplification	2	7
P-0000907	P-0000907-T01-IM3	Outside	FFPE	Resection	250	944	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.Q628*)					LEVEL_3B	ATM p.Q628*;TP53 p.R273S;STK11 p.E223*	1	3
P-0000908	P-0000908-T01-IM3	Outside	FFPE	Resection	250	609	75	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.E79D)	Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)	Tazemetostat(KDM6A p.N1117Mfs*34)				LEVEL_3A	BRAF p.V600E;TP53 p.E271K;ERBB2 p.S310F;ARID2 p.Q1411*;TP53 p.V173L;FBXW7 p.D520N;PIK3R1 p.Q241*;RB1 p.Q384*;RB1 p.S576*;ERCC2 p.E79D;MED12 p.Q31H;CREBBP p.S1680del;CREBBP p.E371Kfs*53;KDM6A p.N1117Mfs*34	4	14
P-0000909	P-0000909-T03-IM3	In-House	FFPE	Resection	250	461	NA	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000910	P-0000910-T01-IM3	In-House	FFPE	Resection	250	647	40	Matched	Metastasis	Major Salivary Gland	Liver	Tumor	MUCC	Salivary Gland Cancer	Mucoepidermoid Carcinoma				Tipifarnib(HRAS p.G13V)					LEVEL_3B	HRAS p.G13V	1	1
P-0000911	P-0000911-T01-IM3	In-House	FFPE	Resection	250	579	70	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_4	TP53 p.R273H;PTEN p.X268_splice;APC p.S1346*;AKT2 Amplification	1	4
P-0000912	P-0000912-T01-IM3	In-House	FFPE	Resection	250	523	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133S	0	1
P-0000913	P-0000913-T02-IM5	In-House	FFPE	Cytology	250	979	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Trametinib,Cobimetinib(BRAF AGK-BRAF fusion);Trametinib,Cobimetinib(AGK AGK-BRAF fusion)					LEVEL_1	EGFR p.E746_A750del;TP53 p.E198*;EGFR Amplification;BRAF AGK-BRAF fusion;AGK AGK-BRAF fusion	3	5
P-0000913	P-0000913-T03-IM5	In-House	FFPE	Resection	250	771	35	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.E198*;EGFR Amplification	2	4
P-0000914	P-0000914-T01-IM3	Outside	FFPE	Resection	250	704	75	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										FAT1 p.H4155Tfs*50;B2M p.L15Ffs*41	0	2
P-0000916	P-0000916-T01-IM3	In-House	FFPE	Resection	250	528	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Everolimus(TSC1 p.Q516*)					LEVEL_3B	ERBB2 p.S310F;ERBB4 p.F1102C;TSC1 p.Q516*;TP53 p.E336*;NOTCH3 p.R103*;AXL p.A273V;CCND1 Amplification;FGF19 Amplification	2	8
P-0000917	P-0000917-T01-IM3	In-House	FFPE	Biopsy	250	973	10	Matched	Metastasis	Cancer of Unknown Primary	Sigmoid Colon	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										SMAD4 p.G365D	0	1
P-0000918	P-0000918-T01-IM3	In-House	FFPE	Resection	250	520	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Q110*);Lapatinib(EGFR p.R108K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.Q110*;EGFR p.R108K;EGFR p.P589L;PTPN11 p.E76K;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	4	7
P-0000919	P-0000919-T01-IM3	In-House	FFPE	Resection	250	778	20	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_3B	ERBB2 p.S310F;NOTCH2 p.X994_splice;ATR p.R1886*;PIK3R1 p.Q478*;NOTCH1 p.X1673_splice;NOTCH1 p.X135_splice;NOTCH3 p.W1495*;TP53 p.X187_splice;CDKN2A p.W110*	2	9
P-0000920	P-0000920-T01-IM3	Outside	FFPE	Biopsy	250	251	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 p.T2061Ifs*9)				LEVEL_4	KDM6A p.Y294*;TP53 p.T118Gfs*6;NF1 p.T2061Ifs*9	1	3
P-0000921	P-0000921-T01-IM3	Outside	FFPE	Resection	250	262	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;MAP2K4 p.X212_splice;CCND1 Amplification;FGF19 Amplification	2	4
P-0000922	P-0000922-T01-IM3	In-House	FFPE	Biopsy	250	980	90	Matched	Metastasis	Skin	Adrenal Gland	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;APC p.E1544*	2	2
P-0000923	P-0000923-T01-IM3	In-House	FFPE	Resection	250	504	60	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	MYEC	Salivary Gland Cancer	Myoepithelial Carcinoma											0	0
P-0000924	P-0000924-T01-IM3	In-House	FFPE	Resection	250	667	60	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A68E)				LEVEL_3A	KRAS p.G12C;TP53 p.E271V;CDKN2A p.A68E;CDK4 Amplification;KRAS Amplification	4	5
P-0000925	P-0000925-T01-IM3	In-House	FFPE	Biopsy	115	746	50	Matched	Metastasis	Upper Tract	Lymph Node	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma					Tazemetostat(KDM6A p.X1095_splice)				LEVEL_4	TP53 p.K132R;KDM6A p.X1095_splice;DDR2 Amplification;NCOR1 Deletion	1	4
P-0000926	P-0000926-T01-IM3	In-House	FFPE	Biopsy	250	480	30	Matched	Metastasis	Lower Extremity	Bone	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma											0	0
P-0000927	P-0000927-T01-IM3	In-House	FFPE	Resection	250	825	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0000928	P-0000928-T01-IM3	Outside	FFPE	Biopsy	250	567	40	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.R280S;CDK4 Amplification;GATA3 Deletion;MDM2 Amplification	2	4
P-0000929	P-0000929-T01-IM3	In-House	FFPE	Cytology	250	624	50	Matched	Metastasis	Lung	Pancreas	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.K120Sfs*3;RB1 p.X46_splice;EGFR Amplification;NKX2-1 Amplification	1	5
P-0000930	P-0000930-T01-IM3	In-House	FFPE	Resection	250	544	50	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Enasidenib(IDH2 p.R172K)					LEVEL_3B	IDH2 p.R172K;DNMT3A Deletion	1	2
P-0000931	P-0000931-T01-IM3	In-House	FFPE	Resection	250	589	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F102C	0	1
P-0000932	P-0000932-T01-IM3	In-House	FFPE	Biopsy	250	687	30	Matched	Metastasis	Liver	Pelvis	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0000933	P-0000933-T01-IM3	Outside	FFPE	Biopsy	250	559	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	PLX8394(BRAF p.G469A)				LEVEL_3B	PIK3CA p.E542K;BRAF p.G469A;APC p.R283*;TP53 p.T125A;APC p.N942Ifs*13	2	5
P-0000934	P-0000934-T01-IM3	Outside	FFPE	Resection	250	589	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R;ARID1A p.Q372Afs*28;BLM p.K390Nfs*2	1	3
P-0000935	P-0000935-T01-IM3	In-House	FFPE	Cytology	250	578	30	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.F134V;AR Amplification;MAP3K1 Deletion;PTEN Deletion	1	4
P-0000936	P-0000936-T01-IM3	Outside	FFPE	Biopsy	250	575	25	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L78Hfs*41)				LEVEL_4	KRAS p.G12V;U2AF1 p.S34F;CDKN2A p.L78Hfs*41	2	3
P-0000937	P-0000937-T01-IM3	In-House	FFPE	Resection	250	415	60	Matched	Primary	Bone	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0000938	P-0000938-T01-IM3	Outside	FFPE	Biopsy	250	991	30	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.C238Y;ARID1A p.G1293*;MET Amplification	1	3
P-0000939	P-0000939-T02-IM5	In-House	FFPE	Biopsy	250	701	50	Matched	Metastasis	Skin	Lung	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.L485Pfs*12)						LEVEL_3A	TGFBR1 p.R487W;TP53 p.C238F;PTCH1 p.L485Pfs*12;SMO p.V321M	1	4
P-0000939	P-0000939-T01-IM3	In-House	FFPE	Resection	250	485	50	Matched	Metastasis	Skin	Lung	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.L485Pfs*12)						LEVEL_3A	TGFBR1 p.R487W;TP53 p.C238F;PTCH1 p.L485Pfs*12	1	3
P-0000940	P-0000940-T01-IM3	In-House	FFPE	Resection	250	500	15	Matched	Metastasis	Transverse Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R130Q);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R273C;PTEN p.R130Q;APC p.R805*;APC p.P1497Qfs*10;KRAS p.G13D	2	5
P-0000941	P-0000941-T01-IM3	In-House	FFPE	Resection	250	387	30	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0000942	P-0000942-T01-IM3	In-House	FFPE	Biopsy	128.26	470	20	Matched	Metastasis	Liver	Peritoneum	Tumor	HCCIHCH	Hepatobiliary Cancer	Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma				Everolimus(TSC2 p.R1138*)					LEVEL_3B	TP53 p.C141Y;RB1 p.L158*;TSC2 p.R1138*;CDKN1A p.G14Afs*12;JUN Amplification	1	5
P-0000943	P-0000943-T01-IM3	In-House	FFPE	Biopsy	250	802	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										TP53 Deletion	0	1
P-0000944	P-0000944-T01-IM3	In-House	FFPE	Resection	250	622	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Everolimus(TSC2 p.W304*);Everolimus(TSC2 p.Q1104*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*);Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.E545K;TP53 p.X332_splice;CASP8 p.G325D;BAP1 p.X630_splice;PRDM1 p.Q78*;LATS1 p.W178*;ARID1B p.X838_splice;SDHAF2 p.W121*;TSC2 p.W304*;TSC2 p.Q1104*;CDKN2A p.W110*;EGFR Amplification;GATA3 Deletion;MDM4 Amplification	5	14
P-0000945	P-0000945-T01-IM3	In-House	FFPE	Biopsy	250	371	35	Matched	Primary	Oropharynx	Not Applicable	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma											0	0
P-0000946	P-0000946-T01-IM3	Outside	FFPE	Biopsy	250	697	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.E545K;CCND1 Amplification;MDM2 Amplification	3	3
P-0000947	P-0000947-T01-IM3	Outside	FFPE	Resection	250	454	50	Matched	Metastasis	Breast	Bone	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H419_C420del)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H419_C420del)		GSK2636771,AZD8186(PTEN p.A126V)				LEVEL_1	TP53 p.R248Q;PTEN p.A126V;PIK3CA p.H419_C420del;CCND1 Amplification;FGF19 Amplification	3	5
P-0000948	P-0000948-T01-IM3	In-House	FFPE	Resection	250	237	80	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										KDM6A p.I970Tfs*8;KDR Amplification;KIT Amplification;PDGFRA Amplification;YAP1 Amplification	0	5
P-0000949	P-0000949-T01-IM3	In-House	FFPE	Biopsy	55	261	50	Matched	Metastasis	Oral Cavity	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma											0	0
P-0000950	P-0000950-T02-IM3	In-House	FFPE	Resection	250	336	20	Matched	Primary	Small Bowel	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;APC p.E443*;APC p.E1554*;TET1 p.S1714*;TP53 p.S127Y	2	5
P-0000950	P-0000950-T01-IM3	In-House	FFPE	Resection	250	569	20	Matched	Primary	Duodenum-Jejunum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;APC p.E443*;APC p.E1554*;TP53 p.S127Y;PTPRD p.E246*;RB1 p.X566_splice	2	6
P-0000951	P-0000951-T01-IM3	In-House	FFPE	Resection	250	364	60	Matched	Metastasis	Skin	Scalp	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T93K)				LEVEL_4	TP53 p.N131I;NOTCH2 p.W1450*;FAT1 p.Y2633*;FAT1 p.S1361*;NOTCH1 p.C467F;TP53 p.E286V;SMAD4 p.R445*;NOTCH3 p.W266*;PPP2R1A p.Y85*;RB1 p.S194Ffs*7;CDKN2A p.T93K	1	11
P-0000952	P-0000952-T02-IM5	In-House	FFPE	Biopsy	250	1214	50	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;U2AF1 p.S34F;ARID1A p.R693*;CTNNB1 p.D32Y;FAT1 p.D1403Rfs*16;AKT1 Amplification	1	6
P-0000952	P-0000952-T01-IM3	In-House	FFPE	Biopsy	250	568	40	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;U2AF1 p.S34F;ARID1A p.R693*;CTNNB1 p.D32Y;FAT1 p.D1403Rfs*16;AKT1 Amplification	1	6
P-0000952	P-0000952-T03-IM5	In-House	FFPE	Cytology	250	1074	30	Matched	Metastasis	Uterus	Rib	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;U2AF1 p.S34F;ARID1A p.R693*;CTNNB1 p.D32Y;FAT1 p.D1403Rfs*16;AKT1 Amplification	1	6
P-0000954	P-0000954-T01-IM3	In-House	FFPE	Resection	250	617	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer										RB1 p.E672*;CREBBP p.X1305_splice;TP53 p.R249T	0	3
P-0000955	P-0000955-T01-IM3	In-House	FFPE	Biopsy	250	439	75	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.E380Q)						LEVEL_3A	ESR1 p.E380Q;CDH1 p.X278_splice;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	1	5
P-0000956	P-0000956-T01-IM3	Outside	FFPE	Resection	250	442	50	Matched	Metastasis	Jejunum	Omentum	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer										GNAS p.R201H	0	1
P-0000957	P-0000957-T01-IM3	In-House	FFPE	Resection	250	97	30	Matched	Metastasis	Minor Salivary Gland	Orbit	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma					Trametinib,Cobimetinib(NF1 p.S1150*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108N)				LEVEL_4	TP53 p.X332_splice;NF1 p.S1150*;CDKN2A p.D108N	2	3
P-0000958	P-0000958-T01-IM3	In-House	FFPE	Biopsy	250	719	60	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.Q167*	2	2
P-0000960	P-0000960-T01-IM3	Outside	FFPE	Biopsy	250	1759	25	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.X70_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	SETD2 p.Q1409*;PTEN p.X70_splice;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	4	6
P-0000961	P-0000961-T01-IM3	In-House	FFPE	Resection	250	857	70	Matched	Metastasis	Testis	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0000962	P-0000962-T01-IM3	In-House	FFPE	Resection	250	545	70	Matched	Metastasis	Uterus	Retroperitoneum	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;ERBB3 Amplification;MDM2 Amplification	2	3
P-0000963	P-0000963-T01-IM3	Outside	FFPE	Biopsy	250	529	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.A83Rfs*40	1	2
P-0000964	P-0000964-T01-IM3	In-House	FFPE	Resection	250	618	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.K2075*)			Talazoparib,Niraparib(BRCA2 p.K2075*)					LEVEL_1	SMAD2 p.S464*;APC p.T1556Nfs*3;SPEN p.G1705Rfs*6;BRCA2 p.K2075*	2	4
P-0000964	P-0000964-T02-IM3	In-House	FFPE	Resection	250	434	15	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.K2075*)			Talazoparib,Niraparib(BRCA2 p.K2075*)					LEVEL_1	SMAD2 p.S464*;APC p.T1556Nfs*3;SPEN p.G1705Rfs*6;BRCA2 p.K2075*	2	4
P-0000965	P-0000965-T01-IM3	In-House	FFPE	Biopsy	250	1254	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_3A	ESR1 p.Y537S;NFE2L2 p.Q26K;CCND1 Amplification;FGF19 Amplification	1	4
P-0000966	P-0000966-T01-IM3	In-House	FFPE	Biopsy	86.14	260	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										KMT2C p.Q2394*;ASXL1 p.Y700*	0	2
P-0000966	P-0000966-T02-IM3	Outside	FFPE	Biopsy	250	537	30	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RNF43 p.G659Vfs*41;AR p.H875Y;KMT2C p.Q3250*;RNF43 p.Q488*;STAG2 p.R1205*;ASXL1 p.W796Gfs*3;PTEN Deletion	1	7
P-0000967	P-0000967-T01-IM3	In-House	FFPE	Resection	250	371	70	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer				Everolimus(TSC2 p.F1275Lfs*46)					LEVEL_3B	TSC2 p.F1275Lfs*46	1	1
P-0000968	P-0000968-T01-IM3	In-House	FFPE	Biopsy	250	514	80	Matched	Metastasis	Anus	Lymph Node, Regional	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma										GNAQ p.R183Q;MAPK1 Amplification;PRDM1 Deletion;TGFBR2 Deletion	0	4
P-0000969	P-0000969-T01-IM3	In-House	FFPE	Resection	250	385	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.S106R;FBXW7 p.M268Dfs*18;MCL1 Amplification;PIK3CA Amplification	0	4
P-0000970	P-0000970-T01-IM3	In-House	FFPE	Resection	250	414	75	Matched	Primary	Small Bowel	Not Applicable	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor										SMAD4 p.S154*;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	0	4
P-0000972	P-0000972-T01-IM3	In-House	FFPE	Resection	250	1002	80	Matched	Metastasis	Rib	Diaphragm	Tumor	MYCHS	Bone Cancer	Myxoid Chondrosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion	1	1
P-0000973	P-0000973-T01-IM3	In-House	FFPE	Resection	250	239	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.R273H;FGFR1 Amplification;MEF2B Amplification;PAK1 Amplification;PTEN Deletion	2	5
P-0000976	P-0000976-T01-IM3	Outside	FFPE	Resection	250	1056	80	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0000977	P-0000977-T01-IM3	Outside	FFPE	Biopsy	250	589	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L32P)				LEVEL_4	TP53 p.X126_splice;CDKN2A p.L32P	1	2
P-0000978	P-0000978-T02-IM5	In-House	DNA	Biopsy	250	839	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	SMAD4 p.R361H;APC p.S1272*;APC p.G1499Ffs*7;APC p.Q1480Lfs*11;MET p.X963_splice;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	5	8
P-0000978	P-0000978-T01-IM3	In-House	FFPE	Biopsy	250	381	15	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										SMAD4 p.R361H	0	1
P-0000979	P-0000979-T01-IM3	In-House	FFPE	Biopsy	250	459	60	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.D1868Vfs*5)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;TP53 p.S241F;RASA1 p.X180_splice;BRCA2 p.D1868Vfs*5;SMAD4 Deletion	2	5
P-0000980	P-0000980-T01-IM3	In-House	FFPE	Biopsy	250	619	90	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										RASA1 p.X868_splice;FAT1 p.V3388Rfs*27;NOTCH1 p.T633Dfs*12;BCOR p.A385Sfs*60	0	4
P-0000982	P-0000982-T01-IM3	In-House	FFPE	Biopsy	250	665	15	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R196*;TP53 p.R158H;APC p.E1353*;ERBB2 p.V842I;ERBB2 Amplification	3	5
P-0000982	P-0000982-T02-IM5	In-House	FFPE	Biopsy	250	856	60	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R196*;TP53 p.R158H;APC p.E1353*;ERBB2 p.V842I;ERBB2 Amplification	3	5
P-0000984	P-0000984-T01-IM3	Outside	FFPE	Resection	250	641	85	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CTCF p.H288Y;MDM4 Amplification	2	3
P-0000985	P-0000985-T01-IM3	In-House	FFPE	Biopsy	250	620	70	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.S426Ifs*81;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;SMAD4 Deletion	0	5
P-0000987	P-0000987-T01-IM3	In-House	FFPE	Biopsy	250	608	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;FLT1 p.R1146T;TP53 p.Q104*;EGFR Amplification;MYC Amplification	1	5
P-0000988	P-0000988-T01-IM3	In-House	FFPE	Biopsy	250	552	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;TP53 p.V173L;APC p.E1353*;TP53 p.X307_splice;APC p.T240Afs*18;CCND1 Amplification;FGF19 Amplification	1	7
P-0000989	P-0000989-T01-IM3	Outside	FFPE	Biopsy	174	365	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;KEAP1 p.R336*;SMARCA4 p.X835_splice	2	3
P-0000990	P-0000990-T02-IM3	In-House	FFPE	Resection	250	457	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0000991	P-0000991-T01-IM3	Outside	FFPE	Resection	250	556	50	Matched	Metastasis	Esophagus	Lung	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R282W;BAP1 p.Q277Rfs*6;ERBB2 Amplification	2	3
P-0000992	P-0000992-T01-IM3	In-House	FFPE	Resection	250	679	70	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										SMAD4 p.R380S;BCL2L1 Amplification;DNMT3B Amplification	0	3
P-0000993	P-0000993-T01-IM3	Outside	FFPE	Biopsy	250	707	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KMT2D p.S2312*;FAT1 p.L4081*;PIK3R1 p.G376R;KMT2C p.Q3470*;KMT2D p.R5179L;TP53 p.X126_splice;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification	2	9
P-0000994	P-0000994-T01-IM3	Outside	FFPE	Biopsy	250	603	15	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;APC p.R1114*;SMAD4 p.E526D	0	3
P-0000995	P-0000995-T01-IM3	In-House	FFPE	Biopsy	250	588	60	Matched	Metastasis	Stomach	Liver	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors										CCNE1 Amplification;KRAS Amplification;SMAD4 Deletion;TERT Amplification;TP53 Deletion	0	5
P-0000997	P-0000997-T01-IM3	In-House	FFPE	Biopsy	250	593	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.R173C)				LEVEL_1	BRAF p.V600E;PTEN p.R173C;SMAD4 p.A118V;TP53 p.R306*;PARP1 p.Q875Sfs*6	4	5
P-0000997	P-0000997-T02-IM3	Outside	FFPE	Resection	250	864	40	Matched	Metastasis	Ascending Colon	Abdomen	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.R173C)				LEVEL_1	BRAF p.V600E;PTEN p.R173C;SMAD4 p.A118V;TP53 p.R306*	4	4
P-0000998	P-0000998-T01-IM3	In-House	FFPE	Biopsy	250	304	80	Matched	Metastasis	Lung	Skin	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										ARID5B Deletion;CCND1 Amplification;TERT Amplification;TGFBR2 Deletion	0	4
P-0000999	P-0000999-T01-IM3	In-House	FFPE	Resection	250	480	70	Matched	Metastasis	Stomach	Liver	Tumor	SWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumors of the Stomach											0	0
P-0001000	P-0001000-T01-IM3	In-House	FFPE	Resection	250	307	70	Matched	Primary	Pelvis	Not Applicable	Tumor	ASPS	Soft Tissue Sarcoma	Alveolar Soft Part Sarcoma										SDHA Deletion	0	1
P-0001001	P-0001001-T01-IM3	Outside	FFPE	Biopsy	189	352	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Olaparib(ATM p.E2570*)	Trametinib,Cobimetinib(NF1 p.Q1577*)				LEVEL_3B	ERBB2 p.S310F;PTPRD p.X1138_splice;ATM p.E2570*;ERBB3 p.G284R;ERBB3 p.E928G;NF1 p.Q1577*;MEN1 p.E473Kfs*85	3	7
P-0001002	P-0001002-T01-IM3	In-House	FFPE	Biopsy	250	821	80	Matched	Primary	Bone	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice)				LEVEL_4	SUZ12 p.E612*;CDKN2A p.X51_splice	1	2
P-0001003	P-0001003-T01-IM3	In-House	FFPE	Resection	250	369	90	Matched	Primary	Liver	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma										BLM p.X1120_splice	0	1
P-0001004	P-0001004-T01-IM3	Outside	FFPE	Resection	250	611	50	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										RAC1 p.Q61K	0	1
P-0001005	P-0001005-T01-IM3	Outside	FFPE	Resection	250	1334	30	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13E)				LEVEL_4	TP53 p.H179L;PPP2R1A p.S256F;KRAS p.G13E	1	3
P-0001006	P-0001006-T01-IM3	In-House	FFPE	Biopsy	250	979	50	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer					GSK2636771,AZD8186(PTEN p.X267_splice);Trametinib,Cobimetinib(NF1 p.E318Kfs*11)				LEVEL_4	PTEN p.X267_splice;TP53 p.R65Cfs*79;NF1 p.E318Kfs*11;EP300 p.R1934Sfs*138	2	4
P-0001007	P-0001007-T02-IM5	In-House	FFPE	Biopsy	250	1140	65	Matched	Metastasis	Thyroid	Retroperitoneum	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										TP53 p.P151H;DICER1 p.E1813K;AURKA Amplification	0	3
P-0001007	P-0001007-T01-IM3	In-House	FFPE	Resection	250	719	80	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer					GSK2636771,AZD8186(PTEN p.C124Y)				LEVEL_4	TP53 p.P151H;PTEN p.C124Y;DICER1 p.E1813K;AURKA Amplification	1	4
P-0001008	P-0001008-T01-IM3	In-House	FFPE	Biopsy	250	766	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;ERBB3 p.E928G;TGFBR2 p.E526Q;FOXP1 p.X630_splice;ARID1A p.G248Sfs*147	1	5
P-0001009	P-0001009-T01-IM3	In-House	FFPE	Resection	250	743	25	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(NF1 p.X510_splice)				LEVEL_3B	CREBBP p.S381*;NF1 p.X510_splice;MDM2 Amplification	2	3
P-0001010	P-0001010-T01-IM3	In-House	FFPE	Biopsy	76	282	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0001010	P-0001010-T02-IM5	In-House	FFPE	Cytology	191.763	100	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)						LEVEL_1	KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	6	2
P-0001011	P-0001011-T01-IM3	Outside	FFPE	Biopsy	250	358	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.Y336*)				LEVEL_4	PTEN p.Y336*;TP53 p.M133K;FGFR2 Amplification	1	3
P-0001012	P-0001012-T01-IM3	Outside	FFPE	Resection	250	670	60	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification	0	2
P-0001013	P-0001013-T01-IM3	In-House	FFPE	Resection	250	503	25	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0001014	P-0001014-T01-IM3	In-House	FFPE	Biopsy	73.7	129	60	Matched	Metastasis	Testis	Retroperitoneum	Tumor	SEM	Germ Cell Tumor	Seminoma										GNAQ p.Q209P	0	1
P-0001015	P-0001015-T01-IM3	Outside	FFPE	Resection	250	310	90	Unmatched	Metastasis	Thyroid	Liver	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer											0	0
P-0001016	P-0001016-T01-IM3	Outside	FFPE	Resection	250	1092	80	Matched	Primary	Not available	Not available	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma										TP53 p.G245S;DICER1 p.G1809R;FAT1 Deletion	0	3
P-0001017	P-0001017-T01-IM3	In-House	FFPE	Resection	250	728	35	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										SMAD4 p.A118V;APC p.L592*;TP53 p.Y234H;HIST1H1C p.K23del;MYC Amplification;PIK3CA Amplification	0	6
P-0001018	P-0001018-T01-IM3	Outside	FFPE	Resection	250	222	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;RBM10 p.Q850*	1	2
P-0001019	P-0001019-T01-IM3	Outside	FFPE	Resection	250	484	80	Unmatched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del)								LEVEL_1	KIT p.W557_K558del	1	1
P-0001020	P-0001020-T01-IM3	Outside	FFPE	Resection	250	423	40	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	GSK2636771,AZD8186(PTEN p.Y27H);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.N345K;CREBBP p.P1946Hfs*30;FBXW7 p.R393*;PTEN p.Y27H;EP300 p.Q149*;APC p.S367Cfs*10;APC p.L1129Ffs*6;APC p.K1628Sfs*22;KRAS p.G13D	3	9
P-0001021	P-0001021-T01-IM3	In-House	FFPE	Biopsy	250	1072	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(PALB2 p.Q150_Q151delinsH*)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)					LEVEL_1	PIK3CA p.Q546P;PTPRD p.S431L;FOXA1 p.R219S;PALB2 p.Q150_Q151delinsH*;AR Amplification;CDH1 Deletion;FANCA Deletion;SMAD2 Deletion;SMAD4 Deletion;EWSR1 GAS2L1-EWSR1 fusion;GAS2L1 GAS2L1-EWSR1 fusion	2	11
P-0001023	P-0001023-T01-IM3	In-House	FFPE	Biopsy	180.36	383	10	Matched	Metastasis	Esophagus	Lung	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.H193R;CCNE1 Amplification	0	2
P-0001026	P-0001026-T01-IM3	Outside	FFPE	Biopsy	250	650	70	Matched	Primary	Not available	Not available	Tumor	SCOS	Bone Cancer	Small Cell Osteosarcoma											0	0
P-0001027	P-0001027-T01-IM3	In-House	FFPE	Resection	82.5	266	15	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										SUFU p.T13Wfs*29	0	1
P-0001028	P-0001028-T01-IM3	Outside	FFPE	Biopsy	146.88	724	40	Matched	Metastasis	Thyroid	Trachea	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer					Trametinib,Cobimetinib(NF1 p.R1534*)				LEVEL_4	TP53 p.Q331*;TP53 p.R213*;RB1 p.X463_splice;NF1 p.R1534*	1	4
P-0001029	P-0001029-T01-IM3	In-House	FFPE	Biopsy	250	775	50	Matched	Metastasis	Foot	Liver	Tumor	ACRM	Melanoma	Acral Melanoma					Trametinib,Cobimetinib(NF1 p.E2578*);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	NF1 p.E2578*;AKT2 Amplification;AURKA Amplification;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;PTEN Deletion	2	7
P-0001030	P-0001030-T01-IM3	Outside	FFPE	Resection	250	708	60	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										CREBBP p.S1172Qfs*7;BCL6 Amplification;PIK3CA Amplification	0	3
P-0001031	P-0001031-T01-IM3	Outside	FFPE	Biopsy	100.98	660	40	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Enasidenib(IDH2 p.R172W)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	IDH2 p.R172W;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PAX5 Deletion	2	5
P-0001032	P-0001032-T01-IM3	In-House	FFPE	Biopsy	250	1075	30	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0001034	P-0001034-T01-IM3	In-House	FFPE	Resection	250	803	50	Matched	Metastasis	Minor Salivary Gland	Lymph Node	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0001035	P-0001035-T01-IM3	In-House	FFPE	Resection	250	920	35	Matched	Metastasis	Scalp	Scalp	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	ERCC3 p.R109*;NFE2L2 p.L30F;KMT2D p.Q4387*;KEAP1 p.Q530*;FAT1 p.N109Ifs*4;NOTCH1 p.W327*;KMT2C p.Q49Rfs*56;TP53 p.S46Gfs*4;MRE11 p.X134_splice;CDKN2A p.R58*	1	10
P-0001036	P-0001036-T01-IM3	Outside	FFPE	Resection	191.4	576	NA	Matched	Metastasis	Ovary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Trametinib,Cobimetinib(MKRN1 BRAF-MKRN1 fusion);Trametinib,Cobimetinib(BRAF BRAF-MKRN1 fusion)					LEVEL_3B	MKRN1 BRAF-MKRN1 fusion;BRAF BRAF-MKRN1 fusion	2	2
P-0001037	P-0001037-T01-IM3	In-House	FFPE	Biopsy	250	856	60	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010H)	Crizotinib(MET p.D1010H);Crizotinib(MET Amplification)	Cabozantinib(MET p.D1010H)	Milademetan Tosylate,RO5045337(MDM2 Amplification);Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	APC p.R1920*;MET p.D1010H;KLF4 p.M1?;DICER1 p.Q1776*;BCL2L1 Amplification;KDM5A Amplification;MDM2 Amplification;MET Amplification;NKX3-1 Deletion;RB1 Deletion;TERT Amplification	6	11
P-0001038	P-0001038-T01-IM3	In-House	FFPE	Resection	250	808	80	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										TP53 p.E339_F341delinsV;CCNE1 Amplification	0	2
P-0001039	P-0001039-T01-IM3	Outside	FFPE	Biopsy	250	639	70	Matched	Primary	Peritoneum	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma										RHOA p.E47K;RBM10 p.Q757*	0	2
P-0001040	P-0001040-T01-IM3	In-House	FFPE	Biopsy	195	227	10	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.F212Sfs*3	0	1
P-0001040	P-0001040-T02-IM3	In-House	FFPE	Resection	250	224	NA	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0001041	P-0001041-T01-IM3	In-House	FFPE	Resection	191.4	640	60	Matched	Metastasis	Thyroid	Bone	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;NKX2-1 Amplification	2	2
P-0001042	P-0001042-T01-IM3	In-House	FFPE	Resection	250	654	30	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Olaparib(ATM p.R2849*);Cisplatin(ERCC2 p.R631H)	Trametinib,Cobimetinib(NF1 p.E568*)				LEVEL_3B	TP53 p.G245S;RPTOR p.R139H;ARID1A p.R1461*;SMAD4 p.R361H;APC p.R564*;NOTCH2 p.K1350*;ASXL2 p.M1?;MSH6 p.R581*;PMS1 p.R55*;ERBB4 p.R306C;SETD2 p.R400*;TET2 p.R1214W;SDHA p.R329*;PIK3R1 p.R642*;RAD50 p.R1061*;NSD1 p.R1031*;CARD11 p.N62D;EGFR p.R222C;NOTCH1 p.A465T;TET1 p.R590*;ATM p.R2849*;KMT2A p.R1633*;RAD52 p.R396H;TBX3 p.R131*;GRIN2A p.R1206*;CTCF p.S354F;CTCF p.R377C;TP53 p.R181H;NCOR1 p.R694*;NF1 p.E568*;RNF43 p.G29*;CIC p.X23_splice;ERCC2 p.R631H;TOP1 p.R708*;MSH6 p.V1192Cfs*2;LATS1 p.K662Nfs*3;ARID5B p.I497*;KMT2D p.P647Hfs*283;NOTCH3 p.C43Lfs*32	3	39
P-0001043	P-0001043-T01-IM3	Outside	FFPE	Biopsy	250	270	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.R93L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93L)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.R93L;MAP3K1 p.P550Lfs*7;MAP3K1 p.G608Afs*48	4	4
P-0001044	P-0001044-T01-IM3	In-House	FFPE	Biopsy	250	787	70	Matched	Metastasis	Uterus	Omentum	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	TP53 p.R175H;SPEN p.R229*;PIK3R1 p.X582_splice;RASA1 p.Y615*;NF1 NF1-intragenic	1	5
P-0001046	P-0001046-T01-IM3	In-House	FFPE	Resection	250	788	80	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.X332_splice;ATRX p.L738Gfs*13	0	2
P-0001047	P-0001047-T01-IM3	In-House	FFPE	Biopsy	250	775	30	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	AURKA Amplification;MDM2 Amplification	1	2
P-0001047	P-0001047-T02-IM5	In-House	FFPE	Resection	250	970	30	Matched	Metastasis	GE Junction	Omentum	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Olaparib(ATM Deletion);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Everolimus,Temsirolimus(MTOR p.I1973M)				LEVEL_3B	MTOR p.I1973M;ATM Deletion;AURKA Amplification;BCL6 Amplification;MDM2 Amplification;SRC Amplification	3	6
P-0001048	P-0001048-T01-IM3	Outside	FFPE	Resection	250	548	60	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0001049	P-0001049-T01-IM3	Outside	FFPE	Biopsy	177.6	695	30	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	CDK4 Amplification;MDM4 Amplification;PTEN Deletion	2	3
P-0001050	P-0001050-T01-IM3	In-House	FFPE	Resection	250	655	50	Matched	Metastasis	Ovary	Bowel	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R248W;BAP1 p.X311_splice;FGFR1 Amplification;MYC Amplification	1	4
P-0001051	P-0001051-T01-IM3	In-House	FFPE	Biopsy	170	506	70	Matched	Primary	Brain	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma										NOTCH2 p.C1443Afs*110;IKZF1 Deletion	0	2
P-0001052	P-0001052-T01-IM3	In-House	FFPE	Biopsy	109.8	350	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.Q261*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTEN p.Q261*;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	3	4
P-0001053	P-0001053-T01-IM3	In-House	FFPE	Resection	250	909	60	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma					GSK2636771,AZD8186(PTEN p.R173C)				LEVEL_4	PTEN p.R173C;FBXW7 p.R465C;RB1 p.S149*;TP53 p.I255N	1	4
P-0001054	P-0001054-T02-IM3	In-House	FFPE	Biopsy	250	406	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K);Lorlatinib,Brigatinib(ALK p.R395H)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.Q546K;ALK p.R395H;TP53 p.C242S;SMAD4 p.G352R;APC p.A1492Vfs*12	3	6
P-0001054	P-0001054-T01-IM3	Outside	FFPE	Biopsy	83.3	287	25	Matched	Metastasis	Cecum	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K);Lorlatinib,Brigatinib(ALK p.R395H);Olaparib(BARD1 p.G576Vfs*10)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.Q546K;ALK p.R395H;TP53 p.C242S;SMAD4 p.G352R;BARD1 p.G576Vfs*10;APC p.A1492Vfs*12	4	7
P-0001055	P-0001055-T01-IM3	In-House	FFPE	Resection	250	587	80	Matched	Metastasis	Brain	Kidney	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0001056	P-0001056-T01-IM3	In-House	FFPE	Biopsy	124.3	595	40	Matched	Metastasis	Groin	Soft Tissue	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CCND2 Amplification;CDK4 Amplification;MDM2 Amplification	2	3
P-0001057	P-0001057-T01-IM3	In-House	FFPE	Resection	250	829	10	Matched	Metastasis	Cervix	Small Bowel	Tumor	GCEMU	Cervical Cancer	Gastric Type Mucinous Carcinoma											0	0
P-0001058	P-0001058-T01-IM3	In-House	FFPE	Resection	250	753	60	Matched	Metastasis	Mediastinum	Lung	Tumor	BCCA	Germ Cell Tumor	Choriocarcinoma					GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_4	PTEN p.X70_splice;TP53 p.P151T;AXIN1 p.W635*;CREBBP p.Q1928*;TP53 p.F341S;TP53 p.C176*	1	6
P-0001059	P-0001059-T02-IM3	In-House	FFPE	Resection	250	729	60	Matched	Primary	Penis	Not Applicable	Tumor	PSCC	Penile Cancer	Penile Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	FAT1 p.Q3572*;TP53 p.Q136*;FAT1 p.L3578Sfs*74;NOTCH1 p.A1707Pfs*22;CDKN2A p.R58*;RICTOR Amplification;YAP1 Amplification	1	7
P-0001060	P-0001060-T01-IM3	Outside	FFPE	Resection	250	424	70	Matched	Primary	Kidney	Not Applicable	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma											0	0
P-0001061	P-0001061-T01-IM3	Outside	FFPE	Biopsy	81.6	235	20	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.Y537N)						LEVEL_1	PIK3CA p.H1047R;ESR1 p.Y537N	3	2
P-0001062	P-0001062-T02-IM3	Outside	FFPE	Biopsy	250	249	40	Matched	Primary	Not available	Not available	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0001063	P-0001063-T01-IM3	Outside	FFPE	Biopsy	250	753	50	Matched	Primary	Thymus	Not Applicable	Tumor	THYC	Thymic Tumor	Thymic Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12*)				LEVEL_4	TP53 p.R282W;CDKN2A p.S12*;MCL1 Amplification	1	3
P-0001070	P-0001070-T01-IM3	Outside	FFPE	Resection	250	871	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	RNF43 p.S455Tfs*2;CDKN2A Deletion;CDKN2B Deletion;PAX5 Amplification	1	4
P-0001071	P-0001071-T01-IM3	In-House	FFPE	Biopsy	250	641	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)					LEVEL_3B	PTCH1 p.S1203Afs*52;TP53 p.R248Q;JAK1 p.P430Rfs*2;NSD1 p.R1031*;SPOP p.W131G;TOP1 p.M1?;AR p.H875Y;JAK1 p.T868Hfs*8;JAK1 p.K345Nfs*32;CIC p.P1116Qfs*45;RUNX1 p.P330Rfs*237;APC Deletion;MSH2 Deletion	1	13
P-0001073	P-0001073-T01-IM3	Outside	FFPE	Biopsy	173.7	505	60	Matched	Metastasis	Uterus	Omentum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				AZD9496,Fulvestrant(ESR1 p.Y537S)	GSK2636771,AZD8186(PTEN p.F81Ifs*2);GSK2636771,AZD8186(PTEN p.F215Vfs*28)				LEVEL_3B	CREBBP p.I1084Sfs*15;ESR1 p.Y537S;KDM5C p.R929*;PIK3R1 p.L449del;PTEN p.F81Ifs*2;PTEN p.F215Vfs*28	3	6
P-0001074	P-0001074-T01-IM3	Outside	FFPE	Cytology	250	858	NA	Matched	Metastasis	Bladder	Prostate	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Cabozantinib,Crizotinib(MET Amplification)	Tazemetostat(KDM6A p.Q541Sfs*6)				LEVEL_3B	KMT2A p.E1608*;IGF1R p.M1255I;TP53 p.E286K;KDM6A p.Q541Sfs*6;APC p.E1156Kfs*9;CCNE1 Amplification;MET Amplification	2	7
P-0001076	P-0001076-T01-IM3	In-House	FFPE	Resection	250	428	60	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.P278R;ATRX p.R1426*;BCOR Deletion	1	4
P-0001077	P-0001077-T01-IM3	Outside	FFPE	Biopsy	250	785	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;TP53 p.E285K;CDKN2A Deletion;CDC73 CDC73-intragenic	2	4
P-0001078	P-0001078-T01-IM3	Outside	FFPE	Biopsy	235.32	717	30	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.S241C;CDH1 p.D257_N258delinsND	1	3
P-0001079	P-0001079-T01-IM3	In-House	FFPE	Biopsy	250	957	25	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.Q1551*)					LEVEL_3B	APC p.R216*;BRCA2 p.Q1551*;TP53 p.P152L;APC p.A1296Qfs*9;AXIN2 p.L215Tfs*16;MAPK1 Amplification	1	6
P-0001080	P-0001080-T01-IM3	In-House	FFPE	Resection	250	573	50	Matched	Metastasis	Ovary	Heart	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib(NF1 p.L1267*)				LEVEL_4	TP53 p.E171*;NF1 p.L1267*;RB1 p.K63Rfs*38;PIK3CA Amplification	1	4
P-0001081	P-0001081-T01-IM3	In-House	FFPE	Resection	250	662	80	Matched	Metastasis	Skin	Ovary	Tumor	SKCM	Melanoma	Cutaneous Melanoma										MSH2 p.R383*;RAF1 p.S259F;TP53 p.F109I;PAK5 p.M173I	0	4
P-0001082	P-0001082-T01-IM3	In-House	FFPE	Resection	250	422	40	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110_G111delins*)				LEVEL_4	FAT1 p.R2726*;CASP8 p.Q361*;FAT1 p.X3077_splice;NSD1 p.E2028*;NOTCH1 p.Y550*;KMT2D p.E604*;TP53 p.C242S;CDKN2A p.W110_G111delins*;CD274 Amplification;JAK2 Amplification	1	10
P-0001083	P-0001083-T01-IM3	In-House	FFPE	Resection	250	824	90	Matched	Primary	Soft Tissue	Not Applicable	Tumor	EPIS	Soft Tissue Sarcoma	Epithelioid Sarcoma	Tazemetostat(SMARCB1 Deletion)								LEVEL_1	SMARCB1 Deletion	1	1
P-0001084	P-0001084-T01-IM3	Outside	FFPE	Cytology	108.12	508	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										RB1 p.X840_splice;TP53 p.G266*;ARID1A p.N917Ifs*2	0	3
P-0001085	P-0001085-T01-IM3	In-House	FFPE	Resection	250	604	70	Matched	Metastasis	Uterus	Vagina	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										TP53 p.L257R;CCNE1 Amplification;FAT1 Deletion;FGFR2 Amplification;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion;NF2 GRM4-NF2 fusion;GRM4 GRM4-NF2 fusion	0	9
P-0001086	P-0001086-T01-IM3	In-House	FFPE	Biopsy	250	836	30	Matched	Metastasis	Ovary	Kidney	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Y163C;PRKN PARK2-intragenic	0	2
P-0001087	P-0001087-T01-IM3	In-House	FFPE	Resection	250	824	80	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										ATRX p.X1929_splice;RB1 Deletion;TP53 Deletion	0	3
P-0001088	P-0001088-T01-IM3	In-House	FFPE	Resection	250	632	80	Matched	Metastasis	Lower Extremity	Small Bowel	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma										ARID1B p.R894*;RAD50 Deletion	0	2
P-0001089	P-0001089-T01-IM3	In-House	FFPE	Biopsy	250	681	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.V1001_F1007del)	Crizotinib(MET p.V1001_F1007del);Crizotinib(MET Amplification)	Cabozantinib(MET p.V1001_F1007del)	Cabozantinib(MET Amplification)	Trametinib,Cobimetinib(NF1 p.X2705_splice)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	TP53 p.R248P;NF1 p.X2705_splice;MET p.V1001_F1007del;MET Amplification;MYC Amplification;NKX2-1 Amplification;RB1 Deletion;TERT Amplification	6	8
P-0001090	P-0001090-T01-IM3	Outside	FFPE	Biopsy	250	478	60	Matched	Primary	Not available	Not available	Tumor	SCRMS	Soft Tissue Sarcoma	Spindle Cell Rhabdomyosarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111del);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	PIK3CA p.K111del;BCOR p.S1271Ffs*6;MDM2 Amplification	2	3
P-0001091	P-0001091-T01-IM3	Outside	FFPE	Resection	250	614	50	Matched	Primary	Lung	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	SUFU p.S267Mfs*12;FGFR1 Amplification	1	2
P-0001092	P-0001092-T01-IM3	In-House	FFPE	Biopsy	250	1068	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.S240R;CTNNB1 p.Q26_D32delinsH;AR Amplification;PTPRD Deletion	0	4
P-0001093	P-0001093-T01-IM3	In-House	FFPE	Biopsy	250	540	15	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										SETD2 p.K308*;TP53 p.R249M;ARID1B p.G678Efs*6	0	3
P-0001094	P-0001094-T01-IM3	Outside	FFPE	Biopsy	148.4	461	15	Matched	Metastasis	Uterus	Lymph Node	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R175H;PIK3R1 p.K575_R577dup;ARID1A p.P146Qfs*86;ERBB2 Amplification	2	4
P-0001095	P-0001095-T01-IM3	Outside	FFPE	Resection	250	844	50	Matched	Primary	Uterus	Not Applicable	Tumor	USTUMP	Uterine Sarcoma	Uterine Smooth Muscle Tumor of Uncertain Malignant Potential											0	0
P-0001096	P-0001096-T01-IM3	In-House	FFPE	Biopsy	250	779	80	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										ASXL2 p.R357Tfs*4;MSH6 p.X1216_splice;BRAF Amplification;KRAS Amplification;MAP2K4 Deletion	0	5
P-0001097	P-0001097-T01-IM3	In-House	FFPE	Biopsy	250	900	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.E746_A750del;CDK4 Amplification;MDM2 Amplification	3	3
P-0001097	P-0001097-T02-IM5	In-House	FFPE	Resection	250	820	45	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;CDK4 Amplification;MDM2 Amplification	4	4
P-0001098	P-0001098-T01-IM3	Outside	FFPE	Resection	250	524	15	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix										TP53 p.P223L	0	1
P-0001099	P-0001099-T01-IM3	Outside	FFPE	Biopsy	250	808	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.G266E;FGFR2 Amplification;MAP2K4 Deletion	2	4
P-0001100	P-0001100-T01-IM3	In-House	FFPE	Resection	250	433	40	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Tazemetostat(KDM6A p.Q753*)				LEVEL_3B	PIK3CA p.E542K;KDM6A p.Q753*;MED12 p.Q27E;TP53 p.X259_splice;CCND1 Amplification;FGF19 Amplification;ATR ATR-intragenic	2	7
P-0001101	P-0001101-T01-IM3	Outside	FFPE	Resection	250	753	90	Matched	Primary	Not available	Not available	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0001102	P-0001102-T01-IM3	In-House	FFPE	Resection	250	631	50	Matched	Metastasis	Jejunum	Bone	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Olaparib(ATM p.R1898*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12A;TP53 p.G245S;ATM p.R1898*;SMAD4 p.S232Qfs*3;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0001103	P-0001103-T01-IM3	Outside	FFPE	Resection	250	655	15	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 p.K240*	0	1
P-0001104	P-0001104-T01-IM3	In-House	FFPE	Biopsy	250	852	40	Matched	Metastasis	Ascending Colon	Liver	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	TP53 p.R273H;BRAF p.V600E;RNF43 p.W200Sfs*60;KRAS Amplification	3	4
P-0001104	P-0001104-T05-IM3	In-House	FFPE	Biopsy	69	677	30	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.T3085Nfs*26)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R273H;BRAF p.V600E;BRCA2 p.T3085Nfs*26;RNF43 p.W200Sfs*60;APC Deletion;CDKN2A Deletion;CDKN2B Deletion;SMAD4 Deletion	5	8
P-0001104	P-0001104-T02-IM3	Outside	FFPE	Biopsy	250	909	NA	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	TP53 p.R273H;BRAF p.V600E;RNF43 p.W200Sfs*60	3	3
P-0001104	P-0001104-T03-IM3	Outside	FFPE	Biopsy	250	372	30	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	TP53 p.R273H;BRAF p.V600E;RNF43 p.W200Sfs*60	3	3
P-0001105	P-0001105-T01-IM3	In-House	FFPE	Resection	250	879	25	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C378F);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.W146*;PIK3CA p.R108H;PIK3CA p.C378F;ARID1A p.N919Ifs*5;BBC3 p.G173Afs*56;ERBB2 Amplification	3	6
P-0001106	P-0001106-T01-IM3	In-House	FFPE	Resection	250	865	20	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KRAS Amplification;MYCN Amplification	0	3
P-0001107	P-0001107-T01-IM3	Outside	FFPE	Biopsy	250	528	15	Matched	Primary	Rectum	Not Applicable	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.Y220C;RB1 p.E691*;SMAD3 p.R268H;APC p.E1156Gfs*8;APC p.S1411Rfs*4;PHOX2B Deletion	1	7
P-0001108	P-0001108-T01-IM3	In-House	FFPE	Resection	250	737	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R282W;PTEN Deletion	1	2
P-0001109	P-0001109-T01-IM3	Outside	FFPE	Resection	250	1289	50	Matched	Primary	Not available	Not available	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0001110	P-0001110-T01-IM3	In-House	FFPE	Resection	250	674	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										NF2 p.M519_E520delinsI*;BAP1 Deletion	0	2
P-0001111	P-0001111-T01-IM3	Outside	FFPE	Biopsy	107.87	204	20	Matched	Primary	Bone	Not Applicable	Tumor	CHOS	Bone Cancer	Chondroblastic Osteosarcoma										GNAS p.R201C;TP53 p.Y107dup	0	2
P-0001112	P-0001112-T01-IM3	Outside	FFPE	Biopsy	250	671	50	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma					GSK2636771,AZD8186(PTEN p.L70F)				LEVEL_4	TP53 p.G266R;PTEN p.L70F;KMT2D p.Q3441*;NOTCH3 p.W1434*;GRIN2A p.W7*;CCNE1 Amplification;RB1 Deletion;TGFBR2 Deletion	1	8
P-0001113	P-0001113-T01-IM3	Outside	FFPE	Resection	250	705	70	Matched	Primary	Uterus	Not Applicable	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion	1	1
P-0001114	P-0001114-T02-IM3	In-House	FFPE	Cytology	250	463	30	Matched	Metastasis	Breast	Mediastinum	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.E453Q)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 p.W1258*)				LEVEL_1	PIK3CA p.E545K;PIK3CA p.E453Q;KMT2C p.Q1473*;JAK1 p.Q986*;NF1 p.W1258*;AURKA Amplification;FGFR1 Amplification;PAK1 Amplification	6	8
P-0001114	P-0001114-T03-IM5	In-House	FFPE	Resection	250	632	20	Matched	Metastasis	Breast	Pericardium	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.E545K;FGFR1 Amplification	3	2
P-0001115	P-0001115-T01-IM3	In-House	FFPE	Resection	250	937	40	Matched	Metastasis	Uterus	Rectum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R38C);Everolimus(TSC2 p.X1204_splice);Olaparib(ATM p.S214Pfs*16);Olaparib(ATM p.K2811Sfs*46);Olaparib(PALB2 p.F440Lfs*12)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.R130G);GSK2636771,AZD8186(PTEN p.Y27C)				LEVEL_3B	KRAS p.G12D;PTCH1 p.S1203Afs*52;PTEN p.R130G;JAK1 p.K860Nfs*16;JAK1 p.L431Vfs*22;PIK3CA p.R38C;CIC p.P1597Hfs*23;NOTCH3 p.C43Lfs*32;PTEN p.Y27C;TSC2 p.X1204_splice;ARID1A p.Q766Sfs*67;JAK1 p.N339Ifs*3;NSD1 p.M1531Nfs*4;NBN p.R466Gfs*18;TET1 p.K22Rfs*23;ATM p.S214Pfs*16;ATM p.K2811Sfs*46;LATS2 p.Q345Rfs*89;CREBBP p.P1423Lfs*36;PALB2 p.F440Lfs*12;CIC p.S1595Pfs*25	9	21
P-0001117	P-0001117-T01-IM3	Outside	FFPE	Biopsy	250	640	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 EZR-ROS1 fusion);Crizotinib,Entrectinib(EZR EZR-ROS1 fusion)								LEVEL_1	ROS1 EZR-ROS1 fusion;EZR EZR-ROS1 fusion	2	2
P-0001118	P-0001118-T01-IM3	Outside	FFPE	Resection	129.86	213	60	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(RAD51B p.X106_splice)					LEVEL_3B	RAD51B p.X106_splice;GATA3 p.T440Sfs*68;CCND1 Amplification;FOXA1 Amplification;GATA3 Amplification	1	5
P-0001120	P-0001120-T01-IM3	In-House	FFPE	Resection	250	797	50	Matched	Primary	Pleura	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0001121	P-0001121-T01-IM3	In-House	FFPE	Biopsy	250	728	90	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										RB1 p.V450Sfs*13;FLCN Deletion	0	2
P-0001123	P-0001123-T01-IM3	In-House	FFPE	Biopsy	250	548	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.H214R;TP53 p.H179L;EGFR Amplification	1	4
P-0001123	P-0001123-T02-IM5	In-House	FFPE	Biopsy	250	944	50	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.H214R;TP53 p.H179L	1	3
P-0001124	P-0001124-T01-IM3	In-House	FFPE	Biopsy	130.8	258	75	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										RB1 p.Q62*;TP53 p.L194R	0	2
P-0001125	P-0001125-T01-IM3	In-House	FFPE	Resection	250	565	60	Matched	Metastasis	Soft Tissue	Lung	Tumor	MFS	Soft Tissue Sarcoma	Myxofibrosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	CDKN2A p.R58*	1	1
P-0001126	P-0001126-T01-IM3	In-House	FFPE	Resection	250	574	30	Matched	Metastasis	Umbilical Mass	Bowel	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										BAP1 p.X306_splice;SETD2 Deletion	0	2
P-0001127	P-0001127-T02-IM3	Outside	FFPE	Biopsy	127.6	560	40	Matched	Metastasis	Lung	Mediastinum	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R280I;EPHA3 p.K929*;BCL6 Amplification;EZH2 Amplification;PIK3CA Amplification	0	5
P-0001128	P-0001128-T01-IM3	In-House	FFPE	Resection	250	373	35	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;CTNNB1 p.T41A;TP53 p.S215C;PARP1 p.X206_splice;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0001129	P-0001129-T01-IM3	In-House	FFPE	Resection	250	299	75	Matched	Primary	Upper Extremity	Not Applicable	Tumor	MYCHS	Bone Cancer	Myxoid Chondrosarcoma										KMT2D p.S2633*;EWSR1 NR4A3-EWSR1 fusion;NR4A3 NR4A3-EWSR1 fusion	0	3
P-0001130	P-0001130-T01-IM3	Outside	FFPE	Cytology	213	1020	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R248Q;KEAP1 p.D165N;PBRM1 p.G508Lfs*14;STK11 p.Q100Pfs*51;SMARCA4 p.M210Dfs*77;MCL1 Amplification	0	6
P-0001131	P-0001131-T01-IM3	Outside	FFPE	Resection	250	1038	25	Matched	Metastasis	Lung	Uterus	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.X332_splice;TP53 p.L43Afs*7;CDK4 Amplification;EGFR Amplification	2	5
P-0001135	P-0001135-T02-IM3	In-House	FFPE	Resection	250	874	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										RB1 p.Y606*;TP53 p.T125R;RAF1 Amplification	0	3
P-0001136	P-0001136-T01-IM3	In-House	FFPE	Biopsy	250	880	30	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Everolimus(TSC1 p.H823*)					LEVEL_3B	TP53 p.X332_splice;CIC p.Q1025Hfs*8;TSC1 p.H823*	1	3
P-0001137	P-0001137-T01-IM3	Outside	FFPE	Biopsy	250	401	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;TP53 p.Y220C;TP53 p.R249T;CCNE1 Amplification	1	4
P-0001138	P-0001138-T01-IM3	In-House	FFPE	Resection	250	440	40	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor											0	0
P-0001140	P-0001140-T01-IM3	In-House	FFPE	Biopsy	250	347	25	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Y234C;BCOR Deletion;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MCL1 Amplification;MYCL Amplification;PIK3CA Amplification	0	8
P-0001141	P-0001141-T01-IM3	In-House	FFPE	Biopsy	250	730	40	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	3
P-0001144	P-0001144-T01-IM3	In-House	FFPE	Biopsy	250	686	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.Q214*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L65Afs*55)				LEVEL_4	TP53 p.A159V;PTEN p.Q214*;CDKN2A p.L65Afs*55;MEF2B Amplification	2	4
P-0001146	P-0001146-T01-IM3	Outside	FFPE	Resection	250	658	10	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D	1	1
P-0001149	P-0001149-T01-IM3	Outside	FFPE	Biopsy	250	620	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	MAP3K1 p.L1477Cfs*13;GATA3 p.L396Qfs*109;MAP3K1 p.F1046_Q1048delinsE*;FGFR1 Amplification	1	4
P-0001150	P-0001150-T01-IM3	In-House	FFPE	Biopsy	250	834	50	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(BARD1 p.Q237*)					LEVEL_3B	BARD1 p.Q237*;BRAF p.G466V;TP53 p.A161S;APC p.Y796Wfs*2;APC p.L1488Yfs*18;MAP2K4 Deletion;PRKN Deletion;PIK3R1 Deletion;TGFBR2 Deletion	1	9
P-0001151	P-0001151-T01-IM3	Outside	FFPE	Resection	250	897	40	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				BLU-667,Cabozantinib,Selpercatinib,Vandetanib(RET NCOA4-RET fusion);BLU-667,Cabozantinib,Selpercatinib,Vandetanib(NCOA4 NCOA4-RET fusion)	Trametinib,Cobimetinib(NF1 p.E2560*)				LEVEL_3B	TP53 p.R282W;NF1 p.E2560*;RNF43 p.Q84*;RET NCOA4-RET fusion;NCOA4 NCOA4-RET fusion	3	5
P-0001152	P-0001152-T01-IM3	In-House	FFPE	Resection	250	441	50	Matched	Metastasis	Breast	Brain	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.Y205S;SOX9 p.Q416Nfs*54;ERBB2 Amplification;MAP3K1 Deletion	2	4
P-0001153	P-0001153-T01-IM3	Outside	FFPE	Biopsy	250	619	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.P223L;APC p.E893*;SPOP p.F133L	0	3
P-0001154	P-0001154-T01-IM3	In-House	FFPE	Biopsy	250	615	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H	1	1
P-0001155	P-0001155-T01-IM3	Outside	FFPE	Biopsy	250	833	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(RET NCOA4-RET fusion);Selpercatinib(NCOA4 NCOA4-RET fusion)	Cabozantinib,Vandetanib(RET NCOA4-RET fusion);Cabozantinib,Vandetanib(NCOA4 NCOA4-RET fusion)	BLU-667(RET NCOA4-RET fusion);BLU-667(NCOA4 NCOA4-RET fusion)						LEVEL_1	SETD2 p.Q872*;RET NCOA4-RET fusion;NCOA4 NCOA4-RET fusion	6	3
P-0001156	P-0001156-T01-IM3	In-House	FFPE	Resection	250	446	40	Matched	Metastasis	Breast	Retroperitoneum	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.R175H;ERBB2 Amplification	4	3
P-0001157	P-0001157-T01-IM3	In-House	FFPE	Resection	250	220	50	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0001157	P-0001157-T02-IM5	In-House	FFPE	Resection	250	917	80	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										TP53 p.R280S	0	1
P-0001158	P-0001158-T01-IM3	Outside	FFPE	Biopsy	71.04	292	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R248Q;SMAD4 p.K507E;ERBB2 Amplification	2	3
P-0001163	P-0001163-T01-IM3	In-House	FFPE	Biopsy	250	714	25	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.E223*;BRAF p.G466A;KEAP1 p.E258*;TP53 p.S96Lfs*27	0	4
P-0001164	P-0001164-T01-IM3	Outside	FFPE	Resection	250	617	50	Matched	Primary	Uterus	Not Applicable	Tumor	HGESS	Uterine Sarcoma	High-Grade Endometrial Stromal Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0001165	P-0001165-T01-IM3	In-House	FFPE	Biopsy	250	881	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					GSK2636771,AZD8186(PTEN p.Q171*);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	PTEN p.Q171*;TP53 p.N131I;NF1 Deletion;PBRM1 Deletion	2	4
P-0001166	P-0001166-T01-IM3	Outside	FFPE	Resection	250	538	25	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K	1	1
P-0001168	P-0001168-T01-IM3	In-House	FFPE	Biopsy	250	871	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.G251Vfs*6)				LEVEL_4	TP53 p.R248P;PTEN p.G251Vfs*6	1	2
P-0001169	P-0001169-T01-IM3	Outside	FFPE	Resection	250	291	50	Matched	Primary	Bone	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										KLF4 p.K409Q	0	1
P-0001170	P-0001170-T01-IM3	Outside	FFPE	Resection	250	502	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R216*;TP53 p.P152L;TGFBR1 p.S241L;RBM10 p.W425*;ARID1A p.L1745Wfs*25	0	5
P-0001171	P-0001171-T01-IM3	In-House	FFPE	Biopsy	250	1189	60	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.V272M;SETD2 p.S1310*;RYBP p.X233_splice;INPP4B p.M1?;KMT2C p.X3125_splice;PTPRD p.E1639*;BMPR1A p.M1?;SDHAF2 p.S10L;BLM p.S53*;RICTOR Amplification	1	11
P-0001172	P-0001172-T02-IM3	Outside	FFPE	Biopsy	226.2	569	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R306*;CDH1 p.D254E	0	2
P-0001173	P-0001173-T01-IM3	Outside	FFPE	Resection	250	494	40	Matched	Primary	Heart	Not Applicable	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;ERBB3 Amplification;MDM2 Amplification;TERT Amplification	2	4
P-0001174	P-0001174-T01-IM3	In-House	FFPE	Resection	250	371	50	Matched	Metastasis	Nailbed	In-transit	Tumor	ACRM	Melanoma	Acral Melanoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ERBB2 Amplification	1	1
P-0001175	P-0001175-T01-IM3	In-House	FFPE	Biopsy	250	215	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										NCOR1 p.Q59*	0	1
P-0001176	P-0001176-T01-IM3	In-House	FFPE	Biopsy	250	237	NA	Matched	Primary	Breast	Not Applicable	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS										PIK3R1 p.N453_Q455delinsK;TP53 p.A119Sfs*3	0	2
P-0001177	P-0001177-T01-IM3	Outside	FFPE	Resection	250	432	20	Matched	Metastasis	Pleura	Appendix	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										SETD2 p.D1939Ifs*6	0	1
P-0001179	P-0001179-T01-IM3	Outside	FFPE	Biopsy	250	425	50	Matched	Primary	Vagina	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Tipifarnib(HRAS p.Q61K)					LEVEL_3B	HRAS p.Q61K;ATRX p.S558Ifs*4	1	2
P-0001180	P-0001180-T01-IM3	In-House	FFPE	Biopsy	250	535	10	Matched	Metastasis	Stomach	Breast	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R175H;FGFR1 Amplification	1	2
P-0001181	P-0001181-T01-IM3	In-House	FFPE	Resection	250	638	25	Matched	Metastasis	Testis	Neck	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	APC Deletion;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;RB1 Deletion;SDHB Deletion;SPEN Deletion;TNFRSF14 Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	2	10
P-0001182	P-0001182-T01-IM3	In-House	FFPE	Resection	250	509	35	Matched	Primary	Breast	Not Applicable	Tumor	MBC	Breast Cancer	Metaplastic Breast Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R175H;PTEN Deletion	1	2
P-0001183	P-0001183-T01-IM3	In-House	FFPE	Resection	250	370	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.L452_G460del)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.L452_G460del)		GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	TP53 p.C275R;FBXW7 p.E588*;PIK3CA p.L452_G460del;PTEN Deletion	3	4
P-0001184	P-0001184-T01-IM3	In-House	FFPE	Biopsy	250	598	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	SPEN p.N3652Pfs*13;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	5
P-0001184	P-0001184-T02-IM5	In-House	FFPE	Biopsy	250	1190	45	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	ESR1 p.D538G;SPEN p.N3652Pfs*13;BRD4 Amplification;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification;TCF3 LOC100101266-TCF3 fusion;LOC100101266 LOC100101266-TCF3 fusion;TCF3 FAM108A1-TCF3 fusion;ABHD17A FAM108A1-TCF3 fusion	2	11
P-0001185	P-0001185-T01-IM3	Outside	FFPE	Biopsy	250	1128	30	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H)	Tazemetostat(SMARCB1 p.K364del)				LEVEL_3B	ARID1A p.S11Afs*91;PIK3CA p.R108H;B2M p.L15Ffs*41;KMT2A p.R407*;ARID2 p.Q1013*;ARID1A p.F2141Sfs*59;RASA1 p.K511Nfs*9;TET1 p.R1744Kfs*26;ARID2 p.L370*;KMT2D p.A221Gfs*13;TP53 p.C229Yfs*10;CIC p.S146*;SMARCB1 p.K364del	2	13
P-0001186	P-0001186-T01-IM3	In-House	FFPE	Biopsy	250	818	25	Matched	Metastasis	Oropharynx	Bone	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma											0	0
P-0001187	P-0001187-T01-IM3	Outside	FFPE	Resection	250	453	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 Amplification	0	1
P-0001188	P-0001188-T01-IM3	In-House	FFPE	Resection	250	411	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.T41A	0	1
P-0001189	P-0001189-T01-IM3	Outside	FFPE	Cytology	250	669	70	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.S310F)	Neratinib(ERBB2 p.S310F)	Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	ERBB2 p.S310F;PBRM1 p.E842*;TP53 p.Q144*;PHOX2B p.C36Lfs*10;ERBB2 Amplification	3	5
P-0001190	P-0001190-T01-IM3	In-House	FFPE	Resection	250	334	30	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R213*;APC p.L1489Ffs*18;CDK8 Amplification;FLT3 Amplification	1	5
P-0001191	P-0001191-T01-IM3	Outside	FFPE	Resection	250	462	40	Matched	Primary	Breast	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma											0	0
P-0001192	P-0001192-T01-IM3	In-House	FFPE	Resection	250	332	50	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.K57E)					LEVEL_3B	TP53 p.R273H;APC p.Q1237*;MAP2K1 p.K57E;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	1	6
P-0001193	P-0001193-T01-IM3	In-House	FFPE	Resection	250	1270	60	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	NF1 Deletion	1	1
P-0001194	P-0001194-T01-IM3	Outside	FFPE	Biopsy	250	479	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y129*)				LEVEL_4	TP53 p.R175H;CTNNB1 p.S37F;ERBB3 p.P262H;SMARCA4 p.R1415*;SMARCA4 p.Q1554*;CDKN2A p.Y129*	1	6
P-0001195	P-0001195-T01-IM3	In-House	FFPE	Resection	250	230	30	Matched	Metastasis	Nasopharynx	Lung	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma											0	0
P-0001196	P-0001196-T01-IM3	Outside	FFPE	Cytology	183.6	791	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.C135R	0	1
P-0001197	P-0001197-T01-IM3	Outside	FFPE	Biopsy	250	205	10	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										CDH1 p.D254E;TP53 p.N288Ifs*57;MCL1 Amplification	0	3
P-0001198	P-0001198-T01-IM3	In-House	FFPE	Resection	250	612	NA	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E2663Q)					LEVEL_3B	TP53 p.X225_splice;PIK3CA p.E542K;JAK1 p.X751_splice;FAT1 p.Q4354*;FAT1 p.Q3929*;NOTCH1 p.Q1508*;KMT2D p.Q2174*;BRCA2 p.E2663Q;TP53 p.R290C;TP53 p.G199E;TOP1 p.X94_splice;ATR p.X1913_splice	2	12
P-0001199	P-0001199-T01-IM3	In-House	FFPE	Cytology	85.26	438	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;TP53 p.S215I;CBFB Deletion;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0001200	P-0001200-T01-IM3	In-House	FFPE	Resection	250	704	15	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.E1151*;TP53 p.H193Y;APC p.S1415Rfs*4	0	3
P-0001201	P-0001201-T01-IM3	In-House	FFPE	Biopsy	250	673	50	Matched	Metastasis	Minor Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										ASXL2 p.R284*;KMT2D p.R4484*;PTPN11 p.S502L;RASA1 p.V944Gfs*6;BCOR p.E1042Rfs*37;KDR Amplification;KIT Amplification;PDGFRA Amplification	0	8
P-0001202	P-0001202-T01-IM3	Outside	FFPE	Biopsy	250	572	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										MED12 p.L1224F	0	1
P-0001203	P-0001203-T01-IM3	Outside	FFPE	Resection	250	82	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.V122Hfs*24;MYC Amplification;PTPRD Deletion	0	3
P-0001204	P-0001204-T02-IM5	In-House	FFPE	Biopsy	250	630	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										HIST1H2BD p.D52H;SPOP p.F133L;AR Amplification;MAP3K1 Deletion;APC APC-intragenic	0	5
P-0001204	P-0001204-T03-IM5	In-House	FFPE	Resection	250	827	70	Matched	Metastasis	Prostate	Brain	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										HIST1H2BD p.D52H;SPOP p.F133L;APC Deletion;AR Amplification;DIS3 Deletion;FOXO1 Deletion;MAP3K1 Deletion;MYC Amplification;PIK3R1 Deletion;RB1 Deletion;APC APC-intragenic	0	11
P-0001204	P-0001204-T01-IM3	Outside	FFPE	Biopsy	250	1130	15	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										HIST1H2BD p.D52H;SPOP p.F133L;APC APC-intragenic	0	3
P-0001205	P-0001205-T01-IM3	In-House	FFPE	Resection	165.6	756	60	Matched	Primary	Brain	Not Applicable	Tumor	HPCCNS	CNS Cancer	Hemangiopericytoma of the Central Nervous System										KDM5C p.L1391Tfs*3	0	1
P-0001206	P-0001206-T01-IM3	Outside	FFPE	Biopsy	250	849	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0001208	P-0001208-T01-IM3	Outside	FFPE	Biopsy	79.2	297	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108L)					LEVEL_1	PIK3CA p.R108L;MET p.X1010_splice;TET2 p.I1871Nfs*4	4	3
P-0001209	P-0001209-T01-IM3	Outside	FFPE	Biopsy	115.44	452	50	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)				LEVEL_4	KRAS p.A146V;RB1 p.E675*;TP53 p.L114*	1	3
P-0001210	P-0001210-T01-IM3	In-House	FFPE	Biopsy	250	659	60	Matched	Metastasis	Testis	Liver	Tumor	SEM	Germ Cell Tumor	Seminoma										AXL Amplification;CCNE1 Amplification;MCL1 Amplification;PTPRD Deletion	0	4
P-0001211	P-0001211-T01-IM3	In-House	FFPE	Resection	250	313	60	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.R342*;TP53 p.Q192L;ARID2 p.A1566Vfs*3;MAPK1 Amplification	0	4
P-0001212	P-0001212-T01-IM3	Outside	FFPE	Resection	250	779	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;MAP2K4 p.X363_splice;ARID1A p.R1446Dfs*35;ARID1A p.L1745Afs*12;CDH1 p.V384Gfs*3;CCND1 Amplification;FGF19 Amplification;MYC Amplification	2	8
P-0001214	P-0001214-T01-IM3	Outside	FFPE	Biopsy	250	813	60	Matched	Primary	Minor Salivary Gland	Not Applicable	Tumor	MUCC	Salivary Gland Cancer	Mucoepidermoid Carcinoma										EWSR1 ATF1-EWSR1 fusion;ATF1 ATF1-EWSR1 fusion	0	2
P-0001215	P-0001215-T01-IM3	Outside	FFPE	Resection	250	438	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Cisplatin(ERCC2 p.R631H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E365K);Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.Y823D);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S1442*)	GSK2636771,AZD8186(PTEN p.R173H);GSK2636771,AZD8186(PTEN p.F341V);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.R203C);Trametinib,Cobimetinib,Binimetinib(KRAS p.K147T);Trametinib,Cobimetinib,Binimetinib(KRAS p.V14I);Trametinib,Cobimetinib(NF1 p.W223*);Trametinib,Cobimetinib(NF1 p.S2137*);Trametinib,Cobimetinib,Binimetinib(KRAS p.Y71_M72delinsSV)	Cetuximab,Panitumumab(KRAS p.K147T);Cetuximab,Panitumumab(KRAS p.V14I);Cetuximab,Panitumumab(KRAS p.Y71_M72delinsSV)			LEVEL_3B	TP63 p.S365L;TP53 p.R213*;SMAD4 p.R361H;PTPRD p.S431L;ERCC2 p.R631H;PIK3CA p.E365K;SPEN p.R1403*;SDHC p.X136_splice;ASXL2 p.R312*;ASXL2 p.E45*;TGFBR2 p.R537H;PIK3CB p.R321Q;BCL6 p.R594Q;KIT p.Y823D;FBXW7 p.R658Q;FAT1 p.E1675*;PIK3R1 p.E507*;APC p.S457*;APC p.E1536*;RAD50 p.E120*;ARID1B p.Y1673*;ARID1B p.S1943*;TET1 p.S964*;PTEN p.R173H;PTEN p.F341V;FGFR2 p.R203C;ETV6 p.R369W;KRAS p.K147T;KRAS p.V14I;POLE p.P286R;FLT3 p.A927V;BRCA2 p.S1442*;GRIN2A p.R681*;TP53 p.V274A;TP53 p.F113S;NF1 p.W223*;NF1 p.S2137*;SMAD4 p.E520*;PTPRS p.S1497*;PTPRS p.X1256_splice;KDM5C p.E158K;MSH6 p.N1124Kfs*40;KRAS p.Y71_M72delinsSV	12	43
P-0001216	P-0001216-T01-IM3	In-House	FFPE	Resection	250	665	50	Matched	Metastasis	Thyroid	Bone	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer					Trametinib,Cobimetinib(NF1 p.G629R)				LEVEL_4	TP53 p.S362Afs*8;ARID1A p.R693*;KMT2D p.R5179H;NF1 p.G629R;FAT1 p.K2139Sfs*8;KMT2D p.N2517Ifs*26	1	6
P-0001217	P-0001217-T01-IM3	In-House	FFPE	Biopsy	188	695	70	Matched	Metastasis	Upper Extremity	Lymph Node	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R342*;TP53 p.E286*;CDK6 Amplification;CDKN2A Deletion;PAK1 Amplification	1	5
P-0001218	P-0001218-T01-IM3	In-House	FFPE	Biopsy	250	779	25	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0001219	P-0001219-T02-IM5	In-House	DNA	Biopsy	250	853	NA	Matched	Primary	Blood	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease			Trametinib,Cobimetinib(MAP2K1 p.P105_I107delinsL)						LEVEL_3A	MAP2K1 p.P105_I107delinsL	1	1
P-0001219	P-0001219-T03-IM5	In-House	FFPE	Biopsy	250	832	20	Matched	Primary	Tongue	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease											0	0
P-0001220	P-0001220-T01-IM3	In-House	FFPE	Biopsy	250	575	50	Matched	Metastasis	Major Salivary Gland	Liver	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0001221	P-0001221-T01-IM3	In-House	FFPE	Resection	250	543	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0001221	P-0001221-T02-IM5	In-House	FFPE	Resection	250	883	70	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.G275Afs*36	0	1
P-0001222	P-0001222-T01-IM3	Outside	FFPE	Biopsy	176.3	531	20	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	PTEN p.T319*;TP53 p.P250L	1	2
P-0001223	P-0001223-T01-IM3	In-House	FFPE	Biopsy	176.4	816	30	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Poziotinib(EGFR p.D770_N771insGF)					LEVEL_3B	KMT2D p.E1738*;EGFR p.D770_N771insGF	1	2
P-0001224	P-0001224-T02-IM3	In-House	FFPE	Biopsy	106.2	482	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										PMAIP1 p.Q28*;PRKN p.E98Sfs*5;TP53 p.E56Kfs*67;CTNNB1 p.G34L;BCOR Deletion;EGFR Amplification	0	6
P-0001225	P-0001225-T01-IM3	Outside	FFPE	Resection	250	564	50	Matched	Metastasis	Major Salivary Gland	Pleura	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0001226	P-0001226-T01-IM3	In-House	FFPE	Biopsy	250	829	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 PPM1D-NF1 fusion);Trametinib,Cobimetinib(PPM1D PPM1D-NF1 fusion)				LEVEL_1	PIK3CA p.E545K;TP53 p.G245S;ERBB2 Amplification;NF1 PPM1D-NF1 fusion;PPM1D PPM1D-NF1 fusion	6	5
P-0001227	P-0001227-T01-IM3	Outside	FFPE	Biopsy	250	618	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.T1556Nfs*3	2	2
P-0001228	P-0001228-T01-IM3	In-House	FFPE	Cytology	250	890	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0001229	P-0001229-T01-IM3	Outside	FFPE	Biopsy	203.5	223	25	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_4	FLT3 p.G822E;SMAD4 p.Q334*;ATR p.L728Ffs*7;TP53 p.S46Afs*5;CDKN2A p.P114L	1	5
P-0001230	P-0001230-T01-IM3	In-House	FFPE	Biopsy	250	515	30	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.Y87N;APC Deletion	0	2
P-0001231	P-0001231-T01-IM3	Outside	FFPE	Biopsy	250	737	40	Matched	Metastasis	Esophagus	Liver	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.C229Yfs*10;ARID1A Deletion;ERBB2 Amplification	2	3
P-0001232	P-0001232-T02-IM5	In-House	DNA	Biopsy	250	947	50	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.W117L;PBRM1 p.H447Rfs*5	0	2
P-0001232	P-0001232-T01-IM3	Outside	FFPE	Resection	250	628	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.W117L;BAP1 p.X686_splice;PBRM1 p.H447Rfs*5	0	3
P-0001233	P-0001233-T01-IM3	In-House	FFPE	Biopsy	89.09	189	30	Matched	Primary	Leg	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0001234	P-0001234-T01-IM3	In-House	FFPE	Resection	250	582	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.E632_L633del)		BLU-667(RET p.E632_L633del)						LEVEL_1	RET p.E632_L633del	2	1
P-0001235	P-0001235-T01-IM3	Outside	FFPE	Resection	250	579	20	Matched	Primary	Jejunum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.R248Q;KRAS p.G13D	1	2
P-0001236	P-0001236-T02-IM5	In-House	FFPE	Biopsy	250	959	60	Matched	Metastasis	Cancer of Unknown Primary	Breast	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										BCOR p.E1415*	0	1
P-0001236	P-0001236-T01-IM3	Outside	FFPE	Biopsy	129.72	356	40	Matched	Metastasis	Cancer of Unknown Primary	Breast	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										BCOR p.E1415*	0	1
P-0001237	P-0001237-T01-IM3	In-House	FFPE	Resection	250	210	40	Matched	Primary	Transverse Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(ATM p.W1710*)	GSK2636771,AZD8186(PTEN p.R173H);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_1	BRAF p.V600E;PIK3R1 p.N564D;PTEN p.R173H;MSH6 p.R922*;FOXP1 p.R514H;FBXW7 p.Q43*;APC p.Q1193*;APC p.E1284*;ATM p.W1710*;SMARCA4 p.X992_splice;KRAS p.G13D;MCL1 Amplification	6	12
P-0001238	P-0001238-T01-IM3	In-House	FFPE	Resection	250	700	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	NOTCH1 p.F357del;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	4
P-0001239	P-0001239-T01-IM3	In-House	FFPE	Biopsy	250	963	70	Matched	Metastasis	Minor Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										KDR Amplification;KIT Amplification;PDGFRA Amplification	0	3
P-0001240	P-0001240-T01-IM3	In-House	FFPE	Resection	250	551	40	Unmatched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)					LEVEL_3B	PPP2R1A p.P179R;PIK3CA p.M1043V;TP53 p.Q167*;PIK3R1 p.E462Ifs*2;AKT2 Amplification	1	5
P-0001241	P-0001241-T01-IM3	In-House	FFPE	Resection	250	274	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010Y)	Crizotinib(MET p.D1010Y)	Cabozantinib(MET p.D1010Y)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.D1010Y;CDK4 Amplification;JUN Amplification;MCL1 Amplification;MDM2 Amplification;RICTOR Amplification	5	6
P-0001241	P-0001241-T02-IM3	In-House	FFPE	Resection	250	273	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010Y)	Crizotinib(MET p.D1010Y)	Cabozantinib(MET p.D1010Y)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.D1010Y;CDK4 Amplification;MDM2 Amplification	5	3
P-0001242	P-0001242-T03-IM5	In-House	FFPE	Biopsy	218	124	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.M246*;EPHA7 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0001242	P-0001242-T01-IM3	In-House	FFPE	Resection	250	543	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.M246*	0	1
P-0001242	P-0001242-T02-IM3	In-House	FFPE	Resection	113.12	357	60	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.M246*	0	1
P-0001244	P-0001244-T02-IM3	Outside	FFPE	Biopsy	165.6	586	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.S33P;FOXA1 Amplification	0	2
P-0001246	P-0001246-T01-IM3	In-House	FFPE	Resection	250	287	70	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer										NKX2-1 Amplification	0	1
P-0001247	P-0001247-T01-IM3	In-House	FFPE	Resection	250	566	60	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R175H;AR Amplification;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion	1	5
P-0001248	P-0001248-T01-IM3	Outside	FFPE	Resection	250	668	20	Matched	Metastasis	Uterus	Lymph Node	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;ARID1A p.D1850Tfs*33;ARID1A p.F2141Sfs*59;MLH1 p.R226*;MLH1 p.S726*;CCND1 p.T286I;KDM5C p.W983*;ARID1B p.Q1424Rfs*11;KMT2D p.Q809Rfs*121;B2M p.D96Mfs*7;PTPRS p.V608Wfs*30	1	11
P-0001250	P-0001250-T01-IM3	In-House	FFPE	Resection	250	302	50	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0001251	P-0001251-T01-IM3	In-House	FFPE	Resection	250	484	50	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Trametinib,Cobimetinib(MAP2K1 p.P124L)	Everolimus(TSC2 p.R1032*)	Trametinib,Cobimetinib(NF1 p.I2270Ffs*10);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3A	BCL2L11 p.G156R;MLH1 p.R100*;KMT2C p.R4549C;PTPRD p.G446R;MAP2K1 p.P124L;TSC2 p.R1032*;DNMT3B p.R576*;NF2 p.R57*;NF1 p.I2270Ffs*10;CIC p.T1442Qfs*12;CDKN2A p.R80*;TERT Amplification	4	12
P-0001253	P-0001253-T01-IM3	In-House	FFPE	Resection	250	563	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132C)	Lapatinib(EGFR Amplification)				LEVEL_3B	IDH1 p.R132C;TP53 p.M237I;TP53 p.M246T;EGFR Amplification;MYCN Amplification;ATRX ATRX-intragenic	2	6
P-0001254	P-0001254-T02-IM3	Outside	FFPE	Resection	250	704	50	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)				Imatinib(PDGFRA p.D842V)			LEVEL_1	PDGFRA p.D842V	2	1
P-0001255	P-0001255-T01-IM3	Outside	FFPE	Biopsy	65	380	15	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.L19F);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Y)				LEVEL_4	TP53 p.E285*;MAP3K1 p.E1162*;KRAS p.L19F;AXIN1 p.E548*;SMAD4 p.Q448*;ARID1A p.A1978Sfs*36;CDKN2A p.D108Y	2	7
P-0001257	P-0001257-T01-IM3	Outside	FFPE	Cytology	102.29	368	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.Y163C;TP53 p.P128A	2	3
P-0001258	P-0001258-T01-IM3	In-House	FFPE	Biopsy	250	158	40	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.S463P)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3A	ESR1 p.S463P;GATA3 p.D335Efs*17;BCL2L1 Amplification;CDK4 Amplification;FOXA1 Amplification;GATA3 Amplification;MAP2K4 Deletion;MCL1 Amplification;MDM2 Amplification	3	9
P-0001259	P-0001259-T01-IM3	Outside	FFPE	Resection	250	799	30	Matched	Primary	Lung	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma											0	0
P-0001260	P-0001260-T01-IM3	Outside	FFPE	Resection	250	996	30	Matched	Metastasis	Stomach	Omentum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.X33_splice;SMAD4 p.Q366K;CDH1 CDH1-intragenic	0	3
P-0001261	P-0001261-T01-IM3	Outside	FFPE	Cytology	100	451	40	Matched	Metastasis	Colon	Omentum	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	KRAS p.G12A;APC p.R213*;APC p.S1411Rfs*4;SMARCA4 p.R973Q;FAT1 p.I3008Kfs*3;MITF Deletion;PTEN Deletion;RB1 Deletion	2	8
P-0001262	P-0001262-T01-IM3	In-House	FFPE	Resection	250	443	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.N131S	0	1
P-0001263	P-0001263-T01-IM3	Outside	FFPE	Biopsy	160	623	60	Matched	Metastasis	Breast	Bone	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										SMAD4 Deletion	0	1
P-0001265	P-0001265-T01-IM3	Outside	FFPE	Resection	250	496	50	Matched	Primary	Ovary	Not Applicable	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.E298Dfs*7;MYC Amplification;PTEN Deletion;PTPRS Deletion;RB1 Deletion;STK11 Deletion	1	6
P-0001266	P-0001266-T01-IM3	In-House	FFPE	Resection	250	431	70	Matched	Primary	Not available	Not available	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										BAP1 Deletion;PBRM1 Deletion;SETD2 Deletion	0	3
P-0001267	P-0001267-T01-IM3	Outside	FFPE	Resection	250	598	50	Matched	Primary	Ovary	Not Applicable	Tumor	SLCT	Sex Cord Stromal Tumor	Sertoli-Leydig Cell Tumor				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;DICER1 p.E1813Q;FGFR1 Amplification	2	3
P-0001268	P-0001268-T01-IM3	In-House	FFPE	Biopsy	161	736	30	Matched	Metastasis	Bladder	Pelvis	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.F270S;CCND1 Amplification;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MYC Amplification;RAF1 Amplification	1	8
P-0001269	P-0001269-T01-IM3	In-House	FFPE	Biopsy	153	588	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	TP53 p.Q331*;ERBB2 p.Y772_A775dup	2	2
P-0001272	P-0001272-T01-IM3	In-House	FFPE	Resection	250	652	35	Matched	Metastasis	Ovary	Diaphragm	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer	Niraparib,Olaparib,Rucaparib(BRCA1 p.A1708P)			Talazoparib(BRCA1 p.A1708P)					LEVEL_1	TP53 p.P278Lfs*67;BRCA1 p.A1708P;KDM6A KDM6A-intragenic	2	3
P-0001273	P-0001273-T01-IM3	In-House	FFPE	Resection	250	542	50	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0001274	P-0001274-T01-IM3	In-House	FFPE	Biopsy	125.4	731	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.X224_splice;KMT2C p.R199*;PTEN Deletion	1	3
P-0001275	P-0001275-T01-IM3	Outside	FFPE	Biopsy	250	720	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	APC p.Q222*;MDM2 Amplification;RB1 Deletion	1	3
P-0001276	P-0001276-T01-IM3	In-House	FFPE	Biopsy	179.3	597	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	SETD2 p.E1412Vfs*19;CDK4 Amplification;MDM2 Amplification;PTEN Deletion	3	4
P-0001278	P-0001278-T01-IM3	In-House	FFPE	Biopsy	220	750	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.E198*;RB1 p.X203_splice;AXIN1 p.S428*;KMT2D p.G962Wfs*7;AKT2 Amplification;AXL Amplification;BCL6 Amplification;PIK3CA Amplification	0	8
P-0001279	P-0001279-T01-IM3	In-House	FFPE	Biopsy	192	530	25	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R213*;IDH1 p.R132H;TP53 p.Y163H;ATRX p.E1450Gfs*15	1	4
P-0001280	P-0001280-T01-IM3	Outside	FFPE	Resection	250	815	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;TP53 p.C277F;ALK Amplification;SRC Amplification	2	4
P-0001281	P-0001281-T01-IM3	In-House	FFPE	Resection	116	581	15	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.T160I);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.T160I;CDKN2A Deletion;EGFR Amplification	3	3
P-0001283	P-0001283-T01-IM3	Outside	FFPE	Biopsy	120	491	70	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 p.S249C);Everolimus(TSC1 p.Q527*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X153_splice)				LEVEL_3B	FGFR3 p.S249C;FBXW7 p.R479P;TSC1 p.Q527*;TP53 p.N239S;CDKN2A p.X153_splice;CDK6 Amplification;MAP3K1 Deletion	3	7
P-0001284	P-0001284-T01-IM3	In-House	FFPE	Biopsy	129.8	443	30	Matched	Metastasis	Ovary	Diaphragm	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer	Olaparib,Rucaparib,Niraparib(BRCA2 p.R329Gfs*20)			Talazoparib(BRCA2 p.R329Gfs*20)					LEVEL_1	TP53 p.Y220C;RASA1 p.E781*;BRCA2 p.R329Gfs*20	2	3
P-0001285	P-0001285-T01-IM3	In-House	FFPE	Resection	250	353	50	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.C275Y	0	1
P-0001286	P-0001286-T01-IM3	Outside	FFPE	Resection	250	543	20	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.P577L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.W111*);GSK2636771,AZD8186(PTEN p.E157*)				LEVEL_3B	KRAS p.G12V;ARID1A p.Q56*;ARID1A p.Q1818*;PDGFRA p.P577L;PTEN p.W111*;PIK3R1 p.R557Pfs*6;PTEN p.E157*;EP300 EP300-intragenic	4	8
P-0001287	P-0001287-T01-IM3	In-House	FFPE	Resection	250	710	25	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.R213*;ARID1A p.Q1856*;APC p.E1309*;SMAD4 p.D537E	0	4
P-0001288	P-0001288-T01-IM3	In-House	FFPE	Biopsy	123.3	656	50	Matched	Primary	Muscle	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma											0	0
P-0001289	P-0001289-T01-IM3	Outside	FFPE	Resection	250	427	25	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344G)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	TP53 p.R248W;PIK3CA p.H1047R;APC p.R213*;PIK3CA p.V344G;KRAS p.G13D	3	5
P-0001290	P-0001290-T01-IM3	In-House	FFPE	Biopsy	250	878	70	Matched	Metastasis	Breast	Retroperitoneum	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										FAT1 Deletion;BLM BLM-intragenic	0	2
P-0001292	P-0001292-T01-IM3	In-House	FFPE	Biopsy	250	690	60	Matched	Metastasis	Liver	Liver	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma					PLX8394(BRAF p.G469V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ARID1A p.G276*;RAF1 p.P261R;BRAF p.G469V;RYBP p.R103Kfs*15;CDKN2A Deletion;CDKN2B Deletion;PBRM1 Deletion;SMAD4 Deletion	2	8
P-0001293	P-0001293-T01-IM3	Outside	FFPE	Biopsy	250	1000	30	Matched	Metastasis	Cancer of Unknown Primary	Scalp	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.R280K;IKBKE Amplification;MCL1 Amplification	0	3
P-0001294	P-0001294-T01-IM3	Outside	FFPE	Resection	250	994	90	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;NKX2-1 Amplification	2	2
P-0001295	P-0001295-T01-IM3	In-House	FFPE	Resection	250	666	30	Matched	Metastasis	Sigmoid Colon	Brain	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C);Cabozantinib,Crizotinib(MET Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.S1465Wfs*3;TP53 p.V173L;APC p.R405*;PIK3R1 p.E458del;MET Amplification;TERT Amplification	3	7
P-0001296	P-0001296-T01-IM3	In-House	FFPE	Cytology	70.85	303	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.A159P;AKT2 Amplification;CCNE1 Amplification;FGFR1 Amplification;FOXA1 Amplification;NKX2-1 Amplification	2	7
P-0001296	P-0001296-T02-IM5	In-House	DNA	Cytology	141.955	844	20	Unmatched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.A159P;SMAD2 p.P221Ffs*12	2	4
P-0001297	P-0001297-T01-IM3	Outside	FFPE	Resection	250	597	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										NOTCH1 p.S990Lfs*34;CCND1 Amplification;FOXA1 Amplification	0	3
P-0001298	P-0001298-T01-IM3	Outside	FFPE	Biopsy	141.94	315	25	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R248W	0	1
P-0001299	P-0001299-T01-IM3	Outside	FFPE	Resection	250	650	25	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0001300	P-0001300-T01-IM3	In-House	FFPE	Biopsy	250	949	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;APC p.K581Gfs*20	1	2
P-0001300	P-0001300-T02-IM5	In-House	FFPE	Biopsy	132.65	633	60	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Everolimus(MTOR p.E2419K)	Temsirolimus(MTOR p.E2419K)				LEVEL_1	EGFR p.L858R;NUP93 p.E14K;MTOR p.E2419K;APC p.K581Gfs*20	3	4
P-0001301	P-0001301-T01-IM3	In-House	FFPE	Cytology	155.7	817	35	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R306*;CDH1 p.X522_splice;AKT2 Amplification;BCL2L1 Amplification;CDK6 Amplification;DNMT3B Amplification;SRC Amplification	0	7
P-0001302	P-0001302-T01-IM3	In-House	FFPE	Resection	250	853	25	Matched	Metastasis	Sigmoid Colon	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R232*;APC p.Q1204*;TP53 p.T102Nfs*47;RB1 Deletion	0	4
P-0001303	P-0001303-T01-IM3	In-House	FFPE	Biopsy	250	934	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR p.V689M;TP53 p.P36Rfs*7	1	3
P-0001303	P-0001303-T02-IM3	In-House	FFPE	Biopsy	250	741	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR p.V689M;TP53 p.P36Rfs*7	1	3
P-0001303	P-0001303-T03-IM5	In-House	FFPE	Biopsy	250	964	80	Unmatched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Ivosidenib(IDH1 p.R132G)					LEVEL_1	EGFR p.L858R;IDH1 p.R132G;EGFR p.V689M;TP53 p.P36Rfs*7	2	4
P-0001304	P-0001304-T01-IM3	Outside	FFPE	Biopsy	250	619	25	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0001305	P-0001305-T01-IM3	Outside	FFPE	Resection	250	501	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R273L;MED12 p.K68N;CCND2 Amplification;EPHA3 Deletion;KDM5A Amplification	0	5
P-0001306	P-0001306-T01-IM3	Outside	FFPE	Biopsy	101.2	752	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;CDH1 p.L355*	2	2
P-0001307	P-0001307-T01-IM3	Outside	FFPE	Biopsy	73.35	331	20	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										NFE2L2 p.W24S;CTNNB1 p.D32G;CDKN1B p.Y89*	0	3
P-0001308	P-0001308-T01-IM3	Outside	FFPE	Resection	250	349	50	Unmatched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma		Olaparib,Talazoparib(BRCA2 p.S1982Rfs*22);Olaparib,Talazoparib(BRCA2 p.D3095G)		Rucaparib,Niraparib(BRCA2 p.S1982Rfs*22);Rucaparib,Niraparib(BRCA2 p.D3095G)					LEVEL_2	BRCA2 p.S1982Rfs*22;BRCA2 p.D3095G;CDH1 p.R150*;NOTCH3 p.G406Pfs*12	4	4
P-0001309	P-0001309-T01-IM3	In-House	FFPE	Resection	250	435	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	GRIN2A p.X138_splice;STK11 p.X155_splice;APC p.S2575Cfs*7;KEAP1 p.M409*;B2M Deletion;CDKN2A Deletion;DDR2 Amplification;ERBB2 Amplification;FOXA1 Amplification;NKX2-1 Amplification;NTRK1 Amplification	2	11
P-0001310	P-0001310-T01-IM3	In-House	FFPE	Resection	250	773	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	ASXL1 p.T683Rfs*28;NCOR1 Deletion;PTEN Deletion;SMAD3 Deletion	1	4
P-0001311	P-0001311-T01-IM3	Outside	FFPE	Resection	250	705	NA	Matched	Metastasis	Ovary	Diaphragm	Tumor	EOV	Ovarian Cancer	Endometrioid Ovarian Cancer											0	0
P-0001312	P-0001312-T01-IM3	Outside	FFPE	Resection	250	922	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.X331_splice;CCND2 Amplification;FGFR1 Amplification;FGFR4 Amplification;KDM5A Amplification	1	5
P-0001314	P-0001314-T01-IM3	In-House	FFPE	Biopsy	250	707	80	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;FOXA1 Amplification;MCL1 Amplification;NKX2-1 Amplification	1	5
P-0001315	P-0001315-T01-IM3	In-House	FFPE	Resection	250	1132	70	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Trametinib,Cobimetinib(NF1 p.Q83Vfs*23);Trametinib,Cobimetinib(NF1 p.F1275Pfs*8)				LEVEL_3B	BRAF p.V600E;RB1 p.X738_splice;NF1 p.Q83Vfs*23;NF1 p.F1275Pfs*8	3	4
P-0001315	P-0001315-T02-IM5	In-House	FFPE	Resection	250	1023	90	Matched	Metastasis	Duodenum	Skin	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Trametinib,Cobimetinib(NF1 p.Q83Vfs*23);Trametinib,Cobimetinib(NF1 p.F1275Pfs*8)				LEVEL_3B	BRAF p.V600E;RB1 p.X738_splice;NF1 p.Q83Vfs*23;NF1 p.F1275Pfs*8	3	4
P-0001316	P-0001316-T01-IM3	In-House	FFPE	Resection	250	529	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Everolimus,Temsirolimus(MTOR p.W1456_L1460delinsC)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R175H;APC p.X582_splice;MTOR p.W1456_L1460delinsC;APC p.I1580Ffs*70;FBXW7 Deletion	2	6
P-0001317	P-0001317-T01-IM3	Outside	FFPE	Resection	250	748	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R342*;SMAD4 p.K428T;RNF43 p.D300Wfs*120;ERBB2 Amplification	2	4
P-0001318	P-0001318-T01-IM3	Outside	FFPE	Resection	250	722	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R273H;ARID1A p.Q840*;FBXW7 p.D520G;APC p.C1270*;FBXW7 p.E117Gfs*9	0	5
P-0001319	P-0001319-T05-IM5	In-House	FFPE	Biopsy	250	1206	80	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PIK3R1 p.X600_splice;GPS2 p.K52Rfs*11;TOP1 p.X650_splice;CDKN2A Deletion;CDKN2B Deletion;EED Deletion;FANCC Deletion;MITF Deletion;MLH1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	11
P-0001319	P-0001319-T03-IM5	In-House	FFPE	Resection	250	506	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PIK3R1 p.X600_splice;GPS2 p.K52Rfs*11;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0001320	P-0001320-T01-IM3	In-House	FFPE	Resection	250	485	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R196*;IDH1 p.R132H;SMARCA4 p.R1243W;ATRX p.K823Rfs*7	1	4
P-0001321	P-0001321-T01-IM3	In-House	FFPE	Biopsy	250	736	30	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										ARID1A p.D1850Gfs*4;ARID1B p.R1931*	0	2
P-0001322	P-0001322-T01-IM3	Outside	FFPE	Resection	250	924	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMAD2 p.S464*;ARID1A p.Q678*;SMAD3 p.R93*	1	4
P-0001323	P-0001323-T01-IM3	Outside	FFPE	Biopsy	250	952	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										CCNE1 Amplification;KRAS Amplification;MCL1 Amplification;SMAD4 Deletion;RND1 MLL2-RND1 fusion;KMT2D MLL2-RND1 fusion	0	6
P-0001324	P-0001324-T01-IM3	In-House	FFPE	Resection	250	226	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										NSD1 p.K2266*;CDKN1A p.R83Lfs*41;MCL1 Amplification	0	3
P-0001325	P-0001325-T02-IM5	In-House	FFPE	Biopsy	250	618	80	Matched	Metastasis	Prostate	Flank	Tumor	PRSCC	Prostate Cancer	Prostate Small Cell Carcinoma	Olaparib,Rucaparib(BRCA2 p.N1784Tfs*7)			Talazoparib,Niraparib(BRCA2 p.N1784Tfs*7);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.A440T)					LEVEL_1	BRCA2 p.N1784Tfs*7;TP53 p.R248Q;APC p.S1465Wfs*3;RNF43 p.G659Vfs*41;PIK3CD p.R894Q;TP53 p.X225_splice;ERBB2 p.A440T;APC p.D849Ifs*12;RB1 p.G100Efs*11;FOXA1 p.A274Pfs*47;AMER1 p.R353*;ZFHX3 p.R237*;RAD50 p.N795Ifs*6;HLA-A p.A16Pfs*4;ZFHX3 p.Q3197Pfs*42;ZFHX3 p.R1893Gfs*35;EPHA7 Deletion	3	17
P-0001325	P-0001325-T01-IM3	Outside	FFPE	Biopsy	250	660	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRSCC	Prostate Cancer	Prostate Small Cell Carcinoma	Olaparib,Rucaparib(BRCA2 p.N1784Tfs*7)			Talazoparib,Niraparib(BRCA2 p.N1784Tfs*7);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.A440T)					LEVEL_1	BRCA2 p.N1784Tfs*7;TP53 p.R248Q;APC p.S1465Wfs*3;RNF43 p.G659Vfs*41;PIK3CD p.R894Q;TP53 p.X225_splice;ERBB2 p.A440T;APC p.D849Ifs*12;RB1 p.G100Efs*11;FOXA1 p.A274Pfs*47;MAP3K1 Deletion	3	11
P-0001326	P-0001326-T01-IM3	Outside	FFPE	Resection	250	985	40	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0001327	P-0001327-T01-IM3	In-House	FFPE	Biopsy	190.4	984	70	Matched	Metastasis	Minor Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;KDR Amplification;KIT Amplification;PDGFRA Amplification	1	5
P-0001328	P-0001328-T01-IM3	In-House	FFPE	Biopsy	165.6	766	60	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				GSK2636771,AZD8186(PTEN p.K125T);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.S106R;EGFR p.E709K;PTEN p.K125T;CARD11 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ETV1 Amplification;FOXA1 Amplification;NKX2-1 Amplification;RAC1 Amplification	4	13
P-0001330	P-0001330-T01-IM3	In-House	FFPE	Resection	250	897	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0001331	P-0001331-T01-IM3	Outside	FFPE	Biopsy	91	136	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R110Vfs*13;TP53 p.Y107*;CCND2 Amplification;KDM5A Amplification	0	4
P-0001332	P-0001332-T01-IM3	In-House	FFPE	Resection	250	816	NA	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(RAD51B Deletion)								LEVEL_1	DIS3 Deletion;PTPRT Deletion;RAD51B Deletion	1	3
P-0001332	P-0001332-T02-IM3	In-House	FFPE	Resection	250	550	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(RAD51B Deletion)								LEVEL_1	RAD51B Deletion	1	1
P-0001335	P-0001335-T01-IM3	In-House	FFPE	Resection	250	842	35	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;TBX3 p.G730Pfs*151;TP53 p.G105Afs*18	2	3
P-0001336	P-0001336-T01-IM3	In-House	FFPE	Biopsy	250	755	NA	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.D32V	0	1
P-0001337	P-0001337-T01-IM3	In-House	FFPE	Resection	250	441	35	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.N184Efs*6)				LEVEL_4	PTEN p.N184Efs*6	1	1
P-0001338	P-0001338-T01-IM3	In-House	FFPE	Biopsy	181.8	703	NA	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K);Neratinib(ERBB2 p.R678Q)	Ado-Trastuzumab Emtansine(ERBB2 p.R678Q)					LEVEL_1	PIK3CA p.N345K;TP53 p.R273C;ERBB2 p.R678Q;AURKA Amplification;SRC Amplification;DHX35 TOP1-DHX35 fusion;TOP1 TOP1-DHX35 fusion	4	7
P-0001338	P-0001338-T02-IM3	In-House	FFPE	Biopsy	250	759	30	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K);Neratinib(ERBB2 p.R678Q)	Ado-Trastuzumab Emtansine(ERBB2 p.R678Q);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.N345K;TP53 p.R273C;ERBB2 p.R678Q;AURKA Amplification;ERBB2 Amplification;SRC Amplification;DHX35 TOP1-DHX35 fusion;TOP1 TOP1-DHX35 fusion	6	8
P-0001339	P-0001339-T01-IM3	In-House	FFPE	Biopsy	250	884	NA	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	NOTCH2 p.P6Rfs*27;CCND2 Amplification;CDK4 Amplification;ERBB3 Amplification;KDR Amplification;KIT Amplification;MAPK1 Amplification;MDM2 Amplification;PDGFRA Amplification	2	9
P-0001340	P-0001340-T01-IM3	In-House	FFPE	Biopsy	250	861	NA	Matched	Metastasis	Lung	Liver	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer										TP53 p.X307_splice;FOXP1 FOXP1-intragenic	0	2
P-0001341	P-0001341-T01-IM3	Outside	FFPE	Biopsy	192.5	695	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										NCOR1 p.Q709*;AKT3 Amplification;EGFR Amplification;IKBKE Amplification;IKZF1 Deletion;MCL1 Amplification;MDM4 Amplification;PHOX2B Deletion	0	8
P-0001342	P-0001342-T02-IM5	In-House	FFPE	Resection	250	525	80	Matched	Metastasis	Kidney	Lung	Tumor	RAML	Renal Cell Carcinoma	Renal Angiomyolipoma				Everolimus(TSC2 p.D1696Efs*127)					LEVEL_3B	TSC2 p.D1696Efs*127	1	1
P-0001342	P-0001342-T01-IM3	Outside	FFPE	Resection	250	167	50	Matched	Primary	Kidney	Not Applicable	Tumor	RAML	Renal Cell Carcinoma	Renal Angiomyolipoma				Everolimus(TSC2 p.D1696Efs*127)					LEVEL_3B	TSC2 p.D1696Efs*127	1	1
P-0001343	P-0001343-T01-IM3	In-House	FFPE	Resection	250	633	60	Matched	Metastasis	Retroperitoneum	Paracaval	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;CCND2 Amplification;EZH2 Deletion;KDM5A Amplification;KRAS Amplification	1	5
P-0001345	P-0001345-T01-IM3	In-House	FFPE	Biopsy	250	566	20	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	EPIS	Soft Tissue Sarcoma	Epithelioid Sarcoma											0	0
P-0001346	P-0001346-T01-IM3	Outside	FFPE	Resection	250	757	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN Deletion)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.L145P;SMARCA4 p.R1189*;APC p.E1540Kfs*22;NCOR1 Deletion;PTEN Deletion	2	6
P-0001347	P-0001347-T02-IM5	In-House	DNA	Resection	250	1030	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	PIK3CA p.E542K;TP53 p.V272L;APC p.R499*;APC p.P1439Lfs*34;FGFR1 Amplification;TP53 TP53-intragenic	2	6
P-0001348	P-0001348-T02-IM3	Outside	FFPE	Biopsy	250	763	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										STK11 p.X307_splice;APC p.S780Ffs*40	0	2
P-0001348	P-0001348-T01-IM3	Outside	FFPE	Resection	250	241	50	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P11Rfs*5)				LEVEL_4	TP53 p.X32_splice;STK11 p.X307_splice;APC p.S780Vfs*40;TP53 p.E285_K292del;CDKN2A p.P11Rfs*5	1	5
P-0001350	P-0001350-T01-IM3	In-House	FFPE	Resection	250	999	60	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;CDH1 p.X379_splice;FGFR1 Amplification;IKBKE Amplification;MDM4 Amplification;PAK1 Amplification	3	6
P-0001351	P-0001351-T01-IM3	In-House	FFPE	Biopsy	113	336	25	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;NOTCH2 p.X1928_splice;KMT2C p.Q2788*;KEAP1 p.Y491*;PTPRT p.Q615*;CDH1 p.A617Gfs*46	2	6
P-0001351	P-0001351-T02-IM5	In-House	FFPE	Cytology	250	888	10	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;KMT2C p.Q2788*;CDH1 p.A617Gfs*46	2	3
P-0001352	P-0001352-T01-IM3	Outside	FFPE	Resection	250	867	20	Matched	Primary	Breast	Not Applicable	Tumor	MBC	Breast Cancer	Metaplastic Breast Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.G35V)				LEVEL_4	TP53 p.Y220*;CDKN2A p.G35V;KDM5A Amplification	1	3
P-0001354	P-0001354-T01-IM3	In-House	FFPE	Biopsy	152.1	793	10	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CDKN1A p.E108Gfs*21	0	1
P-0001355	P-0001355-T01-IM3	Outside	FFPE	Resection	250	919	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	0	3
P-0001357	P-0001357-T02-IM5	In-House	FFPE	Resection	142.5	755	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)	Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L858R;TP53 p.R280S;TP53 p.X261_splice;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;FGF19 Amplification;MET Amplification	4	9
P-0001358	P-0001358-T02-IM3	Outside	FFPE	Resection	250	266	40	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	PIK3CA p.H1047R;NRAS p.Q61R;NKX2-1 Amplification	3	3
P-0001359	P-0001359-T01-IM3	In-House	FFPE	Resection	250	634	30	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R	1	1
P-0001361	P-0001361-T01-IM3	In-House	FFPE	Resection	250	500	40	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P48L)				LEVEL_4	TP63 p.S365L;TP53 p.A159V;CDKN2A p.P48L	1	3
P-0001362	P-0001362-T01-IM3	In-House	FFPE	Biopsy	250	727	25	Matched	Metastasis	Thymus	Bone	Tumor	THYC	Thymic Tumor	Thymic Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	TET2 p.T1063Yfs*5;FBXW7 p.D607Ifs*21;CDKN2A p.R80*	1	3
P-0001363	P-0001363-T01-IM3	In-House	FFPE	Resection	135	281	50	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										TP53 p.R196*;JUN Amplification	0	2
P-0001364	P-0001364-T01-IM3	In-House	FFPE	Resection	250	629	25	Matched	Primary	Lung	Not Applicable	Tumor	PECOMA	Soft Tissue Sarcoma	Perivascular Epithelioid Cell Tumor										ATRX p.E1447*	0	1
P-0001364	P-0001364-T02-IM3	In-House	FFPE	Resection	250	1089	40	Matched	Primary	Rectum	Not Applicable	Tumor	PECOMA	Soft Tissue Sarcoma	Perivascular Epithelioid Cell Tumor										ATRX p.E1447*	0	1
P-0001365	P-0001365-T01-IM3	In-House	FFPE	Biopsy	250	683	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Q104*;NF2 p.E215*;PTPRT p.Y951*	0	3
P-0001365	P-0001365-T02-IM3	In-House	FFPE	Biopsy	182	534	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TET2 p.E1483*;FBXW7 p.R689Q;TP53 p.V216L;STK11 p.S216F;STK11 p.Q220*	0	5
P-0001366	P-0001366-T01-IM3	In-House	FFPE	Biopsy	250	639	20	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Palbociclib,Abemaciclib(CDK4 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.H1047R;ASXL2 p.Q353*;CCND1 Amplification;CDK4 Amplification;FGFR1 Amplification;MDM2 Amplification;SRC Amplification	5	7
P-0001367	P-0001367-T01-IM3	In-House	FFPE	Resection	250	449	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.X126_splice;PIK3R2 p.G373R;CDH1 p.G212Dfs*3;PTEN Deletion	1	4
P-0001368	P-0001368-T01-IM3	In-House	FFPE	Biopsy	250	855	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.E746_A750del;PIK3CA p.H1047R;CCND3 Amplification;CDK4 Amplification;MDM2 Amplification;MYC Amplification;TERT Amplification	4	7
P-0001369	P-0001369-T01-IM3	In-House	FFPE	Biopsy	250	636	30	Matched	Metastasis	Kidney	Small Bowel	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										ARID5B p.H979Rfs*21	0	1
P-0001370	P-0001370-T01-IM3	In-House	FFPE	Resection	250	237	30	Matched	Metastasis	Lung	Lymph Node	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.Y220C;SMARCA4 p.X648_splice;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0001372	P-0001372-T01-IM3	In-House	FFPE	Resection	250	322	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										KMT2C p.X2481_splice;TP53 p.L265Tfs*7;FOXA1 Amplification	0	3
P-0001373	P-0001373-T01-IM3	In-House	FFPE	Biopsy	250	687	65	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	MYEC	Salivary Gland Cancer	Myoepithelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.X32_splice;CDKN2A Deletion;CDKN2B Deletion;SMARCA4 LPAR2-SMARCA4 fusion;LPAR2 LPAR2-SMARCA4 fusion;RYBP RYBP-intragenic	1	6
P-0001374	P-0001374-T01-IM3	In-House	FFPE	Biopsy	250	583	50	Matched	Metastasis	Vulva	Pelvis	Tumor	VSC	Vaginal Cancer	Squamous Cell Carcinoma of the Vulva/Vagina				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Tipifarnib(HRAS p.Q61L)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E542K;HRAS p.Q61L;FAT1 p.D4333Vfs*17;FAT1 p.S666Gfs*6;NOTCH1 p.L1531Pfs*79;CASP8 p.X138_splice;CDKN2A Deletion;CDKN2B Deletion	3	8
P-0001375	P-0001375-T01-IM3	In-House	FFPE	Biopsy	250	392	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	NSD1 p.E2116*;ARID2 p.S1692*;TP53 p.R65*;KEAP1 p.S224Pfs*123;MET Amplification	2	5
P-0001376	P-0001376-T01-IM3	In-House	FFPE	Biopsy	250	335	60	Matched	Metastasis	Breast	Skin	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.E235*)				LEVEL_4	TP53 p.Y126C;MAP3K1 p.S371*;PTEN p.E235*;ARID2 p.E533*;AURKA Amplification;CCND1 Amplification;FGF19 Amplification;GATA3 Amplification;PHOX2B Deletion	1	9
P-0001377	P-0001377-T01-IM3	Outside	FFPE	Resection	250	499	70	Matched	Primary	Not available	Not available	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0001377	P-0001377-T02-IM5	Outside	FFPE	Resection	250	1085	20	Matched	Metastasis	Soft Tissue	Heart	Tumor	ES	Bone Cancer	Ewing Sarcoma											0	0
P-0001380	P-0001380-T01-IM3	In-House	FFPE	Biopsy	216.7	436	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMAD4 p.D351Y;DNMT3B p.V229M;TP53 p.P250_L252del	1	4
P-0001381	P-0001381-T01-IM3	Outside	FFPE	Cytology	250	464	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										MYC p.P74S;TP53 p.D281Y;STK11 p.X245_splice;TP53 p.P75Lfs*74	0	4
P-0001382	P-0001382-T01-IM3	In-House	FFPE	Biopsy	250	619	15	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PAX5 p.V26G;TP53 p.S241P	0	2
P-0001383	P-0001383-T01-IM3	Outside	FFPE	Biopsy	166.1	336	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.S1053*)				LEVEL_1	TP53 p.R248Q;PIK3CA p.H1047R;ARID1A p.Q633*;NF1 p.S1053*;RASA1 p.X485_splice;MAP2K4 p.E82Mfs*7;ERBB2 Amplification	5	7
P-0001384	P-0001384-T01-IM3	In-House	FFPE	Biopsy	250	475	50	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer					GSK2636771,AZD8186(PTEN p.S287*)				LEVEL_4	PPP2R1A p.R183Q;DNMT3A p.S770*;PTEN p.S287*;TP53 p.P177_C182del	1	4
P-0001385	P-0001385-T01-IM3	In-House	FFPE	Biopsy	250	580	NA	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13R)				LEVEL_4	U2AF1 p.S34F;KRAS p.G13R;TP53 p.R273G;STK11 p.X288_splice;KEAP1 p.G186C	1	5
P-0001388	P-0001388-T01-IM3	In-House	FFPE	Biopsy	250	541	35	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.D326Y);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	PTEN p.D326Y;NF1 Deletion	2	2
P-0001389	P-0001389-T01-IM3	In-House	FFPE	Cytology	250	644	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_1	TP53 p.R273H;EGFR p.E746_A750del;PTEN p.T319*;RNF43 p.S251Afs*168	2	4
P-0001390	P-0001390-T01-IM3	In-House	FFPE	Resection	250	148	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification;NKX2-1 Amplification;RICTOR Amplification	1	3
P-0001391	P-0001391-T01-IM3	In-House	FFPE	Resection	250	667	10	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344G)					LEVEL_3B	TP53 p.Q192*;PIK3CA p.V344G	1	2
P-0001392	P-0001392-T01-IM3	In-House	FFPE	Resection	250	523	20	Matched	Metastasis	Ovary	Abdomen	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;PPP2R1A p.R183Q;CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification;PAK1 Amplification	2	6
P-0001393	P-0001393-T01-IM3	In-House	FFPE	Biopsy	250	683	40	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453_D454del);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PTPRS p.X524_splice;PIK3CA p.E453_D454del;TP53 p.T253dup;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification	4	6
P-0001394	P-0001394-T02-IM5	In-House	FFPE	Resection	250	675	20	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	KRAS p.G13D;APC p.K1182*;MAP3K1 p.E187*;SOX9 p.S33Lfs*219;APC p.G1635Yfs*5	1	5
P-0001395	P-0001395-T01-IM3	In-House	FFPE	Biopsy	250	618	40	Matched	Metastasis	Breast	Axilla	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;MAP3K1 p.L380S	2	2
P-0001396	P-0001396-T01-IM3	In-House	FFPE	Biopsy	250	666	NA	Matched	Metastasis	Breast	Back	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.T253P;TGFBR2 p.E152Nfs*11	2	3
P-0001396	P-0001396-T02-IM5	In-House	DNA	Biopsy	250	311	10	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.T253P;TGFBR2 p.E152Nfs*11;EGFR Amplification	2	4
P-0001397	P-0001397-T01-IM3	In-House	FFPE	Resection	250	482	NA	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 p.A1676Sfs*5)				LEVEL_3B	PAX5 p.X71_splice;KDM5C p.E1310*;AXIN1 p.P748Gfs*33;NF1 p.A1676Sfs*5;FGFR1 Amplification;MYC Amplification;STK11 Deletion	2	7
P-0001398	P-0001398-T01-IM3	Outside	FFPE	Biopsy	250	529	60	Matched	Metastasis	Anus	Lymph Node	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										AKT2 Amplification	0	1
P-0001400	P-0001400-T01-IM3	In-House	FFPE	Resection	250	476	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.G245S;IDH1 p.R132H;PIK3R1 p.H450_E451del	1	3
P-0001401	P-0001401-T02-IM3	Outside	FFPE	Resection	250	125	20	Matched	Primary	Gallbladder	Not Applicable	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors										DAXX p.X69_splice	0	1
P-0001402	P-0001402-T01-IM3	Outside	FFPE	Resection	250	838	20	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201C	1	2
P-0001402	P-0001402-T02-IM3	Outside	FFPE	Resection	250	418	20	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0001403	P-0001403-T01-IM3	Outside	FFPE	Resection	250	993	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Olaparib(ATM p.L1144*)					LEVEL_3B	ATM p.L1144*;EZH2 Amplification	1	2
P-0001405	P-0001405-T01-IM3	Outside	FFPE	Resection	250	786	50	Matched	Metastasis	Nasopharynx	Lymph Node	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma											0	0
P-0001406	P-0001406-T01-IM3	In-House	FFPE	Biopsy	250	583	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2C p.N97Lfs*28;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	4
P-0001407	P-0001407-T01-IM3	In-House	FFPE	Resection	250	461	15	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PIK3R2 Deletion	0	1
P-0001408	P-0001408-T01-IM3	In-House	FFPE	Resection	250	557	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Trametinib,Cobimetinib(NF1 p.R1534*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.R1534*;PIK3R1 p.T576del;CDKN2A Deletion	2	3
P-0001409	P-0001409-T01-IM3	In-House	FFPE	Resection	250	424	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0001410	P-0001410-T01-IM3	In-House	FFPE	Resection	250	810	60	Matched	Primary	Gastric Wall	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_V559delinsF)			Everolimus(TSC1 p.S276Lfs*42)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KMT2D p.Q3601*;KIT p.W557_V559delinsF;TSC1 p.S276Lfs*42;CDKN2A Deletion;CDKN2B Deletion;PRDM1 Deletion	3	6
P-0001411	P-0001411-T01-IM3	Outside	FFPE	Resection	250	1055	30	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201C	1	2
P-0001412	P-0001412-T01-IM3	In-House	FFPE	Resection	250	547	80	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;NOTCH1 p.V324Qfs*6;SMARCA4 p.G1232S;FUBP1 p.R37Sfs*11	1	4
P-0001413	P-0001413-T01-IM3	In-House	FFPE	Resection	250	403	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0001415	P-0001415-T01-IM3	Outside	FFPE	Resection	250	426	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	ARID1A p.Y395*;GATA3 p.G334Wfs*18;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MDM2 Amplification	3	6
P-0001416	P-0001416-T01-IM3	In-House	FFPE	Resection	250	488	60	Matched	Metastasis	Skin	Pleura	Tumor	SKAC	Skin Cancer, Non-Melanoma	Skin Adnexal Carcinoma										TP53 p.S241F;BAP1 p.S628Pfs*8	0	2
P-0001417	P-0001417-T02-IM3	Outside	FFPE	Biopsy	250	225	90	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										NSD1 p.S1359*	0	1
P-0001417	P-0001417-T01-IM3	Outside	FFPE	Resection	250	607	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										NSD1 p.S1359*	0	1
P-0001418	P-0001418-T01-IM3	Outside	FFPE	Resection	250	564	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	GSK2636771,AZD8186(PTEN p.Y177*)				LEVEL_3B	PIK3CA p.E542K;KMT2D p.Q3913*;PTEN p.Y177*;RB1 p.W681*;CDKN1B p.R15Gfs*27;TP53 Deletion	2	6
P-0001419	P-0001419-T01-IM3	Outside	FFPE	Biopsy	250	670	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.N345K;CDK4 Amplification;FGFR3 Amplification;MDM2 Amplification	4	4
P-0001420	P-0001420-T02-IM5	In-House	DNA	Biopsy	250	865	40	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);Ivosidenib(IDH1 p.R132H)	Tazemetostat(SMARCB1 p.K364del)				LEVEL_3B	PIK3CA p.G118D;IDH1 p.R132H;CDKN2C p.L86Tfs*9;CIC p.S605Kfs*85;KMT2C p.W4357*;SUFU p.E414*;SMARCB1 p.K364del;TGFBR1 Deletion;TNFRSF14 Deletion	3	9
P-0001420	P-0001420-T01-IM3	In-House	FFPE	Resection	250	448	35	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)	Tazemetostat(SMARCB1 p.K364del)				LEVEL_3B	IDH1 p.R132H;SMARCB1 p.K364del;CDKN2C p.L86Tfs*9;CIC p.S605Kfs*85	2	4
P-0001421	P-0001421-T01-IM3	In-House	FFPE	Resection	250	555	60	Matched	Metastasis	Ovary	Cecum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R248Q;BCL6 Amplification;BCOR Deletion;CCNE1 Amplification;KDM6A Deletion;KRAS Amplification;PIK3CA Amplification;PIK3CB Amplification	0	8
P-0001422	P-0001422-T01-IM3	In-House	FFPE	Resection	250	302	70	Matched	Metastasis	Minor Salivary Gland	Bone	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)					LEVEL_3B	PIK3CA p.C420R;RUNX1 p.P330Rfs*237;NOTCH1 p.X135_splice;RUNX1 p.R293*	1	4
P-0001423	P-0001423-T01-IM3	In-House	FFPE	Resection	250	682	90	Matched	Metastasis	Brain	Abdomen	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BCOR Deletion;CDKN2A Deletion;CDKN2B Deletion;BCOR BCOR-intragenic	1	4
P-0001424	P-0001424-T01-IM3	In-House	FFPE	Biopsy	250	862	30	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	BRAF p.V600E;PIK3CA p.E545K;APC p.T1556Nfs*3;TP53 p.P250L;APC p.R213Tfs*39	4	5
P-0001424	P-0001424-T02-IM3	Outside	FFPE	Biopsy	250	648	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	BRAF p.V600E;PIK3CA p.E545K;APC p.T1556Nfs*3;TP53 p.P250L;APC p.R213Tfs*39;FAT1 Deletion;FBXW7 Deletion	4	7
P-0001425	P-0001425-T01-IM3	In-House	FFPE	Biopsy	250	1100	35	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.R233*);Trametinib,Cobimetinib(NF1 p.L2345*)				LEVEL_4	PTEN p.R233*;TP53 p.W23*;NF1 p.L2345*	2	3
P-0001426	P-0001426-T01-IM3	Outside	FFPE	Resection	250	829	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.G132V);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PDGFRB p.N666K;PTEN p.G132V;KMT2D p.E153*;TP53 p.X32_splice;FOXA1 p.L320Gfs*23;B2M Deletion;BMPR1A Deletion;FAT1 Deletion;MYC Amplification;PTEN Deletion;RAD51 Deletion;RB1 Deletion	2	12
P-0001427	P-0001427-T01-IM3	In-House	FFPE	Resection	250	262	30	Matched	Metastasis	Ascending Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.X332_splice	1	2
P-0001428	P-0001428-T01-IM3	In-House	FFPE	Biopsy	250	850	40	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.E287*;EPHA3 p.R385*;APC p.R876*;FOXP1 p.Q280Hfs*46;APC p.D1486Ifs*21;MET Amplification;PARD3B ERBB4-PARD3B fusion;ERBB4 ERBB4-PARD3B fusion;FAT1 FAT1-intragenic	1	9
P-0001429	P-0001429-T01-IM3	In-House	FFPE	Resection	250	356	80	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										CASP8 Deletion	0	1
P-0001430	P-0001430-T01-IM3	In-House	FFPE	Resection	250	509	80	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										KMT2D p.G1913Wfs*44;CBL CBL-intragenic	0	2
P-0001431	P-0001431-T01-IM3	In-House	FFPE	Biopsy	250	602	50	Unmatched	Primary	Rectum	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K558_V560del)								LEVEL_1	KIT p.K558_V560del	1	1
P-0001432	P-0001432-T02-IM5	In-House	FFPE	Biopsy	250	684	10	Matched	Primary	Brain	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.F1174L)					LEVEL_3B	ALK p.F1174L;BCOR p.E1073*;MYCN Amplification	1	3
P-0001432	P-0001432-T01-IM3	In-House	FFPE	Resection	250	497	30	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;MYCN Amplification	1	2
P-0001433	P-0001433-T01-IM3	Outside	FFPE	Biopsy	250	926	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.R304*)				LEVEL_4	NF1 p.R304*;FUBP1 Deletion	1	2
P-0001434	P-0001434-T01-IM3	In-House	FFPE	Resection	250	673	80	Matched	Metastasis	Lower Extremity	Lung	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma										TP53 p.E349*;TP53 p.M169Dfs*11	0	2
P-0001435	P-0001435-T01-IM3	Outside	FFPE	Resection	250	473	40	Matched	Metastasis	Testis	Soft Tissue	Tumor	TT	Germ Cell Tumor	Teratoma										CCND2 Amplification;KDM5A Amplification;KRAS Amplification;TP53 Deletion	0	4
P-0001436	P-0001436-T01-IM3	Outside	FFPE	Resection	250	438	90	Matched	Primary	Not available	Not available	Tumor	OSOS	Bone Cancer	Osteoblastic Osteosarcoma											0	0
P-0001436	P-0001436-T02-IM3	Outside	FFPE	Resection	250	941	50	Matched	Primary	Not available	Not available	Tumor	OSOS	Bone Cancer	Osteoblastic Osteosarcoma											0	0
P-0001437	P-0001437-T01-IM3	Outside	FFPE	Biopsy	250	595	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	TP53 p.G154D;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	3
P-0001438	P-0001438-T01-IM3	In-House	FFPE	Biopsy	186	566	20	Matched	Metastasis	Pelvis	Pelvis	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.M340Cfs*5	0	1
P-0001439	P-0001439-T01-IM3	In-House	FFPE	Resection	250	469	90	Matched	Metastasis	Uterus	Brain	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										RB1 p.Q444R;MYC Amplification;TP53 Deletion	0	3
P-0001440	P-0001440-T01-IM3	In-House	FFPE	Biopsy	222	606	30	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.C176F;PBRM1 p.X79_splice;BAP1 p.E198Rfs*33;CREBBP CREBBP-intragenic	0	4
P-0001441	P-0001441-T01-IM3	Outside	FFPE	Resection	250	488	70	Unmatched	Metastasis	Breast	Bowel	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.Q23*;FBXW7 p.R479Q;TP53 p.E336*	0	3
P-0001442	P-0001442-T02-IM5	In-House	FFPE	Biopsy	250	792	25	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				GSK2636771,AZD8186(PTEN p.R233*);Osimertinib(EGFR p.D761Y)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)	Gefitinib(EGFR p.D761Y)		LEVEL_1	EGFR p.T790M;EGFR p.L858R;PTEN p.R233*;CTNNB1 p.S33F;EGFR p.D761Y;AURKA Amplification;TERT Amplification	4	7
P-0001442	P-0001442-T01-IM3	Outside	FFPE	Cytology	250	598	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				GSK2636771,AZD8186(PTEN p.R233*);Osimertinib(EGFR p.D761Y)		Gefitinib(EGFR p.D761Y)		LEVEL_1	EGFR p.L858R;PTEN p.R233*;CTNNB1 p.S33F;EGFR p.D761Y;AURKA Amplification;MCL1 Amplification;TERT Amplification	3	7
P-0001443	P-0001443-T01-IM3	Outside	FFPE	Resection	250	792	40	Unmatched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)						LEVEL_1	NF2 p.X39_splice;IKBKE Amplification;MDM4 Amplification;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	6	5
P-0001444	P-0001444-T01-IM3	In-House	FFPE	Biopsy	145.2	220	70	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	ACRM	Melanoma	Acral Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.G12A)						LEVEL_3A	NRAS p.G12A;CTNNB1 p.G34R	1	2
P-0001445	P-0001445-T01-IM3	In-House	FFPE	Biopsy	133.2	537	15	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.L257P;RB1 p.F514Pfs*8;FOXA1 p.H377Rfs*10	0	3
P-0001446	P-0001446-T01-IM3	In-House	FFPE	Biopsy	250	674	40	Matched	Metastasis	Prostate	Kidney	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	AR p.L702H;TP53 p.S303Afs*42;AR Amplification;ATRX Deletion;FANCA Deletion;PTEN Deletion	1	6
P-0001447	P-0001447-T01-IM3	Outside	FFPE	Resection	250	108	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										LATS2 p.P479_A480dup;MYC Amplification	0	2
P-0001448	P-0001448-T01-IM3	In-House	FFPE	Resection	250	552	60	Unmatched	Primary	Mediastinum	Not Applicable	Tumor	PLLS	Soft Tissue Sarcoma	Pleomorphic Liposarcoma										TP53 p.R175H;KMT2A p.R2696*;CIC p.R202Q;EP300 p.H2324Pfs*55;ATRX p.F2113Sfs*9;ASXL2 Deletion;DNMT3A Deletion;MSH2 Deletion;RICTOR Amplification;ROS1 Amplification	0	10
P-0001449	P-0001449-T02-IM5	In-House	FFPE	Biopsy	250	807	50	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.E2981Rfs*37)			Talazoparib,Niraparib(BRCA2 p.E2981Rfs*37)					LEVEL_1	BRCA2 p.E2981Rfs*37;APC p.G1466*;TMPRSS2 ETV1-TMPRSS2 fusion;ETV1 ETV1-TMPRSS2 fusion	2	4
P-0001449	P-0001449-T01-IM3	Outside	FFPE	Biopsy	164.4	351	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.E2981Rfs*37)			Talazoparib,Niraparib(BRCA2 p.E2981Rfs*37)					LEVEL_1	BRCA2 p.E2981Rfs*37;TMPRSS2 ETV1-TMPRSS2 fusion;ETV1 ETV1-TMPRSS2 fusion	2	3
P-0001450	P-0001450-T01-IM3	In-House	FFPE	Resection	250	705	70	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.K132Q;IDH1 p.R132H;TP53 p.A159V;ATRX p.N2219Ifs*31;KIT Amplification;PDGFRA Amplification	1	6
P-0001451	P-0001451-T01-IM3	In-House	FFPE	Biopsy	250	342	40	Matched	Primary	Trachea	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										NOTCH1 p.S2467Rfs*10;ARID1A p.E1886*;NOTCH1 p.V53Gfs*89;KDM6A p.N613Kfs*8	0	4
P-0001452	P-0001452-T01-IM3	Outside	FFPE	Biopsy	250	666	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CTNNB1 p.S45del	2	2
P-0001453	P-0001453-T01-IM3	In-House	FFPE	Resection	250	818	80	Matched	Metastasis	Bladder	Bone	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification);Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	FBXW7 p.A481Hfs*3;MDM2 Amplification;RB1 Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	3	5
P-0001454	P-0001454-T01-IM3	In-House	FFPE	Biopsy	180.18	561	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F;TP53 p.N310Tfs*35;CTNNB1 p.S33C	2	4
P-0001454	P-0001454-T02-IM5	In-House	FFPE	Resection	250	570	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;CDK4 p.R24L;RBM10 p.E698*	2	3
P-0001456	P-0001456-T01-IM3	Outside	FFPE	Resection	250	253	30	Matched	Primary	Uterus	Not Applicable	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	EP300 p.D1399N;TP53 p.S215T;CDK4 Amplification	1	3
P-0001457	P-0001457-T01-IM3	In-House	FFPE	Resection	250	683	60	Matched	Metastasis	Ovary	Paracolic Gutter	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										NPM1 p.X283_splice;TP53 p.Q136Hfs*34;AMER1 Deletion;BCOR Deletion;CCNE1 Amplification;MYCL Amplification	0	6
P-0001458	P-0001458-T01-IM3	Outside	FFPE	Resection	250	485	80	Matched	Metastasis	Liver	Lung	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										INPP4B p.I3Lfs*57	0	1
P-0001459	P-0001459-T01-IM3	Outside	FFPE	Resection	250	411	50	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.G262V;APC p.R1114Efs*12	1	3
P-0001460	P-0001460-T01-IM3	Outside	FFPE	Resection	250	754	40	Matched	Metastasis	Uterus	Lymph Node	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										PPP2R1A p.P179R;TP53 p.R158G;TP53 p.D393Rfs*78;MYC Amplification	0	4
P-0001461	P-0001461-T01-IM3	In-House	FFPE	Resection	250	459	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Q556_V560delinsH)								LEVEL_1	KIT p.Q556_V560delinsH;KIT Amplification	1	2
P-0001462	P-0001462-T01-IM3	Outside	FFPE	Biopsy	175.14	392	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;FOXA1 Amplification;NKX2-1 Amplification	1	3
P-0001463	P-0001463-T01-IM3	In-House	FFPE	Biopsy	220.82	762	30	Matched	Metastasis	Cervix	Peritoneum	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;BAP1 p.E154*;KMT2C p.Q1473*;TOP1 p.Q633*	1	4
P-0001464	P-0001464-T01-IM3	In-House	FFPE	Resection	250	665	80	Matched	Metastasis	Uterus	Rectosigmoid Colon	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.X126_splice;ATRX p.Q883Rfs*13;ATRX Deletion;PTEN Deletion;RB1 Deletion	1	5
P-0001465	P-0001465-T01-IM3	In-House	FFPE	Resection	250	752	90	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EP300 Deletion	1	3
P-0001467	P-0001467-T01-IM3	Outside	FFPE	Resection	250	890	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	HNSCUP	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma of Unknown Primary				BLU-667,Selpercatinib(RET p.C634Y)					LEVEL_3B	RET p.C634Y;RB1 p.Y655*;TP53 p.E343*;TP53 p.G154Rfs*27	1	4
P-0001468	P-0001468-T01-IM3	In-House	FFPE	Biopsy	250	625	30	Matched	Metastasis	Uterus	Vagina	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;FBXW7 p.R658*;MYC Amplification	1	3
P-0001469	P-0001469-T01-IM3	Outside	FFPE	Resection	250	725	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_4	APC p.R499*;KRAS p.Q61H;TP53 p.H179Q;APC p.E1309Dfs*4	1	4
P-0001470	P-0001470-T01-IM3	Outside	FFPE	Resection	250	116	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	TP53 p.R342*;KRAS p.A146T;APC p.E1322*	1	3
P-0001471	P-0001471-T01-IM3	In-House	FFPE	Biopsy	250	500	20	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.K6Rfs*4);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.I255del;PTEN p.K6Rfs*4;RB1 p.N258Efs*11;ATRX p.K1045*;PTEN Deletion	2	5
P-0001472	P-0001472-T01-IM3	In-House	FFPE	Resection	250	433	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R216*;TP53 p.S315Lfs*30;CCND2 Amplification;KDM5A Amplification	0	4
P-0001473	P-0001473-T01-IM3	In-House	FFPE	Resection	250	569	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K	2	1
P-0001474	P-0001474-T01-IM3	In-House	FFPE	Resection	250	635	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TBX3 p.D406Qfs*8;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MYC Amplification	1	5
P-0001475	P-0001475-T01-IM3	Outside	FFPE	Biopsy	157.76	396	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TBX3 p.L368Yfs*264;AURKA Amplification;CDK4 Amplification;ERBB3 Amplification;MDM2 Amplification	4	6
P-0001478	P-0001478-T01-IM3	In-House	FFPE	Biopsy	250	592	60	Matched	Metastasis	Ovary	Pelvis	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer										NFE2L2 p.T80A;KMT2C p.E3937*;KMT2D p.Q3934*	0	3
P-0001479	P-0001479-T01-IM3	Outside	FFPE	Resection	250	644	90	Matched	Primary	Soft Tissue	Not Applicable	Tumor	LGFMS	Soft Tissue Sarcoma	Low-Grade Fibromyxoid Sarcoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	CARD11 Amplification;MET Amplification	1	2
P-0001481	P-0001481-T01-IM3	Outside	FFPE	Resection	250	560	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;CDH1 p.I435Hfs*11;CCND1 Amplification;FGF19 Amplification;IKBKE Amplification;MDM4 Amplification	2	6
P-0001482	P-0001482-T01-IM3	In-House	FFPE	Resection	250	472	80	Matched	Primary	Lower Extremity	Not Applicable	Tumor	EMCHS	Bone Cancer	Extraskeletal Myxoid Chondrosarcoma											0	0
P-0001483	P-0001483-T01-IM3	In-House	FFPE	Resection	250	389	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;PAX5 Deletion	2	4
P-0001484	P-0001484-T01-IM3	In-House	FFPE	Biopsy	250	634	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM p.N1549Rfs*2)					LEVEL_3B	GATA3 p.D335Gfs*17;ARID1A p.Q802Sfs*15;ATM p.N1549Rfs*2	1	3
P-0001484	P-0001484-T02-IM5	In-House	FFPE	Biopsy	250	915	30	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM p.N1549Rfs*2)					LEVEL_3B	GATA3 p.D335Gfs*17;ARID1A p.Q802Sfs*15;ATM p.N1549Rfs*2	1	3
P-0001485	P-0001485-T01-IM3	Outside	FFPE	Resection	250	569	10	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.Q1218*);Trametinib,Cobimetinib(NF1 p.X2355_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	TET2 p.P1146S;GATA3 p.K377*;NF1 p.Q1218*;NF1 p.X2355_splice;PMAIP1 p.X20_splice;PAX5 p.W358*;CDKN2A p.R58*	3	7
P-0001487	P-0001487-T01-IM3	Outside	FFPE	Resection	50	271	20	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	KMT2D p.R5432W;CDK4 Amplification;MDM2 Amplification;PTEN Deletion	3	4
P-0001488	P-0001488-T01-IM3	In-House	FFPE	Biopsy	250	796	70	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545K;SMAD4 p.S154*;ARID1A p.Q379*;ATR p.E1326*;NSD1 p.R604*;KMT2C p.X1460_splice;SMAD2 p.S467L;BCL2L1 Amplification;ERBB2 Amplification;GATA3 Amplification;SETD2 Deletion	4	11
P-0001489	P-0001489-T01-IM3	Outside	FFPE	Biopsy	250	295	50	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.S241C;GATA3 p.P408Qfs*97;CCND1 Amplification;FGFR1 Amplification	1	4
P-0001491	P-0001491-T01-IM3	Outside	FFPE	Biopsy	250	523	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.E545K;GATA3 p.D335Gfs*17;FGFR4 p.V550L;STK11 p.E165Q;AURKA Amplification;CDK4 Amplification;MDM2 Amplification;PTPRT Deletion	4	8
P-0001493	P-0001493-T01-IM3	Outside	FFPE	Resection	250	966	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.E897*)			Talazoparib,Niraparib(BRCA2 p.E897*)					LEVEL_1	BRCA2 p.E897*;FOXA1 p.N252_C258del	2	2
P-0001494	P-0001494-T01-IM3	Outside	FFPE	Resection	250	652	50	Matched	Primary	Transverse Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.V45I)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;B2M p.V69Wfs*34;KMT2D p.P2354Lfs*30;PIK3R1 p.N564D;B2M p.L15Ffs*41;PTPRS p.V608Wfs*30;MLH1 p.G67R;PTEN p.V45I;RB1 p.R552*;RNF43 p.R132*;PPP2R1A p.R221W;MSH2 p.L277Ffs*7;BAP1 p.V27Cfs*45;TET2 p.T1002Hfs*5;RB1 p.T9Rfs*56;DIS3 p.S445Hfs*20;ERCC4 p.M361Nfs*4;CTCF p.E691Sfs*30;MAP2K4 p.P29Rfs*11;RNF43 p.G263Efs*18;AXIN2 p.A417Rfs*41;PIK3R2 p.D334Tfs*7	2	22
P-0001495	P-0001495-T02-IM5	In-House	DNA	Biopsy	250	964	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_1	KRAS p.G12V;TP53 p.G245S;FBXW7 p.Q218*;KMT2A p.E2439Kfs*14;NOTCH4 p.X542_splice;ERBB2 Amplification;EP300 MEI1-EP300 fusion;MEI1 MEI1-EP300 fusion	3	8
P-0001495	P-0001495-T03-IM5	In-House	FFPE	Biopsy	250	777	75	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_1	KRAS p.G12V;TP53 p.G245S;FBXW7 p.Q218*;KMT2A p.E2439Kfs*14;NOTCH4 p.X542_splice;KMT2D p.E785Gfs*145;ERBB2 Amplification	3	7
P-0001495	P-0001495-T01-IM3	Outside	FFPE	Biopsy	115	308	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.G245S;FBXW7 p.Q218*;KMT2A p.E2439Kfs*14;ERBB2 Amplification	2	4
P-0001496	P-0001496-T01-IM3	In-House	FFPE	Resection	250	366	20	Matched	Metastasis	Liver	Liver	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;SMARCA4 p.R1243W	1	2
P-0001497	P-0001497-T01-IM3	Outside	FFPE	Resection	250	329	40	Matched	Primary	Ovary	Not Applicable	Tumor	OSMCA	Ovarian Cancer	Ovarian Seromucinous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3B	KRAS p.G12V;PIK3CA p.Q546R;CDKN2A p.H83Y	3	3
P-0001498	P-0001498-T02-IM3	Outside	FFPE	Resection	66.27	647	40	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0001499	P-0001499-T01-IM3	Outside	FFPE	Biopsy	250	747	15	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.E1397*;TP53 p.P322Hfs*23	0	3
P-0001500	P-0001500-T02-IM5	In-House	FFPE	Resection	250	804	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	FBXW7 p.R479Q;TP53 p.R156Afs*14;APC p.R499*;ERBB3 p.V104M;APC p.T1487Lfs*16;FLCN p.P340Afs*50;KRAS p.G13D	1	7
P-0001501	P-0001501-T01-IM3	Outside	FFPE	Resection	250	669	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				AZD5363(AKT1 p.E17K);Poziotinib(EGFR p.N771_H773dup)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	AKT1 p.E17K;EGFR p.N771_H773dup;ARID1A p.E49*;KMT2D p.E309*;CDKN1A p.D26Tfs*5;CDKN1A p.G91Rfs*38;KMT2D p.S4140Ffs*28;CDKN2A Deletion;CDKN2B Deletion;DICER1 Deletion;GATA3 Amplification	3	11
P-0001502	P-0001502-T01-IM3	In-House	FFPE	Cytology	250	426	60	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0001503	P-0001503-T01-IM3	Outside	FFPE	Resection	250	330	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TBX3 p.Q590Gfs*104;TBX3 p.E100Wfs*40;CBFB p.X55_splice;CDH1 p.T394*;RUNX1 p.Q370Kfs*197	2	6
P-0001504	P-0001504-T02-IM5	In-House	FFPE	Resection	250	911	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MYC Amplification	1	4
P-0001505	P-0001505-T02-IM3	In-House	FFPE	Biopsy	111	217	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	AURKA Amplification;MDM2 Amplification;PAK1 Amplification	1	3
P-0001505	P-0001505-T01-IM3	In-House	FFPE	Resection	83.6	478	10	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	AURKA Amplification;MDM2 Amplification;PAK1 Amplification	1	3
P-0001506	P-0001506-T01-IM3	Outside	FFPE	Biopsy	187	906	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R158L;NFE2L2 p.E79Q;NFE2L2 p.V32G;PTPRD p.P1200Qfs*31;EGFR Amplification	0	5
P-0001507	P-0001507-T01-IM3	In-House	FFPE	Resection	250	636	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Everolimus(TSC2 Deletion)					LEVEL_3B	CTNNB1 p.S45P;CDH1 GGGEEDQ759fs;AXIN1 Deletion;CREBBP Deletion;MEN1 Deletion;TSC2 Deletion;MAP2K4 MAP2K4-intragenic	1	7
P-0001508	P-0001508-T01-IM3	In-House	FFPE	Biopsy	250	767	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537C)						LEVEL_3A	SPEN p.E358*;ESR1 p.Y537C;CBFB p.Q140*;GATA3 p.Y344Lfs*8	1	4
P-0001509	P-0001509-T01-IM3	In-House	FFPE	Resection	250	517	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.X266_splice;FOXL2 Deletion;PHOX2B Deletion	0	3
P-0001510	P-0001510-T01-IM3	In-House	FFPE	Resection	250	640	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R248Q;SMARCA4 p.R1135W	0	2
P-0001511	P-0001511-T01-IM3	In-House	FFPE	Biopsy	250	873	10	Matched	Metastasis	Anus	Liver	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										CREBBP p.R1446H	0	1
P-0001512	P-0001512-T01-IM3	In-House	FFPE	Resection	250	659	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)			Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Imatinib(PDGFRA p.D842V)			LEVEL_1	FOXP1 p.X510_splice;PDGFRA p.D842V;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;IKZF1 Deletion	3	6
P-0001513	P-0001513-T01-IM3	In-House	FFPE	Resection	250	527	80	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.X225_splice	0	1
P-0001514	P-0001514-T01-IM3	In-House	FFPE	Biopsy	250	983	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0001515	P-0001515-T01-IM3	In-House	FFPE	Resection	250	400	50	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	EED p.R414*;NF2 p.F47*;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;FAT1 Deletion;RB1 Deletion;TNFRSF14 Deletion	1	8
P-0001516	P-0001516-T01-IM3	In-House	FFPE	Biopsy	250	1013	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.Q546P)		AZD5363(AKT1 p.E17K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)						LEVEL_1	AKT1 p.E17K;PIK3CA p.Q546P;TP53 p.M246L;CTCF p.V51Gfs*27;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	3	7
P-0001516	P-0001516-T02-IM5	In-House	FFPE	Biopsy	250	1577	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.Q546P)		AZD5363(AKT1 p.E17K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)						LEVEL_1	AKT1 p.E17K;PIK3CA p.Q546P;TP53 p.M246L;CTCF p.V51Gfs*27	3	4
P-0001517	P-0001517-T01-IM3	In-House	FFPE	Resection	250	359	80	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559_V560delinsAD)								LEVEL_1	KMT2D p.X1377_splice;KIT p.V559_V560delinsAD	1	2
P-0001518	P-0001518-T01-IM3	In-House	FFPE	Biopsy	250	765	30	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0001519	P-0001519-T01-IM3	Outside	FFPE	Biopsy	250	486	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										KMT2D p.R5027*;TP53 p.E56*;KMT2D p.L2689Rfs*2;CCND1 Amplification;FGF19 Amplification;KDM5A Amplification;KRAS Amplification	0	7
P-0001520	P-0001520-T01-IM3	In-House	FFPE	Resection	250	562	60	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0001521	P-0001521-T01-IM3	Outside	FFPE	Biopsy	250	836	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Everolimus(TSC1 p.Q906*);Everolimus(TSC1 p.R500*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CB p.E1051K;TSC1 p.Q906*;TSC1 p.R500*;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0001522	P-0001522-T01-IM3	In-House	FFPE	Resection	250	548	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X114_splice;BAP1 p.C91F;PIK3CB p.D1067H	0	3
P-0001523	P-0001523-T01-IM3	Outside	FFPE	Resection	250	501	50	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344G);Tipifarnib(HRAS p.G12D)					LEVEL_3B	PIK3CA p.V344G;HRAS p.G12D	2	2
P-0001524	P-0001524-T01-IM3	Outside	FFPE	Biopsy	250	740	50	Matched	Metastasis	Cancer of Unknown Primary	Pleura	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.C229Yfs*10;PIK3CD p.N334S;SMARCA4 p.E1587*;NFE2L2 p.L76_E82del;APC p.N1535Mfs*30;MCL1 Amplification;MYC Amplification;STK11 Deletion	0	8
P-0001525	P-0001525-T01-IM3	In-House	FFPE	Resection	250	971	40	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.H168R	0	1
P-0001526	P-0001526-T02-IM5	In-House	FFPE	Biopsy	250	503	80	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.X267_splice;DAXX p.E410*	0	2
P-0001526	P-0001526-T03-IM5	In-House	FFPE	Biopsy	250	1043	50	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					GSK2636771,AZD8186(PTEN p.Q298*)				LEVEL_4	MEN1 p.X267_splice;PTEN p.Q298*;ARID2 p.R1792Dfs*9;DAXX p.D407Tfs*121	1	4
P-0001526	P-0001526-T01-IM3	In-House	FFPE	Resection	250	169	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.X267_splice	0	1
P-0001527	P-0001527-T01-IM3	In-House	FFPE	Resection	172.8	192	60	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)					LEVEL_3B	PIK3CA p.N345K	1	1
P-0001528	P-0001528-T03-IM5	In-House	DNA	Biopsy	250	769	NA	Unmatched	Metastasis	Lung	Bone	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)		GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_3A	TP53 p.T155P;PTEN p.X70_splice;CBL p.Q561*;EGFR Amplification;FGFR1 Amplification;MDM4 Amplification	2	6
P-0001528	P-0001528-T02-IM3	In-House	FFPE	Biopsy	250	592	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)		GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_3A	TP53 p.T155P;PTEN p.X70_splice;EGFR Amplification;FGFR1 Amplification	2	4
P-0001529	P-0001529-T01-IM3	In-House	FFPE	Biopsy	250	794	30	Matched	Metastasis	Cancer of Unknown Primary	Umbilical Cord	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R337C	1	2
P-0001530	P-0001530-T01-IM3	In-House	FFPE	Resection	250	668	60	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)	Everolimus(TSC1 p.R908Tfs*42);Everolimus(TSC2 p.S1774Kfs*51);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3A	NRAS p.Q61K;MEN1 p.Q171*;TSC1 p.R908Tfs*42;TSC2 p.S1774Kfs*51;BRAF Amplification;CARD11 Amplification;CDK6 Amplification;EGFR Amplification;ETV1 Amplification;EZH2 Amplification;MCL1 Amplification;MET Amplification;RAC1 Amplification;TP53 Deletion	4	14
P-0001531	P-0001531-T01-IM3	Outside	FFPE	Resection	250	895	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X574_splice)				LEVEL_4	TP53 p.R175H;APC p.S1346*;APC p.E1345*;NF1 p.X574_splice;FLT3 Amplification	1	5
P-0001532	P-0001532-T01-IM3	In-House	FFPE	Biopsy	250	1194	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	SF3B1 p.G740E;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	3
P-0001533	P-0001533-T01-IM3	Outside	FFPE	Resection	250	916	70	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0001534	P-0001534-T01-IM3	In-House	FFPE	Resection	250	751	20	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.P278T	0	1
P-0001535	P-0001535-T01-IM3	In-House	FFPE	Resection	250	256	40	Matched	Metastasis	Thymus	Mediastinum	Tumor	THYM	Thymic Tumor	Thymoma											0	0
P-0001536	P-0001536-T01-IM3	In-House	FFPE	Biopsy	91.98	709	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.K132R;AKT2 Amplification;MEF2B Amplification	0	3
P-0001537	P-0001537-T01-IM3	In-House	FFPE	Resection	250	469	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 Amplification	0	1
P-0001538	P-0001538-T01-IM3	Outside	FFPE	Biopsy	250	709	30	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										CD274 Amplification	0	1
P-0001539	P-0001539-T01-IM3	Outside	FFPE	Biopsy	55	371	30	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										STK11 STK11-intragenic	0	1
P-0001540	P-0001540-T01-IM3	In-House	FFPE	Biopsy	250	529	40	Matched	Primary	Not available	Not available	Tumor	OS	Bone Cancer	Osteosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X2313_splice)					LEVEL_3B	BRCA2 p.X2313_splice;BRD4 Amplification	1	2
P-0001541	P-0001541-T01-IM3	In-House	FFPE	Resection	250	88	60	Matched	Metastasis	Thyroid	Thigh	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer				Olaparib(ATM p.Q2177*)					LEVEL_3B	ATM p.Q2177*;ARID1B Deletion;LATS1 Deletion;PRKN Deletion	1	4
P-0001542	P-0001542-T01-IM3	In-House	FFPE	Resection	250	567	80	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822K)					LEVEL_3B	KIT p.N822K	1	1
P-0001543	P-0001543-T01-IM3	Outside	FFPE	Biopsy	250	803	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	SMAD4 p.L540del;CDKN2A p.R80*;CDK4 Amplification;ERBB3 Amplification;FAT1 Deletion;MDM2 Amplification	3	6
P-0001544	P-0001544-T01-IM3	In-House	FFPE	Resection	250	269	80	Matched	Primary	Not available	Not available	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										TP53 p.N235D	0	1
P-0001545	P-0001545-T01-IM3	Outside	FFPE	Resection	250	758	90	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.D335Gfs*17;FOXA1 Amplification	0	2
P-0001546	P-0001546-T02-IM5	In-House	DNA	Biopsy	214.2	690	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.X1010_splice;MDM2 Amplification	4	2
P-0001547	P-0001547-T01-IM3	In-House	FFPE	Biopsy	250	1060	50	Matched	Metastasis	Ovary	Liver	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;ARID1A p.X996_splice;ARID1A p.F1941Lfs*15	1	3
P-0001548	P-0001548-T01-IM3	Outside	FFPE	Biopsy	250	886	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.R280G;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0001549	P-0001549-T01-IM3	Outside	FFPE	Resection	250	491	60	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R342*;B2M Deletion;CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion;RAD51 Deletion	1	6
P-0001550	P-0001550-T01-IM3	In-House	FFPE	Resection	250	684	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.R158L;RAD50 p.X835_splice	2	3
P-0001551	P-0001551-T01-IM3	In-House	FFPE	Biopsy	250	869	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.Y205C;FGFR2 Amplification	0	2
P-0001551	P-0001551-T02-IM5	In-House	FFPE	Biopsy	250	1804	25	Matched	Metastasis	Stomach	Lung	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.Y205C;AKT2 Amplification;FGFR2 Amplification	0	3
P-0001552	P-0001552-T02-IM5	Outside	DNA	Resection	250	764	90	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma											0	0
P-0001553	P-0001553-T02-IM5	In-House	FFPE	Biopsy	250	972	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750delinsD)			Olaparib(BARD1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	SMAD4 p.S232Qfs*3;EGFR p.E746_A750delinsD;B2M Deletion;BARD1 Deletion;CDKN2A Deletion;CDKN2B Deletion;MEF2B Amplification;PIK3R2 Amplification	3	8
P-0001553	P-0001553-T01-IM3	In-House	FFPE	Resection	250	562	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0001554	P-0001554-T01-IM3	Outside	FFPE	Resection	236.5	341	40	Matched	Primary	Transverse Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.R1450*;APC p.R1239*;TP53 p.M237Tfs*7;FOXA1 Amplification;SMAD2 Deletion	1	6
P-0001555	P-0001555-T01-IM3	In-House	FFPE	Cytology	250	1074	40	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R273H;TET2 p.E1350K;RB1 p.L647Ffs*5	0	3
P-0001556	P-0001556-T01-IM3	Outside	FFPE	Resection	250	805	50	Unmatched	Primary	Brain	Not Applicable	Tumor	ANM	CNS Cancer	Anaplastic Meningioma										NF2 p.W191Gfs*18	0	1
P-0001557	P-0001557-T01-IM3	In-House	FFPE	Biopsy	250	595	60	Matched	Metastasis	Larynx	Lung	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma				Olaparib(BRIP1 p.X793_splice);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.X307_splice;BRIP1 p.X793_splice;KDM6A p.X980_splice;ARID1A p.C884*;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;FGF19 Amplification	3	9
P-0001558	P-0001558-T01-IM3	In-House	FFPE	Biopsy	195.64	478	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	ERBB2 Amplification;FGFR1 Amplification;FOXA1 Amplification;PRKN Deletion	3	4
P-0001559	P-0001559-T01-IM3	Outside	FFPE	Resection	250	633	50	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545K;CCND1 Amplification;ERBB2 Amplification;FGFR2 Amplification;FOXA1 Amplification	4	5
P-0001560	P-0001560-T01-IM3	In-House	FFPE	Biopsy	250	1167	20	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3A	TP53 p.G266R;NRAS p.Q61K;ARID1A p.R1446*;CDKN2A Deletion;CDKN2B Deletion;PTEN Deletion	3	6
P-0001561	P-0001561-T01-IM3	In-House	FFPE	Resection	250	539	30	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.E339*;CCNE1 Amplification	0	2
P-0001562	P-0001562-T01-IM3	In-House	FFPE	Resection	250	384	60	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0001563	P-0001563-T01-IM3	In-House	FFPE	Resection	250	678	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 Amplification	0	1
P-0001564	P-0001564-T01-IM3	Outside	FFPE	Resection	105.86	438	50	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN p.L186Rfs*3)				LEVEL_4	ATRX p.K1583Nfs*22;TP53 p.R158P;PTEN p.L186Rfs*3;RB1 Deletion	1	4
P-0001565	P-0001565-T01-IM3	In-House	FFPE	Biopsy	250	1047	30	Matched	Metastasis	Uterus	Liver	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	TP53 p.Y163C;PIK3CA p.E542K;KMT2D p.Q3980*;PPP2R1A p.W257C	1	4
P-0001566	P-0001566-T01-IM3	In-House	FFPE	Biopsy	250	1348	40	Matched	Metastasis	Breast	Stomach	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G	1	1
P-0001568	P-0001568-T01-IM3	In-House	FFPE	Biopsy	227.12	1013	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545Q);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q)	Olaparib(ATM p.E2145*);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545Q;ATM p.E2145*;TP53 p.X126_splice;ERBB2 Amplification	5	4
P-0001569	P-0001569-T01-IM3	In-House	FFPE	Biopsy	104.4	465	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.R267W;CDK4 Amplification	1	2
P-0001570	P-0001570-T01-IM3	In-House	FFPE	Resection	250	547	50	Matched	Metastasis	Ovary	Cul-de-sac	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.X187_splice;MYC Amplification;TET2 Deletion	0	3
P-0001571	P-0001571-T01-IM3	In-House	FFPE	Biopsy	250	955	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T18Rfs*8)				LEVEL_4	KRAS p.G12A;TP53 p.C238F;HNF1A p.G296*;CDKN2A p.T18Rfs*8;AMER1 Deletion;ATRX Deletion;BCOR Deletion;FOXA1 Amplification;KDM5C Deletion;KDM6A Deletion;MED12 Deletion;MYC Amplification;NKX2-1 Amplification;PTPRD Deletion;RBM10 Deletion	2	15
P-0001572	P-0001572-T01-IM3	In-House	FFPE	Resection	250	776	50	Matched	Metastasis	Uterus	Bone	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib(BARD1 Deletion)					LEVEL_3B	TP53 p.Y236_M237delinsL;BARD1 Deletion	1	2
P-0001573	P-0001573-T01-IM3	In-House	FFPE	Resection	250	635	60	Matched	Primary	Anus	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma					Trametinib,Cobimetinib(NF1 Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.X261_splice;ATRX p.T1172Lfs*18;CDK6 Amplification;MITF Amplification;NF1 Deletion;PTEN Deletion	2	6
P-0001574	P-0001574-T01-IM3	In-House	FFPE	Biopsy	250	954	50	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12C;ARID1A p.Q1142*;STK11 p.X125_splice;KEAP1 p.V167Lfs*63;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0001575	P-0001575-T01-IM3	In-House	FFPE	Resection	250	664	50	Matched	Metastasis	Ovary	Paracolic Gutter	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R273H;FAT1 Deletion	0	2
P-0001576	P-0001576-T01-IM3	In-House	FFPE	Cytology	250	813	NA	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification	2	2
P-0001577	P-0001577-T01-IM3	In-House	FFPE	Resection	250	535	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.K534*;BCL2L1 Amplification	0	3
P-0001578	P-0001578-T01-IM3	In-House	FFPE	Biopsy	250	1122	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R248Q;TP53 p.S241F;KMT2D p.L4214*;ERBB3 p.E332K;RB1 p.Y321*;MCL1 Amplification	0	6
P-0001579	P-0001579-T01-IM3	In-House	FFPE	Resection	250	820	50	Matched	Primary	Kidney	Not Applicable	Tumor	WT	Wilms Tumor	Wilms' Tumor										TP53 p.D281E	0	1
P-0001580	P-0001580-T01-IM3	Outside	FFPE	Biopsy	250	731	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CCND1 Amplification;MDM2 Amplification;SRC Amplification	1	3
P-0001581	P-0001581-T02-IM5	In-House	FFPE	Biopsy	250	512	30	Matched	Metastasis	Appendix	Omentum	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.E285*;ERBB2 Amplification	1	2
P-0001582	P-0001582-T01-IM3	In-House	FFPE	Resection	250	357	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PIK3R1 p.G376R;DICER1 p.D1636Tfs*7;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MDM4 Amplification	2	6
P-0001583	P-0001583-T01-IM3	In-House	FFPE	Biopsy	250	1038	40	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)				LEVEL_4	KRAS p.A146T;TP53 p.G245S;APC p.R1450*;SPEN p.R637*;ARID1A p.X451_splice;RAF1 p.S257L;PBRM1 p.K100*;SETD2 p.D2004Ifs*13;SMAD4 Deletion	1	9
P-0001585	P-0001585-T01-IM3	Outside	FFPE	Resection	250	669	60	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										ARID1A p.S11Afs*91;BCOR p.F977Cfs*50	0	2
P-0001586	P-0001586-T02-IM5	Outside	DNA	Resection	250	877	20	Matched	Metastasis	GE Junction	Brain	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D769H);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	ERBB2 p.D769H;ERBB3 p.P262S;ERBB2 Amplification;PAX5 Amplification	3	4
P-0001589	P-0001589-T01-IM3	Outside	FFPE	Biopsy	250	909	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.V697L)	Ado-Trastuzumab Emtansine(ERBB2 p.V697L);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3A	ERBB3 p.K329E;ERBB2 p.V697L;CDK4 Amplification;ERBB3 Amplification;MYCL Amplification	3	5
P-0001591	P-0001591-T01-IM3	Outside	FFPE	Biopsy	250	924	30	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.Y555C)					LEVEL_3B	PDGFRA p.Y555C	1	1
P-0001594	P-0001594-T01-IM3	Outside	FFPE	Resection	250	661	50	Unmatched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.X187_splice;ERBB2 Amplification;MYC Amplification	4	4
P-0001595	P-0001595-T01-IM3	Outside	FFPE	Biopsy	250	653	10	Unmatched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										TP53 p.R342*;MYC Amplification	0	2
P-0001596	P-0001596-T01-IM3	Outside	FFPE	Resection	250	311	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0001597	P-0001597-T01-IM3	Outside	FFPE	Biopsy	250	796	40	Matched	Primary	Jejunum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;CCND2 Amplification;SMAD4 Deletion	1	3
P-0001598	P-0001598-T01-IM3	In-House	FFPE	Biopsy	250	1149	50	Matched	Primary	Sinonasal	Not Applicable	Tumor	SNSC	Head and Neck Cancer	Sinonasal Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.G380R)	GSK2636771,AZD8186(PTEN p.R130*);GSK2636771,AZD8186(PTEN p.Q214*);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.M528I);GSK2636771,AZD8186(PTEN p.Q245*)				LEVEL_3B	KMT2D p.R4904*;PTEN p.R130*;FGFR3 p.G380R;PTEN p.Q214*;FGFR3 p.M528I;PTEN p.Q245*	5	6
P-0001598	P-0001598-T02-IM5	In-House	FFPE	Biopsy	250	652	60	Matched	Metastasis	Sinonasal	Eyelid	Tumor	SNSC	Head and Neck Cancer	Sinonasal Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.G380R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.M528I);GSK2636771,AZD8186(PTEN p.Q245*)				LEVEL_3B	FGFR3 p.G380R;FGFR3 p.M528I;PTEN p.Q245*;XRCC2 p.L265*	3	4
P-0001599	P-0001599-T03-IM5	In-House	FFPE	Biopsy	250	627	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.E438*)				LEVEL_4	TP53 p.V73Wfs*50;NF1 p.E438*;RASA1 p.C402*	1	3
P-0001600	P-0001600-T01-IM3	Outside	FFPE	Resection	250	1495	15	Matched	Metastasis	Stomach	Ovary	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										ERBB3 p.K329E;PBRM1 p.R298*;KMT2D p.T4271Dfs*63	0	3
P-0001601	P-0001601-T01-IM3	Outside	FFPE	Resection	250	1514	60	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Tipifarnib(HRAS p.G12N)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KMT2D p.R5432W;JAK1 p.R174*;CASP8 p.X435_splice;PTPRD p.X1503_splice;AXIN1 p.E839*;TP53 p.R248Q;NOTCH1 p.W287*;TP53 p.P250L;HRAS p.G12N;CCNE1 Amplification;CDKN2A Deletion;CDKN2B Deletion;PIK3R1 Deletion;RB1 Deletion	2	14
P-0001602	P-0001602-T01-IM3	Outside	FFPE	Resection	250	1498	40	Matched	Metastasis	Ovary	Pelvis	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor											0	0
P-0001603	P-0001603-T01-IM3	In-House	FFPE	Resection	250	527	NA	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P81L)				LEVEL_3A	TP53 p.R213*;NRAS p.Q61K;TP53 p.E258K;TET1 p.P1752S;STAG2 p.C308*;CDKN2A p.P81L	2	6
P-0001604	P-0001604-T01-IM3	Outside	FFPE	Resection	250	1137	60	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma											0	0
P-0001605	P-0001605-T01-IM3	In-House	FFPE	Resection	250	249	40	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0001606	P-0001606-T01-IM3	Outside	FFPE	Resection	250	1116	60	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	B2M Deletion;BCOR Deletion;CDK4 Amplification;EP300 Deletion;ERBB3 Amplification;MDM2 Amplification;RAD51 Deletion	2	7
P-0001607	P-0001607-T01-IM3	Outside	FFPE	Biopsy	189.6	270	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;GATA3 p.A332Cfs*20	2	2
P-0001608	P-0001608-T01-IM3	In-House	FFPE	Biopsy	250	739	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CREBBP p.Q1856*	0	1
P-0001609	P-0001609-T01-IM3	Outside	FFPE	Biopsy	240	781	20	Matched	Metastasis	Ampulla of Vater	Liver	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	KRAS p.G12D;TP53 p.G266E;CDKN2A p.R58*	2	3
P-0001610	P-0001610-T01-IM3	In-House	FFPE	Resection	250	731	15	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Tazemetostat(KDM6A p.Q1003*)				LEVEL_3B	PIK3CA p.E542K;ERBB3 p.K329E;TP53 p.D259Y;KDM6A p.Q1003*	2	4
P-0001611	P-0001611-T01-IM3	In-House	FFPE	Resection	250	1001	80	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.H179D;AKT2 Amplification;CCNE1 Amplification;FOXA1 Amplification;KDM5A Amplification;NKX2-1 Amplification;PTEN Deletion	1	7
P-0001612	P-0001612-T01-IM3	In-House	FFPE	Resection	250	799	40	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0001613	P-0001613-T02-IM5	In-House	FFPE	Biopsy	238	816	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.M237I;AKT2 Amplification;CCNE1 Amplification;EGFR Amplification;ERBB2 Amplification	2	6
P-0001613	P-0001613-T01-IM3	Outside	FFPE	Cytology	74	458	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR p.E709K;TP53 p.M237I;CCNE1 Amplification;EGFR Amplification	1	5
P-0001614	P-0001614-T01-IM3	Outside	FFPE	Biopsy	250	318	40	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma			Tipifarnib(HRAS p.G60D)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(ATM p.S1455Vfs*3)	GSK2636771,AZD8186(PTEN p.N323Mfs*21)				LEVEL_3A	ARID1A p.M1564*;SETD2 p.R1407Gfs*5;PIK3CA p.H1047R;PTEN p.N323Mfs*21;APC p.R2166*;RNF43 p.P660Sfs*87;MLH1 p.E297*;KMT2C p.R2257*;NOTCH1 p.R1107*;HRAS p.G60D;TGFBR2 p.L5Cfs*32;MLH1 p.N64Wfs*14;SETD2 p.T305Qfs*35;EZH2 p.N598Mfs*72;NOTCH1 p.S356del;ATM p.S1455Vfs*3	4	16
P-0001615	P-0001615-T01-IM3	Outside	FFPE	Resection	250	924	60	Matched	Primary	Uterus	Not Applicable	Tumor	UMLMS	Uterine Sarcoma	Uterine Myxoid Leiomyosarcoma										BCOR ZC3H7B-BCOR fusion;ZC3H7B ZC3H7B-BCOR fusion	0	2
P-0001616	P-0001616-T01-IM3	In-House	FFPE	Resection	250	761	50	Matched	Metastasis	Ovary	Bladder	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Y220C	0	1
P-0001618	P-0001618-T01-IM3	In-House	FFPE	Resection	250	458	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ERCC3 p.R425*;TP53 p.C229Vfs*18	0	2
P-0001619	P-0001619-T01-IM3	In-House	FFPE	Resection	250	737	15	Matched	Metastasis	Anus	Heart	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K	1	1
P-0001620	P-0001620-T01-IM3	In-House	FFPE	Biopsy	127.6	647	60	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047L;PPP2R1A p.R183W;MAP3K1 p.Q1220*;KMT2C p.S397*;CBFB p.X55_splice;MAP3K1 p.G1229Rfs*10;TBX3 p.W113Kfs*29;FGFR1 Amplification	3	8
P-0001621	P-0001621-T01-IM3	In-House	FFPE	Resection	250	694	70	Matched	Metastasis	Oral Cavity	Lymph Node	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.I255N;FANCA p.W22*;CCND1 Amplification;FGF19 Amplification	0	4
P-0001622	P-0001622-T01-IM3	In-House	FFPE	Biopsy	250	1186	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.G266V;KMT2D p.L1461Tfs*30;BCL6 Amplification;GATA3 Deletion;PIK3CA Amplification	0	5
P-0001623	P-0001623-T01-IM3	In-House	FFPE	Biopsy	250	450	50	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;MAP3K1 p.P550Lfs*7;MAP3K1 p.Q367*;ERBB2 Amplification	4	4
P-0001624	P-0001624-T01-IM3	In-House	FFPE	Resection	181.2	704	40	Matched	Metastasis	Adrenal Gland	Lung	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										PBRM1 p.R921*;FGFR4 Amplification	0	2
P-0001625	P-0001625-T01-IM3	Outside	FFPE	Biopsy	123	467	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)								LEVEL_1	MSH6 p.N897Kfs*3;EGFR p.E746_S752delinsV	1	2
P-0001627	P-0001627-T01-IM3	In-House	FFPE	Biopsy	250	1049	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047Q);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Q)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.Y236C;PIK3CA p.H1047Q;ERBB2 Amplification;TERT Amplification	4	4
P-0001627	P-0001627-T02-IM5	In-House	FFPE	Resection	250	655	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047Q);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Q)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.Y236C;PIK3CA p.H1047Q;SMAD4 p.Q224*;ERBB2 Amplification;TERT Amplification	4	5
P-0001628	P-0001628-T01-IM3	Outside	FFPE	Biopsy	250	544	40	Matched	Metastasis	Cancer of Unknown Primary	Adrenal Gland	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.C277F;NF2 p.R249*;KEAP1 p.S391Afs*9;SMARCA4 p.A1168Qfs*4;ARID2 ARID2-intragenic;STK11 STK11-intragenic	0	6
P-0001629	P-0001629-T01-IM3	In-House	FFPE	Biopsy	250	757	30	Matched	Metastasis	Uterus	Pelvis	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)	AZD9496,Fulvestrant(ESR1 p.L536P)	Everolimus,Temsirolimus(MTOR p.T1977I)				LEVEL_3A	AKT1 p.E17K;CTNNB1 p.G34V;MTOR p.T1977I;ESR1 p.L536P	3	4
P-0001630	P-0001630-T01-IM3	In-House	FFPE	Resection	250	383	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R273C;SPOP p.F133L	0	2
P-0001631	P-0001631-T02-IM5	In-House	DNA	Biopsy	250	1036	60	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.M1043L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043L)						LEVEL_1	PIK3CA p.E545K;PIK3CA p.M1043L;KMT2C p.Q4534*;CDH1 T522fs;NOTCH4 p.G414Afs*24	4	5
P-0001631	P-0001631-T01-IM3	Outside	FFPE	Resection	250	656	60	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.M1043L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043L)						LEVEL_1	PIK3CA p.E545K;PIK3CA p.M1043L;KMT2C p.Q4534*;CDH1 T522fs	4	4
P-0001632	P-0001632-T01-IM3	In-House	FFPE	Biopsy	250	1494	NA	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)	Palbociclib,Abemaciclib(CDK4 Amplification);Olaparib(CHEK1 Deletion);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3A	ESR1 p.D538G;KMT2C p.S1449*;CDH1 p.R63*;CDK4 Amplification;CHEK1 Deletion;MDM2 Amplification;MDM4 Amplification;PTEN Deletion	5	8
P-0001633	P-0001633-T01-IM3	In-House	FFPE	Resection	250	758	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										PMS2 p.X83_splice;STK11 p.F204Sfs*83;DNMT3A p.R887Sfs*32	0	3
P-0001634	P-0001634-T01-IM3	In-House	FFPE	Resection	250	536	50	Matched	Metastasis	Ovary	Spleen	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.I195F;BCL2L1 Amplification;KRAS Amplification;MCL1 Amplification	0	4
P-0001635	P-0001635-T01-IM3	In-House	FFPE	Resection	250	885	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.C135Afs*35;ARID2 ARID2-intragenic	0	2
P-0001636	P-0001636-T01-IM3	Outside	FFPE	Resection	250	375	15	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 Amplification;PIK3R2 Deletion	0	2
P-0001637	P-0001637-T01-IM3	In-House	FFPE	Cytology	165.6	234	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.X2441_splice)				LEVEL_1	TP53 p.G266R;NF1 p.X2441_splice;PIK3R1 p.K567_I571del;ERBB2 Amplification	3	4
P-0001638	P-0001638-T01-IM3	Outside	FFPE	Cytology	204.1	926	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(KIAA1217 FGFR2-KIAA1217 fusion);Pemigatinib(FGFR2 FGFR2-KIAA1217 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(KIAA1217 FGFR2-KIAA1217 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-KIAA1217 fusion)						LEVEL_1	ARID1A p.V2132Gfs*17;KIAA1217 FGFR2-KIAA1217 fusion;FGFR2 FGFR2-KIAA1217 fusion	4	3
P-0001639	P-0001639-T01-IM3	In-House	FFPE	Resection	250	206	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0001640	P-0001640-T01-IM3	Outside	FFPE	Resection	250	254	60	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R175H;APC p.E1317*;FGFR1 Amplification;MYC Amplification;PRKN Deletion	1	5
P-0001641	P-0001641-T01-IM3	In-House	FFPE	Resection	250	501	50	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										FAT1 p.Q465*;BCL6 Amplification;EGFR Amplification;PIK3CA Amplification	0	4
P-0001642	P-0001642-T01-IM3	In-House	FFPE	Biopsy	250	655	30	Matched	Metastasis	Kidney	Liver	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma				Olaparib(CHEK2 p.X282_splice)	GSK2636771,AZD8186(PTEN p.Y65*)				LEVEL_3B	TP53 p.H193Y;PTEN p.Y65*;CHEK2 p.X282_splice	2	3
P-0001642	P-0001642-T02-IM5	Outside	FFPE	Resection	250	122	60	Matched	Metastasis	Kidney	Bone	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma				Olaparib(CHEK2 p.X282_splice)					LEVEL_3B	CHEK2 p.X282_splice	1	1
P-0001642	P-0001642-T03-IM5	Outside	FFPE	Resection	250	118	40	Matched	Metastasis	Kidney	Bone	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma				Olaparib(CHEK2 p.X282_splice)					LEVEL_3B	CHEK2 p.X282_splice	1	1
P-0001643	P-0001643-T01-IM3	Outside	FFPE	Biopsy	250	416	15	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.Q38Wfs*4;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MYC Amplification	1	5
P-0001645	P-0001645-T01-IM3	In-House	FFPE	Biopsy	250	275	40	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0001646	P-0001646-T01-IM3	In-House	FFPE	Biopsy	115	545	15	Matched	Metastasis	Skin	Stomach	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;FOXA1 Amplification	2	2
P-0001647	P-0001647-T01-IM3	Outside	FFPE	Resection	250	965	50	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	NRAS p.Q61K;APC p.E1408*;APC p.K1030*;NCOR1 Deletion;SMAD4 Deletion	1	5
P-0001648	P-0001648-T01-IM3	In-House	FFPE	Biopsy	250	580	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.R330Efs*22;CDKN2B Deletion;PTPRD Deletion;RICTOR Amplification	0	4
P-0001649	P-0001649-T01-IM3	In-House	FFPE	Resection	250	588	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K);Cisplatin(ERCC2 p.X436_splice)	Tazemetostat(SMARCB1 p.T118Pfs*25)				LEVEL_1	BRAF p.V600E;PIK3CA p.Q546K;KMT2C p.R4541*;TGFBR1 p.Q459*;ERCC2 p.X436_splice;PBRM1 p.E1608Gfs*7;TET1 p.Y1116Ifs*19;CDKN1B p.R43Gfs*28;KMT2D p.S3314Ffs*109;SMARCB1 p.T118Pfs*25;CASP8 p.E200Gfs*18	6	11
P-0001652	P-0001652-T01-IM3	Outside	FFPE	Resection	250	280	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SEF	Soft Tissue Sarcoma	Sclerosing Epithelioid Fibrosarcoma										CCND1 Amplification;EWSR1 CREB3L1-EWSR1 fusion;CREB3L1 CREB3L1-EWSR1 fusion	0	3
P-0001653	P-0001653-T01-IM3	In-House	FFPE	Biopsy	250	316	40	Matched	Metastasis	Uterus	Peritoneum	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.D281E	1	2
P-0001654	P-0001654-T01-IM3	In-House	FFPE	Biopsy	250	670	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0001654	P-0001654-T02-IM5	In-House	FFPE	Biopsy	250	871	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;NF1 Deletion;NF2 TNFRSF1B-NF2 fusion;TNFRSF1B TNFRSF1B-NF2 fusion	2	5
P-0001655	P-0001655-T01-IM3	In-House	FFPE	Biopsy	250	702	30	Matched	Metastasis	Cervix	Lymph Node	Tumor	CEAS	Cervical Cancer	Cervical Adenosquamous Carcinoma										SETD2 p.Q2135*;EP300 p.S396Tfs*13	0	2
P-0001656	P-0001656-T01-IM3	Outside	FFPE	Resection	250	899	40	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF2 p.G302Sfs*8;CDKN2A Deletion;CDKN2B Deletion;TGFBR2 Deletion	1	4
P-0001657	P-0001657-T01-IM3	Outside	FFPE	Resection	250	369	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)					LEVEL_3B	NRAS p.Q61H;MYCN Amplification	1	2
P-0001658	P-0001658-T01-IM3	In-House	FFPE	Resection	250	877	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.G245S;APC p.E1322*;APC p.R232*;FBXW7 p.R278*;FANCA p.Q240Lfs*17	1	6
P-0001659	P-0001659-T01-IM3	Outside	FFPE	Resection	250	489	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L101R;PBRM1 p.K124Sfs*50;KDM5C p.D702Efs*62	0	3
P-0001660	P-0001660-T01-IM3	In-House	FFPE	Cytology	250	436	40	Matched	Metastasis	Major Salivary Gland	Bone	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0001661	P-0001661-T01-IM3	In-House	FFPE	Biopsy	250	511	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;MAP2K4 Deletion	1	2
P-0001662	P-0001662-T01-IM3	In-House	FFPE	Resection	250	654	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.C176F;FGFR1 Amplification	1	2
P-0001663	P-0001663-T01-IM3	Outside	FFPE	Resection	250	440	20	Matched	Primary	Testis	Not Applicable	Tumor	TT	Germ Cell Tumor	Teratoma											0	0
P-0001664	P-0001664-T01-IM3	In-House	FFPE	Cytology	250	829	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Olaparib(CHEK1 p.X411_splice)					LEVEL_3A	TP53 p.R158L;CHEK1 p.X411_splice;HNF1A p.N62Mfs*93;AKT2 Amplification;FGFR1 Amplification;RB1 Deletion;SPEN SPEN-intragenic;ARID1A ARID1A-intragenic;LATS1 LATS1-intragenic	2	9
P-0001665	P-0001665-T01-IM3	In-House	FFPE	Cytology	238.5	551	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.H773dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.H773dup)			LEVEL_3A	EGFR p.H773dup;EGFR Amplification	1	2
P-0001667	P-0001667-T01-IM3	Outside	FFPE	Biopsy	250	822	50	Matched	Metastasis	GE Junction	Liver	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	TGFBR1 p.L340Wfs*2;KDM5A Amplification;MAPK1 Amplification;SMARCB1 Deletion;TP53 Deletion	1	5
P-0001669	P-0001669-T01-IM3	Outside	FFPE	Biopsy	250	665	20	Matched	Primary	Rectum	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma										SF3B1 p.R625C	0	1
P-0001670	P-0001670-T01-IM3	In-House	FFPE	Resection	250	733	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344G)					LEVEL_3B	TP53 p.R342*;APC p.R1450*;APC p.R213*;PIK3CA p.V344G	1	4
P-0001671	P-0001671-T01-IM3	Outside	FFPE	Biopsy	250	584	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	TP53 p.R273H;NRAS p.Q61R;EPHA3 p.G628*;FOXA1 Deletion	2	4
P-0001672	P-0001672-T01-IM3	Outside	FFPE	Biopsy	116	399	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	TP53 p.Q331*;PIK3CA p.H1047R;FAT1 p.S4243*;FAT1 p.E2095*;FGFR3 Amplification	2	5
P-0001673	P-0001673-T01-IM3	In-House	FFPE	Resection	250	424	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	KRAS p.G12A;PIK3CA p.H1047L;FBXW7 p.R465C;NOTCH3 p.R2080Afs*15	2	4
P-0001675	P-0001675-T01-IM3	In-House	FFPE	Biopsy	250	400	15	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	SMAD4 p.Y95H;CDK4 Amplification;ERBB3 Amplification;MDM2 Amplification	2	4
P-0001676	P-0001676-T01-IM3	Outside	FFPE	Resection	250	773	30	Matched	Metastasis	Cecum	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	TP53 p.Q331*;PIK3CA p.H1047L;SMAD4 p.R361C;KRAS p.G13D	2	4
P-0001677	P-0001677-T01-IM3	Outside	FFPE	Biopsy	250	810	20	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R248Q;FBXW7 p.R465H;MCL1 Amplification	0	3
P-0001678	P-0001678-T01-IM3	In-House	FFPE	Biopsy	250	1028	15	Matched	Metastasis	Cancer of Unknown Primary	Mediastinum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;NF2 p.X80_splice;TP53 p.X367_splice;SETD2 p.S1207*	1	4
P-0001679	P-0001679-T01-IM3	In-House	FFPE	Biopsy	178.02	484	60	Matched	Metastasis	Rectum	Adrenal Gland	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K642E)					LEVEL_3B	SF3B1 p.R625H;KIT p.K642E;TP53 p.H178Pfs*3;AKT3 Amplification;DDR2 Amplification;KDR Amplification;KIT Amplification;MCL1 Amplification;NTRK1 Amplification;PDGFRA Amplification;RAC1 Amplification	1	11
P-0001680	P-0001680-T02-IM3	Outside	FFPE	Biopsy	250	787	40	Matched	Metastasis	Lung	Cervix	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W15*)				LEVEL_4	MAPK1 p.E322K;FBXW7 p.R367*;PIK3R1 p.E451_Y452del;CDKN2A p.W15*	1	4
P-0001680	P-0001680-T01-IM3	Outside	FFPE	Resection	250	698	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W15*)				LEVEL_4	KMT2D p.R2685*;MAPK1 p.E322K;FBXW7 p.R367*;PIK3R1 p.E451_Y452del;CDKN2A p.W15*	1	5
P-0001681	P-0001681-T01-IM3	Outside	FFPE	Resection	250	209	40	Matched	Primary	Ovary	Not Applicable	Tumor	SBMOV	Ovarian Cancer	Serous Borderline Ovarian Tumor, Micropapillary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0001681	P-0001681-T02-IM3	Outside	FFPE	Resection	250	833	40	Matched	Metastasis	Ovary	Lymph Node	Tumor	SBMOV	Ovarian Cancer	Serous Borderline Ovarian Tumor, Micropapillary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0001682	P-0001682-T01-IM3	Outside	FFPE	Biopsy	250	624	30	Matched	Primary	Oropharynx	Not Applicable	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma											0	0
P-0001683	P-0001683-T01-IM3	Outside	FFPE	Resection	250	659	60	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Q317Sfs*28	0	1
P-0001684	P-0001684-T01-IM3	In-House	FFPE	Biopsy	60.9	194	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0001684	P-0001684-T02-IM3	In-House	FFPE	Resection	250	167	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0001685	P-0001685-T01-IM3	In-House	FFPE	Resection	250	812	40	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.R203H);GSK2636771,AZD8186(PTEN p.F104Ifs*3);Trametinib,Cobimetinib(NF1 p.K1386Rfs*20)				LEVEL_3B	PTCH1 p.S1203Afs*52;PTEN p.K267Rfs*9;NCOR1 p.R572Efs*18;RNF43 p.G659Vfs*41;FGFR2 p.R203H;APC p.R232*;KMT2D p.P647Hfs*283;PTPRT p.P1075Rfs*6;NF2 p.R57*;SMAD3 p.R93*;EPHA3 p.X324_splice;PIK3CB p.A1048V;PPP2R1A p.R157*;PBRM1 p.E1214Rfs*6;TET2 p.K1409Nfs*39;INPP4B p.N299Mfs*10;MAP3K1 p.R763Cfs*35;RASA1 p.N492Ifs*6;RASA1 p.N838Mfs*4;APC p.Q1935Sfs*35;GATA3 p.P135Rfs*60;PTEN p.F104Ifs*3;GRIN2A p.L63Cfs*5;NF1 p.K1386Rfs*20;SMAD4 p.S32*;PTPRS p.P622Lfs*16;SMARCA4 p.G102Afs*201	5	27
P-0001685	P-0001685-T02-IM3	In-House	FFPE	Resection	250	728	30	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);GSK2636771,AZD8186(PTEN p.N323Mfs*21)				LEVEL_3B	PTCH1 p.S1203Afs*52;PTEN p.K267Rfs*9;PTEN p.N323Mfs*21;RNF43 p.G659Vfs*41;APC p.T1556Nfs*3;JAK1 p.P430Rfs*2;APC p.R213*;APC p.R232*;FBXW7 p.R689Q;TGFBR2 p.X152_splice;TGFBR2 p.R537C;KDR p.T771M;SOX9 p.Q164*;SOX9 p.E226*;DNMT3A p.P59Rfs*13;CASP8 p.I333Sfs*4;RNF43 p.A273Vfs*147	3	17
P-0001686	P-0001686-T01-IM3	Outside	FFPE	Resection	250	596	50	Matched	Primary	Vulva	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Olaparib(CHEK1 Deletion);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.I1482Nfs*4);Trametinib,Cobimetinib(NF1 p.T2196Rfs*5)				LEVEL_3B	B2M p.X23_splice;NF1 p.I1482Nfs*4;NF1 p.T2196Rfs*5;ARID1B Deletion;CBL Deletion;CHEK1 Deletion;ERBB2 Amplification;EZH2 Deletion;GATA3 Deletion;LATS1 Deletion;KMT2A Deletion;PRKN Deletion;PRDM1 Deletion;PTPRD Deletion;RAF1 Amplification;TNFAIP3 Deletion;TP63 Deletion	4	17
P-0001687	P-0001687-T01-IM3	In-House	FFPE	Biopsy	244.76	665	40	Matched	Metastasis	Prostate	Bone	Tumor	PRSCC	Prostate Cancer	Prostate Small Cell Carcinoma	Olaparib,Rucaparib(BRCA2 p.E2872*)			Talazoparib,Niraparib(BRCA2 p.E2872*);Trametinib,Cobimetinib(SND1 BRAF-SND1 fusion);Trametinib,Cobimetinib(BRAF BRAF-SND1 fusion)					LEVEL_1	BRCA2 p.E2872*;FOXA1 p.S95Kfs*132;STK11 p.Q100Nfs*3;DIS3 Deletion;MCL1 Amplification;RB1 Deletion;SND1 BRAF-SND1 fusion;BRAF BRAF-SND1 fusion	4	8
P-0001688	P-0001688-T01-IM3	In-House	FFPE	Biopsy	250	902	40	Matched	Metastasis	Cervix	Pelvis	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma				AZD5363(AKT1 p.E17K);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 p.S249C)	Trametinib,Cobimetinib(NF1 p.Q554*)				LEVEL_3B	AKT1 p.E17K;FGFR3 p.S249C;MAPK1 p.R135K;KMT2D p.Q3454*;NF1 p.Q554*	3	5
P-0001688	P-0001688-T02-IM5	In-House	FFPE	Cytology	250	959	20	Matched	Metastasis	Cervix	Pelvis	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma				AZD5363(AKT1 p.E17K);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 p.S249C)	Trametinib,Cobimetinib(NF1 p.Q554*)				LEVEL_3B	AKT1 p.E17K;FGFR3 p.S249C;MAPK1 p.R135K;NF1 p.Q554*	3	4
P-0001690	P-0001690-T01-IM3	Outside	FFPE	Biopsy	250	715	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)					LEVEL_3B	PIK3CA p.N345K;APC p.R216*;APC p.E1374*;TP53 p.E221*;PRKN Deletion	1	5
P-0001692	P-0001692-T02-IM3	Outside	FFPE	Biopsy	69.85	413	40	Matched	Metastasis	Stomach	Mesentery	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)				Imatinib(PDGFRA p.D842V)			LEVEL_1	PDGFRA p.D842V	2	1
P-0001692	P-0001692-T01-IM3	Outside	FFPE	Resection	250	106	60	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)				Imatinib(PDGFRA p.D842V)			LEVEL_1	PDGFRA p.D842V;PDGFRA Amplification	2	2
P-0001693	P-0001693-T02-IM3	Outside	FFPE	Biopsy	67.84	205	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R282W;APC p.Q1303*;CBL p.V581Cfs*4;FUBP1 p.X569_splice;SMAD3 p.W326*	1	6
P-0001694	P-0001694-T01-IM3	Outside	FFPE	Resection	250	737	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0001695	P-0001695-T01-IM3	Outside	FFPE	Cytology	250	703	30	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	TP53 p.H193Y;MAX p.G55*;TP53 p.R337P;BRCA2 Deletion;KMT2D Deletion;RB1 Deletion	1	6
P-0001696	P-0001696-T01-IM3	Outside	FFPE	Resection	250	675	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R196*;MYC Amplification;PTEN Deletion	1	3
P-0001697	P-0001697-T02-IM3	In-House	FFPE	Biopsy	225.4	247	NA	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.V73Rfs*76;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0001698	P-0001698-T01-IM3	In-House	FFPE	Biopsy	250	792	60	Matched	Metastasis	Prostate	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.G245V;AXIN1 p.I343Sfs*71;CCNE1 Amplification;FANCA Deletion;FAT1 Deletion;FOXP1 Deletion;NCOR1 Deletion;PRKN Deletion;PTEN Deletion;RYBP Deletion;SHQ1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	13
P-0001699	P-0001699-T02-IM5	In-House	DNA	Biopsy	250	1012	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										EPHA7 Deletion;PBRM1 PBRM1-intragenic	0	2
P-0001699	P-0001699-T01-IM3	Outside	FFPE	Biopsy	95.19	236	50	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0001700	P-0001700-T01-IM3	Outside	FFPE	Resection	250	643	40	Matched	Primary	Ovary	Not Applicable	Tumor	EOV	Ovarian Cancer	Endometrioid Ovarian Cancer			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;CTNNB1 p.S33F;ARID1A p.Q497*;SOX17 p.S403I	1	4
P-0001701	P-0001701-T01-IM3	Outside	FFPE	Resection	250	179	60	Matched	Metastasis	Uterus	Omentum	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.R248W;TP53 p.X332_splice;RB1 Deletion;ATRX ATRX-intragenic	0	4
P-0001702	P-0001702-T01-IM3	In-House	FFPE	Resection	250	856	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.H1047R;APC p.R283*;APC p.X178_splice;SOX9 p.P267Sfs*9	2	5
P-0001703	P-0001703-T01-IM3	In-House	FFPE	Resection	250	730	30	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)						LEVEL_1	CREBBP p.I1084Sfs*15;KMT2D p.R1615*;KMT2D p.R2685*;SETD2 p.D2064Pfs*8;ARID1A p.Q269*;MSH2 p.Q252*;BAP1 p.Q694*;FOXP1 p.Q280*;FGFR3 p.R248C;APC p.Q1680*;NSD1 p.R1984*;NOTCH1 p.Q442*;KMT2A p.R173*;HNF1A p.Q481*;AXIN1 p.X372_splice;TP53 p.R290H;RBM10 p.M1?;KDM5C p.Q1206*;TET2 p.N1118Ifs*19;NSD1 p.S589Yfs*9;NBN p.R551Kfs*5;NOTCH3 p.G1269Vfs*3;BCOR p.L7Cfs*9	2	23
P-0001704	P-0001704-T01-IM3	In-House	FFPE	Biopsy	250	1076	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TNFRSF14 p.C111W;TET2 p.S1290P;RB1 p.R255*	0	3
P-0001705	P-0001705-T01-IM3	In-House	FFPE	Resection	250	525	50	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0001706	P-0001706-T01-IM3	In-House	FFPE	Resection	250	333	60	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;ARID2 p.Q1318*;PTPRT p.Q625*;ARID2 p.X1591_splice	1	4
P-0001707	P-0001707-T01-IM3	In-House	FFPE	Biopsy	250	1094	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)	Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L858R;BRAF p.D594V;TP53 p.X307_splice;MET Amplification	3	4
P-0001708	P-0001708-T01-IM3	In-House	FFPE	Resection	250	394	50	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma					Trametinib,Cobimetinib(NF1 p.R461*)				LEVEL_4	TP53 p.R337C;MSH2 p.X504_splice;FLT3 p.A953V;NF1 p.R461*	1	4
P-0001709	P-0001709-T01-IM3	Outside	FFPE	Resection	250	744	20	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3B	TP53 p.V147Lfs*23;CDKN2A p.H83Y;MET Amplification	2	3
P-0001710	P-0001710-T01-IM3	In-House	FFPE	Resection	250	300	40	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;APC p.E1554Kfs*11;APC SRP19-APC fusion;SRP19 SRP19-APC fusion	2	4
P-0001711	P-0001711-T01-IM3	In-House	FFPE	Resection	216.6	440	20	Matched	Metastasis	Lower Extremity	Blood Vessel	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma											0	0
P-0001713	P-0001713-T01-IM3	In-House	FFPE	Resection	250	414	60	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0001714	P-0001714-T01-IM3	In-House	FFPE	Resection	250	701	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;TP53 p.R110P	1	2
P-0001715	P-0001715-T01-IM3	In-House	FFPE	Biopsy	250	824	50	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	AURKA Amplification;ERBB2 Amplification;MAP2K4 Deletion	2	3
P-0001716	P-0001716-T01-IM3	In-House	FFPE	Resection	250	695	60	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	SF3B1 p.R625H;GNA11 p.Q209P;MET Amplification;KMT2C Deletion	1	4
P-0001717	P-0001717-T01-IM3	In-House	FFPE	Biopsy	250	663	40	Matched	Metastasis	Prostate	Retroperitoneum	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 Deletion)								LEVEL_1	ATRX p.R907*;AR Amplification;CDK12 Deletion;MAP2K4 Deletion;ARID1A EPB41-ARID1A fusion;EPB41 EPB41-ARID1A fusion;KMT2C DPP6-MLL3 fusion;DPP6 DPP6-MLL3 fusion	1	8
P-0001718	P-0001718-T01-IM3	Outside	FFPE	Biopsy	211.12	652	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.D769Y)	Ado-Trastuzumab Emtansine(ERBB2 p.D769Y)	GSK2636771,AZD8186(PTEN p.A126D)				LEVEL_3A	SF3B1 p.K700E;PTEN p.A126D;ERBB2 p.D769Y;CDH1 p.X49_splice	3	4
P-0001720	P-0001720-T01-IM3	In-House	FFPE	Resection	250	339	40	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0001721	P-0001721-T01-IM3	Outside	FFPE	Resection	250	142	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										TP53 p.N268I;CDH1 p.L582Cfs*2;FOXA1 Amplification;MYC Amplification	0	4
P-0001722	P-0001722-T01-IM3	Outside	FFPE	Resection	250	545	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E);Trametinib,Cobimetinib(NF1 p.Q83*)				LEVEL_3B	BCOR p.N1459S;BRAF p.K601E;NF1 p.Q83*;NOTCH2 p.C1527Wfs*10	3	4
P-0001723	P-0001723-T01-IM3	Outside	FFPE	Resection	250	565	30	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma					GSK2636771,AZD8186(PTEN p.Y346C)				LEVEL_4	TP53 p.R196*;PTEN p.Y346C;CD274 Amplification;JAK2 Amplification	1	4
P-0001724	P-0001724-T01-IM3	In-House	FFPE	Biopsy	250	378	NA	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;NFE2L2 p.G81S;STK11 p.X245_splice;AURKA Amplification;MYC Amplification;MYT1 RECQL4-MYT1 fusion;RECQL4 RECQL4-MYT1 fusion	1	7
P-0001725	P-0001725-T01-IM3	Outside	FFPE	Resection	250	536	40	Matched	Primary	Not available	Not available	Tumor	ES	Bone Cancer	Ewing Sarcoma										TP53 p.E285K;STAG2 p.X435_splice;EWSR1 ERG-EWSR1 fusion;ERG ERG-EWSR1 fusion	0	4
P-0001726	P-0001726-T01-IM3	Outside	FFPE	Resection	250	731	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.V73Rfs*76;EGFR Amplification	1	3
P-0001727	P-0001727-T01-IM3	In-House	FFPE	Biopsy	250	646	20	Matched	Primary	Pelvis	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma											0	0
P-0001728	P-0001728-T02-IM5	In-House	DNA	Biopsy	250	955	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.X342_splice)				LEVEL_3B	TP53 p.R273H;TP53 p.D281H;PTEN p.X342_splice;CDK4 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	2	7
P-0001729	P-0001729-T01-IM3	Outside	FFPE	Cytology	250	683	40	Matched	Metastasis	Sigmoid Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.P190L;FBXW7 Deletion;NKX3-1 Deletion	1	4
P-0001730	P-0001730-T01-IM3	Outside	FFPE	Resection	250	450	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ATRX p.R840Kfs*9	1	2
P-0001731	P-0001731-T01-IM3	In-House	FFPE	Biopsy	250	505	NA	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.C235Y)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R342*;TP53 p.R175H;PDGFRA p.C235Y;ATRX p.F888Sfs*17;CDKN2A Deletion;CDKN2B Deletion;PMAIP1 Deletion	2	7
P-0001731	P-0001731-T02-IM5	In-House	FFPE	Biopsy	250	765	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.C235Y)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R342*;TP53 p.R175H;PDGFRA p.C235Y;ATRX p.F888Sfs*17;CDKN2A Deletion;CDKN2B Deletion;EPHA3 Deletion	2	7
P-0001732	P-0001732-T01-IM3	Outside	FFPE	Biopsy	250	323	30	Matched	Metastasis	Sigmoid Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;PIK3CA p.E542K;PIK3CA p.M1043I;APC p.A1296Qfs*9;SOX9 p.W335*	3	5
P-0001733	P-0001733-T01-IM3	In-House	FFPE	Biopsy	250	949	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.G266R;DNMT3B p.R54*;RB1 Deletion	0	3
P-0001734	P-0001734-T01-IM3	Outside	FFPE	Biopsy	250	681	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_1	BRAF p.V600E;PIK3CA p.E542K;TP53 p.R273C;APC p.R1450*;APC p.R876*	4	5
P-0001735	P-0001735-T01-IM3	Outside	FFPE	Resection	250	341	40	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer										ARID1A p.E896*	0	1
P-0001736	P-0001736-T01-IM3	In-House	FFPE	Resection	250	848	30	Matched	Metastasis	Skin	Soft Tissue	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Trametinib,Cobimetinib(NF1 p.K814Rfs*7)				LEVEL_4	TP53 p.E286K;NF1 p.K814Rfs*7;TP53 p.N247I	1	3
P-0001737	P-0001737-T01-IM3	Outside	FFPE	Resection	250	947	50	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(VCL ALK-VCL fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK ALK-VCL fusion)					LEVEL_3B	VCL ALK-VCL fusion;ALK ALK-VCL fusion	2	2
P-0001738	P-0001738-T01-IM3	Outside	FFPE	Resection	250	774	60	Matched	Primary	Kidney	Not Applicable	Tumor	MTSCC	Renal Cell Carcinoma	Renal Mucinous Tubular Spindle Cell Carcinoma											0	0
P-0001739	P-0001739-T01-IM3	In-House	FFPE	Biopsy	250	301	50	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 Deletion	0	1
P-0001740	P-0001740-T01-IM3	Outside	FFPE	Resection	250	566	50	Matched	Primary	Testis	Not Applicable	Tumor	BEC	Germ Cell Tumor	Embryonal Carcinoma										CCND2 Amplification;KDM5A Amplification	0	2
P-0001741	P-0001741-T02-IM3	In-House	FFPE	Resection	250	576	60	Matched	Metastasis	Cancer of Unknown Primary	Trachea	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;KEAP1 p.D422Y;TP53 p.L35Cfs*9;SMARCA4 p.P135Rfs*23;KDM6A Deletion;MCL1 Amplification;STK11 Deletion	1	7
P-0001741	P-0001741-T01-IM3	Outside	FFPE	Biopsy	250	437	50	Matched	Metastasis	Cancer of Unknown Primary	Abdomen	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;KEAP1 p.D422Y;TP53 p.L35Cfs*9;SMARCA4 p.P135Rfs*23	1	4
P-0001742	P-0001742-T01-IM3	In-House	FFPE	Resection	250	56	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	APC p.I1307Nfs*8;KRAS p.G13D	1	2
P-0001743	P-0001743-T01-IM3	Outside	FFPE	Resection	250	916	60	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0001744	P-0001744-T01-IM3	In-House	FFPE	Resection	250	329	50	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D153N)				LEVEL_4	TP53 p.X332_splice;TP53 p.R282W;FAT1 p.Q4023*;FAT1 p.R304*;RASA1 p.K466*;DNMT3B p.W736*;CDKN2A p.D153N;CCND1 Amplification;FGF19 Amplification;YAP1 Amplification	1	10
P-0001745	P-0001745-T02-IM5	In-House	FFPE	Biopsy	250	2073	10	Matched	Metastasis	Lung	Pelvis	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion)	Cabozantinib,Vandetanib(RET CCDC6-RET fusion);Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion)	BLU-667(RET CCDC6-RET fusion);BLU-667(CCDC6 CCDC6-RET fusion)						LEVEL_1	RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	6	2
P-0001746	P-0001746-T01-IM3	In-House	FFPE	Resection	250	193	40	Matched	Metastasis	Cecum	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN p.D92G);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R213*;APC p.R1450*;PTEN p.D92G;KRAS p.G13D;MYC Amplification	2	5
P-0001747	P-0001747-T02-IM5	In-House	FFPE	Biopsy	250	1030	20	Matched	Metastasis	Ovary	Peritoneum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Y220C;SOX17 p.L124Afs*35;AKT2 Amplification;CCNE1 Amplification;WT1 WIT1-WT1 fusion;WT1-AS WIT1-WT1 fusion	0	6
P-0001747	P-0001747-T01-IM3	Outside	FFPE	Resection	250	324	40	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Everolimus(TSC2 Deletion)					LEVEL_3B	TP53 p.Y220C;SOX17 p.L124Afs*35;STK11 Deletion;TSC2 Deletion	1	4
P-0001749	P-0001749-T01-IM3	In-House	FFPE	Biopsy	250	901	15	Matched	Metastasis	Testis	Liver	Tumor	SEM	Germ Cell Tumor	Seminoma										EP300 p.C351*;KRAS Amplification	0	2
P-0001750	P-0001750-T01-IM3	Outside	FFPE	Biopsy	133.56	899	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)	Crizotinib(MET Amplification)		Palbociclib,Abemaciclib(CDK4 Amplification);Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L747_P753delinsS;TP53 p.L130V;BRAF Amplification;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;KDM5A Amplification;KDM5C Deletion;MET Amplification	5	10
P-0001751	P-0001751-T01-IM3	In-House	FFPE	Biopsy	250	794	40	Matched	Metastasis	Breast	Epidural	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537D)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3A	ESR1 p.Y537D;CCND1 Amplification;FGF19 Amplification;MDM2 Amplification	2	4
P-0001752	P-0001752-T01-IM3	In-House	FFPE	Resection	250	751	40	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.K132R;CREBBP p.D1435N	0	2
P-0001753	P-0001753-T01-IM3	Outside	FFPE	Resection	250	720	50	Matched	Metastasis	Kidney	Lymph Node	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0001754	P-0001754-T01-IM3	Outside	FFPE	Biopsy	77	542	10	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Everolimus(TSC2 p.R1200Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;APC p.R1450*;TSC2 p.R1200Q;APC p.R854Efs*7	3	5
P-0001755	P-0001755-T01-IM3	In-House	FFPE	Resection	250	763	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542Q)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.E542Q;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PRDM1 Deletion;TNFAIP3 Deletion	3	6
P-0001756	P-0001756-T01-IM3	In-House	FFPE	Biopsy	250	458	35	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.G1801Afs*33)	Trametinib,Cobimetinib(NF1 p.R416*);Trametinib,Cobimetinib(NF1 p.W1236*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	RAC1 p.P29S;RIT1 p.F82L;BRAF p.G466E;KMT2A p.Q3103*;ARID2 p.S297F;NF1 p.R416*;RUNX1 p.X242_splice;BRCA1 p.G1801Afs*33;NF1 p.W1236*;CDKN2A Deletion;CDKN2B Deletion;DNMT3A DNMT3A-intragenic	4	12
P-0001757	P-0001757-T01-IM3	In-House	FFPE	Biopsy	250	1318	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.Y236C;RUNX1 p.R45Efs*66;ERBB2 Amplification;LATS2 Deletion;MAP2K4 Deletion;RB1 Deletion;RICTOR Amplification	2	7
P-0001758	P-0001758-T01-IM3	Outside	FFPE	Biopsy	250	940	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G776delinsAVGC)	Neratinib(ERBB2 p.G776delinsAVGC)						LEVEL_2	ERBB2 p.G776delinsAVGC;FGFR4 Amplification;MCL1 Amplification	2	3
P-0001759	P-0001759-T01-IM3	Outside	FFPE	Biopsy	250	1027	60	Matched	Metastasis	Thyroid	Brain	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.L1705V)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;BRCA1 p.L1705V;CDKN2A Deletion;CDKN2B Deletion;NKX2-1 Amplification	3	5
P-0001760	P-0001760-T01-IM3	Outside	FFPE	Resection	250	307	40	Matched	Primary	Breast	Not Applicable	Tumor	MBC	Breast Cancer	Metaplastic Breast Cancer										FBXW7 p.X473_splice;TP53 p.I232Sfs*15;ACTN4 AKT2-ACTN4 fusion;AKT2 AKT2-ACTN4 fusion;MYC XCR1-MYC fusion;XCR1 XCR1-MYC fusion	0	6
P-0001761	P-0001761-T01-IM3	Outside	FFPE	Biopsy	250	454	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R213*;APC p.R1450*;SOX9 p.M469Ifs*109	0	3
P-0001762	P-0001762-T01-IM3	Outside	FFPE	Biopsy	250	549	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.X307_splice;ERBB2 Amplification;MYC Amplification;PAX5 Amplification	4	5
P-0001763	P-0001763-T01-IM3	Outside	FFPE	Resection	250	464	40	Matched	Metastasis	Cancer of Unknown Primary	Spleen	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)					LEVEL_3B	TP53 p.Y234C;NRAS p.G12D;AKT2 Amplification;AMER1 Deletion;ATRX Deletion;AXL Amplification;BCL2L1 Amplification;BCOR Deletion;CCNE1 Amplification;DNMT3B Amplification;FLCN Deletion;KDM5C Deletion;KDM6A Deletion;MED12 Deletion;MEF2B Amplification;NCOR1 Deletion;PIK3R2 Amplification;PTPRS Deletion;RBM10 Deletion;SH2D1A Deletion;SMARCA4 Deletion;STAG2 Deletion;STK11 Deletion	1	23
P-0001764	P-0001764-T01-IM3	Outside	FFPE	Biopsy	250	684	50	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R273C;CCND1 Amplification;CCND3 Amplification;EGFR Amplification;FGF19 Amplification;KRAS Amplification;PAK1 Amplification	0	7
P-0001766	P-0001766-T01-IM3	Outside	FFPE	Biopsy	250	461	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0001767	P-0001767-T01-IM3	Outside	FFPE	Resection	250	1069	25	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D769Y)					LEVEL_3B	TP53 p.R273L;ERBB2 p.D769Y;APC p.X438_splice;APC p.S1400*;ATRX p.K994Efs*6;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	1	9
P-0001768	P-0001768-T01-IM3	Outside	FFPE	Biopsy	250	376	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Lorlatinib,Brigatinib(ALK p.R1275Q)					LEVEL_3B	ALK p.R1275Q;TP53 p.L114Ffs*33	1	2
P-0001769	P-0001769-T01-IM3	Outside	FFPE	Resection	250	714	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.R1450*;PPP2R1A p.R183W;B2M p.L15Ffs*41;ERBB3 p.G284R;ARID1B p.Q595*;TGFBR1 p.T375R;SOX9 p.E190*;APC p.S906Ffs*6	1	9
P-0001771	P-0001771-T01-IM3	Outside	FFPE	Resection	250	153	40	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248W;APC p.E1379*	0	2
P-0001773	P-0001773-T01-IM3	In-House	FFPE	Resection	250	424	80	Matched	Metastasis	Skin	Subcutaneous Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;PIK3CB p.D1067V;CDK4 p.R24C;ETV1 Amplification;MITF Amplification;PMAIP1 Deletion	2	6
P-0001774	P-0001774-T01-IM3	In-House	FFPE	Biopsy	237.12	583	60	Matched	Metastasis	Prostate	Prostate	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SOX17 p.P328Rfs*59;SPOP p.W131G;AR p.H875Y;ETV6 p.N382S;AKT1 p.W80R;INPP4B p.L661*;LATS1 p.S267Ffs*48;GATA3 p.S237Afs*28;KMT2D p.A221Lfs*40;DIS3 p.K10Rfs*7;CREBBP p.H2384Tfs*12;ASXL2 Deletion;DNMT3A Deletion;EPCAM Deletion;MSH2 Deletion	0	15
P-0001775	P-0001775-T01-IM3	In-House	FFPE	Resection	250	439	50	Matched	Metastasis	Adrenal Gland	Lung	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										CCNE1 Amplification	0	1
P-0001776	P-0001776-T01-IM3	In-House	FFPE	Resection	250	530	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E271V;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0001777	P-0001777-T01-IM3	In-House	FFPE	Resection	250	933	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.D335Gfs*17;TP53 p.R110P;AURKA Amplification;ERBB2 Amplification;FOXA1 Amplification;NKX2-1 Amplification	2	6
P-0001778	P-0001778-T01-IM3	Outside	FFPE	Resection	250	761	NA	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.X166_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)	Cetuximab,Panitumumab(KRAS p.G12R)			LEVEL_3B	KRAS p.G12R;APC p.E1309Dfs*4;ATM p.X166_splice;TP53 p.C277*	2	4
P-0001779	P-0001779-T01-IM3	In-House	FFPE	Resection	250	403	NA	Matched	Metastasis	Kidney	Liver	Tumor	NETNOS	Cancer of Unknown Primary	Neuroendocrine Tumor, NOS											0	0
P-0001780	P-0001780-T01-IM3	In-House	FFPE	Resection	250	722	80	Matched	Metastasis	Uterus	Skin	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma											0	0
P-0001781	P-0001781-T01-IM3	In-House	FFPE	Resection	250	237	70	Matched	Metastasis	Uterus	Pelvis	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	BRAF p.V600E;MED12 p.G44C;ATRX p.Q727*;CDK4 Amplification;MCL1 Amplification	2	5
P-0001782	P-0001782-T01-IM3	Outside	FFPE	Resection	250	611	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.G1202*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E149*)				LEVEL_3B	ATM p.G1202*;CREBBP p.V1802M;SOX9 p.Q312*;MED12 p.X1472_splice;TP53 p.X261_splice;CDKN2A p.E149*	2	6
P-0001783	P-0001783-T01-IM3	In-House	FFPE	Biopsy	69.3	428	40	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.D259Y;ARID2 p.Q1016*;AXIN1 p.E716*;CCNE1 Amplification;PTEN Deletion;RB1 Deletion;SMAD4 Deletion	1	7
P-0001784	P-0001784-T01-IM3	In-House	FFPE	Resection	250	541	40	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.R175H;LATS2 p.X889_splice;CCNE1 Amplification;CREBBP Deletion;GRIN2A Deletion;STK11 Deletion;DIP2B NOTCH4-DIP2B fusion;NOTCH4 NOTCH4-DIP2B fusion	2	9
P-0001785	P-0001785-T03-IM5	In-House	DNA	Biopsy	250	981	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.I195T;CCND1 Amplification;FGF19 Amplification	0	3
P-0001785	P-0001785-T02-IM3	Outside	FFPE	Biopsy	250	782	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.I195T;CCND1 Amplification;EGFR Amplification	0	3
P-0001787	P-0001787-T01-IM3	Outside	FFPE	Biopsy	73.2	260	15	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.E287*;STK11 p.L282Sfs*5;MYC Amplification	0	3
P-0001788	P-0001788-T01-IM3	In-House	FFPE	Biopsy	250	1276	50	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										TP53 p.M237I;GNA11 p.Q209L;BAP1 p.A323Tfs*66;MYC Amplification	0	4
P-0001790	P-0001790-T01-IM3	In-House	FFPE	Biopsy	248.4	1493	40	Matched	Metastasis	Lung	Mediastinum	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Olaparib(PALB2 Deletion)					LEVEL_3B	TP53 p.L130R;BCOR p.Y376*;PALB2 Deletion	1	3
P-0001791	P-0001791-T01-IM3	Outside	FFPE	Resection	250	109	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.S170Vfs*13)				LEVEL_4	JAK1 p.K860Nfs*16;RNF43 p.G659Vfs*41;JAK1 p.L431Vfs*22;CTCF p.T204Nfs*26;PIK3R1 p.E462Ifs*2;ERBB3 p.V104M;ARID1A p.Q1331*;NFE2L2 p.E82D;ASXL1 p.G360*;EP300 p.Y1467N;PIK3R1 p.G665Afs*3;PTEN p.S170Vfs*13;MCL1 Amplification	1	13
P-0001793	P-0001793-T01-IM3	Outside	FFPE	Biopsy	250	181	30	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;SF3B1 p.K700E;ERBB4 p.R306H	1	3
P-0001794	P-0001794-T01-IM3	In-House	FFPE	Cytology	70.4	394	50	Matched	Metastasis	Larynx	Lung	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NFE2L2 p.R34Q;TP53 p.X187_splice;BCL6 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;FAT1 Deletion;PIK3CA Amplification	1	8
P-0001795	P-0001795-T01-IM3	In-House	FFPE	Biopsy	250	1293	40	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E285K;CUL3 p.M299R;MYC Amplification	0	3
P-0001795	P-0001795-T02-IM5	In-House	FFPE	Biopsy	250	808	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E285K;CUL3 p.M299R;AR Amplification;MYC Amplification;MIPOL1 FOXA1-MIPOL1 fusion;FOXA1 FOXA1-MIPOL1 fusion	0	6
P-0001796	P-0001796-T01-IM3	In-House	FFPE	Biopsy	154.8	913	20	Matched	Metastasis	Ovary	Peritoneum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.W91Sfs*32;CCNE1 Amplification;KRAS Amplification	0	3
P-0001797	P-0001797-T01-IM3	In-House	FFPE	Biopsy	250	260	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.V422del)						LEVEL_1	PIK3CA p.E545K;SPEN p.R732*;ESR1 p.V422del;GATA3 p.H434Pfs*42;CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;GATA3 Amplification;NKX2-1 Amplification	3	9
P-0001798	P-0001798-T01-IM3	In-House	FFPE	Resection	250	612	60	Matched	Metastasis	Uterus	Pelvis	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma										TP53 p.G245S;CCNE1 Amplification;FAT1 Deletion;MYC Amplification	0	4
P-0001799	P-0001799-T01-IM3	Outside	FFPE	Resection	250	472	60	Matched	Metastasis	Ovary	Cul-de-sac	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R248W	0	1
P-0001800	P-0001800-T01-IM3	In-House	FFPE	Resection	250	200	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer											0	0
P-0001801	P-0001801-T01-IM3	In-House	FFPE	Resection	250	225	50	Matched	Metastasis	Ovary	Peritoneum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Q192*;AMER1 Deletion;KDM5A Amplification;SH2D1A Deletion	0	4
P-0001802	P-0001802-T01-IM3	In-House	FFPE	Biopsy	250	862	30	Matched	Metastasis	Lung	Chest Wall	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R248L;EGFR Amplification;MCL1 Amplification;MYC Amplification	0	4
P-0001803	P-0001803-T01-IM3	In-House	FFPE	Biopsy	250	431	50	Matched	Metastasis	Penis	Skin	Tumor	PSCC	Penile Cancer	Penile Squamous Cell Carcinoma										BAP1 p.S513*	0	1
P-0001804	P-0001804-T01-IM3	In-House	FFPE	Resection	250	185	40	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R196*;JAK1 p.Q387Lfs*66;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification	2	6
P-0001805	P-0001805-T01-IM3	In-House	FFPE	Resection	250	626	60	Matched	Metastasis	Bladder	Prostate	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q)					LEVEL_3B	PIK3CA p.E545Q;TP53 p.Q192*;FLT3 p.E803Q;AKT2 Amplification;AXL Amplification;CCNE1 Amplification;MYC Amplification;PIK3CA Amplification;PTPRD Deletion	1	9
P-0001806	P-0001806-T01-IM3	In-House	FFPE	Biopsy	65	343	40	Matched	Metastasis	Liver	Adrenal Gland	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Imatinib(KIT p.R888W)					LEVEL_3B	KIT p.R888W;TP53 p.Y163N;CREBBP p.N2181Kfs*5;MCL1 Amplification;MYC Amplification;NTRK1 Amplification	1	6
P-0001807	P-0001807-T01-IM3	In-House	FFPE	Resection	250	397	50	Matched	Metastasis	Rectum	Lymph Node	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)		Cetuximab,Panitumumab(NRAS p.Q61R)			LEVEL_2	NRAS p.Q61R;APC p.R1114*;TP53 p.E294*;APC p.S1298Lfs*7;AKT2 Amplification;AXL Amplification;ERBB2 Amplification	3	7
P-0001808	P-0001808-T01-IM3	In-House	FFPE	Biopsy	250	1054	30	Matched	Metastasis	Cecum	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E2129*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T);GSK2636771,AZD8186(PTEN p.R130Q)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	TP53 p.R213*;KRAS p.A146T;PTEN p.R130Q;TGFBR1 p.S241L;POLE p.P286R;SETD2 p.E517*;ATR p.E148*;RASA1 p.E1031*;APC p.S1222*;APC p.L1564*;KMT2C p.R4478*;KMT2C p.E718*;TET1 p.S1002*;KMT2A p.R2188*;ARID2 p.E71*;BRCA2 p.E2129*;RB1 p.E323*;DIS3 p.R689Q;PTPRT p.S169*;RBM10 p.E667*	3	20
P-0001809	P-0001809-T01-IM3	In-House	FFPE	Resection	250	667	50	Matched	Metastasis	Ovary	Bladder	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W	0	1
P-0001810	P-0001810-T01-IM3	In-House	FFPE	Biopsy	93.1	662	30	Matched	Metastasis	Trachea	Skin	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0001811	P-0001811-T01-IM3	In-House	FFPE	Biopsy	188.1	631	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0001812	P-0001812-T01-IM3	In-House	FFPE	Biopsy	250	669	30	Matched	Metastasis	Small Bowel	Peritoneum	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	TP53 p.R196*;KRAS p.G12V;ERBB3 p.V104M	1	3
P-0001813	P-0001813-T01-IM3	In-House	FFPE	Biopsy	136	610	80	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1008_splice)	Crizotinib(MET p.X1008_splice)	Cabozantinib(MET p.X1008_splice)		Trametinib,Cobimetinib(NF1 p.E572Rfs*14)				LEVEL_1	TP53 p.X225_splice;FAT1 p.R782Vfs*9;MET p.X1008_splice;NF1 p.E572Rfs*14	4	4
P-0001813	P-0001813-T02-IM3	In-House	FFPE	Biopsy	97.2	917	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1008_splice)	Crizotinib(MET p.X1008_splice)	Cabozantinib(MET p.X1008_splice)		Trametinib,Cobimetinib(NF1 p.E572Rfs*14);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.X225_splice;FAT1 p.R782Vfs*9;MET p.X1008_splice;NF1 p.E572Rfs*14;CDKN2A Deletion;CDKN2B Deletion	5	6
P-0001814	P-0001814-T01-IM3	In-House	FFPE	Resection	250	873	60	Matched	Metastasis	Uterus	Sigmoid Colon	Tumor	UMLMS	Uterine Sarcoma	Uterine Myxoid Leiomyosarcoma										CTNNB1 p.G34R;B2M Deletion;RAD51 Deletion	0	3
P-0001816	P-0001816-T01-IM3	In-House	FFPE	Resection	250	265	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	PHC	Pheochromocytoma	Pheochromocytoma											0	0
P-0001817	P-0001817-T02-IM5	In-House	FFPE	Biopsy	250	1161	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;TP53 p.R248Q;EGFR p.E746_A750del;EGFR Amplification	2	4
P-0001817	P-0001817-T01-IM3	Outside	FFPE	Biopsy	250	446	NA	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	TP53 p.R248Q;EGFR p.E746_A750del	1	2
P-0001818	P-0001818-T01-IM3	Outside	FFPE	Biopsy	66.5	351	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Olaparib(RAD51C PPM1D-RAD51C fusion);Olaparib(PPM1D PPM1D-RAD51C fusion)					LEVEL_1	ERBB2 Amplification;RAD51C PPM1D-RAD51C fusion;PPM1D PPM1D-RAD51C fusion	4	3
P-0001819	P-0001819-T01-IM3	In-House	FFPE	Biopsy	250	667	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E365K)	Lapatinib(EGFR p.T263P);Lapatinib(EGFR p.A289V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.E365K;EGFR p.T263P;EGFR p.A289V;EGFR p.G598V;PTPN11 p.I282V;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;KIT Amplification;PDGFRA Amplification	5	11
P-0001820	P-0001820-T01-IM3	In-House	FFPE	Resection	250	524	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.R130P)				LEVEL_4	BCOR p.N1459S;PTEN p.R130P	1	2
P-0001821	P-0001821-T01-IM3	In-House	FFPE	Resection	250	577	50	Matched	Metastasis	Uterus	Lung	Tumor	UELMS	Uterine Sarcoma	Uterine Epithelioid Leiomyosarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546H)	GSK2636771,AZD8186(PTEN p.D268Gfs*30);GSK2636771,AZD8186(PTEN p.R130Q);GSK2636771,AZD8186(PTEN p.R173H);Trametinib,Cobimetinib(NF1 p.G823*);Trametinib,Cobimetinib(NF1 p.G824*)				LEVEL_3B	PTEN p.D268Gfs*30;PTEN p.R130Q;ARID1A p.R1276*;CTCF p.T204Nfs*26;PTEN p.R173H;ARID1A p.R1722*;PARP1 p.R78Q;PIK3CA p.R88Q;PIK3CA p.Q546H;NOTCH4 p.Q1232*;ARID1B p.Q1331*;ARID1B p.L1875*;PAX5 p.X304_splice;CCND1 p.P287S;NCOR1 p.G166*;NF1 p.G823*;NF1 p.G824*;LATS1 p.N1067Mfs*61;ARID2 p.N1778Ifs*13;ASXL1 p.G645Wfs*12	7	20
P-0001822	P-0001822-T01-IM3	In-House	FFPE	Biopsy	250	793	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	MED12 p.L1224F;BRCA2 Deletion;CDKN1B Deletion;DIS3 Deletion;RB1 Deletion	2	5
P-0001823	P-0001823-T01-IM3	In-House	FFPE	Biopsy	250	1686	NA	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H);Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.A138V;IDH1 p.R132H;CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion;MET Amplification;MYCN Amplification;PTPRD Deletion	3	8
P-0001824	P-0001824-T01-IM3	Outside	FFPE	Biopsy	250	554	20	Matched	Metastasis	Liver	Peritoneum	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0001825	P-0001825-T01-IM3	In-House	FFPE	Resection	250	438	40	Matched	Metastasis	Uterus	Stomach	Tumor	UELMS	Uterine Sarcoma	Uterine Epithelioid Leiomyosarcoma										TP53 p.X126_splice	0	1
P-0001826	P-0001826-T01-IM3	In-House	FFPE	Biopsy	250	898	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;APC p.S1200Efs*8;CDKN2A Deletion;CDKN2B Deletion;EPHA3 Deletion;MYC Amplification;NKX3-1 Deletion;PTEN Deletion;SETD2 Deletion;TGFBR2 Deletion	4	11
P-0001827	P-0001827-T01-IM3	In-House	FFPE	Resection	250	577	70	Matched	Primary	Pelvis	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	MEN1 p.E371Kfs*2;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0001828	P-0001828-T01-IM3	In-House	FFPE	Resection	250	546	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.H179L;TP53 p.P177R	2	3
P-0001829	P-0001829-T02-IM5	In-House	FFPE	Biopsy	250	1161	15	Matched	Metastasis	Prostate	Sacral Mass	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.T3033Nfs*11)			Talazoparib,Niraparib(BRCA2 p.T3033Nfs*11)					LEVEL_1	SPEN p.L355Wfs*5;BRCA2 p.T3033Nfs*11	2	2
P-0001829	P-0001829-T01-IM3	In-House	FFPE	Resection	250	184	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPEN p.L355Wfs*5;FOXA1 Amplification	0	2
P-0001830	P-0001830-T01-IM3	In-House	FFPE	Biopsy	250	722	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;PIK3CA p.M1043I;TP53 p.R249M;STK11 p.Y131*;STAG2 p.Q269*	2	5
P-0001830	P-0001830-T02-IM5	In-House	FFPE	Biopsy	250	1396	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				AZD5363(AKT1 p.E17K);Olaparib(ATM p.Q2828*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	AKT1 p.E17K;KRAS p.G12A;TP53 p.R249M;STK11 p.Y131*;ATM p.Q2828*;CIC Deletion;MYC Amplification;RICTOR Amplification;TERT Amplification	3	9
P-0001832	P-0001832-T01-IM3	In-House	FFPE	Biopsy	198.8	534	30	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_T751del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.L747_T751del;TP53 p.V173*;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;FOXA1 Amplification;KDM5C Deletion;NKX2-1 Amplification	2	8
P-0001833	P-0001833-T01-IM3	Outside	FFPE	Resection	250	705	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	SMARCA4 p.X1072_splice;MET Amplification	2	2
P-0001834	P-0001834-T01-IM3	Outside	FFPE	Resection	250	88	50	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0001835	P-0001835-T01-IM3	In-House	FFPE	Biopsy	250	420	50	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Everolimus(TSC1 p.Y185*)					LEVEL_3B	SETD2 p.Q2362*;TSC1 p.Y185*;PBRM1 *1686fs*;NF2 p.K130Rfs*44	1	4
P-0001835	P-0001835-T02-IM3	In-House	FFPE	Biopsy	250	417	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										SETD2 p.Q2362*;PBRM1 *1686fs*;NF2 p.K130Rfs*44	0	3
P-0001836	P-0001836-T01-IM3	Outside	FFPE	Resection	250	748	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D74Y)				LEVEL_4	TP53 p.G266*;CTNNB1 p.S37C;KDM5C p.E276*;ARID1A p.M1613_Q1614delinsI*;CDKN2A p.D74Y	1	5
P-0001837	P-0001837-T01-IM3	Outside	FFPE	Cytology	246	925	40	Matched	Metastasis	Lung	Heart	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0001838	P-0001838-T01-IM3	In-House	FFPE	Biopsy	250	640	40	Matched	Metastasis	Uterus	Liver	Tumor	UUS	Uterine Sarcoma	Undifferentiated Uterine Sarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification	2	2
P-0001839	P-0001839-T01-IM3	Outside	FFPE	Resection	250	1119	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CARD11 Amplification;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	5
P-0001840	P-0001840-T01-IM3	In-House	FFPE	Biopsy	250	1100	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(SDC4 ROS1-SDC4 fusion);Crizotinib,Entrectinib(ROS1 ROS1-SDC4 fusion)								LEVEL_1	RBM10 p.S770Afs*32;MYC Amplification;TP53 Deletion;SDC4 ROS1-SDC4 fusion;ROS1 ROS1-SDC4 fusion	2	5
P-0001840	P-0001840-T02-IM5	In-House	DNA	Biopsy	77.5	547	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(SDC4 ROS1-SDC4 fusion);Crizotinib,Entrectinib(ROS1 ROS1-SDC4 fusion)								LEVEL_1	RBM10 p.S770Afs*32;TP53 Deletion;SDC4 ROS1-SDC4 fusion;ROS1 ROS1-SDC4 fusion	2	4
P-0001841	P-0001841-T01-IM3	In-House	FFPE	Cytology	172.7	1035	50	Matched	Metastasis	Skin	Lymph Node, Non-Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)								LEVEL_1	CTNNB1 p.K335I;BRAF p.V600K;NSD1 Deletion	1	3
P-0001842	P-0001842-T01-IM3	Outside	FFPE	Resection	250	488	40	Matched	Metastasis	Testis	Vas deferens	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Imatinib,Sunitinib,Regorafenib,Sorafenib,Avapritinib,Ripretinib(KIT p.D816V)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_3B	KRAS p.G12R;KIT p.D816V	2	2
P-0001843	P-0001843-T01-IM3	In-House	FFPE	Resection	54	330	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.T202Lfs*19)				LEVEL_3B	TP53 p.I255del;PTEN p.T202Lfs*19;CDK4 Amplification	2	3
P-0001843	P-0001843-T02-IM5	In-House	FFPE	Resection	250	938	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.T202Lfs*19)				LEVEL_4	TP53 p.I255del;PTEN p.T202Lfs*19;RB1 p.X886_splice;FGFR4 Amplification	1	4
P-0001844	P-0001844-T01-IM3	In-House	FFPE	Resection	250	442	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor					GSK2636771,AZD8186(PTEN p.Q219*);GSK2636771,AZD8186(PTEN p.P213Lfs*8)				LEVEL_4	PTEN p.Q219*;TP53 p.H179R;TP53 p.V147G;PTEN p.P213Lfs*8	2	4
P-0001845	P-0001845-T01-IM3	Outside	FFPE	Biopsy	169	418	15	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AKT1 p.Q79K;KDM6A Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0001846	P-0001846-T01-IM3	In-House	FFPE	Biopsy	233	665	NA	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.Q546P)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.Q546P;RB1 p.G617Rfs*36;MDM2 Amplification	3	3
P-0001847	P-0001847-T01-IM3	In-House	FFPE	Resection	250	605	NA	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Ivosidenib(IDH1 p.R132H)					LEVEL_3B	PIK3CA p.H1047R;IDH1 p.R132H;PBRM1 p.E867*;CIC p.S1389Lfs*51	2	4
P-0001848	P-0001848-T01-IM3	In-House	FFPE	Resection	250	467	70	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)					LEVEL_3B	PIK3CA p.C420R;ARID1A p.Q1363*;BRAF p.N581S	1	3
P-0001849	P-0001849-T01-IM3	In-House	FFPE	Resection	250	312	70	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										ARID1A p.Y1734*	0	1
P-0001850	P-0001850-T01-IM3	Outside	FFPE	Biopsy	124.8	538	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ARID1A p.Q1098*;CD274 Amplification;JAK2 Amplification;MDM2 Amplification	1	4
P-0001851	P-0001851-T01-IM3	Outside	FFPE	Cytology	250	634	60	Matched	Metastasis	Adrenal Gland	Pancreas	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma				Imatinib(KIT p.R888Q)					LEVEL_3B	RB1 p.R556*;TP53 p.N239S;CTNNB1 p.D32N;KIT p.R888Q;CREBBP p.Q2103*;BCOR p.R1217*;PIK3R3 p.Q187Vfs*6	1	7
P-0001852	P-0001852-T01-IM3	Outside	FFPE	Resection	250	176	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										JAK1 p.L910S;APC p.D1297Qfs*2;TERT Amplification	0	3
P-0001853	P-0001853-T01-IM3	Outside	FFPE	Resection	250	119	50	Matched	Metastasis	Thyroid	Neck	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer				Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib(NF1 p.L1869*)				LEVEL_3B	NF1 p.L1869*;NF2 p.C51*;KEAP1 p.L291Cfs*26;NF2 p.L49Ffs*37;CDK4 Amplification;MCL1 Amplification	2	6
P-0001854	P-0001854-T01-IM3	Outside	FFPE	Biopsy	250	669	40	Matched	Metastasis	Testis	Pelvis	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0001855	P-0001855-T01-IM3	In-House	FFPE	Biopsy	250	588	15	Matched	Metastasis	Esophagus	Liver	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.T253Pfs*92;ERBB2 Amplification	2	2
P-0001856	P-0001856-T01-IM3	Outside	FFPE	Resection	250	600	50	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Imatinib,Sunitinib,Regorafenib,Sorafenib,Avapritinib,Ripretinib(KIT p.D816V)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;KIT p.D816V;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	2	5
P-0001857	P-0001857-T01-IM3	In-House	FFPE	Biopsy	80	532	30	Matched	Metastasis	Appendix	Peritoneum	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma										PPP2R1A p.R183W;SOX9 p.F69Sfs*41	0	2
P-0001858	P-0001858-T01-IM3	In-House	FFPE	Resection	176.8	211	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										PBRM1 p.P42Qfs*3;FOXA1 Amplification;MCL1 Amplification	0	3
P-0001859	P-0001859-T01-IM3	In-House	FFPE	Biopsy	250	1139	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PIK3R3 p.Q189Rfs*23;PARP1 p.K664Sfs*12;AR Amplification;PTPRS Deletion	0	4
P-0001859	P-0001859-T02-IM3	In-House	FFPE	Biopsy	250	914	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PIK3R3 p.Q189Rfs*23;PARP1 p.K664Sfs*12;AR Amplification;PTPRS Deletion	0	4
P-0001860	P-0001860-T01-IM3	In-House	FFPE	Biopsy	126.5	902	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	SMAD4 p.R361H;ERBB3 p.V104M;TP53 p.Y220Mfs*27;ERBB2 Amplification	2	4
P-0001861	P-0001861-T01-IM3	In-House	FFPE	Resection	250	509	11	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.C176F	0	1
P-0001862	P-0001862-T01-IM3	In-House	FFPE	Biopsy	250	825	40	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.P408Afs*99;ERBB2 Amplification;FOXA1 Amplification;MCL1 Amplification;MDM4 Amplification	2	5
P-0001863	P-0001863-T01-IM3	Outside	FFPE	Biopsy	250	836	30	Matched	Metastasis	Breast	Upper Extremity	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										MYC Amplification	0	1
P-0001864	P-0001864-T01-IM3	In-House	FFPE	Cytology	235.4	861	20	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13V)	Cetuximab,Panitumumab(KRAS p.G13V)			LEVEL_4	APC p.R1450*;APC p.S1276*;TP53 p.X258_splice;KRAS p.G13V;CDK8 Amplification;FLT3 Amplification	1	6
P-0001866	P-0001866-T01-IM3	In-House	FFPE	Resection	250	391	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0001867	P-0001867-T01-IM3	In-House	FFPE	Cytology	111.6	439	30	Matched	Metastasis	Sigmoid Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273L;TP53 p.R267Q;SMAD4 p.D351N;APC APC-intragenic	0	4
P-0001868	P-0001868-T01-IM3	In-House	FFPE	Resection	250	419	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer					GSK2636771,AZD8186(PTEN p.E40Kfs*14)				LEVEL_4	PTEN p.E40Kfs*14	1	1
P-0001869	P-0001869-T01-IM3	In-House	FFPE	Resection	81.6	257	30	Matched	Metastasis	Testis	Lymph Node	Tumor	BEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0001870	P-0001870-T01-IM3	In-House	FFPE	Resection	250	331	50	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_2	CDK4 Amplification;DDR2 Amplification;FGFR1 Amplification;MDM2 Amplification	3	4
P-0001871	P-0001871-T01-IM3	In-House	FFPE	Resection	250	465	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Olaparib(CHEK2 p.R145L)	Tazemetostat(KDM6A p.Q333*)				LEVEL_1	FGFR3 p.S249C;KMT2D p.Q4329*;CHEK2 p.R145L;KDM6A p.Q333*;STAG2 p.D326Ifs*3	4	5
P-0001872	P-0001872-T01-IM3	Outside	FFPE	Resection	122.4	469	50	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	MYEC	Salivary Gland Cancer	Myoepithelial Carcinoma										EWSR1 ATF1-EWSR1 fusion;ATF1 ATF1-EWSR1 fusion	0	2
P-0001874	P-0001874-T01-IM3	In-House	FFPE	Biopsy	250	1128	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Neratinib(ERBB2 p.V777L)	Ado-Trastuzumab Emtansine(ERBB2 p.V777L)					LEVEL_1	PIK3CA p.H1047R;GATA3 p.M293K;ERBB2 p.V777L;MAP3K1 p.N599Mfs*57;MAP3K1 p.K919Nfs*2	4	5
P-0001875	P-0001875-T01-IM3	In-House	FFPE	Resection	250	314	40	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CTCF p.H284Y;MAP2K4 p.G241*;FOXP1 p.Q167Lfs*38;GATA3 p.T322Dfs*30;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification	2	8
P-0001876	P-0001876-T03-IM5	In-House	FFPE	Biopsy	250	914	15	Matched	Metastasis	Prostate	Sacral Mass	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0001876	P-0001876-T02-IM5	In-House	DNA	Resection	250	379	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0001877	P-0001877-T01-IM3	Outside	FFPE	Resection	250	494	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 p.L2439*)				LEVEL_4	TP53 p.L194P;NF1 p.L2439*;CCND1 Amplification;FOXA1 Amplification;IKBKE Amplification;MAP2K4 Deletion;MDM4 Amplification	1	7
P-0001878	P-0001878-T01-IM3	In-House	FFPE	Resection	250	800	50	Matched	Metastasis	Lower Extremity	Hip	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma				Olaparib(ATM p.R2849*);Olaparib(CHEK2 p.R346S)	Trametinib,Cobimetinib(NF1 p.Y2285Tfs*5);Trametinib,Cobimetinib(NF1 p.F945Lfs*9)				LEVEL_3B	KMT2D p.P2354Lfs*30;B2M p.S16Afs*27;NF1 p.Y2285Tfs*5;CIC p.P1597Hfs*23;ATM p.R2849*;JAK1 p.X990_splice;MSH6 p.R1331*;CHEK2 p.R346S;PBRM1 p.I873Yfs*2;NSD1 p.V1486*;TET1 p.T62Qfs*13;KMT2D p.S286*;NF1 p.F945Lfs*9	4	13
P-0001879	P-0001879-T02-IM5	In-House	FFPE	Biopsy	250	937	20	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										JAK1 ZNF678-JAK1 fusion;ZNF678 ZNF678-JAK1 fusion	0	2
P-0001879	P-0001879-T01-IM3	In-House	FFPE	Resection	250	118	50	Matched	Metastasis	Pancreas	Abdomen	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion	1	1
P-0001880	P-0001880-T01-IM3	Outside	FFPE	Resection	250	879	30	Matched	Primary	Bladder	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma											0	0
P-0001881	P-0001881-T01-IM3	In-House	FFPE	Resection	250	224	40	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.G245S;IDH1 p.R132H;DNMT3A p.W893*;ATRX Deletion	1	4
P-0001882	P-0001882-T01-IM3	In-House	FFPE	Resection	250	950	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CDKN1B p.X159_splice;KMT2D p.X134_splice;CIC p.R215W;FUBP1 p.K77Lfs*23;EPCAM Deletion;MSH2 Deletion;MSH6 Deletion	1	8
P-0001882	P-0001882-T02-IM5	In-House	FFPE	Resection	250	832	70	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);Ivosidenib(IDH1 p.R132H)					LEVEL_3B	PIK3CA p.G118D;IDH1 p.R132H;CDKN1B p.X159_splice;KMT2D p.X134_splice;CIC p.R215W;FUBP1 p.K77Lfs*23;EPHA7 p.G656R;EPCAM Deletion;MSH2 Deletion;MSH6 Deletion	2	10
P-0001883	P-0001883-T01-IM3	In-House	FFPE	Resection	250	445	30	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.P301Lfs*41;BCOR Deletion;ERBB2 Amplification	4	4
P-0001884	P-0001884-T01-IM3	In-House	FFPE	Biopsy	148.5	682	15	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.W131G;SDHB p.W47*;AKT3 p.E17K;SETD2 p.S918*;APC p.L1506*;AR Amplification;POU2F2 CIC-POU2F2 fusion;CIC CIC-POU2F2 fusion	0	8
P-0001884	P-0001884-T02-IM5	In-House	DNA	Biopsy	250	651	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0001885	P-0001885-T01-IM3	In-House	FFPE	Resection	250	504	70	Matched	Primary	Brain	Not Applicable	Tumor	HPCCNS	CNS Cancer	Hemangiopericytoma of the Central Nervous System											0	0
P-0001886	P-0001886-T01-IM3	Outside	FFPE	Biopsy	90.75	335	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					GSK2636771,AZD8186(PTEN p.Y76*)				LEVEL_4	PTEN p.Y76*	1	1
P-0001887	P-0001887-T01-IM3	In-House	FFPE	Biopsy	250	990	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Q136E;PAK1 Amplification	0	2
P-0001888	P-0001888-T01-IM3	In-House	FFPE	Biopsy	250	596	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib(NF1 p.I679Dfs*21);GSK2636771,AZD8186(PTEN p.D109*)				LEVEL_3B	TP53 p.C135Y;NF1 p.I679Dfs*21;PTEN p.D109*;CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;PAK1 Amplification	3	7
P-0001889	P-0001889-T01-IM3	In-House	FFPE	Biopsy	250	1070	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SF3B1 p.K700E;TP53 p.C141W;GATA3 p.S407Afs*99	0	3
P-0001890	P-0001890-T01-IM3	Outside	FFPE	Resection	250	971	50	Unmatched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										KMT2C p.E2718*;CREBBP p.X406_splice;KMT2C p.Y3699Mfs*6;NOTCH1 p.V1605del;KMT2D p.P3334Lfs*22;RBM10 p.A631Tfs*41	0	6
P-0001891	P-0001891-T01-IM3	In-House	FFPE	Resection	250	412	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	RECQL4 p.X687_splice;TP53 p.E285V;STK11 p.K311Nfs*4;CDKN2A p.R80*;CCND1 Amplification;FGF19 Amplification	1	6
P-0001892	P-0001892-T01-IM3	In-House	FFPE	Biopsy	250	720	50	Matched	Primary	Rectum	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V560del)					LEVEL_3B	SF3B1 p.R625C;CTNNB1 p.G34R;KIT p.V560del;KIT Amplification;PRKN Deletion	1	5
P-0001893	P-0001893-T01-IM3	Outside	FFPE	Resection	250	193	70	Matched	Primary	Lung	Not Applicable	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid										EIF1AX p.G15D;ETV1 Amplification;FOXA1 Amplification;MCL1 Amplification;NKX2-1 Amplification	0	5
P-0001894	P-0001894-T01-IM3	Outside	FFPE	Biopsy	66	909	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.E746_A750del;CDK4 Amplification;MDM2 Amplification	3	3
P-0001895	P-0001895-T01-IM3	Outside	FFPE	Biopsy	250	612	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F102C;SPOP p.F133L	0	2
P-0001896	P-0001896-T01-IM3	Outside	FFPE	Biopsy	250	756	30	Matched	Primary	Not available	Not available	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0001897	P-0001897-T01-IM3	Outside	FFPE	Resection	250	505	50	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										MAX p.R60Q;KRAS Amplification	0	2
P-0001898	P-0001898-T01-IM3	In-House	FFPE	Resection	250	483	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion);Selpercatinib(RET RASSF4-RET fusion);Selpercatinib(RASSF4 RASSF4-RET fusion)	Cabozantinib,Vandetanib(RET CCDC6-RET fusion);Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion);Cabozantinib,Vandetanib(RET RASSF4-RET fusion);Cabozantinib,Vandetanib(RASSF4 RASSF4-RET fusion)	BLU-667(RET CCDC6-RET fusion);BLU-667(CCDC6 CCDC6-RET fusion);BLU-667(RET RASSF4-RET fusion);BLU-667(RASSF4 RASSF4-RET fusion)						LEVEL_1	MYC Amplification;RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion;RET RASSF4-RET fusion;RASSF4 RASSF4-RET fusion	12	5
P-0001899	P-0001899-T01-IM3	In-House	FFPE	Biopsy	250	1473	40	Matched	Metastasis	Prostate	Liver	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma										TP53 p.R282W;TP53 p.N239K;CDKN1B Deletion;KRAS Amplification;RB1 Deletion	0	5
P-0001901	P-0001901-T01-IM3	Outside	FFPE	Resection	250	1034	50	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R);Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;GRIN2A p.R52*;ARID2 p.Y141*;NRAS p.Q61R;GRIN2A p.R52*;ARID2 p.Y141*	2	6
P-0001902	P-0001902-T01-IM3	Outside	FFPE	Resection	250	531	20	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Fulvestrant+Alpelisib(PIK3CA p.E545D)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545D)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_1	KRAS p.G12R;PIK3CA p.E542K;ARID1A p.E1735*;PIK3CA p.E545D;FOXA1 p.S250Y;NCOR1 p.S2380*;CDH1 p.T468Pfs*13	5	7
P-0001903	P-0001903-T01-IM3	In-House	FFPE	Resection	250	205	40	Matched	Primary	Hypopharynx	Not Applicable	Tumor	HPHSC	Head and Neck Cancer	Hypopharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;TET2 p.E628*;TP53 p.M66Nfs*83;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0001904	P-0001904-T02-IM5	In-House	DNA	Biopsy	149.4	401	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Tazemetostat(KDM6A p.H698Qfs*32);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.H1047R;TP53 p.G245S;FGFR3 p.Y373C;KDM6A p.H698Qfs*32;KMT2C p.Q3422Hfs*2;CDKN2A Deletion;CDKN2B Deletion	5	7
P-0001904	P-0001904-T01-IM3	In-House	FFPE	Resection	250	384	NA	Matched	Metastasis	Bladder	Kidney	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Tazemetostat(KDM6A p.H698Qfs*32);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.H1047R;FGFR3 p.Y373C;KDM6A p.H698Qfs*32;CDKN2A Deletion;CDKN2B Deletion	5	5
P-0001906	P-0001906-T01-IM3	Outside	FFPE	Resection	250	792	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R213*;EGFR Amplification;PTEN Deletion	1	3
P-0001907	P-0001907-T01-IM3	In-House	FFPE	Resection	250	415	50	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.F109C;PAX5 Deletion	0	2
P-0001908	P-0001908-T01-IM3	Outside	FFPE	Biopsy	136.8	327	50	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification;FOXA1 Amplification;GATA3 Amplification	1	3
P-0001909	P-0001909-T01-IM3	In-House	FFPE	Resection	250	635	50	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	APC p.R232*;APC p.Y1376*;TP53 p.X261_splice;ERBB2 Amplification;MYC Amplification;TP53 Deletion	2	6
P-0001910	P-0001910-T01-IM3	In-House	FFPE	Resection	250	756	60	Matched	Metastasis	Thyroid	Esophagus	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer										CTNNB1 p.S33P;TBX3 p.F346Qfs*17	0	2
P-0001911	P-0001911-T01-IM3	In-House	FFPE	Resection	250	612	40	Matched	Metastasis	Ovary	Rectosigmoid Colon	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer	Niraparib,Olaparib,Rucaparib(BRCA1 p.E1446*)			Talazoparib(BRCA1 p.E1446*)					LEVEL_1	TP53 p.R196*;BRCA1 p.E1446*	2	2
P-0001912	P-0001912-T01-IM3	In-House	FFPE	Biopsy	250	631	50	Matched	Metastasis	Oropharynx	Liver	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma											0	0
P-0001913	P-0001913-T02-IM5	In-House	FFPE	Biopsy	250	628	20	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R273H;APC p.Q1338*;ASXL1 CDH26-ASXL1 fusion;CDH26 CDH26-ASXL1 fusion	0	4
P-0001914	P-0001914-T01-IM3	In-House	FFPE	Biopsy	250	502	NA	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma										EGFR p.T725M	0	1
P-0001915	P-0001915-T01-IM3	Outside	FFPE	Cytology	250	1387	40	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.F134V;LATS1 p.Q317*;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification	3	5
P-0001916	P-0001916-T01-IM3	In-House	FFPE	Biopsy	83.4	510	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.R461*)				LEVEL_4	TP53 p.X224_splice;BRAF p.G466V;NF1 p.R461*;DNMT3A p.E240*;STK11 p.P179Q	1	5
P-0001917	P-0001917-T01-IM3	Outside	FFPE	Resection	250	385	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 p.X146_splice	0	1
P-0001918	P-0001918-T01-IM3	Outside	FFPE	Resection	250	760	60	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib(KIT p.K642Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;RAC1 p.P34R;KIT p.K642Q	2	3
P-0001919	P-0001919-T01-IM3	Outside	FFPE	Resection	250	738	60	Matched	Primary	Back	Not Applicable	Tumor	DFSP	Skin Cancer, Non-Melanoma	Dermatofibrosarcoma Protuberans					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EP300 Deletion	1	3
P-0001920	P-0001920-T01-IM3	In-House	FFPE	Biopsy	188.4	587	NA	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.G245S;TP53 p.R273C;IDH1 p.R132H;ATRX Deletion	1	4
P-0001921	P-0001921-T01-IM3	In-House	FFPE	Resection	250	561	70	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R196*;TP53 p.R248Q;IDH1 p.R132H;ATRX p.X2109_splice	1	4
P-0001922	P-0001922-T01-IM3	Outside	FFPE	Resection	250	1056	40	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0001923	P-0001923-T01-IM3	In-House	FFPE	Resection	250	444	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R213*;CCNE1 Amplification	0	2
P-0001924	P-0001924-T01-IM3	Outside	FFPE	Biopsy	142	304	20	Matched	Primary	Duodenum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;RB1 p.V654Cfs*4;TP53 p.P128Lfs*42	1	3
P-0001925	P-0001925-T01-IM3	Outside	FFPE	Resection	74	287	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0001926	P-0001926-T01-IM3	In-House	FFPE	Resection	250	463	50	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										RB1 p.E322*;TP53 p.F134L;TP53 p.G266K;DIS3 Deletion;MYCN Amplification;RB1 Deletion;TERT Amplification;TGFBR2 Deletion	0	8
P-0001927	P-0001927-T01-IM3	Outside	FFPE	Cytology	250	528	16	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.E271*;CDKN2C p.Q87*;KEAP1 p.G430C;RBM10 p.E429*;EGFR Amplification	0	5
P-0001928	P-0001928-T01-IM3	In-House	FFPE	Resection	250	459	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PIK3R1 p.Y452dup;TP53 p.P153del;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	5
P-0001929	P-0001929-T01-IM3	Outside	FFPE	Resection	250	491	50	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.X307_splice;IDH1 p.R132H;TP53 p.G244D	1	3
P-0001930	P-0001930-T01-IM3	Outside	FFPE	Biopsy	250	458	50	Matched	Primary	Thymus	Not Applicable	Tumor	THYC	Thymic Tumor	Thymic Carcinoma										CD274 Amplification	0	1
P-0001931	P-0001931-T01-IM3	Outside	FFPE	Cytology	118.8	553	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.D208V;EGFR Amplification	0	2
P-0001932	P-0001932-T01-IM3	In-House	FFPE	Biopsy	250	473	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.I33del)				LEVEL_3B	PTEN p.I33del;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	2	5
P-0001933	P-0001933-T01-IM3	In-House	FFPE	Biopsy	162	430	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										ARID1A p.X1289_splice;BAP1 p.E278*	0	2
P-0001934	P-0001934-T01-IM3	Outside	FFPE	Biopsy	250	457	50	Matched	Metastasis	Breast	Axilla	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MAP2K4 p.R304*;KEAP1 p.R320Q;APC p.K1593Sfs*57;PTPRD Deletion	0	4
P-0001935	P-0001935-T01-IM3	Outside	FFPE	Biopsy	250	538	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537N)						LEVEL_3A	ESR1 p.Y537N;ARID1A p.P1162Sfs*19;MAP2K4 p.N311Kfs*4;AMER1 Deletion;CCND1 Amplification;MCL1 Amplification	1	6
P-0001936	P-0001936-T01-IM3	In-House	FFPE	Resection	250	465	50	Matched	Metastasis	Uterus	Lymph Node	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma										KMT2D p.R5097*;AURKA Amplification	0	2
P-0001937	P-0001937-T01-IM3	In-House	FFPE	Biopsy	250	523	50	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.P301Qfs*44;RB1 p.X89_splice;KMT2D p.P2210Rfs*54;FANCA Deletion	0	4
P-0001939	P-0001939-T02-IM5	In-House	FFPE	Resection	250	1013	85	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.C420R;TET2 p.S1486*;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	3	5
P-0001940	P-0001940-T01-IM3	In-House	FFPE	Resection	250	571	50	Unmatched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.G118D;KRAS p.G12V;PIK3CA p.H1047R;ARID1A p.E1787*;APC p.X244_splice;PMS2 p.S46I;APC p.Y1166*	3	7
P-0001941	P-0001941-T01-IM3	Outside	FFPE	Resection	250	84	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R273H;NOTCH3 p.R2078Pfs*3;CARD11 Amplification	0	3
P-0001941	P-0001941-T02-IM3	Outside	FFPE	Resection	250	418	50	Matched	Metastasis	Breast	Axilla	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R273H;NOTCH3 p.R2078Pfs*3;CARD11 Amplification	0	3
P-0001942	P-0001942-T03-IM3	In-House	FFPE	Biopsy	250	192	30	Matched	Primary	Cervix	Not Applicable	Tumor	MCCE	Cervical Cancer	Mixed Cervical Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E26*)				LEVEL_4	TP53 p.R175H;BRAF p.D594G;CDKN2A p.E26*	1	3
P-0001943	P-0001943-T02-IM5	Outside	DNA	Cytology	250	268	50	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										ARID1A p.X1180_splice;SETD2 p.E2034*	0	2
P-0001944	P-0001944-T01-IM3	In-House	FFPE	Resection	250	716	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;STK11 p.X155_splice	1	2
P-0001945	P-0001945-T01-IM3	Outside	FFPE	Biopsy	250	232	20	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.E203K)		GSK2636771,AZD8186(PTEN p.G293*);GSK2636771,AZD8186(PTEN p.X343_splice)				LEVEL_3A	TP53 p.V157F;CTNNB1 p.S37F;PTEN p.G293*;PTEN p.X343_splice;MAP2K1 p.E203K;KDM5C p.M759Cfs*5;MCL1 Amplification	3	7
P-0001946	P-0001946-T01-IM3	In-House	FFPE	Resection	250	405	50	Matched	Metastasis	Soft Tissue	Lung	Tumor	OFMT	Soft Tissue Sarcoma	Ossifying Fibromyxoid Tumor					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	BMPR1A Deletion;PTEN Deletion	1	2
P-0001947	P-0001947-T01-IM3	In-House	FFPE	Resection	250	525	90	Matched	Metastasis	Mesentery	Liver	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0001948	P-0001948-T01-IM3	In-House	FFPE	Resection	250	129	40	Matched	Metastasis	Rectum	Liver	Tumor	FDCS	Soft Tissue Sarcoma	Follicular Dendritic Cell Sarcoma											0	0
P-0001949	P-0001949-T01-IM3	In-House	FFPE	Resection	250	653	40	Matched	Metastasis	Rectum	Pelvis	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.P278R;CTNNB1 p.S23_S33del;ARID5B Deletion;EGFR Amplification	0	4
P-0001952	P-0001952-T01-IM3	In-House	FFPE	Biopsy	50	265	60	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		AZD5363(AKT1 p.E17K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	AKT1 p.E17K;PIK3CA p.E545K;CTCF p.H284Y;MAP3K1 p.R273Sfs*27	3	4
P-0001952	P-0001952-T02-IM3	In-House	FFPE	Biopsy	250	709	75	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		AZD5363(AKT1 p.E17K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	AKT1 p.E17K;PIK3CA p.E545K;CTCF p.H284Y;MAP3K1 p.R273Sfs*27;BCOR p.E1611Qfs*10;MAP3K1 p.X279_splice;MCL1 Amplification	3	7
P-0001954	P-0001954-T01-IM3	Outside	FFPE	Resection	250	416	30	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	STK11 p.L117Ifs*45;MDM2 Amplification	1	2
P-0001955	P-0001955-T01-IM3	In-House	FFPE	Resection	250	358	60	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.Y130H)		GSK2636771,AZD8186(PTEN p.X164_splice)				LEVEL_3A	PTEN p.X164_splice;MAP2K1 p.Y130H	2	2
P-0001956	P-0001956-T01-IM3	In-House	FFPE	Resection	250	657	60	Matched	Metastasis	Brain	Peritoneum	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0001957	P-0001957-T01-IM3	Outside	FFPE	Resection	250	195	60	Matched	Metastasis	Breast	Fallopian Tube	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.N622Kfs*9	0	1
P-0001959	P-0001959-T01-IM3	In-House	FFPE	Biopsy	250	584	NA	Matched	Metastasis	Cervix	Liver	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS										FLT3 p.P893T	0	1
P-0001961	P-0001961-T02-IM5	In-House	DNA	Biopsy	250	831	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R248Q;APC p.R216*;SMAD4 p.Q534*;APC p.Y1376*;MAP2K4 Deletion;MYC Amplification	1	7
P-0001961	P-0001961-T03-IM5	In-House	DNA	Biopsy	250	440	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R248Q;APC p.R216*;SMAD4 p.Q534*;APC p.Y1376*	1	5
P-0001961	P-0001961-T01-IM3	Outside	FFPE	Resection	250	248	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma											0	0
P-0001963	P-0001963-T01-IM3	Outside	FFPE	Resection	250	452	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer										BRAF p.V600_K601delinsE;BRAF p.V600_K601delinsE	0	2
P-0001964	P-0001964-T01-IM3	Outside	FFPE	Resection	250	113	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;TP53 p.V157F;APC p.R876*;FOXA1 Amplification;MET Amplification;MYC Amplification	2	6
P-0001965	P-0001965-T01-IM3	In-House	FFPE	Resection	250	525	50	Matched	Metastasis	Ovary	Fallopian Tube	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(ATM Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.T253_L257del;AKT3 Amplification;ATM Deletion;PTEN Deletion;SDHD Deletion	2	5
P-0001966	P-0001966-T01-IM3	Outside	FFPE	Resection	250	844	50	Unmatched	Metastasis	Ovary	Omentum	Tumor	OOVC	Ovarian Cancer	Ovarian Cancer, Other				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q);Olaparib(CDK12 p.L666Qfs*86)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L666Qfs*86)				LEVEL_3B	KRAS p.G12A;PIK3CA p.E545Q;CDK12 p.L666Qfs*86	4	3
P-0001967	P-0001967-T01-IM3	In-House	FFPE	Biopsy	250	554	40	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.Q546P)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.Q546P;CDH1 p.N613Kfs*4;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MAP2K4 Deletion;PAK1 Amplification;TP53 Deletion	3	8
P-0001968	P-0001968-T01-IM3	In-House	FFPE	Biopsy	250	414	15	Matched	Metastasis	Lung	Pleura	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.E171*;NOTCH1 p.E663*	0	2
P-0001970	P-0001970-T01-IM3	Outside	FFPE	Resection	250	867	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);Ivosidenib(IDH1 p.R132H)					LEVEL_3B	PIK3CA p.E453K;IDH1 p.R132H;CIC p.T1375Hfs*66;CIC p.S1419Rfs*32;FUBP1 Deletion	2	5
P-0001971	P-0001971-T01-IM3	In-House	FFPE	Resection	250	474	50	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma										EGFR p.G598V	0	1
P-0001972	P-0001972-T01-IM3	Outside	FFPE	Cytology	250	556	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.N771delinsSTH)	Ivosidenib(IDH1 p.R132C)		Erlotinib,Gefitinib,Afatinib(EGFR p.N771delinsSTH)			LEVEL_3A	IDH1 p.R132C;TP53 p.P250L;EGFR p.N771delinsSTH;CCND1 Amplification;EGFR Amplification;FGF19 Amplification;PAK1 Amplification	2	7
P-0001973	P-0001973-T01-IM3	In-House	FFPE	Resection	250	566	80	Matched	Primary	Small Bowel	Mesentery	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0001974	P-0001974-T01-IM3	Outside	FFPE	Biopsy	250	461	50	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion;RECQL4 Deletion	1	2
P-0001975	P-0001975-T01-IM3	In-House	FFPE	Biopsy	250	408	50	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132S)					LEVEL_3B	IDH1 p.R132S;TP53 p.H193R;ATRX p.K1045*;TP53 p.X261_splice	1	4
P-0001976	P-0001976-T01-IM3	Outside	FFPE	Biopsy	250	399	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 p.E1816*);GSK2636771,AZD8186(PTEN p.V45Yfs*9)				LEVEL_4	KMT2C p.Q1534*;NF1 p.E1816*;ASXL1 p.R625*;PIK3R1 p.N453del;PTEN p.V45Yfs*9;AKT1 Amplification	2	6
P-0001977	P-0001977-T01-IM3	In-House	FFPE	Cytology	250	159	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.V173L	1	2
P-0001978	P-0001978-T01-IM3	In-House	FFPE	Resection	250	571	60	Matched	Primary	Ovary	Not Applicable	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.R130*);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3B	PIK3CA p.H1047R;PTEN p.R130*;AKT1 p.E40K;ARID1A p.V1982Gfs*34;KMT2D p.S2910Rfs*32;KRAS p.G13D	3	6
P-0001979	P-0001979-T01-IM3	Outside	FFPE	Biopsy	250	504	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	1	4
P-0001980	P-0001980-T01-IM3	Outside	FFPE	Resection	250	459	60	Matched	Primary	Rectum	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma										TP53 p.R248Q	0	1
P-0001982	P-0001982-T01-IM3	In-House	FFPE	Resection	250	619	50	Matched	Primary	Not available	Not available	Tumor	OS	Bone Cancer	Osteosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.C277F;SMAD2 p.Q429*;BCOR p.E485*;CDKN2A Deletion;CDKN2B Deletion;KDR Amplification;KIT Amplification;PDGFRA Amplification	1	8
P-0001983	P-0001983-T01-IM3	In-House	FFPE	Biopsy	250	628	20	Matched	Primary	Pelvis	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Everolimus(TSC2 p.W1740*)					LEVEL_3B	TSC2 p.W1740*;TP53 p.R110L;CD274 Amplification;JAK2 Amplification	1	4
P-0001984	P-0001984-T01-IM3	In-House	FFPE	Resection	250	457	50	Unmatched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										EPHA3 p.R512*;SOX9 p.D168Efs*84	0	2
P-0001985	P-0001985-T01-IM3	In-House	FFPE	Resection	250	268	60	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.P151S;MRE11 p.Q629Afs*9;BCL2L1 Amplification;JAK2 Amplification;MCL1 Amplification	0	5
P-0001986	P-0001986-T01-IM3	In-House	FFPE	Resection	250	425	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.E223*;KEAP1 p.E213*;TP53 p.T231_I232del	0	3
P-0001987	P-0001987-T01-IM3	In-House	FFPE	Biopsy	244	465	30	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.K57N)						LEVEL_3A	NFE2L2 p.R34Q;MAP2K1 p.K57N;TP53 p.M237I;TP63 p.Q70*;TET2 p.X1137_splice;INPP4B p.R126*;CDK4 p.R24L	1	7
P-0001988	P-0001988-T01-IM3	In-House	FFPE	Resection	250	390	50	Matched	Primary	Brain	Not Applicable	Tumor	PAST	Glioma	Pilocytic Astrocytoma				Trametinib,Cobimetinib(BRAF FAM131B-BRAF fusion);Trametinib,Cobimetinib(FAM131B FAM131B-BRAF fusion)					LEVEL_3B	BRAF FAM131B-BRAF fusion;FAM131B FAM131B-BRAF fusion	2	2
P-0001989	P-0001989-T01-IM3	In-House	FFPE	Resection	250	593	70	Matched	Metastasis	Uterus	Liver	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.R337L;ERBB4 p.E452D;FAT1 p.D3626Efs*13;BRD4 Amplification;PIK3R2 Amplification;RB1 Deletion	0	6
P-0001990	P-0001990-T01-IM3	In-House	FFPE	Biopsy	250	646	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K);Fulvestrant+Alpelisib(PIK3CA p.H1047Y)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K);AZD9496,Fulvestrant(ESR1 p.Y537S);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y)	Olaparib(BRIP1 p.Q815*)					LEVEL_1	PIK3CA p.N345K;ESR1 p.Y537S;PIK3CA p.H1047Y;BRIP1 p.Q815*;AR Amplification	6	5
P-0001991	P-0001991-T01-IM3	In-House	FFPE	Biopsy	236	324	30	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Enasidenib(IDH2 p.R172K)					LEVEL_3B	IDH2 p.R172K;NOTCH2 p.Q1283*;CIC Deletion	1	3
P-0001992	P-0001992-T01-IM3	In-House	FFPE	Resection	250	570	40	Matched	Metastasis	Ovary	Rectum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.L93Cfs*30;B2M Deletion	0	2
P-0001993	P-0001993-T01-IM3	In-House	FFPE	Resection	250	258	50	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Everolimus(TSC2 p.X161_splice)					LEVEL_3B	MEN1 p.Q64*;TSC2 p.X161_splice;DAXX p.L191Wfs*38;TP63 Deletion	1	4
P-0001994	P-0001994-T01-IM3	In-House	FFPE	Resection	250	236	40	Matched	Metastasis	Uterus	Lung	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;MCL1 Amplification	1	2
P-0001995	P-0001995-T01-IM3	In-House	FFPE	Resection	250	611	60	Matched	Primary	Brain	Not Applicable	Tumor	PPTID	Pineal Tumor	Pineal Parenchymal Tumor of Intermediate Differentiation										ATRX p.X1246_splice;ARID2 p.G1762Dfs*3	0	2
P-0001996	P-0001996-T01-IM3	In-House	FFPE	Resection	250	320	20	Matched	Metastasis	Stomach	Brain	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X2301_splice)				LEVEL_4	TP53 p.E271*;NF1 p.X2301_splice;PTPRT p.G31Lfs*4;CREBBP Deletion;FBXW7 Deletion;PRKN Deletion;SMAD4 Deletion;SRC Amplification	1	8
P-0001997	P-0001997-T01-IM3	In-House	FFPE	Biopsy	250	307	70	Matched	Primary	Bone	Not Applicable	Tumor	SCHW	Nerve Sheath Tumor	Schwannoma										NF2 p.M179Ifs*11	0	1
P-0001998	P-0001998-T01-IM3	In-House	FFPE	Resection	250	311	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										NF2 Deletion;TP53 Deletion	0	2
P-0001999	P-0001999-T01-IM3	Outside	FFPE	Resection	250	711	70	Unmatched	Primary	Ovary	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										FANCA Deletion;KDR Amplification;KIT Amplification;PDGFRA Amplification	0	4
P-0002000	P-0002000-T01-IM3	In-House	FFPE	Biopsy	250	679	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	ERBB2 p.Y772_A775dup	2	1
P-0002000	P-0002000-T02-IM5	In-House	FFPE	Cytology	250	792	60	Unmatched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	TP53 p.C135F;ERBB2 p.Y772_A775dup;RYBP p.N195Kfs*11	2	3
P-0002001	P-0002001-T01-IM3	In-House	FFPE	Biopsy	178.2	305	30	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.F270V;MAX p.Q91Rfs*79	2	3
P-0002002	P-0002002-T01-IM3	Outside	FFPE	Biopsy	250	143	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;NKX2-1 Amplification	1	2
P-0002003	P-0002003-T01-IM3	In-House	FFPE	Resection	250	315	50	Matched	Metastasis	Nerve Sheath	Eye	Tumor	MSCHW	Nerve Sheath Tumor	Melanotic Schwannoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDKN2B Deletion;MDM2 Amplification	1	2
P-0002004	P-0002004-T01-IM3	In-House	FFPE	Resection	250	639	50	Matched	Metastasis	Uterus	Omentum	Tumor	UDDC	Endometrial Cancer	Uterine Dedifferentiated Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345I)	GSK2636771,AZD8186(PTEN p.Y155H);GSK2636771,AZD8186(PTEN p.X55_splice)				LEVEL_3B	PIK3CA p.N345I;U2AF1 p.S34F;CTNNB1 p.S33C;PTEN p.Y155H;SMARCA4 p.Q1053*;PIK3R1 S660fs;PTEN p.X55_splice;SMARCA4 p.F172Sfs*127;EP300 p.H1744Mfs*18	3	9
P-0002005	P-0002005-T01-IM3	In-House	FFPE	Resection	155.1	314	20	Matched	Primary	Brain	Not Applicable	Tumor	HMBL	Miscellaneous Brain Tumor	Hemangioblastoma										VHL p.T157Ifs*2	0	1
P-0002006	P-0002006-T01-IM3	In-House	FFPE	Resection	250	643	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										PIK3R1 p.X434_splice;TP53 p.D228*	0	2
P-0002007	P-0002007-T01-IM3	In-House	FFPE	Resection	250	973	NA	Matched	Primary	Bone	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease			Sorafenib,Cobimetinib(ARAF p.S214A)						LEVEL_3A	ARAF p.S214A	1	1
P-0002008	P-0002008-T01-IM3	Outside	FFPE	Biopsy	250	79	20	Matched	Primary	Skin	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										TP53 p.Y163C	0	1
P-0002009	P-0002009-T01-IM3	In-House	FFPE	Resection	250	487	50	Matched	Primary	Liver	Not Applicable	Tumor	HCCIHCH	Hepatobiliary Cancer	Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma											0	0
P-0002010	P-0002010-T02-IM5	In-House	FFPE	Resection	250	862	70	Matched	Metastasis	Ovary	Liver	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;ARID1A p.G801Vfs*32;MYC Amplification;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	1	6
P-0002010	P-0002010-T01-IM3	Outside	FFPE	Resection	250	616	50	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;ARID1A p.G801Vfs*32;MYC Amplification	1	3
P-0002011	P-0002011-T01-IM3	Outside	FFPE	Resection	250	575	50	Matched	Primary	Ovary	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										ARID1A p.R1528*	0	1
P-0002012	P-0002012-T01-IM3	In-House	FFPE	Resection	250	1178	80	Unmatched	Primary	Not available	Not available	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma				Cisplatin(ERCC2 p.M1?)					LEVEL_3B	ERCC2 p.M1?	1	1
P-0002013	P-0002013-T01-IM3	In-House	FFPE	Biopsy	250	197	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C;TP53 p.R273C	1	2
P-0002014	P-0002014-T01-IM3	Outside	FFPE	Resection	250	270	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MCL1 Amplification;MDM2 Amplification	1	2
P-0002015	P-0002015-T02-IM5	In-House	DNA	Biopsy	250	948	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;EGFR Amplification	2	2
P-0002015	P-0002015-T01-IM3	Outside	FFPE	Resection	250	689	50	Unmatched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;EGFR Amplification	2	2
P-0002016	P-0002016-T01-IM3	Outside	FFPE	Cytology	250	331	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Imatinib(KIT p.D572Y);Olaparib(ATM p.D1682H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.I154Tfs*39)				LEVEL_3B	SPEN p.S1078*;KIT p.D572Y;RASA1 p.S919*;ATM p.D1682H;SMARCA4 p.Q1304*;TP53 p.N235del;CDKN2A p.I154Tfs*39	3	7
P-0002017	P-0002017-T01-IM3	Outside	FFPE	Cytology	250	462	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										FOXA1 Amplification	0	1
P-0002018	P-0002018-T01-IM3	Outside	FFPE	Biopsy	250	757	50	Matched	Metastasis	Cancer of Unknown Primary	Subcutaneous Tissue	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;CDKN2A Deletion;CDKN2B Deletion	3	3
P-0002019	P-0002019-T01-IM3	Outside	FFPE	Resection	250	496	60	Matched	Metastasis	Eye	Spleen	Tumor	UM	Melanoma	Uveal Melanoma										BAP1 p.Q684*	0	1
P-0002020	P-0002020-T01-IM3	Outside	FFPE	Resection	250	436	60	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										EED Deletion;FOXA1 Deletion	0	2
P-0002021	P-0002021-T01-IM3	Outside	FFPE	Resection	250	544	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L91Wfs*55)				LEVEL_4	TP53 p.R273C;CDKN2A p.L91Wfs*55;MYC Amplification	1	3
P-0002022	P-0002022-T01-IM3	In-House	FFPE	Resection	250	555	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(ATM p.Y731*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3R1 p.E451_Y452del;MAX p.R60Q;ATM p.Y731*;NSD1 p.M2261Ifs*20;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0002023	P-0002023-T01-IM3	Outside	FFPE	Resection	250	464	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)	Talazoparib,Olaparib(BRCA1 Deletion)		Niraparib,Rucaparib(BRCA1 Deletion);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.S401Vfs*106;BRCA1 Deletion;ERBB2 Amplification	4	3
P-0002024	P-0002024-T01-IM3	In-House	FFPE	Resection	250	319	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0002025	P-0002025-T01-IM3	Outside	FFPE	Resection	250	394	15	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	ERBB3 p.V104L;KRAS p.A146T;TP53 p.R273C;APC p.Q1444*;APC p.E918Rfs*37	1	5
P-0002026	P-0002026-T01-IM3	In-House	FFPE	Biopsy	250	820	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719A)								LEVEL_1	TP53 p.C277F;EGFR p.G719A;TP53 p.X331_splice;PTPRT p.R190*;WT1 p.W486Cfs*14	1	5
P-0002027	P-0002027-T01-IM3	In-House	FFPE	Biopsy	250	435	NA	Matched	Metastasis	Stomach	Bone	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.M537I)				LEVEL_4	FGFR2 p.C382R;FGFR2 p.M537I;KMT2D p.Q2816*;ARID1A p.S795Tfs*11;AXIN1 p.V220Sfs*22	2	5
P-0002028	P-0002028-T01-IM3	In-House	FFPE	Biopsy	250	623	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_4	TP53 p.R337L;PTEN p.X268_splice;AKT2 Amplification;CCNE1 Amplification	1	4
P-0002029	P-0002029-T01-IM3	Outside	FFPE	Resection	250	829	NA	Matched	Primary	Bladder	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)		Tazemetostat(KDM6A p.D1062Vfs*20)				LEVEL_1	TP53 p.R280G;FGFR3 p.Y373C;KDM6A p.D1062Vfs*20	3	3
P-0002030	P-0002030-T01-IM3	Outside	FFPE	Resection	249.7	719	NA	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Enasidenib(IDH2 p.R172K)					LEVEL_3B	IDH2 p.R172K;SMARCA4 p.T910M;TET2 p.K1317E;PIK3R1 p.E403_L404delinsV;CIC p.P1579Rfs*34;ASXL1 p.G645Wfs*12;ASXL1 p.G645Vfs*58	1	7
P-0002032	P-0002032-T01-IM3	Outside	FFPE	Resection	250	541	NA	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.Q317*;APC p.E1353*;CARD11 p.R423W;ARID2 p.R274*;SMAD4 p.E538*;MAP3K1 p.T1412Dfs*8;ERBB2 Amplification;FLCN Deletion	2	8
P-0002033	P-0002033-T01-IM3	Outside	FFPE	Cytology	250	887	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C);Trametinib,Cobimetinib(NF1 p.N1039Ifs*4)				LEVEL_4	KRAS p.G13C;STK11 p.X155_splice;NF1 p.N1039Ifs*4	2	3
P-0002034	P-0002034-T01-IM3	Outside	FFPE	Resection	250	596	70	Matched	Metastasis	Soft Tissue	Trachea	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma				Tazemetostat(SMARCB1 Deletion);Everolimus(TSC2 C6orf106-TSC2 fusion);Everolimus(C6orf106 C6orf106-TSC2 fusion)					LEVEL_3B	AXIN1 Deletion;EP300 Deletion;GRIN2A Deletion;NF2 Deletion;SMARCB1 Deletion;TSC2 C6orf106-TSC2 fusion;C6orf106 C6orf106-TSC2 fusion	3	7
P-0002035	P-0002035-T01-IM3	Outside	FFPE	Resection	250	315	NA	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R976*;TP53 p.E171Rfs*3;BCL2L1 Amplification;MCL1 Amplification;MYC Amplification	0	5
P-0002036	P-0002036-T01-IM3	Outside	FFPE	Resection	250	750	NA	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.N239D;TP53 p.Y236C;CCNE1 Amplification;ERBB2 Amplification	2	4
P-0002037	P-0002037-T01-IM3	In-House	FFPE	Resection	250	626	NA	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	PIK3CA p.E542K;STK11 p.E223K;TP53 p.R158_A159del;MDM2 Amplification;RB1 RB1-intragenic	2	5
P-0002038	P-0002038-T01-IM3	In-House	FFPE	Biopsy	250	702	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Afatinib(EGFR p.L747P)				LEVEL_4	TP53 p.F328Sfs*17;EGFR p.L747P	1	2
P-0002039	P-0002039-T01-IM3	Outside	FFPE	Biopsy	250	930	NA	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(FGFR2 RASAL2-FGFR2 fusion);Pemigatinib(RASAL2 RASAL2-FGFR2 fusion);Pemigatinib(FGFR2 TACC2-FGFR2 fusion);Pemigatinib(TACC2 TACC2-FGFR2 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 RASAL2-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(RASAL2 RASAL2-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 TACC2-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(TACC2 TACC2-FGFR2 fusion)						LEVEL_1	FGFR2 RASAL2-FGFR2 fusion;RASAL2 RASAL2-FGFR2 fusion;FGFR2 TACC2-FGFR2 fusion;TACC2 TACC2-FGFR2 fusion	8	4
P-0002040	P-0002040-T01-IM3	Outside	FFPE	Resection	250	590	30	Matched	Metastasis	Breast	Lung	Tumor	MBC	Breast Cancer	Metaplastic Breast Cancer	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.P36Afs*7;SOX9 p.Q500Hfs*74;CCND1 Amplification	2	4
P-0002042	P-0002042-T01-IM3	In-House	FFPE	Resection	250	695	30	Matched	Primary	Cecum	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	APC p.E1397*;ARID1A p.G276*;KRAS p.G13D;FOXA1 Amplification	1	4
P-0002043	P-0002043-T01-IM3	In-House	FFPE	Biopsy	250	579	NA	Matched	Primary	Brain	Not Applicable	Tumor	OAST	Glioma	Oligoastrocytoma				Ivosidenib(IDH1 p.R132G)					LEVEL_3B	IDH1 p.R132G;ATRX p.R1514*;ATRX p.H1338Kfs*17	1	3
P-0002044	P-0002044-T01-IM3	Outside	FFPE	Biopsy	250	860	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_1	TP53 p.E258K;CDKN2A p.H83Y;ERBB2 Amplification	3	3
P-0002045	P-0002045-T01-IM3	In-House	FFPE	Resection	226.8	453	NA	Matched	Metastasis	Major Salivary Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.S90Pfs*33;ERBB2 Amplification	1	2
P-0002046	P-0002046-T01-IM3	In-House	FFPE	Biopsy	154.8	532	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;EGFR Amplification;MDM2 Amplification	2	3
P-0002047	P-0002047-T01-IM3	Outside	FFPE	Biopsy	150	373	50	Matched	Metastasis	Liver	Rectum	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										NCOR1 p.S1519*;MCL1 Amplification	0	2
P-0002048	P-0002048-T01-IM3	Outside	FFPE	Biopsy	250	839	30	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245D;PIK3R2 p.G373R;APC p.E1345*;SETD2 p.Q1924*;APC p.X278_splice;TP53 p.S90Lfs*59;FAT1 Deletion;MYC Amplification	0	8
P-0002049	P-0002049-T01-IM3	In-House	FFPE	Resection	250	473	30	Matched	Primary	Rectum	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	APC p.Q1338*;ARID1A p.P1898Hfs*25;ARID1A p.R1461*;SMAD2 p.R182*;APC p.W423*;LATS1 p.W296*;SMAD2 p.R120*;EIF1AX p.X6_splice;MSH6 p.I1183Efs*2;KRAS p.G13D	1	10
P-0002050	P-0002050-T01-IM3	Outside	FFPE	Cytology	250	657	50	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										RB1 p.V654Cfs*4;TP53 p.X187_splice;CREBBP CREBBP-intragenic	0	3
P-0002051	P-0002051-T01-IM3	Outside	FFPE	Resection	250	542	50	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R273C;IDH1 p.R132H;TP53 p.V274A;ATRX p.R840Kfs*9	1	4
P-0002052	P-0002052-T01-IM3	Outside	FFPE	Resection	250	866	40	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.R337L;KRAS p.Q61H;PTPRT p.L1072Sfs*9	1	3
P-0002053	P-0002053-T01-IM3	In-House	FFPE	Biopsy	250	745	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R306*	0	1
P-0002054	P-0002054-T01-IM3	In-House	FFPE	Biopsy	250	434	30	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.P1257Hfs*4)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	KRAS p.G12V;KEAP1 p.M409*;SDHAF2 p.E133*;DIS3 p.D479Y;TP53 p.K139T;STK11 p.S240*;ATM p.P1257Hfs*4;CDKN2A p.R80*	3	8
P-0002054	P-0002054-T02-IM3	In-House	FFPE	Resection	250	465	50	Matched	Metastasis	Lung	Rectum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										BRAF p.D594G;TET2 p.S354*;TP53 p.R110C	0	3
P-0002055	P-0002055-T02-IM5	Outside	FFPE	Resection	250	446	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THFO	Thyroid Cancer	Follicular Thyroid Cancer				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R;EIF1AX p.X113_splice	1	2
P-0002056	P-0002056-T01-IM3	Outside	FFPE	Biopsy	250	716	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;BCOR p.S3*	2	2
P-0002057	P-0002057-T01-IM3	Outside	FFPE	Resection	250	893	60	Matched	Primary	Cecum	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum										CDH1 p.T680Rfs*8	0	1
P-0002058	P-0002058-T01-IM3	In-House	FFPE	Resection	250	642	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Tipifarnib(HRAS p.Q61K)					LEVEL_3B	HRAS p.Q61K	1	1
P-0002059	P-0002059-T01-IM3	In-House	FFPE	Resection	250	289	30	Unmatched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Olaparib(ATM p.Y2437*)					LEVEL_3B	KMT2C p.K822Rfs*6;ATM p.Y2437*;BCL2L1 Amplification;MYC Amplification	1	4
P-0002060	P-0002060-T01-IM3	In-House	FFPE	Biopsy	250	666	50	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R110L;STK11 p.E130*;CCND1 Amplification;FGF19 Amplification;MYC Amplification	0	5
P-0002061	P-0002061-T01-IM3	In-House	FFPE	Resection	250	439	40	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer											0	0
P-0002063	P-0002063-T01-IM3	Outside	FFPE	Resection	250	249	60	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Everolimus(TSC1 p.L669Ffs*52)					LEVEL_3B	TSC1 p.L669Ffs*52	1	1
P-0002064	P-0002064-T01-IM3	In-House	FFPE	Biopsy	89.5	644	40	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										FOXA1 Amplification;NKX2-1 Amplification	0	2
P-0002066	P-0002066-T01-IM3	In-House	FFPE	Resection	250	730	70	Matched	Primary	Not available	Not available	Tumor	PLRMS	Soft Tissue Sarcoma	Pleomorphic Rhabdomyosarcoma										TP53 p.Y234C;MAPK1 Amplification	0	2
P-0002068	P-0002068-T01-IM3	In-House	FFPE	Resection	250	674	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.Y935*;APC p.P1497Ffs*7	1	3
P-0002069	P-0002069-T01-IM3	Outside	FFPE	Biopsy	151.2	723	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0002070	P-0002070-T01-IM3	Outside	FFPE	Resection	250	835	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	GNAS p.R201H;RHOA p.Q63K;KRAS p.G13D	1	3
P-0002071	P-0002071-T01-IM3	In-House	FFPE	Resection	250	690	60	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas											0	0
P-0002071	P-0002071-T02-IM5	Outside	DNA	Biopsy	250	821	60	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Trametinib,Cobimetinib(SND1 BRAF-SND1 fusion);Trametinib,Cobimetinib(BRAF BRAF-SND1 fusion)					LEVEL_3B	SND1 BRAF-SND1 fusion;BRAF BRAF-SND1 fusion	2	2
P-0002072	P-0002072-T01-IM3	Outside	FFPE	Biopsy	250	639	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R282W;ERBB2 Amplification	2	2
P-0002073	P-0002073-T01-IM3	In-House	FFPE	Resection	250	857	60	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.R175H;FAT1 p.E3176*;NOTCH1 p.W861*;CD274 Amplification;EGFR Amplification;JAK2 Amplification;FAT1 FAT1-intragenic	0	7
P-0002075	P-0002075-T01-IM3	Outside	FFPE	Biopsy	250	816	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_4	TP53 p.P36Rfs*8;NOTCH4 p.X308_splice;TET1 p.Q355*;CDK8 p.R65T;FANCA p.S251*;NCOR1 p.X897_splice;EP300 p.F1373L;PTEN p.X268_splice;MCL1 Amplification;MYC Amplification	1	10
P-0002076	P-0002076-T01-IM3	Outside	FFPE	Resection	250	593	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;EIF1AX p.X113_splice;NOTCH1 p.D1429Tfs*14	2	3
P-0002077	P-0002077-T01-IM3	In-House	FFPE	Biopsy	250	777	50	Matched	Metastasis	Lower Extremity	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 Deletion	0	1
P-0002078	P-0002078-T01-IM3	In-House	FFPE	Resection	250	834	30	Matched	Metastasis	Sigmoid Colon	Peritoneum	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum										TP53 p.Y163C;RNF43 p.V31Gfs*9;TP53 p.Y163C;RNF43 p.V31Gfs*9	0	4
P-0002079	P-0002079-T01-IM3	Outside	FFPE	Cytology	250	991	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										KMT2C p.D2713*	0	1
P-0002080	P-0002080-T01-IM3	Outside	FFPE	Resection	250	402	50	Matched	Metastasis	Transverse Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D);Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.G266E;APC p.R216*;APC p.E1345*;SMAD2 p.S464*;KRAS p.G13D;TP53 p.G266E;APC p.R216*;APC p.E1345*;SMAD2 p.S464*;KRAS p.G13D	2	10
P-0002081	P-0002081-T01-IM3	Outside	FFPE	Biopsy	250	376	60	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.R267W;STK11 p.Y272*;SMARCA4 p.I1151Hfs*25;MYC Amplification	2	5
P-0002082	P-0002082-T01-IM3	Outside	FFPE	Cytology	250	755	50	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	4
P-0002083	P-0002083-T01-IM3	Outside	FFPE	Resection	250	631	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.I168Sfs*11);Trametinib,Cobimetinib(NF1 TTLL6-NF1 fusion);Trametinib,Cobimetinib(TTLL6 TTLL6-NF1 fusion)				LEVEL_4	PTPN11 p.E76K;PTEN p.I168Sfs*11;NF1 TTLL6-NF1 fusion;TTLL6 TTLL6-NF1 fusion	3	4
P-0002084	P-0002084-T01-IM3	Outside	FFPE	Biopsy	250	159	30	Matched	Primary	Not available	Not available	Tumor	ES	Bone Cancer	Ewing Sarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P447_L455del)					LEVEL_3B	PIK3CA p.P447_L455del	1	1
P-0002085	P-0002085-T02-IM5	In-House	DNA	Cytology	250	751	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				GSK2636771,AZD8186(PTEN p.L247Ffs*6)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;EGFR p.T854S;TP53 p.X187_splice;PBRM1 p.N110Ifs*3;PTEN p.L247Ffs*6;HLA-A p.E197Gfs*24	3	7
P-0002085	P-0002085-T01-IM3	Outside	FFPE	Biopsy	250	517	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				GSK2636771,AZD8186(PTEN p.L247Ffs*6)				LEVEL_1	EGFR p.L858R;EGFR p.T854S;RB1 p.V654M;TP53 p.X187_splice;PBRM1 p.N110Ifs*3;PTEN p.L247Ffs*6	2	6
P-0002086	P-0002086-T01-IM3	Outside	FFPE	Biopsy	250	611	NA	Matched	Metastasis	Mediastinum	Liver	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)				LEVEL_4	KRAS p.A146V;CBL p.X410_splice;ARID1A p.Q780Hfs*52	1	3
P-0002087	P-0002087-T01-IM3	Outside	FFPE	Biopsy	250	850	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.Y205C;ASXL2 p.S872*;SMARCA4 p.Q595*;MET Amplification	1	4
P-0002088	P-0002088-T01-IM3	In-House	FFPE	Biopsy	250	674	40	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.G778_P780dup)	Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)					LEVEL_3A	ERBB2 p.G778_P780dup;TBX3 p.I645Sfs*244;CCND1 Amplification;FGF19 Amplification;MYC Amplification;PAK1 Amplification;ERMP1 TGFBR1-ERMP1 fusion;TGFBR1 TGFBR1-ERMP1 fusion	2	8
P-0002088	P-0002088-T02-IM5	In-House	FFPE	Biopsy	250	658	60	Matched	Metastasis	Breast	Peritoneum	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		Neratinib(ERBB2 p.G778_P780dup);Neratinib(ERBB2 p.S310Y)	Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup);Ado-Trastuzumab Emtansine(ERBB2 p.S310Y);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	ERBB2 p.G778_P780dup;ERBB2 p.S310Y;TBX3 p.I645Sfs*244;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;FGF19 Amplification;ID3 Deletion;MYC Amplification;PAK1 Amplification;TERT Amplification;ERMP1 TGFBR1-ERMP1 fusion;TGFBR1 TGFBR1-ERMP1 fusion	7	14
P-0002091	P-0002091-T02-IM5	In-House	FFPE	Biopsy	135	570	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;RB1 p.X314_splice;TP53 p.C275W;FOXA1 Amplification;NKX2-1 Amplification	2	6
P-0002091	P-0002091-T01-IM3	In-House	FFPE	Resection	250	845	50	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	EGFR p.E746_A750del;RB1 p.X314_splice;TP53 p.C275W;EGFR Amplification;FOXA1 Amplification;NKX2-1 Amplification;PTEN Deletion;RAC1 Amplification	2	8
P-0002092	P-0002092-T01-IM3	Outside	FFPE	Resection	250	998	40	Matched	Primary	Rectum	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										PMS1 p.Q226*;BAP1 p.R385*;EP300 p.X1539_splice	0	3
P-0002093	P-0002093-T01-IM3	In-House	FFPE	Resection	250	504	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.E78*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A36Rfs*17);Tazemetostat(KDM6A Deletion)				LEVEL_3B	TSC1 p.E78*;CDKN2A p.A36Rfs*17;KDM6A Deletion;RAF1 Amplification;TP53 Deletion	3	5
P-0002094	P-0002094-T01-IM3	In-House	FFPE	Resection	250	447	40	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822Y)					LEVEL_3B	KIT p.N822Y	1	1
P-0002095	P-0002095-T01-IM3	In-House	FFPE	Resection	250	489	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V	1	1
P-0002096	P-0002096-T01-IM3	In-House	FFPE	Cytology	54.52	461	30	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CCND1 Amplification;CCND3 Amplification;CDK6 Amplification;CDK8 Amplification;FGF19 Amplification;FLT3 Amplification;MCL1 Amplification;MYC Amplification;WT1 Deletion	0	9
P-0002097	P-0002097-T01-IM3	Outside	FFPE	Resection	250	859	40	Unmatched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.P151S;NOTCH2 p.P6Rfs*27;TP53 p.P151S;RB1 p.R787*;BAP1 p.X577_splice;STK11 p.Y253*;RB1 p.R787*;BAP1 p.X577_splice;STK11 p.Y253*;RECQL4 p.R758*	0	10
P-0002098	P-0002098-T01-IM3	Outside	FFPE	Resection	250	293	80	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										KDM6A p.Y609*	0	1
P-0002099	P-0002099-T02-IM3	In-House	FFPE	Resection	250	410	40	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0002100	P-0002100-T01-IM3	In-House	FFPE	Resection	250	613	60	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.V274F;PTEN Deletion	1	2
P-0002101	P-0002101-T01-IM3	Outside	FFPE	Resection	250	136	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0002102	P-0002102-T01-IM3	Outside	FFPE	Biopsy	81	824	40	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.R2842C)					LEVEL_3B	PIK3CA p.E542K;BRCA2 p.R2842C;FBXW7 p.R473Kfs*4;APC p.I1056Mfs*5;APC p.A1460Lfs*13;SMAD3 Deletion	2	6
P-0002103	P-0002103-T01-IM3	In-House	FFPE	Biopsy	250	1048	20	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Everolimus(TSC1 p.K629*)					LEVEL_3B	TSC1 p.K629*	1	1
P-0002105	P-0002105-T01-IM3	Outside	FFPE	Resection	250	297	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTPRD p.Q1597*;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;TP53 Deletion	1	5
P-0002106	P-0002106-T01-IM3	In-House	FFPE	Biopsy	250	785	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.S106Rfs*16;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	4
P-0002107	P-0002107-T01-IM3	Outside	FFPE	Resection	250	552	50	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS											0	0
P-0002108	P-0002108-T01-IM3	In-House	FFPE	Resection	250	696	50	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	EMYOCA	Head and Neck Cancer	Epithelial-Myoepithelial Carcinoma				Tipifarnib(HRAS p.Q61R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	HRAS p.Q61R;PIK3CA p.Q546R;FGFR1 Amplification	3	3
P-0002109	P-0002109-T01-IM3	Outside	FFPE	Resection	250	924	40	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer										TP53 p.R306*;ARID1A p.Q633*;SPOP p.E47K;ARID1B p.Q1183Pfs*14;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	0	7
P-0002110	P-0002110-T01-IM3	Outside	FFPE	Resection	250	378	60	Matched	Metastasis	Ovary	Umbilical Area	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0002111	P-0002111-T01-IM3	Outside	FFPE	Resection	250	176	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFS	Soft Tissue Sarcoma	Myxofibrosarcoma											0	0
P-0002115	P-0002115-T01-IM3	Outside	FFPE	Biopsy	250	531	60	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma											0	0
P-0002116	P-0002116-T01-IM3	In-House	FFPE	Resection	250	340	40	Matched	Metastasis	Ovary	Pelvis	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R175G;BAP1 p.X256_splice	0	2
P-0002117	P-0002117-T01-IM3	In-House	FFPE	Biopsy	250	649	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(CLIP4 ALK-CLIP4 fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK ALK-CLIP4 fusion)			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_1	ARID2 p.R80Efs*10;CDKN2A p.R80*;MDM2 Amplification;CLIP4 ALK-CLIP4 fusion;ALK ALK-CLIP4 fusion	4	5
P-0002118	P-0002118-T01-IM3	In-House	FFPE	Resection	250	797	60	Matched	Metastasis	Stomach	Ovary	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										ARID1A p.R1906Tfs*8;TP53 p.S240_S241del	0	2
P-0002119	P-0002119-T01-IM3	In-House	FFPE	Biopsy	250	906	40	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ARID1A p.P845Lfs*10;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	1	4
P-0002119	P-0002119-T02-IM5	In-House	FFPE	Resection	250	183	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)		GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_1	PIK3CA p.C420R;TP53 p.V274A;PTEN p.X70_splice;CCNE1 Amplification;EGFR Amplification	3	5
P-0002120	P-0002120-T01-IM3	In-House	FFPE	Resection	250	358	40	Unmatched	Metastasis	Testis	Lymph Node	Tumor	BEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0002121	P-0002121-T01-IM3	Outside	FFPE	Resection	250	657	50	Matched	Primary	Testis	Not Applicable	Tumor	BEC	Germ Cell Tumor	Embryonal Carcinoma										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0002122	P-0002122-T01-IM3	In-House	FFPE	Cytology	250	835	15	Matched	Metastasis	Ovary	Lung	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.G105C	0	1
P-0002123	P-0002123-T02-IM5	In-House	FFPE	Resection	250	1031	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.G245S;PIK3CB Amplification;PTEN Deletion	1	3
P-0002123	P-0002123-T01-IM3	Outside	FFPE	Resection	250	262	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.G245S;FOXA1 Amplification	0	2
P-0002124	P-0002124-T01-IM3	In-House	FFPE	Biopsy	250	1010	95	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.E365K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E365K)						LEVEL_1	PIK3CA p.H1047R;CDH1 p.Q23*;PIK3CA p.E365K;PIK3R3 p.Q61*;JAK1 p.W1047*;SETD2 p.Q1667*;EGFR p.R669Q;FLT3 p.S941L;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification;PAK1 Amplification	4	12
P-0002125	P-0002125-T01-IM3	In-House	FFPE	Resection	250	802	10	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										TP53 p.G105S;NOTCH1 p.Q1547*;TP53 p.T256R;SPOP p.X279_splice;RB1 p.L317*	0	5
P-0002126	P-0002126-T01-IM3	In-House	FFPE	Biopsy	121	834	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Y220C;EGFR Amplification	0	2
P-0002127	P-0002127-T01-IM3	In-House	FFPE	Biopsy	250	1047	40	Matched	Metastasis	Lung	Breast	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid											0	0
P-0002128	P-0002128-T01-IM3	In-House	FFPE	Resection	250	478	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R196*;TP53 p.R248Q;IDH1 p.R132H;PIK3R1 p.X434_splice;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0002129	P-0002129-T01-IM3	In-House	FFPE	Biopsy	250	888	20	Matched	Metastasis	Breast	Pterygoid Palatine Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;KDM6A p.R1054Efs*29;MAP2K4 p.G67Efs*7;NCOR1 p.G1208Rfs*6	1	4
P-0002130	P-0002130-T02-IM3	Outside	FFPE	Resection	250	474	NA	Matched	Metastasis	Retroperitoneum	Lung	Tumor	FIBS	Soft Tissue Sarcoma	Fibrosarcoma										BCOR p.D807*;EWSR1 CREB3L1-EWSR1 fusion;CREB3L1 CREB3L1-EWSR1 fusion	0	3
P-0002131	P-0002131-T02-IM5	Outside	FFPE	Resection	250	182	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	MAP3K1 p.T657Hfs*2;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;FOXA1 Amplification;GATA3 Amplification;MYC Amplification	1	7
P-0002132	P-0002132-T01-IM3	In-House	FFPE	Resection	250	820	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;AURKA Amplification;BAP1 Deletion;CCND1 Amplification;CDK6 Amplification;FGF19 Amplification	1	6
P-0002133	P-0002133-T01-IM3	In-House	FFPE	Cytology	97.5	324	30	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;ARID1A p.Q1584*;CDH1 p.E852Rfs*9	2	3
P-0002134	P-0002134-T01-IM3	Outside	FFPE	Resection	250	764	60	Matched	Metastasis	Neck	Lung	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor											0	0
P-0002134	P-0002134-T02-IM3	Outside	FFPE	Resection	250	414	70	Matched	Primary	Neck	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor											0	0
P-0002135	P-0002135-T01-IM3	In-House	FFPE	Resection	250	759	40	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BAP1 p.S319*;CDKN2A Deletion;JUN Amplification;MCL1 Amplification;MYCL Amplification	1	5
P-0002136	P-0002136-T01-IM3	Outside	FFPE	Resection	250	402	60	Matched	Primary	Ovary	Not Applicable	Tumor	MXOV	Ovarian Cancer	Mixed Ovarian Carcinoma										TP53 p.G245S	0	1
P-0002137	P-0002137-T01-IM3	Outside	FFPE	Resection	250	830	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer											0	0
P-0002138	P-0002138-T01-IM3	In-House	FFPE	Biopsy	250	883	60	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma					GSK2636771,AZD8186(PTEN p.N184Efs*6);Trametinib,Cobimetinib(NF1 p.Q2589*)				LEVEL_4	RB1 p.R467*;PTEN p.N184Efs*6;NF1 p.Q2589*;TP53 p.P80Lfs*43;RB1 Deletion	2	5
P-0002139	P-0002139-T01-IM3	In-House	FFPE	Biopsy	250	740	60	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SMAD4 p.K428N;KDM5A Amplification;PAK1 Amplification	0	3
P-0002140	P-0002140-T01-IM3	Outside	FFPE	Resection	250	522	40	Matched	Metastasis	Jejunum	Ovary	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Trametinib,Cobimetinib(MAP2K1 p.D67N)					LEVEL_3B	FBXW7 p.R465H;RAF1 p.S259F;BRAF p.N581Y;MAP2K1 p.D67N;TP53 p.I255S	1	5
P-0002141	P-0002141-T01-IM3	Outside	FFPE	Resection	250	601	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;RBM10 p.Q767Rfs*18	1	2
P-0002142	P-0002142-T01-IM3	Outside	FFPE	Resection	250	637	20	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;TP53 p.R273C	1	2
P-0002143	P-0002143-T01-IM3	Outside	FFPE	Resection	250	826	NA	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_3A	IDH1 p.R132C;KRAS p.Q61H;ARID1A p.E1763*;KMT2C p.G1624*	2	4
P-0002144	P-0002144-T01-IM3	Outside	FFPE	Resection	250	651	40	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										DNMT3A p.Q842*;RHOA p.G17V;CDH1 p.P127Afs*41;KDM6A p.P941Tfs*26	0	4
P-0002145	P-0002145-T01-IM3	Outside	FFPE	Resection	250	907	50	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer	Selpercatinib(RET PDCD10-RET fusion);Selpercatinib(PDCD10 PDCD10-RET fusion);Selpercatinib(RET TFG-RET fusion);Selpercatinib(TFG TFG-RET fusion)			BLU-667,Cabozantinib,Vandetanib(RET PDCD10-RET fusion);BLU-667,Cabozantinib,Vandetanib(PDCD10 PDCD10-RET fusion);BLU-667,Cabozantinib,Vandetanib(RET TFG-RET fusion);BLU-667,Cabozantinib,Vandetanib(TFG TFG-RET fusion)					LEVEL_1	RET PDCD10-RET fusion;PDCD10 PDCD10-RET fusion;RET TFG-RET fusion;TFG TFG-RET fusion	8	4
P-0002146	P-0002146-T01-IM3	In-House	FFPE	Resection	250	465	20	Matched	Metastasis	Bladder	Lymph Node	Tumor	SRCBC	Bladder Cancer	Plasmacytoid/Signet Ring Cell Bladder Carcinoma										TP53 p.G245V;TP53 p.E258A;CDKN1A p.F159Lfs*38;RB1 p.E287Rfs*2;CDH1 CDH1-intragenic	0	5
P-0002147	P-0002147-T01-IM3	Outside	FFPE	Biopsy	250	866	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.C135Y;CDH1 p.X278_splice;CBFB Deletion;CCND1 Amplification;CDH1 Deletion;CTCF Deletion;DDR2 Amplification;ERBB2 Amplification;FANCA Deletion;FGF19 Amplification;FOXA1 Amplification	2	11
P-0002148	P-0002148-T01-IM3	In-House	FFPE	Resection	250	832	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0002149	P-0002149-T02-IM3	In-House	FFPE	Biopsy	176	618	30	Matched	Metastasis	Prostate	Urethra	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;TP53 p.X332_splice;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0002149	P-0002149-T01-IM3	Outside	FFPE	Resection	250	653	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.X332_splice;PTEN Deletion	1	2
P-0002150	P-0002150-T01-IM3	In-House	FFPE	Biopsy	250	807	20	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0002151	P-0002151-T01-IM3	In-House	FFPE	Biopsy	250	819	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;NOTCH3 p.G942Afs*2;CCND1 Amplification;NKX2-1 Amplification	1	4
P-0002152	P-0002152-T01-IM3	Outside	FFPE	Biopsy	172.8	861	25	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0002153	P-0002153-T01-IM3	In-House	FFPE	Cytology	250	1029	20	Matched	Metastasis	Lung	Neck	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Trametinib,Cobimetinib(NF1 p.L2623Sfs*10)				LEVEL_4	KRAS p.G12V;KEAP1 p.G430C;NF1 p.L2623Sfs*10;STK11 p.G135Afs*23	2	4
P-0002154	P-0002154-T01-IM3	Outside	FFPE	Resection	250	1052	30	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R273H;APC p.E1322*;APC p.Y191*;FGFR1 Amplification	1	4
P-0002155	P-0002155-T01-IM3	Outside	FFPE	Biopsy	250	503	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.S215N;APC p.A1402Cfs*7	1	3
P-0002156	P-0002156-T01-IM3	In-House	FFPE	Resection	250	771	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ARID1A p.P947Hfs*21	1	2
P-0002157	P-0002157-T01-IM3	Outside	FFPE	Resection	250	659	50	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma										TP53 p.R196*;RAC1 p.P29S;RB1 p.X830_splice;TET1 p.K1393Ffs*2;CBL p.X366_splice;ARID1A p.L1769*	0	6
P-0002159	P-0002159-T01-IM3	Outside	FFPE	Resection	250	1148	30	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease											0	0
P-0002160	P-0002160-T01-IM3	Outside	FFPE	Biopsy	250	690	15	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Q317*;RB1 p.Q35*;SMARCA4 p.E669*;SMARCA4 p.E798*	0	4
P-0002161	P-0002161-T01-IM3	Outside	FFPE	Biopsy	132	696	20	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction										TP53 p.R273H;TP53 p.R196*;EGFR Amplification	0	3
P-0002162	P-0002162-T01-IM3	Outside	FFPE	Biopsy	250	1121	30	Matched	Metastasis	Anus	Liver	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;STK11 p.X155_splice	1	2
P-0002163	P-0002163-T01-IM3	In-House	FFPE	Biopsy	250	1048	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Everolimus(TSC2 p.X1690_splice)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83D)				LEVEL_3B	TP53 p.G244S;TSC2 p.X1690_splice;RBM10 p.E231*;SPOP p.L186Pfs*5;KEAP1 p.H424Qfs*15;CDKN2A p.H83D	2	6
P-0002164	P-0002164-T01-IM3	In-House	FFPE	Resection	250	821	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.E1554*;APC p.E1309*;TP53 p.S215N;MAP3K1 p.R183*;NSD1 p.E519*;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	0	9
P-0002165	P-0002165-T01-IM3	In-House	FFPE	Resection	250	908	50	Matched	Metastasis	Foot	Lymph Node, Regional	Tumor	ACRM	Melanoma	Acral Melanoma										BRAF p.D594N;BRAF p.D594N;FLT3 p.Q956E;TET1 TET1-intragenic	0	4
P-0002166	P-0002166-T02-IM5	In-House	FFPE	Biopsy	250	947	10	Matched	Metastasis	Bladder	Left floor of oral cavity	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Tazemetostat(KDM6A p.X189_splice)				LEVEL_1	FGFR3 p.S249C;PIK3CA p.E542K;TP53 p.E258*;CREBBP p.Q719*;KDM6A p.X189_splice;STAG2 p.V687Afs*6	4	6
P-0002166	P-0002166-T01-IM3	Outside	FFPE	Biopsy	250	743	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib(ATM Deletion)	Tazemetostat(KDM6A p.X189_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;PIK3CA p.E542K;CREBBP p.Q719*;KDM6A p.X189_splice;STAG2 p.V687Afs*6;ATM Deletion;CDKN2A Deletion;PTPRD Deletion	6	8
P-0002167	P-0002167-T01-IM3	In-House	FFPE	Resection	250	240	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MED12 p.W510*;MEN1 p.L105Pfs*12;MED12 p.W510*;MEN1 p.L105Pfs*12	0	4
P-0002168	P-0002168-T01-IM3	In-House	FFPE	Resection	250	674	NA	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACCC	Salivary Gland Cancer	Acinic Cell Carcinoma											0	0
P-0002169	P-0002169-T01-IM3	Outside	FFPE	Resection	250	345	50	Matched	Primary	Testis	Not Applicable	Tumor	BEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0002170	P-0002170-T01-IM3	In-House	FFPE	Biopsy	250	987	50	Matched	Metastasis	Bone	Chest Wall	Tumor	ES	Bone Cancer	Ewing Sarcoma										EWSR1 ERG-EWSR1 fusion;ERG ERG-EWSR1 fusion	0	2
P-0002171	P-0002171-T01-IM3	In-House	FFPE	Biopsy	250	826	50	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										APC p.T1556Nfs*3;SMAD4 p.C363F	0	2
P-0002172	P-0002172-T01-IM3	Outside	FFPE	Resection	250	960	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer										NFE2L2 p.T80R	0	1
P-0002174	P-0002174-T01-IM3	In-House	FFPE	Resection	250	987	NA	Matched	Metastasis	Uterus	Abdomen	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Olaparib(CDK12 GRB7-CDK12 fusion);Olaparib(GRB7 GRB7-CDK12 fusion)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 GRB7-CDK12 fusion);Pembrolizumab,Nivolumab,Cemiplimab(GRB7 GRB7-CDK12 fusion)				LEVEL_3B	TP53 p.P278R;HRAS Amplification;CDK12 GRB7-CDK12 fusion;GRB7 GRB7-CDK12 fusion	4	4
P-0002176	P-0002176-T01-IM3	Outside	FFPE	Resection	250	800	50	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SF3B1 p.K700E;FOXA1 p.C227R	0	2
P-0002177	P-0002177-T01-IM3	In-House	FFPE	Biopsy	250	1139	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification;MYC Amplification	1	2
P-0002178	P-0002178-T01-IM3	In-House	FFPE	Biopsy	62.1	541	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Everolimus(TSC1 p.E474*)					LEVEL_3B	STK11 p.E165Q;TP53 p.E294*;TSC1 p.E474*;RB1 p.E864*;TNFAIP3 TNFAIP3-intragenic	1	5
P-0002179	P-0002179-T01-IM3	Outside	FFPE	Resection	250	625	NA	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										PPP2R1A Deletion	0	1
P-0002181	P-0002181-T01-IM3	In-House	FFPE	Resection	250	803	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	PIK3R1 p.N564D;AKT3 Amplification;CDK4 Amplification;MDM2 Amplification;MDM4 Amplification	2	5
P-0002181	P-0002181-T02-IM5	In-House	FFPE	Resection	250	927	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(NF1 p.X160_splice);Trametinib,Cobimetinib(NF1 p.X668_splice);Trametinib,Cobimetinib(NF1 p.Q756*)				LEVEL_3B	PIK3R1 p.N564D;PBRM1 p.X1633_splice;FAT1 p.Q1943*;DICER1 p.Q493*;NF1 p.X160_splice;NF1 p.X668_splice;NF1 p.Q756*;CDK4 Amplification;MDM2 Amplification	5	9
P-0002182	P-0002182-T01-IM3	In-House	FFPE	Resection	250	830	50	Matched	Metastasis	Skin	Lymph Node, Non-Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;PTEN Deletion	2	2
P-0002183	P-0002183-T01-IM3	Outside	FFPE	Biopsy	84	693	50	Matched	Metastasis	 Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.P190Lfs*53;CDKN2A Deletion;CDKN2B Deletion;MET Amplification	3	4
P-0002184	P-0002184-T01-IM3	In-House	FFPE	Biopsy	250	1114	50	Matched	Metastasis	Colon	Liver	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;TP53 p.R273C;FOXA1 Amplification;MYC Amplification;PRKN Deletion	1	5
P-0002185	P-0002185-T01-IM3	Outside	FFPE	Resection	250	689	50	Matched	Metastasis	Oral Cavity	Neck	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)					LEVEL_3B	PIK3CA p.C420R;TP53 p.M237I;FAT1 p.L1097Pfs*6	1	3
P-0002186	P-0002186-T01-IM3	In-House	FFPE	Resection	250	1018	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.N238S);Cisplatin(ERCC2 p.M1?)	Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3A	ERBB2 p.S310F;ARID1A p.Q464*;FBXW7 p.T532I;JAK2 p.S518F;RB1 p.X702_splice;ERCC2 p.N238S;ERCC2 p.M1?;MED12 p.Q1929*;RB1 p.Y813Qfs*10;MDM2 Amplification	4	10
P-0002187	P-0002187-T01-IM3	In-House	FFPE	Biopsy	250	824	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.Y1442Ifs*9)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	ATM p.Y1442Ifs*9;CDKN2A Deletion;CDKN2B Deletion;EZH2 Amplification;FGFR3 Amplification;NF1 Deletion	3	6
P-0002188	P-0002188-T01-IM3	In-House	FFPE	Resection	250	929	50	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ATR p.L1537*;TP53 p.G108Afs*34;CCND1 Amplification;FGF19 Amplification;KRAS Amplification	0	5
P-0002189	P-0002189-T01-IM3	In-House	FFPE	Biopsy	81.45	501	50	Matched	Metastasis	Minor Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0002190	P-0002190-T01-IM3	In-House	FFPE	Resection	250	1031	50	Matched	Metastasis	Bone	Lung	Tumor	OSOS	Bone Cancer	Osteoblastic Osteosarcoma										SMARCA4 p.T910A	0	1
P-0002190	P-0002190-T02-IM5	In-House	FFPE	Resection	250	933	40	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0002191	P-0002191-T01-IM3	In-House	FFPE	Resection	250	890	50	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor											0	0
P-0002192	P-0002192-T01-IM3	Outside	FFPE	Biopsy	250	652	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										DNMT3B p.Q30*	0	1
P-0002193	P-0002193-T01-IM3	In-House	FFPE	Biopsy	250	946	50	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										B2M p.M1?	0	1
P-0002194	P-0002194-T01-IM3	Outside	FFPE	Biopsy	250	1069	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification	2	2
P-0002195	P-0002195-T01-IM3	Outside	FFPE	Biopsy	250	1041	60	Matched	Metastasis	Heart	Liver	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										RB1 p.X500_splice;ATRX Deletion;ATRX ATRX-intragenic	0	3
P-0002196	P-0002196-T01-IM3	In-House	FFPE	Resection	250	971	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.L427Cfs*9);Olaparib(CDK12 p.L554Cfs*56)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L427Cfs*9);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L554Cfs*56)				LEVEL_1	CDK12 p.L427Cfs*9;CDK12 p.L554Cfs*56	4	2
P-0002197	P-0002197-T01-IM3	Outside	FFPE	Biopsy	148.5	677	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas				Trametinib,Cobimetinib(SND1 BRAF-SND1 fusion);Trametinib,Cobimetinib(BRAF BRAF-SND1 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	MEN1 p.Q541*;SMAD4 p.Q534*;CDKN2A Deletion;CDKN2B Deletion;SND1 BRAF-SND1 fusion;BRAF BRAF-SND1 fusion	3	6
P-0002198	P-0002198-T01-IM3	Outside	FFPE	Biopsy	230.4	1119	10	Matched	Metastasis	Nasopharynx	Lung	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma											0	0
P-0002199	P-0002199-T01-IM3	Outside	FFPE	Biopsy	246.6	331	30	Matched	Metastasis	Bladder	Pelvis	Tumor	BLAD	Bladder Cancer	Bladder Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;FBXW7 p.R465H;GNAS p.R201H;ERBB3 p.S846I;CTNNB1 p.G34R;RNF43 p.R145*	1	6
P-0002200	P-0002200-T01-IM3	In-House	FFPE	Resection	250	795	20	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer											0	0
P-0002200	P-0002200-T02-IM5	Outside	FFPE	Resection	250	629	10	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.R306*;ARID1A p.Y551Lfs*72	0	2
P-0002202	P-0002202-T01-IM3	In-House	FFPE	Biopsy	250	1039	50	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										SMAD4 p.D537V;DAXX p.L532*;SH2D1A Deletion;STAG2 Deletion	0	4
P-0002203	P-0002203-T01-IM3	Outside	FFPE	Resection	250	269	40	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;CDK4 Amplification;MCL1 Amplification	2	3
P-0002203	P-0002203-T02-IM3	Outside	FFPE	Resection	250	446	60	Matched	Metastasis	Testis	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										FAT1 p.V1577Lfs*8	0	1
P-0002204	P-0002204-T01-IM3	In-House	FFPE	Resection	250	1093	30	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer										SETD2 p.Q2277*;TP53 p.R249K;PBRM1 p.Y1192Mfs*26	0	3
P-0002205	P-0002205-T01-IM3	Outside	FFPE	Resection	250	387	40	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;ARID1A p.S1153Hfs*39	1	2
P-0002206	P-0002206-T01-IM3	In-House	FFPE	Resection	250	848	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	3
P-0002207	P-0002207-T01-IM3	Outside	FFPE	Resection	250	798	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.I162F	1	2
P-0002208	P-0002208-T02-IM5	In-House	DNA	Biopsy	250	783	30	Matched	Metastasis	GE Junction	Liver	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R175H;XRCC2 p.L127Hfs*5;CCND3 Amplification;ERBB2 Amplification;VEGFA Amplification	2	5
P-0002208	P-0002208-T01-IM3	Outside	FFPE	Biopsy	250	765	20	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R175H;CCND3 Amplification;ERBB2 Amplification	2	3
P-0002208	P-0002208-T03-IM5	Outside	DNA	Biopsy	250	636	30	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R175H;XRCC2 p.L127Hfs*5;CCND3 Amplification;ERBB2 Amplification;VEGFA Amplification	2	5
P-0002209	P-0002209-T02-IM5	In-House	FFPE	Resection	250	578	60	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_4	FGFR2 p.C382R;APC p.K2057*;MRE11 p.X665_splice;PPM1D p.Q524*;MSH2 p.V923Kfs*2;CDKN2A p.W110*	2	6
P-0002209	P-0002209-T01-IM3	Outside	FFPE	Resection	250	905	30	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_4	FGFR2 p.C382R;CDKN2A p.W110*	2	2
P-0002210	P-0002210-T01-IM3	In-House	FFPE	Biopsy	250	871	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;TP53 p.Y234_M237del;NF2 p.Y66Ifs*15;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0002211	P-0002211-T01-IM3	In-House	FFPE	Resection	250	1108	40	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ERBB3 p.A232V;ARID1A p.Q2176Rfs*48;MDM2 Amplification	1	3
P-0002212	P-0002212-T01-IM3	Outside	FFPE	Resection	250	740	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R	2	1
P-0002213	P-0002213-T01-IM3	Outside	FFPE	Biopsy	250	830	10	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.X307_splice;FGFR3 Amplification	1	3
P-0002214	P-0002214-T01-IM3	Outside	FFPE	Resection	250	547	60	Matched	Metastasis	Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0002215	P-0002215-T01-IM3	Outside	FFPE	Biopsy	250	822	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R273H;APC p.Q1367*	0	2
P-0002216	P-0002216-T01-IM3	In-House	FFPE	Biopsy	250	1100	60	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0002217	P-0002217-T02-IM3	In-House	FFPE	Biopsy	250	348	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0002218	P-0002218-T01-IM3	In-House	FFPE	Biopsy	214.8	958	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.R248G;RB1 p.L337Wfs*12	1	3
P-0002218	P-0002218-T02-IM5	In-House	FFPE	Resection	250	1354	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.R248G;RB1 p.L337Wfs*12;EGFR Amplification	2	5
P-0002219	P-0002219-T01-IM3	In-House	FFPE	Resection	250	701	50	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma											0	0
P-0002220	P-0002220-T01-IM3	In-House	FFPE	Biopsy	250	1111	10	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Tazemetostat(SMARCB1 p.S284*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L78Hfs*41)				LEVEL_1	BRAF p.V600E;SMARCB1 p.S284*;CDKN2A p.L78Hfs*41	4	3
P-0002221	P-0002221-T02-IM5	In-House	DNA	Biopsy	250	1035	80	Matched	Metastasis	Thyroid	Mediastinum	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;NSD1 p.W2157*;MEN1 p.X280_splice	1	3
P-0002221	P-0002221-T01-IM3	Outside	FFPE	Resection	250	560	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;NSD1 p.W2157*;MEN1 p.X280_splice	1	3
P-0002222	P-0002222-T01-IM3	Outside	FFPE	Biopsy	250	889	40	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	KMT2D p.H4132Pfs*11;CDKN2A p.R58*	1	2
P-0002223	P-0002223-T01-IM3	In-House	FFPE	Resection	250	332	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0002224	P-0002224-T01-IM3	Outside	FFPE	Biopsy	250	902	60	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Enasidenib(IDH2 p.R172K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_3B	IDH2 p.R172K;KRAS p.Q61H;NOTCH2 p.E850Vfs*5;NOTCH1 p.P1443Afs*36	2	4
P-0002225	P-0002225-T01-IM3	In-House	FFPE	Biopsy	250	1000	20	Matched	Metastasis	Lung	Neck	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0002225	P-0002225-T02-IM5	In-House	DNA	Resection	250	1232	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0002226	P-0002226-T01-IM3	In-House	FFPE	Biopsy	250	1151	50	Matched	Metastasis	Uterus	Abdomen	Tumor	OUSARC	Uterine Sarcoma	Uterine Sarcoma, Other				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K944*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	CDC73 p.M1?;BRCA2 p.K944*;CDKN2A Deletion;CDKN2B Deletion;PTEN Deletion	3	5
P-0002226	P-0002226-T02-IM5	In-House	FFPE	Resection	250	1011	70	Matched	Metastasis	Uterus	Pelvis	Tumor	OUSARC	Uterine Sarcoma	Uterine Sarcoma, Other				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K944*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	CDC73 p.M1?;BRCA2 p.K944*;CDKN2A Deletion;CDKN2B Deletion;PTEN Deletion	3	5
P-0002227	P-0002227-T01-IM3	In-House	FFPE	Resection	250	848	30	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.D259V;FBXW7 p.G579Afs*25;AKT2 Amplification;CCND2 Amplification;KRAS Amplification	0	5
P-0002228	P-0002228-T01-IM3	In-House	FFPE	Resection	250	610	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										IKBKE Amplification;MDM4 Amplification	0	2
P-0002229	P-0002229-T01-IM3	In-House	FFPE	Resection	250	676	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;TBX3 p.L44Dfs*66;AURKA Amplification;CCND1 Amplification;FGFR3 Amplification	2	5
P-0002230	P-0002230-T01-IM3	In-House	FFPE	Resection	250	701	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.D281N	1	2
P-0002231	P-0002231-T01-IM3	Outside	FFPE	Resection	250	626	50	Matched	Metastasis	Pelvis	Abdomen	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma				Olaparib(RAD51B Deletion)					LEVEL_3B	CDKN1A Deletion;MEN1 Deletion;RAD51B Deletion;SDHAF2 Deletion;SDHB Deletion;SPEN Deletion;TNFRSF14 Deletion;TP53 Deletion	1	8
P-0002232	P-0002232-T01-IM3	In-House	FFPE	Biopsy	250	895	30	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		AZD9496,Fulvestrant(ESR1 p.D538G);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	ESR1 p.D538G;PIK3CA p.N345K;CDH1 p.I615Hfs*2;MAP3K1 p.N807Gfs*15;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	3	7
P-0002233	P-0002233-T01-IM3	In-House	FFPE	Resection	250	679	50	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										DAXX p.Q638*;CDKN2C Deletion	0	2
P-0002234	P-0002234-T02-IM3	Outside	FFPE	Resection	250	832	60	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;SETD2 p.K899*;TP53 p.Y107*;ALK Amplification;EGFR Amplification;MYCN Amplification	2	6
P-0002234	P-0002234-T01-IM3	Outside	FFPE	Resection	250	425	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.Y112*;EZH2 p.L101Qfs*24	0	2
P-0002235	P-0002235-T01-IM3	Outside	FFPE	Resection	250	829	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Everolimus,Temsirolimus(MTOR p.T1977K)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.T1556Nfs*3;MTOR p.T1977K;APC p.Y951*;MYC Amplification	3	5
P-0002236	P-0002236-T01-IM3	Outside	FFPE	Biopsy	250	702	30	Matched	Metastasis	Adrenal Gland	Brain	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0002237	P-0002237-T01-IM3	Outside	FFPE	Biopsy	250	694	30	Matched	Metastasis	Breast	Scalp	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Talazoparib,Olaparib(BRCA1 p.E1219Ffs*12)		Niraparib,Rucaparib(BRCA1 p.E1219Ffs*12);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_2	TP53 p.Q100*;BRCA1 p.E1219Ffs*12;FGFR1 Amplification;MYC Amplification;PTEN Deletion	4	5
P-0002239	P-0002239-T01-IM3	In-House	FFPE	Resection	250	629	50	Matched	Primary	Breast	Not Applicable	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;TP53 p.X332_splice;MAP3K1 p.N305Tfs*7;KMT2C p.D2624Rfs*33	2	4
P-0002240	P-0002240-T01-IM3	Outside	FFPE	Resection	250	701	30	Matched	Metastasis	Chest	Lung	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	TP53 p.V173L;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	3
P-0002242	P-0002242-T01-IM3	Outside	FFPE	Biopsy	250	710	15	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.L252P;MDM2 Amplification	1	2
P-0002242	P-0002242-T02-IM3	Outside	FFPE	Resection	250	1028	40	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.L252P;FANCA Deletion;JAK2 Amplification;PPP2R1A Deletion	0	4
P-0002243	P-0002243-T01-IM3	In-House	FFPE	Resection	250	307	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Q167Afs*13	0	1
P-0002244	P-0002244-T01-IM3	In-House	FFPE	Resection	250	614	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MEN1 p.R29*;GATA3 p.E359Afs*44;GATA3 p.S413Qfs*94;AURKA Amplification;CCND1 Amplification;FGF19 Amplification;LATS2 Deletion;MYC Amplification	0	8
P-0002245	P-0002245-T01-IM3	Outside	FFPE	Biopsy	185	481	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										KDM6A p.R1279*;GATA3 p.P408Afs*99;CCND1 Amplification;FOXA1 Amplification;GATA3 Amplification;MCL1 Amplification;PAK1 Amplification	0	7
P-0002247	P-0002247-T01-IM3	In-House	FFPE	Biopsy	174	628	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	RBM10 p.Q649*;KRAS p.G13C;SF3B1 p.V701F;ARID1A p.Q546Rfs*73	1	4
P-0002248	P-0002248-T01-IM3	Outside	FFPE	Resection	250	192	60	Unmatched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.F109_R110insL;CCND3 Amplification;TERT Amplification	0	3
P-0002249	P-0002249-T01-IM3	Outside	FFPE	Resection	207	105	20	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	SOX17 p.H128Qfs*28;ERBB2 Amplification;JUN Amplification;MCL1 Amplification	2	4
P-0002250	P-0002250-T01-IM3	In-House	FFPE	Resection	250	492	50	Unmatched	Primary	Not available	Not available	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma				Tipifarnib(HRAS p.G12V)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NOTCH2 p.P6Rfs*27;HRAS p.G12V;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;PRDM1 Deletion	2	6
P-0002251	P-0002251-T01-IM3	In-House	FFPE	Resection	108	294	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.E1345*;APC p.R838*;MCL1 Amplification	0	3
P-0002252	P-0002252-T01-IM3	In-House	FFPE	Resection	250	342	30	Matched	Metastasis	Lung	Adrenal Gland	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.Y234C;NOTCH1 p.A1741Rfs*57;KMT2D p.Q2665Rfs*26;CD274 Amplification;JAK2 Amplification;NKX2-1 Amplification;PAX5 Amplification;TP53 Deletion	0	8
P-0002253	P-0002253-T02-IM5	In-House	DNA	Biopsy	250	551	30	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										SETD2 p.R1424Efs*8;DAXX p.A103Sfs*40;MEN1 p.N194Mfs*35;RHEB p.Y35S	0	4
P-0002253	P-0002253-T01-IM3	In-House	FFPE	Resection	250	358	50	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										SETD2 p.R1424Efs*8;DAXX p.A103Sfs*40;MEN1 p.N194Mfs*35	0	3
P-0002254	P-0002254-T01-IM3	In-House	FFPE	Biopsy	142.8	717	30	Matched	Primary	Brain	Not Applicable	Tumor	LGGNOS	Glioma	Low-Grade Glioma, NOS										SETD2 p.E1595*;PRKN p.W453*	0	2
P-0002255	P-0002255-T01-IM3	In-House	FFPE	Resection	250	416	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.Q694*)					LEVEL_3B	PBRM1 p.X1560_splice;TSC1 p.Q694*	1	2
P-0002256	P-0002256-T02-IM5	Outside	FFPE	Resection	250	771	60	Matched	Primary	Uterus	Not Applicable	Tumor	OUSARC	Uterine Sarcoma	Uterine Sarcoma, Other										TP53 p.R209Kfs*6;RB1 Deletion	0	2
P-0002257	P-0002257-T01-IM3	In-House	FFPE	Resection	250	568	40	Matched	Metastasis	Ovary	Colon	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor										TP53 p.S127F;MYC Amplification	0	2
P-0002258	P-0002258-T01-IM3	Outside	FFPE	Resection	250	734	60	Matched	Primary	Not available	Not available	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma											0	0
P-0002259	P-0002259-T01-IM3	Outside	FFPE	Resection	250	418	60	Matched	Primary	Pituitary Mass	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma											0	0
P-0002260	P-0002260-T01-IM3	Outside	FFPE	Cytology	250	830	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										SETD2 Deletion;LIMD1 BAP1-LIMD1 fusion;BAP1 BAP1-LIMD1 fusion	0	3
P-0002262	P-0002262-T01-IM3	In-House	FFPE	Biopsy	250	880	NA	Matched	Metastasis	Lower Extremity	Pleura	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K	1	1
P-0002263	P-0002263-T01-IM3	Outside	FFPE	Resection	250	739	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;BCOR p.Q1430*;TP53 Deletion;YAP1 Amplification	2	4
P-0002265	P-0002265-T01-IM3	In-House	FFPE	Resection	250	335	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MITF Deletion;VHL Deletion	2	5
P-0002265	P-0002265-T02-IM5	In-House	FFPE	Resection	250	863	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(ATM p.W1710*)	Lapatinib(EGFR p.R108K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	EGFR p.R108K;ATM p.W1710*;RAD50 p.X836_splice;NSD1 p.W2625*;PRDM1 p.Q530*;ARID1B p.Q615*;ARID1B p.W2001*;EZH2 p.X121_splice;KMT2C p.X3938_splice;ARID2 p.X500_splice;MGA p.X2467_splice;MGA p.W2758*;FLCN p.X392_splice;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	4	16
P-0002266	P-0002266-T01-IM3	In-House	FFPE	Resection	250	538	15	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0002267	P-0002267-T01-IM3	Outside	FFPE	Resection	250	617	50	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma											0	0
P-0002268	P-0002268-T01-IM3	In-House	FFPE	Resection	250	326	60	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.L1814Ffs*9)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	KRAS p.A146T;APC p.R1450*;ATM p.L1814Ffs*9;SOX9 p.V245Gfs*7	2	4
P-0002269	P-0002269-T01-IM3	In-House	FFPE	Resection	250	727	40	Matched	Primary	Not available	Not available	Tumor	CHOS	Bone Cancer	Chondroblastic Osteosarcoma										GRIN2A p.G510Tfs*28;FANCA Deletion;JUN Amplification;MCL1 Amplification	0	4
P-0002270	P-0002270-T01-IM3	In-House	FFPE	Resection	250	473	40	Matched	Metastasis	Kidney	Lymph Node	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TET2 p.P732Hfs*19;KDM5C p.C618Afs*41	1	3
P-0002272	P-0002272-T01-IM3	In-House	FFPE	Resection	250	610	30	Matched	Metastasis	Uterus	Pelvis	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										KEAP1 p.D589Rfs*30;DDR2 Amplification;NTRK1 Amplification;RB1 Deletion;SUFU Deletion	0	5
P-0002273	P-0002273-T03-IM5	In-House	FFPE	Biopsy	250	764	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0002273	P-0002273-T02-IM3	In-House	FFPE	Resection	250	310	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM C633fs)								LEVEL_1	ATM C633fs;MCL1 Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0002273	P-0002273-T01-IM3	Outside	FFPE	Resection	250	401	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM C633fs)								LEVEL_1	ATM C633fs	1	1
P-0002274	P-0002274-T01-IM3	Outside	FFPE	Resection	250	199	50	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Palbociclib,Abemaciclib(CDK4 Amplification)	PLX8394(BRAF p.G469V)				LEVEL_3B	TP53 p.Q100*;BRAF p.G469V;ARID1A p.Q497*;CCND1 Amplification;CDK4 Amplification;FGF19 Amplification	2	6
P-0002275	P-0002275-T01-IM3	In-House	FFPE	Resection	250	686	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0002276	P-0002276-T01-IM3	In-House	FFPE	Resection	250	674	60	Matched	Metastasis	Small Bowel	Small Bowel	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	MAX p.R33*;NF1 Deletion;TERT Amplification	1	3
P-0002277	P-0002277-T01-IM3	Outside	FFPE	Resection	250	684	50	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										ASXL2 p.P405Qfs*18	0	1
P-0002278	P-0002278-T01-IM3	In-House	FFPE	Biopsy	250	238	50	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A	1	1
P-0002279	P-0002279-T01-IM3	In-House	FFPE	Biopsy	249.7	820	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A30Rfs*23)				LEVEL_4	TP53 p.R158P;ARID1A p.Q2100*;NOTCH1 p.Q1978*;CDKN2A p.A30Rfs*23;PIK3CA Amplification;PIK3CB Amplification	1	6
P-0002280	P-0002280-T01-IM3	In-House	FFPE	Biopsy	250	888	50	Matched	Metastasis	Uterus	Lymph Node	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G914R)	GSK2636771,AZD8186(PTEN p.R130G)				LEVEL_3B	PTEN p.R130G;JAK1 p.K860Nfs*16;HNF1A p.P379Lfs*5;ARID1A p.Y551Lfs*72;CTNNB1 p.G34R;PIK3CA p.G914R;CTCF p.E217*;CIC p.P203A;PRDM1 p.Y418Tfs*3;KMT2D p.G1235Vfs*95;DNMT3B p.M200Hfs*89;ARID1A p.S2104Pfs*31	2	12
P-0002281	P-0002281-T01-IM3	In-House	FFPE	Biopsy	135.75	630	10	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.S310F)	Ado-Trastuzumab Emtansine(ERBB2 p.S310F)					LEVEL_3A	ERBB2 p.S310F;CBFB p.R3Qfs*9	2	2
P-0002283	P-0002283-T01-IM3	In-House	FFPE	Biopsy	250	697	30	Matched	Primary	Skin	Not Applicable	Tumor	DF	Skin Cancer, Non-Melanoma	Dermatofibroma											0	0
P-0002284	P-0002284-T01-IM3	In-House	FFPE	Resection	250	616	60	Matched	Metastasis	Uterus	Lung	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.E287*;MED12 p.G44C;CDKN2A Deletion	1	3
P-0002285	P-0002285-T01-IM3	In-House	FFPE	Resection	250	133	30	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Sonidegib,Vismodegib(PTCH1 p.G17Afs*63);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.P278R;SPEN p.Q477*;PTCH1 p.G17Afs*63;CDK4 Amplification;MCL1 Amplification;SMAD3 Deletion	2	6
P-0002286	P-0002286-T01-IM3	Outside	FFPE	Biopsy	250	693	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132L)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)					LEVEL_3A	PIK3CA p.E545K;PIK3CA p.C420R;PBRM1 p.N258Kfs*6;IDH1 p.R132L;TET2 p.V1949Sfs*7	3	5
P-0002287	P-0002287-T01-IM3	In-House	FFPE	Biopsy	250	812	10	Matched	Metastasis	Cancer of Unknown Primary	Chest Wall	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.D393Rfs*78	0	1
P-0002288	P-0002288-T01-IM3	In-House	FFPE	Resection	250	609	20	Matched	Metastasis	Ovary	Kidney	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer											0	0
P-0002289	P-0002289-T01-IM3	Outside	FFPE	Biopsy	250	728	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0002290	P-0002290-T01-IM3	Outside	FFPE	Resection	250	557	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										GNAS p.R201C;CCND2 Amplification;KDM5A Amplification;SRC Amplification	0	4
P-0002291	P-0002291-T01-IM3	Outside	FFPE	Resection	250	727	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	TP53 p.R196*;PIK3CA p.E542K;TP53 p.R282W;FOXP1 p.H284Qfs*8	1	4
P-0002292	P-0002292-T01-IM3	In-House	FFPE	Resection	250	805	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	RB1 p.Q471*;ERBB2 p.S310F;TP53 p.R213Q;TP53 p.R280T;ARID1A p.S634*;NF2 p.S288*;EP300 p.R397*;CDKN1A p.F22Sfs*9;FOXA1 Amplification	1	9
P-0002293	P-0002293-T01-IM3	In-House	FFPE	Biopsy	250	1132	40	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D820Y);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K558_V560delinsN)	Sorafenib(KIT p.D820Y)		Everolimus(TSC1 p.Q3Hfs*23)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib,Sunitinib(KIT p.D820Y)		LEVEL_1	KIT p.D820Y;KIT p.K558_V560delinsN;TSC1 p.Q3Hfs*23;CDKN2A Deletion;CDKN2B Deletion	5	5
P-0002294	P-0002294-T01-IM3	In-House	FFPE	Biopsy	250	583	40	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Ivosidenib(IDH1 p.R132H)	Trametinib,Cobimetinib(NF1 p.R758Sfs*27)				LEVEL_3B	TP53 p.A138P;IDH1 p.R132H;NF1 p.R758Sfs*27;ATRX p.E1395Dfs*95	2	4
P-0002294	P-0002294-T02-IM5	In-House	FFPE	Biopsy	250	758	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);Ivosidenib(IDH1 p.R132H);Everolimus(TSC1 p.X305_splice);Olaparib(ATM p.X221_splice);Cabozantinib,Crizotinib(MET Amplification)	Trametinib,Cobimetinib(NF1 p.R758Sfs*27);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E453K;NFE2L2 p.E79K;TP53 p.A138P;IDH1 p.R132H;NF1 p.R758Sfs*27;ATRX p.E1395Dfs*95;PTPN11 p.A72T;JAK1 p.X1087_splice;FUBP1 p.Q644*;MSH6 p.X1147_splice;TET2 p.T1220I;TET2 p.R1302I;MAP3K1 p.W1449*;PTPRD p.X1138_splice;TSC1 p.X305_splice;ATM p.X221_splice;PTPN11 p.P491S;NOTCH3 p.X268_splice;CCND2 Amplification;CDKN2A Deletion;CDKN2B Deletion;KDM5A Amplification;MET Amplification;NPM1 Deletion;TGFBR2 Deletion	7	25
P-0002295	P-0002295-T01-IM3	In-House	FFPE	Biopsy	250	892	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										SETD2 p.S1390*;SETD2 p.Q884*	0	2
P-0002296	P-0002296-T01-IM3	In-House	FFPE	Biopsy	250	953	30	Matched	Metastasis	Prostate	Liver	Tumor	PRSCC	Prostate Cancer	Prostate Small Cell Carcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	KMT2A p.Y3874*;RB1 p.I532Nfs*57;BRCA2 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion;FOXP1 FOXP1-intragenic	2	6
P-0002297	P-0002297-T01-IM3	Outside	FFPE	Biopsy	250	928	20	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;KMT2C p.T610Sfs*4	2	2
P-0002298	P-0002298-T01-IM3	In-House	FFPE	Biopsy	147.74	137	20	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.Q564*	1	2
P-0002299	P-0002299-T01-IM3	In-House	FFPE	Biopsy	250	721	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										BAP1 p.P190Wfs*4;PMAIP1 Deletion	0	2
P-0002301	P-0002301-T01-IM3	In-House	FFPE	Resection	110.5	220	60	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CCNE1 Amplification;CDK4 Amplification;EGFR Amplification;JUN Amplification;MDM2 Amplification;RICTOR Amplification	2	6
P-0002302	P-0002302-T01-IM3	In-House	FFPE	Resection	250	177	NA	Matched	Metastasis	Ovary	Pelvis	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					GSK2636771,AZD8186(PTEN p.I67V)				LEVEL_4	PTEN p.I67V;TP53 p.L43*;BRD4 Amplification;FOXA1 Deletion;KRAS Amplification	1	5
P-0002303	P-0002303-T01-IM3	In-House	FFPE	Biopsy	156.2	773	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R273C;NCOR1 p.X451_splice	0	2
P-0002304	P-0002304-T01-IM3	In-House	FFPE	Biopsy	217	801	20	Matched	Metastasis	Prostate	Testis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.R219S;FOXA1 p.S285Rfs*26;PIK3R1 Deletion;SHBG TP53-SHBG fusion;TP53 TP53-SHBG fusion;TP53 SPDYE4-TP53 fusion;SPDYE4 SPDYE4-TP53 fusion	0	7
P-0002305	P-0002305-T01-IM3	In-House	FFPE	Biopsy	250	754	30	Matched	Metastasis	Skin	In-transit	Tumor	ACRM	Melanoma	Acral Melanoma			Trametinib,Cobimetinib(METTL2B BRAF-METTL2B fusion);Trametinib,Cobimetinib(BRAF BRAF-METTL2B fusion)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3A	PIK3CB p.D1067V;SETD2 p.F1575Lfs*13;CDKN2A p.R80*;BRAF Amplification;TERT Amplification;METTL2B BRAF-METTL2B fusion;BRAF BRAF-METTL2B fusion	3	7
P-0002306	P-0002306-T01-IM3	In-House	FFPE	Resection	250	791	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133S;TP53 p.L252del	0	2
P-0002307	P-0002307-T01-IM3	Outside	FFPE	Resection	171	172	30	Matched	Primary	Uterus	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										TRAF7 p.N520S;MCL1 Amplification	0	2
P-0002308	P-0002308-T01-IM3	In-House	FFPE	Resection	250	604	70	Matched	Metastasis	Testis	Omentum	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										TP53 p.R273C;TP53 p.C135F;CCND2 Amplification;KRAS Amplification;PTPRD Deletion	0	5
P-0002308	P-0002308-T02-IM3	Outside	FFPE	Resection	250	638	60	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										KRAS Amplification	0	1
P-0002309	P-0002309-T01-IM3	In-House	FFPE	Biopsy	250	798	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.A159V;CTNNB1 p.S37F	2	4
P-0002310	P-0002310-T01-IM3	In-House	FFPE	Resection	250	759	NA	Matched	Metastasis	Ovary	Perigastric nodules	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										PMS2 p.R20Q;FANCA p.S1088F;TP53 p.P128Lfs*42;CCNE1 Amplification;KRAS Amplification	0	5
P-0002311	P-0002311-T01-IM3	In-House	FFPE	Biopsy	250	1173	40	Matched	Metastasis	Bladder	Pelvis	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		GSK2636771,AZD8186(PTEN p.L25F);Tazemetostat(KDM6A p.Q329*)				LEVEL_1	FGFR3 p.S249C;ARID1A p.Q566*;NSD1 p.E1391*;PTEN p.L25F;AKT2 p.E17K;KDM6A p.Q329*;CDKN1A p.S31Rfs*13;EGFR Amplification	4	8
P-0002312	P-0002312-T01-IM3	Outside	FFPE	Biopsy	67	304	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;RB1 p.Q257*	2	2
P-0002313	P-0002313-T01-IM3	Outside	FFPE	Resection	250	677	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.G245S;TP53 p.R273C;IDH1 p.R132H;ATRX p.A834Pfs*35	1	4
P-0002314	P-0002314-T01-IM3	In-House	FFPE	Resection	250	894	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0002315	P-0002315-T01-IM3	Outside	FFPE	Resection	250	583	60	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Olaparib(RAD51C p.S356*)					LEVEL_3B	TP53 p.Q104*;RAD51C p.S356*;NOTCH4 p.C1220Wfs*15	1	3
P-0002316	P-0002316-T01-IM3	Outside	FFPE	Biopsy	250	777	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S313Lfs*11)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRCA2 p.S313Lfs*11;NCOR1 p.K1316Sfs*3;ATRX p.S342*;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0002317	P-0002317-T01-IM3	In-House	FFPE	Resection	250	650	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Everolimus(TSC2 Deletion)					LEVEL_3B	TP53 p.G154Afs*28;ARID1B Deletion;AXIN1 Deletion;CDKN1A Deletion;MEN1 Deletion;SOCS1 Deletion;TERT Amplification;TP53 Deletion;TSC2 Deletion	1	9
P-0002318	P-0002318-T01-IM3	In-House	FFPE	Resection	250	1367	50	Matched	Metastasis	Retroperitoneum	Peritoneum	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.H193Y;CTCF Deletion;RB1 Deletion	0	3
P-0002319	P-0002319-T01-IM3	In-House	FFPE	Resection	250	683	10	Matched	Primary	Liver	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0002320	P-0002320-T01-IM3	Outside	FFPE	Cytology	250	1494	20	Matched	Metastasis	Lung	Mediastinum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G776delinsVC)	Neratinib(ERBB2 p.G776delinsVC)	Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	ERBB2 p.G776delinsVC;TP53 p.E286*;ERBB2 Amplification;FOXA1 Amplification;NKX2-1 Amplification	3	5
P-0002321	P-0002321-T01-IM3	Outside	FFPE	Resection	250	761	30	Matched	Metastasis	Cecum	Ovary	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R273C;TP53 p.G105C;APC p.T1556Nfs*3;APC p.S943*;SMAD4 p.E390*;KRAS p.G13D;CUL1 EZH2-CUL1 fusion;EZH2 EZH2-CUL1 fusion	1	8
P-0002322	P-0002322-T01-IM3	Outside	FFPE	Resection	250	546	10	Matched	Primary	Appendix	Not Applicable	Tumor	GCCAP	Appendiceal Cancer	Goblet Cell Carcinoid of the Appendix										ARID1A p.R750*;KDM6A p.R612*;SMAD4 p.G365_E377del	0	3
P-0002323	P-0002323-T01-IM3	Outside	FFPE	Biopsy	250	717	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.E286K;CTNNB1 p.D32H;TRAP1 CREBBP-TRAP1 fusion;CREBBP CREBBP-TRAP1 fusion	1	5
P-0002324	P-0002324-T01-IM3	In-House	FFPE	Biopsy	250	652	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;GATA3 p.P408Afs*99	1	2
P-0002326	P-0002326-T01-IM3	In-House	FFPE	Resection	250	724	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;DDR2 Amplification;MDM2 Amplification	2	3
P-0002326	P-0002326-T02-IM5	Outside	FFPE	Resection	250	741	60	Matched	Primary	Inguinal Canal	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;DDR2 Amplification;JUN Amplification;MDM2 Amplification	2	4
P-0002327	P-0002327-T01-IM3	Outside	FFPE	Resection	250	626	15	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	BRAF p.V600E;PIK3CA p.E545K;TP53 p.L130V;BMPR1A p.V141Cfs*8	4	4
P-0002328	P-0002328-T02-IM5	Outside	FFPE	Biopsy	250	523	40	Matched	Primary	Ethmoid Sinus	Not Applicable	Tumor	HNNE	Head and Neck Cancer	Head and Neck Neuroendocrine Carcinoma											0	0
P-0002328	P-0002328-T01-IM3	Outside	FFPE	Resection	250	801	20	Matched	Metastasis	Ethmoid Sinus	Lymph Node	Tumor	HNNE	Head and Neck Cancer	Head and Neck Neuroendocrine Carcinoma											0	0
P-0002329	P-0002329-T01-IM3	In-House	FFPE	Resection	250	654	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719C);Afatinib(EGFR p.S768I)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.G719C;EGFR p.S768I;CDK4 Amplification;ETV1 Amplification;MDM2 Amplification	4	5
P-0002330	P-0002330-T01-IM3	In-House	FFPE	Biopsy	250	992	60	Matched	Metastasis	Colon	Liver	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_3B	KRAS p.G12R;TP53 p.R342*;APC p.R1114*;APC p.S1355Cfs*9;RB1 p.V654Sfs*14;BRCA2 Deletion;ERCC3 Deletion;FGFR1 Amplification;LATS2 Deletion;PMS1 Deletion	3	10
P-0002331	P-0002331-T01-IM3	Outside	FFPE	Resection	250	689	30	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Tazemetostat(SMARCB1 p.L356Dfs*4)				LEVEL_4	SMARCB1 p.L356Dfs*4	1	1
P-0002332	P-0002332-T01-IM3	In-House	FFPE	Biopsy	250	833	50	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Olaparib(CDK12 p.Y319*)	PLX8394(BRAF p.G469A);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Y319*)				LEVEL_3B	BRAF p.G469A;CDK12 p.Y319*;MAX Deletion	3	3
P-0002333	P-0002333-T01-IM3	In-House	FFPE	Resection	250	479	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0002334	P-0002334-T01-IM3	Outside	FFPE	Resection	250	398	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PBRM1 PBRM1-intragenic	0	1
P-0002335	P-0002335-T01-IM3	Outside	FFPE	Resection	250	732	60	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.P278T;IDH1 p.R132H;EIF1AX p.R13C;TP53 p.P219R;ARID1A p.S1001Ffs*6;ATRX p.S871Hfs*34	1	6
P-0002336	P-0002336-T01-IM3	In-House	FFPE	Biopsy	250	538	30	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	Olaparib(BRIP1 p.V723Hfs*13);Olaparib(BARD1 Deletion)					LEVEL_1	PIK3CA p.H1047L;TP53 p.I255N;CBFB p.L119Wfs*20;NCOR1 p.L291Ffs*2;BRIP1 p.V723Hfs*13;BARD1 Deletion;CBFB Deletion;CDH1 Deletion;CTCF Deletion;RB1 Deletion;ARID2 ARID2-intragenic	4	11
P-0002337	P-0002337-T01-IM3	In-House	FFPE	Resection	250	882	60	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma										TP53 p.S127P;AKT2 Amplification;AURKA Amplification;CCNE1 Amplification;ERBB3 Amplification	0	5
P-0002338	P-0002338-T01-IM3	Outside	FFPE	Resection	250	488	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.E746_A750del;SMAD4 p.K428M;CDK4 Amplification;MDM2 Amplification;PIK3CB Amplification	3	5
P-0002339	P-0002339-T01-IM3	Outside	FFPE	Biopsy	250	843	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.R248Q;SMAD4 p.R361H;RNF43 p.A356Cfs*87	3	4
P-0002340	P-0002340-T01-IM3	Outside	FFPE	Cytology	250	761	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;RB1 p.Q685*;EP300 p.X1243_splice;STK11 p.E57Gfs*106;KEAP1 p.M147_E149delinsIG*;MCL1 Amplification	2	6
P-0002341	P-0002341-T01-IM3	In-House	FFPE	Biopsy	250	719	50	Matched	Metastasis	Penis	Lymph Node	Tumor	PSCC	Penile Cancer	Penile Squamous Cell Carcinoma										TP53 p.R213*;CREBBP p.S1680del;SETD2 p.Q1797*;EZH2 p.S639*;KMT2C p.S1200*;KMT2D p.W4987*;KMT2D p.S3614*	0	7
P-0002342	P-0002342-T01-IM3	In-House	FFPE	Resection	250	636	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	IMT	Soft Tissue Sarcoma	Inflammatory Myofibroblastic Tumor											0	0
P-0002343	P-0002343-T01-IM3	In-House	FFPE	Resection	250	555	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X3215_splice)					LEVEL_3B	TP53 p.R213*;APC p.Q1367*;BRCA2 p.X3215_splice	1	3
P-0002344	P-0002344-T01-IM3	In-House	FFPE	Resection	250	493	50	Matched	Metastasis	Uterus	Adrenal Gland	Tumor	BCCA	Germ Cell Tumor	Choriocarcinoma										TGFBR2 p.E214*;GRIN2A p.X786_splice;TP53 p.R249I	0	3
P-0002345	P-0002345-T01-IM3	Outside	FFPE	Biopsy	250	1415	60	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					GSK2636771,AZD8186(PTEN p.S170I)				LEVEL_4	TP53 p.V157F;MLH1 p.G232*;EPHA3 p.E98*;PTEN p.S170I;CDKN1B p.S138*;RB1 p.E166*;BCOR Deletion;TERT Amplification	1	8
P-0002347	P-0002347-T01-IM3	Outside	FFPE	Resection	250	740	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Trametinib,Cobimetinib(NF1 p.I679Dfs*21);Trametinib,Cobimetinib(NF1 p.X160_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R282W;TP53 p.R158H;PIK3CA p.R88Q;NF1 p.I679Dfs*21;MSH2 p.X264_splice;PTPN11 p.A72V;NF1 p.X160_splice;ASXL1 p.Q428Tfs*10;BCOR p.S158Kfs*28;CDKN2A Deletion;CDKN2B Deletion	4	11
P-0002348	P-0002348-T01-IM3	In-House	FFPE	Resection	250	472	40	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma											0	0
P-0002349	P-0002349-T02-IM5	Outside	DNA	Resection	250	653	70	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Tazemetostat(SMARCB1 p.R377H)				LEVEL_4	SMARCB1 p.R377H;NF2 p.E335Sfs*11	1	2
P-0002351	P-0002351-T01-IM3	In-House	FFPE	Cytology	250	692	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	TP53 p.R248L;AKT2 Amplification;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	2	4
P-0002353	P-0002353-T01-IM3	In-House	FFPE	Biopsy	250	913	60	Matched	Metastasis	Skin	Bone	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;ARID2 p.S297F;PTPRT p.Q1180*;PTPRT p.E548K	1	4
P-0002354	P-0002354-T01-IM3	Outside	FFPE	Resection	250	388	50	Matched	Primary	Oral Cavity	Not Applicable	Tumor	ASPS	Soft Tissue Sarcoma	Alveolar Soft Part Sarcoma											0	0
P-0002356	P-0002356-T01-IM3	In-House	FFPE	Resection	250	834	80	Matched	Metastasis	Uterus	Liver	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib(RAD51B Deletion)					LEVEL_3B	TP53 p.R213*;MED12 p.G44S;TP53 p.F113Qfs*5;FH Deletion;KDM5C Deletion;RAD51B Deletion;RB1 Deletion	1	7
P-0002357	P-0002357-T01-IM3	Outside	FFPE	Resection	250	846	70	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D1029H)					LEVEL_3B	FBXW7 p.R465H;PIK3CA p.H1047Y;PIK3CA p.D1029H;TP53 p.P301Qfs*44	2	4
P-0002358	P-0002358-T01-IM3	Outside	FFPE	Resection	250	220	10	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0002359	P-0002359-T01-IM3	In-House	FFPE	Resection	250	795	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										U2AF1 p.S34F;TGFBR2 p.X466_splice;STK11 p.Y118*;SMARCA4 p.X1545_splice	0	4
P-0002360	P-0002360-T01-IM3	Outside	FFPE	Resection	250	608	20	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0002361	P-0002361-T01-IM3	Outside	FFPE	Resection	250	580	40	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Everolimus(TSC2 p.S1431*);Olaparib(ATM p.R2138Kfs*8);Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CTNNB1 p.S45P;TSC2 p.S1431*;EED p.H305Qfs*14;ATM p.R2138Kfs*8;CDKN2A Deletion;CDKN2B Deletion;MET Amplification	4	7
P-0002362	P-0002362-T01-IM3	Outside	FFPE	Resection	250	254	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R273C;ERBB2 Amplification	2	2
P-0002363	P-0002363-T01-IM3	In-House	FFPE	Resection	250	285	40	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.G245D;KMT2C p.V3969Lfs*18	0	2
P-0002364	P-0002364-T01-IM3	In-House	FFPE	Resection	250	402	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	KMT2C p.R2884*;KMT2C p.N1818Kfs*31;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	5
P-0002366	P-0002366-T01-IM3	Outside	FFPE	Biopsy	250	990	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;CDH1 p.Q23*;APC p.Q2375*;TBX3 p.Q590*;FGFR1 Amplification	3	5
P-0002367	P-0002367-T01-IM3	In-House	FFPE	Resection	250	759	30	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	TP53 p.R248Q;CDKN2A p.R80*	1	2
P-0002368	P-0002368-T02-IM3	Outside	FFPE	Resection	250	451	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.F113C;EGFR Amplification;GATA3 Amplification	0	3
P-0002369	P-0002369-T01-IM3	In-House	FFPE	Resection	250	515	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					GSK2636771,AZD8186(PTEN p.X212_splice)				LEVEL_4	PPP2R1A p.R183Q;PTEN p.X212_splice;ARID1A p.K2159Pfs*64	1	3
P-0002370	P-0002370-T01-IM3	Outside	FFPE	Resection	250	683	60	Matched	Metastasis	Thymus	Mediastinum	Tumor	THYM	Thymic Tumor	Thymoma											0	0
P-0002373	P-0002373-T01-IM3	In-House	FFPE	Resection	250	451	NA	Matched	Metastasis	Ovary	Colon	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(BRIP1 p.X170_splice)					LEVEL_3B	TP53 p.V272M;ETV6 p.G381E;BRIP1 p.X170_splice;SMAD2 p.F273Lfs*2;BCOR Deletion;JUN Amplification;MYC Amplification	1	7
P-0002374	P-0002374-T01-IM3	In-House	FFPE	Biopsy	250	799	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R196*;KMT2A p.R2516Gfs*7;FGFR1 Amplification	1	3
P-0002375	P-0002375-T01-IM3	In-House	FFPE	Biopsy	185.92	610	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	AR Amplification;AURKA Amplification;BRCA2 Deletion;ETV1 Amplification;FANCA Deletion;RB1 Deletion;TP53 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	9
P-0002376	P-0002376-T01-IM3	In-House	FFPE	Resection	250	832	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;KDR Amplification;KIT Amplification;KRAS Amplification;PDGFRA Amplification;RB1 Deletion	1	7
P-0002377	P-0002377-T01-IM3	In-House	FFPE	Resection	250	690	50	Matched	Metastasis	Liver	Diaphragm	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma											0	0
P-0002378	P-0002378-T01-IM3	In-House	FFPE	Resection	250	706	50	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0002379	P-0002379-T01-IM3	In-House	FFPE	Resection	250	489	50	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E110del)		Neratinib(ERBB2 p.L755S);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E110del)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_1	ERBB2 p.L755S;PIK3CA p.E110del;FOXA1 Amplification	4	3
P-0002380	P-0002380-T01-IM3	In-House	FFPE	Resection	250	841	NA	Matched	Metastasis	Skin	Axilla	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;EIF1AX p.R13G	2	2
P-0002382	P-0002382-T01-IM3	Outside	FFPE	Resection	250	793	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA1 p.X71_splice);Olaparib(CHEK2 Deletion)			Niraparib,Talazoparib(BRCA1 p.X71_splice);Sonidegib,Vismodegib(PTCH1 C9orf130-PTCH1 fusion);Sonidegib,Vismodegib(LINC00476 C9orf130-PTCH1 fusion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRCA1 p.X71_splice;BMPR1A Deletion;CHEK2 Deletion;FOXA1 Amplification;MYC Amplification;PTEN Deletion;RB1 Deletion;PTCH1 C9orf130-PTCH1 fusion;LINC00476 C9orf130-PTCH1 fusion	6	9
P-0002383	P-0002383-T01-IM3	In-House	FFPE	Biopsy	250	1185	40	Matched	Metastasis	Colon	Liver	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor										ARID5B p.E550*	0	1
P-0002384	P-0002384-T01-IM3	In-House	FFPE	Resection	250	841	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.L111Ffs*40	0	1
P-0002385	P-0002385-T01-IM3	In-House	FFPE	Resection	250	632	NA	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.M66Qfs*56	0	1
P-0002386	P-0002386-T02-IM5	In-House	FFPE	Resection	250	692	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R175H;IDH1 p.R132H;ATRX p.I383Nfs*11;KLF4 KLF4-intragenic	1	4
P-0002386	P-0002386-T03-IM5	In-House	FFPE	Resection	250	1113	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Ivosidenib(IDH1 p.R132H);Trametinib,Cobimetinib(MAP2K1 p.K57E);Olaparib(RAD51C p.Q181Sfs*3)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R175H;IDH1 p.R132H;MAP2K1 p.K57E;ATRX p.I383Nfs*11;RAD51C p.Q181Sfs*3;KLF4 KLF4-intragenic	4	7
P-0002386	P-0002386-T01-IM3	Outside	FFPE	Biopsy	250	440	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Ivosidenib(IDH1 p.R132H);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	PIK3CA p.H1047R;TP53 p.R175H;IDH1 p.R132H;ATRX p.I383Nfs*11;ALK Amplification;CDK4 Amplification;ERBB3 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	3	10
P-0002387	P-0002387-T01-IM3	In-House	FFPE	Resection	250	613	50	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		AZD9496,Fulvestrant(ESR1 p.D538G);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	ESR1 p.D538G;PIK3CA p.E542K;GATA3 p.P408Afs*99;AKT2 Amplification;ARID1A Deletion;AURKA Amplification;MAP3K1 Deletion;NOTCH1 Deletion;PRDM1 Deletion	3	9
P-0002388	P-0002388-T01-IM3	Outside	FFPE	Resection	250	667	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K;SMAD4 p.D439Gfs*3	2	2
P-0002390	P-0002390-T01-IM3	In-House	FFPE	Biopsy	250	975	50	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	GATA3 p.D335Gfs*17;AURKA Amplification;CCND1 Amplification;CDKN1B Deletion;FGF19 Amplification;FGFR1 Amplification;KDM5A Amplification;MDM2 Amplification;MYC Amplification	2	9
P-0002391	P-0002391-T01-IM3	In-House	FFPE	Cytology	170	740	30	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Everolimus(TSC2 Deletion)					LEVEL_3B	MEN1 p.Y227Tfs*2;CDKN2C Deletion;TSC2 Deletion	1	3
P-0002392	P-0002392-T01-IM3	In-House	FFPE	Resection	250	703	60	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.X615_splice);Trametinib,Cobimetinib(NF1 p.X2308_splice)				LEVEL_4	RB1 p.X203_splice;NF1 p.X615_splice;NF2 p.X525_splice;NF1 p.X2308_splice	2	4
P-0002393	P-0002393-T01-IM3	In-House	FFPE	Biopsy	163	810	40	Matched	Metastasis	Retroperitoneum	Liver	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	NSD1 p.H1808Tfs*13;CDK4 Amplification;JUN Amplification;MDM2 Amplification;TERT Amplification	2	5
P-0002394	P-0002394-T01-IM3	In-House	FFPE	Resection	157	768	40	Matched	Metastasis	Lung	Bone	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.G35W)				LEVEL_3B	TP53 p.L35Cfs*9;ARID1A p.E2078*;ASXL1 p.E705*;TP53 p.E294Sfs*51;CDKN2A p.G35W;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	2	8
P-0002395	P-0002395-T01-IM3	Outside	FFPE	Biopsy	72.45	326	20	Matched	Metastasis	Sigmoid Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0002396	P-0002396-T01-IM3	In-House	FFPE	Biopsy	250	957	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Trametinib,Cobimetinib(NF1 p.X68_splice);GSK2636771,AZD8186(PTEN p.P248Tfs*5)				LEVEL_3B	PIK3CA p.R88Q;RB1 p.X464_splice;NF1 p.X68_splice;PTEN p.P248Tfs*5	3	4
P-0002397	P-0002397-T01-IM3	Outside	FFPE	Biopsy	144	622	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0002398	P-0002398-T01-IM3	In-House	FFPE	Biopsy	250	659	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	PAX5 p.X202_splice;EP300 p.X541_splice;BRCA2 Deletion;TMPRSS2 ETV1-TMPRSS2 fusion;ETV1 ETV1-TMPRSS2 fusion	2	5
P-0002398	P-0002398-T02-IM3	In-House	FFPE	Resection	250	212	NA	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	EP300 p.X541_splice;BRCA2 Deletion;TMPRSS2 ETV1-TMPRSS2 fusion;ETV1 ETV1-TMPRSS2 fusion	2	4
P-0002399	P-0002399-T01-IM3	In-House	FFPE	Biopsy	250	799	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P408Afs*99;MCL1 Amplification	0	2
P-0002400	P-0002400-T01-IM3	In-House	FFPE	Biopsy	61	408	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Y68H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	TP53 p.P278S;PTEN p.Y68H;CDKN2A p.H83Y	2	3
P-0002401	P-0002401-T01-IM3	Outside	FFPE	Resection	250	802	30	Matched	Metastasis	Testis	Retroperitoneum	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor				Olaparib(CHEK1 Deletion);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	CCND2 Amplification;CHEK1 Deletion;KDM5A Amplification;KRAS Amplification;MET Amplification	2	5
P-0002402	P-0002402-T01-IM3	Outside	FFPE	Resection	250	833	NA	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 p.Q277*;BAP1 p.Q253*;NCOR1 MPRIP-NCOR1 fusion;MPRIP MPRIP-NCOR1 fusion	0	4
P-0002403	P-0002403-T01-IM3	Outside	FFPE	Biopsy	250	793	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Olaparib(BRIP1 p.E1230Qfs*3)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108H)				LEVEL_1	EGFR p.L858R;TP53 p.R280K;BRIP1 p.E1230Qfs*3;CDKN2A p.D108H	3	4
P-0002404	P-0002404-T01-IM3	Outside	FFPE	Resection	250	632	NA	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KMT2D p.A1390Gfs*42;TP53 p.C176Sfs*67;BCL2L1 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MYCN Amplification;RAF1 Amplification	1	8
P-0002405	P-0002405-T01-IM3	Outside	FFPE	Resection	250	946	NA	Matched	Metastasis	Sweat Gland	Kidney	Tumor	SGAD	Skin Cancer, Non-Melanoma	Sweat Gland Adenocarcinoma										TP53 p.G245D;ARID1A p.E2246*;MAP2K4 Deletion	0	3
P-0002406	P-0002406-T01-IM3	In-House	FFPE	Cytology	250	842	NA	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.G334V;SMARCA4 p.V318Ffs*69	0	2
P-0002407	P-0002407-T01-IM3	Outside	FFPE	Resection	250	846	NA	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R213*;APC p.E941*;CDK8 Amplification;FLT3 Amplification;ATR ATR-intragenic	0	5
P-0002408	P-0002408-T02-IM5	In-House	FFPE	Cytology	90	538	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0002408	P-0002408-T01-IM3	Outside	FFPE	Resection	250	871	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0002409	P-0002409-T01-IM3	Outside	FFPE	Resection	250	794	NA	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V654A)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib(KIT p.V654A)		LEVEL_1	KIT p.V654A;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	2	4
P-0002410	P-0002410-T01-IM3	In-House	FFPE	Biopsy	250	846	50	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										TP53 p.X33_splice;SETD2 p.A2460Rfs*5;NF2 p.Y144*	0	3
P-0002411	P-0002411-T01-IM3	In-House	FFPE	Biopsy	149	936	40	Matched	Primary	Nasopharynx	Not Applicable	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;FBXW7 p.R479Q;NFE2L2 p.L30F;ARID1A p.R1989*;BCL6 p.R594G;KMT2D p.W4987*	1	6
P-0002412	P-0002412-T01-IM3	Outside	FFPE	Resection	250	586	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.Q37*	2	2
P-0002413	P-0002413-T01-IM3	Outside	FFPE	Resection	250	862	30	Matched	Primary	Colorectal NOS	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	PIK3CA p.Q546K;KRAS p.A146T;APC p.Q1429*;MAP3K1 p.R288*;SOX9 p.E400*;APC p.T772Lfs*5	2	6
P-0002414	P-0002414-T01-IM3	In-House	FFPE	Resection	250	913	40	Matched	Primary	Small Bowel	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib(NF1 p.R1276*);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.R306*;FBXW7 p.R479Q;NF1 p.R1276*;SMAD3 p.S418Afs*58;KRAS p.G13D;SMAD4 Deletion	2	6
P-0002415	P-0002415-T01-IM3	In-House	FFPE	Resection	250	690	40	Matched	Metastasis	Pleura	Lymph Node	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0002416	P-0002416-T01-IM3	Outside	FFPE	Biopsy	105.6	517	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;DICER1 p.G314*	2	2
P-0002417	P-0002417-T02-IM5	In-House	FFPE	Biopsy	250	918	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AZD5363(AKT1 p.E17K);Trametinib,Cobimetinib(MAP2K1 p.K57N)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	AKT1 p.E17K;MAP2K1 p.K57N;GATA3 p.R366*;KMT2A p.I1305Sfs*53;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0002417	P-0002417-T01-IM3	Outside	FFPE	Resection	250	723	30	Matched	Metastasis	Cancer of Unknown Primary	Pelvis	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AZD5363(AKT1 p.E17K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	AKT1 p.E17K;GATA3 p.R366*;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0002418	P-0002418-T01-IM3	In-House	FFPE	Resection	250	608	30	Matched	Metastasis	Skin	Abdomen	Tumor	SKCM	Melanoma	Cutaneous Melanoma										SF3B1 p.R625C;GNAQ p.Q209L	0	2
P-0002419	P-0002419-T01-IM3	Outside	FFPE	Biopsy	204.12	565	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.V216M;SMAD4 p.K436Rfs*40	1	3
P-0002420	P-0002420-T01-IM3	In-House	FFPE	Cytology	250	653	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R273L	0	1
P-0002421	P-0002421-T01-IM3	In-House	FFPE	Resection	250	745	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.T118Qfs*5;KEAP1 p.E441*;PTPRT p.W348Cfs*49;STK11 p.X97_splice	2	5
P-0002422	P-0002422-T01-IM3	Outside	FFPE	Biopsy	250	859	60	Matched	Primary	Urethra	Not Applicable	Tumor	URMM	Melanoma	Mucosal Melanoma of the Urethra				Cabozantinib,Crizotinib(MET Amplification)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	TP53 p.R282W;CCND1 Amplification;CDK6 Amplification;FAT1 Deletion;FGF19 Amplification;MET Amplification;NF1 Deletion;PAK1 Amplification	2	8
P-0002423	P-0002423-T01-IM3	Outside	FFPE	Biopsy	81	455	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.N771_P772insV)			Erlotinib,Gefitinib,Afatinib(EGFR p.N771_P772insV)			LEVEL_3A	TP53 p.C238F;LATS1 p.M57Nfs*20;EGFR p.N771_P772insV;EGFR Amplification	1	4
P-0002424	P-0002424-T01-IM3	Outside	FFPE	Resection	250	1071	30	Matched	Metastasis	Cancer of Unknown Primary	Mediastinum	Tumor	SCCNOS	Cancer of Unknown Primary	Squamous Cell Carcinoma, NOS					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R248Q;PTEN Deletion	1	2
P-0002425	P-0002425-T01-IM3	In-House	FFPE	Biopsy	250	943	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.D281V	1	2
P-0002426	P-0002426-T01-IM3	In-House	FFPE	Biopsy	250	976	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D579del)					LEVEL_1	EGFR p.E746_A750del;CTNNB1 p.S37C;TP53 p.C135Y;KIT p.D579del	2	4
P-0002428	P-0002428-T01-IM3	Outside	FFPE	Biopsy	250	398	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R273H;CDH1 p.Y190C;FOXA1 Amplification	0	3
P-0002429	P-0002429-T01-IM3	Outside	FFPE	Resection	250	617	60	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma										SF3B1 p.R625H;GNAQ p.Q209L	0	2
P-0002430	P-0002430-T01-IM3	In-House	FFPE	Resection	250	843	60	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										RB1 p.R467*	0	1
P-0002431	P-0002431-T01-IM3	In-House	FFPE	Resection	250	692	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0002433	P-0002433-T01-IM3	In-House	FFPE	Biopsy	250	633	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Olaparib(BRIP1 p.C693Ffs*23)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	TP53 p.R248W;KRAS p.G12V;ARID1A p.Q563*;TGFBR1 p.Y182*;BRIP1 p.C693Ffs*23	2	5
P-0002434	P-0002434-T01-IM3	Outside	FFPE	Cytology	135.3	744	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;CDKN2A Deletion;CDKN2B Deletion;MAP2K4 Deletion	2	4
P-0002435	P-0002435-T01-IM3	In-House	FFPE	Biopsy	86	669	50	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(BRIP1 BRIP1-intragenic)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	SPEN p.E2910*;TP53 p.R283P;ERCC4 p.G914Rfs*26;AMER1 Deletion;ATRX Deletion;BCOR Deletion;BMPR1A Deletion;CDKN2A Deletion;ERCC3 Deletion;FAT1 Deletion;FGFR3 Amplification;FH Deletion;FLCN Deletion;FLT3 Amplification;KDM5C Deletion;KDM6A Deletion;LATS1 Deletion;MED12 Deletion;PARP1 Deletion;PTEN Deletion;RBM10 Deletion;SH2D1A Deletion;STAG2 Deletion;TNFRSF14 Deletion;BRIP1 BRIP1-intragenic	3	25
P-0002436	P-0002436-T01-IM3	Outside	FFPE	Biopsy	250	509	50	Matched	Primary	Rectum	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										KMT2D p.Q4045*;AMER1 Deletion	0	2
P-0002437	P-0002437-T01-IM3	Outside	FFPE	Biopsy	250	233	40	Matched	Metastasis	Skin	Bone	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;CTNNB1 p.S45A;ARID2 p.Q288*;TP53 p.M243I	2	4
P-0002438	P-0002438-T01-IM3	In-House	FFPE	Resection	250	831	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R640W;LATS1 p.E1072*;TP53 p.H179Y	0	3
P-0002439	P-0002439-T01-IM3	In-House	FFPE	Resection	250	458	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.F266L	0	1
P-0002440	P-0002440-T01-IM3	In-House	FFPE	Biopsy	250	722	60	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(MAP2K1 p.P124L);Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*)				LEVEL_3A	MAP2K1 p.P124L;RAF1 p.S257L;NRAS p.Q61H;CDKN2A p.E88*	3	4
P-0002441	P-0002441-T01-IM3	Outside	FFPE	Resection	250	700	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	TP53 p.R248W;KRAS p.G12V	1	2
P-0002442	P-0002442-T01-IM3	In-House	FFPE	Biopsy	250	556	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;NCOR1 p.R414*;APC p.A1299Lfs*6	0	3
P-0002443	P-0002443-T01-IM3	Outside	FFPE	Resection	99.4	191	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FOXP1 p.L199_Q200delinsF*;FOXP1 p.Q56Rfs*26;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;GATA3 Amplification;MCL1 Amplification;PAK1 Amplification	1	8
P-0002444	P-0002444-T01-IM3	Outside	FFPE	Biopsy	232.2	737	NA	Matched	Metastasis	Lung	Muscle	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3A	KRAS p.G12C;INPP4B p.X168_splice;STK11 p.R304W;SMARCA4 p.Q413Rfs*88;KRAS p.G13D;KEAP1 p.S338F	3	6
P-0002445	P-0002445-T01-IM3	Outside	FFPE	Biopsy	250	483	20	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.Y174*)				LEVEL_4	SETD2 p.R424*;PTEN p.Y174*;CDH1 p.P277Qfs*5	1	3
P-0002446	P-0002446-T01-IM3	Outside	FFPE	Biopsy	238.74	549	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.L861Q;ARID1A p.G1267Afs*19;TP53 p.R337_E343del;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion	2	6
P-0002447	P-0002447-T01-IM3	Outside	FFPE	Resection	250	154	NA	Matched	Metastasis	Breast	Brain	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification;KDM5A Amplification;NCOR1 Deletion	2	3
P-0002448	P-0002448-T02-IM3	In-House	FFPE	Resection	250	526	60	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma										SUFU p.X106_splice;TP53 Deletion	0	2
P-0002449	P-0002449-T01-IM3	Outside	FFPE	Resection	250	769	50	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										TP53 p.R273H	0	1
P-0002449	P-0002449-T02-IM5	Outside	FFPE	Resection	250	395	90	Matched	Metastasis	Kidney	Lymph Node	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										TP53 p.R273H	0	1
P-0002450	P-0002450-T01-IM3	Outside	FFPE	Biopsy	250	474	NA	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast					GSK2636771,AZD8186(PTEN p.Y68H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.Y68H;RUNX1 p.Y376Wfs*192;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0002451	P-0002451-T01-IM3	In-House	FFPE	Resection	250	549	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.A767_V769dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.A767_V769dup)			LEVEL_3A	TP53 p.X187_splice;EGFR p.A767_V769dup;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0002451	P-0002451-T02-IM5	Outside	FFPE	Resection	250	666	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.A767_V769dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.A767_V769dup)			LEVEL_3A	TP53 p.X187_splice;EGFR p.A767_V769dup	1	2
P-0002452	P-0002452-T01-IM3	Outside	FFPE	Biopsy	144	609	NA	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	CDK4 Amplification;TP53 Deletion	1	2
P-0002453	P-0002453-T01-IM3	In-House	FFPE	Resection	250	411	NA	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0002454	P-0002454-T01-IM3	In-House	FFPE	Biopsy	250	776	NA	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R87P)				LEVEL_4	TP53 p.R342Efs*3;CDKN2A p.R87P;CDK6 Amplification;EGFR Amplification	1	4
P-0002455	P-0002455-T01-IM3	Outside	FFPE	Biopsy	250	549	NA	Matched	Metastasis	Cecum	Pelvis	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(BARD1 p.Q206Afs*8)	Trametinib,Cobimetinib(NF1 p.Y628Tfs*3);Trametinib,Cobimetinib(NF1 p.S825Ifs*6)				LEVEL_1	SUFU p.A25Gfs*23;BRAF p.V600E;EP300 p.M1470Cfs*26;RNF43 p.G659Vfs*41;NF1 p.Y628Tfs*3;CIC p.P1597Hfs*23;MUTYH p.R182W;EED p.R313*;PMS1 p.K549Nfs*4;BARD1 p.Q206Afs*8;PBRM1 p.K651Nfs*5;FOXL2 p.K193Sfs*78;TET2 p.V1949*;FAT1 p.F3952Lfs*31;FAT1 p.V1878Cfs*8;APC p.K1686Nfs*23;PMS2 p.Y268Tfs*39;TET1 p.R1744Efs*18;NF1 p.S825Ifs*6;AXIN2 p.L688*;SMARCA4 p.D1175*;ASXL1 p.G646Vfs*58;BCOR p.S158Vfs*3;FOXA1 Amplification	6	24
P-0002456	P-0002456-T01-IM3	Outside	FFPE	Biopsy	250	808	NA	Matched	Primary	Esophagus	Not Applicable	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345D)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	CTNNB1 p.S37F;PIK3CA p.N345D;CDKN2A Deletion;NF1 Deletion	3	4
P-0002457	P-0002457-T01-IM3	Outside	FFPE	Biopsy	165	607	NA	Matched	Primary	Mediastinum	Not Applicable	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;TP53 p.P250L	1	2
P-0002458	P-0002458-T01-IM3	In-House	FFPE	Resection	250	511	NA	Matched	Metastasis	Pancreas	Ovary	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	KRAS p.G12D;ARID1A p.X1663_splice;CDKN2A p.R80*	2	3
P-0002459	P-0002459-T01-IM3	Outside	FFPE	Biopsy	250	593	NA	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Tazemetostat(SMARCB1 p.G33Efs*22)				LEVEL_4	KRAS p.Q61H;STAG2 p.Q167*;SMARCB1 p.G33Efs*22;KRAS Amplification;NKX2-1 Amplification	2	5
P-0002460	P-0002460-T01-IM3	Outside	FFPE	Biopsy	250	373	NA	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.N210Hfs*5;CCNE1 Amplification;RICTOR Amplification	0	3
P-0002461	P-0002461-T02-IM5	In-House	DNA	Resection	250	694	30	Matched	Metastasis	Appendix	Ovary	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma										SOX9 p.Q393Sfs*10;RNF43 p.P52Nfs*20;CCND2 Amplification	0	3
P-0002462	P-0002462-T01-IM3	In-House	FFPE	Biopsy	250	474	NA	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 p.G614Sfs*25	0	1
P-0002463	P-0002463-T01-IM3	In-House	FFPE	Biopsy	250	1101	NA	Matched	Metastasis	Cecum	Vagina	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Sonidegib,Vismodegib(PTCH1 p.R1308Qfs*17)	GSK2636771,AZD8186(PTEN p.N323Mfs*21);Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_1	BRAF p.V600E;FBXW7 p.S668Vfs*39;EP300 p.M1470Cfs*26;PIK3CA p.H1047R;PTEN p.N323Mfs*21;KRAS p.G12A;CDC73 p.R120*;CIC p.S902*;PTPRD p.G61Efs*11;PTCH1 p.R1308Qfs*17;ARID2 p.P851Hfs*4;KMT2D p.G5182Afs*61;SMAD3 p.P182Lfs*4;CREBBP p.L524Wfs*6;SOCS1 p.L84*;ATRX p.G859Rfs*4	7	16
P-0002463	P-0002463-T02-IM5	Outside	FFPE	Resection	250	675	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	BRAF p.V600E;FBXW7 p.S668Vfs*39;EP300 p.M1470Cfs*26;PIK3CA p.H1047R;RNF43 p.G659Vfs*41;CDC73 p.R120*;PTPRD p.G61Efs*11;ARID2 p.P851Hfs*4;KMT2D p.G5182Afs*61;SMAD3 p.P182Lfs*4;CREBBP p.L524Wfs*6;SOCS1 p.L84*;ATRX p.G859Rfs*4;HLA-A p.Q139*;EP300 p.X1485_splice;BCOR p.T938Pfs*18;SPEN p.I1052Sfs*40;ATRX p.T1582Nfs*19	4	18
P-0002464	P-0002464-T01-IM3	In-House	FFPE	Biopsy	250	541	NA	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	GNAQ p.R183Q;SF3B1 p.R625H;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0002464	P-0002464-T02-IM5	In-House	FFPE	Biopsy	250	899	60	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	GNAQ p.R183Q;SF3B1 p.R625H;ZRSR2 p.X14_splice;CDKN2A Deletion;CDKN2B Deletion;EPHA7 Deletion;ID3 Deletion	1	7
P-0002465	P-0002465-T01-IM3	In-House	FFPE	Biopsy	250	765	NA	Matched	Metastasis	GE Junction	Liver	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.E835*)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.Y220C;PTCH1 p.E835*;CCNE1 Amplification;CIC Deletion;PTEN Deletion	2	5
P-0002466	P-0002466-T01-IM3	In-House	FFPE	Resection	250	401	NA	Matched	Metastasis	Pleura	Chest Wall	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma				Sonidegib,Vismodegib(PTCH1 p.Q688*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	SF3B1 p.E622D;PTCH1 p.Q688*;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0002467	P-0002467-T01-IM3	Outside	FFPE	Resection	250	1077	NA	Unmatched	Primary	Lower Extremity	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	JUN Amplification;MDM2 Amplification;NTRK1 Amplification;YAP1 Amplification	1	4
P-0002468	P-0002468-T01-IM3	In-House	FFPE	Resection	250	413	NA	Matched	Metastasis	Stomach	Ovary	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										TP53 p.I195T;CDH1 p.R335*	0	2
P-0002469	P-0002469-T01-IM3	In-House	FFPE	Resection	250	689	NA	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	NOTCH1 p.E455K;ERBB2 Amplification;ATR ATR-intragenic	1	3
P-0002470	P-0002470-T01-IM3	In-House	FFPE	Biopsy	225	695	NA	Matched	Metastasis	Kidney	Liver	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										SMAD4 p.D52Rfs*2	0	1
P-0002472	P-0002472-T01-IM3	In-House	FFPE	Resection	250	521	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R213*;MCL1 Amplification	0	2
P-0002473	P-0002473-T01-IM3	In-House	FFPE	Resection	250	504	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)		Trametinib,Cobimetinib(NF1 R1870fs)				LEVEL_1	PIK3CA p.C420R;TET2 p.E576*;ARID1A p.Q428Afs*195;GATA3 p.Y344Sfs*12;CBFB p.X55_splice;NF1 R1870fs	3	6
P-0002474	P-0002474-T01-IM3	In-House	FFPE	Resection	250	1001	NA	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0002475	P-0002475-T01-IM3	Outside	FFPE	Resection	250	846	NA	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G12D);Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.M1043I;APC p.R216*;SMAD4 p.P356H;SMAD4 p.G386R;KRAS p.G13D	3	6
P-0002476	P-0002476-T01-IM3	In-House	FFPE	Resection	250	732	NA	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification;NTRK1 Amplification;PMS1 Deletion	2	4
P-0002477	P-0002477-T01-IM3	In-House	FFPE	Resection	250	434	NA	Matched	Metastasis	Small Bowel	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V654A);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib(KIT p.V654A)		LEVEL_1	KIT p.V654A;KIT p.L576P;CCND2 Amplification;CDKN2A Deletion;KDM5A Amplification;RB1 Deletion	3	6
P-0002478	P-0002478-T01-IM3	In-House	FFPE	Biopsy	185	476	NA	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.I67T)				LEVEL_1	TP53 p.R342*;PTEN p.I67T;CDH1 p.E445*;ERBB2 Amplification	3	4
P-0002479	P-0002479-T01-IM3	In-House	FFPE	Resection	250	417	NA	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	BRAF p.K601E;MED12 p.G44D	2	2
P-0002480	P-0002480-T01-IM3	Outside	FFPE	Resection	250	445	40	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0002481	P-0002481-T01-IM3	Outside	FFPE	Resection	250	810	NA	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0002482	P-0002482-T01-IM3	In-House	FFPE	Resection	250	577	60	Matched	Metastasis	Stomach	Ovary	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										ERBB3 p.V104M	0	1
P-0002483	P-0002483-T01-IM3	In-House	FFPE	Biopsy	250	477	NA	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.E9Sfs*17)					LEVEL_3B	VHL p.S65L;PBRM1 p.X989_splice;TSC1 p.E9Sfs*17	1	3
P-0002485	P-0002485-T01-IM3	In-House	FFPE	Biopsy	250	608	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.Q245*)				LEVEL_4	PTEN p.Q245*;TP53 p.R156H;BMPR1A p.M470Yfs*3	1	3
P-0002486	P-0002486-T01-IM3	In-House	FFPE	Resection	250	199	NA	Matched	Primary	Minor Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										NOTCH1 p.S2467*;NOTCH1 p.N390Tfs*243;CREBBP p.S801Qfs*29	0	3
P-0002487	P-0002487-T01-IM3	In-House	FFPE	Resection	250	562	20	Matched	Metastasis	Cecum	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.M133Dfs*16;RNF43 p.F103Cfs*19;HRAS Amplification;MYC Amplification	3	5
P-0002488	P-0002488-T01-IM3	In-House	FFPE	Biopsy	250	719	NA	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	EGFR p.L858R;TP53 p.R282W;ERBB2 p.S310F;APC p.E1322*;SOX9 p.Q410*;APC p.Q1260Dfs*15;NKX3-1 Deletion;SMAD4 SMAD4-intragenic	2	8
P-0002489	P-0002489-T01-IM3	In-House	FFPE	Biopsy	250	393	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719S)								LEVEL_1	EGFR p.G719S;EGFR p.E709K;EGFR Amplification;ETV1 Amplification;MCL1 Amplification;NKX2-1 Amplification	1	6
P-0002490	P-0002490-T01-IM3	In-House	FFPE	Biopsy	250	565	NA	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.S127F;ARID2 p.Q1313*;TP63 p.E609K;KDR p.P1105S;IKZF1 p.E304K;ARID2 p.R314C;TBX3 p.W197*;TP53 p.E224*;SPEN p.T2701Rfs*4;B2M Deletion;KDM5A Amplification	1	12
P-0002491	P-0002491-T01-IM3	In-House	FFPE	Biopsy	250	569	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.P27Lfs*17	2	3
P-0002492	P-0002492-T01-IM3	In-House	FFPE	Resection	250	365	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										TNFRSF14 Deletion	0	1
P-0002493	P-0002493-T01-IM3	In-House	FFPE	Resection	250	330	30	Matched	Metastasis	Liver	Lung	Tumor	LIHB	Hepatobiliary Cancer	Hepatoblastoma										CTNNB1 p.W25_H36del	0	1
P-0002495	P-0002495-T01-IM3	In-House	FFPE	Resection	250	571	NA	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										BRAF p.N581S;RNF43 RNF43-intragenic	0	2
P-0002496	P-0002496-T01-IM3	Outside	FFPE	Resection	250	925	NA	Matched	Primary	Neck	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3B	NRAS p.Q61K;PIK3R1 p.K575_R577del	1	2
P-0002497	P-0002497-T01-IM3	Outside	FFPE	Resection	250	585	NA	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Everolimus(TSC2 Deletion);AZD9496,Fulvestrant(CCDC170 ESR1-C6orf97 fusion);AZD9496,Fulvestrant(ESR1 ESR1-C6orf97 fusion)	Trametinib,Cobimetinib(NF1 p.Q1763*)				LEVEL_3B	RAD50 p.X1067_splice;NF1 p.Q1763*;TP53 p.Y236*;CCNE1 Amplification;TSC2 Deletion;CCDC170 ESR1-C6orf97 fusion;ESR1 ESR1-C6orf97 fusion	4	7
P-0002499	P-0002499-T01-IM3	In-House	FFPE	Resection	250	646	NA	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.X1032_splice)			Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.X1032_splice)				LEVEL_1	BRAF p.K601E;CDK12 p.X1032_splice	4	2
P-0002500	P-0002500-T01-IM3	Outside	FFPE	Resection	250	643	NA	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	HNSCUP	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma of Unknown Primary											0	0
P-0002501	P-0002501-T01-IM3	Outside	FFPE	Resection	250	630	NA	Matched	Primary	Leg	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										RB1 p.X654_splice;TP53 Deletion	0	2
P-0002502	P-0002502-T01-IM3	Outside	FFPE	Biopsy	250	586	NA	Matched	Primary	Pleural Fluid	Not Applicable	Tumor	PLBMESO	Mesothelioma	Pleural Mesothelioma, Biphasic Type					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BAP1 p.E673Dfs*19;CDKN2A Deletion;CDKN2B Deletion;NF2 Deletion	1	4
P-0002503	P-0002503-T01-IM3	Outside	FFPE	Resection	250	274	NA	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V777L)					LEVEL_3B	TP53 p.Y236C;CTNNB1 p.T41A;ERBB2 p.V777L;ARID2 p.R1754*;SMAD4 p.Q442*	1	5
P-0002505	P-0002505-T01-IM3	In-House	FFPE	Resection	250	422	NA	Matched	Primary	Rectum	Not Applicable	Tumor	RWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumor of the Rectum										SF3B1 p.R625H	0	1
P-0002506	P-0002506-T01-IM3	In-House	FFPE	Biopsy	250	468	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	PIK3CA p.E545K;EGFR p.E746_A750del;TP53 p.P177_C182del;EGFR Amplification	2	4
P-0002506	P-0002506-T02-IM5	In-House	DNA	Biopsy	250	891	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)	Crizotinib(MET Amplification)		Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	PIK3CA p.E545K;EGFR p.E746_A750del;TP53 p.P177_C182del;EGFR Amplification;MET Amplification	4	5
P-0002507	P-0002507-T01-IM3	In-House	FFPE	Resection	250	680	NA	Matched	Primary	Rectum	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma										BRAF p.D594N;SF3B1 p.R625H;MYC Amplification	0	3
P-0002508	P-0002508-T01-IM3	Outside	FFPE	Resection	250	82	60	Matched	Primary	Skin	Not Applicable	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma										ARID1A p.X1136_splice;STK11 p.P179L;FANCC Deletion;MCL1 Amplification;PHOX2B Deletion	0	5
P-0002509	P-0002509-T01-IM3	Outside	FFPE	Biopsy	250	716	NA	Matched	Metastasis	Brain	Unknown	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Tazemetostat(SMARCB1 p.S42Lfs*13);Tazemetostat(SMARCB1 p.D259Sfs*7)				LEVEL_4	SMARCB1 p.S42Lfs*13;SMARCB1 p.D259Sfs*7	2	2
P-0002510	P-0002510-T01-IM3	In-House	FFPE	Resection	88.4	369	NA	Matched	Primary	Thyroid	Not Applicable	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer										MCL1 Amplification	0	1
P-0002511	P-0002511-T01-IM3	In-House	FFPE	Resection	145.2	196	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;GATA3 Amplification;MCL1 Amplification	2	3
P-0002512	P-0002512-T01-IM3	In-House	FFPE	Resection	250	378	NA	Matched	Primary	Rectum	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum											0	0
P-0002512	P-0002512-T02-IM5	In-House	DNA	Resection	250	901	80	Matched	Metastasis	Rectum	Chest Wall	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R342*;SMAD4 p.E526K;RICTOR Amplification;SMAD2 Deletion	0	4
P-0002513	P-0002513-T02-IM5	In-House	DNA	Resection	250	398	80	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.M237I	0	1
P-0002514	P-0002514-T01-IM3	In-House	FFPE	Biopsy	133	145	NA	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.E339Vfs*10;ERBB2 Amplification	2	2
P-0002515	P-0002515-T01-IM3	In-House	FFPE	Resection	250	702	NA	Matched	Primary	Small Bowel	Not Applicable	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0002516	P-0002516-T01-IM3	In-House	FFPE	Biopsy	250	1039	NA	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion);Trametinib,Cobimetinib(BRAF VIPR2-BRAF fusion);Trametinib,Cobimetinib(VIPR2 VIPR2-BRAF fusion)					LEVEL_1	TP53 p.C275F;AR Amplification;BRCA2 Deletion;MYC Amplification;NKX3-1 Deletion;PMAIP1 Deletion;PRDM1 Deletion;RB1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion;BRAF VIPR2-BRAF fusion;VIPR2 VIPR2-BRAF fusion	4	12
P-0002517	P-0002517-T01-IM3	Outside	FFPE	Resection	250	761	NA	Matched	Metastasis	Eye	Heart	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209P;SF3B1 p.R625H	0	2
P-0002519	P-0002519-T01-IM3	In-House	FFPE	Biopsy	250	670	NA	Matched	Metastasis	Pancreas	Bone	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	CDKN2A p.H83Y	1	1
P-0002520	P-0002520-T01-IM3	Outside	FFPE	Resection	250	388	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer										TP53 p.R213*;DIS3 Deletion;INPP4B Deletion;MSH2 Deletion;DIS3 ELTD1-DIS3 fusion;ADGRL4 ELTD1-DIS3 fusion	0	6
P-0002522	P-0002522-T01-IM3	In-House	FFPE	Resection	250	227	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0002523	P-0002523-T01-IM3	In-House	FFPE	Cytology	250	743	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.L858R;TP53 p.G245R;RBM10 p.K165*;PIK3R1 p.Y452_Q457del;CCND3 Amplification;CCNE1 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;KEAP1 Deletion;PAX5 Deletion;PTPRD Deletion;PTPRS Deletion;SMARCA4 Deletion;STK11 Deletion	2	15
P-0002524	P-0002524-T01-IM3	In-House	FFPE	Biopsy	144	294	50	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Trametinib,Cobimetinib,Binimetinib(KRAS p.Q22K)				LEVEL_1	EGFR p.L858R;TP53 p.Y163C;KRAS p.Q61H;KRAS p.Q22K;EGFR Amplification	3	5
P-0002525	P-0002525-T01-IM3	In-House	FFPE	Resection	250	400	50	Matched	Primary	Rectum	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_E561delinsPS)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	KIT p.W557_E561delinsPS;CDKN2A Deletion;MAPK1 Amplification;PTEN Deletion	3	4
P-0002526	P-0002526-T01-IM3	In-House	FFPE	Resection	250	285	NA	Matched	Metastasis	Ovary	Colonic serosa	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.H193R	0	1
P-0002527	P-0002527-T01-IM3	In-House	FFPE	Biopsy	149	685	50	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CDKN1B p.K96Qfs*29	2	2
P-0002528	P-0002528-T01-IM3	In-House	FFPE	Resection	250	487	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0002529	P-0002529-T01-IM3	Outside	FFPE	Resection	250	623	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TET2 p.R1261H;APC p.X278_splice;TP53 p.W53*;KMT2D p.X5444_splice;SOX9 p.Q246Cfs*8;KRAS p.G13D	1	6
P-0002530	P-0002530-T01-IM3	In-House	FFPE	Biopsy	250	676	40	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		Neratinib(ERBB2 p.S310F)	Ado-Trastuzumab Emtansine(ERBB2 p.S310F);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 p.S310F;CDH1 p.L46Wfs*10;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	4	5
P-0002531	P-0002531-T01-IM3	In-House	FFPE	Resection	250	561	NA	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	4
P-0002532	P-0002532-T01-IM3	In-House	FFPE	Biopsy	250	156	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 p.K25_Q28del;MCL1 Amplification	0	2
P-0002533	P-0002533-T01-IM3	In-House	FFPE	Biopsy	250	722	20	Matched	Metastasis	Testis	Diaphragm	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										PTPRD p.R427*;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	4
P-0002534	P-0002534-T01-IM3	In-House	FFPE	Resection	250	399	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.X257_splice;EGFR Amplification	1	3
P-0002536	P-0002536-T01-IM3	Outside	FFPE	Resection	250	669	30	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R273C;ASXL2 Deletion;RB1 Deletion	0	3
P-0002537	P-0002537-T02-IM5	In-House	FFPE	Biopsy	250	669	50	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.L996*)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L996*)				LEVEL_1	FOXA1 p.R261H;CDK12 p.L996*	2	2
P-0002537	P-0002537-T01-IM3	Outside	FFPE	Biopsy	134.82	104	NA	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ASXL1 Deletion;FUBP1 Deletion;GRIN2A Deletion;HNF1A Deletion;MAP2K4 Deletion;PBRM1 Deletion;PTPN11 Deletion;PTPRT Deletion;TGFBR1 Deletion;WT1 Deletion	0	10
P-0002538	P-0002538-T01-IM3	Outside	FFPE	Biopsy	250	477	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification	2	1
P-0002539	P-0002539-T01-IM3	Outside	FFPE	Resection	250	324	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1044K)					LEVEL_3B	TP53 p.P278L;PIK3CA p.N1044K;RB1 p.L76*;TP53 p.R333Vfs*12	1	4
P-0002540	P-0002540-T01-IM3	Outside	FFPE	Biopsy	250	1053	NA	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.G245S;APC p.S1465Wfs*3;APC p.S932*;SOX9 p.I418Mfs*52;KRAS p.G13D	1	5
P-0002542	P-0002542-T01-IM3	Outside	FFPE	Biopsy	250	631	NA	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V	2	2
P-0002543	P-0002543-T01-IM3	Outside	FFPE	Biopsy	250	573	30	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.R364G;MAP2K4 p.S184L;CBFB p.X55_splice	0	3
P-0002544	P-0002544-T01-IM3	In-House	FFPE	Resection	250	362	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.R273C	2	2
P-0002545	P-0002545-T01-IM3	Outside	FFPE	Biopsy	108.75	406	40	Matched	Metastasis	Breast	Soft Tissue	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma				Trametinib(BRAF p.K601N)	PLX8394(BRAF p.K601N)				LEVEL_3B	BRAF p.K601N;TP53 p.R342Lfs*4;AURKA Amplification;CDKN2B Deletion;PAK1 Amplification	2	5
P-0002546	P-0002546-T01-IM3	In-House	FFPE	Biopsy	102.05	282	20	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	MET p.X1010_splice;CDK4 Amplification	4	2
P-0002547	P-0002547-T01-IM3	Outside	FFPE	Resection	250	961	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										FBXW7 p.R505C;TP53 p.R175H;APC p.R564*;TP53 p.F270L;CDK8 Amplification;FLT3 Amplification	0	6
P-0002548	P-0002548-T01-IM3	Outside	FFPE	Cytology	250	852	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)					LEVEL_3B	NRAS p.Q61H;TP53 p.P151A;TP53 p.W146C;STK11 p.W308L;NFE2L2 p.G31del	1	5
P-0002549	P-0002549-T01-IM3	In-House	FFPE	Resection	250	497	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q);Trametinib,Cobimetinib(MAP2K1 p.K57N)					LEVEL_3B	ERBB2 p.R678Q;MAP2K1 p.K57N	2	2
P-0002551	P-0002551-T01-IM3	In-House	FFPE	Resection	250	692	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										NOTCH4 p.C1125*;SMAD4 p.E330K	0	2
P-0002552	P-0002552-T01-IM3	Outside	FFPE	Resection	250	1016	80	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Trametinib,Cobimetinib(NF1 p.R1241Qfs*25)				LEVEL_4	MAX p.Q91Pfs*53;NF1 p.R1241Qfs*25	1	2
P-0002553	P-0002553-T01-IM3	Outside	FFPE	Biopsy	250	715	NA	Matched	Primary	Stomach	Not Applicable	Tumor	MSTAD	Esophagogastric Cancer	Mucinous Stomach Adenocarcinoma										TP53 p.C238S;CCND1 Amplification;FGF19 Amplification	0	3
P-0002555	P-0002555-T01-IM3	In-House	FFPE	Resection	250	708	70	Matched	Metastasis	Lower Extremity	Lung	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0002556	P-0002556-T01-IM3	In-House	FFPE	Biopsy	250	633	60	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0002557	P-0002557-T01-IM3	In-House	FFPE	Resection	250	609	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;SMAD4 p.R361C	1	2
P-0002558	P-0002558-T01-IM3	In-House	FFPE	Resection	250	520	60	Matched	Primary	Lung	Stomach	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.L50Rfs*12;MYC Amplification	0	2
P-0002559	P-0002559-T01-IM3	In-House	FFPE	Biopsy	250	727	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0002562	P-0002562-T02-IM5	In-House	FFPE	Biopsy	250	1160	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.E453Q)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.S227F);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.M53Ifs*68)				LEVEL_1	PIK3CA p.E545K;PIK3CA p.E453Q;KMT2C p.Q1759*;SPEN p.S1354Ffs*7;CREBBP p.C1444Hfs*6;PTEN p.S227F;CDKN2A p.M53Ifs*68;FGFR1 Amplification;MAPK1 Amplification	7	9
P-0002562	P-0002562-T01-IM3	In-House	FFPE	Cytology	250	332	40	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.E453Q)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453Q);AZD9496,Fulvestrant(ESR1 p.E380Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.M53Ifs*68)				LEVEL_1	PIK3CA p.E545K;PIK3CA p.E453Q;ESR1 p.E380Q;KMT2C p.Q1759*;SPEN p.S1354Ffs*7;CREBBP p.C1444Hfs*6;CDKN2A p.M53Ifs*68;FGFR1 Amplification;MAPK1 Amplification	7	9
P-0002563	P-0002563-T01-IM3	In-House	FFPE	Resection	250	516	20	Unmatched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.Q1338*;SMAD4 p.P356L;APC p.L1342Yfs*73	1	4
P-0002564	P-0002564-T01-IM3	In-House	FFPE	Resection	250	468	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.C238G	0	1
P-0002565	P-0002565-T01-IM3	In-House	FFPE	Resection	250	586	60	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				BLU-667,Selpercatinib(RET p.E511K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;TP53 p.V157F;RET p.E511K;APC p.N1455Ifs*18	2	4
P-0002566	P-0002566-T01-IM3	In-House	FFPE	Resection	250	197	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.M237I	1	2
P-0002567	P-0002567-T01-IM3	Outside	FFPE	Biopsy	250	751	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.D92Y)				LEVEL_1	PTEN p.D92Y;TP53 p.V197E;ERBB2 Amplification;PRKN Deletion	3	4
P-0002568	P-0002568-T01-IM3	In-House	FFPE	Biopsy	78.75	699	40	Matched	Metastasis	Upper Tract	Lymph Node	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3B	TP53 p.R248W;NRAS p.Q61K	1	2
P-0002569	P-0002569-T01-IM3	Outside	FFPE	Resection	250	534	20	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor					Everolimus,Temsirolimus(MTOR p.T1977K)				LEVEL_4	MTOR p.T1977K	1	1
P-0002570	P-0002570-T01-IM3	In-House	FFPE	Resection	250	458	20	Matched	Metastasis	Cervix	Ovary	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;PIK3CA p.E542K;SDHB Deletion	2	3
P-0002571	P-0002571-T01-IM3	In-House	FFPE	Biopsy	250	863	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.P6Rfs*18);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KEAP1 p.G333C;TP53 p.S241F;STK11 p.X200_splice;NF1 p.P6Rfs*18;APC Deletion;CDKN2A Deletion;CDKN2B Deletion	2	7
P-0002572	P-0002572-T01-IM3	In-House	FFPE	Resection	250	760	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Enasidenib(IDH2 p.R172K)					LEVEL_3B	PIK3CA p.H1047R;IDH2 p.R172K;RIMBP2 INPP4B-RIMBP2 fusion;INPP4B INPP4B-RIMBP2 fusion	2	4
P-0002573	P-0002573-T01-IM3	In-House	FFPE	Resection	250	786	30	Matched	Metastasis	Ovary	Lung	Tumor	EOV	Ovarian Cancer	Endometrioid Ovarian Cancer				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)	GSK2636771,AZD8186(PTEN p.R233*)				LEVEL_3B	PTEN p.R233*;NRAS p.G12D	2	2
P-0002574	P-0002574-T01-IM3	In-House	FFPE	Resection	250	252	40	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	GATA3 p.S390*;CBL Deletion;CCND1 Amplification;ERBB2 Amplification;FANCA Deletion;FGF19 Amplification;FGFR1 Amplification;FLCN Deletion;MEN1 Deletion;MYC Amplification;SMAD4 Deletion	3	11
P-0002575	P-0002575-T01-IM3	Outside	FFPE	Resection	250	99	40	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma										RUNX1 p.S418Afs*149;RBM10 p.X242_splice	0	2
P-0002576	P-0002576-T02-IM5	In-House	FFPE	Resection	250	250	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(ATM p.L2890P);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ATM p.L2890P;KMT2D p.W4982*;TGFBR2 p.P104Tfs*16;CDK4 Amplification;FOXA1 Amplification;MDM2 Amplification;RAC1 Amplification;SH2D1A Deletion	3	8
P-0002577	P-0002577-T01-IM3	In-House	FFPE	Resection	250	720	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.R159S);GSK2636771,AZD8186(PTEN p.R130Qfs*4)				LEVEL_3B	KRAS p.G12D;PIK3CA p.N345K;TP53 p.P250L;PTEN p.R159S;PTEN p.R130Qfs*4;CCND1 Amplification;FGF19 Amplification	4	7
P-0002578	P-0002578-T01-IM3	In-House	FFPE	Resection	250	672	50	Matched	Primary	Brain	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842I)					LEVEL_3B	CTNNB1 p.S45F;PDGFRA p.D842I;ARID1A p.L1977Cfs*21;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	1	9
P-0002579	P-0002579-T01-IM3	In-House	FFPE	Resection	250	761	30	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0002580	P-0002580-T01-IM3	In-House	FFPE	Biopsy	250	735	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;AKT2 Amplification;AURKA Amplification;CCNE1 Amplification;MCL1 Amplification;MEF2B Amplification	2	7
P-0002581	P-0002581-T02-IM5	In-House	FFPE	Biopsy	119	395	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.S1154*)				LEVEL_4	KDM6A p.S1154*	1	1
P-0002582	P-0002582-T01-IM3	In-House	FFPE	Resection	250	1114	30	Matched	Metastasis	Breast	Bladder	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										NF2 p.E394*;ZFP90 CDH1-ZFP90 fusion;CDH1 CDH1-ZFP90 fusion;MIR1281 EP300-MIR1281 fusion;EP300 EP300-MIR1281 fusion	0	5
P-0002583	P-0002583-T01-IM3	In-House	FFPE	Resection	250	495	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0002584	P-0002584-T01-IM3	In-House	FFPE	Biopsy	250	1056	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										KMT2A p.X3631_splice;RB1 p.S391*;RBM10 p.Q419*;ARID1A p.Y2254Tfs*21;TP53 p.A76Vfs*55;DDR2 Amplification;EGFR Amplification;MYC Amplification;RICTOR Amplification;NBN NBN-intragenic	0	10
P-0002585	P-0002585-T01-IM3	In-House	FFPE	Resection	250	269	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										TP53 p.H193N;CD274 Amplification;ETV1 Amplification;JAK2 Amplification	0	4
P-0002586	P-0002586-T01-IM3	In-House	FFPE	Resection	250	1027	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLAD	Bladder Cancer	Bladder Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R280K;STAG2 p.T1122Nfs*14;CBFB Deletion;CCNE1 Amplification;CTCF Deletion;RB1 Deletion	1	7
P-0002587	P-0002587-T01-IM3	Outside	FFPE	Resection	250	626	50	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Everolimus(BCL2L1 TSC2-BCL2L1 fusion);Everolimus(TSC2 TSC2-BCL2L1 fusion)	GSK2636771,AZD8186(PTEN p.R173C);GSK2636771,AZD8186(PTEN p.T277*)				LEVEL_3B	PTEN p.R173C;ARID1A p.S552*;PIK3CA p.R88Q;PTEN p.T277*;ARID1A p.Y1285*;ERBB2 Amplification;BCL2L1 TSC2-BCL2L1 fusion;TSC2 TSC2-BCL2L1 fusion	6	8
P-0002588	P-0002588-T01-IM3	Outside	FFPE	Resection	151	197	50	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFS	Soft Tissue Sarcoma	Myxofibrosarcoma					Trametinib,Cobimetinib(NF1 p.Y1545Wfs*17)				LEVEL_4	NF1 p.Y1545Wfs*17;CD274 Amplification;JAK2 Amplification;TP53 Deletion;YAP1 Amplification	1	5
P-0002589	P-0002589-T01-IM3	In-House	FFPE	Resection	250	364	40	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Everolimus(TSC1 p.K741Tfs*11);Everolimus(TSC1 p.E647Gfs*41)					LEVEL_3B	TSC1 p.K741Tfs*11;TSC1 p.E647Gfs*41	2	2
P-0002590	P-0002590-T01-IM3	In-House	FFPE	Resection	250	445	60	Matched	Primary	Skin	Not Applicable	Tumor	DFSP	Skin Cancer, Non-Melanoma	Dermatofibrosarcoma Protuberans					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	SUZ12 p.X342_splice;MED12 p.S1891Pfs*40;CDKN2A Deletion;CDKN2C Deletion;FANCA Deletion;NF1 Deletion	2	6
P-0002591	P-0002591-T01-IM3	In-House	FFPE	Biopsy	250	731	30	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)	Talazoparib,Olaparib(BRCA1 Deletion)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Niraparib,Rucaparib(BRCA1 Deletion)					LEVEL_1	PIK3CA p.H1047R;TP53 p.Q375*;CDH1 p.R74Dfs*9;BRCA1 Deletion;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;TP53 Deletion	4	8
P-0002592	P-0002592-T01-IM3	In-House	FFPE	Biopsy	250	779	30	Matched	Metastasis	Hypopharynx	Lung	Tumor	HPHSC	Head and Neck Cancer	Hypopharynx Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.I255N;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;PTEN Deletion	2	6
P-0002593	P-0002593-T01-IM3	In-House	FFPE	Biopsy	250	727	30	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.V272M;PIK3R1 p.E462_R465del;MED12 p.P13Efs*22;AURKA Amplification;FAT1 Deletion;FGFR2 Amplification;PTEN Deletion;RB1 Deletion	1	8
P-0002594	P-0002594-T02-IM5	In-House	FFPE	Biopsy	250	1022	80	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										SDHA p.R31*	0	1
P-0002594	P-0002594-T01-IM3	In-House	FFPE	Resection	250	444	50	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										SDHA p.R31*	0	1
P-0002595	P-0002595-T01-IM3	In-House	FFPE	Biopsy	250	787	20	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0002596	P-0002596-T01-IM3	In-House	FFPE	Resection	250	302	30	Matched	Metastasis	Testis	Retroperitoneum	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0002597	P-0002597-T02-IM5	In-House	FFPE	Resection	250	194	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										DAXX p.H163Pfs*65	0	1
P-0002599	P-0002599-T01-IM3	In-House	FFPE	Resection	250	322	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R213*;FGFR3 p.S249C;ASXL2 p.E445Kfs*77;STAG2 p.Y815*;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;YAP1 Amplification	3	9
P-0002601	P-0002601-T01-IM3	In-House	FFPE	Resection	250	268	20	Matched	Metastasis	Testis	Mediastinum	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	PTEN p.T319*;TP53 p.V173A	1	2
P-0002602	P-0002602-T01-IM3	In-House	FFPE	Resection	250	521	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;RBM10 p.R660Gfs*46	2	2
P-0002603	P-0002603-T01-IM3	In-House	FFPE	Biopsy	250	587	30	Matched	Metastasis	Sinonasal	Lung	Tumor	SNSC	Head and Neck Cancer	Sinonasal Squamous Cell Carcinoma			Tipifarnib(HRAS p.Q22K)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-intragenic)				LEVEL_3A	HRAS p.Q22K;CDKN2A CDKN2A-intragenic	2	2
P-0002604	P-0002604-T02-IM5	In-House	DNA	Biopsy	250	517	30	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.R1275Q)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ALK p.R1275Q;LATS1 p.X961_splice;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	2	5
P-0002604	P-0002604-T01-IM3	In-House	FFPE	Resection	250	561	40	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.R1275Q)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ALK p.R1275Q;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	2	4
P-0002605	P-0002605-T01-IM3	Outside	FFPE	Biopsy	250	648	20	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)	Trametinib,Cobimetinib(NF1 p.X1166_splice)				LEVEL_3B	NRAS p.Q61L;PBRM1 p.X642_splice;TP53 p.V203L;NF1 p.X1166_splice;KEAP1 p.R601L;ARID1B p.N136Tfs*102;CCND1 Amplification	2	7
P-0002606	P-0002606-T01-IM3	Outside	FFPE	Resection	250	537	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.M270Cfs*6)				LEVEL_4	TP53 p.L111M;SETD2 p.D350Ffs*2;PTEN p.M270Cfs*6;RB1 p.E204Gfs*8;TP53 Deletion	1	5
P-0002607	P-0002607-T01-IM3	In-House	FFPE	Resection	250	563	40	Matched	Primary	Bladder	Not Applicable	Tumor	SRCBC	Bladder Cancer	Plasmacytoid/Signet Ring Cell Bladder Carcinoma										TP53 p.E286K;RB1 p.S397*;CDH1 p.Q346*;CDH1 p.Q351*	0	4
P-0002608	P-0002608-T01-IM3	Outside	FFPE	Resection	240	384	60	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										NF2 p.Y144*;RYBP p.A109Kfs*25	0	2
P-0002609	P-0002609-T01-IM3	Outside	FFPE	Cytology	79.65	403	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Niraparib,Olaparib,Rucaparib,Talazoparib(ELAC2 BRCA1-ELAC2 fusion);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 BRCA1-ELAC2 fusion)					LEVEL_3B	BRAF p.V600E;APC p.T1556Nfs*3;TP53 p.M237I;APC p.Y1179Ifs*3;ELAC2 BRCA1-ELAC2 fusion;BRCA1 BRCA1-ELAC2 fusion	3	6
P-0002610	P-0002610-T01-IM3	Outside	FFPE	Resection	250	535	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 JAKMIP1-FGFR3 fusion);Erdafitinib(JAKMIP1 JAKMIP1-FGFR3 fusion)		Debio1347,BGJ398,AZD4547(FGFR3 JAKMIP1-FGFR3 fusion);Debio1347,BGJ398,AZD4547(JAKMIP1 JAKMIP1-FGFR3 fusion)		Tazemetostat(SMARCB1 p.L166Ffs*10)				LEVEL_1	SMARCB1 p.L166Ffs*10;RBM10 p.*931Lext*43;FGFR3 JAKMIP1-FGFR3 fusion;JAKMIP1 JAKMIP1-FGFR3 fusion	5	4
P-0002611	P-0002611-T01-IM3	In-House	FFPE	Cytology	103	464	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.F270V;CASP8 p.Q49*;LATS2 p.E722*;KEAP1 p.K216*;KDM5C p.L482_E483delinsF*;BCL2L1 Amplification	0	6
P-0002613	P-0002613-T01-IM3	Outside	FFPE	Biopsy	250	712	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0002614	P-0002614-T02-IM5	In-House	FFPE	Resection	250	421	70	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Afatinib(EGFR p.G719A)					LEVEL_3B	EGFR p.G719A;EGFR p.E709A;FLT1 p.E1011K;CDKN1A p.K75Qfs*14;CCND1 Amplification;FGF19 Amplification	1	6
P-0002614	P-0002614-T01-IM3	Outside	FFPE	Biopsy	250	552	30	Matched	Metastasis	Upper Tract	Lung	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Afatinib(EGFR p.G719A);Everolimus(TSC1 p.Q516*)					LEVEL_3B	PIK3CA p.E545K;EGFR p.G719A;TSC1 p.Q516*;EGFR p.E709A;FLT1 p.E1011K;CDKN1A p.K75Qfs*14;CCND1 Amplification;FGF19 Amplification;PRKN Deletion	3	9
P-0002615	P-0002615-T01-IM3	In-House	FFPE	Resection	250	359	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MSH6 p.X153_splice;VHL p.R82P;BAP1 p.X417_splice;MDM2 Amplification	1	4
P-0002615	P-0002615-T02-IM5	In-House	FFPE	Resection	250	410	60	Matched	Metastasis	Kidney	Pleura	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	MSH6 p.X153_splice;VHL p.R82P;BAP1 p.X417_splice;CDKN2A p.R80*;MDM2 Amplification	2	5
P-0002616	P-0002616-T01-IM3	Outside	FFPE	Biopsy	250	583	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0002617	P-0002617-T02-IM5	In-House	FFPE	Biopsy	206.8	299	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.E380Q)						LEVEL_3A	ESR1 p.E380Q	1	1
P-0002619	P-0002619-T01-IM3	In-House	FFPE	Resection	250	362	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										CDH1 p.R48Tfs*5	0	1
P-0002620	P-0002620-T01-IM3	In-House	FFPE	Resection	250	741	40	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS										PTPN11 p.A72V;PTPN11 p.E76G;SETD2 p.C495Lfs*6	0	3
P-0002620	P-0002620-T02-IM5	Outside	FFPE	Resection	250	1001	80	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.E258K;SETD2 p.C495Lfs*6;CDKN2A Deletion;CDKN2B Deletion;BCOR TRAP1-BCOR fusion;TRAP1 TRAP1-BCOR fusion	1	6
P-0002621	P-0002621-T02-IM5	In-House	FFPE	Cytology	220	77	60	Matched	Metastasis	Lung	Liver	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										MEN1 p.R108*;PRDM1 Deletion	0	2
P-0002622	P-0002622-T02-IM5	In-House	DNA	Biopsy	250	1115	NA	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)		Trametinib,Cobimetinib(NF1 p.Q1815Pfs*4)				LEVEL_3A	AKT1 p.E17K;KMT2C p.K1205*;CBFB p.W73*;NF1 p.Q1815Pfs*4;TP53 p.N268Pfs*45	2	5
P-0002622	P-0002622-T01-IM3	In-House	FFPE	Biopsy	250	611	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)		Trametinib,Cobimetinib(NF1 p.Q1815Pfs*4)				LEVEL_3A	AKT1 p.E17K;KMT2C p.K1205*;CBFB p.W73*;NF1 p.Q1815Pfs*4	2	4
P-0002624	P-0002624-T01-IM3	Outside	FFPE	Resection	250	377	30	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CBL Deletion;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;KMT2A Deletion;SDHD Deletion	0	6
P-0002625	P-0002625-T01-IM3	In-House	FFPE	Biopsy	250	516	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;KMT2C p.Q88*;FOXA1 p.R294Pfs*24;FOXA1 p.G284_G290del;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	2	10
P-0002627	P-0002627-T01-IM3	In-House	FFPE	Resection	250	1535	70	Matched	Metastasis	Small Bowel	Liver	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor										CDKN1B p.W76*	0	1
P-0002629	P-0002629-T01-IM3	In-House	FFPE	Biopsy	250	730	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.S241C;TP53 p.R249S	0	2
P-0002630	P-0002630-T01-IM3	Outside	FFPE	Biopsy	250	726	30	Matched	Metastasis	Breast	Pleura	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R280K;MAP3K1 p.L380S;CDH1 p.T199Nfs*10;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;RUNX1 RUNX1-intragenic	1	7
P-0002631	P-0002631-T01-IM3	In-House	FFPE	Biopsy	250	592	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.C363R;KEAP1 p.X442_splice;MYC Amplification	1	4
P-0002632	P-0002632-T02-IM5	In-House	FFPE	Biopsy	250	450	40	Matched	Metastasis	Kidney	Lung	Tumor	MRC	Renal Cell Carcinoma	Renal Medullary Carcinoma										NSD1 p.E2550Dfs*14	0	1
P-0002633	P-0002633-T01-IM3	Outside	FFPE	Resection	250	249	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Sonidegib,Vismodegib(PTCH1 p.Y224Ffs*4)	Trametinib,Cobimetinib(NF1 p.P678Rfs*10)				LEVEL_3B	TP53 p.R273C;PIK3CA p.Q546R;PIK3CA p.R88Q;MSH2 p.X315_splice;ATRX p.R2111*;ASXL2 p.D718Efs*80;PTCH1 p.Y224Ffs*4;RB1 p.S648Tfs*4;NF1 p.P678Rfs*10;EP300 p.K1228Nfs*48;ETV1 Amplification	4	11
P-0002634	P-0002634-T01-IM3	In-House	FFPE	Resection	250	201	20	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Avapritinib,Ripretinib(KIT p.D816A)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;KIT p.D816A	2	2
P-0002635	P-0002635-T01-IM3	In-House	FFPE	Cytology	250	703	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R213Q;KEAP1 p.R413Vfs*45;CTNNB1 p.D32N;STK11 p.X307_splice;MYC Amplification	0	5
P-0002636	P-0002636-T01-IM3	Outside	FFPE	Resection	250	485	30	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										FBXW7 p.R505H;CCND2 Amplification;KRAS Amplification;MCL1 Amplification	0	4
P-0002637	P-0002637-T01-IM3	In-House	FFPE	Resection	250	1086	50	Matched	Metastasis	Lung	Abdomen	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	ARID1A p.M1564*;TP53 p.R249S;PTPRD p.Y803*;RB1 p.A525Pfs*7;CCNE1 Amplification;PTEN Deletion	1	6
P-0002638	P-0002638-T01-IM3	In-House	FFPE	Resection	250	1022	NA	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.I253Yfs*45);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R248W;RB1 p.K652*;CREBBP p.X705_splice;PTEN p.I253Yfs*45;TP53 p.L308Sfs*30;CDKN2A Deletion;MYC Amplification;MYCN Amplification	2	8
P-0002639	P-0002639-T01-IM3	Outside	FFPE	Resection	250	760	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.A138V;TP53 p.F134L;SMARCA4 p.R1429Afs*34	0	3
P-0002640	P-0002640-T01-IM3	Outside	FFPE	Resection	250	195	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CCND1 Amplification;FGFR2 Amplification;FOXA1 Amplification;GATA3 Amplification	0	4
P-0002641	P-0002641-T01-IM3	In-House	FFPE	Biopsy	250	1287	NA	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma				Olaparib(BARD1 Deletion)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	ATRX Deletion;BARD1 Deletion;EZH2 Amplification;FANCC Deletion;NF1 Deletion;RB1 Deletion;SUZ12 Deletion;PTPRS JAK3-PTPRS fusion;JAK3 JAK3-PTPRS fusion	2	9
P-0002642	P-0002642-T01-IM3	Outside	FFPE	Resection	250	534	NA	Matched	Metastasis	Buttock	Bone	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	GSK2636771,AZD8186(PTEN p.R173H);GSK2636771,AZD8186(PTEN p.L112P)				LEVEL_3B	PIK3CA p.E542K;PTEN p.R173H;PTEN p.L112P	3	3
P-0002643	P-0002643-T01-IM3	Outside	FFPE	Biopsy	250	1113	NA	Matched	Metastasis	Ovary	Pleural Fluid	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.N239Tfs*8	0	1
P-0002645	P-0002645-T01-IM3	Outside	FFPE	Biopsy	250	528	30	Matched	Metastasis	Ovary	Diaphragm	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12C;TP53 p.R273C;CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification	3	5
P-0002646	P-0002646-T01-IM3	In-House	FFPE	Biopsy	250	885	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.H179R	0	1
P-0002647	P-0002647-T01-IM3	In-House	FFPE	Biopsy	250	866	NA	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(PALB2 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	EGFR p.A289T;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;FAT1 Deletion;PALB2 Deletion	3	6
P-0002647	P-0002647-T02-IM5	In-House	FFPE	Biopsy	250	816	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;GATA3 Deletion;PRDM1 Deletion	2	5
P-0002648	P-0002648-T02-IM5	In-House	DNA	Biopsy	250	750	20	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.X32_splice;TP53 p.L265del;KRAS Amplification	1	4
P-0002648	P-0002648-T01-IM3	In-House	FFPE	Resection	250	745	NA	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.X32_splice;TP53 p.L265del;KRAS Amplification	1	4
P-0002649	P-0002649-T01-IM3	Outside	FFPE	Resection	250	226	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										KLF4 p.N191Tfs*3;CDH1 p.E841Kfs*5;HDAC7 MLL2-HDAC7 fusion;KMT2D MLL2-HDAC7 fusion	0	4
P-0002650	P-0002650-T01-IM3	In-House	FFPE	Resection	250	522	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S	1	1
P-0002651	P-0002651-T01-IM3	Outside	FFPE	Biopsy	250	494	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.E198*;CCND1 Amplification;FGF19 Amplification;RICTOR Amplification;TERT Amplification	0	5
P-0002652	P-0002652-T01-IM3	In-House	FFPE	Biopsy	250	635	30	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.R108del)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108del)						LEVEL_1	CDKN1B p.W60*;PIK3CA p.R108del;RUNX1 p.G394Afs*171;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	6
P-0002653	P-0002653-T01-IM3	Outside	FFPE	Resection	250	738	20	Matched	Primary	Transverse Colon	Not Applicable	Tumor	SRCCR	Colorectal Cancer	Signet Ring Cell Adenocarcinoma of the Colon and Rectum										SMAD4 p.R361C;RICTOR Amplification	0	2
P-0002654	P-0002654-T01-IM3	In-House	FFPE	Resection	250	515	30	Matched	Metastasis	Kidney	Lymph Node	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										VHL p.R161Q;KDM5C p.S509*	0	2
P-0002655	P-0002655-T01-IM3	Outside	FFPE	Resection	250	868	50	Matched	Metastasis	Breast	Brain	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	B2M p.L15Ffs*41;TP53 p.X126_splice;NOTCH1 p.S2467Pfs*7;CDK4 Amplification;KDM5A Amplification;MYC Amplification;NOTCH1 Deletion;PIK3CA Amplification	1	8
P-0002656	P-0002656-T01-IM3	Outside	FFPE	Biopsy	250	556	20	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Trametinib,Cobimetinib(NF1 p.X68_splice)				LEVEL_4	NF1 p.X68_splice;ATRX p.S471Vfs*43	1	2
P-0002657	P-0002657-T01-IM3	In-House	FFPE	Resection	250	608	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G118D);Fulvestrant+Alpelisib(PIK3CA p.G364R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G364R)						LEVEL_1	PIK3CA p.G118D;PIK3CA p.G364R;CDH1 p.V694Afs*28;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	4	6
P-0002658	P-0002658-T01-IM3	In-House	FFPE	Biopsy	198.8	259	60	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										RB1 p.Q685*;KMT2C p.W4357*;KMT2D p.W4377*;KMT2D p.G2721Vfs*12;TP53 p.P191_L201del	0	5
P-0002659	P-0002659-T01-IM3	Outside	FFPE	Resection	250	651	20	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.E271K;RB1 p.E747*;NCOR1 p.S1394*	1	4
P-0002660	P-0002660-T01-IM3	Outside	FFPE	Resection	250	930	60	Matched	Primary	Ovary	Not Applicable	Tumor	OVT	Ovarian Cancer	Ovarian Epithelial Tumor				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;DIS3 Deletion;ERBB3 Amplification;MDM2 Amplification;RB1 Deletion;TERT Amplification;CDC73 CDC73-intragenic	2	7
P-0002661	P-0002661-T01-IM3	In-House	FFPE	Biopsy	250	557	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0002662	P-0002662-T01-IM3	In-House	FFPE	Resection	250	715	60	Matched	Primary	Lower Extremity	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										PRDM1 p.Y418*	0	1
P-0002663	P-0002663-T01-IM3	In-House	FFPE	Biopsy	104.8	572	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.S183*;KRAS p.Q61H;SETD2 p.R620*;ARID1A p.S220Ifs*178	1	4
P-0002664	P-0002664-T01-IM3	Outside	FFPE	Resection	250	749	40	Matched	Primary	Ovary	Not Applicable	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P449R);Everolimus(TSC1 p.X666_splice);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	TP53 p.G266R;PIK3CA p.P449R;TSC1 p.X666_splice;AXIN1 p.E410*;CDKN2A p.R58*;BRD4 Amplification;ERBB2 Amplification	4	7
P-0002665	P-0002665-T01-IM3	Outside	FFPE	Biopsy	179	243	50	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.R213*;SMAD2 p.R182*;SMAD3 p.R268C;SMAD3 p.R287W;APC p.S1495Vfs*12;DIS3 PIBF1-DIS3 fusion;PIBF1 PIBF1-DIS3 fusion	1	8
P-0002666	P-0002666-T01-IM3	In-House	FFPE	Biopsy	180	103	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0002667	P-0002667-T01-IM3	In-House	FFPE	Biopsy	250	660	40	Matched	Primary	Breast	Breast	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.N107I)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.D538G);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N107I)						LEVEL_1	PIK3CA p.H1047R;ESR1 p.D538G;PIK3CA p.N107I;FOXA1 p.S242_Y243delinsCS;SMAD4 p.S343*	5	5
P-0002668	P-0002668-T01-IM3	In-House	FFPE	Resection	250	523	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R248P;KMT2D p.R3982*;RB1 p.Q344*;CREBBP p.S547*;CD274 Amplification;CREBBP Deletion;JAK2 Amplification;MCL1 Amplification;RICTOR Amplification	0	9
P-0002669	P-0002669-T01-IM3	In-House	FFPE	Cytology	250	316	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										SDHB p.X181_splice;ARID1A p.Q479*;BRAF p.Q257H;RB1 p.G581*;TP53 p.G279*;RNF43 p.S661_E662delinsF*;PTPRD p.F1114Sfs*10	0	7
P-0002670	P-0002670-T01-IM3	Outside	FFPE	Resection	250	423	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.E1309*;TP53 p.R283C;APC p.E1111Gfs*15	0	4
P-0002671	P-0002671-T01-IM3	In-House	FFPE	Resection	250	577	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)			Olaparib(PALB2 p.H130Tfs*47)	Trametinib,Cobimetinib(NF1 p.Y628Tfs*3);GSK2636771,AZD8186(PTEN p.C124Y);Trametinib,Cobimetinib(NF1 p.R1276Q)				LEVEL_1	NF1 p.Y628Tfs*3;KMT2A p.S774Vfs*12;PTEN p.C124Y;RHOA p.T37I;TET2 p.R1440Q;NOTCH1 p.C980*;NF1 p.R1276Q;GNAS p.R160C;GNAS p.R201S;ATR p.S1038Ffs*11;FAT1 p.D3086Ifs*30;KMT2C p.N2842Kfs*2;FANCC p.L228Ffs*24;KMT2D p.G2525Vfs*18;KMT2D p.S102Efs*6;PALB2 p.H130Tfs*47;AXIN2 p.N666Qfs*41;BCOR p.L1646Sfs*28;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	6	20
P-0002672	P-0002672-T01-IM3	In-House	FFPE	Resection	250	597	30	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Y553_E554del)				GSK2636771,AZD8186(PTEN p.C105S);Trametinib,Cobimetinib(NF1 p.K111*)				LEVEL_1	SETD2 p.S204*;PTEN p.C105S;RB1 p.E54*;NF1 p.K111*;KIT p.Y553_E554del;TP53 p.M340Dfs*7	3	6
P-0002673	P-0002673-T01-IM3	In-House	FFPE	Resection	250	504	30	Matched	Metastasis	Sigmoid Colon	Peritoneum	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.L114Cfs*9;CCND1 Amplification;FGF19 Amplification;MYC Amplification	1	5
P-0002674	P-0002674-T01-IM3	In-House	FFPE	Resection	250	715	30	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_4	TP53 p.X186_splice;CDKN2A p.Y44*	1	2
P-0002675	P-0002675-T01-IM3	In-House	FFPE	Biopsy	250	548	30	Matched	Metastasis	Bile Duct	Liver	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma	Pemigatinib(BICC1 FGFR2-BICC1 fusion);Pemigatinib(FGFR2 FGFR2-BICC1 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(BICC1 FGFR2-BICC1 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-BICC1 fusion)						LEVEL_1	BICC1 FGFR2-BICC1 fusion;FGFR2 FGFR2-BICC1 fusion	4	2
P-0002676	P-0002676-T01-IM3	In-House	FFPE	Resection	250	592	40	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma											0	0
P-0002677	P-0002677-T01-IM3	Outside	FFPE	Cytology	112	128	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										KEAP1 p.E258*;LATS1 p.K1046*;STK11 p.D53Tfs*11;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	0	8
P-0002678	P-0002678-T01-IM3	In-House	FFPE	Resection	250	1028	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum										APC p.E1309Dfs*4;TP53 p.M169Ifs*12;MYC Amplification	0	3
P-0002679	P-0002679-T01-IM3	Outside	FFPE	Resection	250	530	30	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.D48*	0	1
P-0002680	P-0002680-T01-IM3	In-House	FFPE	Resection	250	425	40	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A502_Y503dup)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.A502_Y503dup;CDKN2A Deletion	2	2
P-0002682	P-0002682-T01-IM3	In-House	FFPE	Biopsy	250	251	30	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma		Olaparib,Talazoparib(BRCA2 p.E1581*)	AZD5363(AKT1 p.E17K)	Rucaparib,Niraparib(BRCA2 p.E1581*);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_2	AKT1 p.E17K;SMAD2 p.S464*;CDH1 p.R598*;TP53 p.Q375*;SETD2 p.Q1829*;BRCA2 p.E1581*;MAP2K4 p.E82*;MDM2 Amplification	4	8
P-0002683	P-0002683-T01-IM3	In-House	FFPE	Biopsy	250	420	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X880_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TP53 p.S241F;ATM p.X880_splice;FLT3 p.A680E;FLT3 p.D651H;RBM10 p.K715Vfs*4	2	6
P-0002684	P-0002684-T01-IM3	In-House	FFPE	Resection	250	272	30	Matched	Metastasis	Thyroid	Neck	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer											0	0
P-0002685	P-0002685-T01-IM3	In-House	FFPE	Resection	250	543	60	Matched	Primary	Pelvis	Pelvis	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma					GSK2636771,AZD8186(PTEN p.G132A);Trametinib,Cobimetinib(NF1 p.T586Vfs*18);Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	PTEN p.G132A;NF1 p.T586Vfs*18;RB1 Deletion;NF1 NF1-intragenic	3	4
P-0002687	P-0002687-T01-IM3	Outside	FFPE	Cytology	250	286	20	Matched	Metastasis	Cervix	Lymph Node	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R)				LEVEL_4	FGFR2 p.C382R;CTNNB1 p.S37F;CREBBP p.R1446C;MED12 p.L36R	1	4
P-0002688	P-0002688-T02-IM3	In-House	FFPE	Resection	250	726	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;RAC1 p.G12V;CCND3 Amplification;VEGFA Amplification	1	4
P-0002689	P-0002689-T01-IM3	Outside	FFPE	Biopsy	250	378	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ARID1A p.X379_splice;TP53 p.R283Afs*62;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification;RICTOR Amplification;TERT Amplification	1	7
P-0002691	P-0002691-T01-IM3	Outside	FFPE	Resection	250	340	60	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ATRX p.K1045*;ARID2 p.E74Gfs*10;TP53 p.H179del;CDKN1B CDKN1B-intragenic	1	5
P-0002692	P-0002692-T01-IM3	In-House	FFPE	Resection	250	625	30	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.N239*	0	1
P-0002694	P-0002694-T02-IM3	Outside	FFPE	Biopsy	250	639	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MDM2 Amplification;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	7	3
P-0002695	P-0002695-T01-IM3	In-House	FFPE	Resection	250	723	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Ivosidenib(IDH1 p.R132H);Olaparib(BRIP1 p.G690R)	GSK2636771,AZD8186(PTEN p.X70_splice);Everolimus,Temsirolimus(MTOR p.A1459V);GSK2636771,AZD8186(PTEN p.G132D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;PTEN p.X70_splice;IDH1 p.R132H;TOP1 p.X94_splice;MTOR p.A1459V;MSH2 p.X359_splice;MSH2 p.Q855*;PTEN p.G132D;ARID2 p.X258_splice;BRIP1 p.G690R;TP53 p.H214Lfs*33;ASXL1 p.R596Gfs*107;CCND2 Amplification;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;KDM5A Amplification;KIT Amplification;KRAS Amplification;MAP2K4 Deletion;NCOR1 Deletion;PDGFRA Amplification;PTPRD Deletion	7	23
P-0002696	P-0002696-T01-IM3	In-House	FFPE	Biopsy	250	750	20	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_3A	ERBB2 p.L755S;CDH1 p.R87Kfs*7	2	2
P-0002697	P-0002697-T01-IM3	In-House	FFPE	Resection	250	394	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.I35S;KMT2A p.L3730Sfs*29	0	2
P-0002698	P-0002698-T01-IM3	In-House	FFPE	Resection	250	625	30	Matched	Metastasis	Neck	Pleura	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0002700	P-0002700-T01-IM3	Outside	FFPE	Resection	250	317	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;CDH1 p.H632Tfs*31;CCND1 Amplification;FGF19 Amplification	1	4
P-0002701	P-0002701-T01-IM3	In-House	FFPE	Resection	250	331	70	Matched	Metastasis	Bone	Skin	Tumor	CHDM	Bone Cancer	Chordoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CBL p.Q740*;CDKN2A Deletion;CDKN2B Deletion;PAX5 Deletion	1	4
P-0002702	P-0002702-T01-IM3	In-House	FFPE	Biopsy	250	796	30	Matched	Metastasis	Ascending Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R232*;TP53 p.R249M;APC p.K1245*;NCOR1 p.A1648Qfs*8;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;NKX3-1 Deletion;SMAD4 Deletion;SRC Amplification;PRKN PARK2-intragenic	0	11
P-0002703	P-0002703-T01-IM3	In-House	FFPE	Resection	250	726	80	Matched	Metastasis	Soft Tissue	Bone	Tumor	STMYEC	Soft Tissue Sarcoma	Soft Tissue Myoepithelial Carcinoma											0	0
P-0002705	P-0002705-T01-IM3	Outside	FFPE	Biopsy	250	671	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0002706	P-0002706-T01-IM3	In-House	FFPE	Resection	250	504	40	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(MAP2K1 p.N109_R113del)	Olaparib(PALB2 p.Q228*)	GSK2636771,AZD8186(PTEN p.C105*)				LEVEL_3A	KMT2C p.Q608*;PTEN p.C105*;CDK4 p.R24H;PALB2 p.Q228*;MAP2K1 p.N109_R113del	3	5
P-0002707	P-0002707-T01-IM3	In-House	FFPE	Biopsy	250	554	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	ROS1 p.D2033N;TERT Amplification;SPEN ZBTB40-SPEN fusion;ZBTB40 ZBTB40-SPEN fusion;SPEN USP48-SPEN fusion;USP48 USP48-SPEN fusion;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	8
P-0002707	P-0002707-T03-IM5	In-House	Cell Pellet	Cytology	250	1087	50	Matched	Metastasis	Lung	Abdomen	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Crizotinib,Cabozantinib,Capmatinib(MET p.D1228N)		LEVEL_1	MET p.D1228N;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	3	6
P-0002708	P-0002708-T01-IM3	Outside	FFPE	Resection	244	105	40	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)					LEVEL_3B	TP53 p.R280K;PIK3CA p.M1043V;PPP2R1A p.X455_splice;MCL1 Amplification;PIK3CA Amplification	1	5
P-0002709	P-0002709-T01-IM3	In-House	FFPE	Biopsy	250	465	40	Matched	Metastasis	Lung	Abdomen	Tumor	LCLC	Non-Small Cell Lung Cancer	Large Cell Lung Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ARID1A p.S2256*;PIK3R3 p.E278*;PBRM1 p.S383*;INPP4B p.X394_splice;PTPRD p.I311Lfs*4;TP53 p.P75Lfs*48;CCND1 Amplification;FGF19 Amplification;KDM5A Amplification;KRAS Amplification;MYC Amplification;SMARCA4 LDLR-SMARCA4 fusion;LDLR LDLR-SMARCA4 fusion	2	14
P-0002710	P-0002710-T01-IM3	Outside	FFPE	Biopsy	250	195	20	Matched	Primary	GE Junction	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.X187_splice;TP53 p.V73Rfs*76;KMT2C p.R2139*;NOTCH3 p.C873*;RBM10 p.Q867*;MAP2K4 p.P326Sfs*5	0	6
P-0002712	P-0002712-T01-IM3	In-House	FFPE	Biopsy	250	844	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Olaparib(CHEK2 p.Q336*);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.E286K;CUL3 p.M299R;CHEK2 p.Q336*;MDM2 Amplification	2	4
P-0002713	P-0002713-T01-IM3	In-House	FFPE	Resection	250	657	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.Q100*;POLE p.E18K;MAP2K4 p.S184L;JAK1 p.E864*;ARID1B p.D1652Y;GRIN2A p.X551_splice;STAG2 p.Q275*;AXIN1 p.*863Sext*1	2	9
P-0002714	P-0002714-T01-IM3	Outside	FFPE	Resection	250	827	40	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma					GSK2636771,AZD8186(PTEN p.D162V)				LEVEL_4	PTEN p.D162V	1	1
P-0002715	P-0002715-T01-IM3	Outside	FFPE	Resection	250	846	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Olaparib(ATM p.Q1636*)					LEVEL_3B	ARID1A p.S711*;CCND1 p.S41L;ATM p.Q1636*;EP300 p.Q1455H;GATA3 Amplification	1	5
P-0002716	P-0002716-T01-IM3	In-House	FFPE	Resection	250	700	30	Matched	Metastasis	Pleura	Lymph Node	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0002717	P-0002717-T01-IM3	In-House	FFPE	Biopsy	250	743	20	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111del)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	FBXW7 p.R505C;KRAS p.G12V;PIK3CA p.K111del;ARID1A p.P887Tfs*49;CDKN2A p.R80*	3	5
P-0002718	P-0002718-T01-IM3	In-House	FFPE	Biopsy	250	816	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMAD4 p.Q289*	1	2
P-0002719	P-0002719-T01-IM3	In-House	FFPE	Resection	250	451	50	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										LATS1 p.Y143_D145delinsN*IH;CCND1 Amplification;FGF19 Amplification	0	3
P-0002720	P-0002720-T01-IM3	In-House	FFPE	Resection	250	588	30	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma										RB1 p.X776_splice	0	1
P-0002721	P-0002721-T01-IM3	Outside	FFPE	Biopsy	250	233	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.R283*;KMT2C p.R4541*;APC p.S1315*;BCL2L1 Amplification	0	5
P-0002722	P-0002722-T01-IM3	In-House	FFPE	Resection	250	487	20	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma											0	0
P-0002723	P-0002723-T01-IM3	Outside	FFPE	Biopsy	101	59	50	Matched	Metastasis	GE Junction	Liver	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	RYBP p.Q246*;CDKN1B p.L118*;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0002724	P-0002724-T01-IM3	In-House	FFPE	Resection	250	885	40	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;APC p.R232*;APC p.P1424Qfs*49;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	0	7
P-0002725	P-0002725-T01-IM3	Outside	FFPE	Biopsy	218.4	461	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3CA p.E542K;MRE11 p.X409_splice	3	3
P-0002726	P-0002726-T01-IM3	Outside	FFPE	Resection	250	1107	60	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0002728	P-0002728-T01-IM3	Outside	FFPE	Resection	250	660	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.C238Y;APC p.R283*;TP53 p.S90Lfs*59;PTPRT p.E491*;APC p.P1319Lfs*2;SOX9 p.D274Wfs*6	1	7
P-0002729	P-0002729-T01-IM3	In-House	FFPE	Biopsy	250	531	40	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R175H;TP53 p.R282W;IDH1 p.R132H	1	3
P-0002730	P-0002730-T01-IM3	In-House	FFPE	Resection	250	835	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.G244S;APC p.W553Gfs*5;CDK8 Amplification;FLT3 Amplification;SMAD3 Deletion	2	6
P-0002731	P-0002731-T02-IM5	In-House	FFPE	Cytology	250	776	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.V272L;KEAP1 p.G480W;STK11 p.X155_splice;MGA p.D2732Tfs*20;MAPK1 Amplification	0	5
P-0002732	P-0002732-T01-IM3	Outside	FFPE	Resection	250	413	30	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										SMARCA4 p.G1232S	0	1
P-0002733	P-0002733-T01-IM3	Outside	FFPE	Biopsy	250	831	20	Matched	Metastasis	Gallbladder	Peritoneum	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										SMAD4 p.D351N	0	1
P-0002734	P-0002734-T01-IM3	Outside	FFPE	Resection	250	623	20	Matched	Primary	Bone	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0002735	P-0002735-T01-IM3	Outside	FFPE	Resection	250	938	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0002736	P-0002736-T01-IM3	Outside	FFPE	Resection	250	670	40	Matched	Metastasis	Liver	Mediastinum	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma											0	0
P-0002737	P-0002737-T02-IM5	Outside	FFPE	Resection	250	450	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TP53 p.H297Tfs*48	1	2
P-0002738	P-0002738-T01-IM3	In-House	FFPE	Biopsy	170.8	263	30	Matched	Metastasis	Lung	Paratracheal mass	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	GSK2636771,AZD8186(PTEN p.S229*);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.P301Qfs*44;PIK3CA p.E542K;PTEN p.S229*;AURKA Amplification;BMPR1A Deletion;CDKN1B Deletion;FOXP1 Deletion;PTEN Deletion;RB1 Deletion	3	9
P-0002738	P-0002738-T02-IM5	In-House	DNA	Biopsy	250	352	30	Matched	Metastasis	Lung	Liver	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	GSK2636771,AZD8186(PTEN p.S229*)				LEVEL_3B	TP53 p.P301Qfs*44;PIK3CA p.E542K;PTEN p.S229*;FOXP1 FOXP1-intragenic	2	4
P-0002740	P-0002740-T01-IM3	In-House	FFPE	Biopsy	250	271	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.Y236C;TBX3 p.S644Tfs*246;AR Amplification	0	3
P-0002741	P-0002741-T01-IM3	In-House	FFPE	Resection	250	676	30	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.Y185*)	Tazemetostat(KDM6A p.T535Yfs*18);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;BRAF p.D594G;TSC1 p.Y185*;EP300 p.P318Qfs*44;KDM6A p.T535Yfs*18;CDKN2A Deletion;CDKN2B Deletion;FGFR3 Amplification	5	8
P-0002743	P-0002743-T01-IM3	In-House	FFPE	Resection	250	703	50	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				AMG-510(KRAS p.G12C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;PIK3CA p.E545K;SOX9 p.W86*	3	3
P-0002744	P-0002744-T01-IM3	In-House	FFPE	Biopsy	250	150	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R248Q;RB1 p.X776_splice	0	2
P-0002745	P-0002745-T01-IM3	Outside	FFPE	Resection	250	374	20	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.G245S;TP53 p.R273C	0	2
P-0002746	P-0002746-T01-IM3	In-House	FFPE	Cytology	182	260	60	Matched	Metastasis	Larynx	Lung	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma										SUFU p.X386_splice;FAT1 p.P3333Rfs*13;TP53 p.X183_splice;PIK3CA Amplification	0	4
P-0002747	P-0002747-T01-IM3	In-House	FFPE	Resection	250	614	20	Matched	Metastasis	Ovary	Omentum	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer											0	0
P-0002748	P-0002748-T02-IM5	In-House	FFPE	Biopsy	219.7	547	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib(NF1 p.E1333*);Trametinib,Cobimetinib(NF1 p.X2580_splice)				LEVEL_3B	PIK3CA p.E545K;NF1 p.E1333*;ATR p.X781_splice;NOTCH1 p.A2425T;NF1 p.X2580_splice;CDKN1A p.G72Wfs*17;CDKN1A p.D7Gfs*25;MYCL Amplification	3	8
P-0002749	P-0002749-T02-IM3	Outside	FFPE	Resection	250	784	20	Matched	Metastasis	Appendix	Peritoneum	Tumor	SRAP	Appendiceal Cancer	Signet Ring Cell Type of the Appendix				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification	2	2
P-0002750	P-0002750-T02-IM3	Outside	FFPE	Resection	250	697	50	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.G380R)					LEVEL_3B	FGFR3 p.G380R;NFE2L2 p.R34G;JUN Amplification;MCL1 Amplification;TERT Amplification	1	5
P-0002751	P-0002751-T01-IM3	In-House	FFPE	Biopsy	250	91	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.G302Rfs*4	2	2
P-0002752	P-0002752-T01-IM3	In-House	FFPE	Resection	250	104	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.S241P;APC p.K1333*	1	3
P-0002753	P-0002753-T01-IM3	In-House	FFPE	Biopsy	250	546	30	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Everolimus(TSC2 Deletion)					LEVEL_3B	TP53 p.X224_splice;MCL1 Amplification;TSC2 Deletion	1	3
P-0002754	P-0002754-T01-IM3	Outside	FFPE	Resection	250	697	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(NF1 Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	RB1 p.V654Cfs*4;MDM2 Amplification;NF1 Deletion;PTEN Deletion;SOX9 Deletion;SUZ12 Deletion	3	6
P-0002755	P-0002755-T02-IM3	In-House	FFPE	Biopsy	250	644	50	Matched	Metastasis	Major Salivary Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.V73Rfs*76;KDM6A p.N1156*;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;MCL1 Amplification	2	6
P-0002755	P-0002755-T01-IM3	Outside	FFPE	Biopsy	250	840	30	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	SAAD	Salivary Gland Cancer	Salivary Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.V73Rfs*76;KDM6A p.N1156*;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;MCL1 Amplification;MYC Amplification;PTPRD Deletion	2	8
P-0002756	P-0002756-T02-IM5	In-House	FFPE	Biopsy	250	869	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.E453Q)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.E545K;PIK3CA p.E453Q;TBX3 p.X314_splice;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	5	6
P-0002756	P-0002756-T03-IM5	In-House	FFPE	Biopsy	250	1151	60	Unmatched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TBX3 p.X314_splice;HIST1H3B p.E51K;ARID2 p.Q958*;FANCA p.E1420*;CCND1 Amplification;FGF19 Amplification;KRAS Amplification	2	8
P-0002756	P-0002756-T01-IM3	Outside	FFPE	Biopsy	250	275	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.E545K;TBX3 p.X314_splice;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	3	5
P-0002757	P-0002757-T01-IM3	Outside	FFPE	Biopsy	250	1533	20	Matched	Primary	Blood Vessel	Not Applicable	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R273C;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;RICTOR Amplification;TERT Amplification	1	7
P-0002758	P-0002758-T01-IM3	Outside	FFPE	Biopsy	250	112	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58Efs*88)				LEVEL_4	TP53 p.R337L;GNAS p.R201C;ATRX p.E2281*;APC p.E135*;DICER1 p.X48_splice;TP53 p.Y103*;KEAP1 p.R272P;SMARCA4 p.E523*;RBM10 p.S391Vfs*87;RBM10 p.A400Gfs*37;RBM10 p.I407Tfs*76;CDKN2A p.R58Efs*88;CDK6 Amplification;TERT Amplification;STK11 MIDN-STK11 fusion;MIDN MIDN-STK11 fusion	1	16
P-0002759	P-0002759-T01-IM3	In-House	FFPE	Cytology	250	422	20	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer										TP53 p.X331_splice	0	1
P-0002761	P-0002761-T01-IM3	Outside	FFPE	Resection	250	626	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.R130*)				LEVEL_4	PTEN p.R130*;MAP2K4 p.Q163*;TP53 p.T123Ifs*47	1	3
P-0002762	P-0002762-T02-IM5	Outside	FFPE	Resection	250	258	40	Matched	Primary	Upper Extremity	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma											0	0
P-0002763	P-0002763-T01-IM3	In-House	FFPE	Resection	250	353	50	Matched	Primary	Pelvis	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0002764	P-0002764-T01-IM3	In-House	FFPE	Resection	250	466	40	Matched	Primary	Bone	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma										ARID1B Deletion	0	1
P-0002765	P-0002765-T01-IM3	In-House	FFPE	Resection	250	507	NA	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_1	BRAF p.V600E;CTNNB1 p.N387K;B2M p.P52Qfs*7;CDKN2A p.R58*	3	4
P-0002766	P-0002766-T01-IM3	In-House	FFPE	Resection	250	757	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.V28_E33del)				LEVEL_4	KRAS p.Q61H;STK11 p.E57Kfs*7;CDKN2A p.V28_E33del	2	3
P-0002767	P-0002767-T01-IM3	In-House	FFPE	Resection	250	600	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.T155N;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MYC Amplification	2	5
P-0002768	P-0002768-T01-IM3	In-House	FFPE	Biopsy	250	565	30	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;PIK3CB p.D1067V;EGFR p.L747_A750delinsP;ARID2 p.K350Yfs*17	2	4
P-0002769	P-0002769-T01-IM3	In-House	FFPE	Resection	250	663	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;CDK8 p.S62L;MYC Amplification;SMAD4 Deletion	0	4
P-0002770	P-0002770-T01-IM3	In-House	FFPE	Resection	250	171	20	Matched	Metastasis	Rectum	Lymph Node	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.C93Mfs*14)				LEVEL_4	TP53 p.E271*;APC p.R216*;NF1 p.C93Mfs*14	1	3
P-0002771	P-0002771-T01-IM3	Outside	FFPE	Resection	250	442	30	Matched	Metastasis	Ovary	Pelvic wall	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(CDK12 p.S366*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S366*)				LEVEL_3B	TP53 p.E326*;CDK12 p.S366*	2	2
P-0002772	P-0002772-T01-IM3	In-House	FFPE	Resection	250	454	40	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor											0	0
P-0002773	P-0002773-T01-IM3	In-House	FFPE	Biopsy	250	618	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0002775	P-0002775-T01-IM3	Outside	FFPE	Resection	250	439	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;KMT2A p.S2226*;DIS3 p.D479H;MAX p.E8*	2	4
P-0002776	P-0002776-T01-IM3	In-House	FFPE	Resection	250	661	50	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast				AZD5363(AKT1 p.E17K)	Trametinib,Cobimetinib(NF1 p.X2355_splice)				LEVEL_3B	AKT1 p.E17K;TP53 p.R249S;NF1 p.X2355_splice;RB1 p.P609Cfs*43;MED12 p.P49_E55del;EGFR Amplification	2	6
P-0002777	P-0002777-T01-IM3	Outside	FFPE	Resection	250	771	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.Q245*)				LEVEL_3B	TP53 p.R213*;TP53 p.R282W;ERBB2 p.S310F;TP53 p.D281N;PTEN p.Q245*;FBXW7 p.Q242*;RB1 p.X654_splice;CDKN1A p.R83Pfs*6;ERBB2 Amplification;RHOA Amplification	3	10
P-0002778	P-0002778-T01-IM3	In-House	FFPE	Resection	250	618	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.Q1406*;RUNX1 p.X242_splice;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;EGFR Amplification;FAT1 Deletion;MAP2K4 Deletion;SRC Amplification;BMPR1B TET2-BMPR1B fusion;TET2 TET2-BMPR1B fusion;TET2 SEC24B-TET2 fusion;SEC24B SEC24B-TET2 fusion;TET2 PAPSS1-TET2 fusion;PAPSS1 PAPSS1-TET2 fusion	0	16
P-0002779	P-0002779-T01-IM3	In-House	FFPE	Resection	250	407	30	Matched	Primary	Jejunum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;SMAD4 p.R361H;GNAS p.Q227H	1	3
P-0002780	P-0002780-T01-IM3	In-House	FFPE	Biopsy	135.8	146	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;BRAF Amplification;CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;NKX2-1 Amplification;PRDM1 Deletion;YAP1 Amplification	2	9
P-0002781	P-0002781-T01-IM3	Outside	FFPE	Biopsy	250	368	20	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.A159V;KMT2C p.F3544Lfs*9;ARID5B Deletion;PRDM1 Deletion	0	4
P-0002782	P-0002782-T01-IM3	In-House	FFPE	Biopsy	250	724	30	Matched	Primary	Stomach	Not Applicable	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;GNAS p.R201H;NFE2L2 p.E82Q;APC p.Q222Sfs*71;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0002783	P-0002783-T01-IM3	In-House	FFPE	Biopsy	250	572	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.R196*;CTNNB1 p.S37F;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MYCN Amplification	3	8
P-0002784	P-0002784-T01-IM3	In-House	FFPE	Resection	250	712	30	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Olaparib(RAD51B RAD51L1-intragenic)					LEVEL_3B	TP53 p.R273H;PIK3CA p.E542K;ERBB2 Amplification;MYC Amplification;RAD51B RAD51L1-intragenic	3	5
P-0002786	P-0002786-T01-IM3	In-House	FFPE	Resection	250	545	30	Matched	Metastasis	Pleura	Chest Wall	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										NF2 p.Y221*;BAP1 Deletion	0	2
P-0002787	P-0002787-T01-IM3	In-House	FFPE	Biopsy	250	622	30	Matched	Metastasis	Nasopharynx	Liver	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)					LEVEL_3B	KMT2D p.P648Tfs*2;NRAS p.G12D;KMT2D p.L2331Pfs*46;TGFBR2 Deletion	1	4
P-0002788	P-0002788-T01-IM3	In-House	FFPE	Resection	250	571	40	Matched	Metastasis	Ascending Colon	Abdomen	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	TP53 p.R273H;KRAS p.G12D;PIK3CA p.E542K;APC p.S1465Wfs*3;SMAD4 p.R361H;PPP2R1A p.R183W;FBXW7 p.R465C;APC p.R876*;SMARCA4 p.R1005*	2	9
P-0002789	P-0002789-T01-IM3	Outside	FFPE	Resection	250	520	30	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545K;TP53 p.E294Sfs*51;ERBB2 Amplification	4	3
P-0002791	P-0002791-T01-IM3	Outside	FFPE	Biopsy	250	769	30	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.M246V;APC p.G1357*;FLT3 Amplification	0	3
P-0002792	P-0002792-T01-IM3	Outside	FFPE	Biopsy	250	504	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 SMAD3-BRCA1 fusion);Niraparib,Olaparib,Rucaparib,Talazoparib(SMAD3 SMAD3-BRCA1 fusion)					LEVEL_3B	BAP1 p.X662_splice;RBM10 p.X242_splice;APC p.V1173Lfs*6;TP53 p.I195Nfs*14;BRCA1 SMAD3-BRCA1 fusion;SMAD3 SMAD3-BRCA1 fusion	2	6
P-0002793	P-0002793-T02-IM3	Outside	FFPE	Resection	250	688	50	Matched	Primary	Rectum	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	SF3B1 p.R625H;NRAS p.G12D;BCOR Deletion;CDKN2A Deletion;FAT1 Deletion	2	5
P-0002794	P-0002794-T02-IM5	In-House	FFPE	Biopsy	199.1	738	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;TP53 p.K382Nfs*40	1	2
P-0002794	P-0002794-T01-IM3	Outside	FFPE	Biopsy	250	213	20	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0002795	P-0002795-T01-IM3	Outside	FFPE	Biopsy	250	669	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.E271*;APC p.Q1328*	0	2
P-0002796	P-0002796-T01-IM3	In-House	FFPE	Biopsy	250	281	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.L447Vfs*15)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L447Vfs*15)				LEVEL_1	DNMT3B p.X558_splice;CDK12 p.L447Vfs*15;AR Amplification	2	3
P-0002797	P-0002797-T01-IM3	Outside	FFPE	Biopsy	250	543	40	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										CCND1 Amplification;HRAS Amplification	0	2
P-0002798	P-0002798-T01-IM3	In-House	FFPE	Biopsy	250	751	60	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209P;BAP1 p.T495Nfs*4;MYC Amplification	0	3
P-0002799	P-0002799-T01-IM3	Outside	FFPE	Resection	250	423	60	Matched	Primary	Mediastinum	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										TP53 p.R248W;MED12 p.S63I	0	2
P-0002800	P-0002800-T01-IM3	In-House	FFPE	Biopsy	250	590	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										NOTCH2 p.R2400Qfs*16;TP53 p.C242Afs*5	0	2
P-0002801	P-0002801-T01-IM3	In-House	FFPE	Biopsy	250	747	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A68T)				LEVEL_1	TP53 p.R175H;SMAD4 p.G352A;CDKN2A p.A68T;CCNE1 Amplification;ERBB2 Amplification	3	5
P-0002802	P-0002802-T01-IM3	In-House	FFPE	Resection	250	454	20	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R273C;BCOR Deletion;CCNE1 Amplification	0	3
P-0002803	P-0002803-T01-IM3	Outside	FFPE	Resection	250	536	20	Matched	Metastasis	Ovary	Bladder	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.Q16Rfs*28;ERBB2 Amplification;PAK1 Amplification	1	3
P-0002804	P-0002804-T01-IM3	In-House	FFPE	Resection	250	876	30	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248W;APC p.Q1378*;EGFR Amplification	0	3
P-0002805	P-0002805-T01-IM3	Outside	FFPE	Resection	250	988	40	Matched	Metastasis	Kidney	Lung	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma											0	0
P-0002806	P-0002806-T01-IM3	Outside	FFPE	Resection	250	613	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A59_G60delinsGV)				LEVEL_4	STK11 p.K64Rfs*32;KRAS p.A59_G60delinsGV	1	2
P-0002807	P-0002807-T01-IM3	In-House	FFPE	Resection	250	606	60	Matched	Metastasis	Uterus	Pelvic Mass	Tumor	UELMS	Uterine Sarcoma	Uterine Epithelioid Leiomyosarcoma				Olaparib(RAD51B Deletion)					LEVEL_3B	CIC Deletion;RAD51B Deletion	1	2
P-0002808	P-0002808-T01-IM3	Outside	FFPE	Biopsy	250	789	40	Matched	Metastasis	Lung	Bone	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0002809	P-0002809-T01-IM3	Outside	FFPE	Resection	250	583	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.G266E	0	1
P-0002810	P-0002810-T01-IM3	Outside	FFPE	Biopsy	250	644	20	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma				Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(KIAA1217 FGFR2-KIAA1217 fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 FGFR2-KIAA1217 fusion)					LEVEL_3B	MED12 p.C1100*;KIAA1217 FGFR2-KIAA1217 fusion;FGFR2 FGFR2-KIAA1217 fusion	2	3
P-0002811	P-0002811-T01-IM3	In-House	FFPE	Resection	250	716	50	Matched	Metastasis	Lower Extremity	Lower Extremity	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma											0	0
P-0002812	P-0002812-T01-IM3	In-House	FFPE	Resection	250	251	40	Matched	Metastasis	Uterus	Para-aortic mass	Tumor	UELMS	Uterine Sarcoma	Uterine Epithelioid Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.V726Sfs*25)					LEVEL_3B	ATRX p.K823Rfs*7;TP53 p.R337C;MITF p.Q30Tfs*36;BRCA2 p.V726Sfs*25;RB1 p.R7Pfs*24;KDM6A p.E235Ifs*6	1	6
P-0002813	P-0002813-T01-IM3	In-House	FFPE	Biopsy	126	261	20	Matched	Metastasis	Breast	Peritoneum	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										TP53 p.E287D;PAK1 Amplification	0	2
P-0002814	P-0002814-T01-IM3	In-House	FFPE	Resection	250	328	30	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146P)	Cetuximab,Panitumumab(KRAS p.A146P)			LEVEL_4	TP53 p.G245S;KRAS p.A146P	1	2
P-0002815	P-0002815-T01-IM3	Outside	FFPE	Biopsy	250	474	30	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.R215Q;CIC p.N1425Afs*34	1	3
P-0002816	P-0002816-T01-IM3	Outside	FFPE	Resection	250	723	70	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification;TERT Amplification	2	3
P-0002817	P-0002817-T01-IM3	In-House	FFPE	Resection	250	656	60	Matched	Metastasis	Uterus	Liver	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification;RB1 Deletion	2	4
P-0002818	P-0002818-T01-IM3	In-House	FFPE	Resection	250	528	NA	Matched	Metastasis	Cancer of Unknown Primary	Neck	Tumor	HNNE	Head and Neck Cancer	Head and Neck Neuroendocrine Carcinoma					GSK2636771,AZD8186(PTEN p.Q245*)				LEVEL_4	TP53 p.R248Q;NFE2L2 p.E79Q;PTEN p.Q245*;PMS2 p.Q604*;KMT2D p.Q4217*;KMT2D p.Q3927*;RB1 p.S648*;TERT Amplification	1	8
P-0002819	P-0002819-T01-IM3	Outside	FFPE	Resection	250	739	60	Matched	Primary	Testis	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.I251M;TP53 p.R273Ffs*71;TP53 p.P190Sfs*17;TP53 p.L14Sfs*15	0	4
P-0002820	P-0002820-T01-IM3	In-House	FFPE	Biopsy	250	499	20	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Tazemetostat(SMARCB1 p.X121_splice)				LEVEL_4	VHL p.L135*;SMARCB1 p.X121_splice;NBN p.S240Cfs*8;NF2 p.R446Efs*48	1	4
P-0002821	P-0002821-T01-IM3	In-House	FFPE	Resection	140	232	20	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										TRAF7 p.N520S	0	1
P-0002822	P-0002822-T01-IM3	Outside	FFPE	Resection	250	647	40	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										KDR Amplification;KRAS Amplification	0	2
P-0002823	P-0002823-T01-IM3	In-House	FFPE	Resection	250	574	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010N)	Crizotinib(MET p.D1010N)	Cabozantinib(MET p.D1010N)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Everolimus(TSC2 p.W441*)					LEVEL_1	PIK3CA p.E545K;SMAD2 p.S464*;TP53 p.L194F;TP53 p.R280T;MET p.D1010N;TSC2 p.W441*;CREBBP p.Y659*;TP53 p.M246I;EP300 p.X1087_splice	5	9
P-0002824	P-0002824-T01-IM3	In-House	FFPE	Resection	250	736	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(ATM p.E2621*)					LEVEL_3B	ATM p.E2621*;EP300 p.L1215*;KMT2D p.L1875Ffs*28;KMT2D p.P1002Hfs*14;EGFR Amplification	1	5
P-0002825	P-0002825-T01-IM3	In-House	FFPE	Biopsy	250	593	20	Matched	Metastasis	Kidney	Liver	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										ASXL2 p.R312Hfs*8;TP53 p.S261Tfs*2	0	2
P-0002825	P-0002825-T02-IM5	Outside	FFPE	Resection	250	361	20	Unmatched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										ASXL2 p.R312Hfs*8;TP53 p.S261Tfs*2	0	2
P-0002826	P-0002826-T01-IM3	In-House	FFPE	Biopsy	250	777	40	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	CREBBP p.R1341*;STK11 p.K108*;KRAS p.G13D	1	3
P-0002827	P-0002827-T01-IM3	Outside	FFPE	Resection	250	432	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)						LEVEL_1	PIK3CA p.C420R;TP53 p.X126_splice	2	2
P-0002828	P-0002828-T01-IM3	Outside	FFPE	Biopsy	250	509	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0002829	P-0002829-T01-IM3	Outside	FFPE	Resection	250	629	30	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.H1047R;ARID1A p.D641Sfs*4	1	3
P-0002830	P-0002830-T01-IM3	Outside	FFPE	Resection	250	339	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0002832	P-0002832-T01-IM3	Outside	FFPE	Resection	250	962	40	Unmatched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A	1	1
P-0002833	P-0002833-T01-IM3	Outside	FFPE	Biopsy	250	617	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.H179Y;ATRX p.K2182Vfs*8;MET Amplification	1	3
P-0002835	P-0002835-T01-IM3	In-House	FFPE	Biopsy	250	1130	NA	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)		Cetuximab,Panitumumab(NRAS p.G12D)			LEVEL_3B	APC p.R283*;TP53 p.Q104*;NRAS p.G12D;SMAD4 p.X142_splice;APC p.S1421Vfs*52;PMAIP1 Deletion;SMAD4 Deletion	1	7
P-0002836	P-0002836-T01-IM3	Outside	FFPE	Biopsy	250	756	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(BRIP1 Deletion)	Trametinib,Cobimetinib(NF1 p.R1534*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NF1 p.R1534*;BRIP1 Deletion;CDKN2A Deletion;CDKN2B Deletion	3	4
P-0002837	P-0002837-T01-IM3	In-House	FFPE	Biopsy	250	671	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13E)				LEVEL_4	TP53 p.R273L;STK11 p.D162_G163delinsYF;KRAS p.G13E	1	3
P-0002838	P-0002838-T03-IM5	In-House	FFPE	Resection	250	791	10	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	BRAF p.V600E;PIK3CA p.E545K	2	2
P-0002838	P-0002838-T02-IM5	Outside	FFPE	Resection	250	326	20	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Lorlatinib,Brigatinib(ALK p.G1202E)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	BRAF p.V600E;KRAS p.G12V;ALK p.G1202E	3	3
P-0002839	P-0002839-T01-IM3	Outside	FFPE	Resection	250	712	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										TP53 p.R248Q;MEN1 p.Q513*	0	2
P-0002840	P-0002840-T02-IM3	In-House	FFPE	Resection	250	767	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R213Dfs*34	0	1
P-0002840	P-0002840-T01-IM3	Outside	FFPE	Resection	250	966	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R213Dfs*34;GLRA2 KDM5C-GLRA2 fusion;KDM5C KDM5C-GLRA2 fusion	0	3
P-0002841	P-0002841-T01-IM3	In-House	FFPE	Resection	250	846	30	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.K111N)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111N)	Olaparib(BCAS3 BRIP1-BCAS3 fusion);Olaparib(BRIP1 BRIP1-BCAS3 fusion)					LEVEL_1	PIK3CA p.H1047R;PIK3CA p.K111N;JAK1 p.N357Tfs*20;MAP2K4 Deletion;MDM4 Amplification;MYC Amplification;TP53 Deletion;BCAS3 BRIP1-BCAS3 fusion;BRIP1 BRIP1-BCAS3 fusion	6	9
P-0002842	P-0002842-T01-IM3	Outside	FFPE	Biopsy	250	725	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.E597*);Olaparib(ATM p.G197Dfs*9)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;BRCA1 p.E597*;ATM p.G197Dfs*9	4	3
P-0002843	P-0002843-T01-IM3	In-House	FFPE	Resection	250	712	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L101_P102delinsPT	0	1
P-0002843	P-0002843-T02-IM5	In-House	FFPE	Resection	250	653	40	Matched	Metastasis	Kidney	Lymph Node	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L101_P102delinsPT	0	1
P-0002844	P-0002844-T01-IM3	Outside	FFPE	Biopsy	250	597	30	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E33*)				LEVEL_3B	BRAF p.V600E;CDKN2A p.E33*	2	2
P-0002845	P-0002845-T01-IM3	Outside	FFPE	Biopsy	250	546	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T);Trametinib,Cobimetinib,Binimetinib(KRAS p.R149K)				LEVEL_4	KRAS p.A146T;TP53 p.L194R;KRAS p.R149K;KRAS Amplification	2	4
P-0002846	P-0002846-T01-IM3	In-House	FFPE	Biopsy	250	839	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0002847	P-0002847-T01-IM3	Outside	FFPE	Resection	250	330	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.V173M;NCOR1 p.S270*;FGFR1 Amplification	3	4
P-0002848	P-0002848-T01-IM3	In-House	FFPE	Biopsy	211.2	728	20	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.X2657_splice)				LEVEL_1	NF1 p.X2657_splice;TP53 p.N239_S240del;CCND1 Amplification;DDR2 Amplification;ERBB2 Amplification;FGF19 Amplification;MDM4 Amplification	3	7
P-0002849	P-0002849-T01-IM3	Outside	FFPE	Resection	250	352	40	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0002850	P-0002850-T01-IM3	In-House	FFPE	Cytology	250	777	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.V157F;TP53 p.E171*;GNAS p.Q227L;KMT2C p.C3677Yfs*10;FOXA1 Amplification;MYC Amplification;NKX2-1 Amplification	0	7
P-0002851	P-0002851-T01-IM3	In-House	FFPE	Resection	250	778	30	Matched	Metastasis	Lung	Bone	Tumor	CHS	Bone Cancer	Chondrosarcoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C	1	1
P-0002852	P-0002852-T01-IM3	Outside	FFPE	Resection	250	568	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.Y1376Cfs*9;TP53 p.E198*;APC p.R216*;FBXW7 p.R479*;FBXW7 p.R278*;ATRX p.E1522*;CDK8 Amplification;FLT3 Amplification	1	9
P-0002853	P-0002853-T01-IM3	In-House	FFPE	Biopsy	250	577	50	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma											0	0
P-0002854	P-0002854-T01-IM3	In-House	FFPE	Biopsy	250	798	30	Matched	Metastasis	Oropharynx	Bone	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										BCL2L1 Amplification;DNMT3B Amplification	0	2
P-0002855	P-0002855-T01-IM3	Outside	FFPE	Biopsy	250	739	20	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	TP53 p.R175H;KRAS p.A146T;APC p.E1309Dfs*4;TOP1MT RECQL4-TOP1MT fusion;RECQL4 RECQL4-TOP1MT fusion	1	5
P-0002856	P-0002856-T01-IM3	Outside	FFPE	Biopsy	250	376	20	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.V272M;BCL2L1 Amplification	2	3
P-0002858	P-0002858-T01-IM3	Outside	FFPE	Biopsy	250	111	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Olaparib(CDK12 p.S24*);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S24*)				LEVEL_1	PIK3CA p.H1047R;PIK3CB p.R321Q;RIT1 p.M90I;FLT3 p.E672K;FLT3 p.S638L;CDK12 p.S24*;NSD1 p.E249Kfs*12;AURKA Amplification;BCL6 Amplification;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MCL1 Amplification;PIK3CA Amplification	6	14
P-0002859	P-0002859-T01-IM3	Outside	FFPE	Cytology	250	633	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Trametinib,Cobimetinib(MAP2K1 p.K57N);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3A	PIK3CA p.E542K;TP53 p.E298*;MAP2K1 p.K57N;FGFR1 Amplification	3	4
P-0002860	P-0002860-T01-IM3	Outside	FFPE	Resection	250	814	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H450_L455del)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.H450_L455del;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	5
P-0002861	P-0002861-T01-IM3	In-House	FFPE	Biopsy	250	770	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.Q165*;EGFR Amplification	1	3
P-0002862	P-0002862-T01-IM3	Outside	FFPE	Resection	250	1107	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	TP53 p.R196*;TP53 p.W146*;CDK4 Amplification;FGFR3 Amplification;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	3	6
P-0002863	P-0002863-T01-IM3	Outside	FFPE	Resection	250	611	50	Matched	Metastasis	Bone	Subcutaneous Tissue	Tumor	CHDM	Bone Cancer	Chordoma											0	0
P-0002864	P-0002864-T01-IM3	Outside	FFPE	Resection	250	766	20	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										LATS2 p.K863Pfs*27;NF2 p.L163Ffs*40	0	2
P-0002865	P-0002865-T01-IM3	Outside	FFPE	Biopsy	250	384	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	STK11 p.D194Y;RB1 p.S397*;TP53 p.S240C;KEAP1 p.D422N;AMER1 Deletion;ATRX Deletion;BCL6 Amplification;BCOR Deletion;KDM6A Deletion;MED12 Deletion;MLH1 Deletion;NPM1 Deletion;PIK3CA Amplification;PIK3CB Amplification;PTEN Deletion	1	15
P-0002866	P-0002866-T01-IM3	In-House	FFPE	Biopsy	250	611	30	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										SPEN p.X348_splice	0	1
P-0002867	P-0002867-T01-IM3	In-House	FFPE	Biopsy	250	556	20	Matched	Metastasis	Cancer of Unknown Primary	Chest Wall	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0002868	P-0002868-T02-IM5	Outside	FFPE	Biopsy	250	531	30	Matched	Primary	Rectum	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del)								LEVEL_1	KIT p.W557_K558del	1	1
P-0002869	P-0002869-T01-IM3	Outside	FFPE	Cytology	250	526	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsAPS)								LEVEL_1	TP53 p.C275F;MED12 p.Q2051*;EGFR p.E746_T751delinsAPS;FOXA1 Amplification	1	4
P-0002870	P-0002870-T01-IM3	Outside	FFPE	Resection	250	771	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.G132D);Lapatinib(EGFR Amplification)				LEVEL_3B	PTEN p.G132D;CDK4 Amplification;EGFR Amplification;MDM2 Amplification	4	4
P-0002871	P-0002871-T01-IM3	Outside	FFPE	Biopsy	250	663	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LECLC	Non-Small Cell Lung Cancer	Lymphoepithelioma-like Carcinoma of the Lung				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TGFBR2 p.E526Q	1	2
P-0002872	P-0002872-T01-IM3	In-House	FFPE	Biopsy	250	615	20	Matched	Metastasis	Lung	Adrenal Gland	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer										TP53 p.X125_splice;ARID1A p.Q633*;APC p.E1265*	0	3
P-0002873	P-0002873-T01-IM3	Outside	FFPE	Biopsy	250	560	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R248W;KDM5C p.Q168*;CDKN2A Deletion;CDKN2B Deletion;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	7	6
P-0002874	P-0002874-T01-IM3	Outside	FFPE	Resection	250	1045	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.M237I;KEAP1 p.R601L;NBN p.X107_splice;TGFBR2 p.E221Gfs*3;YAP1 Amplification	2	6
P-0002875	P-0002875-T01-IM3	Outside	FFPE	Resection	250	473	70	Matched	Metastasis	Thyroid	Bone	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R	2	1
P-0002876	P-0002876-T01-IM3	In-House	FFPE	Cytology	250	602	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)	Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_2	ERBB2 p.Y772_A775dup;TP53 p.P278A;CDK4 Amplification;FOXA1 Amplification;NKX2-1 Amplification	3	5
P-0002877	P-0002877-T01-IM3	In-House	FFPE	Biopsy	250	681	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	SETD2 p.A2053Pfs*94;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	3
P-0002878	P-0002878-T01-IM3	Outside	FFPE	Resection	250	556	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)					LEVEL_3B	PIK3CA p.M1043V;APC p.E1408*;TP53 p.P152L;SMARCA4 p.R1157Q;APC p.I1056Kfs*5	1	5
P-0002879	P-0002879-T01-IM3	Outside	FFPE	Resection	250	788	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.Q104*;TET1 p.S334*;RB1 p.K615*;MED12 p.E1780*	0	4
P-0002880	P-0002880-T01-IM3	In-House	FFPE	Resection	250	528	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E258*;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0002881	P-0002881-T01-IM3	In-House	FFPE	Biopsy	250	455	NA	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										NFE2L2 p.W24C;KMT2D p.Q1402*	0	2
P-0002882	P-0002882-T01-IM3	Outside	FFPE	Biopsy	250	786	20	Matched	Primary	Sinonasal	Not Applicable	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma											0	0
P-0002883	P-0002883-T02-IM5	In-House	FFPE	Biopsy	250	1085	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R282W;FLT3 p.A627T;ERBB2 Amplification	2	3
P-0002883	P-0002883-T01-IM3	Outside	FFPE	Biopsy	165	191	30	Matched	Primary	Esophagus	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification	2	1
P-0002884	P-0002884-T01-IM3	Outside	FFPE	Biopsy	250	618	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AZD5363(AKT1 p.E17K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	AKT1 p.E17K;KRAS p.G12V;GNAS p.R201H;TP53 p.A74Gfs*75;CDK6 Amplification	2	5
P-0002885	P-0002885-T01-IM3	Outside	FFPE	Resection	250	784	90	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion);Olaparib(CHEK2 Deletion)					LEVEL_3B	ATRX p.X1604_splice;BCOR Deletion;BRCA2 Deletion;CHEK2 Deletion;KDM6A Deletion;MCL1 Amplification;NF2 Deletion;NTRK1 Amplification;RBM10 Deletion	2	9
P-0002886	P-0002886-T01-IM3	Outside	FFPE	Resection	250	667	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);PLX8394(BRAF p.G469A)				LEVEL_4	KRAS p.G12D;RAD50 p.X407_splice;BRAF p.G469A;SETD2 p.T305Nfs*4;EP300 p.X1087_splice;MTAP CDKN2B-MTAP fusion;CDKN2B CDKN2B-MTAP fusion	2	7
P-0002887	P-0002887-T01-IM3	In-House	FFPE	Resection	250	748	40	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer	Niraparib,Olaparib,Rucaparib(CASC3 BRCA1-CASC3 fusion);Niraparib,Olaparib,Rucaparib(BRCA1 BRCA1-CASC3 fusion)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Talazoparib(CASC3 BRCA1-CASC3 fusion);Talazoparib(BRCA1 BRCA1-CASC3 fusion)					LEVEL_1	TP53 p.R248W;ERBB2 Amplification;CASC3 BRCA1-CASC3 fusion;BRCA1 BRCA1-CASC3 fusion	5	4
P-0002888	P-0002888-T01-IM3	In-House	FFPE	Resection	250	594	60	Matched	Metastasis	Kidney	Liver	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Olaparib(ATM p.R2568Ffs*14)					LEVEL_3B	ATM p.R2568Ffs*14	1	1
P-0002889	P-0002889-T01-IM3	In-House	FFPE	Resection	250	451	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	NSGCT	Germ Cell Tumor	Non-Seminomatous Germ Cell Tumor											0	0
P-0002890	P-0002890-T01-IM3	In-House	FFPE	Biopsy	132	678	40	Matched	Metastasis	Lung	Retroperitoneum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Debio1347,Erdafitinib,BGJ398,AZD4547(PBDC1 FGFR3-CXorf26 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-CXorf26 fusion)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;SMAD4 p.S144*;TP53 p.R283Hfs*22;EGFR Amplification;PBDC1 FGFR3-CXorf26 fusion;FGFR3 FGFR3-CXorf26 fusion	4	7
P-0002891	P-0002891-T01-IM3	Outside	FFPE	Biopsy	250	297	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.M1?);GSK2636771,AZD8186(PTEN p.K269Nfs*28);Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	TP53 p.R248W;RB1 p.V654Sfs*14;NF1 p.M1?;SETD2 p.K583Sfs*17;PTEN p.K269Nfs*28;NF1 NF1-intragenic	3	6
P-0002892	P-0002892-T01-IM3	In-House	FFPE	Resection	250	602	70	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										KRAS Amplification	0	1
P-0002893	P-0002893-T01-IM3	In-House	FFPE	Resection	250	386	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;U2AF1 p.S34F;RBM10 p.X651_splice	1	3
P-0002894	P-0002894-T01-IM3	In-House	FFPE	Biopsy	250	663	50	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.Q165*;AR Amplification;FGFR1 Amplification;MET Amplification;MYC Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	7
P-0002895	P-0002895-T01-IM3	In-House	FFPE	Resection	250	181	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0002896	P-0002896-T01-IM3	In-House	FFPE	Resection	250	666	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;RAC1 p.Q61R	1	2
P-0002897	P-0002897-T01-IM3	In-House	FFPE	Resection	250	159	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.Y163C;SPOP p.F102C	0	2
P-0002898	P-0002898-T02-IM5	In-House	FFPE	Biopsy	250	576	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	BRAF p.K601E;KDM6A p.M1384Kfs*8;TOP1 p.R210Lfs*3;EPHA7 Deletion	2	4
P-0002898	P-0002898-T03-IM5	In-House	FFPE	Biopsy	250	1308	70	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(RAD51B Deletion)			Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_1	BRAF p.K601E;KDM6A p.M1384Kfs*8;TOP1 p.R210Lfs*3;EPHA7 Deletion;RAD51B Deletion	3	5
P-0002898	P-0002898-T01-IM3	In-House	FFPE	Resection	250	389	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	BRAF p.K601E;KDM6A p.M1384Kfs*8	2	2
P-0002899	P-0002899-T01-IM3	In-House	FFPE	Resection	250	728	30	Matched	Metastasis	Lower Extremity	Bone	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma											0	0
P-0002900	P-0002900-T01-IM3	Outside	FFPE	Resection	250	473	20	Matched	Primary	Brain	Not Applicable	Tumor	RGNT	Miscellaneous Neuroepithelial Tumor	Rosette-forming Glioneuronal Tumor of the Fourth Ventricle				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;TP53 p.G266R	1	2
P-0002901	P-0002901-T01-IM3	In-House	FFPE	Biopsy	226.8	364	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	FLT3 p.G617V;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0002901	P-0002901-T03-IM5	In-House	FFPE	Resection	250	350	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FLT3 p.G617V;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0002902	P-0002902-T01-IM3	In-House	FFPE	Resection	250	688	20	Matched	Primary	Rectum	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Everolimus(TSC2 p.S1292Pfs*33)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;APC p.E1309*;FBXW7 p.X413_splice;FBXW7 p.E117*;APC p.C661*;ARID2 p.F26Sfs*32;TSC2 p.S1292Pfs*33	2	7
P-0002903	P-0002903-T01-IM3	Outside	FFPE	Resection	250	290	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Olaparib(ATM p.L2738*)	GSK2636771,AZD8186(PTEN p.Y336Cfs*18)				LEVEL_3B	RHOA p.T37I;SETD2 p.R2040*;ATM p.L2738*;ARID2 p.Q1347*;SMARCD1 p.R183Q;RAD51 p.X115_splice;KDM5C p.R943*;MSH6 p.E490Kfs*2;PTEN p.Y336Cfs*18	2	9
P-0002904	P-0002904-T01-IM3	Outside	FFPE	Resection	250	774	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.E349*;ARID1A p.S304*;EGFR Amplification;PTPRD Deletion	0	4
P-0002905	P-0002905-T01-IM3	In-House	FFPE	Biopsy	93.5	430	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;STK11 p.X97_splice	1	2
P-0002906	P-0002906-T01-IM3	In-House	FFPE	Resection	250	750	40	Matched	Primary	Bile Duct	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Everolimus(TSC1 p.V25Lfs*16)					LEVEL_3B	TP53 p.Q52*;TSC1 p.V25Lfs*16;MCL1 Amplification	1	3
P-0002907	P-0002907-T01-IM3	In-House	FFPE	Biopsy	250	600	70	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;NOTCH1 p.I471T;TP53 p.G325Efs*20;KRAS Amplification	1	4
P-0002908	P-0002908-T01-IM3	In-House	FFPE	Resection	250	75	50	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										VHL p.Y112C;TET2 p.F1901Lfs*4;MEN1 p.I85Lfs*35;ATRX p.V2108Gfs*15	0	4
P-0002909	P-0002909-T01-IM3	In-House	FFPE	Resection	250	368	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.G245S	1	2
P-0002910	P-0002910-T02-IM5	In-House	FFPE	Biopsy	194.9	875	40	Matched	Metastasis	Thyroid	Bone	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;CDKN1B p.E86*;DIS3 p.R780T;DICER1 p.Q84*;BCOR p.Q430*	1	5
P-0002911	P-0002911-T01-IM3	In-House	FFPE	Biopsy	250	446	70	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;DNMT3A p.X427_splice;CDH1 p.E497*;SMAD4 p.G508D;SPEN p.N788Kfs*2	1	5
P-0002912	P-0002912-T01-IM3	In-House	FFPE	Resection	250	509	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	TP53 p.G199E;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	3
P-0002913	P-0002913-T01-IM3	In-House	FFPE	Biopsy	250	740	90	Matched	Metastasis	Lung	Liver	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										MEN1 p.S313*	0	1
P-0002914	P-0002914-T01-IM3	In-House	FFPE	Resection	250	522	50	Unmatched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)		Trametinib,Cobimetinib(MAP2K1 p.P124R)	Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.R158C;PTPRD p.R1674C;MAP2K1 p.P124R	3	4
P-0002915	P-0002915-T01-IM3	In-House	FFPE	Biopsy	250	609	20	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E970K)	Talazoparib,Olaparib(BRCA1 p.E729Rfs*10)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E970K)	Niraparib,Rucaparib(BRCA1 p.E729Rfs*10)	Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_1	PIK3CA p.E970K;KMT2C p.Q2503*;MAP3K1 p.C571Mfs*4;GATA3 p.N333Kfs*19;BRCA1 p.E729Rfs*10;TET1 TET1-intragenic;NF1 NF1-intragenic	5	7
P-0002916	P-0002916-T02-IM5	In-House	DNA	Biopsy	243.6	598	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3A	PIK3CA p.E542K;EGFR p.E709_T710delinsD;EGFR Amplification	2	3
P-0002916	P-0002916-T01-IM3	Outside	FFPE	Cytology	228.6	549	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)						LEVEL_3A	EGFR p.E709_T710delinsD	1	1
P-0002917	P-0002917-T01-IM3	Outside	FFPE	Resection	250	200	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.K96*	1	2
P-0002919	P-0002919-T01-IM3	In-House	FFPE	Resection	250	741	90	Matched	Primary	Retroperitoneum	Para-aortic Mass	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0002920	P-0002920-T02-IM5	In-House	FFPE	Biopsy	250	1087	30	Matched	Metastasis	Minor Salivary Gland	Liver	Tumor	SAAD	Salivary Gland Cancer	Salivary Adenocarcinoma										TP53 p.D259Y;CCND1 Amplification;FGF19 Amplification;KIT Amplification;MYCL Amplification;PDGFRA Amplification	0	6
P-0002920	P-0002920-T01-IM3	In-House	FFPE	Resection	250	735	30	Matched	Metastasis	Minor Salivary Gland	Liver	Tumor	SAAD	Salivary Gland Cancer	Salivary Adenocarcinoma										TP53 p.D259Y;CCND1 Amplification;FGF19 Amplification;JUN Amplification;KIT Amplification;MYCL Amplification;PDGFRA Amplification	0	7
P-0002921	P-0002921-T01-IM3	In-House	FFPE	Resection	250	438	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;NFE2L2 p.G31A;BAP1 p.X417_splice;MAP3K1 p.E460*;TGFBR1 p.S336*;DIS3 p.D479G;DNMT3B p.E451*;RBM10 p.E611*	1	8
P-0002922	P-0002922-T01-IM3	In-House	FFPE	Resection	250	799	70	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.E545Q)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.E545Q;TP53 p.X187_splice;AR Amplification;MAP2K4 Deletion;MYC Amplification	4	6
P-0002936	P-0002936-T01-IM3	In-House	FFPE	Biopsy	250	635	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(RAD51D p.V247Rfs*80)	Lapatinib(EGFR Amplification)				LEVEL_3B	TP53 p.D281H;RB1 p.S182Ifs*3;RAD51D p.V247Rfs*80;TP53 p.C176*;ARID5B Deletion;EGFR Amplification	2	6
P-0002937	P-0002937-T01-IM3	In-House	FFPE	Resection	250	508	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;PBRM1 p.R298*	1	2
P-0002939	P-0002939-T01-IM3	In-House	FFPE	Biopsy	250	654	30	Matched	Primary	Sinonasal	Not Applicable	Tumor	SNSC	Head and Neck Cancer	Sinonasal Squamous Cell Carcinoma				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	SMARCB1 Deletion	1	1
P-0002940	P-0002940-T01-IM3	Outside	FFPE	Biopsy	250	532	20	Matched	Metastasis	Kidney	Lymph Node	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;RBM10 p.S60*	1	2
P-0002941	P-0002941-T01-IM3	In-House	FFPE	Biopsy	250	677	20	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.G114A;BAP1 p.G686Afs*6	0	2
P-0002942	P-0002942-T01-IM3	In-House	FFPE	Biopsy	250	616	20	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification	1	1
P-0002943	P-0002943-T01-IM3	Outside	FFPE	Biopsy	250	456	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.F270V;RB1 p.E551*;FLCN p.R477*;NPM1 Deletion	0	4
P-0002944	P-0002944-T01-IM3	In-House	FFPE	Resection	250	381	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.R273H;CDK6 Amplification;MDM2 Amplification	1	3
P-0002945	P-0002945-T01-IM3	In-House	FFPE	Resection	250	987	30	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y)					LEVEL_3B	TP53 p.X225_splice;PPP2R1A p.P179R;PIK3CA p.H1047Y	1	3
P-0002946	P-0002946-T01-IM3	Outside	FFPE	Resection	250	443	50	Matched	Primary	Bone	Not Applicable	Tumor	PGNG	Miscellaneous Neuroepithelial Tumor	Paraganglioma										ATRX p.W1958*	0	1
P-0002947	P-0002947-T01-IM3	Outside	FFPE	Resection	250	806	20	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0002948	P-0002948-T02-IM5	Outside	FFPE	Biopsy	250	456	20	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.R175H;ERBB2 Amplification	1	2
P-0002949	P-0002949-T01-IM3	In-House	FFPE	Resection	250	658	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;RBM10 p.E67*	1	2
P-0002950	P-0002950-T01-IM3	Outside	FFPE	Biopsy	250	680	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	SF3B1 p.K700E;GATA3 p.G443Pfs*34;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification	1	6
P-0002951	P-0002951-T01-IM3	Outside	FFPE	Resection	250	737	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R213*;APC p.S1315*;APC p.R554*;CCND1 Amplification;EGFR Amplification;FGF19 Amplification	0	6
P-0002952	P-0002952-T01-IM3	Outside	FFPE	Biopsy	250	410	50	Matched	Primary	Bone	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0002953	P-0002953-T01-IM3	In-House	FFPE	Biopsy	250	781	30	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.G370C)		Debio1347,BGJ398,AZD4547(FGFR3 p.G370C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.F276I);Tazemetostat(KDM6A p.X54_splice)				LEVEL_1	PIK3CA p.E545K;TP53 p.R175H;KMT2A p.R2188*;ARID1A p.G660*;FGFR3 p.G370C;ARID5B p.E589*;FGFR2 p.F276I;KDM6A p.X54_splice	5	8
P-0002954	P-0002954-T01-IM3	Outside	FFPE	Biopsy	250	480	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.W3055*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ATM p.W3055*	3	2
P-0002955	P-0002955-T01-IM3	Outside	FFPE	Biopsy	250	462	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;NOTCH2 p.Q767*;CDC73 p.L63Tfs*2;STK11 p.D208Qfs*53	1	4
P-0002956	P-0002956-T01-IM3	In-House	FFPE	Resection	250	703	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.S216F;CREBBP p.D1435N;SMARCA4 p.R1189L;RB1 p.L649Ffs*11	1	5
P-0002957	P-0002957-T01-IM3	Outside	FFPE	Biopsy	250	349	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										ARID1B p.G914*;TP53 p.G154Afs*16;PTPRT p.T443Pfs*14;CCNE1 Amplification;DDR2 Amplification;FOXA1 Amplification;KDR Amplification;KIT Amplification;MCL1 Amplification;MYC Amplification;NKX2-1 Amplification;NTRK1 Amplification;PDGFRA Amplification;TERT Amplification	0	14
P-0002958	P-0002958-T01-IM3	Outside	FFPE	Resection	250	356	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.D335Gfs*17;MEN1 p.L129Pfs*25;CCND1 Amplification;FGF19 Amplification	0	4
P-0002959	P-0002959-T02-IM5	In-House	FFPE	Biopsy	250	654	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C;FOXA1 p.H247R	1	2
P-0002959	P-0002959-T01-IM3	Outside	FFPE	Biopsy	250	252	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C;FOXA1 p.H247R	1	2
P-0002960	P-0002960-T01-IM3	In-House	FFPE	Biopsy	250	578	20	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R282W;RNF43 p.P370Hfs*49	0	2
P-0002961	P-0002961-T01-IM3	In-House	FFPE	Resection	250	424	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion	1	1
P-0002962	P-0002962-T01-IM3	In-House	FFPE	Resection	250	803	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	FLT3 p.N734K;SPOP p.F133I;MED12 p.L1224V;BRCA2 Deletion	2	4
P-0002963	P-0002963-T01-IM3	In-House	FFPE	Biopsy	250	666	70	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.Y220C;IDH1 p.R132H;RAD50 p.M1?	1	3
P-0002964	P-0002964-T02-IM3	Outside	FFPE	Biopsy	250	515	30	Matched	Metastasis	Cancer of Unknown Primary	Mediastinum	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma		Cabozantinib(MET Amplification)		Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T79P)				LEVEL_2	TP53 p.V272L;ARID1A p.Q1142*;FH p.S186I;EPHA3 p.K200*;FAT1 p.S2713*;ARID1B p.Q1585*;SOX17 p.C245*;GRIN2A p.X336_splice;CDKN2A p.T79P;MET Amplification	3	10
P-0002964	P-0002964-T01-IM3	Outside	FFPE	Resection	250	537	70	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										NF2 p.E408Gfs*19;KDM6A p.K831Lfs*34	0	2
P-0002965	P-0002965-T01-IM3	In-House	FFPE	Biopsy	250	970	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Olaparib(BRIP1 p.Q866*)					LEVEL_3A	TP53 p.Q192*;BRIP1 p.Q866*;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	2	5
P-0002966	P-0002966-T01-IM3	Outside	FFPE	Resection	250	219	20	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0002967	P-0002967-T01-IM3	Outside	FFPE	Resection	250	310	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										CTCF p.E141*;NCOR1 p.Q800*;NKX2-1 Amplification	0	3
P-0002968	P-0002968-T01-IM3	In-House	FFPE	Biopsy	250	815	20	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R	1	1
P-0002969	P-0002969-T01-IM3	In-House	FFPE	Biopsy	250	462	20	Matched	Metastasis	Lung	Pancreas	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.S241F;STK11 p.X288_splice;KEAP1 p.R470C;SMARCA4 p.Q1166*;PAK1 Amplification	0	5
P-0002970	P-0002970-T01-IM3	In-House	FFPE	Biopsy	250	1087	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R248W;U2AF1 p.S34F;TGFBR2 p.S295*;FAT1 p.S2466*;NSD1 p.E1447*	0	5
P-0002971	P-0002971-T01-IM3	In-House	FFPE	Resection	250	673	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0002971	P-0002971-T02-IM5	Outside	FFPE	Resection	250	623	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0002972	P-0002972-T01-IM3	Outside	FFPE	Resection	250	809	50	Matched	Primary	Mediastinum	Not Applicable	Tumor	PLLS	Soft Tissue Sarcoma	Pleomorphic Liposarcoma										TP53 p.H193Y;CCNE1 Amplification;MYC Amplification	0	3
P-0002973	P-0002973-T01-IM3	In-House	FFPE	Resection	250	480	50	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Olaparib(CHEK1 Deletion)					LEVEL_3B	CCND2 Amplification;CHEK1 Deletion;KRAS Amplification;PAK1 Amplification	1	4
P-0002974	P-0002974-T01-IM3	In-House	FFPE	Biopsy	250	967	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;PMAIP1 Deletion;PRDM1 Deletion;PTEN Deletion	2	5
P-0002975	P-0002975-T02-IM5	In-House	FFPE	Biopsy	220	385	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;GATA3 p.P408Afs*99;MEN1 p.K267Sfs*19;CCND1 Amplification;FGF19 Amplification	1	5
P-0002975	P-0002975-T01-IM3	In-House	FFPE	Resection	250	346	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.P408Afs*99;MEN1 p.K267Sfs*19;ERBB2 Amplification	2	3
P-0002976	P-0002976-T01-IM3	In-House	FFPE	Resection	250	359	80	Matched	Metastasis	Kidney	Abdomen	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L128H;JAK1 p.R835Efs*12	0	2
P-0002977	P-0002977-T01-IM3	In-House	FFPE	Resection	250	351	50	Matched	Metastasis	Kidney	Lung	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma										SETD2 p.K690*;NOTCH1 p.Q2501*;SETD2 p.V932*	0	3
P-0002978	P-0002978-T02-IM5	In-House	FFPE	Biopsy	250	672	30	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	HNMASC	Salivary Gland Cancer	Mammary Analogue Secretory Carcinoma of Salivary Gland Origin	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	MYC p.P74Q;RB1 p.A17Pfs*3;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	4
P-0002978	P-0002978-T04-IM5	In-House	DNA	Biopsy	250	1186	30	Matched	Metastasis	Salivary Gland	Chest Wall	Tumor	HNMASC	Salivary Gland Cancer	Mammary Analogue Secretory Carcinoma of Salivary Gland Origin	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)						Larotrectinib(NTRK3 p.G623R)		LEVEL_1	MYC p.P74Q;RB1 p.A17Pfs*3;NTRK3 p.G623R;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	5
P-0002978	P-0002978-T03-IM5	In-House	DNA	Resection	250	628	90	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	HNMASC	Salivary Gland Cancer	Mammary Analogue Secretory Carcinoma of Salivary Gland Origin	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	AKT3 Amplification;BLM Deletion;DDR2 Amplification;EPHA7 Deletion;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification;PRDM1 Deletion;PTPRS Deletion;TNFAIP3 Deletion;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	13
P-0002979	P-0002979-T01-IM3	In-House	FFPE	Resection	250	721	30	Matched	Metastasis	Kidney	Retroperitoneum	Tumor	RAML	Renal Cell Carcinoma	Renal Angiomyolipoma				Everolimus(TSC2 p.S470Cfs*10)					LEVEL_3B	TP53 p.P219Lfs*28;TSC2 p.S470Cfs*10	1	2
P-0002979	P-0002979-T02-IM3	In-House	FFPE	Resection	250	420	60	Matched	Primary	Kidney	Not Applicable	Tumor	RAML	Renal Cell Carcinoma	Renal Angiomyolipoma				Everolimus(TSC2 p.S470Cfs*10)					LEVEL_3B	TP53 p.P219Lfs*28;TSC2 p.S470Cfs*10;RB1 p.I768Cfs*23	1	3
P-0002980	P-0002980-T01-IM3	In-House	FFPE	Resection	250	831	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Trametinib,Cobimetinib,Binimetinib(KRAS p.T74A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S56Afs*90)				LEVEL_4	KRAS p.G12A;KRAS p.T74A;CDH1 p.M1?;STK11 p.W239S;CDKN2A p.S56Afs*90	3	5
P-0002981	P-0002981-T01-IM3	In-House	FFPE	Biopsy	250	538	70	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma											0	0
P-0002981	P-0002981-T02-IM5	In-House	DNA	Resection	250	834	70	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.Q100*;IDH1 p.R132H;CDK6 Amplification;KDR Amplification;PDGFRA Amplification	1	5
P-0002982	P-0002982-T01-IM3	In-House	FFPE	Resection	250	392	50	Matched	Metastasis	Ovary	Chest Wall	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0002983	P-0002983-T01-IM3	In-House	FFPE	Biopsy	250	1142	80	Matched	Metastasis	Thymus	Lung	Tumor	THYM	Thymic Tumor	Thymoma											0	0
P-0002984	P-0002984-T01-IM3	In-House	FFPE	Biopsy	250	637	50	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.C275F;AR Amplification;FGFR1 Amplification;MYC Amplification;NKX3-1 Deletion	1	5
P-0002985	P-0002985-T01-IM3	In-House	FFPE	Resection	250	690	60	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R213*;TGFBR2 p.E485*;ARID1A p.Q507Sfs*116	1	4
P-0002986	P-0002986-T01-IM3	In-House	FFPE	Biopsy	220	62	20	Matched	Metastasis	Thyroid	Neck	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0002987	P-0002987-T01-IM3	In-House	FFPE	Resection	250	567	80	Matched	Metastasis	Kidney	Lymph Node	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma					GSK2636771,AZD8186(PTEN p.R130Q);GSK2636771,AZD8186(PTEN p.D92Rfs*4)				LEVEL_4	PTEN p.R130Q;PTEN p.D92Rfs*4;TP53 p.N310Tfs*35;PTPRD Deletion	2	4
P-0002989	P-0002989-T01-IM3	In-House	FFPE	Biopsy	250	961	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R158L;MAX p.X58_splice;PIK3R1 p.R577del	1	4
P-0002990	P-0002990-T02-IM5	In-House	DNA	Biopsy	250	779	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CTNNB1 p.S45P;KMT2D p.E4834Sfs*2;BMPR1A Deletion;KMT2C Deletion;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	7
P-0002990	P-0002990-T01-IM3	In-House	FFPE	Resection	250	702	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CTNNB1 p.S45P;KMT2D p.E4834Sfs*2;BMPR1A Deletion;KMT2C Deletion;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	7
P-0002991	P-0002991-T01-IM3	In-House	FFPE	Biopsy	250	870	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R248Q;ARID1A p.Q2115*;RB1 p.X500_splice;MAPK1 Amplification;RICTOR Amplification	0	5
P-0002992	P-0002992-T01-IM3	In-House	FFPE	Resection	250	916	70	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										ATRX p.X199_splice	0	1
P-0002993	P-0002993-T01-IM3	In-House	FFPE	Resection	250	257	60	Matched	Metastasis	Nailbed	Lymph Node, Regional	Tumor	ACRM	Melanoma	Acral Melanoma				Everolimus(TSC1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	MSH6 p.L1244*;B2M Deletion;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;JUN Amplification;MITF Amplification;PAK1 Amplification;RAC1 Amplification;TSC1 Deletion	2	10
P-0002994	P-0002994-T01-IM3	In-House	FFPE	Cytology	250	570	20	Matched	Metastasis	Rectum	Pelvis	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R282W;APC p.A1296Qfs*9;APC p.Y935Ifs*19;PRKN Deletion;SOX9 Deletion	0	5
P-0002995	P-0002995-T01-IM3	Outside	FFPE	Biopsy	250	705	70	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R342*;TBX3 p.K288Rfs*2;CDH1 p.A592Kfs*9;ERBB2 Amplification	2	4
P-0002996	P-0002996-T01-IM3	In-House	FFPE	Resection	250	655	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.N131I;STK11 p.E223*;FLT3 p.H671Q;TP53 p.C229Y	1	5
P-0002996	P-0002996-T02-IM3	In-House	FFPE	Resection	250	704	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0002997	P-0002997-T01-IM3	Outside	FFPE	Biopsy	250	327	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.H193L;ERBB2 Amplification;SORBS2 FAT1-SORBS2 fusion;FAT1 FAT1-SORBS2 fusion	2	4
P-0002998	P-0002998-T01-IM3	In-House	FFPE	Resection	250	607	60	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Everolimus(TSC2 p.K1168*)					LEVEL_3B	TP53 p.R213*;NOTCH2 p.Q270*;NOTCH1 p.R365C;KMT2D p.Q4347*;FLT3 p.S883L;DIS3 p.G844*;TSC2 p.K1168*;SMARCA4 p.R1093*;TP53 p.E286_E287del	1	9
P-0002999	P-0002999-T01-IM3	In-House	FFPE	Resection	250	468	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EGFR p.R252H;PTEN Deletion	1	2
P-0003000	P-0003000-T01-IM3	In-House	FFPE	Resection	250	800	40	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.S1042*)				LEVEL_4	KDM6A p.S1042*;ARID1A p.L295Pfs*68;FOXA1 p.A75Gfs*152	1	3
P-0003001	P-0003001-T01-IM3	In-House	FFPE	Resection	250	410	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003002	P-0003002-T01-IM3	Outside	FFPE	Biopsy	250	556	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	GATA3 p.P408Afs*99;CDK4 Amplification;RAC1 Amplification	1	3
P-0003003	P-0003003-T01-IM3	In-House	FFPE	Biopsy	250	672	60	Matched	Metastasis	Kidney	Abdomen	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										TP53 p.X32_splice;TET2 p.R1440Tfs*38;LATS1 p.D839Ffs*3;CDKN2C Deletion	0	4
P-0003004	P-0003004-T01-IM3	Outside	FFPE	Resection	250	731	20	Matched	Primary	Cervix	Not Applicable	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma											0	0
P-0003005	P-0003005-T01-IM3	In-House	FFPE	Biopsy	250	697	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K)				LEVEL_1	PIK3CA p.H1047R;TP53 p.Q136*;FGFR2 p.N549K	3	3
P-0003006	P-0003006-T01-IM3	In-House	FFPE	Resection	250	680	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.A276_C277dup;RNF43 p.Q488Afs*16	1	3
P-0003007	P-0003007-T01-IM3	In-House	FFPE	Resection	250	687	50	Matched	Metastasis	Cancer of Unknown Primary	Abdomen	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_4	TP53 p.R174W;CDKN2A p.P114L;PTPRD Deletion;SMARCA4 Deletion;TERT Amplification	1	5
P-0003008	P-0003008-T01-IM3	Outside	FFPE	Cytology	104	254	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A76Cfs*64)				LEVEL_4	KRAS p.G12D;TP53 p.X307_splice;CDKN2A p.A76Cfs*64;SMAD4 SMAD4-intragenic	2	4
P-0003009	P-0003009-T01-IM3	Outside	FFPE	Biopsy	250	628	20	Matched	Primary	Larynx	Not Applicable	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.G245C;MITF p.G462*;ARID1A p.S366Afs*25;NSD1 p.G2010Lfs*11;SORBS2 FAT1-SORBS2 fusion;FAT1 FAT1-SORBS2 fusion	1	7
P-0003010	P-0003010-T01-IM3	Outside	FFPE	Resection	250	718	20	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(MAP2K1 p.I99_K104del)						LEVEL_3A	MAP2K1 p.I99_K104del	1	1
P-0003011	P-0003011-T01-IM3	In-House	FFPE	Resection	250	692	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.Q1338*;TP53 p.P142Lfs*28	0	2
P-0003012	P-0003012-T01-IM3	In-House	FFPE	Biopsy	221	725	20	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer											0	0
P-0003013	P-0003013-T01-IM3	Outside	FFPE	Resection	250	539	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;MDM2 Amplification;TERT Amplification	2	3
P-0003014	P-0003014-T01-IM3	In-House	FFPE	Biopsy	250	871	20	Matched	Metastasis	Uterus	Retroperitoneum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G)	GSK2636771,AZD8186(PTEN p.D252V);GSK2636771,AZD8186(PTEN p.V85Efs*15)				LEVEL_3B	KMT2D p.P648Tfs*2;JAK1 p.K860Nfs*16;ARID1A p.D1850Tfs*33;CTCF p.T204Nfs*26;CTNNB1 p.T41I;PTPRS p.V1025Sfs*18;PIK3CA p.E545G;PTEN p.D252V;EP300 p.E1053*;ASXL2 p.K128Rfs*39;INPP4B p.R818Efs*4;ARID1B p.P2172Rfs*8;PTEN p.V85Efs*15;KMT2D p.L973Ffs*17;GRIN2A p.S1341Afs*56;EP300 p.I1781Hfs*102	3	16
P-0003015	P-0003015-T01-IM3	Outside	FFPE	Resection	250	904	80	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0003016	P-0003016-T01-IM3	In-House	FFPE	Resection	250	609	20	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										TP53 p.P151S;KDM6A p.W355*	0	2
P-0003017	P-0003017-T01-IM3	In-House	FFPE	Biopsy	250	839	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0003018	P-0003018-T01-IM3	In-House	FFPE	Biopsy	216	1055	60	Matched	Primary	Testis	Not Applicable	Tumor	BCCA	Germ Cell Tumor	Choriocarcinoma				Everolimus(TSC2 p.A889G)					LEVEL_3B	TSC2 p.A889G;FOXO4 MED12-FOXO4 fusion;MED12 MED12-FOXO4 fusion	1	3
P-0003019	P-0003019-T01-IM3	In-House	FFPE	Resection	250	590	60	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										CCND2 Amplification;CDK6 Amplification;ETV1 Amplification;KDM5A Amplification;KRAS Amplification;RAC1 Amplification	0	6
P-0003020	P-0003020-T01-IM3	In-House	FFPE	Biopsy	250	260	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043T);Sonidegib,Vismodegib(PTCH1 p.L87_F88delins*)	GSK2636771,AZD8186(PTEN p.W274*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E149*)				LEVEL_3B	TP53 p.R248W;PIK3CA p.M1043T;PTCH1 p.L87_F88delins*;PTEN p.W274*;CDKN2A p.E149*;ETV1 Amplification	4	6
P-0003021	P-0003021-T01-IM3	In-House	FFPE	Biopsy	108	191	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	AKT1 p.L52H;ARID1A p.Q1331Rfs*150;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	6
P-0003022	P-0003022-T01-IM3	Outside	FFPE	Resection	250	435	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.D820G)					LEVEL_3B	KIT p.D820G	1	1
P-0003023	P-0003023-T01-IM3	In-House	FFPE	Resection	250	741	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R273C;KMT2D p.R1687Tfs*4;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0003024	P-0003024-T01-IM3	In-House	FFPE	Biopsy	250	569	60	Matched	Metastasis	Bladder	Subcutaneous Tissue	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.Y72C)		Everolimus,Temsirolimus(MTOR p.A1971T)				LEVEL_3A	TP53 p.E271K;CTNNB1 p.S37F;MTOR p.A1971T;ARID1A p.Q467*;ARID1A p.X1335_splice;TP53 p.D228H;ERCC2 p.Y72C;EP300 p.W403*;KMT2A p.X2166_splice	2	9
P-0003025	P-0003025-T01-IM3	Outside	FFPE	Resection	250	484	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0003025	P-0003025-T02-IM5	Outside	FFPE	Resection	250	718	10	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0003026	P-0003026-T01-IM3	In-House	FFPE	Resection	250	532	20	Unmatched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003027	P-0003027-T01-IM3	Outside	FFPE	Resection	250	601	20	Matched	Metastasis	Stomach	Ovary	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										FBXW7 p.Y545C	0	1
P-0003028	P-0003028-T01-IM3	In-House	FFPE	Resection	250	577	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003029	P-0003029-T01-IM3	In-House	FFPE	Resection	250	884	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84Y)				LEVEL_3B	PIK3CA p.E545K;ASXL2 p.W13*;BAP1 p.E242*;BAP1 p.C91R;TP53 p.E271Q;NCOR1 p.E1005*;CDKN2A p.D84Y	2	7
P-0003030	P-0003030-T01-IM3	In-House	FFPE	Biopsy	82.2	567	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.G245D;SMARCA4 p.G1232V;AKT2 Amplification;AXL Amplification	1	5
P-0003031	P-0003031-T01-IM5	In-House	FFPE	Biopsy	127.5	363	90	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										LATS1 p.E980Kfs*4;KDM6A p.E1052Kfs*31;NSD1 p.P753Kfs*11	0	3
P-0003032	P-0003032-T01-IM5	In-House	FFPE	Resection	250	572	20	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										RB1 p.L564Sfs*47	0	1
P-0003033	P-0003033-T02-IM5	In-House	FFPE	Biopsy	250	596	50	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	NOTCH1 p.E1148*;TP53 p.Y103Tfs*20;MYC Amplification;PTEN Deletion	1	4
P-0003033	P-0003033-T01-IM5	Outside	FFPE	Biopsy	131.56	562	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	NOTCH1 p.E1148*;TP53 p.Y103Tfs*20;CCND1 Amplification;FGF19 Amplification;PTEN Deletion	1	5
P-0003034	P-0003034-T01-IM5	In-House	FFPE	Biopsy	250	1021	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)					LEVEL_3B	NRAS p.Q61H;TP53 p.G244D;HLA-A p.E299*;KMT2D p.P2931Hfs*12;CDKN2B Deletion	1	5
P-0003035	P-0003035-T01-IM5	In-House	FFPE	Biopsy	250	820	40	Matched	Metastasis	Descending Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R232*;TP53 p.T155Hfs*26;BCL2L1 Amplification	0	3
P-0003036	P-0003036-T01-IM5	In-House	FFPE	Resection	250	746	90	Matched	Primary	Chest Wall	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PIK3R1 p.N564D;PTEN Deletion	1	2
P-0003037	P-0003037-T01-IM5	In-House	FFPE	Resection	250	644	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Tipifarnib(HRAS p.Q61K)					LEVEL_3B	HRAS p.Q61K	1	1
P-0003038	P-0003038-T01-IM5	In-House	FFPE	Biopsy	250	737	70	Matched	Primary	Uterus	Not Applicable	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma					PLX8394(BRAF p.G469V);Crizotinib(MET ST7-MET fusion);Crizotinib(ST7 ST7-MET fusion)				LEVEL_4	TP53 p.C141Y;BRAF p.G469V;FBXW7 p.G423V;MYC Amplification;MET ST7-MET fusion;ST7 ST7-MET fusion;NBN CALB1-NBN fusion;CALB1 CALB1-NBN fusion	3	8
P-0003039	P-0003039-T01-IM5	Outside	FFPE	Resection	250	668	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.P86S	0	1
P-0003040	P-0003040-T01-IM5	In-House	FFPE	Biopsy	250	791	70	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	AR Amplification;CDK4 Amplification;ERBB3 Amplification;ERCC3 Deletion;GLI1 Amplification;MDM2 Amplification;PTEN Deletion	3	7
P-0003041	P-0003041-T01-IM5	In-House	FFPE	Resection	250	1096	NA	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R273C;IDH1 p.R132H;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion	2	5
P-0003042	P-0003042-T01-IM5	Outside	FFPE	Biopsy	250	184	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.L137Q;EGFR Amplification	2	3
P-0003043	P-0003043-T01-IM5	In-House	FFPE	Resection	250	712	80	Matched	Metastasis	Abdomen	Small Bowel	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										RB1 p.Q383Nfs*3;TP53 p.L299Rfs*46;NOTCH1 Deletion	0	3
P-0003044	P-0003044-T01-IM3	Outside	FFPE	Resection	250	471	80	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0003045	P-0003045-T01-IM3	Outside	FFPE	Resection	250	478	90	Matched	Metastasis	Uterus	Omentum	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.G132A)				LEVEL_4	SUFU p.A25Gfs*23;KRAS p.G12V;ARID1A p.D1850Tfs*33;PTEN p.G132A;DICER1 p.D1810Y;MSH6 p.G1070Vfs*9;ASXL1 p.G645Vfs*58;PIK3R2 p.G722Afs*152;HNF1A p.P291Qfs*51;ARID1A p.T294Pfs*69;KMT2A p.N2776Mfs*11	2	11
P-0003046	P-0003046-T01-IM3	Outside	FFPE	Biopsy	250	526	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.X332_splice;SMAD4 p.E49_K50delinsD*	3	3
P-0003047	P-0003047-T01-IM3	Outside	FFPE	Biopsy	250	874	50	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										RB1 p.X464_splice;FLT3 p.S638L;KDR p.S1037L;FAT1 p.X1089_splice;RB1 p.X474_splice;TP53 p.Y234*;TP53 p.V216G	0	7
P-0003048	P-0003048-T01-IM3	In-House	FFPE	Biopsy	250	334	40	Matched	Metastasis	Esophagus	Liver	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.C277F;PIK3R2 p.X473_splice;ARID1A p.F1343Sfs*138	1	4
P-0003049	P-0003049-T01-IM3	Outside	FFPE	Biopsy	250	398	30	Matched	Primary	Larynx	Not Applicable	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma										TP53 p.L289F;TP53 p.X327_splice;EGFR Amplification;JUN Amplification	0	4
P-0003050	P-0003050-T01-IM3	Outside	FFPE	Resection	250	510	50	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										FLT3 p.V643I;TP53 p.C176W;AKT2 Amplification;ERBB3 Amplification;FGFR2 Amplification;GATA3 Amplification;GLI1 Amplification;MAP3K1 Deletion	0	8
P-0003051	P-0003051-T01-IM3	In-House	FFPE	Biopsy	97.2	458	20	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108H)				LEVEL_4	TP53 p.C135R;MEN1 p.Y232*;CDKN2A p.D108H;AKT3 Amplification;GATA3 Amplification	1	5
P-0003052	P-0003052-T01-IM3	In-House	FFPE	Resection	250	382	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.N184Efs*6)				LEVEL_4	PTEN p.N184Efs*6;TP53 p.C242Afs*5;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0003053	P-0003053-T01-IM3	In-House	FFPE	Resection	250	582	50	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										TP53 p.C238Y	0	1
P-0003054	P-0003054-T01-IM3	Outside	FFPE	Biopsy	250	806	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.S310F)	Ado-Trastuzumab Emtansine(ERBB2 p.S310F);Everolimus(TSC2 p.E74*)	GSK2636771,AZD8186(PTEN p.T319*);GSK2636771,AZD8186(PTEN p.H61R)				LEVEL_3A	ERBB2 p.S310F;PTEN p.T319*;TP63 p.Q523*;TP53 p.H193R;PTEN p.H61R;FLT3 p.S684L;TSC2 p.E74*;SMARCA4 p.Q300*	5	8
P-0003054	P-0003054-T02-IM5	Outside	FFPE	Biopsy	250	1051	40	Matched	Metastasis	Breast	Liver	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		GSK2636771,AZD8186(PTEN p.T319*);GSK2636771,AZD8186(PTEN p.H61R);Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L)				LEVEL_1	PIK3CA p.E542K;PTEN p.T319*;TP53 p.H193R;PTEN p.H61R;SMARCA4 p.Q300*;PARP1 p.X691_splice;CCND1 p.E9K;KMT2D p.Q1029*;KRAS p.Q61L	5	9
P-0003055	P-0003055-T01-IM3	In-House	FFPE	Biopsy	250	885	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 BRCA2-intragenic)					LEVEL_3B	TP53 p.X307_splice;RB1 p.E323*;ERBB2 Amplification;BRCA2 BRCA2-intragenic	2	4
P-0003056	P-0003056-T01-IM3	In-House	FFPE	Resection	250	237	80	Matched	Metastasis	Minor Salivary Gland	Brain	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	KMT2D p.Y2199Lfs*3;FGFR1 Amplification;YAP1 Amplification	1	3
P-0003057	P-0003057-T01-IM3	In-House	FFPE	Resection	250	652	NA	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R337C;ERBB2 Amplification	2	2
P-0003058	P-0003058-T01-IM3	In-House	FFPE	Resection	250	283	20	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0003059	P-0003059-T01-IM3	Outside	FFPE	Biopsy	250	703	30	Matched	Primary	Oropharynx	Not Applicable	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										YAP1 Amplification	0	1
P-0003060	P-0003060-T01-IM3	In-House	FFPE	Resection	250	759	80	Matched	Primary	Lung	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0003061	P-0003061-T01-IM3	In-House	FFPE	Resection	250	236	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003062	P-0003062-T01-IM3	In-House	FFPE	Biopsy	250	643	90	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	Ivosidenib(IDH1 p.R132C)	GSK2636771,AZD8186(PTEN p.P38S);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	IDH1 p.R132C;NRAS p.Q61R;PPP6C p.R264C;PTEN p.P38S;PTPRT p.K699*;ARID2 Deletion;CDKN2A Deletion;CDKN2B Deletion	4	8
P-0003063	P-0003063-T01-IM3	In-House	FFPE	Biopsy	250	714	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R273H;AKT1 Amplification;AKT3 Amplification;IKBKE Amplification;MAP3K1 Deletion;MCL1 Amplification;MYC Amplification	0	7
P-0003064	P-0003064-T01-IM3	In-House	FFPE	Biopsy	250	801	60	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										CCND1 Amplification;FGF19 Amplification;MYCN Amplification	0	3
P-0003064	P-0003064-T02-IM5	In-House	DNA	Resection	250	1002	90	Matched	Primary	Flank	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										FLT3 p.R704I;CCND1 Amplification;FGF19 Amplification;MYCN Amplification	0	4
P-0003065	P-0003065-T01-IM3	In-House	FFPE	Biopsy	250	333	30	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Enasidenib(IDH2 p.R172W)					LEVEL_3B	IDH2 p.R172W;NOTCH1 p.G310R;CIC p.V1075Sfs*73	1	3
P-0003066	P-0003066-T01-IM3	In-House	FFPE	Biopsy	250	586	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0003067	P-0003067-T01-IM3	In-House	FFPE	Biopsy	250	852	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	KRAS p.G12D;PTEN Deletion	2	2
P-0003068	P-0003068-T01-IM5	Outside	FFPE	Biopsy	250	653	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EPHB1 p.R743Q;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERRFI1 Deletion;PAX5 Deletion	2	6
P-0003069	P-0003069-T01-IM5	Outside	FFPE	Biopsy	250	355	40	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)						LEVEL_3A	NRAS p.G12D;FLT3 p.S638L;BRAF p.G469E;KMT2A p.Q814*	1	4
P-0003070	P-0003070-T02-IM5	In-House	FFPE	Biopsy	250	1034	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;PIK3CA p.N345K;EGFR p.E746_A750del;TP53 p.V272_R273insL	3	4
P-0003070	P-0003070-T01-IM5	Outside	FFPE	Biopsy	250	609	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)					LEVEL_1	PIK3CA p.N345K;EGFR p.E746_A750del;TP53 p.V272_R273insL	2	3
P-0003071	P-0003071-T01-IM5	Outside	FFPE	Resection	250	796	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.Y24C)		Tazemetostat(KDM6A p.W449*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	TP53 p.P278A;DNMT3A p.R771Q;TGFBR1 p.R487Q;ERCC2 p.Y24C;KDM6A p.W449*;CDKN2A Deletion;CDKN2B Deletion	3	7
P-0003072	P-0003072-T01-IM5	Outside	FFPE	Resection	250	733	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.P471A)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P471A)						LEVEL_1	TP53 p.D281H;PIK3CA p.P471A;TP53 p.D41Gfs*2;AKT2 Amplification;MYC Amplification	2	5
P-0003073	P-0003073-T01-IM5	In-House	FFPE	Biopsy	250	544	60	Matched	Metastasis	Kidney	Bone	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										NF2 p.E432*	0	1
P-0003074	P-0003074-T01-IM5	In-House	FFPE	Biopsy	250	417	20	Matched	Metastasis	Appendix	Liver	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	GNAS p.R201H;CTNNB1 p.D32N;TP53 p.G244D;KRAS p.G13D;RB1 p.X474_splice;BCOR p.X1017_splice	1	6
P-0003075	P-0003075-T01-IM5	In-House	FFPE	Biopsy	250	439	40	Matched	Metastasis	Thyroid	Paratracheal	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.Q192*;ZFHX3 p.R3429Vfs*56	2	3
P-0003077	P-0003077-T01-IM5	Outside	FFPE	Biopsy	250	881	60	Matched	Metastasis	Rectum	Brain	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.X331_splice;APC p.F937Sfs*18;CDK8 Amplification;FLT3 Amplification	1	5
P-0003078	P-0003078-T01-IM5	Outside	FFPE	Biopsy	250	670	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L78Hfs*41)				LEVEL_4	TP53 p.M246K;STK11 p.X285_splice;KDM6A p.S552*;CDKN2A p.L78Hfs*41;CCND2 Amplification;KRAS Amplification;RNF43 RNF43-intragenic	1	7
P-0003079	P-0003079-T01-IM5	In-House	FFPE	Biopsy	250	722	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.R173H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN p.R173H;EGFR p.L62R;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;GATA3 Deletion;PTEN Deletion	4	7
P-0003080	P-0003080-T01-IM5	Outside	FFPE	Resection	250	691	40	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	HNSCUP	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.Q192*;ATR p.E409*;TP63 p.X194_splice;CCND1 Amplification;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MCL1 Amplification;MITF Deletion;MRE11 Deletion;MYC Amplification;RYBP Deletion;SHQ1 Deletion	1	14
P-0003096	P-0003096-T01-IM5	In-House	FFPE	Resection	250	875	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R);Afatinib(EGFR p.S768I)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-intragenic)				LEVEL_1	EGFR p.L858R;EGFR p.S768I;CDKN2A CDKN2A-intragenic	3	3
P-0003097	P-0003097-T01-IM5	In-House	FFPE	Biopsy	250	440	90	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(TACC3 FGFR3-TACC3 fusion);Erdafitinib(FGFR3 FGFR3-TACC3 fusion)		Debio1347,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)		Tazemetostat(KDM6A p.R511Kfs*15);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EP300 p.Q1256*;KDM6A p.R511Kfs*15;ANKRD11 p.A2258Gfs*2;CDKN2A Deletion;CDKN2B Deletion;TGFBR1 Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	6	8
P-0003098	P-0003098-T01-IM5	In-House	FFPE	Resection	250	348	NA	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.D631_L633delinsE)		BLU-667(RET p.D631_L633delinsE)						LEVEL_1	RET p.D631_L633delinsE	2	1
P-0003099	P-0003099-T01-IM5	In-House	FFPE	Biopsy	250	646	90	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										KDM6A p.T581*;FAT1 p.G1076Wfs*9;NF2 HORMAD2-NF2 fusion;HORMAD2 HORMAD2-NF2 fusion	0	4
P-0003100	P-0003100-T01-IM5	In-House	FFPE	Resection	250	589	30	Matched	Metastasis	Testis	Mediastinum	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Olaparib(NPAT ATM-NPAT fusion);Olaparib(ATM ATM-NPAT fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.V172D;CCND2 Amplification;CDKN2A Deletion;CDKN2B Deletion;KDM5A Amplification;KRAS Amplification;SMAD4 Deletion;NPAT ATM-NPAT fusion;ATM ATM-NPAT fusion	3	9
P-0003101	P-0003101-T01-IM5	In-House	FFPE	Biopsy	250	461	NA	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	PTEN p.R130Q;RB1 p.L76*;TP53 p.E298Cfs*46	1	3
P-0003101	P-0003101-T03-IM5	In-House	FFPE	Biopsy	250	1013	80	Matched	Metastasis	Prostate	Brain	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	PTEN p.R130Q;RB1 p.L76*;TP53 p.E298Cfs*46;ASXL2 Deletion;DIS3 Deletion	1	5
P-0003101	P-0003101-T02-IM5	In-House	FFPE	Cytology	96.8	173	20	Matched	Metastasis	Prostate	Kidney	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	PTEN p.R130Q;RB1 p.L76*;TP53 p.E298Cfs*46	1	3
P-0003102	P-0003102-T01-IM5	In-House	FFPE	Biopsy	250	135	NA	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	TP53 p.R248W;PPP2R1A p.P179R;PIK3CA p.E542K;ARID1A p.S138*;CCNE1 Amplification;MYC Amplification	1	6
P-0003103	P-0003103-T01-IM5	In-House	FFPE	Resection	250	509	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1068Y)					LEVEL_3B		1	0
P-0003104	P-0003104-T01-IM5	Outside	FFPE	Biopsy	250	627	NA	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Lorlatinib,Brigatinib(ALK p.R395H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P48L)				LEVEL_3B	TP53 p.R248G;ALK p.R395H;TP53 p.E171*;NOTCH2 p.X918_splice;TGFBR2 p.E526*;ATR p.W2640*;RASA1 p.K484*;EGFR p.P596L;KMT2C p.Q2354*;NOTCH1 p.X1301_splice;KMT2D p.Q4275*;TP53 p.T125P;NOTCH3 p.Q231*;CDKN2A p.P48L	2	14
P-0003105	P-0003105-T01-IM5	In-House	FFPE	Resection	250	717	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.D820V)	Trametinib,Cobimetinib,Binimetinib(KRAS p.D33E)				LEVEL_3B	KIT p.D820V;KRAS p.D33E	2	2
P-0003106	P-0003106-T01-IM5	In-House	FFPE	Resection	250	805	NA	Matched	Metastasis	Larynx	Lung	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A19Gfs*23)				LEVEL_3B	PIK3CA p.Q546K;CDKN2A p.A19Gfs*23	2	2
P-0003107	P-0003107-T01-IM5	Outside	FFPE	Resection	250	904	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719A)								LEVEL_1	EGFR p.E709K;EGFR p.G719A;SMAD4 p.K507N	1	3
P-0003108	P-0003108-T01-IM5	In-House	FFPE	Cytology	250	701	90	Matched	Metastasis	Breast	Pleura	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma		Olaparib,Talazoparib(BRCA2 BRCA2-intragenic)		Rucaparib,Niraparib(BRCA2 BRCA2-intragenic)					LEVEL_2	EGFR p.R222H;ATRX Deletion;CDH1 Deletion;BRCA2 BRCA2-intragenic;ARHGAP45 STK11-HMHA1 fusion;STK11 STK11-HMHA1 fusion;KLHL13 RB1-KLHL13 fusion;RB1 RB1-KLHL13 fusion	2	8
P-0003109	P-0003109-T01-IM5	Outside	FFPE	Biopsy	250	294	NA	Unmatched	Metastasis	Uterus	Scalp	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										ARID1B p.Q641*;ATRX Deletion	0	2
P-0003110	P-0003110-T01-IM5	In-House	FFPE	Resection	250	636	40	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R196*;TP53 p.R110L;APC p.E403Kfs*51;BCL2L1 Amplification;SRC Amplification	0	5
P-0003111	P-0003111-T01-IM5	In-House	FFPE	Biopsy	250	414	90	Matched	Metastasis	Perineal	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										SF3B1 p.R625C;EPHA7 Deletion;GPS2 Deletion;PRDM1 Deletion	0	4
P-0003113	P-0003113-T01-IM5	In-House	FFPE	Biopsy	119.9	65	NA	Matched	Metastasis	Uterus	Lung	Tumor	ESS	Uterine Sarcoma	Endometrial Stromal Sarcoma										CTNNB1 p.T41A	0	1
P-0003114	P-0003114-T01-IM5	In-House	FFPE	Biopsy	250	599	NA	Matched	Primary	Bone	Not Applicable	Tumor	SM	Mastocytosis	Systemic Mastocytosis											0	0
P-0003116	P-0003116-T01-IM5	In-House	FFPE	Resection	250	784	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.R280I;B2M p.M1?	1	3
P-0003116	P-0003116-T02-IM5	Outside	FFPE	Biopsy	250	771	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.R280I	1	2
P-0003117	P-0003117-T01-IM5	Outside	FFPE	Resection	250	611	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.W1157*;BAP1 p.G128Dfs*59	0	2
P-0003118	P-0003118-T01-IM5	Outside	FFPE	Resection	250	375	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.G778_P780dup)	Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)					LEVEL_3A	ERBB2 p.G778_P780dup;MAP3K1 p.E484Tfs*8;XPO1 p.E571K;TP53 p.R273C;CDKN1B p.P137Rfs*8	2	5
P-0003119	P-0003119-T01-IM5	In-House	FFPE	Biopsy	250	951	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M983I);Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.Q317*;MGA p.G2119*;KEAP1 p.E488V;PTPRD p.L1349Ffs*5;MET Amplification	3	5
P-0003120	P-0003120-T01-IM5	Outside	FFPE	Biopsy	250	265	70	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;FUBP1 p.X526_splice;PBRM1 p.X272_splice;SRSF2 p.S54F;CIC p.S231N;PIK3R1 p.Y463_E468dup	1	6
P-0003122	P-0003122-T01-IM5	In-House	FFPE	Biopsy	250	581	50	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R158L;SMAD4 p.N107Kfs*2	1	3
P-0003123	P-0003123-T01-IM5	Outside	FFPE	Resection	250	590	NA	Matched	Primary	Heart	Not Applicable	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CARD11 Amplification;CDK4 Amplification;KDR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification;RAC1 Amplification;TERT Amplification	2	8
P-0003124	P-0003124-T01-IM5	Outside	FFPE	Biopsy	250	616	30	Unmatched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.M237I;SMAD4 p.D537Kfs*14;APC p.T1493Rfs*14;MYC Amplification;SMAD2 Deletion	3	6
P-0003125	P-0003125-T01-IM5	In-House	FFPE	Biopsy	84	348	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)						LEVEL_1	SETD2 p.Q1218*;TP53 p.P128Tfs*12;NOTCH1 p.E848*;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	6	5
P-0003126	P-0003126-T01-IM5	Outside	FFPE	Biopsy	250	518	70	Matched	Primary	Spinal cord	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma										KMT2D p.A3076Dfs*45;MYCN Amplification	0	2
P-0003127	P-0003127-T01-IM5	Outside	FFPE	Biopsy	250	474	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										RASA1 p.K588*	0	1
P-0003128	P-0003128-T01-IM5	In-House	FFPE	Biopsy	250	673	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lapatinib(EGFR p.A289V);GSK2636771,AZD8186(PTEN p.P244Lfs*12);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	EGFR p.A289V;BCOR p.Y1350*;PTEN p.P244Lfs*12;STAG2 R370fs;ARID5B Deletion;B2M Deletion;CDK4 Amplification;EGFR Amplification;MDM2 Amplification;PTEN Deletion	6	10
P-0003129	P-0003129-T01-IM5	In-House	FFPE	Resection	250	601	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	KRAS p.G12V;TP53 p.E171*;TBX3 p.E108*;NOTCH3 p.S2264Rfs*5;MET Amplification	3	5
P-0003130	P-0003130-T01-IM5	Outside	FFPE	Biopsy	250	576	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R175H;APC p.R876*;ARID1A p.R1989*;APC p.S1392*;FLT3 Amplification;ZFHX3 Deletion	1	7
P-0003131	P-0003131-T01-IM5	Outside	FFPE	Resection	250	618	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ARID1A p.P252Lfs*146;DDR2 Amplification;ERBB2 Amplification	1	3
P-0003132	P-0003132-T01-IM5	In-House	FFPE	Biopsy	250	620	30	Matched	Metastasis	Lung	Epidural	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R175L;NFE2L2 p.D77H;CASP8 p.Q465*;EIF4A2 p.E389Q;PLK2 p.E98K;MYC p.P74R;MGA p.G612Efs*9;FOXP1 p.X448_splice;PMAIP1 p.L43*;CD274 Amplification;KMT2D MLL2-intragenic	0	11
P-0003133	P-0003133-T01-IM5	Outside	FFPE	Biopsy	250	744	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P419Afs*88;AURKA Amplification;PPM1D Amplification	0	3
P-0003134	P-0003134-T01-IM5	Outside	FFPE	Biopsy	250	716	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;SUZ12 p.R654*	2	2
P-0003135	P-0003135-T04-IM5	In-House	DNA	Resection	250	945	40	Matched	Metastasis	Appendix	Peritoneum	Tumor	GCCAP	Appendiceal Cancer	Goblet Cell Carcinoid of the Appendix										TP53 p.R248W	0	1
P-0003136	P-0003136-T01-IM5	Outside	FFPE	Biopsy	250	85	20	Matched	Metastasis	Cecum	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;APC p.E1322*;PIK3CA p.H1047Y;RUNX1 p.R139*	2	4
P-0003137	P-0003137-T01-IM5	Outside	FFPE	Biopsy	250	629	10	Matched	Metastasis	Cancer of Unknown Primary	Omentum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;RHOA p.L57V;BCOR p.Y755*;CDKN1B p.K73Qfs*52;SOX9 p.V71Cfs*39;SMAD4 SMAD4-intragenic	1	6
P-0003138	P-0003138-T01-IM5	Outside	FFPE	Resection	250	829	80	Matched	Metastasis	Uterus	Omentum	Tumor	UAS	Uterine Sarcoma	Uterine Adenosarcoma				Cisplatin(ERCC2 Deletion)					LEVEL_3B	AKT2 Amplification;AXL Amplification;BBC3 Deletion;CCND2 Amplification;ERCC2 Deletion;KDM5A Amplification;TERT Amplification;TP63 Deletion	1	8
P-0003139	P-0003139-T02-IM5	In-House	DNA	Biopsy	250	918	70	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM Deletion)								LEVEL_1	APC Deletion;AR Amplification;ATM Deletion;CCND1 Amplification;DIS3 Deletion;FBXW7 Deletion;FGF19 Amplification;RB1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	10
P-0003139	P-0003139-T01-IM5	Outside	FFPE	Resection	250	655	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0003140	P-0003140-T01-IM5	In-House	FFPE	Biopsy	250	662	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.Y297*);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ARID1A p.Q944*;TSC1 p.Y297*;CDKN2A Deletion;CDKN2B Deletion;DNMT3B Amplification;FOXP1 Deletion;MDM2 Amplification;NKX3-1 Deletion;PTPRD Deletion;RICTOR Amplification;ASXL1 ASXL1-intragenic	3	11
P-0003141	P-0003141-T01-IM5	In-House	FFPE	Resection	250	334	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.Y346*)				LEVEL_4	PTEN p.Y346*;MAP3K1 p.X1204_splice	1	2
P-0003142	P-0003142-T01-IM5	Outside	FFPE	Cytology	250	684	80	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_1	PIK3CA p.E542K;ESR1 p.Y537S	3	2
P-0003143	P-0003143-T01-IM5	In-House	FFPE	Resection	250	487	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.P151A	2	2
P-0003144	P-0003144-T01-IM5	In-House	FFPE	Resection	250	684	90	Matched	Primary	Upper Extremity	Upper Extremity	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	PIK3R1 p.K379E;CDK4 Amplification;MDM2 Amplification;TERT Amplification	2	4
P-0003145	P-0003145-T01-IM5	Outside	FFPE	Resection	250	598	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	KRAS p.Q61R	1	1
P-0003146	P-0003146-T01-IM5	In-House	FFPE	Resection	250	614	20	Matched	Primary	Lung	Not Applicable	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid				Everolimus(TSC1 p.W750Ifs*20);Everolimus(TSC1 p.M209Ifs*2)					LEVEL_3B	RAF1 p.R391W;TSC1 p.W750Ifs*20;TSC1 p.M209Ifs*2	2	3
P-0003147	P-0003147-T01-IM5	In-House	FFPE	Biopsy	250	689	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Trametinib,Cobimetinib(MAP2K1 p.K57E)					LEVEL_3B	NFE2L2 p.G31E;MAP2K1 p.K57E	1	2
P-0003149	P-0003149-T01-IM5	In-House	FFPE	Biopsy	250	1020	90	Matched	Metastasis	Adrenal Gland	Para-tracheal	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Olaparib(ATM Deletion);Olaparib(CHEK1 Deletion);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	CREBBP p.X1021_splice;CREBBP p.S331*;ATRX p.R1022*;ANKRD11 Deletion;ATM Deletion;BIRC3 Deletion;BLM Deletion;CBL Deletion;CHEK1 Deletion;EED Deletion;ERBB2 Amplification;FANCA Deletion;FH Deletion;KMT2A Deletion;MRE11 Deletion;PPM1D Amplification;PPP2R1A Deletion;SDHD Deletion;CIC CIC-intragenic	3	19
P-0003150	P-0003150-T01-IM5	In-House	FFPE	Resection	250	221	60	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PIK3R1 p.X582_splice	0	1
P-0003150	P-0003150-T02-IM5	Outside	FFPE	Resection	250	299	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003152	P-0003152-T01-IM5	Outside	FFPE	Biopsy	250	537	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RASA1 p.E551*;B2M p.X116_splice;TP53 p.R181P;RB1 p.R73Sfs*36;PTEN Deletion	1	5
P-0003153	P-0003153-T01-IM5	In-House	FFPE	Biopsy	147	492	80	Matched	Metastasis	Testis	Liver	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib(KIT p.W557S)					LEVEL_3B	KIT p.W557S;CCND2 Amplification;KDM5A Amplification;KIT Amplification	1	4
P-0003154	P-0003154-T01-IM5	In-House	FFPE	Biopsy	250	617	10	Matched	Metastasis	Rectum	Lymph Node	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R158H;BRAF p.Y472S;APC p.S1355Ffs*19	1	4
P-0003155	P-0003155-T01-IM5	In-House	FFPE	Biopsy	250	436	20	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma											0	0
P-0003156	P-0003156-T01-IM5	Outside	FFPE	Biopsy	250	529	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)			Olaparib(ATM p.Y2019C)					LEVEL_1	EGFR p.L747_P753delinsS;ATM p.Y2019C;ZRSR2 p.X313_splice;RBM10 p.Q707Afs*12;EGFR Amplification;RICTOR Amplification	2	6
P-0003157	P-0003157-T01-IM5	Outside	FFPE	Resection	250	765	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Capmatinib(MET p.D1010N)	Crizotinib(MET p.D1010N)	Cabozantinib(MET p.D1010N)						LEVEL_1	TP53 p.E294*;MET p.D1010N;SETD2 p.Y1666C;MGA p.L2167Rfs*27	3	4
P-0003158	P-0003158-T01-IM5	In-House	FFPE	Biopsy	250	487	20	Matched	Primary	Peri-colic gutter	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma											0	0
P-0003159	P-0003159-T01-IM5	In-House	FFPE	Resection	250	639	50	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.F1245V)					LEVEL_3B	ALK p.F1245V	1	1
P-0003160	P-0003160-T01-IM5	In-House	FFPE	Resection	250	583	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(SMARCB1 p.R377H)				LEVEL_3B	SMARCB1 p.R377H;CTNNB1 p.T41A;RB1 p.R445*;STK11 p.E70*;ERBB3 Amplification;MDM2 Amplification	2	6
P-0003161	P-0003161-T01-IM5	In-House	FFPE	Biopsy	250	683	20	Matched	Metastasis	Skin	Medial Canthal	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										TP53 p.P278L;TP53 p.X187_splice;FAT1 p.Y3028*;FAT1 p.Q2285*;MEN1 p.W441*;TOP1 p.X20_splice;NOTCH1 p.R1368Afs*37	0	7
P-0003162	P-0003162-T01-IM5	In-House	FFPE	Resection	250	642	90	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.W557_K558del;MAX p.R75*;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0003164	P-0003164-T01-IM5	In-House	FFPE	Biopsy	250	624	70	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										CCNE1 Amplification;KDR Amplification;KIT Amplification;MAPK1 Amplification;PDGFRA Amplification	0	5
P-0003165	P-0003165-T01-IM5	Outside	FFPE	Resection	250	745	60	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TET1 p.S905*;TP53 p.V274D;ATRX p.E431*;PIK3R3 p.G107Efs*6;MRE11 p.M309_E310delinsI*;CCNE1 Amplification;FOXA1 Amplification;NKX2-1 Amplification	0	8
P-0003166	P-0003166-T02-IM5	In-House	FFPE	Resection	250	974	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)		Trametinib,Cobimetinib(NF1 p.R2517*)				LEVEL_3A	AKT1 p.E17K;NF1 p.R2517*	2	2
P-0003167	P-0003167-T01-IM5	In-House	FFPE	Biopsy	250	695	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(BARD1 p.S179*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R87P)				LEVEL_3B	U2AF1 p.S34F;TP53 p.R280T;BARD1 p.S179*;HLA-A p.S95*;CTCF p.E698*;KEAP1 p.G333F;CDKN2A p.R87P;EGFR Amplification;YAP1 Amplification;STK11 STK11-intragenic	2	10
P-0003168	P-0003168-T01-IM5	In-House	FFPE	Biopsy	133.9	190	10	Matched	Primary	Epidural	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease			Trametinib,Cobimetinib(MAP2K1 p.E51_Q58del)						LEVEL_3A	MAP2K1 p.E51_Q58del	1	1
P-0003169	P-0003169-T01-IM5	In-House	FFPE	Biopsy	250	525	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719S);Afatinib(EGFR p.S768I)								LEVEL_1	EGFR p.G719S;EGFR p.S768I;TP53 p.L344R	2	3
P-0003170	P-0003170-T01-IM5	Outside	FFPE	Resection	250	900	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;EPHA7 Deletion;PPM1D Amplification	2	5
P-0003171	P-0003171-T01-IM5	Outside	FFPE	Resection	250	587	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	FBXW7 p.X329_splice;CDK4 Amplification;MDM2 Amplification	2	3
P-0003172	P-0003172-T01-IM5	In-House	FFPE	Resection	250	697	80	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(CDK12 p.E98*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.E98*)				LEVEL_3B	RB1 p.E315*;CDK12 p.E98*;TP53 p.X330_splice	2	3
P-0003173	P-0003173-T01-IM5	Outside	FFPE	Biopsy	182.6	86	30	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CCND1 Amplification;EPHA7 Deletion;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	5
P-0003174	P-0003174-T01-IM5	Outside	FFPE	Resection	250	586	40	Matched	Primary	Ovary	Not Applicable	Tumor	BMT	Germ Cell Tumor	Mature Teratoma											0	0
P-0003175	P-0003175-T01-IM5	In-House	FFPE	Resection	250	449	40	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.R306*;RHOA p.E40Q;FAT1 p.D1703Mfs*33;KMT2D p.P741Rfs*189	0	4
P-0003176	P-0003176-T01-IM5	Outside	FFPE	Resection	250	531	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)					LEVEL_1	BRAF p.V600E;PIK3CA p.M1043V;TP53 p.V172F	3	3
P-0003177	P-0003177-T01-IM5	Outside	FFPE	Resection	250	520	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(BICC1 FGFR2-BICC1 fusion);Pemigatinib(FGFR2 FGFR2-BICC1 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(BICC1 FGFR2-BICC1 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-BICC1 fusion)						LEVEL_1	PBRM1 p.R534*;LATS2 p.S872*;BICC1 FGFR2-BICC1 fusion;FGFR2 FGFR2-BICC1 fusion	4	4
P-0003178	P-0003178-T01-IM5	Outside	FFPE	Resection	250	854	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	GSK2636771,AZD8186(PTEN p.R130*)				LEVEL_3A	PIK3CA p.H1047R;PTEN p.R130*;PIK3CA p.E542K;NRAS p.Q61R	5	4
P-0003179	P-0003179-T02-IM5	In-House	FFPE	Biopsy	250	814	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Cisplatin(ERCC2 p.N238S)					LEVEL_1	PIK3CA p.E542K;ERBB3 p.E928G;ERCC2 p.N238S;FOXO1 p.Q529*;TP53 p.K320*;AURKA Amplification;CCND1 Amplification;FGF19 Amplification;MYC Amplification;YAP1 Amplification	3	10
P-0003179	P-0003179-T01-IM5	Outside	FFPE	Biopsy	250	546	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Cisplatin(ERCC2 p.N238S)					LEVEL_1	PIK3CA p.E542K;ERBB3 p.E928G;ERCC2 p.N238S;FOXO1 p.Q529*;TP53 p.K320*;AURKA Amplification;CCND1 Amplification;FGF19 Amplification;MYC Amplification;YAP1 Amplification	3	10
P-0003180	P-0003180-T01-IM5	In-House	FFPE	Resection	250	719	70	Matched	Metastasis	Retroperitoneum	Sigmoid Colon	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E600K);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 Deletion)					LEVEL_3B	PIK3CA p.E600K;CDKN1A p.W49*;BRCA1 Deletion;EZH2 Deletion;FAT1 Deletion;FLCN Deletion;KMT2C Deletion;RB1 Deletion	2	8
P-0003181	P-0003181-T01-IM5	In-House	FFPE	Biopsy	250	855	70	Matched	Metastasis	Prostate	Chest Wall	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma										MCL1 Amplification;PPM1D Amplification;PPP2R1A Deletion;RB1 Deletion	0	4
P-0003181	P-0003181-T02-IM5	In-House	FFPE	Biopsy	250	301	60	Matched	Metastasis	Prostate	Brain	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma										PPM1D Amplification;PPP2R1A Deletion;RB1 Deletion	0	3
P-0003182	P-0003182-T01-IM5	In-House	FFPE	Biopsy	198	390	30	Matched	Metastasis	Skin	Lymph Node	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.X195_splice)		Trametinib,Cobimetinib(NF1 p.Q1370*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_3A	TP53 p.E258K;NOTCH2 p.X676_splice;EPHA3 p.R728*;FAT1 p.R2597*;NBN p.Q644*;PTCH1 p.X195_splice;ARID2 p.X235_splice;KMT2D p.R4536*;NF1 p.Q1370*;SMARCA4 p.R1192C;PTPRT p.L695F;SH2D1A p.W64*;ARID1A p.S90Pfs*11;FAT1 p.T3356Wfs*20;CDKN2A p.P114L;GPS2 Deletion	3	16
P-0003183	P-0003183-T01-IM5	In-House	FFPE	Resection	250	720	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Trametinib,Cobimetinib(NF1 p.N1563*);GSK2636771,AZD8186(PTEN Deletion)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R196*;APC p.R213*;BRAF p.D594V;APC p.N1455Ifs*18;KRAS p.G13D;TCF7L2 p.R522*;NF1 p.N1563*;PTEN Deletion	3	8
P-0003184	P-0003184-T01-IM5	In-House	FFPE	Resection	122.1	225	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.S241C;KRAS p.G13D	1	2
P-0003185	P-0003185-T01-IM5	In-House	FFPE	Resection	250	728	80	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	KMT2A p.S774Vfs*12;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MYC Amplification;PAK1 Amplification	1	6
P-0003186	P-0003186-T01-IM5	In-House	FFPE	Resection	250	675	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLAD	Bladder Cancer	Bladder Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R248Q;PPP2R1A p.S256Y	1	3
P-0003187	P-0003187-T02-IM5	In-House	DNA	Resection	250	663	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0003188	P-0003188-T01-IM5	In-House	FFPE	Resection	250	829	40	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.Q192*;KMT2C p.Q419*;KMT2D p.Q3905*;CCNE1 Amplification;RAF1 Amplification	1	6
P-0003190	P-0003190-T01-IM5	In-House	FFPE	Resection	250	661	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;KMT2D p.S4456*;ZFHX3 p.Q3322*	2	3
P-0003191	P-0003191-T01-IM5	Outside	FFPE	Resection	250	313	30	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	ARID1A p.P1618Sfs*30;MET Amplification	1	2
P-0003192	P-0003192-T01-IM5	In-House	FFPE	Resection	250	764	40	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										TP53 p.R342*	0	1
P-0003193	P-0003193-T01-IM5	In-House	FFPE	Biopsy	250	499	70	Matched	Metastasis	Lung	Chest Wall	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid										ARID1A p.Q528*;EIF1AX p.G9D;ARID1A p.N874Yfs*61	0	3
P-0003194	P-0003194-T01-IM5	Outside	FFPE	Resection	250	587	30	Matched	Metastasis	Ovary	Lymph Node	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer										CTNNB1 p.S37F;SMARCA4 p.A840Gfs*105	0	2
P-0003195	P-0003195-T01-IM5	Outside	FFPE	Biopsy	250	406	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 p.N1066Ifs*11)		Rucaparib,Niraparib(BRCA2 p.N1066Ifs*11)					LEVEL_2	BRCA2 p.N1066Ifs*11;NCOR1 p.E16Vfs*33	2	2
P-0003196	P-0003196-T01-IM5	In-House	FFPE	Cytology	250	730	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.W53*;ATR p.X2587_splice;SMARCA4 p.S828Pfs*3	1	4
P-0003197	P-0003197-T01-IM5	Outside	FFPE	Biopsy	250	598	70	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209P;EIF1AX p.P2L	0	2
P-0003198	P-0003198-T02-IM5	In-House	FFPE	Biopsy	250	251	30	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R248Q;ERBB2 Amplification;MYC Amplification	2	3
P-0003198	P-0003198-T03-IM5	In-House	FFPE	Biopsy	250	718	30	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R248Q;ERBB2 Amplification	2	2
P-0003199	P-0003199-T01-IM5	Outside	FFPE	Resection	250	533	40	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma										GNAQ p.Q209L;BAP1 p.E31del	0	2
P-0003200	P-0003200-T01-IM5	In-House	FFPE	Biopsy	250	671	30	Matched	Metastasis	Lung	Bone	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										EPHA3 p.S521Mfs*19	0	1
P-0003201	P-0003201-T01-IM5	Outside	FFPE	Biopsy	73.35	375	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E119*)				LEVEL_4	TP53 p.S166*;SMARCA4 p.Q194Sfs*109;CDKN2A p.E119*	1	3
P-0003202	P-0003202-T01-IM5	In-House	FFPE	Biopsy	250	763	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0003203	P-0003203-T01-IM5	Outside	FFPE	Resection	250	752	80	Matched	Metastasis	Major Salivary Gland	Bone	Tumor	EMYOCA	Head and Neck Cancer	Epithelial-Myoepithelial Carcinoma										ERRFI1 p.D279Rfs*4	0	1
P-0003204	P-0003204-T01-IM5	Outside	FFPE	Resection	250	218	60	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.R273C;PPP2R1A p.S256F;CCNE1 Amplification;PIK3R2 Amplification	0	4
P-0003205	P-0003205-T01-IM5	Outside	FFPE	Resection	250	751	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L118P	0	1
P-0003205	P-0003205-T02-IM5	Outside	FFPE	Resection	250	541	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L118P	0	1
P-0003206	P-0003206-T01-IM5	In-House	FFPE	Cytology	250	614	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	CASP8 p.E200*;MEN1 p.E196Dfs*3;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	4
P-0003207	P-0003207-T01-IM5	Outside	FFPE	Biopsy	98.8	266	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 TPM3-ROS1 fusion);Crizotinib,Entrectinib(TPM3 TPM3-ROS1 fusion)								LEVEL_1	TP53 p.R342*;ROS1 TPM3-ROS1 fusion;TPM3 TPM3-ROS1 fusion	2	3
P-0003209	P-0003209-T01-IM5	In-House	FFPE	Resection	250	715	70	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(BARD1 p.D172Mfs*40)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);PLX8394(BRAF p.G469A);GSK2636771,AZD8186(PTEN p.R233*)				LEVEL_3B	TP53 p.R175H;PTEN p.K267Rfs*9;BRAF p.G469A;APC p.R232*;ARID1A p.F2141Sfs*59;KMT2D p.A221Gfs*13;PTEN p.R233*;PBRM1 p.R921*;ARID1A p.G801Vfs*32;APC p.R554*;MSH2 p.Y98*;DIS3 p.R924*;TP53 p.R175C;CIC p.P1529Lfs*91;ZFHX3 p.E763Sfs*61;ATR p.L1255Yfs*7;BARD1 p.D172Mfs*40;MRE11 p.F321Lfs*8;CDKN1B p.D17Gfs*108;MGA p.K1525Nfs*18	4	20
P-0003210	P-0003210-T01-IM5	Outside	FFPE	Resection	250	719	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.G1288*;ATRX p.S729*;APC p.D170Vfs*4;TCF7L2 p.N186*	1	5
P-0003211	P-0003211-T01-IM5	Outside	FFPE	Resection	250	817	80	Matched	Metastasis	Cecum	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12A;APC p.Q1429*;APC p.R805*;ASXL1 p.R693*;TP53 p.K24Nfs*20	2	6
P-0003212	P-0003212-T01-IM5	In-House	FFPE	Biopsy	250	556	70	Matched	Metastasis	Liver	Adrenal Gland	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.D32V	0	1
P-0003213	P-0003213-T01-IM5	In-House	FFPE	Biopsy	213.2	451	80	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.C242Y;ARID1A p.S1149*;RBM10 p.E47Afs*81;CDKN2A Deletion;CDKN2B Deletion;PAK1 Amplification	3	8
P-0003214	P-0003214-T01-IM5	In-House	FFPE	Cytology	142	292	50	Matched	Metastasis	Bile Duct	Lymph Node	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.H975Pfs*4)				LEVEL_3B	SMAD4 p.R361C;TP53 p.Q167*;NF1 p.H975Pfs*4;ERBB2 Amplification	2	4
P-0003216	P-0003216-T01-IM5	In-House	FFPE	Biopsy	250	673	80	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.I195T;ARID2 Deletion;FOXA1 Amplification;KMT2D Deletion;PTEN Deletion;RB1 Deletion	1	6
P-0003217	P-0003217-T01-IM5	Outside	FFPE	Resection	250	671	70	Matched	Metastasis	Lower Extremity	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 Deletion	0	1
P-0003218	P-0003218-T01-IM5	Outside	FFPE	Resection	250	200	30	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CREBBP p.Q1852*;CDKN2A Deletion;CDKN2B Deletion;CSF1R PDGFRB-CSF1R fusion;PDGFRB PDGFRB-CSF1R fusion	1	5
P-0003219	P-0003219-T01-IM5	In-House	FFPE	Resection	250	553	40	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										PPP2R1A p.P179R;TP53 p.S183*	0	2
P-0003220	P-0003220-T01-IM5	Outside	FFPE	Biopsy	250	261	40	Matched	Metastasis	Upper Tract	Lung	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma											0	0
P-0003221	P-0003221-T01-IM5	In-House	FFPE	Resection	250	476	70	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.Y16*);GSK2636771,AZD8186(PTEN p.Y65*)				LEVEL_4	SOX17 p.S403I;PTEN p.Y16*;PTEN p.Y65*	2	3
P-0003222	P-0003222-T01-IM5	In-House	FFPE	Cytology	250	765	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.R273G;KMT2D p.E3123*;CDKN1B p.S10Afs*32;BRD4 Amplification	2	5
P-0003223	P-0003223-T01-IM5	In-House	FFPE	Biopsy	127	310	30	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	PIK3CA p.E542K;CDH1 p.Q706*;IKBKE Amplification;MDM4 Amplification;PTEN Deletion	3	5
P-0003223	P-0003223-T02-IM5	In-House	FFPE	Resection	250	479	80	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	PIK3CA p.E542K;CDH1 p.Q706*;IKBKE Amplification;MDM4 Amplification;PTEN Deletion	3	5
P-0003224	P-0003224-T01-IM5	In-House	FFPE	Biopsy	250	528	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.G106V)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.D538G);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106V)						LEVEL_1	ARID1A p.S138*;PIK3CA p.H1047R;ESR1 p.D538G;POLE p.E18K;PIK3CA p.G106V;CDH1 p.X814_splice;GATA3 p.C338Lfs*14;CCND1 Amplification;FGF19 Amplification	5	9
P-0003225	P-0003225-T01-IM5	In-House	FFPE	Biopsy	250	639	90	Matched	Metastasis	Skin	Bone	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61R;SF3B1 p.E902K;TET2 p.Q1654*;FLT3 p.G905E;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0003226	P-0003226-T01-IM5	In-House	FFPE	Biopsy	250	459	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	APC p.N1548Kfs*8;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0003227	P-0003227-T01-IM5	Outside	FFPE	Resection	250	169	30	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										KRAS Amplification	0	1
P-0003228	P-0003228-T01-IM5	In-House	FFPE	Resection	250	434	40	Matched	Metastasis	Retroperitoneum	Transverse Colon	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;DDR2 Amplification;GLI1 Amplification;MCL1 Amplification;MDM2 Amplification	2	5
P-0003229	P-0003229-T01-IM5	In-House	FFPE	Resection	250	550	60	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(BRIP1 p.Y147*)	Trametinib,Cobimetinib(NF1 p.E1192*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84N)				LEVEL_3B	TP53 p.E204*;FBXW7 p.R658*;NOTCH3 p.W1434*;ARID1A p.E1108*;ARID1A p.G1901*;ASXL2 p.E742*;MRE11 p.X521_splice;POLE p.L424V;MGA p.E2039*;MAP2K4 p.E221*;NF1 p.E1192*;BRIP1 p.Y147*;ARID2 p.T1723Hfs*6;ARID1A p.Q1148Sfs*13;CDKN2A p.D84N;EGFR Amplification	3	16
P-0003230	P-0003230-T01-IM5	In-House	FFPE	Resection	250	230	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0003231	P-0003231-T01-IM5	In-House	FFPE	Resection	250	506	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										PTPN11 p.S502L	0	1
P-0003232	P-0003232-T01-IM5	In-House	FFPE	Resection	250	581	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SCRMS	Soft Tissue Sarcoma	Spindle Cell Rhabdomyosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	CDK4 Amplification;DNMT3B Amplification;ETV1 Amplification;GLI1 Amplification;TERT Amplification	1	5
P-0003233	P-0003233-T01-IM5	Outside	FFPE	Resection	250	74	60	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;RB1 p.S565*	2	2
P-0003234	P-0003234-T01-IM5	In-House	FFPE	Resection	250	719	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R273C;PPP6C p.V162Pfs*7;CCNE1 Amplification;MAP3K1 Deletion	0	4
P-0003235	P-0003235-T01-IM5	In-House	FFPE	Resection	250	516	80	Matched	Primary	Scalp	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.R2842C)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R99Q)				LEVEL_3B	TP53 p.E286K;BRCA2 p.R2842C;RB1 p.R579*;KMT2C p.Q4820*;NOTCH1 p.Y670*;ARID2 p.X1641_splice;PTPRT p.Q795*;CRLF2 p.S128L;RB1 p.W78_E79delins*;CDKN2A p.R99Q	2	10
P-0003236	P-0003236-T01-IM5	Outside	FFPE	Resection	250	804	30	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;CDH1 p.G715*	2	2
P-0003237	P-0003237-T01-IM5	In-House	FFPE	Biopsy	69.55	203	20	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P70Gfs*51)				LEVEL_4	KRAS p.G12V;CDKN2A p.P70Gfs*51	2	2
P-0003238	P-0003238-T01-IM5	In-House	FFPE	Resection	250	600	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.R248C;SMARCA4 p.R1189Q;STAG2 p.Q573*;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0003239	P-0003239-T01-IM5	In-House	FFPE	Resection	250	184	40	Matched	Primary	Minor Salivary Gland	Not Applicable	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	TP53 p.R175H;ARID1A p.R2158*;MAP2K4 p.S184W;KDR Amplification;KIT Amplification;PDGFRA Amplification;NF1 NF1-intragenic	1	7
P-0003240	P-0003240-T01-IM5	In-House	FFPE	Resection	250	739	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.P281Rfs*6;SMARCA4 p.X1259_splice;KEAP1 p.R601*	2	4
P-0003241	P-0003241-T02-IM5	In-House	FFPE	Biopsy	250	993	60	Matched	Metastasis	Breast	Ovary	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.T319*);GSK2636771,AZD8186(PTEN p.X212_splice)				LEVEL_4	PTEN p.T319*;PTEN p.X212_splice;CDH1 p.I206Vfs*6	2	3
P-0003241	P-0003241-T01-IM5	In-House	FFPE	Resection	250	384	70	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.T319*);GSK2636771,AZD8186(PTEN p.X212_splice)				LEVEL_4	PTEN p.T319*;PTEN p.X212_splice;CDH1 p.I206Vfs*6	2	3
P-0003243	P-0003243-T01-IM5	In-House	FFPE	Biopsy	113.4	68	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	TP53 p.N239D;EGFR p.E746_A750del;CTNNB1 p.T41A;ARID5B Deletion;MYC Amplification	1	5
P-0003244	P-0003244-T01-IM5	Outside	FFPE	Resection	250	833	40	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.G262V;CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification	1	4
P-0003245	P-0003245-T01-IM5	Outside	FFPE	Resection	250	279	30	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0003246	P-0003246-T01-IM5	Outside	FFPE	Resection	250	333	80	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										MYCN Amplification	0	1
P-0003247	P-0003247-T01-IM5	In-House	FFPE	Biopsy	250	597	20	Matched	Metastasis	Lung	RUQ	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;DNMT3A p.E907*;TP53 p.I255F	1	3
P-0003248	P-0003248-T01-IM5	In-House	FFPE	Biopsy	250	512	10	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R213Q	0	1
P-0003249	P-0003249-T01-IM5	Outside	FFPE	Resection	250	760	90	Matched	Primary	Heart	Not Applicable	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN1A p.R140Qfs*56;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification	2	4
P-0003250	P-0003250-T01-IM5	In-House	FFPE	Biopsy	250	572	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;CDK4 Amplification;MDM2 Amplification;TERT Amplification	3	4
P-0003251	P-0003251-T01-IM5	In-House	FFPE	Resection	250	478	10	Matched	Metastasis	Appendix	Spleen	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0003253	P-0003253-T01-IM5	Outside	FFPE	Biopsy	190.3	209	10	Matched	Metastasis	Ileum	Peritoneum	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer											0	0
P-0003254	P-0003254-T01-IM5	In-House	FFPE	Biopsy	250	579	40	Matched	Metastasis	Sigmoid Colon	Peritoneum	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V;APC p.E902*;APC p.S1206Rfs*59;SMAD4 Deletion	2	5
P-0003255	P-0003255-T01-IM5	In-House	FFPE	Biopsy	94.05	531	40	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.X85_splice)				LEVEL_1	BRAF p.V600E;B2M p.L15Ffs*41;ASXL2 p.R357*;TP53 p.X261_splice;PTEN p.X85_splice	3	5
P-0003256	P-0003256-T01-IM5	In-House	FFPE	Biopsy	250	564	50	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										PTPRD Deletion	0	1
P-0003257	P-0003257-T01-IM5	In-House	FFPE	Biopsy	250	918	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	NFE2L2 p.R34G;KRAS p.Q61H;RAF1 p.S257L	1	3
P-0003258	P-0003258-T01-IM5	In-House	FFPE	Resection	250	530	20	Matched	Metastasis	Rectum	Ovary	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R273C	0	1
P-0003259	P-0003259-T01-IM5	Outside	FFPE	Resection	250	565	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.R248W;KRAS p.Q61H	1	2
P-0003260	P-0003260-T02-IM5	In-House	FFPE	Biopsy	250	480	40	Matched	Metastasis	Colon	Liver	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors											0	0
P-0003260	P-0003260-T01-IM5	In-House	FFPE	Resection	250	234	40	Matched	Primary	Lung	Not Applicable	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										ARID1A p.Q562*	0	1
P-0003261	P-0003261-T01-IM5	In-House	FFPE	Biopsy	250	625	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib(ATM p.E1592*)	Tazemetostat(KDM6A p.Q1133*)				LEVEL_3B	PIK3CA p.E545K;TP53 p.E285*;PTPRD p.X1052_splice;TET1 p.S483*;ATM p.E1592*;DIS3 p.R382G;MGA p.X2337_splice;KDM6A p.Q1133*;CCND1 Amplification;FGF19 Amplification	3	10
P-0003262	P-0003262-T01-IM5	In-House	FFPE	Biopsy	250	462	40	Matched	Metastasis	Anus	Lymph Node	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.D107Y)				LEVEL_4	PTEN p.D107Y	1	1
P-0003264	P-0003264-T01-IM5	In-House	FFPE	Resection	250	789	40	Matched	Metastasis	Retroperitoneum	Pelvis	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MED12 Deletion	0	1
P-0003264	P-0003264-T02-IM5	In-House	FFPE	Resection	250	893	80	Matched	Metastasis	Retroperitoneum	Soft Tissue	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										PTPRT p.X1379_splice	0	1
P-0003265	P-0003265-T01-IM5	In-House	FFPE	Biopsy	250	833	60	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.L536R)	Olaparib(BARD1 Deletion)					LEVEL_1	PIK3CA p.H1047R;ESR1 p.L536R;AKT3 Amplification;BARD1 Deletion;IKBKE Amplification;INHA Deletion;MDM4 Amplification	4	7
P-0003266	P-0003266-T01-IM5	In-House	FFPE	Resection	250	562	30	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;PIK3R1 p.G376R;CIC p.R215Q;CIC p.K586*;CIC p.S902*;CIC p.V1345Gfs*16	1	6
P-0003267	P-0003267-T01-IM5	In-House	FFPE	Biopsy	250	518	80	Matched	Metastasis	Uterus	Pelvis	Tumor	HGESS	Uterine Sarcoma	High-Grade Endometrial Stromal Sarcoma				Olaparib(CDK12 Deletion);Everolimus(TSC2 Deletion)					LEVEL_3B	AKT2 Amplification;ASXL1 Deletion;AXL Amplification;CDK12 Deletion;DNMT3B Deletion;MED12 Deletion;PTPRT Deletion;TSC2 Deletion;ZRSR2 Deletion	2	9
P-0003268	P-0003268-T01-IM5	Outside	FFPE	Biopsy	250	227	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.Y163H;ATRX p.K330Nfs*2;KDR Amplification;KIT Amplification;PDGFRA Amplification	1	6
P-0003269	P-0003269-T01-IM5	In-House	FFPE	Biopsy	250	571	30	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Ivosidenib(IDH1 p.R132H)	Trametinib,Cobimetinib(NF1 p.S340Cfs*12);Trametinib,Cobimetinib(NF1 p.T1881Yfs*3)				LEVEL_3B	PIK3CA p.H1047R;IDH1 p.R132H;NF1 p.S340Cfs*12;NF1 p.T1881Yfs*3	4	4
P-0003270	P-0003270-T02-IM5	In-House	FFPE	Resection	250	387	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.X267_splice)				LEVEL_4	TP53 p.T256P;RASA1 p.X231_splice;PTEN p.X267_splice;EGFR Amplification	1	4
P-0003271	P-0003271-T01-IM5	In-House	FFPE	Resection	250	103	30	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification;MED23 TNFAIP3-MED23 fusion;TNFAIP3 TNFAIP3-MED23 fusion;TNFAIP3 PERP-TNFAIP3 fusion;PERP PERP-TNFAIP3 fusion	2	6
P-0003272	P-0003272-T01-IM5	In-House	FFPE	Resection	250	724	70	Matched	Metastasis	Mandible	Neck	Tumor	ODGC	Head and Neck Cancer	Odontogenic Carcinoma										CIC p.I686Pfs*43;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	0	3
P-0003273	P-0003273-T01-IM5	In-House	FFPE	Biopsy	250	304	60	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		Neratinib(ERBB2 p.V777L)	Ado-Trastuzumab Emtansine(ERBB2 p.V777L);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 p.V777L;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;PAK1 Amplification	4	5
P-0003273	P-0003273-T03-IM5	In-House	DNA	Cytology	250	84	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		Neratinib(ERBB2 p.V777L)	Ado-Trastuzumab Emtansine(ERBB2 p.V777L);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 p.V777L;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;PAK1 Amplification	4	5
P-0003274	P-0003274-T01-IM5	In-House	FFPE	Biopsy	54.74	421	20	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.R273C	2	3
P-0003275	P-0003275-T01-IM5	In-House	FFPE	Biopsy	140.22	689	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Tazemetostat(SMARCB1 p.R377C)				LEVEL_3A	KRAS p.G12C;SMARCB1 p.R377C	3	2
P-0003276	P-0003276-T01-IM5	In-House	FFPE	Biopsy	250	700	50	Matched	Metastasis	Lung	Iliac	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;TP53 p.S106R;ARID2 p.Q1043*;STK11 p.Y36_K48delins*;KEAP1 p.X570_splice	1	5
P-0003277	P-0003277-T01-IM5	Outside	FFPE	Biopsy	250	320	30	Matched	Primary	Skin	Not Applicable	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.L1073Pfs*72)						LEVEL_3A	RHOA p.G17E;PTCH1 p.L1073Pfs*72	1	2
P-0003278	P-0003278-T01-IM5	In-House	FFPE	Cytology	204	589	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83N);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83N)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.P316Lfs*21;BRAF p.T599dup;ARID2 p.L419Pfs*21;CDKN2A p.H83N;CDKN2A p.H83N;FOXA1 Amplification;MET Amplification;NKX2-1 Amplification	4	8
P-0003279	P-0003279-T01-IM5	Outside	FFPE	Biopsy	250	652	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.Q331*;MED12 p.Q27E;RECQL4 p.E63*;RUNX1 p.I315Hfs*258	1	5
P-0003280	P-0003280-T01-IM5	In-House	FFPE	Resection	250	523	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.Q61R;CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification	2	4
P-0003281	P-0003281-T01-IM5	In-House	FFPE	Resection	250	736	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	4
P-0003282	P-0003282-T01-IM5	In-House	FFPE	Biopsy	89.4	566	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.A767_V769dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.A767_V769dup)			LEVEL_3A	EGFR p.A767_V769dup;FANCA p.V801Lfs*13;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0003283	P-0003283-T01-IM5	Outside	FFPE	Biopsy	132	102	30	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Tazemetostat(SMARCB1 p.T118Hfs*52)				LEVEL_4	SMARCB1 p.T118Hfs*52	1	1
P-0003284	P-0003284-T01-IM5	In-House	FFPE	Resection	250	560	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;SMAD2 p.D300G;BRAF p.N581S;ARID1A p.R2158*;APC p.X582_splice;APC p.I1580Ffs*70;SMAD3 p.V389Dfs*8	1	7
P-0003285	P-0003285-T01-IM5	In-House	FFPE	Resection	250	703	30	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TGFBR1 p.G301Efs*2;APC p.Y935*;APC p.A1492Sfs*22	0	3
P-0003286	P-0003286-T01-IM5	Outside	FFPE	Biopsy	250	744	30	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R248Q;PIK3CA p.E542K;NF2 p.E463*;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;PAK1 Amplification;SMAD4 Deletion	4	8
P-0003287	P-0003287-T01-IM5	In-House	FFPE	Resection	250	846	NA	Unmatched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A502_Y503dup)								LEVEL_1	KIT p.A502_Y503dup	1	1
P-0003289	P-0003289-T02-IM5	In-House	DNA	Biopsy	250	477	30	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ERBB2 p.S310F;TP53 p.E343Gfs*2;AMER1 Deletion;CCNE1 Amplification;CDK6 Amplification;ERBB2 Amplification;KDM5C Deletion;MED12 Deletion;RBM10 Deletion;RICTOR Amplification;RNF43 Deletion;TERT Amplification	2	12
P-0003289	P-0003289-T03-IM5	In-House	FFPE	Biopsy	250	893	60	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.R2520*)					LEVEL_3B	TP53 p.E343Gfs*2;BRCA2 p.R2520*;AURKA Amplification;CDK6 Amplification	1	4
P-0003290	P-0003290-T01-IM5	In-House	FFPE	Biopsy	250	439	NA	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_3B	TP53 p.T253Hfs*11;STAG2 p.D1136Gfs*2;CCNE1 Amplification;CDC73 Deletion;FGFR1 Amplification;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	3	7
P-0003291	P-0003291-T01-IM5	In-House	FFPE	Biopsy	250	362	50	Matched	Metastasis	Breast	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	GSK2636771,AZD8186(PTEN p.R130Qfs*4)				LEVEL_3B	PIK3CA p.H1047L;PTEN p.R130Qfs*4;TP53 p.T211I;TP53 p.V225Gfs*20	2	4
P-0003292	P-0003292-T01-IM5	Outside	FFPE	Resection	250	409	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132C)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	IDH1 p.R132C;TP53 p.R273C;CTCF p.T204Nfs*26;MDM4 p.G57D;ATRX p.K945Rfs*25;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification;ZRSR2 Deletion	2	9
P-0003293	P-0003293-T01-IM5	In-House	FFPE	Biopsy	250	674	50	Matched	Metastasis	Skin	Lung	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	STK11 p.Y60*;TP53 p.R110Wfs*12;ERBB2 Amplification;PPFIBP1 MLL2-PPFIBP1 fusion;KMT2D MLL2-PPFIBP1 fusion;MED12 MED12-intragenic	1	6
P-0003294	P-0003294-T01-IM5	Outside	FFPE	Biopsy	250	286	30	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma											0	0
P-0003294	P-0003294-T02-IM5	Outside	FFPE	Biopsy	250	525	80	Matched	Metastasis	Breast	Chest Wall	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										CDH11 CBFB-CDH11 fusion;CBFB CBFB-CDH11 fusion;ERG PDE1C-ERG fusion;PDE1C PDE1C-ERG fusion	0	4
P-0003295	P-0003295-T01-IM5	Outside	FFPE	Resection	250	540	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification;MEF2B Amplification	2	4
P-0003296	P-0003296-T01-IM5	In-House	FFPE	Resection	250	779	70	Matched	Metastasis	Liver	Bile Duct	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0003297	P-0003297-T01-IM5	In-House	FFPE	Resection	250	702	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0003298	P-0003298-T01-IM5	In-House	FFPE	Resection	250	689	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	KRAS p.G12A;PIK3CA p.E542K;APC p.S1465Wfs*3;APC p.E1257*;AMER1 p.R353*;SOX9 p.H396Rfs*8	2	6
P-0003299	P-0003299-T01-IM5	Outside	FFPE	Biopsy	250	554	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.I195N;BAP1 p.S460*;FBXW7 p.E115*	0	3
P-0003300	P-0003300-T01-IM5	Outside	FFPE	Resection	250	796	20	Matched	Primary	Skull Base	Not Applicable	Tumor	LCH	Histiocytosis	Langerhans Cell Histiocytosis			Cobimetinib(BRAF p.N486_P490del)						LEVEL_3A	BRAF p.N486_P490del	1	1
P-0003301	P-0003301-T01-IM5	Outside	FFPE	Resection	250	738	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	APC p.G1357*;KRAS p.G13D;CDKN2A p.H83Y	2	3
P-0003302	P-0003302-T01-IM5	In-House	FFPE	Resection	250	238	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X2580_splice)				LEVEL_4	RASA1 p.W351*;NF1 p.X2580_splice;NFE2L2 p.I22_D29del	1	3
P-0003303	P-0003303-T01-IM5	In-House	FFPE	Resection	250	543	40	Matched	Metastasis	Lung	Paratracheal	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.V216M;BRAF p.E586K	2	3
P-0003306	P-0003306-T01-IM5	In-House	FFPE	Biopsy	250	425	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;GATA3 p.P408Afs*99	2	2
P-0003307	P-0003307-T01-IM5	Outside	FFPE	Resection	250	663	60	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	CTNNB1 p.S45F;HRAS p.Q61R;EPHA7 Deletion	1	3
P-0003308	P-0003308-T01-IM5	Outside	FFPE	Resection	250	472	60	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	TP53 p.R175H;PIK3CA p.E542K;APC p.R283*;PBRM1 p.X1178_splice;APC p.S1344*;MED12 p.Q2106_Q2115del	1	6
P-0003309	P-0003309-T01-IM5	Outside	FFPE	Biopsy	250	537	90	Matched	Primary	Lymph Node	Not Applicable	Tumor	WM	Mature B-Cell Neoplasms	Waldenstrom Macroglobulinemia										ARID1A p.R1276*;MYD88 p.L265P	0	2
P-0003311	P-0003311-T01-IM5	Outside	FFPE	Resection	250	488	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R47Gfs*6)				LEVEL_4	TP53 p.S215I;DNMT3A p.G332*;CDKN1A p.E125*;CBL p.X366_splice;KEAP1 p.E57*;ATRX p.X1246_splice;SMARCA4 p.L1161Afs*15;CDKN2A p.R47Gfs*6	1	8
P-0003313	P-0003313-T01-IM5	In-House	FFPE	Biopsy	250	655	20	Matched	Metastasis	Testis	Retroperitoneum	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S	1	1
P-0003314	P-0003314-T01-IM5	Outside	FFPE	Resection	250	573	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.G1049R;TP53 p.G266*;RB1 p.N328*	2	4
P-0003315	P-0003315-T01-IM5	Outside	FFPE	Resection	250	736	30	Matched	Metastasis	Testis	Lymph Node	Tumor	TYST	Germ Cell Tumor	Yolk Sac Tumor											0	0
P-0003316	P-0003316-T01-IM5	Outside	FFPE	Biopsy	250	402	40	Matched	Metastasis	Lung	Forehead	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR p.E709K;BCOR p.E1476*	1	3
P-0003317	P-0003317-T01-IM5	In-House	FFPE	Resection	250	713	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0003317	P-0003317-T02-IM5	In-House	FFPE	Resection	250	632	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.R273L;RBM10 p.S395Tfs*88;EGFR Amplification	1	4
P-0003319	P-0003319-T01-IM5	Outside	FFPE	Resection	250	450	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Poziotinib(EGFR p.H773dup)					LEVEL_3B	EGFR p.H773dup;MDM4 Amplification;MYC Amplification	1	3
P-0003320	P-0003320-T01-IM5	Outside	FFPE	Biopsy	250	613	30	Matched	Primary	Larynx	Not Applicable	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	GSK2636771,AZD8186(PTEN p.Q245*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.N39Tfs*14)				LEVEL_3B	PIK3CA p.E545K;TP53 p.C176F;TP53 p.L194F;PTEN p.Q245*;KMT2C p.Q202*;NBN p.X638_splice;KMT2D p.E1965*;KMT2D p.G1616*;CDKN2A p.N39Tfs*14	3	9
P-0003321	P-0003321-T01-IM5	In-House	FFPE	Cytology	250	299	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R158L;NFE2L2 p.T80R;KMT2D p.W1422*;ASXL1 p.E788*;CDKN2A Deletion;CDKN2B Deletion	1	6
P-0003322	P-0003322-T01-IM5	In-House	FFPE	Biopsy	250	745	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.S752_I759del)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	CTNNB1 p.S33C;TP53 p.L194R;EGFR p.S752_I759del;ERBB2 Amplification	2	4
P-0003323	P-0003323-T01-IM5	In-House	FFPE	Biopsy	250	185	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0003324	P-0003324-T01-IM5	In-House	FFPE	Resection	250	623	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;U2AF1 p.S34F	1	2
P-0003324	P-0003324-T02-IM5	In-House	FFPE	Resection	250	594	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F	2	2
P-0003325	P-0003325-T01-IM5	Outside	FFPE	Biopsy	250	575	70	Matched	Primary	Scalp	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K2555*)	Trametinib,Cobimetinib(NF1 p.X1575_splice)				LEVEL_3B	MSH2 p.X463_splice;BRCA2 p.K2555*;TP53 p.G199V;NF1 p.X1575_splice;RB1 p.M460Ifs*3;MYCL Amplification	2	6
P-0003326	P-0003326-T01-IM5	Outside	FFPE	Resection	250	416	10	Matched	Primary	Testis	Not Applicable	Tumor	EMBCA	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0003327	P-0003327-T01-IM5	In-House	FFPE	Resection	250	642	60	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										PPP2R1A p.R183W;KMT2D p.W1469*;NOTCH1 p.S2486Cfs*106	0	3
P-0003328	P-0003328-T01-IM5	In-House	FFPE	Biopsy	250	655	70	Matched	Primary	Lower Extremity	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0003329	P-0003329-T01-IM5	Outside	FFPE	Biopsy	250	593	10	Matched	Metastasis	Gallbladder	Omentum	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer	Larotrectinib,Entrectinib(LMNA NTRK1-LMNA fusion);Larotrectinib,Entrectinib(NTRK1 NTRK1-LMNA fusion)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MED12 p.E10K;CDK4 Amplification;MDM2 Amplification;LMNA NTRK1-LMNA fusion;NTRK1 NTRK1-LMNA fusion;AXIN1 AXIN1-intragenic;SOX9 SOX9-intragenic	4	7
P-0003330	P-0003330-T01-IM5	In-House	FFPE	Biopsy	250	571	50	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0003331	P-0003331-T01-IM5	In-House	FFPE	Resection	250	410	20	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*)				LEVEL_4	CASP8 p.G155*;TP53 p.R282P;ASXL1 p.E948*;CDKN2A p.E88*;PDGFRA Amplification	1	5
P-0003332	P-0003332-T01-IM5	Outside	FFPE	Biopsy	250	451	90	Matched	Metastasis	Breast	Lung	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.R273C;STK11 p.E165*;ARID2 p.X500_splice	2	4
P-0003333	P-0003333-T01-IM5	In-House	FFPE	Biopsy	250	260	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R273C;IDH1 p.R132H;ATRX p.E1017Dfs*5;KRAS Amplification;RAC1 Amplification	1	5
P-0003334	P-0003334-T02-IM5	Outside	FFPE	Biopsy	250	381	40	Matched	Metastasis	Appendix	Peritoneum	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H;BCL6 p.R594Q;MAP2K4 COX19-MAP2K4 fusion;COX19 COX19-MAP2K4 fusion	1	5
P-0003335	P-0003335-T01-IM5	In-House	FFPE	Biopsy	250	173	90	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										PRDM1 Deletion	0	1
P-0003338	P-0003338-T01-IM5	In-House	FFPE	Resection	250	342	70	Matched	Metastasis	Ethmoid Sinus	Lymph Node	Tumor	ONBL	Embryonal Tumor	Olfactory Neuroblastoma											0	0
P-0003339	P-0003339-T01-IM5	In-House	FFPE	Resection	250	282	70	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0003340	P-0003340-T01-IM5	In-House	FFPE	Resection	250	196	60	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										NF2 p.E206*;RICTOR Amplification;TERT Amplification	0	3
P-0003342	P-0003342-T01-IM5	In-House	FFPE	Resection	250	415	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.S313Afs*32;RB1 Deletion	0	2
P-0003343	P-0003343-T01-IM5	Outside	FFPE	Resection	250	79	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer											0	0
P-0003344	P-0003344-T01-IM5	In-House	FFPE	Biopsy	250	708	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 ST7L-FGFR3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(ST7L ST7L-FGFR3 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R273H;DNMT3A p.X423_splice;ANKRD11 Deletion;CBFB Deletion;CDH1 Deletion;CDKN2A Deletion;CDKN2B Deletion;CTCF Deletion;FANCA Deletion;KDR Amplification;KIT Amplification;PAX5 Amplification;PDGFRA Amplification;SDHA Deletion;TP63 Deletion;ZFHX3 Deletion;FGFR3 ST7L-FGFR3 fusion;ST7L ST7L-FGFR3 fusion	3	18
P-0003345	P-0003345-T01-IM5	Outside	FFPE	Resection	250	641	40	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ARID1A p.S1558Cfs*11	0	1
P-0003346	P-0003346-T01-IM5	In-House	FFPE	Resection	250	371	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas											0	0
P-0003347	P-0003347-T01-IM5	In-House	FFPE	Resection	250	684	50	Matched	Metastasis	Lung	Brain	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_4	ARID1A p.Q802Sfs*15;KEAP1 p.E488K;BCL2L11 p.R154Gfs*17;TP53 p.P72Afs*51;CDKN2A p.W110*;PIK3CA Amplification	1	6
P-0003348	P-0003348-T01-IM5	In-House	FFPE	Resection	250	314	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248W;APC p.L1488Yfs*19;ARID1A p.W2091*	0	3
P-0003349	P-0003349-T01-IM5	Outside	FFPE	Biopsy	250	223	40	Matched	Primary	Mediastinum	Not Applicable	Tumor	TYST	Germ Cell Tumor	Yolk Sac Tumor				Olaparib(CDK12 p.X1032_splice)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.X1032_splice)				LEVEL_3B	CBL p.X410_splice;CDK12 p.X1032_splice;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	2	5
P-0003350	P-0003350-T01-IM5	In-House	FFPE	Biopsy	250	716	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PTEN Deletion;EYS PARK2-EYS fusion;PRKN PARK2-EYS fusion	3	6
P-0003351	P-0003351-T01-IM5	In-House	FFPE	Biopsy	250	751	10	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.R88Q)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)						LEVEL_1	PIK3CA p.R88Q;CDH1 p.E26*;NCOR1 p.Q661*	2	3
P-0003352	P-0003352-T01-IM5	In-House	FFPE	Biopsy	250	698	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)		Tazemetostat(KDM6A p.Y143*)				LEVEL_1	U2AF1 p.S34F;FGFR3 p.Y373C;KDM6A p.Y143*;DDR2 Amplification	3	4
P-0003353	P-0003353-T01-IM5	In-House	FFPE	Biopsy	250	255	40	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Olaparib(RAD51C ABCA8-RAD51C fusion);Olaparib(ABCA8 ABCA8-RAD51C fusion)					LEVEL_1	RHOA p.G17A;EIF4A2 p.R335C;FOXA1 p.S242Y;PBRM1 p.R760Lfs*8;AURKA Amplification;ERBB2 Amplification;RAD51C ABCA8-RAD51C fusion;ABCA8 ABCA8-RAD51C fusion	4	8
P-0003354	P-0003354-T01-IM5	In-House	FFPE	Biopsy	250	485	40	Matched	Metastasis	Bladder	Retroperitoneum	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;RB1 p.R661W;TP53 p.H193R;FOXO1 p.Q557*;ZFHX3 p.S2600*;CIC p.S1058*;RAF1 Amplification	1	7
P-0003355	P-0003355-T01-IM5	In-House	FFPE	Biopsy	250	617	50	Matched	Metastasis	Ovary	Abdomen	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer											0	0
P-0003356	P-0003356-T01-IM5	In-House	FFPE	Biopsy	250	598	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma											0	0
P-0003357	P-0003357-T01-IM5	Outside	FFPE	Biopsy	250	99	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.G631*)				LEVEL_4	TP53 p.R280T;NF1 p.G631*	1	2
P-0003358	P-0003358-T01-IM5	In-House	FFPE	Resection	250	795	90	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)	Ivosidenib(IDH1 p.R132C)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P81Rfs*35);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T79A)				LEVEL_3A	IDH1 p.R132C;NRAS p.Q61K;TP53 p.X225_splice;CDKN2A p.P81Rfs*35;CDKN2A p.T79A	4	5
P-0003359	P-0003359-T01-IM5	In-House	FFPE	Biopsy	250	506	70	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	SF3B1 p.R625H;GNAQ p.Q209L;B2M Deletion;CDKN2A Deletion;CDKN2B Deletion;EPHA7 Deletion;ID3 Deletion;MYC Amplification	1	8
P-0003360	P-0003360-T01-IM5	Outside	FFPE	Biopsy	250	793	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)	Lapatinib(EGFR p.R108K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	EGFR p.R108K;ARID5B Deletion;BRCA2 Deletion;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;GATA3 Deletion;NF2 Deletion;PTEN Deletion;PTPRT Deletion;TOP1 Deletion	5	11
P-0003361	P-0003361-T01-IM5	In-House	FFPE	Resection	250	553	20	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast										MED12 p.G44D	0	1
P-0003362	P-0003362-T01-IM5	In-House	FFPE	Biopsy	250	593	90	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C);Cisplatin(ERCC2 p.P463Q)		Tazemetostat(SMARCB1 p.Q368*)				LEVEL_1	FGFR3 p.Y373C;ASXL2 p.E347*;ASXL2 p.Q36*;HIST1H3B p.E51K;ERCC2 p.P463Q;SMARCB1 p.Q368*;PIK3R1 p.X154_splice;CREBBP p.L545Ffs*16;GATA3 p.A441Rfs*66	4	9
P-0003363	P-0003363-T01-IM5	Outside	FFPE	Biopsy	250	328	30	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;SMAD4 Deletion	1	3
P-0003364	P-0003364-T01-IM5	In-House	FFPE	Resection	250	650	20	Matched	Metastasis	Esophagus	Lymph Node	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma										TP53 p.S90Pfs*33;KMT2D p.X5262_splice;ATR p.E1776Qfs*47	0	3
P-0003365	P-0003365-T01-IM5	In-House	FFPE	Resection	250	576	30	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R335Pfs*2	0	1
P-0003366	P-0003366-T01-IM5	In-House	FFPE	Biopsy	250	576	60	Matched	Metastasis	Kidney	Soft Tissue	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.*214Lfs*42	0	1
P-0003367	P-0003367-T01-IM5	In-House	FFPE	Biopsy	250	570	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R	1	1
P-0003368	P-0003368-T01-IM5	In-House	FFPE	Biopsy	250	743	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.G154V;NOTCH2 p.E253*	1	3
P-0003370	P-0003370-T01-IM5	In-House	FFPE	Biopsy	250	677	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib(ATM p.E737Kfs*6)					LEVEL_1	FGFR3 p.S249C;PIK3CA p.E542K;ATM p.E737Kfs*6	4	3
P-0003371	P-0003371-T01-IM5	In-House	FFPE	Cytology	250	407	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201H;MYC Amplification	1	3
P-0003372	P-0003372-T01-IM5	In-House	FFPE	Resection	250	497	50	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83D)				LEVEL_1	BRAF p.V600E;CDKN2A p.H83D	3	2
P-0003373	P-0003373-T01-IM5	In-House	FFPE	Resection	250	491	40	Matched	Metastasis	Bladder	Urethra	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.Y772_A775dup)					LEVEL_3B	ERBB2 p.Y772_A775dup;EP300 p.E1423*;CDKN1A p.A17Pfs*14;DDR2 Amplification	1	4
P-0003374	P-0003374-T01-IM5	Outside	FFPE	Resection	250	884	30	Matched	Metastasis	Nasopharynx	Lymph Node	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma										KMT2A p.S2672Kfs*5;KMT2D p.M4159Cfs*2	0	2
P-0003375	P-0003375-T01-IM5	In-House	FFPE	Biopsy	250	617	20	Matched	Metastasis	Breast	Epidural Mass	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);AZD9496,Fulvestrant(ESR1 p.Y537S)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.E542K;ESR1 p.Y537S;FGFR1 Amplification	4	3
P-0003376	P-0003376-T02-IM5	Outside	FFPE	Resection	250	123	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.T319Kfs*24);Trametinib,Cobimetinib(NF1 p.K1036*)				LEVEL_4	PTEN p.T319Kfs*24;TP53 p.E298*;NF1 p.K1036*;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification	2	6
P-0003377	P-0003377-T01-IM5	Outside	FFPE	Biopsy	250	671	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.E271K;TP53 p.E286Q;TP53 p.E198Kfs*49;AKT2 Amplification	0	4
P-0003381	P-0003381-T01-IM5	In-House	FFPE	Biopsy	242	387	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SMARCA4 p.R1192H;RB1 p.L343Sfs*3;KMT2A USP2-MLL fusion;USP2 USP2-MLL fusion	0	4
P-0003382	P-0003382-T01-IM5	Outside	FFPE	Resection	250	778	60	Matched	Metastasis	Thyroid	Chest Wall	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer										EPHA3 p.R104*	0	1
P-0003383	P-0003383-T01-IM5	Outside	FFPE	Resection	250	823	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0003385	P-0003385-T02-IM5	Outside	FFPE	Resection	250	147	30	Unmatched	Primary	Lung	Not Applicable	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor											0	0
P-0003388	P-0003388-T01-IM5	In-House	FFPE	Biopsy	250	627	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Tazemetostat(KDM6A p.F95Sfs*5)				LEVEL_1	FGFR3 p.S249C;PIK3CA p.E542K;CDH1 p.X440_splice;STAG2 p.Q123*;STAG2 p.S1068*;EP300 p.T2391Hfs*9;KDM6A p.F95Sfs*5	4	7
P-0003389	P-0003389-T01-IM5	Outside	FFPE	Resection	169.4	52	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLAD	Bladder Cancer	Bladder Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)					LEVEL_3B	PIK3CA p.H1047L;ATRX p.E976Dfs*2	1	2
P-0003390	P-0003390-T01-IM5	In-House	FFPE	Resection	250	201	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.R202C;KMT2D p.F2766Sfs*19;CDK4 Amplification	1	3
P-0003391	P-0003391-T01-IM5	In-House	FFPE	Biopsy	250	105	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Tazemetostat(KDM6A p.Q240*);Tazemetostat(KDM6A p.W1193*);Tazemetostat(KDM6A p.I342Lfs*21)				LEVEL_1	PIK3CA p.E545K;FGFR3 p.S249C;KDM6A p.Q240*;KDM6A p.W1193*;STAG2 p.I913Nfs*5;STAG2 p.L513Nfs*3;KDM6A p.I342Lfs*21	6	7
P-0003392	P-0003392-T01-IM5	In-House	FFPE	Biopsy	181.5	83	80	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132G);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	IDH1 p.R132G;TP53 p.E258Q;ATRX p.R1504Qfs*5;CDK4 Amplification;ETV1 Amplification	2	5
P-0003393	P-0003393-T01-IM5	Outside	FFPE	Biopsy	250	494	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537N)						LEVEL_3A	ESR1 p.Y537N	1	1
P-0003394	P-0003394-T01-IM5	In-House	FFPE	Biopsy	250	563	20	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										KMT2C p.E1623*;GATA3 p.F430Lfs*77	0	2
P-0003395	P-0003395-T01-IM5	In-House	FFPE	Biopsy	250	441	30	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R175H;AR Amplification	0	2
P-0003396	P-0003396-T01-IM5	In-House	FFPE	Resection	250	538	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C);Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.G380R);Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)						LEVEL_1	FGFR3 p.S249C;CTNNB1 p.S45P;FGFR3 p.G380R;FGFR3 p.Y373C;STAG2 p.I731Tfs*16;STAG2 p.R766Kfs*19	5	6
P-0003397	P-0003397-T01-IM5	Outside	FFPE	Resection	250	530	10	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.S1276*;ARID1B p.Q1331*	0	2
P-0003398	P-0003398-T01-IM5	In-House	FFPE	Biopsy	250	409	40	Matched	Primary	Thymus	Not Applicable	Tumor	THYC	Thymic Tumor	Thymic Carcinoma										EED Deletion;MEN1 Deletion	0	2
P-0003400	P-0003400-T01-IM5	In-House	FFPE	Resection	250	669	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;NCOR1 p.I199Nfs*79	1	2
P-0003401	P-0003401-T01-IM5	In-House	FFPE	Biopsy	250	644	30	Matched	Metastasis	Rectum	Lung	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R	1	1
P-0003402	P-0003402-T01-IM5	In-House	FFPE	Resection	250	288	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Palbociclib,Ribociclib,Abemaciclib(MTAP CDKN2A-MTAP fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-MTAP fusion)				LEVEL_3B	PIK3CA p.E542K;TP53 p.K132R;FOXP1 p.X511_splice;KMT2C p.Q3151*;MTAP CDKN2A-MTAP fusion;CDKN2A CDKN2A-MTAP fusion	3	6
P-0003403	P-0003403-T01-IM5	In-House	FFPE	Biopsy	250	759	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	PIK3CA p.E545K;PBRM1 p.E1214Rfs*6;FGFR3 p.Y373C;STAG2 p.C487Sfs*4;BAP1 p.V233Tfs*13	3	5
P-0003404	P-0003404-T01-IM5	In-House	FFPE	Biopsy	250	498	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;SF3B1 p.E902Q;ARID1A p.H1548Lfs*14	1	3
P-0003405	P-0003405-T01-IM5	In-House	FFPE	Resection	250	461	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0003406	P-0003406-T01-IM5	In-House	FFPE	Biopsy	250	412	60	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Olaparib(ATM p.S2394Qfs*12)					LEVEL_3B	VHL p.C162Y;ATM p.S2394Qfs*12	1	2
P-0003407	P-0003407-T01-IM5	In-House	FFPE	Resection	250	558	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma										TP53 p.X126_splice	0	1
P-0003408	P-0003408-T01-IM5	In-House	FFPE	Biopsy	250	314	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;KMT2D p.S1976*;CDKN1A p.D7Gfs*29;EP300 Deletion;EPHA3 Deletion;PTPRD Deletion;EP300 PTPRN2-EP300 fusion;PTPRN2 PTPRN2-EP300 fusion	2	8
P-0003409	P-0003409-T01-IM5	Outside	FFPE	Biopsy	250	402	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.Q247Tfs*16)				LEVEL_4	RB1 p.A562Hfs*49;TP53 p.Q317Afs*19;KDM6A p.Q247Tfs*16	1	3
P-0003410	P-0003410-T01-IM5	Outside	FFPE	Resection	250	568	40	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0003410	P-0003410-T02-IM5	Outside	FFPE	Resection	250	562	60	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0003411	P-0003411-T01-IM5	Outside	FFPE	Biopsy	250	422	60	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0003412	P-0003412-T01-IM5	Outside	FFPE	Resection	250	359	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.E224D	1	2
P-0003413	P-0003413-T01-IM5	In-House	FFPE	Resection	250	458	80	Matched	Primary	Pelvis	Not Applicable	Tumor	STMYEC	Soft Tissue Sarcoma	Soft Tissue Myoepithelial Carcinoma					Tazemetostat(SMARCB1 p.Q123*);Tazemetostat(POM121L4P SMARCB1-POM121L4P fusion);Tazemetostat(SMARCB1 SMARCB1-POM121L4P fusion)				LEVEL_4	SMARCB1 p.Q123*;POM121L4P SMARCB1-POM121L4P fusion;SMARCB1 SMARCB1-POM121L4P fusion	3	3
P-0003414	P-0003414-T01-IM5	In-House	FFPE	Resection	250	437	30	Matched	Primary	Lung	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0003415	P-0003415-T01-IM5	Outside	FFPE	Biopsy	250	345	30	Matched	Primary	Heart	Not Applicable	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	BCOR Deletion;CDK4 Amplification;ERBB3 Amplification;GLI1 Amplification;KDM6A Deletion;MDM2 Amplification	2	6
P-0003416	P-0003416-T02-IM5	In-House	FFPE	Resection	250	864	30	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559D)								LEVEL_1	KIT p.V559D	1	1
P-0003417	P-0003417-T01-IM5	In-House	FFPE	Biopsy	250	546	30	Matched	Metastasis	Kidney	Soft Tissue	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.A1459D)				LEVEL_4	MTOR p.A1459D;PBRM1 p.X79_splice;CBL p.L95Sfs*28;VHL p.P154Qfs*5;TET2 p.T505Dfs*27	1	5
P-0003419	P-0003419-T02-IM5	Outside	FFPE	Biopsy	250	763	NA	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	3
P-0003421	P-0003421-T01-IM5	Outside	FFPE	Biopsy	250	532	60	Unmatched	Primary	Brain	Not Applicable	Tumor	GNG	Glioma	Ganglioglioma		Dabrafenib+Trametinib,Vemurafenib+Cobimetinib(BRAF p.V600E)		Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_2	BRAF p.V600E	2	1
P-0003422	P-0003422-T01-IM5	Outside	FFPE	Biopsy	250	301	20	Matched	Metastasis	Lung	Colon	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)						LEVEL_1	MET p.X1010_splice	3	1
P-0003423	P-0003423-T01-IM5	Outside	FFPE	Resection	250	423	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ARID1A p.Q766Sfs*67;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PPM1D Amplification	1	5
P-0003424	P-0003424-T01-IM5	Outside	FFPE	Biopsy	250	580	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R249G;ATRX p.F2113Sfs*9;CDKN2A Deletion;CDKN2B Deletion;KIT Amplification;MET Amplification;PDGFRA Amplification;PIK3R1 PIK3R1-intragenic	2	8
P-0003425	P-0003425-T01-IM5	In-House	FFPE	Cytology	76	404	NA	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsA)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;TP53 p.X307_splice;PBRM1 p.Q1298*;RBM10 p.X723_splice;EGFR p.E746_T751delinsA;EGFR Amplification	2	6
P-0003426	P-0003426-T01-IM5	Outside	FFPE	Biopsy	250	199	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.V173L	0	1
P-0003428	P-0003428-T01-IM5	In-House	FFPE	Biopsy	250	407	60	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132G)					LEVEL_3B	IDH1 p.R132G;TP53 p.E286Q;ATRX p.K971Tfs*31;TERT p.P308Hfs*43	1	4
P-0003429	P-0003429-T01-IM5	Outside	FFPE	Biopsy	250	387	20	Matched	Metastasis	Upper Tract	Liver	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	FGFR3 p.S249C;PBRM1 p.I279Nfs*8;MDM2 Amplification	3	3
P-0003430	P-0003430-T01-IM5	Outside	FFPE	Resection	250	717	50	Matched	Primary	Lung	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.H179N;KMT2D p.V1432Gfs*15;ARID1B Deletion;CCND2 Amplification;FGFR1 Amplification;KDM5A Amplification;KRAS Amplification;MYC Amplification;RICTOR Amplification;SUZ12 Deletion;TERT Amplification	1	11
P-0003431	P-0003431-T01-IM5	Outside	FFPE	Biopsy	250	737	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification);Olaparib(RAD51B Deletion)					LEVEL_3B	AURKA Amplification;DICER1 Deletion;FGFR1 Amplification;MDM2 Amplification;MYC Amplification;RAD51B Deletion	3	6
P-0003432	P-0003432-T01-IM5	In-House	FFPE	Cytology	133.1	146	70	Matched	Metastasis	Esophagus	Manubrium	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	TP53 p.R273H;MEN1 p.C426*;CDKN2A p.R58*	1	3
P-0003433	P-0003433-T01-IM5	In-House	FFPE	Biopsy	250	636	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.T484A)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3A	PIK3CA p.E453K;PIK3CA p.E542K;MAP3K1 p.W1433*;CREBBP p.S1778L;NCOR1 p.Q1167*;SMARCA4 p.E821K;CIC p.S914*;ERCC2 p.T484A;CDKN1A p.R67Afs*13	3	9
P-0003434	P-0003434-T01-IM5	In-House	FFPE	Biopsy	250	174	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.Y24C)	Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L755S);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)					LEVEL_3A	ERBB2 p.L755S;ERBB2 p.R678Q;ERCC2 p.Y24C;BAP1 p.M1?;EP300 p.Q824*;FOXA1 p.D391Pfs*51;SDHA p.G183Afs*43;SPEN p.P3165Rfs*17	3	8
P-0003435	P-0003435-T01-IM5	In-House	FFPE	Resection	250	640	80	Unmatched	Metastasis	Soft Tissue	Spleen	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										SMARCA4 p.G1232S;DICER1 Deletion;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	4
P-0003436	P-0003436-T01-IM5	In-House	FFPE	Biopsy	250	300	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.G660D)					LEVEL_3B	ERBB2 p.S310F;ERBB2 p.G660D	2	2
P-0003437	P-0003437-T01-IM5	Outside	FFPE	Resection	250	861	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R282W;APC p.Q1429*;APC p.R213*;KRAS p.G13D	1	4
P-0003438	P-0003438-T01-IM5	In-House	FFPE	Biopsy	250	692	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;KMT2D p.Y959*;STAG2 p.R216*	2	3
P-0003439	P-0003439-T01-IM5	In-House	FFPE	Resection	250	254	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Everolimus(TSC1 p.R245*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A100Cfs*11)				LEVEL_3B	TP53 p.Y220C;SPEN p.S1534*;FBXW7 p.R505G;TSC1 p.R245*;CDKN2A p.A100Cfs*11	2	5
P-0003440	P-0003440-T01-IM5	Outside	FFPE	Cytology	250	736	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0003442	P-0003442-T02-IM5	In-House	FFPE	Biopsy	250	578	80	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.S149Ffs*32;RB1 p.R861Efs*12;LATS1 p.V542Dfs*6;ZFHX3 Deletion	0	4
P-0003444	P-0003444-T01-IM5	Outside	FFPE	Biopsy	250	831	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Everolimus(TSC1 p.E636Gfs*51)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.V216M;RBM10 p.E481*;TSC1 p.E636Gfs*51;CCND2 Amplification;KRAS Amplification	3	6
P-0003445	P-0003445-T01-IM5	Outside	FFPE	Resection	250	509	60	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										MAPK1 Amplification	0	1
P-0003446	P-0003446-T01-IM5	In-House	FFPE	Resection	250	608	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	FUBP1 p.A487Wfs*33;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	3
P-0003447	P-0003447-T01-IM5	Outside	FFPE	Resection	250	179	30	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R282W;TP53 p.R273C;IDH1 p.R132H;ATRX p.R2131*	1	4
P-0003448	P-0003448-T01-IM5	In-House	FFPE	Biopsy	250	383	30	Matched	Primary	Lung	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0003449	P-0003449-T01-IM5	In-House	FFPE	Biopsy	250	166	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CDC73 p.R222*;ATRX p.R1302Kfs*7;TP53 p.Y234Tfs*11	1	4
P-0003450	P-0003450-T01-IM5	In-House	FFPE	Biopsy	250	715	70	Matched	Metastasis	Prostate	Retroperitoneum	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E180*;AR p.L702H;ANKRD11 Deletion;AR Amplification;CARD11 Amplification;FANCA Deletion;FAT1 Deletion;RAC1 Amplification;ZFHX3 Deletion	0	9
P-0003451	P-0003451-T01-IM5	Outside	FFPE	Resection	250	689	70	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0003453	P-0003453-T01-IM5	In-House	FFPE	Biopsy	250	898	60	Matched	Metastasis	Uterus	Lymph Node	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)	GSK2636771,AZD8186(PTEN p.G127V);GSK2636771,AZD8186(PTEN p.I135V)				LEVEL_3B	PIK3CA p.M1043V;PTEN p.G127V;NFE2L2 p.E82D;PTEN p.I135V;ARID1A Deletion;PIK3R1 PIK3R1-intragenic	3	6
P-0003455	P-0003455-T02-IM5	In-House	FFPE	Biopsy	240	384	10	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMAD4 p.Q448Rfs*28;STK11 C19orf26-STK11 fusion;CBARP C19orf26-STK11 fusion	1	4
P-0003456	P-0003456-T01-IM5	In-House	FFPE	Biopsy	250	537	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EGFR p.G598V;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PTEN Deletion	3	5
P-0003457	P-0003457-T01-IM5	In-House	FFPE	Resection	250	479	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										TP53 p.C275Y	0	1
P-0003458	P-0003458-T02-IM5	In-House	FFPE	Biopsy	250	536	80	Matched	Primary	Brain	Not Applicable	Tumor	LGGNOS	Glioma	Low-Grade Glioma, NOS					Trametinib,Cobimetinib(NF1 p.Y2285Tfs*5);Trametinib,Cobimetinib(NF1 p.F1247Ifs*18)				LEVEL_4	TP53 p.R273C;NF1 p.Y2285Tfs*5;NF1 p.F1247Ifs*18;SETD2 p.E282Ifs*18	2	4
P-0003459	P-0003459-T01-IM5	Outside	FFPE	Biopsy	250	521	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K	2	1
P-0003460	P-0003460-T01-IM5	In-House	FFPE	Biopsy	250	268	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	MGA p.X1833_splice;BAP1 Deletion;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification;PBRM1 Deletion	1	6
P-0003461	P-0003461-T02-IM5	In-House	FFPE	Biopsy	151.8	354	40	Matched	Metastasis	Gallbladder	Pelvis	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)					LEVEL_3B	U2AF1 p.S34F;PIK3CA p.R88Q;TP53 p.Y234N;CCND2 Amplification;KDM5A Amplification;PIK3CA Amplification	1	6
P-0003462	P-0003462-T01-IM5	In-House	FFPE	Resection	250	450	40	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Olaparib(ATM p.X1249_splice)	GSK2636771,AZD8186(PTEN p.G293Efs*14)				LEVEL_3B	TP53 p.S215I;BIRC3 p.E553*;ATM p.X1249_splice;PTEN p.G293Efs*14;RB1 Deletion	2	5
P-0003463	P-0003463-T02-IM5	Outside	FFPE	Resection	250	388	80	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										CCND2 Amplification;KDM5A Amplification;KRAS Amplification;PMAIP1 Deletion	0	4
P-0003464	P-0003464-T02-IM5	In-House	FFPE	Resection	250	429	50	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										FOXO1 p.F292Vfs*14	0	1
P-0003465	P-0003465-T01-IM5	Outside	FFPE	Cytology	63.25	223	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0003466	P-0003466-T01-IM5	In-House	FFPE	Biopsy	250	811	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_1	KRAS p.G12D;SMAD4 p.R361C;TP53 p.G302Rfs*4;RB1 p.X738_splice;APC p.E1464Vfs*8;APC Deletion;ERBB2 Amplification;RASA1 Deletion;RB1 RB1-intragenic	3	9
P-0003467	P-0003467-T01-IM5	Outside	FFPE	Biopsy	233.2	232	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E110del)					LEVEL_3B	EIF1AX p.R13L;IDH1 p.R132H;TP53 p.C242S;PIK3CA p.E110del;SMARCA4 p.R1189Q;ATRX p.R1302Kfs*7	2	6
P-0003468	P-0003468-T01-IM5	In-House	FFPE	Biopsy	250	596	10	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.K1860*);Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 p.K1860*);Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	TP53 p.P27Lfs*17;BRCA2 p.K1860*;AR Amplification;BRCA2 Deletion;DIS3 Deletion;FOXO1 Deletion;FOXP1 Deletion;MYC Amplification;PTEN Deletion;RB1 Deletion;RYBP Deletion;SHQ1 Deletion;TP63 Deletion	5	13
P-0003468	P-0003468-T02-IM5	In-House	FFPE	Cytology	250	382	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.K1860*);Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 p.K1860*);Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	TP53 p.P27Lfs*17;BRCA2 p.K1860*;AR Amplification;BRCA2 Deletion;DIS3 Deletion;FOXO1 Deletion;FOXP1 Deletion;MYC Amplification;PTEN Deletion;RB1 Deletion;RYBP Deletion;SHQ1 Deletion;TP63 Deletion	5	13
P-0003469	P-0003469-T01-IM5	In-House	FFPE	Biopsy	250	524	40	Matched	Metastasis	Minor Salivary Gland	Liver	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										MEN1 p.Y106Efs*11	0	1
P-0003470	P-0003470-T01-IM5	In-House	FFPE	Resection	250	512	40	Matched	Primary	Bladder	Not Applicable	Tumor	GCT	Sellar Tumor	Granular Cell Tumor											0	0
P-0003471	P-0003471-T01-IM5	In-House	FFPE	Resection	250	721	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										SDHA Deletion	0	1
P-0003472	P-0003472-T01-IM5	Outside	FFPE	Resection	250	826	40	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										CCND3 Amplification;VEGFA Amplification	0	2
P-0003473	P-0003473-T01-IM5	In-House	FFPE	Biopsy	250	505	10	Matched	Metastasis	Bile Duct	Omentum	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0003474	P-0003474-T01-IM5	In-House	FFPE	Resection	250	684	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;APC p.S895*;SMAD2 p.X427_splice;APC p.K1449Sfs*24	2	5
P-0003475	P-0003475-T01-IM5	In-House	FFPE	Resection	250	462	60	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.X307_splice;APC p.R302*;SOX9 p.L259*;APC p.F1491Lfs*16;FAT1 Deletion	2	6
P-0003476	P-0003476-T01-IM5	In-House	FFPE	Resection	250	680	90	Matched	Metastasis	Uterus	Pelvis	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	ATRX p.X1856_splice;BRCA2 Deletion;PTEN Deletion;TP53 Deletion	2	4
P-0003477	P-0003477-T01-IM5	Outside	FFPE	Biopsy	250	649	30	Matched	Primary	GE Junction	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.V173L;CDKN2A Deletion;CDKN2B Deletion;MAPK1 Amplification;SMAD4 Deletion	1	5
P-0003478	P-0003478-T01-IM5	Outside	FFPE	Cytology	250	507	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										FOXP1 Deletion;TGFBR2 Deletion;RAD21 RAD21-intragenic	0	3
P-0003479	P-0003479-T01-IM5	In-House	FFPE	Biopsy	250	695	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.M237Cfs*10;EGFR Amplification;ETV1 Amplification;RAC1 Amplification	1	5
P-0003480	P-0003480-T01-IM5	Outside	FFPE	Resection	250	508	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1007_splice)	Crizotinib(MET p.X1007_splice)	Cabozantinib(MET p.X1007_splice)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.X1007_splice;CDK4 Amplification;KRAS Amplification;MDM2 Amplification	5	4
P-0003481	P-0003481-T01-IM5	Outside	FFPE	Resection	250	269	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	MAP2K4 p.X131_splice;GATA3 p.T418Afs*86;MEN1 p.D70Afs*45;CCND1 Amplification;ERBB2 Amplification	2	5
P-0003482	P-0003482-T01-IM5	Outside	FFPE	Resection	250	361	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.X331_splice;KMT2C p.A96Sfs*20	1	3
P-0003483	P-0003483-T01-IM5	Outside	FFPE	Biopsy	250	571	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				AMG-510(KRAS p.G12C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1007R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.R213*;PIK3CA p.G1007R	3	3
P-0003484	P-0003484-T01-IM5	Outside	FFPE	Resection	250	561	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	TP53 p.V216Gfs*5;NF1 Deletion;SUZ12 Deletion	1	3
P-0003485	P-0003485-T01-IM5	Outside	FFPE	Cytology	250	286	80	Matched	Metastasis	Cervix	Neck	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;HLA-A p.S95*;MGA p.S311*;ARID1B Deletion;LATS1 Deletion;PRKN Deletion	1	6
P-0003486	P-0003486-T01-IM5	Outside	FFPE	Resection	250	574	60	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma											0	0
P-0003487	P-0003487-T01-IM5	Outside	FFPE	Resection	250	839	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										NF2 p.E394*;KMT2D p.M1575*;TP53 p.E258_D259delinsDH	0	3
P-0003488	P-0003488-T01-IM5	Outside	FFPE	Resection	250	222	90	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma		Cabozantinib(MET Amplification)		Olaparib(ATM p.L1194*);Crizotinib(MET Amplification)					LEVEL_2	PBRM1 p.Y54*;ATM p.L1194*;MET Amplification;RUNX1 Amplification	3	4
P-0003489	P-0003489-T01-IM5	In-House	FFPE	Resection	250	697	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	KRAS p.G13C;CTNNB1 p.S37F;TP53 p.V272M;SETD2 p.G1672*	1	4
P-0003490	P-0003490-T01-IM5	In-House	FFPE	Resection	250	511	50	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Trametinib,Cobimetinib(NF1 p.Q181*)				LEVEL_4	NF1 p.Q181*	1	1
P-0003491	P-0003491-T02-IM5	In-House	FFPE	Biopsy	250	1162	70	Matched	Metastasis	Appendix	Breast	Tumor	AWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumor of the Appendix										EIF1AX p.K10E	0	1
P-0003491	P-0003491-T01-IM5	In-House	FFPE	Resection	250	418	90	Matched	Metastasis	Appendix	Liver	Tumor	AWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumor of the Appendix										PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	0	3
P-0003492	P-0003492-T01-IM5	In-House	FFPE	Resection	250	707	70	Matched	Metastasis	Nasal Cavity	Lymph Node	Tumor	ONBL	Embryonal Tumor	Olfactory Neuroblastoma											0	0
P-0003493	P-0003493-T01-IM5	In-House	FFPE	Biopsy	250	521	80	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)		Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K)				LEVEL_1	PIK3CA p.N345K;FGFR2 p.N549K;FOXA1 p.C258_R261del;AKT1 Amplification;AKT3 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification	3	8
P-0003494	P-0003494-T01-IM5	In-House	FFPE	Resection	250	865	50	Matched	Metastasis	Bone	Lung	Tumor	MCHS	Bone Cancer	Mesenchymal Chondrosarcoma											0	0
P-0003495	P-0003495-T01-IM5	Outside	FFPE	Resection	250	530	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1065Y)	Afatinib(EGFR p.L747P)				LEVEL_3B	TP53 p.S215R;EGFR p.L747P	2	2
P-0003496	P-0003496-T01-IM5	In-House	FFPE	Resection	250	205	40	Matched	Metastasis	Lower Extremity	Liver	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										RB1 p.L743*	0	1
P-0003498	P-0003498-T01-IM5	In-House	FFPE	Biopsy	250	772	50	Matched	Metastasis	Lower Extremity	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										RB1 p.M761Nfs*21;ATRX p.C1844Lfs*14;TP53 Deletion	0	3
P-0003499	P-0003499-T01-IM5	Outside	FFPE	Biopsy	250	486	30	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.P278S;FBXW7 p.Y545C;SMAD4 p.Q249*;CDKN2A p.R80*	2	5
P-0003500	P-0003500-T01-IM5	Outside	FFPE	Biopsy	250	1001	60	Matched	Metastasis	Major Salivary Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Tipifarnib(HRAS p.G13R)					LEVEL_3B	PIK3CA p.H1047R;HRAS p.G13R;ZFHX3 p.H3555Qfs*15	2	3
P-0003501	P-0003501-T01-IM5	In-House	FFPE	Biopsy	250	737	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R273H	0	1
P-0003502	P-0003502-T01-IM5	In-House	FFPE	Biopsy	250	386	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Trametinib,Cobimetinib(BRAF PJA2-BRAF fusion);Trametinib,Cobimetinib(PJA2 PJA2-BRAF fusion)					LEVEL_1	EGFR p.E746_A750del;TP53 p.R249T;ASXL2 p.X620_splice;FOXA1 Amplification;NKX2-1 Amplification;BRAF PJA2-BRAF fusion;PJA2 PJA2-BRAF fusion	3	7
P-0003503	P-0003503-T01-IM5	In-House	FFPE	Biopsy	128.7	121	60	Matched	Metastasis	Bile Duct	Liver	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	STK11 p.R304W;BCOR p.X1529_splice;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0003504	P-0003504-T01-IM5	In-House	FFPE	Cytology	250	899	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Tazemetostat(KDM6A p.Q555*)				LEVEL_3B	ERBB3 p.M91I;GPS2 p.Q117*;KDM6A p.Q555*;CCND1 Amplification;ERBB2 Amplification;ERBB3 Amplification;FGF19 Amplification;FOXA1 Deletion;NKX3-1 Deletion	2	9
P-0003504	P-0003504-T02-IM5	Outside	FFPE	Biopsy	250	463	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.R261S	0	1
P-0003505	P-0003505-T01-IM5	In-House	FFPE	Biopsy	250	555	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;EPHA7 p.E876*;DIS3 p.D488N;STK11 p.X155_splice;CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification;SMARCA4 Deletion	3	8
P-0003506	P-0003506-T01-IM5	Outside	FFPE	Biopsy	250	521	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_4	PTEN p.X268_splice	1	1
P-0003507	P-0003507-T01-IM5	In-House	FFPE	Biopsy	250	804	40	Matched	Metastasis	Bladder	Pubic bone	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification);Crizotinib,Entrectinib(SLC16A10 ROS1-SLC16A10 fusion);Crizotinib,Entrectinib(ROS1 ROS1-SLC16A10 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KMT2D p.E2433*;CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion;FBXW7 Deletion;GATA3 Amplification;MDM2 Amplification;SLC16A10 ROS1-SLC16A10 fusion;ROS1 ROS1-SLC16A10 fusion	4	9
P-0003508	P-0003508-T01-IM5	In-House	FFPE	Resection	250	570	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0003509	P-0003509-T01-IM5	In-House	FFPE	Biopsy	250	541	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Olaparib(CDK12 p.W719*);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.W719*)				LEVEL_1	CDK12 p.W719*;ERBB2 Amplification;IKBKE Amplification;MDM4 Amplification	4	4
P-0003510	P-0003510-T01-IM5	Outside	FFPE	Resection	250	454	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.R1450*;TP53 p.L145R;KMT2C p.A2576Lfs*7	1	4
P-0003511	P-0003511-T01-IM5	In-House	FFPE	Biopsy	250	624	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R158P;TET2 p.V1227A;AR Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion;MED12 MED12-intragenic	0	6
P-0003511	P-0003511-T02-IM5	In-House	FFPE	Biopsy	250	483	10	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R158P;TET2 p.V1227A;AR Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	5
P-0003511	P-0003511-T03-IM5	Outside	FFPE	Resection	250	633	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R158P;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0003512	P-0003512-T01-IM5	Outside	FFPE	Resection	161.2	409	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										CCND2 Amplification;KDM5A Amplification;JAK2 LRP8-JAK2 fusion;LRP8 LRP8-JAK2 fusion	0	4
P-0003513	P-0003513-T01-IM5	Outside	FFPE	Biopsy	250	369	20	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E365K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	TP53 p.E285K;APC p.R283*;FBXW7 p.R465C;PIK3CA p.E365K;APC p.Q1378*;KRAS p.G13D;FOXP1 p.X382_splice;PIK3CA p.H1047Q;SOX9 p.E277Dfs*106	3	9
P-0003514	P-0003514-T01-IM5	Outside	FFPE	Resection	250	732	40	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN Deletion)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;RNF43 p.R132*;TP53 p.L265P;AXIN2 p.R129*;PTEN Deletion;SMAD4 Deletion	2	6
P-0003515	P-0003515-T01-IM5	Outside	FFPE	Biopsy	250	640	50	Matched	Primary	Rectum	Not Applicable	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum										ASXL1 p.G646Wfs*12;BCL2L11 Deletion;FANCC Deletion;KDM6A Deletion;KLF4 Deletion;PRKN Deletion;TGFBR1 Deletion	0	7
P-0003516	P-0003516-T01-IM5	Outside	FFPE	Biopsy	250	512	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	PBRM1 p.R1120*;MET Amplification	1	2
P-0003517	P-0003517-T01-IM5	In-House	FFPE	Biopsy	250	723	NA	Matched	Metastasis	Testis	Lymph Node	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										RAC1 p.G12R;ARID2 p.Q904*	0	2
P-0003518	P-0003518-T01-IM5	In-House	FFPE	Resection	250	485	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R337C)					LEVEL_3B	TP53 p.R248Q;ATM p.R337C	1	2
P-0003519	P-0003519-T01-IM5	In-House	FFPE	Biopsy	250	409	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.T253A;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0003520	P-0003520-T01-IM5	In-House	FFPE	Resection	250	741	90	Unmatched	Metastasis	Small Bowel	Small Bowel	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.N822Y);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V654A);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.P551_V555del)	Sorafenib(KIT p.N822Y)			Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib,Sunitinib(KIT p.N822Y);Imatinib(KIT p.V654A)		LEVEL_1	KIT p.N822Y;KIT p.V654A;KIT p.P551_V555del;RB1 p.K844Rfs*6;CDKN2A Deletion;CDKN2B Deletion	5	6
P-0003521	P-0003521-T02-IM5	In-House	FFPE	Resection	250	443	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma				Olaparib(RAD51B p.V207A);Olaparib(BARD1 BARD1-intragenic)					LEVEL_3B	TP53 p.R248Q;RAD51B p.V207A;EP300 p.X1243_splice;CCNE1 Amplification;BARD1 BARD1-intragenic;FOXP1 FOXP1-intragenic	2	6
P-0003522	P-0003522-T01-IM5	In-House	FFPE	Resection	250	781	70	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Olaparib(CDK12 p.Q602*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q602*)				LEVEL_1	PIK3CA p.E545K;FOXA1 p.I176V;CDK12 p.Q602*;TBX3 p.R256Kfs*4;ASXL2 p.L242Rfs*11	4	5
P-0003523	P-0003523-T01-IM5	In-House	FFPE	Resection	250	277	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;BRAF p.D594Y;KEAP1 p.G509E;PRKN p.G355Afs*80;STK11 p.H202Pfs*64;CDKN2A Deletion;CDKN2B Deletion	2	7
P-0003523	P-0003523-T02-IM5	In-House	DNA	Resection	250	719	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R158L;GNAS p.R201H;TP53 p.P152L	0	3
P-0003524	P-0003524-T01-IM5	In-House	FFPE	Resection	250	503	30	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Olaparib(ATM p.R3008H);Olaparib(ATM p.D2708N);Everolimus(TSC1 p.P603Rfs*26);Everolimus(TSC1 p.N891Tfs*40)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_1	CREBBP p.I1084Sfs*15;RNF43 p.G659Vfs*41;KMT2A p.P773Rfs*8;AXL p.A273V;FGFR3 p.R248C;PTPRS p.V1025Sfs*18;ATM p.R3008H;SMARCA4 p.R1189Q;NSD1 p.R1320*;ATM p.D2708N;KMT2A p.R1264*;KMT2D p.R5282*;FOXO1 p.R269*;NSD1 p.M1531Cfs*43;TSC1 p.P603Rfs*26;KMT2D p.T4688Mfs*107;TSC1 p.N891Tfs*40;CDKN2A p.R58*	7	18
P-0003526	P-0003526-T01-IM5	In-House	FFPE	Resection	250	663	90	Unmatched	Metastasis	Small Bowel	Stomach	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A502_Y503dup)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.A502_Y503dup;CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion	2	4
P-0003527	P-0003527-T01-IM5	In-House	FFPE	Resection	250	487	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;U2AF1 p.S34F;TP53 p.L137Q;INPP4B p.X279_splice;FGFR3 Amplification;TGFBR2 Deletion	1	6
P-0003528	P-0003528-T01-IM5	In-House	FFPE	Biopsy	250	682	40	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 p.Q514Rfs*43)				LEVEL_4	TP53 p.R342P;NF1 p.Q514Rfs*43;KDR Amplification;KIT Amplification;PDGFRA Amplification	1	5
P-0003529	P-0003529-T01-IM5	In-House	FFPE	Biopsy	250	592	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.A1066V);Sonidegib,Vismodegib(PTCH1 p.Q242*);Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	GSK2636771,AZD8186(PTEN p.T319*);Trametinib,Cobimetinib(NF1 p.R1968*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTEN p.T319*;TP53 p.X307_splice;ARID1A p.X1368_splice;PIK3CA p.A1066V;PTCH1 p.Q242*;KMT2D p.X1302_splice;ZFHX3 p.E1203*;FANCA p.W451*;TP53 p.G279E;NF1 p.R1968*;STK11 p.X288_splice;PTPRS p.X1788_splice;PTPRT p.X190_splice;CDKN2A Deletion;CDKN2B Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	7	17
P-0003530	P-0003530-T01-IM5	Outside	FFPE	Resection	250	48	NA	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Poziotinib(EGFR p.N771_H773dup)					LEVEL_3B	EGFR p.N771_H773dup	1	1
P-0003531	P-0003531-T01-IM5	In-House	FFPE	Cytology	250	736	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.E258K;SETD2 p.A1192Pfs*44	1	3
P-0003532	P-0003532-T01-IM5	In-House	FFPE	Biopsy	250	592	60	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0003532	P-0003532-T02-IM5	Outside	FFPE	Biopsy	250	1280	50	Matched	Metastasis	Submandibular Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0003533	P-0003533-T01-IM5	In-House	FFPE	Resection	250	541	10	Matched	Primary	Mediastinum	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										PIK3CD p.G124D;TP53 p.Q144Rfs*26	0	2
P-0003533	P-0003533-T03-IM5	In-House	FFPE	Resection	250	798	20	Matched	Metastasis	Mediastinum	Spleen	Tumor	TMT	Germ Cell Tumor	Teratoma with Malignant Transformation										NRAS p.Q61H;PIK3CD p.G124D;TP53 p.Q144Rfs*26	0	3
P-0003534	P-0003534-T01-IM5	In-House	FFPE	Resection	250	642	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0003535	P-0003535-T01-IM5	In-House	FFPE	Biopsy	250	921	80	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.E326Ifs*10;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0003536	P-0003536-T01-IM5	In-House	FFPE	Biopsy	250	914	20	Matched	Metastasis	Esophagus	Lung	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_1	KRAS p.G12D;TP53 p.R248W;CDKN2A p.Y44*;ERBB2 Amplification	4	4
P-0003536	P-0003536-T02-IM5	In-House	FFPE	Biopsy	250	841	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_1	TP53 p.R248W;CDKN2A p.Y44*;ERBB2 Amplification;TSHZ3 AKT2-TSHZ3 fusion;AKT2 AKT2-TSHZ3 fusion	3	5
P-0003537	P-0003537-T02-IM5	Outside	FFPE	Biopsy	250	575	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.K97*;KEAP1 p.R260L	0	2
P-0003538	P-0003538-T02-IM5	In-House	FFPE	Biopsy	250	614	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.V274A;AR Amplification	0	2
P-0003538	P-0003538-T01-IM5	Outside	FFPE	Biopsy	250	632	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.V274A	0	1
P-0003539	P-0003539-T01-IM5	In-House	FFPE	Biopsy	250	595	30	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.T256P;KMT2D p.F1386Sfs*12;BRD4 Amplification;CCNE1 Amplification;FGFR4 Amplification	0	5
P-0003540	P-0003540-T01-IM5	In-House	FFPE	Resection	250	409	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R213*	1	2
P-0003541	P-0003541-T01-IM5	In-House	FFPE	Biopsy	250	572	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CTNNB1 p.G34V;BMPR1A p.L307_I308ins*;CDKN1B Deletion;GPS2 Deletion;MAP2K4 Deletion;PTEN Deletion;RB1 Deletion;TP53 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	10
P-0003542	P-0003542-T01-IM5	In-House	FFPE	Resection	250	538	20	Matched	Metastasis	Appendix	Ovary	Tumor	GCCAP	Appendiceal Cancer	Goblet Cell Carcinoid of the Appendix										ARID1A p.G1063*;SOX9 p.R257Afs*39	0	2
P-0003543	P-0003543-T01-IM5	In-House	FFPE	Biopsy	250	433	50	Matched	Metastasis	Esophagus	Neck	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma										NOTCH1 p.Q2102*;TP53 p.E336Vfs*10;FOXA1 Amplification	0	3
P-0003544	P-0003544-T01-IM5	In-House	FFPE	Resection	250	447	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0003545	P-0003545-T01-IM5	Outside	FFPE	Resection	250	464	60	Matched	Primary	Brain	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma											0	0
P-0003546	P-0003546-T01-IM5	In-House	FFPE	Resection	250	647	20	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0003546	P-0003546-T02-IM5	In-House	FFPE	Resection	250	574	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L169P;SETD2 p.E457*;PBRM1 p.M1268Qfs*11	0	3
P-0003547	P-0003547-T01-IM5	Outside	FFPE	Biopsy	250	558	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R248Q;STK11 p.X200_splice;SMAD4 p.E31Ffs*11	0	3
P-0003548	P-0003548-T01-IM5	Outside	FFPE	Biopsy	250	816	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										PAX5 p.V26G;TP53 p.N29Kfs*13;DICER1 p.E1144*;BAP1 Deletion;PBRM1 Deletion	0	5
P-0003550	P-0003550-T01-IM5	In-House	FFPE	Biopsy	250	451	10	Matched	Metastasis	Unknown	Soft Tissue	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.Q144*	0	1
P-0003551	P-0003551-T01-IM5	In-House	FFPE	Biopsy	233.6	405	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.P151S;TP53 p.D148E;EGFR Amplification;MCL1 Amplification	1	5
P-0003552	P-0003552-T01-IM5	Outside	FFPE	Resection	250	508	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.H179Y	0	1
P-0003553	P-0003553-T01-IM5	In-House	FFPE	Biopsy	250	535	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E1555*)	GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_3B	PTEN p.T319*;TP53 p.P75Lfs*48;INPP4B p.G479*;ARID2 p.E1389*;BRCA2 p.E1555*;B2M p.M1?;CIC p.S950*;ATR p.I1014Sfs*12;SETD2 p.R2094Kfs*4;RB1 p.K616Nfs*7;RICTOR Amplification;TERT Amplification	2	12
P-0003554	P-0003554-T01-IM5	In-House	FFPE	Biopsy	250	419	80	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0003555	P-0003555-T01-IM5	In-House	FFPE	Biopsy	250	621	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)						LEVEL_1	FBXW7 p.S668Vfs*39;TP53 p.R342*;RNF43 p.G659Vfs*41;CTCF p.T204Nfs*26;NCOR1 p.T525Qfs*30;KMT2D p.R4484*;CTCF p.E691Sfs*30;RASA1 p.N838Mfs*4;FGFR3 p.Y373C;ARID1A p.R1335*;KMT2D p.R1757*;NF2 p.W41*;ZFHX3 p.A3407Lfs*78;FUBP1 p.G205Efs*17;GATA3 p.V378Cfs*26;ARID5B p.K967Nfs*15;ZFHX3 p.T1213Qfs*31;FOXP1 p.S554Lfs*44;NOTCH4 p.Q709Sfs*22;LATS1 p.Q273Nfs*41;ARID5B p.I213Hfs*18	2	21
P-0003556	P-0003556-T01-IM5	In-House	FFPE	Biopsy	250	393	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L	0	1
P-0003557	P-0003557-T01-IM5	Outside	FFPE	Biopsy	250	419	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CCND1 Amplification;FGF19 Amplification;IKBKE Amplification;MDM4 Amplification;PAK1 Amplification	2	6
P-0003558	P-0003558-T01-IM5	Outside	FFPE	Biopsy	119.9	303	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;SMAD4 p.E538*;KMT2D p.Y2199Ifs*65;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0003559	P-0003559-T01-IM5	In-House	FFPE	Biopsy	250	682	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										FGFR2 Amplification	0	1
P-0003560	P-0003560-T01-IM5	Outside	FFPE	Biopsy	250	480	70	Matched	Metastasis	Cancer of Unknown Primary	Subcutaneous Tissue	Tumor	MUP	Melanoma	Melanoma of Unknown Primary				Tipifarnib(HRAS p.G13C);Everolimus(TSC1 p.N302Kfs*16)	Trametinib,Cobimetinib(NF1 p.R440*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PPP6C p.R264C;FH p.Y465F;EPHA3 p.R136*;EPHA3 p.R684*;BRAF p.N581I;HRAS p.G13C;NF1 p.R440*;MGA p.E525Dfs*22;TSC1 p.N302Kfs*16;CDKN2A Deletion;CDKN2B Deletion;PIK3R1 PIK3R1-intragenic	4	12
P-0003561	P-0003561-T01-IM5	Outside	FFPE	Biopsy	250	315	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	PIK3CA p.E545K;FGFR3 p.S249C;EP300 p.Q1455H;NSD1 p.E1100*;RBM10 p.G746Afs*56;NSD1 p.L1064Rfs*22;CREBBP p.N1612Tfs*23;KMT2D p.P2940Lfs*3	3	8
P-0003562	P-0003562-T01-IM5	In-House	FFPE	Biopsy	250	629	90	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.K814*)				LEVEL_4	TP53 p.C277F;RAF1 p.S257L;PARP1 p.E235*;TP63 p.X450_splice;EPHA7 p.X909_splice;ARID2 p.S1470*;NF1 p.K814*;DDR2 Amplification;MCL1 Amplification;NKX3-1 Deletion;NTRK1 Amplification;RICTOR Amplification	1	12
P-0003563	P-0003563-T01-IM5	Outside	FFPE	Resection	250	667	70	Matched	Metastasis	Lung	Skin	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0003564	P-0003564-T01-IM5	In-House	FFPE	Resection	250	408	40	Matched	Primary	Mediastinum	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.D820Y)					LEVEL_3B	TP53 p.H178D;KIT p.D820Y	1	2
P-0003565	P-0003565-T01-IM5	In-House	FFPE	Resection	250	718	10	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0003566	P-0003566-T01-IM5	Outside	FFPE	Biopsy	250	394	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C);Cisplatin(ERCC2 p.E86Q)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib(PALB2 p.Q1091*)					LEVEL_1	FGFR3 p.S249C;PIK3CA p.E542K;ARID2 p.Q1676*;MGA p.Q550*;CREBBP p.X1427_splice;PALB2 p.Q1091*;ERCC2 p.E86Q;ARID1A p.L1970Tfs*43	5	8
P-0003567	P-0003567-T01-IM5	In-House	FFPE	Biopsy	250	420	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.N276K);Trametinib,Cobimetinib(NF1 p.E547*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.N276K;NF1 p.E547*;CDKN2A Deletion;CDKN2B Deletion	3	4
P-0003568	P-0003568-T01-IM5	In-House	FFPE	Biopsy	250	386	60	Matched	Metastasis	Kidney	Adrenal Gland	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										KDM5C p.K370Sfs*60;VHL p.X114_splice	0	2
P-0003569	P-0003569-T01-IM5	In-House	FFPE	Resection	250	393	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;MEN1 p.S606Vfs*78;TP53 p.L145R	1	3
P-0003570	P-0003570-T01-IM5	Outside	FFPE	Biopsy	250	380	90	Matched	Metastasis	Breast	Brain	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545K;TP53 p.V272M;AURKA Amplification;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MEF2B Amplification;PIK3R2 Amplification;PPM1D Amplification	4	9
P-0003571	P-0003571-T01-IM5	In-House	FFPE	Resection	250	211	30	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										PTPN11 p.E69K	0	1
P-0003572	P-0003572-T01-IM5	In-House	FFPE	Resection	250	576	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719C);Afatinib(EGFR p.S768I)								LEVEL_1	CTNNB1 p.T41A;TP53 p.N247I;EGFR p.G719C;EGFR p.S768I	2	4
P-0003573	P-0003573-T01-IM5	In-House	FFPE	Biopsy	250	728	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0003573	P-0003573-T02-IM5	In-House	FFPE	Resection	250	456	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.I254S	1	2
P-0003575	P-0003575-T01-IM5	In-House	FFPE	Resection	250	512	60	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.M133T;APC p.F814Lfs*6;BCL2L1 Amplification	0	3
P-0003576	P-0003576-T01-IM5	Outside	FFPE	Resection	250	668	40	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										RAC1 p.G12V;FLCN FLCN-intragenic	0	2
P-0003577	P-0003577-T01-IM5	In-House	FFPE	Biopsy	250	468	20	Matched	Metastasis	Cancer of Unknown Primary	Abdomen	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;TP53 p.T18Hfs*26	1	2
P-0003578	P-0003578-T01-IM5	Outside	FFPE	Resection	250	750	60	Matched	Primary	Mediastinum	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										ARID1A p.E97*;TP53 p.E286A;BCL2 p.A131V;KMT2D p.M1379Vfs*52;KMT2D p.Q4609Rfs*8;PTEN Deletion;RB1 Deletion	0	7
P-0003579	P-0003579-T01-IM5	In-House	FFPE	Biopsy	250	515	90	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C;TP53 p.R282W;ATRX p.S1960*	1	3
P-0003580	P-0003580-T01-IM5	Outside	FFPE	Resection	250	705	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G60E);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_3B	KRAS p.G12R;ARID2 p.Q507*;NRAS p.G60E;SMAD4 p.D493G;TP53 p.S241dup;MDM2 Amplification	3	6
P-0003581	P-0003581-T01-IM5	In-House	FFPE	Biopsy	250	588	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;GATA3 p.C320Lfs*32;GATA3 p.S426Afs*82;EPHA7 Deletion;PAK1 Amplification;PRDM1 Deletion;WT1 Deletion	1	7
P-0003582	P-0003582-T01-IM5	Outside	FFPE	Resection	250	425	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.K57N)					LEVEL_3B	TP53 p.R248Q;MAP2K1 p.K57N;APC p.T1301Nfs*14;APC p.R283*;FBXW7 p.R465S;PHOX2B p.L70Sfs*64;SMAD3 p.G82Ffs*36	1	7
P-0003583	P-0003583-T01-IM5	In-House	FFPE	Resection	250	399	40	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0003583	P-0003583-T02-IM5	In-House	DNA	Resection	250	744	20	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L89H	0	1
P-0003584	P-0003584-T01-IM5	In-House	FFPE	Biopsy	134.4	513	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Trametinib,Cobimetinib(NF1 p.X1575_splice)				LEVEL_4	KRAS p.G12V;RBM10 p.X242_splice;NF1 p.X1575_splice	2	3
P-0003586	P-0003586-T01-IM5	In-House	FFPE	Biopsy	146	542	80	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.D48Gfs*4;FOXA1 Amplification;NKX2-1 Amplification;NPM1 Deletion;NSD1 Deletion;SMAD4 Deletion	0	6
P-0003587	P-0003587-T01-IM5	Outside	FFPE	Resection	250	337	60	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.X126_splice;RB1 p.D697Qfs*23;MED12 p.N46_S52del;CBL Deletion;CDKN2A Deletion;CDKN2B Deletion	1	6
P-0003589	P-0003589-T02-IM5	In-House	FFPE	Resection	250	400	70	Matched	Metastasis	Testis	Lung	Tumor	TCCA	Germ Cell Tumor	Choriocarcinoma										CCND2 Amplification;FOXO1 Deletion;KDM5A Amplification;KRAS Amplification	0	4
P-0003590	P-0003590-T01-IM5	In-House	FFPE	Resection	250	448	NA	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										PBRM1 p.X47_splice;TET2 p.G1145V;RASA1 Deletion	0	3
P-0003591	P-0003591-T01-IM5	In-House	FFPE	Resection	250	281	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.R233*)				LEVEL_4	PTEN p.R233*	1	1
P-0003592	P-0003592-T01-IM5	In-House	FFPE	Biopsy	250	404	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E271*;AR Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0003592	P-0003592-T02-IM5	In-House	FFPE	Biopsy	250	646	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E271*;AR Amplification;NCOR1 NCOR1-intragenic;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	5
P-0003593	P-0003593-T01-IM5	In-House	FFPE	Biopsy	250	642	30	Matched	Metastasis	Adrenal Gland	Bone	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										TP53 p.R337C	0	1
P-0003594	P-0003594-T01-IM5	In-House	FFPE	Biopsy	250	538	10	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.C176*;EGFR Amplification	0	2
P-0003595	P-0003595-T01-IM5	Outside	FFPE	Cytology	250	478	70	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Cfs*11)				LEVEL_1	BRAF p.V600E;TP53 p.E294*;CDKN2A p.D108Cfs*11	3	3
P-0003596	P-0003596-T01-IM5	Outside	FFPE	Resection	250	313	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.X246_splice)	GSK2636771,AZD8186(PTEN p.Q245*);Tazemetostat(KDM6A p.Q271*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.G199E;PTEN p.Q245*;RHOA p.G17E;TSC1 p.X246_splice;KDM6A p.Q271*;TP53 p.E171Qfs*3;CDKN2A Deletion;CDKN2B Deletion	4	8
P-0003597	P-0003597-T02-IM5	In-House	FFPE	Biopsy	250	514	60	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R248Q;AR p.T878A;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0003597	P-0003597-T01-IM5	Outside	FFPE	Resection	250	218	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R248Q;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0003598	P-0003598-T02-IM5	In-House	FFPE	Biopsy	250	961	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.H185Qfs*13);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.H185Qfs*13;ARID5B Deletion;EGFR Amplification;GATA3 Deletion;RB1 Deletion	2	5
P-0003598	P-0003598-T03-IM5	In-House	FFPE	Biopsy	250	593	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Everolimus(TSC2 p.R1138*)	Lapatinib(EGFR Amplification)				LEVEL_3B	TSC2 p.R1138*;ARID5B p.H915Pfs*29;EGFR Amplification	2	3
P-0003598	P-0003598-T01-IM5	In-House	FFPE	Resection	250	326	NA	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Lapatinib(EGFR Amplification)				LEVEL_4	EGFR Amplification;RB1 Deletion	1	2
P-0003599	P-0003599-T01-IM5	In-House	FFPE	Resection	250	603	60	Matched	Metastasis	Uterus	Lung	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.G245D;FBXW7 p.R479Q;PIK3R1 p.K567E;PIK3R1 p.H450_K459del;CCNE1 Amplification;FGFR1 Amplification;ZRSR2 Deletion;NCOR1 NCOR1-intragenic	1	8
P-0003600	P-0003600-T01-IM5	In-House	FFPE	Biopsy	250	589	NA	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R158G;PIK3R1 p.E451_Y452del;CDKN2A Deletion	1	3
P-0003601	P-0003601-T01-IM5	Outside	FFPE	Resection	250	272	60	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										KMT2C p.Y460*;EP300 p.D1330Efs*34;EP300 p.S1295Wfs*10	0	3
P-0003602	P-0003602-T02-IM5	In-House	FFPE	Biopsy	250	531	30	Matched	Metastasis	Ampulla of Vater	Liver	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.R273C;SMAD4 p.R361H;NKX3-1 Deletion;NCOR1 PIGL-NCOR1 fusion;PIGL PIGL-NCOR1 fusion	2	6
P-0003602	P-0003602-T01-IM5	In-House	FFPE	Biopsy	250	459	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.L320*)				LEVEL_4	TP53 p.R273C;PTEN p.L320*;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0003603	P-0003603-T01-IM5	In-House	FFPE	Biopsy	250	554	50	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma		Olaparib,Talazoparib(BRCA2 p.E816Kfs*9)		Rucaparib,Niraparib(BRCA2 p.E816Kfs*9);Cisplatin(ERCC2 ERCC2-intragenic)	GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_2	PTEN p.T319*;LATS1 p.Q407*;ARID1A p.X601_splice;BRCA2 p.E816Kfs*9;ERCC2 ERCC2-intragenic	4	5
P-0003604	P-0003604-T01-IM5	Outside	FFPE	Resection	250	735	30	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CD274 Amplification;CDKN2A Deletion;CDKN2B Deletion;JAK2 Amplification	1	4
P-0003605	P-0003605-T01-IM5	In-House	FFPE	Resection	250	481	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003606	P-0003606-T01-IM5	In-House	FFPE	Cytology	145.95	280	NA	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0003607	P-0003607-T01-IM5	In-House	FFPE	Biopsy	250	675	40	Matched	Metastasis	Urethra	Lymph Node	Tumor	USCC	Bladder Cancer	Urethral Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;LATS1 p.R744*	1	2
P-0003608	P-0003608-T01-IM5	Outside	FFPE	Resection	250	236	40	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										KRAS Amplification	0	1
P-0003609	P-0003609-T01-IM5	Outside	FFPE	Resection	250	285	60	Matched	Metastasis	Skin	Subcutaneous Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;MAP2K2 p.V64D	2	2
P-0003610	P-0003610-T01-IM5	In-House	FFPE	Biopsy	250	490	60	Matched	Metastasis	Skin	Forehead	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	RAC1 p.P29S;TP53 p.R248W;TP53 p.E271K;FAT1 p.R2726*;NOTCH1 p.G310R;ARID2 p.S889*;ARID2 p.Q1041*;CDKN2A p.R80*	1	8
P-0003611	P-0003611-T01-IM5	Outside	FFPE	Resection	250	589	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A19Rfs*6)	Cetuximab,Panitumumab(KRAS p.Q61R)			LEVEL_4	TP53 p.G245S;KRAS p.Q61R;CDKN2A p.A19Rfs*6;EGFR Amplification	2	4
P-0003612	P-0003612-T01-IM5	Outside	FFPE	Resection	250	469	60	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.S94*;CCNE1 Amplification	0	2
P-0003613	P-0003613-T01-IM5	In-House	FFPE	Biopsy	245.7	160	20	Matched	Metastasis	Ileum	Peritoneum	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Ivosidenib(IDH1 p.R132C);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 TACC2-FGFR2 fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(TACC2 TACC2-FGFR2 fusion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;IDH1 p.R132C;TP53 p.V173L;SOX9 p.P103Afs*149;FGFR2 TACC2-FGFR2 fusion;TACC2 TACC2-FGFR2 fusion	4	6
P-0003614	P-0003614-T01-IM5	Outside	FFPE	Biopsy	100.98	93	80	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;PIK3R1 p.H450_Q455dup	1	2
P-0003615	P-0003615-T01-IM5	Outside	FFPE	Resection	250	397	80	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	2
P-0003616	P-0003616-T02-IM5	In-House	FFPE	Biopsy	250	1116	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	MED12 p.L1224F;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0003616	P-0003616-T01-IM5	Outside	FFPE	Biopsy	116.55	142	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	MED12 p.L1224F;CDKN2A Deletion;CDKN2B Deletion;GATA3 Deletion	1	4
P-0003617	P-0003617-T01-IM5	In-House	FFPE	Biopsy	250	430	20	Matched	Primary	Liver	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C	1	1
P-0003618	P-0003618-T01-IM5	In-House	FFPE	Biopsy	250	389	30	Matched	Metastasis	Colon	Liver	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	RB1 p.R787*;ERBB3 p.V104L;KRAS p.G13D;KMT2D p.E1067*;APC p.T1459Nfs*3;TP53 p.T150Afs*16;APC p.Y935Lfs*5	1	7
P-0003619	P-0003619-T01-IM5	In-House	FFPE	Biopsy	250	472	80	Matched	Metastasis	Prostate	Retroperitoneum	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM Deletion);Olaparib(CHEK1 Deletion)								LEVEL_1	TP53 p.P151A;ATM Deletion;CBL Deletion;CCNE1 Amplification;CHEK1 Deletion;DDR2 Amplification;MCL1 Amplification;KMT2A Deletion;RB1 Deletion;SDHD Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	12
P-0003620	P-0003620-T01-IM5	In-House	FFPE	Resection	250	474	80	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma		Imatinib(KIT p.K642E)		Sunitinib,Regorafenib,Ripretinib(KIT p.K642E)	GSK2636771,AZD8186(PTEN p.H93Y);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	KIT p.K642E;FAT1 p.L1745*;PTEN p.H93Y;MAP2K2 p.C125S;CDKN2A Deletion	4	5
P-0003620	P-0003620-T02-IM5	In-House	DNA	Resection	250	726	70	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma		Imatinib(KIT p.K642E)		Sunitinib,Regorafenib,Ripretinib(KIT p.K642E)	GSK2636771,AZD8186(PTEN p.Y178H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	KIT p.K642E;MAP2K2 p.C125S;PTEN p.Y178H;CDKN2A Deletion;MITF Amplification;SMAD3 Deletion	4	6
P-0003621	P-0003621-T01-IM5	In-House	FFPE	Biopsy	250	479	60	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)	Imatinib(KIT p.D579del)		Sunitinib,Regorafenib,Ripretinib(KIT p.D579del)					LEVEL_1	KIT p.D579del;BRAF p.V600K	3	2
P-0003622	P-0003622-T01-IM5	Outside	FFPE	Resection	250	583	60	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										FAT1 Deletion;RUNX1 Amplification	0	2
P-0003623	P-0003623-T01-IM5	In-House	FFPE	Resection	250	185	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma	Capmatinib(MET p.X1006_splice)	Crizotinib(MET p.X1006_splice)	Cabozantinib(MET p.X1006_splice)						LEVEL_1	TP53 p.Y234C;MET p.X1006_splice;ARID2 p.K1010*	3	3
P-0003624	P-0003624-T01-IM5	In-House	FFPE	Biopsy	250	615	10	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.X331_splice;PIK3CA p.H1047R;ERBB2 Amplification	4	3
P-0003625	P-0003625-T01-IM5	In-House	FFPE	Biopsy	250	455	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.X988_splice);Olaparib(CDK12 p.V136Sfs*21)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.X988_splice);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.V136Sfs*21)				LEVEL_1	CDK12 p.X988_splice;FOXA1 p.D249_F254del;CDK12 p.V136Sfs*21;AR Amplification;ANKRD11 ANKRD11-intragenic	4	5
P-0003626	P-0003626-T01-IM5	In-House	FFPE	Biopsy	250	575	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	AR Amplification;FGFR1 Amplification;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	5
P-0003627	P-0003627-T01-IM5	Outside	FFPE	Resection	250	516	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.S166*;IKBKE Amplification;MYC Amplification;PIK3CA Amplification	2	5
P-0003628	P-0003628-T01-IM5	In-House	FFPE	Biopsy	250	788	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.R248Q;SETD2 p.E265*;TP63 p.X21_splice;TET1 p.K1712*	2	5
P-0003630	P-0003630-T02-IM5	In-House	FFPE	Biopsy	250	453	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R248W	0	1
P-0003630	P-0003630-T01-IM5	In-House	FFPE	Resection	250	179	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R248W	0	1
P-0003631	P-0003631-T01-IM5	In-House	FFPE	Biopsy	250	462	30	Matched	Metastasis	Ovary	Abdomen	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer										ROS1 p.S1986F	0	1
P-0003632	P-0003632-T01-IM5	In-House	FFPE	Biopsy	250	561	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										GNAS p.R201C;RBM10 p.E52*;TP53 p.E198*;MYC Amplification;PAK1 Amplification	0	5
P-0003633	P-0003633-T01-IM5	In-House	FFPE	Resection	250	711	50	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										BRAF Amplification;EZH2 Amplification;RHEB Amplification	0	3
P-0003634	P-0003634-T01-IM5	In-House	FFPE	Resection	250	731	90	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3A	ESR1 p.D538G;FOXP1 p.F499Hfs*9;FGFR1 Amplification;KRAS Amplification;MAP2K4 Deletion;MDM2 Amplification	3	6
P-0003635	P-0003635-T01-IM5	In-House	FFPE	Biopsy	250	667	50	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)					LEVEL_1	EGFR p.E746_A750del;PIK3CA p.M1043I;TP53 p.R342P;RB1 p.X405_splice;PTPRT Deletion;TOP1 Deletion	2	6
P-0003636	P-0003636-T01-IM5	In-House	FFPE	Biopsy	250	88	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.I33del);Trametinib,Cobimetinib(NF1 p.Q83Vfs*23)				LEVEL_4	TP53 p.R175H;PTEN p.I33del;NF1 p.Q83Vfs*23;ATRX p.T1582Nfs*19;MLH1 p.X182_splice	2	5
P-0003637	P-0003637-T01-IM5	In-House	FFPE	Resection	250	344	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXP1 p.Q189*;SPOP p.W131L	0	2
P-0003638	P-0003638-T01-IM5	In-House	FFPE	Resection	250	223	60	Matched	Metastasis	Appendix	Ovary	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R282W;KMT2D p.X4667_splice	1	3
P-0003639	P-0003639-T01-IM5	In-House	FFPE	Resection	250	450	50	Matched	Primary	Scalp	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										IKZF1 Deletion	0	1
P-0003640	P-0003640-T01-IM5	In-House	FFPE	Resection	250	490	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0003641	P-0003641-T01-IM5	In-House	FFPE	Biopsy	250	311	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N1044K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1044K)						LEVEL_1	PIK3CA p.N1044K;MAP3K1 p.L228Efs*6;MAP3K1 p.K1234Ifs*11	2	3
P-0003642	P-0003642-T01-IM5	In-House	FFPE	Resection	250	158	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM p.F2558Lfs*5)					LEVEL_3B	ATM p.F2558Lfs*5	1	1
P-0003643	P-0003643-T01-IM5	Outside	FFPE	Resection	250	471	30	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R248Q;IDH1 p.R132H;BCOR p.Y869*;ATRX p.K1143Rfs*47	1	4
P-0003644	P-0003644-T01-IM5	In-House	FFPE	Biopsy	250	701	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										AURKA Amplification;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	0	4
P-0003645	P-0003645-T01-IM5	In-House	FFPE	Resection	250	147	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.X2477_splice;VHL p.E186Gfs*70;PBRM1 p.A1423Qfs*6;KDM5C p.Y469*	0	4
P-0003646	P-0003646-T01-IM5	Outside	FFPE	Resection	250	728	40	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.Q331*;ERBB2 Amplification	1	2
P-0003647	P-0003647-T01-IM5	In-House	FFPE	Biopsy	250	766	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.C275R;ERBB2 Amplification	2	2
P-0003648	P-0003648-T01-IM5	In-House	FFPE	Resection	250	729	NA	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	SMAD4 p.D351Y;MED12 p.E545Dfs*3;MDM2 Amplification	1	3
P-0003649	P-0003649-T01-IM5	In-House	FFPE	Resection	250	329	30	Matched	Primary	Minor Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										BCOR p.N1686Tfs*39	0	1
P-0003650	P-0003650-T01-IM5	In-House	FFPE	Resection	250	640	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.L759Ffs*3)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T);GSK2636771,AZD8186(PTEN p.V290*)				LEVEL_3B	PTEN p.K267Rfs*9;KRAS p.A146T;GNAS p.R201H;KMT2A p.P773Rfs*8;TP53 p.R273C;CTCF p.T204Nfs*26;TP53 p.V73Wfs*50;ARID1A p.Q766Sfs*67;ARID1A p.F2141Sfs*59;KMT2D p.Q809Rfs*121;ERBB3 p.V104M;PTPRD p.Q1756*;KDM5C p.R159C;B2M p.X87_splice;SMAD3 p.F348Lfs*18;SETD2 p.S2382Lfs*29;MSH2 p.E569Ifs*2;PBRM1 p.K553Rfs*16;KMT2C p.K4647Sfs*12;PTEN p.V290*;XRCC2 p.F241Sfs*15;BCOR p.P1621Qfs*53;BRCA2 p.L759Ffs*3	4	23
P-0003651	P-0003651-T01-IM5	In-House	FFPE	Resection	250	480	60	Matched	Metastasis	Thyroid	Bone	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	KRAS p.Q61R;RBM10 p.Y615*	1	2
P-0003652	P-0003652-T01-IM5	Outside	FFPE	Resection	250	118	20	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										NUP93 p.E14K;CCND1 Amplification;FGF19 Amplification	0	3
P-0003653	P-0003653-T01-IM5	Outside	FFPE	Resection	250	370	10	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0003654	P-0003654-T01-IM5	In-House	FFPE	Biopsy	250	652	20	Unmatched	Metastasis	Lung	Retroperitoneum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										ARID1A p.D1850Gfs*4;TP53 p.E56*;KDR p.A1103S;RB1 p.X406_splice;GRIN2A p.S1390*;EGFR Amplification	0	6
P-0003655	P-0003655-T01-IM5	In-House	FFPE	Resection	250	591	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003656	P-0003656-T02-IM5	In-House	FFPE	Biopsy	250	188	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.E380Q)		GSK2636771,AZD8186(PTEN p.Q149*)				LEVEL_3A	ESR1 p.E380Q;RHOA p.G17E;ARID1B p.Q577*;PTEN p.Q149*;CDH1 p.Q610*;CCND1 Amplification;FGF19 Amplification	2	7
P-0003657	P-0003657-T01-IM5	Outside	FFPE	Resection	250	597	40	Matched	Metastasis	Appendix	Colon	Tumor	GCCAP	Appendiceal Cancer	Goblet Cell Carcinoid of the Appendix										SMAD4 p.R361C;MSH6 p.E544*;SKA1 SMAD4-SKA1 fusion;SMAD4 SMAD4-SKA1 fusion	0	4
P-0003658	P-0003658-T01-IM5	In-House	FFPE	Resection	250	606	60	Matched	Primary	Muscle	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										NF1 p.G1128Wfs*66	0	1
P-0003658	P-0003658-T02-IM5	In-House	FFPE	Resection	250	623	10	Matched	Primary	Mediastinum	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										B2M p.L15Ffs*41;SOCS1 p.H87Rfs*26	0	2
P-0003659	P-0003659-T01-IM5	In-House	FFPE	Resection	250	292	60	Matched	Primary	Kidney	Not Applicable	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma											0	0
P-0003660	P-0003660-T01-IM5	Outside	FFPE	Biopsy	250	649	20	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 KIF14-FGFR2 fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(KIF14 KIF14-FGFR2 fusion)					LEVEL_3B	FGFR2 KIF14-FGFR2 fusion;KIF14 KIF14-FGFR2 fusion	2	2
P-0003661	P-0003661-T01-IM5	In-House	FFPE	Biopsy	250	696	40	Matched	Metastasis	Breast	Chest Wall	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.E285K	1	2
P-0003662	P-0003662-T01-IM5	Outside	FFPE	Resection	250	595	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.G245S;APC p.Y1376Cfs*9;KRAS p.G13D	1	3
P-0003664	P-0003664-T01-IM5	Outside	FFPE	Resection	250	863	20	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer				Trametinib,Cobimetinib(KIAA1549 BRAF-KIAA1549 fusion);Trametinib,Cobimetinib(BRAF BRAF-KIAA1549 fusion)					LEVEL_3B	TP53 p.R175L;KIAA1549 BRAF-KIAA1549 fusion;BRAF BRAF-KIAA1549 fusion	2	3
P-0003665	P-0003665-T01-IM5	In-House	FFPE	Biopsy	250	590	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	JAK1 p.K860Nfs*16;TP53 p.C238Y;JAK1 p.P430Rfs*2;GRIN2A p.A33Rfs*105;RB1 p.R579*;TP53 p.K382Nfs*40;MSH2 p.E48*;MSH6 p.R361C;PIK3R1 p.L573_K575del;FOXP1 p.K149Nfs*57;KMT2D p.P3466Tfs*2;AR Amplification;PTEN Deletion	1	13
P-0003666	P-0003666-T01-IM5	In-House	FFPE	Biopsy	250	693	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Trametinib,Cobimetinib(NF1 p.X1757_splice)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.S127F;ARID2 p.Q1043*;KMT2C p.X1365_splice;SMAD4 p.I383R;NF1 p.X1757_splice;MET Amplification	3	6
P-0003667	P-0003667-T01-IM5	In-House	FFPE	Biopsy	250	563	70	Matched	Primary	Brain	Not Applicable	Tumor	PTCY	Sellar Tumor	Pituicytoma											0	0
P-0003668	P-0003668-T01-IM5	In-House	FFPE	Resection	250	703	80	Matched	Primary	Bladder	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RB1 p.X180_splice;ATRX p.E1909*;TP53 p.R282Afs*23;AR Amplification;PTEN Deletion	1	5
P-0003669	P-0003669-T01-IM5	In-House	FFPE	Resection	250	416	40	Matched	Primary	Brain	Not Applicable	Tumor	LGGNOS	Glioma	Low-Grade Glioma, NOS				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.Y220C;IDH1 p.R132H;ATRX p.A1410Qfs*80	1	3
P-0003670	P-0003670-T01-IM5	In-House	FFPE	Biopsy	250	662	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0003671	P-0003671-T01-IM5	Outside	FFPE	Biopsy	250	385	60	Matched	Metastasis	Kidney	Soft Tissue	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;PBRM1 p.Q238*;VHL p.T133Nfs*2;SETD2 p.S2104Lfs*43;TET2 p.K87Sfs*8;PBRM1 p.F872Lfs*43	1	6
P-0003672	P-0003672-T01-IM5	In-House	FFPE	Biopsy	250	473	60	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										KMT2D p.X1655_splice;NF2 p.X150_splice;SETD2 p.Q1998Ffs*25;SETD2 p.V775Kfs*22	0	4
P-0003673	P-0003673-T01-IM5	Outside	FFPE	Resection	250	220	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0003674	P-0003674-T01-IM5	In-House	FFPE	Cytology	250	617	40	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E33*)				LEVEL_4	TP53 p.H179R;JAK1 p.Y568*;ARID1A p.P1569Sfs*3;CDKN2A p.E33*;BCL2L1 Amplification	1	5
P-0003676	P-0003676-T01-IM5	In-House	FFPE	Cytology	116.6	170	70	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G199V;NOTCH4 p.X1252_splice;CCNE1 Amplification;KDR Amplification;KIT Amplification;MCL1 Amplification;MYC Amplification;NTRK1 Amplification;PDGFRA Amplification	0	9
P-0003677	P-0003677-T01-IM5	In-House	FFPE	Biopsy	250	654	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(TACC3 FGFR3-TACC3 fusion);Erdafitinib(FGFR3 FGFR3-TACC3 fusion)		Debio1347,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)						LEVEL_1	TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	4	2
P-0003678	P-0003678-T01-IM5	In-House	FFPE	Biopsy	250	621	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E204_L206del;AR Amplification	0	2
P-0003679	P-0003679-T01-IM5	Outside	FFPE	Biopsy	250	615	40	Matched	Primary	GE Junction	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	EGFR p.R108K;MED12 p.E237Rfs*19;MDM2 Amplification	1	3
P-0003681	P-0003681-T01-IM5	In-House	FFPE	Biopsy	250	490	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	STK11 p.S216F;ERBB2 Amplification;FGFR1 Amplification;SRC Amplification	2	4
P-0003682	P-0003682-T01-IM5	In-House	FFPE	Biopsy	250	454	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.K1352Dfs*36)				LEVEL_1	FGFR3 p.S249C;KDM5C p.Q1557*;KMT2C p.R4549S;CREBBP p.E1205*;KDM6A p.K1352Dfs*36;KMT2D p.S3159Rfs*2	3	6
P-0003683	P-0003683-T01-IM5	In-House	FFPE	Resection	250	528	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.C242Afs*5;ARID2 p.P79Sfs*6	0	2
P-0003684	P-0003684-T01-IM5	Outside	FFPE	Biopsy	250	566	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003686	P-0003686-T01-IM5	Outside	FFPE	Biopsy	250	634	30	Matched	Primary	Liver	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Everolimus(TSC2 p.W358*)					LEVEL_3B	TP53 p.G245R;TSC2 p.W358*	1	2
P-0003687	P-0003687-T01-IM5	In-House	FFPE	Biopsy	250	590	70	Matched	Metastasis	Uterus	Liver	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma										CTNNB1 p.D32Y;RB1 p.Q257*;SF3B1 p.N626D;PIK3R1 p.P568Tfs*34	0	4
P-0003688	P-0003688-T01-IM5	In-House	FFPE	Resection	250	671	30	Matched	Primary	Retroperitoneum	Psoas Muscle	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification;YAP1 Amplification	2	3
P-0003689	P-0003689-T01-IM5	Outside	FFPE	Biopsy	250	103	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0003690	P-0003690-T01-IM5	In-House	FFPE	Biopsy	250	129	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1068Kfs*5)	Tazemetostat(KDM6A p.Q641Lfs*51)				LEVEL_1	TP53 p.V157F;FGFR3 p.S249C;PIK3CA p.N1068Kfs*5;KMT2D p.X5262_splice;KMT2D p.L2761Pfs*8;EP300 p.C1201Lfs*2;KDM6A p.Q641Lfs*51	4	7
P-0003691	P-0003691-T01-IM5	In-House	FFPE	Resection	250	484	60	Matched	Metastasis	Thyroid	Neck	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;VHL p.R167Q	2	2
P-0003692	P-0003692-T01-IM5	In-House	FFPE	Biopsy	250	387	60	Matched	Metastasis	Cancer of Unknown Primary	Mesentery	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12D;CTNNB1 p.T41I;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB3 Amplification;GLI1 Amplification;MDM2 Amplification;STK11 Deletion	4	9
P-0003693	P-0003693-T02-IM5	In-House	FFPE	Biopsy	250	851	10	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Everolimus(TSC1 p.X121_splice)	GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_3B	TSC1 p.X121_splice;PTEN p.X268_splice	2	2
P-0003693	P-0003693-T01-IM5	In-House	FFPE	Biopsy	250	676	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Everolimus(TSC1 p.X121_splice)	GSK2636771,AZD8186(PTEN p.X268_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTPRD p.Q1718*;TSC1 p.X121_splice;PTEN p.X268_splice;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0003694	P-0003694-T01-IM5	Outside	FFPE	Biopsy	250	342	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.X751_splice);Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.G244V;NF1 p.X751_splice;EGFR Amplification;MYCN Amplification	2	4
P-0003695	P-0003695-T01-IM5	In-House	FFPE	Resection	250	294	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ZFHX3 p.S1705*;SPOP p.W131S;KDM6A p.X398_splice	0	3
P-0003696	P-0003696-T01-IM5	In-House	FFPE	Biopsy	250	433	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										SPEN p.P414Qfs*16;BAP1 p.G581Vfs*36	0	2
P-0003698	P-0003698-T02-IM5	In-House	FFPE	Resection	250	473	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.X331_splice;EP300 p.X711_splice;MCL1 Amplification	0	3
P-0003699	P-0003699-T01-IM5	In-House	FFPE	Biopsy	250	521	80	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0003700	P-0003700-T01-IM5	In-House	FFPE	Resection	250	834	60	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(MAP2K1 p.E203K)						LEVEL_3A	MAP2K1 p.E203K	1	1
P-0003701	P-0003701-T01-IM5	Outside	FFPE	Biopsy	250	498	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 BRCA1-intragenic);AZD9496,Fulvestrant(ESR1 TACR1-ESR1 fusion);AZD9496,Fulvestrant(TACR1 TACR1-ESR1 fusion)					LEVEL_3B	MDM2 Amplification;BRCA1 BRCA1-intragenic;MAP3K1 MAP3K1-intragenic;ESR1 TACR1-ESR1 fusion;TACR1 TACR1-ESR1 fusion	4	5
P-0003702	P-0003702-T02-IM5	In-House	FFPE	Biopsy	250	191	20	Matched	Metastasis	Breast	Epidural Mass	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	EGFR p.E330K;TP53 p.A347P;ERBB2 Amplification	2	3
P-0003703	P-0003703-T01-IM5	Outside	FFPE	Biopsy	64.32	326	60	Matched	Primary	Vagina	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	ATRX p.X2037_splice;MDM4 Amplification;MET Amplification	1	3
P-0003704	P-0003704-T01-IM5	In-House	FFPE	Biopsy	183.7	289	60	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										SF3B1 p.R625C;GNAQ p.Q209P	0	2
P-0003705	P-0003705-T01-IM5	Outside	FFPE	Biopsy	250	526	10	Matched	Metastasis	Appendix	Colon	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix	Larotrectinib,Entrectinib(LMNA NTRK1-LMNA fusion);Larotrectinib,Entrectinib(NTRK1 NTRK1-LMNA fusion)								LEVEL_1	TP53 p.R248Q;GNAS p.R201H;MYC Amplification;LMNA NTRK1-LMNA fusion;NTRK1 NTRK1-LMNA fusion	2	5
P-0003706	P-0003706-T01-IM5	Outside	FFPE	Resection	60	240	60	Matched	Primary	Vagina	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	SF3B1 p.R625H;NF1 Deletion	1	2
P-0003707	P-0003707-T01-IM5	Outside	FFPE	Resection	130	136	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma											0	0
P-0003708	P-0003708-T01-IM5	Outside	FFPE	Resection	250	584	80	Matched	Primary	Ovary	Not Applicable	Tumor	SBOV	Ovarian Cancer	Serous Borderline Ovarian Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0003709	P-0003709-T01-IM5	In-House	FFPE	Biopsy	250	667	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;RBM10 p.R230*;NOTCH3 p.L2092Pfs*3	2	3
P-0003710	P-0003710-T01-IM5	In-House	FFPE	Resection	250	481	60	Matched	Metastasis	Rectum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.N235_Y236dup	0	1
P-0003711	P-0003711-T01-IM5	Outside	FFPE	Biopsy	250	566	10	Matched	Metastasis	Oropharynx	Neck	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										MAPK1 p.E322K;ATR p.X2347_splice	0	2
P-0003712	P-0003712-T01-IM5	In-House	FFPE	Resection	250	621	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;RBM10 p.S295*	1	2
P-0003713	P-0003713-T01-IM5	Outside	FFPE	Biopsy	250	356	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.C135F;SMARCA4 p.Q331*;CCNE1 Amplification;ERBB2 Amplification	2	4
P-0003714	P-0003714-T01-IM5	Outside	FFPE	Biopsy	76.5	361	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_T751del)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.L747_T751del;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;PIK3CA Amplification	3	5
P-0003715	P-0003715-T01-IM5	In-House	FFPE	Biopsy	250	443	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.K132R;ARID2 p.Q613*;NCOR1 p.X470_splice	2	4
P-0003716	P-0003716-T01-IM5	Outside	FFPE	Cytology	250	418	70	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SETD2 p.Y1666C;MGA p.Q690*;SMARCA4 Deletion;SMARCA4 LDLR-SMARCA4 fusion;LDLR LDLR-SMARCA4 fusion	2	6
P-0003717	P-0003717-T01-IM5	In-House	FFPE	Resection	250	556	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;SMAD3 p.W232*	0	2
P-0003719	P-0003719-T01-IM5	In-House	FFPE	Biopsy	250	594	70	Matched	Metastasis	Bladder	Retroperitoneum	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										BMPR1A p.E313*;KMT2D p.E766*;ASXL1 p.Q575*;EP300 p.Q102*;BCL2L1 Amplification;DNMT3B Amplification;YAP1 Amplification	0	7
P-0003720	P-0003720-T01-IM5	In-House	FFPE	Resection	250	481	20	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93Q)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.H1047R;PIK3CA p.R93Q;APC p.E1322*;CDKN2B p.P40S;APC p.E1322Kfs*93;SOX9 p.H406Sfs*58;MYC Amplification	2	8
P-0003721	P-0003721-T01-IM5	In-House	FFPE	Resection	250	658	20	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.Y98*;ARID2 p.Y1584*	0	2
P-0003722	P-0003722-T01-IM5	In-House	FFPE	Biopsy	250	673	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(PALB2 p.L35F)	Trametinib,Cobimetinib(NF1 p.E2214*)				LEVEL_3B	CTNNB1 p.S33F;TP53 p.V274F;PALB2 p.L35F;NF1 p.E2214*;ARID1A ARID1A-intragenic	2	5
P-0003723	P-0003723-T01-IM5	In-House	FFPE	Resection	250	207	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0003724	P-0003724-T01-IM5	In-House	FFPE	Resection	250	653	50	Matched	Metastasis	Lower Extremity	Muscle	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma				Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(CEP112 FGFR2-CCDC46 fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 FGFR2-CCDC46 fusion)					LEVEL_3B	SETD2 p.C2494*;BCOR p.L287Pfs*20;CEP112 FGFR2-CCDC46 fusion;FGFR2 FGFR2-CCDC46 fusion	2	4
P-0003725	P-0003725-T01-IM5	In-House	FFPE	Resection	250	483	20	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 CLVS1-FGFR1 fusion);Debio1347,BGJ398,Erdafitinib,AZD4547(CLVS1 CLVS1-FGFR1 fusion)	Cetuximab,Panitumumab(NRAS p.G13R)			LEVEL_3B	TP53 p.R175H;NRAS p.G13R;APC p.R499*;APC p.T1448Nfs*7;AMER1 p.S518Lfs*23;CDK8 Amplification;FLT3 Amplification;FGFR1 CLVS1-FGFR1 fusion;CLVS1 CLVS1-FGFR1 fusion	3	9
P-0003726	P-0003726-T02-IM5	In-House	FFPE	Biopsy	250	1173	20	Matched	Metastasis	Oropharynx	Soft Tissue	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										CBL Deletion;KMT2A Deletion	0	2
P-0003726	P-0003726-T01-IM5	Outside	FFPE	Resection	250	650	70	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma											0	0
P-0003727	P-0003727-T01-IM5	In-House	FFPE	Resection	250	424	40	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R248W;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MAP3K1 Deletion;MDM4 Amplification;MYC Amplification;NTRK1 Amplification;PIK3R1 Deletion;PMS2 Deletion;RASA1 Deletion;RUNX1 Amplification	0	12
P-0003728	P-0003728-T01-IM5	Outside	FFPE	Cytology	250	477	80	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary		Imatinib(KIT p.D820V)		Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.D820V)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)				LEVEL_2	KRAS p.A146T;BRAF p.D594N;ARID2 p.R274*;KIT p.D820V;ARID1A p.Q758*;NOTCH3 p.X998_splice;AMER1 p.Q10*	3	7
P-0003729	P-0003729-T01-IM5	Outside	FFPE	Resection	250	577	30	Matched	Primary	Testis	Not Applicable	Tumor	TMESO	Mesothelioma	Testicular Mesothelioma										AURKA Amplification;NF2 Deletion;RB1 Deletion	0	3
P-0003730	P-0003730-T01-IM5	Outside	FFPE	Resection	250	716	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0003731	P-0003731-T01-IM5	In-House	FFPE	Resection	250	843	50	Matched	Primary	Vagina	Not Applicable	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3B	TP53 p.R213*;NRAS p.Q61K;KMT2D p.E431*;TP53 p.K321*;KMT2D p.S4507Afs*12;MYC Amplification	1	6
P-0003732	P-0003732-T01-IM5	Outside	FFPE	Resection	250	642	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Everolimus,Temsirolimus(MTOR p.I2500F)				LEVEL_3B	RAF1 p.S257L;MTOR p.I2500F;RBM10 p.S241*;MDM2 Amplification	2	4
P-0003733	P-0003733-T01-IM5	In-House	FFPE	Biopsy	250	581	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 p.S249C)					LEVEL_3B	FGFR3 p.S249C;TP53 p.R158L	1	2
P-0003734	P-0003734-T01-IM5	In-House	FFPE	Biopsy	250	433	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(BRIP1 p.E1042*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_3B	KRAS p.G13C;DICER1 p.D1709N;BRIP1 p.E1042*;STK11 p.K78N;RBM10 p.E743*;KEAP1 p.R565*	2	6
P-0003735	P-0003735-T01-IM5	In-House	FFPE	Biopsy	250	429	NA	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)						LEVEL_1	MET p.X963_splice	3	1
P-0003736	P-0003736-T01-IM5	In-House	FFPE	Biopsy	250	503	10	Matched	Metastasis	Gallbladder	Peritoneum	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										ARID1A p.D1850Gfs*4	0	1
P-0003737	P-0003737-T01-IM5	In-House	FFPE	Biopsy	250	633	70	Matched	Metastasis	Liver	Lung	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										AXIN1 p.X821_splice;ARID1A p.G1110Efs*51	0	2
P-0003738	P-0003738-T02-IM5	In-House	FFPE	Biopsy	250	859	70	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;MGA p.Q2216*;NF2 p.X226_splice	1	3
P-0003739	P-0003739-T01-IM5	In-House	FFPE	Resection	250	449	20	Matched	Primary	Scalp	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										TP53 p.R181C;TP53 p.P142L;ATRX p.K1052*	0	3
P-0003740	P-0003740-T01-IM5	Outside	FFPE	Resection	250	383	60	Matched	Metastasis	Bladder	Ovary	Tumor	UA	Bladder Cancer	Urachal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)				LEVEL_4	KRAS p.A146T;PMS1 p.K472*;TP53 p.R290Gfs*13;CDK8 Amplification;FLT3 Amplification;PMAIP1 Deletion;SMAD4 Deletion	1	7
P-0003741	P-0003741-T01-IM5	In-House	FFPE	Resection	250	231	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.Q263Afs*60	0	1
P-0003742	P-0003742-T01-IM5	In-House	FFPE	Resection	250	520	50	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.Q136*;CTNNB1 p.I35S;GATA3 Deletion	2	4
P-0003743	P-0003743-T01-IM5	In-House	FFPE	Resection	250	632	NA	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma											0	0
P-0003744	P-0003744-T01-IM5	In-House	FFPE	Resection	250	477	30	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R273C;RBM10 p.X111_splice	0	2
P-0003745	P-0003745-T02-IM5	Outside	FFPE	Resection	250	691	10	Matched	Primary	Testis	Not Applicable	Tumor	TCCA	Germ Cell Tumor	Choriocarcinoma											0	0
P-0003746	P-0003746-T01-IM5	In-House	FFPE	Resection	250	360	60	Matched	Primary	Retroperitoneum	Sigmoid Colon	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification;YAP1 Amplification	2	3
P-0003747	P-0003747-T01-IM5	In-House	FFPE	Resection	250	470	50	Matched	Metastasis	Liver	Lymph Node	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.D119G)				LEVEL_4	KRAS p.D119G	1	1
P-0003748	P-0003748-T01-IM5	Outside	FFPE	Resection	250	307	10	Matched	Metastasis	Ovary	Uterus	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;TP53 p.Q167Afs*13	1	2
P-0003749	P-0003749-T01-IM5	In-House	FFPE	Biopsy	250	436	50	Matched	Primary	Oral Cavity	Not Applicable	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	FH p.E362Qfs*10;CDK4 Amplification;GLI1 Amplification;KRAS Amplification;MDM2 Amplification;MITF Amplification;RAF1 Amplification;TERT Amplification;YAP1 Amplification	2	9
P-0003750	P-0003750-T01-IM5	In-House	FFPE	Biopsy	250	695	70	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0003751	P-0003751-T01-IM5	Outside	FFPE	Biopsy	250	623	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	1	3
P-0003752	P-0003752-T03-IM5	In-House	FFPE	Biopsy	87.1	586	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.R175H;RB1 p.Q62*;STAT3 p.E616G;CCND3 Amplification;VEGFA Amplification	2	7
P-0003752	P-0003752-T02-IM5	In-House	FFPE	Resection	250	152	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.R175H;STAT3 p.E616G;CDK4 Amplification;MCL1 Amplification	2	5
P-0003753	P-0003753-T01-IM5	In-House	FFPE	Biopsy	250	588	10	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)		Cetuximab,Panitumumab(NRAS p.Q61L)			LEVEL_3B	TP53 p.R209Kfs*6;SMAD4 p.R361C;NRAS p.Q61L;APC p.E1309*;APC p.R554*;AXIN2 p.Q37*	1	6
P-0003754	P-0003754-T01-IM5	In-House	FFPE	Resection	250	444	70	Matched	Metastasis	Uterus	Upper Tract	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib(RAD51D Deletion)	Trametinib,Cobimetinib(NF1 p.K1977*);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	TP53 p.R248Q;CDKN2C p.X43_splice;NF1 p.K1977*;NF1 Deletion;RAD51D Deletion;SUZ12 Deletion;TERT Amplification;STK11 CACNA1A-STK11 fusion;CACNA1A CACNA1A-STK11 fusion	3	9
P-0003755	P-0003755-T01-IM5	In-House	FFPE	Biopsy	250	484	10	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										APC p.R805*;APC p.G1312Efs*9;CDK8 Amplification;FLT3 Amplification;KDM5A Amplification	0	5
P-0003756	P-0003756-T01-IM5	In-House	FFPE	Resection	250	385	10	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	FBXW7 p.R505C;KRAS p.G12V;PIK3CA p.Q546K;TP53 p.R213*;APC p.T1556Nfs*3	2	5
P-0003757	P-0003757-T01-IM5	Outside	FFPE	Resection	250	750	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Trametinib(BRAF p.K601E);Trametinib,Cobimetinib(MAP2K1 p.E203K)		PLX8394(BRAF p.K601E)				LEVEL_3A	BRAF p.K601E;MAP2K1 p.E203K	3	2
P-0003758	P-0003758-T01-IM5	In-House	FFPE	Biopsy	250	561	40	Matched	Metastasis	Prostate	Pelvis	Tumor	PRSCC	Prostate Cancer	Prostate Small Cell Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	APC p.X113_splice;RB1 p.T497Hfs*22;ANKRD11 Deletion;APC Deletion;CBFB Deletion;CDH1 Deletion;CDKN1A Deletion;CDKN1B Deletion;CTCF Deletion;FANCA Deletion;FAT1 Deletion;MGA Deletion;NKX3-1 Deletion;PTEN Deletion;TET2 Deletion;ZFHX3 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	18
P-0003759	P-0003759-T01-IM5	In-House	FFPE	Biopsy	250	557	10	Matched	Metastasis	Testis	Lymph Node	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0003760	P-0003760-T01-IM5	In-House	FFPE	Biopsy	250	681	60	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Trametinib,Cobimetinib(NF1 p.X1370_splice)				LEVEL_4	NF1 p.X1370_splice	1	1
P-0003761	P-0003761-T01-IM5	In-House	FFPE	Biopsy	250	506	80	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.D208V;BRAF Amplification;ERBB2 Amplification;EZH2 Amplification;MYC Amplification	2	5
P-0003762	P-0003762-T01-IM5	In-House	FFPE	Biopsy	250	663	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Olaparib(CDK12 ADCY9-CDK12 fusion);Olaparib(ADCY9 ADCY9-CDK12 fusion)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 ADCY9-CDK12 fusion);Pembrolizumab,Nivolumab,Cemiplimab(ADCY9 ADCY9-CDK12 fusion)				LEVEL_1	TP53 p.D281E;ERBB2 Amplification;MYC Amplification;CDK12 ADCY9-CDK12 fusion;ADCY9 ADCY9-CDK12 fusion	6	5
P-0003762	P-0003762-T02-IM5	In-House	FFPE	Biopsy	250	981	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(CDK12 ADCY9-CDK12 fusion);Olaparib(ADCY9 ADCY9-CDK12 fusion)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 ADCY9-CDK12 fusion);Pembrolizumab,Nivolumab,Cemiplimab(ADCY9 ADCY9-CDK12 fusion)				LEVEL_3B	TP53 p.D281E;MYC Amplification;CDK12 ADCY9-CDK12 fusion;ADCY9 ADCY9-CDK12 fusion;KDM6A KDM6A-intragenic	4	5
P-0003763	P-0003763-T01-IM5	In-House	FFPE	Biopsy	250	477	30	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.I255F;RB1 p.F514*;PIK3CA Amplification	0	3
P-0003764	P-0003764-T01-IM5	In-House	FFPE	Resection	250	613	60	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Cisplatin(ERCC2 p.X630_splice);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.X126_splice;ERCC2 p.X630_splice;CCND2 Amplification;KDM5A Amplification;MDM2 Amplification;TGFBR1 Deletion	2	6
P-0003765	P-0003765-T01-IM5	Outside	FFPE	Resection	250	520	20	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma					GSK2636771,AZD8186(PTEN p.A126S)				LEVEL_4	TP53 p.R282W;PTEN p.A126S;CCND1 p.Q264*	1	3
P-0003766	P-0003766-T01-IM5	Outside	FFPE	Resection	250	745	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X114_splice;TET2 p.Q884Kfs*37	0	2
P-0003767	P-0003767-T01-IM5	Outside	FFPE	Resection	250	729	20	Matched	Metastasis	Uterus	Omentum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453del)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;BCOR p.N1459S;PIK3CA p.H1047R;MAX p.H28R;ARID1A p.G276Efs*87;CCND1 p.P287A;PIK3CA p.E453del;ZFHX3 p.P106Afs*13;SOX9 p.I198Lfs*53;ARID1B p.G1271Efs*2	3	10
P-0003768	P-0003768-T01-IM5	In-House	FFPE	Resection	250	463	30	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.R282W;SMAD4 p.D52Rfs*2;CCND1 Amplification;FGF19 Amplification;MIAT NF2-MIAT fusion;NF2 NF2-MIAT fusion	2	7
P-0003770	P-0003770-T01-IM5	Outside	FFPE	Resection	250	426	50	Matched	Primary	Kidney	Not Applicable	Tumor	MTSCC	Renal Cell Carcinoma	Renal Mucinous Tubular Spindle Cell Carcinoma											0	0
P-0003770	P-0003770-T02-IM5	Outside	FFPE	Resection	250	668	50	Matched	Metastasis	Kidney	Vena cava	Tumor	MTSCC	Renal Cell Carcinoma	Renal Mucinous Tubular Spindle Cell Carcinoma											0	0
P-0003770	P-0003770-T03-IM5	Outside	FFPE	Resection	250	552	40	Matched	Metastasis	Kidney	Retroperitoneum	Tumor	MTSCC	Renal Cell Carcinoma	Renal Mucinous Tubular Spindle Cell Carcinoma											0	0
P-0003771	P-0003771-T01-IM5	Outside	FFPE	Resection	250	465	50	Unmatched	Primary	Lung	Lung	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Olaparib(ATM p.X2806_splice)					LEVEL_3B	ATM p.X2806_splice	1	1
P-0003772	P-0003772-T01-IM5	Outside	FFPE	Biopsy	250	445	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;KMT2C p.Q4279*;GATA3 p.P432Tfs*74	2	3
P-0003773	P-0003773-T01-IM5	Outside	FFPE	Biopsy	250	716	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)								LEVEL_1	DIS3 p.X329_splice;RASA1 p.S222Afs*3;CTNNB1 p.I35_A39delinsV;EGFR p.L747_A750delinsP	1	4
P-0003774	P-0003774-T01-IM5	Outside	FFPE	Resection	250	676	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	KRAS p.G12A;TP53 p.C275F;CCND2 Amplification;KDM5A Amplification	1	4
P-0003775	P-0003775-T01-IM5	In-House	FFPE	Resection	250	670	30	Matched	Primary	Liver	Not Applicable	Tumor	LIHB	Hepatobiliary Cancer	Hepatoblastoma											0	0
P-0003776	P-0003776-T01-IM5	Outside	FFPE	Resection	250	664	50	Matched	Primary	Lymph node	Not Applicable	Tumor	CLLSLL	Mature B-Cell Neoplasms	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma											0	0
P-0003777	P-0003777-T01-IM5	Outside	FFPE	Resection	250	477	60	Matched	Primary	Mediastinum	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Olaparib(CDK12 p.Q286*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN p.P95S);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q286*)				LEVEL_3B	KRAS p.G12A;PTEN p.P95S;CDK12 p.Q286*	4	3
P-0003778	P-0003778-T01-IM5	In-House	FFPE	Biopsy	250	542	30	Matched	Metastasis	Breast	Liver	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		GSK2636771,AZD8186(PTEN p.I33S)				LEVEL_1	PIK3CA p.H1047R;KMT2C p.Q507*;PTEN p.I33S;TP53 p.D148_T150del;RB1 Deletion	3	5
P-0003779	P-0003779-T01-IM5	Outside	FFPE	Resection	250	353	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K	2	1
P-0003780	P-0003780-T01-IM5	In-House	FFPE	Resection	250	755	10	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.Y220C;U2AF1 p.S34F;APC p.Q1447*	1	4
P-0003781	P-0003781-T01-IM5	Outside	FFPE	Resection	250	808	NA	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib(NF1 p.X1938_splice)				LEVEL_3B	PIK3CA p.E542K;NF1 p.X1938_splice	2	2
P-0003782	P-0003782-T01-IM5	In-House	FFPE	Biopsy	250	708	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;U2AF1 p.S34F;TP53 p.Y236H	1	3
P-0003783	P-0003783-T01-IM5	Outside	FFPE	Resection	250	671	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EGFR p.A289T;CDKN2A Deletion;CDKN2B Deletion;CREBBP Deletion;EGFR Amplification;GATA3 Deletion;PTEN Deletion	3	7
P-0003784	P-0003784-T01-IM5	Outside	FFPE	Biopsy	250	537	50	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;NOTCH2 p.Q1080*;CTCF p.Y226C;TBX3 p.M539Ifs*92	1	4
P-0003785	P-0003785-T01-IM5	In-House	FFPE	Resection	250	739	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	PLX8394(BRAF p.G469A);Trametinib,Cobimetinib(NF1 p.V472*)				LEVEL_3B	PIK3CA p.E542K;BRAF p.G469A;NF1 p.V472*;TERT Amplification	3	4
P-0003786	P-0003786-T01-IM5	Outside	FFPE	Biopsy	183.7	119	20	Matched	Metastasis	Kidney	Lymph Node	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma				Olaparib(ATM p.L2945Vfs*10)					LEVEL_3B	ATM p.L2945Vfs*10	1	1
P-0003787	P-0003787-T01-IM5	Outside	FFPE	Biopsy	250	636	10	Matched	Metastasis	Breast	Upper Tract	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);AZD9496,Fulvestrant(ESR1 p.Y537S)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.C420R;ESR1 p.Y537S;FGFR1 Amplification	4	3
P-0003788	P-0003788-T01-IM5	Outside	FFPE	Resection	250	462	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.Y24C)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3A	MAPK1 p.R135K;ERCC2 p.Y24C;FLCN Deletion;GATA3 Amplification;MDM2 Amplification;NCOR1 Deletion;NKX3-1 Deletion;RB1 Deletion	2	8
P-0003789	P-0003789-T01-IM5	In-House	FFPE	Resection	250	670	20	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.E1379*;TCF7L2 p.X334_splice;TP53 p.Y126*	2	4
P-0003790	P-0003790-T01-IM5	In-House	FFPE	Biopsy	142	526	20	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ARID1A p.Y212Lfs*2;ERBB2 Amplification;MDM2 Amplification	2	3
P-0003790	P-0003790-T02-IM5	Outside	DNA	Biopsy	250	596	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(CHEK2 p.M1?);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CHEK2 p.M1?;ARID1A p.Y212Lfs*2;ERBB2 Amplification;MDM2 Amplification;RAF1 Amplification	3	5
P-0003791	P-0003791-T01-IM5	Outside	FFPE	Biopsy	250	785	20	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_2	KRAS p.G12V;TP53 p.G245C;APC p.E984*;APC p.R1331*;AKT2 Amplification;ERBB2 Amplification	3	6
P-0003792	P-0003792-T01-IM5	Outside	FFPE	Resection	250	822	60	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R	1	1
P-0003793	P-0003793-T01-IM5	In-House	FFPE	Resection	250	647	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R554*;TP53 p.I232N;PTPRT p.R1207*;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	0	7
P-0003794	P-0003794-T01-IM5	In-House	FFPE	Resection	250	723	30	Matched	Metastasis	Uterus	Liver	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.G266V;STAG2 p.R216*;PIK3R1 p.K567E;CCNE1 Amplification;ERBB2 Amplification;ERBB3 Amplification;KRAS Amplification;MDM2 Amplification	2	8
P-0003795	P-0003795-T01-IM5	In-House	FFPE	Resection	250	557	30	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;TP53 p.D281E;EGFR Amplification	1	3
P-0003796	P-0003796-T01-IM5	In-House	FFPE	Resection	250	802	10	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.X267_splice)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;MSH6 p.F1088Lfs*5;FBXW7 p.R465H;CTCF p.T204Nfs*26;TP53 p.D281N;APC p.R216*;PTEN p.X267_splice;ARID1A p.M1564Hfs*8;SPEN p.P2495Lfs*4;PAX5 p.A322Rfs*19;CIC p.P509Hfs*14;SOX9 p.G263Afs*16;KMT2D p.H2560Pfs*95;APC p.K1165Nfs*17	2	14
P-0003797	P-0003797-T01-IM5	In-House	FFPE	Resection	250	300	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K	2	1
P-0003798	P-0003798-T01-IM5	Outside	FFPE	Resection	250	237	20	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;MCL1 Amplification	0	3
P-0003799	P-0003799-T02-IM5	In-House	DNA	Biopsy	214	1019	60	Matched	Metastasis	Prostate	Liver	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma										TP53 p.W146G;DIS3 Deletion;MCL1 Amplification;RB1 Deletion	0	4
P-0003799	P-0003799-T01-IM5	Outside	FFPE	Biopsy	250	510	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.W146G	0	1
P-0003801	P-0003801-T01-IM5	In-House	FFPE	Biopsy	250	409	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0003802	P-0003802-T01-IM5	In-House	FFPE	Resection	250	637	30	Matched	Metastasis	Uterus	Omentum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.R130*);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.P253R)				LEVEL_4	PTEN p.R130*;PPP2R1A p.R183W;ARID1A p.Q780*;RHOA p.T19R;FGFR2 p.P253R;CTCF p.R377H;PIK3R1 p.P568_L573del	2	7
P-0003803	P-0003803-T01-IM5	In-House	FFPE	Resection	250	680	60	Matched	Metastasis	Cancer of Unknown Primary	Bladder	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.R273H;PPP2R1A p.P179R;AKT2 Amplification;CCNE1 Amplification;FLCN Deletion;MAP2K4 Deletion;NCOR1 Deletion;DACH1 DIS3-DACH1 fusion;DIS3 DIS3-DACH1 fusion	0	9
P-0003804	P-0003804-T01-IM5	In-House	FFPE	Resection	250	575	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	BRAF p.K601E;CREBBP p.Y659Tfs*7	2	2
P-0003805	P-0003805-T01-IM5	In-House	FFPE	Resection	250	570	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.I122N);Lapatinib(EGFR Amplification)				LEVEL_3B	TP53 p.X126_splice;PTEN p.I122N;STAG2 p.Y479*;NOTCH3 p.N1961Kfs*5;CDK4 Amplification;EGFR Amplification;ETV1 Amplification;MYCN Amplification;PDGFRA Amplification	3	9
P-0003806	P-0003806-T01-IM5	In-House	FFPE	Biopsy	250	468	50	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion;RB1 Deletion;TP53 Deletion	1	3
P-0003807	P-0003807-T01-IM5	In-House	FFPE	Resection	250	555	10	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	ERBB2 p.R678Q;KRAS p.G13D;TGFBR1 p.T375I	2	3
P-0003808	P-0003808-T01-IM5	In-House	FFPE	Resection	250	196	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										DIS3 p.S831*	0	1
P-0003809	P-0003809-T01-IM5	Outside	FFPE	Biopsy	250	583	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q)					LEVEL_3B	PIK3CA p.E545Q;TP53 p.X261_splice;ARID1A p.M753Ifs*64	1	3
P-0003810	P-0003810-T01-IM5	Outside	FFPE	Resection	250	663	40	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.C238Y;MGA Deletion;RAD51 Deletion	0	3
P-0003811	P-0003811-T01-IM5	In-House	FFPE	Cytology	250	381	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Olaparib(CDK12 p.E1222*)	GSK2636771,AZD8186(PTEN p.Q245*);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.E1222*)				LEVEL_3B	TP53 p.K132R;PTEN p.Q245*;KMT2D p.P3466Tfs*2;TGFBR2 p.R497*;TET2 p.R1262W;CDK12 p.E1222*;KMT2D p.G61Vfs*69	3	7
P-0003812	P-0003812-T01-IM5	In-House	FFPE	Resection	250	535	10	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H)					LEVEL_3B	PIK3CA p.R108H;TP53 p.P36Afs*7;ARID1A p.R1721*;KMT2C p.K4351Nfs*5	1	4
P-0003813	P-0003813-T01-IM5	In-House	FFPE	Resection	250	608	20	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer	Niraparib,Olaparib,Rucaparib(BRCA1 p.E1167*)			Talazoparib(BRCA1 p.E1167*)					LEVEL_1	TP53 p.E294*;BRCA1 p.E1167*	2	2
P-0003814	P-0003814-T01-IM5	In-House	FFPE	Resection	250	556	30	Matched	Primary	Urethra	Not Applicable	Tumor	UAD	Bladder Cancer	Urethral Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;ARID1A p.Q1458Rfs*31	1	2
P-0003816	P-0003816-T01-IM5	Outside	FFPE	Biopsy	250	686	30	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM p.D1548Mfs*11)					LEVEL_3B	TP53 p.Q192*;AXIN2 p.S464Afs*42;ATM p.D1548Mfs*11;MCL1 Amplification	1	4
P-0003817	P-0003817-T01-IM5	In-House	FFPE	Biopsy	250	656	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Tipifarnib(HRAS p.G13R)					LEVEL_3B	PIK3CA p.E545K;HRAS p.G13R;SF3B1 p.G740E;STAG2 p.Q656*	2	4
P-0003818	P-0003818-T01-IM5	In-House	FFPE	Biopsy	250	489	20	Matched	Metastasis	Ovary	Cecum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.P222Rfs*25	0	1
P-0003819	P-0003819-T01-IM5	In-House	FFPE	Biopsy	250	844	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.P177_C182del;DAXX p.C106*;BAP1 Deletion;CREBBP Deletion;FGFR1 Amplification;SUFU TRIM8-SUFU fusion;TRIM8 TRIM8-SUFU fusion	1	7
P-0003820	P-0003820-T01-IM5	Outside	FFPE	Biopsy	250	595	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.H178P;ATRX p.K2076*;TNFAIP3 Deletion	1	4
P-0003821	P-0003821-T01-IM5	In-House	FFPE	Resection	250	485	30	Matched	Metastasis	Major Salivary Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D350G)	Trametinib,Cobimetinib(NF1 p.R2424Kfs*3)				LEVEL_3B	PIK3CA p.D350G;TP53 p.S215G;ASXL1 p.E1227*;NF1 p.R2424Kfs*3	2	4
P-0003822	P-0003822-T02-IM5	In-House	FFPE	Biopsy	250	844	90	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R273C;IDH1 p.R132H;ATRX p.K1045*;CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion;FBXW7 Deletion;INPP4B Deletion	2	8
P-0003823	P-0003823-T01-IM5	In-House	FFPE	Biopsy	250	235	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;CDKN2A Deletion;CDKN2B Deletion;FGFR3 Amplification	3	4
P-0003824	P-0003824-T01-IM5	In-House	FFPE	Biopsy	105.45	344	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.P34R)				LEVEL_4	CTNNB1 p.S45P;BRAF p.D594N;KRAS p.P34R;KMT2D p.K1288*;MEN1 p.Y133*;BMPR1A p.L50Rfs*18	1	6
P-0003825	P-0003825-T01-IM5	Outside	FFPE	Resection	250	714	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R;NKX2-1 Amplification	1	2
P-0003826	P-0003826-T01-IM5	Outside	FFPE	Resection	250	942	40	Matched	Primary	Bladder	Not Applicable	Tumor	SRCBC	Bladder Cancer	Plasmacytoid/Signet Ring Cell Bladder Carcinoma										CDH1 p.Q23*;CDKN1A p.R84Vfs*40;FBXW7 p.G419Dfs*11	0	3
P-0003827	P-0003827-T01-IM5	Outside	FFPE	Resection	250	206	10	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification);Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	4	5
P-0003828	P-0003828-T01-IM5	In-House	FFPE	Biopsy	250	152	40	Matched	Metastasis	Skin	Lung	Tumor	SKAC	Skin Cancer, Non-Melanoma	Skin Adnexal Carcinoma										MAX p.T68Rfs*18	0	1
P-0003829	P-0003829-T01-IM5	In-House	FFPE	Resection	250	607	40	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(CHEK2 p.X282_splice)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.E171*;CHEK2 p.X282_splice;PTEN Deletion	2	3
P-0003830	P-0003830-T01-IM5	Outside	FFPE	Resection	250	273	40	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										EPHA3 p.R510*	0	1
P-0003831	P-0003831-T01-IM5	In-House	FFPE	Resection	250	515	40	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma											0	0
P-0003832	P-0003832-T01-IM5	In-House	FFPE	Biopsy	126	79	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Tazemetostat(KDM6A p.S942*)				LEVEL_3B	SF3B1 p.E902K;CDKN1B p.X159_splice;KDM6A p.S942*;ERBB2 Amplification	2	4
P-0003833	P-0003833-T01-IM5	Outside	FFPE	Biopsy	250	369	30	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.L942Afs*210	1	2
P-0003834	P-0003834-T01-IM5	In-House	FFPE	Resection	250	444	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G60S)				LEVEL_4	KRAS p.G60S;TP53 p.V217G;MYCN Amplification	1	3
P-0003835	P-0003835-T01-IM5	In-House	FFPE	Resection	250	534	70	Matched	Primary	Upper Extremity	Upper Extremity	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										CTCF Deletion;MAPK1 Amplification;MCL1 Amplification;NTRK1 Amplification;RB1 Deletion;TP53 Deletion	0	6
P-0003836	P-0003836-T01-IM5	In-House	FFPE	Resection	250	484	20	Matched	Metastasis	Kidney	Lung	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma		Cabozantinib(MET Amplification)		Crizotinib(MET Amplification)					LEVEL_2	MET Amplification	2	1
P-0003838	P-0003838-T01-IM5	In-House	FFPE	Resection	250	452	40	Matched	Metastasis	Kidney	Muscle	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Olaparib(ATM p.G2496*)					LEVEL_3B	VHL p.S65P;SETD2 p.R1105*;PIK3CB p.D1067Y;ATM p.G2496*	1	4
P-0003838	P-0003838-T02-IM5	In-House	FFPE	Resection	250	464	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib(ATM p.G2496*)					LEVEL_3B	PIK3CA p.E542K;VHL p.S65P;SETD2 p.R1105*;ATM p.G2496*	2	4
P-0003839	P-0003839-T01-IM5	In-House	FFPE	Biopsy	250	637	40	Matched	Metastasis	Ascending Colon	Abdomen	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);GSK2636771,AZD8186(PTEN p.M35L)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R342*;KRAS p.G13D;PTEN p.M35L;APC p.T1487Nfs*27;AKT2 Amplification	2	5
P-0003840	P-0003840-T01-IM5	In-House	FFPE	Biopsy	147.84	477	70	Matched	Primary	Lung	Not Applicable	Tumor	SCB	Bladder Cancer	Sarcomatoid Carcinoma of the Urinary Bladder				Capmatinib,Crizotinib,Cabozantinib(MET p.X963_splice);Palbociclib,Abemaciclib(CDK4 Amplification);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	MET p.X963_splice;CDK4 Amplification;GLI1 Amplification;MET Amplification	3	4
P-0003841	P-0003841-T01-IM5	In-House	FFPE	Biopsy	250	608	60	Unmatched	Metastasis	Bladder	Abdomen	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(CHEK2 p.R145W);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	NOTCH1 p.R365C;CHEK2 p.R145W;ARID1A p.Q479*;RHOA p.A161T;DDR2 Amplification;FANCC Deletion;KLF4 Deletion;MCL1 Amplification;MDM2 Amplification;MYCL Amplification;TGFBR1 Deletion	2	11
P-0003842	P-0003842-T01-IM5	Outside	FFPE	Resection	250	563	20	Matched	Primary	Leg	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0003843	P-0003843-T01-IM5	In-House	FFPE	Biopsy	250	630	20	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Olaparib(RAD51C p.M1?)					LEVEL_3B	RAD51C p.M1?;KDM5C p.X452_splice;VHL p.X155_splice;PIK3R1 p.I571_K575del	1	4
P-0003843	P-0003843-T02-IM5	Outside	FFPE	Resection	250	286	20	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										KDM5C p.X452_splice;VHL p.X155_splice;SETD2 p.K1364Rfs*9	0	3
P-0003844	P-0003844-T01-IM5	In-House	FFPE	Biopsy	250	145	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.S183*;CDKN1A p.R48*;ERCC4 p.R692*;TP53 p.E180K;ARID1A p.T286Sfs*75;RB1 p.M484Vfs*8	0	6
P-0003845	P-0003845-T01-IM5	In-House	FFPE	Biopsy	250	463	40	Matched	Primary	Liver	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0003846	P-0003846-T01-IM5	In-House	FFPE	Biopsy	250	590	10	Matched	Primary	Duodenum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer										APC p.E1464Vfs*8;MITF Amplification	0	2
P-0003847	P-0003847-T01-IM5	Outside	FFPE	Resection	250	339	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		GSK2636771,AZD8186(PTEN p.N334Tfs*10)				LEVEL_1	PIK3CA p.H1047R;CDH1 p.E841Kfs*5;PTEN p.N334Tfs*10;FOXA1 Amplification;MCL1 Amplification	3	5
P-0003848	P-0003848-T01-IM5	In-House	FFPE	Biopsy	250	675	10	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	CDK8 p.S62L;NOTCH1 p.E1219*;TCF7L2 p.Q131*;SETD2 p.D1211Mfs*25;TP53 p.P60Qfs*63;ERBB2 Amplification	1	6
P-0003849	P-0003849-T01-IM5	In-House	FFPE	Biopsy	141	365	10	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma					Everolimus,Temsirolimus(MTOR p.C1483R)				LEVEL_4	MTOR p.C1483R;PTPN11 p.S502P	1	2
P-0003850	P-0003850-T01-IM5	Outside	FFPE	Resection	250	806	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.R222C;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERRFI1 Deletion	2	5
P-0003851	P-0003851-T01-IM5	Outside	FFPE	Resection	250	732	60	Matched	Metastasis	Bone	Lower Extremity	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 p.R213*;FAT1 Deletion;RB1 Deletion	0	3
P-0003852	P-0003852-T01-IM5	Outside	FFPE	Biopsy	250	541	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	SPOP p.F133V;BRCA2 Deletion;EZH2 Amplification	2	3
P-0003853	P-0003853-T01-IM5	In-House	FFPE	Resection	250	478	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	Trametinib,Cobimetinib(NF1 p.Q2234*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NF1 p.Q2234*;PIK3R1 p.N453_Q457del;CDKN2A Deletion;CDKN2B Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	4	6
P-0003854	P-0003854-T02-IM5	Outside	FFPE	Biopsy	250	580	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(RAD51C Deletion)					LEVEL_3B	TP53 p.R248W;STK11 p.E223*;PTPRT p.X726_splice;MCL1 Amplification;NKX2-1 Amplification;RAD51C Deletion;RNF43 Deletion	1	7
P-0003854	P-0003854-T01-IM5	Outside	FFPE	Cytology	250	450	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R248W;STK11 p.E223*;PTPRT p.X726_splice;MYC Amplification	0	4
P-0003855	P-0003855-T01-IM5	In-House	FFPE	Resection	250	377	20	Matched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										TNFRSF14 p.M1?;ARID1A p.K71*;CARD11 p.F115I;CREBBP p.X1084_splice;MEF2B p.Y69H	0	5
P-0003856	P-0003856-T01-IM5	Outside	FFPE	Biopsy	250	329	70	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	CDK4 Amplification	1	1
P-0003857	P-0003857-T01-IM5	In-House	FFPE	Resection	250	524	40	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										LATS1 p.Q435*;RB1 p.C221*;NF2 p.L127*;TP53 p.G245N	0	4
P-0003858	P-0003858-T01-IM5	Outside	FFPE	Resection	250	540	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.E657*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108N)				LEVEL_4	ASXL2 p.E330K;KDM6A p.E657*;CDKN2A p.D108N	2	3
P-0003859	P-0003859-T01-IM5	In-House	FFPE	Biopsy	206	332	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_3A	ERBB2 p.L755S	2	1
P-0003860	P-0003860-T01-IM5	Outside	FFPE	Biopsy	250	440	50	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.P151S;KRAS p.G13D;CCNE1 Amplification;SRRM2 CREBBP-SRRM2 fusion;CREBBP CREBBP-SRRM2 fusion	1	5
P-0003861	P-0003861-T01-IM5	Outside	FFPE	Biopsy	248.16	427	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.W146Pfs*19	0	1
P-0003862	P-0003862-T01-IM5	In-House	FFPE	Resection	250	760	30	Matched	Primary	Breast	Lymph Node	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma					Trametinib,Cobimetinib(NF1 p.X2235_splice)				LEVEL_4	TP53 p.R249T;NF1 p.X2235_splice;NOTCH2 p.F1017Sfs*19;ATRX ATRX-intragenic	1	4
P-0003863	P-0003863-T01-IM5	Outside	FFPE	Resection	250	562	60	Matched	Metastasis	Lung	Colon	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.N771_P772insHH)		GSK2636771,AZD8186(PTEN p.R130Q)	Erlotinib,Gefitinib,Afatinib(EGFR p.N771_P772insHH)			LEVEL_3A	PTEN p.R130Q;TP53 p.K164E;EGFR p.N771_P772insHH;EGFR Amplification;ETV1 Amplification	2	5
P-0003864	P-0003864-T01-IM5	In-House	FFPE	Resection	250	684	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										ARID2 p.Q798*;CCND2 Amplification;KDM5A Amplification;MEN1 Deletion;PRKN Deletion	0	5
P-0003865	P-0003865-T01-IM5	In-House	FFPE	Resection	250	612	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344G)					LEVEL_3B	PIK3CA p.V344G;ACVR1 p.G328E;RB1 p.L512*;TP53 p.F113del;FBXW7 p.X413_splice;PIK3CA Amplification	1	6
P-0003866	P-0003866-T02-IM5	In-House	FFPE	Biopsy	250	734	50	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;CDKN1B p.H23Pfs*102	2	2
P-0003866	P-0003866-T01-IM5	In-House	FFPE	Resection	250	292	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K	2	1
P-0003867	P-0003867-T01-IM5	In-House	FFPE	Resection	250	748	60	Matched	Metastasis	Uterus	Pelvis	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RB1 p.R358*;PTEN Deletion;TP53 TP53-intragenic	1	3
P-0003868	P-0003868-T01-IM5	In-House	FFPE	Biopsy	250	632	80	Matched	Metastasis	Skin	Adrenal Gland	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88K);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;TP53 p.P278L;SETD2 p.R1492*;RECQL4 p.L913Wfs*35;CDKN2A p.E88K;MITF Amplification;PTEN Deletion	4	7
P-0003869	P-0003869-T01-IM5	In-House	FFPE	Resection	250	643	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Trametinib,Cobimetinib(NF1 p.Y2702*)				LEVEL_4	TP53 p.G154V;STK11 p.S216F;KMT2C p.W4357*;KRAS p.G13D;TET2 p.E808*;NF1 p.Y2702*;NOTCH3 p.S1871*;PTPRT p.Q162*	2	8
P-0003870	P-0003870-T01-IM5	In-House	FFPE	Biopsy	250	759	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.Q136E;PBRM1 p.E1214Rfs*6;SMAD4 p.R420C;ARID1A p.D1975Vfs*23;CDKN2A Deletion;CDKN2B Deletion;TGFBR2 Deletion;ARID1A ARID1A-intragenic	2	9
P-0003871	P-0003871-T01-IM5	In-House	FFPE	Biopsy	250	607	90	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.R440*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	TP53 p.Q192*;PTPRT p.E548K;NF1 p.R440*;TP63 p.M1?;EPHA7 p.G656E;KMT2C p.Q2632*;PPP2R1A p.K266*;EP300 p.Q852*;GPS2 p.P175*;CDKN2A p.R80*;EZH2 Amplification;KDR Amplification;KIT Amplification;PAX5 Amplification;PDGFRA Amplification;RHEB Amplification;NCOR1 CBX4-NCOR1 fusion;CBX4 CBX4-NCOR1 fusion;KCND2 MLL3-KCND2 fusion;KMT2C MLL3-KCND2 fusion	2	20
P-0003872	P-0003872-T01-IM5	In-House	FFPE	Biopsy	250	675	60	Matched	Metastasis	Skin	Abdomen	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_1	BRAF p.V600E;MRE11 p.Q90*;CDKN2A p.P114L;EPHA7 Deletion;NTRK1 Amplification;PRDM1 Deletion;RUNX1 Deletion	3	7
P-0003873	P-0003873-T01-IM5	In-House	FFPE	Resection	250	708	70	Matched	Metastasis	Ovary	Peritoneum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R248W;BCL6 Amplification;MYC Amplification;PTEN Deletion	1	4
P-0003874	P-0003874-T01-IM5	In-House	FFPE	Resection	250	855	30	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification;RAC1 Amplification;SMARCA4 SLITRK5-SMARCA4 fusion;SLITRK5 SLITRK5-SMARCA4 fusion	2	5
P-0003875	P-0003875-T01-IM5	In-House	FFPE	Resection	250	457	70	Matched	Metastasis	Stomach	Ovary	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										CDH1 p.R74*;ARID1A p.L2016Cfs*14	0	2
P-0003876	P-0003876-T01-IM5	In-House	FFPE	Biopsy	250	933	50	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.Q546P;AURKA Amplification	1	3
P-0003877	P-0003877-T01-IM5	Outside	FFPE	Biopsy	129.28	502	40	Matched	Metastasis	Breast	Stomach	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;CDH1 p.I650Yfs*13	1	2
P-0003878	P-0003878-T01-IM5	In-House	FFPE	Biopsy	250	474	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.G660D)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E542K;ERBB2 p.S310F;ERBB2 p.G660D;STAG2 p.R216*;RIT1 p.M90I;CDKN2A Deletion;CDKN2B Deletion	4	7
P-0003879	P-0003879-T01-IM5	In-House	FFPE	Biopsy	250	889	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010H);Capmatinib(MET p.X963_splice)	Crizotinib(MET p.D1010H);Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.D1010H);Cabozantinib(MET p.X963_splice)						LEVEL_1	MET p.D1010H;MET p.X963_splice;TP53 p.X125_splice;TET2 p.N71Kfs*5;NKX2-1 Amplification;TERT Amplification	6	6
P-0003880	P-0003880-T01-IM5	Outside	FFPE	Resection	250	808	40	Matched	Metastasis	Ovary	Omentum	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer										PPP2R1A p.R183Q;ARID1A p.S645*;ARID1A p.A228Tfs*126	0	3
P-0003881	P-0003881-T01-IM5	In-House	FFPE	Resection	250	747	40	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	SF3B1 p.R625C;GNAQ p.Q209P;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0003882	P-0003882-T01-IM5	In-House	FFPE	Resection	250	426	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.E380Q)						LEVEL_3A	ESR1 p.E380Q;CCND1 Amplification;FGF19 Amplification	1	3
P-0003884	P-0003884-T01-IM5	In-House	FFPE	Resection	250	904	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer					GSK2636771,AZD8186(PTEN p.D24H)				LEVEL_4	TP53 p.R273C;SETD2 p.R1625C;PTEN p.D24H;TCF7L2 p.S52*;MAP2K4 p.R110*	1	5
P-0003885	P-0003885-T01-IM5	In-House	FFPE	Biopsy	250	666	10	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.E545K)	Talazoparib,Olaparib(BRCA1 p.E648*)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Niraparib,Rucaparib(BRCA1 p.E648*)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.P253R)				LEVEL_1	PIK3CA p.E545K;FGFR2 p.P253R;FOXP1 p.E294*;NCOR1 p.R1275*;BRCA1 p.E648*;SMAD2 p.Q168*;TP53 p.X23_splice;ERCC4 p.E631Kfs*4	5	8
P-0003886	P-0003886-T01-IM5	In-House	FFPE	Biopsy	250	692	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	APC p.R876*;SOX9 p.Q208*;SMAD4 p.G386D;TP53 p.F109Sfs*14;NF1 Deletion	1	5
P-0003888	P-0003888-T01-IM5	In-House	FFPE	Biopsy	250	79	20	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										RB1 p.X406_splice;CDH1 p.V204Lfs*4	0	2
P-0003889	P-0003889-T01-IM5	Outside	FFPE	Resection	250	672	40	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Y)				LEVEL_3B	PIK3CA p.E545K;PBRM1 p.E602*;BCL2L11 p.R153Lfs*16;CDKN2A p.D108Y	2	4
P-0003890	P-0003890-T01-IM5	Outside	FFPE	Resection	250	724	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	TP53 p.R196*;BRAF p.K601E;APC p.P1424Qfs*49	2	3
P-0003891	P-0003891-T01-IM5	In-House	FFPE	Biopsy	250	619	60	Matched	Metastasis	Skin	Soft Tissue	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Olaparib(CHEK2 p.Q100*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	TP53 p.E285K;MGA p.Q550*;CASP8 p.E126*;FAT1 p.Q4125*;INHBA p.R379P;ARID2 p.Q819*;KMT2D p.Q1927*;CHEK2 p.Q100*;RBM10 p.X387_splice;ARID2 p.S297F;CDKN2A p.R58*	2	11
P-0003892	P-0003892-T01-IM5	In-House	FFPE	Resection	250	655	30	Matched	Metastasis	Stomach	Ovary	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										SMAD4 p.D537V;GNAS p.R201C	0	2
P-0003893	P-0003893-T01-IM5	Outside	FFPE	Biopsy	250	293	40	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										MAP3K1 p.L515Sfs*42	0	1
P-0003894	P-0003894-T01-IM5	Outside	FFPE	Biopsy	250	434	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X153_splice)				LEVEL_4	TP53 p.R282W;ARID1A p.G1015Rfs*25;CDKN2A p.X153_splice;AMER1 Deletion;EGFR Amplification	1	5
P-0003895	P-0003895-T01-IM5	In-House	FFPE	Resection	250	440	40	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										SETD2 p.R1694Sfs*17;BAP1 p.L137Pfs*11	0	2
P-0003898	P-0003898-T01-IM5	In-House	FFPE	Cytology	250	378	80	Matched	Metastasis	Bile Duct	Pleura	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ARID2 Deletion;BCL6 Amplification;CCND1 Amplification;CDKN2A Deletion;ERBB2 Amplification;FGF19 Amplification;KRAS Amplification;MAP2K4 Deletion;MDM2 Amplification;PIK3CA Amplification;PIK3CB Amplification	3	11
P-0003899	P-0003899-T01-IM5	In-House	FFPE	Resection	250	904	60	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	ACRM	Melanoma	Acral Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3A	NRAS p.Q61R;NF2 p.X447_splice;CDK4 Amplification	2	3
P-0003900	P-0003900-T01-IM5	In-House	FFPE	Biopsy	250	433	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Trametinib,Cobimetinib(MAP2K1 p.E203K);Olaparib(CHEK1 p.X22_splice);Everolimus(TSC2 p.X989_splice);Olaparib(CDK12 p.T1463Nfs*50)	GSK2636771,AZD8186(PTEN p.F241V);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.T1463Nfs*50);Trametinib,Cobimetinib(NF1 p.A1404Cfs*20);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	MAP2K1 p.E203K;ARID1A p.W1686*;MUTYH p.W472*;MUTYH p.W260*;FUBP1 p.X348_splice;PARP1 p.X887_splice;MSH2 p.Q314*;MSH2 p.X426_splice;PBRM1 p.R710*;SHQ1 p.X162_splice;EPHA3 p.W924*;RAD50 p.X916_splice;PDGFRB p.P584S;NOTCH4 p.X723_splice;KMT2C p.W1639*;NOTCH1 p.X557_splice;PTEN p.F241V;EED p.X375_splice;CHEK1 p.X22_splice;FLT3 p.E800K;TSC2 p.X989_splice;ASXL1 p.W1065*;PTPRT p.X1379_splice;PTPRT p.W976*;PTPRT p.X962_splice;RUNX1 p.X143_splice;MED12 p.X185_splice;CDK12 p.T1463Nfs*50;NF1 p.A1404Cfs*20;CDKN2A Deletion;CDKN2B Deletion;GATA3 Deletion;RAD21 Deletion	8	33
P-0003901	P-0003901-T01-IM5	In-House	FFPE	Resection	250	600	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;SMAD4 p.R361C;APC p.T1556Nfs*3;APC p.R876*;AMER1 p.R601*	2	5
P-0003902	P-0003902-T01-IM5	In-House	FFPE	Biopsy	250	355	10	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R	1	1
P-0003903	P-0003903-T02-IM5	In-House	FFPE	Biopsy	250	1004	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	PIK3CA p.H1047R;TP53 p.Q136*;APC p.Q1477*;BLM p.G1378*;FOXA1 p.L349Ffs*66;CCND1 Amplification;FGF19 Amplification;FGFR2 Amplification;MYC Amplification;PTEN Deletion	3	10
P-0003903	P-0003903-T01-IM5	Outside	FFPE	Biopsy	250	796	70	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	PIK3CA p.H1047R;TP53 p.Q136*;CCND1 Amplification;FGF19 Amplification;FGFR2 Amplification;MYC Amplification;PTEN Deletion	3	7
P-0003908	P-0003908-T01-IM3	In-House	FFPE	Biopsy	225.5	704	70	Matched	Metastasis	Prostate	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										BCOR p.E1573Gfs*10;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0003909	P-0003909-T01-IM5	Outside	FFPE	Biopsy	250	268	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification	2	1
P-0003911	P-0003911-T01-IM5	In-House	FFPE	Biopsy	250	451	70	Matched	Metastasis	Upper Tract	Liver	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	FGFR3 p.S249C;ARID1A p.Q2176*;KMT2C p.H4278Rfs*57;MDM2 Amplification;MYC Amplification;NKX3-1 Deletion	3	6
P-0003912	P-0003912-T01-IM3	In-House	FFPE	Resection	250	1166	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0003913	P-0003913-T01-IM3	In-House	FFPE	Resection	250	818	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(NF1 p.X2143_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.Q192*;NF1 p.X2143_splice;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MDM2 Amplification;PAK1 Amplification;TERT Amplification;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	5	11
P-0003914	P-0003914-T01-IM3	Outside	FFPE	Biopsy	250	1060	25	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Olaparib(ATM p.X2269_splice)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L130Q)				LEVEL_3B	TP53 p.R213L;RHOA p.R5Q;ATM p.X2269_splice;NF2 p.R467Sfs*27;NF2 p.E465Rfs*29;CDKN2A p.L130Q	2	6
P-0003915	P-0003915-T01-IM3	Outside	FFPE	Biopsy	250	1010	25	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					GSK2636771,AZD8186(PTEN p.K13Wfs*24)				LEVEL_4	LATS2 p.P479_A480dup;TP53 p.P278S;PTEN p.K13Wfs*24	1	3
P-0003916	P-0003916-T01-IM3	In-House	FFPE	Biopsy	235.2	251	40	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.X126_splice;KMT2D p.Q1949*;RB1 Deletion	0	3
P-0003918	P-0003918-T01-IM3	Outside	FFPE	Biopsy	250	859	NA	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CBFB p.P70Sfs*13;CDH1 p.T368Nfs*4;CDKN1B Deletion;MDM2 Amplification	1	4
P-0003920	P-0003920-T01-IM5	Outside	FFPE	Resection	250	584	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.S44L)	Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L755S);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Olaparib(ATM p.E2295*)	Tazemetostat(KDM6A p.Y1378*)				LEVEL_3A	ERBB2 p.L755S;ERBB3 p.D297Y;ERBB2 p.S310F;ERBB3 p.E332K;SMARCA4 p.E821K;RBM10 p.R230*;FBXW7 p.W649*;ATM p.E2295*;KMT2A p.R3741*;MGA p.R1242*;SMARCA4 p.X813_splice;ERCC2 p.S44L;KDM6A p.Y1378*;GATA3 p.S426Yfs*50	5	14
P-0003921	P-0003921-T01-IM5	Outside	FFPE	Biopsy	250	739	70	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP63 p.E609K;SETD2 p.R1625C;NOTCH2 p.L2092Pfs*13	2	4
P-0003923	P-0003923-T01-IM5	In-House	FFPE	Biopsy	214.5	635	40	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Afatinib(EGFR p.G719C);Afatinib(EGFR p.S768I)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;PIK3CA p.E545K;CTNNB1 p.S37F;EGFR p.G719C;EGFR p.S768I;SMAD4 p.T277Lfs*58	4	6
P-0003925	P-0003925-T01-IM3	In-House	FFPE	Resection	135	670	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.I255F;CDH1 p.Q673*;AR Amplification;RB1 RB1-intragenic	0	4
P-0003926	P-0003926-T01-IM5	In-House	FFPE	Biopsy	250	391	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0003927	P-0003927-T01-IM3	Outside	FFPE	Resection	250	1072	30	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559G)								LEVEL_1	KIT p.V559G	1	1
P-0003928	P-0003928-T01-IM5	Outside	FFPE	Biopsy	250	408	50	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.E294*;RAC1 Amplification	0	2
P-0003929	P-0003929-T01-IM3	In-House	FFPE	Biopsy	250	695	NA	Matched	Primary	Testis	Brain	Tumor	NSGCT	Germ Cell Tumor	Non-Seminomatous Germ Cell Tumor										KMT2C LOC647309-MLL3 fusion;LOC647309 LOC647309-MLL3 fusion;MCPH1 MLL3-MCPH1 fusion;KMT2C MLL3-MCPH1 fusion	0	4
P-0003930	P-0003930-T01-IM3	In-House	FFPE	Biopsy	250	986	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										GNAS p.R201C;TP53 p.D184Efs*24	0	2
P-0003932	P-0003932-T01-IM3	In-House	FFPE	Biopsy	250	650	50	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.K132R;FAT1 p.G970*;ATRX p.S567*	0	3
P-0003933	P-0003933-T01-IM3	In-House	FFPE	Biopsy	250	839	NA	Matched	Primary	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	PIK3CA p.H1047R;CDH1 p.Q610*;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PTEN Deletion	4	6
P-0003934	P-0003934-T02-IM5	Outside	FFPE	Biopsy	250	817	60	Matched	Primary	Lymph Node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										KMT2D p.Q3860*;KMT2D p.Q3575*;CREBBP p.W1502R	0	3
P-0003934	P-0003934-T03-IM5	Outside	FFPE	Biopsy	250	788	50	Matched	Primary	Lymph Node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										BCL10 p.L174*;KMT2D p.Q3860*;KMT2D p.Q3575*;CREBBP p.W1502R	0	4
P-0003934	P-0003934-T01-IM5	Outside	FFPE	Biopsy	250	616	50	Matched	Primary	Lymph Node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										KMT2D p.Q3860*;KMT2D p.Q3575*;CREBBP p.W1502R;TOP1 p.X11_splice;BCL10 p.L174*;NOTCH2 p.I2294Pfs*16	0	6
P-0003935	P-0003935-T01-IM3	In-House	FFPE	Biopsy	131.04	732	65	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TP53 p.G105V;POLE p.E18K;RB1 p.S618*	1	4
P-0003936	P-0003936-T01-IM3	Outside	FFPE	Resection	250	831	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM p.R337H)					LEVEL_3B	ATM p.R337H;TP53 p.I195N	1	2
P-0003937	P-0003937-T02-IM5	In-House	FFPE	Biopsy	149.4	510	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X296_splice)					LEVEL_3B	CREBBP p.Q2235*;STK11 p.L85*;ATM p.X296_splice;FOXA1 Amplification;NKX2-1 Amplification	1	5
P-0003937	P-0003937-T01-IM5	In-House	FFPE	Biopsy	83.7	394	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X296_splice)					LEVEL_3B	CREBBP p.Q2235*;STK11 p.L85*;ATM p.X296_splice	1	3
P-0003938	P-0003938-T01-IM5	Outside	FFPE	Biopsy	250	328	40	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;TP53 p.L137Q;ARID1A p.Y1027_L1028delins*	1	3
P-0003939	P-0003939-T01-IM3	Outside	FFPE	Biopsy	250	894	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.Y163H	0	1
P-0003940	P-0003940-T01-IM3	In-House	FFPE	Resection	248.06	671	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.H193L;ARID1B p.K1762*;ERBB2 Amplification	2	3
P-0003941	P-0003941-T01-IM3	In-House	FFPE	Biopsy	209	731	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.E542K;TP53 p.V274A;AURKA Amplification;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	3	7
P-0003942	P-0003942-T01-IM3	In-House	FFPE	Resection	250	773	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.Y234C;ARID1A p.D1850Tfs*33;CDK4 Amplification;MCL1 Amplification	1	4
P-0003943	P-0003943-T01-IM3	Outside	FFPE	Resection	250	671	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R158L;ARID2 p.Q1620*;RB1 p.Y756*;ASXL1 p.X295_splice;APC p.L1342Ffs*10;NPM1 Deletion;TGFBR2 Deletion	1	8
P-0003944	P-0003944-T01-IM3	Outside	FFPE	Biopsy	250	698	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										LATS2 p.P479_A480dup;CCNE1 Amplification	0	2
P-0003945	P-0003945-T01-IM3	In-House	FFPE	Biopsy	250	534	90	Matched	Metastasis	Prostate	Bladder Neck	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.V166G);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	AR p.L702H;PTEN p.V166G;PTEN Deletion	2	3
P-0003946	P-0003946-T01-IM3	In-House	FFPE	Resection	250	719	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;BAP1 p.L112*	1	2
P-0003947	P-0003947-T01-IM3	Outside	FFPE	Resection	250	736	NA	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.L869R)	Ado-Trastuzumab Emtansine(ERBB2 p.L869R)					LEVEL_3A	ERBB2 p.L869R;FOXA1 p.S285Tfs*6;CDH1 p.E745Rfs*3	2	3
P-0003948	P-0003948-T01-IM3	Outside	FFPE	Resection	250	503	NA	Matched	Primary	Soft Tissue	Testis	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 WFIKKN2-TP53 fusion;WFIKKN2 WFIKKN2-TP53 fusion	0	2
P-0003949	P-0003949-T01-IM5	In-House	FFPE	Resection	250	438	60	Matched	Primary	Bone	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification;KMT2D MON2-MLL2 fusion;MON2 MON2-MLL2 fusion	1	3
P-0003950	P-0003950-T01-IM5	In-House	FFPE	Biopsy	171.9	437	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	ESR1 p.D538G;TP53 p.V173M;GATA3 p.R366*;AKT2 p.C60_I75dup;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0003950	P-0003950-T02-IM5	In-House	FFPE	Biopsy	250	1025	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537N)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	TP53 p.V173M;ESR1 p.Y537N;GATA3 p.R366*;AKT2 p.C60_I75dup;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0003951	P-0003951-T01-IM3	In-House	FFPE	Biopsy	250	846	80	Matched	Metastasis	Skin	Lung	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Tipifarnib(HRAS p.Q61L)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L78Hfs*41)				LEVEL_3B	TP53 p.Q136P;TP53 p.L194F;HRAS p.Q61L;TP53 p.V225I;ASXL1 p.Q491*;ETV6 p.P214L;CDKN2A p.L78Hfs*41	2	7
P-0003953	P-0003953-T01-IM5	Outside	FFPE	Biopsy	250	345	50	Matched	Primary	Soft Tissue	Not Applicable	Tumor	EHAE	Soft Tissue Sarcoma	Epithelioid Hemangioendothelioma											0	0
P-0003954	P-0003954-T01-IM3	Outside	FFPE	Biopsy	250	833	NA	Unmatched	Metastasis	Lung	Skin	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										RB1 p.C666*;ETV1 Amplification	0	2
P-0003955	P-0003955-T01-IM3	In-House	FFPE	Biopsy	250	700	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.G660D)	Tazemetostat(KDM6A p.E1337*)				LEVEL_3B	ERBB2 p.G660D;KDM6A p.E1337*;RBM10 p.Q138Sfs*3	2	3
P-0003958	P-0003958-T01-IM3	In-House	FFPE	Biopsy	250	782	NA	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G);AZD9496,Fulvestrant(ESR1 p.Y537C)						LEVEL_3A	ESR1 p.D538G;ESR1 p.Y537C;KMT2C p.R2884*;KMT2C p.H1551Tfs*12;CDH1 p.Q136Pfs*32;MCL1 Amplification	2	6
P-0003958	P-0003958-T02-IM5	In-House	FFPE	Biopsy	250	909	60	Unmatched	Metastasis	Breast	Bone	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS			AZD9496,Fulvestrant(ESR1 p.Y537C)						LEVEL_3A	ESR1 p.Y537C;CDH1 p.Q136Pfs*32	1	2
P-0003959	P-0003959-T01-IM3	Outside	FFPE	Biopsy	250	741	60	Matched	Primary	Orbit	Not Applicable	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma				Tipifarnib(HRAS p.Q61K)					LEVEL_3B	HRAS p.Q61K	1	1
P-0003960	P-0003960-T01-IM3	In-House	FFPE	Resection	250	445	NA	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;KMT2C p.Q3489*;CDH1 p.E138*	1	3
P-0003961	P-0003961-T01-IM3	Outside	FFPE	Resection	214.56	591	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	GATA3 p.P408Afs*99;EGFR Amplification;MDM2 Amplification	1	3
P-0003962	P-0003962-T02-IM5	In-House	FFPE	Resection	250	483	80	Matched	Metastasis	Kidney	Lymph Node	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma					GSK2636771,AZD8186(PTEN p.P96L)				LEVEL_4	PTEN p.P96L	1	1
P-0003962	P-0003962-T03-IM5	Outside	DNA	Resection	250	242	80	Matched	Metastasis	Kidney	Lymph Node	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0003963	P-0003963-T01-IM3	In-House	FFPE	Biopsy	250	895	NA	Matched	Metastasis	Testis	Lung	Tumor	SEM	Germ Cell Tumor	Seminoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0003964	P-0003964-T01-IM3	In-House	FFPE	Biopsy	250	654	60	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP63 p.Y202Kfs*29;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification	2	5
P-0003965	P-0003965-T01-IM5	In-House	FFPE	Resection	250	307	30	Matched	Metastasis	Adrenal Gland	Epidural	Tumor	PHC	Pheochromocytoma	Pheochromocytoma											0	0
P-0003966	P-0003966-T01-IM5	In-House	FFPE	Biopsy	250	532	50	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0003967	P-0003967-T01-IM5	In-House	FFPE	Resection	250	481	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	EGFR p.L858R;RB1 p.Q762*;AKT1 Amplification;ERBB2 Amplification;FOXA1 Amplification;NKX2-1 Amplification	2	6
P-0003968	P-0003968-T01-IM5	Outside	FFPE	Resection	250	632	80	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ACVR1 p.R258G;CIC p.P1372Lfs*68;FUBP1 p.G131Mfs*8	1	4
P-0003970	P-0003970-T01-IM5	In-House	FFPE	Biopsy	250	481	40	Matched	Metastasis	Lung	Breast	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 EZR-ROS1 fusion);Crizotinib,Entrectinib(EZR EZR-ROS1 fusion)								LEVEL_1	TP53 p.R248W;AXIN1 p.Q732_E733delinsR*;MYC Amplification;ROS1 EZR-ROS1 fusion;EZR EZR-ROS1 fusion	2	5
P-0003970	P-0003970-T02-IM5	In-House	FFPE	Biopsy	250	866	30	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 EZR-ROS1 fusion);Crizotinib,Entrectinib(EZR EZR-ROS1 fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R248W;AXIN1 p.Q732_E733delinsR*;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification;ROS1 EZR-ROS1 fusion;EZR EZR-ROS1 fusion	3	8
P-0003971	P-0003971-T02-IM5	In-House	DNA	Resection	250	102	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PIK3R1 p.G678Sfs*9;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0003972	P-0003972-T01-IM5	In-House	FFPE	Biopsy	135.3	533	10	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.E336*;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification	1	4
P-0003973	P-0003973-T01-IM3	Outside	FFPE	Biopsy	213.12	481	60	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										RB1 p.R251*;ASXL1 p.Q377*;B2M Deletion;IKZF1 Deletion;KDM5A Amplification;PMS2 Deletion;RASA1 Deletion;TGFBR2 Deletion	0	8
P-0003974	P-0003974-T01-IM3	Outside	FFPE	Resection	250	491	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ARID1B Deletion;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;FOXA1 Amplification;LATS1 Deletion;MEF2B Amplification;PAK1 Amplification;PRKN Deletion;PRDM1 Deletion;TNFAIP3 Deletion	1	11
P-0003977	P-0003977-T01-IM3	In-House	FFPE	Resection	250	909	NA	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.L114Ffs*35	0	1
P-0003978	P-0003978-T01-IM3	Outside	FFPE	Biopsy	250	918	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.C242F;NOTCH1 p.X1215_splice;RB1 p.G540Afs*3	0	3
P-0003980	P-0003980-T01-IM3	Outside	FFPE	Resection	250	647	NA	Matched	Primary	Uterus	Not Applicable	Tumor	UUS	Uterine Sarcoma	Undifferentiated Uterine Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.P301Qfs*44;MED12 p.G44D;CARD11 Amplification;CDKN2A Deletion;RAC1 Amplification	1	5
P-0003981	P-0003981-T01-IM3	In-House	FFPE	Biopsy	125.4	877	50	Matched	Primary	Esophagus	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R342*;FBXW7 p.R465C;CCNE1 Amplification;ERBB2 Amplification;SMAD4 Deletion	2	5
P-0003982	P-0003982-T01-IM3	Outside	FFPE	Resection	250	247	NA	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.R130G)				LEVEL_4	PTEN p.R130G;BCOR p.N1459S;DICER1 p.D1709N;ARID1A p.R1742Nfs*13	1	4
P-0003983	P-0003983-T01-IM3	Outside	FFPE	Biopsy	250	1070	NA	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	LATS2 p.P479_A480dup;TP53 p.M237I;ERBB2 Amplification	2	3
P-0003984	P-0003984-T01-IM5	Outside	FFPE	Resection	250	337	10	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma										TP53 p.A70Rfs*76	0	1
P-0003985	P-0003985-T01-IM3	Outside	FFPE	Resection	250	810	50	Matched	Metastasis	Breast	Peritoneum	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;CDKN1B p.E53Kfs*18	2	2
P-0003986	P-0003986-T01-IM5	Outside	FFPE	Biopsy	250	405	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification	2	1
P-0003987	P-0003987-T01-IM5	Outside	FFPE	Biopsy	250	422	70	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.E545K;PIK3CA p.H1047R;RB1 p.Q217*;TP53 p.R196Q;CDH1 p.L731Gfs*38;MAP3K1 p.A1387Cfs*33;MAP3K1 p.S1002*	4	7
P-0003990	P-0003990-T01-IM3	Outside	FFPE	Biopsy	250	541	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;TP53 p.Y220C;APC p.V1472Efs*35	1	3
P-0003993	P-0003993-T01-IM5	In-House	FFPE	Biopsy	250	602	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0003994	P-0003994-T01-IM3	In-House	FFPE	Resection	250	436	80	Matched	Metastasis	Mediastinum	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G60V)				LEVEL_3B	PIK3CA p.E542K;TP53 p.H178D;KRAS p.G60V;CCND2 Amplification;KDM5A Amplification;MCL1 Amplification	2	6
P-0003995	P-0003995-T01-IM5	Outside	FFPE	Cytology	157.68	87	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0003996	P-0003996-T01-IM5	Outside	FFPE	Biopsy	162.15	301	10	Matched	Metastasis	Cancer of Unknown Primary	Abdomen	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.X224_splice	0	1
P-0003998	P-0003998-T01-IM5	In-House	FFPE	Biopsy	250	639	50	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										RB1 p.R320*;TP53 p.V173A;ARID1B LOC729234-ARID1B fusion;LOC729234 LOC729234-ARID1B fusion	0	4
P-0003999	P-0003999-T01-IM5	In-House	FFPE	Resection	250	570	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344G)					LEVEL_3B	PIK3CA p.V344G;TP53 p.K382Nfs*40;PIK3R1 p.E683*;APC p.S1356*;TCF7L2 p.X185_splice	1	5
P-0004000	P-0004000-T01-IM5	Outside	FFPE	Biopsy	250	486	20	Matched	Metastasis	Lung	Liver	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.H179Y	0	1
P-0004001	P-0004001-T01-IM3	Outside	FFPE	Biopsy	250	1070	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										BRAF Amplification;BRD4 Amplification;CCND1 Amplification;EZH2 Amplification;FGF19 Amplification;MEF2B Amplification;PAK1 Amplification;PRKN Deletion;PIK3R2 Amplification;TGFBR1 Deletion	0	10
P-0004002	P-0004002-T01-IM3	In-House	FFPE	Resection	250	673	70	Matched	Primary	Mediastinum	Not Applicable	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146P)				LEVEL_4	TP53 p.V173L;KRAS p.A146P;CREBBP p.Y1230*	1	3
P-0004005	P-0004005-T01-IM3	In-House	FFPE	Biopsy	250	1224	40	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.X261_splice	0	1
P-0004006	P-0004006-T01-IM3	In-House	FFPE	Cytology	87.9	629	50	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R342*;RB1 p.L199Ffs*4;JUN Amplification;MYCL Amplification	0	4
P-0004007	P-0004007-T01-IM3	Outside	FFPE	Biopsy	227.7	1099	15	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;TP53 p.C242F;BRAF p.G469E;SMAD3 p.C64*	1	4
P-0004007	P-0004007-T02-IM3	Outside	FFPE	Resection	250	482	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;TP53 p.C242F;BRAF p.G469E;SMAD3 p.C64*	1	4
P-0004008	P-0004008-T01-IM3	Outside	FFPE	Resection	250	352	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.S289*)	Tazemetostat(KDM6A p.E630*)				LEVEL_3B	RHOA p.G17A;TSC1 p.S289*;KDM6A p.E630*	2	3
P-0004010	P-0004010-T01-IM3	In-House	FFPE	Resection	250	233	70	Matched	Metastasis	Rectum	Lung	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K)	Cetuximab,Panitumumab(KRAS p.Q61K)			LEVEL_3B	PIK3CA p.E545K;APC p.T1556Nfs*3;KRAS p.Q61K;FBXW7 p.X412_splice;SMAD4 p.D537A	2	5
P-0004011	P-0004011-T01-IM5	In-House	FFPE	Biopsy	250	431	10	Matched	Metastasis	Transverse Colon	Omentum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.Q56P);Olaparib(CDK12 p.Q1216*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q1216*)				LEVEL_3B	MAP2K1 p.Q56P;RPS6KA4 p.R629H;SOX17 p.P328Rfs*59;PIK3CB p.E470K;RAF1 p.S257L;CIC p.R215W;AXIN2 p.G665Afs*24;LATS1 p.F1010Lfs*10;MSH2 p.Q298*;CDK12 p.Q1216*;PPP2R1A p.A136V;ASXL1 p.R965*;ATRX p.T1582Qfs*24;RNF43 p.I164Sfs*9;ANKRD11 p.K1461Efs*69;TCF7L2 p.L200Sfs*25;ZFHX3 p.Q1137Rfs*50;AXIN1 p.N587Tfs*118;TBX3 p.K104Rfs*35	3	19
P-0004012	P-0004012-T01-IM3	Outside	FFPE	Resection	250	797	90	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer											0	0
P-0004014	P-0004014-T01-IM5	In-House	FFPE	Resection	250	236	30	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.A829P)					LEVEL_3B	KIT p.A829P	1	1
P-0004015	P-0004015-T01-IM3	In-House	FFPE	Resection	250	601	NA	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;EIF1AX p.G9R	2	2
P-0004016	P-0004016-T01-IM5	Outside	FFPE	Biopsy	250	290	40	Matched	Primary	Esophagus	Not Applicable	Tumor	EPDCA	Esophagogastric Cancer	Esophageal Poorly Differentiated Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	RBM10 p.E683*;TP53 p.K319Rfs*26;CDKN2A p.W110*;CDKN2A Deletion;CDKN2B Deletion;ERBB3 Amplification;PTPRD Deletion	2	7
P-0004017	P-0004017-T01-IM5	Outside	FFPE	Resection	250	429	20	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)					LEVEL_3B	PIK3CA p.E453K;PIK3CA p.H1047L;TP53 p.S127Y;PBRM1 p.R58*;RB1 p.G100*;TP53 p.X126_splice;KMT2C p.Q1546Hfs*20;ARID1A p.H1871Qfs*30;ARID1A p.A2181Gfs*44;RB1 p.V754Sfs*4	2	10
P-0004018	P-0004018-T01-IM3	In-House	FFPE	Resection	250	644	NA	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;TP53 p.G266E;APC p.R876*;DNMT3B p.R54*;APC p.E1306*;FBXW7 p.S582L;CCND2 Amplification;MAP2K4 Deletion	1	8
P-0004019	P-0004019-T01-IM3	Outside	FFPE	Biopsy	230	757	40	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										SETD2 p.T387Lfs*97	0	1
P-0004020	P-0004020-T01-IM5	In-House	FFPE	Biopsy	250	693	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G364A)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3B	KRAS p.G13D;PIK3CA p.G364A;RBM10 p.X890_splice	2	3
P-0004021	P-0004021-T01-IM3	Outside	FFPE	Resection	250	559	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				BLU-667,Selpercatinib(RET p.M918T)					LEVEL_3B	RET p.M918T	1	1
P-0004023	P-0004023-T01-IM3	Outside	FFPE	Biopsy	250	928	80	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										TP53 p.I251F;CCND1 Amplification	0	2
P-0004025	P-0004025-T01-IM5	Outside	FFPE	Biopsy	250	561	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R196*;CCNE1 Amplification;ERBB2 Amplification	2	3
P-0004026	P-0004026-T01-IM5	In-House	FFPE	Resection	250	522	50	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.V101Rfs*16	0	1
P-0004027	P-0004027-T01-IM5	In-House	FFPE	Resection	250	393	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.R215W;FUBP1 p.Y582Ifs*83	1	3
P-0004028	P-0004028-T01-IM3	In-House	FFPE	Biopsy	250	732	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047_H1048delinsRR)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047_H1048delinsRR)						LEVEL_1	ERBB3 p.A232V;NCOR1 p.R2008*;MAP3K1 p.Q390Cfs*48;MAP3K1 p.T457Nfs*4;PIK3CA p.H1047_H1048delinsRR	2	5
P-0004029	P-0004029-T02-IM5	In-House	FFPE	Biopsy	130	521	10	Matched	Metastasis	Ovary	Spleen	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;FOXL2 p.C134W	1	2
P-0004029	P-0004029-T01-IM5	In-House	FFPE	Resection	250	519	60	Matched	Metastasis	Ovary	Liver	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W;KDM5C p.L394Afs*11;RUNX1 p.Y254*	0	3
P-0004030	P-0004030-T01-IM5	Outside	FFPE	Biopsy	250	443	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_4	TP53 p.G105C;APC p.T1556Nfs*3;B2M p.E19*;KEAP1 p.I461M;MGA p.M490Cfs*33;FAT1 p.I2725Sfs*28;STK11 p.D343Gfs*17;CDKN2A p.Y44*	1	8
P-0004031	P-0004031-T01-IM3	Outside	FFPE	Resection	250	284	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ARID2 p.E74Gfs*10;GATA3 p.T355*;ARID2 p.D333Tfs*3	0	3
P-0004032	P-0004032-T01-IM5	Outside	FFPE	Biopsy	250	166	30	Matched	Primary	Brain	Not Applicable	Tumor	AGNG	Glioma	Anaplastic Ganglioglioma				Trametinib,Cobimetinib(KIAA1549 BRAF-KIAA1549 fusion);Trametinib,Cobimetinib(BRAF BRAF-KIAA1549 fusion)					LEVEL_3B	KIAA1549 BRAF-KIAA1549 fusion;BRAF BRAF-KIAA1549 fusion	2	2
P-0004034	P-0004034-T01-IM5	Outside	FFPE	Resection	250	290	60	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)					LEVEL_3B	KIT p.L576P	1	1
P-0004035	P-0004035-T01-IM5	Outside	FFPE	Biopsy	250	623	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P104R)	GSK2636771,AZD8186(PTEN p.E284*)				LEVEL_3B	TP53 p.W146*;PIK3CA p.P104R;PTEN p.E284*;RB1 p.Y446*;BRAF Amplification	2	5
P-0004038	P-0004038-T01-IM3	Outside	FFPE	Biopsy	250	556	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PTEN Deletion;TNFRSF14 Deletion	3	6
P-0004039	P-0004039-T01-IM5	Outside	FFPE	Resection	250	113	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0004040	P-0004040-T02-IM5	Outside	DNA	Biopsy	136.8	661	20	Matched	Metastasis	Uterus	Liver	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				AZD9496,Fulvestrant(ESR1 p.D538G)					LEVEL_3B	BCOR p.N1459S;ESR1 p.D538G;CTNNB1 p.D32N;ZFHX3 p.S1660Cfs*5;PIK3R1 p.I571Yfs*31;JAK1 p.L346Tfs*4	1	6
P-0004041	P-0004041-T01-IM5	In-House	FFPE	Resection	250	449	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma				Ivosidenib(IDH1 p.R132C)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	IDH1 p.R132C;TP53 p.C277Y;PTEN Deletion;TERT Amplification	2	4
P-0004042	P-0004042-T01-IM5	In-House	FFPE	Biopsy	250	607	80	Matched	Primary	Retroperitoneum	Pelvis	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CCND2 Amplification;CDK4 Amplification;MDM2 Amplification	2	3
P-0004043	P-0004043-T01-IM3	In-House	FFPE	Resection	250	801	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D769Y);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.X187_splice;ERBB2 p.D769Y;ERBB2 Amplification	3	3
P-0004044	P-0004044-T01-IM3	Outside	FFPE	Biopsy	250	746	50	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_1	TP53 p.R213*;PTPRT p.X385_splice;ERBB2 Amplification;MET Amplification	3	4
P-0004045	P-0004045-T01-IM3	In-House	FFPE	Resection	250	865	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	ERBB2 p.Y772_A775dup;TP53 p.R213Q;SDHAF2 p.S10L;TP53 p.I254M;RB1 Deletion	2	5
P-0004046	P-0004046-T02-IM5	In-House	FFPE	Biopsy	250	865	20	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction										TP53 p.R175H;CCNE1 Amplification	0	2
P-0004046	P-0004046-T01-IM3	Outside	FFPE	Biopsy	250	1192	20	Matched	Primary	Esophagus	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R175H;TP53 p.G244S;CCNE1 Amplification;ERBB2 Amplification	2	4
P-0004047	P-0004047-T01-IM5	In-House	FFPE	Biopsy	250	605	60	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										BAP1 p.P618Rfs*24	0	1
P-0004048	P-0004048-T01-IM5	In-House	FFPE	Biopsy	250	422	40	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	NRAS p.Q61K;MITF Amplification	1	2
P-0004050	P-0004050-T01-IM3	In-House	FFPE	Biopsy	250	344	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E365K)	Tazemetostat(KDM6A p.X325_splice)				LEVEL_3B	PIK3CA p.E365K;MITF p.E521*;TP53 p.R249W;KDM6A p.X325_splice;MYC Amplification	2	5
P-0004051	P-0004051-T01-IM5	Outside	FFPE	Resection	250	342	30	Matched	Metastasis	Cecum	Abdomen	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		AZD5363(AKT1 p.E17K);Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Everolimus(TSC1 p.F608Lfs*21);Everolimus(TSC1 p.R420Gfs*20);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.K654Sfs*47)					LEVEL_1	AKT1 p.E17K;BRAF p.V600E;CREBBP p.I1084Sfs*15;RNF43 p.G659Vfs*41;TET1 p.N1611Tfs*13;B2M p.L15Ffs*41;MRE11 p.F321Lfs*8;CASP8 p.R432*;RNF43 p.X125_splice;KMT2C p.K1201Nfs*4;ZFHX3 p.G3406Rfs*25;CIC p.T1375Pfs*40;AXIN1 p.G508Vfs*197;JAK1 p.P861Tfs*4;AXIN1 p.P432Qfs*48;TSC1 p.F608Lfs*21;B2M p.T93Hfs*2;PPM1D p.N512Ifs*2;TSC1 p.R420Gfs*20;NOTCH2 p.N1059Tfs*6;TNFAIP3 p.A766Pfs*50;PRKN p.N428Kfs*141;BRCA1 p.K654Sfs*47;BCOR p.K100Rfs*85	7	24
P-0004052	P-0004052-T01-IM5	Outside	FFPE	Resection	250	99	70	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CDKN1B CDKN1B-intragenic	2	2
P-0004054	P-0004054-T01-IM5	Outside	FFPE	Biopsy	250	437	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.E287*;STK11 p.G196R;ARID2 p.P628Lfs*19;TGFBR2 p.K105*;CCND3 Amplification;FGFR1 Amplification;MCL1 Amplification;VEGFA Amplification	1	8
P-0004055	P-0004055-T01-IM5	Outside	FFPE	Resection	250	619	60	Matched	Metastasis	Major Salivary Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	KMT2C p.T180Efs*10;TP53 p.L344_E346del;ERBB2 Amplification;NF1 Deletion;LATS1 LATS1-intragenic	2	5
P-0004056	P-0004056-T01-IM5	Outside	FFPE	Biopsy	250	614	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S611*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	LATS1 p.Q435*;NOTCH2 p.Q1392*;CDKN1A p.S2*;BRCA2 p.S611*;NF2 p.X373_splice;CDKN2A Deletion;CDKN2B Deletion	2	7
P-0004057	P-0004057-T01-IM5	In-House	FFPE	Biopsy	250	670	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.N239S;FLCN Deletion;MYC Amplification	0	3
P-0004058	P-0004058-T01-IM5	Outside	FFPE	Biopsy	250	273	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.L265Pfs*5;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	1	4
P-0004059	P-0004059-T01-IM5	Outside	FFPE	Biopsy	136.4	78	10	Matched	Primary	Chest Wall	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease	Vemurafenib(BRAF p.V600E)		Cobimetinib(BRAF p.V600E)						LEVEL_1	BRAF p.V600E	2	1
P-0004060	P-0004060-T01-IM5	In-House	FFPE	Biopsy	250	687	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer				Tipifarnib(HRAS p.Q61K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)					LEVEL_3B	TP53 p.R213*;HRAS p.Q61K;PIK3CA p.M1043I;TP53 p.X186_splice	2	4
P-0004061	P-0004061-T02-IM5	In-House	DNA	Resection	250	716	50	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.K1817Ifs*45;CDKN1B Deletion;EPHA7 Deletion;FUBP1 Deletion	0	4
P-0004062	P-0004062-T01-IM5	Outside	FFPE	Resection	250	734	50	Matched	Primary	Appendix	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										TNFRSF14 p.M1?;PBRM1 p.E1132*;CREBBP p.X1378_splice;EP300 p.L415P;KMT2D p.M3777Afs*234;KMT2D p.S2431Lfs*53;EPHA7 Deletion	0	7
P-0004063	P-0004063-T01-IM5	In-House	FFPE	Biopsy	178.2	224	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.N1055Ifs*5)			Talazoparib,Niraparib(BRCA2 p.N1055Ifs*5)					LEVEL_1	FOXA1 p.Q263_G281del;BRCA2 p.N1055Ifs*5	2	2
P-0004064	P-0004064-T01-IM5	In-House	FFPE	Biopsy	192.5	389	50	Matched	Metastasis	Bladder	Bone	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D277H);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.C118*)				LEVEL_3B	TP53 p.G154V;ERBB2 p.D277H;RAF1 p.P261R;NF1 p.C118*;RB1 p.Q207Tfs*5;ERBB2 Amplification	3	6
P-0004065	P-0004065-T01-IM5	In-House	FFPE	Cytology	250	690	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.G244C;NSD1 p.E484*;PTPRT p.G1226*;MET Amplification;RICTOR Amplification	2	5
P-0004066	P-0004066-T02-IM5	In-House	FFPE	Biopsy	250	839	10	Matched	Metastasis	Lung	Pericardium	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR p.E709K;TP53 p.M246K	1	3
P-0004066	P-0004066-T01-IM5	Outside	FFPE	Biopsy	69.2	483	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR p.E709K	1	2
P-0004067	P-0004067-T01-IM5	In-House	FFPE	Biopsy	250	739	40	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.G154V;KRAS p.G13D;TP53 p.X125_splice;CDKN2A Deletion;CDKN2B Deletion;FOXA1 Amplification;NKX2-1 Amplification	2	7
P-0004068	P-0004068-T01-IM5	In-House	FFPE	Biopsy	250	604	50	Matched	Primary	Thymus	Not Applicable	Tumor	THYC	Thymic Tumor	Thymic Carcinoma		Sunitinib(KIT p.W557S)		Imatinib(KIT p.W557S)					LEVEL_2	KIT p.W557S;NOTCH1 p.V1578del;ASXL2 Deletion	2	3
P-0004069	P-0004069-T01-IM5	In-House	FFPE	Resection	250	579	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										SETD2 p.S595*;DAXX p.D288Mfs*6	0	2
P-0004070	P-0004070-T02-IM5	Outside	FFPE	Resection	250	575	50	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.R248Q;MED12 p.G44C;ATRX Deletion;CTCF Deletion;FH Deletion	0	5
P-0004071	P-0004071-T01-IM5	In-House	FFPE	Biopsy	250	565	60	Matched	Primary	Abdomen	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0004072	P-0004072-T01-IM5	In-House	FFPE	Cytology	250	807	NA	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.K57T)					LEVEL_3B	TP53 p.R248W;ARID1A p.G2087R;MAP2K1 p.K57T	1	3
P-0004073	P-0004073-T01-IM5	Outside	FFPE	Resection	250	633	40	Matched	Primary	Brain	Not Applicable	Tumor	OAST	Glioma	Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R273H;TP53 p.R158H;IDH1 p.R132H;ARID2 p.E1670*;ATRX p.A400Gfs*14	1	5
P-0004074	P-0004074-T01-IM5	In-House	FFPE	Biopsy	203.06	553	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	KRAS p.G13C;FAT1 p.X4086_splice;STK11 p.X155_splice;PPP2R1A p.X507_splice;ARID2 p.L293*	1	5
P-0004075	P-0004075-T01-IM5	In-House	FFPE	Resection	250	709	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.R273H;PPP2R1A p.P179R;ERBB2 Amplification	1	3
P-0004076	P-0004076-T01-IM5	In-House	FFPE	Resection	250	530	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Olaparib(ATM p.N1000Tfs*2)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3B	ARID1A p.D1850Tfs*33;PPP2R1A p.R183Q;RNF43 p.G659Vfs*41;ERBB3 p.Q809R;KMT2A p.S774Vfs*12;ERBB3 p.E928G;KMT2D p.P647Hfs*283;ARID1A p.F2141Sfs*59;KRAS p.G13D;TP53 p.R181C;B2M p.T93Hfs*2;ATR p.R1951*;NOTCH2 p.S1419Afs*8;MDC1 p.K1025del;BLM p.V1208Cfs*71;ZFHX3 p.D1894Gfs*21;MAP3K1 p.K1160Rfs*12;RNF43 p.E37Vfs*2;SPOP p.M35Rfs*30;ATM p.N1000Tfs*2	2	20
P-0004077	P-0004077-T01-IM5	In-House	FFPE	Resection	250	614	50	Matched	Metastasis	Kidney	Retroperitoneum	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	FUBP1 p.R331*;SMARCA4 p.R1243L;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0004078	P-0004078-T01-IM5	In-House	FFPE	Resection	250	399	60	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0004079	P-0004079-T01-IM5	In-House	FFPE	Resection	250	699	20	Matched	Primary	Soft Tissue	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										TET2 p.S1392R;KMT2C p.R199Hfs*7;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	4
P-0004080	P-0004080-T01-IM5	In-House	FFPE	Resection	250	670	50	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										PBRM1 p.Q1587*;BAP1 p.I271Ffs*64	0	2
P-0004081	P-0004081-T01-IM5	In-House	FFPE	Biopsy	250	645	30	Matched	Metastasis	Rectum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;TP53 p.P151S;APC p.P1319Lfs*2;TCF7L2 p.R66Afs*29	1	4
P-0004082	P-0004082-T01-IM5	In-House	FFPE	Resection	250	673	50	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma										BCOR p.S214*;HRAS Amplification	0	2
P-0004083	P-0004083-T01-IM5	In-House	DNA	Resection	250	787	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)	Trametinib,Cobimetinib,Binimetinib(KRAS p.K117N)	Cetuximab,Panitumumab(KRAS p.K117N)			LEVEL_3B	PTCH1 p.S1203Afs*52;CTNNB1 p.S45F;ARID1A p.D1850Tfs*33;B2M p.L15Ffs*41;FBXW7 p.R465C;TCF7L2 p.K485Sfs*23;DDR2 p.G505S;KRAS p.K117N;B2M p.X23_splice;AXIN1 p.T79Pfs*5;ARID5B p.N432Mfs*47	2	11
P-0004084	P-0004084-T01-IM5	Outside	FFPE	Biopsy	250	433	10	Matched	Metastasis	Testis	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0004085	P-0004085-T01-IM5	Outside	FFPE	Resection	250	481	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(ATM p.S2394L);Olaparib(ATM p.E2904Dfs*29)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108N)				LEVEL_3B	ATM p.S2394L;STAG2 p.S1201*;KMT2D p.A2485Gfs*126;ATM p.E2904Dfs*29;MGA p.W2174*;KMT2D p.C1430*;CDKN2A p.D108N;RAF1 Amplification	3	8
P-0004086	P-0004086-T01-IM5	In-House	FFPE	Biopsy	250	552	30	Matched	Metastasis	Stomach	Lung	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										ERBB3 p.S846I;TP53 p.P128Lfs*42;BAP1 p.R208Sfs*22	0	3
P-0004087	P-0004087-T01-IM5	Outside	FFPE	Biopsy	154	650	70	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S3376*)	Tazemetostat(SMARCB1 p.Q323Lfs*38)				LEVEL_3B	TP53 p.R158L;STK11 p.E223*;KMT2C p.X130_splice;BRCA2 p.S3376*;TP53 p.G244C;SMARCB1 p.Q323Lfs*38;APC Deletion;MAP3K1 Deletion;MCL1 Amplification;PIK3R1 Deletion;RAD50 Deletion;RASA1 Deletion;SH2D1A Deletion	2	13
P-0004088	P-0004088-T01-IM5	In-House	FFPE	Biopsy	250	1208	10	Matched	Metastasis	Uterus	Lymph Node	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344M)					LEVEL_3B	PIK3CA p.V344M	1	1
P-0004089	P-0004089-T01-IM5	In-House	FFPE	Biopsy	250	622	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(VCL FGFR2-VCL fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 FGFR2-VCL fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BAP1 Deletion;CDKN2A Deletion;CDKN2B Deletion;VCL FGFR2-VCL fusion;FGFR2 FGFR2-VCL fusion	3	5
P-0004090	P-0004090-T01-IM5	Outside	FFPE	Biopsy	250	691	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R273H;AURKA Amplification;FGFR1 Amplification;MYC Amplification	1	4
P-0004091	P-0004091-T01-IM5	In-House	FFPE	Resection	250	990	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Trametinib,Cobimetinib(NF1 p.L1737*)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.L194R;NF1 p.L1737*;MET Amplification	3	3
P-0004092	P-0004092-T01-IM5	In-House	FFPE	Resection	250	814	50	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	TP53 p.R342*;PIK3CA p.E542K;KMT2D p.Q2800*;EPHA3 p.M1?;NSD1 p.Q2572*;PRKN p.W447*;AXIN1 p.R841*;NOTCH3 p.C608*;RB1 p.N133*;MYC Amplification	1	10
P-0004093	P-0004093-T01-IM5	Outside	FFPE	Resection	250	710	10	Matched	Primary	Vulva	Not Applicable	Tumor	VSC	Vaginal Cancer	Squamous Cell Carcinoma of the Vulva/Vagina					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	TP53 p.R213Q;RAF1 p.S257L;TP53 p.Y234*;ATRX p.E1065*;NOTCH1 p.R1984*;FAT1 p.T3326Rfs*2;CDKN2A p.H83Y	1	7
P-0004095	P-0004095-T01-IM5	Outside	FFPE	Biopsy	250	705	10	Matched	Primary	Uterus	Not Applicable	Tumor	UCCA	Gestational Trophoblastic Disease	Choriocarcinoma											0	0
P-0004096	P-0004096-T01-IM5	In-House	FFPE	Biopsy	157.3	318	10	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61P)				LEVEL_4	TP53 p.R175H;KRAS p.Q61P	1	2
P-0004097	P-0004097-T01-IM5	Outside	FFPE	Biopsy	250	618	10	Matched	Metastasis	Bone	Lung	Tumor	CHOS	Bone Cancer	Chondroblastic Osteosarcoma										SETD2 p.R1407Gfs*5;TP53 p.H178Tfs*69;KMT2D p.N2517Ifs*26;KMT2D p.R5340*;BCOR p.K1207Nfs*31;KMT2A p.K1773Vfs*8	0	6
P-0004098	P-0004098-T01-IM5	In-House	FFPE	Resection	250	530	60	Matched	Primary	Oral Cavity	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										TP53 p.Q165*;KMT2D p.A3403Qfs*18;KDM5A Amplification	0	3
P-0004099	P-0004099-T01-IM5	In-House	FFPE	Resection	250	652	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.S127P;FOXP1 Deletion	0	2
P-0004100	P-0004100-T01-IM5	Outside	FFPE	Biopsy	250	670	30	Matched	Primary	Bone	Not Applicable	Tumor	SFTCNS	CNS Cancer	Solitary Fibrous Tumor of the Central Nervous System					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	SUZ12 p.X599_splice;SUZ12 p.C653Sfs*12;CDKN2A Deletion;CDKN2B Deletion;KDM5C Deletion;NF1 Deletion;SUZ12 Deletion	2	7
P-0004101	P-0004101-T01-IM5	In-House	FFPE	Biopsy	250	649	50	Matched	Metastasis	Retroperitoneum	Epidural	Tumor	PGNG	Miscellaneous Neuroepithelial Tumor	Paraganglioma											0	0
P-0004102	P-0004102-T01-IM5	In-House	FFPE	Biopsy	250	330	60	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.X1487_splice;FUBP1 p.R65Kfs*12;SPOCK3 FAT1-SPOCK3 fusion;FAT1 FAT1-SPOCK3 fusion	1	5
P-0004103	P-0004103-T01-IM5	In-House	FFPE	Biopsy	250	691	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Trametinib,Cobimetinib(SND1 BRAF-SND1 fusion);Trametinib,Cobimetinib(BRAF BRAF-SND1 fusion)					LEVEL_3B	NKX2-1 Amplification;VEGFA Amplification;SND1 BRAF-SND1 fusion;BRAF BRAF-SND1 fusion	2	4
P-0004104	P-0004104-T01-IM5	Outside	FFPE	Biopsy	250	511	40	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537C)	Olaparib(ATM p.S2812Vfs*3)					LEVEL_3A	ESR1 p.Y537C;MAP2K4 p.R134W;ATM p.S2812Vfs*3;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	6
P-0004105	P-0004105-T01-IM5	In-House	FFPE	Resection	250	658	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A755delinsSMS)								LEVEL_1	TP53 p.R273C;EGFR p.L747_A755delinsSMS	1	2
P-0004106	P-0004106-T01-IM5	Outside	FFPE	Resection	250	654	20	Matched	Primary	Small Bowel	Not Applicable	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0004107	P-0004107-T01-IM5	In-House	FFPE	Resection	250	680	70	Matched	Metastasis	Pelvis	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.V143M;ATRX Deletion	0	2
P-0004108	P-0004108-T01-IM5	In-House	FFPE	Resection	96.5	466	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;ARID1A ARID1A-intragenic	2	2
P-0004109	P-0004109-T01-IM5	In-House	FFPE	Biopsy	199.8	364	20	Matched	Metastasis	Skin	In-transit	Tumor	ACRM	Melanoma	Acral Melanoma											0	0
P-0004110	P-0004110-T01-IM5	In-House	FFPE	Biopsy	250	793	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.S283*	2	2
P-0004111	P-0004111-T01-IM5	In-House	FFPE	Biopsy	250	580	30	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.V217F)				LEVEL_4	PTEN p.V217F;EP300 p.W1466C;BCL6 Amplification;PIK3CA Amplification	1	4
P-0004112	P-0004112-T01-IM5	In-House	FFPE	Biopsy	250	603	70	Matched	Metastasis	Lower Extremity	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.W53*;ATRX p.I1049Nfs*4;BMPR1A Deletion;CCNE1 Amplification;PTEN Deletion	1	5
P-0004113	P-0004113-T01-IM5	In-House	FFPE	Resection	250	737	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Ivosidenib(IDH1 p.R132C);Olaparib(ATM p.L2051Pfs*5)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;IDH1 p.R132C;ATM p.L2051Pfs*5;TP53 TP53-intragenic	4	4
P-0004114	P-0004114-T01-IM5	In-House	FFPE	Biopsy	250	685	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				BLU-667,Selpercatinib(RET p.M848V)					LEVEL_3B	KMT2C p.S2237*;RET p.M848V;FLCN p.K100*;PPP2R1A p.X554_splice;RBM10 p.E750*;PTPRT p.T987Qfs*9;BCL2L1 Amplification	1	7
P-0004115	P-0004115-T01-IM5	In-House	FFPE	Resection	250	441	NA	Matched	Metastasis	Pancreas	Bile Duct	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.E717D)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12A;SMAD4 p.R361C;AXIN1 p.R723*;TP53 p.D281Y;ERBB2 p.E717D;CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification	3	8
P-0004116	P-0004116-T01-IM5	In-House	FFPE	Biopsy	250	678	60	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.W91*;CDK6 Amplification;ERBB2 Amplification	2	3
P-0004117	P-0004117-T01-IM5	In-House	FFPE	Biopsy	250	734	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.T751_A755del)								LEVEL_1	TP53 p.Y163N;EGFR p.L747S;EGFR p.T751_A755del	1	3
P-0004118	P-0004118-T01-IM5	Outside	FFPE	Resection	250	385	60	Unmatched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)					LEVEL_3B	PIK3CA p.H1047L	1	1
P-0004119	P-0004119-T01-IM5	Outside	FFPE	Resection	250	816	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PTEN Deletion	3	4
P-0004120	P-0004120-T01-IM5	In-House	FFPE	Biopsy	132	587	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.A767_V769dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.A767_V769dup)			LEVEL_3A	EGFR p.A767_V769dup	1	1
P-0004121	P-0004121-T01-IM5	In-House	FFPE	Biopsy	250	576	30	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.L22Yfs*22;FGFR1 Amplification;KDM5A Amplification	1	3
P-0004121	P-0004121-T02-IM5	In-House	FFPE	Resection	250	694	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	MAP3K1 p.S748*;FGFR1 Amplification	1	2
P-0004122	P-0004122-T01-IM5	Outside	FFPE	Resection	250	802	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R249M;STAG2 p.X675_splice	0	2
P-0004123	P-0004123-T01-IM5	In-House	FFPE	Biopsy	250	651	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.V272L;CTNNB1 p.S33_A39del;EGFR Amplification	1	4
P-0004124	P-0004124-T01-IM5	In-House	FFPE	Biopsy	250	691	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(CHEK2 p.R117M)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;STK11 p.E130*;CHEK2 p.R117M;KEAP1 p.D529Pfs*44;PBRM1 p.E1132Rfs*11	2	5
P-0004125	P-0004125-T01-IM5	In-House	FFPE	Resection	250	512	40	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;TP53 p.R280T;ARID1A p.Q1403*;DDR2 Amplification;MCL1 Amplification	1	5
P-0004126	P-0004126-T02-IM5	In-House	FFPE	Resection	250	773	30	Matched	Primary	Sinus	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										ARID1A p.S1149*	0	1
P-0004127	P-0004127-T01-IM5	Outside	FFPE	Biopsy	250	515	50	Matched	Metastasis	Breast	Soft Tissue	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Olaparib(ATM p.W1805*)	GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_1	PIK3CA p.E542K;PTEN p.T319*;FGFR4 p.Y367C;TGFBR2 p.E311*;ATM p.W1805*;FOXA1 p.F266L;MGA p.S1983*;MAP3K1 p.K1119Nfs*4;BCL10 Deletion	4	9
P-0004128	P-0004128-T01-IM5	Outside	FFPE	Biopsy	141.9	242	20	Matched	Metastasis	Blood Vessel	Lung	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	KDR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification;TERT Amplification	1	5
P-0004129	P-0004129-T02-IM5	In-House	FFPE	Biopsy	250	1051	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	PIK3CA p.E545K;EGFR p.E709_T710delinsD;ARID2 p.X63_splice;RBM10 p.E215*;AMER1 p.E283*;MED12 p.X1800_splice;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	9
P-0004129	P-0004129-T01-IM5	Outside	FFPE	Biopsy	250	486	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	PIK3CA p.E545K;EGFR p.E709_T710delinsD;ARID2 p.X63_splice;RBM10 p.E215*;AMER1 p.E283*;MED12 p.X1800_splice;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ETV1 Amplification;RAC1 Amplification	3	11
P-0004130	P-0004130-T01-IM5	In-House	FFPE	Cytology	250	1031	40	Matched	Metastasis	Auditory Canal	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										TP53 p.C275F;LATS1 p.D881Ifs*11;EPHA7 p.R172Tfs*35	0	3
P-0004130	P-0004130-T02-IM5	Outside	FFPE	Biopsy	250	531	60	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.C275F;LATS1 p.D881Ifs*11;EPHA7 p.R172Tfs*35;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion	1	6
P-0004131	P-0004131-T01-IM5	In-House	FFPE	Cytology	250	741	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										KEAP1 p.R272C;TP53 p.R267L	0	2
P-0004132	P-0004132-T01-IM5	In-House	FFPE	Biopsy	250	573	40	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)								LEVEL_1	BRAF p.V600K;BRAF Amplification	1	2
P-0004133	P-0004133-T01-IM5	Outside	FFPE	Biopsy	250	775	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Palbociclib,Abemaciclib(CDK4 Amplification);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	TP53 p.E349*;CDK4 Amplification;ERBB2 Amplification;FGFR1 Amplification;GLI1 Amplification	4	5
P-0004135	P-0004135-T01-IM5	In-House	FFPE	Resection	250	574	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	UCCA	Gestational Trophoblastic Disease	Choriocarcinoma										SMAD4 p.G476Sfs*19	0	1
P-0004136	P-0004136-T01-IM5	In-House	FFPE	Biopsy	250	574	50	Matched	Metastasis	Uterus	Vagina	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.I1058L);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.X71_splice);Olaparib(ATM p.R337C)	GSK2636771,AZD8186(PTEN p.D268Gfs*30)				LEVEL_3B	PIK3CA p.E542K;PTEN p.D268Gfs*30;CTCF p.R377C;BRCA1 p.X71_splice;ATM p.R337C;ACVR1 p.G356D;CTNNB1 p.S33A;CTCF p.K209Rfs*13;PAX5 p.A322Lfs*11	5	9
P-0004137	P-0004137-T01-IM5	In-House	FFPE	Biopsy	250	480	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E970K);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.G2078Ifs*2);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.Y163C;TP53 p.E285K;PIK3CA p.E970K;RUNX1 p.Q256*;RBM10 p.Q267*;MEN1 p.R115Gfs*67;FOXA1 p.S36Lfs*191;BRCA2 p.G2078Ifs*2;ERBB2 Amplification	3	9
P-0004138	P-0004138-T01-IM5	In-House	FFPE	Biopsy	250	566	30	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0004139	P-0004139-T01-IM5	In-House	FFPE	Biopsy	250	670	10	Matched	Primary	Vagina	Not Applicable	Tumor	VSC	Vaginal Cancer	Squamous Cell Carcinoma of the Vulva/Vagina										FBXW7 p.V37Sfs*24	0	1
P-0004140	P-0004140-T01-IM5	In-House	FFPE	Biopsy	250	627	50	Matched	Metastasis	Transverse Colon	Abdomen	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SMAD4 p.X79_splice;TP53 Deletion;RNF43 RNF43-intragenic	3	4
P-0004140	P-0004140-T02-IM5	In-House	DNA	Biopsy	127.6	578	10	Matched	Metastasis	Transverse Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SMAD4 p.X79_splice;TP53 TP53-intragenic	3	3
P-0004140	P-0004140-T03-IM5	Outside	FFPE	Resection	250	714	50	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SMAD4 p.X79_splice;CARD11 Amplification;CCND3 Amplification;VEGFA Amplification;TP53 TP53-intragenic	3	6
P-0004141	P-0004141-T01-IM5	In-House	FFPE	Resection	250	633	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										VHL p.S65T;MEN1 p.D158Tfs*32	0	2
P-0004142	P-0004142-T01-IM5	In-House	FFPE	Resection	250	725	60	Matched	Metastasis	Skin	Subcutaneous Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	RAC1 p.P29S;CTNNB1 p.S37Y;NRAS p.Q61K;ARID2 p.Q961*;ARID1B Deletion	1	5
P-0004143	P-0004143-T01-IM5	Outside	FFPE	Resection	250	184	10	Matched	Primary	Lung	Not Applicable	Tumor	EHAE	Soft Tissue Sarcoma	Epithelioid Hemangioendothelioma											0	0
P-0004145	P-0004145-T01-IM5	In-House	FFPE	Resection	250	542	20	Matched	Metastasis	Pelvis	Blood Vessel	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0004146	P-0004146-T01-IM5	In-House	FFPE	Biopsy	172.2	710	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.S59*);GSK2636771,AZD8186(PTEN p.C211*)				LEVEL_1	PIK3CA p.E545K;TP53 p.R213*;EGFR p.E746_A750del;FBXW7 p.R465C;PTEN p.S59*;PTEN p.C211*;ERBB2 Amplification;RB1 Deletion;TERT Amplification	5	9
P-0004147	P-0004147-T01-IM5	In-House	FFPE	Resection	250	659	70	Matched	Metastasis	Small Bowel	Liver	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0004148	P-0004148-T01-IM5	In-House	FFPE	Resection	250	527	40	Matched	Primary	Retroperitoneum	Jejunum	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0004149	P-0004149-T01-IM5	Outside	FFPE	Resection	250	517	20	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0004150	P-0004150-T01-IM5	In-House	FFPE	Resection	250	527	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										NF2 p.Q470*;BAP1 p.L216Afs*48	0	2
P-0004151	P-0004151-T01-IM5	In-House	FFPE	Cytology	250	728	50	Matched	Metastasis	Breast	Pleural Fluid	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0004152	P-0004152-T01-IM5	In-House	FFPE	Biopsy	250	708	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.K132N;JAK1 p.X751_splice;EP300 p.G1375V;BMPR1A Deletion;PTEN Deletion	1	5
P-0004153	P-0004153-T01-IM5	In-House	FFPE	Biopsy	250	638	50	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ARID1A p.X1239_splice;TP53 p.G108Vfs*13;PIK3R1 p.R557Qfs*7;KDM6A p.G904Wfs*4	0	4
P-0004154	P-0004154-T01-IM5	Outside	FFPE	Resection	250	688	40	Matched	Primary	Ileum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer										PPP2R1A p.R183Q;TP53 p.A39Mfs*3	0	2
P-0004155	P-0004155-T01-IM5	In-House	FFPE	Resection	250	438	10	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049A)					LEVEL_3B	PIK3CA p.G1049A;TP53 p.I251S	1	2
P-0004156	P-0004156-T01-IM5	In-House	FFPE	Biopsy	250	500	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	AWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumor of the Appendix											0	0
P-0004157	P-0004157-T01-IM5	In-House	FFPE	Resection	250	708	50	Matched	Metastasis	Colon	Soft Tissue	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor					Trametinib,Cobimetinib(NF1 p.Y489C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.Y489C;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0004158	P-0004158-T01-IM5	In-House	FFPE	Biopsy	250	493	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G245D;FGFR2 Amplification	0	2
P-0004159	P-0004159-T01-IM5	In-House	FFPE	Biopsy	250	744	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.R216*;ARID1A p.Q1947*	1	3
P-0004160	P-0004160-T01-IM5	Outside	FFPE	Biopsy	250	143	10	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.A161D;RUNX1 p.L201Afs*28;ERBB2 Amplification	2	3
P-0004161	P-0004161-T01-IM5	In-House	FFPE	Resection	250	668	60	Matched	Metastasis	Rectum	Uterus	Tumor	RWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumor of the Rectum										STAG2 p.X1224_splice;CDKN1B p.S125*	0	2
P-0004162	P-0004162-T01-IM5	Outside	FFPE	Biopsy	250	828	30	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma										RB1 p.S414Kfs*14	0	1
P-0004163	P-0004163-T01-IM5	In-House	FFPE	Resection	250	527	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										PRKN Deletion;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	3
P-0004164	P-0004164-T01-IM5	Outside	FFPE	Resection	250	902	50	Matched	Metastasis	Uterus	Lung	Tumor	HGESS	Uterine Sarcoma	High-Grade Endometrial Stromal Sarcoma										CEBPA NELL1-CEBPA fusion;NELL1 NELL1-CEBPA fusion	0	2
P-0004165	P-0004165-T01-IM5	Outside	FFPE	Resection	250	318	50	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.E180K;TBX3 p.P48Lfs*56	2	3
P-0004166	P-0004166-T01-IM5	Outside	FFPE	Cytology	125.4	267	70	Matched	Metastasis	Cervix	Ascites	Tumor	GCEMU	Cervical Cancer	Gastric Type Mucinous Carcinoma				Tipifarnib(HRAS p.G12V)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_3B	GNAS p.R201H;HRAS p.G12V;MGA p.R2490*;TP53 p.G199_E204del;CDKN2A p.Y44*;CDK6 Amplification;FAT1 Deletion;KDM6A Deletion;KRAS Amplification	2	9
P-0004167	P-0004167-T01-IM5	Outside	FFPE	Resection	250	501	60	Matched	Metastasis	Ovary	Vagina	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer											0	0
P-0004168	P-0004168-T01-IM5	In-House	FFPE	Biopsy	250	704	50	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.C242F;TBX3 p.H246Qfs*13;ARID1B Deletion;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;FGFR2 Amplification;MYCN Amplification;PAK1 Amplification;PRKN Deletion;ROS1 Amplification	1	11
P-0004169	P-0004169-T01-IM5	In-House	FFPE	Biopsy	250	720	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010H)	Crizotinib(MET p.D1010H)	Cabozantinib(MET p.D1010H)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.D1010H;RBM10 p.S738Rfs*63;CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;GLI1 Amplification;MDM2 Amplification	5	7
P-0004170	P-0004170-T01-IM5	In-House	FFPE	Biopsy	250	673	30	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.F119L	0	1
P-0004172	P-0004172-T01-IM5	Outside	FFPE	Biopsy	250	715	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R175H;APC p.R499*;SOX9 p.Q500Hfs*74;AMER1 p.G76*;MED12 p.X1510_splice;APC p.G1499Dfs*8	1	7
P-0004173	P-0004173-T01-IM5	Outside	FFPE	Resection	250	327	20	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.Q149*);GSK2636771,AZD8186(PTEN p.F145Lfs*34)				LEVEL_4	BCOR p.N1459S;PTEN p.Q149*;CTNNB1 p.G34E;PIK3R1 p.X580_splice;PTEN p.F145Lfs*34	2	5
P-0004174	P-0004174-T01-IM5	In-House	FFPE	Resection	250	609	20	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.P151S;EP300 p.Y1397H	0	2
P-0004175	P-0004175-T01-IM5	In-House	FFPE	Biopsy	250	724	20	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.L130R;MRE11 p.X367_splice	0	2
P-0004176	P-0004176-T01-IM5	In-House	FFPE	Biopsy	250	839	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.Q192*;TP53 p.R280T;EP300 p.Q1455H	0	3
P-0004177	P-0004177-T01-IM5	In-House	FFPE	Biopsy	250	788	50	Matched	Primary	Lymph node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										TET2 p.R1516*;RHOA p.G17V;TET2 p.R1359S	0	3
P-0004178	P-0004178-T01-IM5	In-House	FFPE	Biopsy	250	480	30	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	NCOR1 p.I239Mfs*45;FGFR1 Amplification;MYCL Amplification	1	3
P-0004179	P-0004179-T01-IM5	In-House	FFPE	Resection	250	529	40	Matched	Primary	Rectum	Not Applicable	Tumor	RWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumor of the Rectum										CDKN1B p.A98Cfs*27	0	1
P-0004180	P-0004180-T01-IM5	Outside	FFPE	Cytology	110	172	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_1	AKT1 Amplification;ERBB2 Amplification;FGFR1 Amplification;NF1 Deletion	4	4
P-0004181	P-0004181-T01-IM5	In-House	FFPE	Biopsy	250	814	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										KMT2C p.N3695Ifs*4;TP53 p.M133Ifs*12;CDH1 p.N315Kfs*41;SPEN p.T791Rfs*2;CDKN1B Deletion	0	5
P-0004182	P-0004182-T01-IM5	In-House	FFPE	Biopsy	250	433	50	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.R213*;NSD1 p.Q1058Sfs*5;MYC Amplification;PIK3R2 Amplification	2	5
P-0004183	P-0004183-T01-IM5	In-House	FFPE	Biopsy	250	519	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;NCOR1 p.X391_splice	1	2
P-0004183	P-0004183-T02-IM5	In-House	DNA	Biopsy	250	1007	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	AKT1 p.E17K;ESR1 p.D538G	2	2
P-0004183	P-0004183-T03-IM5	In-House	FFPE	Biopsy	250	985	20	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS			AZD5363(AKT1 p.E17K);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	AKT1 p.E17K;ESR1 p.D538G	2	2
P-0004184	P-0004184-T01-IM5	Outside	FFPE	Resection	250	327	20	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0004185	P-0004185-T01-IM5	In-House	FFPE	Resection	250	285	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.Y328Tfs*45	0	1
P-0004186	P-0004186-T01-IM5	In-House	FFPE	Biopsy	250	636	20	Matched	Metastasis	Minor Salivary Gland	Orbit	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										EPHA7 Deletion	0	1
P-0004187	P-0004187-T01-IM5	In-House	FFPE	Biopsy	250	714	70	Matched	Metastasis	Breast	Stomach	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.E970K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E970K)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.E970K;SPEN p.S2292*;CDH1 p.G134*;ARID1A p.G945Dfs*23	4	5
P-0004188	P-0004188-T01-IM5	Outside	FFPE	Resection	250	791	10	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				Olaparib(ATM p.K2303Rfs*7)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PTPRT p.R999*;GNAS p.R201C;SMARCA4 p.X813_splice;KMT2D p.P4684Lfs*113;KMT2D p.N4208Tfs*7;ATM p.K2303Rfs*7	2	7
P-0004189	P-0004189-T01-IM5	Outside	FFPE	Biopsy	159	568	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.R1751L)					LEVEL_3B	POLE p.E18K;KEAP1 p.G570*;DNMT3A p.X618_splice;SETD2 p.W1640C;FAT1 p.X3881_splice;RAD50 p.E500*;BRCA1 p.R1751L;PTPRT p.E181*;RBM10 p.E829*;PBRM1 p.Q167Kfs*7;ERCC3 p.L170Ffs*9;AMER1 p.D307Gfs*17;TP53 p.S116Ffs*7;CCND3 Amplification;VEGFA Amplification	1	15
P-0004190	P-0004190-T01-IM5	Outside	FFPE	Biopsy	250	855	60	Matched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										CREBBP p.S1680del;PIM1 p.G28D;KMT2D p.Q2514*;KMT2D p.K1077Sfs*5	0	4
P-0004191	P-0004191-T01-IM5	Outside	FFPE	Resection	250	531	40	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;PTPRD p.W775*;CDH1 p.X765_splice	2	3
P-0004192	P-0004192-T02-IM5	In-House	FFPE	Resection	250	750	10	Matched	Primary	Ileocecal Valve	Not Applicable	Tumor	SRAP	Appendiceal Cancer	Signet Ring Cell Type of the Appendix											0	0
P-0004192	P-0004192-T01-IM5	Outside	FFPE	Resection	250	656	20	Matched	Metastasis	Appendix	Colon	Tumor	GCCAP	Appendiceal Cancer	Goblet Cell Carcinoid of the Appendix											0	0
P-0004193	P-0004193-T01-IM5	In-House	FFPE	Resection	250	512	70	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0004194	P-0004194-T01-IM5	In-House	FFPE	Biopsy	250	688	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.R337C;NCOR1 p.Q800*;FUBP1 p.R430H;CBFB -55fs;MAP2K4 p.K322Tfs*6	2	6
P-0004195	P-0004195-T02-IM5	In-House	FFPE	Biopsy	250	1197	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.R174G;GATA3 p.N331Efs*21;SMAD4 p.R361L;FGFR4 Amplification;PPM1D Amplification;TERT Amplification	1	7
P-0004195	P-0004195-T01-IM5	Outside	FFPE	Biopsy	119.78	304	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;SMAD4 p.C363R;TP53 p.R174G;GATA3 p.N331Efs*21;FGFR4 Amplification;MAP2K4 Deletion;NCOR1 Deletion;PPM1D Amplification;TERT Amplification	1	9
P-0004196	P-0004196-T01-IM5	Outside	FFPE	Resection	250	390	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;FOXA1 p.I176V;MAP2K4 p.K187*;NCOR1 p.S879Ffs*8;FOXA1 Amplification	2	5
P-0004197	P-0004197-T01-IM5	In-House	FFPE	Biopsy	250	710	60	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)						LEVEL_1	FGFR3 p.Y373C;KMT2D p.X5308_splice;STAG2 p.X340_splice	2	3
P-0004198	P-0004198-T01-IM5	In-House	FFPE	Resection	250	546	80	Matched	Primary	Lower Extremity	Lower Extremity	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;NF1 Deletion	2	3
P-0004199	P-0004199-T01-IM5	In-House	FFPE	Biopsy	250	697	60	Matched	Primary	Groin	Not Applicable	Tumor	EPIS	Soft Tissue Sarcoma	Epithelioid Sarcoma	Tazemetostat(SMARCB1 Deletion)								LEVEL_1	SMARCB1 Deletion	1	1
P-0004200	P-0004200-T01-IM5	In-House	FFPE	Biopsy	250	635	30	Matched	Primary	Leg	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma				Enasidenib(IDH2 p.R172S)					LEVEL_3B	IDH2 p.R172S	1	1
P-0004201	P-0004201-T01-IM5	Outside	FFPE	Biopsy	250	667	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A;TP53 p.D281Y;PIK3R1 p.V671Hfs*15;SUZ12 Deletion	1	4
P-0004202	P-0004202-T01-IM5	Outside	FFPE	Biopsy	250	639	10	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.Y772_A775dup)					LEVEL_3B	ERBB2 p.Y772_A775dup;ARID1A p.D734Gfs*83	1	2
P-0004203	P-0004203-T01-IM5	In-House	FFPE	Biopsy	250	701	50	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(CDK5RAP2 BRAF-CDK5RAP2 fusion);Trametinib,Cobimetinib(BRAF BRAF-CDK5RAP2 fusion)		GSK2636771,AZD8186(PTEN p.W111S)				LEVEL_3A	PTEN p.W111S;CDK4 p.K22M;TP53 p.M160_Y163delinsIG;MITF Amplification;CDK5RAP2 BRAF-CDK5RAP2 fusion;BRAF BRAF-CDK5RAP2 fusion	3	6
P-0004204	P-0004204-T01-IM5	In-House	FFPE	Biopsy	250	578	70	Matched	Metastasis	Uterus	Pelvis	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R213*;FBXW7 p.R479Q;TP53 p.C242W;DICER1 p.D1810V;CCNE1 Amplification;FGFR1 Amplification;RAD21 Deletion	1	7
P-0004205	P-0004205-T01-IM5	Outside	FFPE	Biopsy	250	234	60	Matched	Metastasis	Kidney	Brain	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BAP1 p.N330Tfs*5;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0004206	P-0004206-T01-IM5	Outside	FFPE	Biopsy	250	695	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.L348W	1	2
P-0004207	P-0004207-T01-IM5	Outside	FFPE	Biopsy	250	804	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.L177V)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3A	KRAS p.G12D;MAP2K1 p.L177V;CIC p.Q835Hfs*81	2	3
P-0004208	P-0004208-T01-IM5	Outside	FFPE	Resection	250	751	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;ARID5B p.A505Efs*33;MDM2 Amplification	2	3
P-0004209	P-0004209-T01-IM5	In-House	FFPE	Resection	250	574	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										KDR Amplification;KIT Amplification;PDGFRA Amplification	0	3
P-0004210	P-0004210-T01-IM5	Outside	FFPE	Resection	250	594	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.X307_splice;AKT2 Amplification;CCNE1 Amplification;CD274 Amplification;ERBB2 Amplification;GATA3 Amplification;JAK2 Amplification	2	7
P-0004211	P-0004211-T01-IM5	Outside	FFPE	Resection	250	731	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;CTNNB1 p.D32N;MAX p.X99_splice	2	3
P-0004212	P-0004212-T01-IM5	Outside	FFPE	Biopsy	250	544	70	Matched	Metastasis	Kidney	Pleura	Tumor	CDRCC	Renal Cell Carcinoma	Collecting Duct Renal Cell Carcinoma					Tazemetostat(SMARCB1 p.E24Gfs*50)				LEVEL_4	TP53 p.R273C;SMARCB1 p.E24Gfs*50	1	2
P-0004213	P-0004213-T01-IM5	In-House	FFPE	Cytology	250	603	60	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.V274G;AKT3 Amplification;CCND3 Amplification;IKBKE Amplification;MDM4 Amplification;VEGFA Amplification;ZFHX3 AGBL1-ZFHX3 fusion;AGBL1 AGBL1-ZFHX3 fusion	0	8
P-0004214	P-0004214-T01-IM5	Outside	FFPE	Biopsy	137.24	373	70	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L);Trametinib,Cobimetinib(MAP2K1 p.E203K)	Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S2303F)					LEVEL_3A	NRAS p.Q61L;MAP2K1 p.E203K;SMARCA4 p.X813_splice;KDR p.A1065T;ARID2 p.R542*;ARID2 p.Q983*;BRCA2 p.S2303F;PTPRT p.Q228*	3	8
P-0004215	P-0004215-T01-IM5	Outside	FFPE	Resection	250	450	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										NFE2L2 p.T80R;TP53 p.F212_H214del;BCL2L1 Amplification;CCND1 Amplification;FGF19 Amplification;KDM5A Amplification;KMT2D FAM19A2-MLL2 fusion;FAM19A2 FAM19A2-MLL2 fusion	0	8
P-0004216	P-0004216-T01-IM5	In-House	FFPE	Biopsy	250	384	30	Matched	Metastasis	Breast	Bone	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										AURKA Amplification;MYC Amplification	0	2
P-0004217	P-0004217-T01-IM5	In-House	FFPE	Biopsy	250	606	70	Matched	Primary	Sacrum	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										SF3B1 p.R625H;FANCC p.P541Mfs*7	0	2
P-0004218	P-0004218-T01-IM5	Outside	FFPE	Biopsy	250	547	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	CDKN2A Deletion;CDKN2B Deletion;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	3	4
P-0004219	P-0004219-T01-IM5	In-House	FFPE	Resection	250	515	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	GNAS p.R201C;KRAS p.G13D;SMAD4 p.D537Y	1	3
P-0004220	P-0004220-T01-IM5	Outside	FFPE	Biopsy	250	301	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AZD5363(AKT1 p.E17K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Everolimus,Temsirolimus(MTOR p.R2505P)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	AKT1 p.E17K;KRAS p.G12D;APC p.R876*;APC p.Q1444*;MTOR p.R2505P;SMAD2 p.R321Q;SMAD4 p.W524C;SMAD3 p.L15Afs*79;SOX9 p.P404Sfs*59	3	9
P-0004221	P-0004221-T01-IM5	Outside	FFPE	Resection	250	426	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R273C;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0004222	P-0004222-T01-IM5	Outside	FFPE	Biopsy	250	647	10	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88Gfs*32)				LEVEL_4	KRAS p.G12D;SMAD4 p.C443*;KDM6A p.X292_splice;TP53 p.V218dup;CDKN2A p.E88Gfs*32	2	5
P-0004223	P-0004223-T01-IM5	In-House	FFPE	Biopsy	250	145	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										TP53 p.W53*;SETD2 p.Q2266*;MEN1 p.W428*;SMAD4 p.X83_splice;DAXX p.A406Rfs*11	0	5
P-0004224	P-0004224-T01-IM5	In-House	FFPE	Biopsy	250	799	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.X122_splice);Olaparib(BARD1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;TP53 p.R280T;FBXW7 p.R479G;TSC1 p.X122_splice;BARD1 Deletion;CDKN2A Deletion;CDKN2B Deletion;RBM10 FLJ22536-RBM10 fusion;FLJ22536 FLJ22536-RBM10 fusion	5	9
P-0004225	P-0004225-T01-IM5	Outside	FFPE	Resection	250	809	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0004226	P-0004226-T01-IM5	In-House	FFPE	Biopsy	250	473	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Trametinib,Cobimetinib,Binimetinib(KRAS p.L19F)				LEVEL_4	KRAS p.G12R;KRAS p.L19F;RAF1 p.S259F	2	3
P-0004227	P-0004227-T01-IM5	In-House	FFPE	Biopsy	250	549	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ARID1A p.D1196Efs*17;FGFR1 Amplification;NTRK1 Amplification;TERT Amplification	1	4
P-0004228	P-0004228-T01-IM5	In-House	FFPE	Biopsy	67	193	40	Matched	Metastasis	GE Junction	Liver	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.X125_splice;TP53 p.E294*;NFE2L2 p.G81D;FAT1 p.Q4324*;CD274 Amplification;CDKN2A Deletion;CDKN2B Deletion;HRAS Amplification;JAK2 Amplification;MYC Amplification	1	10
P-0004229	P-0004229-T01-IM5	In-House	FFPE	Resection	250	487	50	Matched	Primary	Breast	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344M)					LEVEL_3B	PIK3CA p.V344M;KDR p.T771R	1	2
P-0004230	P-0004230-T01-IM5	Outside	FFPE	Cytology	250	703	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)						LEVEL_3A	TP53 p.W53*;BCL2L1 Amplification;FGFR1 Amplification	1	3
P-0004231	P-0004231-T02-IM5	In-House	FFPE	Cytology	250	610	50	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ARID5B p.E815Rfs*12;MDM4 Amplification	0	2
P-0004231	P-0004231-T01-IM5	In-House	FFPE	Resection	250	951	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ARID5B p.E815Rfs*12;ANKRD11 Deletion;AR Amplification;IKBKE Amplification;MDM4 Amplification;MYC Amplification;ZFHX3 Deletion	0	7
P-0004232	P-0004232-T01-IM5	Outside	FFPE	Resection	250	496	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345Y)					LEVEL_1	EGFR p.L858R;TP53 p.R273H;RB1 p.R445*;PIK3CA p.N345Y	2	4
P-0004233	P-0004233-T01-IM5	In-House	FFPE	Biopsy	250	1173	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification);Olaparib(CHEK2 Deletion);Tazemetostat(SMARCB1 Deletion)	Lapatinib(EGFR Amplification)				LEVEL_3B	TP53 p.S127F;ATRX p.R2407*;CDK4 Amplification;CHEK2 Deletion;EGFR Amplification;GLI1 Amplification;SMARCB1 Deletion	4	7
P-0004234	P-0004234-T01-IM5	Outside	FFPE	Resection	250	846	60	Matched	Primary	Abdomen	Not Applicable	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0004235	P-0004235-T01-IM5	In-House	FFPE	Resection	250	372	70	Matched	Metastasis	Intraabdominal	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.P551_Y553delinsH)								LEVEL_1	KIT p.P551_Y553delinsH;TNFRSF14 Deletion	1	2
P-0004236	P-0004236-T01-IM5	Outside	FFPE	Resection	250	321	50	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)	Ivosidenib(IDH1 p.R132C)	Trametinib,Cobimetinib(NF1 p.K1581*)				LEVEL_3A	IDH1 p.R132C;NRAS p.Q61L;NF1 p.K1581*;PBRM1 p.X1292_splice	3	4
P-0004237	P-0004237-T01-IM5	In-House	FFPE	Resection	250	147	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K);Neratinib(ERBB2 p.T862A)	Ado-Trastuzumab Emtansine(ERBB2 p.T862A);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.N345K;ERBB2 p.T862A;PPP2R1A p.R182W;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	5	7
P-0004238	P-0004238-T01-IM5	In-House	FFPE	Resection	250	447	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;MYC Amplification	1	2
P-0004239	P-0004239-T01-IM5	Outside	FFPE	Biopsy	250	364	20	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										MSH2 p.Q429*;FAT1 p.W805*;ARID2 p.Q725*;KMT2D p.Q2388*;FAT1 p.Y4519Lfs*30;FAT1 p.F1363Lfs*5;NOTCH1 p.X672_splice	0	7
P-0004240	P-0004240-T01-IM5	Outside	FFPE	Resection	250	714	30	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(KDM6A p.D1092Mfs*12)				LEVEL_3B	PIK3CA p.E545K;KDM6A p.D1092Mfs*12;MDM2 Amplification;RAF1 Amplification	3	4
P-0004241	P-0004241-T01-IM5	Outside	FFPE	Resection	250	543	50	Matched	Primary	Liver	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										FGFR3 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification;PTPRD Deletion;TP53 Deletion	0	6
P-0004242	P-0004242-T01-IM5	Outside	FFPE	Resection	250	403	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R175H;IDH1 p.R132H;TP53 p.R306*;ATRX p.R907*;RB1 p.X405_splice;PBRM1 p.K485Sfs*14;CBL Deletion;CCND1 Amplification;DIS3 Deletion;EED Deletion;FGF19 Amplification;FOXO1 Deletion;MRE11 Deletion;MYCN Amplification;NPM1 Deletion;RB1 Deletion;DLAT MLL-DLAT fusion;KMT2A MLL-DLAT fusion	1	18
P-0004243	P-0004243-T01-IM5	In-House	FFPE	Biopsy	250	358	70	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.Q612*)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q612*)				LEVEL_1	CDK12 p.Q612*;FOXA1 p.L260Ffs*61;FOXA1 Amplification;MYC Amplification	2	4
P-0004244	P-0004244-T01-IM5	Outside	FFPE	Biopsy	250	555	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.X125_splice;EGFR Amplification	0	2
P-0004245	P-0004245-T01-IM5	In-House	FFPE	Biopsy	238	761	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.R273L;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ETV1 Amplification	2	5
P-0004246	P-0004246-T01-IM5	Outside	FFPE	Biopsy	250	531	50	Matched	Metastasis	Breast	Bladder	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.R130P)				LEVEL_4	PTEN p.R130P;TP53 p.E180*;CDH1 p.W103*;MAP2K4 p.R228T;TBX3 p.N211Qfs*16	1	5
P-0004247	P-0004247-T01-IM5	Outside	FFPE	Resection	250	725	30	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										KDM5C p.S1250*	0	1
P-0004248	P-0004248-T01-IM5	In-House	FFPE	Biopsy	250	360	30	Matched	Metastasis	Kidney	Lymph Node	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ARID1A p.R110Efs*3;ARID1A p.T1470Sfs*19	1	3
P-0004248	P-0004248-T02-IM5	Outside	DNA	Resection	250	516	30	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma		Cabozantinib(MET Amplification)		Crizotinib(MET Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_2	KRAS p.G12D;ARID1A p.R110Efs*3;ARID1A p.T1470Sfs*19;MET Amplification	3	4
P-0004249	P-0004249-T01-IM5	Outside	FFPE	Resection	250	624	40	Matched	Metastasis	Colorectal NOS	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;FLT3 p.E858K;SMAD4 p.E307*;TBX3 p.G302Dfs*38;TP53 p.N210Tfs*7;CDKN2A Deletion;CDKN2B Deletion	2	7
P-0004250	P-0004250-T01-IM5	In-House	FFPE	Biopsy	214	1217	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										FAT1 p.X3451_splice;TP53 p.P72Lfs*51	0	2
P-0004251	P-0004251-T01-IM5	In-House	FFPE	Resection	250	363	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.R1450*;PIK3R1 p.K567E;TP53 p.L93Vfs*55;APC p.K758*	1	5
P-0004252	P-0004252-T01-IM5	Outside	FFPE	Biopsy	113.4	511	30	Matched	Metastasis	Bile Duct	Liver	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.L43*;SMAD4 p.K113Ifs*7;MET Amplification	1	3
P-0004253	P-0004253-T01-IM5	Outside	FFPE	Resection	250	475	60	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;FOXP1 p.S448L;CTCF p.Q26*	1	3
P-0004255	P-0004255-T01-IM5	In-House	FFPE	Resection	250	356	30	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	GSK2636771,AZD8186(PTEN p.K164Rfs*3)				LEVEL_3B	PTCH1 p.S1203Afs*52;BCOR p.N1459S;PIK3CA p.H1047R;RNF43 p.G659Vfs*41;ARID1A p.R693*;PIK3CA p.R88Q;NFE2L2 p.G81R;PTEN p.K164Rfs*3;PIK3R1 p.D708Lfs*8;RECQL4 p.H81Ifs*2;ZFHX3 p.S1993Ffs*36;KDM6A p.N634Tfs*57	4	12
P-0004256	P-0004256-T01-IM5	In-House	FFPE	Biopsy	250	190	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C;ATRX p.T1346*;TP53 p.P142dup	1	3
P-0004257	P-0004257-T01-IM5	In-House	FFPE	Biopsy	250	1135	70	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Tazemetostat(KDM6A p.H848Rfs*17);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_1	PIK3CA p.E542K;FGFR3 p.Y373C;KMT2A p.P2181Lfs*29;KDM6A p.H848Rfs*17;CDKN2A p.R80*	5	5
P-0004257	P-0004257-T02-IM5	In-House	FFPE	Resection	250	638	70	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Tazemetostat(KDM6A p.H848Rfs*17);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_1	PIK3CA p.E542K;FGFR3 p.Y373C;KMT2A p.P2181Lfs*29;KDM6A p.H848Rfs*17;CDKN2A p.R80*	5	5
P-0004258	P-0004258-T01-IM5	In-House	FFPE	Biopsy	250	549	10	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SOX9 p.C72Lfs*180	1	2
P-0004259	P-0004259-T01-IM5	In-House	FFPE	Resection	250	397	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.R273H;IDH1 p.R132H;ATRX p.K1583Nfs*22;TP53 p.K132E;CDK4 Amplification	2	5
P-0004260	P-0004260-T01-IM5	In-House	FFPE	Biopsy	250	512	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Everolimus(TSC2 p.G654Lfs*2);Olaparib(CHEK2 p.P90Lfs*20);Everolimus(TSC2 p.F298Lfs*65)	Tazemetostat(KDM6A p.R658*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_1	EP300 p.M1470Cfs*26;FBXW7 p.R465H;TSC2 p.G654Lfs*2;SMARCA4 p.R1135W;FGFR3 p.R248C;SMARCA4 p.R1093*;ASXL1 p.G645Vfs*58;KMT2C p.K2797Rfs*26;PAX5 p.A322Lfs*11;PPP2R1A p.R182W;MSH2 p.D603Y;KDM6A p.R658*;CHEK2 p.P90Lfs*20;NOTCH3 p.G2035Vfs*50;KMT2D p.L4089Afs*17;KMT2D p.R845Pfs*3;CREBBP p.E1061Rfs*4;SUZ12 p.T596Nfs*6;CASP8 p.D363Gfs*2;TSC2 p.F298Lfs*65;CDKN2A p.R58*	7	21
P-0004260	P-0004260-T02-IM5	In-House	FFPE	Resection	250	456	40	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Olaparib(ATM p.K2811Sfs*46)					LEVEL_1	CREBBP p.I1084Sfs*15;FBXW7 p.R465H;SMARCA4 p.L1161Sfs*3;KMT2C p.R1351Gfs*23;ATM p.K2811Sfs*46;FGFR3 p.R248C;KMT2D p.A221Lfs*40;KMT2D p.G1235Vfs*95;KMT2C p.R2139*;MSH2 p.W764*;NCOA3 p.R80C;KMT2D p.A2119Lfs*25;GATA3 p.S402Pfs*3	3	13
P-0004261	P-0004261-T01-IM5	In-House	FFPE	Biopsy	125.4	307	40	Matched	Metastasis	Uterus	Abdomen	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.X125_splice	0	1
P-0004262	P-0004262-T01-IM5	In-House	DNA	Resection	250	600	50	Unmatched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.X126_splice	0	1
P-0004263	P-0004263-T01-IM5	In-House	FFPE	Biopsy	250	489	70	Matched	Primary	Lung	Not Applicable	Tumor	SPCC	Non-Small Cell Lung Cancer	Spindle Cell Carcinoma of the Lung										STK11 p.P179L;TP53 p.G244C;PPM1D p.R528*;SMARCA4 p.S828Lfs*117;CCNE1 Amplification;EGFR Amplification;ETV1 Amplification;RAC1 Amplification	0	8
P-0004264	P-0004264-T01-IM5	In-House	FFPE	Cytology	250	746	10	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.E380Q)						LEVEL_1	TP53 p.R248Q;PIK3CA p.H1047R;ESR1 p.E380Q	3	3
P-0004265	P-0004265-T01-IM5	In-House	FFPE	Biopsy	250	565	80	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	RUNX1 p.R142Kfs*44;CDH1 p.K268*;CCNE1 Amplification;FGFR1 Amplification;KRAS Amplification	1	5
P-0004266	P-0004266-T01-IM5	In-House	FFPE	Resection	250	648	40	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF2 p.X38_splice;BRD4 Amplification;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0004267	P-0004267-T01-IM5	Outside	FFPE	Resection	250	512	80	Matched	Primary	Pelvis	Not Applicable	Tumor	PLLS	Soft Tissue Sarcoma	Pleomorphic Liposarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.Q165*;PTEN Deletion;RB1 Deletion	1	3
P-0004268	P-0004268-T01-IM5	Outside	FFPE	Biopsy	188.7	456	80	Matched	Primary	GE Junction	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.Q317*;SMAD4 p.K122*;ARID1A p.D1193Kfs*4;EGFR Amplification;MET Amplification	1	5
P-0004269	P-0004269-T01-IM5	Outside	FFPE	Resection	250	514	60	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	ATRX p.Q1213*;BRCA2 Deletion;RB1 Deletion	1	3
P-0004270	P-0004270-T01-IM5	Outside	FFPE	Resection	250	374	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R273C;IDH1 p.R132H;ATRX p.K1583Nfs*22;TP53 p.X32_splice	1	4
P-0004270	P-0004270-T02-IM5	Outside	FFPE	Resection	250	1056	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G);Palbociclib,Abemaciclib(CDK4 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R273C;IDH1 p.R132H;ATRX p.K1583Nfs*22;TP53 p.X32_splice;PIK3CA p.E545G;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;GLI1 Amplification;MYC Amplification	4	10
P-0004271	P-0004271-T01-IM5	In-House	FFPE	Resection	250	422	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0004272	P-0004272-T01-IM5	In-House	FFPE	Biopsy	250	510	60	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	NRAS p.Q61K;RB1 p.Q702K;TP53 p.X187_splice;MEF2B Amplification;PIK3R2 Amplification	1	5
P-0004273	P-0004273-T01-IM5	Outside	FFPE	Resection	250	596	70	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										RAC1 p.G12V	0	1
P-0004274	P-0004274-T01-IM5	In-House	FFPE	Biopsy	250	848	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Tipifarnib(HRAS p.Q61K)	GSK2636771,AZD8186(PTEN p.X70_splice);GSK2636771,AZD8186(PTEN p.Y27N)				LEVEL_3B	HRAS p.Q61K;PTEN p.X70_splice;PTEN p.Y27N;ARID2 p.R1769*	3	4
P-0004275	P-0004275-T01-IM5	Outside	FFPE	Resection	250	382	70	Matched	Primary	Sinonasal	Not Applicable	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma					PLX8394(BRAF p.G469A);Trametinib,Cobimetinib(NF1 p.L925Sfs*9);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	BRAF p.G469A;RB1 p.S443*;NF1 p.L925Sfs*9;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MDM4 Amplification;MYC Amplification;NF1 Deletion;NTRK1 Amplification;PRDM1 Deletion;TNFAIP3 Deletion	3	12
P-0004276	P-0004276-T01-IM5	Outside	FFPE	Resection	250	587	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.X187_splice;RB1 p.R7Efs*58	0	2
P-0004277	P-0004277-T01-IM5	Outside	FFPE	Resection	250	302	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	DIS3 p.G424*;NCOR1 p.X1299_splice;TP53 p.S46Pfs*77;MAP3K1 p.R399Sfs*5;FGFR1 Amplification	1	5
P-0004278	P-0004278-T01-IM5	Outside	FFPE	Resection	250	143	60	Matched	Metastasis	Lung	Brain	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X637_splice)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	TP53 p.E204*;FUBP1 p.Q413*;BRCA2 p.X637_splice;APC p.R1227Pfs*39;ID3 Deletion;NF1 Deletion	2	6
P-0004279	P-0004279-T01-IM5	In-House	FFPE	Biopsy	250	544	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.S768_D770dup)	Olaparib(ATM p.R2723*)		Erlotinib,Gefitinib,Afatinib(EGFR p.S768_D770dup)			LEVEL_3A	ATM p.R2723*;EGFR p.S768_D770dup	2	2
P-0004280	P-0004280-T01-IM5	In-House	FFPE	Cytology	119.9	268	30	Matched	Metastasis	Anus	Lymph Node	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										AKT2 Amplification;CD274 Amplification;GPS2 Deletion;JAK2 Amplification;YAP1 Amplification	0	5
P-0004281	P-0004281-T01-IM5	Outside	FFPE	Resection	250	519	60	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										KEAP1 p.K108Rfs*49	0	1
P-0004282	P-0004282-T03-IM5	Outside	FFPE	Biopsy	250	870	50	Matched	Metastasis	Soft Tissue	Bone	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma										RBM10 p.Q200*;PIK3R1 p.E596Gfs*3	0	2
P-0004283	P-0004283-T01-IM5	Outside	FFPE	Biopsy	101.7	153	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0004284	P-0004284-T01-IM5	Outside	FFPE	Resection	250	581	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1007R)	Trametinib,Cobimetinib(NF1 STAT5B-NF1 fusion);Trametinib,Cobimetinib(STAT5B STAT5B-NF1 fusion)				LEVEL_3B	TP53 p.C135Y;PIK3CA p.G1007R;VHL p.L89P;NF1 STAT5B-NF1 fusion;STAT5B STAT5B-NF1 fusion	3	5
P-0004285	P-0004285-T01-IM5	In-House	FFPE	Biopsy	250	471	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.T1556Nfs*3;TP53 p.Q52*;ARID2 p.Q934*;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	5
P-0004286	P-0004286-T01-IM5	In-House	FFPE	Biopsy	250	590	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D74N)				LEVEL_4	TP53 p.R335Lfs*10;CDKN2A p.D74N;FGFR2 Amplification;PAK1 Amplification	1	4
P-0004287	P-0004287-T01-IM5	Outside	FFPE	Resection	250	495	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										TP53 p.R249G;SETD2 p.S1624C	0	2
P-0004288	P-0004288-T01-IM5	In-House	FFPE	Resection	250	381	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132G)					LEVEL_3B	TP53 p.N239D;IDH1 p.R132G;ATRX Deletion	1	3
P-0004289	P-0004289-T01-IM5	In-House	FFPE	Biopsy	250	353	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;GATA3 p.R364T;GATA3 p.G443Vfs*32;CCND1 Amplification;FGF19 Amplification	1	5
P-0004290	P-0004290-T03-IM5	In-House	DNA	Resection	250	797	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA1 p.E597*)			Niraparib,Talazoparib(BRCA1 p.E597*)					LEVEL_1	BRCA1 p.E597*	2	1
P-0004291	P-0004291-T01-IM5	Outside	FFPE	Resection	250	656	60	Matched	Primary	Colon	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;PDGFRB p.V665A;GATA3 Deletion	1	3
P-0004292	P-0004292-T01-IM5	In-House	FFPE	Cytology	144.2	233	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.Y178Lfs*2)				LEVEL_3B	TP53 p.R196*;PTEN p.Y178Lfs*2;FGFR1 Amplification	2	3
P-0004293	P-0004293-T01-IM5	Outside	FFPE	Resection	250	516	40	Matched	Metastasis	Breast	Peritoneum	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Olaparib(CHEK2 p.Q27*);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	FOXA1 p.I176V;CHEK2 p.Q27*;CDH1 p.X645_splice;RUNX1 p.Y376Lfs*197;ERBB2 Amplification;MDM2 Amplification;PPM1D Amplification	4	7
P-0004294	P-0004294-T01-IM5	Outside	FFPE	Resection	250	569	40	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma		Cabozantinib(MET Amplification)		Crizotinib(MET Amplification)					LEVEL_2	MET p.Y1230S;ARID1A p.V1781*;MET Amplification	2	3
P-0004295	P-0004295-T01-IM5	In-House	FFPE	Biopsy	250	505	20	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	GATA3 p.H434Pfs*42;KMT2A p.X3582_splice;CDH1 p.Y190Lfs*9;ARID1A Deletion;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification	1	8
P-0004297	P-0004297-T02-IM5	Outside	FFPE	Resection	166.5	160	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0004298	P-0004298-T01-IM5	In-House	FFPE	Biopsy	250	704	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Ivosidenib(IDH1 p.R132H);Palbociclib,Abemaciclib(CDK4 Amplification)	Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.H1047R;IDH1 p.R132H;TP53 p.L308Afs*6;TGFBR1 p.S496Kfs*28;ARID5B Deletion;CDK4 Amplification;EGFR Amplification;GLI1 Amplification;PDGFRA Amplification	4	9
P-0004300	P-0004300-T01-IM5	In-House	FFPE	Biopsy	250	473	10	Matched	Metastasis	Uterus	Pelvis	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										TP53 p.R196*	0	1
P-0004301	P-0004301-T01-IM5	Outside	FFPE	Biopsy	242	616	70	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K	2	1
P-0004302	P-0004302-T01-IM5	Outside	FFPE	Resection	250	289	40	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12V);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Q575del)					LEVEL_3B	NRAS p.G12V;CBL p.Q367P;KIT p.Q575del	2	3
P-0004303	P-0004303-T01-IM5	In-House	FFPE	Cytology	250	888	50	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0004304	P-0004304-T01-IM5	In-House	FFPE	Biopsy	250	339	60	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.R215W;FUBP1 p.M1?	1	3
P-0004305	P-0004305-T01-IM5	In-House	FFPE	Resection	250	1225	50	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558delinsC)								LEVEL_1	KIT p.W557_K558delinsC	1	1
P-0004306	P-0004306-T01-IM5	In-House	FFPE	Resection	250	368	40	Matched	Primary	Lower Extremity	Not Applicable	Tumor	EMCHS	Bone Cancer	Extraskeletal Myxoid Chondrosarcoma										EWSR1 NR4A3-EWSR1 fusion;NR4A3 NR4A3-EWSR1 fusion	0	2
P-0004307	P-0004307-T01-IM5	In-House	FFPE	Resection	250	227	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										DAXX p.Q193*;MEN1 p.X263_splice	0	2
P-0004309	P-0004309-T01-IM5	In-House	FFPE	Biopsy	143.85	508	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;KMT2C p.V2905Cfs*20;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	5
P-0004310	P-0004310-T01-IM5	In-House	FFPE	Resection	250	232	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545K;TP53 p.R248W;ERBB2 Amplification	4	3
P-0004311	P-0004311-T01-IM5	In-House	FFPE	Biopsy	250	387	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.A333Pfs*11);GSK2636771,AZD8186(PTEN p.M198*)				LEVEL_4	PTEN p.A333Pfs*11;PTEN p.M198*	2	2
P-0004312	P-0004312-T01-IM5	Outside	FFPE	Biopsy	250	388	40	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.V143G;APC Deletion;AR Amplification;BMPR1A Deletion;MAP3K1 Deletion;PIK3R1 Deletion;PTEN Deletion;RAD50 Deletion;RASA1 Deletion;RICTOR Amplification;SMAD2 Deletion;TET2 Deletion	1	12
P-0004313	P-0004313-T01-IM5	In-House	FFPE	Biopsy	250	694	60	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)					LEVEL_3B	IDH1 p.R132H;PIK3CA p.R88Q;CIC p.R1214*	2	3
P-0004314	P-0004314-T01-IM5	In-House	FFPE	Biopsy	250	634	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_1	PIK3CA p.H1047R;ESR1 p.D538G;TBX3 p.X367_splice;TBX3 p.A431Sfs*8;CCND1 Amplification;FGF19 Amplification	3	6
P-0004315	P-0004315-T01-IM5	In-House	FFPE	Biopsy	250	686	20	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.P179R;PBRM1 p.I279Yfs*4	1	3
P-0004316	P-0004316-T01-IM5	In-House	FFPE	Resection	250	118	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.D92V)				LEVEL_4	MAP3K1 p.X345_splice;PTEN p.D92V;RUNX1 p.A311Rfs*262;MAP3K1 p.M566Nfs*10	1	4
P-0004317	P-0004317-T01-IM5	In-House	FFPE	Biopsy	250	510	40	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Olaparib(ATM p.L186*);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ATM p.L186*;CDH1 Deletion;ERBB2 Amplification;GATA3 Amplification	3	4
P-0004318	P-0004318-T01-IM5	In-House	FFPE	Resection	197.2	578	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 EZR-ROS1 fusion);Crizotinib,Entrectinib(EZR EZR-ROS1 fusion)								LEVEL_1	ROS1 EZR-ROS1 fusion;EZR EZR-ROS1 fusion	2	2
P-0004319	P-0004319-T01-IM5	In-House	FFPE	Biopsy	250	716	50	Matched	Primary	Brain	Not Applicable	Tumor	ASTB	Miscellaneous Neuroepithelial Tumor	Astroblastoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R175H;IDH1 p.R132H;ATRX p.K1935Efs*7	1	3
P-0004320	P-0004320-T01-IM5	In-House	FFPE	Resection	250	609	60	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1068Kfs*5)					LEVEL_3B	PIK3CA p.N1068Kfs*5	1	1
P-0004322	P-0004322-T01-IM5	In-House	FFPE	Resection	250	568	20	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R213*	1	2
P-0004323	P-0004323-T01-IM5	In-House	FFPE	Biopsy	250	623	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(CDK12 p.R882W)					LEVEL_3B	TP53 p.R175H;APC p.E1309Dfs*4;CDK12 p.R882W;SRC Amplification	1	4
P-0004324	P-0004324-T01-IM5	Outside	FFPE	Resection	250	360	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X2355_splice)				LEVEL_4	TP53 p.E258K;STK11 p.W308L;STAG2 p.R216*;RB1 p.V654L;NF1 p.X2355_splice	1	5
P-0004325	P-0004325-T01-IM5	In-House	FFPE	Resection	250	671	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0004326	P-0004326-T01-IM5	In-House	FFPE	Biopsy	250	839	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										ERBB3 p.R475W;CDH1 p.X228_splice	0	2
P-0004327	P-0004327-T01-IM5	Outside	FFPE	Resection	250	334	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(CDK12 p.R1242*);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R1242*)				LEVEL_3B	CDK12 p.R1242*;TP53 p.H193L;RB1 p.E748*;TP53 p.R202C;KDR p.L161H;FAT1 p.E3190*;ATR p.C790Vfs*13;CCNE1 Amplification;ERBB2 Amplification	3	9
P-0004328	P-0004328-T02-IM5	In-House	FFPE	Biopsy	250	1142	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R);Afatinib(EGFR p.S768I)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S7Rfs*8)				LEVEL_1	EGFR p.L858R;TP53 p.C275Y;EGFR p.S768I;CDKN2A p.S7Rfs*8;EGFR Amplification	3	5
P-0004328	P-0004328-T01-IM5	In-House	FFPE	Cytology	117.65	494	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R);Afatinib(EGFR p.S768I)			Olaparib(RAD51B p.X106_splice)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S7Rfs*8)				LEVEL_1	EGFR p.L858R;TP53 p.C275Y;EGFR p.S768I;RAD51B p.X106_splice;CDKN2A p.S7Rfs*8	4	5
P-0004329	P-0004329-T01-IM5	Outside	FFPE	Biopsy	250	496	50	Matched	Metastasis	Cancer of Unknown Primary	Pelvis	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										FOXP1 FOXP1-intragenic	0	1
P-0004330	P-0004330-T01-IM5	In-House	FFPE	Biopsy	250	523	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93Q)					LEVEL_1	PIK3CA p.R93Q;NSD1 p.R1031*;ERBB3 p.V104M;FGFR3 p.R248C;KMT2D p.R5021*;KMT2D p.R1903*;CREBBP p.R1360*;CREBBP p.R370*;CTCF p.E584*;NOTCH3 p.W1675*;STAG2 p.R604*	3	11
P-0004331	P-0004331-T01-IM5	In-House	FFPE	Resection	250	456	50	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										CDKN2C p.A161Wfs*23;NF2 p.N226Kfs*18	0	2
P-0004333	P-0004333-T01-IM5	In-House	FFPE	Resection	250	458	20	Matched	Primary	Lung	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma											0	0
P-0004334	P-0004334-T01-IM5	In-House	FFPE	Biopsy	250	531	50	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0004335	P-0004335-T01-IM5	In-House	FFPE	Resection	250	560	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;U2AF1 p.S34F;KEAP1 p.R601L;STK11 STK11-intragenic	1	4
P-0004336	P-0004336-T01-IM5	In-House	FFPE	Biopsy	250	729	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	CTNNB1 p.S37C;KMT2D p.Q2876*;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	4
P-0004337	P-0004337-T01-IM5	In-House	FFPE	Biopsy	250	308	40	Matched	Metastasis	Ovary	Abdomen	Tumor	SCT	Sex Cord Stromal Tumor	Steroid Cell Tumor, NOS				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	GNAS p.R201C;CDK4 Amplification;ERBB3 Amplification;MDM2 Amplification;TERT Amplification	2	5
P-0004338	P-0004338-T01-IM5	Outside	FFPE	Biopsy	250	538	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.E229K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PDGFRA p.E229K;CDKN1A p.M1?;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;KDR Amplification;KIT Amplification;MAP3K1 Deletion;MDM4 Amplification;PDGFRA Amplification;PIK3R1 Deletion;RASA1 Deletion	2	12
P-0004339	P-0004339-T01-IM5	Outside	FFPE	Biopsy	250	680	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										CASP8 p.Q358*;SETD2 p.S512*;SETD2 p.E325*;SMAD4 p.Y353C	0	4
P-0004340	P-0004340-T01-IM5	Outside	FFPE	Resection	250	412	40	Matched	Metastasis	Ovary	Abdomen	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0004341	P-0004341-T01-IM5	Outside	FFPE	Biopsy	250	492	40	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.S338Lfs*6)				LEVEL_4	TP53 p.R213*;PTEN p.S338Lfs*6	1	2
P-0004342	P-0004342-T01-IM5	Outside	FFPE	Biopsy	88	265	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0004343	P-0004343-T01-IM5	In-House	FFPE	Resection	250	426	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0004344	P-0004344-T01-IM5	Outside	FFPE	Biopsy	250	628	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										SETD2 p.C1516R	0	1
P-0004345	P-0004345-T01-IM5	In-House	FFPE	Resection	250	497	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0004346	P-0004346-T01-IM5	In-House	FFPE	Biopsy	250	196	30	Matched	Metastasis	Breast	Soft Tissue	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.N239D;CDH1 p.W156Tfs*60;FGFR1 Amplification;NOTCH4 C6orf10-NOTCH4 fusion;C6orf10 C6orf10-NOTCH4 fusion	1	5
P-0004347	P-0004347-T01-IM5	In-House	FFPE	Resection	250	329	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.H196Tfs*3)				LEVEL_4	PTEN p.H196Tfs*3;TP53 p.M246Ifs*99;BCL6 Amplification;PIK3CB Amplification	1	4
P-0004348	P-0004348-T01-IM5	Outside	FFPE	Resection	250	439	60	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib(BRAF p.L597Q);Trametinib(BRAF p.K601_S602delinsNT)		PLX8394(BRAF p.L597Q);PLX8394(BRAF p.K601_S602delinsNT)				LEVEL_3A	IKZF1 p.E304K;BRAF p.L597Q;BRAF p.P367S;BRAF p.K601_S602delinsNT	4	4
P-0004349	P-0004349-T01-IM5	In-House	FFPE	Resection	250	533	50	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;CDKN2A Deletion	3	2
P-0004350	P-0004350-T01-IM5	Outside	FFPE	Resection	250	257	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R357Q)		Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	TP53 p.R342*;NRAS p.Q61K;SMAD4 p.R361H;PIK3CA p.R357Q;APC p.Q1071*;APC p.P1439Hfs*35	2	6
P-0004351	P-0004351-T01-IM5	Outside	FFPE	Biopsy	250	762	10	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma										TP53 p.R342P	0	1
P-0004352	P-0004352-T01-IM5	Outside	FFPE	Resection	250	637	20	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.C24F)					LEVEL_3B	TP53 p.R196*;TGFBR2 p.W287*;BRCA1 p.C24F;DNMT3B p.R106*;NOTCH1 p.N1023Kfs*142	1	5
P-0004353	P-0004353-T01-IM5	In-House	FFPE	Biopsy	250	282	10	Matched	Metastasis	Breast	Bone	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0004354	P-0004354-T01-IM5	In-House	FFPE	Resection	250	459	60	Matched	Primary	Breast	Not Applicable	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS										TP53 p.E285Gfs*20;JUN Amplification;MGA Deletion;MYCL Amplification;RB1 Deletion	0	5
P-0004355	P-0004355-T01-IM5	In-House	FFPE	Biopsy	250	277	40	Matched	Metastasis	Prostate	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM p.P292L)								LEVEL_1	ATM p.P292L;FOXA1 p.F254_R262delinsKRY;MCL1 Amplification	1	3
P-0004356	P-0004356-T01-IM5	In-House	FFPE	Resection	250	782	30	Matched	Metastasis	Appendix	Ovary	Tumor	SRAP	Appendiceal Cancer	Signet Ring Cell Type of the Appendix				Olaparib(ATM p.L2945Vfs*10)					LEVEL_3B	GNAS p.R201C;ATM p.L2945Vfs*10;KDR Amplification;KIT Amplification;PDGFRA Amplification	1	5
P-0004357	P-0004357-T01-IM5	In-House	FFPE	Resection	250	769	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Trametinib,Cobimetinib(NF1 p.L1793*)				LEVEL_4	TP53 p.C238Y;NF1 p.L1793*	1	2
P-0004358	P-0004358-T01-IM5	In-House	FFPE	Biopsy	250	763	20	Matched	Metastasis	Esophagus	Lymph Node	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma										TP53 p.R342*;KMT2C p.S1189Ffs*11;CCND1 Amplification;EGFR Amplification;FGF19 Amplification	0	5
P-0004359	P-0004359-T01-IM5	In-House	FFPE	Resection	250	919	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)	Neratinib(ERBB2 p.G778_P780dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	ERBB2 p.G778_P780dup;TP53 p.H168R;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion	3	5
P-0004360	P-0004360-T01-IM5	In-House	FFPE	Biopsy	250	190	60	Matched	Metastasis	Ovary	Pelvis	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.A138V	0	1
P-0004361	P-0004361-T01-IM5	In-House	FFPE	Resection	250	793	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.A159P;PMS1 p.X106_splice;MGA p.K940*	2	4
P-0004361	P-0004361-T02-IM5	Outside	DNA	Resection	250	411	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.A159P;PMS1 p.X106_splice;MGA p.K940*	2	4
P-0004362	P-0004362-T01-IM5	Outside	FFPE	Resection	250	226	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Everolimus(TSC1 p.R420Gfs*20);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.T3033Lfs*29)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;CREBBP p.I1084Sfs*15;ARID1A p.G2087R;APC p.S1465Rfs*9;APC p.R564*;EP300 p.H2324Pfs*55;TSC1 p.R420Gfs*20;TCF7L2 p.L200Sfs*25;PIK3R1 p.R358*;BRCA2 p.T3033Lfs*29;TCF7L2 p.K485Sfs*23;KMT2C p.K3604Rfs*26;MITF p.E194Rfs*19;AMER1 p.F173Lfs*36;PMS1 p.E59Rfs*10;NOTCH1 p.G1320Afs*125	3	16
P-0004363	P-0004363-T01-IM5	In-House	FFPE	Resection	250	543	10	Matched	Primary	Descending Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R273C;CTNNB1 p.S33F;SMAD4 p.Q442*;SOX9 p.S215Pfs*4	1	5
P-0004364	P-0004364-T01-IM5	Outside	FFPE	Resection	250	581	30	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;ARID1A p.K1808*	1	2
P-0004364	P-0004364-T02-IM5	Outside	FFPE	Resection	250	566	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0004364	P-0004364-T03-IM5	Outside	FFPE	Resection	250	584	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;ARID1A p.K1808*	1	2
P-0004365	P-0004365-T01-IM5	Outside	FFPE	Biopsy	250	886	80	Matched	Primary	Salivary Gland	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										KRAS p.V14I;CDKN1B p.Q57*;ARID2 p.X42_splice;ARID1A p.A162Gfs*235;ARID2 Deletion	0	5
P-0004366	P-0004366-T01-IM5	Outside	FFPE	Biopsy	250	759	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Everolimus(TSC1 p.R786*)					LEVEL_1	FGFR3 p.Y373C;TSC1 p.R786*;STAG2 p.X699_splice	3	3
P-0004367	P-0004367-T01-IM5	In-House	FFPE	Resection	250	760	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Binimetinib,Binimetinib+Ribociclib(NRAS p.G12C)	Tazemetostat(KDM6A p.Q863*);Tazemetostat(KDM6A p.T968Yfs*11)				LEVEL_1	PIK3CA p.H1047R;FGFR3 p.S249C;KDM6A p.Q863*;FUBP1 p.Q158*;NRAS p.G12C;STAG2 p.X699_splice;KDM6A p.T968Yfs*11	6	7
P-0004368	P-0004368-T01-IM5	Outside	FFPE	Biopsy	250	486	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										RHOA p.E47K	0	1
P-0004369	P-0004369-T01-IM5	In-House	FFPE	Resection	250	549	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R175H;BCL2L1 Amplification;DNMT3B Amplification	1	4
P-0004370	P-0004370-T01-IM5	Outside	FFPE	Biopsy	250	634	50	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;PIK3R1 p.L449del;CIC p.R215W;CIC p.P612Rfs*77;FUBP1 p.E189Dfs*4	1	5
P-0004371	P-0004371-T01-IM5	Outside	FFPE	Biopsy	250	804	80	Matched	Metastasis	Minor Salivary Gland	Liver	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NOTCH1 p.Q2315Hfs*12;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0004372	P-0004372-T01-IM5	Outside	FFPE	Biopsy	250	640	20	Matched	Metastasis	Small Bowel	Mesentery	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0004373	P-0004373-T02-IM5	In-House	FFPE	Biopsy	104	464	60	Matched	Metastasis	Testis	Liver	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Milademetan Tosylate,RO5045337(MDM2 Amplification);Trametinib,Cobimetinib(MKRN1 BRAF-MKRN1 fusion);Trametinib,Cobimetinib(BRAF BRAF-MKRN1 fusion)					LEVEL_3B	RASA1 p.E1015Vfs*8;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MDM2 Amplification;WASHC3 SH2B3-CCDC53 fusion;SH2B3 SH2B3-CCDC53 fusion;MKRN1 BRAF-MKRN1 fusion;BRAF BRAF-MKRN1 fusion	3	9
P-0004373	P-0004373-T01-IM5	Outside	FFPE	Resection	250	575	70	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MDM2 Amplification	1	4
P-0004374	P-0004374-T01-IM5	In-House	FFPE	Resection	250	470	20	Matched	Metastasis	Cancer of Unknown Primary	Epidural	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;KMT2C p.R4541*;MAP3K1 p.S1330L;TP53 p.X182_splice	1	4
P-0004375	P-0004375-T01-IM5	In-House	FFPE	Biopsy	250	676	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;AURKA Amplification;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	5
P-0004376	P-0004376-T01-IM5	In-House	FFPE	Resection	250	676	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.V74Afs*85	0	1
P-0004377	P-0004377-T01-IM5	Outside	FFPE	Resection	250	389	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										CD274 Amplification;JAK2 Amplification;MGA Deletion;NKX3-1 Deletion;RAD51 Deletion	0	5
P-0004378	P-0004378-T01-IM5	In-House	FFPE	Biopsy	250	856	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12F)				LEVEL_4	KRAS p.G12F	1	1
P-0004379	P-0004379-T01-IM5	In-House	FFPE	Biopsy	250	650	50	Matched	Metastasis	Uterus	Chest Wall	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);Olaparib(BARD1 p.R112*);Everolimus(TSC1 p.L191F);Olaparib(CHEK1 p.E76*);Olaparib(CHEK2 p.E360*);Everolimus(TSC1 p.S1086Kfs*13)	GSK2636771,AZD8186(PTEN p.N323Kfs*2);GSK2636771,AZD8186(PTEN p.R173H);GSK2636771,AZD8186(PTEN p.R233*);Trametinib,Cobimetinib(NF1 p.C383*)				LEVEL_3B	LATS1 p.R63*;PIK3CA p.H1047L;EPHB1 p.D762N;NOTCH4 p.R1158*;PTEN p.N323Kfs*2;EP300 p.R1462*;CBL p.R420Q;B2M p.L15Ffs*41;PTPRD p.S431L;TGFBR1 p.S241L;ASXL2 p.R312*;PTEN p.R173H;ETV6 p.R369W;PTEN p.R233*;ARID1A p.R1989*;SMAD4 p.D52Rfs*2;GNAS p.R160C;B2M p.M1?;ARID1A p.E992*;FUBP1 p.R430C;MSH6 p.E877*;BARD1 p.R112*;TP63 p.R594*;TET2 p.F1287C;FBXW7 p.R14Q;RASA1 p.E560*;RASA1 p.X976_splice;PMS2 p.R107W;EZH2 p.E197*;KMT2C p.E2763*;TGFBR1 p.R157*;TSC1 p.L191F;ARID5B p.E454*;CHEK1 p.E76*;POLE p.V411L;FLT3 p.E952D;FLT3 p.P686S;RB1 p.R451C;DICER1 p.E1843*;DICER1 p.E428*;MGA p.E2417*;CTCF p.R339W;ZFHX3 p.X1323_splice;NCOR1 p.X618_splice;NF1 p.C383*;STAT3 p.F384V;PPP2R1A p.R260H;ASXL1 p.E635*;ASXL1 p.G1529*;CHEK2 p.E360*;KDM5C p.R198*;ATRX p.E680*;STAG2 p.X15_splice;TSC1 p.S1086Kfs*13;TET2 p.T1091Dfs*13;STK11 p.E120_E121delinsK*	10	56
P-0004380	P-0004380-T01-IM5	In-House	FFPE	Resection	250	200	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Olaparib(PALB2 p.M296*);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N986Ifs*5)	Tazemetostat(KDM6A p.X944_splice);Tazemetostat(KDM6A p.R1213*)				LEVEL_1	TP53 p.R158H;CTCF p.T204Nfs*26;FOXP1 p.R514H;FGFR3 p.R248C;KMT2D p.G1235Vfs*95;ZFHX3 p.E763Sfs*61;CREBBP p.R1360*;RASA1 p.R903*;KDM6A p.X944_splice;KDM6A p.R1213*;ARID1A p.Q372Sfs*19;FUBP1 p.S11Lfs*43;PALB2 p.M296*;KMT2C p.F4496Lfs*21;MGA p.S2228Vfs*10;BRCA2 p.N986Ifs*5;ARID1A p.P1326Rfs*155	6	17
P-0004381	P-0004381-T01-IM5	Outside	FFPE	Resection	250	445	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	AURKA Amplification;ERBB2 Amplification;PPM1D Amplification	2	3
P-0004382	P-0004382-T01-IM5	In-House	FFPE	Cytology	250	471	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X2116_splice);Everolimus(TSC2 p.W1060*)					LEVEL_3B	B2M p.V69Wfs*34;TP53 p.Y234C;ARID1A p.F2141Sfs*59;FUBP1 p.G62*;MLH1 p.Q516*;ATM p.X2116_splice;TSC2 p.W1060*;KEAP1 p.K97*;FLCN p.H429Tfs*39;RB1 p.H483Sfs*10;PRDM1 p.Y418Lfs*6;BCL6 Amplification;FOXA1 Amplification;PIK3CA Amplification;PIK3CB Amplification	2	15
P-0004383	P-0004383-T01-IM5	In-House	FFPE	Resection	250	553	60	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	SMARCA4 p.R1189G;BRCA2 Deletion;FOXO1 Deletion;RB1 Deletion	1	4
P-0004384	P-0004384-T01-IM5	In-House	FFPE	Resection	250	608	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.H179Q	0	1
P-0004385	P-0004385-T01-IM5	In-House	FFPE	Biopsy	250	840	30	Matched	Primary	Forehead	Forehead	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Olaparib(ATM p.W308*);Olaparib(ATM p.X1774_splice)					LEVEL_3B	ATM p.W308*;ATM p.X1774_splice	2	2
P-0004386	P-0004386-T01-IM5	In-House	FFPE	Biopsy	250	744	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.G245_P250delinsA;CDK8 Amplification;DDR2 Amplification;EPHA3 Deletion;FLT3 Amplification;KDM5A Amplification;KRAS Amplification;MYC Amplification;ROS1 Amplification;SMAD2 Deletion;CUL5 NOTCH1-CUL5 fusion;NOTCH1 NOTCH1-CUL5 fusion	2	13
P-0004387	P-0004387-T01-IM5	In-House	FFPE	Biopsy	216.7	57	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ARID1A p.Q515*;CDKN1A p.P82Afs*7;MDM2 Amplification	1	3
P-0004388	P-0004388-T02-IM5	In-House	FFPE	Biopsy	250	1039	25	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.E380Q)		GSK2636771,AZD8186(PTEN p.H93R)				LEVEL_3A	HIST1H3B p.E106Q;ESR1 p.E380Q;FAT1 p.E1518*;PTEN p.H93R;FOXA1 p.F266*;SH2B3 p.E122*;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	9
P-0004389	P-0004389-T01-IM5	In-House	FFPE	Biopsy	250	508	60	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification;RNF43 RNF43-intragenic	0	2
P-0004390	P-0004390-T01-IM5	In-House	FFPE	Biopsy	250	364	10	Matched	Metastasis	Appendix	Ovary	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Trametinib,Cobimetinib(NF1 p.X1611_splice)				LEVEL_3B	KRAS p.G12C;GNAS p.R201H;NF1 p.X1611_splice	3	3
P-0004391	P-0004391-T01-IM5	In-House	FFPE	Resection	250	637	10	Matched	Metastasis	Parotid	Lymph Node	Tumor	SEBA	Skin Cancer, Non-Melanoma	Sebaceous Carcinoma										TP53 p.K132E	0	1
P-0004392	P-0004392-T01-IM5	In-House	FFPE	Biopsy	250	455	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.X332_splice;KMT2C p.Q2161*	1	3
P-0004393	P-0004393-T01-IM5	In-House	FFPE	Resection	250	788	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.Y192Lfs*21);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;TSC1 p.Y192Lfs*21;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	5	5
P-0004394	P-0004394-T01-IM5	In-House	FFPE	Biopsy	250	568	60	Matched	Metastasis	Lung	Liver	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Olaparib(ATM p.K573Nfs*13)					LEVEL_3B	ATM p.K573Nfs*13;MYCL Amplification	1	2
P-0004395	P-0004395-T01-IM5	In-House	FFPE	Biopsy	250	510	50	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.S310F)	Neratinib(ERBB2 p.S310F)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_2	ERBB2 p.S310F;KDM6A p.X1293_splice;CDK4 Amplification;ERBB3 Amplification;GLI1 Amplification;MDM2 Amplification;TERT Amplification	4	7
P-0004396	P-0004396-T01-IM5	Outside	FFPE	Biopsy	250	503	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.H193Y;ATRX p.S1382*	1	3
P-0004397	P-0004397-T01-IM5	In-House	FFPE	Resection	250	236	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L128P;SETD2 p.E919Sfs*3	0	2
P-0004398	P-0004398-T01-IM5	Outside	FFPE	Resection	250	479	30	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0004399	P-0004399-T01-IM5	Outside	FFPE	Resection	250	904	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.R175H;CDKN2A Deletion;CDKN2B Deletion;PRKN Deletion	2	5
P-0004400	P-0004400-T01-IM5	In-House	FFPE	Resection	250	423	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(BRIP1 p.X69_splice);Cisplatin(ERCC2 p.G665D)	GSK2636771,AZD8186(PTEN p.Q171*);Lapatinib(EGFR p.A289V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTEN p.Q171*;EGFR p.R222C;TP53 p.E286K;MED12 p.G44C;EGFR p.A289V;KMT2D p.W1469*;DICER1 p.W1024*;BRIP1 p.X69_splice;PIK3R2 p.X139_splice;ERCC2 p.G665D;CDKN2A Deletion;CDKN2B Deletion;CBL CBL-intragenic	5	13
P-0004401	P-0004401-T01-IM5	Outside	FFPE	Resection	250	480	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Tazemetostat(SMARCB1 p.R377H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	SMARCB1 p.R377H;TP53 p.L35Cfs*9;CCND1 Amplification;CDK8 Amplification;CDKN2A Deletion;FGF19 Amplification;FLT3 Amplification;MYC Amplification;PAK1 Amplification;LATS2 ATP8A2-LATS2 fusion;ATP8A2 ATP8A2-LATS2 fusion	2	11
P-0004402	P-0004402-T01-IM5	Outside	FFPE	Biopsy	250	494	40	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R248Q;KRAS p.G13D;APC p.Q1291*;PIK3R1 p.W583*	1	4
P-0004403	P-0004403-T01-IM5	In-House	FFPE	Resection	250	368	10	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	GSK2636771,AZD8186(PTEN p.Y68*)	Cetuximab,Panitumumab(NRAS p.Q61R)			LEVEL_3B	NRAS p.Q61R;APC p.R1450*;TP53 p.S90Pfs*33;PTEN p.Y68*;SMAD4 p.R97H;AMER1 p.A668Efs*51;FLT3 Amplification	2	7
P-0004404	P-0004404-T01-IM5	Outside	FFPE	Resection	250	609	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;KMT2D p.C392Kfs*9	2	2
P-0004405	P-0004405-T01-IM5	In-House	FFPE	Resection	250	477	60	Matched	Metastasis	Prostate	Lung	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0004406	P-0004406-T01-IM5	In-House	FFPE	Biopsy	250	510	50	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TBX3 p.X219_splice;CDH1 p.K184Qfs*15;CCND1 Amplification;FGF19 Amplification	2	5
P-0004407	P-0004407-T01-IM5	In-House	FFPE	Resection	250	461	50	Matched	Primary	Stomach	Not Applicable	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										TP53 p.R175H;ARID1A p.D1850Gfs*4;SOX9 p.X229_splice;SOX9 p.S494Afs*81	0	4
P-0004408	P-0004408-T01-IM5	In-House	FFPE	Resection	250	400	60	Matched	Primary	Upper Extremity	Not Applicable	Tumor	PLLS	Soft Tissue Sarcoma	Pleomorphic Liposarcoma										TP53 p.R209Kfs*6;PIK3R1 p.L449del;KDM6A p.Y1256*	0	3
P-0004409	P-0004409-T01-IM5	In-House	FFPE	Biopsy	250	499	30	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										CTNNB1 p.S45P	0	1
P-0004410	P-0004410-T01-IM5	In-House	FFPE	Biopsy	250	332	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.M237I;RHOA p.E40Q;FBXW7 p.X195_splice;AKT1 Amplification;BRCA2 Deletion;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MYC Amplification;PIK3CA Amplification;PIK3CB Amplification;PTEN Deletion	2	12
P-0004411	P-0004411-T01-IM5	In-House	FFPE	Resection	250	656	40	Matched	Metastasis	Abdomen	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										AKT3 p.E17K	0	1
P-0004412	P-0004412-T01-IM5	In-House	FFPE	Biopsy	192.08	264	30	Matched	Metastasis	Kidney	Adrenal Gland	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L135*;PBRM1 p.G1499Afs*40;KDM6A p.L105Ifs*20	0	3
P-0004413	P-0004413-T01-IM5	In-House	FFPE	Resection	250	497	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.N837Vfs*11)					LEVEL_3B	VHL p.A56Pfs*11;TSC1 p.N837Vfs*11	1	2
P-0004414	P-0004414-T01-IM5	Outside	FFPE	Biopsy	75.6	514	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(SDC4 ROS1-SDC4 fusion);Crizotinib,Entrectinib(ROS1 ROS1-SDC4 fusion)								LEVEL_1	TP53 p.E346*;SDC4 ROS1-SDC4 fusion;ROS1 ROS1-SDC4 fusion	2	3
P-0004415	P-0004415-T01-IM5	In-House	FFPE	Resection	250	650	70	Matched	Primary	Arm	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0004416	P-0004416-T01-IM5	In-House	FFPE	Biopsy	250	585	30	Matched	Metastasis	Oropharynx	Bone	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										TP53 p.Y236*;RB1 Deletion	0	2
P-0004417	P-0004417-T01-IM5	Outside	FFPE	Resection	250	245	30	Matched	Metastasis	Testis	Lymph Node	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification	0	1
P-0004419	P-0004419-T01-IM5	In-House	FFPE	Biopsy	250	136	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	FGFR3 p.S249C;CDKN1B Deletion;MDM2 Amplification	3	3
P-0004420	P-0004420-T01-IM5	In-House	FFPE	Biopsy	250	258	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)						LEVEL_1	FGFR3 p.Y373C;ARID2 p.Q793*;RBM10 p.K210Qfs*6;FAT1 p.S3830Ffs*19	2	4
P-0004421	P-0004421-T01-IM5	In-House	FFPE	Biopsy	250	593	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.X1010_splice;CDK4 Amplification;MDM2 Amplification;MYC Amplification	5	4
P-0004423	P-0004423-T01-IM5	Outside	FFPE	Resection	250	660	70	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Olaparib(ATM Deletion);Olaparib(CHEK1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12L)				LEVEL_3B	TP53 p.R342*;SUFU p.M1?;RB1 p.E465*;TP53 p.V218M;CDKN2A p.S12L;ATM Deletion;BIRC3 Deletion;CBL Deletion;CHEK1 Deletion;KMT2A Deletion;MRE11 Deletion;SDHD Deletion	3	12
P-0004424	P-0004424-T01-IM5	In-House	FFPE	Biopsy	250	979	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C);Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C);Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Tazemetostat(KDM6A p.X901_splice)				LEVEL_1	PIK3CA p.H1047R;FGFR3 p.S249C;PIK3CA p.E542K;FGFR3 p.Y373C;KMT2D p.L1272*;KDM6A p.X901_splice;MED12 p.P22T;KMT2A p.A1078Gfs*11;DIS3 Deletion	7	9
P-0004425	P-0004425-T01-IM5	In-House	FFPE	Cytology	230	302	30	Matched	Metastasis	Skin	Axilla	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										ARID5B Deletion;RAD50 Deletion	0	2
P-0004426	P-0004426-T01-IM5	In-House	FFPE	Biopsy	250	506	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Tazemetostat(KDM6A p.Q154*)				LEVEL_1	PIK3CA p.E545K;FGFR3 p.S249C;KMT2C p.R3507*;KDM6A p.Q154*;KMT2C p.H450Rfs*6	4	5
P-0004427	P-0004427-T01-IM5	Outside	FFPE	Biopsy	250	733	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	RB1 p.D346Rfs*4;CDKN2A Deletion;CDKN2B Deletion;MAPK1 Amplification;MYC Amplification;RUNX1 Amplification;NCOR1 NCOR1-intragenic;NF1 NF1-intragenic	2	8
P-0004428	P-0004428-T01-IM5	Outside	FFPE	Biopsy	250	209	60	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										PAK1 Amplification	0	1
P-0004429	P-0004429-T01-IM5	In-House	FFPE	Resection	250	390	50	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										KRAS Amplification	0	1
P-0004430	P-0004430-T02-IM5	In-House	FFPE	Resection	187.8	586	50	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R273H;IDH1 p.R132H;ATRX p.H1338Qfs*11	1	3
P-0004430	P-0004430-T03-IM5	In-House	FFPE	Resection	227.7	626	50	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.S1382*	1	2
P-0004430	P-0004430-T01-IM5	In-House	FFPE	Resection	250	254	30	Matched	Metastasis	Thyroid	Soft Tissue	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0004431	P-0004431-T01-IM5	In-House	DNA	Biopsy	250	693	50	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V;APC p.R302*;APC p.D1318Ifs*3;TCF7L2 p.D10Mfs*3	2	5
P-0004432	P-0004432-T01-IM5	In-House	DNA	Cytology	250	581	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)								LEVEL_1	TP53 p.R273H;EGFR p.E746_S752delinsV	1	2
P-0004433	P-0004433-T01-IM5	Outside	DNA	Biopsy	250	972	10	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.R213Dfs*34;RNF43 BCAS3-RNF43 fusion;BCAS3 BCAS3-RNF43 fusion	2	4
P-0004434	P-0004434-T01-IM5	Outside	DNA	Biopsy	250	718	50	Matched	Metastasis	Breast	Ipsilateral Breast	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.K13*)				LEVEL_4	PTEN p.K13*;KDM5C p.M1?;CDH1 p.V252Efs*30;RB1 p.N867Sfs*2;INPP4B Deletion;MYC Amplification	1	6
P-0004435	P-0004435-T01-IM5	In-House	DNA	Resection	250	583	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.L1488Yfs*19;SPOP p.F133V;MGA p.N1982Kfs*23	0	3
P-0004436	P-0004436-T01-IM5	In-House	DNA	Biopsy	250	836	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.F2732L)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ARID1A p.P146Qfs*86;NFE2L2 p.G81S;ATM p.F2732L;STK11 p.Q305*;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0004437	P-0004437-T01-IM5	Outside	DNA	Resection	176.88	323	50	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		GSK2636771,AZD8186(PTEN p.K125N)				LEVEL_3A	NRAS p.Q61R;PTEN p.K125N	2	2
P-0004438	P-0004438-T01-IM5	In-House	DNA	Biopsy	119	500	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	BRAF p.V600E;CDKN1A p.S130Vfs*67;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	4	5
P-0004439	P-0004439-T01-IM5	Outside	DNA	Resection	250	1100	20	Matched	Metastasis	Sinonasal	Soft Tissue	Tumor	SAAD	Salivary Gland Cancer	Salivary Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	TP53 p.R175H;ERBB2 p.S310F;KMT2D p.Q3741*;AXIN1 p.A593Pfs*112	1	4
P-0004440	P-0004440-T01-IM5	In-House	DNA	Resection	250	1234	30	Matched	Metastasis	Peritoneum	Pelvis	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										MYD88 p.L265P;NCOR1 p.T1661Nfs*53;SLC38A3 PBRM1-SLC38A3 fusion;PBRM1 PBRM1-SLC38A3 fusion	0	4
P-0004441	P-0004441-T01-IM5	In-House	DNA	Resection	250	746	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.Q1294*;BRAF p.N581I;APC p.S1282*;TP53 p.G187R;SMAD4 p.Q450Lfs*17;MAP2K4 Deletion	0	6
P-0004442	P-0004442-T01-IM5	In-House	DNA	Resection	173.6	305	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R213L;ARID1A p.X911_splice;FOXP1 p.X290_splice;DICER1 p.Q548*;STK11 p.K329*;SH2D1A p.K105Sfs*13;ARID2 p.T418Rfs*45	0	7
P-0004444	P-0004444-T01-IM5	In-House	FFPE	Biopsy	250	596	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.P250Q)				LEVEL_1	PIK3CA p.E545K;FGFR3 p.R248C;FGFR3 p.P250Q;BRAF p.L485W;BAP1 p.T266Nfs*18	4	5
P-0004445	P-0004445-T01-IM5	In-House	FFPE	Resection	250	655	30	Matched	Primary	Ovary	Not Applicable	Tumor	SBOV	Ovarian Cancer	Serous Borderline Ovarian Tumor				Crizotinib,Entrectinib(ROS1 GOLGB1-ROS1 fusion);Crizotinib,Entrectinib(GOLGB1 GOLGB1-ROS1 fusion)					LEVEL_3B	ROS1 GOLGB1-ROS1 fusion;GOLGB1 GOLGB1-ROS1 fusion	2	2
P-0004446	P-0004446-T01-IM5	Outside	FFPE	Resection	250	491	30	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0004447	P-0004447-T01-IM5	In-House	FFPE	Resection	250	707	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.F53C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)				LEVEL_3A	KRAS p.A146T;MAP2K1 p.F53C;STK11 p.R42Lfs*9	2	3
P-0004448	P-0004448-T01-IM5	In-House	FFPE	Resection	250	612	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR p.H875Y;MAP3K1 Deletion	0	2
P-0004449	P-0004449-T01-IM5	In-House	FFPE	Resection	250	351	10	Matched	Metastasis	Jejunum	Abdominal Wall	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R248Q;TP53 p.R175H;CDK6 Amplification;KRAS Amplification;SMAD4 Deletion;TERT Amplification	1	7
P-0004450	P-0004450-T01-IM5	In-House	FFPE	Resection	250	509	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.E380Q)	Olaparib(RAD51C p.P21A)					LEVEL_1	PIK3CA p.E545K;ESR1 p.E380Q;SETD2 p.Q2484*;RAD51C p.P21A;DNMT3B p.Q475*;ARID1A p.W1670*	4	6
P-0004451	P-0004451-T01-IM5	In-House	FFPE	Resection	250	603	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;KMT2D p.Q3634*;RNF43 p.L12Qfs*23;TP53 p.Q144Afs*5;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0004452	P-0004452-T01-IM5	Outside	FFPE	Biopsy	250	618	10	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										ARID1A Deletion;MYCL Amplification	0	2
P-0004453	P-0004453-T01-IM5	Outside	FFPE	Biopsy	250	580	60	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										RASA1 p.R512*;TP53 p.T155P;RB1 Deletion	0	3
P-0004454	P-0004454-T01-IM5	In-House	FFPE	Resection	250	466	NA	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H);Everolimus(SLC9A3R2 TSC2-SLC9A3R2 fusion);Everolimus(TSC2 TSC2-SLC9A3R2 fusion)					LEVEL_1	BRAF p.V600E;TP53 p.R306*;PIK3CA p.R108H;RNF43 p.I51Efs*30;CCND2 Amplification;FBXW7 Deletion;KDM5A Amplification;SLC9A3R2 TSC2-SLC9A3R2 fusion;TSC2 TSC2-SLC9A3R2 fusion	6	9
P-0004455	P-0004455-T01-IM5	In-House	FFPE	Biopsy	250	669	20	Matched	Primary	Breast	Not Applicable	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.I195T;RB1 p.X605_splice;ERBB2 Amplification;SETD2 SETD2-intragenic	2	4
P-0004456	P-0004456-T01-IM5	In-House	FFPE	Biopsy	250	655	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										KMT2D p.S2910Rfs*32;CREBBP p.R1446C;FUBP1 p.Q135Lfs*14	0	3
P-0004457	P-0004457-T01-IM5	In-House	FFPE	Biopsy	250	586	70	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)						LEVEL_3A	RAF1 p.S259F;ARID2 p.S297F;NRAS p.Q61H;ARID1B p.Y233*;BRAF p.W604G	1	5
P-0004458	P-0004458-T01-IM5	Outside	DNA	Resection	250	475	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										KDM5C p.R681*;PBRM1 p.T857Sfs*17;STAG2 p.D659Efs*33;VHL p.Y112*	0	4
P-0004459	P-0004459-T01-IM5	Outside	DNA	Biopsy	250	283	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.C176W;ERBB2 Amplification	2	2
P-0004460	P-0004460-T01-IM5	In-House	DNA	Resection	250	590	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.Y234N;RB1 p.E125Kfs*11;ARID1A p.Y560Tfs*59	1	4
P-0004462	P-0004462-T01-IM5	In-House	DNA	Cytology	250	372	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	PIK3CA p.H1047R;GATA3 p.N331Efs*21;ASXL2 p.X620_splice;GPS2 p.R28Afs*11;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;PTEN Deletion	5	9
P-0004463	P-0004463-T01-IM5	In-House	DNA	Cytology	91.8	566	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.M237K;KRAS Amplification	0	2
P-0004464	P-0004464-T01-IM5	In-House	DNA	Biopsy	209.04	959	10	Matched	Primary	Skin	Not Applicable	Tumor	NHL	Non-Hodgkin Lymphoma	Non-Hodgkin Lymphoma										U2AF1 p.S34F	0	1
P-0004466	P-0004466-T01-IM5	In-House	DNA	Resection	250	344	60	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E542K;KMT2D p.L4296*;FOXA1 p.Q333Hfs*81;ERBB2 Amplification	4	4
P-0004467	P-0004467-T01-IM5	Outside	DNA	Resection	250	482	40	Matched	Metastasis	Uterus	Omentum	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										NOTCH4 Deletion;RB1 Deletion	0	2
P-0004468	P-0004468-T01-IM5	Outside	DNA	Biopsy	250	575	50	Matched	Primary	Lung	Not Applicable	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										KMT2C p.R4456*;MEN1 p.E568*	0	2
P-0004472	P-0004472-T01-IM5	In-House	DNA	Biopsy	50	201	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_2	ERBB2 p.Y772_A775dup;TET2 p.Q769*;TP53 p.V218L;FOXA1 Amplification;MDM2 Amplification;NKX2-1 Amplification	3	6
P-0004473	P-0004473-T01-IM5	Outside	DNA	Resection	250	844	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										LEUTX CIC-LEUTX fusion;CIC CIC-LEUTX fusion	0	2
P-0004474	P-0004474-T01-IM5	In-House	DNA	Biopsy	250	1179	20	Unmatched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.P278Lfs*67	0	1
P-0004476	P-0004476-T01-IM5	In-House	DNA	Biopsy	91.8	301	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;APC p.E418*;PRKN Deletion	1	3
P-0004477	P-0004477-T01-IM5	In-House	DNA	Biopsy	250	507	50	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib(BRAF AGK-BRAF fusion);Trametinib,Cobimetinib(AGK AGK-BRAF fusion)					LEVEL_1	PIK3CA p.H1047R;BRAF AGK-BRAF fusion;AGK AGK-BRAF fusion	4	3
P-0004478	P-0004478-T02-IM5	In-House	DNA	Biopsy	250	683	30	Matched	Metastasis	Duodenum	Lung	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;PIK3R3 p.E194Dfs*2;AURKA Amplification;MYCL Amplification	1	4
P-0004481	P-0004481-T01-IM5	In-House	DNA	Biopsy	250	841	30	Matched	Metastasis	Adrenal Gland	Bone Marrow	Tumor	NBL	Peripheral Nervous System	Neuroblastoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ATRX Deletion;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0004482	P-0004482-T01-IM5	In-House	DNA	Biopsy	250	696	60	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 Deletion);Olaparib(PALB2 Deletion)				GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	CBL Deletion;CDK12 Deletion;CDKN1B Deletion;CDKN2C Deletion;FANCA Deletion;PALB2 Deletion;PPP6C Deletion;PTEN Deletion;ZFHX3 Deletion	3	9
P-0004483	P-0004483-T01-IM5	In-House	DNA	Resection	250	122	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.E336*;KDM6A p.X1070_splice	0	2
P-0004484	P-0004484-T01-IM5	In-House	DNA	Biopsy	250	272	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.Q154*)				LEVEL_1	FGFR3 p.S249C;KDM6A p.Q154*;BAP1 p.I47M;EP300 p.C1164S;STAG2 p.T549Nfs*11	3	5
P-0004486	P-0004486-T01-IM5	In-House	DNA	Biopsy	250	798	60	Unmatched	Metastasis	Rectum	Lymph Node	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.R282W;APC p.R876*;SMAD4 p.Y434*;APC p.S1501Lfs*6	2	5
P-0004488	P-0004488-T01-IM5	In-House	DNA	Biopsy	250	655	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;KEAP1 p.R272Lfs*77	2	2
P-0004489	P-0004489-T01-IM5	In-House	DNA	Biopsy	250	484	40	Matched	Metastasis	Prostate	Retroperitoneum	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	AR p.L702H;BRCA2 Deletion	2	2
P-0004491	P-0004491-T01-IM5	Outside	DNA	Biopsy	250	935	40	Unmatched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.A289V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.A289V;SETD2 p.W1827*;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;FH Deletion	3	7
P-0004492	P-0004492-T01-IM5	In-House	DNA	Biopsy	242	701	40	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib(CDK12 p.F969Lfs*4)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.F969Lfs*4)				LEVEL_3B	PIK3CA p.E545K;MAPK1 p.E322K;CDK12 p.F969Lfs*4;MCL1 Amplification	3	4
P-0004493	P-0004493-T01-IM5	Outside	DNA	Resection	250	562	50	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Enasidenib(IDH2 p.R172K)					LEVEL_3B	IDH2 p.R172K;CIC p.Q1110*	1	2
P-0004494	P-0004494-T01-IM5	Outside	DNA	Resection	250	462	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R337C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T);Trametinib,Cobimetinib(NF1 p.A95Lfs*8)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	KRAS p.A146T;SMAD4 p.R361C;APC p.R564*;ATM p.R337C;NF1 p.A95Lfs*8;APC p.R1435Nfs*32	3	6
P-0004495	P-0004495-T01-IM5	Outside	DNA	Cytology	250	959	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										CCND1 p.E279*;TP53 p.R273L;ASXL1 p.E705*;FLT3 p.E611V;YAP1 Amplification	0	5
P-0004496	P-0004496-T01-IM5	In-House	DNA	Biopsy	107.21	546	50	Unmatched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;ETV1 Amplification	2	3
P-0004497	P-0004497-T01-IM5	Outside	DNA	Biopsy	250	876	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										SPEN p.E1100Kfs*20	0	1
P-0004497	P-0004497-T02-IM5	Outside	DNA	Biopsy	250	816	60	Matched	Primary	Axilla	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										NOTCH2 p.Q2409*;BIRC3 p.L514Sfs*5;CCND1 Amplification;MCL1 Amplification	0	4
P-0004498	P-0004498-T01-IM5	Outside	DNA	Resection	250	574	40	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0004499	P-0004499-T01-IM5	In-House	DNA	Resection	157.56	570	60	Matched	Metastasis	Breast	Brain	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.E286K;MAPK1 Amplification;PTEN Deletion;RB1 Deletion	1	4
P-0004500	P-0004500-T01-IM5	In-House	DNA	Biopsy	250	567	40	Matched	Metastasis	Cancer of Unknown Primary	Skin	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;ARID1A p.R1276*;CTNNB1 p.G34V;ARID1A p.S2096Qfs*39	1	4
P-0004501	P-0004501-T01-IM5	In-House	DNA	Biopsy	250	709	20	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SF3B1 p.R625L	0	1
P-0004502	P-0004502-T01-IM5	In-House	DNA	Resection	250	440	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	TP53 p.R248Q;KRAS p.G12A	1	2
P-0004503	P-0004503-T01-IM5	Outside	DNA	Resection	250	780	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.Y236C;RB1 p.L512*;BCL2L1 Amplification;CDKN2A Deletion;CDKN2B Deletion;RICTOR Amplification;TERT Amplification	1	7
P-0004504	P-0004504-T01-IM5	In-House	DNA	Resection	250	396	50	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										TBL3 CREBBP-TBL3 fusion;CREBBP CREBBP-TBL3 fusion	0	2
P-0004505	P-0004505-T01-IM5	In-House	DNA	Resection	250	468	70	Matched	Metastasis	Leg	Lung	Tumor	OS	Bone Cancer	Osteosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	AMER1 Deletion;ATRX Deletion;CDKN2A Deletion;CDKN2B Deletion;NF1 Deletion;SUZ12 Deletion;TP53 Deletion	2	7
P-0004506	P-0004506-T01-IM5	In-House	DNA	Resection	250	571	50	Matched	Metastasis	Testis	Lymph Node	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CARD11 Amplification;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;RAC1 Amplification	0	5
P-0004507	P-0004507-T01-IM5	Outside	DNA	Resection	250	281	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.Q73*;SETD2 p.Y2444*;PBRM1 p.G883*	0	3
P-0004508	P-0004508-T01-IM5	In-House	DNA	Resection	250	890	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133V;PIK3R2 p.D557Y;KMT2D p.A4469Mfs*48	0	3
P-0004509	P-0004509-T01-IM5	In-House	DNA	Resection	250	689	60	Matched	Metastasis	Intraabdominal	Abdomen	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D820A);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K550_W557delinsIL)	Sorafenib(KIT p.D820A)			Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib,Sunitinib(KIT p.D820A)		LEVEL_1	KIT p.D820A;KIT p.K550_W557delinsIL;CDKN2A Deletion;PMAIP1 Deletion	4	4
P-0004510	P-0004510-T01-IM5	Outside	DNA	Biopsy	250	1368	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.Q963*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTPN11 p.E69K;EGFR p.G598V;NF1 p.Q963*;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0004511	P-0004511-T01-IM5	In-House	DNA	Resection	250	564	30	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;APC p.R1450*;FBXW7 p.W673*;SMAD3 p.E239K;SMAD3 p.R243C;SMAD2 p.T303R;AMER1 p.E411*;APC p.I638Yfs*8;SMAD3 p.R69Gfs*47	2	10
P-0004512	P-0004512-T01-IM5	In-House	DNA	Resection	250	628	60	Matched	Metastasis	Soft Tissue	Liver	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	TP53 p.K382Nfs*40;ATRX p.X2109_splice;BRCA2 Deletion;DIS3 Deletion;FOXO1 Deletion;IKZF1 Deletion;LATS2 Deletion;RB1 Deletion	1	8
P-0004513	P-0004513-T01-IM5	Outside	DNA	Resection	250	677	60	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Olaparib(ATM p.F2571Yfs*4)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R282Q;ATM p.F2571Yfs*4;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0004514	P-0004514-T01-IM5	In-House	DNA	Resection	250	696	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.E911Rfs*8);Olaparib(CDK12 p.F83Sfs*9)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.E911Rfs*8);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.F83Sfs*9)				LEVEL_1	FOXA1 p.F254_E255del;CDK12 p.E911Rfs*8;CDK12 p.F83Sfs*9	4	3
P-0004515	P-0004515-T01-IM5	Outside	DNA	Biopsy	250	809	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R248Q;IDH1 p.R132H;ATRX p.R444*;ATRX p.N1318Kfs*6	1	4
P-0004516	P-0004516-T01-IM5	In-House	DNA	Biopsy	218.3	578	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0004516	P-0004516-T02-IM5	In-House	FFPE	Biopsy	250	1060	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK GCC2-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(GCC2 GCC2-ALK fusion)								LEVEL_1	ALK GCC2-ALK fusion;GCC2 GCC2-ALK fusion	2	2
P-0004517	P-0004517-T01-IM5	In-House	DNA	Biopsy	250	726	50	Matched	Metastasis	Lung	Liver	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E119*)				LEVEL_4	TP53 p.G154V;ARID1A p.A226Pfs*6;CDKN2A p.E119*;AKT2 Amplification;AXL Amplification;CCND1 Amplification;EGFR Amplification;FGF19 Amplification;PAK1 Amplification;PIK3CA Amplification	1	10
P-0004518	P-0004518-T01-IM5	In-House	DNA	Biopsy	115.5	447	40	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)	Lorlatinib,Brigatinib(ALK p.G1202R)					LEVEL_3A	NRAS p.Q61K;DICER1 p.E1813G;PAK5 p.M173I;ALK p.G1202R;KMT2A p.R745*;CTNNB1 p.T41_S45del;RAD51 RAD51-intragenic	2	7
P-0004519	P-0004519-T01-IM5	In-House	DNA	Resection	250	567	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.F1421Kfs*4)	Tazemetostat(KDM6A p.V553Lfs*37)				LEVEL_3B	RIT1 p.M90I;MSH6 p.Y589*;FAT1 p.S3707*;ARID1B p.S1075*;BRCA2 p.F1421Kfs*4;GATA3 p.P435Tfs*41;FOXA1 p.M181Nfs*46;KDM6A p.V553Lfs*37;CCND1 Amplification;FGF19 Amplification	2	10
P-0004520	P-0004520-T01-IM5	In-House	DNA	Biopsy	250	776	30	Matched	Metastasis	Liver	Lung	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(BICC1 FGFR2-BICC1 fusion);Pemigatinib(FGFR2 FGFR2-BICC1 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(BICC1 FGFR2-BICC1 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-BICC1 fusion)						LEVEL_1	BICC1 FGFR2-BICC1 fusion;FGFR2 FGFR2-BICC1 fusion	4	2
P-0004521	P-0004521-T01-IM5	In-House	DNA	Biopsy	250	889	40	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_3B	PIK3CA p.E545K;KRAS p.G12S;ARID1A p.W337*;ARID1A p.G95*	2	4
P-0004522	P-0004522-T01-IM5	In-House	DNA	Resection	250	107	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.E255_N256del;ARID1A p.A898Vfs*21	0	2
P-0004523	P-0004523-T01-IM5	In-House	DNA	Biopsy	250	850	30	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.T360Gfs*5	0	1
P-0004524	P-0004524-T01-IM5	In-House	DNA	Resection	250	663	40	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R196*	0	1
P-0004524	P-0004524-T02-IM5	In-House	FFPE	Resection	250	952	90	Matched	Metastasis	Ovary	Gallbladder	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(PALB2 Deletion);Everolimus(TSC2 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.R196*;CREBBP p.Q356*;AXIN1 Deletion;BCL6 Amplification;CBFB Deletion;CDH1 Deletion;CDKN2A Deletion;CDKN2B Deletion;CREBBP Deletion;CTCF Deletion;ERCC4 Deletion;GRIN2A Deletion;JAK2 Amplification;PALB2 Deletion;PIK3CA Amplification;PIK3CB Amplification;PTEN Deletion;RAD21 Deletion;SOCS1 Deletion;TSC2 Deletion;ZFHX3 Deletion	4	21
P-0004526	P-0004526-T01-IM5	In-House	DNA	Resection	250	718	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L;FOXA1 p.G273Afs*32	0	2
P-0004527	P-0004527-T01-IM5	In-House	DNA	Biopsy	159	256	60	Matched	Metastasis	Foot	In-transit	Tumor	ACRM	Melanoma	Acral Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0004528	P-0004528-T01-IM5	In-House	DNA	Resection	250	226	30	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										PPP2R1A p.P179R;CREBBP p.S1680del;TP53 p.H178P;TP53 p.L43*;ASXL1 p.T740Nfs*34	0	5
P-0004529	P-0004529-T01-IM5	Outside	DNA	Biopsy	250	722	50	Matched	Primary	Nasopharynx	Not Applicable	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.E99Dfs*14);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	PTEN p.E99Dfs*14;CDK4 Amplification;GLI1 Amplification;NF1 Deletion;PPM1D Amplification;TERT Amplification	3	6
P-0004530	P-0004530-T01-IM5	In-House	DNA	Biopsy	250	742	30	Matched	Metastasis	Ovary	Paracolic Gutter	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R273H	0	1
P-0004531	P-0004531-T01-IM5	In-House	DNA	Biopsy	241.5	677	50	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Enasidenib(IDH2 p.R172K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G)					LEVEL_3B	PIK3CA p.C420R;IDH2 p.R172K;PIK3CA p.E545G;CIC p.Q834*;ETV1 Amplification	3	5
P-0004532	P-0004532-T01-IM5	In-House	DNA	Resection	250	309	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0004533	P-0004533-T01-IM5	In-House	DNA	Resection	250	514	10	Matched	Primary	Stomach	Not Applicable	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										CTNNB1 p.S33Y;CDH1 p.X722_splice;TP53 p.V143Afs*21	0	3
P-0004534	P-0004534-T01-IM5	In-House	DNA	Biopsy	250	951	30	Matched	Metastasis	Bile Duct	Liver	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma										TP53 p.V97Sfs*26	0	1
P-0004535	P-0004535-T01-IM5	Outside	DNA	Cytology	218	180	40	Matched	Metastasis	Bile Duct	Lung	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;PBRM1 p.N258Kfs*6	1	2
P-0004536	P-0004536-T01-IM5	Outside	DNA	Biopsy	250	742	40	Matched	Primary	GE Junction	Not Applicable	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R248W;ERBB2 Amplification	2	2
P-0004537	P-0004537-T01-IM5	In-House	DNA	Biopsy	250	538	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.X212_splice);Trametinib,Cobimetinib(NF1 p.E258*)				LEVEL_3B	TP53 p.Y163C;TP63 p.E636*;PTEN p.X212_splice;NCOR1 p.S903*;NF1 p.E258*;EGFR Amplification;FGFR1 Amplification;FGFR2 Amplification	3	8
P-0004538	P-0004538-T01-IM5	Outside	DNA	Biopsy	250	698	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L	0	1
P-0004539	P-0004539-T01-IM5	In-House	DNA	Resection	250	682	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)					LEVEL_3B	PIK3CA p.N345K;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	3
P-0004540	P-0004540-T01-IM5	Outside	DNA	Resection	250	802	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.P408Afs*99;ERBB2 Amplification;PPM1D Amplification	2	3
P-0004541	P-0004541-T01-IM5	Outside	DNA	Biopsy	230	573	30	Matched	Primary	GE Junction	Not Applicable	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										TP53 p.R306*;TP53 p.N268Kfs*4;CCND1 Amplification;FGF19 Amplification;MYC Amplification	0	5
P-0004542	P-0004542-T01-IM5	In-House	DNA	Resection	250	735	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0004543	P-0004543-T01-IM5	Outside	DNA	Biopsy	250	304	50	Matched	Primary	Small Bowel	Not Applicable	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0004544	P-0004544-T01-IM5	Outside	DNA	Resection	250	880	40	Matched	Metastasis	Uterus	Omentum	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.C296*);GSK2636771,AZD8186(PTEN p.V166Sfs*14);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KMT2D p.R5179H;TP53 p.I195F;PTEN p.C296*;PTEN p.V166Sfs*14;PIK3R1 p.L449_Y452delinsFH;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;FGFR1 Amplification	4	10
P-0004545	P-0004545-T01-IM5	In-House	DNA	Resection	250	953	40	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Tazemetostat(KDM6A p.Y396*)				LEVEL_3B	PIK3CA p.E545K;TP53 p.H179L;STAG2 p.Q123*;PBRM1 p.E1180*;KDM6A p.Y396*;STAG2 p.S125*;DIS3 PIBF1-DIS3 fusion;PIBF1 PIBF1-DIS3 fusion	2	8
P-0004546	P-0004546-T01-IM5	In-House	DNA	Resection	250	527	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.G244C	0	1
P-0004547	P-0004547-T01-IM5	In-House	DNA	Biopsy	224	564	20	Matched	Metastasis	Liver	Peritoneum	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;ARID1A p.X1709_splice	1	2
P-0004548	P-0004548-T01-IM5	In-House	DNA	Resection	250	873	40	Matched	Metastasis	Uterus	Liver	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor				Everolimus(TSC2 Deletion);Everolimus(TSC2 MLST8-TSC2 fusion);Everolimus(MLST8 MLST8-TSC2 fusion)					LEVEL_3B	TP53 p.R209Kfs*6;RB1 Deletion;TSC2 Deletion;TSC2 MLST8-TSC2 fusion;MLST8 MLST8-TSC2 fusion	3	5
P-0004549	P-0004549-T01-IM5	Outside	DNA	Cytology	250	633	30	Matched	Metastasis	Sigmoid Colon	Peritoneal Fluid	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;TP53 p.E294Sfs*51;APC p.E1494Vfs*12;CCND2 Amplification;CDK8 Amplification;FGFR1 Amplification;FLT3 Amplification;KDM5A Amplification;MYC Amplification	2	9
P-0004550	P-0004550-T01-IM5	In-House	DNA	Cytology	250	659	30	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TET1 p.S1361*;HLA-A p.X305_splice;BRAF Amplification;GATA3 Amplification;PTEN Deletion;PTPRD Deletion	1	6
P-0004551	P-0004551-T01-IM5	In-House	DNA	Biopsy	242	872	10	Matched	Metastasis	Stomach	Falciform Ligament	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.E285K;CDH1 p.W409*	0	2
P-0004552	P-0004552-T01-IM5	Outside	DNA	Resection	250	689	40	Matched	Metastasis	Stomach	Lymph Node	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.E56*;BIRC3 Deletion;CCNE1 Amplification;MYC Amplification;PTEN Deletion	1	5
P-0004553	P-0004553-T01-IM5	In-House	DNA	Biopsy	250	776	20	Matched	Metastasis	Cancer of Unknown Primary	Abdomen	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201H	1	2
P-0004554	P-0004554-T01-IM5	Outside	DNA	Resection	250	646	40	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(MAP2K1 p.I103_K104del)		GSK2636771,AZD8186(PTEN p.R14Kfs*30)				LEVEL_3A	PTEN p.R14Kfs*30;MAP2K1 p.I103_K104del	2	2
P-0004555	P-0004555-T01-IM5	In-House	DNA	Biopsy	250	274	30	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_1	PIK3CA p.E542K;ERBB2 p.L755S;CDH1 p.Q23*;TP53 p.R290H;KRAS p.G13D;FUBP1 p.S11Lfs*43;MLH1 p.E414*;MLH1 p.E439*;KMT2C p.Q448*;PPP6C p.S45*;MEN1 p.Q141*	5	11
P-0004556	P-0004556-T01-IM5	In-House	DNA	Resection	250	739	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.P190L;NOTCH4 p.C143Sfs*109	0	2
P-0004557	P-0004557-T01-IM5	In-House	DNA	Resection	250	455	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0004558	P-0004558-T01-IM5	Outside	DNA	Biopsy	250	595	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_1	PIK3CA p.H1047R;ERBB2 p.L755S;JAK1 p.P861Tfs*4;CCND1 Amplification;FGF19 Amplification	4	5
P-0004559	P-0004559-T01-IM5	Outside	DNA	Biopsy	250	636	40	Matched	Primary	Lymph Node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS				Enasidenib(IDH2 p.R172G)					LEVEL_3B	RHOA p.G17V;IDH2 p.R172G;TET2 p.P562Qfs*6;TET2 p.E1555Dfs*16	1	4
P-0004560	P-0004560-T01-IM5	In-House	DNA	Biopsy	250	641	40	Matched	Primary	Stomach	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CREBBP p.S1680del;LATS1 p.R744*;BCL10 p.G158*;NOTCH1 p.F2509Lfs*7	0	4
P-0004561	P-0004561-T01-IM5	In-House	DNA	Resection	250	583	40	Matched	Metastasis	Kidney	Brain	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.L152V)				LEVEL_4	PTEN p.L152V;PBRM1 p.L1279Hfs*7;VHL p.E55Afs*11	1	3
P-0004562	P-0004562-T01-IM5	Outside	DNA	Resection	250	155	60	Unmatched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.C176F;FGFR3 Amplification;MYC Amplification;VEGFA Amplification	0	4
P-0004563	P-0004563-T01-IM5	In-House	DNA	Resection	250	689	20	Matched	Metastasis	Testis	Lymph Node	Tumor	EMBCA	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0004564	P-0004564-T01-IM5	In-House	DNA	Biopsy	250	857	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.L194F;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;RUNX1 RUNX1-intragenic	0	5
P-0004565	P-0004565-T01-IM5	In-House	DNA	Biopsy	250	223	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.L194R;TCF7L2 p.X185_splice;RB1 p.I66Yfs*11	0	3
P-0004566	P-0004566-T01-IM5	Outside	DNA	Resection	250	696	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	PIK3CA p.E545K;PIK3CA p.H1047R;KRAS p.A146T;APC p.Q1469Mfs*34;TCF7L2 p.C486Vfs*8	3	5
P-0004567	P-0004567-T01-IM5	In-House	DNA	Biopsy	250	712	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										POLE p.E18K;MAPK1 p.E322K;SETD2 p.Q1667*;ARID1A p.Q425*;EZH2 p.X209_splice;NCOR1 p.E1262*;SUZ12 p.R413*;RUNX1 p.Q237*;KMT2D p.D1648Afs*5	0	9
P-0004568	P-0004568-T01-IM5	In-House	DNA	Resection	250	698	40	Matched	Metastasis	Ovary	Lung	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Olaparib(ATM p.K2237*)					LEVEL_3B	ATM p.K2237*;ARID1A p.P1113Sfs*9;AURKA Amplification	1	3
P-0004569	P-0004569-T01-IM5	In-House	DNA	Resection	250	994	40	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ARID5B p.K967Nfs*15;BCOR p.K839Sfs*17;CDK4 Amplification;GLI1 Amplification;KDM5A Amplification;MDM2 Amplification	2	6
P-0004570	P-0004570-T01-IM5	Outside	DNA	Resection	250	582	60	Matched	Primary	Brain	Not Applicable	Tumor	ATM	CNS Cancer	Atypical Meningioma										CREBBP p.R1392*;PIK3R2 Amplification	0	2
P-0004571	P-0004571-T01-IM5	In-House	DNA	Biopsy	144.32	547	10	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R	1	1
P-0004572	P-0004572-T01-IM5	In-House	DNA	Resection	250	447	40	Matched	Metastasis	Testis	Lymph Node	Tumor	EMBCA	Germ Cell Tumor	Embryonal Carcinoma										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0004573	P-0004573-T01-IM5	In-House	DNA	Biopsy	250	726	10	Matched	Metastasis	Cervix	Lung	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma										KMT2C p.E2708*	0	1
P-0004574	P-0004574-T01-IM5	In-House	DNA	Biopsy	250	879	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0004576	P-0004576-T01-IM5	In-House	DNA	Biopsy	250	556	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification;MYC Amplification;TP53 Deletion	2	3
P-0004577	P-0004577-T01-IM5	In-House	DNA	Resection	250	169	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										KRAS Amplification	0	1
P-0004578	P-0004578-T01-IM5	In-House	DNA	Biopsy	250	553	50	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0004580	P-0004580-T01-IM5	In-House	DNA	Biopsy	101.7	562	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.N345K;ARID5B p.S958*;TP53 p.S269Rfs*74;MAP3K1 p.L319*;AURKA Amplification;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	4	8
P-0004584	P-0004584-T01-IM5	In-House	DNA	Biopsy	250	758	20	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma					Trametinib,Cobimetinib(NF1 p.L555Ifs*12)				LEVEL_4	NF1 p.L555Ifs*12	1	1
P-0004585	P-0004585-T01-IM5	In-House	DNA	Biopsy	250	725	20	Matched	Primary	Lymph Node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										RHOA p.G17V;TET2 p.C1396R	0	2
P-0004588	P-0004588-T01-IM5	Outside	DNA	Cytology	250	756	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.W91*	2	2
P-0004589	P-0004589-T01-IM5	In-House	DNA	Biopsy	250	618	30	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R273H;PIK3CA p.H1047R;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;CTCF CTCF-intragenic	4	6
P-0004590	P-0004590-T01-IM5	In-House	FFPE	Biopsy	250	685	70	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.V173M;BRCA2 Deletion;CARD11 Amplification;CCND3 Amplification;CDK4 Amplification;ETV1 Amplification;LATS2 Deletion;MDM2 Amplification;MYC Amplification;RAC1 Amplification;VEGFA Amplification	3	11
P-0004591	P-0004591-T01-IM5	In-House	DNA	Biopsy	136.8	602	40	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KEAP1 p.G186C;KRAS p.Q61H;STK11 p.G268Vfs*9;CDKN2A Deletion;SMARCA4 Deletion	2	5
P-0004593	P-0004593-T01-IM5	In-House	DNA	Resection	250	230	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	SMAD3 p.X203_splice;BCOR p.X1283_splice;AKT3 Amplification;BRCA2 Deletion;CIC Deletion;FOXO1 Deletion;IKBKE Amplification;MDM4 Amplification;RASA1 Deletion;RB1 Deletion	2	10
P-0004594	P-0004594-T01-IM5	In-House	DNA	Resection	250	358	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F102C;SETD2 p.F569Lfs*10;MGA p.S1918Efs*5	0	3
P-0004595	P-0004595-T01-IM5	In-House	DNA	Resection	250	323	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										ATRX p.K1332*;CREBBP p.P2077Afs*264;MEN1 p.V162Gfs*22	0	3
P-0004596	P-0004596-T01-IM5	In-House	DNA	Resection	250	529	90	Matched	Metastasis	Uterus	Lung	Tumor	OUSARC	Uterine Sarcoma	Uterine Sarcoma, Other					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RB1 p.R320Dfs*12;PTEN Deletion	1	2
P-0004597	P-0004597-T01-IM5	In-House	DNA	Resection	108.64	390	30	Matched	Metastasis	Cancer of Unknown Primary	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.D393Gfs*78;PIK3R1 PIK3R1-intragenic	0	2
P-0004597	P-0004597-T02-IM5	Outside	DNA	Biopsy	250	775	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.D393Gfs*78;TP53 p.R283H	0	2
P-0004598	P-0004598-T01-IM5	Outside	DNA	Biopsy	250	568	60	Matched	Primary	Lymph Node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS											0	0
P-0004599	P-0004599-T01-IM5	In-House	DNA	Biopsy	114.24	103	40	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.Y220C;IDH1 p.R132H;ATRX p.S1960*	1	3
P-0004600	P-0004600-T01-IM5	In-House	DNA	Biopsy	250	1047	40	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 ACPP-FGFR1 fusion);Debio1347,BGJ398,Erdafitinib,AZD4547(ACPP ACPP-FGFR1 fusion)				LEVEL_4	INPP4B p.E519*;KMT2C p.X3125_splice;CCND1 Amplification;FGF19 Amplification;TP53 Deletion;FGFR1 ACPP-FGFR1 fusion;ACPP ACPP-FGFR1 fusion	2	7
P-0004600	P-0004600-T02-IM5	In-House	DNA	Resection	250	420	40	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 ACPP-FGFR1 fusion);Debio1347,BGJ398,Erdafitinib,AZD4547(ACPP ACPP-FGFR1 fusion)				LEVEL_4	INPP4B p.E519*;KMT2C p.X3125_splice;TP53 Deletion;FGFR1 ACPP-FGFR1 fusion;ACPP ACPP-FGFR1 fusion	2	5
P-0004601	P-0004601-T01-IM5	Outside	DNA	Resection	250	352	10	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0004602	P-0004602-T01-IM5	In-House	DNA	Resection	250	688	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R)	GSK2636771,AZD8186(PTEN p.N323Mfs*21)				LEVEL_3B	PTEN p.N323Mfs*21;B2M p.X23_splice;NBN p.R551Gfs*8;B2M p.L15Ffs*41;PIK3CA p.Q546R;KMT2C p.F4496Lfs*21;SYK p.R42C;RNF43 p.R330*;SMARCA4 p.R1157W	2	9
P-0004603	P-0004603-T01-IM5	In-House	DNA	Resection	250	553	80	Matched	Metastasis	Uterus	Abdomen	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Olaparib(CHEK1 Deletion);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ATRX p.Q984*;CDH1 Deletion;CDK4 Amplification;CHEK1 Deletion;ERBB3 Amplification;GATA3 Deletion;GLI1 Amplification;MDM2 Amplification;MEF2B Amplification;KMT2D Deletion;PIK3R2 Amplification;SH2D1A Deletion;STAG2 Deletion;SUFU Deletion;TCF3 Deletion;YAP1 Amplification	3	16
P-0004604	P-0004604-T01-IM5	In-House	DNA	Resection	250	620	50	Matched	Primary	Groin	Not Applicable	Tumor	EPIS	Soft Tissue Sarcoma	Epithelioid Sarcoma	Tazemetostat(SMARCB1 Deletion)								LEVEL_1	SMARCB1 Deletion	1	1
P-0004605	P-0004605-T02-IM5	In-House	FFPE	Biopsy	250	1304	60	Matched	Metastasis	Esophagus	Lung	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.X771_splice)				LEVEL_1	PIK3CA p.E542K;TP53 p.V173*;NF1 p.X771_splice;CCNE1 Amplification;ERBB2 Amplification;SMAD4 Deletion;BRMS1L RB1-BRMS1L fusion;RB1 RB1-BRMS1L fusion	4	8
P-0004605	P-0004605-T01-IM5	Outside	DNA	Biopsy	250	651	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.X771_splice)				LEVEL_1	TP53 p.V173*;NF1 p.X771_splice;ERBB2 Amplification;BRMS1L RB1-BRMS1L fusion;RB1 RB1-BRMS1L fusion	3	5
P-0004606	P-0004606-T01-IM5	In-House	DNA	Resection	250	880	50	Matched	Metastasis	Breast	Lung	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS										NOTCH1 p.L2472Qfs*5	0	1
P-0004607	P-0004607-T03-IM5	In-House	FFPE	Biopsy	133.85	857	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.C238R;STK11 p.Q100*;KEAP1 Deletion;MDM4 Amplification;TERT Amplification	1	6
P-0004607	P-0004607-T02-IM5	In-House	DNA	Cytology	134.42	571	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.C238R;STK11 p.S69*;STK11 p.Q100*;EGFR Amplification;TERT Amplification	1	6
P-0004608	P-0004608-T01-IM5	Outside	DNA	Resection	250	1072	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R337C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	KRAS p.G13D;ATM p.R337C;APC p.S747*;ASXL1 p.G710Efs*15;APC p.E1538Nfs*27	2	5
P-0004609	P-0004609-T01-IM5	In-House	DNA	Biopsy	250	557	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.X85_splice)				LEVEL_3B	TP53 p.P250L;PTEN p.X85_splice;TP53 p.K120E;CDK4 Amplification;GLI1 Amplification	2	5
P-0004610	P-0004610-T01-IM5	Outside	DNA	Biopsy	235.52	887	50	Matched	Primary	Mediastinum	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										FUBP1 p.L426*;PIM1 p.H68Y;B2M p.M1?;B2M p.X23_splice;TNFAIP3 p.A766Rfs*3;TNFAIP3 p.L147Qfs*7;TNFAIP3 p.X633_splice;CD274 Amplification	0	8
P-0004611	P-0004611-T01-IM5	In-House	DNA	Biopsy	250	1026	30	Matched	Metastasis	Breast	Ipsilateral Breast	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_3A	ESR1 p.Y537S;TP53 p.Y236C;MYC Amplification	1	3
P-0004612	P-0004612-T01-IM5	In-House	DNA	Cytology	118.8	454	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.L257Gfs*6;NKX2-1 Amplification	0	2
P-0004613	P-0004613-T01-IM5	In-House	DNA	Biopsy	250	1007	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsIP)								LEVEL_1	TP53 p.P153Afs*16;EGFR p.E746_T751delinsIP;MCL1 Amplification;MYC Amplification	1	4
P-0004614	P-0004614-T01-IM5	Outside	DNA	Biopsy	250	520	20	Matched	Primary	Skin	Not Applicable	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma				Olaparib(CDK12 p.Q22*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q22*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	TP53 p.R248W;FAT1 p.Q16*;NF2 p.R57*;PARP1 p.R78W;FOXP1 p.W509*;KMT2D p.Q3783*;FLT3 p.D811N;CDK12 p.Q22*;CTNNB1 p.G38_P44del;NOTCH1 p.X480_splice;BAP1 p.W196_G197delins*;CDKN2A p.R80*;CCND1 Amplification;FGF19 Amplification;MYC Amplification	3	15
P-0004615	P-0004615-T01-IM5	In-House	DNA	Biopsy	250	514	60	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.V157F;BRAF p.G596C;KEAP1 p.V152Pfs*21;MET Amplification	2	4
P-0004616	P-0004616-T01-IM5	Outside	DNA	Biopsy	250	760	40	Matched	Primary	Esophagus	Not Applicable	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										TP53 p.R306*;KRAS Amplification;FH FH-intragenic;KMT2D MLL2-intragenic	0	4
P-0004617	P-0004617-T01-IM5	In-House	DNA	Biopsy	250	729	30	Matched	Metastasis	Lung	Brain	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.E349*;APC p.E1080*;FOXP1 p.X511_splice;ARID1A Deletion;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	1	7
P-0004618	P-0004618-T01-IM5	In-House	DNA	Biopsy	250	652	20	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Y)				LEVEL_4	TP53 p.E258G;LATS1 p.K987*;CDKN2A p.D108Y	1	3
P-0004618	P-0004618-T02-IM5	Outside	DNA	Resection	250	1125	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										CTNNB1 p.S33C;ERBB3 p.M91I;ARID1A p.S1791*;ARID1A p.S2272*;KMT2A p.S1603*;CDKN1A p.M38Nfs*10;FOXA1 p.M406Hfs*9	0	7
P-0004619	P-0004619-T01-IM5	In-House	DNA	Biopsy	250	583	30	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 p.S249C)	GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_3B	FGFR3 p.S249C;PTEN p.T319*;MAPK1 p.E322K;PTPRS p.R1492Q;NFKBIA p.A127Cfs*2	2	5
P-0004620	P-0004620-T01-IM5	In-House	DNA	Biopsy	250	1215	60	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;SOX17 p.S403I;SOX17 p.L377Pfs*7	1	3
P-0004621	P-0004621-T01-IM5	In-House	DNA	Resection	250	321	50	Matched	Metastasis	Testis	Lung	Tumor	SEM	Germ Cell Tumor	Seminoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0004622	P-0004622-T01-IM5	In-House	DNA	Biopsy	250	356	40	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.A186Hfs*24)	Tazemetostat(KDM6A p.S1114*)				LEVEL_1	FGFR3 p.S249C;ASXL2 p.E330K;KDM6A p.S1114*;ARID1A p.S1919Vfs*27;CDKN1A p.Q29*;TSC1 p.A186Hfs*24	4	6
P-0004622	P-0004622-T02-IM5	In-House	DNA	Biopsy	250	706	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.A186Hfs*24)	Tazemetostat(KDM6A p.S1114*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;ASXL2 p.E330K;KDM6A p.S1114*;ARID1A p.S1919Vfs*27;CDKN1A p.Q29*;TSC1 p.A186Hfs*24;CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion	5	9
P-0004623	P-0004623-T01-IM5	In-House	DNA	Biopsy	250	508	50	Matched	Primary	Thymus	Not Applicable	Tumor	THYC	Thymic Tumor	Thymic Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3B	PIK3CA p.E542K;NRAS p.Q61K;FOXP1 p.L414Pfs*47;ARID1A p.M890Hfs*46	2	4
P-0004624	P-0004624-T01-IM5	In-House	DNA	Resection	250	677	20	Matched	Metastasis	Cecum	Lung	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.L350Rfs*2;AURKA Amplification;MYC Amplification	1	4
P-0004625	P-0004625-T01-IM5	Outside	DNA	Resection	250	752	40	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.G245S;IDH1 p.R132H	1	2
P-0004626	P-0004626-T01-IM5	In-House	DNA	Resection	250	513	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F	1	1
P-0004627	P-0004627-T01-IM5	In-House	DNA	Biopsy	250	608	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.Q270*);Trametinib,Cobimetinib(NF1 p.E1459Nfs*10);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.Q270*;RB1 p.V291Ifs*9;BCOR p.L372Vfs*8;NF1 p.E1459Nfs*10;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0004628	P-0004628-T02-IM5	In-House	FFPE	Biopsy	99.2	290	40	Matched	Metastasis	Cervix	Lung	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.E542K;KMT2C p.R4478*;SMARCA4 GALNTL6-SMARCA4 fusion;GALNTL6 GALNTL6-SMARCA4 fusion	2	5
P-0004629	P-0004629-T01-IM5	In-House	DNA	Resection	250	582	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C242Y;PIK3R1 p.S155Ffs*23;APC p.E1286Kfs*2	0	3
P-0004630	P-0004630-T01-IM5	In-House	DNA	Resection	250	471	40	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0004631	P-0004631-T01-IM5	Outside	DNA	Biopsy	250	580	50	Matched	Metastasis	Ovary	Pleura	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.C135Y;MAP3K1 p.Q525*;MCL1 Amplification;MEF2B Amplification	0	4
P-0004632	P-0004632-T01-IM5	Outside	DNA	Resection	250	652	30	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0004633	P-0004633-T01-IM5	Outside	DNA	Biopsy	250	720	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0004634	P-0004634-T01-IM5	In-House	DNA	Resection	250	700	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0004635	P-0004635-T01-IM5	Outside	DNA	Resection	250	300	50	Matched	Primary	Breast	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y)					LEVEL_3B	PIK3CA p.C420R;PIK3CA p.H1047Y;KMT2D p.R2635*	2	3
P-0004636	P-0004636-T01-IM5	Outside	DNA	Resection	250	620	50	Matched	Metastasis	Pleura	Lymph Node	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 p.X577_splice;SETD2 p.Q1667*	0	2
P-0004637	P-0004637-T01-IM5	Outside	DNA	Resection	250	358	40	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										TP53 p.P301Qfs*44	0	1
P-0004638	P-0004638-T01-IM5	In-House	DNA	Resection	250	331	60	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L755S)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;ERBB2 p.L755S;TP53 p.S94*;FBXW7 p.V514F;APC p.E1550*;APC p.Y825Hfs*3	2	6
P-0004639	P-0004639-T01-IM5	In-House	DNA	Resection	250	756	40	Matched	Metastasis	Stomach	Spleen	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557R);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Y823D)	Sorafenib(KIT p.Y823D)			Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib,Sunitinib(KIT p.Y823D)		LEVEL_1	KIT p.W557R;KIT p.Y823D;CDKN2A Deletion;CDKN2B Deletion	4	4
P-0004640	P-0004640-T01-IM5	Outside	DNA	Biopsy	250	225	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0004641	P-0004641-T01-IM5	In-House	DNA	Resection	250	950	50	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;PTPRT p.Q162*;PARP1 p.X96_splice;CASP8 p.X184_splice;KMT2C p.L2735*;TP53 p.R248Q;MYC Amplification	1	7
P-0004642	P-0004642-T01-IM5	In-House	DNA	Resection	250	796	40	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0004643	P-0004643-T01-IM5	Outside	DNA	Cytology	61.2	365	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.E1220*)				LEVEL_4	NF1 p.E1220*;KEAP1 p.A356Gfs*55;RASA1 p.K949Rfs*19	1	3
P-0004644	P-0004644-T01-IM5	In-House	DNA	Biopsy	250	605	40	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										SETD2 p.L2328Rfs*36	0	1
P-0004645	P-0004645-T01-IM5	In-House	DNA	Resection	250	722	50	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D579del)								LEVEL_1	KIT p.D579del	1	1
P-0004646	P-0004646-T01-IM5	In-House	DNA	Biopsy	169.05	486	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.R248Q;FGFR2 Amplification;PIK3CA Amplification;RICTOR Amplification;TERT Amplification	2	6
P-0004647	P-0004647-T01-IM5	In-House	DNA	Biopsy	250	533	40	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R273C;ERBB3 p.V104M;PIK3R1 p.R724*;RNF43 p.M203Nfs*56	1	5
P-0004648	P-0004648-T01-IM5	In-House	DNA	Resection	250	738	10	Matched	Metastasis	Appendix	Stomach	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201C	1	2
P-0004649	P-0004649-T01-IM5	Outside	DNA	Biopsy	250	648	20	Unmatched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;NSD1 NBPF4-NSD1 fusion;NBPF4 NBPF4-NSD1 fusion	1	3
P-0004650	P-0004650-T01-IM5	Outside	DNA	Resection	250	809	40	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Trametinib,Cobimetinib(NF1 p.W571*)				LEVEL_4	LATS1 p.R82*;CBL p.X366_splice;NF1 p.W571*;RB1 p.X474_splice;TP53 p.P152K;JUN Amplification;PPP1R2C KDM5C-PPP1R2P9 fusion;KDM5C KDM5C-PPP1R2P9 fusion;KDM5C HUWE1-KDM5C fusion;HUWE1 HUWE1-KDM5C fusion	1	10
P-0004651	P-0004651-T01-IM5	Outside	DNA	Resection	250	589	50	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)				Imatinib(PDGFRA p.D842V)			LEVEL_1	PDGFRA p.D842V	2	1
P-0004652	P-0004652-T01-IM5	Outside	DNA	Biopsy	250	678	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R282W;APC p.S1392*;TP53 p.Y236*	0	3
P-0004653	P-0004653-T01-IM5	Outside	DNA	Resection	250	1045	40	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0004654	P-0004654-T01-IM5	Outside	DNA	Biopsy	250	743	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Ivosidenib(IDH1 p.R132C);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	IDH1 p.R132C;GATA3 p.D335Gfs*21;FGFR1 Amplification;MDM2 Amplification	3	4
P-0004655	P-0004655-T01-IM5	In-House	DNA	Cytology	250	1142	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1007_splice)	Crizotinib(MET p.X1007_splice)	Cabozantinib(MET p.X1007_splice)						LEVEL_1	PPM1D p.E475*;MET p.X1007_splice	3	2
P-0004656	P-0004656-T01-IM5	Outside	DNA	Resection	250	681	20	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										BAP1 p.Q322*	0	1
P-0004657	P-0004657-T01-IM5	In-House	DNA	Biopsy	250	172	50	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Trametinib,Cobimetinib(NF1 p.A1240Efs*25)				LEVEL_4	NF1 p.A1240Efs*25;ETV1 Amplification;KIT Amplification	1	3
P-0004657	P-0004657-T02-IM5	In-House	DNA	Resection	250	638	60	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0004658	P-0004658-T01-IM5	In-House	DNA	Biopsy	250	440	20	Matched	Metastasis	Lung	Epidural	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.K64*;KEAP1 p.D479Y;SMARCA4 p.Y507*	0	3
P-0004659	P-0004659-T01-IM5	In-House	DNA	Resection	72	421	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.E223*;KEAP1 p.G364C;NBN NBN-intragenic	0	3
P-0004660	P-0004660-T01-IM5	In-House	DNA	Resection	250	723	50	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0004661	P-0004661-T01-IM5	In-House	DNA	Biopsy	250	752	50	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;CDK4 p.R24S	2	2
P-0004662	P-0004662-T02-IM5	In-House	DNA	Resection	250	243	50	Matched	Primary	Oral Cavity	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										PIK3R1 p.X279_splice	0	1
P-0004663	P-0004663-T01-IM5	In-House	DNA	Biopsy	250	711	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLBMESO	Mesothelioma	Pleural Mesothelioma, Biphasic Type					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;FOXA1 Deletion;PTEN Deletion	2	4
P-0004664	P-0004664-T01-IM5	In-House	DNA	Biopsy	250	790	30	Matched	Metastasis	Soft Tissue	Colon	Tumor	STMYEC	Soft Tissue Sarcoma	Soft Tissue Myoepithelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E61Dfs*85)				LEVEL_4	CDKN2A p.E61Dfs*85;EWSR1 ZNF444-EWSR1 fusion;ZNF444 ZNF444-EWSR1 fusion	1	3
P-0004665	P-0004665-T01-IM5	Outside	DNA	Biopsy	250	702	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559G);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FOXP1 p.R544*;KIT p.V559G;KMT2C p.E82*;WT1 p.Q409*;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	2	8
P-0004666	P-0004666-T01-IM5	In-House	DNA	Biopsy	250	708	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	PIK3CA p.G1049R;APC p.X215_splice;EGFR p.S492R;TP53 p.P151R;CIC p.Q1008*;ERBB2 Amplification	3	6
P-0004667	P-0004667-T01-IM5	In-House	DNA	Resection	250	665	80	Matched	Metastasis	Pelvis	Muscle	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma					GSK2636771,AZD8186(PTEN p.G36R)				LEVEL_4	PTEN p.G36R;BCL2L11 Deletion;MGA Deletion;RAD51 Deletion	1	4
P-0004668	P-0004668-T01-IM5	Outside	DNA	Resection	250	460	20	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										CDH1 p.X130_splice;MCL1 Amplification	0	2
P-0004669	P-0004669-T01-IM5	Outside	DNA	Cytology	119	207	20	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(MIR31 CDKN2A-MIR31 fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-MIR31 fusion)				LEVEL_4	KRAS p.G12R;TP53 p.L257Gfs*6;MIR31 CDKN2A-MIR31 fusion;CDKN2A CDKN2A-MIR31 fusion	3	4
P-0004670	P-0004670-T01-IM5	Outside	DNA	Biopsy	250	565	50	Matched	Metastasis	Breast	Bladder	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.S310Y)	Ado-Trastuzumab Emtansine(ERBB2 p.S310Y);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	ERBB2 p.S310Y;CDH1 p.Q129*;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification;ARID1A ARID1A-intragenic	3	7
P-0004671	P-0004671-T01-IM5	In-House	DNA	Resection	250	520	20	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0004672	P-0004672-T01-IM5	In-House	DNA	Resection	250	797	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201H	1	2
P-0004673	P-0004673-T01-IM5	In-House	DNA	Resection	250	557	20	Matched	Metastasis	Cecum	Sigmoid Colon	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										SMAD4 p.R361H;SMAD4 p.R361L	0	2
P-0004674	P-0004674-T01-IM5	In-House	DNA	Biopsy	250	671	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;NOTCH1 p.D469N;SMARCA4 p.M781I;NOTCH1 p.V1576Gfs*34;NOTCH1 p.Y550*	1	5
P-0004675	P-0004675-T01-IM5	In-House	DNA	Resection	250	742	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0004676	P-0004676-T01-IM5	In-House	DNA	Biopsy	173.8	858	70	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D350G);Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.C71F);Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.D350G;PTEN p.C71F;BCOR p.W1218*;TP53 p.L32Cfs*12;CDK4 Amplification;EGFR Amplification;COP1 Deletion	4	7
P-0004677	P-0004677-T01-IM5	In-House	DNA	Resection	250	852	50	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)								LEVEL_1	KIT p.L576P	1	1
P-0004678	P-0004678-T01-IM5	In-House	DNA	Resection	250	693	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0004679	P-0004679-T01-IM5	In-House	DNA	Biopsy	250	785	20	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	NRAS p.Q61K;TP53 p.C176Y;APC p.Q1367*;FBXW7 p.D520N	1	4
P-0004680	P-0004680-T01-IM5	Outside	DNA	Biopsy	250	478	30	Matched	Metastasis	GE Junction	Liver	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	CCNE1 Amplification;ERBB2 Amplification;FGFR1 Amplification	3	3
P-0004680	P-0004680-T02-IM5	Outside	FFPE	Cytology	245.1	926	30	Matched	Metastasis	Esophagus	Liver	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	CCNE1 Amplification;ERBB2 Amplification;FGFR1 Amplification	3	3
P-0004681	P-0004681-T01-IM5	Outside	DNA	Resection	250	412	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.X187_splice;RHOA p.G17E;BCL6 p.R618C;HIST1H3H p.R9G;PBRM1 p.Y697*;AR Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;MYC Amplification;PTPRD Deletion;RICTOR Amplification;EWSR1 RASL10A-EWSR1 fusion;RASL10A RASL10A-EWSR1 fusion	3	14
P-0004682	P-0004682-T01-IM5	In-House	DNA	Resection	250	841	40	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	ATRX Deletion;CCND2 Amplification;CDK4 Amplification;JUN Amplification;MDM2 Amplification	2	5
P-0004683	P-0004683-T01-IM5	In-House	DNA	Biopsy	250	688	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Q)				LEVEL_3B	IDH1 p.R132H;PIK3R1 p.K567E;ARID1A p.Q553*;CIC p.E561*;CDKN2A p.H83Q	2	5
P-0004684	P-0004684-T01-IM5	In-House	DNA	Resection	250	826	30	Matched	Metastasis	Ovary	Diaphragm	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.V197E	0	1
P-0004685	P-0004685-T02-IM5	In-House	DNA	Biopsy	250	538	30	Matched	Primary	Pelvis	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma				Ivosidenib(IDH1 p.R132I)					LEVEL_3B	ATRX p.E886Lfs*18;IDH1 p.R132I	1	2
P-0004686	P-0004686-T01-IM5	Outside	DNA	Biopsy	250	1057	40	Matched	Primary	Anus	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)					LEVEL_3B	NRAS p.G12D;EIF1AX p.K10T	1	2
P-0004687	P-0004687-T01-IM5	Outside	DNA	Cytology	98.8	502	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ARID1A p.R1721*;EPHA3 p.Q184*;ATRX p.K826*;CD274 Amplification;JAK2 Amplification	2	6
P-0004688	P-0004688-T01-IM5	In-House	DNA	Biopsy	250	912	10	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.G380R);Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H);Tipifarnib(HRAS p.G12D);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1007D);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.D946Rfs*13)	Trametinib,Cobimetinib(NF1 p.X1477_splice);Tazemetostat(KDM6A p.Y1330*);Tazemetostat(KDM6A p.R519Hfs*29)				LEVEL_1	ARID1A p.R693*;RPTOR p.R139H;ARID1A p.R1276*;SMAD4 p.R361H;PIK3CA p.R108H;FGFR3 p.G380R;HRAS p.G12D;FGFR3 p.R248C;SMARCA4 p.R1093*;KMT2D p.R1757*;FOXP1 p.Q189*;ARID1A p.Q761*;CDKN2C p.R68*;NOTCH2 p.Y1508*;BCL2L11 p.R185*;ERCC3 p.R325*;MITF p.R377*;PIK3CA p.G1007D;TET2 p.X1394_splice;FAT1 p.X1214_splice;FAT1 p.R1070*;NSD1 p.R788*;EPHA7 p.W10*;KMT2C p.R4533*;KMT2C p.R4108*;KMT2D p.X134_splice;FLT3 p.A813V;MGA p.Q6*;B2M p.E64*;TRAF7 p.R189W;CTCF p.E112*;MAP2K4 p.A279T;NF1 p.X1477_splice;JAK3 p.R657Q;PIK3R2 p.R67*;PIK3R2 p.D557G;BCOR p.Y1015*;KDM6A p.Y1330*;MSH6 p.P386Lfs*25;BRCA2 p.D946Rfs*13;KDM6A p.R519Hfs*29	10	41
P-0004689	P-0004689-T01-IM5	In-House	DNA	Biopsy	250	963	20	Matched	Primary	Stomach	Not Applicable	Tumor	DSTAD	Esophagogastric Cancer	Diffuse Type Stomach Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	TP53 p.R273H;PIK3CA p.H1047R;ARID1A p.R1276*	1	3
P-0004690	P-0004690-T01-IM5	In-House	DNA	Resection	250	740	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.Y205C;APC p.R919Kfs*4;FGFR1 Amplification	1	3
P-0004691	P-0004691-T01-IM5	In-House	DNA	Biopsy	250	733	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0004691	P-0004691-T02-IM5	In-House	FFPE	Biopsy	130.02	872	55	Matched	Metastasis	Lung	Thigh	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)	Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L858R;RB1 p.R552*;TP53 p.A119G;EGFR Amplification;MET Amplification;RICTOR Amplification;TERT Amplification	3	7
P-0004692	P-0004692-T01-IM5	Outside	DNA	Resection	250	815	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	FBXW7 p.X329_splice;TP53 p.Y126*;APC p.S1346Ifs*8;PTEN Deletion	1	4
P-0004693	P-0004693-T01-IM5	In-House	DNA	Biopsy	250	872	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;TP53 p.C176F;STK11 p.P221L	1	3
P-0004694	P-0004694-T01-IM5	In-House	DNA	Biopsy	250	778	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	Trametinib,Cobimetinib(NF1 p.D1116Afs*25);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	STAG2 p.Q656*;NF1 p.D1116Afs*25;CDKN2A Deletion;CDKN2B Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	4	6
P-0004695	P-0004695-T01-IM5	Outside	DNA	Biopsy	250	835	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.G245S;RB1 p.S807*;EGFR Amplification	2	5
P-0004696	P-0004696-T01-IM5	In-House	DNA	Biopsy	250	788	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.D208N;TP53 p.E287Q;BAP1 p.N349Tfs*13	0	3
P-0004697	P-0004697-T01-IM5	In-House	DNA	Resection	250	687	40	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R273C;APC p.E1464Vfs*8;SMAD4 p.G419V;APC p.A783Efs*11	1	5
P-0004698	P-0004698-T01-IM5	In-House	DNA	Resection	250	601	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.N239D;APC p.Q1294*;APC p.R302*;XRCC2 p.F269Vfs*10;CDK8 Amplification;FLT3 Amplification	0	6
P-0004699	P-0004699-T01-IM5	In-House	DNA	Biopsy	250	815	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.S83*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G13D;STK11 p.S69*;ATM p.S83*;KEAP1 p.V155F;SMARCA4 p.X873_splice;APC p.L577*;CDKN2A Deletion;CDKN2B Deletion	3	8
P-0004700	P-0004700-T01-IM5	In-House	DNA	Biopsy	250	732	20	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma											0	0
P-0004700	P-0004700-T02-IM5	In-House	FFPE	Biopsy	250	892	50	Matched	Metastasis	Skin	Chest Wall	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61R;PTPRT p.W230*;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0004701	P-0004701-T01-IM5	In-House	DNA	Cytology	100.8	595	20	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer										TP53 p.V172F;ARID1A p.E1726*;RECQL4 p.X569_splice;STK11 p.P217Rfs*70;KMT2C p.I4307Sfs*19	0	5
P-0004702	P-0004702-T02-IM5	In-House	DNA	Biopsy	250	500	30	Matched	Metastasis	Breast	Bowel	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.Q546R)		AZD9496,Fulvestrant(ESR1 p.Y537S);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R)						LEVEL_1	ESR1 p.Y537S;PIK3CA p.Q546R	3	2
P-0004702	P-0004702-T03-IM5	In-House	FFPE	Biopsy	250	955	50	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.Q546R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.Q546R;CDH1 p.T115Nfs*53;ERBB2 Amplification	4	3
P-0004703	P-0004703-T01-IM5	In-House	DNA	Biopsy	250	802	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_1	FGFR3 p.R248C;KMT2C p.S1618*;KMT2D p.Q3729*;EP300 p.C1164Y;KMT2C p.X1596_splice;FBXW7 p.Y509Ifs*2;KMT2D p.F2518Lfs*25;CDKN2A p.H83Y	3	8
P-0004704	P-0004704-T01-IM5	In-House	DNA	Cytology	170.1	433	40	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR p.H875Y;NFKBIA p.R143Efs*21;PBRM1 p.I1073Lfs*86;PIK3R1 MUC1-PIK3R1 fusion;MUC1 MUC1-PIK3R1 fusion	0	5
P-0004705	P-0004705-T01-IM5	Outside	DNA	Resection	250	665	50	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	SMAD4 p.G352E;RB1 p.X731_splice;MDM2 Amplification;RAF1 Amplification	1	4
P-0004706	P-0004706-T01-IM5	Outside	DNA	Resection	250	577	60	Matched	Metastasis	Eye	Colon	Tumor	UM	Melanoma	Uveal Melanoma										SF3B1 p.R625C;GNA11 p.Q209L;CARD11 Amplification;ETV1 Amplification;MYC Amplification;RAC1 Amplification	0	6
P-0004707	P-0004707-T01-IM5	In-House	DNA	Biopsy	169.6	657	40	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.X225_splice;STK11 p.S216F;DNMT3A p.X694_splice;RB1 p.G435*	0	4
P-0004708	P-0004708-T01-IM5	In-House	DNA	Biopsy	250	599	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										KEAP1 p.Y396*;LATS2 LATS2-intragenic	0	2
P-0004709	P-0004709-T01-IM5	In-House	DNA	Biopsy	182	643	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.G196V;TP53 p.D57Vfs*64;RB1 Deletion	2	4
P-0004710	P-0004710-T01-IM5	In-House	DNA	Cytology	250	1006	10	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.G154V;PBRM1 p.X363_splice;WT1 p.K454*;FLT3 p.A796D	2	5
P-0004711	P-0004711-T01-IM5	Outside	DNA	Biopsy	250	1005	50	Matched	Primary	Lymph Node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS											0	0
P-0004712	P-0004712-T01-IM5	Outside	DNA	Biopsy	250	784	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma										PTPN11 p.E139D;ATRX p.Q292*	0	2
P-0004713	P-0004713-T01-IM5	Outside	DNA	Biopsy	250	652	40	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										FUBP1 p.W615*	0	1
P-0004714	P-0004714-T01-IM5	In-House	DNA	Resection	250	828	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.E171*;CCNE1 Amplification	1	3
P-0004716	P-0004716-T02-IM5	In-House	DNA	Resection	250	618	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.R335*)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.R302*;PTEN p.R335*;SMAD4 p.G419R;AMER1 p.P450Lfs*5	2	5
P-0004717	P-0004717-T01-IM5	In-House	DNA	Biopsy	250	659	40	Matched	Metastasis	Uterus	Pelvis	Tumor	ESS	Uterine Sarcoma	Endometrial Stromal Sarcoma										DNMT3A Deletion	0	1
P-0004718	P-0004718-T01-IM5	In-House	DNA	Biopsy	250	656	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)					LEVEL_1	EGFR p.L858R;TP53 p.M246V;PIK3CA p.H1047L;NOTCH2 p.D1761Gfs*2;NKX2-1 Amplification;PIK3CA Amplification;RB1 Deletion	2	7
P-0004719	P-0004719-T01-IM5	In-House	DNA	Biopsy	182.7	501	20	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma											0	0
P-0004720	P-0004720-T01-IM5	In-House	DNA	Biopsy	250	727	50	Matched	Metastasis	Breast	Brain	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545Q);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545Q;KMT2D p.Q3831Sfs*50;MGA p.V292Sfs*37;TP53 p.X185_splice;ERBB2 Amplification	4	5
P-0004721	P-0004721-T01-IM5	In-House	DNA	Resection	250	534	40	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Enasidenib(IDH2 p.R172K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E110del)					LEVEL_3B	IDH2 p.R172K;PIK3CA p.E110del;SETD2 p.W1101*;CIC p.S1117Kfs*34	2	4
P-0004722	P-0004722-T01-IM5	In-House	DNA	Resection	250	669	50	Matched	Metastasis	Ovary	Rectum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(CHEK2 Deletion)					LEVEL_3B	TP53 p.R273H;AKT2 Amplification;AKT3 Amplification;AXL Amplification;CHEK2 Deletion;FAT1 Deletion;FBXW7 Deletion;IKBKE Amplification;MDM4 Amplification;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion;STK11 Deletion;TCF3 Deletion	1	14
P-0004723	P-0004723-T01-IM5	Outside	DNA	Resection	250	657	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ATRX p.Q391*;ARID1A p.G458Afs*161	1	3
P-0004724	P-0004724-T01-IM5	In-House	DNA	Resection	250	840	30	Matched	Metastasis	Appendix	Ileum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R248Q;MYCL Amplification;SMAD4 Deletion	1	4
P-0004725	P-0004725-T01-IM5	In-House	DNA	Biopsy	250	600	10	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R282W	0	1
P-0004726	P-0004726-T02-IM5	In-House	DNA	Resection	250	455	50	Unmatched	Metastasis	Testis	Pelvis	Tumor	NSGCT	Germ Cell Tumor	Non-Seminomatous Germ Cell Tumor											0	0
P-0004726	P-0004726-T01-IM5	In-House	DNA	Resection	250	516	50	Unmatched	Metastasis	Testis	Liver	Tumor	NSGCT	Germ Cell Tumor	Non-Seminomatous Germ Cell Tumor											0	0
P-0004727	P-0004727-T01-IM5	In-House	DNA	Resection	250	825	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0004728	P-0004728-T01-IM5	In-House	DNA	Cytology	250	797	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;MDM2 Amplification;NKX2-1 Amplification;PPM1D Amplification	1	6
P-0004729	P-0004729-T01-IM5	In-House	DNA	Resection	250	632	NA	Matched	Metastasis	Lung	Epidural	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;ARID1A p.D1850Gfs*4;TP53 p.P190L;APC p.Q1131*;SMAD4 p.G508Afs*29;KDM5A Amplification	1	6
P-0004730	P-0004730-T01-IM5	In-House	DNA	Resection	250	766	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0004731	P-0004731-T01-IM5	In-House	DNA	Biopsy	113.75	352	50	Matched	Metastasis	Uterus	Soft Tissue	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN p.D326H)				LEVEL_4	PTEN p.D326H;RB1 p.X203_splice	1	2
P-0004732	P-0004732-T01-IM5	In-House	DNA	Resection	250	647	30	Matched	Metastasis	Testis	Paraspinal	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0004733	P-0004733-T01-IM5	In-House	DNA	Biopsy	250	170	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma										U2AF1 p.S34F;BRAF p.L485W;MED12 p.V41G;KMT2C p.C4600_E4617delins*;KMT2D p.G4459Tfs*20;KMT2D p.E1661Gfs*5;ARID1A p.P1177Qfs*3;CREBBP p.S2055Afs*20	0	8
P-0004733	P-0004733-T02-IM5	In-House	FFPE	Resection	250	781	NA	Matched	Metastasis	Lung	Brain	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D92Efs*28)				LEVEL_4	CTNNB1 p.S37F;TP53 p.Q167*;TBX3 p.Q590*;TET2 p.W1198C;FOXL2 p.T44Qfs*106;KDM5C p.X528_splice;CDKN2A p.D92Efs*28	1	7
P-0004734	P-0004734-T01-IM5	In-House	DNA	Resection	250	456	60	Matched	Metastasis	Thyroid	Larynx	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer					GSK2636771,AZD8186(PTEN p.I253*)				LEVEL_4	PTEN p.I253*	1	1
P-0004735	P-0004735-T01-IM5	In-House	DNA	Resection	250	581	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.R645Efs*15)			Talazoparib,Niraparib(BRCA2 p.R645Efs*15)	GSK2636771,AZD8186(PTEN p.X55_splice)				LEVEL_1	PTEN p.X55_splice;BRCA2 p.R645Efs*15	3	2
P-0004736	P-0004736-T01-IM5	In-House	DNA	Biopsy	250	458	20	Matched	Metastasis	Sigmoid Colon	Pelvis	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;PIK3R1 p.D560Y;ARID1A p.P568Sfs*52;ARID1A p.L1769Rfs*3;APC p.N627Lfs*2	1	5
P-0004737	P-0004737-T01-IM5	Outside	DNA	Biopsy	135.45	1009	30	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	2
P-0004738	P-0004738-T01-IM5	In-House	DNA	Resection	250	455	40	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.T464Pfs*11);Everolimus(TSC1 p.N891Kfs*13);Everolimus(TSC1 p.R420Qfs*22)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	MSH6 p.F1088Lfs*5;TP53 p.X331_splice;FBXW7 p.R465H;APC p.T1556Nfs*3;APC p.R856Nfs*6;PIK3CA p.R108H;ERBB3 p.E928G;RAF1 p.S257L;KMT2D p.S102Efs*6;KRAS p.G13D;PIK3R1 p.K567E;PBRM1 p.I279Yfs*4;BCL6 p.R618C;B2M p.C45*;SOX9 p.R394*;TGFBR2 p.S59Ffs*4;NSD1 p.A2268Sfs*13;PBRM1 p.R926Kfs*4;BRCA1 p.T464Pfs*11;MAP3K1 p.K1453Nfs*8;BLM p.D757Tfs*4;AMER1 p.Q723Pfs*3;NCOR1 p.G639Vfs*2;SMARCA4 p.G271Rfs*16;HNF1A p.L377Sfs*7;ARID1A p.S1134Lfs*27;SPEN p.T156Dfs*5;MRE11 p.V198*;TSC1 p.N891Kfs*13;PPM1D p.N512Kfs*16;MGA p.E2160Rfs*19;ARID2 p.D196Ifs*19;CBFB p.P70Sfs*13;SOX9 p.S23Afs*38;TSC1 p.R420Qfs*22;KMT2C p.N2842Mfs*21;BCL10 p.A200Gfs*20	5	37
P-0004739	P-0004739-T01-IM5	In-House	DNA	Biopsy	250	910	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R273C;EGFR p.L747_A750delinsP;ERBB2 Amplification	2	3
P-0004740	P-0004740-T01-IM5	In-House	DNA	Biopsy	197.96	557	30	Matched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.R248Q;CD79B p.Y196S;CIC p.R201W;MED12 p.Q1955Hfs*31;CDKN2A p.R58*;HLA-A Deletion	0	6
P-0004741	P-0004741-T01-IM5	In-House	DNA	Resection	250	532	20	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib(BARD1 p.X560_splice)	Trametinib,Cobimetinib(NF1 p.Q1341*)				LEVEL_3B	PIK3CA p.E542K;BARD1 p.X560_splice;EED p.X400_splice;NF1 p.Q1341*;RYBP p.N195Ifs*13	3	5
P-0004742	P-0004742-T01-IM5	In-House	DNA	Resection	250	744	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	TP53 p.R273H;NFE2L2 p.D29H;MYC p.P74L;CDKN2A p.H83Y	1	4
P-0004743	P-0004743-T01-IM5	In-House	DNA	Cytology	83.72	545	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345H)					LEVEL_1	TP53 p.A138V;RB1 p.X314_splice;PIK3CA p.N345H;EGFR p.L747_A750delinsP;EGFR Amplification;PRDM1 Deletion	2	6
P-0004744	P-0004744-T01-IM5	In-House	DNA	Resection	250	940	30	Matched	Metastasis	Ascending Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.C135*	3	2
P-0004745	P-0004745-T01-IM5	In-House	DNA	Resection	250	846	40	Matched	Primary	Esophagus	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma											0	0
P-0004746	P-0004746-T01-IM5	In-House	DNA	Resection	250	1212	60	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung											0	0
P-0004747	P-0004747-T01-IM5	In-House	DNA	Resection	250	528	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	2
P-0004748	P-0004748-T01-IM5	Outside	DNA	Resection	250	342	30	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K	2	1
P-0004752	P-0004752-T01-IM5	In-House	DNA	Resection	250	580	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										ARID2 p.K198*;NRG1 CD74-NRG1 fusion;CD74 CD74-NRG1 fusion	0	3
P-0004753	P-0004753-T01-IM5	In-House	DNA	Biopsy	250	957	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										PMS1 p.E424*;NCOR1 p.X941_splice;RB1 p.K143Mfs*19;FOXA1 p.M138Ifs*2;TBX3 p.E73Dfs*35;TP53 p.L35Pfs*10;KMT2C p.L901Afs*30;ARID2 Deletion	0	8
P-0004754	P-0004754-T01-IM5	In-House	DNA	Resection	250	559	40	Matched	Metastasis	Colorectal NOS	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.F1978Lfs*26);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K3416Nfs*11);Sonidegib,Vismodegib(PTCH1 p.L39Cfs*41)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.Y375C)				LEVEL_3B	PTPRT p.Q131Kfs*17;ERBB3 p.A232V;RNF43 p.G659Vfs*41;HNF1A p.P291Qfs*51;KMT2D p.P647Hfs*283;RNF43 p.R132*;DIS3 p.S445Hfs*20;TET1 p.R1744Efs*18;AXIN2 p.G665Afs*24;FGFR2 p.Y375C;APC p.R302*;CIC p.P509Hfs*14;ARID1A p.Q372Sfs*19;CIC p.S1117Kfs*34;APC p.Q236*;SH2D1A p.R55*;CDKN1A p.R83Gfs*65;KMT2A p.L2447Ffs*10;BRCA2 p.F1978Lfs*26;BRCA2 p.K3416Nfs*11;PTCH1 p.L39Cfs*41;CBFB p.R19*;FAT1 p.V3229Cfs*3;NOTCH4 p.L1638Cfs*68;ZFHX3 p.P2229Lfs*26;RAD50 p.K583Gfs*5;SPEN p.A2840Gfs*7	4	27
P-0004755	P-0004755-T01-IM5	In-House	DNA	Resection	250	666	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.W247*)	Tazemetostat(KDM6A p.E991*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Y);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12*)				LEVEL_3B	ERBB3 p.V104L;TP53 p.E285K;BRAF p.D594N;JUN p.E112Q;NOTCH4 p.Q153*;TSC1 p.W247*;KMT2D p.Q2458*;DIS3 p.Q921*;KDM6A p.E991*;STAG2 p.K89*;CREBBP p.S985*;CDKN2A p.D108Y;CDKN2A p.S12*;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification;PPM1D Amplification;RAF1 Amplification	4	18
P-0004756	P-0004756-T01-IM5	Outside	DNA	Resection	250	384	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L	0	1
P-0004757	P-0004757-T01-IM5	In-House	DNA	Biopsy	250	131	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	AZD5363(AKT1 p.E17K)	Tazemetostat(KDM6A p.T1245Nfs*6)				LEVEL_1	AKT1 p.E17K;FGFR3 p.S249C;ERBB3 p.D297Y;ASXL1 p.G645Vfs*58;RBM10 p.W425*;CDKN1A p.E60Gfs*3;CDKN1A p.G40Afs*108;KDM6A p.T1245Nfs*6;CDKN1A p.R83Lfs*6	4	9
P-0004758	P-0004758-T01-IM5	In-House	DNA	Biopsy	250	762	20	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 p.X757_splice)				LEVEL_3B	TP53 p.R273L;NF1 p.X757_splice;FGFR1 Amplification	2	3
P-0004759	P-0004759-T01-IM5	Outside	DNA	Cytology	206	677	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.C176F;EGFR Amplification;FGFR3 Amplification;FOXA1 Amplification;NKX2-1 Amplification;TERT Amplification;STK11 STK11-intragenic;TCF3 TCF3-intragenic;MSL3 RB1-MSL3 fusion;RB1 RB1-MSL3 fusion	0	10
P-0004760	P-0004760-T01-IM5	In-House	DNA	Resection	250	182	60	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Y823D);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_E561del)	Sorafenib(KIT p.Y823D)					Imatinib,Sunitinib(KIT p.Y823D)		LEVEL_1	KIT p.Y823D;KIT p.W557_E561del	3	2
P-0004761	P-0004761-T01-IM5	Outside	DNA	Biopsy	250	849	20	Matched	Primary	Cervix	Not Applicable	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma										TGFBR2 p.E311*	0	1
P-0004762	P-0004762-T01-IM5	In-House	DNA	Biopsy	250	321	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Tazemetostat(KDM6A p.E33*)				LEVEL_1	KRAS p.G12D;PIK3CA p.E545K;FGFR3 p.S249C;KDM6A p.E33*	5	4
P-0004763	P-0004763-T01-IM5	Outside	DNA	Biopsy	250	89	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib(KIT p.N655K);Imatinib(KIT p.Y823C)					LEVEL_3B	CBL p.X366_splice;KIT p.N655K;KIT p.Y823C	2	3
P-0004764	P-0004764-T01-IM5	In-House	DNA	Biopsy	250	989	30	Matched	Metastasis	Brain	Epidural	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										ATRX Deletion;CIC Deletion;PRDM1 Deletion	0	3
P-0004765	P-0004765-T01-IM5	Outside	DNA	Resection	250	827	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Olaparib(BRIP1 p.Q645*);Everolimus(TSC1 p.H171Qfs*39);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_1	FGFR3 p.S249C;ARID1A p.E2246*;FOXP1 p.Q344*;BRIP1 p.Q645*;TSC1 p.H171Qfs*39;CDKN1A p.R32Pfs*4;CDKN2A p.H83Y;ERBB2 Amplification;FOXA1 Deletion	6	9
P-0004766	P-0004766-T01-IM5	Outside	DNA	Resection	250	554	10	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Tipifarnib(HRAS p.K117N)					LEVEL_3B	HRAS p.K117N	1	1
P-0004768	P-0004768-T01-IM5	In-House	DNA	Biopsy	250	503	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)		GSK2636771,AZD8186(PTEN p.I253Nfs*45)				LEVEL_1	PIK3CA p.E545K;PTEN p.I253Nfs*45;TP53 p.K120Qfs*29;PIK3CA Amplification	3	4
P-0004769	P-0004769-T01-IM5	Outside	DNA	Biopsy	250	600	30	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;MCL1 Amplification;NTRK1 Amplification	1	3
P-0004770	P-0004770-T01-IM5	Outside	DNA	Biopsy	250	554	20	Matched	Primary	Bone	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease											0	0
P-0004770	P-0004770-T02-IM5	Outside	DNA	Biopsy	250	713	20	Matched	Primary	Bone	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease											0	0
P-0004771	P-0004771-T01-IM5	Outside	DNA	Biopsy	250	743	20	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.D2346Vfs*49)				LEVEL_4	NF1 p.D2346Vfs*49;PIK3R1 E604fs	1	2
P-0004772	P-0004772-T01-IM5	Outside	DNA	Resection	250	716	80	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma											0	0
P-0004773	P-0004773-T01-IM5	In-House	DNA	Resection	250	992	60	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	STMYEC	Soft Tissue Sarcoma	Soft Tissue Myoepithelial Carcinoma											0	0
P-0004774	P-0004774-T01-IM5	In-House	DNA	Biopsy	250	631	40	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BAP1 Deletion;CDKN2A Deletion;CDKN2B Deletion;NCOR1 GALK2-NCOR1 fusion;GALK2 GALK2-NCOR1 fusion	1	5
P-0004775	P-0004775-T01-IM5	Outside	DNA	Resection	250	743	40	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.X169_splice;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;MYC Amplification;RUNX1 Deletion;SRC Amplification	0	7
P-0004776	P-0004776-T01-IM5	In-House	DNA	Resection	250	705	60	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.M552_V555delinsI)								LEVEL_1	KIT p.M552_V555delinsI	1	1
P-0004777	P-0004777-T01-IM5	Outside	DNA	Biopsy	250	530	30	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R158L;CDKN1B p.X3_splice;RB1 p.K95*	0	3
P-0004778	P-0004778-T02-IM5	In-House	FFPE	Resection	250	1002	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.L1018*)				LEVEL_4	NF1 p.L1018*	1	1
P-0004778	P-0004778-T01-IM5	Outside	DNA	Resection	250	732	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.L1018*)				LEVEL_4	NF1 p.L1018*	1	1
P-0004779	P-0004779-T01-IM5	In-House	DNA	Cytology	250	695	10	Matched	Metastasis	Bile Duct	Lymph Node	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										TP53 p.V157A;RB1 RB1-intragenic	0	2
P-0004780	P-0004780-T01-IM5	In-House	DNA	Biopsy	250	510	20	Matched	Metastasis	Upper Extremity	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										ATRX p.K1583Sfs*15	0	1
P-0004781	P-0004781-T01-IM5	Outside	DNA	Biopsy	250	855	40	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R38C)					LEVEL_3B	PIK3CA p.R38C;FBXW7 p.R465C;APC p.R1435Hfs*32;TP53 p.E68Gfs*80	1	4
P-0004782	P-0004782-T01-IM5	In-House	DNA	Resection	250	588	60	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.V73Wfs*50	0	1
P-0004783	P-0004783-T01-IM5	In-House	DNA	Resection	250	587	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Olaparib(CDK12 p.P1475Lfs*24)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Trametinib,Cobimetinib,Binimetinib(KRAS p.A59T);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.P1475Lfs*24)	Cetuximab,Panitumumab(KRAS p.G12D);Cetuximab,Panitumumab(KRAS p.A59T)			LEVEL_3B	FBXW7 p.R505C;KRAS p.G12D;ARID1A p.G889Afs*2;APC p.Q1429*;APC p.R876*;CTCF p.E691Sfs*30;KRAS p.A59T;PPM1D p.L450*;MRE11 p.V198*;MSH2 p.L310R;PIK3R1 p.R639*;NOTCH4 p.W1740*;CIC p.P1248Hfs*54;CDK12 p.P1475Lfs*24;TMEM127 p.A235Cfs*41;TCF7L2 p.P180Rfs*45;ATR p.S2207Ifs*15	4	17
P-0004784	P-0004784-T01-IM5	In-House	DNA	Resection	250	732	60	Matched	Metastasis	Abdomen	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D820Y);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K550_V555delinsQ)	Sorafenib(KIT p.D820Y)					Imatinib,Sunitinib(KIT p.D820Y)		LEVEL_1	KIT p.D820Y;RB1 p.X654_splice;KIT p.K550_V555delinsQ	3	3
P-0004785	P-0004785-T01-IM5	In-House	DNA	Resection	250	486	40	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0004786	P-0004786-T01-IM5	In-House	DNA	Resection	250	744	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.S241F;APC p.Q1378*;TET2 p.R550*;APC p.D1297Efs*3;CCND2 Amplification;KDM5A Amplification	1	7
P-0004787	P-0004787-T01-IM5	In-House	DNA	Biopsy	250	980	50	Matched	Metastasis	Uterus	Pelvis	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	ZFHX3 p.E3020*;ASXL1 p.R421*;RB1 p.Y655Ifs*3;BRCA2 Deletion;FOXO1 Deletion;PIK3CA Amplification;ZFHX3 ZFHX3-intragenic	1	7
P-0004788	P-0004788-T01-IM5	In-House	DNA	Biopsy	250	684	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0004789	P-0004789-T01-IM5	In-House	DNA	Resection	250	688	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R175H;SMAD4 p.R445*;RB1 p.X422_splice;ARID1A p.E1956Rfs*53	1	5
P-0004790	P-0004790-T01-IM5	In-House	DNA	Biopsy	250	883	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	MED12 p.Q27E;KMT2C p.E2825*;SMAD4 p.Q366E;ARID1A p.Y551Tfs*68;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	6
P-0004791	P-0004791-T01-IM5	Outside	DNA	Resection	250	594	40	Unmatched	Primary	Ovary	Not Applicable	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer											0	0
P-0004792	P-0004792-T01-IM5	In-House	DNA	Resection	250	903	40	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SMAD2 p.R182*;SMAD2 p.S464*;SMAD3 p.S425F;CDH1 p.G239R	3	5
P-0004793	P-0004793-T01-IM5	In-House	DNA	Resection	250	573	70	Matched	Metastasis	Uterus	Spleen	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	FBXW7 p.R465C;KMT2C p.S682*;MYC p.S161L;KMT2D p.X2037_splice;TP53 p.X225_splice;ERBB2 Amplification	2	6
P-0004794	P-0004794-T01-IM5	Outside	DNA	Biopsy	250	725	60	Matched	Metastasis	Ovary	Abdomen	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer										AMER1 p.C1060*	0	1
P-0004795	P-0004795-T01-IM5	Outside	DNA	Biopsy	250	664	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(BRAF CUL1-BRAF fusion);Trametinib,Cobimetinib(CUL1 CUL1-BRAF fusion)					LEVEL_3B	TP53 p.X126_splice;B2M p.S40*;SMAD4 p.D493H;RNF43 p.F210Lfs*2;BRAF CUL1-BRAF fusion;CUL1 CUL1-BRAF fusion	2	6
P-0004796	P-0004796-T01-IM5	In-House	DNA	Resection	250	716	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.G386D;TP53 p.Y236D	1	3
P-0004798	P-0004798-T01-IM5	In-House	DNA	Resection	250	694	60	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.R173C)				LEVEL_1	BRAF p.V600E;PTEN p.R173C;SMAD4 p.R361H;TP53 p.P152L;BCOR p.T431Rfs*5	4	5
P-0004799	P-0004799-T01-IM5	Outside	DNA	Biopsy	250	715	50	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.E258K;RB1 p.R251*	0	2
P-0004800	P-0004800-T01-IM5	Outside	DNA	Resection	250	774	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;EIF1AX p.X113_splice	2	2
P-0004801	P-0004801-T01-IM5	In-House	DNA	Resection	250	983	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Cisplatin(ERCC2 p.R631C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.R280G;ERCC2 p.R631C;KMT2A p.X1666_splice;HLA-A p.L317Hfs*17	2	5
P-0004802	P-0004802-T01-IM5	In-House	DNA	Biopsy	250	934	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.H178Tfs*69;TP53 p.F134L;MUTYH p.X490_splice;FOXL2 p.G269Afs*2;ARID1A p.E1765Dfs*4;KRAS Amplification;PAX5 Amplification	2	8
P-0004803	P-0004803-T01-IM5	Outside	DNA	Resection	250	532	60	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R175H;APC p.R554*;SMAD4 p.G419V;APC p.D1486Efs*21	1	5
P-0004804	P-0004804-T01-IM5	Outside	DNA	Resection	250	638	70	Matched	Metastasis	Uterus	Pelvis	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										RB1 Deletion;TP53 Deletion	0	2
P-0004805	P-0004805-T01-IM5	Outside	DNA	Resection	250	541	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.T41A;ID3 Deletion	0	2
P-0004806	P-0004806-T01-IM5	Outside	DNA	Resection	250	664	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0004807	P-0004807-T01-IM5	Outside	DNA	Resection	250	419	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Y76*);Trametinib,Cobimetinib(NF1 p.L2419Gfs*2);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.Y76*;NF1 p.L2419Gfs*2;CCND2 Amplification;EGFR Amplification	3	4
P-0004808	P-0004808-T01-IM5	In-House	DNA	Biopsy	250	422	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 BET1-FGFR2 fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(BET1 BET1-FGFR2 fusion)					LEVEL_1	PIK3CA p.E545K;PAK1 Amplification;FGFR2 BET1-FGFR2 fusion;BET1 BET1-FGFR2 fusion	4	4
P-0004809	P-0004809-T01-IM5	In-House	DNA	Resection	250	586	20	Matched	Metastasis	Appendix	Ileum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				AZD5363(AKT1 p.E17K);Olaparib(CHEK2 p.X366_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3B	AKT1 p.E17K;APC p.Q1444*;APC p.R554*;KRAS p.G13D;CHEK2 p.X366_splice;AMER1 p.S444Afs*2	3	6
P-0004809	P-0004809-T02-IM5	In-House	DNA	Resection	250	825	70	Matched	Metastasis	Appendix	Small Bowel	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				AZD5363(AKT1 p.E17K);Olaparib(CHEK2 p.X366_splice);Everolimus(TSC2 p.X1690_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3B	AKT1 p.E17K;APC p.Q1444*;APC p.R554*;KRAS p.G13D;CHEK2 p.X366_splice;AMER1 p.S444Afs*2;TSC2 p.X1690_splice;SOX9 p.S405Pfs*66	4	8
P-0004810	P-0004810-T01-IM5	In-House	DNA	Resection	250	969	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.X187_splice;SUZ12 p.Y480Lfs*7;CCND3 Amplification;VEGFA Amplification	1	5
P-0004811	P-0004811-T01-IM5	In-House	DNA	Biopsy	250	605	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_3B	TP53 p.R196*;KRAS p.Q61H;AKT2 Amplification;AXL Amplification;ERBB2 Amplification	2	5
P-0004812	P-0004812-T01-IM5	Outside	DNA	Biopsy	250	744	70	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Ivosidenib(IDH1 p.R132S);Everolimus(TSC1 p.V46Wfs*16)					LEVEL_3B	IDH1 p.R132S;TSC1 p.V46Wfs*16	2	2
P-0004813	P-0004813-T02-IM5	In-House	DNA	Resection	250	854	60	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.C162*;SETD2 p.R1592*;KDM5C p.X374_splice	0	3
P-0004814	P-0004814-T01-IM5	Outside	DNA	Biopsy	250	802	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										FBXW7 p.X374_splice;NF2 p.X200_splice	0	2
P-0004815	P-0004815-T01-IM5	In-House	DNA	Biopsy	250	1296	80	Matched	Metastasis	Conjunctiva	Liver	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	ATRX p.K459*;AKT3 Amplification;MAPK1 Amplification;NF1 Deletion;TP63 SPEN-TP63 fusion;SPEN SPEN-TP63 fusion	1	6
P-0004816	P-0004816-T01-IM5	Outside	DNA	Biopsy	250	181	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0004817	P-0004817-T02-IM5	In-House	FFPE	Biopsy	250	1033	50	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma										DNMT3A p.X427_splice;TET2 p.P594Sfs*42	0	2
P-0004817	P-0004817-T01-IM5	In-House	DNA	Resection	250	926	30	Matched	Primary	Lymph Node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma				Enasidenib(IDH2 p.R172K)					LEVEL_3B	IDH2 p.R172K;RHOA p.G17V;DNMT3A p.X427_splice;TET2 p.P594Sfs*42	1	4
P-0004818	P-0004818-T01-IM5	In-House	DNA	Resection	250	917	60	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.G129R);GSK2636771,AZD8186(PTEN p.E157Kfs*2);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R175H;PTEN p.G129R;APC p.P1778Lfs*12;PTEN p.E157Kfs*2;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;FGFR1 Amplification;KDM5A Amplification;ZFHX3 Deletion	4	11
P-0004819	P-0004819-T01-IM5	In-House	DNA	Biopsy	250	836	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	PRKN p.N428Mfs*7;AKT2 Amplification;ATRX Deletion;AXL Amplification;CCNE1 Amplification;CD274 Amplification;CDK4 Amplification;JAK2 Amplification;MDM2 Amplification	2	9
P-0004820	P-0004820-T01-IM5	In-House	DNA	Biopsy	250	202	30	Matched	Metastasis	Testis	Mediastinum	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0004821	P-0004821-T01-IM5	In-House	DNA	Resection	250	1125	30	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					GSK2636771,AZD8186(PTEN p.T160A)				LEVEL_4	TP53 p.G244D;PTEN p.T160A;MGA p.E1170Hfs*6;CREBBP p.K1051Rfs*5	1	4
P-0004822	P-0004822-T01-IM5	Outside	DNA	Resection	250	777	60	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.G262V;CCNE1 Amplification;MAPK1 Amplification;MED12 Deletion	0	4
P-0004823	P-0004823-T01-IM5	Outside	DNA	Resection	250	425	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;TP53 p.R282W;APC p.R1450*;AMER1 p.R626*	1	4
P-0004824	P-0004824-T01-IM5	Outside	DNA	Biopsy	195	654	60	Unmatched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 p.S2052*)		Rucaparib,Niraparib(BRCA2 p.S2052*)					LEVEL_2	TET2 p.N1390I;BRCA2 p.S2052*	2	2
P-0004825	P-0004825-T01-IM5	In-House	DNA	Biopsy	250	711	80	Matched	Primary	Lymph node	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										BIRC3 p.V559Kfs*10	0	1
P-0004826	P-0004826-T01-IM5	In-House	DNA	Resection	250	681	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RYBP p.X224_splice;APC p.D1519Gfs*13;PTEN Deletion;ZFHX3 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0004827	P-0004827-T01-IM5	In-House	DNA	Biopsy	250	662	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Sonidegib,Vismodegib(PTCH1 p.X854_splice)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_3B	PTCH1 p.X854_splice;TET2 p.Y1645Ifs*16;CDKN2A p.W110*;CCND1 Amplification;TP53 TP53-intragenic	2	5
P-0004828	P-0004828-T02-IM5	In-House	DNA	Resection	250	625	80	Matched	Metastasis	Intraabdominal	Pancreas	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)			Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Imatinib(PDGFRA p.D842V)			LEVEL_1	PDGFRA p.D842V;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	3	4
P-0004829	P-0004829-T01-IM5	Outside	DNA	Resection	250	521	60	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib(NF1 p.D352Vfs*24)				LEVEL_4	TP53 p.R213Dfs*34;NOTCH1 p.X400_splice;RB1 p.X445_splice;NF1 p.D352Vfs*24	1	4
P-0004830	P-0004830-T01-IM5	In-House	DNA	Biopsy	250	412	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM p.N2875S)								LEVEL_1	TP53 p.R248Q;RPTOR p.R139H;ATM p.N2875S;EPHA7 Deletion;FANCA Deletion;PRKN Deletion;PTPRT Deletion	1	7
P-0004831	P-0004831-T01-IM5	In-House	DNA	Biopsy	250	847	30	Matched	Metastasis	Skin	Lung	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P471L)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	TP53 p.R248W;TP53 p.W146*;RB1 p.R251*;PIK3CA p.P471L;WT1 p.X417_splice;CDKN2A p.R80*	2	6
P-0004832	P-0004832-T01-IM5	In-House	DNA	Resection	250	773	80	Matched	Metastasis	Skin	In-transit	Tumor	ACRM	Melanoma	Acral Melanoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	AURKA Amplification;BRCA2 Deletion;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;EED Deletion;ERBB3 Amplification;FGF19 Amplification;FOXO1 Deletion;GATA3 Deletion;MAPK1 Amplification;MDM2 Amplification;MRE11 Deletion;PAK1 Amplification;PRDM1 Deletion;RAD50 Deletion;RB1 Deletion;RHEB Amplification;ZFHX3 Deletion	3	20
P-0004834	P-0004834-T01-IM5	In-House	DNA	Biopsy	250	604	30	Matched	Metastasis	Rectosigmoid Colon	Pleura	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R213*;APC p.E1295*;APC p.L616Ffs*17;APC p.F615Ifs*19;CCND2 Amplification;KDM5A Amplification	0	6
P-0004835	P-0004835-T01-IM5	Outside	DNA	Resection	250	823	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Olaparib(PTRH2 BRIP1-PTRH2 fusion);Olaparib(BRIP1 BRIP1-PTRH2 fusion)					LEVEL_3B	GATA3 p.T417Dfs*90;CCND1 Amplification;FGFR1 Amplification;IKBKE Amplification;MDM4 Amplification;MYC Amplification;PPM1D Amplification;PTRH2 BRIP1-PTRH2 fusion;BRIP1 BRIP1-PTRH2 fusion	3	9
P-0004836	P-0004836-T01-IM5	Outside	DNA	Biopsy	250	526	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0004837	P-0004837-T01-IM5	Outside	DNA	Biopsy	250	683	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.R108K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.R108K;EGFR p.R108G;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;TP63 Deletion	3	6
P-0004838	P-0004838-T01-IM5	Outside	DNA	Biopsy	250	766	20	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	KRAS p.G12C;GNAS p.R201C;CDKN2A p.R58*	3	3
P-0004839	P-0004839-T01-IM5	Outside	DNA	Biopsy	250	950	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.D252Vfs*24)	Talazoparib,Niraparib(BRCA2 p.D252Vfs*24)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_3A	KRAS p.G12R;SMAD4 p.Q256*;HLA-A p.X349_splice;BRCA2 p.D252Vfs*24;PBRM1 p.Q422Hfs*16	3	5
P-0004840	P-0004840-T01-IM5	Outside	DNA	Resection	250	379	40	Matched	Metastasis	Testis	Lymph Node	Tumor	EMBCA	Germ Cell Tumor	Embryonal Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0004841	P-0004841-T01-IM5	Outside	DNA	Biopsy	250	309	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G106R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.G106R;TP53 p.I255S;ERBB2 Amplification;ARID2 ARID2-intragenic	4	4
P-0004842	P-0004842-T01-IM5	In-House	DNA	Resection	250	814	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 PBRM1-BAP1 fusion;PBRM1 PBRM1-BAP1 fusion	0	2
P-0004843	P-0004843-T01-IM5	Outside	DNA	Resection	250	881	60	Matched	Primary	Lung	Not Applicable	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid										ARID1A p.X1708_splice	0	1
P-0004844	P-0004844-T01-IM5	Outside	DNA	Resection	250	850	40	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.E1309Dfs*4;APC p.X278_splice;TCF7L2 p.X424_splice	1	4
P-0004845	P-0004845-T01-IM5	In-House	DNA	Resection	250	854	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		Cetuximab,Panitumumab(NRAS p.Q61R)			LEVEL_3B	TP53 p.R175H;NRAS p.Q61R;APC p.Q1429*;APC p.R499*;EPHA3 p.S738*;PIK3R1 p.N453_S460delinsK;CDK8 Amplification;FLT3 Amplification	1	8
P-0004846	P-0004846-T01-IM5	In-House	DNA	Biopsy	250	491	30	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.R175H;EGFR p.T363I;TP53 p.E224D;CDK4 Amplification;GLI1 Amplification;MDM4 Amplification	1	6
P-0004847	P-0004847-T01-IM5	Outside	DNA	Biopsy	124	927	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.Q165*;FOXA1 Amplification;MYC Amplification;NKX2-1 Amplification	1	5
P-0004848	P-0004848-T01-IM5	In-House	DNA	Biopsy	250	874	50	Unmatched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209L	0	1
P-0004849	P-0004849-T01-IM5	Outside	DNA	Biopsy	138.6	568	20	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.L1253Pfs*9)				LEVEL_4	TP53 p.M246V;DNMT3A p.X338_splice;PIK3R1 p.X582_splice;NF1 p.L1253Pfs*9;ATRX p.K2096Sfs*12;DNMT3A p.V338Qfs*8	1	6
P-0004850	P-0004850-T01-IM5	In-House	DNA	Biopsy	250	1123	20	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										TP53 p.R282W;CEBPA p.X83_splice;CCND1 Amplification;CDH1 Deletion;FGF19 Amplification;MAP2K4 Deletion;PAK1 Amplification;GNA11 TYK2-GNA11 fusion;TYK2 TYK2-GNA11 fusion	0	9
P-0004851	P-0004851-T01-IM5	Outside	DNA	Resection	250	688	60	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A36Rfs*17)				LEVEL_4	KRAS p.Q61L;TP53 p.X126_splice;KDM5C p.R681*;RBM10 p.X242_splice;CDKN2A p.A36Rfs*17	2	5
P-0004852	P-0004852-T01-IM5	Outside	DNA	Biopsy	250	481	20	Matched	Primary	Mesentery	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease											0	0
P-0004853	P-0004853-T01-IM5	Outside	DNA	Biopsy	250	764	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	PIK3CA p.H1047R;CDK4 Amplification;GLI1 Amplification;KDR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification	3	7
P-0004854	P-0004854-T01-IM5	In-House	DNA	Resection	250	826	80	Matched	Primary	Leg	Not Applicable	Tumor	MCHS	Bone Cancer	Mesenchymal Chondrosarcoma											0	0
P-0004855	P-0004855-T01-IM5	Outside	DNA	Resection	250	1010	70	Matched	Primary	Anus	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma										SF3B1 p.R625H;CCND3 Amplification;VEGFA Amplification	0	3
P-0004856	P-0004856-T01-IM5	In-House	DNA	Biopsy	250	595	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	GNAS p.R201C;KRAS p.Q61H;TP53 p.E258D;MYC Amplification	1	4
P-0004857	P-0004857-T01-IM5	Outside	DNA	Biopsy	250	851	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Ivosidenib(IDH1 p.R132H)	Trametinib,Cobimetinib(NF1 p.L1507Tfs*19);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;IDH1 p.R132H;NF1 p.L1507Tfs*19;CDKN2A Deletion;CDKN2B Deletion	4	5
P-0004858	P-0004858-T01-IM5	In-House	DNA	Biopsy	250	635	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.W239C	0	1
P-0004858	P-0004858-T02-IM5	In-House	FFPE	Cytology	250	920	20	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										NOTCH2 p.X994_splice;STK11 p.W239C	0	2
P-0004859	P-0004859-T01-IM5	Outside	DNA	Resection	250	415	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.F134V;MAP3K1 p.Q1199*	2	3
P-0004860	P-0004860-T01-IM5	In-House	DNA	Resection	250	817	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;FAT1 p.R1230*;TP53 p.X187_splice;AMER1 p.E752*	2	5
P-0004861	P-0004861-T01-IM5	In-House	DNA	Resection	250	899	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.H179R;KMT2D p.S1476Lfs*14;FAT1 Deletion;KDR Amplification;KIT Amplification;MAPK1 Amplification;PTPRD Deletion;BBC3 C2orf63-BBC3 fusion;CLHC1 C2orf63-BBC3 fusion	0	9
P-0004862	P-0004862-T01-IM5	Outside	DNA	Biopsy	250	734	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	TP53 p.R248W;KRAS p.G12V;APC p.R499*	1	3
P-0004863	P-0004863-T01-IM5	Outside	DNA	Resection	250	790	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.X187_splice;STAT3 p.E616G;RPS6KA4 p.S236L;NCOR1 p.E1949Nfs*27;PTPRD p.S1312_H1313delins*;SMARCA4 LDLR-SMARCA4 fusion;LDLR LDLR-SMARCA4 fusion	0	7
P-0004864	P-0004864-T01-IM5	In-House	DNA	Cytology	166.95	279	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.P278H	1	2
P-0004865	P-0004865-T01-IM5	In-House	DNA	Resection	250	838	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111N);Sonidegib,Vismodegib(PTCH1 p.R602*);Trametinib,Cobimetinib(MAP2K1 p.G128D)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.M1?)				LEVEL_3B	TP53 p.R213*;PIK3CA p.E542K;PIK3CA p.K111N;APC p.Q1529*;ASXL2 p.E45*;POLE p.P286R;SMAD4 p.E520*;MAP3K1 p.R183*;RB1 p.E54*;KMT2D p.R5282*;FOXP1 p.S448L;CDC73 p.X141_splice;SETD2 p.E965*;ATR p.X1678_splice;ATR p.E254*;ATR p.X98_splice;TP63 p.R266*;TET2 p.F1147V;FAT1 p.E1360*;RASA1 p.E298*;APC p.R2204*;APC p.R2237*;KMT2C p.E87*;XRCC2 p.R188C;PTPRD p.E97*;PTCH1 p.R602*;BIRC3 p.X344_splice;GLI1 p.R380Q;TBX3 p.E312*;RB1 p.E125*;MAP2K1 p.G128D;GRIN2A p.E953*;CDH1 p.E648*;ASXL1 p.E917*;AMER1 p.E462*;CDKN2A p.M1?	5	36
P-0004866	P-0004866-T01-IM5	In-House	DNA	Resection	250	488	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_4	KRAS p.G12R;SMAD4 p.R361H;CDKN2A p.Y44*	2	3
P-0004867	P-0004867-T01-IM5	In-House	DNA	Biopsy	250	651	30	Matched	Metastasis	Ovary	Abdomen	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.V157F;CCNE1 Amplification;C19orf12 AKT2-C19orf12 fusion;AKT2 AKT2-C19orf12 fusion	0	4
P-0004868	P-0004868-T01-IM5	Outside	DNA	Resection	250	417	NA	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										RAC1 p.Q61K;CARD11 Amplification;RAC1 Amplification	0	3
P-0004869	P-0004869-T01-IM5	Outside	DNA	Biopsy	250	725	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Trametinib,Cobimetinib(NF1 p.G722*)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.H214R;BMPR1A p.X112_splice;SMARCA4 p.E465*;NF1 p.G722*;BRAF Amplification;EZH2 Amplification;MET Amplification;RHEB Amplification	3	8
P-0004871	P-0004871-T01-IM5	In-House	DNA	Resection	250	838	50	Matched	Primary	Vagina	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Trametinib,Cobimetinib(BRAF NCRNA00244-BRAF fusion);Trametinib,Cobimetinib(LINC00244 NCRNA00244-BRAF fusion)					LEVEL_3B	TP53 p.V73Rfs*76;DIS3 p.Q727*;ATRX p.R781*;BRAF NCRNA00244-BRAF fusion;LINC00244 NCRNA00244-BRAF fusion	2	5
P-0004872	P-0004872-T01-IM5	Outside	DNA	Biopsy	250	782	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E542K;APC p.Q1193*;APC p.Q1303*;CDKN1B p.K59Sfs*12	2	5
P-0004873	P-0004873-T01-IM5	In-House	DNA	Resection	250	720	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;TP53 p.X32_splice;STK11 p.G188Afs*99	1	3
P-0004874	P-0004874-T01-IM5	In-House	DNA	Resection	250	742	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										SMAD4 p.R361H	0	1
P-0004875	P-0004875-T01-IM5	In-House	DNA	Resection	250	890	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ARID2 p.Q819*;PMS1 p.E914*;KEAP1 p.G417V;RBM10 p.E513*;STK11 p.K44Tfs*2;FBXW7 p.C629Yfs*8	1	7
P-0004876	P-0004876-T01-IM5	In-House	DNA	Biopsy	250	807	30	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.S33C;NCOR1 p.X245_splice;STAG2 p.X607_splice;ARID1A p.M967Gfs*35;SETD2 p.F1262Rfs*11;ARID1A p.A2204Pfs*27	0	6
P-0004876	P-0004876-T02-IM5	In-House	FFPE	Cytology	250	382	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										ARID1A p.M967Gfs*35;SETD2 p.F1262Rfs*11;CTNNB1 p.A43_P44dup	0	3
P-0004878	P-0004878-T01-IM5	In-House	DNA	Resection	250	677	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	MET Amplification	2	1
P-0004879	P-0004879-T01-IM5	In-House	DNA	Resection	250	782	50	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										CREBBP p.V1057*;ATRX Deletion	0	2
P-0004880	P-0004880-T02-IM5	In-House	FFPE	Biopsy	250	708	40	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma										EP300 EP300-intragenic	0	1
P-0004880	P-0004880-T01-IM5	Outside	DNA	Resection	250	452	40	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0004881	P-0004881-T01-IM5	Outside	DNA	Resection	250	761	70	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	2
P-0004882	P-0004882-T01-IM5	In-House	DNA	Biopsy	250	667	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										SMAD4 p.C523W	0	1
P-0004883	P-0004883-T01-IM5	Outside	DNA	Biopsy	250	205	80	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor				Imatinib(KIT p.K550_K558del)					LEVEL_3B	TP53 p.R248Q;KIT p.K550_K558del	1	2
P-0004884	P-0004884-T01-IM5	Outside	DNA	Resection	250	514	80	Matched	Primary	Brain	Not Applicable	Tumor	EVN	Miscellaneous Neuroepithelial Tumor	Extraventricular Neurocytoma										PRDM1 Deletion;TNFAIP3 Deletion	0	2
P-0004885	P-0004885-T01-IM5	In-House	DNA	Biopsy	207.9	359	80	Matched	Metastasis	Stomach	Liver	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors				Everolimus(TSC2 p.Q595*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CCND3 p.Q276*;MEN1 p.Q263*;TSC2 p.Q595*;ATRX p.P190Hfs*15;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0004886	P-0004886-T01-IM5	Outside	DNA	Resection	250	494	40	Matched	Metastasis	Ascending Colon	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.R68S)	Cetuximab,Panitumumab(KRAS p.R68S)			LEVEL_4	FAT1 p.X3155_splice;KRAS p.R68S;APC p.Q1328Pfs*11;TP53 p.T304Qfs*44;AKT2 Amplification	1	5
P-0004887	P-0004887-T01-IM5	Outside	DNA	Resection	250	759	50	Matched	Metastasis	Major Salivary Gland	Lymph Node	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Tipifarnib(HRAS p.Q61R);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.R248Q;HRAS p.Q61R;ERBB2 Amplification	2	3
P-0004888	P-0004888-T01-IM5	Outside	DNA	Resection	250	150	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;TP53 p.K291Sfs*51	2	2
P-0004889	P-0004889-T01-IM5	In-House	DNA	Biopsy	250	660	60	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.I195T;CCND1 Amplification;CDK6 Amplification;FGF19 Amplification	0	4
P-0004890	P-0004890-T01-IM5	In-House	DNA	Cytology	144.5	515	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(CHEK2 Deletion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;NBN p.E726*;STK11 p.Y60Sfs*4;CHEK2 Deletion	3	4
P-0004891	P-0004891-T01-IM5	In-House	DNA	Resection	250	523	40	Matched	Metastasis	Lung	Neck	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.W239*;KEAP1 p.E444*	2	3
P-0004892	P-0004892-T01-IM5	In-House	DNA	Biopsy	250	904	40	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 INSC-BRCA2 fusion);Olaparib,Rucaparib(INSC INSC-BRCA2 fusion)			Tipifarnib(HRAS p.Q61R);Talazoparib,Niraparib(BRCA2 INSC-BRCA2 fusion);Talazoparib,Niraparib(INSC INSC-BRCA2 fusion)	GSK2636771,AZD8186(ATAD1 PTEN-ATAD1 fusion);GSK2636771,AZD8186(PTEN PTEN-ATAD1 fusion)				LEVEL_1	HRAS p.Q61R;KMT2C p.L1984Pfs*22;FAT1 p.L1833Wfs*31;NOTCH2 p.C579Pfs*9;ATAD1 PTEN-ATAD1 fusion;PTEN PTEN-ATAD1 fusion;BRCA2 INSC-BRCA2 fusion;INSC INSC-BRCA2 fusion	7	8
P-0004893	P-0004893-T01-IM5	In-House	DNA	Resection	250	926	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R196*;RUNX1 RUNX1-intragenic	0	2
P-0004894	P-0004894-T01-IM5	Outside	DNA	Resection	250	367	30	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.I255T;SMAD4 p.G352E	0	2
P-0004895	P-0004895-T01-IM5	In-House	DNA	Resection	250	303	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L32Q)				LEVEL_4	KRAS p.G12V;TP53 p.W91*;CDKN2A p.L32Q;CCND1 Amplification;FGF19 Amplification;SMAD4 Deletion	2	6
P-0004896	P-0004896-T01-IM5	In-House	DNA	Biopsy	250	584	50	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.L536H)						LEVEL_1	PIK3CA p.E545K;ESR1 p.L536H;BIRC3 Deletion	3	3
P-0004897	P-0004897-T01-IM5	Outside	DNA	Biopsy	250	668	NA	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.L1545Rfs*3)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	TP53 p.R342*;KRAS p.A146T;APC p.D170Vfs*4;BRCA2 p.L1545Rfs*3	2	4
P-0004898	P-0004898-T01-IM5	Outside	DNA	Resection	250	878	40	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Olaparib(ATM p.Q1825*)					LEVEL_3B	ARID1A p.S90Pfs*11;RHOA p.G62R;ATM p.Q1825*;CDH1 p.E482*	1	4
P-0004899	P-0004899-T01-IM5	In-House	DNA	Resection	250	404	20	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					Trametinib,Cobimetinib(NF1 p.X2274_splice)				LEVEL_4	NF1 p.X2274_splice;RB1 p.Y655Lfs*13	1	2
P-0004900	P-0004900-T01-IM5	Outside	DNA	Resection	250	447	10	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_4	KRAS p.G12D;CDKN2A p.Y44*	2	2
P-0004901	P-0004901-T01-IM5	In-House	DNA	Biopsy	250	883	60	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion)			BLU-667,Cabozantinib,Vandetanib(RET CCDC6-RET fusion);BLU-667,Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion)					LEVEL_1	EPHA7 Deletion;RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	4	3
P-0004902	P-0004902-T01-IM5	Outside	DNA	Resection	250	786	30	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	TP53 p.D207Afs*39;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	2	3
P-0004903	P-0004903-T01-IM5	In-House	DNA	Resection	250	754	40	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.E242Dfs*23)				LEVEL_3B	TP53 p.R282P;PTEN p.E242Dfs*23;FGFR1 Amplification	2	3
P-0004904	P-0004904-T01-IM5	In-House	DNA	Resection	250	496	60	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12A);Olaparib(ATM p.K2530Nfs*7)		Cetuximab,Panitumumab(NRAS p.G12A)			LEVEL_3B	NRAS p.G12A;APC p.Q1378*;SMAD4 p.C115S;ATM p.K2530Nfs*7	2	4
P-0004905	P-0004905-T01-IM5	In-House	DNA	Resection	250	625	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAASC	Pancreatic Cancer	Adenosquamous Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.X33_splice;RNF43 p.W159*;MYC Amplification	1	4
P-0004906	P-0004906-T01-IM5	In-House	DNA	Resection	250	625	20	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;RB1 p.R320*;TP53 p.C238Y;TGFBR2 p.Q511*	1	4
P-0004907	P-0004907-T01-IM5	Outside	DNA	Biopsy	250	578	20	Matched	Metastasis	Bladder	Abdomen	Tumor	BLSC	Bladder Cancer	Bladder Squamous Cell Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.X1336_splice)				LEVEL_1	TP53 p.R342*;FGFR3 p.S249C;EP300 p.L415P;KDM6A p.X1336_splice	3	4
P-0004908	P-0004908-T01-IM5	In-House	DNA	Biopsy	250	632	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.G778_P780dup)	Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)					LEVEL_3A	MAP3K1 p.N305Tfs*7;ERBB2 p.G778_P780dup;TBX3 p.A43Rfs*2;MAP3K1 p.M857Ifs*39	2	4
P-0004908	P-0004908-T02-IM5	In-House	FFPE	Biopsy	250	842	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.G778_P780dup)	Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)					LEVEL_3A	MAP3K1 p.N305Tfs*7;ERBB2 p.G778_P780dup;TBX3 p.A43Rfs*2;MAP3K1 p.M857Ifs*39;IKBKE Amplification;MDM4 Amplification;NTRK1 Amplification	2	7
P-0004909	P-0004909-T01-IM5	In-House	DNA	Biopsy	250	1150	10	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.V274L;NOTCH2 p.M1?;FGFR1 Amplification	3	4
P-0004909	P-0004909-T02-IM5	In-House	FFPE	Biopsy	106.6	510	80	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.V274L;ARID1A p.S261*;CCND1 Amplification;FGF19 Amplification;FGFR4 Amplification;IKBKE Amplification;MDM4 Amplification;MYC Amplification;PAK1 Amplification;ROS1 Amplification;TERT Amplification	2	12
P-0004910	P-0004910-T01-IM5	In-House	DNA	Biopsy	250	531	50	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CHEK1 p.K225Nfs*19);Olaparib(CDK12 p.I732Lfs*21)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.I732Lfs*21)				LEVEL_1	RNF43 p.G659Vfs*41;APC p.T1556Nfs*3;PPP2R1A p.R183W;AR p.T878A;ASXL1 p.G646Wfs*12;FOXL2 p.G269Afs*2;KMT2A p.R1855*;MSH6 p.F1104Lfs*11;ATR p.F1134Lfs*6;CHEK1 p.K225Nfs*19;KMT2A p.A1750Sfs*32;CDK12 p.I732Lfs*21;CDKN1B Deletion;MSH2 Deletion	3	14
P-0004910	P-0004910-T03-IM5	In-House	DNA	Biopsy	228	518	50	Matched	Metastasis	Prostate	Adrenal Gland	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA1 p.K654Sfs*47);Olaparib(BARD1 p.D172Rfs*10)			Niraparib,Talazoparib(BRCA1 p.K654Sfs*47);BLU-667,Selpercatinib(RET p.R886W);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.A1232Lfs*70)	GSK2636771,AZD8186(PTEN p.R173H)				LEVEL_1	MSH6 p.F1088Lfs*5;APC p.T1556Nfs*3;PPP2R1A p.R183W;AR p.T878A;ASXL1 p.G646Wfs*12;AR p.H875Y;PTEN p.R173H;BRCA1 p.K654Sfs*47;FOXL2 p.G269Afs*2;KMT2A p.R1855*;KMT2A p.A1750Sfs*32;MLH1 p.T82A;RET p.R886W;ERBB2 p.A1232Lfs*70;BARD1 p.D172Rfs*10;CDKN1B Deletion	6	16
P-0004910	P-0004910-T04-IM5	In-House	DNA	Biopsy	250	637	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.A1232Lfs*70)	GSK2636771,AZD8186(PTEN p.R173H)				LEVEL_3B	MSH6 p.F1088Lfs*5;APC p.T1556Nfs*3;PPP2R1A p.R183W;AR p.T878A;AR p.H875Y;PTEN p.R173H;KMT2C p.F4496Lfs*21;FOXL2 p.G269Afs*2;KMT2A p.R1855*;KMT2A p.A1750Sfs*32;MLH1 p.T82A;ERBB2 p.A1232Lfs*70;NCOR1 p.X1961_splice	2	13
P-0004910	P-0004910-T02-IM5	In-House	DNA	Resection	250	316	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Tipifarnib(HRAS p.Q61K)					LEVEL_3B	HRAS p.Q61K;PPP2R1A p.R183W	1	2
P-0004911	P-0004911-T01-IM5	In-House	DNA	Resection	250	469	60	Matched	Metastasis	Uterus	Omentum	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R175H;RASA1 p.V33Gfs*79;ERBB2 Amplification	2	3
P-0004912	P-0004912-T01-IM5	In-House	DNA	Biopsy	250	575	60	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.I195N;PIK3R2 p.D557N;GATA3 p.M422Dfs*85;ERBB2 Amplification;ARID1A WDTC1-ARID1A fusion;WDTC1 WDTC1-ARID1A fusion;IGSF8 SDHC-IGSF8 fusion;SDHC SDHC-IGSF8 fusion	2	8
P-0004913	P-0004913-T01-IM5	In-House	DNA	Resection	250	532	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.E542A)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542A)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.E542A	4	2
P-0004914	P-0004914-T01-IM5	In-House	DNA	Resection	250	821	70	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L32_L37del)				LEVEL_3A	NRAS p.Q61K;TP53 p.P151S;ARID1A p.R1721*;KMT2A p.X1362_splice;CDKN2A p.L32_L37del	2	5
P-0004915	P-0004915-T01-IM5	In-House	DNA	Resection	250	233	80	Matched	Primary	Lower Extremity	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma										IKZF1 Deletion	0	1
P-0004916	P-0004916-T01-IM5	In-House	DNA	Biopsy	250	619	60	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion)			BLU-667,Cabozantinib,Vandetanib(RET CCDC6-RET fusion);BLU-667,Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion)					LEVEL_1	RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	4	2
P-0004917	P-0004917-T01-IM5	In-House	DNA	Biopsy	250	692	80	Matched	Metastasis	Ovary	Pelvis	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W	0	1
P-0004918	P-0004918-T01-IM5	In-House	DNA	Resection	250	188	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TBX3 p.S244Yfs*3;TP53 p.F113P;CCND1 Amplification;FOXA1 Amplification;MCL1 Amplification;PAK1 Amplification;SOX9 NPTX1-SOX9 fusion;NPTX1 NPTX1-SOX9 fusion	2	9
P-0004919	P-0004919-T01-IM5	Outside	DNA	Resection	250	798	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										ATRX p.T844Yfs*5	0	1
P-0004920	P-0004920-T01-IM5	In-House	DNA	Biopsy	250	804	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Everolimus(MTOR p.E2014K)	Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Temsirolimus(MTOR p.E2014K)				LEVEL_3A	TP53 p.Y220C;SOX9 p.*510Sext*49;ARID1A p.S552*;MTOR p.E2014K;ASXL2 p.Q301*;ASXL2 p.X135_splice;APC p.Q901*;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;FGFR1 Amplification;MYCN Amplification	4	12
P-0004921	P-0004921-T01-IM5	Outside	DNA	Biopsy	126	778	NA	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R248Q;RHOA p.G17E;EPHB1 p.R351W;TGFBR1 p.T491Hfs*56;MAP3K1 p.S620Kfs*26;ERBB2 Amplification	2	6
P-0004922	P-0004922-T01-IM5	In-House	DNA	Biopsy	250	804	60	Matched	Primary	Scalp	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	TP53 p.R280G;ATRX Deletion;NF1 Deletion;NPM1 Deletion;RAF1 Amplification;STK11 Deletion;SUZ12 Deletion;TCF3 Deletion	1	8
P-0004923	P-0004923-T01-IM5	In-House	DNA	Biopsy	250	853	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.I195T;KDM6A p.R1054Kfs*5	1	3
P-0004924	P-0004924-T01-IM5	In-House	DNA	Biopsy	250	698	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.S246Y)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R103Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Tazemetostat(KDM6A p.W632*);Trametinib,Cobimetinib(NF1 p.D1710Rfs*8)				LEVEL_3A	KRAS p.G12D;PIK3CA p.H1047L;ARID1A p.E72*;ARID1A p.E78*;ERBB2 p.R103Q;ERCC2 p.S246Y;EP300 p.Y1467H;KDM6A p.W632*;BBC3 p.R121Afs*126;NF1 p.D1710Rfs*8;DNMT3B p.L489Pfs*57	6	11
P-0004925	P-0004925-T01-IM5	In-House	DNA	Resection	250	931	20	Matched	Primary	Thymus	Not Applicable	Tumor	THYC	Thymic Tumor	Thymic Carcinoma										SMARCA4 p.R973Q;SPEN p.R189*;KMT2D p.L1226Pfs*24	0	3
P-0004926	P-0004926-T01-IM5	In-House	DNA	Resection	250	846	60	Matched	Metastasis	Adrenal Gland	Pleura	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0004927	P-0004927-T01-IM5	In-House	DNA	Biopsy	185.2	1009	50	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification);Cisplatin(ERCC2 Deletion);Milademetan Tosylate,RO5045337(MDM2 Amplification)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;ZFHX3 p.E470*;BBC3 Deletion;CDK4 Amplification;EGFR Amplification;ERBB3 Amplification;ERCC2 Deletion;MDM2 Amplification;PPP2R1A Deletion	5	10
P-0004928	P-0004928-T01-IM5	Outside	DNA	Biopsy	250	651	30	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;PIK3CA p.E542K;APC p.E1397Gfs*18;ARID1A p.D1258*	3	5
P-0004929	P-0004929-T01-IM5	In-House	DNA	Biopsy	250	621	20	Matched	Metastasis	Uterus	Peritoneum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Trametinib(BRAF p.L597V)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);PLX8394(BRAF p.L597V)				LEVEL_3B	KRAS p.G12V;BRAF p.L597V;TP53 p.D184Afs*62;AURKA Amplification	3	4
P-0004929	P-0004929-T02-IM5	Outside	DNA	Resection	250	394	70	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Trametinib(BRAF p.L597V)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);PLX8394(BRAF p.L597V)				LEVEL_3B	KRAS p.G12V;BRAF p.L597V;TP53 p.D184Afs*62;RNF43 p.E448*	3	4
P-0004930	P-0004930-T01-IM5	In-House	DNA	Resection	250	617	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.D32_S37delinsA	0	1
P-0004931	P-0004931-T02-IM5	In-House	DNA	Resection	250	482	60	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	KMT2D p.E2643Kfs*11;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	3
P-0004932	P-0004932-T01-IM5	In-House	DNA	Resection	250	1008	90	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;PPM1D Amplification;PPP2R1A Deletion	1	5
P-0004933	P-0004933-T01-IM5	In-House	DNA	Biopsy	250	779	60	Matched	Metastasis	Skin	Epidural	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib(BRAF p.L597S)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	GSK2636771,AZD8186(PTEN p.G36Dfs*18);PLX8394(BRAF p.L597S);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3A	PIK3CA p.E545K;RNF43 p.W200*;PTEN p.G36Dfs*18;BRAF p.L597S;CDKN2A p.R58*;AURKA Amplification	5	6
P-0004934	P-0004934-T01-IM5	In-House	DNA	Biopsy	235.8	952	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1007R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Trametinib,Cobimetinib(TAOK1 NF1-TAOK1 fusion);Trametinib,Cobimetinib(NF1 NF1-TAOK1 fusion)				LEVEL_3B	KRAS p.G12D;PIK3CA p.G1007R;ARID1A p.X911_splice;TGFBR2 p.E499*;RBM10 p.E740*;TAOK1 NF1-TAOK1 fusion;NF1 NF1-TAOK1 fusion	4	7
P-0004935	P-0004935-T01-IM5	In-House	DNA	Resection	250	898	40	Matched	Metastasis	Cancer of Unknown Primary	Bowel	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;FOXA1 p.M116Pfs*10	1	2
P-0004936	P-0004936-T01-IM5	In-House	DNA	Resection	250	711	40	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.R273C;ARID2 p.Q904*;ARID2 p.E65*;EP300 p.S952*	0	4
P-0004937	P-0004937-T01-IM5	In-House	DNA	Resection	250	470	60	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)			Olaparib(ATM C11orf65-ATM fusion);Olaparib(C11orf65 C11orf65-ATM fusion)					LEVEL_1	KIT p.L576P;FBXW7 p.Y193Ifs*63;CCNE1 Amplification;MCL1 Amplification;ATM C11orf65-ATM fusion;C11orf65 C11orf65-ATM fusion	3	6
P-0004938	P-0004938-T01-IM5	In-House	DNA	Resection	250	599	60	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_1	ERBB3 p.E928G;KMT2A p.Q3413*;CDH1 p.D644Tfs*9;ERBB2 Amplification;MYC Amplification;NF1 NF1-intragenic	3	6
P-0004939	P-0004939-T01-IM5	In-House	DNA	Resection	131.25	270	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)	Tazemetostat(KDM6A p.Q271*)				LEVEL_3B	ERBB2 p.S310F;KDM6A p.Q271*	2	2
P-0004940	P-0004940-T01-IM5	In-House	DNA	Resection	250	428	70	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.H1047R;TP53 p.R280G;BAP1 p.P723Gfs*38;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0004941	P-0004941-T01-IM5	In-House	DNA	Resection	250	756	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.Q333Rfs*26);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KDM6A p.Q333Rfs*26;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification	2	5
P-0004942	P-0004942-T01-IM5	In-House	DNA	Biopsy	250	265	30	Matched	Metastasis	Uterus	Vagina	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.S215G;PIK3R1 p.N441_T454del;AKT2 Amplification;CD274 Amplification;JAK2 Amplification	0	5
P-0004943	P-0004943-T01-IM5	In-House	DNA	Resection	250	512	80	Matched	Primary	Kidney	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0004944	P-0004944-T02-IM5	In-House	DNA	Biopsy	250	924	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.C176F;KMT2D p.S4617Vfs*23;KEAP1 Deletion	1	4
P-0004945	P-0004945-T01-IM5	In-House	DNA	Resection	250	730	60	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib(NF1 p.K1714Sfs*3)				LEVEL_4	NF1 p.K1714Sfs*3;TP53 p.T312Pfs*20	1	2
P-0004946	P-0004946-T01-IM5	In-House	DNA	Resection	250	565	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 BRCA2-intragenic)			Talazoparib,Niraparib(BRCA2 BRCA2-intragenic)					LEVEL_1	PMS2 p.R287*;BRCA2 BRCA2-intragenic	2	2
P-0004947	P-0004947-T01-IM5	In-House	DNA	Resection	250	867	80	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0004948	P-0004948-T01-IM5	Outside	DNA	Resection	250	862	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	FIBS	Soft Tissue Sarcoma	Fibrosarcoma										CEBPA Deletion;EP300 Deletion;FAT1 Deletion;FBXW7 Deletion;INPP4B Deletion;PPM1D Amplification;STK11 Deletion;TCF3 Deletion	0	8
P-0004949	P-0004949-T02-IM5	In-House	DNA	Cytology	250	842	70	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.S436Lfs*71;MCL1 Amplification;PPM1D Amplification	0	3
P-0004950	P-0004950-T01-IM5	Outside	DNA	Resection	250	828	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;MAP3K1 p.P1228Tfs*11;CDH1 p.Y190Lfs*9	2	3
P-0004951	P-0004951-T01-IM5	Outside	DNA	Biopsy	250	277	60	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		AZD5363(AKT1 p.E17K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	AKT1 p.E17K;PIK3CA p.E542K;CDH1 p.Y523*	3	3
P-0004952	P-0004952-T01-IM5	In-House	DNA	Resection	250	876	60	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.R1276*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.R1276*;TP53 p.F109S;SOX9 p.Q458*;KDM6A p.X1183_splice;ATRX p.N676Kfs*17;ANKRD11 Deletion;CDKN2A Deletion;CDKN2B Deletion;FANCA Deletion	2	9
P-0004953	P-0004953-T01-IM5	In-House	DNA	Resection	250	797	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										KMT2D p.R4282*	0	1
P-0004953	P-0004953-T02-IM5	Outside	DNA	Biopsy	250	965	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(ATM p.S421*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12A;STAG2 p.Q573*;ARID1A p.Q2128*;BAP1 p.*730Sext*205;TCF7L2 p.Q56*;ATM p.S421*;GPS2 p.X133_splice;CDKN1A p.V25Sfs*11;CDKN2A Deletion;CDKN2B Deletion	3	10
P-0004954	P-0004954-T01-IM5	Outside	DNA	Resection	250	731	60	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K1691Nfs*15);Sonidegib,Vismodegib(PTCH1 p.N97Tfs*20)	GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_1	FUBP1 p.I301Yfs*22;BRAF p.V600E;BRCA2 p.K1691Nfs*15;RNF43 p.G659Vfs*41;PTEN p.R130Q;CTCF p.T204Nfs*26;BMPR1A p.L59*;HNF1A p.P291Qfs*51;AXIN1 p.G508Vfs*197;TCF7L2 p.K485Sfs*23;AXIN2 p.E405Gfs*56;RNF43 p.M1?;SMARCA4 p.X473_splice;PTCH1 p.N97Tfs*20;SMARCA4 p.R905Afs*5;WT1 p.P132Rfs*26;CASP8 p.V205Gfs*13	6	17
P-0004954	P-0004954-T02-IM5	Outside	DNA	Resection	250	883	60	Matched	Primary	Colon	Not Applicable	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K1691Nfs*15);Sonidegib,Vismodegib(PTCH1 p.N97Tfs*20)	GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_3B	FUBP1 p.I301Yfs*22;BRAF p.V600E;BRCA2 p.K1691Nfs*15;RNF43 p.G659Vfs*41;PTEN p.R130Q;CTCF p.T204Nfs*26;BMPR1A p.L59*;HNF1A p.P291Qfs*51;AXIN1 p.G508Vfs*197;TCF7L2 p.K485Sfs*23;AXIN2 p.E405Gfs*56;RNF43 p.M1?;SMARCA4 p.X473_splice;PTCH1 p.N97Tfs*20;SMARCA4 p.R905Afs*5;WT1 p.P132Rfs*26;CASP8 p.V205Gfs*13;BLM p.N515Mfs*16;SMAD2 p.L87Tfs*20	4	19
P-0004955	P-0004955-T01-IM5	In-House	DNA	Resection	250	981	30	Matched	Metastasis	Liver	Peritoneum	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	IDH1 p.R132C;NRAS p.Q61R;ASXL2 p.K265*	2	3
P-0004956	P-0004956-T01-IM5	Outside	DNA	Cytology	250	942	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMARCA4 p.T910M	1	2
P-0004957	P-0004957-T01-IM5	In-House	DNA	Resection	250	1054	60	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R248Q;APC p.S1465Wfs*3;ASXL1 p.G646Wfs*12;APC p.D903Efs*13	1	5
P-0004958	P-0004958-T01-IM5	Outside	DNA	Biopsy	250	892	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.C135Y;ANKRD11 p.V2156Wfs*19	0	2
P-0004959	P-0004959-T01-IM5	In-House	DNA	Resection	250	153	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0004960	P-0004960-T01-IM5	In-House	DNA	Biopsy	250	1393	20	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.K117N)	Cetuximab,Panitumumab(KRAS p.K117N)			LEVEL_3B	PIK3CA p.E545K;APC p.T1556Nfs*3;TP53 p.C242F;KRAS p.K117N;AMER1 p.R358*;APC p.Y1135*	2	6
P-0004961	P-0004961-T01-IM5	In-House	DNA	Biopsy	250	855	10	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										CTNNB1 p.T41A	0	1
P-0004963	P-0004963-T01-IM5	Outside	DNA	Biopsy	250	1004	80	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;MYCL Amplification;BCOR BCOR-intragenic	0	5
P-0004964	P-0004964-T01-IM5	In-House	DNA	Biopsy	250	1008	70	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.E298*;TP53 p.X33_splice;SMAD2 p.S2*;RB1 Deletion	1	5
P-0004965	P-0004965-T01-IM5	Outside	DNA	Resection	250	626	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.S127Y;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;GATA3 Amplification	3	5
P-0004967	P-0004967-T01-IM5	Outside	DNA	Resection	250	980	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Everolimus(TSC2 TSC2-intragenic)					LEVEL_3B	APC p.R232*;PIK3R1 p.E489*;TP53 p.H115Afs*34;TSC2 TSC2-intragenic	1	4
P-0004968	P-0004968-T01-IM5	In-House	DNA	Resection	250	944	60	Matched	Primary	Cecum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.S1465Wfs*3;APC p.N942Ffs*3;AMER1 p.D817Efs*50	1	4
P-0004969	P-0004969-T01-IM5	Outside	DNA	Biopsy	250	488	40	Matched	Metastasis	Skull	Soft Tissue	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0004970	P-0004970-T01-IM5	In-House	DNA	Resection	250	928	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.P179L;RBM10 p.R765*;RNF43 p.P14Rfs*5	1	4
P-0004971	P-0004971-T01-IM5	Outside	DNA	Biopsy	250	1106	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lapatinib(EGFR p.A289V);Lapatinib(EGFR Amplification)				LEVEL_3B	EGFR p.A289V;RB1 p.X737_splice;EGFR Amplification;MDM2 Amplification	3	4
P-0004972	P-0004972-T01-IM5	In-House	DNA	Resection	250	998	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SETD2 p.Y1666C	1	2
P-0004973	P-0004973-T01-IM5	Outside	DNA	Biopsy	250	790	80	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ATRX Deletion;FGFR1 Amplification;RB1 Deletion	1	3
P-0004974	P-0004974-T01-IM5	In-House	DNA	Resection	250	1078	60	Matched	Metastasis	Breast	Bowel	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.E380Q)						LEVEL_3A	ESR1 p.E380Q;CDH1 p.X522_splice;FOXP1 p.X511_splice	1	3
P-0004975	P-0004975-T01-IM5	Outside	DNA	Biopsy	250	395	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.R2450*)				LEVEL_1	NCOR1 p.T525Nfs*11;PTPN11 p.A72T;NF1 p.R2450*;ERBB2 Amplification;ROS1 Amplification	3	5
P-0004976	P-0004976-T01-IM5	In-House	DNA	Biopsy	250	553	60	Matched	Metastasis	Uterus	Abdomen	Tumor	LGESS	Uterine Sarcoma	Low-Grade Endometrial Stromal Sarcoma											0	0
P-0004977	P-0004977-T01-IM5	In-House	DNA	Resection	250	599	40	Matched	Metastasis	Descending Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	TP53 p.R175H;KRAS p.G12A;APC p.L1488Yfs*19;APC p.D802*	1	4
P-0004978	P-0004978-T01-IM5	Outside	DNA	Resection	250	348	20	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0004980	P-0004980-T01-IM5	In-House	DNA	Biopsy	250	433	10	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.Y220C;ERBB2 Amplification	2	2
P-0004981	P-0004981-T01-IM5	Outside	DNA	Resection	250	616	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	GATA3 p.N331Efs*21;ARID1A p.Q1399*;ARID1A p.A53Wfs*50;FGFR1 Amplification;FLCN Deletion;IKBKE Amplification;MDM2 Amplification;MDM4 Amplification;NCOR1 Deletion;ERG FZD10-ERG fusion;FZD10 FZD10-ERG fusion	2	11
P-0004982	P-0004982-T01-IM5	In-House	DNA	Resection	250	287	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P435Rfs*42;CCND1 Amplification;FGF19 Amplification;MAP2K4 Deletion	0	4
P-0004983	P-0004983-T01-IM5	Outside	DNA	Resection	250	497	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Tipifarnib(HRAS p.G12D)					LEVEL_3B	TP53 p.R306*;HRAS p.G12D	1	2
P-0004986	P-0004986-T01-IM5	In-House	DNA	Resection	250	407	70	Matched	Metastasis	Small Bowel	Liver	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors											0	0
P-0004987	P-0004987-T01-IM5	In-House	DNA	Biopsy	250	658	60	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_1	PIK3CA p.E545K;ESR1 p.D538G;KMT2C p.R56*;SETD2 p.Q1797*;SPEN p.E1400*;RAF1 p.L613V;FOXP1 p.X511_splice;FGFR4 p.N535K;NBN p.X745_splice;MED12 p.R1467*;CDH1 p.L731Ffs*39;EPHA7 Deletion	3	12
P-0004988	P-0004988-T01-IM5	In-House	DNA	Cytology	250	539	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3CA p.E542K;STK11 p.X155_splice;EPHB1 p.R351Q	3	4
P-0004989	P-0004989-T01-IM5	Outside	DNA	Resection	250	394	30	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma										KRAS Amplification	0	1
P-0004990	P-0004990-T01-IM5	In-House	DNA	Cytology	77	346	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;ERRFI1 p.C142Rfs*11	1	2
P-0004991	P-0004991-T01-IM5	Outside	DNA	Biopsy	250	423	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453_T462del)	Trametinib,Cobimetinib(NF1 p.T2034Nfs*26);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E453_T462del;NF1 p.T2034Nfs*26;CDKN2A Deletion;CDKN2B Deletion	3	4
P-0004994	P-0004994-T01-IM5	Outside	DNA	Biopsy	250	701	50	Matched	Primary	Lymph Node	Not Applicable	Tumor	MTNN	Mature T and NK Neoplasms	Mature T and NK Neoplasms											0	0
P-0004995	P-0004995-T01-IM5	In-House	DNA	Cytology	232	370	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	GNAS p.Q227K;CDK4 Amplification;MDM2 Amplification;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	8	5
P-0004996	P-0004996-T02-IM5	In-House	FFPE	Biopsy	250	1223	60	Matched	Metastasis	Lung	Mediastinum	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0004997	P-0004997-T01-IM5	In-House	DNA	Biopsy	250	472	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;KMT2C p.Q3352*;KMT2D p.Q3322*;KMT2D p.E3117*	2	4
P-0004998	P-0004998-T01-IM5	Outside	DNA	Biopsy	250	341	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.C277F;SDHA p.X153_splice;CREBBP p.R1446P;KDM5C p.R778*;HLA-A p.V3Afs*93;CCNE1 Amplification;SOX17 MOS-SOX17 fusion;MOS MOS-SOX17 fusion	1	9
P-0004999	P-0004999-T01-IM5	In-House	DNA	Biopsy	250	431	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P408Afs*99;PRKN p.E16*;AURKA Amplification;PPM1D Amplification;STAG2 OR13H1-STAG2 fusion;OR13H1 OR13H1-STAG2 fusion	0	6
P-0005000	P-0005000-T01-IM5	In-House	DNA	Biopsy	250	643	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										BAP1 p.C91F;ARID1A p.Q1614*;SMARCA4 p.V364Rfs*25;PBRM1 Deletion	0	4
P-0005002	P-0005002-T01-IM5	In-House	DNA	Biopsy	250	496	60	Matched	Metastasis	Lung	Bone	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer					Trametinib,Cobimetinib(NF1 p.W1236*)				LEVEL_4	NF1 p.W1236*;STK11 p.G163R;TP53 p.A119G;FGFR2 Amplification;MYC Amplification;SMARCA4 Deletion	1	6
P-0005003	P-0005003-T01-IM5	In-House	DNA	Resection	250	569	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P104_V105del)	GSK2636771,AZD8186(PTEN p.T319*);GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_1	FBXW7 p.R505C;BRAF p.V600E;PTEN p.T319*;APC p.R1450*;TP53 p.F212Sfs*3;APC p.E763*;PTEN p.X268_splice;CREBBP p.L1499Q;PIK3CA p.P104_V105del	6	9
P-0005004	P-0005004-T01-IM5	Outside	DNA	Resection	250	455	70	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma				Olaparib(ATM p.X2929_splice);Olaparib(ATM p.K742*)					LEVEL_3B	ATM p.X2929_splice;ATM p.K742*	2	2
P-0005005	P-0005005-T01-IM5	Outside	DNA	Biopsy	250	502	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.S315Nfs*24;CCND1 Amplification;FGF19 Amplification	2	4
P-0005006	P-0005006-T01-IM5	Outside	DNA	Biopsy	250	875	80	Matched	Metastasis	Blood Vessel	Lung	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma										MAX Deletion	0	1
P-0005007	P-0005007-T01-IM5	Outside	DNA	Biopsy	250	672	20	Matched	Metastasis	Bile Duct	Omentum	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L)				LEVEL_4	GNAS p.R201C;KRAS p.Q61L;SMAD4 p.R361S	1	3
P-0005008	P-0005008-T01-IM5	In-House	DNA	Resection	250	389	60	Matched	Primary	Bone	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										SMO p.L412F	0	1
P-0005009	P-0005009-T02-IM5	In-House	FFPE	Biopsy	250	1158	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;TP53 p.P58_H115del	2	2
P-0005009	P-0005009-T01-IM5	Outside	DNA	Biopsy	250	507	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.P58_H115del	2	2
P-0005010	P-0005010-T01-IM5	Outside	DNA	Biopsy	250	726	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.Y220C;ERBB2 Amplification	2	2
P-0005011	P-0005011-T01-IM5	In-House	DNA	Biopsy	250	470	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		AZD5363(AKT1 p.E17K);Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	AKT1 p.E17K;BRAF p.V600E;APC p.S1465Wfs*3;GPS2 TP53-GPS2 fusion;TP53 TP53-GPS2 fusion	4	5
P-0005012	P-0005012-T01-IM5	In-House	DNA	Resection	250	940	70	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RB1 p.W99*;EGFR Amplification;PTEN Deletion	2	3
P-0005013	P-0005013-T01-IM5	Outside	DNA	Resection	250	732	80	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0005014	P-0005014-T01-IM5	In-House	DNA	Cytology	250	759	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.W131C;ZFHX3 p.T3024Qfs*52;APC Deletion;CDKN1B Deletion;PMAIP1 Deletion	0	5
P-0005015	P-0005015-T01-IM5	Outside	DNA	Resection	250	493	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										ATRX p.R1514*;CDH1 p.L776Qfs*2	0	2
P-0005016	P-0005016-T01-IM5	In-House	DNA	Resection	250	554	30	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;PIK3CA p.E542K;SMAD4 p.R361S;APC p.E1306*;SOX9 p.Q339*;SMAD2 p.S467Hfs*13	2	6
P-0005017	P-0005017-T02-IM5	In-House	FFPE	Biopsy	250	1166	50	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)								LEVEL_1	TP53 p.H193R;EGFR p.E746_S752delinsV	1	2
P-0005018	P-0005018-T01-IM5	In-House	DNA	Resection	250	1057	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.F1174L)					LEVEL_3B	ALK p.F1174L	1	1
P-0005019	P-0005019-T01-IM5	Outside	DNA	Biopsy	250	956	80	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			BLU-667,Selpercatinib(RET p.R833C);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.E349*;RET p.R833C;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification	4	5
P-0005020	P-0005020-T01-IM5	Outside	DNA	Biopsy	250	913	30	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;MYC Amplification	1	2
P-0005021	P-0005021-T01-IM5	In-House	DNA	Resection	250	896	70	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma			Cisplatin(ERCC2 p.E576K)	Olaparib(ATM p.R35*);Olaparib(ATM p.R248*);Olaparib(ATM p.R250*);Olaparib(ATM p.E1959*);Olaparib(PALB2 p.E1002*)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K);Trametinib,Cobimetinib(NF1 p.R2450*);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.K659N);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549H);Tazemetostat(KDM6A p.E22*)				LEVEL_3A	TP53 p.R213*;ERBB3 p.G284R;ASXL2 p.R312*;POLE p.P286R;FOXP1 p.R525*;KMT2C p.R2884*;FGFR2 p.N549K;ASXL2 p.R357*;APC p.R2204*;NF1 p.R2450*;SDHB p.R46Q;PIK3R3 p.E239*;MSH6 p.E171*;MSH6 p.E665*;CXCR4 p.R334*;TGFBR2 p.Y448*;PBRM1 p.R1670*;FAT1 p.E3724*;RAD50 p.E838*;NSD1 p.E581*;NOTCH4 p.C1055*;LATS1 p.E33*;CDK6 p.R220C;TET1 p.E55*;FGFR2 p.K659N;FGFR2 p.N549H;ATM p.R35*;ATM p.R248*;ATM p.R250*;ATM p.E1959*;GRIN2A p.E1003*;ERCC4 p.Y610*;PALB2 p.E1002*;FANCA p.E169*;TP53 p.E287D;SUZ12 p.E683*;DNMT1 p.E432K;SMARCA4 p.E659*;ERCC2 p.E576K;EP300 p.E643*;KDM6A p.E22*;ATRX p.E2388*;PMS2 p.E41Gfs*13;KMT2D p.A3871Efs*10;KMT2D p.R5403Afs*15	11	45
P-0005022	P-0005022-T01-IM5	In-House	DNA	Biopsy	250	998	20	Matched	Metastasis	Thyroid	Neck	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.E285K;FBXW7 p.R224Q;EP300 p.Q577*;ARID2 p.R95Afs*16;ARID2 p.H27Tfs*31	2	6
P-0005023	P-0005023-T01-IM5	Outside	DNA	Resection	250	713	60	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma					GSK2636771,AZD8186(PTEN p.N48Ifs*5)				LEVEL_4	TP53 p.R248Q;RB1 p.R320*;TP53 p.R158H;DAXX p.R238*;PTEN p.N48Ifs*5	1	5
P-0005024	P-0005024-T01-IM5	In-House	DNA	Biopsy	92.82	1266	60	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;KEAP1 p.V167F;STK11 p.Y60*;RBM10 p.H544Ifs*3;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0005025	P-0005025-T01-IM5	Outside	DNA	Resection	250	995	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.Q1338*;TP53 p.G245S;FBXW7 p.R479*;LATS2 p.R1043*	0	4
P-0005026	P-0005026-T01-IM5	In-House	FFPE	Resection	250	1100	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TP53 p.E349*;NFE2L2 p.D29H	1	3
P-0005027	P-0005027-T01-IM5	Outside	DNA	Resection	250	560	40	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma										APC p.S1465Wfs*3;TP53 p.V147G	0	2
P-0005028	P-0005028-T01-IM5	In-House	DNA	Resection	250	709	70	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										PPM1D p.N491Yfs*3;RB1 Deletion	0	2
P-0005029	P-0005029-T01-IM5	In-House	DNA	Resection	250	962	60	Matched	Metastasis	Rectum	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R273H;APC p.E1317*;KRAS p.G13D;NKX3-1 Deletion;SMAD4 Deletion	1	5
P-0005030	P-0005030-T02-IM5	Outside	DNA	Resection	250	689	40	Matched	Primary	Small Bowel	Not Applicable	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0005031	P-0005031-T01-IM5	Outside	DNA	Biopsy	250	1032	50	Matched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										PTEN p.R173H;RHOA p.R5Q;TCF3 p.Q169*;PTEN p.I4Efs*13;ARID1A p.G285_T286delins*;TNFRSF14 Deletion	0	6
P-0005032	P-0005032-T01-IM5	Outside	DNA	Resection	250	1062	30	Matched	Metastasis	Breast	Ipsilateral Breast	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.E286V;FOXA1 p.K264_K267del	0	2
P-0005033	P-0005033-T01-IM5	In-House	DNA	Biopsy	250	212	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										RB1 p.S443*	0	1
P-0005034	P-0005034-T01-IM5	In-House	DNA	Biopsy	156.2	979	70	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)				Trametinib,Cobimetinib(NF1 SP2-NF1 fusion);Trametinib,Cobimetinib(SP2 SP2-NF1 fusion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.R213L;EGFR Amplification;PRDM1 Deletion;NF1 SP2-NF1 fusion;SP2 SP2-NF1 fusion	4	7
P-0005035	P-0005035-T01-IM5	In-House	DNA	Biopsy	250	442	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.H179Y;SMAD4 p.X263_splice	1	3
P-0005036	P-0005036-T01-IM5	In-House	DNA	Biopsy	250	1304	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.C420R;KMT2C p.S3786*;MAP3K1 p.L318Ffs*8;MAP3K1 V211fs;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	5	9
P-0005037	P-0005037-T01-IM5	In-House	DNA	Biopsy	250	981	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K);Fulvestrant+Alpelisib(PIK3CA p.R93Q)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.N345K;PIK3CA p.R93Q;TP53 p.X321_splice;CDKN1B p.E86Kfs*33;AURKA Amplification;FGFR1 Amplification;PPM1D Amplification;TERT Amplification	5	8
P-0005038	P-0005038-T01-IM5	In-House	DNA	Resection	250	275	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										JAK1 p.S729C;MEN1 p.X224_splice;STAT3 p.H410R	0	3
P-0005039	P-0005039-T01-IM5	In-House	DNA	Biopsy	242	434	40	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)	Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.G1743V)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	RAC1 p.P29S;NRAS p.Q61L;PTPRD p.X1462_splice;ARID2 p.X1688_splice;FLT3 p.E708K;BRCA1 p.G1743V;CARD11 Amplification;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;RAC1 Amplification	3	11
P-0005041	P-0005041-T01-IM5	In-House	DNA	Resection	250	478	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.S215I;KRAS p.Q61H	1	2
P-0005042	P-0005042-T01-IM5	Outside	DNA	Biopsy	250	643	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	ESR1 p.D538G;MAP3K1 p.Q1492*;FGFR1 Amplification;MYC Amplification	2	4
P-0005043	P-0005043-T01-IM5	In-House	DNA	Resection	250	314	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Enasidenib(IDH2 p.R140W)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.I195T;IDH2 p.R140W	2	3
P-0005044	P-0005044-T01-IM5	In-House	DNA	Resection	250	648	70	Matched	Metastasis	Kidney	Retroperitoneum	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma			Temsirolimus(MTOR p.L2427Q)		Everolimus(MTOR p.L2427Q)				LEVEL_3A	MTOR p.L2427Q;VHL p.W117*	2	2
P-0005045	P-0005045-T01-IM5	In-House	DNA	Resection	250	412	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;FOXA1 Amplification;PTEN Deletion;PTPRD Deletion	2	5
P-0005046	P-0005046-T01-IM5	In-House	DNA	Resection	250	695	50	Matched	Metastasis	Uterus	Lymph Node	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										SMARCA4 p.A1419Hfs*29;TP53 p.I195Sfs*52	0	2
P-0005047	P-0005047-T01-IM5	In-House	DNA	Biopsy	250	856	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Cisplatin(ERCC2 p.X2_splice)					LEVEL_3B	ERCC2 p.X2_splice;TP53 p.P142Afs*5;AR Amplification;TMPRSS2 ETV4-TMPRSS2 fusion;ETV4 ETV4-TMPRSS2 fusion	1	5
P-0005048	P-0005048-T01-IM5	In-House	DNA	Biopsy	250	965	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_3B	PIK3CA p.E542K;KRAS p.Q61H;MGA p.Q1100Rfs*33	2	3
P-0005049	P-0005049-T01-IM5	In-House	FFPE	Resection	250	1142	80	Matched	Primary	Pelvis	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0005050	P-0005050-T01-IM5	In-House	DNA	Resection	250	802	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L;APC Deletion	0	2
P-0005051	P-0005051-T01-IM5	Outside	DNA	Resection	250	824	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.R222C;EGFR Amplification;MDM4 Amplification	1	3
P-0005052	P-0005052-T01-IM5	In-House	DNA	Resection	250	712	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma											0	0
P-0005052	P-0005052-T02-IM5	Outside	DNA	Resection	250	344	70	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										KMT2A Deletion	0	1
P-0005053	P-0005053-T01-IM5	Outside	DNA	Biopsy	250	998	30	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(MAP2K1 p.P105_A106del)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3A	PIK3CA p.E545K;MAP2K1 p.P105_A106del	2	2
P-0005054	P-0005054-T01-IM5	In-House	DNA	Biopsy	250	585	30	Unmatched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D277Y)					LEVEL_3B	TP53 p.E285K;RB1 p.Q395*;ASXL2 p.L1125*;MGA p.S1778*;ERBB2 p.D277Y;RNF43 p.Q723*;BMPR1A p.C124Mfs*8;CDKN1B p.T42Lfs*30;CD274 Amplification;ETV1 Amplification;JAK2 Amplification	1	11
P-0005055	P-0005055-T01-IM5	Outside	DNA	Resection	250	593	30	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0005057	P-0005057-T02-IM5	In-House	DNA	Biopsy	250	452	30	Matched	Metastasis	Liver	Lymph Node	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma				Olaparib(PALB2 p.M723Vfs*21)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;PALB2 p.M723Vfs*21	2	2
P-0005058	P-0005058-T01-IM5	In-House	DNA	Resection	250	843	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.V73Wfs*50;KDM6A p.W632*	0	2
P-0005059	P-0005059-T01-IM5	In-House	DNA	Biopsy	94.5	968	10	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.Y126C;APC p.Q1204*	2	4
P-0005060	P-0005060-T01-IM5	In-House	DNA	Biopsy	250	948	50	Matched	Metastasis	Stomach	Omentum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.V274G;NOTCH4 p.W1221*;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;FGFR1 Amplification;MYC Amplification;TERT Amplification	4	8
P-0005061	P-0005061-T01-IM5	In-House	DNA	Resection	250	361	20	Matched	Metastasis	Uterus	Lymph Node	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										PPP2R1A p.P179R;TP53 p.N239S;ERRFI1 p.N258Qfs*3;AKT2 Amplification	0	4
P-0005062	P-0005062-T01-IM5	In-House	DNA	Biopsy	250	585	90	Matched	Metastasis	Cancer of Unknown Primary	Adrenal Gland	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;ASXL2 Deletion;DNMT3A Deletion;MAPK1 Amplification	2	4
P-0005063	P-0005063-T01-IM5	In-House	DNA	Biopsy	250	755	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)								LEVEL_1	EGFR p.E746_S752delinsV;TP53 p.E336*;EGFR Amplification	1	3
P-0005064	P-0005064-T01-IM5	In-House	DNA	Biopsy	250	527	60	Matched	Metastasis	Prostate	Liver	Tumor	PRSCC	Prostate Cancer	Prostate Small Cell Carcinoma										TP53 p.V73Rfs*76;PIK3R1 p.X582_splice;TP53 p.P190S;CIC Deletion;RB1 Deletion;TCF3 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	8
P-0005065	P-0005065-T03-IM5	In-House	DNA	Biopsy	250	594	60	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.Y220C;AR Amplification;MRE11 FEZ1-MRE11A fusion;FEZ1 FEZ1-MRE11A fusion;EP300 TOP2A-EP300 fusion;TOP2A TOP2A-EP300 fusion	0	6
P-0005065	P-0005065-T02-IM5	In-House	DNA	Resection	250	395	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.Y220C;NOTCH1 Deletion;ZFHX3 Deletion	0	3
P-0005066	P-0005066-T01-IM5	In-House	DNA	Resection	250	780	90	Matched	Metastasis	Small Bowel	Pelvis	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D820V);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K558_V560delinsL)	Sorafenib(KIT p.D820V)					Imatinib,Sunitinib(KIT p.D820V)		LEVEL_1	KIT p.D820V;KIT p.K558_V560delinsL;RB1 Deletion;TNFRSF14 Deletion	3	4
P-0005067	P-0005067-T01-IM5	Outside	DNA	Resection	250	469	40	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	GSK2636771,AZD8186(PTEN p.H93R)				LEVEL_3B	PIK3CA p.E545K;TP53 p.W146*;PTEN p.H93R	2	3
P-0005068	P-0005068-T01-IM5	In-House	DNA	Biopsy	250	414	40	Matched	Metastasis	Adrenal Gland	Bone	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										FAT1 p.E904*;NF2 p.K123*;MYCN Amplification;TERT Amplification	0	4
P-0005069	P-0005069-T01-IM5	In-House	DNA	Cytology	250	915	60	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)						LEVEL_1	TP53 p.K132R;MET p.X1010_splice	3	2
P-0005070	P-0005070-T01-IM5	In-House	DNA	Cytology	250	587	60	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y234H;KDM5C Deletion	0	2
P-0005073	P-0005073-T01-IM5	Outside	DNA	Biopsy	250	234	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;FAT1 Deletion	2	2
P-0005074	P-0005074-T01-IM5	In-House	DNA	Biopsy	250	887	60	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.E285K;RECQL4 p.X569_splice;KMT2D p.A2214Pfs*50;CCND3 Amplification;MCL1 Amplification;RAF1 Amplification	0	6
P-0005075	P-0005075-T01-IM5	In-House	DNA	Biopsy	250	941	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.H179D	1	2
P-0005076	P-0005076-T01-IM5	Outside	DNA	Resection	250	363	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ARID1A p.S138*;ERBB2 p.S310F;ERRFI1 p.S391*;EGFR p.E884K;CREBBP p.E349*	1	5
P-0005077	P-0005077-T01-IM5	In-House	DNA	Resection	250	398	40	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005078	P-0005078-T01-IM5	In-House	DNA	Resection	250	319	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ZFHX3 p.S1178*;KDM6A p.Q542*;RYBP p.I146Sfs*62	0	3
P-0005078	P-0005078-T02-IM5	In-House	FFPE	Resection	250	750	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ZFHX3 p.S1178*;RYBP p.I146Sfs*62	0	2
P-0005079	P-0005079-T01-IM5	Outside	DNA	Resection	250	413	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;ERBB2 Amplification	4	2
P-0005080	P-0005080-T01-IM5	Outside	DNA	Biopsy	250	965	70	Matched	Metastasis	Lung	Breast	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	FBXW7 p.R465C;TP53 p.G245C;KRAS p.G13D;KEAP1 p.E488K;SPEN p.E327*;CDC73 p.R139*;PRDM1 p.E234*;ARID2 p.E258*;DIS3 p.M163Nfs*15;NFKBIA p.L148Yfs*16;APC p.S1631Lfs*18;RASA1 p.N407Sfs*3	1	12
P-0005081	P-0005081-T01-IM5	In-House	DNA	Resection	250	319	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0005082	P-0005082-T01-IM5	In-House	DNA	Resection	250	1183	10	Matched	Metastasis	Oral Cavity	Lymph Node	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										CD274 Amplification	0	1
P-0005083	P-0005083-T01-IM5	Outside	DNA	Biopsy	250	422	50	Matched	Primary	Kidney	Not Applicable	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0005084	P-0005084-T02-IM5	In-House	FFPE	Biopsy	250	1093	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.K50*)				LEVEL_4	NF1 p.K50*	1	1
P-0005085	P-0005085-T01-IM5	In-House	DNA	Resection	250	1286	70	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)					LEVEL_3B	TP53 p.R273H;PPP2R1A p.P179R;PIK3CA p.E542K;NRAS p.G12D;MYC Amplification;ST6GALNAC5 FUBP1-ST6GALNAC5 fusion;FUBP1 FUBP1-ST6GALNAC5 fusion	2	7
P-0005086	P-0005086-T01-IM5	Outside	DNA	Biopsy	250	226	60	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Crizotinib,Entrectinib(ROS1 GOPC-ROS1 fusion);Crizotinib,Entrectinib(GOPC GOPC-ROS1 fusion)					LEVEL_3B	ROS1 GOPC-ROS1 fusion;GOPC GOPC-ROS1 fusion	2	2
P-0005087	P-0005087-T01-IM5	In-House	DNA	Biopsy	250	607	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.T484A)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Everolimus(TSC1 p.Q527*)	Tazemetostat(KDM6A p.W1258*)				LEVEL_3A	PIK3CA p.E542K;TP53 p.R282W;ERBB2 p.S310F;TSC1 p.Q527*;TP53 p.X32_splice;ERCC2 p.T484A;TP63 p.Q575*;FBXW7 p.S546L;MEN1 p.R98*;ERBB3 p.F219L;SMAD4 p.E330G;KDM6A p.W1258*;MEN1 p.F23Lfs*87;FOXL2 p.K164Tfs*100	5	14
P-0005088	P-0005088-T02-IM5	In-House	FFPE	Cytology	250	972	30	Matched	Metastasis	Pleura	Pleural Fluid	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										SETD2 p.T305Nfs*4;BAP1 p.W5*;KDM6A p.E657Dfs*34	0	3
P-0005089	P-0005089-T01-IM5	In-House	DNA	Biopsy	245.7	630	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										RBM10 p.Q779*	0	1
P-0005091	P-0005091-T01-IM5	In-House	DNA	Resection	250	1043	30	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.Y737*;ANKRD11 p.X249_splice;TP53 p.T155Afs*28;CDK8 Amplification;FLT3 Amplification	0	5
P-0005092	P-0005092-T01-IM5	In-House	DNA	Resection	250	1063	60	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.N268Efs*4	0	1
P-0005093	P-0005093-T01-IM5	In-House	DNA	Biopsy	250	1038	30	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	MUCC	Salivary Gland Cancer	Mucoepidermoid Carcinoma										BAP1 p.X126_splice	0	1
P-0005094	P-0005094-T01-IM5	In-House	DNA	Resection	250	1208	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719A)								LEVEL_1	EGFR p.G719A;TP53 p.D281V	1	2
P-0005095	P-0005095-T01-IM5	In-House	DNA	Resection	220.8	1183	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MCL1 Amplification;PAK1 Amplification	2	5
P-0005096	P-0005096-T01-IM5	In-House	DNA	Resection	250	533	70	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										NF2 p.E327Rfs*19	0	1
P-0005097	P-0005097-T01-IM5	In-House	DNA	Biopsy	250	448	30	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.X331_splice	0	1
P-0005098	P-0005098-T01-IM5	Outside	DNA	Biopsy	250	422	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.M246V	0	1
P-0005098	P-0005098-T02-IM5	Outside	DNA	Resection	250	1242	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.M246V;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0005099	P-0005099-T01-IM5	In-House	DNA	Resection	250	339	40	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0005101	P-0005101-T01-IM5	In-House	DNA	Biopsy	250	781	NA	Matched	Metastasis	Bone	Soft Tissue	Tumor	ES	Bone Cancer	Ewing Sarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	HNF1A p.Q350*;PTEN Deletion	1	2
P-0005102	P-0005102-T01-IM5	Outside	DNA	Biopsy	250	864	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.E294*;RBM10 p.H643Rfs*25	1	3
P-0005103	P-0005103-T01-IM5	In-House	DNA	Biopsy	250	549	60	Matched	Metastasis	Cecum	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R213*;APC p.R1450*;APC p.Q789*;KRAS p.G13D	1	4
P-0005104	P-0005104-T01-IM5	In-House	DNA	Biopsy	250	450	30	Matched	Metastasis	Lung	Pleura	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.G129E);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S7Afs*19)				LEVEL_4	TP53 p.Y220C;NFE2L2 p.G31A;PTEN p.G129E;CDKN2A p.S7Afs*19	2	4
P-0005105	P-0005105-T01-IM5	Outside	DNA	Biopsy	250	366	40	Matched	Primary	Liver	Not Applicable	Tumor	EHAE	Soft Tissue Sarcoma	Epithelioid Hemangioendothelioma											0	0
P-0005106	P-0005106-T01-IM5	Outside	FFPE	Biopsy	250	448	80	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Olaparib(CDK12 CDK12-intragenic)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 CDK12-intragenic)				LEVEL_1	TP53 p.R213*;SMAD4 p.H92Y;CDK6 Amplification;ERBB2 Amplification;CDK12 CDK12-intragenic	4	5
P-0005107	P-0005107-T01-IM5	In-House	FFPE	Resection	250	776	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.C218*)				LEVEL_4	TP53 p.P142Lfs*28;FAT1 p.Y1176*;PTEN p.C218*	1	3
P-0005108	P-0005108-T01-IM5	Outside	DNA	Resection	250	541	40	Matched	Primary	Uterus	Not Applicable	Tumor	HGESS	Uterine Sarcoma	High-Grade Endometrial Stromal Sarcoma										EPHA7 Deletion	0	1
P-0005109	P-0005109-T01-IM5	In-House	DNA	Cytology	250	497	20	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					PLX8394(BRAF p.G469R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BRAF p.G469R;TP53 p.P128S;CDKN2A Deletion	2	3
P-0005110	P-0005110-T01-IM5	In-House	DNA	Resection	250	576	80	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										TP53 p.X33_splice;PTPRT p.R364*;ERRFI1 p.R286Efs*9	0	3
P-0005111	P-0005111-T01-IM5	In-House	DNA	Biopsy	250	566	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PMS2 p.Q275*;FOXA1 p.S282_G283dup	0	2
P-0005112	P-0005112-T01-IM5	Outside	DNA	Biopsy	250	505	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;BAP1 p.V346Ffs*16	1	2
P-0005113	P-0005113-T01-IM5	Outside	DNA	Resection	250	485	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.M199del);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.M199del;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	4
P-0005114	P-0005114-T01-IM5	In-House	DNA	Biopsy	250	411	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	3	4
P-0005115	P-0005115-T01-IM5	Outside	DNA	Cytology	250	539	70	Matched	Metastasis	Lung	Neck	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										ASXL2 Deletion;DNMT3A Deletion	0	2
P-0005116	P-0005116-T01-IM5	Outside	DNA	Resection	250	1009	40	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13R)					LEVEL_3B	NRAS p.G13R	1	1
P-0005117	P-0005117-T02-IM5	In-House	DNA	Biopsy	250	363	10	Matched	Metastasis	Penis	Chest Wall	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.L248Tfs*3)						LEVEL_3A	TP53 p.R175H;MYCN p.P44L;PTCH1 p.L248Tfs*3;GPS2 p.V93Sfs*4	1	4
P-0005117	P-0005117-T01-IM5	Outside	DNA	Biopsy	250	139	50	Matched	Metastasis	Penis	Mons Pubis	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.L248Tfs*3)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106V);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3A	PIK3CA p.G106V;CREBBP p.H397Afs*30;PTCH1 p.L248Tfs*3;NOTCH1 p.G446Afs*185;GPS2 p.V93Sfs*4;CDK4 Amplification	3	6
P-0005118	P-0005118-T01-IM5	Outside	DNA	Resection	250	813	80	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.G13R)						LEVEL_3A	NRAS p.G13R;EPHA3 p.R136*;EIF1AX p.G8R	1	3
P-0005119	P-0005119-T02-IM5	In-House	DNA	Biopsy	250	405	NA	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma										STAG2 p.N928*;EWSR1 ETV4-EWSR1 fusion;ETV4 ETV4-EWSR1 fusion	0	3
P-0005120	P-0005120-T01-IM5	Outside	DNA	Biopsy	250	330	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;CDH1 p.P620Lfs*11;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification;PAK1 Amplification;SDHD Deletion	2	7
P-0005121	P-0005121-T02-IM5	In-House	DNA	Biopsy	250	864	50	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	ACRM	Melanoma	Acral Melanoma			Trametinib,Cobimetinib(KIAA1549 BRAF-KIAA1549 fusion);Trametinib,Cobimetinib(BRAF BRAF-KIAA1549 fusion)		GSK2636771,AZD8186(PTEN p.T319Nfs*6)				LEVEL_3A	PTEN p.T319Nfs*6;KIAA1549 BRAF-KIAA1549 fusion;BRAF BRAF-KIAA1549 fusion	3	3
P-0005122	P-0005122-T01-IM5	In-House	DNA	Biopsy	250	945	60	Matched	Metastasis	Lung	Liver	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.Y220C;CREBBP p.R1446C;CBFB Deletion;FLCN Deletion;MAP2K4 Deletion;NCOR1 Deletion;RB1 Deletion;ARID2 ARID2-intragenic	0	8
P-0005123	P-0005123-T01-IM5	In-House	DNA	Cytology	101.12	134	10	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719A)								LEVEL_1	TP53 p.G105C;EGFR p.G719A	1	2
P-0005124	P-0005124-T01-IM5	Outside	DNA	Biopsy	250	968	50	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.E171*;APC p.S1415Rfs*4;PBRM1 p.R434*;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	0	6
P-0005125	P-0005125-T01-IM5	In-House	DNA	Resection	250	988	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005126	P-0005126-T01-IM5	In-House	DNA	Resection	250	827	80	Matched	Metastasis	Soft Tissue	Prostate	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)					LEVEL_3B	TP53 p.R248Q;NRAS p.Q61H	1	2
P-0005127	P-0005127-T02-IM5	In-House	FFPE	Biopsy	250	944	85	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				BLU-667,Selpercatinib(RET p.S891L)					LEVEL_3B	TP53 p.W91*;TP53 p.P278S;EPHA3 p.R136*;EPHA3 p.R842*;RET p.S891L;FLT3 p.E720K;ATRX p.E643*;FAT1 p.F2224Sfs*16;TNFAIP3 p.E366Gfs*22;RB1 p.R579*;RICTOR Amplification;SPOP Deletion;TERT Amplification	1	13
P-0005127	P-0005127-T01-IM5	In-House	DNA	Resection	250	734	70	Matched	Metastasis	Cancer of Unknown Primary	Soft Tissue	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				BLU-667,Selpercatinib(RET p.S891L)					LEVEL_3B	TP53 p.W91*;TP53 p.P278S;RB1 p.R579*;EPHA3 p.R136*;EPHA3 p.R842*;RET p.S891L;FLT3 p.E720K;PTPRT p.W506*;ATRX p.E643*;TNFAIP3 p.E366Gfs*22;FAT1 p.P2223Sfs*17;RICTOR Amplification;SPOP Deletion;TERT Amplification	1	14
P-0005128	P-0005128-T01-IM5	In-House	DNA	Resection	250	804	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	GSK2636771,AZD8186(PTEN p.P95S);Trametinib,Cobimetinib(NF1 p.D2346Vfs*49);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D116Pfs*3);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTEN p.P95S;NF1 p.D2346Vfs*49;CDKN2A p.D116Pfs*3;CDKN2A Deletion;CDKN2B Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	6	7
P-0005129	P-0005129-T01-IM5	In-House	DNA	Biopsy	250	617	60	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;DICER1 p.D1810N;PBRM1 p.V902Efs*15;STK11 Deletion	1	4
P-0005130	P-0005130-T01-IM5	Outside	DNA	Resection	250	297	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas										SMAD4 p.G386R;AKT3 Amplification;IKBKE Amplification;MDM4 Amplification	0	4
P-0005131	P-0005131-T01-IM5	In-House	DNA	Biopsy	250	909	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.C420R;TP53 p.F113V;FGFR1 Amplification	3	3
P-0005131	P-0005131-T02-IM5	In-House	FFPE	Biopsy	250	690	60	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Everolimus(TSC1 p.L463Ffs*69);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_1	PIK3CA p.C420R;TP53 p.F113V;TSC1 p.L463Ffs*69;ARID1A p.A325Rfs*51;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;NF1 Deletion;PAK1 Amplification	5	9
P-0005132	P-0005132-T01-IM5	In-House	DNA	Resection	250	920	40	Matched	Metastasis	Cecum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Sorafenib(ARAF p.S214P)					LEVEL_3B	TP53 p.R282W;BRAF p.D594G;TP53 p.T125M;SMAD4 p.G419W;ARAF p.S214P	1	5
P-0005133	P-0005133-T01-IM5	In-House	DNA	Resection	250	740	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.W88R;PBRM1 p.T311Dfs*7;GRIN2A p.F459Sfs*6;MLH1 p.A353Lfs*14	0	4
P-0005134	P-0005134-T01-IM5	In-House	DNA	Resection	250	806	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X114_splice;KMT2C p.N3372Mfs*12;CDC73 p.Q254Pfs*61	0	3
P-0005135	P-0005135-T01-IM5	In-House	DNA	Resection	250	548	70	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	2
P-0005136	P-0005136-T01-IM5	In-House	DNA	Resection	250	600	80	Matched	Primary	Kidney	Not Applicable	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma											0	0
P-0005137	P-0005137-T02-IM5	In-House	DNA	Resection	250	641	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.N235del;APC p.E1309Rfs*6;APC p.Y737*;PIK3R1 p.N282Kfs*3;SMAD3 Deletion	0	5
P-0005138	P-0005138-T01-IM5	In-House	DNA	Resection	250	787	60	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R248Q;IDH1 p.R132H;ATRX p.S465*	1	3
P-0005139	P-0005139-T01-IM5	In-House	DNA	Biopsy	250	829	70	Matched	Metastasis	Lymph Node	Pelvis	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										BCL2L11 p.Q150*;CCND1 p.Y44D;CDKN2A Deletion;CDKN2B Deletion	0	4
P-0005140	P-0005140-T01-IM5	Outside	DNA	Biopsy	250	487	40	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(FAM13C FGFR2-FAM13C fusion);Pemigatinib(FGFR2 FGFR2-FAM13C fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(FAM13C FGFR2-FAM13C fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-FAM13C fusion)						LEVEL_1	MGA p.X1144_splice;FAM13C FGFR2-FAM13C fusion;FGFR2 FGFR2-FAM13C fusion	4	3
P-0005141	P-0005141-T01-IM5	In-House	DNA	Biopsy	250	1015	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PIK3R1 p.G376R;B2M Deletion;CDKN2A Deletion;CDKN2B Deletion;ERRFI1 Deletion;MGA Deletion;PTEN Deletion;RAD51 Deletion	2	8
P-0005142	P-0005142-T01-IM5	In-House	DNA	Biopsy	250	425	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMARCA4 LDLR-SMARCA4 fusion;LDLR LDLR-SMARCA4 fusion	1	3
P-0005143	P-0005143-T01-IM5	In-House	DNA	Biopsy	250	542	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.X305_splice)					LEVEL_1	FGFR3 p.S249C;TSC1 p.X305_splice;STAG2 p.E143Dfs*6;CREBBP p.S893Pfs*27;PAX5 Deletion;PTPRD Deletion	3	6
P-0005144	P-0005144-T01-IM5	In-House	DNA	Biopsy	250	612	40	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Olaparib(ATM p.I2888T)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ATM p.I2888T;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;RAC1 Amplification	2	5
P-0005145	P-0005145-T01-IM5	In-House	DNA	Biopsy	250	653	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G	1	1
P-0005146	P-0005146-T01-IM5	In-House	DNA	Biopsy	250	704	60	Matched	Metastasis	Skin	Subcutaneous Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma		Imatinib(KIT p.D579del)		Sunitinib,Regorafenib,Ripretinib(KIT p.D579del)					LEVEL_2	KIT p.D579del;CBL p.I393S;TP53 p.L330H;KIT Amplification	2	4
P-0005147	P-0005147-T01-IM5	In-House	FFPE	Resection	250	512	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.C176F	0	1
P-0005148	P-0005148-T01-IM5	In-House	DNA	Biopsy	250	868	20	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;JAK2 p.D519H;JAK2 p.L545F;TP53 p.Y220S;CDK4 Amplification;GLI1 Amplification;TERT Amplification	3	8
P-0005149	P-0005149-T01-IM5	Outside	DNA	Resection	250	947	90	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.C242_M243delinsWL	0	1
P-0005150	P-0005150-T01-IM5	In-House	DNA	Resection	250	342	60	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)						LEVEL_1	FGFR3 p.R248C	2	1
P-0005150	P-0005150-T02-IM5	In-House	FFPE	Resection	250	841	60	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)						LEVEL_1	FGFR3 p.R248C;FGFR3 Amplification	2	2
P-0005151	P-0005151-T01-IM5	In-House	DNA	Resection	250	423	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(CDK12 p.Q127*);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.I605Yfs*9);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.L1764*)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q127*)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_3B	CTNNB1 p.S45F;PTEN p.K267Rfs*9;TBX3 p.G529Afs*103;ERBB3 p.A232V;RNF43 p.G659Vfs*41;KMT2A p.P773Rfs*8;SOX17 p.P328Rfs*59;NSD1 p.R1031*;KRAS p.Q61H;PTPRS p.P622Lfs*16;ERRFI1 p.C378*;NOTCH1 p.D469E;CDK12 p.Q127*;PIK3R1 p.G588Vfs*7;BCOR p.K1061Sfs*52;BRCA2 p.I605Yfs*9;ETV6 p.I407del;ERRFI1 p.P348Rfs*104;RAD50 p.T271Lfs*5;BRCA1 p.L1764*	6	20
P-0005152	P-0005152-T01-IM5	In-House	DNA	Biopsy	250	522	NA	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.N345K;MDM2 Amplification;PIK3CA Amplification;SOX17 XKR4-SOX17 fusion;XKR4 XKR4-SOX17 fusion	3	5
P-0005153	P-0005153-T01-IM5	In-House	DNA	Biopsy	250	624	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K);AZD9496,Fulvestrant(ESR1 p.Y537N);AZD9496,Fulvestrant(ESR1 p.V422del)						LEVEL_3A	AKT1 p.E17K;ESR1 p.Y537N;ESR1 p.V422del;GATA3 p.P408Afs*99;MDM4 Amplification	3	5
P-0005154	P-0005154-T01-IM5	In-House	DNA	Biopsy	250	426	NA	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.E542K;ASXL1 p.R628*;STAG2 p.E721*;GATA3 p.P408Lfs*98	4	5
P-0005155	P-0005155-T01-IM5	Outside	DNA	Resection	250	55	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0005156	P-0005156-T01-IM5	Outside	DNA	Resection	250	762	80	Matched	Metastasis	Uterus	Soft Tissue	Tumor	ESS	Uterine Sarcoma	Endometrial Stromal Sarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	2	3
P-0005157	P-0005157-T01-IM5	In-House	DNA	Resection	250	869	80	Matched	Metastasis	Eye	Subcutaneous Tissue	Tumor	UM	Melanoma	Uveal Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	GNA11 p.Q209L;BAP1 p.X125_splice;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification;TNFRSF14 Deletion	1	6
P-0005158	P-0005158-T01-IM5	Outside	DNA	Biopsy	250	975	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.V173*;RB1 p.S751C	0	2
P-0005159	P-0005159-T01-IM5	In-House	DNA	Resection	250	844	70	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.X1870_splice);Trametinib,Cobimetinib(NF1 p.N2092*)				LEVEL_4	BRAF p.D594G;PTPRD p.R1674C;APC p.R2204*;FUBP1 p.X212_splice;MLH1 p.Y690*;PBRM1 p.Q98*;PTPRD p.W466*;NF1 p.X1870_splice;NF1 p.N2092*	2	9
P-0005160	P-0005160-T01-IM5	Outside	DNA	Biopsy	250	497	10	Matched	Metastasis	Lung	Bone	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.G101W)				LEVEL_4	TP53 p.M237I;KMT2D p.E1527*;RB1 p.S758*;CDKN2A p.G101W;RAC1 Amplification	1	5
P-0005161	P-0005161-T01-IM5	Outside	DNA	Resection	250	861	90	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										ARID1A p.Q449Afs*173;FGFR2 Amplification;MYC Amplification	0	3
P-0005162	P-0005162-T01-IM5	In-House	DNA	Resection	250	859	60	Matched	Primary	Pelvis	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										STAG2 STAG2-intragenic	0	1
P-0005163	P-0005163-T01-IM5	Outside	FFPE	Biopsy	250	615	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C;SMAD4 p.S154*;APC p.E1309Dfs*4;TCF7L2 p.H210Lfs*117	0	4
P-0005164	P-0005164-T01-IM5	In-House	FFPE	Resection	250	657	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	KRAS p.G12A;FBXW7 p.S582L;APC p.L1489Yfs*18	1	3
P-0005165	P-0005165-T01-IM5	Outside	DNA	Biopsy	250	444	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Neratinib(ERBB2 p.L755_T759delinsAQSQQ)	Ado-Trastuzumab Emtansine(ERBB2 p.L755_T759delinsAQSQQ)					LEVEL_1	TP53 p.R209Kfs*6;PIK3CA p.H1047R;SMARCA4 p.V880Gfs*64;FOXA1 p.H374Pfs*40;CDH1 p.S337Ffs*12;ERBB2 p.L755_T759delinsAQSQQ	4	6
P-0005167	P-0005167-T01-IM5	Outside	DNA	Biopsy	250	732	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Olaparib(RAD51D Deletion)					LEVEL_3B	KDM6A p.E946*;EGFR Amplification;KRAS Amplification;RAD51D Deletion	1	4
P-0005168	P-0005168-T01-IM5	In-House	DNA	Biopsy	250	729	30	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				BLU-667,Cabozantinib,Selpercatinib,Vandetanib(RET CCDC6-RET fusion);BLU-667,Cabozantinib,Selpercatinib,Vandetanib(CCDC6 CCDC6-RET fusion)					LEVEL_3B	ARID1A p.R693*;RHOA p.Y42C;RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	2	4
P-0005169	P-0005169-T01-IM5	Outside	DNA	Resection	250	738	40	Matched	Metastasis	Kidney	Lung	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										TP53 p.T125R	0	1
P-0005170	P-0005170-T01-IM5	In-House	DNA	Resection	250	765	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.A1066T);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	PIK3CA p.A1066T;NPM1 p.S214*;STK11 p.X97_splice;KEAP1 p.I461F;CDK4 Amplification;FGFR4 Amplification;GLI1 Amplification;MDM2 Amplification	3	8
P-0005171	P-0005171-T01-IM5	Outside	DNA	Biopsy	250	444	20	Matched	Primary	Lymph Node	Not Applicable	Tumor	MLYM	Miscellaneous Brain Tumor	Malignant Lymphoma											0	0
P-0005172	P-0005172-T01-IM5	In-House	DNA	Biopsy	250	529	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.G245S;APC p.R216*	1	3
P-0005173	P-0005173-T01-IM5	In-House	DNA	Resection	250	850	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										ARID2 p.E258*;TP53 p.K132*;RBM10 p.R726*;PTPRD p.Y1182_G1183delins*	0	4
P-0005174	P-0005174-T01-IM5	In-House	FFPE	Resection	250	679	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.I102_E103delinsK)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.I102_E103delinsK)						LEVEL_1	TP53 p.C135Y;RUNX1 p.X242_splice;PIK3CA p.I102_E103delinsK;MYC Amplification	2	4
P-0005175	P-0005175-T01-IM5	In-House	DNA	Biopsy	250	574	70	Matched	Metastasis	Retroperitoneum	Lung	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;JUN Amplification;MDM2 Amplification	2	3
P-0005176	P-0005176-T01-IM5	In-House	FFPE	Biopsy	226	419	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN PTEN-intragenic)				LEVEL_4	TP53 p.S116Afs*34;EPHA7 Deletion;RAF1 Amplification;PTEN PTEN-intragenic;RB1 RB1-intragenic;EP300 EP300-intragenic	1	6
P-0005177	P-0005177-T01-IM5	In-House	FFPE	Biopsy	250	472	60	Matched	Metastasis	Kidney	Lymph Node	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SF3B1 p.R625C	0	1
P-0005178	P-0005178-T01-IM5	In-House	DNA	Biopsy	114.4	561	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R175H;NRAS p.Q61K;EGFR p.E746_A750del;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERBB2 Amplification;RICTOR Amplification	4	8
P-0005179	P-0005179-T01-IM5	In-House	DNA	Biopsy	250	596	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E27*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.V126F)				LEVEL_4	KRAS p.G12V;TP53 p.R158L;B2M p.L15Ffs*41;SF3B1 p.K666N;PTPRS p.R979*;RBM10 p.X6_splice;B2M p.D96Efs*7;MUTYH p.P342Qfs*62;CDKN2A p.E27*;CDKN2A p.V126F	3	10
P-0005180	P-0005180-T01-IM5	In-House	DNA	Resection	250	334	60	Matched	Primary	Foot	Not Applicable	Tumor	ACRM	Melanoma	Acral Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;ARID1B ARID1B-intragenic	1	2
P-0005181	P-0005181-T01-IM5	Outside	FFPE	Resection	250	924	60	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.R130G);GSK2636771,AZD8186(PTEN p.Y68C)				LEVEL_4	KRAS p.G12V;PTEN p.R130G;PTEN p.Y68C	3	3
P-0005182	P-0005182-T01-IM5	In-House	FFPE	Resection	250	780	40	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0005183	P-0005183-T01-IM5	In-House	DNA	Resection	250	420	60	Matched	Metastasis	Thyroid	Neck	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;EIF1AX p.X113_splice;ZFHX3 p.L1787Qfs*3	2	3
P-0005185	P-0005185-T01-IM5	In-House	FFPE	Cytology	133	115	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A36Rfs*17)				LEVEL_4	KRAS p.G12D;TP53 p.X187_splice;NCOR1 p.L1871Qfs*12;MAP2K4 p.E82Sfs*14;CDKN2A p.A36Rfs*17	2	5
P-0005186	P-0005186-T01-IM5	In-House	DNA	Biopsy	250	584	50	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R213*;AURKA Amplification;BCL2L1 Amplification;BMPR1A Deletion;CDKN1B Deletion;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;DNMT3B Amplification;ERCC4 Deletion;GRIN2A Deletion;PTEN Deletion;SOCS1 Deletion;SRC Amplification	2	14
P-0005187	P-0005187-T01-IM5	In-House	DNA	Resection	250	825	30	Matched	Metastasis	Kidney	Lymph Node	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.N239D;ARID1A p.F2141Sfs*59;PTPRS p.V1025Sfs*18;MLH1 p.G221*;BAP1 p.K453Ifs*9	0	5
P-0005189	P-0005189-T01-IM5	Outside	DNA	Resection	250	552	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.G266R;KRAS p.G13D;APC p.P824Hfs*3	1	3
P-0005190	P-0005190-T01-IM5	In-House	DNA	Resection	250	621	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;STK11 p.V243Gfs*23;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification;EMID1 EWSR1-EMID1 fusion;EWSR1 EWSR1-EMID1 fusion	1	10
P-0005191	P-0005191-T01-IM5	In-House	DNA	Resection	250	654	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;TP53 p.G244C;B2M p.X110_splice;MUTYH p.Q460Rfs*4;RBM10 p.G261Vfs*5;GRIN2A p.D1297Efs*6;STK11 MIDN-STK11 fusion;MIDN MIDN-STK11 fusion	1	8
P-0005192	P-0005192-T01-IM5	Outside	DNA	Biopsy	250	259	10	Unmatched	Primary	Eye	Not Applicable	Tumor	HDCN	Histiocytosis	Histiocytic and Dendritic Cell Neoplasms											0	0
P-0005193	P-0005193-T01-IM5	In-House	DNA	Resection	250	693	20	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma											0	0
P-0005194	P-0005194-T01-IM5	In-House	DNA	Resection	250	650	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.W308L;CIC p.R215Q;RAD50 p.X45_splice;CDH1 p.A289Yfs*4	1	5
P-0005195	P-0005195-T01-IM5	Outside	DNA	Resection	250	550	60	Matched	Primary	Ovary	Not Applicable	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer											0	0
P-0005196	P-0005196-T01-IM5	In-House	DNA	Biopsy	250	758	40	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R342Efs*3;AKT3 Amplification;MYC Amplification;PTEN Deletion	1	4
P-0005197	P-0005197-T01-IM5	In-House	DNA	Resection	250	798	50	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	FBXW7 p.R505C;KRAS p.G12D;FUBP1 p.X84_splice;RNF43 p.G659Vfs*41;RNF43 p.R117Afs*41;AXIN2 p.G665Afs*24;ERCC3 p.R452*;ANKRD11 p.A2265Pfs*72;NCOR1 p.I307Sfs*19;HLA-A p.R45Afs*32;LATS2 p.L914Wfs*10;SMARCA4 p.P109Rfs*194;BLM p.K1217Nfs*62;RNF43 p.A115Pfs*43;KDM6A p.S40Afs*2;KMT2C p.T3840Nfs*6;MGA p.E1249Rfs*25	1	17
P-0005198	P-0005198-T01-IM5	In-House	DNA	Resection	250	475	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)								LEVEL_1	CTNNB1 p.S33P;RBM10 p.S492*;MED12 p.V1985*;EGFR p.E746_S752delinsV	1	4
P-0005199	P-0005199-T01-IM5	In-House	DNA	Resection	250	721	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.F1888I)				LEVEL_4	MTOR p.F1888I;PBRM1 p.E1122*;AKT1 p.D323N	1	3
P-0005200	P-0005200-T01-IM5	In-House	DNA	Resection	250	541	NA	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.Q546K;APC p.R564*;APC p.Q1429*;PIK3CB p.R48Q;SMAD4 p.G510R	2	6
P-0005201	P-0005201-T01-IM5	In-House	DNA	Resection	250	587	70	Matched	Metastasis	Conjunctiva	Lymph Node, Regional	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)	GSK2636771,AZD8186(PTEN p.V166Sfs*14)				LEVEL_3B	TP53 p.R175H;BRAF p.V600K;PTEN p.V166Sfs*14;PTPRT p.W506*;PPP6C p.R177*	2	5
P-0005202	P-0005202-T01-IM5	Outside	DNA	Resection	250	314	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										KDM6A p.L1273Ffs*19	0	1
P-0005203	P-0005203-T01-IM5	In-House	DNA	Resection	250	537	70	Matched	Metastasis	Anus	Lung	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										CREBBP p.R1446H	0	1
P-0005204	P-0005204-T01-IM5	In-House	DNA	Resection	250	749	80	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma											0	0
P-0005205	P-0005205-T01-IM5	In-House	DNA	Biopsy	250	667	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.E204*;ERBB2 Amplification	2	2
P-0005206	P-0005206-T01-IM5	Outside	DNA	Resection	250	484	30	Matched	Primary	Bladder	Not Applicable	Tumor	UA	Bladder Cancer	Urachal Adenocarcinoma										TP53 p.X326_splice	0	1
P-0005207	P-0005207-T01-IM5	In-House	DNA	Resection	250	526	60	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;PIK3CA p.N345K;APC p.R1450*;APC p.R876*;DIS3 p.X129_splice	2	5
P-0005208	P-0005208-T01-IM5	In-House	DNA	Resection	250	369	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	KRAS p.Q61R	1	1
P-0005209	P-0005209-T01-IM5	Outside	DNA	Biopsy	250	681	50	Matched	Metastasis	Major Salivary Gland	Soft Tissue	Tumor	HNNE	Head and Neck Cancer	Head and Neck Neuroendocrine Carcinoma										MGA p.S1619Lfs*31	0	1
P-0005210	P-0005210-T01-IM5	In-House	DNA	Resection	250	516	30	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R213*;APC p.T1556Nfs*3;APC p.D849Rfs*2;AMER1 p.R358*;CCND2 Amplification;CDK8 Amplification;FLT3 Amplification;KDM5A Amplification	1	9
P-0005211	P-0005211-T01-IM5	Outside	DNA	Cytology	250	460	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.V73Rfs*76;MAPK4 SMAD4-MAPK4 fusion;SMAD4 SMAD4-MAPK4 fusion	1	4
P-0005212	P-0005212-T01-IM5	In-House	DNA	Resection	250	418	60	Matched	Metastasis	Oropharynx	Lymph Node	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E78K)					LEVEL_3B	PIK3CA p.E542K;NFE2L2 p.G31A;PIK3CA p.E78K;KMT2D p.E1069*;BLM p.Q723*;FOXA1 Amplification;NKX2-1 Amplification	2	7
P-0005213	P-0005213-T01-IM5	In-House	FFPE	Resection	250	674	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R273C;SPOP p.Y87C;MYC Amplification	0	3
P-0005214	P-0005214-T01-IM5	In-House	DNA	Resection	250	667	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.S2215Y)				LEVEL_4	MTOR p.S2215Y	1	1
P-0005215	P-0005215-T01-IM5	In-House	DNA	Biopsy	250	728	30	Matched	Primary	Penis	Not Applicable	Tumor	PSCC	Penile Cancer	Penile Squamous Cell Carcinoma											0	0
P-0005216	P-0005216-T01-IM5	In-House	FFPE	Cytology	250	870	10	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(BARD1 Deletion)								LEVEL_1	ASXL1 p.G646Wfs*12;BRAF p.G466E;ARID2 p.X638_splice;FOXA1 p.F266V;SPOP p.D130H;TP53 p.I255Nfs*9;AR Amplification;ARID5B Deletion;BARD1 Deletion;CDKN1B Deletion;GATA3 Deletion;NCOR1 Deletion;RB1 Deletion;RYBP Deletion;SHQ1 Deletion	1	15
P-0005217	P-0005217-T03-IM5	In-House	DNA	Resection	250	855	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R248W;FOXA1 p.G251_G257del	0	2
P-0005219	P-0005219-T01-IM5	Outside	DNA	Cytology	250	126	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537S)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	ESR1 p.Y537S;SF3B1 p.Y623H;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB3 Amplification;FGF19 Amplification;FOXA1 Amplification;FOXO1 Deletion;GATA3 Amplification;MAP2K4 Deletion;PRDM1 Deletion	2	12
P-0005220	P-0005220-T01-IM5	Outside	DNA	Resection	250	1119	60	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.R213*;CBFB p.X55_splice;GATA3 p.X350_splice;CCND1 Amplification;EZH2 Amplification;FGF19 Amplification;FGFR1 Amplification;FGFR2 Amplification;FOXA1 Amplification;MYC Amplification;RHEB Amplification;NUB1 MLL3-NUB1 fusion;KMT2C MLL3-NUB1 fusion;KMT2C DPP6-MLL3 fusion;DPP6 DPP6-MLL3 fusion	3	16
P-0005221	P-0005221-T01-IM5	Outside	DNA	Biopsy	250	124	30	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.M237I;ERBB2 Amplification	2	2
P-0005222	P-0005222-T01-IM5	In-House	DNA	Resection	250	681	60	Matched	Metastasis	Cancer of Unknown Primary	Skin	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;RAC1 p.P29S;SETD2 p.R620*	2	3
P-0005223	P-0005223-T01-IM5	In-House	DNA	Biopsy	250	849	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0005224	P-0005224-T01-IM5	Outside	DNA	Resection	250	314	60	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Cisplatin(ERCC2 Deletion)					LEVEL_3B	TP53 p.E343*;AKT2 Amplification;BBC3 Deletion;CCNE1 Amplification;CIC Deletion;ERCC2 Deletion;MLH1 Deletion;PPP2R1A Deletion;PTPRS Deletion;STK11 Deletion;TCF3 Deletion;ZRSR2 Deletion	1	12
P-0005225	P-0005225-T01-IM5	In-House	DNA	Resection	250	647	30	Matched	Metastasis	Upper Tract	Lung	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Palbociclib,Abemaciclib(CDK4 Amplification)	Everolimus,Temsirolimus(MTOR p.T1977I);Tazemetostat(KDM6A p.F146Ifs*6)				LEVEL_1	PIK3CA p.E545K;MTOR p.T1977I;FGFR3 p.R248C;MGA p.R1818*;SMAD3 p.*426Yext*6;KDM6A p.F146Ifs*6;CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;GLI1 Amplification	6	10
P-0005226	P-0005226-T01-IM5	In-House	DNA	Resection	250	945	50	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	VHL p.G127Wfs*5;BAP1 p.N365Lfs*32;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0005227	P-0005227-T01-IM5	In-House	DNA	Resection	250	298	40	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005228	P-0005228-T01-IM5	Outside	DNA	Resection	250	459	70	Matched	Metastasis	Skin	Subcutaneous Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.X465_splice);Trametinib,Cobimetinib(NF1 p.X1237_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	ARID2 p.R314C;NF1 p.X465_splice;EPCAM p.Q197*;TP63 p.Q182*;FAT1 p.X1395_splice;ARID1B p.Q468*;PMS2 p.R20W;NF1 p.X1237_splice;PPM1D p.R458*;ARID2 p.X359_splice;PTPRS p.G88Efs*4;CDKN2A p.R80*	3	12
P-0005230	P-0005230-T01-IM5	In-House	DNA	Resection	250	562	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V777M)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.V126A)	Cetuximab,Panitumumab(KRAS p.G12D);Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	KRAS p.G12D;APC p.R1450*;RNF43 p.P660Sfs*87;CTNNB1 p.T41A;TGFBR1 p.S241L;KRAS p.G13D;SYK p.R42C;MSH6 p.R174*;CDK6 p.V234M;KMT2D p.R1252*;DICER1 p.R676*;SMAD3 p.R243H;CDH1 p.R732Q;ERBB2 p.V777M;SOX9 p.E134*;MSH6 p.A729Pfs*7;CDKN2A p.V126A	4	17
P-0005231	P-0005231-T01-IM5	In-House	DNA	Resection	250	466	50	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.X165_splice)				LEVEL_4	PTEN p.X165_splice;VHL p.I75_C77del	1	2
P-0005232	P-0005232-T01-IM5	In-House	DNA	Resection	250	451	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	FGFR3 p.R248C;MGA p.Q45*;FAT1 p.I168Rfs*21;MDM2 Amplification;PPP6C Deletion	3	5
P-0005233	P-0005233-T01-IM5	In-House	DNA	Biopsy	250	501	30	Matched	Metastasis	Adrenal Gland	Intercostal space	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										TP53 p.Y234*;ARID1B p.G548Rfs*92	0	2
P-0005234	P-0005234-T01-IM5	In-House	DNA	Resection	250	831	40	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005235	P-0005235-T02-IM5	In-House	FFPE	Biopsy	250	795	80	Matched	Metastasis	Skin	Brain	Tumor	ACRM	Melanoma	Acral Melanoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;KDR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification	2	7
P-0005235	P-0005235-T01-IM5	Outside	DNA	Resection	250	804	60	Matched	Metastasis	Foot	Lung	Tumor	ACRM	Melanoma	Acral Melanoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;KIT Amplification;MDM2 Amplification;MYC Amplification	2	6
P-0005237	P-0005237-T01-IM5	In-House	DNA	Resection	250	598	NA	Matched	Metastasis	Rectosigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Lorlatinib,Brigatinib(ALK p.R1275Q);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D277V)					LEVEL_3B	NCOR1 p.E529Kfs*26;TP53 p.R282W;ALK p.R1275Q;APC p.Y935*;ERBB2 p.D277V;CCND2 Amplification;KDM5A Amplification	2	7
P-0005239	P-0005239-T01-IM5	In-House	DNA	Biopsy	250	901	10	Matched	Metastasis	Cancer of Unknown Primary	Retroperitoneum	Tumor	SCCNOS	Cancer of Unknown Primary	Squamous Cell Carcinoma, NOS				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;SMARCA4 SMARCA4-intragenic	1	2
P-0005240	P-0005240-T01-IM5	In-House	DNA	Resection	250	860	NA	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;TCF7L2 p.M1?;APC p.H298Lfs*28;BCL2L1 Amplification;EGFR Amplification	0	5
P-0005241	P-0005241-T01-IM5	In-House	DNA	Resection	250	742	40	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma										PTPRT p.X994_splice	0	1
P-0005242	P-0005242-T01-IM5	In-House	DNA	Biopsy	250	775	30	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;SPEN p.Q1019*;MAP3K1 p.S1039*	2	3
P-0005243	P-0005243-T01-IM5	Outside	DNA	Biopsy	250	299	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R175H;IDH1 p.R132H;ATRX p.R907*;MYCN Amplification;SPATS1 SPEN-SPATS1 fusion;SPEN SPEN-SPATS1 fusion	1	6
P-0005244	P-0005244-T01-IM5	In-House	DNA	Resection	250	989	70	Matched	Metastasis	Thyroid	Lung	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer										MSH6 p.F1088Sfs*2;DAXX p.R318*;XRCC2 p.R17*	0	3
P-0005245	P-0005245-T01-IM5	In-House	DNA	Biopsy	250	318	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(CHEK2 p.R137*)	Tazemetostat(KDM6A p.K1105Nfs*15)				LEVEL_3B	CHEK2 p.R137*;FAT1 p.P1560Rfs*24;KDM6A p.K1105Nfs*15	2	3
P-0005247	P-0005247-T01-IM5	In-House	DNA	Resection	250	318	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;APC p.E1345*;APC p.L1021Rfs*7	0	3
P-0005249	P-0005249-T01-IM5	Outside	DNA	Biopsy	250	177	40	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.G245S;IDH1 p.R132H;ATRX p.G1071*	1	3
P-0005250	P-0005250-T01-IM5	In-House	DNA	Resection	250	945	30	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	TP53 p.R273H;KRAS p.G12D;RB1 p.X474_splice	1	3
P-0005251	P-0005251-T01-IM5	In-House	DNA	Biopsy	250	495	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;KMT2C p.X1670_splice;KMT2C p.S1154*;KMT2D p.Q4228*;KMT2D p.E1588*	2	5
P-0005252	P-0005252-T01-IM5	Outside	DNA	Cytology	157.3	56	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F;KEAP1 p.G364C	2	3
P-0005253	P-0005253-T01-IM5	In-House	DNA	Biopsy	250	165	40	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.R130G);Trametinib,Cobimetinib(NF1 p.E318Kfs*11);Trametinib,Cobimetinib(NF1 p.R125Qfs*39)				LEVEL_4	PTEN p.R130G;NF1 p.E318Kfs*11;KDM5C p.X415_splice;NF1 p.R125Qfs*39;NFKBIA p.I94Rfs*29;ZFHX3 p.Q2491Vfs*42;TP53 p.C141_P142del;PIK3R1 p.K567_L570del	3	8
P-0005254	P-0005254-T01-IM5	In-House	FFPE	Biopsy	250	549	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.R1870Q);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.R1870Q;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification	2	5
P-0005255	P-0005255-T01-IM5	Outside	DNA	Biopsy	250	696	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;PPP6C p.F274Lfs*4;CDH1 p.D334Tfs*22;IKBKE Amplification;MCL1 Amplification	1	5
P-0005256	P-0005256-T01-IM5	In-House	FFPE	Biopsy	250	566	40	Matched	Metastasis	Kidney	Bone	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Everolimus(TSC1 p.Q763*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BAP1 p.E31del;TSC1 p.Q763*;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification	2	5
P-0005257	P-0005257-T01-IM5	Outside	DNA	Biopsy	250	402	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.P75Lfs*48;SMAD4 p.H21Qfs*6;CCNE1 Amplification;KRAS Amplification;PRKN Deletion;PTPRD Deletion	1	7
P-0005258	P-0005258-T01-IM5	Outside	DNA	Resection	250	690	30	Matched	Primary	Lymph Node	Not Applicable	Tumor	MLYM	Miscellaneous Brain Tumor	Malignant Lymphoma										TET2 p.N1753Kfs*3	0	1
P-0005259	P-0005259-T01-IM5	In-House	DNA	Cytology	250	837	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.R273C;FLT3 p.S873L	1	3
P-0005260	P-0005260-T01-IM5	Outside	DNA	Resection	250	271	50	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.G165*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A57Ffs*89);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A57Efs*89)				LEVEL_1	BRAF p.V600E;ERBB4 p.E452K;EPHA7 p.R231*;PTEN p.G165*;CDKN2A p.A57Ffs*89;CDKN2A p.A57Efs*89	5	6
P-0005261	P-0005261-T01-IM5	In-House	FFPE	Biopsy	185	643	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.E204*;RBM10 p.S622_A623delins*;FOXA1 Amplification;NKX2-1 Amplification;RAD21 RAD21-intragenic	0	5
P-0005262	P-0005262-T01-IM5	In-House	DNA	Biopsy	250	846	60	Matched	Metastasis	Small Bowel	Liver	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0005263	P-0005263-T01-IM5	Outside	DNA	Resection	250	648	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.G129E);Everolimus,Temsirolimus(MTOR p.E1799K)				LEVEL_4	PTEN p.G129E;MTOR p.E1799K;ARID1A p.S558Vfs*65;PAK1 Amplification	2	4
P-0005264	P-0005264-T01-IM5	In-House	DNA	Cytology	104	546	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;RBM10 p.R5Kfs*7;EGFR Amplification;MDM2 Amplification	2	4
P-0005265	P-0005265-T01-IM5	In-House	DNA	Cytology	250	577	10	Matched	Metastasis	Breast	Pleural Fluid	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K	1	1
P-0005266	P-0005266-T01-IM5	In-House	DNA	Biopsy	141.6	588	40	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(KDM6A p.Q369*)				LEVEL_3B	RB1 p.R467*;ERBB2 p.R678Q;KDM6A p.Q369*;MCL1 Amplification;MDM2 Amplification	3	5
P-0005267	P-0005267-T01-IM5	In-House	DNA	Resection	217.6	572	30	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.E285K;PTPRD p.V1565I;SOX9 p.*510Sext*49;CDH1 p.Q351*;TP53 p.E287D;TBX3 p.F136Yfs*3	0	6
P-0005268	P-0005268-T01-IM5	In-House	DNA	Biopsy	110.4	508	50	Matched	Metastasis	Breast	Bone	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;KMT2C p.L2749*;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	4	5
P-0005268	P-0005268-T02-IM5	In-House	FFPE	Biopsy	250	1000	70	Matched	Metastasis	Breast	Liver	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_1	PIK3CA p.H1047R;ESR1 p.Y537S;CCND1 Amplification;FGF19 Amplification;IKBKE Amplification;MDM4 Amplification	3	6
P-0005270	P-0005270-T01-IM5	In-House	DNA	Resection	122.85	300	80	Matched	Metastasis	Adrenal Gland	Lung	Tumor	PHC	Pheochromocytoma	Pheochromocytoma											0	0
P-0005271	P-0005271-T01-IM5	Outside	DNA	Biopsy	250	678	30	Matched	Metastasis	Kidney	Skin	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Q)					LEVEL_3B	VHL p.L169P;PIK3CA p.H1047Q;TGFBR2 p.K381*;SETD2 p.X1800_splice;PBRM1 p.Q1400Nfs*81	1	5
P-0005272	P-0005272-T01-IM5	Outside	FFPE	Biopsy	250	726	20	Matched	Primary	Brain	Not Applicable	Tumor	APE	CNS Cancer	Anaplastic Ependymoma										MAP2K4 Deletion	0	1
P-0005273	P-0005273-T01-IM5	In-House	DNA	Resection	250	389	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	RUNX1 p.D96Gfs*15;ERBB2 Amplification	2	2
P-0005274	P-0005274-T01-IM5	In-House	FFPE	Biopsy	250	685	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R249S;KMT2D p.Q5248Tfs*18;MYC Amplification	0	3
P-0005275	P-0005275-T01-IM5	In-House	FFPE	Resection	250	604	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R282W;FGFR3 Amplification	1	3
P-0005276	P-0005276-T01-IM5	Outside	DNA	Resection	250	649	20	Matched	Primary	Testis	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0005277	P-0005277-T01-IM5	In-House	DNA	Biopsy	250	785	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;SETD2 p.R1625H	1	2
P-0005277	P-0005277-T02-IM5	Outside	DNA	Biopsy	250	753	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;SETD2 p.R1625H	1	2
P-0005278	P-0005278-T01-IM5	In-House	DNA	Biopsy	250	925	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma											0	0
P-0005279	P-0005279-T01-IM5	In-House	DNA	Resection	250	976	40	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma			Tipifarnib(HRAS p.G12S)						LEVEL_3A	TP53 p.X187_splice;HRAS p.G12S;PTPRT p.Q162*;NOTCH3 p.C1747*	1	4
P-0005280	P-0005280-T01-IM5	In-House	DNA	Biopsy	250	650	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.R1275Q);Olaparib(ATM Deletion);Olaparib(CHEK1 Deletion)					LEVEL_3B	ALK p.R1275Q;ATRX p.R250*;ATM Deletion;BIRC3 Deletion;CBL Deletion;CHEK1 Deletion;EED Deletion;KMT2A Deletion;MRE11 Deletion;MYCN Amplification;SDHD Deletion	3	11
P-0005281	P-0005281-T01-IM5	Outside	DNA	Resection	250	783	40	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.E118*;FUBP1 p.X526_splice	1	3
P-0005282	P-0005282-T01-IM5	In-House	DNA	Biopsy	250	583	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W15*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P48Rfs*3)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F;TP53 p.R282W;NCOR1 p.S2436*;CDKN2A p.W15*;CDKN2A p.P48Rfs*3	4	6
P-0005283	P-0005283-T02-IM5	In-House	FFPE	Biopsy	250	880	90	Matched	Metastasis	Adrenal Gland	Brain	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										ALK Amplification;MYCN Amplification;PPM1D Amplification	0	3
P-0005283	P-0005283-T01-IM5	In-House	DNA	Resection	250	342	60	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										ALK Amplification;MYCN Amplification	0	2
P-0005284	P-0005284-T01-IM5	In-House	DNA	Biopsy	250	708	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	RHOA p.E47K;FGFR3 p.S249C;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0005285	P-0005285-T01-IM5	In-House	DNA	Cytology	107.1	487	30	Matched	Metastasis	Uterus	Pelvis	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N1784Tfs*7);Olaparib(PALB2 p.N280Tfs*8);Olaparib(CDK12 p.K721Nfs*32)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN p.X85_splice);GSK2636771,AZD8186(PTEN p.E157Gfs*3);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K721Nfs*32)				LEVEL_3B	BRCA2 p.N1784Tfs*7;BCOR p.N1459S;KRAS p.G12A;KMT2A p.P773Rfs*8;ARID1A p.Q449Afs*173;PTEN p.X85_splice;KDM6A p.F1339Lfs*17;ARID1A p.N2059Kfs*40;CCND1 p.D289del;PTEN p.E157Gfs*3;PALB2 p.N280Tfs*8;CDK12 p.K721Nfs*32;ARID1B p.G507Dfs*16;ARID1A p.E2250Gfs*17;SH2B3 p.L347Cfs*26;DNMT3A p.A114Pfs*48;PARP1 p.S507Afs*17;ARID1B p.P174Rfs*6	7	18
P-0005285	P-0005285-T02-IM5	Outside	DNA	Resection	250	929	20	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN p.X85_splice);GSK2636771,AZD8186(PTEN p.E157Gfs*3)				LEVEL_4	BCOR p.N1459S;KRAS p.G12A;MYCN p.P44L;PTEN p.X85_splice;CCND1 p.D289del;PTEN p.E157Gfs*3;ARID1A p.E2250Gfs*17	3	7
P-0005286	P-0005286-T01-IM5	In-House	FFPE	Biopsy	90	512	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.A767_V769dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.A767_V769dup)			LEVEL_3A	TP53 p.G244D;EGFR p.A767_V769dup	1	2
P-0005288	P-0005288-T01-IM5	In-House	DNA	Biopsy	250	542	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.X187_splice;SMAD4 p.H261Ifs*75	1	3
P-0005289	P-0005289-T01-IM5	Outside	DNA	Cytology	72.1	202	90	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;CTNNB1 p.G34R;TET2 p.Q1532*	2	3
P-0005290	P-0005290-T01-IM5	In-House	FFPE	Resection	250	580	50	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005291	P-0005291-T01-IM5	In-House	DNA	Biopsy	250	780	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(FGFR2 TFEC-FGFR2 fusion);Pemigatinib(TFEC TFEC-FGFR2 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 TFEC-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(TFEC TFEC-FGFR2 fusion)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	CDKN2A Deletion;CDKN2B Deletion;FGFR2 TFEC-FGFR2 fusion;TFEC TFEC-FGFR2 fusion	5	4
P-0005292	P-0005292-T01-IM5	Outside	DNA	Biopsy	250	771	30	Matched	Primary	Breast	Not Applicable	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS										TP53 p.Y107*	0	1
P-0005293	P-0005293-T01-IM5	Outside	DNA	Resection	250	475	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;EIF1AX p.X113_splice	2	2
P-0005294	P-0005294-T01-IM5	Outside	DNA	Biopsy	250	640	30	Matched	Primary	Lung	Not Applicable	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	SF3B1 p.K700E;NOTCH3 p.X1890_splice;CDK4 Amplification;MDM4 Amplification;MYEOV FUBP1-MYEOV fusion;FUBP1 FUBP1-MYEOV fusion	1	6
P-0005295	P-0005295-T01-IM5	In-House	FFPE	Biopsy	250	839	50	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										NF2 p.Y144*	0	1
P-0005296	P-0005296-T01-IM5	In-House	DNA	Biopsy	250	826	20	Matched	Metastasis	Appendix	Sigmoid Colon	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R273C	1	2
P-0005297	P-0005297-T01-IM5	In-House	DNA	Resection	250	734	30	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0005298	P-0005298-T01-IM5	In-House	DNA	Resection	250	881	40	Matched	Primary	Colorectal NOS	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	GSK2636771,AZD8186(PTEN p.H123R)				LEVEL_3B	PIK3CA p.E545K;APC p.T1556Nfs*3;PTEN p.H123R;AMER1 p.E559*;SMAD4 p.Q449Hfs*34;APC p.D1498Rfs*16;BCOR p.S336Lfs*45	2	7
P-0005299	P-0005299-T01-IM5	In-House	DNA	Biopsy	250	882	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R282W;CDKN2A p.E88*;EGFR Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification;PTEN Deletion;PTPRD Deletion	3	8
P-0005300	P-0005300-T01-IM5	Outside	DNA	Biopsy	250	740	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R175H;ERBB2 Amplification	2	2
P-0005301	P-0005301-T01-IM5	Outside	DNA	Resection	250	865	70	Matched	Primary	Blood Vessel	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										ATRX p.R840Kfs*9;RB1 p.X350_splice;NOTCH3 p.G2035Rfs*60;PMS2 Deletion;TP53 Deletion	0	5
P-0005302	P-0005302-T01-IM5	Outside	DNA	Biopsy	250	685	40	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.R1512L	1	2
P-0005303	P-0005303-T01-IM5	In-House	DNA	Biopsy	250	861	30	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					GSK2636771,AZD8186(PTEN p.T277N)				LEVEL_4	EGFR p.G598V;PTEN p.T277N	1	2
P-0005304	P-0005304-T01-IM5	In-House	DNA	Biopsy	250	888	60	Matched	Primary	Rectum	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12S)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NRAS p.G12S;CDKN2A Deletion	2	2
P-0005305	P-0005305-T01-IM5	Outside	DNA	Resection	250	897	30	Matched	Metastasis	Lung	Lymph Node	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion)				LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion	4	4
P-0005306	P-0005306-T01-IM5	In-House	DNA	Resection	250	915	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.L345Qfs*2);GSK2636771,AZD8186(PTEN p.K163Nfs*2)				LEVEL_4	VHL p.L158P;PTEN p.L345Qfs*2;BAP1 p.X194_splice;PTEN p.K163Nfs*2	2	4
P-0005307	P-0005307-T01-IM5	Outside	DNA	Biopsy	250	1158	20	Matched	Metastasis	Cecum	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;APC p.S1068Gfs*57;SMAD4 p.G419W;MED12 p.D34Y;APC p.A1492Cfs*22	2	6
P-0005308	P-0005308-T01-IM5	Outside	DNA	Resection	250	974	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.S246Y)	Olaparib(ATM p.D2822Ffs*34)	Tazemetostat(KDM6A p.E168Ffs*11)				LEVEL_3A	TP53 p.H214R;ERBB3 p.D297Y;FBXW7 p.R479P;TP53 p.P152L;KMT2D p.Q2514*;ERCC2 p.S246Y;RB1 p.X830_splice;TP53 p.K164*;CIC p.X1003_splice;KDM6A p.E168Ffs*11;ATM p.D2822Ffs*34;TP53 p.S215Ifs*36	3	12
P-0005309	P-0005309-T01-IM5	Outside	DNA	Resection	250	672	40	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	ADNOS	Cancer of Unknown Primary	Adenocarcinoma, NOS										APC p.G265*;NOTCH4 p.G723*;PTPRD p.C45*;PAX5 p.X260_splice;KEAP1 p.S21*;TP53 p.R290Afs*55;SMARCA4 p.Q515Efs*17;TP53 TP53-intragenic	0	8
P-0005310	P-0005310-T01-IM5	Outside	DNA	Biopsy	151	265	50	Matched	Metastasis	Soft Tissue	Lung	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0005311	P-0005311-T01-IM5	In-House	DNA	Biopsy	124.8	439	20	Matched	Metastasis	Ascending Colon	Small Bowel	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.S1465Wfs*3;SOX9 p.P374Rfs*9	1	3
P-0005311	P-0005311-T02-IM5	Outside	DNA	Resection	250	928	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.S1465Wfs*3;SOX9 p.P374Rfs*9	1	3
P-0005312	P-0005312-T01-IM5	Outside	DNA	Biopsy	250	827	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N1784Tfs*7);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L755S);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.A1708T)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L37_Y44delinsVR)				LEVEL_3B	BRCA2 p.N1784Tfs*7;EP300 p.M1470Cfs*26;SMAD4 p.A118V;ERBB2 p.L755S;TP53 p.R273C;APC p.T1556Nfs*3;KMT2A p.S774Vfs*12;ERBB3 p.V104M;NOTCH4 p.W1482*;BRCA1 p.A1708T;EP300 p.D1399E;NBN p.M83Cfs*9;MLH1 p.Q197Tfs*7;CDKN2A p.L37_Y44delinsVR;BRD4 Amplification	4	15
P-0005313	P-0005313-T02-IM5	In-House	DNA	Resection	250	1023	60	Matched	Metastasis	Adrenal Gland	Lung	Tumor	ACA	Adrenocortical Adenoma	Adrenocortical Adenoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S648*)	Trametinib,Cobimetinib(NF1 p.E1089*)				LEVEL_3B	TP53 p.D259Y;KMT2A p.S2803*;BRCA2 p.S648*;RB1 p.R698S;NF1 p.E1089*;ATRX p.E482*	2	6
P-0005314	P-0005314-T01-IM5	Outside	DNA	Resection	250	426	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;TP53 p.E285K;SPEN p.S2075*;ZFHX3 p.Q2291*	2	4
P-0005315	P-0005315-T01-IM5	Outside	DNA	Biopsy	250	656	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	RUNX1 p.D133*;FGFR1 Amplification;MYC Amplification	1	3
P-0005316	P-0005316-T01-IM5	Outside	DNA	Biopsy	128	605	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	STK11 p.X200_splice;KEAP1 p.G186V;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification;MYC Amplification	2	6
P-0005317	P-0005317-T01-IM5	In-House	DNA	Biopsy	250	611	60	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										BAP1 p.C91F;VHL p.P86L;ARID1B p.P244Wfs*5	0	3
P-0005318	P-0005318-T01-IM5	In-House	DNA	Resection	250	471	70	Matched	Primary	Pleura	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0005319	P-0005319-T01-IM5	In-House	DNA	Biopsy	250	733	30	Matched	Metastasis	Kidney	Liver	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Everolimus(TSC1 p.X305_splice)					LEVEL_3B	BAP1 p.R208Sfs*22;TP53 p.C229*;TSC1 p.X305_splice;VHL p.N78Kfs*82	1	4
P-0005320	P-0005320-T01-IM5	Outside	DNA	Biopsy	152.8	709	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	SMARCA4 p.E665Rfs*109;TP53 p.P153Sfs*28;MET Amplification	2	3
P-0005321	P-0005321-T01-IM5	In-House	DNA	Biopsy	58.05	537	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	CDKN2A Deletion;CDKN2B Deletion;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	3	4
P-0005322	P-0005322-T01-IM5	In-House	DNA	Resection	250	645	20	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.F1174L)					LEVEL_3B	ALK p.F1174L;MYCN Amplification	1	2
P-0005322	P-0005322-T02-IM5	In-House	FFPE	Resection	250	944	70	Matched	Metastasis	Retroperitoneum	Brain	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.R1275Q)					LEVEL_3B	ALK p.R1275Q;MYCN Amplification	1	2
P-0005323	P-0005323-T01-IM5	In-House	DNA	Resection	250	952	30	Matched	Metastasis	Groin	Epidural	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MCL1 Amplification;MDM2 Amplification;PAX5 Deletion	2	4
P-0005324	P-0005324-T01-IM5	In-House	DNA	Resection	250	361	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0005325	P-0005325-T01-IM5	In-House	DNA	Biopsy	250	1093	40	Matched	Metastasis	Uterus	Lung	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor				Everolimus(TSC2 p.X326_splice)	Trametinib,Cobimetinib(NF1 CREB5-NF1 fusion);Trametinib,Cobimetinib(CREB5 CREB5-NF1 fusion)				LEVEL_3B	TSC2 p.X326_splice;IKZF1 Deletion;NF1 CREB5-NF1 fusion;CREB5 CREB5-NF1 fusion	3	4
P-0005325	P-0005325-T02-IM5	Outside	FFPE	Resection	250	700	70	Matched	Primary	Uterus	Not Applicable	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor				Everolimus(TSC2 p.X326_splice)					LEVEL_3B	TSC2 p.X326_splice	1	1
P-0005326	P-0005326-T01-IM5	In-House	DNA	Resection	250	772	20	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Sonidegib,Vismodegib(PTCH1 p.L39Cfs*41);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.I986Sfs*14);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.G2044Afs*7)					LEVEL_3B	FUBP1 p.I301Yfs*22;PTCH1 p.S1203Afs*52;TP53 p.R158H;APC p.S1465Wfs*3;ARID1A p.D1850Gfs*4;APC p.Q1260Dfs*15;TCF7L2 p.K485Sfs*23;FLCN p.H429Tfs*39;PTCH1 p.L39Cfs*41;BCL10 p.X19_splice;MSH2 p.R680*;RHOA p.Y34C;HLA-A p.Q78*;NOTCH4 p.P1441Lfs*17;BRCA1 p.I986Sfs*14;BRCA2 p.G2044Afs*7;MRE11 p.N511Ifs*13;NOTCH4 p.G1892Rfs*24;NSD1 G2155fs;KMT2D p.V1554Lfs*48;KMT2A p.F3671Lfs*23;HLA-A p.R7Efs*13;ATR p.F1091Lfs*28;APC p.G375Afs*79	4	24
P-0005327	P-0005327-T01-IM5	In-House	DNA	Resection	250	1148	20	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.Q104*	2	2
P-0005328	P-0005328-T01-IM5	In-House	DNA	Biopsy	250	718	30	Matched	Metastasis	Kidney	Retroperitoneum	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.M134Yfs*8)				LEVEL_4	TP53 p.G266R;PBRM1 p.K651Nfs*5;PIK3R1 p.X582_splice;VHL p.X155_splice;PTEN p.M134Yfs*8	1	5
P-0005329	P-0005329-T01-IM5	In-House	DNA	Resection	250	808	20	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma											0	0
P-0005330	P-0005330-T02-IM5	In-House	DNA	Resection	250	682	NA	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V654A)			Olaparib(RAD51B Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib(KIT p.V654A)		LEVEL_1	KIT p.W557_K558del;KIT p.V654A;CDKN2A Deletion;CDKN2B Deletion;RAD51B Deletion	4	5
P-0005331	P-0005331-T01-IM5	In-House	DNA	Resection	250	747	70	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.R282G;ATR Deletion;RB1 Deletion	0	3
P-0005332	P-0005332-T01-IM5	In-House	DNA	Resection	250	367	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.R509*)					LEVEL_3B	VHL p.N78Y;TSC1 p.R509*	1	2
P-0005333	P-0005333-T01-IM5	In-House	DNA	Resection	250	629	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										NFE2L2 p.D29H;PBRM1 p.S14Afs*29	0	2
P-0005334	P-0005334-T01-IM5	Outside	DNA	Resection	250	931	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(CHEK2 Deletion);Tazemetostat(SMARCB1 Deletion)	GSK2636771,AZD8186(PTEN p.D92E);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PTEN p.D92E;CDKN2A Deletion;CDKN2B Deletion;CHEK2 Deletion;EGFR Amplification;EP300 Deletion;FAT1 Deletion;NF2 Deletion;PAX5 Deletion;PTPRD Deletion;SMARCB1 Deletion;TET1 Deletion	5	12
P-0005335	P-0005335-T01-IM5	Outside	DNA	Biopsy	250	579	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.K132N;CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification	2	5
P-0005336	P-0005336-T01-IM5	In-House	DNA	Resection	250	672	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005337	P-0005337-T01-IM5	In-House	DNA	Biopsy	145	797	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.T155Hfs*21;RB1 p.A11Rfs*20;RBM10 p.D719*;FOXA1 Amplification;NKX2-1 Amplification	2	7
P-0005338	P-0005338-T01-IM5	In-House	DNA	Resection	250	690	40	Unmatched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0005339	P-0005339-T01-IM5	In-House	DNA	Resection	250	712	70	Matched	Primary	Ovary	Not Applicable	Tumor	SCCO	Ovarian Cancer	Small Cell Carcinoma of the Ovary										TP53 p.R282W;B2M Deletion;FAT1 Deletion;MGA Deletion;PMAIP1 Deletion;RAD51 Deletion;RB1 Deletion	0	7
P-0005340	P-0005340-T01-IM5	In-House	DNA	Resection	206	549	30	Matched	Metastasis	Ovary	Cul-de-sac	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Y220C	0	1
P-0005341	P-0005341-T01-IM5	Outside	DNA	Resection	250	679	50	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer										ARID1A p.Q1424Sfs*21;ARID1A p.N942Tfs*26;INPP4B p.X141_splice	0	3
P-0005342	P-0005342-T01-IM5	In-House	DNA	Cytology	120	163	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ERBB3 p.V104L;ERBB3 p.E928G;CDH1 p.X337_splice;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	1	6
P-0005343	P-0005343-T01-IM5	In-House	DNA	Biopsy	162	797	20	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;TP53 p.R282W	1	2
P-0005344	P-0005344-T01-IM5	In-House	DNA	Biopsy	103	607	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR p.W742L	0	1
P-0005345	P-0005345-T01-IM5	In-House	DNA	Biopsy	250	835	30	Matched	Metastasis	Liver	Peritoneum	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132L)						LEVEL_3A	IDH1 p.R132L;MCL1 Amplification	1	2
P-0005346	P-0005346-T01-IM5	In-House	DNA	Biopsy	216	504	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.M528I);Tazemetostat(KDM6A p.X189_splice);Tazemetostat(KDM6A p.N332Ifs*27);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;FUBP1 p.S270*;FGFR3 p.M528I;KMT2D p.S3378*;KDM6A p.X189_splice;KDM6A p.N332Ifs*27;STAG2 p.Y159Ifs*24;CDKN1A p.C117Lfs*12;CDKN1A p.P4Tfs*32;CDKN2A Deletion;CDKN2B Deletion	6	11
P-0005347	P-0005347-T01-IM5	In-House	DNA	Resection	250	217	40	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										MCL1 Amplification	0	1
P-0005348	P-0005348-T01-IM5	In-House	DNA	Biopsy	216	717	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.Q263Tfs*60	0	1
P-0005349	P-0005349-T01-IM5	Outside	DNA	Resection	250	666	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0005350	P-0005350-T01-IM5	In-House	DNA	Resection	250	776	50	Matched	Metastasis	Breast	Lung	Tumor	MBC	Breast Cancer	Metaplastic Breast Cancer	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0005351	P-0005351-T01-IM5	In-House	DNA	Resection	250	797	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.K321Nfs*24;ERBB2 Amplification;YAP1 Amplification	2	3
P-0005352	P-0005352-T01-IM5	In-House	DNA	Biopsy	228	1101	40	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;PBRM1 Deletion;DNAH1 PBRM1-DNAH1 fusion;PBRM1 PBRM1-DNAH1 fusion	1	4
P-0005353	P-0005353-T01-IM5	In-House	DNA	Resection	250	775	30	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	TP53 p.X261_splice;EPHA3 p.X949_splice;BTK p.R544M;TBX3 p.C390Lfs*17;NF1 NF1-intragenic	1	5
P-0005354	P-0005354-T01-IM5	In-House	DNA	Resection	250	521	60	Matched	Metastasis	Kidney	Adrenal Gland	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X114_splice;BAP1 p.Y223*	0	2
P-0005355	P-0005355-T01-IM5	In-House	DNA	Biopsy	130.5	675	40	Matched	Metastasis	Kidney	Liver	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.L2427R)				LEVEL_4	MTOR p.L2427R	1	1
P-0005356	P-0005356-T01-IM5	In-House	DNA	Biopsy	250	1041	30	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Olaparib(ATM p.Y2019C)	Tazemetostat(KDM6A p.G1232Lfs*34)				LEVEL_3B	ATM p.Y2019C;EP300 p.Q1068*;KDM6A p.G1232Lfs*34;ERBB3 p.V104L;ARID1A Deletion;FGFR3 Amplification;GATA3 Amplification;KDM5A Amplification	2	8
P-0005357	P-0005357-T01-IM5	In-House	DNA	Biopsy	250	984	20	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										ARID1A p.D1850Gfs*4;AXIN1 p.Q96*;CCND1 Amplification;FGF19 Amplification	0	4
P-0005359	P-0005359-T01-IM5	In-House	DNA	Resection	115.2	321	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.E606Q)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Tipifarnib(HRAS p.Q61R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K);Tazemetostat(KDM6A p.W632*)				LEVEL_3A	KRAS p.G12D;PIK3CA p.E545K;HRAS p.Q61R;FGFR2 p.N549K;KDM6A p.W632*;CASP8 p.Q32*;CDKN1A p.Q10*;BRAF p.T599I;ERCC2 p.E606Q;MGA p.K1084Rfs*6;ARID2 p.A308Sfs*2;GATA3 p.S237Qfs*66;MGA p.W763Lfs*12	6	13
P-0005360	P-0005360-T01-IM5	Outside	DNA	Biopsy	250	596	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_1	PIK3CA p.H1047R;ESR1 p.D538G;FOXA1 p.S242_Y243delinsCS	3	3
P-0005361	P-0005361-T01-IM5	In-House	DNA	Biopsy	250	855	30	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	GSK2636771,AZD8186(PTEN p.M35I)				LEVEL_3B	PTPN11 p.E76K;PTEN p.M35I;EP300 p.R1645*;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	3	5
P-0005361	P-0005361-T02-IM5	In-House	FFPE	Resection	250	700	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	GSK2636771,AZD8186(PTEN p.M35I)				LEVEL_3B	PTEN p.M35I;EP300 p.R1645*;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	3	4
P-0005362	P-0005362-T02-IM5	In-House	DNA	Resection	250	436	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005363	P-0005363-T01-IM5	Outside	DNA	Biopsy	250	791	10	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Tazemetostat(SMARCB1 p.R377L)				LEVEL_3B	BRAF p.V600E;TP53 p.L201*;SMARCB1 p.R377L	2	3
P-0005364	P-0005364-T01-IM5	Outside	DNA	Resection	250	1178	30	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Tazemetostat(KDM6A p.X1293_splice)				LEVEL_4	KRAS p.G12D;CCND1 p.T286I;ZFHX3 p.Q2304*;KDM6A p.X1293_splice;KRAS Amplification	2	5
P-0005365	P-0005365-T01-IM5	In-House	DNA	Biopsy	250	783	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										ARID1A p.Q268*;PBRM1 p.E923*;KMT2A p.R721*;TP53 p.A129Pfs*42;NF2 p.L54Rfs*31	0	5
P-0005366	P-0005366-T01-IM5	In-House	DNA	Biopsy	250	693	70	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Sonidegib,Vismodegib(PTCH1 p.Q663*);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L785F);Cisplatin(ERCC2 p.M1?)	Trametinib,Cobimetinib(NF1 p.Q1577*);Trametinib,Cobimetinib(NF1 p.X1612_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114S)				LEVEL_3B	TP53 p.R213*;ERBB2 p.S310F;DICER1 p.R509*;BRAF p.D594N;KMT2C p.Q3470*;NF1 p.Q1577*;FLT3 p.G822E;PTPRD p.R1674C;CRLF2 p.S128L;FAT1 p.Q958*;PTPRD p.X1554_splice;PTCH1 p.Q663*;ERBB2 p.L785F;ERCC2 p.M1?;PTPRT p.X1131_splice;NF1 p.X1612_splice;CDKN2A p.P114S	7	17
P-0005367	P-0005367-T01-IM5	In-House	DNA	Biopsy	250	736	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		GSK2636771,AZD8186(PTEN p.Q245*);Trametinib,Cobimetinib,Binimetinib(KRAS p.E63K);Tazemetostat(KDM6A p.Q208*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;PTEN p.Q245*;ARID1A p.Q386*;PMS1 p.S381*;KRAS p.E63K;KDM6A p.Q208*;CDKN2A Deletion	6	7
P-0005368	P-0005368-T01-IM5	In-House	DNA	Resection	250	1407	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.Q331*;ERBB2 Amplification	2	2
P-0005369	P-0005369-T01-IM5	In-House	DNA	Resection	250	819	50	Matched	Metastasis	Thyroid	Chest Wall	Tumor	THFO	Thyroid Cancer	Follicular Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R	2	1
P-0005370	P-0005370-T01-IM5	In-House	DNA	Biopsy	250	875	50	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;CDKN2A Deletion;CDKN2B Deletion	3	3
P-0005371	P-0005371-T01-IM5	In-House	DNA	Resection	250	906	20	Matched	Primary	Foot	Not Applicable	Tumor	ACRM	Melanoma	Acral Melanoma										PAK1 Amplification;YAP1 Amplification	0	2
P-0005372	P-0005372-T01-IM5	Outside	DNA	Biopsy	250	957	30	Matched	Metastasis	Bladder	Prostate	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.N238S)		Tazemetostat(KDM6A p.X129_splice)				LEVEL_3A	TP53 p.S241C;ERCC2 p.N238S;ERCC4 p.Y610*;KDM6A p.X129_splice;RUNX1 p.L94Pfs*3;RBM10 p.X890_splice;AKT2 Amplification;AXL Amplification;MCL1 Amplification;RAF1 Amplification	2	10
P-0005373	P-0005373-T01-IM5	In-House	DNA	Biopsy	250	691	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Tazemetostat(KDM6A p.P1107Lfs*13)				LEVEL_1	PIK3CA p.H1047R;TP53 p.Y205C;FGFR3 p.Y373C;KMT2D p.Q3826*;KDM6A p.P1107Lfs*13	4	5
P-0005374	P-0005374-T01-IM5	In-House	DNA	Biopsy	250	2148	60	Matched	Metastasis	Prostate	Retroperitoneum	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.R882W);Olaparib(CDK12 p.P702Tfs*27)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.P702Tfs*27)				LEVEL_1	AR p.L702H;CDK12 p.R882W;CDK12 p.P702Tfs*27;ANKRD11 Deletion;EGFR Amplification;FANCA Deletion;MCL1 Amplification;MYC Amplification;RAC1 Amplification;ZFHX3 Deletion	3	10
P-0005375	P-0005375-T01-IM5	In-House	DNA	Resection	250	1095	20	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma											0	0
P-0005376	P-0005376-T01-IM5	In-House	DNA	Resection	250	921	40	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0005377	P-0005377-T01-IM5	In-House	DNA	Biopsy	250	862	60	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										GATA3 p.P408Qfs*97	0	1
P-0005378	P-0005378-T01-IM5	Outside	DNA	Biopsy	250	1244	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										RB1 p.R255*;TP53 p.L130F;CIC p.S961Afs*6	0	3
P-0005379	P-0005379-T01-IM5	Outside	DNA	Resection	250	554	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										ARID2 p.X1757_splice	0	1
P-0005380	P-0005380-T01-IM5	In-House	DNA	Biopsy	75	509	30	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.D280N);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12*)				LEVEL_4	STK11 p.X155_splice;FGFR3 p.D280N;TP53 p.X261_splice;KEAP1 p.R415C;CDKN2A p.S12*;KRAS Amplification	2	6
P-0005381	P-0005381-T01-IM5	Outside	DNA	Biopsy	217.6	378	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Cetuximab,Panitumumab(KRAS p.A146V)			LEVEL_4	TP53 p.R175H;FBXW7 p.R465H;KRAS p.A146V;APC p.E1309Dfs*4;APC p.K1182*;EP300 p.X428_splice;CDKN2A Deletion;CDKN2B Deletion	2	8
P-0005382	P-0005382-T01-IM5	In-House	DNA	Biopsy	250	1154	60	Matched	Primary	Oral Cavity	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										PPP2R1A p.R183Q	0	1
P-0005383	P-0005383-T01-IM5	Outside	DNA	Biopsy	250	855	50	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary				Tipifarnib(HRAS p.G12D)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88K)				LEVEL_3B	HRAS p.G12D;SF3B1 p.K666M;SPEN p.E1888Yfs*17;CDKN2A p.E88K;HRAS Amplification;MITF Amplification	2	6
P-0005384	P-0005384-T01-IM5	In-House	DNA	Resection	250	875	10	Matched	Metastasis	Descending Colon	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C176R;APC p.S895*	0	2
P-0005385	P-0005385-T01-IM5	Outside	DNA	Biopsy	250	736	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Olaparib(ATM p.R1898*);Everolimus(TSC1 p.S282*)					LEVEL_1	FGFR3 p.S249C;ATM p.R1898*;TSC1 p.S282*;KMT2D p.E2186*	4	4
P-0005386	P-0005386-T01-IM5	In-House	DNA	Biopsy	250	900	50	Matched	Primary	Skin	Not Applicable	Tumor	SGAD	Skin Cancer, Non-Melanoma	Sweat Gland Adenocarcinoma										CTCF p.R377C;SETD2 p.Y1038*;MAP3K1 p.S637Mfs*10;MYC Amplification	0	4
P-0005387	P-0005387-T01-IM5	Outside	DNA	Resection	250	787	80	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0005388	P-0005388-T01-IM5	In-House	DNA	Biopsy	250	714	50	Matched	Primary	Lymph node	Not Applicable	Tumor	MLYM	Miscellaneous Brain Tumor	Malignant Lymphoma										DNMT3A p.R882H;TET2 p.Q1828Sfs*5	0	2
P-0005390	P-0005390-T01-IM5	In-House	DNA	Biopsy	250	978	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.Y234N	1	2
P-0005391	P-0005391-T01-IM5	In-House	DNA	Biopsy	250	521	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.L2696*)	Talazoparib,Niraparib(BRCA2 p.L2696*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3A	KRAS p.G12V;ERBB3 p.V104L;ASXL2 p.X19_splice;BRCA2 p.L2696*;KMT2D p.E4245Sfs*33	3	5
P-0005392	P-0005392-T01-IM5	In-House	DNA	Biopsy	250	750	80	Matched	Metastasis	Salivary Gland	Liver	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma					Everolimus,Temsirolimus(MTOR p.I2500M)				LEVEL_4	KDM6A p.Y362*;NOTCH1 p.V1578del;MTOR p.I2500M;LATS1 Deletion;NSD1 Deletion	1	5
P-0005393	P-0005393-T01-IM5	In-House	DNA	Biopsy	250	1083	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)								LEVEL_1	EGFR p.L861Q;TP53 p.G199E;MED12 p.*2178Lext*18;CIC CSMD1-CIC fusion;CSMD1 CSMD1-CIC fusion	1	5
P-0005395	P-0005395-T01-IM5	In-House	DNA	Biopsy	250	1245	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R273C;NBN p.K236*	0	2
P-0005396	P-0005396-T01-IM5	Outside	DNA	Resection	250	377	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;JUN Amplification;MDM2 Amplification	2	3
P-0005397	P-0005397-T01-IM5	In-House	DNA	Resection	250	736	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0005398	P-0005398-T01-IM5	In-House	DNA	Resection	250	605	70	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.I2500N)				LEVEL_4	MTOR p.I2500N	1	1
P-0005399	P-0005399-T01-IM5	In-House	DNA	Resection	250	953	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	AURKA Amplification;ERBB2 Amplification;MYC Amplification	2	3
P-0005400	P-0005400-T01-IM5	Outside	DNA	Resection	250	812	40	Matched	Metastasis	Bile Duct	Lymph Node	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma				Olaparib(ATM p.R805*)					LEVEL_3B	KMT2A p.P773Rfs*8;ARID1A p.D1850Gfs*4;CIC p.P1597Hfs*23;ARID1A p.Q372Afs*28;KMT2D p.G1235Vfs*95;EGFR p.E114K;CASP8 p.V205Gfs*13;BCOR p.S336Lfs*45;NBN p.M83Cfs*9;RAF1 p.S259P;ATM p.R805*;VHL p.F148Lfs*11;AXIN1 p.P345Hfs*69;CDH1 p.P126Rfs*89;DAXX p.E457dup;CASP8 p.F356Lfs*26;MSH2 p.I883Lfs*9	1	17
P-0005404	P-0005404-T02-IM5	In-House	DNA	Biopsy	250	595	60	Matched	Metastasis	Cervix	Lymph Node	Tumor	SCCE	Cervical Cancer	Small Cell Carcinoma of the Cervix				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;SF3B1 p.G742D;KMT2C p.Q1392*;MYC Amplification	1	4
P-0005404	P-0005404-T01-IM5	Outside	DNA	Resection	250	1089	50	Matched	Metastasis	Cervix	Lymph Node	Tumor	SCCE	Cervical Cancer	Small Cell Carcinoma of the Cervix				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;SF3B1 p.G742D;KMT2C p.Q1392*;MYC Amplification	1	4
P-0005409	P-0005409-T02-IM5	Outside	DNA	Resection	250	555	80	Matched	Metastasis	Kidney	Lymph Node	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										ASXL1 p.N859Tfs*8	0	1
P-0005409	P-0005409-T01-IM5	Outside	DNA	Resection	250	606	60	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0005416	P-0005416-T01-IM5	In-House	DNA	Biopsy	250	1806	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	AKT1 p.E17K;ESR1 p.D538G;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	5
P-0005417	P-0005417-T01-IM5	In-House	DNA	Resection	250	882	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.N311Kfs*2)				LEVEL_4	PTEN p.N311Kfs*2;CCND1 Amplification;MCL1 Amplification;PAK1 Amplification	1	4
P-0005418	P-0005418-T01-IM5	In-House	DNA	Resection	250	514	40	Matched	Metastasis	Cervix	Lung	Tumor	CEAS	Cervical Cancer	Cervical Adenosquamous Carcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	PTEN p.R130Q;SMAD4 p.Q116*;KDM6A p.X1246_splice;MED12 p.G1498*;PIK3R1 p.D569_L581delinsE	1	5
P-0005419	P-0005419-T01-IM5	In-House	DNA	Biopsy	190	465	30	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.F270L;TGFBR2 p.V419M;DNMT3A p.R792Pfs*10;PIK3R1 p.L380del;ERBB2 Amplification;FOXA1 Amplification;MCL1 Amplification	2	7
P-0005420	P-0005420-T01-IM5	In-House	DNA	Biopsy	233.7	1101	50	Matched	Metastasis	Bile Duct	Liver	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R282W;CTNNB1 p.S45P;AURKA Amplification;BCL2L1 Amplification;CDKN2A Deletion;CDKN2B Deletion;DNMT3B Amplification;EGFR Amplification;FAT1 Deletion;PBRM1 Deletion;SRC Amplification;TERT Amplification	1	12
P-0005421	P-0005421-T01-IM5	In-House	DNA	Resection	250	1404	30	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Vemurafenib+Atezolizumab+Cobimetinib(BRAF p.V600R)	Encorafenib+Binimetinib,Dabrafenib+Trametinib,Vemurafenib+Cobimetinib(BRAF p.V600R)		Olaparib(ATM p.Q1636*)					LEVEL_1	ATM p.Q1636*;FAT1 p.R2597*;APC p.R2204*;BRAF p.V600R	3	4
P-0005422	P-0005422-T01-IM5	Outside	DNA	Resection	250	650	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										RNF43 p.Q283*;FUBP1 p.Y589Tfs*76;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0005423	P-0005423-T01-IM5	In-House	DNA	Biopsy	250	1282	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)	Talazoparib,Olaparib(BRCA1 p.E23Afs*18)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Niraparib,Rucaparib(BRCA1 p.E23Afs*18)					LEVEL_1	PIK3CA p.E542K;GATA3 p.P408Qfs*97;BRCA1 p.E23Afs*18	4	3
P-0005424	P-0005424-T01-IM5	Outside	DNA	Biopsy	250	706	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion	3	4
P-0005425	P-0005425-T01-IM5	Outside	DNA	Resection	250	438	70	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0005426	P-0005426-T01-IM5	Outside	DNA	Biopsy	250	767	10	Matched	Metastasis	Breast	Peritoneum	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.M438Wfs*37	0	1
P-0005427	P-0005427-T01-IM5	In-House	DNA	Biopsy	250	581	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.G222C)	Tazemetostat(KDM6A p.Q641*)				LEVEL_3B	ERBB2 p.S310F;BCL6 p.R594G;ARID1B p.S1340*;ERBB2 p.G222C;KDM6A p.Q641*;RBM10 p.Q138*;CREBBP p.S1382Yfs*2	3	7
P-0005428	P-0005428-T01-IM5	In-House	DNA	Biopsy	250	542	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR p.L702H;AR p.F877L;PIK3R1 p.T623Gfs*40;MYC Amplification	0	4
P-0005429	P-0005429-T01-IM5	In-House	DNA	Biopsy	250	542	50	Matched	Metastasis	Breast	Peritoneum	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CDH1 p.K653*;MAP2K4 p.X347_splice;NCOR1 p.K532Rfs*2;AKT2 Amplification;CDK6 Amplification;FGFR1 Amplification	1	6
P-0005430	P-0005430-T01-IM5	Outside	DNA	Resection	250	706	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.S1400*;TP53 p.V172F	0	2
P-0005431	P-0005431-T01-IM5	Outside	DNA	Biopsy	142.5	349	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R	1	1
P-0005432	P-0005432-T01-IM5	Outside	DNA	Resection	250	845	10	Matched	Metastasis	Cancer of Unknown Primary	Uterus	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;PIK3CA p.Q546R;FBXW7 p.R689Q;PPP6C p.Y141*	2	4
P-0005434	P-0005434-T01-IM5	In-House	DNA	Resection	250	971	60	Matched	Metastasis	Pancreas	Gallbladder	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										CTNNB1 p.S45F;ARID2 p.Q507*;TP53 p.H179Y;ARID2 p.E74Gfs*11;SMAD4 Deletion	0	5
P-0005435	P-0005435-T01-IM5	In-House	DNA	Resection	250	895	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)								LEVEL_1	TP53 p.R248Q;EGFR p.L861Q	1	2
P-0005436	P-0005436-T02-IM5	In-House	FFPE	Biopsy	250	1079	80	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.E298*;PTEN Deletion;SMAD3 KLF4-SMAD3 fusion;KLF4 KLF4-SMAD3 fusion	1	4
P-0005436	P-0005436-T01-IM5	Outside	DNA	Resection	250	388	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.E298*;PTEN Deletion	1	2
P-0005437	P-0005437-T01-IM5	Outside	DNA	Resection	250	648	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0005438	P-0005438-T01-IM5	Outside	DNA	Resection	250	884	30	Matched	Primary	Kidney	Not Applicable	Tumor	TT	Germ Cell Tumor	Teratoma											0	0
P-0005439	P-0005439-T01-IM5	Outside	DNA	Resection	250	741	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q);Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R273H;ERBB2 p.R678Q;APC p.R876*;APC p.F1491Lfs*16;SOX9 p.E57Gfs*50;BCL2L1 Amplification;BMPR1A Deletion;CDKN2A Deletion;CDKN2B Deletion;MET Amplification	3	10
P-0005440	P-0005440-T01-IM5	In-House	DNA	Biopsy	250	902	70	Matched	Metastasis	Stomach	Liver	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors										TP53 p.E258K	0	1
P-0005441	P-0005441-T01-IM5	Outside	DNA	Resection	250	827	60	Matched	Primary	Testis	Not Applicable	Tumor	EMBCA	Germ Cell Tumor	Embryonal Carcinoma										SOCS1 p.P36Vfs*75	0	1
P-0005442	P-0005442-T01-IM5	In-House	DNA	Resection	250	349	NA	Matched	Metastasis	Bone	Epidural	Tumor	ES	Bone Cancer	Ewing Sarcoma										ARID1B Deletion;LATS1 Deletion;PRKN Deletion	0	3
P-0005443	P-0005443-T01-IM5	In-House	DNA	Resection	250	778	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(CDK12 p.G1271Dfs*23)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.G1271Dfs*23)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;B2M p.X23_splice;TP53 p.Y236C;APC p.R856Nfs*6;AXIN1 p.R723*;B2M p.L15Ffs*41;APC p.R876*;PPP2R1A p.R221W;CTCF p.E691Sfs*30;KMT2D p.G1235Vfs*95;CREBBP p.L524Wfs*6;NOTCH4 p.G1099*;AXIN1 p.A804T;TCF3 p.V357Wfs*37;CREBBP p.Q1209Tfs*25;FBXW7 p.V341Sfs*22;LATS1 p.P237Hfs*6;CDK12 p.G1271Dfs*23;CBL p.P580Lfs*35;TET2 p.Y1148Ifs*4	3	20
P-0005444	P-0005444-T01-IM5	Outside	DNA	Resection	250	471	60	Matched	Metastasis	Retroperitoneum	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R	1	1
P-0005445	P-0005445-T01-IM5	In-House	DNA	Resection	250	317	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.Q563*);Olaparib(CDK12 p.I76Nfs*4)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q563*);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.I76Nfs*4)				LEVEL_1	CDK12 p.Q563*;CDK12 p.I76Nfs*4;KMT2C p.D2461Sfs*3;MCL1 Amplification	4	4
P-0005446	P-0005446-T01-IM5	In-House	DNA	Biopsy	250	946	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Everolimus(TSC2 p.X325_splice)					LEVEL_3B	TP53 p.R213*;TSC2 p.X325_splice;MYC Amplification;NKX3-1 Deletion	1	4
P-0005447	P-0005447-T01-IM5	In-House	DNA	Biopsy	250	455	NA	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										MCL1 Amplification	0	1
P-0005448	P-0005448-T01-IM5	Outside	DNA	Resection	250	812	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAASC	Pancreatic Cancer	Adenosquamous Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0005449	P-0005449-T01-IM5	In-House	DNA	Resection	250	705	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)	Tazemetostat(KDM6A p.R549Sfs*25);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ERBB2 p.S310F;TP53 p.R280T;TP53 p.X332_splice;CDKN1A p.E47*;KMT2D p.E1352*;GPS2 p.X32_splice;RUNX1 p.D110N;STAG2 p.Q140*;KMT2D p.Q3980Pfs*32;KDM6A p.R549Sfs*25;CDKN2A Deletion;CDKN2B Deletion	3	12
P-0005450	P-0005450-T01-IM5	In-House	DNA	Resection	250	645	60	Matched	Metastasis	Testis	Brain	Tumor	TCCA	Germ Cell Tumor	Choriocarcinoma				Everolimus(TSC1 Deletion)					LEVEL_3B	TSC1 Deletion	1	1
P-0005451	P-0005451-T01-IM5	Outside	DNA	Biopsy	250	880	50	Matched	Primary	Lymph Node	Not Applicable	Tumor	NHL	Non-Hodgkin Lymphoma	Non-Hodgkin Lymphoma										RHOA p.G17V;TET2 p.C1271G;TET2 p.X1349_splice	0	3
P-0005452	P-0005452-T01-IM5	In-House	DNA	Biopsy	250	948	20	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										KMT2C p.Q2396*;CCND1 Amplification	0	2
P-0005453	P-0005453-T01-IM5	In-House	DNA	Resection	250	868	80	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										CARD11 Amplification;ETV1 Amplification;RAC1 Amplification	0	3
P-0005454	P-0005454-T01-IM5	Outside	DNA	Resection	250	967	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.R175H;AR Amplification;FGFR1 Amplification;MYC Amplification;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	7
P-0005455	P-0005455-T01-IM5	In-House	DNA	Resection	250	785	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H);Tipifarnib(HRAS p.A59T)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);Trametinib,Cobimetinib(NF1 p.K1299Nfs*10)				LEVEL_3B	MSH6 p.F1088Lfs*5;PTEN p.K267Rfs*9;APC p.T1556Nfs*3;FBXW7 p.R479Q;PIK3CA p.R108H;CCND1 p.P287S;ARID1A p.G801Vfs*32;HRAS p.A59T;TCF7L2 p.L200Sfs*25;TCF7L2 p.K485Sfs*23;B2M p.X23_splice;RECQL4 p.Q847*;SUZ12 p.W361*;PTPRS p.X1440_splice;DNMT3B p.G199Afs*27;NOTCH1 p.G2131Afs*117;U2AF1 p.G222_G223del;SMARCA4 p.Q335Sfs*76;NF1 p.K1299Nfs*10;MLH1 p.E414Rfs*77;AMER1 p.E370Gfs*8;APC p.K993Ffs*11	4	22
P-0005456	P-0005456-T01-IM5	In-House	DNA	Biopsy	250	713	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.Q171*)				LEVEL_4	PTEN p.Q171*;TP53 p.R181P;HLA-A p.E152*	1	3
P-0005457	P-0005457-T01-IM5	Outside	DNA	Biopsy	250	1096	60	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.R273H;CCND1 Amplification;FGF19 Amplification;FGFR3 Amplification	0	4
P-0005458	P-0005458-T01-IM5	Outside	DNA	Resection	250	888	20	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.C135F;VHL p.D121Y	0	2
P-0005459	P-0005459-T01-IM5	Outside	DNA	Resection	250	907	60	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.X237_splice;BMPR1A Deletion;ZFHX3 Deletion	0	3
P-0005460	P-0005460-T01-IM5	In-House	DNA	Resection	250	889	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R282W;SPOP p.F102V;MYC Amplification	0	3
P-0005461	P-0005461-T02-IM5	In-House	DNA	Resection	250	1517	40	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(CDK5RAP2 BRAF-CDK5RAP2 fusion);Trametinib,Cobimetinib(BRAF BRAF-CDK5RAP2 fusion)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3A	CDKN2A p.R80*;CDK5RAP2 BRAF-CDK5RAP2 fusion;BRAF BRAF-CDK5RAP2 fusion	3	3
P-0005462	P-0005462-T01-IM5	In-House	DNA	Resection	250	680	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NOTCH1 p.M2318Tfs*34;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0005463	P-0005463-T01-IM5	In-House	DNA	Resection	250	716	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TBX3 p.P38Rfs*7;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0005464	P-0005464-T01-IM5	In-House	DNA	Biopsy	250	896	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Olaparib(BRIP1 p.I983Nfs*19)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;TP53 p.M246V;APC p.S1100Vfs*19;BRIP1 p.I983Nfs*19	3	5
P-0005465	P-0005465-T01-IM5	In-House	DNA	Resection	159.3	710	40	Matched	Metastasis	Upper Extremity	Lung	Tumor	CHS	Bone Cancer	Chondrosarcoma										TP53 p.X125_splice;KDM5A Amplification;KRAS Amplification	0	3
P-0005466	P-0005466-T01-IM5	Outside	DNA	Resection	250	889	80	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma				Olaparib(CHEK2 Deletion)					LEVEL_3B	CHEK2 Deletion	1	1
P-0005467	P-0005467-T01-IM5	In-House	DNA	Resection	250	867	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.E746_A750del;CDK4 Amplification;FOXA1 Amplification;MDM2 Amplification;MYCL Amplification;NKX2-1 Amplification	3	6
P-0005468	P-0005468-T01-IM5	In-House	DNA	Resection	250	732	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;PIK3CA p.E542K;TP53 p.Y205F	2	3
P-0005469	P-0005469-T01-IM5	In-House	DNA	Resection	250	935	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	GATA3 p.R330Efs*22;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MCL1 Amplification;MDM2 Amplification;PPM1D Amplification	2	7
P-0005470	P-0005470-T01-IM5	In-House	DNA	Resection	250	1070	80	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										SF3B1 p.R625C;GNA11 p.Q209L	0	2
P-0005471	P-0005471-T01-IM5	In-House	DNA	Biopsy	250	1160	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T18Afs*15)				LEVEL_4	TP53 p.R175H;APC p.L180*;SMAD4 p.T59Gfs*15;CDKN2A p.T18Afs*15;MYC Amplification;PTPRD Deletion;RASA1 Deletion	1	7
P-0005472	P-0005472-T01-IM5	In-House	DNA	Biopsy	250	389	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	Lapatinib(EGFR Amplification)				LEVEL_3B	TP53 p.F19Kfs*24;CDK4 Amplification;EGFR Amplification;MDM4 Amplification	2	4
P-0005473	P-0005473-T01-IM5	In-House	DNA	Resection	250	915	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R342*	0	1
P-0005474	P-0005474-T02-IM5	In-House	FFPE	Biopsy	250	1187	10	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0005474	P-0005474-T01-IM5	In-House	DNA	Resection	250	721	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0005475	P-0005475-T01-IM5	In-House	DNA	Resection	250	749	10	Matched	Primary	Cervix	Not Applicable	Tumor	MCCE	Cervical Cancer	Mixed Cervical Carcinoma										FBXW7 p.R465C;U2AF1 p.R156H;GATA3 p.M422Dfs*85;MYCN Amplification	0	4
P-0005475	P-0005475-T02-IM5	In-House	DNA	Resection	250	702	80	Matched	Primary	Cervix	Not Applicable	Tumor	MCCE	Cervical Cancer	Mixed Cervical Carcinoma										TP53 p.G244S;U2AF1 p.R156H;GATA3 p.M422Dfs*85;MYCN Amplification	0	4
P-0005476	P-0005476-T01-IM5	Outside	DNA	Resection	250	540	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	TP53 p.G245C;CDKN2A p.R80*;CCND2 Amplification;CCNE1 Amplification;KDM5A Amplification;KRAS Amplification;SMARCA4 Deletion;STK11 Deletion	1	8
P-0005477	P-0005477-T01-IM5	Outside	DNA	Resection	250	1309	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.H61N);Lapatinib(EGFR Amplification)				LEVEL_3B	PTEN p.H61N;EGFR Amplification;MDM2 Amplification;RB1 Deletion	3	4
P-0005478	P-0005478-T01-IM5	Outside	DNA	Resection	250	611	60	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;FGFR4 Amplification;MDM2 Amplification	2	3
P-0005479	P-0005479-T01-IM5	In-House	DNA	Resection	250	859	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TP53 p.R282W;SMAD4 p.X436_splice;RB1 p.T140Nfs*6;DDR2 Amplification;ERBB2 Amplification	2	6
P-0005480	P-0005480-T01-IM5	In-House	DNA	Biopsy	250	715	20	Matched	Primary	Abdomen	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										B2M p.M1?;PIM1 p.G28D;MDM4 Amplification	0	3
P-0005481	P-0005481-T01-IM5	In-House	DNA	Resection	250	830	70	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)				Imatinib(PDGFRA p.D842V)			LEVEL_1	PDGFRA p.D842V	2	1
P-0005482	P-0005482-T01-IM5	In-House	DNA	Biopsy	250	721	20	Matched	Metastasis	Cervix	Lung	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;CCNE1 Amplification	1	2
P-0005483	P-0005483-T01-IM5	In-House	DNA	Biopsy	250	848	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44Sfs*76)				LEVEL_2	TP53 p.L194R;ERBB2 p.Y772_A775dup;CDKN2A p.Y44Sfs*76;MYC Amplification	3	4
P-0005483	P-0005483-T02-IM5	In-House	FFPE	Biopsy	250	1001	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44Sfs*76)				LEVEL_2	TP53 p.L194R;ERBB2 p.Y772_A775dup;APC p.Q2117*;CDKN2A p.Y44Sfs*76;MYC Amplification	3	5
P-0005484	P-0005484-T01-IM5	Outside	DNA	Biopsy	250	714	80	Matched	Primary	Liver	Not Applicable	Tumor	FIBS	Soft Tissue Sarcoma	Fibrosarcoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12R;TP53 p.R213Q;KDM6A p.C343Lfs*16;CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification;NTRK1 Amplification	2	7
P-0005485	P-0005485-T01-IM5	Outside	DNA	Resection	250	894	70	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma										GLI1 Amplification	0	1
P-0005486	P-0005486-T01-IM5	Outside	DNA	Resection	250	629	50	Unmatched	Primary	Kidney	Not Applicable	Tumor	MRC	Renal Cell Carcinoma	Renal Medullary Carcinoma											0	0
P-0005487	P-0005487-T01-IM5	In-House	DNA	Biopsy	250	833	20	Matched	Metastasis	Transverse Colon	Paracolic Gutter	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;SMAD4 p.X483_splice;NOTCH3 p.A1802Gfs*8;RNF43 p.A115Tfs*11;AXIN2 Deletion;PTEN Deletion	4	6
P-0005488	P-0005488-T01-IM5	Outside	DNA	Biopsy	250	755	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_1	KRAS p.G12D;TP53 p.L201Cfs*46;ERBB2 Amplification;MYC Amplification	3	4
P-0005489	P-0005489-T01-IM5	In-House	DNA	Biopsy	243.54	739	10	Matched	Metastasis	Bladder	liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S76*)	Tazemetostat(KDM6A p.H1124Yfs*7)				LEVEL_3B	PIK3CA p.E542K;ARID1A p.Q479*;HIST1H3B p.E106K;BRCA2 p.S76*;KDM6A p.H1124Yfs*7	3	5
P-0005490	P-0005490-T01-IM5	Outside	DNA	Biopsy	166.68	491	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.I767M)	Tazemetostat(KDM6A p.N638*)				LEVEL_3B	ERBB2 p.I767M;TP53 p.S127Y;FBXW7 p.S546L;KMT2D p.Q2634*;GPS2 p.Q179*;NCOR1 p.S2318*;KDM6A p.N638*;MYCL Amplification	2	8
P-0005492	P-0005492-T01-IM5	Outside	DNA	Biopsy	183.33	701	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma		Crizotinib(MET Amplification)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Cabozantinib(MET Amplification)	GSK2636771,AZD8186(PTEN p.X343_splice);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.W290C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.Y220C;NFE2L2 p.R34Q;PTEN p.X343_splice;FGFR2 p.W290C;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;MET Amplification	6	8
P-0005493	P-0005493-T01-IM5	In-House	Other	Cytology	186	1474	NA	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.X331_splice;RB1 p.R787*;SMARCA4 GCDH-SMARCA4 fusion;GCDH GCDH-SMARCA4 fusion;CIC POLD1-CIC fusion;POLD1 POLD1-CIC fusion	2	7
P-0005494	P-0005494-T01-IM5	In-House	DNA	Biopsy	167.2	314	40	Matched	Metastasis	Kidney	Pancreas	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0005495	P-0005495-T01-IM5	In-House	DNA	Cytology	173.79	671	50	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)	Everolimus(TSC1 p.Y195*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	ESR1 p.D538G;TSC1 p.Y195*;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MYC Amplification	3	7
P-0005496	P-0005496-T01-IM5	In-House	DNA	Biopsy	250	915	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R248P;BCL6 Amplification;CCND2 Amplification;CDKN2A Deletion;CDKN2B Deletion;KDM5A Amplification;KRAS Amplification;MYCL Amplification;PIK3CA Amplification	1	9
P-0005497	P-0005497-T01-IM5	Outside	DNA	Biopsy	250	664	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.V274F;TP53 p.E271Q;ARID1A p.S2249*;GPS2 p.*328Sext*?	0	4
P-0005498	P-0005498-T01-IM5	Outside	DNA	Resection	128.52	594	40	Matched	Primary	Appendix	Not Applicable	Tumor	AWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumor of the Appendix											0	0
P-0005499	P-0005499-T01-IM5	In-House	DNA	Resection	250	893	70	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTPRT p.R1359*;PIK3R2 p.L179Rfs*147;MED12 p.X34_splice;NRAS p.Q61K;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0005500	P-0005500-T01-IM5	In-House	DNA	Biopsy	133.1	501	30	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N2556Mfs*92);Everolimus(TSC2 p.P961Tfs*23)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L16Pfs*9)				LEVEL_3B	JAK1 p.K860Nfs*16;PTEN p.K267Rfs*9;PBRM1 p.W1157*;ARID1B p.K1130Sfs*68;BRCA2 p.N2556Mfs*92;TSC2 p.P961Tfs*23;ARID1A p.P224Rfs*8;CDKN2A p.L16Pfs*9	4	8
P-0005501	P-0005501-T01-IM5	In-House	DNA	Resection	250	1133	30	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Olaparib(CDK12 p.Y161Wfs*38)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Y161Wfs*38)				LEVEL_3B	TP53 p.C124*;CDK12 p.Y161Wfs*38	2	2
P-0005502	P-0005502-T01-IM5	In-House	DNA	Resection	250	1267	20	Matched	Metastasis	Descending Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R213*;ERBB2 Amplification	2	2
P-0005504	P-0005504-T01-IM5	Outside	DNA	Cytology	250	488	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.N771_H773dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.N771_H773dup)			LEVEL_3A	EGFR p.N771_H773dup;TP53 p.M246L;EGFR Amplification;FOXA1 Amplification;NKX2-1 Amplification	1	5
P-0005505	P-0005505-T01-IM5	In-House	DNA	Resection	250	1005	60	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557R)								LEVEL_1	KIT p.W557R	1	1
P-0005506	P-0005506-T01-IM5	In-House	DNA	Biopsy	104.76	523	40	Matched	Metastasis	Oropharynx	Lymph Node	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				AZD5363(AKT1 p.E17K);Olaparib(CHEK2 p.K317*)					LEVEL_3B	AKT1 p.E17K;CHEK2 p.K317*;AKT1 Amplification;FGFR3 Amplification	2	4
P-0005507	P-0005507-T01-IM5	In-House	DNA	Resection	250	723	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Olaparib(CHEK2 p.K255Sfs*20)					LEVEL_3B	FANCA p.R880*;VHL p.X114_splice;CHEK2 p.K255Sfs*20;PBRM1 p.M658Nfs*7	1	4
P-0005508	P-0005508-T01-IM5	Outside	DNA	Biopsy	142.02	694	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537N)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3A	ESR1 p.Y537N;FOXO1 p.R267*;CCND1 Amplification;FGF19 Amplification;FGFR3 Amplification;FLT3 Amplification;MDM2 Amplification;MYC Amplification	2	8
P-0005509	P-0005509-T01-IM5	In-House	DNA	Resection	250	1012	70	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Olaparib(CHEK2 p.Q487*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	TP53 p.R248W;NOTCH2 p.Q1870*;FAT1 p.Q2884*;FAT1 p.R191*;HIST1H3G p.P44S;TGFBR1 p.Q425*;NOTCH1 p.X1339_splice;TP53 p.R337S;CHEK2 p.Q487*;CDKN2A p.R58*	2	10
P-0005510	P-0005510-T01-IM5	In-House	DNA	Resection	250	1384	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.D53Gfs*110	2	2
P-0005511	P-0005511-T01-IM5	In-House	DNA	Resection	250	1246	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.N238S)	Olaparib(CDK12 p.X988_splice)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.X988_splice)				LEVEL_3A	TP53 p.P278S;TP53 p.R213L;ERCC2 p.N238S;RB1 p.X830_splice;EGFR p.T785S;CDKN1B p.G72D;CDK12 p.X988_splice;RB1 p.X731_splice;MYCL Amplification	3	9
P-0005511	P-0005511-T02-IM5	Outside	DNA	Resection	250	1101	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.N238S)	Olaparib(CDK12 p.X988_splice)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.X988_splice)				LEVEL_3A	TP53 p.P278S;TP53 p.R213L;ERCC2 p.N238S;RB1 p.X830_splice;EGFR p.T785S;CDKN1B p.G72D;CDK12 p.X988_splice;RB1 p.X731_splice	3	8
P-0005512	P-0005512-T01-IM5	Outside	DNA	Resection	250	1159	NA	Matched	Primary	Lymph node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS				Enasidenib(IDH2 p.R172G)					LEVEL_3B	RHOA p.G17V;IDH2 p.R172G;DNMT3A p.X646_splice;TET2 p.R1216*	1	4
P-0005513	P-0005513-T01-IM5	In-House	DNA	Biopsy	182.34	810	30	Matched	Metastasis	Kidney	Lung	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma											0	0
P-0005514	P-0005514-T01-IM5	In-House	DNA	Biopsy	165.4	755	50	Matched	Primary	Bone	Not Applicable	Tumor	SCHW	Nerve Sheath Tumor	Schwannoma										NF2 p.X482_splice;NF2 p.E537_Q538delinsD*	0	2
P-0005515	P-0005515-T01-IM5	Outside	DNA	Resection	250	769	20	Matched	Primary	Testis	Not Applicable	Tumor	BEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0005516	P-0005516-T01-IM5	Outside	DNA	Cytology	250	699	60	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.I195T;CCNE1 Amplification;ERBB2 Amplification	1	3
P-0005517	P-0005517-T01-IM5	In-House	DNA	Resection	250	958	70	Matched	Primary	Epidural	Not Applicable	Tumor	SECOS	Bone Cancer	Secondary Osteosarcoma										RB1 p.V450Sfs*13;ATRX Deletion;JUN Amplification	0	3
P-0005518	P-0005518-T01-IM5	In-House	DNA	Biopsy	250	824	40	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.P190T	1	2
P-0005519	P-0005519-T01-IM5	In-House	DNA	Resection	250	582	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma											0	0
P-0005520	P-0005520-T02-IM5	In-House	DNA	Biopsy	250	151	NA	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										ARID1A p.W1498*;MPL p.F517C	0	2
P-0005521	P-0005521-T01-IM5	Outside	DNA	Resection	250	714	30	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer											0	0
P-0005522	P-0005522-T01-IM5	Outside	DNA	Resection	250	656	40	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.E203K);Everolimus(TSC1 p.X122_splice)					LEVEL_3B	MAP2K1 p.E203K;TP53 p.C135S;TSC1 p.X122_splice;APC p.M1383Vfs*2	2	4
P-0005523	P-0005523-T01-IM5	In-House	DNA	Resection	250	990	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Trametinib(BRAF p.K601E);Everolimus(TSC1 p.X344_splice)	PLX8394(BRAF p.K601E)				LEVEL_3B	BRAF p.K601E;TSC1 p.X344_splice	3	2
P-0005524	P-0005524-T03-IM5	Outside	FFPE	Biopsy	148.2	690	70	Matched	Metastasis	Leg	Lung	Tumor	PLLS	Soft Tissue Sarcoma	Pleomorphic Liposarcoma					Trametinib,Cobimetinib(NF1 p.Q1336*)				LEVEL_4	TP53 p.C141G;NF1 p.Q1336*	1	2
P-0005525	P-0005525-T01-IM5	In-House	DNA	Resection	250	476	30	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer										TP53 p.R273C;CREBBP p.Y1828*;MEN1 p.P497Efs*34;TBX3 p.H626Tfs*6;MEN1 p.I85Yfs*32	0	5
P-0005526	P-0005526-T01-IM5	In-House	DNA	Biopsy	193	293	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;ARID1B p.N1052Qfs*2;MAP3K1 p.R162Lfs*2	2	3
P-0005527	P-0005527-T01-IM5	Outside	DNA	Biopsy	116.6	701	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X2806_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;EPHA3 p.X692_splice;ATM p.X2806_splice;RBM10 p.E576*	2	4
P-0005528	P-0005528-T01-IM5	Outside	DNA	Resection	250	916	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V73Wfs*50;APC p.E1353Dfs*21;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	0	6
P-0005529	P-0005529-T01-IM5	Outside	DNA	Resection	250	856	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K3416Nfs*11)					LEVEL_1	BRAF p.V600E;TGFBR2 p.K128Afs*3;CIC p.P509Hfs*14;B2M p.X23_splice;BRCA2 p.K3416Nfs*11;ERCC3 p.R452*;CEBPA p.L146Cfs*14;AXIN2 p.K642Rfs*47;KMT2D p.E4650Gfs*12;FAT1 p.P1877Lfs*20;AMER1 p.L546Cfs*16;PARP1 p.S507Kfs*14;CUL1 EZH2-CUL1 fusion;EZH2 EZH2-CUL1 fusion	4	14
P-0005530	P-0005530-T02-IM5	Outside	DNA	Biopsy	157.3	1334	NA	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Olaparib(SYNRG CDK12-SYNRG fusion);Olaparib(CDK12 CDK12-SYNRG fusion)	Trametinib,Cobimetinib(NF1 p.X96_splice);Pembrolizumab,Nivolumab,Cemiplimab(SYNRG CDK12-SYNRG fusion);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 CDK12-SYNRG fusion)				LEVEL_3B	NF1 p.X96_splice;STK11 p.X148_splice;KEAP1 p.E134Rfs*5;ERBB2 Amplification;SYNRG CDK12-SYNRG fusion;CDK12 CDK12-SYNRG fusion	6	6
P-0005531	P-0005531-T01-IM5	Outside	DNA	Resection	250	821	60	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R213*;CCND3 Amplification;CCNE1 Amplification;FLCN Deletion;MAP2K4 Deletion;NCOR1 Deletion;PAK1 Amplification;VEGFA Amplification	0	8
P-0005532	P-0005532-T01-IM5	Outside	DNA	Resection	250	997	10	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma										TP53 p.Y220C	0	1
P-0005533	P-0005533-T01-IM5	Outside	DNA	Biopsy	250	896	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.D770_N771insG)			Erlotinib,Gefitinib,Afatinib(EGFR p.D770_N771insG)			LEVEL_3A	TP53 p.C176S;EGFR p.D770_N771insG;FOXA1 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NKX2-1 Amplification	1	7
P-0005534	P-0005534-T01-IM5	Outside	DNA	Biopsy	250	910	NA	Matched	Metastasis	Cancer of Unknown Primary	Mediastinum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Tazemetostat(SMARCB1 p.R374Q)				LEVEL_4	TET2 p.R550*;MGA p.S1885*;SMARCB1 p.R374Q	1	3
P-0005535	P-0005535-T01-IM5	Outside	DNA	Biopsy	224.37	910	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.F254_N256delinsY;HIST1H3B p.E106K;TP53 p.P75Yfs*68;CDKN1B p.G97Vfs*22;FOXA1 Amplification;TET2 Deletion;SKINT1L CDKN2C-SKINTL fusion;CDKN2C CDKN2C-SKINTL fusion	0	8
P-0005537	P-0005537-T01-IM5	In-House	DNA	Cytology	137.16	859	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)	Neratinib(ERBB2 p.G778_P780dup)						LEVEL_2	ERBB2 p.G778_P780dup;TP53 p.C238G	2	2
P-0005538	P-0005538-T01-IM5	Outside	DNA	Resection	250	1008	70	Matched	Metastasis	Liver	Brain	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(BICC1 FGFR2-BICC1 fusion);Pemigatinib(FGFR2 FGFR2-BICC1 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(BICC1 FGFR2-BICC1 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-BICC1 fusion)						LEVEL_1	TP53 p.P13Lfs*2;FBXW7 Deletion;BICC1 FGFR2-BICC1 fusion;FGFR2 FGFR2-BICC1 fusion	4	4
P-0005539	P-0005539-T01-IM5	Outside	DNA	Biopsy	250	1071	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lapatinib(EGFR Amplification)				LEVEL_3B	CDK4 Amplification;EGFR Amplification;ETV1 Amplification;JUN Amplification;MCL1 Amplification;MDM2 Amplification;RAC1 Amplification	3	7
P-0005540	P-0005540-T01-IM5	Outside	DNA	Resection	250	821	30	Matched	Primary	Kidney	Not Applicable	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma											0	0
P-0005541	P-0005541-T01-IM5	In-House	DNA	Resection	250	1004	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	KRAS p.G13C;BIRC3 p.X541_splice	1	2
P-0005542	P-0005542-T01-IM5	In-House	DNA	Biopsy	250	1022	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.H272Sfs*26)				LEVEL_4	TP53 p.R248W;PTEN p.H272Sfs*26;RB1 Deletion	1	3
P-0005543	P-0005543-T02-IM5	In-House	DNA	Resection	250	635	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					PLX8394(BRAF p.G469A)				LEVEL_4	TP53 p.R158L;BRAF p.G469A;MGA p.Q604*;TP53 p.G154Afs*16	1	4
P-0005544	P-0005544-T01-IM5	In-House	DNA	Resection	250	967	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A	1	1
P-0005544	P-0005544-T02-IM5	In-House	DNA	Resection	250	881	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R273L;RBM10 p.G280*	1	3
P-0005545	P-0005545-T01-IM5	In-House	DNA	Resection	250	746	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ARMS	Soft Tissue Sarcoma	Alveolar Rhabdomyosarcoma										FGFR4 Amplification	0	1
P-0005546	P-0005546-T01-IM5	In-House	DNA	Biopsy	250	861	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.T230Hfs*9;KRAS Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0005547	P-0005547-T02-IM5	In-House	DNA	Biopsy	250	825	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					GSK2636771,AZD8186(PTEN p.Y16Dfs*9)				LEVEL_4	PTEN p.Y16Dfs*9;AXIN1 Deletion;B2M Deletion;MGA Deletion;MYCN Amplification;SMAD3 Deletion;TP53 Deletion	1	7
P-0005548	P-0005548-T01-IM5	In-House	DNA	Resection	250	786	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.Q56P);Olaparib(PALB2 p.R753*);Olaparib(CDK12 p.G1461Afs*38)	GSK2636771,AZD8186(PTEN p.R233*);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.G1461Afs*38)				LEVEL_3B	MAP2K1 p.Q56P;MSH6 p.F1088Lfs*5;PIK3CB p.E1051K;APC p.R1450*;SMAD4 p.R361H;ARID1A p.Q802Sfs*15;APC p.R232*;ASXL2 p.R312*;PTEN p.R233*;EP300 p.H2324Pfs*55;ASXL2 p.R357*;B2M p.T93Hfs*2;MRE11 p.N511Ifs*13;PIK3R1 p.L573P;PALB2 p.R753*;BCOR p.E994*;MSH6 p.D936*;CDK12 p.G1461Afs*38	5	18
P-0005549	P-0005549-T01-IM5	Outside	DNA	Resection	250	979	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer					GSK2636771,AZD8186(PTEN p.T319Kfs*24)				LEVEL_4	PTEN p.T319Kfs*24;TP53 p.H214R;ARID1A p.Q1363*;APC p.R564*	1	4
P-0005550	P-0005550-T01-IM5	In-House	DNA	Resection	250	1056	10	Matched	Primary	Mediastinum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005551	P-0005551-T02-IM5	In-House	DNA	Resection	250	774	60	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma				Everolimus(TSC1 p.K1118Rfs*16)					LEVEL_3B	LATS2 p.X633_splice;TSC1 p.K1118Rfs*16	1	2
P-0005552	P-0005552-T01-IM5	In-House	DNA	Resection	250	667	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ASXL1 p.E391Dfs*71	0	1
P-0005553	P-0005553-T01-IM5	In-House	DNA	Biopsy	250	1033	60	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.Q52Hfs*71;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MYC Amplification	3	7
P-0005553	P-0005553-T02-IM5	In-House	FFPE	Cytology	250	832	20	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Trametinib,Cobimetinib(BRAF MRPS33-BRAF fusion);Trametinib,Cobimetinib(MRPS33 MRPS33-BRAF fusion)					LEVEL_1	EGFR p.E746_A750del;TP53 p.Q52Hfs*71;BRAF MRPS33-BRAF fusion;MRPS33 MRPS33-BRAF fusion	3	4
P-0005554	P-0005554-T01-IM5	In-House	DNA	Cytology	204.126	952	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										STK11 p.G242R;KEAP1 p.G523V;FOXA1 Amplification;MYC Amplification;NKX2-1 Amplification	0	5
P-0005555	P-0005555-T01-IM5	In-House	DNA	Biopsy	250	1119	60	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.E98Gfs*21);Olaparib(CDK12 p.L635Ffs*20)			Palbociclib,Abemaciclib(CDK4 Amplification)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.E98Gfs*21);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L635Ffs*20)				LEVEL_1	CDK12 p.E98Gfs*21;CDK12 p.L635Ffs*20;ANKRD11 Deletion;AR Amplification;CCND1 Amplification;CDK4 Amplification;FANCA Deletion;FGF19 Amplification;MDM4 Amplification;PPM1D Amplification;VEGFA Amplification	5	11
P-0005556	P-0005556-T01-IM5	In-House	DNA	Resection	250	978	10	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion)			BLU-667,Cabozantinib,Vandetanib(RET CCDC6-RET fusion);BLU-667,Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion)					LEVEL_1	RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	4	2
P-0005557	P-0005557-T01-IM5	In-House	DNA	Resection	250	762	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0005558	P-0005558-T01-IM5	In-House	DNA	Resection	250	807	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice)				LEVEL_4	KRAS p.G12V;TP53 p.Y220H;SMAD4 p.R38Kfs*4;CDKN2A p.X51_splice;CDKN2A p.X51_splice	3	5
P-0005560	P-0005560-T01-IM5	In-House	DNA	Resection	250	1004	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(CDK12 p.N474Ifs*8)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.N474Ifs*8)				LEVEL_1	SUFU p.A25Gfs*23;BRAF p.V600E;NCOR1 p.E529Kfs*26;RNF43 p.G659Vfs*41;DNMT3A p.P59Rfs*13;FBXW7 p.R367*;KMT2C p.K3604Rfs*26;NBN p.L654Afs*5;TBX3 p.Q316Tfs*11;CDK12 p.N474Ifs*8;SETD2 p.N1396Mfs*16;STK11 p.F255Ifs*11	5	12
P-0005561	P-0005561-T01-IM5	Outside	DNA	Resection	250	491	40	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132L)						LEVEL_3A	IDH1 p.R132L;ERBB3 Amplification;FGFR4 Amplification	1	3
P-0005562	P-0005562-T01-IM5	In-House	DNA	Resection	250	982	40	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	ERBB2 p.Y772_A775dup;TP53 p.L201Cfs*46	2	2
P-0005563	P-0005563-T02-IM5	In-House	DNA	Biopsy	250	979	NA	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.Y220C;ARID1A p.D1850Gfs*4;DAXX p.E457del;MDM2 Amplification	2	5
P-0005564	P-0005564-T01-IM5	Outside	DNA	Resection	250	667	60	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Olaparib(ATM p.S214Pfs*16);Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P104L);Everolimus(TSC1 p.X797_splice);Everolimus(TSC2 p.R1451Pfs*73);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.R3237Gfs*12)	GSK2636771,AZD8186(PTEN p.R130G);GSK2636771,AZD8186(PTEN p.Y155C)				LEVEL_3B	ARID1A p.M1564*;NCOR1 p.E529Kfs*26;PTEN p.R130G;RNF43 p.P660Sfs*87;PPP2R1A p.R183W;ASXL1 p.G1376Vfs*74;HNF1A p.P291Qfs*51;KMT2D p.P647Hfs*283;ATM p.S214Pfs*16;KMT2C p.I1344*;PTEN p.Y155C;PTCH1 p.R1308Efs*64;PPM1D p.N512Ifs*2;MSH6 p.R361H;PMS1 p.X322_splice;PIK3CA p.P104L;TSC1 p.X797_splice;CTCF p.X667_splice;ZFHX3 p.R2284*;MED12 p.V24A;FUBP1 p.G395Efs*5;ARID1A p.H902Pfs*14;KMT2D p.P1460Hfs*46;CTCF p.T204Qfs*18;TSC2 p.R1451Pfs*73;BRCA2 p.R3237Gfs*12;RNF43 p.G384Afs*35;FOXA1 p.S304Afs*17	8	28
P-0005565	P-0005565-T01-IM5	In-House	DNA	Biopsy	250	742	NA	Matched	Primary	Skin	Not Applicable	Tumor	TLL	T-Lymphoblastic Leukemia/Lymphoma	T-Lymphoblastic Leukemia/Lymphoma										RHOA p.T19I;BRAF p.G464E	0	2
P-0005566	P-0005566-T01-IM5	In-House	DNA	Resection	250	793	20	Matched	Primary	Brain	Not Applicable	Tumor	ATM	CNS Cancer	Atypical Meningioma										NF2 p.Y192*	0	1
P-0005567	P-0005567-T01-IM5	In-House	DNA	Resection	250	838	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.V157F;TP53 p.S241Y;CDK4 Amplification	1	3
P-0005568	P-0005568-T01-IM5	In-House	DNA	Resection	250	998	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.A161D;SMAD4 p.Q366*;STK11 p.X199_splice	1	4
P-0005569	P-0005569-T01-IM5	In-House	DNA	Biopsy	250	988	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C	0	1
P-0005570	P-0005570-T01-IM5	In-House	DNA	Biopsy	244.343	529	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AKT1 p.Q79K;KMT2C p.N3374Ifs*10	0	2
P-0005571	P-0005571-T01-IM5	In-House	DNA	Resection	250	291	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R213*;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0005572	P-0005572-T03-IM5	Outside	DNA	Biopsy	250	895	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	1	4
P-0005573	P-0005573-T01-IM5	In-House	DNA	Resection	250	829	NA	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)						LEVEL_1	BAP1 p.Q28*;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	6	3
P-0005574	P-0005574-T01-IM5	In-House	DNA	Cytology	250	707	10	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K;RBM10 p.Q525*	2	2
P-0005575	P-0005575-T01-IM5	Outside	DNA	Cytology	140.16	207	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R213*;KRAS Amplification	1	3
P-0005576	P-0005576-T01-IM5	In-House	DNA	Biopsy	250	779	60	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										CCND1 Amplification;FGF19 Amplification;PPM1D Amplification;SDHA Deletion	0	4
P-0005577	P-0005577-T01-IM5	Outside	DNA	Resection	250	569	30	Matched	Primary	Uterus	Not Applicable	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma										FBXW7 p.R465H;TP53 p.H193R;PIK3R1 p.T576del	0	3
P-0005578	P-0005578-T01-IM5	Outside	DNA	Biopsy	250	827	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.S241F;CARD11 Amplification;CDKN2A Deletion;CDKN2B Deletion;PDGFRA Amplification;PTPRD Deletion	1	6
P-0005579	P-0005579-T01-IM5	Outside	DNA	Biopsy	140.295	936	30	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.R273L	2	2
P-0005580	P-0005580-T01-IM5	In-House	DNA	Resection	250	661	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0005581	P-0005581-T01-IM5	Outside	DNA	Resection	250	474	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0005582	P-0005582-T01-IM5	In-House	DNA	Resection	250	811	90	Matched	Metastasis	Uterus	Pelvis	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										RB1 p.I799Ffs*11;TNFRSF14 Deletion	0	2
P-0005583	P-0005583-T01-IM5	In-House	DNA	Resection	250	864	NA	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;B2M p.N41Kfs*16;CREBBP p.P1947Tfs*19;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion;BIRC3 SIK3-BIRC3 fusion;SIK3 SIK3-BIRC3 fusion	3	8
P-0005584	P-0005584-T01-IM5	In-House	DNA	Resection	250	800	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.X183_splice);Everolimus(TSC2 Deletion)	Trametinib,Cobimetinib(NF1 p.G2166Afs*12)				LEVEL_3B	TP53 p.R175H;BRCA1 p.X183_splice;RB1 p.I324Mfs*17;NF1 p.G2166Afs*12;AXIN1 Deletion;ETV1 Amplification;GRIN2A Deletion;MCL1 Amplification;MYC Amplification;NTRK1 Amplification;RAC1 Amplification;TSC2 Deletion	3	12
P-0005585	P-0005585-T01-IM5	In-House	DNA	Resection	250	788	40	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma					Trametinib,Cobimetinib(NF1 p.L1927Ffs*15)				LEVEL_4	TP53 p.D259Rfs*5;NF1 p.L1927Ffs*15	1	2
P-0005586	P-0005586-T01-IM5	In-House	DNA	Biopsy	191.68	856	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.P278S;ARID1A p.S90Pfs*11	0	2
P-0005587	P-0005587-T01-IM5	In-House	DNA	Biopsy	248.3	387	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G)					LEVEL_3B	KMT2D p.Q2553*;PIK3CA p.E545G;FAT1 p.Q2830*;TGFBR1 p.S360*	1	4
P-0005588	P-0005588-T01-IM5	In-House	DNA	Biopsy	250	380	50	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 p.Q104*;ATRX Deletion;RB1 Deletion	0	3
P-0005589	P-0005589-T01-IM5	In-House	DNA	Resection	250	751	30	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1065Y)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)	Cetuximab,Panitumumab(KRAS p.G12R)			LEVEL_3B	KRAS p.G12R;TP53 p.R273C;APC p.R876*;APC p.P1453Lfs*20;SMAD4 p.V335Afs*7	2	5
P-0005590	P-0005590-T01-IM5	In-House	DNA	Biopsy	114.6	97	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0005591	P-0005591-T01-IM5	In-House	DNA	Resection	250	771	20	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;SMAD4 p.R361H	1	2
P-0005592	P-0005592-T01-IM5	In-House	DNA	Cytology	118.872	681	30	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;ARID1A p.S11Afs*91;ARID1A p.S733*	1	3
P-0005593	P-0005593-T01-IM5	Outside	DNA	Resection	250	499	60	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.V87_W88ins*	0	1
P-0005594	P-0005594-T01-IM5	In-House	DNA	Biopsy	250	1009	30	Matched	Metastasis	Rectum	Liver	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										PRKN p.E49*;AMER1 p.E702*	0	2
P-0005595	P-0005595-T01-IM5	Outside	DNA	Resection	250	1241	80	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma											0	0
P-0005596	P-0005596-T01-IM5	In-House	DNA	Biopsy	250	937	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	FANCA Deletion;FOXO1 Deletion;PTEN Deletion;RB1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0005597	P-0005597-T01-IM5	In-House	DNA	Resection	250	918	10	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	KRAS p.G12V;SMAD4 p.R361C;SMAD4 p.P356L;CDKN2A p.H83Y	2	4
P-0005598	P-0005598-T01-IM5	In-House	DNA	Resection	250	1046	50	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										NF2 p.Q362*;ARID2 p.S218Ffs*13	0	2
P-0005599	P-0005599-T01-IM5	Outside	DNA	Resection	250	885	60	Matched	Primary	Ovary	Not Applicable	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor										TP53 p.V157F;CCND2 Amplification;KDM5A Amplification	0	3
P-0005600	P-0005600-T02-IM5	In-House	FFPE	Resection	250	854	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.R181P;WT1 p.E65*;CDKN1B p.*199Sext*60;FLCN p.M1?;ERBB2 Amplification;YAP1 Amplification	1	6
P-0005600	P-0005600-T01-IM5	Outside	DNA	Biopsy	250	913	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R181P;WT1 p.E65*;CDKN1B p.*199Sext*60;FLCN p.M1?;ERBB2 Amplification;FGFR1 Amplification	2	6
P-0005601	P-0005601-T01-IM5	Outside	DNA	Resection	250	1365	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										KMT2D Deletion;ARF3 MLL2-ARF3 fusion;KMT2D MLL2-ARF3 fusion;BCOR MLL2-BCOR fusion;KMT2D MLL2-BCOR fusion	0	5
P-0005602	P-0005602-T02-IM5	In-House	FFPE	Biopsy	250	1092	30	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_3B	PTEN p.X268_splice;GATA3 p.T355Qfs*97;FGFR2 Amplification;MDM2 Amplification;PAK1 Amplification;RUNX1 Amplification	2	6
P-0005602	P-0005602-T01-IM5	Outside	DNA	Biopsy	250	767	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.I135V)				LEVEL_1	PTEN p.I135V;GATA3 p.T355Qfs*97;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	3	5
P-0005603	P-0005603-T01-IM5	In-House	DNA	Biopsy	250	744	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	ARID2 p.I199Yfs*13;CDKN2A Deletion;CDKN2B Deletion;NPM1 Deletion;PTEN Deletion	2	5
P-0005604	P-0005604-T01-IM5	In-House	DNA	Resection	250	1073	80	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma										ARID2 p.X140_splice;TP53 p.P278F	0	2
P-0005605	P-0005605-T01-IM5	In-House	DNA	Resection	250	1005	60	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.W557_K558del;PIK3CA p.H1047L;CDKN2A Deletion;CDKN2B Deletion	3	4
P-0005606	P-0005606-T01-IM5	In-House	DNA	Biopsy	250	642	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.E606Q)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R103Q);Tipifarnib(HRAS p.G13D)	PLX8394(BRAF p.G469V);Tazemetostat(KDM6A p.K1105*)				LEVEL_3A	NRAS p.Q61K;TP53 p.E286K;BRAF p.G469V;ERBB2 p.R103Q;ERCC2 p.E606Q;NOTCH2 p.Q1194*;ARID1B p.W490*;HRAS p.G13D;ARID2 p.Q609*;KDM6A p.K1105*;ARID1A p.G328Afs*35;NKX3-1 Deletion	6	12
P-0005607	P-0005607-T01-IM5	Outside	DNA	Resection	197.184	505	40	Matched	Metastasis	Upper Extremity	Lung	Tumor	EMCHS	Bone Cancer	Extraskeletal Myxoid Chondrosarcoma										SMAD2 p.M1?	0	1
P-0005608	P-0005608-T01-IM5	In-House	DNA	Resection	250	925	40	Matched	Metastasis	Testis	Lymph Node	Tumor	NSGCT	Germ Cell Tumor	Non-Seminomatous Germ Cell Tumor											0	0
P-0005609	P-0005609-T01-IM5	In-House	DNA	Resection	250	1076	20	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Enasidenib(IDH2 p.R172K)	PLX8394(BRAF p.G469A)				LEVEL_3B	BRAF p.G469A;IDH2 p.R172K	2	2
P-0005610	P-0005610-T01-IM5	Outside	DNA	Biopsy	217.1	392	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										PPM1D p.E540*;CD274 Amplification;JAK2 Amplification;SNAPC4 NOTCH1-SNAPC4 fusion;NOTCH1 NOTCH1-SNAPC4 fusion	0	5
P-0005611	P-0005611-T01-IM5	In-House	DNA	Resection	250	966	20	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.M1043I);Fulvestrant+Alpelisib(PIK3CA p.E39K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E39K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.M1043I;PIK3CA p.E39K;ERBB2 Amplification;PPM1D Amplification	6	4
P-0005612	P-0005612-T01-IM5	In-House	DNA	Biopsy	250	1110	30	Matched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.E285K;KMT2D p.R5282*;ARID1A p.Q625*;HIST1H2BD p.S37R;LOC729991-MEF2B MYC-LOC729991-MEF2B fusion;MYC MYC-LOC729991-MEF2B fusion	0	6
P-0005613	P-0005613-T01-IM5	In-House	DNA	Biopsy	250	1223	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	TP53 p.E286K;FGFR1 Amplification;MAP2K4 Deletion;NF1 Deletion;PTPRS ACER1-PTPRS fusion;ACER1 ACER1-PTPRS fusion;PTPRS UNC5D-PTPRS fusion;UNC5D UNC5D-PTPRS fusion	2	8
P-0005614	P-0005614-T01-IM5	In-House	DNA	Biopsy	250	483	70	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	TP53 p.R273C;CCND1 Amplification;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion;STAG2 STAG2-intragenic	2	5
P-0005615	P-0005615-T02-IM5	Outside	DNA	Resection	250	1015	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Cisplatin(ERCC2 ST3GAL3-ERCC2 fusion);Cisplatin(ST3GAL3 ST3GAL3-ERCC2 fusion)	GSK2636771,AZD8186(PTEN p.T319*);GSK2636771,AZD8186(PTEN p.Y336*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R175H;PTEN p.T319*;PIK3R1 p.G376R;PTEN p.Y336*;TP53 p.S376Pfs*45;CDKN2A Deletion;CDKN2B Deletion;ERCC2 ST3GAL3-ERCC2 fusion;ST3GAL3 ST3GAL3-ERCC2 fusion	5	9
P-0005615	P-0005615-T03-IM5	Outside	FFPE	Resection	250	723	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Cisplatin(ERCC2 ST3GAL3-ERCC2 fusion);Cisplatin(ST3GAL3 ST3GAL3-ERCC2 fusion)	GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_3B	TP53 p.R175H;PTEN p.T319*;PIK3R1 p.G376R;ERCC2 ST3GAL3-ERCC2 fusion;ST3GAL3 ST3GAL3-ERCC2 fusion	3	5
P-0005616	P-0005616-T02-IM5	Outside	DNA	Biopsy	250	325	30	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K);Enasidenib(IDH2 p.R172K)					LEVEL_3B	NRAS p.Q61K;IDH2 p.R172K	2	2
P-0005617	P-0005617-T02-IM5	In-House	DNA	Resection	250	915	10	Matched	Primary	Penis	Not Applicable	Tumor	PSCC	Penile Cancer	Penile Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;ASXL2 p.Q36*;TGFBR2 p.Q166*;LATS1 p.Q188*;KMT2C p.W1671*	1	5
P-0005618	P-0005618-T02-IM5	In-House	DNA	Biopsy	250	831	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E542K;TP53 p.Y126C;HLA-A p.X24_splice;ARID1A p.L1688Sfs*12;ERBB2 Amplification	3	5
P-0005619	P-0005619-T02-IM5	In-House	DNA	Cytology	50	785	20	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84N)				LEVEL_4	ARID2 p.X235_splice;SETD2 p.L578*;PTPRD p.X559_splice;NOTCH1 p.Q1193*;KMT2D p.Q827*;ZFHX3 p.Q2587*;TP53 p.V143A;ATRX p.S2365*;ARID2 p.P118Lfs*92;MEN1 p.X8_splice;NOTCH1 p.Y291_C292delins*;CDKN2A p.D84N	1	12
P-0005620	P-0005620-T02-IM5	Outside	DNA	Biopsy	250	619	40	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.G266E;PIK3CA p.E542K;ERBB2 Amplification;MYC Amplification;SOX9 SOX9-intragenic	4	5
P-0005621	P-0005621-T02-IM5	Outside	DNA	Biopsy	229.245	625	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.F90Sfs*56)				LEVEL_4	TP53 p.Y220C;ARID1A p.A325Cfs*60;PBRM1 p.N882Kfs*19;CDKN2A p.F90Sfs*56;CCND1 Amplification;FGF19 Amplification	1	6
P-0005622	P-0005622-T03-IM5	Outside	DNA	Resection	250	708	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C229Yfs*10	0	1
P-0005623	P-0005623-T02-IM5	Outside	DNA	Resection	250	1109	50	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R248Q;TCF7L2 p.R407*;FLT3 Amplification	1	4
P-0005624	P-0005624-T02-IM5	In-House	DNA	Biopsy	250	957	70	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;KDM6A p.X1246_splice;MGA p.T850Nfs*11	1	3
P-0005625	P-0005625-T02-IM5	In-House	DNA	Biopsy	206.388	616	40	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;TP53 p.R248Q;MYC Amplification;SMAD4 Deletion	1	4
P-0005626	P-0005626-T02-IM5	In-House	DNA	Resection	250	846	60	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.M552_E554delinsI)								LEVEL_1	KIT p.M552_E554delinsI;MYC Amplification	1	2
P-0005627	P-0005627-T02-IM5	Outside	DNA	Biopsy	250	864	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.G522Efs*26)				LEVEL_4	TP53 p.C238Y;TP53 p.Q192*;CDK4 p.R24H;FH p.Q227*;SMO p.I408V;FANCA p.X298_splice;KDM6A p.G522Efs*26	1	7
P-0005628	P-0005628-T02-IM5	In-House	DNA	Resection	250	767	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	DES	Soft Tissue Sarcoma	Desmoid/Aggressive Fibromatosis											0	0
P-0005629	P-0005629-T02-IM5	Outside	DNA	Biopsy	198.815	472	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.E2096Vfs*29)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;SMARCA4 p.Q1053Sfs*53;STK11 p.A43Pfs*8;ATM p.E2096Vfs*29	2	4
P-0005630	P-0005630-T01-IM5	In-House	DNA	Resection	250	542	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.S1545*	0	1
P-0005631	P-0005631-T01-IM5	In-House	DNA	Biopsy	92.96	138	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N1044K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1044K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.N1044K;TP53 p.I232S;ERBB2 Amplification	4	3
P-0005632	P-0005632-T01-IM5	In-House	DNA	Resection	250	776	20	Matched	Metastasis	Thyroid	Bone	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;PIK3R2 Amplification	1	3
P-0005633	P-0005633-T01-IM5	Outside	DNA	Resection	250	1151	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0005634	P-0005634-T01-IM5	In-House	DNA	Biopsy	250	823	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.G245S;APC p.E1309Dfs*4;KRAS p.G13D;APC p.Q886*;CBL p.S100*	1	5
P-0005635	P-0005635-T01-IM5	In-House	DNA	Resection	250	869	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.H179R;DNMT3A p.Q362*;ATRX p.L359Tfs*3;CCND2 Amplification;KDM5A Amplification	1	6
P-0005636	P-0005636-T01-IM5	In-House	DNA	Biopsy	250	1073	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R337L;AR Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0005637	P-0005637-T01-IM5	Outside	DNA	Biopsy	111.86	331	20	Matched	Primary	GE Junction	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma										TP53 p.E294*;CCNE1 Amplification;FGFR2 Amplification;KRAS Amplification;MCL1 Amplification	0	5
P-0005638	P-0005638-T01-IM5	In-House	DNA	Resection	250	673	60	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0005639	P-0005639-T01-IM5	In-House	DNA	Biopsy	211.99	346	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.D725Efs*3)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.D725Efs*3)				LEVEL_1	CDK12 p.D725Efs*3;CCND1 Amplification	2	2
P-0005640	P-0005640-T01-IM5	Outside	DNA	Resection	250	732	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.E542K;ARID1A p.Q1420*;GATA3 p.S404Hfs*107;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;PPM1D Amplification	4	7
P-0005641	P-0005641-T01-IM5	Outside	DNA	Resection	250	694	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0005642	P-0005642-T01-IM5	In-House	DNA	Resection	250	651	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L94Rfs*53)				LEVEL_4	TP53 p.W91*;KRAS p.Q61H;CDKN2A p.L94Rfs*53	2	3
P-0005643	P-0005643-T01-IM5	Outside	DNA	Biopsy	242.925	617	30	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.R15K)				LEVEL_3B	BRAF p.V600E;PIK3CA p.H1047R;PTEN p.R15K	3	3
P-0005644	P-0005644-T01-IM5	In-House	DNA	Biopsy	250	937	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.E285*	0	1
P-0005645	P-0005645-T01-IM5	In-House	DNA	Biopsy	250	893	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.Q218*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;PDGFRB p.R561P;ATM p.Q218*;NKX2-1 Amplification	2	4
P-0005645	P-0005645-T02-IM5	In-House	FFPE	Biopsy	250	1086	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.Q218*);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;PDGFRB p.R561P;ATM p.Q218*;ERBB3 Amplification;MDM2 Amplification;NKX2-1 Amplification	3	6
P-0005646	P-0005646-T01-IM5	In-House	DNA	Biopsy	250	1408	70	Matched	Primary	Lymph node	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										BIRC3 p.L444*;KMT2D p.Q3312*;BCOR p.K1577Ifs*4;MAX p.Q72Sfs*99;APC Deletion;ATM Deletion;BIRC3 Deletion;CCND1 Amplification;MAX Deletion;RAD50 Deletion;RAD51B Deletion;SDHD Deletion	0	12
P-0005647	P-0005647-T01-IM5	In-House	DNA	Resection	250	1140	10	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib(NF1 p.F1247Ifs*18);Trametinib,Cobimetinib(NF1 p.R2637*)				LEVEL_4	RNF43 p.P660Sfs*87;NF1 p.F1247Ifs*18;NF1 p.R2637*;RASA1 p.G89Efs*7;RASA1 p.G149Afs*25;MLH1 p.E717Gfs*62	2	6
P-0005648	P-0005648-T01-IM5	In-House	DNA	Resection	250	505	60	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma										TP53 p.H179L;EP300 p.C1164Y;SMAD2 p.W134*;CCNE1 Amplification	0	4
P-0005649	P-0005649-T01-IM5	Outside	DNA	Biopsy	132.1	627	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 Deletion	0	1
P-0005650	P-0005650-T01-IM5	In-House	DNA	Resection	243.746	95	20	Matched	Metastasis	Bladder	Epidural	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.P278S;ERBB3 p.K329E;RHOA p.Q63K;CCND1 Amplification;FGF19 Amplification	0	5
P-0005651	P-0005651-T01-IM5	In-House	DNA	Biopsy	128.69	281	60	Matched	Metastasis	Thyroid	Bone	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										TERT Amplification	0	1
P-0005652	P-0005652-T01-IM5	Outside	DNA	Biopsy	250	1031	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D350N)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.D350N;TP53 p.P278S;RB1 Deletion	2	4
P-0005655	P-0005655-T02-IM5	In-House	FFPE	Biopsy	250	1120	80	Matched	Metastasis	Urethra	Soft Tissue	Tumor	URMM	Melanoma	Mucosal Melanoma of the Urethra					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	TP53 p.R175L;TP53 p.R333Vfs*12;ATRX p.C1122Lfs*8;CD274 Amplification;CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion;JAK2 Amplification;KDR Amplification;KIT Amplification;NF1 Deletion;PDGFRA Amplification	2	12
P-0005655	P-0005655-T01-IM5	In-House	DNA	Resection	250	661	40	Matched	Primary	Urethra	Not Applicable	Tumor	URMM	Melanoma	Mucosal Melanoma of the Urethra										TP53 p.R175L;TP53 p.R333Vfs*12;ATRX p.C1122Lfs*8;CD274 Amplification;JAK2 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	0	8
P-0005656	P-0005656-T01-IM5	In-House	DNA	Biopsy	250	1327	80	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209P;BAP1 p.R237Afs*12;EPHA7 Deletion;MYC Amplification;RUNX1 Amplification	0	5
P-0005662	P-0005662-T01-IM5	Outside	DNA	Biopsy	250	482	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.E204*;SMAD4 p.G477*;SUZ12 p.L426Ifs*10	1	4
P-0005664	P-0005664-T01-IM5	In-House	DNA	Biopsy	215.86	774	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Tazemetostat(KDM6A p.X76_splice)				LEVEL_3B	KRAS p.G12V;PIK3CA p.E542K;ARID1A p.Q594*;KDM6A p.X76_splice;ARID1A p.T653Dfs*23;SUZ12 p.P451Lfs*7;ATRX p.Q2370Pfs*7;ZFHX3 p.N1773Tfs*10	3	8
P-0005666	P-0005666-T01-IM5	In-House	DNA	Resection	250	575	10	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;HIST1H1C p.E115K;GPS2 p.Q237*	2	3
P-0005670	P-0005670-T01-IM5	In-House	DNA	Resection	250	838	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	TP53 p.R196*;BRAF p.V600E;ARID2 p.X95_splice;MAP2K4 p.S83*	3	4
P-0005671	P-0005671-T01-IM5	In-House	DNA	Biopsy	250	803	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.H193L;SH2B3 p.E487Lfs*11;ARID1A p.A1539Pfs*26;KMT2A p.T506Pfs*61;ARID1A p.A2235Rfs*41	0	5
P-0005672	P-0005672-T01-IM5	In-House	DNA	Resection	250	475	50	Matched	Primary	Brain	Not Applicable	Tumor	LGGNOS	Glioma	Low-Grade Glioma, NOS				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0005673	P-0005673-T01-IM5	In-House	DNA	Cytology	250	839	40	Matched	Metastasis	Skin	Subcutaneous Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.G132S)				LEVEL_1	BRAF p.V600E;TP63 p.Q70*;PTEN p.G132S	3	3
P-0005674	P-0005674-T01-IM5	Outside	DNA	Biopsy	250	654	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0005675	P-0005675-T01-IM5	In-House	DNA	Resection	250	824	20	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										SMAD4 p.G386D;SPEN p.E1964*;CDH1 p.Q641*	0	3
P-0005676	P-0005676-T01-IM5	Outside	DNA	Resection	250	881	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	PLRMS	Soft Tissue Sarcoma	Pleomorphic Rhabdomyosarcoma					Trametinib,Cobimetinib(NF1 p.P678Rfs*10)				LEVEL_4	TP53 p.R175H;NF1 p.P678Rfs*10;ATRX p.R840Efs*29;ANKRD11 p.K1461del	1	4
P-0005677	P-0005677-T01-IM5	Outside	DNA	Resection	250	695	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	RBM10 p.Q649*;NF2 p.X226_splice;ASXL1 p.E513*;FGFR1 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification;TP53 TP53-intragenic	1	8
P-0005678	P-0005678-T01-IM5	Outside	DNA	Resection	250	941	60	Matched	Metastasis	Ovary	Bladder	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W	0	1
P-0005679	P-0005679-T01-IM5	Outside	DNA	Resection	250	724	30	Matched	Primary	Kidney	Not Applicable	Tumor	MRC	Renal Cell Carcinoma	Renal Medullary Carcinoma											0	0
P-0005680	P-0005680-T01-IM5	In-House	DNA	Resection	250	780	60	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005681	P-0005681-T01-IM5	Outside	DNA	Resection	250	993	60	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.H179Y;PTPRD p.E1526*;RB1 p.X605_splice	0	3
P-0005682	P-0005682-T01-IM5	In-House	DNA	Resection	250	740	30	Matched	Metastasis	Kidney	Liver	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.X1572_splice;VHL p.M211Dfs*45;BAP1 p.A428Hfs*2	0	3
P-0005683	P-0005683-T01-IM5	Outside	DNA	Biopsy	250	503	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.Y655Vfs*18)	Tazemetostat(SMARCB1 p.R374Q)				LEVEL_3B	TP53 p.R248Q;SMARCB1 p.R374Q;BRCA1 p.Y655Vfs*18;RNF43 p.F69Lfs*7	2	4
P-0005684	P-0005684-T01-IM5	In-House	DNA	Resection	250	989	70	Matched	Metastasis	Testis	Lung	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MYCL Amplification	0	4
P-0005685	P-0005685-T01-IM5	In-House	DNA	Resection	250	633	30	Matched	Metastasis	Testis	Lymph Node	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0005687	P-0005687-T01-IM5	Outside	DNA	Cytology	250	564	50	Matched	Metastasis	Nailbed	Retroperitoneum	Tumor	ACRM	Melanoma	Acral Melanoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.H1047L;BCL6 Amplification;CCND2 Amplification;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;KDM5A Amplification;KRAS Amplification;MAPK1 Amplification;MDM2 Amplification;MGA Deletion;PIK3CA Amplification;PTPRD Deletion;RAD51 Deletion	4	14
P-0005688	P-0005688-T01-IM5	Outside	DNA	Biopsy	250	342	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0005689	P-0005689-T01-IM5	In-House	DNA	Resection	250	973	60	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma											0	0
P-0005690	P-0005690-T01-IM5	In-House	DNA	Biopsy	250	449	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										MAPK1 p.E322K;FBXW7 p.D607Efs*37;ARID1A p.E119Afs*109	0	3
P-0005691	P-0005691-T01-IM5	Outside	DNA	Biopsy	180.3	673	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(BRIP1 PITPNC1-BRIP1 fusion);Olaparib(PITPNC1 PITPNC1-BRIP1 fusion)					LEVEL_3B	GATA3 p.A394Lfs*110;BRIP1 PITPNC1-BRIP1 fusion;PITPNC1 PITPNC1-BRIP1 fusion	2	3
P-0005692	P-0005692-T01-IM5	In-House	DNA	Resection	250	965	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										KMT2C p.E2715*;FOXA1 p.R265_G284del;RAD50 p.X277_splice	0	3
P-0005693	P-0005693-T01-IM5	Outside	DNA	Resection	250	519	60	Matched	Primary	Brain	Not Applicable	Tumor	APE	CNS Cancer	Anaplastic Ependymoma				Tazemetostat(SMARCB1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;CDKN2B Deletion;SMARCB1 Deletion	2	3
P-0005694	P-0005694-T01-IM5	In-House	DNA	Resection	250	959	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.G675*);Trametinib,Cobimetinib(NF1 p.Q854*)				LEVEL_4	GATA3 p.S381*;NF1 p.G675*;NF1 p.Q854*	2	3
P-0005695	P-0005695-T01-IM5	In-House	DNA	Resection	250	738	30	Matched	Metastasis	Uterus	Abdomen	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542A)					LEVEL_3B	FBXW7 p.R505C;TP53 p.E224D;PIK3CA p.E542A	1	3
P-0005696	P-0005696-T01-IM5	Outside	DNA	Resection	250	530	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Tipifarnib(HRAS p.Q61L);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	HRAS p.Q61L;PIK3CA p.R88Q;PTPN11 p.F285S;PTPN11 p.A461T;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0005697	P-0005697-T03-IM5	In-House	DNA	Resection	250	654	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										BRAF p.D594G;TP53 p.L257Q;ZFHX3 Deletion	0	3
P-0005698	P-0005698-T01-IM5	Outside	DNA	Biopsy	250	687	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.G290Lfs*30;DLG4 TP53-DLG4 fusion;TP53 TP53-DLG4 fusion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	5
P-0005699	P-0005699-T01-IM5	Outside	DNA	Biopsy	168.66	299	70	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822K)					LEVEL_3B	KIT p.N822K	1	1
P-0005700	P-0005700-T01-IM5	In-House	DNA	Resection	250	621	70	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)					LEVEL_3B	PIK3CA p.M1043I;TP53 p.M237I;KEAP1 p.G480W;KMT2D p.E81*;STK11 p.H174L	1	5
P-0005701	P-0005701-T01-IM5	Outside	DNA	Resection	250	832	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Afatinib(EGFR p.G719C)	GSK2636771,AZD8186(PTEN p.C71Y);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	EGFR p.G719C;PTPN11 p.A72V;PTEN p.C71Y;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MDM4 Amplification;EGFR SEPT14-EGFR fusion;SEPT14 SEPT14-EGFR fusion	4	9
P-0005702	P-0005702-T01-IM5	Outside	DNA	Biopsy	108.45	325	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V777L)					LEVEL_3B	ERBB2 p.V777L	1	1
P-0005703	P-0005703-T01-IM5	Outside	DNA	Resection	250	556	40	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.X1057_splice)						LEVEL_3A	NOTCH1 p.X1339_splice;TP53 p.V143A;PTCH1 p.X1057_splice;TGFBR1 p.R215*;LATS2 p.Q276*;ERCC3 p.D474Mfs*7;PBRM1 p.D107Vfs*6;CARD11 p.R113Q	1	8
P-0005704	P-0005704-T01-IM5	Outside	DNA	Biopsy	250	881	50	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	PIK3CA p.E542K;TP53 p.C229Yfs*10;AXIN1 Deletion;CCNE1 Amplification;ERBB2 Amplification;MYC Amplification;SMAD4 Deletion	2	7
P-0005705	P-0005705-T01-IM5	In-House	DNA	Biopsy	250	768	80	Matched	Metastasis	Rectum	Liver	Tumor	RWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumor of the Rectum										NCOR1 p.R688*	0	1
P-0005707	P-0005707-T01-IM5	In-House	DNA	Resection	250	639	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A;RBM10 p.Q267*;SETD2 p.X29_splice;PTPRT p.D742Tfs*4;STK11 p.A347Rfs*9;MYC Amplification	1	6
P-0005708	P-0005708-T01-IM5	In-House	DNA	Resection	250	532	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.I195T;ARID1A p.N2173Tfs*27	1	3
P-0005709	P-0005709-T01-IM5	Outside	DNA	Biopsy	250	767	50	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.Q317*;ERBB2 Amplification	2	2
P-0005710	P-0005710-T01-IM5	In-House	DNA	Biopsy	250	759	10	Matched	Metastasis	Soft Tissue	Peritoneum	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0005711	P-0005711-T01-IM5	In-House	DNA	Biopsy	250	723	60	Matched	Metastasis	Lung	Mediastinum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.C229_T230del;CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification;MYC Amplification;DIS3 DAOA-DIS3 fusion;DAOA DAOA-DIS3 fusion	1	7
P-0005712	P-0005712-T01-IM5	In-House	DNA	Biopsy	250	719	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R248W;PIK3R1 p.E635*;KMT2C p.P2264Lfs*6;MCL1 Amplification;MYC Amplification;FH FH-intragenic;ARID2 ARID2-intragenic	0	7
P-0005713	P-0005713-T01-IM5	In-House	DNA	Biopsy	250	324	80	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.R876*;CDKN1B p.P137Rfs*8	0	2
P-0005714	P-0005714-T01-IM5	Outside	DNA	Resection	250	195	70	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.T1977K)				LEVEL_4	MTOR p.T1977K;TP53 p.M246I;VHL p.Q73*;SETD2 p.S470*	1	4
P-0005715	P-0005715-T01-IM5	In-House	DNA	Resection	250	717	70	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.E1309*;GATA3 p.S237Qfs*66;TP53 p.L265R;TP53 p.X261_splice;GATA3 Amplification	0	5
P-0005716	P-0005716-T01-IM5	In-House	DNA	Resection	250	489	90	Matched	Metastasis	Bone	Lung	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0005717	P-0005717-T01-IM5	Outside	DNA	Resection	250	796	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.X187_splice;PTPRD Deletion	2	3
P-0005718	P-0005718-T01-IM5	In-House	DNA	Biopsy	117.18	529	30	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Tipifarnib(HRAS p.G13R)					LEVEL_3B	HRAS p.G13R;KMT2C p.S4077*;TP53 p.C141G;KMT2D p.Q3821Sfs*188	1	4
P-0005719	P-0005719-T01-IM5	In-House	DNA	Resection	250	435	80	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.S338Lfs*6)				LEVEL_4	PTEN p.S338Lfs*6;VHL p.V83Rfs*49;ARID1A p.E2145Rfs*55	1	3
P-0005720	P-0005720-T01-IM5	Outside	DNA	Resection	250	2176	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.T155Afs*28	1	2
P-0005721	P-0005721-T01-IM5	In-House	DNA	Biopsy	103.14	622	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	STK11 p.D53Gfs*110;MDM2 Amplification	1	2
P-0005722	P-0005722-T01-IM5	Outside	DNA	Resection	250	1046	70	Matched	Metastasis	Cancer of Unknown Primary	Testis	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	SMARCB1 Deletion	1	1
P-0005723	P-0005723-T01-IM5	Outside	DNA	Resection	250	1324	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer					GSK2636771,AZD8186(PTEN p.Q298*)				LEVEL_4	STK11 p.Q220*;PTEN p.Q298*;RB1 p.Y728*;MAP2K4 p.Y193Vfs*3;CDKN1B p.X159_splice	1	5
P-0005724	P-0005724-T01-IM5	In-House	DNA	Biopsy	250	1625	80	Matched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										NOTCH2 p.E2206*;HLA-A p.X338_splice;PIM1 p.Q37H;HLA-A p.M122Gfs*23;CDKN2A Deletion;CDKN2B Deletion	0	6
P-0005725	P-0005725-T01-IM5	Outside	DNA	Biopsy	195.21	924	80	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Trametinib,Cobimetinib(NF1 p.Q854*)				LEVEL_4	NF1 p.Q854*;RAF1 p.G361R;ATR p.W1443*;KMT2A p.Q471*;CASP8 p.I208Sfs*21;NOTCH1 p.L2027Wfs*12;MITF MITF-intragenic	1	7
P-0005726	P-0005726-T02-IM5	In-House	DNA	Biopsy	250	819	40	Matched	Metastasis	Breast	Bone	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	KMT2C p.E78Nfs*17;PARP1 p.F638Lfs*6;ANKRD11 p.D1016Ifs*302;FGFR1 Amplification	1	4
P-0005727	P-0005727-T01-IM5	In-House	DNA	Biopsy	250	933	70	Matched	Metastasis	Upper Tract	Liver	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MDM2 Amplification	2	5
P-0005728	P-0005728-T01-IM5	Outside	DNA	Biopsy	250	524	30	Matched	Metastasis	Anus	Lymph Node	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	PIK3CA p.E545K;KRAS p.G12A	2	2
P-0005729	P-0005729-T01-IM5	In-House	DNA	Biopsy	250	824	70	Matched	Primary	Lymph Node	Not Applicable	Tumor	HDCS	Soft Tissue Sarcoma	Histiocytic Dendritic Cell Sarcoma				Imatinib(KIT p.R888W);Trametinib,Cobimetinib(MAP2K1 p.F53L)					LEVEL_3B	KIT p.R888W;CDKN1B p.W76*;MAP2K1 p.F53L;BCL10 p.S141*	2	4
P-0005730	P-0005730-T02-IM5	Outside	DNA	Resection	250	676	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.P151S;APC p.E1309Dfs*4;AURKA Amplification;CARD11 Amplification;FGFR1 Amplification;RAC1 Amplification;SMAD3 Deletion	1	7
P-0005731	P-0005731-T01-IM5	In-House	DNA	Biopsy	250	851	80	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310Y)					LEVEL_3B	TP53 p.E285K;ERBB2 p.S310Y;ARID1A p.E1803*;APC p.S2572*;CCNE1 Amplification	1	5
P-0005732	P-0005732-T01-IM5	Outside	DNA	Cytology	250	621	30	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					Trametinib,Cobimetinib(NF1 p.L691Cfs*57)				LEVEL_4	TP53 p.R273L;PPM1D p.E424*;NF1 p.L691Cfs*57;CREBBP p.R1446_T1447delinsLS;RB1 Deletion	1	5
P-0005733	P-0005733-T02-IM5	In-House	FFPE	Biopsy	250	778	75	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)			Cabozantinib,Crizotinib(MET Amplification)					LEVEL_1	BRAF p.V600K;EED p.R441*;MGA p.Q2271*;KMT2C p.R3960*;BRAF Amplification;CDKN2B Deletion;MET Amplification	2	7
P-0005733	P-0005733-T01-IM5	Outside	DNA	Biopsy	203.84	636	80	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)								LEVEL_1	BRAF p.V600K;EED p.R441*;MGA p.Q2271*;CCND3 Amplification;CDKN2B Deletion	1	5
P-0005734	P-0005734-T02-IM5	In-House	DNA	Cytology	250	455	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.V157F;RB1 p.Q395*;SMARCA4 p.X1545_splice	0	3
P-0005735	P-0005735-T01-IM5	In-House	DNA	Biopsy	250	798	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.D24G)				LEVEL_4	PTEN p.D24G;PIK3R1 p.X571_splice;TP53 p.X300_splice;MYC Amplification;RB1 Deletion	1	5
P-0005736	P-0005736-T01-IM5	In-House	DNA	Biopsy	250	196	20	Matched	Metastasis	Stomach	Liver	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.C277F;RB1 p.R552*	0	2
P-0005737	P-0005737-T02-IM5	In-House	DNA	Resection	250	678	90	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del)								LEVEL_1	KIT p.W557_K558del;GATA3 Deletion	1	2
P-0005738	P-0005738-T02-IM5	Outside	DNA	Resection	250	473	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0005739	P-0005739-T02-IM5	Outside	DNA	Biopsy	228	525	10	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)		Cetuximab,Panitumumab(NRAS p.G12D)			LEVEL_3B	FBXW7 p.R505C;NRAS p.G12D;TET2 p.R1214Q;APC p.S1028Ifs*9	1	4
P-0005740	P-0005740-T02-IM5	In-House	DNA	Resection	250	648	80	Matched	Metastasis	Soft Tissue	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										RB1 Deletion;TP53 Deletion	0	2
P-0005741	P-0005741-T01-IM5	In-House	DNA	Biopsy	250	937	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 BRCA2-intragenic)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TP53 p.V173L;KMT2D p.Q5365*;CCNE1 Amplification;BRCA2 BRCA2-intragenic	2	5
P-0005741	P-0005741-T02-IM5	In-House	Cell Pellet	Cytology	75.06	1004	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.V173L;KMT2D p.Q5365*;CCNE1 Amplification	1	4
P-0005742	P-0005742-T01-IM5	In-House	DNA	Resection	250	902	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	BRAF p.V600E;PIK3CA p.E545K;TP53 p.R290H;APC p.E1554Kfs*11;AKT1 p.W80R;TP53 p.D259H;TGFBR2 p.E312*	4	7
P-0005743	P-0005743-T02-IM5	Outside	DNA	Biopsy	250	488	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	TP53 p.G245D;MYC Amplification;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	4
P-0005744	P-0005744-T01-IM5	Outside	DNA	Resection	250	785	30	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.P278L;CCNE1 Amplification	0	2
P-0005745	P-0005745-T01-IM5	In-House	DNA	Cytology	162.3	366	70	Matched	Metastasis	Ovary	Omentum	Tumor	SOC	Ovarian Cancer	Serous Ovarian Cancer										TP53 p.R273H;B2M p.M1?;MED12 Deletion;MYC Amplification	0	4
P-0005746	P-0005746-T01-IM5	In-House	DNA	Resection	250	1211	60	Matched	Primary	Thymus	Not Applicable	Tumor	THYM	Thymic Tumor	Thymoma										MCL1 Amplification	0	1
P-0005747	P-0005747-T01-IM5	In-House	DNA	Resection	250	457	NA	Matched	Metastasis	Kidney	Mediastinum	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.W88*	0	1
P-0005748	P-0005748-T01-IM5	Outside	DNA	Resection	250	410	NA	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer	Selpercatinib(RET NCOA4-RET fusion);Selpercatinib(NCOA4 NCOA4-RET fusion)			BLU-667,Cabozantinib,Vandetanib(RET NCOA4-RET fusion);BLU-667,Cabozantinib,Vandetanib(NCOA4 NCOA4-RET fusion)					LEVEL_1	TP53 p.T125M;RET NCOA4-RET fusion;NCOA4 NCOA4-RET fusion	4	3
P-0005749	P-0005749-T01-IM5	In-House	DNA	Biopsy	250	643	70	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										SF3B1 p.R625H;GNAQ p.Q209L;CARD11 Amplification;ETV1 Amplification;MYC Amplification;RAC1 Amplification	0	6
P-0005750	P-0005750-T01-IM5	Outside	DNA	Biopsy	250	698	60	Matched	Metastasis	Kidney	Pancreas	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.R1625H;KMT2C p.L4638Wfs*7;PBRM1 p.X1129_splice;VHL p.R69Afs*63	0	4
P-0005751	P-0005751-T01-IM5	In-House	DNA	Resection	250	681	80	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.E242*)				LEVEL_4	TGFBR1 p.Q497*;PTEN p.E242*;VHL p.E189Kfs*13;PBRM1 p.D578Afs*9;SETD2 p.N1733Sfs*9	1	5
P-0005752	P-0005752-T01-IM5	In-House	DNA	Biopsy	235.17	846	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)						LEVEL_1	MET p.X1010_splice;TGFBR1 p.E110*	3	2
P-0005753	P-0005753-T01-IM5	In-House	DNA	Biopsy	250	1146	40	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0005753	P-0005753-T02-IM5	In-House	DNA	Resection	250	424	80	Matched	Metastasis	Kidney	Soft Tissue	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.W117L;ARID1A p.Q723*;SF3B1 p.D894Y;SETD2 p.E1972*;PBRM1 p.F822Lfs*3;ARID2 p.X236_splice	0	6
P-0005754	P-0005754-T01-IM5	In-House	DNA	Biopsy	250	1147	30	Matched	Metastasis	Testis	Sinonasal	Tumor	TYST	Germ Cell Tumor	Yolk Sac Tumor				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	SMARCB1 Deletion	1	1
P-0005755	P-0005755-T01-IM5	In-House	DNA	Biopsy	182.8	281	20	Matched	Metastasis	Descending Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	SMAD4 p.G231Afs*10;APC p.R216*;KRAS p.G13D;RBM10 p.E667Kfs*37;SOX9 p.E191Rfs*28	1	5
P-0005756	P-0005756-T01-IM5	In-House	DNA	Biopsy	250	1188	NA	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TP53 p.F270C;AR Amplification;ATRX Deletion;FH Deletion;MAP3K1 Deletion;MED12 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	9
P-0005757	P-0005757-T01-IM5	Outside	DNA	Resection	250	886	90	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.K335I;TP53 p.Y163H;MYC Amplification	0	3
P-0005758	P-0005758-T01-IM5	Outside	DNA	Resection	250	1016	20	Matched	Metastasis	Pancreas	Ovary	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.R175H;SMAD4 p.L57S	1	3
P-0005759	P-0005759-T01-IM5	Outside	DNA	Resection	250	820	20	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma											0	0
P-0005760	P-0005760-T01-IM5	In-House	DNA	Resection	250	675	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.F254_N256delinsY	0	1
P-0005761	P-0005761-T01-IM5	In-House	DNA	Biopsy	250	936	20	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(PALB2 p.X17_splice)								LEVEL_1	PALB2 p.X17_splice;RAD21 p.Q156Vfs*10;FOXA1 p.G251_E255delinsS;AR Amplification;COX7C APC-COX7C fusion;APC APC-COX7C fusion;NPM1 NPM1-intragenic;FUBP1 FUBP1-intragenic	1	8
P-0005762	P-0005762-T01-IM5	Outside	DNA	Cytology	250	1744	NA	Matched	Metastasis	Colorectal NOS	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;MYC Amplification	0	2
P-0005763	P-0005763-T01-IM5	In-House	DNA	Biopsy	250	950	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.S752_D761delinsPT)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;RB1 p.L385*;MED12 p.Q1992Rfs*18;EGFR p.S752_D761delinsPT;CCND1 Amplification;PAK1 Amplification	2	6
P-0005765	P-0005765-T01-IM5	In-House	DNA	Biopsy	250	659	70	Matched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CREBBP p.R1446H;CREBBP p.X406_splice	0	2
P-0005766	P-0005766-T01-IM5	In-House	DNA	Resection	250	719	40	Matched	Metastasis	Ovary	Liver	Tumor	MXOV	Ovarian Cancer	Mixed Ovarian Carcinoma										TP53 p.R175H;DICER1 p.R1139*;APC p.X470_splice	0	3
P-0005767	P-0005767-T02-IM5	In-House	DNA	Biopsy	204	620	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84A)				LEVEL_4	TP53 p.R248W;TP53 p.Q192*;SOX17 p.X103_splice;CDKN2A p.D84A;KRAS Amplification	1	5
P-0005768	P-0005768-T02-IM5	In-House	DNA	Biopsy	250	527	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	APC p.K1593Sfs*57;PIK3R1 p.E596*;BMPR1A Deletion;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0005769	P-0005769-T01-IM5	Outside	DNA	Resection	250	552	90	Matched	Metastasis	Skin	Small Bowel	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.Y177D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;PTEN p.Y177D;CDKN2A Deletion;CDKN2B Deletion	4	4
P-0005770	P-0005770-T02-IM5	In-House	DNA	Biopsy	250	412	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										CTNNB1 p.S33C;TP53 p.V173M;RB1 p.L60*;CDKN1A p.D26Gfs*10	0	4
P-0005771	P-0005771-T02-IM5	In-House	DNA	Biopsy	250	548	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.F855Sfs*13);Olaparib(CDK12 p.V1023Afs*34)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.F855Sfs*13);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.V1023Afs*34)				LEVEL_1	FOXA1 p.R261G;CDK12 p.F855Sfs*13;CDK12 p.V1023Afs*34;AR Amplification;CCND1 Amplification;EGFR Amplification;FGF19 Amplification;FGFR3 Amplification	4	8
P-0005772	P-0005772-T01-IM5	In-House	DNA	Resection	250	492	30	Matched	Metastasis	Cervix	Soft Tissue	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;BCL2L11 p.Y162*	1	2
P-0005773	P-0005773-T02-IM5	In-House	DNA	Biopsy	250	581	70	Matched	Metastasis	Prostate	Liver	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106R)					LEVEL_3B	PIK3CA p.G106R;SPOP p.F133V;PARP1 p.S257*;CDKN1B Deletion;FOXA1 Amplification;NKX2-1 Amplification;PRDM1 Deletion	1	7
P-0005774	P-0005774-T01-IM5	In-House	DNA	Biopsy	161.352	475	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.E532Rfs*3)			Talazoparib,Niraparib(BRCA2 p.E532Rfs*3)					LEVEL_1	BRCA2 p.E532Rfs*3;KDM6A p.A392Hfs*47	2	2
P-0005775	P-0005775-T02-IM5	In-House	DNA	Resection	250	277	70	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										ATRX p.K983*;TP53 p.P151R	0	2
P-0005776	P-0005776-T02-IM5	In-House	DNA	Resection	250	475	50	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_4	APC p.L1488Yfs*19;KRAS p.Q61H;APC p.Y825Ffs*13;LATS1 p.L41*	1	4
P-0005777	P-0005777-T02-IM5	In-House	DNA	Biopsy	250	312	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	TYST	Germ Cell Tumor	Yolk Sac Tumor				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12S)					LEVEL_3B	NRAS p.G12S;TP53 p.E180K;CBL p.W408R	1	3
P-0005778	P-0005778-T01-IM5	Outside	DNA	Biopsy	250	645	80	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)		Trametinib,Cobimetinib(NF1 p.G1133Kfs*63)				LEVEL_3A	AKT1 p.E17K;TP53 p.A161T;SETD2 p.S112*;MAP2K4 p.X132_splice;TET2 p.N752Rfs*59;NF1 p.G1133Kfs*63;CARD11 Amplification;CDK6 Amplification;EGFR Amplification;RAC1 Amplification;RNF43 Deletion	2	11
P-0005779	P-0005779-T01-IM5	Outside	DNA	Biopsy	250	508	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 Deletion;INPP4B INPP4B-intragenic	0	2
P-0005780	P-0005780-T01-IM5	In-House	DNA	Resection	250	793	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K550_P551del)								LEVEL_1	KIT p.K550_P551del	1	1
P-0005781	P-0005781-T01-IM5	Outside	DNA	Biopsy	250	907	40	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.G431Tfs*41;CCND1 Amplification;FGF19 Amplification	0	3
P-0005782	P-0005782-T01-IM5	Outside	DNA	Biopsy	250	519	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										APC p.E1156Gfs*8;APC p.Q542*	0	2
P-0005783	P-0005783-T01-IM5	In-House	DNA	Biopsy	250	1005	30	Matched	Metastasis	Cancer of Unknown Primary	Chest Wall	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Everolimus(TSC2 p.X212_splice)					LEVEL_3B	TP53 p.L93Cfs*30;RBM10 p.E743*;KMT2C p.E585*;MGA p.E2741*;SPOP p.E183*;SMARCA4 p.X287_splice;ATRX p.S996*;ARID1B p.A458Rfs*25;TSC2 p.X212_splice;EGFR Amplification	1	10
P-0005784	P-0005784-T01-IM5	In-House	DNA	Resection	250	850	50	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0005785	P-0005785-T01-IM5	Outside	DNA	Biopsy	250	1019	90	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;GATA3 p.F430Sfs*38;MAP2K4 Deletion;PPM1D Amplification	1	4
P-0005786	P-0005786-T01-IM5	In-House	DNA	Resection	250	759	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0005787	P-0005787-T01-IM5	In-House	DNA	Biopsy	250	735	80	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.V157Rfs*24;HOXB13 p.K245Efs*76;AR Amplification	0	3
P-0005787	P-0005787-T02-IM5	In-House	FFPE	Biopsy	250	777	40	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.V157Rfs*24;AR Amplification	0	2
P-0005788	P-0005788-T01-IM5	Outside	DNA	Resection	250	716	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R282W;BCOR p.R810*;SOX9 *510fs*	1	4
P-0005789	P-0005789-T01-IM5	Outside	DNA	Resection	250	612	50	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)	Trametinib,Cobimetinib(NF1 p.F1247Ifs*18);Trametinib,Cobimetinib(NF1 p.R2450*)				LEVEL_3B	IDH1 p.R132H;NF1 p.F1247Ifs*18;NF1 p.R2450*	3	3
P-0005790	P-0005790-T01-IM5	Outside	DNA	Biopsy	250	570	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R282W;KEAP1 p.X566_splice;RB1 p.X163_splice;KEAP1 p.N238Rfs*33;TNFAIP3 p.R61Hfs*37;BRD4 Amplification;MYC Amplification	0	7
P-0005791	P-0005791-T01-IM5	Outside	DNA	Biopsy	250	788	60	Matched	Primary	Nasopharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										NOTCH1 p.A16Rfs*17	0	1
P-0005792	P-0005792-T01-IM5	In-House	DNA	Cytology	250	1406	10	Matched	Metastasis	Lung	Liver	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib(NF1 p.P1359Lfs*19)				LEVEL_4	TP53 p.L194R;FBXW7 p.R479G;ARID1B p.L25Qfs*206;NF1 p.P1359Lfs*19;ID3 Deletion;TGFBR2 Deletion;TCF7L2 LOC100169752-TCF7L2 fusion;LOC100169752 LOC100169752-TCF7L2 fusion	1	8
P-0005793	P-0005793-T01-IM5	In-House	DNA	Biopsy	110.1	83	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H;AKT2 Amplification	1	3
P-0005794	P-0005794-T01-IM5	Outside	DNA	Resection	250	335	70	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.F148Lfs*11	0	1
P-0005795	P-0005795-T01-IM5	Outside	DNA	Resection	250	794	50	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0005796	P-0005796-T01-IM5	In-House	DNA	Biopsy	157.7	334	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				AZD5363(AKT1 p.E17K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	AKT1 p.E17K;KRAS p.G12D;GNAS p.R201H	2	3
P-0005797	P-0005797-T01-IM5	Outside	DNA	Resection	250	526	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TERT Amplification;PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	3
P-0005799	P-0005799-T01-IM5	Outside	DNA	Biopsy	250	691	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.X125_splice	0	1
P-0005800	P-0005800-T01-IM5	Outside	DNA	Resection	250	830	80	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification;PTPRD PTPRD-intragenic	1	2
P-0005801	P-0005801-T01-IM5	In-House	DNA	Resection	250	841	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_4	TP53 p.I255del;ARID1A p.P225Afs*175;KRAS p.Q61H;APC p.R554*;MAP3K1 p.Q1424*;SMAD3 p.Y298*;SMAD2 p.P305L	1	7
P-0005802	P-0005802-T01-IM5	Outside	DNA	Biopsy	250	854	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	FOXA1 p.F266Sfs*55;NF1 Deletion	1	2
P-0005803	P-0005803-T01-IM5	In-House	DNA	Biopsy	250	1070	70	Matched	Primary	Lymph Node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										PTEN p.R233*;CDKN1B p.G72D;MYD88 p.S243N;PIM1 p.S97N;BMPR1A p.X77_splice;FOXO1 p.S22W;CREBBP p.Y1450N;NCOR1 p.W440*;TNFAIP3 p.R71Kfs*29;CDKN2A p.R58*;CD274 BCL2L11-CD274 fusion;BCL2L11 BCL2L11-CD274 fusion	0	12
P-0005804	P-0005804-T01-IM5	In-House	DNA	Resection	250	699	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.W131S;APC p.L1302Cfs*3	0	2
P-0005805	P-0005805-T01-IM5	In-House	DNA	Biopsy	250	686	50	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	EGFR p.E746_A750del;RB1 p.W516*;MGA p.G749Efs*50;AKT1 Amplification;CASP8 Deletion;CBFB Deletion;FGFR3 Amplification;HNF1A Deletion;PTEN Deletion;TBX3 Deletion	2	10
P-0005806	P-0005806-T01-IM5	In-House	DNA	Cytology	200.6	484	50	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM Deletion)				GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	PIK3R1 p.X434_splice;AR Amplification;ATM Deletion;B2M Deletion;CCND1 Amplification;FGF19 Amplification;MGA Deletion;PTEN Deletion;RAD51 Deletion	2	9
P-0005807	P-0005807-T01-IM5	In-House	DNA	Resection	250	1036	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;APC p.Q1627Kfs*23	1	2
P-0005808	P-0005808-T01-IM5	In-House	DNA	Resection	250	770	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										KEAP1 p.R260L;VHL p.C162R	0	2
P-0005810	P-0005810-T01-IM5	In-House	DNA	Biopsy	250	974	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133V	0	1
P-0005811	P-0005811-T01-IM5	In-House	DNA	Biopsy	250	1069	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.E2207*)				LEVEL_4	NF1 p.E2207*;FOXP1 p.M345_Q346delinsI*;KDM6A KDM6A-intragenic	1	3
P-0005812	P-0005812-T01-IM5	In-House	DNA	Cytology	250	649	70	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	EPIS	Soft Tissue Sarcoma	Epithelioid Sarcoma	Tazemetostat(SMARCB1 Deletion)								LEVEL_1	SMARCB1 Deletion	1	1
P-0005813	P-0005813-T01-IM5	In-House	DNA	Resection	250	881	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	TP53 p.V157F;EGFR p.E746_A750del;RB1 p.R798Qfs*4;MCL1 Amplification;NTRK1 Amplification	1	5
P-0005814	P-0005814-T01-IM5	Outside	DNA	Biopsy	250	580	10	Matched	Primary	Lymph node	Not Applicable	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms										DNMT3A p.R882H	0	1
P-0005815	P-0005815-T01-IM5	In-House	DNA	Resection	250	773	80	Matched	Metastasis	Pancreas	Ovary	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;TP53 p.S149Pfs*21;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;PAX5 Amplification;VEGFA Amplification	2	7
P-0005816	P-0005816-T01-IM5	In-House	DNA	Biopsy	250	724	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.Q546R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R)						LEVEL_1	PIK3CA p.Q546R;MAP2K4 p.X297_splice;PRKN Deletion	2	3
P-0005817	P-0005817-T01-IM5	In-House	DNA	Biopsy	250	832	60	Matched	Metastasis	Ileum	Liver	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor										BCOR p.N1459S	0	1
P-0005818	P-0005818-T01-IM5	In-House	DNA	Resection	250	698	50	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G118D);Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.G118D;PIK3CA p.H1047R;GATA3 p.G314Rfs*38;EPHA3 EPHA3-intragenic	4	4
P-0005819	P-0005819-T01-IM5	In-House	DNA	Biopsy	250	879	60	Matched	Metastasis	Esophagus	Liver	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ARID2 p.K1076*;STK11 p.E291*;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	2	5
P-0005820	P-0005820-T01-IM5	In-House	DNA	Resection	250	870	90	Matched	Metastasis	Leg	Small Bowel	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 p.G226D;TP53 Deletion	0	2
P-0005821	P-0005821-T01-IM5	In-House	DNA	Biopsy	250	534	NA	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.R445*;APC p.X141_splice;PBRM1 p.I709Ffs*5;ARID1A ARID1A-intragenic	1	5
P-0005822	P-0005822-T01-IM5	Outside	DNA	Resection	250	662	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.E1107*;PBRM1 p.K1282*;B2M p.X116_splice	0	3
P-0005823	P-0005823-T01-IM5	In-House	DNA	Biopsy	250	751	70	Matched	Metastasis	Ascending Colon	Mesentery	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I);Olaparib(CHEK2 p.R145Q);Olaparib(CHEK2 p.T389Pfs*25)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	B2M p.V69Wfs*34;PTEN p.K267Rfs*9;RNF43 p.G659Vfs*41;KMT2D p.P2354Lfs*30;ERBB2 p.V842I;HIST1H1C p.K23del;CDH1 p.X522_splice;SMAD4 p.S32*;ARID2 p.N1778Ifs*13;RHOA p.T37I;KRAS p.G13D;SETD2 p.S2382Lfs*29;PTPRS p.R1492Q;MSH2 p.E881*;RNF43 p.R371*;CHEK2 p.R145Q;EP300 p.W1466R;NOTCH1 p.V1229Lfs*216;BCL10 p.S167Lfs*6;ARID1A p.P1349Lfs*132;CHEK2 p.T389Pfs*25;NOTCH1 p.T712Pfs*60;CASP8 p.I357Rfs*24;KMT2D p.T698Hfs*6;ARID1A p.T1514Rfs*13;B2M p.T93Lfs*10;MGA p.E1249Rfs*42;ARID2 p.I37Sfs*21	5	28
P-0005824	P-0005824-T01-IM5	In-House	DNA	Resection	250	964	60	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R250*);Olaparib(ATM p.E2245*);Olaparib(ATM p.E2676*);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.E1644*)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.R203C);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);GSK2636771,AZD8186(PTEN p.E288*);Trametinib,Cobimetinib(NF1 p.E230*)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	TP53 p.R213*;XPO1 p.E571K;PTPRT p.R999*;TET1 p.R590*;ASXL2 p.E45*;PIK3CB p.R321Q;FGFR2 p.R203C;POLE p.P286R;APC p.R876*;TP53 p.D259Y;DIS3 p.R689Q;KRAS p.G13D;PBRM1 p.R710*;SMAD2 p.R321Q;FAT1 p.E3190*;ATM p.R250*;JAK1 p.G1148*;JAK1 p.X550_splice;JAK1 p.X216_splice;JAK1 p.X69_splice;CDC73 p.E302*;ASXL2 p.E33*;MSH2 p.E580*;ERCC3 p.E263*;PMS1 p.E168*;EPHA3 p.E265*;PHOX2B p.R141*;TET2 p.A1174V;FBXW7 p.R441W;FAT1 p.X3403_splice;IL7R p.K395N;PIK3R1 p.R348*;APC p.E1577*;RAD50 p.E223*;NOTCH4 p.R1489*;TNFAIP3 p.E338*;TNFAIP3 p.E633*;PRKN p.E79*;RAD21 p.E315*;RAD21 p.R65*;PTPRD p.E1360*;ARID5B p.L381*;TET1 p.X1426_splice;PTEN p.E288*;MRE11 p.E460*;BIRC3 p.E430*;ATM p.E2245*;ATM p.E2676*;KMT2D p.R4198*;FLT3 p.H711N;FLT3 p.F691V;DICER1 p.E1799*;MGA p.E2125*;MGA p.E2508*;MGA p.E2829*;B2M p.S108*;GRIN2A p.Y1151*;CTCF p.X613_splice;ANKRD11 p.E1541*;NF1 p.E230*;BRCA1 p.E1644*;NF2 p.X296_splice;AMER1 p.R531*;SUPT4H1 RNF43-SUPT4H1 fusion;RNF43 RNF43-SUPT4H1 fusion	8	65
P-0005825	P-0005825-T01-IM5	Outside	DNA	Resection	250	959	90	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										NFE2L2 p.R34G;RBM10 p.K536Nfs*168;ARID1A p.X1289_splice;TNFAIP3 Deletion	0	4
P-0005826	P-0005826-T01-IM5	Outside	DNA	Biopsy	250	1095	70	Matched	Metastasis	Pharynx	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										BCL2L1 Amplification;DNMT3B Amplification	0	2
P-0005827	P-0005827-T01-IM5	In-House	DNA	Biopsy	250	669	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3CA p.E542K;SOX9 p.E277*;SMAD4 p.D537H;BCOR p.S949*	3	5
P-0005828	P-0005828-T01-IM5	Outside	DNA	Resection	250	1057	90	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0005829	P-0005829-T01-IM5	Outside	DNA	Resection	250	256	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R1466*)					LEVEL_3B	ATM p.R1466*;CCND2 Amplification;CDK6 Amplification;KDM5A Amplification;KDR Amplification;KRAS Amplification;RICTOR Amplification	1	7
P-0005830	P-0005830-T01-IM5	Outside	DNA	Resection	250	1105	80	Matched	Primary	Lung	Not Applicable	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid										MEN1 p.X224_splice	0	1
P-0005831	P-0005831-T01-IM5	Outside	DNA	Resection	250	1282	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0005832	P-0005832-T01-IM5	Outside	DNA	Biopsy	250	260	70	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ZFHX3 p.S219*;ATRX p.Q193*;ERBB2 Amplification;FOXA1 Amplification;GATA3 Amplification;PPM1D Amplification;MUTYH OSBPL9-MUTYH fusion;OSBPL9 OSBPL9-MUTYH fusion	2	8
P-0005833	P-0005833-T01-IM5	Outside	DNA	Resection	250	669	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)		Cetuximab,Panitumumab(NRAS p.Q61H)			LEVEL_3B	TP53 p.X331_splice;APC p.R564*;NRAS p.Q61H;APC p.T1301Sfs*10	1	4
P-0005834	P-0005834-T01-IM5	Outside	DNA	Biopsy	250	1063	80	Matched	Primary	Brain	Not Applicable	Tumor	PXA	Glioma	Pleomorphic Xanthoastrocytoma				Trametinib,Cobimetinib(CCDC6 BRAF-CCDC6 fusion);Trametinib,Cobimetinib(BRAF BRAF-CCDC6 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;CDKN2B Deletion;CCDC6 BRAF-CCDC6 fusion;BRAF BRAF-CCDC6 fusion	3	4
P-0005835	P-0005835-T01-IM5	In-House	DNA	Biopsy	250	867	80	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ARID5B p.L695Afs*31;TP53 p.E326Dfs*6;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0005836	P-0005836-T01-IM5	In-House	DNA	Cytology	152.8	295	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12R;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0005837	P-0005837-T01-IM5	In-House	DNA	Resection	250	991	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.D187Rfs*66	0	1
P-0005838	P-0005838-T01-IM5	In-House	DNA	Biopsy	127.33	378	20	Matched	Metastasis	Thyroid	Liver	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	BRAF p.V600E;PIK3CA p.E545K;ARID2 p.G1190*	3	3
P-0005839	P-0005839-T01-IM5	In-House	DNA	Resection	250	648	30	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0005840	P-0005840-T01-IM5	In-House	DNA	Biopsy	250	909	70	Matched	Metastasis	Stomach	Bladder	Tumor	SWDNET	Gastrointestinal Neuroendocrine Tumor	Well-Differentiated Neuroendocrine Tumors of the Stomach											0	0
P-0005841	P-0005841-T01-IM5	In-House	DNA	Biopsy	250	964	50	Matched	Metastasis	Bone	Lung	Tumor	ES	Bone Cancer	Ewing Sarcoma										SMARCA4 p.T910M;EWSR1 ERG-EWSR1 fusion;ERG ERG-EWSR1 fusion	0	3
P-0005842	P-0005842-T01-IM5	In-House	DNA	Resection	250	836	80	Matched	Metastasis	Upper Tract	Kidney	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Olaparib(ATM p.K2811Sfs*46)	Tazemetostat(KDM6A p.Q369*)				LEVEL_1	CREBBP p.I1084Sfs*15;FBXW7 p.R465H;KMT2A p.S774Vfs*12;KMT2D p.P2354Lfs*30;ATM p.K2811Sfs*46;FGFR3 p.R248C;KDM5C p.R681*;KDM6A p.Q369*;MSH2 p.Q395*;EP300 p.S12*;STAG2 p.X512_splice;ARID1B p.S723Ifs*27;KMT2D p.P5141Afs*3;ARID1A p.P1407Qfs*74;RYBP p.P165Lfs*43;CTCF p.I257Nfs*2	4	16
P-0005843	P-0005843-T01-IM5	In-House	DNA	Resection	250	1448	90	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PBRM1 p.L618R;NF2 p.K69Rfs*54;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0005844	P-0005844-T01-IM5	In-House	DNA	Resection	250	906	40	Matched	Primary	Small Bowel	Not Applicable	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0005845	P-0005845-T01-IM5	In-House	DNA	Biopsy	250	768	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;ATRX p.Q1007*	1	2
P-0005845	P-0005845-T02-IM5	In-House	FFPE	Resection	250	801	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;ATRX p.Q1007*;RB1 Deletion	1	3
P-0005846	P-0005846-T01-IM5	In-House	DNA	Resection	250	823	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0005847	P-0005847-T01-IM5	In-House	DNA	Resection	250	843	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;FBXW7 p.R465H;SOX9 p.Q416*;STK11 p.D327Vfs*28	1	4
P-0005848	P-0005848-T01-IM5	In-House	DNA	Biopsy	250	248	60	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;FBXW7 p.E287Q;FBXW7 p.W486Lfs*4	2	3
P-0005849	P-0005849-T01-IM5	Outside	DNA	Cytology	250	730	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.G245C;STK11 p.Y36*;FGFR1 Amplification	3	4
P-0005850	P-0005850-T01-IM5	Outside	DNA	Biopsy	250	901	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Trametinib,Cobimetinib(NF1 p.K1986Nfs*26)				LEVEL_3A	KRAS p.G12C;NFE2L2 p.E79K;MAP3K1 p.E438*;PIK3R1 p.R262G;CDK8 p.S60C;NF1 p.K1986Nfs*26	3	6
P-0005851	P-0005851-T01-IM5	Outside	DNA	Biopsy	250	608	30	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.G266*;ARID1A p.E1775*;SMAD2 p.Q455*	2	4
P-0005852	P-0005852-T02-IM5	Outside	FFPE	Biopsy	250	809	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.A289V);GSK2636771,AZD8186(PTEN p.X212_splice);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.A289V;CDKN2C p.L122Wfs*2;PIK3R1 p.X434_splice;RAD50 p.E118*;PTEN p.X212_splice;EGFR Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	3	9
P-0005853	P-0005853-T01-IM5	Outside	DNA	Resection	250	1585	70	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;APC p.V1377Sfs*8;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	0	6
P-0005854	P-0005854-T01-IM5	In-House	DNA	Biopsy	250	468	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.I35S;NFE2L2 p.Q73_T80del;CCND3 Amplification;MYC Amplification;VEGFA Amplification	0	5
P-0005855	P-0005855-T01-IM5	In-House	DNA	Biopsy	250	772	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;ARID2 p.P1236Hfs*7;TP53 p.D207Ffs*3;PAX5 PAX5-intragenic	2	4
P-0005856	P-0005856-T01-IM5	Outside	DNA	Biopsy	154.28	245	50	Matched	Primary	Lung	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.X187_splice;CDKN2A Deletion;CDKN2B Deletion;MAPK1 Amplification;PTPRD Deletion	1	5
P-0005858	P-0005858-T01-IM5	In-House	DNA	Biopsy	250	1732	30	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R248W;TP53 p.R282W;BRAF p.D594N;APC p.K534*;APC p.S1400*	0	5
P-0005859	P-0005859-T01-IM5	Outside	DNA	Biopsy	110.175	501	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification;PIK3CA Amplification	2	2
P-0005860	P-0005860-T01-IM5	In-House	DNA	Biopsy	250	379	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.E271K;ARID1A p.Q840*	1	3
P-0005862	P-0005862-T01-IM5	Outside	DNA	Resection	250	415	40	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	TP53 p.X332_splice;TP53 p.G245D;FAT1 p.Y52*;KMT2D p.R2471*;KMT2D p.G1236Wfs*14;NSD1 p.Y1971*;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	2	8
P-0005863	P-0005863-T01-IM5	In-House	DNA	Biopsy	250	1092	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion)	Cabozantinib,Vandetanib(RET CCDC6-RET fusion);Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion)	BLU-667(RET CCDC6-RET fusion);BLU-667(CCDC6 CCDC6-RET fusion)						LEVEL_1	SETD2 p.Q256*;RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	6	3
P-0005864	P-0005864-T01-IM5	In-House	DNA	Resection	250	907	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CDH1 p.E841*;TP53 p.X187_splice;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0005865	P-0005865-T01-IM5	Outside	DNA	Biopsy	250	929	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.Y220C;APC p.H1490Ffs*23;APC p.L749Ffs*12;PIK3R1 p.X579_splice	1	5
P-0005866	P-0005866-T01-IM5	Outside	DNA	Resection	250	271	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THFO	Thyroid Cancer	Follicular Thyroid Cancer				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R	1	1
P-0005867	P-0005867-T01-IM5	In-House	DNA	Biopsy	250	843	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.S80Pfs*12)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S80Pfs*12)				LEVEL_1	RB1 p.S230*;CDK12 p.S80Pfs*12	2	2
P-0005868	P-0005868-T02-IM5	In-House	DNA	Resection	250	869	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;STK11 p.L282Sfs*5;MYC Amplification	1	3
P-0005869	P-0005869-T01-IM5	Outside	DNA	Biopsy	250	790	30	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.Y336*)				LEVEL_4	PTEN p.Y336*	1	1
P-0005870	P-0005870-T01-IM5	Outside	DNA	Biopsy	215.745	947	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	SETD2 p.P2488Efs*7;CDKN2C Deletion;NF1 Deletion	1	3
P-0005871	P-0005871-T01-IM5	In-House	DNA	Resection	250	713	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.V659E)	Neratinib(ERBB2 p.V659E)						LEVEL_2	KEAP1 p.I566Tfs*28;ERBB2 p.V659E	2	2
P-0005872	P-0005872-T01-IM5	In-House	DNA	Resection	250	816	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0005873	P-0005873-T01-IM5	In-House	DNA	Resection	250	749	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D;RBM10 p.G384Vfs*6	1	2
P-0005874	P-0005874-T01-IM5	Outside	DNA	Resection	250	819	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion	1	1
P-0005875	P-0005875-T02-IM5	Outside	DNA	Resection	250	961	90	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										SDHD Deletion	0	1
P-0005876	P-0005876-T01-IM5	Outside	DNA	Biopsy	250	926	50	Matched	Primary	Duodenum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310Y);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.N71Qfs*49);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	TP53 p.G245D;ERBB2 p.S310Y;PIK3CA p.R108H;KRAS p.G13D;APC p.E1464Vfs*8;ERBB4 p.K1223R;SMAD2 p.D450E;RBM10 p.S203Cfs*64;CDKN2A p.N71Qfs*49;CDKN2A p.R80*	5	10
P-0005877	P-0005877-T01-IM5	Outside	DNA	Biopsy	250	706	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	3
P-0005878	P-0005878-T01-IM5	In-House	DNA	Resection	250	656	40	Matched	Metastasis	Testis	Lung	Tumor	BCCA	Germ Cell Tumor	Choriocarcinoma										KDM5A Amplification	0	1
P-0005879	P-0005879-T01-IM5	Outside	DNA	Biopsy	250	680	60	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R342*;KMT2D p.K1060Efs*8;FAT1 p.V1373Lfs*4;FGFR1 Amplification;MYC Amplification	1	5
P-0005881	P-0005881-T02-IM5	In-House	DNA	Resection	250	838	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.R110L;CDK4 p.R24H;ARID1A p.W1545*	2	4
P-0005882	P-0005882-T01-IM5	In-House	DNA	Biopsy	250	656	60	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.R248Q;CDK4 Amplification	1	2
P-0005883	P-0005883-T01-IM5	Outside	DNA	Resection	250	562	30	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.C136R);GSK2636771,AZD8186(PTEN p.C136Mfs*44)				LEVEL_3B	PIK3CA p.H1047R;PTEN p.C136R;CTNNB1 p.S37F;KMT2D p.S4507Afs*12;PTEN p.C136Mfs*44;ARID1A p.A1466Cfs*25;RNF43 p.D144Afs*14	3	7
P-0005884	P-0005884-T01-IM5	In-House	DNA	Biopsy	250	735	60	Matched	Primary	Rectum	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	SF3B1 p.R625C;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0005884	P-0005884-T02-IM5	In-House	FFPE	Biopsy	250	1093	60	Matched	Primary	Rectum	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	SF3B1 p.R625C;CDKN2A Deletion;CDKN2B Deletion;MAST3 PIK3R2-MAST3 fusion;PIK3R2 PIK3R2-MAST3 fusion	1	5
P-0005885	P-0005885-T01-IM5	Outside	DNA	Resection	250	563	80	Matched	Primary	Brain	Not Applicable	Tumor	APE	CNS Cancer	Anaplastic Ependymoma											0	0
P-0005886	P-0005886-T01-IM5	In-House	DNA	Biopsy	250	1072	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.R130Q);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTEN p.R130Q;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;GLI1 Amplification	3	5
P-0005887	P-0005887-T02-IM5	In-House	DNA	Biopsy	250	753	30	Matched	Metastasis	Ampulla of Vater	Liver	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12R;TP53 p.R342*;ARID1A p.A134Gfs*266;CCND3 Amplification;CDKN2A Deletion;VEGFA Amplification	2	6
P-0005888	P-0005888-T01-IM5	Outside	DNA	Biopsy	250	834	50	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	BRAF p.V600E;PIK3CA p.E545K;APC p.R1450*;TP53 p.V272E;FOXP1 Deletion;MITF Deletion;TGFBR2 Deletion;EP300 EP300-intragenic	4	8
P-0005889	P-0005889-T01-IM5	Outside	DNA	Biopsy	250	619	30	Matched	Metastasis	Testis	Lymph Node	Tumor	SEM	Germ Cell Tumor	Seminoma										TET1 p.K1057Nfs*25;KMT2D MLL2-intragenic	0	2
P-0005890	P-0005890-T01-IM5	In-House	DNA	Biopsy	250	723	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0005891	P-0005891-T01-IM5	In-House	DNA	Resection	250	365	90	Matched	Metastasis	Colon	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558delinsQ)								LEVEL_1	SETD2 p.Q1750*;KIT p.W557_K558delinsQ	1	2
P-0005893	P-0005893-T01-IM5	In-House	DNA	Resection	250	619	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.X79_splice;SETD2 p.C687Afs*9;KDM5C p.L28Sfs*47;VHL p.D121Mfs*38	0	4
P-0005895	P-0005895-T01-IM5	Outside	DNA	Cytology	250	824	70	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;PARP1 p.E26*;TP53 p.X307_splice;AKT2 Amplification;CCNE1 Amplification;EGFR Amplification	1	6
P-0005896	P-0005896-T01-IM5	Outside	DNA	Resection	250	607	70	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.R130G);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252W);GSK2636771,AZD8186(PTEN p.V290Sfs*8)				LEVEL_3B	PTEN p.R130G;BCOR p.N1459S;PIK3CA p.H1047R;FGFR2 p.S252W;SMARCA4 p.R1243W;ARID1A p.S2264*;PTEN p.V290Sfs*8;ARID1A p.N1313Tfs*168;HLA-A p.A16Gfs*83	4	9
P-0005897	P-0005897-T02-IM5	In-House	FFPE	Biopsy	250	1061	20	Matched	Metastasis	Lung	Mediastinum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;PBRM1 p.E70Hfs*2;TP53 p.N310Qfs*27	2	3
P-0005898	P-0005898-T01-IM5	In-House	DNA	Biopsy	250	921	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0005899	P-0005899-T01-IM5	In-House	DNA	Resection	250	976	20	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction										ERBB4 p.K1223T;SH2B3 p.C450Wfs*2;TP53 p.X169_splice;KRAS Amplification;RICTOR Amplification	0	5
P-0005900	P-0005900-T01-IM5	Outside	DNA	Resection	250	653	80	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 p.Q73*)		Rucaparib,Niraparib(BRCA2 p.Q73*)					LEVEL_2	GATA3 p.N331Efs*21;BRCA2 p.Q73*;ANKRD11 p.Y213*;ARID1A p.Y1324Lfs*7;ARID1A p.A228Rfs*2	2	5
P-0005901	P-0005901-T01-IM5	Outside	DNA	Resection	250	752	90	Matched	Primary	Kidney	Not Applicable	Tumor	ROCY	Renal Cell Carcinoma	Renal Oncocytoma											0	0
P-0005901	P-0005901-T02-IM5	Outside	DNA	Resection	250	730	80	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0005902	P-0005902-T01-IM5	In-House	DNA	Resection	250	385	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.T1463Nfs*50)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.T1463Nfs*50)				LEVEL_1	TP53 p.A161S;CDK12 p.T1463Nfs*50;CTNNB1 p.S33A;FOXA1 p.H247Y	2	4
P-0005903	P-0005903-T01-IM5	In-House	DNA	Biopsy	250	955	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(KANSL1 BRIP1-KIAA1267 fusion);Olaparib(BRIP1 BRIP1-KIAA1267 fusion)					LEVEL_3B	CTNNB1 p.S45P;STK11 p.E223*;KANSL1 BRIP1-KIAA1267 fusion;BRIP1 BRIP1-KIAA1267 fusion	2	4
P-0005904	P-0005904-T01-IM5	In-House	DNA	Biopsy	250	1069	70	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										KMT2C p.R2198Efs*4	0	1
P-0005905	P-0005905-T01-IM5	In-House	DNA	Resection	250	498	10	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_1	FGFR3 p.S249C;PIK3CA p.E542K;FOXP1 p.S554Ffs*4	3	3
P-0005906	P-0005906-T01-IM5	Outside	DNA	Biopsy	250	647	90	Matched	Primary	Brain	Not Applicable	Tumor	ATM	CNS Cancer	Atypical Meningioma										NF2 p.R198*	0	1
P-0005907	P-0005907-T01-IM5	Outside	DNA	Biopsy	250	762	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										NOTCH1 p.S2205*;CCND1 Amplification;FGF19 Amplification	0	3
P-0005908	P-0005908-T01-IM5	In-House	DNA	Resection	250	836	70	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.R1450*;APC p.R216*;CBFB p.Q41*;AMER1 p.R641*;PIK3R1 p.G100Efs*15;CDKN2A Deletion;CDKN2B Deletion;TBX3 Deletion;TP53 Deletion	2	10
P-0005909	P-0005909-T01-IM5	In-House	DNA	Resection	250	866	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0005910	P-0005910-T01-IM5	Outside	DNA	Biopsy	250	808	40	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.E545K;APC p.Q1338*;TP53 p.R158H;APC p.R213*;KRAS p.G13D;ARID1A p.K2003Pfs*28;KMT2C p.K1508Nfs*55;TCF7L2 LRRC27-TCF7L2 fusion;LRRC27 LRRC27-TCF7L2 fusion	2	9
P-0005911	P-0005911-T01-IM5	Outside	DNA	Biopsy	250	634	70	Matched	Metastasis	Cancer of Unknown Primary	Pelvis	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.E298*;ARID1A p.Q1212*;TGFBR1 p.Q250*;ARID2 p.Q1717*;MGA p.Q1190*;CIC p.G167*	0	6
P-0005912	P-0005912-T01-IM5	Outside	DNA	Biopsy	250	909	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN p.Y65*);Lapatinib(EGFR Amplification)				LEVEL_3B	TP53 p.R213*;PTEN p.Y65*;CDK4 Amplification;EGFR Amplification;GLI1 Amplification	3	5
P-0005913	P-0005913-T01-IM5	Outside	DNA	Resection	250	367	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.R175C;SETD2 p.L1258*;VHL p.E134Nfs*2;PBRM1 p.M103_E104delinsI*	0	4
P-0005914	P-0005914-T01-IM5	Outside	DNA	Biopsy	67	646	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 STK11-intragenic	0	1
P-0005915	P-0005915-T01-IM5	Outside	DNA	Biopsy	250	1129	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y205C;CCND2 Amplification;FBXW7 Deletion;KDM5A Amplification;KRAS Amplification	0	5
P-0005917	P-0005917-T01-IM5	Outside	DNA	Resection	250	772	30	Matched	Primary	Bladder	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										TP53 p.M246V;TP53 p.L299Afs*6;KDR Amplification	0	3
P-0005918	P-0005918-T01-IM5	Outside	DNA	Resection	250	698	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Tipifarnib(HRAS p.G13N)	Trametinib,Cobimetinib(NF1 p.R416*);Trametinib,Cobimetinib(NF1 p.X1392_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58Afs*57)				LEVEL_3B	ARID2 p.Q1313*;NF1 p.R416*;ERBB4 p.E542K;BBC3 p.Q144*;ARID2 p.K1777Vfs*11;NF1 p.X1392_splice;HRAS p.G13N;CDKN2A p.R58Afs*57	4	8
P-0005919	P-0005919-T01-IM5	In-House	DNA	Biopsy	250	965	20	Unmatched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12S)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TP53 p.R282W;APC p.T1556Nfs*3;NRAS p.G12S	2	4
P-0005920	P-0005920-T01-IM5	In-House	DNA	Resection	250	912	70	Matched	Primary	Lung	Not Applicable	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid											0	0
P-0005921	P-0005921-T01-IM5	In-House	DNA	Biopsy	250	729	30	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.Q123*;MYC Amplification	1	3
P-0005922	P-0005922-T01-IM5	Outside	DNA	Resection	250	831	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										DAXX p.E104*;KMT2C p.T3884Sfs*5;MEN1 p.C426Afs*24	0	3
P-0005923	P-0005923-T01-IM5	In-House	DNA	Resection	250	724	90	Matched	Primary	Esophagus	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K642E)								LEVEL_1	KIT p.K642E;FGFR4 Amplification;KIT Amplification	1	3
P-0005924	P-0005924-T01-IM5	In-House	DNA	Biopsy	185.44	630	60	Matched	Metastasis	Retroperitoneum	Soft Tissue	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										APC Deletion;MAPK1 Amplification	0	2
P-0005925	P-0005925-T02-IM5	Outside	DNA	Biopsy	250	846	50	Matched	Metastasis	Lung	Infrahilar mass	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.V157F;PIK3CA p.E542K;SMAD4 p.Q534*;ARID1A p.M1634*;KMT2C p.Q2220*	2	6
P-0005926	P-0005926-T01-IM5	In-House	DNA	Biopsy	250	963	60	Matched	Metastasis	Neck	Skin	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										XPO1 p.E571K;MYD88 p.L265P;HLA-A p.Q204*;PIM1 p.S97R;PIM1 p.L193F;CDKN2A Deletion;CDKN2B Deletion	0	7
P-0005927	P-0005927-T01-IM5	In-House	DNA	Resection	250	861	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.E57Kfs*7	0	1
P-0005928	P-0005928-T01-IM5	In-House	DNA	Biopsy	130.73	549	10	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma		Imatinib(KIT p.K642E)	Binimetinib,Binimetinib+Ribociclib(NRAS p.G13R)	Sunitinib,Regorafenib,Ripretinib(KIT p.K642E);Olaparib(ATM p.R2691C)					LEVEL_2	NRAS p.G13R;KIT p.K642E;ATM p.R2691C	4	3
P-0005929	P-0005929-T01-IM5	In-House	DNA	Biopsy	250	771	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.A289V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EGFR p.A289V;BMPR1A Deletion;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MDM4 Amplification;PTEN Deletion	4	7
P-0005930	P-0005930-T01-IM5	Outside	DNA	Biopsy	250	752	70	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R342*;TP53 p.R175H;CIC CIC-intragenic	0	3
P-0005931	P-0005931-T01-IM5	In-House	DNA	Resection	250	737	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H98Pfs*37)				LEVEL_4	TP53 p.E298*;FBXW7 p.D520Y;KMT2D p.X4692_splice;FAT1 p.G1080Lfs*8;CDKN2A p.H98Pfs*37;CCND1 Amplification;FGF19 Amplification	1	7
P-0005932	P-0005932-T01-IM5	In-House	DNA	Resection	250	252	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		GSK2636771,AZD8186(PTEN p.D52Vfs*2)				LEVEL_1	PIK3CA p.E542K;PTEN p.D52Vfs*2;MAP3K1 p.P1011Lfs*66;MCL1 Amplification	3	4
P-0005933	P-0005933-T01-IM5	Outside	DNA	Resection	250	836	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM p.R2032T)								LEVEL_1	ATM p.R2032T;APC Deletion;AR Amplification;RASA1 Deletion;STK11 Deletion;TCF3 Deletion;ASXL1 ASXL1-intragenic	1	7
P-0005934	P-0005934-T01-IM5	In-House	DNA	Resection	250	400	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.S80R;PBRM1 p.V530Ffs*39;SETD2 p.K1610Rfs*5	0	3
P-0005935	P-0005935-T01-IM5	In-House	DNA	Resection	250	574	30	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer											0	0
P-0005937	P-0005937-T01-IM5	In-House	DNA	Resection	250	597	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.R248W;SMAD4 p.Q442*;EGFR Amplification	2	4
P-0005937	P-0005937-T02-IM5	Outside	FFPE	Resection	250	989	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;SF3B1 p.K741N	2	2
P-0005937	P-0005937-T03-IM5	Outside	FFPE	Resection	250	900	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	GNAS p.Q227L;KRAS p.G13D;RBM10 p.L181*	1	3
P-0005938	P-0005938-T01-IM5	In-House	DNA	Biopsy	250	932	10	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R2763*)					LEVEL_3B	TP53 p.X225_splice;APC p.K1363*;ATM p.R2763*;FLT3 p.L884P	1	4
P-0005939	P-0005939-T01-IM5	In-House	DNA	Biopsy	151.47	169	80	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0005940	P-0005940-T01-IM5	In-House	DNA	Biopsy	168	440	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.C141Y;RUNX1 p.S295*;PIK3R1 p.Y452_N453insF;ERBB2 Amplification;FGFR4 Amplification	2	5
P-0005941	P-0005941-T01-IM5	In-House	DNA	Resection	250	662	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.E286K;APC p.Q1095*;BCL2L1 Amplification;EGFR Amplification;FAT1 Deletion;NKX3-1 Deletion;RAC1 Amplification	0	7
P-0005942	P-0005942-T01-IM5	In-House	DNA	Resection	250	1178	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	ERBB2 p.Y772_A775dup;TP53 p.X261_splice;TP53 p.D184Efs*64	2	3
P-0005943	P-0005943-T01-IM5	In-House	DNA	Biopsy	250	790	70	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;GATA3 p.M293K;ARID1A p.Q268*;SPEN p.E800*;MAP3K1 p.S1039*;MAP3K1 p.Q1207*;KMT2C p.E4026*;HNF1A Deletion	2	8
P-0005944	P-0005944-T01-IM5	In-House	DNA	Cytology	250	443	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;PBRM1 p.E191Kfs*10	1	2
P-0005945	P-0005945-T01-IM5	In-House	DNA	Biopsy	250	1099	90	Matched	Metastasis	Lymph Node	Soft Tissue	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										NOTCH2 p.Y2392*;EGFR p.V148M;PTPRD p.X1794_splice;CREBBP p.Y1482N;NOTCH2 p.L2135Qfs*2	0	5
P-0005946	P-0005946-T01-IM5	Outside	DNA	Biopsy	137.465	829	80	Matched	Metastasis	Ovary	Peritoneum	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;ARID1A p.E1542*	1	2
P-0005947	P-0005947-T01-IM5	In-House	DNA	Resection	250	648	80	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)	GSK2636771,AZD8186(PTEN p.N323Mfs*21)				LEVEL_3B	PTCH1 p.S1203Afs*52;JAK1 p.K860Nfs*16;PTEN p.N323Mfs*21;RNF43 p.G659Vfs*41;TP53 p.R273C;SETD2 p.S2382Lfs*29;NCOA3 p.R80C;TCF7L2 p.K485Sfs*23;FUBP1 p.S11Lfs*43;KMT2C p.N2842Mfs*21;PTPRT p.R453H;FAT1 p.K1225Nfs*9;KMT2D p.F2244Sfs*20;ARID1A p.N2059Tfs*76;TGFBR2 p.K105Sfs*19	2	15
P-0005948	P-0005948-T01-IM5	Outside	DNA	Biopsy	250	677	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.V47Gfs*6;FAT1 Deletion;MAP2K4 Deletion;KMT2C Deletion;MYC Amplification	0	5
P-0005949	P-0005949-T01-IM5	In-House	DNA	Resection	250	604	40	Matched	Metastasis	Cecum	Sigmoid Colon	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma											0	0
P-0005950	P-0005950-T01-IM5	In-House	DNA	Biopsy	250	723	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R273C;MAP3K1 p.S431*;MAP3K1 p.T457Yfs*4;FOXA1 p.N252_G257del;KDM5C p.D443Vfs*11;FOXP1 Deletion;PTEN Deletion;RYBP Deletion	1	8
P-0005951	P-0005951-T01-IM5	In-House	DNA	Biopsy	250	807	20	Matched	Primary	Brain	Not Applicable	Tumor	LGGNOS	Glioma	Low-Grade Glioma, NOS				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0005952	P-0005952-T01-IM5	In-House	DNA	Resection	250	889	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma			Temsirolimus(MTOR p.L1460P)		Everolimus(MTOR p.L1460P)				LEVEL_3A	MTOR p.L1460P;PBRM1 p.X129_splice;VHL p.I147Hfs*7	2	3
P-0005953	P-0005953-T01-IM5	In-House	DNA	Biopsy	250	982	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										HLA-A Deletion;RB1 Deletion;RNF43 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	5
P-0005953	P-0005953-T02-IM5	In-House	DNA	Biopsy	250	610	80	Matched	Metastasis	Prostate	Pelvis	Tumor	PRSCC	Prostate Cancer	Prostate Small Cell Carcinoma										EPHA7 Deletion;RB1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0005954	P-0005954-T01-IM5	Outside	DNA	Resection	250	498	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.S65L;SETD2 p.R541*;TGFBR2 Deletion	0	3
P-0005956	P-0005956-T01-IM5	In-House	DNA	Resection	250	785	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.K132N;BCOR Deletion	0	2
P-0005957	P-0005957-T01-IM5	In-House	DNA	Resection	250	988	80	Matched	Metastasis	Adrenal Gland	Lung	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										CTNNB1 p.Y30_S33del;RB1 p.X240_splice	0	2
P-0005958	P-0005958-T01-IM5	Outside	DNA	Resection	250	642	90	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.T133Nfs*2;SETD2 p.X1529_splice;NKX3-1 p.P80Rfs*25	0	3
P-0005959	P-0005959-T01-IM5	In-House	DNA	Resection	250	899	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X166_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;ATM p.X166_splice;ZFHX3 ZFHX3-intragenic	2	3
P-0005960	P-0005960-T01-IM5	In-House	DNA	Biopsy	250	447	10	Matched	Primary	Duodenum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;APC p.T1556Nfs*3	1	2
P-0005961	P-0005961-T01-IM5	In-House	DNA	Resection	250	875	30	Matched	Metastasis	Sigmoid Colon	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.D92N)				LEVEL_1	BRAF p.V600E;PTEN p.D92N;TP53 p.N131del	4	3
P-0005962	P-0005962-T01-IM5	Outside	DNA	Resection	250	733	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Y163C;BRAF p.D594G	0	2
P-0005963	P-0005963-T01-IM5	Outside	DNA	Biopsy	250	1318	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.T125R;BCOR p.R1164*;AKT1 Amplification;EGFR Amplification;FAT1 Deletion;GATA3 Deletion	1	6
P-0005964	P-0005964-T01-IM5	In-House	DNA	Resection	250	691	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	TMT	Germ Cell Tumor	Teratoma with Malignant Transformation										TP53 p.P301Qfs*44;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	4
P-0005965	P-0005965-T01-IM5	In-House	DNA	Biopsy	201.195	430	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.L2427R)				LEVEL_4	VHL p.P86S;MTOR p.L2427R;PBRM1 p.I252Rfs*11	1	3
P-0005966	P-0005966-T01-IM5	In-House	DNA	Biopsy	250	737	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(TACC3 FGFR3-TACC3 fusion);Erdafitinib(FGFR3 FGFR3-TACC3 fusion)		Debio1347,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TET2 p.V1056Lfs*10;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification;SH2D1A Deletion;STAG2 Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	7	9
P-0005967	P-0005967-T01-IM5	In-House	DNA	Biopsy	250	622	90	Unmatched	Metastasis	Lymph node	Kidney	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MED12 p.G44A;SMAD4 p.H132Y;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;MEN1 Deletion;RUNX1 Amplification;VEGFA Amplification	0	8
P-0005969	P-0005969-T01-IM5	In-House	DNA	Resection	250	843	70	Matched	Metastasis	Bone	Lung	Tumor	CHS	Bone Cancer	Chondrosarcoma				Ivosidenib(IDH1 p.R132G)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A-DT CDKN2A-C9orf53 fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-C9orf53 fusion)				LEVEL_3B	IDH1 p.R132G;CDKN2A-DT CDKN2A-C9orf53 fusion;CDKN2A CDKN2A-C9orf53 fusion	3	3
P-0005970	P-0005970-T01-IM5	In-House	DNA	Biopsy	250	925	50	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification;MAP3K1 Deletion	0	2
P-0005970	P-0005970-T02-IM5	In-House	FFPE	Biopsy	250	855	90	Matched	Metastasis	Prostate	Brain	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ANKRD11 Deletion;AR Amplification;FANCA Deletion;MAP3K1 Deletion;SPEN Deletion	0	5
P-0005970	P-0005970-T03-IM5	In-House	FFPE	Biopsy	250	1048	60	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA1 p.S886Cfs*16)			Niraparib,Talazoparib(BRCA1 p.S886Cfs*16)					LEVEL_1	BRCA1 p.S886Cfs*16;DICER1 p.X1868_splice;DICER1 p.X1843_splice;ANKRD11 Deletion;AR Amplification;FANCA Deletion;MAP3K1 Deletion;SPEN Deletion;DICER1 DICER1-intragenic	2	9
P-0005971	P-0005971-T02-IM5	In-House	FFPE	Resection	250	628	90	Matched	Metastasis	Skin	Ovary	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R115P)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;PIK3CA p.R115P;CDKN2A Deletion;CDKN2B Deletion;PRDM1 Deletion;PTEN Deletion	5	6
P-0005971	P-0005971-T01-IM5	Outside	DNA	Cytology	150.45	706	50	Matched	Metastasis	Skin	Bone	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0005972	P-0005972-T01-IM5	In-House	DNA	Biopsy	250	841	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.L536P)	Everolimus(TSC1 p.E813*)					LEVEL_3A	ESR1 p.L536P;TSC1 p.E813*;TP53 p.R174Gfs*73	2	3
P-0005973	P-0005973-T01-IM5	Outside	DNA	Resection	250	602	70	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557R)					LEVEL_3B	KIT p.W557R;PIK3R2 p.D557H	1	2
P-0005974	P-0005974-T01-IM5	In-House	DNA	Biopsy	250	818	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750delinsP)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R);Everolimus,Temsirolimus(MTOR p.T1977K)				LEVEL_1	KRAS p.Q61R;PPP2R1A p.R183Q;MTOR p.T1977K;EGFR p.E746_A750delinsP;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification;RICTOR Amplification;TERT Amplification	5	9
P-0005975	P-0005975-T01-IM5	In-House	DNA	Resection	250	742	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.E904*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;SMARCA4 p.X1259_splice;PBRM1 p.I279Nfs*8;BRCA1 p.E904*;SMARCA4 p.E1293*;KEAP1 p.G433Afs*25;STK11 p.Y60*	3	7
P-0005976	P-0005976-T01-IM5	In-House	DNA	Biopsy	250	1409	80	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										JAK1 p.Q1143*;BRAF p.S151A;GPS2 Deletion;MAP2K4 Deletion;ACAP1 TP53-ACAP1 fusion;TP53 TP53-ACAP1 fusion	0	6
P-0005977	P-0005977-T01-IM5	In-House	DNA	Biopsy	250	531	60	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;NF2 Deletion;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	3	6
P-0005979	P-0005979-T01-IM5	Outside	DNA	Resection	250	643	80	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										TERT Amplification	0	1
P-0005980	P-0005980-T01-IM5	Outside	DNA	Biopsy	205.83	625	90	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;SETD2 p.N604Ifs*18;CDKN1B Deletion;EPHA7 Deletion	1	4
P-0005981	P-0005981-T01-IM5	In-House	DNA	Resection	250	1121	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;TP53 p.I195T;MAX p.Q110*;TRAF7 p.R189P;RBM10 p.G168Vfs*98;NKX2-1 Amplification	1	6
P-0005983	P-0005983-T01-IM5	In-House	DNA	Resection	250	573	90	Matched	Metastasis	Small Bowel	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma											0	0
P-0005984	P-0005984-T01-IM5	In-House	DNA	Resection	250	763	90	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Niraparib,Olaparib,Rucaparib,Talazoparib(PROCA1 BRCA1-PROCA1 fusion);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 BRCA1-PROCA1 fusion)					LEVEL_1	TP53 p.R273H;SMAD4 p.D537E;BIRC3 p.K596Qfs*18;CCNE1 Amplification;ERBB2 Amplification;FGFR3 Amplification;MYC Amplification;PROCA1 BRCA1-PROCA1 fusion;BRCA1 BRCA1-PROCA1 fusion	4	9
P-0005985	P-0005985-T01-IM5	In-House	DNA	Biopsy	142.2	851	NA	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	EGFR p.L858R;PIK3CA p.E545K;TP53 p.R175H;ZFHX3 p.P2056Afs*100;ANKRD11 Deletion;FANCA Deletion;FOXA1 Amplification;NKX2-1 Amplification;RB1 Deletion	2	9
P-0005986	P-0005986-T01-IM5	In-House	DNA	Biopsy	128.59	278	70	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0005987	P-0005987-T01-IM5	In-House	DNA	Resection	250	860	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.K2811Sfs*46)	GSK2636771,AZD8186(PTEN p.V290*);GSK2636771,AZD8186(PTEN p.V45A)				LEVEL_3B	APC p.T1556Nfs*3;APC p.S1465Rfs*9;ATM p.K2811Sfs*46;ERCC4 p.M361Nfs*4;PIK3R1 p.K567E;PTEN p.V290*;SOX9 p.S23Afs*38;PTEN p.V45A;RB1 p.X88_splice;SMARCA4 p.X1318_splice;NOTCH1 p.S2486Rfs*103;AMER1 p.L489Afs*19	3	12
P-0005988	P-0005988-T01-IM5	Outside	DNA	Biopsy	250	599	80	Matched	Metastasis	Thyroid	Bone	Tumor	THFO	Thyroid Cancer	Follicular Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;TERT Amplification	2	2
P-0005989	P-0005989-T01-IM5	Outside	DNA	Biopsy	250	1056	80	Matched	Primary	Small Bowel	Not Applicable	Tumor	CCS	Soft Tissue Sarcoma	Clear Cell Sarcoma										MGA p.X1219_splice;IKZF1 Deletion;EWSR1 C11orf49-EWSR1 fusion;C11orf49 C11orf49-EWSR1 fusion;EWSR1 CREB1-EWSR1 fusion;CREB1 CREB1-EWSR1 fusion	0	6
P-0005990	P-0005990-T01-IM5	In-House	DNA	Cytology	250	922	20	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										NF2 p.X525_splice;TP53 p.H214Lfs*33	0	2
P-0005991	P-0005991-T01-IM5	Outside	DNA	Biopsy	250	932	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	SMAD4 p.Q116*;TP53 p.I195Lfs*53;AKT2 Amplification;CCNE1 Amplification;NF1 Deletion	1	5
P-0005992	P-0005992-T01-IM5	In-House	DNA	Resection	250	886	40	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y129C)				LEVEL_3B	CDKN2A p.Y129C;MDM2 Amplification	2	2
P-0005993	P-0005993-T01-IM5	In-House	DNA	Resection	250	1127	60	Matched	Metastasis	Esophagus	Lung	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Olaparib(CDK12 CDK12-intragenic)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 CDK12-intragenic)				LEVEL_1	TP53 p.H193Y;KMT2A p.R1101*;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;FGF19 Amplification;CDK12 CDK12-intragenic	5	8
P-0005994	P-0005994-T01-IM5	In-House	DNA	Biopsy	250	1135	20	Matched	Metastasis	Oral Cavity	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.P152T;KDM6A p.E1335*;EGFR Amplification	0	3
P-0005995	P-0005995-T01-IM5	Outside	DNA	Biopsy	250	1036	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.X224_splice;ARID2 p.G1747*;POLD1 p.S478R;ERBB2 Amplification	2	4
P-0005996	P-0005996-T01-IM5	In-House	DNA	Resection	250	786	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(CHEK2 p.S56Afs*5)					LEVEL_1	BRAF p.V600E;TP53 p.P151S;RNF43 p.Y197*;BMPR1A p.Y103*;SOX9 p.S421Kfs*157;CHEK2 p.S56Afs*5	4	6
P-0005997	P-0005997-T01-IM5	Outside	DNA	Cytology	250	955	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12D;TP53 p.R248W;SMAD4 p.*553Lext*40;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification;TERT Amplification	3	7
P-0005998	P-0005998-T01-IM5	In-House	DNA	Biopsy	250	849	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	TP53 p.R248W;KRAS p.G12V;APC p.P1076Lfs*3	1	3
P-0005999	P-0005999-T01-IM5	Outside	DNA	Biopsy	250	921	20	Matched	Primary	Stomach	Not Applicable	Tumor	SPDAC	Esophagogastric Cancer	Poorly Differentiated Carcinoma of the Stomach										TP53 p.K164E	0	1
P-0006000	P-0006000-T02-IM5	In-House	DNA	Biopsy	250	877	20	Matched	Metastasis	Descending Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Everolimus,Temsirolimus(MTOR p.E1799K)				LEVEL_4	TP53 p.R196*;MTOR p.E1799K;APC p.Q1237Efs*2	1	3
P-0006001	P-0006001-T01-IM5	In-House	DNA	Resection	250	883	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	EED p.X323_splice;CDKN2A Deletion;CDKN2B Deletion;SMAD4 Deletion	1	4
P-0006002	P-0006002-T01-IM5	In-House	DNA	Resection	250	547	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.V172D	1	2
P-0006003	P-0006003-T01-IM5	Outside	DNA	Resection	250	995	80	Matched	Metastasis	Lung	Abdomen	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Afatinib(EGFR p.G719A)			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*)				LEVEL_1	EGFR p.E709K;EGFR p.G719A;CDKN2A p.E88*;ARID5B Deletion;CARD11 Amplification;EGFR Amplification;MDM2 Amplification;RAC1 Amplification;YAP1 Amplification;ZFHX3 Deletion	3	10
P-0006004	P-0006004-T01-IM5	In-House	DNA	Resection	250	757	70	Matched	Primary	Lung	Not Applicable	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										MEN1 p.G440Afs*10	0	1
P-0006005	P-0006005-T01-IM5	Outside	DNA	Resection	250	625	70	Matched	Primary	Kidney	Not Applicable	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma										TFE3 ASPSCR1-TFE3 fusion;ASPSCR1 ASPSCR1-TFE3 fusion	0	2
P-0006006	P-0006006-T01-IM5	In-House	DNA	Biopsy	250	908	70	Matched	Primary	Sinonasal	Not Applicable	Tumor	SNUC	Head and Neck Cancer	Sinonasal Undifferentiated Carcinoma				Enasidenib(IDH2 p.R172T)					LEVEL_3B	IDH2 p.R172T;SETD2 p.N261Tfs*8;ASXL1 p.I597Sfs*106	1	3
P-0006007	P-0006007-T01-IM5	Outside	DNA	Resection	250	460	70	Matched	Primary	Cervix	Not Applicable	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.S241F;KMT2D p.S2839*;KMT2C p.D2024Tfs*8	1	4
P-0006008	P-0006008-T01-IM5	In-House	DNA	Biopsy	250	963	60	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.L1317*)					LEVEL_3B	TP53 p.R273C;TP53 p.R196L;KDM5C p.X219_splice;BRCA1 p.L1317*;CDC73 p.Q490Rfs*5	1	5
P-0006011	P-0006011-T01-IM5	In-House	DNA	Resection	250	810	30	Matched	Primary	Bone	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0006012	P-0006012-T01-IM5	Outside	DNA	Resection	250	757	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R213*	0	1
P-0006013	P-0006013-T01-IM5	In-House	DNA	Resection	250	686	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.N239dup	1	2
P-0006014	P-0006014-T01-IM5	In-House	DNA	Resection	250	703	50	Matched	Metastasis	Uterus	Omentum	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V697L);Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R273H;PIK3CA p.M1043V;ERBB2 p.V697L;KMT2D p.P936Lfs*21;CCNE1 Amplification;ERBB2 Amplification	4	6
P-0006015	P-0006015-T01-IM5	In-House	DNA	Biopsy	250	609	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.V242F)	Tipifarnib(HRAS p.G13R)					LEVEL_3A	HRAS p.G13R;ERBB3 p.N126K;ERBB3 p.E332K;FBXW7 p.T532P;RB1 p.L491P;ERCC2 p.V242F;STAG2 p.X1156_splice;TET1 p.X656_splice;EP300 p.G1566Rfs*29;FOXP1 Deletion	2	10
P-0006016	P-0006016-T01-IM5	In-House	DNA	Biopsy	250	809	70	Matched	Metastasis	Ampulla of Vater	Duodenum	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma											0	0
P-0006017	P-0006017-T01-IM5	Outside	DNA	Resection	250	536	90	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.Y823D)					LEVEL_3B	KIT p.Y823D	1	1
P-0006018	P-0006018-T01-IM5	In-House	DNA	Resection	250	564	90	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.Q171*;DAXX p.D738Rfs*3	0	2
P-0006019	P-0006019-T01-IM5	In-House	DNA	Biopsy	250	476	30	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R158H;IDH1 p.R132H;TP53 p.T150Afs*16;ATRX p.H1363Rfs*12	1	4
P-0006020	P-0006020-T01-IM5	Outside	DNA	Resection	250	627	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.E1455_D1458dup)				LEVEL_4	MTOR p.E1455_D1458dup	1	1
P-0006021	P-0006021-T01-IM5	In-House	DNA	Biopsy	250	202	50	Matched	Metastasis	Lung	Epidural	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;CREBBP p.Y1726*;RBM10 p.Q742*	2	3
P-0006022	P-0006022-T01-IM5	Outside	DNA	Biopsy	250	698	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.L42H);Trametinib,Cobimetinib(NF1 p.T956Nfs*19);Trametinib,Cobimetinib(NF1 p.F2650Sfs*9);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTPN11 p.A72V;SETD2 p.R2040*;PTEN p.L42H;NF1 p.T956Nfs*19;NF1 p.F2650Sfs*9;STAG2 p.D840Yfs*2;ARID1A Deletion;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;GATA3 Deletion;ID3 Deletion	4	12
P-0006023	P-0006023-T02-IM5	In-House	DNA	Resection	250	798	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;TP53 p.R282W;APC p.R213*;FAT1 p.K1299Nfs*69;APC p.I1574Mfs*75;SOX9 SOX9-intragenic	0	6
P-0006024	P-0006024-T01-IM5	In-House	DNA	Resection	250	564	80	Matched	Primary	Mediastinum	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0006025	P-0006025-T01-IM5	In-House	DNA	Cytology	250	2778	60	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.E294Sfs*51;KMT2D p.X2037_splice;RB1 p.Q93*;GPS2 Deletion	0	4
P-0006026	P-0006026-T01-IM5	In-House	DNA	Biopsy	250	821	10	Matched	Metastasis	Stomach	Falciform Ligament	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R273H;CREBBP p.Q1209Tfs*25;RICTOR Amplification	0	3
P-0006027	P-0006027-T01-IM5	In-House	DNA	Resection	250	706	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.V272L;SMAD4 p.G386V	1	3
P-0006028	P-0006028-T01-IM5	In-House	DNA	Resection	250	917	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0006029	P-0006029-T01-IM5	In-House	DNA	Biopsy	250	713	60	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_3B	PIK3CA p.H1047R;PTEN p.R130Q;RB1 p.X46_splice;KMT2C p.Q3654Lfs*4;BRAF p.N486_A489delinsK	2	5
P-0006030	P-0006030-T01-IM5	In-House	DNA	Biopsy	164	187	10	Matched	Metastasis	Jejunum	Periumbilical mass	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer										TP53 p.K292Gfs*52;CDK6 Amplification	0	2
P-0006031	P-0006031-T01-IM5	Outside	DNA	Resection	250	512	70	Matched	Metastasis	Kidney	Lymph Node	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										SETD2 p.S791*;SH2B3 p.S303*;NF2 p.L127*	0	3
P-0006032	P-0006032-T01-IM5	In-House	DNA	Biopsy	250	887	50	Matched	Metastasis	Major Salivary Gland	Liver	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										CREBBP p.Y1450N	0	1
P-0006033	P-0006033-T01-IM5	Outside	DNA	Biopsy	250	709	80	Matched	Metastasis	Soft Tissue	Bone	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)					LEVEL_3B	PIK3CA p.M1043V;FGFR4 p.V550L;B2M Deletion;FGFR4 Amplification;MGA Deletion;RAD51 Deletion	1	6
P-0006034	P-0006034-T01-IM5	In-House	DNA	Cytology	215.1	752	60	Matched	Metastasis	Skin	Lymph Node, Non-Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D);Binimetinib,Binimetinib+Ribociclib(NRAS p.T50I)						LEVEL_3A	PBRM1 p.E1214Rfs*6;NRAS p.G12D;PTPRT p.W506*;PBRM1 p.N121*;NRAS p.T50I;CARD11 Amplification;RAC1 Amplification	2	7
P-0006035	P-0006035-T01-IM5	Outside	DNA	Resection	250	627	80	Matched	Primary	Testis	Not Applicable	Tumor	SCST	Sex Cord Stromal Tumor	Sex Cord Stromal Tumor										CTNNB1 p.D32_S33del	0	1
P-0006036	P-0006036-T01-IM5	Outside	DNA	Biopsy	83.7	315	30	Matched	Primary	Diaphragm	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										SETD2 p.Y1097*;BAP1 p.K651*	0	2
P-0006037	P-0006037-T01-IM5	Outside	DNA	Resection	250	564	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132L)					LEVEL_3B	TP53 p.R248W;IDH1 p.R132L;ATRX p.Q176*	1	3
P-0006038	P-0006038-T01-IM5	Outside	DNA	Resection	250	864	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	TP53 p.R273H;KRAS p.G12D;RNF43 p.R371*	1	3
P-0006040	P-0006040-T01-IM5	In-House	DNA	Biopsy	250	951	90	Matched	Primary	Mediastinum	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0006042	P-0006042-T01-IM5	Outside	DNA	Resection	250	690	80	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib(BARD1 Deletion)					LEVEL_3B	MGA p.Q1588*;TP53 p.E326K;MED12 p.G44V;BARD1 Deletion;TP53 Deletion	1	5
P-0006043	P-0006043-T01-IM5	In-House	DNA	Cytology	250	604	20	Matched	Metastasis	Stomach	Lymph Node	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										GNAS p.R201C	0	1
P-0006044	P-0006044-T01-IM5	Outside	DNA	Resection	250	437	70	Matched	Primary	Lung	Not Applicable	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										EIF1AX p.R13P;MYCL Amplification	0	2
P-0006045	P-0006045-T02-IM5	In-House	FFPE	Resection	250	858	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERRFI1 Deletion	2	4
P-0006045	P-0006045-T01-IM5	Outside	DNA	Biopsy	250	904	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	ARID5B Deletion;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERBB3 Amplification;ERRFI1 Deletion;GATA3 Deletion;KMT2D Deletion	3	9
P-0006046	P-0006046-T01-IM5	In-House	DNA	Cytology	250	716	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Cisplatin(ERCC2 p.V407Cfs*16)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.R342*;ERCC2 p.V407Cfs*16;NKX2-1 Amplification	2	4
P-0006047	P-0006047-T02-IM5	In-House	FFPE	Biopsy	159.222	1146	60	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 EZR-ROS1 fusion);Crizotinib,Entrectinib(EZR EZR-ROS1 fusion)								LEVEL_1	TP53 p.T155I;ROS1 EZR-ROS1 fusion;EZR EZR-ROS1 fusion	2	3
P-0006048	P-0006048-T02-IM5	In-House	DNA	Cytology	165	332	70	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					GSK2636771,AZD8186(PTEN p.X343_splice);Trametinib,Cobimetinib(NF1 p.K449*);Trametinib,Cobimetinib(NF1 p.Q1360Sfs*20)				LEVEL_4	TP53 p.P278S;PTEN p.X343_splice;KMT2D p.C1471F;CREBBP p.D1435G;NF1 p.K449*;NOTCH3 p.A625Qfs*11;NF1 p.Q1360Sfs*20;RECQL4 p.A805Pfs*38;RB1 Deletion	3	9
P-0006049	P-0006049-T01-IM5	Outside	DNA	Resection	250	1088	90	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Olaparib(BARD1 Deletion)					LEVEL_3B	TP53 p.P278S;RB1 p.W516*;HOXB13 p.W263*;BARD1 Deletion;INHA Deletion	1	5
P-0006050	P-0006050-T01-IM5	Outside	DNA	Biopsy	250	1001	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.P152L;SMAD4 Deletion;TGFBR2 Deletion	1	4
P-0006051	P-0006051-T01-IM5	Outside	DNA	Resection	217.71	610	40	Matched	Metastasis	Breast	Small Bowel	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;NCOR1 p.K144*;CDH1 p.I135Nfs*33;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	1	9
P-0006052	P-0006052-T01-IM5	Outside	DNA	Resection	250	785	90	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung	Capmatinib(MET p.D1010Y)	Crizotinib(MET p.D1010Y)	Cabozantinib(MET p.D1010Y)		Trametinib,Cobimetinib(NF1 p.V1321Wfs*6)				LEVEL_1	MET p.D1010Y;TP53 p.X261_splice;PTPRD p.X1554_splice;FLCN p.D498Wfs*13;NF1 p.V1321Wfs*6	4	5
P-0006053	P-0006053-T01-IM5	Outside	DNA	Biopsy	250	169	70	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										ANKRD11 p.E1444*	0	1
P-0006054	P-0006054-T01-IM5	Outside	DNA	Biopsy	250	945	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.A289V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.A289V;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;GATA3 Deletion;TCF7L2 Deletion	3	6
P-0006055	P-0006055-T01-IM5	Outside	DNA	Resection	250	985	80	Matched	Metastasis	Kidney	Brain	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.C1483Y)				LEVEL_4	MTOR p.C1483Y;VHL p.V155L;PBRM1 p.Q188*;PTPRT p.Q432Pfs*35;TGFBR2 Deletion	1	5
P-0006056	P-0006056-T01-IM5	Outside	DNA	Biopsy	68.72	332	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.G199_E204del;EP300 p.S82*;SMARCA4 p.Y901Mfs*9	1	4
P-0006057	P-0006057-T01-IM5	In-House	DNA	Resection	250	872	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;TP53 p.F113V;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0006058	P-0006058-T02-IM5	Outside	FFPE	Biopsy	250	666	20	Matched	Primary	Anorectal Junction	Not Applicable	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS					GSK2636771,AZD8186(PTEN p.X85_splice)				LEVEL_4	PTEN p.X85_splice	1	1
P-0006059	P-0006059-T01-IM5	In-House	DNA	Cytology	250	914	30	Matched	Primary	Lymph node	Not Applicable	Tumor	FDCS	Soft Tissue Sarcoma	Follicular Dendritic Cell Sarcoma										B2M p.L15Ffs*41;NFKBIA p.T121Pfs*43;B2M p.L107Cfs*6;MED12 p.R1611Afs*42;NFKBIA Deletion	0	5
P-0006060	P-0006060-T01-IM5	In-House	DNA	Resection	250	807	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.H179R;KMT2C p.R3507*;FAT1 p.E3300*;MAX p.R60W;SETD2 p.A693Gfs*7	2	6
P-0006061	P-0006061-T01-IM5	Outside	DNA	Resection	250	821	40	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;STK11 p.W308*	1	2
P-0006062	P-0006062-T01-IM5	Outside	DNA	Resection	250	1090	90	Matched	Metastasis	Cancer of Unknown Primary	Ovary	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252W)				LEVEL_4	FGFR2 p.S252W;FBXW7 p.R505L;TP53 p.X307_splice;MAP2K4 p.R281*;RB1 p.M148Ifs*8;BCL2L11 Deletion;CCNE1 Amplification;CDC73 Deletion;CDKN1B Deletion;CIC Deletion;PHOX2B Deletion;COP1 Deletion;SDHC Deletion;TERT Amplification	1	14
P-0006063	P-0006063-T01-IM5	Outside	DNA	Resection	250	1075	80	Matched	Metastasis	Lung	Colon	Tumor	LUPC	Non-Small Cell Lung Cancer	Pleomorphic Carcinoma of the Lung			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;TP53 p.G262Vfs*83;CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification	3	5
P-0006064	P-0006064-T01-IM5	Outside	DNA	Resection	250	1002	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0006065	P-0006065-T01-IM5	In-House	DNA	Resection	250	891	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010H)	Crizotinib(MET p.D1010H)	Cabozantinib(MET p.D1010H)						LEVEL_1	MET p.D1010H	3	1
P-0006066	P-0006066-T01-IM5	In-House	DNA	Resection	250	895	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.L130V;SMAD4 p.G508V;ARID1A p.E2250Rfs*28	1	4
P-0006067	P-0006067-T01-IM5	In-House	DNA	Resection	250	941	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;CDKN1B p.E22*;MAP3K1 p.V1147Ifs*23	2	3
P-0006068	P-0006068-T01-IM5	In-House	DNA	Resection	250	1147	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Olaparib(ATM p.E1776*);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	GATA3 p.P408Afs*99;ATM p.E1776*;CCND1 Amplification;ERBB2 Amplification;ERBB3 Amplification;FGF19 Amplification;MDM2 Amplification;PPM1D Amplification	4	8
P-0006069	P-0006069-T01-IM5	Outside	DNA	Biopsy	250	859	70	Matched	Metastasis	Anus	Liver	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)					LEVEL_3B	PIK3CA p.Q546K;RPS6KA4 p.S236L	1	2
P-0006071	P-0006071-T01-IM5	In-House	DNA	Biopsy	250	752	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.A138V;STK11 p.Q220*;IL7R p.I241M;CBL p.H398N;RB1 p.E282*;SMAD4 p.D351_G352delinsVL;MCL1 Amplification;PTPRD Deletion;SOCS1 SOCS1-intragenic	0	9
P-0006072	P-0006072-T01-IM5	In-House	DNA	Resection	250	973	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.H193R	1	2
P-0006073	P-0006073-T01-IM5	In-House	DNA	Resection	250	972	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12D;KRAS p.G12C;TP53 p.R248W	3	3
P-0006074	P-0006074-T01-IM5	Outside	DNA	Biopsy	250	568	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.L536P)						LEVEL_3A	ESR1 p.L536P;TP53 p.G279E;MAP2K4 Deletion;MAPK1 Amplification;MYC Amplification;NCOR1 Deletion;TOP1 SLC13A3-TOP1 fusion;SLC13A3 SLC13A3-TOP1 fusion	1	8
P-0006076	P-0006076-T01-IM5	Outside	DNA	Biopsy	250	727	70	Matched	Primary	Ileocecal Valve	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;APC p.S1465Wfs*3;APC p.R640W;TCF7L2 p.Y151*;CTCF p.P189Lfs*33;SMAD4 p.M294Lfs*6;APC p.N965Vfs*14	1	7
P-0006077	P-0006077-T01-IM5	In-House	DNA	Biopsy	250	1239	40	Matched	Metastasis	Esophagus	Thyroid	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NOTCH1 p.I471T;TET2 p.C1221Y;TP53 p.H179_D184del;CDKN2A Deletion;CDKN2B Deletion;NOTCH1 NOTCH1-intragenic	1	6
P-0006078	P-0006078-T01-IM5	In-House	DNA	Resection	250	821	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	PLX8394(BRAF p.G469A)				LEVEL_1	TP53 p.G266E;BRAF p.G469A;ERBB2 Amplification	3	3
P-0006079	P-0006079-T01-IM5	In-House	DNA	Biopsy	250	925	30	Matched	Metastasis	Cancer of Unknown Primary	Skin	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;ARID1A p.L2238Afs*39;KMT2D p.S705*;TP53 p.V272G;KEAP1 Deletion	1	5
P-0006080	P-0006080-T01-IM5	Outside	DNA	Resection	250	577	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0006081	P-0006081-T01-IM5	Outside	DNA	Resection	250	541	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0006082	P-0006082-T01-IM5	Outside	DNA	Biopsy	133.76	405	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.S45P;SF3B1 p.K741N	0	2
P-0006083	P-0006083-T01-IM5	Outside	DNA	Biopsy	250	941	10	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;PPP2R1A p.R183W;ARID1A p.N1040Cfs*18;PBRM1 p.H1606Qfs*5	1	4
P-0006084	P-0006084-T01-IM5	In-House	DNA	Resection	250	885	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	APC p.E893*;STK11 p.R304W;NFE2L2 p.D21_I22delinsE;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	1	6
P-0006085	P-0006085-T01-IM5	In-House	DNA	Resection	250	845	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0006086	P-0006086-T01-IM5	In-House	DNA	Cytology	250	815	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.M442Hfs*65;CCND1 Amplification;FGF19 Amplification;PPM1D Amplification	0	4
P-0006087	P-0006087-T01-IM5	In-House	DNA	Resection	250	854	70	Matched	Metastasis	Bile Duct	Liver	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma											0	0
P-0006088	P-0006088-T01-IM5	Outside	DNA	Resection	250	923	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										MGA p.E2302*;RBM10 p.Q245*;TP53 p.P322Tfs*15	0	3
P-0006089	P-0006089-T01-IM5	Outside	DNA	Biopsy	250	531	30	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										TP53 p.R342*	0	1
P-0006090	P-0006090-T01-IM5	Outside	DNA	Biopsy	250	1007	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 p.R1306*)				LEVEL_4	TP53 p.R273C;NF1 p.R1306*;SPEN p.S991Ffs*31;ASXL2 Deletion;CCND2 Amplification;CCND3 Amplification;KDM5A Amplification;KRAS Amplification;VEGFA Amplification	1	9
P-0006091	P-0006091-T01-IM5	Outside	DNA	Biopsy	250	1177	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ATRX p.E63*;TP53 p.T150Afs*16;BIRC3 Deletion;CCNE1 Amplification;MYC Amplification;NF2 Deletion;NTRK1 Amplification;RB1 Deletion;SPEN Deletion;NOTCH3 BRD4-NOTCH3 fusion;BRD4 BRD4-NOTCH3 fusion	0	11
P-0006092	P-0006092-T01-IM5	In-House	DNA	Resection	250	930	80	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										CREBBP p.S1737Rfs*8;DIS3 Deletion;KDM5A Amplification;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	5
P-0006093	P-0006093-T01-IM5	In-House	DNA	Resection	250	848	30	Matched	Metastasis	Sigmoid Colon	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.V1653A)					LEVEL_3B	SOX9 p.Q312*;TP53 p.C135Y;APC p.Y935*;BRCA1 p.V1653A	1	4
P-0006094	P-0006094-T01-IM5	In-House	DNA	Resection	250	860	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	APC p.E538*;MET p.X1010_splice;CDK4 Amplification;MDM2 Amplification	5	4
P-0006095	P-0006095-T01-IM5	In-House	DNA	Resection	250	698	60	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										MEN1 p.W126*;MGA p.L1003Tfs*32;DNMT3A p.G642*;CCND3 Amplification;VEGFA Amplification	0	5
P-0006096	P-0006096-T01-IM5	Outside	DNA	Resection	158.7	170	10	Matched	Metastasis	Cancer of Unknown Primary	Stomach	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.R175H;KRAS p.G13D	1	2
P-0006097	P-0006097-T01-IM5	In-House	DNA	Biopsy	250	703	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106R)	Tazemetostat(KDM6A p.S1061*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	FGFR3 p.S249C;PIK3CA p.G106R;SF3B1 p.E902K;KDM6A p.S1061*;STAG2 p.Q786Pfs*8;CDKN2A Deletion;CDKN2B Deletion;PTEN Deletion	6	8
P-0006098	P-0006098-T01-IM5	In-House	DNA	Cytology	250	793	70	Matched	Metastasis	Nasopharynx	Lung	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KMT2D p.S2431Lfs*53;PIK3R1 p.N441_T454del;TRAF2 p.R393C;NFKBIA p.X113_splice;KMT2D p.L3542Vfs*13;CDKN2A Deletion;CDKN2B Deletion;PAX5 Deletion;TGFBR2 Deletion	1	9
P-0006101	P-0006101-T01-IM5	In-House	DNA	Resection	250	792	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0006102	P-0006102-T01-IM5	Outside	DNA	Resection	250	601	90	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.T155N	0	1
P-0006103	P-0006103-T01-IM5	Outside	DNA	Biopsy	250	809	40	Matched	Metastasis	Uterus	Pelvis	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L)				LEVEL_3B	PIK3CA p.H1047R;KRAS p.Q61L;TP53 p.Q52*	2	3
P-0006104	P-0006104-T01-IM5	In-House	DNA	Resection	250	923	90	Matched	Metastasis	Small Bowel	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D820E);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559_E561del)	Sorafenib(KIT p.D820E)			GSK2636771,AZD8186(PTEN p.G129R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib,Sunitinib(KIT p.D820E)		LEVEL_1	PTEN p.G129R;KIT p.D820E;KIT p.V559_E561del;CDKN2A Deletion;CDKN2B Deletion;HLA-A Deletion	5	6
P-0006105	P-0006105-T01-IM5	In-House	DNA	Resection	250	800	40	Matched	Primary	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;CTNNB1 p.S37A;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0006106	P-0006106-T01-IM5	In-House	DNA	Resection	250	733	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84V)				LEVEL_4	KRAS p.G12V;TP53 p.R249S;CDKN2A p.D84V	2	3
P-0006107	P-0006107-T01-IM5	In-House	DNA	Biopsy	220.2	648	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 p.E306*	0	1
P-0006108	P-0006108-T01-IM5	In-House	DNA	Biopsy	250	954	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0006108	P-0006108-T03-IM5	In-House	FFPE	Resection	250	956	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0006108	P-0006108-T02-IM5	Outside	FFPE	Biopsy	250	691	15	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0006109	P-0006109-T01-IM5	Outside	DNA	Biopsy	250	720	80	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										BAP1 p.A379Rfs*16	0	1
P-0006110	P-0006110-T01-IM5	In-House	DNA	Biopsy	250	889	50	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.T1493Rfs*14;SOX9 p.Q340*;APC p.L1004Nfs*3;TP53 p.L201Ifs*47	1	5
P-0006111	P-0006111-T01-IM5	In-House	DNA	Resection	250	803	70	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										CREBBP p.R1498*	0	1
P-0006112	P-0006112-T01-IM5	In-House	DNA	Biopsy	250	941	80	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.G266R;SMAD4 p.X379_splice;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;KRAS Amplification	2	6
P-0006112	P-0006112-T02-IM5	Outside	FFPE	Biopsy	250	829	NA	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.G266R;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	2	4
P-0006113	P-0006113-T01-IM5	Outside	DNA	Resection	250	949	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ARMS	Soft Tissue Sarcoma	Alveolar Rhabdomyosarcoma				Olaparib(RAD51B Deletion)					LEVEL_3B	MAX Deletion;MYCL Amplification;RAD51B Deletion	1	3
P-0006114	P-0006114-T01-IM5	In-House	DNA	Biopsy	250	1179	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;CREBBP p.Q1756*;SETD2 p.T1753Vfs*14	2	3
P-0006114	P-0006114-T02-IM5	In-House	FFPE	Biopsy	250	661	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;CREBBP p.Q1756*;SETD2 p.T1753Vfs*14	2	3
P-0006115	P-0006115-T01-IM5	In-House	DNA	Resection	250	999	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	EGFR p.E746_A750del;TP53 p.W91*;B2M p.L15Ffs*41;ZFHX3 p.P2047Lfs*54;FAT1 p.H4293Qfs*56;ARID1B p.Q613Rfs*42;ERBB2 Amplification	2	7
P-0006116	P-0006116-T01-IM5	In-House	DNA	Biopsy	222.3	609	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.G245D	1	2
P-0006118	P-0006118-T02-IM5	In-House	FFPE	Cytology	250	666	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.T1359Yfs*2)					LEVEL_3B	TP53 p.X224_splice;APC p.R554*;SMAD4 p.R100S;BRCA2 p.T1359Yfs*2;MAP2K4 Deletion;RICTOR Amplification	1	6
P-0006119	P-0006119-T01-IM5	Outside	DNA	Biopsy	250	838	20	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)	GSK2636771,AZD8186(PTEN p.V158Gfs*8)				LEVEL_3B	TP53 p.G244S;IDH1 p.R132H;NOTCH1 p.F357del;TP53 p.T211I;TP53 p.K120E;MLH1 p.X663_splice;FOXA1 p.G87R;CREBBP p.X1305_splice;ZRSR2 p.Q114*;MED12 p.R18Q;FUBP1 p.X83_splice;PTEN p.V158Gfs*8;MSH6 p.F689Lfs*12	2	13
P-0006120	P-0006120-T01-IM5	In-House	DNA	Resection	250	384	70	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.N566_P573del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.N566_P573del;CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification	2	4
P-0006121	P-0006121-T01-IM5	In-House	DNA	Resection	250	551	NA	Matched	Metastasis	Vagina	Lung	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina					Trametinib,Cobimetinib,Binimetinib(KRAS p.A11_G12delinsTD)				LEVEL_4	KRAS p.A11_G12delinsTD;KRAS Amplification	1	2
P-0006122	P-0006122-T01-IM5	Outside	DNA	Biopsy	250	694	70	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice)				LEVEL_4	TP53 p.R213G;CDKN2A p.X51_splice;CCND1 Amplification;FGF19 Amplification;KRAS Amplification;MYC Amplification	1	6
P-0006123	P-0006123-T01-IM5	In-House	DNA	Biopsy	162	1084	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.F2834Lfs*13)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;KMT2C p.X2481_splice;ATM p.F2834Lfs*13	3	3
P-0006124	P-0006124-T01-IM5	In-House	DNA	Biopsy	250	662	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.Q527*);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.Q2159*);Olaparib(PALB2 p.L176Nfs*3);Olaparib(BRIP1 p.L701Sfs*20)					LEVEL_3B	TSC1 p.Q527*;ERBB3 p.E332K;LATS1 p.Q317*;TP53 p.M246I;KMT2D p.Q800*;BRCA2 p.Q2159*;PTPRT p.Q977*;KMT2A p.I962Kfs*35;PALB2 p.L176Nfs*3;KMT2D p.L725Cfs*205;BRIP1 p.L701Sfs*20;FANCA FANCA-intragenic;RUNX1 RUNX1-intragenic	4	13
P-0006125	P-0006125-T01-IM5	In-House	DNA	Resection	250	673	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	TP53 p.R196*;KRAS p.G12V	1	2
P-0006126	P-0006126-T01-IM5	In-House	DNA	Biopsy	250	871	90	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										NF2 p.A148Vfs*3;RAC1 Amplification	0	2
P-0006127	P-0006127-T01-IM5	In-House	DNA	Resection	250	995	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)						LEVEL_1	TP53 p.R248W;MET p.X963_splice;RAC1 Amplification;TERT Amplification	3	4
P-0006128	P-0006128-T01-IM5	In-House	DNA	Biopsy	250	996	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification	0	1
P-0006129	P-0006129-T02-IM5	In-House	FFPE	Resection	250	621	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.S127F	0	1
P-0006129	P-0006129-T01-IM5	Outside	DNA	Resection	250	665	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.Q641*)				LEVEL_4	TP53 p.E271K;TP53 p.S127F;KDM6A p.Q641*;CDH1 p.Q677*	1	4
P-0006130	P-0006130-T01-IM5	In-House	DNA	Biopsy	250	837	80	Matched	Primary	Lymph node	Not Applicable	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms										TP53 p.L194F;KMT2D p.Q4588*;ARID5B Deletion;FBXW7 Deletion;INPP4B Deletion;TET2 Deletion	0	6
P-0006131	P-0006131-T01-IM5	Outside	DNA	Biopsy	250	697	30	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Everolimus(TSC1 p.W347*)					LEVEL_3B	PBRM1 p.E52*;TSC1 p.W347*;ARID1A p.K1603Afs*40	1	3
P-0006132	P-0006132-T01-IM5	Outside	DNA	Biopsy	250	669	80	Matched	Metastasis	Liver	Ovary	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma											0	0
P-0006133	P-0006133-T01-IM5	In-House	DNA	Biopsy	250	684	30	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.E102_I103del)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D1017H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D74Y)				LEVEL_3A	TP53 p.Q100*;MAP2K1 p.E102_I103del;SETD2 p.S918*;KMT2A p.Q814*;B2M p.E67*;CDKN2A p.D74Y;TERT Amplification	3	7
P-0006134	P-0006134-T01-IM5	Outside	DNA	Biopsy	250	1077	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.C238F;MDM2 Amplification	1	2
P-0006135	P-0006135-T01-IM5	Outside	DNA	Resection	250	743	70	Unmatched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)		Cetuximab,Panitumumab(NRAS p.G12D)			LEVEL_3B	TP53 p.R175H;APC p.Q1367*;APC p.R283*;NRAS p.G12D;CCND2 Amplification;KDM5A Amplification	1	6
P-0006136	P-0006136-T01-IM5	In-House	DNA	Biopsy	250	900	20	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R342*;APC p.N627Lfs*2;SMAD4 p.H92Y;TCF7L2 TCF7L2-intragenic	1	5
P-0006137	P-0006137-T01-IM5	Outside	DNA	Resection	250	402	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.S401Vfs*106;KMT2C p.R2403*;KMT2C p.F1359Cfs*17;MED12 p.C746Sfs*33;AURKA Amplification;ERBB2 Amplification;PPM1D Amplification;TERT Amplification;RARA APPBP2-RARA fusion;APPBP2 APPBP2-RARA fusion	2	10
P-0006138	P-0006138-T01-IM5	In-House	DNA	Resection	250	934	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C;APC p.R1450*	0	2
P-0006139	P-0006139-T01-IM5	In-House	DNA	Resection	250	920	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;RBM10 p.T371Nfs*10;FOXA1 Amplification;MDM2 Amplification;NKX2-1 Amplification	2	5
P-0006140	P-0006140-T01-IM5	In-House	DNA	Resection	250	951	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;INPP4B p.K159*;MAX p.K89*	1	3
P-0006141	P-0006141-T01-IM5	In-House	DNA	Resection	250	685	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAASC	Pancreatic Cancer	Adenosquamous Carcinoma of the Pancreas				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;NRAS p.Q61K;TP53 p.L194R	2	3
P-0006142	P-0006142-T01-IM5	In-House	DNA	Biopsy	250	814	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;SMAD4 p.R445*;KMT2C p.Q419*;ARID1A p.S258Rfs*102;KMT2D p.P480Lfs*450;CDKN2A Deletion;CDKN2B Deletion;STAG2 Deletion	3	8
P-0006144	P-0006144-T01-IM5	In-House	DNA	Resection	250	867	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAASC	Pancreatic Cancer	Adenosquamous Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.Y205F	1	2
P-0006145	P-0006145-T01-IM5	Outside	DNA	Resection	250	940	70	Matched	Metastasis	Breast	Lung	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA EXOC1-PDGFRA fusion);Imatinib,Regorafenib,Ripretinib,Sunitinib(EXOC1 EXOC1-PDGFRA fusion)					LEVEL_3B	KDR Amplification;KIT Amplification;PDGFRA Amplification;PDGFRA EXOC1-PDGFRA fusion;EXOC1 EXOC1-PDGFRA fusion	2	5
P-0006147	P-0006147-T02-IM5	In-House	FFPE	Resection	250	828	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma											0	0
P-0006148	P-0006148-T01-IM5	In-House	DNA	Biopsy	250	783	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)					LEVEL_3B	PIK3CA p.R88Q;TP53 p.A86Cfs*63;TP53 p.Y163Lfs*7;KRAS Amplification;RUNX1 Deletion	1	5
P-0006149	P-0006149-T02-IM5	In-House	DNA	Biopsy	128	593	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	ERBB2 p.Y772_A775dup;MAP2K4 p.R228T	2	2
P-0006150	P-0006150-T01-IM5	In-House	DNA	Resection	250	1060	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Olaparib(PALB2 p.X945_splice)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.M54Dfs*66)				LEVEL_3B	PMS2 p.R3*;PALB2 p.X945_splice;TP53 p.R158F;CDKN2A p.M54Dfs*66	2	4
P-0006151	P-0006151-T01-IM5	In-House	DNA	Resection	250	801	70	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.V143M;EGFR Amplification;ZMAT4 RECQL4-ZMAT4 fusion;RECQL4 RECQL4-ZMAT4 fusion	1	5
P-0006152	P-0006152-T01-IM5	Outside	DNA	Biopsy	250	612	30	Matched	Primary	Colon	Not Applicable	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;TP53 p.R282W;TP53 p.Q192*	1	3
P-0006153	P-0006153-T01-IM5	In-House	DNA	Resection	250	904	70	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										KMT2A p.E1677*;TP53 Deletion	0	2
P-0006154	P-0006154-T01-IM5	In-House	DNA	Biopsy	250	883	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 p.Q694*;LATS1 p.R1081*;LATS2 p.E1039*	0	3
P-0006155	P-0006155-T02-IM5	Outside	DNA	Biopsy	129.654	327	50	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	EP300 p.H2324Pfs*55;RPS6KA4 p.R629C;TET1 p.I705Hfs*8;CDKN2A Deletion;CDKN2B Deletion	1	5
P-0006156	P-0006156-T01-IM5	Outside	DNA	Biopsy	250	766	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.V216L;BBC3 p.X30_splice;EGFR Amplification;ERBB2 Amplification	2	4
P-0006157	P-0006157-T01-IM5	In-House	DNA	Cytology	250	396	50	Matched	Metastasis	Conjunctiva	Lymph Node, Regional	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R	1	1
P-0006158	P-0006158-T01-IM5	In-House	DNA	Resection	250	560	70	Matched	Metastasis	Kidney	Adrenal Gland	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.S80R;ARID1B p.X1032_splice;MGA p.S2143*;PBRM1 p.L756Cfs*19	0	4
P-0006159	P-0006159-T01-IM5	In-House	DNA	Resection	250	516	50	Matched	Primary	Perineal mass	Not Applicable	Tumor	EMCHS	Bone Cancer	Extraskeletal Myxoid Chondrosarcoma											0	0
P-0006160	P-0006160-T01-IM5	In-House	DNA	Biopsy	250	674	70	Matched	Metastasis	Soft Tissue	Abdomen	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.H1047R;TP53 p.R175H;NF2 p.Q111*;CARD11 Amplification;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0006161	P-0006161-T02-IM5	In-House	FFPE	Biopsy	250	1021	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	AKT1 p.E17K;TP53 p.V272M;PBRM1 p.X1178_splice;FGFR1 Amplification	2	4
P-0006161	P-0006161-T03-IM5	In-House	FFPE	Biopsy	250	1065	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E453K);Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);AZD9496,Fulvestrant(ESR1 p.E380Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.E453K;PIK3CA p.E542K;TP53 p.V272M;ESR1 p.E380Q;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	6	7
P-0006161	P-0006161-T01-IM5	In-House	DNA	Cytology	250	581	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K	2	1
P-0006162	P-0006162-T01-IM5	In-House	DNA	Biopsy	250	784	60	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.E380Q);AZD9496,Fulvestrant(ESR1 p.Y537C)						LEVEL_1	PIK3CA p.E545K;ESR1 p.E380Q;ESR1 p.Y537C;PIK3CB p.E552K;CCND1 Amplification;FGF19 Amplification	4	6
P-0006163	P-0006163-T01-IM5	In-House	DNA	Resection	250	256	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;EIF1AX p.X113_splice	2	2
P-0006164	P-0006164-T01-IM5	Outside	DNA	Resection	250	738	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006165	P-0006165-T01-IM5	In-House	DNA	Resection	250	1044	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.A159del	1	2
P-0006166	P-0006166-T01-IM5	Outside	DNA	Biopsy	250	237	10	Matched	Metastasis	Breast	Contralateral Breast	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;CDH1 p.Q23*;NUP93 p.E14K	2	3
P-0006167	P-0006167-T01-IM5	In-House	DNA	Biopsy	160	681	20	Matched	Metastasis	Uterus	Lung	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12R)					LEVEL_3B	FBXW7 p.R479Q;TP53 p.E51*;NRAS p.G12R;PIK3R1 p.L710Sfs*5;CCNE1 Amplification;ZFHX3 CNTNAP4-ZFHX3 fusion;CNTNAP4 CNTNAP4-ZFHX3 fusion	1	7
P-0006169	P-0006169-T01-IM5	In-House	DNA	Resection	250	754	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_3A	GATA3 p.C338Lfs*14;ESR1 p.Y537S;PPM1D Amplification	1	3
P-0006170	P-0006170-T01-IM5	In-House	DNA	Resection	250	740	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N1784Tfs*7);Sonidegib,Vismodegib(PTCH1 p.R1308Qfs*17);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	BRCA2 p.N1784Tfs*7;KRAS p.A146T;APC p.T1556Nfs*3;B2M p.L15Ffs*41;SMARCA4 p.T910M;PTCH1 p.R1308Qfs*17;PTPRS p.V1025Sfs*18;PIK3CA p.E545G;SOX9 p.G263Afs*16;SETD2 p.N1396Mfs*16;MSH2 p.Q158*;B2M p.W80*;AMER1 p.R497*;NOTCH1 p.P1442Rfs*3;ERCC4 p.K843Vfs*2;SMAD2 p.L449Wfs*5;CIC p.A785Pfs*139	4	17
P-0006171	P-0006171-T01-IM5	Outside	DNA	Resection	250	1072	50	Matched	Metastasis	Lung	Omentum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L747_A750delinsP;EGFR Amplification;ETV1 Amplification;MCL1 Amplification;MYC Amplification;TERT Amplification	2	7
P-0006172	P-0006172-T01-IM5	Outside	DNA	Resection	250	923	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Larotrectinib,Entrectinib(P2RY8 NTRK1-P2RY8 fusion);Larotrectinib,Entrectinib(NTRK1 NTRK1-P2RY8 fusion)		AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_1	KRAS p.G12C;STK11 p.G196V;KEAP1 p.V420Sfs*38;P2RY8 NTRK1-P2RY8 fusion;NTRK1 NTRK1-P2RY8 fusion	4	5
P-0006173	P-0006173-T01-IM5	In-House	DNA	Biopsy	250	1130	30	Matched	Metastasis	Lung	Pleura	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer										TP53 p.D281G;AKT2 Amplification;CCNE1 Amplification;PIK3CA Amplification	0	4
P-0006174	P-0006174-T01-IM5	In-House	DNA	Biopsy	250	884	40	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS					Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.R248W;TP53 p.H193R;TP53 p.D42Qfs*5;ARID5B Deletion;CCND2 Amplification;CDKN1B Deletion;EGFR Amplification;RICTOR Amplification	1	8
P-0006175	P-0006175-T01-IM5	Outside	DNA	Biopsy	176.4	1002	70	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E1113*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12A;ARID1A p.Q507*;ARID1A p.Q601*;TET1 p.E1252*;BRCA2 p.E1113*;KEAP1 p.M110I;STK11 p.P275Gfs*9;BAP1 Deletion;CDKN2A Deletion	3	9
P-0006176	P-0006176-T01-IM5	Outside	DNA	Biopsy	250	864	30	Matched	Metastasis	Bile Duct	Liver	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006177	P-0006177-T01-IM5	Outside	DNA	Resection	250	1145	60	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.Q282*)				LEVEL_4	NF1 p.Q282*;CBL p.P417S;GRIN2A p.G889E;GRIN2A p.W771*;CCND1 Amplification;FGF19 Amplification	1	6
P-0006178	P-0006178-T01-IM5	Outside	DNA	Resection	250	550	20	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006179	P-0006179-T01-IM5	Outside	DNA	Resection	250	660	10	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	SCHW	Nerve Sheath Tumor	Schwannoma											0	0
P-0006181	P-0006181-T01-IM5	In-House	DNA	Resection	250	849	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;SMAD4 p.P356L;APC p.F1396Lfs*19;TCF7L2 p.A42Sfs*2	2	4
P-0006182	P-0006182-T01-IM5	Outside	DNA	Biopsy	250	1086	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Everolimus(TSC1 Deletion)					LEVEL_3B	TP53 p.R158G;ATRX p.I360Rfs*6;STAG2 p.E1128Afs*7;FAT1 Deletion;KDR Amplification;KIT Amplification;PDGFRA Amplification;TSC1 Deletion	1	8
P-0006183	P-0006183-T01-IM5	Outside	DNA	Resection	250	819	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;TP53 p.S127F;PIK3CA p.Q546P;APC p.V1414*;APC p.Q879*;BCL2 p.N172S;PBRM1 p.X964_splice;ASXL1 p.S846Qfs*5	2	8
P-0006184	P-0006184-T01-IM5	Outside	DNA	Biopsy	250	985	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.X125_splice	0	1
P-0006185	P-0006185-T01-IM5	In-House	DNA	Biopsy	250	835	40	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0006186	P-0006186-T01-IM5	In-House	DNA	Resection	250	553	10	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	TP53 p.R273H;KRAS p.G12D;MED12 p.G44S	1	3
P-0006187	P-0006187-T01-IM5	In-House	DNA	Resection	250	523	70	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification	1	1
P-0006189	P-0006189-T01-IM5	Outside	DNA	Resection	250	762	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.D335Gfs*17;NCOR1 p.R2171Sfs*15;ARID1A p.A900Pfs*19;ARID2 p.D844Lfs*4;ERBB2 Amplification	2	5
P-0006190	P-0006190-T01-IM5	In-House	DNA	Resection	250	735	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Olaparib(ATM p.R1466P);Olaparib(ATM p.Q2593*)	Tazemetostat(KDM6A p.Q555*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12L)				LEVEL_3B	KDM6A p.Q555*;FAT1 p.Q1114*;ATM p.R1466P;ATM p.Q2593*;CREBBP p.R386*;FBXW7 p.R512Kfs*2;CDKN2A p.S12L;DDR2 Amplification;MCL1 Amplification	4	9
P-0006191	P-0006191-T01-IM5	In-House	DNA	Resection	250	949	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0006192	P-0006192-T01-IM5	Outside	DNA	Biopsy	250	1088	80	Matched	Metastasis	Skin	Subcutaneous Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0006193	P-0006193-T01-IM5	In-House	DNA	Biopsy	143.325	548	30	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;PAK5 p.M173I	2	2
P-0006194	P-0006194-T01-IM5	In-House	DNA	Biopsy	250	738	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.V200Rfs*18)					LEVEL_3B	TP53 p.H179Y;CREBBP p.T396K;TSC1 p.V200Rfs*18;MCL1 Amplification;RAF1 Amplification;RICTOR Amplification;TERT Amplification	1	7
P-0006195	P-0006195-T01-IM5	In-House	DNA	Resection	250	831	60	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.G245C;RASA1 p.G237*;RB1 p.K844Sfs*5;DNMT3B Amplification;RB1 RB1-intragenic	0	5
P-0006196	P-0006196-T02-IM5	In-House	DNA	Resection	250	614	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	BAP1 Deletion;FGFR1 Amplification;FOXP1 Deletion;MITF Deletion;MYC Amplification;PBRM1 Deletion;SETD2 Deletion	1	7
P-0006197	P-0006197-T01-IM5	In-House	DNA	Resection	250	565	80	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										SETD2 p.N261*;BAP1 p.X126_splice	0	2
P-0006198	P-0006198-T01-IM5	In-House	DNA	Biopsy	250	889	70	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;EPHA3 p.Q855*	1	2
P-0006199	P-0006199-T01-IM5	In-House	DNA	Biopsy	250	895	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Everolimus,Temsirolimus(MTOR p.S2215F)				LEVEL_3A	KRAS p.G12C;MTOR p.S2215F;SETD2 p.L633_E639delins*;GATA3 p.G246Afs*19	3	4
P-0006199	P-0006199-T03-IM5	In-House	FFPE	Biopsy	235.8	644	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Olaparib(CDK12 p.A1467Ifs*27)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.A1467Ifs*27)				LEVEL_3B	CTNNB1 p.S45A;CDK12 p.A1467Ifs*27;DDR2 Amplification;MCL1 Amplification;MDM4 Amplification;MYC Amplification;NTRK1 Amplification	2	7
P-0006199	P-0006199-T02-IM5	In-House	DNA	Biopsy	250	524	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R273H;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;MYC Amplification	2	5
P-0006200	P-0006200-T01-IM5	Outside	DNA	Resection	250	921	70	Matched	Metastasis	Foot	Lung	Tumor	ACRM	Melanoma	Acral Melanoma				Palbociclib,Abemaciclib(CDK4 Amplification);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;ERBB2 Amplification;MDM2 Amplification;MITF Amplification;TERT Amplification	3	5
P-0006201	P-0006201-T01-IM5	Outside	DNA	Biopsy	250	594	70	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93W);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E365K);Olaparib(ATM p.Q1653*);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N863Ifs*11);Sonidegib,Vismodegib(PTCH1 p.P643Tfs*11)	Trametinib,Cobimetinib(NF1 p.I679Dfs*21);Trametinib,Cobimetinib(NF1 p.V1419Lfs*4)				LEVEL_3B	PTCH1 p.S1203Afs*52;PIK3CA p.R93W;CIC p.P1597Hfs*23;PIK3CA p.E365K;CREBBP p.P1423Lfs*36;NF1 p.I679Dfs*21;ARID1A p.P1326Rfs*155;CBFB p.P70Sfs*13;MSH6 p.F1104Lfs*11;PTPRD p.Q1258*;ATM p.Q1653*;GRIN2A p.X551_splice;BRCA2 p.N863Ifs*11;NF1 p.V1419Lfs*4;ASXL1 p.S846Vfs*21;CREBBP p.K1505Rfs*45;ARID1B p.A1540Rfs*26;EZH2 p.T369Pfs*50;ARID1A p.P1619Qfs*7;PTCH1 p.P643Tfs*11;CIC p.G821Efs*103;KMT2D p.P1804Qfs*48	8	22
P-0006202	P-0006202-T01-IM5	Outside	DNA	Biopsy	250	745	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.X307_splice;EPHB1 p.R351W;EP300 p.R1645*;APC p.X177_splice;FLT3 p.G631E;RB1 p.X776_splice;RB1 p.N472Ifs*6	0	7
P-0006203	P-0006203-T01-IM5	Outside	DNA	Resection	250	1088	80	Matched	Metastasis	Uterus	Colon	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	1	7
P-0006204	P-0006204-T01-IM5	Outside	DNA	Biopsy	250	499	20	Matched	Primary	Bone	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma										AMER1 p.R942*	0	1
P-0006205	P-0006205-T01-IM5	In-House	DNA	Biopsy	250	869	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.Y126S	1	2
P-0006206	P-0006206-T01-IM5	In-House	DNA	Cytology	250	988	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.S166*;CCNE1 Amplification	0	2
P-0006207	P-0006207-T01-IM5	Outside	DNA	Resection	250	801	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R);Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64);Sonidegib,Vismodegib(PTCH1 p.N97Tfs*20);Olaparib(ATM p.M2384*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K)	Cetuximab,Panitumumab(KRAS p.Q61K)			LEVEL_3B	RNF43 p.G659Vfs*41;NOTCH3 p.P695Rfs*165;PPP2R1A p.R183W;ARID1A p.D1850Gfs*4;KRAS p.Q61K;ASXL2 p.M1?;PIK3CA p.Q546R;PTCH1 p.R1308Efs*64;ATRX p.T1582Nfs*19;PTCH1 p.N97Tfs*20;PIK3R3 p.R243*;SMAD4 p.W302*;SMAD4 p.C523R;KMT2A p.T1322Pfs*34;NOTCH1 p.S2486Lfs*21;TET1 p.K776Nfs*19;NOTCH1 p.S402Rfs*229;SPEN p.S3275Vfs*9;ARID2 p.F1182Lfs*6;CASP8 p.L301Tfs*6;ATM p.M2384*	5	21
P-0006208	P-0006208-T01-IM5	Outside	DNA	Resection	250	1014	90	Matched	Primary	Pelvis	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										EWSR1 ERG-EWSR1 fusion;ERG ERG-EWSR1 fusion	0	2
P-0006209	P-0006209-T01-IM5	Outside	DNA	Biopsy	250	940	30	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.E606Q)	Tipifarnib(HRAS p.Q61L);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.G292R)	Tazemetostat(KDM6A p.W127*)				LEVEL_3A	HRAS p.Q61L;RB1 p.Y321*;FBXW7 p.R479G;ERCC2 p.E606Q;RIT1 p.M90I;RB1 p.X703_splice;CREBBP p.I1431S;ERBB2 p.G292R;KDM6A p.W127*;ARID1A p.Q288Sfs*75;ARID1A p.P279Lfs*77;KMT2A p.S1698Ifs*17	4	12
P-0006210	P-0006210-T01-IM5	In-House	DNA	Resection	250	1157	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.X33_splice;MED12 p.Q2053*	1	3
P-0006211	P-0006211-T01-IM5	Outside	DNA	Biopsy	250	796	10	Matched	Metastasis	Cancer of Unknown Primary	Peritoneum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0006213	P-0006213-T01-IM5	In-House	DNA	Biopsy	250	937	20	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R306*;TCF7L2 p.S36*;TP53 p.L201Afs*7;APC p.K1192Tfs*15;APC p.K1363*	1	6
P-0006214	P-0006214-T01-IM5	In-House	DNA	Resection	250	1335	70	Matched	Metastasis	Abdomen	Lung	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										DICER1 Deletion;FH Deletion;PPM1D Amplification	0	3
P-0006215	P-0006215-T01-IM5	In-House	DNA	Resection	250	712	70	Matched	Metastasis	Mediastinum	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										PIK3R1 p.K567_L570del;EGFR Amplification;NTRK1 Amplification	0	3
P-0006215	P-0006215-T02-IM5	In-House	FFPE	Resection	250	903	10	Matched	Metastasis	Mediastinum	Soft Tissue	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										PIK3R1 p.N441_T454del	0	1
P-0006216	P-0006216-T01-IM5	Outside	DNA	Biopsy	250	976	70	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.A1035V)					LEVEL_3B	TP53 p.R196*;RAC1 p.P29S;RB1 p.Q471*;TP53 p.Q136*;BRAF p.R671Q;KMT2C p.W491*;KMT2C p.W225*;NCOR1 p.R350*;AMER1 p.R586*;NOTCH3 p.Q1552*	1	10
P-0006217	P-0006217-T01-IM5	In-House	DNA	Resection	250	456	30	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.V143M;MYCL Amplification;NOTCH1 TRAF2-NOTCH1 fusion;TRAF2 TRAF2-NOTCH1 fusion	0	4
P-0006218	P-0006218-T01-IM5	In-House	DNA	Resection	250	159	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.Q117Pfs*9)				LEVEL_1	FGFR3 p.S249C;TP53 p.D259N;KDM6A p.Q117Pfs*9;STAG2 p.S1137*;ARID1A p.F1750Cfs*21;RBM10 p.G374Afs*111	3	6
P-0006219	P-0006219-T01-IM5	Outside	DNA	Biopsy	205.6	549	20	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.Q1406*;PIK3R1 p.H450_E451dup	2	3
P-0006220	P-0006220-T01-IM5	Outside	DNA	Resection	250	708	70	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0006221	P-0006221-T02-IM5	In-House	FFPE	Biopsy	250	957	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;EP300 p.P474Lfs*7;FOXA1 Amplification;NKX2-1 Amplification;PAK1 Amplification;RAC1 Amplification;UNCX MITF-UNCX fusion;MITF MITF-UNCX fusion	2	8
P-0006222	P-0006222-T01-IM5	Outside	DNA	Biopsy	78.5	287	50	Matched	Metastasis	Kidney	Adrenal Gland	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X114_splice;PBRM1 p.V1505Lfs*34	0	2
P-0006223	P-0006223-T02-IM5	Outside	DNA	Resection	250	736	70	Matched	Primary	Lymph node	Not Applicable	Tumor	NHL	Non-Hodgkin Lymphoma	Non-Hodgkin Lymphoma				Enasidenib(IDH2 p.R172K)					LEVEL_3B	IDH2 p.R172K;RHOA p.G17V;TET2 p.R1465*;TET2 p.Q1526*	1	4
P-0006225	P-0006225-T01-IM5	In-House	DNA	Cytology	250	786	50	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R273C;APC p.R1435Kfs*38	1	3
P-0006226	P-0006226-T01-IM5	In-House	DNA	Resection	250	919	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 Amplification	0	1
P-0006226	P-0006226-T02-IM5	Outside	DNA	Biopsy	250	864	70	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.E731Gfs*19)			Talazoparib,Niraparib(BRCA2 p.E731Gfs*19);BLU-667,Cabozantinib,Selpercatinib,Vandetanib(RET NCOA4-RET fusion);BLU-667,Cabozantinib,Selpercatinib,Vandetanib(NCOA4 NCOA4-RET fusion)					LEVEL_1	DICER1 p.P737Qfs*21;BRCA2 p.E731Gfs*19;CDH1 p.I584Sfs*3;RET NCOA4-RET fusion;NCOA4 NCOA4-RET fusion	4	5
P-0006227	P-0006227-T01-IM5	Outside	DNA	Resection	250	487	70	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.C238Y;RHOA p.G17E;CDH1 p.X765_splice;ZRSR2 p.X258_splice;TBX3 p.S547Vfs*85;AKT1 Amplification	1	7
P-0006228	P-0006228-T01-IM5	In-House	DNA	Resection	250	835	60	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										NF2 p.Q111*	0	1
P-0006229	P-0006229-T01-IM5	In-House	DNA	Resection	250	425	70	Matched	Primary	Mediastinum	Not Applicable	Tumor	TYST	Germ Cell Tumor	Yolk Sac Tumor										TP53 p.E343*;TP53 p.R110L;CBL p.X410_splice	0	3
P-0006230	P-0006230-T01-IM5	In-House	DNA	Resection	250	776	20	Matched	Metastasis	Rectum	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.R216*;TP53 p.X125_splice;AMER1 p.Y654Lfs*53;FAT1 p.T3083Pfs*33;APC p.P1442Sfs*15	1	6
P-0006231	P-0006231-T01-IM5	In-House	DNA	Biopsy	250	1089	20	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.L122Tfs*4)			Tipifarnib(HRAS p.Q61R)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L122Tfs*4)				LEVEL_1	HRAS p.Q61R;CREBBP p.F1523Sfs*27;CDK12 p.L122Tfs*4	3	3
P-0006232	P-0006232-T01-IM5	Outside	DNA	Resection	250	652	30	Unmatched	Primary	Peritoneum	Not Applicable	Tumor	FIBS	Soft Tissue Sarcoma	Fibrosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	2	3
P-0006233	P-0006233-T01-IM5	In-House	DNA	Biopsy	250	664	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Olaparib(CHEK2 p.Q487*)					LEVEL_3B	U2AF1 p.S34F;ERBB2 p.S310F;SMAD4 p.Q245*;CHEK2 p.Q487*;NCOR1 p.Q120*;AXL p.A273P;EP300 p.Q1082*;ARID1A p.G808Tfs*24;CASP8 p.L152Kfs*24	2	9
P-0006234	P-0006234-T01-IM5	In-House	DNA	Resection	250	540	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;DIS3 p.R382Q	1	2
P-0006235	P-0006235-T01-IM5	In-House	DNA	Biopsy	250	447	40	Matched	Metastasis	Liver	Lung	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(ROCK1 FGFR2-ROCK1 fusion);Pemigatinib(FGFR2 FGFR2-ROCK1 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(ROCK1 FGFR2-ROCK1 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-ROCK1 fusion)						LEVEL_1	BAP1 p.E631*;ROCK1 FGFR2-ROCK1 fusion;FGFR2 FGFR2-ROCK1 fusion	4	3
P-0006236	P-0006236-T01-IM5	In-House	DNA	Resection	250	504	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R175H	1	2
P-0006237	P-0006237-T01-IM5	In-House	DNA	Biopsy	250	1023	80	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification);Crizotinib,Entrectinib(ROS1 COL4A3BP-ROS1 fusion);Crizotinib,Entrectinib(COL4A3BP COL4A3BP-ROS1 fusion)					LEVEL_3B	ARID1A Deletion;FAT1 Deletion;ID3 Deletion;MDM2 Amplification;PRDM1 Deletion;ROS1 COL4A3BP-ROS1 fusion;COL4A3BP COL4A3BP-ROS1 fusion	3	7
P-0006238	P-0006238-T01-IM5	Outside	DNA	Resection	250	1039	70	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0006239	P-0006239-T01-IM5	In-House	DNA	Resection	250	709	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0006240	P-0006240-T01-IM5	Outside	DNA	Biopsy	250	947	30	Unmatched	Primary	Lymph node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										RHOA p.G17V;DNMT3A p.X725_splice;TET2 p.W954*;TET2 p.Q1545*	0	4
P-0006241	P-0006241-T01-IM5	Outside	DNA	Biopsy	121.2	735	20	Matched	Primary	Conjunctiva	Not Applicable	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma					Trametinib,Cobimetinib(NF1 p.R2450*);Trametinib,Cobimetinib(NF1 p.Y2182*)				LEVEL_4	NF1 p.R2450*;NF1 p.Y2182*	2	2
P-0006242	P-0006242-T01-IM5	In-House	DNA	Biopsy	250	894	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Enasidenib(IDH2 p.R172S)					LEVEL_3B	IDH2 p.R172S;KMT2C p.Q1870*	1	2
P-0006243	P-0006243-T01-IM5	Outside	DNA	Resection	250	1051	90	Matched	Metastasis	Soft Tissue	Lung	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0006244	P-0006244-T01-IM5	Outside	DNA	Resection	250	778	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Olaparib(ATM p.N1929*);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3A	IDH1 p.R132C;ATM p.N1929*;ERBB2 Amplification;NF1 Deletion	4	4
P-0006245	P-0006245-T02-IM5	In-House	FFPE	Resection	250	657	20	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 BRCA2-intragenic)					LEVEL_3B	CTNNB1 p.D32V;CTNNB1 p.H36P;NFE2L2 p.E82G;MDC1 p.I1020_R1028del;CDKN1A p.D26Afs*7;BRCA2 BRCA2-intragenic	1	6
P-0006246	P-0006246-T02-IM5	In-House	FFPE	Biopsy	250	800	NA	Matched	Metastasis	Rectum	Liver	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;DIS3 p.R689Q;DICER1 p.Q1685*;KDM6A Deletion;TGFBR2 Deletion	1	5
P-0006246	P-0006246-T01-IM5	Outside	DNA	Biopsy	250	1036	30	Matched	Primary	Rectum	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										TGFBR2 Deletion	0	1
P-0006247	P-0006247-T01-IM5	In-House	DNA	Resection	250	730	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.L114Cfs*9	0	1
P-0006248	P-0006248-T01-IM5	In-House	DNA	Resection	250	737	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.X268_splice)				LEVEL_4	PTEN p.X268_splice;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	1	4
P-0006248	P-0006248-T02-IM5	Outside	DNA	Biopsy	250	639	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;PPM1D Amplification	0	4
P-0006249	P-0006249-T01-IM5	Outside	DNA	Biopsy	250	546	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;MAP3K1 p.R763Cfs*35;LATS1 p.R1081*;MAP3K1 p.W1433*	2	4
P-0006250	P-0006250-T01-IM5	In-House	DNA	Biopsy	234.8	111	10	Matched	Metastasis	Gallbladder	Peritoneum	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Trametinib,Cobimetinib(MAP2K1 p.K57E)					LEVEL_3B	ARID1A p.Q1519Pfs*13;TP53 p.E285K;MAP2K1 p.K57E;AXIN1 p.W85*;SMAD4 p.L536_E538delinsQ;SMAD4 p.L535Sfs*42	1	6
P-0006251	P-0006251-T01-IM5	Outside	DNA	Biopsy	250	870	20	Matched	Metastasis	Rectum	Liver	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										NFE2L2 p.D29Y;HLA-A p.L10Vfs*90;SUZ12 p.D409Ifs*18	0	3
P-0006252	P-0006252-T01-IM5	In-House	DNA	Biopsy	240.2	414	10	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.Q1264*;PBRM1 p.E374*	0	2
P-0006253	P-0006253-T01-IM5	In-House	DNA	Resection	250	506	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC2 p.P1675R)					LEVEL_3B	TP53 p.E285K;TP53 p.E287D;CDKN1A p.R48*;KMT2C p.Q448*;RB1 p.S829*;TSC2 p.P1675R;BCL2L1 Amplification;DDR2 Amplification;DNMT3B Amplification	1	9
P-0006255	P-0006255-T01-IM5	In-House	DNA	Resection	250	914	20	Unmatched	Metastasis	Breast	Lymph Node	Tumor	AML	Leukemia	Acute Myeloid Leukemia										NRAS p.G13D;JAK3 p.R657W	0	2
P-0006256	P-0006256-T01-IM5	Outside	DNA	Biopsy	207.7	623	10	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R249S	0	1
P-0006257	P-0006257-T01-IM5	In-House	DNA	Biopsy	250	521	20	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.I195F;PTPN11 p.G503V;RB1 p.Q444L;CCND1 Amplification;EGFR Amplification;FGF19 Amplification	0	6
P-0006258	P-0006258-T01-IM5	In-House	DNA	Resection	250	758	80	Matched	Primary	Retroperitoneum	Colon	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;GLI1 Amplification;MCL1 Amplification;MDM2 Amplification;NTRK1 Amplification	2	5
P-0006259	P-0006259-T01-IM5	In-House	DNA	Resection	250	853	70	Matched	Metastasis	Thyroid	Mediastinum	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006260	P-0006260-T01-IM5	In-House	DNA	Biopsy	250	478	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMAD4 p.R361S	1	2
P-0006261	P-0006261-T01-IM5	In-House	DNA	Resection	250	918	NA	Matched	Metastasis	Rectum	Retroperitoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C176F;APC p.Q1406*;FLT3 Amplification	0	3
P-0006262	P-0006262-T01-IM5	In-House	DNA	Biopsy	250	709	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E542K;TP53 p.F338Sfs*7;ERBB2 Amplification	4	3
P-0006264	P-0006264-T01-IM5	Outside	DNA	Resection	250	943	20	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;KMT2D p.R4904*;TP53 p.R342*;ARID1A p.Q633*	1	4
P-0006265	P-0006265-T01-IM5	In-House	DNA	Resection	250	712	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Olaparib(ATM p.Q2762Afs*6)					LEVEL_3B	TP53 p.E339*;KMT2D p.R845Pfs*3;NFE2L2 p.I28T;HLA-A p.R7*;ATM p.Q2762Afs*6;JAK1 p.N339Kfs*2;KMT2D p.P998Lfs*2;FANCC p.X116_splice;KMT2A p.K1029Rfs*65;CREBBP p.I1084Nfs*3	1	10
P-0006266	P-0006266-T01-IM5	Outside	DNA	Biopsy	111.7	666	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X23_splice)				LEVEL_4	KRAS p.G12V;TP53 p.K132M;CDKN2A p.X23_splice;CCND1 Amplification;FGF19 Amplification	2	5
P-0006267	P-0006267-T01-IM5	Outside	DNA	Resection	250	651	70	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	EPHB1 p.D762N;BRAF p.F595I;CBL p.H398R;NF1 Deletion	1	4
P-0006268	P-0006268-T01-IM5	Outside	DNA	Biopsy	250	591	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										EGFR Amplification	0	1
P-0006269	P-0006269-T01-IM5	Outside	DNA	Resection	250	842	70	Matched	Metastasis	Uterus	Diaphragm	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344M);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y);Olaparib(ATM p.Q628Pfs*7)	Trametinib,Cobimetinib(NF1 p.L1300Tfs*14)				LEVEL_3B	SETD2 p.R1407Gfs*5;PIK3CA p.V344M;TET2 p.R1516*;JAK1 p.N339Ifs*3;PIK3CA p.H1047Y;ARID1A p.P1326Rfs*155;TET2 p.R550*;ARID1A p.P224Rfs*8;MSH2 p.X71_splice;NOTCH4 p.P920Lfs*12;PMS1 p.S426Lfs*16;CDKN1B p.R93Afs*32;ATR p.F270Sfs*8;MSH2 p.A230Lfs*16;MITF p.K313Rfs*6;NF1 p.L1300Tfs*14;FANCA p.N250Tfs*4;ATM p.Q628Pfs*7;STK11 p.D176Tfs*111;MSH2 p.E56Gfs*19	4	20
P-0006270	P-0006270-T01-IM5	Outside	DNA	Biopsy	243.3	749	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0006271	P-0006271-T01-IM5	In-House	DNA	Resection	250	390	10	Matched	Metastasis	Rectosigmoid Colon	Lymph Node	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R249S;APC p.E1286*;MCL1 Amplification	1	4
P-0006272	P-0006272-T01-IM5	In-House	DNA	Biopsy	250	904	10	Matched	Metastasis	Cecum	Lymph Node	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)		Cetuximab,Panitumumab(NRAS p.G12D)			LEVEL_3B	NRAS p.G12D	1	1
P-0006273	P-0006273-T01-IM5	In-House	DNA	Biopsy	250	706	30	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R248Q;RB1 p.X405_splice;KDM6A p.E1370*;MYC Amplification;RAC1 Amplification	1	6
P-0006274	P-0006274-T01-IM5	Outside	DNA	Resection	250	660	50	Matched	Metastasis	Soft Tissue	Ovary	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										ZFHX3 Deletion;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	3
P-0006275	P-0006275-T01-IM5	In-House	DNA	Resection	250	704	50	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R248W;APC p.Q1406*;SOX9 p.C72Afs*27;AURKA Amplification;BCL2L1 Amplification;CDK8 Amplification;DNMT3B Amplification;SRC Amplification	0	8
P-0006277	P-0006277-T01-IM5	Outside	DNA	Resection	250	721	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.V272L;RB1 p.X840_splice;BCL2L11 p.S104Afs*5;AKT2 Amplification;BCL2L1 Amplification;FOXO1 Deletion;GATA3 Amplification;INHA Deletion;MCL1 Amplification;RAF1 Amplification;RICTOR Amplification;SRC Amplification;TERT Amplification	0	13
P-0006278	P-0006278-T01-IM5	In-House	DNA	Resection	250	411	90	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0006279	P-0006279-T01-IM5	In-House	DNA	Biopsy	250	413	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.E285K;TP53 p.D281N	0	2
P-0006280	P-0006280-T01-IM5	In-House	DNA	Resection	250	536	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;STAG2 p.Y815Lfs*4;RB1 p.R150Kfs*7;TP53 p.G244F;RICTOR Amplification;TERT Amplification	1	6
P-0006281	P-0006281-T01-IM5	In-House	DNA	Biopsy	193.5	233	10	Matched	Metastasis	Bladder	Soft Tissue	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										SF3B1 p.E902K;ARID1B p.Q1349*;TET1 p.Q1701*;TP53 p.H193D;CIC p.Q1069*;ARID1A p.T1666Pfs*7;KMT2D p.A4452Gfs*35;RICTOR Amplification;CIC PAFAH1B3-CIC fusion;PAFAH1B3 PAFAH1B3-CIC fusion;RBM10 ZNF157-RBM10 fusion;ZNF157 ZNF157-RBM10 fusion	0	12
P-0006282	P-0006282-T02-IM5	In-House	FFPE	Resection	250	676	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ARID1A p.D1850Gfs*4;PBRM1 p.A344Wfs*15;VHL p.S111Tfs*49;FGFR1 Amplification	1	4
P-0006283	P-0006283-T01-IM5	In-House	DNA	Biopsy	250	401	30	Matched	Metastasis	Breast	Mediastinal Mass	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										NCOR1 p.X537_splice	0	1
P-0006284	P-0006284-T01-IM5	In-House	DNA	Resection	250	244	30	Matched	Primary	Soft Tissue	Soft Tissue	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MCL1 Amplification;MDM2 Amplification	2	3
P-0006286	P-0006286-T01-IM5	In-House	DNA	Cytology	250	505	40	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.D208V;STK11 p.Q152Rfs*9	0	2
P-0006286	P-0006286-T02-IM5	In-House	FFPE	Cytology	250	1300	80	Matched	Metastasis	Breast	Pleural Fluid	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma				Olaparib(BRIP1 p.S772*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.D208V;STK11 p.Q152Rfs*9;BLM p.Q937*;BRIP1 p.S772*;PIK3R1 p.I571_L581del;AURKA Amplification;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;FOXA1 Amplification;MYC Amplification;NKX2-1 Amplification;PAK1 Amplification;PPM1D Amplification;PTPRD Deletion;SRC Amplification;YAP1 Amplification	2	18
P-0006287	P-0006287-T01-IM5	In-House	DNA	Resection	250	123	20	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	KRAS p.G12A;TP53 p.R282W;CDC73 p.E144Gfs*58	1	3
P-0006289	P-0006289-T01-IM5	In-House	DNA	Biopsy	250	809	30	Matched	Metastasis	Lung	Omentum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)		Trametinib,Cobimetinib(MAP2K1 p.N122D)	Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SETD2 p.Q1498*;MAP2K1 p.N122D;TP53 p.R209Sfs*5;SMAD4 p.L109Kfs*4;SETD2 p.K657Ifs*3	3	6
P-0006290	P-0006290-T01-IM5	In-House	DNA	Biopsy	154.8	150	30	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;U2AF1 p.S34F;INHA p.E254*;RUNX1 p.X91_splice;KRAS Amplification	1	5
P-0006291	P-0006291-T01-IM5	In-House	DNA	Resection	250	765	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.P883Tfs*23);Tazemetostat(SMARCB1 p.T357Dfs*4)				LEVEL_1	FGFR3 p.S249C;KDM6A p.P883Tfs*23;SMARCB1 p.T357Dfs*4	4	3
P-0006292	P-0006292-T01-IM5	Outside	DNA	Biopsy	250	541	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0006294	P-0006294-T01-IM5	Outside	DNA	Cytology	250	586	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;MAX p.X99_splice	1	2
P-0006295	P-0006295-T01-IM5	In-House	DNA	Resection	250	559	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D579del)								LEVEL_1	KIT p.D579del	1	1
P-0006296	P-0006296-T01-IM5	Outside	DNA	Resection	250	480	30	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					GSK2636771,AZD8186(PTEN p.G165E)				LEVEL_4	FAT1 p.Q2798*;PTEN p.G165E;KMT2D p.X1528_splice;RB1 p.S567L;NCOR1 p.R933*;BCOR p.X1017_splice;BCL6 Amplification	1	7
P-0006297	P-0006297-T01-IM5	In-House	DNA	Biopsy	250	574	90	Matched	Metastasis	Uterus	Abdomen	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.F1005Lfs*38)					LEVEL_3B	BRCA2 p.F1005Lfs*38;ARID5B Deletion;DICER1 Deletion;RB1 Deletion;SMARCA4 LDLR-SMARCA4 fusion;LDLR LDLR-SMARCA4 fusion	1	6
P-0006299	P-0006299-T01-IM5	Outside	DNA	Biopsy	250	657	50	Matched	Primary	Brain	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	NF1 Deletion;SUZ12 Deletion	1	2
P-0006300	P-0006300-T01-IM5	Outside	DNA	Resection	250	478	20	Matched	Primary	Penis	Not Applicable	Tumor	PSCC	Penile Cancer	Penile Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 BRCA1-intragenic)					LEVEL_3B	PIK3CA p.E545K;ASXL2 p.Q751*;KMT2C p.S606*;BRCA1 BRCA1-intragenic	2	4
P-0006301	P-0006301-T01-IM5	In-House	DNA	Resection	250	538	60	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma											0	0
P-0006302	P-0006302-T01-IM5	Outside	DNA	Resection	250	518	20	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix										GNAS p.R201H	0	1
P-0006303	P-0006303-T01-IM5	Outside	DNA	Resection	250	276	70	Unmatched	Primary	Breast	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.Y234H;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0006304	P-0006304-T01-IM5	In-House	DNA	Biopsy	250	821	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;RB1 p.S567L;FLT3 p.V592I;TP53 p.Y236N;KEAP1 p.D479H	1	5
P-0006305	P-0006305-T01-IM5	In-House	DNA	Biopsy	250	780	80	Matched	Primary	Neck	Not Applicable	Tumor	CSCHW	Nerve Sheath Tumor	Cellular Schwannoma											0	0
P-0006306	P-0006306-T01-IM5	Outside	DNA	Resection	250	819	20	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	APC p.R805*;KRAS p.G13D;TP53 p.C176S;CREBBP p.R440*;NCOR1 p.S177*	1	5
P-0006307	P-0006307-T01-IM5	Outside	DNA	Resection	250	982	70	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	2
P-0006308	P-0006308-T01-IM5	Outside	DNA	Biopsy	224.49	261	60	Matched	Metastasis	Cancer of Unknown Primary	Omentum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.G1567*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;STK11 p.X200_splice;BRCA1 p.G1567*	3	3
P-0006309	P-0006309-T01-IM5	Outside	DNA	Biopsy	250	1061	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	4
P-0006310	P-0006310-T01-IM5	Outside	DNA	Biopsy	250	856	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;STK11 p.P221L;PIK3R2 Amplification	2	3
P-0006311	P-0006311-T01-IM5	Outside	DNA	Biopsy	250	905	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0006311	P-0006311-T02-IM5	Outside	FFPE	Biopsy	250	892	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	PTEN p.T319*;TP53 p.K132E;KMT2D p.S3981Efs*3;BAP1 p.K719Nfs*17;PRKAG1 MLL2-PRKAG1 fusion;KMT2D MLL2-PRKAG1 fusion	1	6
P-0006312	P-0006312-T02-IM5	In-House	FFPE	Biopsy	250	923	60	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice)				LEVEL_4	TP53 p.C242Afs*5;FAT1 p.X1441_splice;SMARCA4 p.Q675*;CDKN2A p.X51_splice	1	4
P-0006312	P-0006312-T01-IM5	Outside	DNA	Cytology	182.4	149	70	Matched	Metastasis	Lung	Pericardium	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.C242Afs*5	0	1
P-0006313	P-0006313-T01-IM5	In-House	DNA	Resection	250	862	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0006314	P-0006314-T01-IM5	In-House	DNA	Cytology	250	685	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.E298*;TP53 p.R337C;ATRX p.D774Mfs*29	0	3
P-0006315	P-0006315-T01-IM5	Outside	DNA	Resection	250	721	40	Matched	Metastasis	Breast	Colon	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;CDH1 p.Q449*	2	2
P-0006316	P-0006316-T01-IM5	Outside	DNA	Resection	250	611	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	TP53 p.R196*;KRAS p.G12S;AXIN2 p.Q37*;APC p.C1274Lfs*5;TBX3 p.S214Qfs*29;FGFR4 Amplification;SMAD4 Deletion	1	7
P-0006317	P-0006317-T01-IM5	Outside	DNA	Biopsy	164.5	106	20	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Olaparib(BARD1 p.X523_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	KRAS p.G12A;APC p.R564*;APC p.E1397*;BARD1 p.X523_splice;SMAD4 p.P356R;CDKN1B p.N8*;TP53 p.V274_C275dup	2	7
P-0006318	P-0006318-T01-IM5	Outside	DNA	Resection	250	891	70	Matched	Metastasis	Stomach	Ovary	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R	1	1
P-0006319	P-0006319-T01-IM5	In-House	DNA	Resection	250	946	70	Matched	Primary	Neck	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.R1275Q)					LEVEL_3B	ALK p.R1275Q	1	1
P-0006320	P-0006320-T01-IM5	In-House	DNA	Resection	250	729	80	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.P551_M552delinsL)			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	KIT p.P551_M552delinsL;FGFR1 Amplification;TNFRSF14 Deletion	2	3
P-0006321	P-0006321-T01-IM5	In-House	DNA	Cytology	155.3	351	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.X224_splice;SMARCA4 p.Q306Rfs*12;CARD11 Amplification;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ETV1 Amplification;MET Amplification;RAC1 Amplification	3	10
P-0006322	P-0006322-T01-IM5	In-House	DNA	Resection	250	871	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.E49*	1	2
P-0006323	P-0006323-T01-IM5	Outside	DNA	Resection	250	422	80	Matched	Primary	Neck	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification	1	3
P-0006324	P-0006324-T01-IM5	In-House	DNA	Cytology	250	598	30	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;DNMT3A p.Q656*	1	2
P-0006325	P-0006325-T01-IM5	In-House	DNA	Resection	250	1243	70	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0006326	P-0006326-T01-IM5	Outside	DNA	Cytology	250	378	30	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.R306*;ERBB2 p.V842I	2	3
P-0006327	P-0006327-T01-IM5	Outside	DNA	Biopsy	250	700	30	Matched	Metastasis	Testis	Lymph Node	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										PPP2R1A p.R183W;ARID1A Deletion;ID3 Deletion;SDHB Deletion;SPEN Deletion;TNFRSF14 Deletion	0	6
P-0006328	P-0006328-T01-IM5	In-House	DNA	Biopsy	250	817	20	Matched	Metastasis	Bile Duct	Soft Tissue	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(NRBF2 FGFR2-NRBF2 fusion);Pemigatinib(FGFR2 FGFR2-NRBF2 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(NRBF2 FGFR2-NRBF2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-NRBF2 fusion)						LEVEL_1	BAP1 p.Q393*;NRBF2 FGFR2-NRBF2 fusion;FGFR2 FGFR2-NRBF2 fusion	4	3
P-0006329	P-0006329-T01-IM5	In-House	DNA	Resection	250	918	20	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R)					LEVEL_3B	PIK3CA p.G1049R;TP53 p.L257P;CXCR4 p.R334*;CDH1 p.R732Q;RBM10 p.Q361*;FBXW7 p.E287D;APC p.S254*;APC p.Q1035*;CCND2 Amplification	1	9
P-0006330	P-0006330-T01-IM5	Outside	DNA	Biopsy	250	178	10	Matched	Metastasis	Cancer of Unknown Primary	Mediastinum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										NOTCH3 p.A1802Gfs*8;EGFR Amplification;MYCL Amplification	0	3
P-0006331	P-0006331-T01-IM5	Outside	DNA	Biopsy	250	1252	20	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLAD	Bladder Cancer	Bladder Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R175H;NRAS p.Q61R;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;SRC Amplification;VEGFA Amplification;EWSR1 SYN3-EWSR1 fusion;SYN3 SYN3-EWSR1 fusion	3	9
P-0006332	P-0006332-T01-IM5	In-House	DNA	Resection	250	982	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.Y220C	1	2
P-0006333	P-0006333-T01-IM5	Outside	DNA	Biopsy	250	506	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D769Y)					LEVEL_3B	ERBB2 p.D769Y;KMT2D p.L656Rfs*274;CCNE1 Amplification	1	3
P-0006334	P-0006334-T01-IM5	In-House	DNA	Resection	250	688	60	Matched	Metastasis	Kidney	Lymph Node	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										BAP1 p.A243Gfs*34	0	1
P-0006335	P-0006335-T01-IM5	In-House	DNA	Cytology	76.8	790	NA	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.T1025A)	Olaparib,Talazoparib(BRCA2 p.X2659_splice)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.T1025A)	Rucaparib,Niraparib(BRCA2 p.X2659_splice)					LEVEL_1	PIK3CA p.E545K;PIK3CA p.T1025A;TBX3 p.Q590*;KMT2C p.E3393*;BRCA2 p.X2659_splice;CREBBP p.Q497*;ARID1A p.I908Tfs*9;CDH1 p.E745Rfs*3	6	8
P-0006336	P-0006336-T01-IM5	In-House	DNA	Resection	250	753	70	Matched	Metastasis	Small Bowel	Liver	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor										CDKN1B p.N31Tfs*11	0	1
P-0006337	P-0006337-T01-IM5	Outside	DNA	Cytology	195.615	122	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ARID1A p.G1469Wfs*22	1	2
P-0006338	P-0006338-T01-IM5	In-House	DNA	Resection	250	395	60	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0006339	P-0006339-T01-IM5	In-House	DNA	Biopsy	250	1647	70	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114F)				LEVEL_4	ARID2 p.Q1411*;IL7R p.S185N;PIK3R1 p.E546*;PRKN p.W74*;PTPRT p.R364Q;BCOR p.W289*;MED12 p.R605*;MAX p.R60_A61delinsQT;CDKN2A p.P114F;BAP1 Deletion;CDKN1B Deletion;PBRM1 Deletion	1	12
P-0006340	P-0006340-T01-IM5	In-House	DNA	Resection	250	750	70	Matched	Metastasis	Ovary	Rectum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(CHEK2 Deletion);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	TP53 p.N247I;TET2 p.R1167G;CHEK2 Deletion;EP300 Deletion;FGFR1 Amplification;NF2 Deletion;SMARCB1 Deletion	3	7
P-0006341	P-0006341-T01-IM5	In-House	DNA	Cytology	250	920	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R158G;KDM5C p.W93C;SMARCA4 p.F1065Vfs*17;DNMT3A p.X803_splice	0	4
P-0006342	P-0006342-T01-IM5	Outside	DNA	Resection	250	448	50	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										APC p.R1858*	0	1
P-0006343	P-0006343-T01-IM5	In-House	DNA	Resection	250	747	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Everolimus(TSC2 p.E392*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TSC2 p.E392*	3	2
P-0006344	P-0006344-T01-IM5	In-House	DNA	Resection	250	280	70	Matched	Metastasis	Uterus	Chest Wall	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	CTNNB1 p.S33Y;PIK3CA p.H1047R;AKT1 p.Q79K;ARID1A p.L2238Afs*39;NOTCH1 p.R1598C;ARID1A p.P1169Qfs*22;CTCF p.A137Lfs*17	1	7
P-0006345	P-0006345-T01-IM5	In-House	DNA	Resection	250	618	20	Matched	Metastasis	Ascending Colon	Abdominal Wall	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R337C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;APC p.R1450*;APC p.R283*;ATM p.R337C;SOX9 p.H493Pfs*85	2	5
P-0006346	P-0006346-T01-IM5	Outside	DNA	Resection	250	525	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0006347	P-0006347-T01-IM5	In-House	DNA	Resection	250	561	50	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0006348	P-0006348-T01-IM5	In-House	DNA	Resection	250	868	20	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CDH1 p.T790Pfs*3;FGFR1 Amplification	1	2
P-0006349	P-0006349-T01-IM5	Outside	DNA	Cytology	250	685	60	Matched	Metastasis	Cancer of Unknown Primary	Pleura	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R249S;KRAS p.G12A;BRAF p.G466V;NF2 p.E378*;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0006350	P-0006350-T02-IM5	In-House	FFPE	Biopsy	250	712	50	Matched	Metastasis	Mediastinum	Bone	Tumor	BIMT	Germ Cell Tumor	Immature Teratoma										SH2D1A Deletion;STAG2 Deletion	0	2
P-0006350	P-0006350-T01-IM5	Outside	DNA	Resection	250	553	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	OIMT	Germ Cell Tumor	Immature Teratoma											0	0
P-0006351	P-0006351-T01-IM5	Outside	DNA	Resection	250	636	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.X187_splice;TERT Amplification	2	3
P-0006352	P-0006352-T01-IM5	Outside	DNA	Resection	250	1814	20	Matched	Primary	Liver	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma				Olaparib(ATM p.L282Ffs*22)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;ATM p.L282Ffs*22	2	2
P-0006353	P-0006353-T01-IM5	In-House	DNA	Biopsy	250	780	20	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3A	IDH1 p.R132C;ARID1A p.W1844Gfs*39;ARID1A p.F266*;CDKN2A p.R80*	2	4
P-0006354	P-0006354-T01-IM5	Outside	DNA	Resection	250	621	60	Matched	Primary	Eye	Not Applicable	Tumor	RBL	Retinoblastoma	Retinoblastoma										RB1 p.Q736*;RB1 p.X702_splice;ARID1B Deletion;CCND3 Amplification;LATS1 Deletion;PRKN Deletion;VEGFA Amplification	0	7
P-0006355	P-0006355-T01-IM5	Outside	DNA	Biopsy	250	744	50	Matched	Metastasis	Breast	Bladder	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.R108_I112delinsV)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108_I112delinsV)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12L)				LEVEL_1	TP53 p.R280T;CDH1 p.X440_splice;NCOR1 p.E1974*;PIK3CA p.R108_I112delinsV;CDKN2A p.S12L;PIK3CA Amplification	3	6
P-0006357	P-0006357-T01-IM5	Outside	DNA	Biopsy	250	799	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.C176R;RB1 p.X737_splice;KMT2D p.Q4219*	0	3
P-0006358	P-0006358-T01-IM5	In-House	DNA	Resection	250	1016	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										GNAS p.R201H;CCND2 Amplification	0	2
P-0006359	P-0006359-T01-IM5	In-House	DNA	Resection	250	1068	70	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93W)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.R93W	2	2
P-0006360	P-0006360-T01-IM5	In-House	DNA	Resection	250	875	50	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	TP53 p.R306*;CDKN2A p.R58*	1	2
P-0006361	P-0006361-T01-IM5	Outside	DNA	Resection	250	638	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion;PTEN Deletion	2	4
P-0006362	P-0006362-T01-IM5	In-House	DNA	Resection	250	813	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	SF3B1 p.K700E;KRAS p.Q61R;KMT2C p.R2028*;SMAD4 p.Y95*;SMARCA4 p.M781V	1	5
P-0006363	P-0006363-T01-IM5	Outside	DNA	Biopsy	250	791	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	Lapatinib(EGFR p.A289V);Lapatinib(EGFR Amplification)				LEVEL_3B	EGFR p.A289V;EGFR p.A289D;CDK4 Amplification;EGFR Amplification;GLI1 Amplification;MDM4 Amplification	3	6
P-0006364	P-0006364-T01-IM5	Outside	DNA	Biopsy	250	1288	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X1249_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;ATM p.X1249_splice;RBM10 p.Y438*	2	3
P-0006365	P-0006365-T01-IM5	In-House	DNA	Resection	250	524	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.K1079Nfs*2);Olaparib(ATM ATM-intragenic)					LEVEL_3B	TP53 p.Q144*;PBRM1 p.I279Yfs*4;TCF7L2 p.K485Sfs*23;MSH2 p.A230Lfs*16;NOTCH3 p.T577Hfs*46;SH2B3 p.E523Sfs*25;ARID1A p.G37Afs*14;ERRFI1 p.N135Tfs*40;APC p.S1272Qfs*16;BRCA1 p.K1079Nfs*2;APC p.M91Cfs*34;ARID1A p.A325Rfs*75;ATM ATM-intragenic	2	13
P-0006366	P-0006366-T01-IM5	In-House	DNA	Biopsy	250	726	20	Unmatched	Primary	Lymph Node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										TP53 p.C238Y;B2M p.M1?;NOTCH2 p.R2400*;SPEN p.E805Dfs*3;TNFAIP3 p.X98_splice	0	5
P-0006367	P-0006367-T01-IM5	In-House	DNA	Resection	250	464	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0006368	P-0006368-T01-IM5	In-House	DNA	Biopsy	250	1319	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				BLU-667,Selpercatinib(RET p.A919S)					LEVEL_3B	ARID1A p.D1850Gfs*4;NOTCH3 p.P42Lfs*194;BRAF p.G466E;TP53 p.W146*;KDM6A p.Q240*;INPP4B p.X522_splice;RET p.A919S;NOTCH3 p.X40_splice;BCOR p.R1514*;NCOR1 p.E529Rfs*7;RASA1 p.Y49Ifs*24;FAT1 p.L2132Ffs*3;FAT1 p.N1151Kfs*4;MSH2 p.M866_E867delinsI*	1	14
P-0006369	P-0006369-T01-IM5	In-House	DNA	Biopsy	250	780	70	Matched	Primary	Leg	Not Applicable	Tumor	PECOMA	Soft Tissue Sarcoma	Perivascular Epithelioid Cell Tumor										RB1 p.X203_splice;FAT1 Deletion;TP53 Deletion;PTPRD PTPRD-intragenic	0	4
P-0006370	P-0006370-T01-IM5	In-House	DNA	Resection	250	762	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	CREBBP p.Q1796*;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	3
P-0006371	P-0006371-T01-IM5	In-House	DNA	Biopsy	250	621	20	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.C141*	1	2
P-0006372	P-0006372-T01-IM5	Outside	DNA	Biopsy	250	679	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	TP53 p.C242F;KRAS p.G12C	2	2
P-0006373	P-0006373-T01-IM5	Outside	DNA	Resection	250	106	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0006374	P-0006374-T01-IM5	Outside	DNA	Resection	250	588	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T79Nfs*41)				LEVEL_4	TP53 p.V73Wfs*50;KRAS p.Q61A;CDKN2A p.T79Nfs*41	2	3
P-0006375	P-0006375-T01-IM5	In-House	DNA	Cytology	250	721	50	Unmatched	Primary	Retroperitoneum	Not Applicable	Tumor	NHL	Non-Hodgkin Lymphoma	Non-Hodgkin Lymphoma										TET2 p.Q129*;TET2 p.G1288D;TET2 p.L1482Wfs*89	0	3
P-0006376	P-0006376-T01-IM5	In-House	DNA	Biopsy	250	1150	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.G778_P780dup)	Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)	Trametinib,Cobimetinib(NF1 p.Q1272*);Trametinib,Cobimetinib(NF1 p.X218_splice)				LEVEL_3A	ARID1A p.R693*;ERBB2 p.G778_P780dup;NF1 p.Q1272*;ARID1A p.D315Rfs*85;NF1 p.X218_splice;ZFHX3 Deletion	4	6
P-0006377	P-0006377-T02-IM5	In-House	DNA	Biopsy	250	714	10	Matched	Primary	Arm	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										PIM1 p.H68N;ETV6 p.X11_splice;BCL10 p.L223*;CDKN2A Deletion;CDKN2B Deletion;DICER1 Deletion;PTPRD Deletion	0	7
P-0006378	P-0006378-T01-IM5	In-House	DNA	Resection	250	818	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN PTEN-intragenic)				LEVEL_4	TP53 p.Y236C;PTEN PTEN-intragenic	1	2
P-0006379	P-0006379-T01-IM5	In-House	DNA	Resection	250	620	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.X212_splice)				LEVEL_4	PTEN p.X212_splice	1	1
P-0006380	P-0006380-T01-IM5	In-House	DNA	Biopsy	250	1064	60	Matched	Metastasis	Ovary	Vagina	Tumor	EOV	Ovarian Cancer	Endometrioid Ovarian Cancer	Olaparib,Rucaparib,Niraparib(BRCA2 p.S1882*)			Talazoparib(BRCA2 p.S1882*)					LEVEL_1	MYC p.S161L;BRCA2 p.S1882*;PIK3R2 p.A36*;ARID5B p.I497Nfs*31;PIK3R1 Deletion;ZFHX3 Deletion;ARID1A ARID1A-intragenic	2	7
P-0006381	P-0006381-T01-IM5	In-House	DNA	Biopsy	250	608	70	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X155_splice	0	1
P-0006381	P-0006381-T02-IM5	In-House	FFPE	Resection	250	730	90	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X155_splice	0	1
P-0006382	P-0006382-T02-IM5	In-House	FFPE	Biopsy	216.9	604	50	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ARID1A p.E1766*;DAXX p.E454*;MEN1 p.E260*;CDKN2A Deletion;CDKN2B Deletion	1	5
P-0006382	P-0006382-T01-IM5	In-House	DNA	Resection	250	684	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										ARID1A p.E1766*;DAXX p.E454*;MEN1 p.E260*	0	3
P-0006383	P-0006383-T01-IM5	In-House	DNA	Biopsy	250	812	60	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.E457*)					LEVEL_3B	BRCA1 p.E457*;ARID2 Deletion;TGFBR2 Deletion	1	3
P-0006384	P-0006384-T01-IM5	In-House	DNA	Biopsy	250	113	30	Matched	Metastasis	Soft Tissue	Mediastinum	Tumor	EPIS	Soft Tissue Sarcoma	Epithelioid Sarcoma	Tazemetostat(SMARCB1 Deletion)								LEVEL_1	MGA p.D582Efs*6;SMARCB1 Deletion	1	2
P-0006387	P-0006387-T01-IM5	In-House	DNA	Biopsy	250	913	50	Matched	Metastasis	Kidney	Pleura	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.F148*;BAP1 p.G424Qfs*4	0	2
P-0006388	P-0006388-T01-IM5	Outside	DNA	Biopsy	250	608	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN p.X212_splice)				LEVEL_3B	GATA3 p.D335Gfs*17;PTEN p.X212_splice;AURKA Amplification;FGFR1 Amplification;MYC Amplification;PIK3CB Amplification;SRC Amplification	2	7
P-0006389	P-0006389-T01-IM5	In-House	DNA	Biopsy	153	111	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	3
P-0006390	P-0006390-T01-IM5	In-House	DNA	Biopsy	250	933	30	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.X331_splice;APC p.Y935*	0	2
P-0006392	P-0006392-T01-IM5	In-House	DNA	Biopsy	250	666	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										KDM5C p.X688_splice;VHL p.P172Afs*2	0	2
P-0006393	P-0006393-T01-IM5	In-House	DNA	Biopsy	250	78	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.S45P	0	1
P-0006394	P-0006394-T01-IM5	In-House	DNA	Resection	250	741	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.R1399Ffs*9;APC p.L629Sfs*4;PRKN Deletion;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	0	7
P-0006395	P-0006395-T01-IM5	In-House	DNA	Resection	250	900	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A	1	1
P-0006396	P-0006396-T01-IM5	Outside	DNA	Biopsy	250	652	30	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.D281G;IDH1 p.R132H;TP53 p.C135Y;ATRX p.Y1758*	1	4
P-0006397	P-0006397-T01-IM5	In-House	DNA	Biopsy	250	835	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.S183*	2	2
P-0006398	P-0006398-T01-IM5	In-House	DNA	Resection	250	517	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Q50R)				LEVEL_4	KRAS p.G12R;TP53 p.R282W;CDKN2A p.Q50R	2	3
P-0006399	P-0006399-T01-IM5	In-House	DNA	Resection	250	445	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.G266E	1	2
P-0006400	P-0006400-T01-IM5	In-House	DNA	Biopsy	213.5	479	10	Matched	Metastasis	Cervix	Abdomen	Tumor	CEAS	Cervical Cancer	Cervical Adenosquamous Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D;ARID2 p.E1794*;GNAS p.R201L;ARID2 p.V1140Dfs*15	1	4
P-0006401	P-0006401-T02-IM5	In-House	FFPE	Biopsy	250	1053	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma											0	0
P-0006402	P-0006402-T01-IM5	In-House	DNA	Resection	250	1303	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719S)								LEVEL_1	EGFR p.G719S;EGFR p.E709A;MED12 p.Q2112*;TP53 p.A307Gfs*30;TP53 p.C229Yfs*8	1	5
P-0006403	P-0006403-T01-IM5	In-House	DNA	Biopsy	250	347	10	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.R249S	0	1
P-0006404	P-0006404-T01-IM5	In-House	DNA	Resection	250	892	70	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS					Trametinib,Cobimetinib(NF1 p.R1306*);GSK2636771,AZD8186(PTEN p.T319Yfs*6);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R273H;NF1 p.R1306*;ATRX p.K945Rfs*25;ARID1A p.E966*;PTEN p.T319Yfs*6;CDKN2A Deletion;CDKN2B Deletion	3	7
P-0006405	P-0006405-T01-IM5	In-House	DNA	Biopsy	250	899	20	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248W;BRAF Amplification;CCNE1 Amplification;TERT Amplification	0	4
P-0006406	P-0006406-T01-IM5	In-House	DNA	Biopsy	250	822	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;MAP3K1 p.S1330W;MEN1 p.R465*;TP53 p.Q165H;MAP3K1 p.R273Sfs*27;CCND1 Amplification;FGF19 Amplification	2	7
P-0006407	P-0006407-T01-IM5	In-House	DNA	Biopsy	250	951	50	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Tipifarnib(HRAS p.G13D)	Trametinib,Cobimetinib(NF1 p.Q282*)				LEVEL_3B	TP53 p.H179Y;NF1 p.Q282*;HRAS p.G13D;RB1 p.F755I;TP53 p.X332_splice;NOTCH1 p.X823_splice;RB1 p.K537Nfs*14	2	7
P-0006408	P-0006408-T01-IM5	In-House	DNA	Biopsy	250	1302	60	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Everolimus(TSC2 p.E393*)					LEVEL_3B	RB1 p.G435*;MGA p.R1106*;TSC2 p.E393*;EP300 p.H1451Q;TP53 p.R156Lfs*25	1	5
P-0006409	P-0006409-T01-IM5	In-House	DNA	Resection	250	813	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(MYOF FGFR2-MYOF fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 FGFR2-MYOF fusion)					LEVEL_3B	AXIN1 p.E195*;MYOF FGFR2-MYOF fusion;FGFR2 FGFR2-MYOF fusion	2	3
P-0006410	P-0006410-T03-IM5	In-House	FFPE	Resection	250	715	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R342*;ATRX p.F2113Sfs*9;ATR Deletion;FOXL2 Deletion;PTEN Deletion	1	5
P-0006410	P-0006410-T02-IM5	Outside	FFPE	Biopsy	250	919	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R342*;ATRX p.F2113Sfs*9;PTEN Deletion	1	3
P-0006410	P-0006410-T01-IM5	Outside	DNA	Resection	250	696	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										TP53 p.R342*;ATRX p.F2113Sfs*9	0	2
P-0006411	P-0006411-T01-IM5	Outside	DNA	Biopsy	250	1220	70	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	TP53 p.R158G;BRCA2 Deletion;DIS3 Deletion;FH Deletion;FOXA1 Deletion;FOXO1 Deletion;KDR Amplification;KIT Amplification;NFKBIA Deletion;PARP1 Deletion;PDGFRA Amplification;RB1 Deletion	1	12
P-0006412	P-0006412-T01-IM5	In-House	DNA	Biopsy	250	952	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Trametinib,Cobimetinib(LUC7L2 BRAF-LUC7L2 fusion);Trametinib,Cobimetinib(BRAF BRAF-LUC7L2 fusion)					LEVEL_3B	TP53 p.V272L;RB1 p.X737_splice;SRC Amplification;LUC7L2 BRAF-LUC7L2 fusion;BRAF BRAF-LUC7L2 fusion	2	5
P-0006413	P-0006413-T01-IM5	Outside	DNA	Resection	250	721	20	Matched	Metastasis	Testis	Lymph Node	Tumor	BYST	Germ Cell Tumor	Yolk Sac Tumor											0	0
P-0006414	P-0006414-T01-IM5	Outside	DNA	Biopsy	250	998	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.Q171R)				LEVEL_4	TP53 p.R248Q;TP53 p.D184Afs*62;PTEN p.Q171R;TET2 p.M906Ifs*17;CCND1 Amplification;FGF19 Amplification	1	6
P-0006415	P-0006415-T01-IM5	Outside	DNA	Cytology	155.7	301	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN p.G127E)				LEVEL_4	KRAS p.G12A;PTPRD p.Y1386*;PTEN p.G127E;SMAD4 p.M294Gfs*13;FOXA1 Amplification;MGA Deletion;NKX2-1 Amplification	2	7
P-0006416	P-0006416-T01-IM5	In-House	DNA	Biopsy	250	752	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Y16*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.Y16*;CDH1 p.D291N;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	5
P-0006416	P-0006416-T02-IM5	In-House	FFPE	Resection	250	880	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	2	7
P-0006417	P-0006417-T01-IM5	In-House	DNA	Resection	250	917	NA	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SF3B1 p.K700E;RNF43 p.X125_splice	1	3
P-0006418	P-0006418-T01-IM5	In-House	DNA	Biopsy	250	702	20	Matched	Metastasis	Uterus	Abdomen	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.H93Y);GSK2636771,AZD8186(PTEN p.V158Efs*3)				LEVEL_4	BCOR p.N1459S;CTNNB1 p.S37F;PTEN p.H93Y;PIK3R1 p.L570P;ARID1A p.R156Qfs*244;PTEN p.V158Efs*3	2	6
P-0006419	P-0006419-T01-IM5	Outside	DNA	Biopsy	250	560	30	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										BAP1 p.V99M;NF2 p.R341*	0	2
P-0006421	P-0006421-T01-IM5	In-House	DNA	Resection	250	825	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	TP53 p.R273H;KRAS p.G12S;RB1 p.F299Lfs*4;TP53 p.L264Hfs*81	1	4
P-0006422	P-0006422-T01-IM5	In-House	DNA	Biopsy	250	366	10	Matched	Primary	Skin	Not Applicable	Tumor	EMPD	Skin Cancer, Non-Melanoma	Extramammary Paget Disease				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;SMARCA4 p.E371*	1	2
P-0006423	P-0006423-T01-IM5	Outside	DNA	Resection	250	1288	60	Matched	Metastasis	Cancer of Unknown Primary	Subcutaneous Tissue	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)	Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N3124S)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61K;FLT3 p.G669E;BRCA2 p.N3124S;PTPRT p.W136*;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0006425	P-0006425-T01-IM5	Outside	DNA	Resection	250	914	80	Matched	Primary	Brain	Not Applicable	Tumor	ANM	CNS Cancer	Anaplastic Meningioma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0006426	P-0006426-T01-IM5	Outside	DNA	Resection	250	856	70	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L	0	1
P-0006427	P-0006427-T01-IM5	Outside	DNA	Resection	250	626	20	Matched	Primary	Testis	Not Applicable	Tumor	BEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0006428	P-0006428-T01-IM5	Outside	DNA	Biopsy	200.34	234	20	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma										FBXW7 p.R505G;NOTCH1 p.G406Afs*225;NOTCH1 p.M1992Pfs*4;BCOR p.N1075*	0	4
P-0006429	P-0006429-T01-IM5	In-House	DNA	Biopsy	250	409	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 TNIP2-FGFR3 fusion);Erdafitinib(TNIP2 TNIP2-FGFR3 fusion)		Debio1347,BGJ398,AZD4547(FGFR3 TNIP2-FGFR3 fusion);Debio1347,BGJ398,AZD4547(TNIP2 TNIP2-FGFR3 fusion)		GSK2636771,AZD8186(PTEN p.R173H);Tazemetostat(KDM6A p.W1319*)				LEVEL_1	PTEN p.R173H;KDM6A p.W1319*;FGFR3 TNIP2-FGFR3 fusion;TNIP2 TNIP2-FGFR3 fusion	6	4
P-0006430	P-0006430-T01-IM5	In-House	DNA	Resection	250	684	10	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TGFBR1 p.S241L;TP53 p.Q167Hfs*4;ARID1A p.L657Pfs*81;ERBB2 Amplification;ERBB3 Amplification	1	5
P-0006431	P-0006431-T01-IM5	In-House	DNA	Resection	250	787	80	Matched	Metastasis	Uterus	Omentum	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C901F)					LEVEL_3B	PIK3CA p.C901F;FBXW7 p.R479Q;MYC Amplification;TNFRSF14 Deletion	1	4
P-0006432	P-0006432-T01-IM5	In-House	DNA	Biopsy	250	1064	40	Matched	Metastasis	Lung	Adrenal Gland	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung	Capmatinib(MET p.D1010N)	Crizotinib(MET p.D1010N)	Cabozantinib(MET p.D1010N)						LEVEL_1	MET p.D1010N;TP53 p.K382Nfs*40;RB1 p.X565_splice	3	3
P-0006433	P-0006433-T01-IM5	Outside	FFPE	Biopsy	250	878	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H;SETD2 p.E95*;SMAD4 p.X483_splice;ARID1A p.L113Qfs*119;MYC Amplification	1	6
P-0006434	P-0006434-T01-IM5	Outside	FFPE	Biopsy	250	469	50	Matched	Metastasis	Sigmoid Colon	Peritoneum	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										ERBB3 p.E928G;TP53 p.K132E;FBXW7 p.S282*;APC p.L1382Hfs*3	0	4
P-0006436	P-0006436-T01-IM5	Outside	FFPE	Biopsy	250	517	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.N292Mfs*15)				LEVEL_4	SF3B1 p.K700E;PTEN p.N292Mfs*15	1	2
P-0006437	P-0006437-T01-IM5	Outside	FFPE	Resection	250	695	50	Matched	Primary	Skin	Not Applicable	Tumor	SKAC	Skin Cancer, Non-Melanoma	Skin Adnexal Carcinoma										TP53 p.R249T;CARD11 p.R113Q;KMT2C p.X3987_splice;NOTCH1 p.R448*;CREBBP p.X29_splice;GRIN2A p.W606*;CDH1 p.X440_splice;NOTCH3 p.E1064*;RB1 p.T625Rfs*24	0	9
P-0006438	P-0006438-T01-IM5	Outside	FFPE	Resection	250	708	30	Matched	Primary	Appendix	Not Applicable	Tumor	GCCAP	Appendiceal Cancer	Goblet Cell Carcinoid of the Appendix											0	0
P-0006439	P-0006439-T01-IM5	In-House	FFPE	Resection	250	722	30	Matched	Primary	Larynx	Not Applicable	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	TP53 p.R248Q;PIK3CA p.H1047R;TP53 p.Y126*;CCND1 Amplification;FGF19 Amplification	1	5
P-0006440	P-0006440-T01-IM5	In-House	FFPE	Resection	250	898	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.C238G	0	1
P-0006441	P-0006441-T01-IM5	Outside	FFPE	Resection	250	1164	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										TP53 p.R248W;RB1 p.X566_splice;PIK3R1 p.D464_Y470dup	0	3
P-0006442	P-0006442-T01-IM5	Outside	FFPE	Biopsy	250	881	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R273C;APC p.X279_splice;EGFR Amplification	0	3
P-0006443	P-0006443-T01-IM5	In-House	FFPE	Biopsy	250	848	40	Matched	Primary	Axilla	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS											0	0
P-0006444	P-0006444-T01-IM5	Outside	FFPE	Resection	250	733	40	Matched	Primary	Ovary	Not Applicable	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3B	NRAS p.Q61K;EIF1AX p.G8R	1	2
P-0006445	P-0006445-T01-IM5	In-House	FFPE	Biopsy	250	361	30	Matched	Metastasis	Cervix	Abdominal Wall	Tumor	CECC	Cervical Cancer	Cervical Clear Cell Carcinoma										PPP2R1A p.W257L;ATRX p.W1883*;PIK3R1 p.Y580_L581delinsM	0	3
P-0006446	P-0006446-T01-IM5	In-House	FFPE	Resection	250	563	40	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										ANKRD11 Deletion;MYCN Amplification	0	2
P-0006447	P-0006447-T01-IM5	Outside	FFPE	Resection	250	516	80	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	KMT2A p.S774Vfs*12;CDH1 p.H453Rfs*10;FGFR1 Amplification	1	3
P-0006448	P-0006448-T01-IM5	Outside	FFPE	Biopsy	250	1051	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A21*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_1	TP53 p.R175H;MAP3K1 p.R288*;ARID1A p.L1176Ifs*17;CDKN2A p.A21*;CDKN2A p.R58*;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	4	8
P-0006449	P-0006449-T01-IM5	Outside	FFPE	Resection	250	755	90	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0006450	P-0006450-T01-IM5	Outside	FFPE	Biopsy	250	149	10	Matched	Primary	Bile Duct	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										TP53 p.R342*;ARID2 p.X56_splice;RASA1 p.T60Kfs*14	0	3
P-0006450	P-0006450-T02-IM5	Outside	FFPE	Resection	246.1	848	10	Matched	Metastasis	Bile Duct	Liver	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										TP53 p.R342*;ARID2 p.X56_splice;RASA1 p.T60Kfs*14;ARID1A p.K2020*	0	4
P-0006451	P-0006451-T01-IM5	In-House	FFPE	Biopsy	250	976	30	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										BCOR p.Y653Tfs*16	0	1
P-0006452	P-0006452-T01-IM5	Outside	FFPE	Resection	250	750	50	Matched	Primary	Omentum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										BAP1 p.X85_splice;SETD2 p.E1234Ifs*8	0	2
P-0006453	P-0006453-T01-IM5	Outside	FFPE	Biopsy	250	922	30	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										ARID1A p.Q538Rfs*81;ARID1A Deletion;ERRFI1 Deletion;ID3 Deletion	0	4
P-0006454	P-0006454-T01-IM5	Outside	FFPE	Biopsy	250	579	60	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	2
P-0006455	P-0006455-T01-IM5	Outside	FFPE	Biopsy	250	749	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 p.L755S;TP53 p.Q192*;ERBB2 Amplification	4	3
P-0006456	P-0006456-T01-IM5	Outside	FFPE	Biopsy	250	386	30	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma			Neratinib(ERBB2 p.L869R)	Ado-Trastuzumab Emtansine(ERBB2 p.L869R)					LEVEL_3A	ERBB2 p.L869R;TBX3 p.S371Afs*261	2	2
P-0006457	P-0006457-T01-IM5	Outside	FFPE	Biopsy	250	599	40	Matched	Metastasis	Lung	Skin	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;U2AF1 p.S34F;TP53 p.L194F	1	3
P-0006458	P-0006458-T01-IM5	Outside	FFPE	Biopsy	250	960	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.Y163C;GNAS p.R160P;ERBB2 Amplification	2	3
P-0006459	P-0006459-T01-IM5	In-House	FFPE	Biopsy	250	1071	30	Matched	Metastasis	Lung	Mediastinum	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R158L;BAP1 Deletion;EPHA3 Deletion;FOXP1 Deletion;MITF Deletion;MYCL Amplification;PBRM1 Deletion;RYBP Deletion;SHQ1 Deletion;TERT Amplification	0	10
P-0006460	P-0006460-T01-IM5	In-House	FFPE	Biopsy	250	1101	20	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K)	Cetuximab,Panitumumab(KRAS p.Q61K)			LEVEL_3B	TP53 p.R175H;PIK3CA p.C420R;SMAD4 p.R361H;KRAS p.Q61K;DNMT3B p.X636_splice	2	5
P-0006461	P-0006461-T01-IM5	In-House	FFPE	Biopsy	250	799	30	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.E2198Nfs*4)			Talazoparib,Niraparib(BRCA2 p.E2198Nfs*4)					LEVEL_1	FOXA1 p.R219C;BRCA2 p.E2198Nfs*4;FOXA1 p.A323_P326del;MYC Amplification	2	4
P-0006462	P-0006462-T01-IM5	Outside	FFPE	Resection	250	716	10	Matched	Metastasis	Skin	Supraclavicular Mass	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.L262*)						LEVEL_3A	TP53 p.R280K;TP53 p.X125_splice;NOTCH2 p.X1977_splice;PTCH1 p.L262*;KDM6A p.X250_splice;TGFBR1 Deletion	1	6
P-0006463	P-0006463-T01-IM5	In-House	FFPE	Biopsy	250	990	50	Matched	Metastasis	Lung	Trachea	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.V73Wfs*50;MAP3K1 Deletion;PIK3R1 Deletion;RASA1 Deletion	0	4
P-0006464	P-0006464-T01-IM5	Outside	FFPE	Resection	250	666	20	Matched	Primary	Brain	Not Applicable	Tumor	RGNT	Miscellaneous Neuroepithelial Tumor	Rosette-forming Glioneuronal Tumor of the Fourth Ventricle				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R	1	1
P-0006465	P-0006465-T01-IM5	Outside	FFPE	Biopsy	151.29	234	20	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma										MDM4 Amplification;PDGFRA Amplification	0	2
P-0006466	P-0006466-T01-IM5	Outside	FFPE	Resection	250	783	NA	Matched	Metastasis	Cancer of Unknown Primary	Breast	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.C275*;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;PAK1 Amplification	1	5
P-0006467	P-0006467-T01-IM5	In-House	FFPE	Biopsy	250	818	40	Matched	Metastasis	Foot	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	BRAF p.V600E;FGFR1 Amplification;PPM1D Amplification	3	3
P-0006468	P-0006468-T01-IM5	Outside	FFPE	Resection	250	875	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(CDK12 p.T1463Nfs*50)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.T1463Nfs*50)				LEVEL_3B	TP53 p.S127F;CDK12 p.T1463Nfs*50;APC p.E1353*;AXIN2 Deletion;CCND2 Amplification;KRAS Amplification;MYC Amplification	2	7
P-0006469	P-0006469-T01-IM5	In-House	FFPE	Resection	250	752	60	Matched	Primary	Transverse Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.R1450*;SMAD4 p.P356L;APC p.R554*;AMER1 p.R531*;SMAD2 p.R57*	1	6
P-0006470	P-0006470-T01-IM5	In-House	FFPE	Resection	250	759	50	Unmatched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.K650M)	GSK2636771,AZD8186(PTEN p.Q245*)				LEVEL_3B	TP53 p.R342*;PTEN p.Q245*;FGFR3 p.K650M;RB1 p.R787*;KMT2D p.Q3634*;CASP8 p.X184_splice;HIST1H3B p.E106K;KMT2C p.E1666*;ARID2 p.S1454*;RB1 p.X495_splice	2	10
P-0006471	P-0006471-T01-IM5	In-House	FFPE	Cytology	250	622	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R110L;RB1 p.N593Tfs*11;RICTOR Amplification;TERT Amplification	0	4
P-0006472	P-0006472-T01-IM5	Outside	FFPE	Biopsy	250	771	60	Matched	Metastasis	Cancer of Unknown Primary	Vagina	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310Y)					LEVEL_3B	TP53 p.D281V;ERBB2 p.S310Y;CCND3 Amplification;CCNE1 Amplification	1	4
P-0006473	P-0006473-T01-IM5	In-House	FFPE	Resection	250	616	30	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)				GSK2636771,AZD8186(PTEN p.I28M);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.L576P;PTEN p.I28M;CDKN2A Deletion	3	3
P-0006474	P-0006474-T01-IM5	In-House	FFPE	Resection	250	463	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345T)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.R273S;PIK3CA p.N345T;GPS2 p.G284*	3	4
P-0006475	P-0006475-T01-IM5	In-House	FFPE	Resection	250	873	20	Matched	Primary	Stomach	Not Applicable	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										ERBB3 p.G284R;RNF43 p.W259*	0	2
P-0006476	P-0006476-T01-IM5	In-House	DNA	Resection	250	638	70	Matched	Metastasis	Skin	Small Bowel	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.R342*;CDK4 p.R24C;PTPRS p.R126*;MITF Amplification	2	5
P-0006477	P-0006477-T01-IM5	In-House	DNA	Resection	224.1	155	10	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma										TP53 p.R248Q	0	1
P-0006478	P-0006478-T01-IM5	In-House	DNA	Resection	250	321	10	Matched	Metastasis	Appendix	Mesentery	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0006479	P-0006479-T01-IM5	In-House	DNA	Cytology	182.1	65	10	Matched	Metastasis	Breast	Bone	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;MYC Amplification	2	2
P-0006480	P-0006480-T01-IM5	In-House	DNA	Cytology	250	240	60	Matched	Metastasis	Major Salivary Gland	Neck	Tumor	HNMASC	Salivary Gland Cancer	Mammary Analogue Secretory Carcinoma of Salivary Gland Origin	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	RUNX1 p.R206Afs*4;ERRFI1 Deletion;NFKBIA Deletion;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	5
P-0006481	P-0006481-T01-IM5	Outside	DNA	Resection	250	702	70	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C901F)					LEVEL_3B	IDH1 p.R132H;PIK3CA p.C901F;NOTCH1 p.F357del;FUBP1 p.X83_splice;NOTCH3 p.R1036*;SUFU p.F30Sfs*17	2	6
P-0006482	P-0006482-T01-IM5	In-House	DNA	Resection	250	826	50	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	PIK3CA p.E545K;KRAS p.G12A;SPOP p.M117V;TP53 p.F134C;MYCN Amplification	2	5
P-0006484	P-0006484-T01-IM5	Outside	DNA	Resection	250	906	90	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										TP53 p.L111R;RB1 Deletion	0	2
P-0006485	P-0006485-T01-IM5	In-House	FFPE	Resection	250	1062	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3CA p.E545K;ARID1A p.Q528*;FAT1 p.K1234*;CREBBP p.L1692Rfs*50;MDM2 Amplification	4	6
P-0006486	P-0006486-T01-IM5	Outside	FFPE	Biopsy	182.4	137	10	Matched	Metastasis	Sinonasal	Skin	Tumor	OHNCA	Head and Neck Cancer	Head and Neck Carcinoma, Other										TP53 p.R273H;ZFHX3 p.Q3365*;TP53 p.M243_G244delinsIS	0	3
P-0006488	P-0006488-T01-IM5	In-House	FFPE	Resection	250	839	70	Matched	Metastasis	Skin	Spleen	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)		Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110_G111delins*)				LEVEL_1	BRAF p.V600E;NRAS p.Q61R;IKZF1 p.E304K;APC p.Q2291*;KEAP1 p.G476K;CDKN2A p.W110_G111delins*;TERT Amplification	4	7
P-0006489	P-0006489-T01-IM5	In-House	FFPE	Biopsy	250	741	30	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					Trametinib,Cobimetinib(NF1 p.E1570*)				LEVEL_4	TP53 p.R248W;SMAD4 p.R445*;NF1 p.E1570*;MAP3K1 p.L319Tfs*7;CCND1 Amplification;FGF19 Amplification	1	6
P-0006490	P-0006490-T01-IM5	In-House	FFPE	Resection	250	129	60	Matched	Primary	Bone	Not Applicable	Tumor	MFS	Soft Tissue Sarcoma	Myxofibrosarcoma										NF2 p.L120*;MIR1976 ARID1A-MIR1976 fusion;ARID1A ARID1A-MIR1976 fusion	0	3
P-0006491	P-0006491-T01-IM5	In-House	FFPE	Resection	250	1097	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.F134I;TGFBR1 p.D435*	1	3
P-0006492	P-0006492-T01-IM5	In-House	FFPE	Resection	250	512	40	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.C176S;TGFBR1 p.P83L;YAP1 Amplification	0	3
P-0006493	P-0006493-T01-IM5	In-House	FFPE	Biopsy	250	989	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.X225_splice;TCF7L2 p.S593*;FAT1 Deletion;MAP3K1 Deletion;MYC Amplification;PIK3CB Amplification;PIK3R1 Deletion	0	7
P-0006494	P-0006494-T01-IM5	In-House	FFPE	Resection	250	946	80	Matched	Metastasis	Pancreas	Adrenal Gland	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Everolimus(TSC2 p.M1?)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	DAXX p.Q638*;TSC2 p.M1?;ARID1A p.V2041Gfs*58;CDKN2A Deletion;CDKN2B Deletion;ERRFI1 Deletion;TNFRSF14 Deletion	2	7
P-0006494	P-0006494-T02-IM5	Outside	FFPE	Cytology	250	769	60	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Everolimus(TSC2 p.M1?)					LEVEL_3B	DAXX p.Q638*;TSC2 p.M1?	1	2
P-0006495	P-0006495-T01-IM5	In-House	FFPE	Resection	250	1180	20	Matched	Metastasis	Esophagus	Thigh	Tumor	ADNOS	Cancer of Unknown Primary	Adenocarcinoma, NOS										TP53 p.N200Ifs*47;NOTCH1 p.P547Vfs*18;EGFR Amplification	0	3
P-0006496	P-0006496-T01-IM5	In-House	FFPE	Resection	250	574	10	Matched	Metastasis	Testis	Liver	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										CTNNB1 p.D32N	0	1
P-0006497	P-0006497-T01-IM5	Outside	FFPE	Biopsy	250	738	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.E545K;CBFB p.M1?;MAP3K1 p.F354Lfs*2;NCOR1 p.X302_splice;TP53 p.R335_F338del;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;FGF19 Amplification;FOXA1 Amplification;KDR Amplification;KIT Amplification;MYC Amplification;PDGFRA Amplification;TERT Amplification	5	16
P-0006498	P-0006498-T01-IM5	In-House	FFPE	Resection	250	216	20	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0006498	P-0006498-T02-IM5	Outside	FFPE	Resection	250	699	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.R509*);Olaparib(BARD1 p.X466_splice)					LEVEL_3B	TSC1 p.R509*;BARD1 p.X466_splice;VHL p.P95Lfs*34	2	3
P-0006498	P-0006498-T03-IM5	Outside	FFPE	Resection	91.6	321	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										ERBB3 p.E928G;VHL p.S80N	0	2
P-0006499	P-0006499-T01-IM5	In-House	FFPE	Biopsy	250	1037	60	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.Y205H;B2M p.C45*;CREBBP p.Y1450D;STAT3 p.D427G	0	4
P-0006500	P-0006500-T01-IM5	In-House	FFPE	Resection	250	674	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.I101T);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.I101T;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;IKBKE Amplification;MDM4 Amplification	3	6
P-0006501	P-0006501-T01-IM5	In-House	FFPE	Resection	250	777	90	Matched	Primary	Stomach	Stomach	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557G)								LEVEL_1	KIT p.W557G;LATS1 p.W268*;MSH6 p.G56Wfs*21	1	3
P-0006502	P-0006502-T01-IM5	Outside	FFPE	Resection	250	912	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201H	1	2
P-0006503	P-0006503-T01-IM5	Outside	FFPE	Biopsy	250	687	70	Matched	Metastasis	Kidney	Chest Wall	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.S430*;NF2 p.P275Tfs*4	0	2
P-0006504	P-0006504-T02-IM5	Outside	FFPE	Cytology	250	870	70	Matched	Metastasis	Breast	Pleural Fluid	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Talazoparib,Olaparib(BRCA1 p.L358Kfs*13)		Niraparib,Rucaparib(BRCA1 p.L358Kfs*13)					LEVEL_2	TP53 p.R213*;TET2 p.R1452*;BRCA1 p.L358Kfs*13	2	3
P-0006505	P-0006505-T01-IM5	In-House	FFPE	Resection	250	738	80	Matched	Metastasis	Pancreas	Liver	Tumor	SPN	Pancreatic Cancer	Solid Pseudopapillary Neoplasm of the Pancreas										CTNNB1 p.D32Y;KDM6A p.Y120delins*	0	2
P-0006505	P-0006505-T02-IM5	In-House	FFPE	Resection	250	257	40	Matched	Metastasis	Pancreas	Chest Wall	Tumor	SPN	Pancreatic Cancer	Solid Pseudopapillary Neoplasm of the Pancreas										CTNNB1 p.D32Y;KDM6A p.Y120delins*	0	2
P-0006506	P-0006506-T01-IM5	In-House	FFPE	Resection	250	615	20	Matched	Primary	Pelvis	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 SLC25A37-EWSR1 fusion;SLC25A37 SLC25A37-EWSR1 fusion	0	2
P-0006507	P-0006507-T01-IM5	Outside	FFPE	Resection	250	965	50	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	KMT2D p.R4198*;PRDM1 p.P441Gfs*63;CDK4 Amplification;MDM2 Amplification;FLRT2 DICER1-FLRT2 fusion;DICER1 DICER1-FLRT2 fusion	2	6
P-0006508	P-0006508-T01-IM5	In-House	FFPE	Resection	250	217	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										STK11 p.D194N;FOXA1 Amplification;JUN Amplification	0	3
P-0006509	P-0006509-T01-IM5	In-House	FFPE	Resection	250	1061	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006510	P-0006510-T01-IM5	In-House	FFPE	Resection	250	587	80	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.E2419D)				LEVEL_4	NOTCH2 p.E2206*;MTOR p.E2419D;VHL p.S111N;RHOA p.R70K;LATS1 p.P557Tfs*22	1	5
P-0006511	P-0006511-T01-IM5	In-House	FFPE	Resection	250	1096	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			AMG-510(KRAS p.G12C);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T18Rfs*8)				LEVEL_3A	KRAS p.G12C;TP53 p.X307_splice;CDKN2A p.T18Rfs*8;FGFR1 Amplification	4	4
P-0006512	P-0006512-T01-IM5	Outside	FFPE	Biopsy	250	827	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)		Cetuximab,Panitumumab(NRAS p.Q61L)			LEVEL_3B	TP53 p.R248Q;NRAS p.Q61L;APC p.R283*;APC p.E1309Dfs*4;CDK8 Amplification;EGFR Amplification;FLT3 Amplification	1	7
P-0006514	P-0006514-T01-IM5	Outside	FFPE	Biopsy	93.5	450	10	Matched	Primary	Brain	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease										MITF Amplification	0	1
P-0006515	P-0006515-T01-IM5	In-House	FFPE	Biopsy	250	678	30	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Tipifarnib(HRAS p.G12S);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	HRAS p.G12S;FOXP1 p.E360*;CDKN1A p.V54Gfs*2;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification	3	6
P-0006516	P-0006516-T01-IM5	In-House	FFPE	Biopsy	250	888	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.I195T	1	2
P-0006517	P-0006517-T01-IM5	Outside	FFPE	Biopsy	250	1028	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification;PPM1D Amplification	2	2
P-0006518	P-0006518-T01-IM5	Outside	FFPE	Resection	250	1001	60	Matched	Metastasis	Sinonasal	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.V272E;NOTCH1 p.Q1733*	1	3
P-0006519	P-0006519-T01-IM5	Outside	FFPE	Biopsy	113	549	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84G)				LEVEL_4	TP53 p.E298*;NOTCH1 p.C440F;PTPRT p.X162_splice;CDKN2A p.D84G;CCND3 Amplification;CDK6 Amplification;VEGFA Amplification	1	7
P-0006520	P-0006520-T01-IM5	In-House	FFPE	Resection	250	874	50	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BAP1 p.X686_splice;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0006522	P-0006522-T01-IM5	Outside	FFPE	Resection	250	754	70	Matched	Primary	Cervix	Not Applicable	Tumor	CEMN	Cervical Cancer	Mesonephric Carcinoma										KMT2D p.R2685*	0	1
P-0006523	P-0006523-T01-IM5	In-House	FFPE	Resection	250	1006	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;RNF43 p.R132*	1	2
P-0006525	P-0006525-T01-IM5	In-House	FFPE	Biopsy	250	339	30	Matched	Metastasis	Oropharynx	Bone	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										KDM6A p.Q641*;NOTCH1 p.Y2323*;NFKBIA p.Q44Rfs*43	0	3
P-0006526	P-0006526-T01-IM5	In-House	FFPE	Biopsy	222.7	136	30	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.R2842C)	Talazoparib,Niraparib(BRCA2 p.R2842C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3A	TP53 p.W53*;BRCA2 p.R2842C;KRAS p.G13D	3	3
P-0006527	P-0006527-T01-IM5	Outside	FFPE	Resection	250	793	50	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.Y174*)				LEVEL_4	PTEN p.Y174*;GATA3 p.S413Qfs*94	1	2
P-0006528	P-0006528-T01-IM5	In-House	FFPE	Biopsy	204	166	10	Matched	Metastasis	Cancer of Unknown Primary	Larynx	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Olaparib(CDK12 p.K181*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K181*)				LEVEL_3B	TP53 p.R196*;NOTCH1 p.E1553*;CDK12 p.K181*;PIK3R2 p.K529*	2	4
P-0006529	P-0006529-T01-IM5	In-House	FFPE	Resection	250	218	90	Matched	Primary	Soft Tissue	Kidney	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0006530	P-0006530-T02-IM5	In-House	FFPE	Biopsy	250	521	30	Matched	Primary	Brain	Not Applicable	Tumor	HMBL	Miscellaneous Brain Tumor	Hemangioblastoma											0	0
P-0006531	P-0006531-T01-IM5	In-House	FFPE	Biopsy	250	860	20	Matched	Metastasis	Ovary	Lung	Tumor	EOV	Ovarian Cancer	Endometrioid Ovarian Cancer				AZD9496,Fulvestrant(ESR1 p.D538G)	GSK2636771,AZD8186(PTEN p.D92G)				LEVEL_3B	ESR1 p.D538G;CTNNB1 p.S33C;PTEN p.D92G;PIK3R1 p.X434_splice	2	4
P-0006532	P-0006532-T01-IM5	In-House	FFPE	Biopsy	250	806	70	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma					GSK2636771,AZD8186(PTEN p.A39E)				LEVEL_4	TP53 p.R342P;PTEN p.A39E;RB1 p.M386Ifs*11	1	3
P-0006533	P-0006533-T01-IM5	In-House	FFPE	Resection	250	178	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G118D)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D)	Tipifarnib(HRAS p.K117N)					LEVEL_1	PIK3CA p.G118D;TP53 p.H179Q;HRAS p.K117N;PIK3CA Amplification;PPM1D Amplification;RAC1 Amplification;RAF1 Amplification	3	7
P-0006535	P-0006535-T01-IM5	In-House	FFPE	Biopsy	250	899	50	Matched	Metastasis	Bladder	Pelvis	Tumor	SCB	Bladder Cancer	Sarcomatoid Carcinoma of the Urinary Bladder					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;RHOA p.A161V;CDKN2A Deletion;CDKN2B Deletion;LATS2 LATS2-intragenic	2	5
P-0006536	P-0006536-T01-IM5	In-House	FFPE	Resection	250	1126	20	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0006537	P-0006537-T01-IM5	Outside	FFPE	Resection	250	1046	70	Matched	Metastasis	Ovary	Small Bowel	Tumor	HGONEC	Ovarian Cancer	High-Grade Neuroendocrine Carcinoma of the Ovary				Olaparib(CHEK2 Deletion)					LEVEL_3B	TP53 p.V173L;NOTCH3 p.C591*;CHEK2 Deletion;INPP4B Deletion;RB1 Deletion;RNF43 Deletion	1	6
P-0006538	P-0006538-T01-IM5	Outside	FFPE	Biopsy	159.5	190	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.Y220S;ZRSR2 p.E102*;CTNNB1 p.G34_S71del;CARD11 Amplification;EGFR Amplification;ETV1 Amplification;MITF Deletion;NOTCH1 Deletion;PIK3CA Amplification;RAC1 Amplification	0	10
P-0006539	P-0006539-T01-IM5	In-House	FFPE	Biopsy	250	943	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.L191H)					LEVEL_3B	TP53 p.G245D;VHL p.P86R;PBRM1 p.R78*;TSC1 p.L191H	1	4
P-0006540	P-0006540-T01-IM5	In-House	FFPE	Biopsy	250	483	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Olaparib(CHEK2 p.R346G)					LEVEL_3B	KMT2D p.E1957*;DNMT3B p.E39*;CHEK2 p.R346G;ARID5B p.V280Rfs*7;TP53 p.P153Afs*28	1	5
P-0006541	P-0006541-T01-IM5	In-House	FFPE	Biopsy	250	863	70	Matched	Metastasis	Cancer of Unknown Primary	Axilla	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)		Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		GSK2636771,AZD8186(PTEN p.X343_splice)				LEVEL_1	NRAS p.Q61K;PTEN p.X343_splice;BRAF p.V600K;PTPRT p.Q162*;BRAF p.L505H;B2M p.L12P;EIF1AX p.G6C;B2M Deletion;MGA Deletion;RAD51 Deletion	3	10
P-0006541	P-0006541-T02-IM5	In-House	FFPE	Biopsy	250	749	80	Matched	Metastasis	Cancer of Unknown Primary	Soft Tissue	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)				GSK2636771,AZD8186(PTEN p.X343_splice)				LEVEL_1	PTEN p.X343_splice;BRAF p.V600K;PTPRT p.Q162*;BRAF p.L505H;EIF1AX p.G6C	2	5
P-0006542	P-0006542-T01-IM5	In-House	FFPE	Biopsy	250	1061	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.C1516S;PBRM1 p.Q402*;TET2 p.E1933*	0	3
P-0006543	P-0006543-T01-IM5	In-House	FFPE	Resection	250	837	70	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	MED12 p.G44S;TP53 p.V218del;KMT2D p.L3457Afs*10;KMT2D p.P462Lfs*7;CDKN2A p.H83Y;EGFR Amplification;GATA3 Deletion;MYC Amplification;RAC1 Amplification	1	9
P-0006544	P-0006544-T01-IM5	In-House	FFPE	Biopsy	250	1013	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R280I;RB1 p.P253Gfs*5;MYC Amplification	0	3
P-0006544	P-0006544-T02-IM5	In-House	FFPE	Biopsy	250	1242	80	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R280I;RB1 p.P253Gfs*5;GATA3 Amplification;MYC Amplification	0	4
P-0006545	P-0006545-T01-IM5	Outside	FFPE	Biopsy	250	681	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										TP53 p.C238Y;ATRX p.E1664*;TP53 p.L137Wfs*33;CDK6 Amplification;MYCN Amplification	0	5
P-0006546	P-0006546-T02-IM5	In-House	FFPE	Resection	250	1046	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;RB1 p.R418Sfs*9;TP53 p.H193R;ATRX p.L2258Gfs*10;B2M Deletion;DIS3 Deletion;FH Deletion;FOXO1 Deletion;MYC Amplification;RB1 Deletion	1	10
P-0006546	P-0006546-T01-IM5	Outside	FFPE	Resection	250	816	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;RB1 p.R418Sfs*9;TP53 p.H193R;ATRX p.L2258Gfs*10;CDKN1B p.D51Hfs*73	1	5
P-0006547	P-0006547-T01-IM5	In-House	FFPE	Biopsy	250	659	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 p.X686_splice;SETD2 p.Q2325Sfs*24	0	2
P-0006548	P-0006548-T01-IM5	In-House	FFPE	Resection	250	682	20	Matched	Primary	Rectum	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)	Cetuximab,Panitumumab(KRAS p.Q61R)			LEVEL_4	KRAS p.Q61R;APC p.R332*;TP53 p.L257P;SMAD4 p.E538*;APC p.R2237*;MED12 p.R621*;APC p.N1531Kfs*2	1	7
P-0006549	P-0006549-T01-IM5	In-House	FFPE	Cytology	246	461	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0006550	P-0006550-T01-IM5	Outside	FFPE	Resection	250	683	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										KDM5C p.E1338*;VHL p.N90Tfs*69;SETD2 Deletion	0	3
P-0006551	P-0006551-T01-IM5	Outside	FFPE	Resection	250	389	30	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;CDH1 p.X722_splice;MAP3K1 p.E168Lfs*16;FGFR1 Amplification	3	4
P-0006552	P-0006552-T01-IM5	Outside	FFPE	Resection	250	566	50	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0006553	P-0006553-T01-IM5	In-House	FFPE	Resection	250	879	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										BAP1 p.X23_splice;RASA1 p.L205Kfs*4	0	2
P-0006554	P-0006554-T01-IM5	In-House	FFPE	Biopsy	183.4	479	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)	GSK2636771,AZD8186(PTEN p.D92N)				LEVEL_3B	IDH1 p.R132H;PTEN p.D92N;MSH2 p.Q160*;EP300 p.X428_splice;CIC p.V1038Sfs*112;TNFRSF14 Deletion	2	6
P-0006555	P-0006555-T01-IM5	In-House	FFPE	Resection	250	597	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PECOMA	Soft Tissue Sarcoma	Perivascular Epithelioid Cell Tumor										KIT Amplification;PDGFRA Amplification	0	2
P-0006556	P-0006556-T01-IM5	In-House	FFPE	Resection	250	1041	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.X349_splice;SPEN p.P3367Tfs*48	0	2
P-0006557	P-0006557-T01-IM5	In-House	FFPE	Biopsy	250	916	50	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.R400*;NFE2L2 p.G81R;PTPRS p.R1492W;VHL p.D92Afs*66	0	4
P-0006558	P-0006558-T01-IM5	In-House	FFPE	Biopsy	250	1015	NA	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CTCF p.H284Y	0	1
P-0006559	P-0006559-T01-IM5	Outside	FFPE	Biopsy	141	1308	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Everolimus,Temsirolimus(MTOR p.M2327I)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.S241F;PTPRT p.R364*;MTOR p.M2327I;APC p.L954*	2	5
P-0006560	P-0006560-T01-IM5	Outside	FFPE	Resection	250	1064	30	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										FBXW7 p.R479Q;KMT2D p.R2471*;KMT2D p.X4839_splice	0	3
P-0006561	P-0006561-T02-IM5	In-House	FFPE	Biopsy	90.2	455	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;PIK3CA p.H1047R;ARID1A p.P1275Tfs*12;RBM10 p.S633Rfs*71;ARID1A p.X997_splice;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification;NKX2-1 Amplification	4	9
P-0006562	P-0006562-T01-IM5	Outside	FFPE	Biopsy	233.3	1105	10	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y129*)				LEVEL_4	KRAS p.G12V;CDKN2A p.Y129*	2	2
P-0006563	P-0006563-T01-IM5	Outside	FFPE	Resection	250	804	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;MAP3K1 p.X1267_splice;MAP3K1 p.L556*;FGFR1 Amplification	2	4
P-0006564	P-0006564-T01-IM5	Outside	FFPE	Biopsy	250	740	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V173L;APC p.Q1378*	0	2
P-0006565	P-0006565-T01-IM5	Outside	FFPE	Resection	250	919	30	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										SETD2 p.S2029Vfs*118;NF2 p.K289Sfs*7	0	2
P-0006566	P-0006566-T01-IM5	Outside	FFPE	Resection	250	706	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3CA p.E545K	3	2
P-0006567	P-0006567-T01-IM5	In-House	FFPE	Biopsy	250	790	70	Matched	Metastasis	Subungual Toe	Subcutaneous Tissue	Tumor	ACRM	Melanoma	Acral Melanoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	BRAF Amplification;CDK4 Amplification;ERBB3 Amplification;GLI1 Amplification;MDM2 Amplification	2	5
P-0006568	P-0006568-T01-IM5	Outside	FFPE	Biopsy	250	608	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 p.D1868Vfs*5)		Rucaparib,Niraparib(BRCA2 p.D1868Vfs*5)					LEVEL_2	TP53 p.R248Q;BRCA2 p.D1868Vfs*5;TBX3 p.T318Sfs*6	2	3
P-0006569	P-0006569-T01-IM5	In-House	FFPE	Biopsy	58.9	583	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_1	EGFR p.E746_A750del;TP53 p.P152L;CDKN2A p.R80*	2	3
P-0006570	P-0006570-T02-IM5	In-House	FFPE	Biopsy	250	1062	70	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CREBBP p.E1559*;NF2 p.E182*;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0006570	P-0006570-T01-IM5	Outside	FFPE	Resection	250	662	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.D261Rfs*2)				LEVEL_1	FGFR3 p.S249C;KDM6A p.D261Rfs*2;STAG2 E675fs	3	3
P-0006571	P-0006571-T01-IM5	In-House	FFPE	Resection	250	1015	20	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.A1027V)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_3B	TP53 p.R273C;ARID2 p.Q1313*;TP53 p.P151S;ARID5B p.K1045*;SDHD p.W43*;ASXL1 p.W960*;CDKN2A p.P114L;HOXB13 Deletion	2	8
P-0006573	P-0006573-T01-IM5	In-House	FFPE	Resection	250	235	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0006574	P-0006574-T01-IM5	In-House	FFPE	Resection	250	589	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.Y327*);Olaparib(CDK12 p.Q740Kfs*13)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Y327*);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q740Kfs*13)				LEVEL_1	PAX5 p.X71_splice;CDK12 p.Y327*;SPOP p.F125L;CDK12 p.Q740Kfs*13	4	4
P-0006575	P-0006575-T01-IM5	In-House	FFPE	Resection	250	824	70	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R342*;APC p.E1374*;APC p.E1374Dfs*41;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	0	6
P-0006577	P-0006577-T01-IM5	In-House	FFPE	Resection	250	1031	70	Matched	Primary	Muscle	Muscle	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	TP53 p.R273C;CARD11 Amplification;CDK4 Amplification;EGFR Amplification;KDM5A Amplification;MDM2 Amplification;RAC1 Amplification;ROS1 Amplification	2	8
P-0006579	P-0006579-T01-IM5	In-House	FFPE	Resection	250	552	30	Unmatched	Primary	Lung	Not Applicable	Tumor	MZL	Mature B-Cell Neoplasms	Marginal Zone Lymphoma											0	0
P-0006580	P-0006580-T01-IM5	In-House	FFPE	Resection	250	648	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L16Pfs*9)				LEVEL_4	KRAS p.G12D;TP53 p.R213*;CDKN2A p.L16Pfs*9	2	3
P-0006581	P-0006581-T01-IM5	In-House	FFPE	Resection	250	926	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;APC p.T1438Hfs*35;SMAD4 p.A118V;TP53 p.C176Y;TP53 p.M237I;TP53 p.Y236N;PBRM1 p.S652Ifs*13	2	8
P-0006582	P-0006582-T02-IM5	In-House	Cell Pellet	Cytology	250	1335	10	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										SMARCA4 p.S1410*;STK11 p.I300Afs*12;MYC Amplification;NTRK1 Amplification	0	4
P-0006582	P-0006582-T01-IM5	In-House	FFPE	Resection	250	814	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										SMARCA4 p.S1410*;STK11 p.I300Gfs*2;MYC Amplification	0	3
P-0006583	P-0006583-T01-IM5	In-House	FFPE	Biopsy	250	986	30	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.C277F;ARID1A p.Q1131Pfs*62;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0006584	P-0006584-T01-IM5	In-House	FFPE	Biopsy	250	618	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.N323Kfs*2)				LEVEL_4	PTEN p.N323Kfs*2;AR Amplification	1	2
P-0006585	P-0006585-T01-IM5	In-House	FFPE	Cytology	151	383	70	Matched	Primary	Leg	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0006586	P-0006586-T01-IM5	In-House	FFPE	Resection	250	595	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.D121G;BAP1 p.K3*;STK11 Deletion;TCF3 Deletion	0	4
P-0006587	P-0006587-T01-IM5	Outside	FFPE	Biopsy	250	1110	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;TP53 p.R248Q;ERBB2 p.R678Q;APC p.R1450*;APC p.R876*;TP53 p.R267W;MYC p.S161L;AMER1 p.R631*;SOX9 p.K253Efs*43;RBM10 p.N593Qfs*35	2	10
P-0006588	P-0006588-T01-IM5	In-House	FFPE	Resection	250	818	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0006589	P-0006589-T01-IM5	Outside	FFPE	Biopsy	250	370	10	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	TP53 p.R273H;KRAS p.G12D;APC p.Q541Tfs*19;APC p.I1418*	1	4
P-0006590	P-0006590-T01-IM5	Outside	FFPE	Resection	250	873	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;TP53 p.R175H;TP53 p.S241C	1	3
P-0006591	P-0006591-T01-IM5	Outside	FFPE	Resection	250	339	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer										TP53 Deletion	0	1
P-0006592	P-0006592-T01-IM5	In-House	FFPE	Resection	250	908	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V143A;APC p.X470_splice;APC Deletion;BCL2L1 Amplification;CCND3 Amplification;CDK8 Amplification;DNMT3B Amplification;FAT1 Deletion;FLT3 Amplification;NKX3-1 Deletion;RASA1 Deletion	0	11
P-0006593	P-0006593-T01-IM5	In-House	FFPE	Resection	250	787	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R282W	1	2
P-0006594	P-0006594-T01-IM5	In-House	FFPE	Resection	250	778	80	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)		GSK2636771,AZD8186(PTEN p.D24E)				LEVEL_2	PTEN p.D24E;CCNE1 Amplification;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification;TERT Amplification	3	6
P-0006595	P-0006595-T01-IM5	In-House	FFPE	Biopsy	250	1175	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R273C;TP53 p.G199V;APC p.D1942Efs*27	0	3
P-0006596	P-0006596-T01-IM5	In-House	FFPE	Resection	250	311	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.E180K;SETD2 p.T896Sfs*2;SETD2 p.G1040*	2	4
P-0006597	P-0006597-T01-IM5	Outside	FFPE	Resection	250	719	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.N193Cfs*62	0	1
P-0006598	P-0006598-T01-IM5	In-House	FFPE	Biopsy	250	1088	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										SETD2 p.E1805*;BAP1 p.X206_splice	0	2
P-0006599	P-0006599-T01-IM5	In-House	FFPE	Resection	250	609	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										JAK1 p.S703I	0	1
P-0006600	P-0006600-T01-IM5	Outside	FFPE	Resection	250	842	80	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0006601	P-0006601-T01-IM5	In-House	FFPE	Cytology	218	120	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TBX3 p.T290Nfs*37;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification;PAK1 Amplification	0	5
P-0006602	P-0006602-T02-IM5	In-House	FFPE	Resection	139.5	199	30	Matched	Metastasis	Prostate	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.T41A;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0006603	P-0006603-T01-IM5	In-House	FFPE	Cytology	143.2	658	NA	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.Y234C;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0006604	P-0006604-T01-IM5	In-House	FFPE	Resection	250	564	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0006605	P-0006605-T01-IM5	In-House	FFPE	Resection	250	913	20	Matched	Primary	Testis	Testis	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma			Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_3A	DDR2 Amplification;JUN Amplification;MDM2 Amplification;YAP1 Amplification	1	4
P-0006606	P-0006606-T01-IM5	In-House	FFPE	Biopsy	250	796	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	EGFR p.E709_T710delinsD;CDKN1B Deletion;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	2	5
P-0006606	P-0006606-T02-IM5	In-House	FFPE	Biopsy	250	903	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	EGFR p.E709_T710delinsD;CDKN1B Deletion;CDKN2A Deletion;CDKN2B Deletion;MAP2K4 Deletion	2	5
P-0006607	P-0006607-T02-IM5	In-House	FFPE	Biopsy	250	964	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0006607	P-0006607-T01-IM5	In-House	FFPE	Resection	250	699	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201H	1	2
P-0006608	P-0006608-T01-IM5	In-House	FFPE	Resection	250	952	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.E258G;APC p.Q445*;SMARCA4 p.R973W;SOX9 p.P299Cfs*85;NKX3-1 Deletion;PMAIP1 Deletion	0	6
P-0006609	P-0006609-T01-IM5	In-House	FFPE	Biopsy	250	708	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K);AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_3A	AKT1 p.E17K;ESR1 p.Y537S	2	2
P-0006610	P-0006610-T01-IM5	In-House	FFPE	Resection	250	702	50	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KMT2D p.X914_splice;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	2	4
P-0006611	P-0006611-T01-IM5	In-House	FFPE	Biopsy	250	769	50	Matched	Primary	Vulva	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina					Trametinib,Cobimetinib(NF1 p.I679Dfs*21)				LEVEL_4	TP53 p.G266R;NF1 p.I679Dfs*21;STAG2 KCNJ15-STAG2 fusion;KCNJ15 KCNJ15-STAG2 fusion	1	4
P-0006612	P-0006612-T01-IM5	In-House	FFPE	Resection	250	865	60	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I);Olaparib(ATM p.S2812Vfs*3);Everolimus(TSC1 p.G633*);Olaparib(ATM p.R2598*)	GSK2636771,AZD8186(PTEN p.R130Q);Trametinib,Cobimetinib(NF1 p.R2450*);Everolimus,Temsirolimus(MTOR p.S2231L);Trametinib,Cobimetinib(NF1 p.E524*)				LEVEL_3B	TP53 p.R213*;B2M p.R117*;PTEN p.R130Q;SMAD4 p.R361H;PIK3CA p.M1043I;NCOR1 p.R414*;APC p.R1920*;PIK3CB p.R321Q;SMAD4 p.E520*;RAF1 p.S257L;KDM6A p.R612*;SMAD4 p.E330K;ATM p.S2812Vfs*3;TP63 p.R594*;KMT2A p.R1855*;NF1 p.R2450*;CDK6 p.R220C;MSH2 p.E580*;PIK3R1 p.R348*;TP53 p.S166*;MTOR p.S2231L;MUTYH p.E104*;PIK3R3 p.E171*;MSH6 p.E1234*;XPO1 p.R749Q;TET2 p.Y1255*;TET2 p.G1288C;FBXW7 p.E4*;RASA1 p.E777*;APC p.S943*;APC p.E1573*;PMS2 p.R315*;KMT2C p.R1906*;PPP6C p.E281*;TSC1 p.G633*;ATM p.R2598*;ARID2 p.S1302*;KMT2D p.R5448*;TBX3 p.E111*;POLE p.S459F;FLT3 p.S806L;MGA p.R1761*;CREBBP p.R1103*;FLCN p.K78*;NF1 p.E524*;DNMT3B p.R299*;PTPRT p.R197*	8	47
P-0006613	P-0006613-T02-IM5	Outside	FFPE	Biopsy	250	425	15	Matched	Metastasis	Pancreas	Abdomen	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H	1	1
P-0006614	P-0006614-T01-IM5	In-House	FFPE	Resection	250	1014	30	Unmatched	Primary	Abdomen	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										PIK3CD p.E1021K;KMT2D p.E2280*;KMT2D p.Q1557*;CREBBP p.Q1041*;EPHA7 Deletion	0	5
P-0006615	P-0006615-T01-IM5	Outside	FFPE	Cytology	250	894	60	Matched	Metastasis	Esophagus	Pleural Fluid	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)					LEVEL_3B	ERBB2 p.R678Q;SMAD4 p.Q534*;AXIN1 p.P378Rfs*35;TP53 p.P295Lfs*50;CARD11 Amplification;CDH1 Deletion;EGFR Amplification;KRAS Amplification;PTPRT Deletion;RAC1 Amplification	1	10
P-0006616	P-0006616-T01-IM5	In-House	FFPE	Biopsy	250	801	40	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	TP53 p.R273H;BRAF p.V600E	3	2
P-0006617	P-0006617-T01-IM5	Outside	FFPE	Cytology	250	759	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ASAP2 ALK-ASAP2 fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK ALK-ASAP2 fusion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.G266R;U2AF1 p.S34F;ASAP2 ALK-ASAP2 fusion;ALK ALK-ASAP2 fusion	3	5
P-0006618	P-0006618-T01-IM5	Outside	FFPE	Cytology	200.8	793	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.N71Kfs*49)				LEVEL_4	KRAS p.G12R;TP53 p.P151S;CDKN2A p.N71Kfs*49;AKT2 Amplification;CCND3 Amplification;SMAD4 Deletion	2	6
P-0006619	P-0006619-T01-IM5	In-House	FFPE	Resection	250	1047	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										VHL p.P81Q;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0006620	P-0006620-T02-IM5	In-House	FFPE	Biopsy	250	965	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.E258*	0	1
P-0006620	P-0006620-T01-IM5	Outside	FFPE	Biopsy	250	1016	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R175H;PIK3R1 p.N564D;RASA1 p.M802Sfs*26	0	3
P-0006621	P-0006621-T01-IM5	Outside	FFPE	Resection	250	819	80	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)						LEVEL_3A	TP53 p.Q331*;NRAS p.Q61H;EPHA7 p.X725_splice;PTPRD p.G1478*;BIRC3 p.Q456*;GRIN2A p.W493*;ERCC3 p.K346Gfs*37;MLH1 p.G67K;INPP4B p.X86_splice;CCNE1 Amplification;GRIP1 TCF7L2-GRIP1 fusion;TCF7L2 TCF7L2-GRIP1 fusion	1	12
P-0006622	P-0006622-T01-IM5	Outside	FFPE	Biopsy	250	985	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;GATA3 p.L416Pfs*83;CARD11 Amplification;MYC Amplification	2	4
P-0006623	P-0006623-T01-IM5	Outside	FFPE	Resection	250	472	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	TP53 p.R248W;KRAS p.G12V;ARID1A p.E2120*	1	3
P-0006624	P-0006624-T01-IM5	In-House	FFPE	Resection	250	738	60	Matched	Metastasis	Cancer of Unknown Primary	Subcutaneous Tissue	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Everolimus,Temsirolimus(MTOR p.I2500F);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;MTOR p.I2500F;NOTCH1 p.H2428Y;CDKN2A Deletion;CDKN2B Deletion	4	5
P-0006625	P-0006625-T01-IM5	In-House	FFPE	Biopsy	250	1068	50	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0006626	P-0006626-T01-IM5	Outside	FFPE	Cytology	250	854	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.H193L;ARID1A p.A163Rfs*236	1	3
P-0006628	P-0006628-T01-IM5	Outside	FFPE	Biopsy	250	219	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.Y772_A775dup);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN1A p.G85*;ERBB2 p.Y772_A775dup;EP300 p.E1334*;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;SH2D1A Deletion;STAG2 Deletion	3	8
P-0006629	P-0006629-T01-IM5	In-House	FFPE	Resection	250	803	20	Matched	Metastasis	Jejunum	Liver	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Trametinib,Cobimetinib(MAP2K1 p.K57T)					LEVEL_3B	TP53 p.G245S;MAP2K1 p.K57T	1	2
P-0006630	P-0006630-T01-IM5	In-House	FFPE	Biopsy	250	1236	60	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										INPP4A p.R829L;RB1 p.Y424*;TP53 p.K120*;AKT2 Amplification;BAP1 Deletion;CCNE1 Amplification;MEF2B Amplification	0	7
P-0006631	P-0006631-T02-IM5	Outside	FFPE	Resection	228.1	277	60	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CDH1 p.Q449*;CCND1 Amplification;FGF19 Amplification;IKZF1 Deletion;PAK1 Amplification	2	6
P-0006632	P-0006632-T01-IM5	In-House	FFPE	Biopsy	250	862	20	Matched	Metastasis	Nasopharynx	Bone	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma											0	0
P-0006633	P-0006633-T01-IM5	In-House	FFPE	Resection	250	752	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Everolimus(TSC2 p.X200_splice)					LEVEL_3B	TP53 p.C275R;TSC2 p.X200_splice	1	2
P-0006634	P-0006634-T01-IM5	In-House	FFPE	Resection	250	855	60	Matched	Metastasis	Ampulla of Vater	Pancreas	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Trametinib,Cobimetinib,Binimetinib(KRAS p.G12I)				LEVEL_4	TP53 p.G245D;CTNNB1 p.T41A;KRAS p.G13D;ARID2 p.S660*;ARID2 p.S1229*;KRAS p.G12I	2	6
P-0006635	P-0006635-T01-IM5	In-House	FFPE	Resection	250	879	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R110L;TP53 p.G112Afs*11;CDKN1B Deletion;PTEN Deletion	1	4
P-0006636	P-0006636-T01-IM5	In-House	FFPE	Biopsy	250	1000	10	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)	Cetuximab,Panitumumab(KRAS p.Q61R)			LEVEL_4	KRAS p.Q61R;TP53 p.M237I;SMAD3 p.R268C	1	3
P-0006637	P-0006637-T01-IM5	Outside	FFPE	Cytology	165.06	963	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.X33_splice;PTPRD p.A420S;STK11 p.W332Cfs*4;MYC Amplification	1	5
P-0006638	P-0006638-T01-IM5	Outside	FFPE	Resection	250	909	80	Matched	Metastasis	Intraabdominal	Colon	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A829P);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559_E561del)	Sorafenib(KIT p.A829P)			Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib,Sunitinib(KIT p.A829P)		LEVEL_1	KIT p.A829P;KIT p.V559_E561del;CDKN2A Deletion;CDKN2B Deletion;ID3 Deletion;NFKBIA Deletion	4	6
P-0006639	P-0006639-T01-IM5	Outside	FFPE	Resection	250	586	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN PTEN-intragenic)				LEVEL_4	PBRM1 p.E70Vfs*25;FOXO1 p.K294Nfs*10;PTEN PTEN-intragenic	1	3
P-0006640	P-0006640-T01-IM5	In-House	FFPE	Resection	250	965	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.E746_A750del;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0006641	P-0006641-T01-IM5	Outside	FFPE	Biopsy	250	869	30	Matched	Metastasis	Oropharynx	Liver	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)					LEVEL_3B	PIK3CA p.R88Q;PIK3R2 p.D557Y;EP300 p.Y1414C;BCL6 Amplification;PIK3CA Amplification	1	5
P-0006642	P-0006642-T01-IM5	Outside	FFPE	Resection	250	1100	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.K164*;NOTCH4 p.C1259*;GATA3 p.Q73*;PTPRT p.Y652*;AMER1 p.E602*;PTPRD p.S1252Qfs*16	0	6
P-0006643	P-0006643-T01-IM5	In-House	FFPE	Resection	250	870	30	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	TP53 p.R249S;NRAS p.Q61R	1	2
P-0006644	P-0006644-T01-IM5	Outside	FFPE	Biopsy	128.52	767	10	Matched	Metastasis	Cancer of Unknown Primary	Duodenum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.R248W;STAG2 STAG2-intragenic	0	2
P-0006645	P-0006645-T01-IM5	In-House	FFPE	Resection	250	893	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.T46S)	Olaparib(ATM p.R337C);Olaparib(ATM p.R1466*)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.R678G);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549T);Tazemetostat(KDM6A p.X76_splice);Tazemetostat(KDM6A p.Q958*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.M53I);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	ATM p.R337C;ATM p.R1466*;EPHA3 p.M1?;TET2 p.G1407*;FGFR2 p.R678G;FGFR2 p.N549T;KMT2D p.Q2665*;ERCC2 p.T46S;KDM6A p.X76_splice;KDM6A p.Q958*;FBXW7 p.D258Vfs*7;GATA3 p.H123Pfs*69;FBXW7 p.R309Vfs*7;CDKN2A p.M53I;CDKN2A Deletion;CDKN2B Deletion	9	16
P-0006646	P-0006646-T01-IM5	In-House	FFPE	Resection	250	813	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(RAB11FIP1 FGFR1-RAB11FIP1 fusion);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 FGFR1-RAB11FIP1 fusion)				LEVEL_4	TP53 p.E258*;APC p.E1309Dfs*4;APC p.Q625*;TCF7L2 p.X423_splice;PAX5 p.I99Nfs*3;RAB11FIP1 FGFR1-RAB11FIP1 fusion;FGFR1 FGFR1-RAB11FIP1 fusion	2	7
P-0006647	P-0006647-T01-IM5	Outside	FFPE	Resection	250	929	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.Q1406*;TP53 p.P67Lfs*54;FLT3 Amplification	0	3
P-0006648	P-0006648-T01-IM5	Outside	FFPE	Resection	250	995	50	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification	0	2
P-0006649	P-0006649-T01-IM5	Outside	FFPE	Resection	250	512	40	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.H1047R;KRAS p.G13D;ARID1B p.G1271Efs*2;NOTCH3 p.G1135Vfs*137	2	4
P-0006650	P-0006650-T01-IM5	In-House	FFPE	Biopsy	250	912	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_1	PIK3CA p.E545K;ESR1 p.D538G;PPM1D p.L484*	3	3
P-0006651	P-0006651-T01-IM5	In-House	FFPE	Resection	250	723	20	Matched	Primary	Stomach	Not Applicable	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										CTCF p.T204Nfs*26;ARID1A p.F2141Sfs*59;ASXL2 p.W13Gfs*9	0	3
P-0006652	P-0006652-T01-IM5	In-House	FFPE	Resection	250	742	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0006653	P-0006653-T01-IM5	Outside	FFPE	Resection	250	889	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										ZFHX3 p.L3302Cfs*51;PBRM1 p.N149Kfs*25;SETD2 p.K2123Sfs*24;MYC Amplification	0	4
P-0006654	P-0006654-T01-IM5	In-House	FFPE	Resection	250	1025	10	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.R2832H)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.X343_splice)				LEVEL_3B	KRAS p.G12D;GNAS p.R201H;ATM p.R2832H;PTEN p.X343_splice	3	4
P-0006655	P-0006655-T01-IM5	Outside	FFPE	Resection	250	625	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										HNF1A p.G338A;KMT2C p.S3331Vfs*30	0	2
P-0006656	P-0006656-T01-IM5	In-House	FFPE	Resection	250	1019	70	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										SOX17 p.E374*;TP53 p.V122Dfs*26;AMER1 Deletion;ATRX Deletion;BCOR Deletion;BRD4 Amplification;CCNE1 Amplification;CIC Deletion;KDM5C Deletion;KDM6A Deletion;MED12 Deletion;MEF2B Amplification;PIK3R2 Amplification;RBM10 Deletion;ZRSR2 Deletion;BAGE2 MGA-BAGE2 fusion;MGA MGA-BAGE2 fusion	0	17
P-0006657	P-0006657-T01-IM5	In-House	FFPE	Resection	250	1001	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	PIK3CA p.H1047R;TP53 p.S241F;APC p.R232*;ERBB2 Amplification	3	4
P-0006658	P-0006658-T01-IM5	In-House	FFPE	Resection	250	966	NA	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R196*	0	1
P-0006659	P-0006659-T01-IM5	In-House	FFPE	Resection	250	1143	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.S241F;APC p.R876*;APC p.A1485Dfs*26	1	4
P-0006660	P-0006660-T01-IM5	In-House	FFPE	Biopsy	250	985	10	Matched	Metastasis	Breast	Uterus	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.R88Q);Fulvestrant+Alpelisib(PIK3CA p.Q546H)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546H)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_1	KRAS p.G12S;PPP2R1A p.R183W;PPP2R1A p.S256F;PIK3CA p.R88Q;PIK3CA p.Q546H	5	5
P-0006661	P-0006661-T01-IM5	Outside	FFPE	Biopsy	250	379	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P48L);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3B	KRAS p.G12C;TP53 p.E258K;SMAD4 p.V506*;CDKN2A p.P48L;CDKN2A p.H83Y	4	5
P-0006662	P-0006662-T01-IM5	In-House	FFPE	Biopsy	250	985	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.G34R;NFE2L2 p.D77V;ARID1B Deletion;CDKN1B Deletion;EPHA7 Deletion;PRKN Deletion;PRDM1 Deletion;TNFAIP3 Deletion	0	8
P-0006663	P-0006663-T01-IM5	In-House	FFPE	Biopsy	250	830	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.D194Y;TP53 p.R158P;MITF p.E39*	0	3
P-0006664	P-0006664-T01-IM5	Outside	FFPE	Biopsy	250	887	10	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.T574_H580dup)								LEVEL_1	KIT p.T574_H580dup	1	1
P-0006665	P-0006665-T01-IM5	In-House	FFPE	Resection	250	805	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006666	P-0006666-T01-IM5	In-House	FFPE	Biopsy	250	812	50	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CXCR4 p.R334*;TNFRSF14 p.Y141*;NFKBIA p.Q68*	0	3
P-0006667	P-0006667-T01-IM5	In-House	FFPE	Resection	250	788	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					GSK2636771,AZD8186(PTEN p.C71Y)				LEVEL_4	PTEN p.C71Y;C15orf54 MGA-C15orf54 fusion;MGA MGA-C15orf54 fusion	1	3
P-0006668	P-0006668-T01-IM5	In-House	FFPE	Biopsy	250	999	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;TP53 p.Y126D;BCL6 Amplification;MCL1 Amplification	2	4
P-0006669	P-0006669-T01-IM5	In-House	FFPE	Biopsy	250	887	40	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	APC p.L1488Ffs*19;TP53 p.V122Dfs*26;ARID1B p.Q258*;APC p.I1060Tfs*3;ERBB2 Amplification	2	5
P-0006670	P-0006670-T01-IM5	In-House	FFPE	Biopsy	135.18	395	60	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RB1 p.X406_splice;PTEN Deletion;RICTOR Amplification;TERT Amplification;DNMT3A ASXL2-DNMT3A fusion;ASXL2 ASXL2-DNMT3A fusion	1	6
P-0006671	P-0006671-T01-IM5	In-House	FFPE	Biopsy	226.7	715	20	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib(BARD1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;CTNNB1 p.S45F;BARD1 Deletion;CDKN2A Deletion;CDKN2B Deletion;EPHA7 Deletion;NKX2-1 Amplification;PRDM1 Deletion	3	8
P-0006672	P-0006672-T01-IM5	Outside	FFPE	Resection	250	705	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D)	Trametinib,Cobimetinib(NF1 p.R2637*)				LEVEL_3B	PIK3CA p.G118D;PTPN11 p.E76G;NF1 p.R2637*	2	3
P-0006673	P-0006673-T01-IM5	In-House	FFPE	Resection	250	737	70	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0006674	P-0006674-T01-IM5	Outside	FFPE	Resection	250	723	50	Matched	Metastasis	Lung	Brain	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Tipifarnib(HRAS p.G13V)					LEVEL_3B	NFE2L2 p.G31E;NFE2L2 p.R34Q;HRAS p.G13V;TP53 p.G266V;PIK3R3 p.S93*;FBXW7 p.S25*;KMT2C p.R1916*;RB1 p.N123Tfs*2;INPP4B p.K483_K484delinsN*	1	9
P-0006675	P-0006675-T01-IM5	In-House	FFPE	Cytology	250	1172	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y220H	0	1
P-0006676	P-0006676-T01-IM5	In-House	FFPE	Biopsy	250	938	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);AZD9496,Fulvestrant(ESR1 p.E380Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.E542K;ESR1 p.E380Q;GATA3 p.S426Ifs*81;CCND1 Amplification;CDH1 Deletion;FGF19 Amplification;FGFR1 Amplification;MDM2 Amplification;ZFHX3 Deletion	5	9
P-0006678	P-0006678-T01-IM5	In-House	FFPE	Resection	234.63	296	60	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R273C;IDH1 p.R132H;TP53 p.H193Y;TP53 p.S240G;TP53 p.N235S	1	5
P-0006679	P-0006679-T01-IM5	In-House	FFPE	Biopsy	250	794	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12R;TP53 p.F134C;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0006680	P-0006680-T01-IM5	In-House	FFPE	Resection	250	754	50	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.I255del;CTNNB1 p.T41A;CDKN1B p.S83Kfs*37;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification	0	6
P-0006681	P-0006681-T01-IM5	In-House	FFPE	Biopsy	250	730	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	B2M p.X116_splice;TP53 p.S269_E271del;CDKN2A p.R80*;FGFR1 Amplification;MYC Amplification;APC APC-intragenic	2	6
P-0006682	P-0006682-T01-IM5	In-House	FFPE	Biopsy	130.68	368	40	Matched	Metastasis	Anus	Liver	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K	1	1
P-0006683	P-0006683-T01-IM5	In-House	FFPE	Biopsy	72.96	488	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A;APC p.R216*;APC p.E1309Dfs*4;TCF7L2 p.P317Qfs*34;TP53 p.M169del	1	5
P-0006684	P-0006684-T01-IM5	In-House	FFPE	Resection	250	832	60	Matched	Metastasis	Prostate	Pancreas	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										BAP1 Deletion;BCOR Deletion	0	2
P-0006685	P-0006685-T01-IM5	In-House	FFPE	Resection	250	1054	NA	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.X331_splice;SMAD3 p.R268C;APC p.E1306*;APC p.H1232Pfs*8	0	4
P-0006686	P-0006686-T01-IM5	In-House	FFPE	Resection	250	574	10	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.G776V)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.R175H;APC p.Q1367*;ERBB2 p.G776V	3	4
P-0006687	P-0006687-T01-IM5	Outside	FFPE	Resection	250	1390	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Olaparib(CDK12 p.S238*);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S238*)				LEVEL_2	TP53 p.C242F;CDK12 p.S238*;ERBB2 Amplification	4	3
P-0006688	P-0006688-T01-IM5	In-House	FFPE	Resection	250	436	20	Matched	Primary	Pancreas	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ARID2 p.S1725*;KRAS Amplification;MDM2 Amplification	1	3
P-0006689	P-0006689-T01-IM5	In-House	FFPE	Resection	250	617	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0006690	P-0006690-T01-IM5	In-House	FFPE	Resection	250	445	60	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										BCOR p.T486Kfs*43;NOTCH1 p.C1505Vfs*75	0	2
P-0006691	P-0006691-T01-IM5	In-House	FFPE	Resection	250	745	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0006692	P-0006692-T01-IM5	In-House	FFPE	Biopsy	250	831	70	Matched	Metastasis	Prostate	Mediastinum	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.W131C;TP53 p.X187_splice;KMT2C p.F2043Lfs*35;CDKN2C Deletion;NKX3-1 Deletion	0	5
P-0006693	P-0006693-T01-IM5	Outside	FFPE	Resection	250	777	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.R233*)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R175H;APC p.R805*;PTEN p.R233*;KMT2D p.R5021*	2	5
P-0006694	P-0006694-T01-IM5	In-House	FFPE	Biopsy	250	1374	70	Unmatched	Primary	Lymph Node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma				Enasidenib(IDH2 p.R172G)					LEVEL_3B	IDH2 p.R172G;TET2 p.P570Rfs*14;TET2 p.I873Tfs*41	1	3
P-0006694	P-0006694-T02-IM5	Outside	FFPE	Resection	250	961	30	Matched	Metastasis	Lymph Node	Skin	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma				Enasidenib(IDH2 p.R172G)					LEVEL_3B	RHOA p.G17V;IDH2 p.R172G;TET2 p.P570Rfs*14;TET2 p.I873Tfs*41	1	4
P-0006695	P-0006695-T01-IM5	In-House	FFPE	Biopsy	250	561	60	Unmatched	Primary	Pelvis	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CARD11 p.D401N;PIK3R1 p.Q241*;HIST1H2BD p.S37T;EPHA7 p.Q336*;BRCA2 p.S196N;SOCS1 p.A3E;STAT3 p.E616Q;NFKBIA p.X251_splice;SOCS1 p.N110*;INHA p.L189Cfs*2;SOCS1 p.X17_splice;SOCS1 p.M1?;SOCS1 p.A3R	0	13
P-0006696	P-0006696-T01-IM5	Outside	FFPE	Biopsy	250	520	70	Matched	Metastasis	Lung	Mediastinum	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.G266R;LATS1 p.R924*;RB1 p.N627Mfs*16	0	3
P-0006697	P-0006697-T01-IM5	In-House	FFPE	Biopsy	250	854	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.G370C)		Debio1347,BGJ398,AZD4547(FGFR3 p.G370C)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	SMAD3 p.R287Q;FGFR3 p.G370C;ATR p.S1660*;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MDM2 Amplification;MYCN Amplification	4	9
P-0006698	P-0006698-T03-IM5	In-House	FFPE	Biopsy	250	1092	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		Neratinib(ERBB2 p.S310F)	Ado-Trastuzumab Emtansine(ERBB2 p.S310F);Cisplatin(ERCC2 p.C155Sfs*30);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 p.S310F;PIK3R1 p.F456_Q457del;TP53 p.A84Gfs*65;ANKRD11 p.I1300Sfs*18;PIK3R1 p.K561Qfs*7;RECQL4 p.X464_splice;ERCC2 p.C155Sfs*30;ERBB2 Amplification;TNFAIP3 Deletion	5	9
P-0006699	P-0006699-T01-IM5	In-House	FFPE	Biopsy	250	816	30	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R175H;NOTCH3 p.E1638*;TOP1 p.Q697*	0	3
P-0006700	P-0006700-T01-IM5	In-House	FFPE	Biopsy	115.74	328	20	Matched	Metastasis	Stomach	Lymph Node	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R248Q;CCNE1 Amplification	0	2
P-0006701	P-0006701-T01-IM5	In-House	FFPE	Resection	250	694	20	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)					LEVEL_3B	ERBB2 p.R678Q;APC p.Q1367*;APC p.R302*;NOTCH4 p.R1476*	1	4
P-0006702	P-0006702-T01-IM5	Outside	FFPE	Biopsy	250	948	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMAD4 p.E390*;TP53 p.Y220N	1	3
P-0006703	P-0006703-T01-IM5	In-House	FFPE	Biopsy	250	1122	50	Matched	Metastasis	Breast	Ipsilateral Breast	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G262V;CCNE1 Amplification	0	2
P-0006704	P-0006704-T01-IM5	In-House	FFPE	Biopsy	250	662	20	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	ERBB3 p.K329E;KRAS p.G13D;CREBBP p.R1360*;APC p.W1049*;APC p.S1407*;FGFR1 Amplification	2	6
P-0006705	P-0006705-T01-IM5	Outside	FFPE	Resection	250	520	40	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma					Tazemetostat(KDM6A p.Q641*)				LEVEL_4	KDM6A p.Q641*;TP53 p.R283H;ARID1A p.Q1404*;GPS2 p.Q192*;TP53 p.E204*;MYCL Amplification	1	6
P-0006706	P-0006706-T01-IM5	In-House	FFPE	Resection	250	984	40	Matched	Metastasis	Descending Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;APC p.E1295*;APC p.A1347Qfs*4	0	3
P-0006707	P-0006707-T01-IM5	In-House	FFPE	Resection	250	705	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R216*;TP53 p.C141Afs*29;TCF7L2 p.R387Gfs*61;APC p.Y1166Ifs*2	0	4
P-0006708	P-0006708-T01-IM5	In-House	FFPE	Resection	250	779	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R282W;APC p.E1397*;KRAS p.G13D;APC p.K670*;KMT2D p.E1838*;SMAD4 p.E538Lfs*2	1	6
P-0006709	P-0006709-T01-IM5	Outside	FFPE	Biopsy	250	562	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R282W;FGFR4 Amplification	1	3
P-0006710	P-0006710-T01-IM5	Outside	FFPE	Resection	250	516	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										ATRX p.Q545*;ARID1A p.Q1650Afs*47;MEN1 p.I85Sfs*33;SETD2 p.G320Vfs*20	0	4
P-0006711	P-0006711-T01-IM5	In-House	FFPE	Resection	250	681	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R175H;APC p.E1309Dfs*4;APC p.S299Tfs*7;CDKN1B Deletion	1	5
P-0006712	P-0006712-T01-IM5	In-House	FFPE	Resection	250	519	60	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K550_E554delinsI)								LEVEL_1	KIT p.K550_E554delinsI	1	1
P-0006713	P-0006713-T01-IM5	In-House	FFPE	Biopsy	250	946	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.C379Lfs*17)				LEVEL_4	TP53 p.R175H;DAXX p.L98Vfs*13;NBN p.X13_splice;PTPRD p.S306*;ARID5B p.E1050*;ARID2 p.X236_splice;FLT3 p.P890H;MGA p.E1980*;MAP2K4 p.R134L;NF1 p.C379Lfs*17;FAT1 p.P3228Lfs*42;ARID1A p.C2094Ffs*41;DNAH2 ERRFI1-DNAH2 fusion;ERRFI1 ERRFI1-DNAH2 fusion	1	14
P-0006713	P-0006713-T02-IM5	In-House	FFPE	Biopsy	141.6	670	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;STK11 p.D194Y;KEAP1 p.F478Lfs*22	1	3
P-0006714	P-0006714-T01-IM5	In-House	FFPE	Biopsy	250	904	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.T484M);Cisplatin(ERCC2 p.E79Kfs*4)	Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E3002K)					LEVEL_3A	MAPK1 p.E322K;ARID1A p.Q379*;FBXW7 p.S546L;CREBBP p.R386*;FBXW7 p.Q492*;FANCC p.Q316*;BRCA2 p.E3002K;KEAP1 p.M550I;ERCC2 p.T484M;ARID1A p.Q1409Sfs*66;ERCC2 p.E79Kfs*4	3	11
P-0006715	P-0006715-T01-IM5	In-House	FFPE	Biopsy	250	854	30	Matched	Metastasis	Descending Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	TP53 p.R273H;KRAS p.G12V;APC p.R283*	1	3
P-0006716	P-0006716-T01-IM5	Outside	FFPE	Biopsy	250	759	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_3B	KRAS p.G12C;TGFBR1 p.R215*;TGFBR1 p.R80*;TP53 p.P27Lfs*17;CDKN2A p.Y44*;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	3	8
P-0006717	P-0006717-T01-IM5	In-House	FFPE	Resection	250	783	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;FBXW7 p.R278*	1	2
P-0006718	P-0006718-T01-IM5	In-House	FFPE	Resection	250	486	20	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.V157F;DIS3 p.L452Sfs*10	0	2
P-0006719	P-0006719-T01-IM5	Outside	FFPE	Resection	250	927	70	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)		Trametinib,Cobimetinib(NF1 p.Q1763*);GSK2636771,AZD8186(PTEN p.X342_splice)				LEVEL_3A	NRAS p.Q61L;TP63 p.E609K;NF1 p.Q1763*;DICER1 p.D1709N;FBXW7 p.W365*;TNFAIP3 p.E284*;PTEN p.X342_splice	3	7
P-0006720	P-0006720-T01-IM5	Outside	FFPE	Cytology	250	888	10	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)	Neratinib(ERBB2 p.G778_P780dup)						LEVEL_2	TP53 p.R248Q;ERBB2 p.G778_P780dup	2	2
P-0006721	P-0006721-T01-IM5	Outside	FFPE	Biopsy	250	767	20	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.S1403Afs*12;ASXL2 p.A732Efs*75;MGA Deletion	0	4
P-0006722	P-0006722-T01-IM5	Outside	FFPE	Biopsy	250	1135	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T18Afs*15)				LEVEL_4	TP53 p.H193L;TP53 p.X307_splice;CDKN2A p.T18Afs*15;CCND1 Amplification;FGF19 Amplification;MYC Amplification;YAP1 Amplification	1	7
P-0006723	P-0006723-T01-IM5	In-House	FFPE	Resection	250	737	50	Matched	Metastasis	Breast	Epidural Mass	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;SMAD4 p.E330K;ZFHX3 p.Q3074*;CDH1 p.N751Kfs*19	2	4
P-0006724	P-0006724-T01-IM5	In-House	FFPE	Biopsy	250	704	60	Matched	Metastasis	Lung	Brain	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12R;TP53 p.V274F;ARID1A p.Y2148*;SMARCA4 p.X587_splice;NF2 p.Q536*;SMARCA4 p.M272Cfs*31;CDKN2A Deletion;CDKN2B Deletion;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	2	11
P-0006725	P-0006725-T01-IM5	Outside	FFPE	Resection	250	707	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Olaparib(ATM p.E1072*);Olaparib(ATM p.W2109*);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R487W);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ERBB2 p.S310F;ARID1A p.Q611*;KMT2C p.S2952*;ATM p.E1072*;ATM p.W2109*;KMT2D p.Q2902*;RB1 p.E492*;ERBB2 p.R487W;TOP1 p.E741*;TP53 p.X126_splice;BRD4 Amplification;ERBB2 Amplification	5	12
P-0006726	P-0006726-T01-IM5	In-House	FFPE	Resection	250	799	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R175H;NOTCH1 p.Q2366*;APC p.E1374Gfs*12	1	4
P-0006727	P-0006727-T01-IM5	In-House	FFPE	Resection	250	809	60	Matched	Metastasis	Kidney	Retroperitoneum	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										FOXO1 p.P433Lfs*20	0	1
P-0006728	P-0006728-T01-IM5	In-House	FFPE	Biopsy	250	647	20	Unmatched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.Q83*);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.E349*;NF1 p.Q83*;HIST1H3B p.E51K;MYC Amplification;PAK1 Amplification;PTEN Deletion	2	6
P-0006729	P-0006729-T01-IM5	In-House	FFPE	Resection	250	789	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)		Cetuximab,Panitumumab(NRAS p.Q61L)			LEVEL_3B	NRAS p.Q61L;APC p.R216*;TP53 p.R280Efs*65	1	3
P-0006730	P-0006730-T01-IM5	Outside	FFPE	Resection	250	798	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.S166*;FBXW7 p.X195_splice;KEAP1 ZNF599-KEAP1 fusion;ZNF599 ZNF599-KEAP1 fusion	3	5
P-0006731	P-0006731-T01-IM5	Outside	FFPE	Biopsy	250	933	50	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0006732	P-0006732-T01-IM5	Outside	FFPE	Biopsy	250	377	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R273C;ARID1A p.W1073*	0	2
P-0006733	P-0006733-T01-IM5	Outside	FFPE	Resection	250	756	70	Matched	Primary	Lymph Node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma				Enasidenib(IDH2 p.R172S)					LEVEL_3B	RHOA p.G17V;IDH2 p.R172S;DNMT3A p.S708Qfs*5	1	3
P-0006734	P-0006734-T01-IM5	In-House	FFPE	Resection	250	873	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	FH p.X89_splice;ARID1A p.L2279Vfs*106;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification	2	5
P-0006735	P-0006735-T01-IM5	In-House	FFPE	Resection	250	823	80	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13C)		Cetuximab,Panitumumab(NRAS p.G13C)			LEVEL_3B	TP53 p.V173L;APC p.R232*;NRAS p.G13C;MYC Amplification;NKX3-1 Deletion	1	5
P-0006736	P-0006736-T01-IM5	In-House	FFPE	Biopsy	142.74	582	10	Matched	Metastasis	Retroperitoneum	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.R175H	0	1
P-0006737	P-0006737-T01-IM5	In-House	FFPE	Resection	250	807	20	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	APC p.D1486Ifs*21;TP53 p.H115Ffs*33;APC p.T1185Qfs*80;ERBB2 Amplification	2	4
P-0006738	P-0006738-T01-IM5	In-House	FFPE	Biopsy	250	1022	80	Matched	Metastasis	Kidney	Adrenal Gland	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.S65P	0	1
P-0006740	P-0006740-T01-IM5	In-House	FFPE	Resection	250	739	50	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R1450*	0	1
P-0006741	P-0006741-T01-IM5	In-House	FFPE	Biopsy	250	1383	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 Deletion)		Rucaparib,Niraparib(BRCA2 Deletion)					LEVEL_2	TP53 p.X307_splice;GATA3 p.H405Efs*103;BRCA2 Deletion;PPM1D Amplification	2	4
P-0006742	P-0006742-T01-IM5	Outside	FFPE	Biopsy	107.4	626	80	Matched	Metastasis	Kidney	Neck	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.E94*;BAP1 p.I72Mfs*6;MYC Amplification	0	3
P-0006743	P-0006743-T01-IM5	In-House	FFPE	Resection	250	825	50	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R283*;TP53 p.K164E;KDM5C p.L1125Ifs*5;SOX9 p.T384Sfs*2;ATRX p.S1772Yfs*10	0	5
P-0006744	P-0006744-T01-IM5	In-House	FFPE	Resection	250	902	70	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.S127F;APC p.E1379*;APC p.G721Efs*6;CDK8 Amplification;FLT3 Amplification;PRKN Deletion	0	6
P-0006745	P-0006745-T01-IM5	In-House	FFPE	Resection	250	690	NA	Matched	Primary	Leg	Not Applicable	Tumor	STMYEC	Soft Tissue Sarcoma	Soft Tissue Myoepithelial Carcinoma					Tazemetostat(SMARCB1 p.Q198*)				LEVEL_4	SMARCB1 p.Q198*	1	1
P-0006746	P-0006746-T01-IM5	Outside	FFPE	Resection	250	1141	20	Matched	Metastasis	Kidney	Lymph Node	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma											0	0
P-0006747	P-0006747-T01-IM5	In-House	FFPE	Resection	250	872	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R156P	1	2
P-0006748	P-0006748-T01-IM5	In-House	FFPE	Biopsy	250	993	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R158Pfs*11;KRAS Amplification	0	2
P-0006749	P-0006749-T01-IM5	In-House	FFPE	Cytology	250	672	10	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.X228_splice)			Talazoparib,Niraparib(BRCA2 p.X228_splice)					LEVEL_1	BRCA2 p.X228_splice;TP53 p.L206Ffs*35;AKT1 Amplification;IKZF1 Deletion	2	4
P-0006750	P-0006750-T01-IM5	In-House	FFPE	Resection	250	820	10	Matched	Metastasis	Sigmoid Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.X261_splice;APC p.N961Mfs*4;MET Amplification	1	3
P-0006751	P-0006751-T01-IM5	Outside	FFPE	Biopsy	250	879	70	Matched	Metastasis	Prostate	Epidural	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ARID1A p.S2068*	0	1
P-0006752	P-0006752-T01-IM5	In-House	FFPE	Resection	250	634	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				AZD5363(AKT1 p.E17K);Lorlatinib,Brigatinib(ALK p.R395H);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.A1232Lfs*70);Olaparib(CDK12 p.G1461Afs*38)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.G1461Afs*38)				LEVEL_3B	AKT1 p.E17K;RNF43 p.G659Vfs*41;SMARCA4 p.T910M;ALK p.R395H;GATA3 p.P135Rfs*60;SMAD4 p.S32*;SETD2 p.S2382Lfs*29;CIC p.P1248Hfs*54;ERBB2 p.A1232Lfs*70;CDK12 p.G1461Afs*38;ARID2 p.Q651Rfs*12	5	11
P-0006753	P-0006753-T01-IM5	Outside	FFPE	Biopsy	250	804	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.V1862*);Sonidegib,Vismodegib(PTCH1 p.X502_splice);Olaparib(BRIP1 p.N1087Ifs*21)					LEVEL_3B	RNF43 p.G659Vfs*41;APC p.T1556Nfs*3;APC p.R213*;ARID5B p.I497*;ARID1A p.G801Vfs*32;GRIN2A p.S1341Afs*56;BRCA2 p.V1862*;NSD1 p.M1531Cfs*43;PTCH1 p.X502_splice;MGA p.Q1929*;CDH1 p.X177_splice;XRCC2 p.H268Tfs*11;BRIP1 p.N1087Ifs*21;CDH1 p.X813_splice;AXIN2 p.L128Tfs*12;AMER1 p.E452Gfs*8;SH2B3 p.G229Mfs*47;AXIN2 p.G406Rfs*53;BLM p.K873Rfs*7;ID3 p.P92Lfs*34;FANCC p.T420Rfs*27;FBXW7 p.D567Mfs*11	3	22
P-0006754	P-0006754-T01-IM5	In-House	FFPE	Resection	250	1009	20	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	TP53 p.R248W;PIK3CB p.R321Q;CREBBP p.R1341*;NOTCH2 p.X1335_splice;TGFBR2 p.R495*;PRKN p.W74*;NOTCH1 p.Q1455*;NOTCH1 p.W745*;PPP2R1A p.V201Afs*29;ASXL1 p.T600Pfs*103;TP53 p.W91*;CDKN2A p.R58*;CCND1 Amplification;FGF19 Amplification	1	14
P-0006755	P-0006755-T01-IM5	In-House	FFPE	Resection	250	812	60	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Trametinib,Cobimetinib(NF1 p.M2031Ifs*4)				LEVEL_4	NF1 p.M2031Ifs*4	1	1
P-0006756	P-0006756-T01-IM5	In-House	FFPE	Resection	250	1080	70	Matched	Metastasis	Uterus	Vagina	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										TP53 p.P190Lfs*57;KMT2A MLL-intragenic	0	2
P-0006757	P-0006757-T01-IM5	In-House	FFPE	Resection	250	644	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0006758	P-0006758-T01-IM5	In-House	FFPE	Resection	250	847	50	Matched	Primary	Cecum	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.H878R);Olaparib(CHEK2 p.W114*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.G44Afs*10)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	FBXW7 p.R505C;KRAS p.G12D;PIK3CA p.H1047L;APC p.R213*;TP53 p.R213Q;APC p.K1456*;CTCF p.Q536*;ERBB2 p.H878R;CHEK2 p.W114*;PTEN p.G44Afs*10;KDM6A p.N1368Kfs*19	5	11
P-0006759	P-0006759-T01-IM5	In-House	FFPE	Resection	250	898	30	Matched	Metastasis	Descending Colon	Lung	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.M237I;APC p.R876*;FLT3 p.S838N	0	3
P-0006760	P-0006760-T01-IM5	In-House	FFPE	Resection	250	1168	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.L344Q	1	2
P-0006761	P-0006761-T01-IM5	In-House	FFPE	Resection	250	780	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R273C;SOX17 p.R273*;APC p.E1309Kfs*5	0	3
P-0006762	P-0006762-T02-IM5	In-House	FFPE	Resection	250	176	80	Matched	Metastasis	Kidney	Pancreatic Head	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.K629Rfs*24)					LEVEL_3B	VHL p.X114_splice;TSC1 p.K629Rfs*24;MGA p.K1034Efs*9	1	3
P-0006763	P-0006763-T01-IM5	In-House	FFPE	Resection	250	224	50	Matched	Metastasis	Rectum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;TP53 p.P151A	2	3
P-0006764	P-0006764-T01-IM5	In-House	FFPE	Resection	250	320	20	Matched	Metastasis	Colorectal NOS	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)	Cetuximab,Panitumumab(KRAS p.G12R)			LEVEL_4	KRAS p.G12R;SMAD4 p.D537G	1	2
P-0006765	P-0006765-T01-IM5	Outside	FFPE	Biopsy	250	1373	10	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344G)					LEVEL_3B	GNAS p.R201C;PIK3CA p.V344G	1	2
P-0006766	P-0006766-T01-IM5	Outside	FFPE	Resection	250	936	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.X307_splice;APC p.X178_splice;CCND2 Amplification;ERRFI1 Deletion;KDM5A Amplification;KRAS Amplification	0	6
P-0006767	P-0006767-T01-IM5	In-House	FFPE	Biopsy	250	971	60	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										TP53 p.R280K	0	1
P-0006768	P-0006768-T01-IM5	In-House	FFPE	Resection	250	1424	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R213*;EGFR Amplification	0	2
P-0006769	P-0006769-T01-IM5	Outside	FFPE	Biopsy	250	545	40	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R342*;SMARCA4 p.Y820*	0	2
P-0006770	P-0006770-T01-IM5	Outside	FFPE	Resection	250	845	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R306*;APC p.S1356*;BCOR p.E1732*;AXIN2 p.A4Yfs*15;APC p.V1077Hfs*2;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;MAPK1 Amplification;SRC Amplification	0	10
P-0006771	P-0006771-T01-IM5	Outside	FFPE	Resection	250	643	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib(NF1 p.E524*)				LEVEL_4	TP53 p.W91*;NF1 p.E524*;RASA1 p.S853*	1	3
P-0006772	P-0006772-T01-IM5	Outside	FFPE	Biopsy	250	669	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										STK11 p.P281Rfs*6;RB1 p.X350_splice;TP53 p.H179P;CBL p.L272*;NOTCH1 p.P2514Rfs*4;CCND3 Amplification;CCNE1 Amplification;DDR2 Amplification;MCL1 Amplification;MYC Amplification;NTRK1 Amplification;VEGFA Amplification	0	12
P-0006773	P-0006773-T01-IM5	Outside	FFPE	Biopsy	250	756	10	Matched	Primary	Anus	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822K)					LEVEL_3B	KIT p.N822K;GNAS p.R201C;PIK3R1 p.X582_splice;TERT Amplification	1	4
P-0006775	P-0006775-T01-IM5	Outside	FFPE	Biopsy	166.4	676	40	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R249T;NFE2L2 p.D29Y;ATRX p.X221_splice	1	4
P-0006776	P-0006776-T01-IM5	Outside	FFPE	Biopsy	250	941	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK DYSF-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(DYSF DYSF-ALK fusion)			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_1	CDKN2A p.R80*;MDM2 Amplification;MYC Amplification;MGA MESP2-MGA fusion;MESP2 MESP2-MGA fusion;ALK DYSF-ALK fusion;DYSF DYSF-ALK fusion	4	7
P-0006777	P-0006777-T01-IM5	Outside	FFPE	Biopsy	250	942	40	Matched	Primary	Skin	Not Applicable	Tumor	BCC	Skin Cancer, Non-Melanoma	Basal Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.Y971*);Sonidegib,Vismodegib(PTCH1 p.X218_splice)	Olaparib(ATM p.R250*)					LEVEL_3A	MGA p.R1242*;TP53 p.F109S;ATM p.R250*;PTCH1 p.Y971*;PTCH1 p.X218_splice;FOXO1 p.Q278*;SMAD2 p.W422*	3	7
P-0006778	P-0006778-T01-IM5	Outside	FFPE	Biopsy	163.9	628	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R175H;SOX9 p.E261*	1	3
P-0006779	P-0006779-T01-IM5	Outside	FFPE	Cytology	250	763	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.S2058*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ATM p.S2058*;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0006780	P-0006780-T01-IM5	Outside	FFPE	Resection	250	766	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.V344M)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344M)		GSK2636771,AZD8186(PTEN p.H259Tfs*7)				LEVEL_1	PIK3CA p.V344M;TP53 p.V143G;PTEN p.H259Tfs*7	3	3
P-0006781	P-0006781-T01-IM5	Outside	FFPE	Biopsy	250	810	70	Matched	Primary	Thigh	Not Applicable	Tumor	PLLS	Soft Tissue Sarcoma	Pleomorphic Liposarcoma										TP53 p.Y236C;ATRX p.C1844*	0	2
P-0006782	P-0006782-T01-IM5	Outside	FFPE	Resection	250	339	30	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R248Q;IDH1 p.R132H;ATRX p.I1049Nfs*4;RAD50 p.R938*;SMARCA4 p.X836_splice;MLH1 p.X226_splice;SETD2 p.T61Qfs*50;ATRX p.R1302Efs*44	1	8
P-0006782	P-0006782-T02-IM5	Outside	FFPE	Resection	250	886	40	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.T3085Qfs*19)	Trametinib,Cobimetinib(NF1 p.I679Dfs*21)				LEVEL_3B	TP53 p.R248Q;IDH1 p.R132H;NOTCH1 p.F357del;NF1 p.I679Dfs*21;NOTCH1 p.R365C;SMARCA4 p.R1192C;TP53 p.R181C;MLH1 p.X226_splice;ATRX p.R1302Efs*44;BRCA2 p.T3085Qfs*19	3	10
P-0006783	P-0006783-T01-IM5	Outside	FFPE	Biopsy	173.7	770	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0006784	P-0006784-T01-IM5	In-House	FFPE	Resection	250	1129	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 p.P278Sfs*28;TET1 p.F228Sfs*6;AKT2 Amplification;AXL Amplification;CCNE1 Amplification	0	5
P-0006785	P-0006785-T01-IM5	Outside	FFPE	Biopsy	214.4	695	50	Matched	Metastasis	Lung	Liver	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.Y205C;KEAP1 p.R320L;KMT2D p.K5091Sfs*56;ARID1A p.P1175Hfs*5;BCL6 Amplification;EPHA3 Deletion;MYCL Amplification;PIK3CA Amplification;RB1 Deletion	0	9
P-0006786	P-0006786-T02-IM5	In-House	FFPE	Resection	250	1088	20	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib(NF1 p.X951_splice)				LEVEL_3B	PIK3CA p.E542K;NF1 p.X951_splice	2	2
P-0006786	P-0006786-T01-IM5	Outside	FFPE	Biopsy	250	856	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib(NF1 p.X951_splice)				LEVEL_3B	PIK3CA p.E542K;PIK3R1 p.L570P;NF1 p.X951_splice	2	3
P-0006787	P-0006787-T01-IM5	Outside	FFPE	Biopsy	250	551	50	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Olaparib(RAD51C p.P21S)	Crizotinib(MET ST7-MET fusion);Crizotinib(ST7 ST7-MET fusion)				LEVEL_1	PIK3CA p.H1047R;RAD51C p.P21S;EPHA7 p.S225Pfs*3;GRIN2A Deletion;PAK1 Amplification;PPM1D Amplification;MET ST7-MET fusion;ST7 ST7-MET fusion	5	8
P-0006788	P-0006788-T01-IM5	Outside	FFPE	Biopsy	250	894	50	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.X1672_splice;KDM5C p.Y639Lfs*6	0	2
P-0006789	P-0006789-T01-IM5	In-House	FFPE	Resection	250	977	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)								LEVEL_1	TP53 p.H214R;EGFR p.L747_P753delinsS;EGFR p.A755G;ERRFI1 p.T187Lfs*61;CCNE1 Amplification	1	5
P-0006790	P-0006790-T01-IM5	Outside	FFPE	Resection	250	1138	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13V)				LEVEL_4	BCOR p.K1207Nfs*31;TP53 p.N263Ifs*82;KRAS p.G13V	1	3
P-0006791	P-0006791-T01-IM5	Outside	FFPE	Biopsy	250	1156	70	Matched	Primary	Breast	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS											0	0
P-0006792	P-0006792-T01-IM5	Outside	FFPE	Biopsy	250	1251	50	Matched	Primary	Pelvis	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	STAG2 p.X892_splice;PTEN Deletion;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	1	4
P-0006793	P-0006793-T01-IM5	In-House	FFPE	Resection	250	1094	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_4	TP53 p.R209Kfs*6;CDKN1B p.W60*;ARID1A p.Q1537*;PMS1 p.E723*;EPHA3 p.X272_splice;SMAD4 p.G510A;STK11 p.E256*;CDKN2A p.P114L;TP53 TP53-intragenic	1	9
P-0006794	P-0006794-T01-IM5	In-House	FFPE	Resection	250	498	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.E941*;APC p.S1436Rfs*38	1	3
P-0006795	P-0006795-T01-IM5	In-House	FFPE	Resection	250	596	30	Matched	Primary	Bile Duct	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;TP53 p.N210Kfs*6	1	2
P-0006796	P-0006796-T01-IM5	In-House	FFPE	Biopsy	250	1301	80	Matched	Metastasis	Skin	Bone	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;DICER1 p.S1344L;AKT3 p.E17K;CBL p.W408*;ZFHX3 p.X1288_splice;TOP1 p.R31*;DICER1 p.I446Ffs*12;FAT1 p.C3782*;FAT1 FAT1-intragenic	1	9
P-0006797	P-0006797-T01-IM5	In-House	FFPE	Biopsy	250	1231	30	Matched	Metastasis	Ovary	Breast	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0006798	P-0006798-T02-IM5	In-House	FFPE	Resection	250	760	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R248Gfs*97	1	2
P-0006799	P-0006799-T01-IM5	In-House	FFPE	Resection	250	772	80	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lorlatinib,Brigatinib(ALK p.R395H)					LEVEL_2	ALK p.R395H;AKT2 Amplification;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	3	5
P-0006800	P-0006800-T01-IM5	In-House	FFPE	Biopsy	250	645	30	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										CREBBP p.X1465_splice;CCNE1 Amplification	0	2
P-0006801	P-0006801-T01-IM5	In-House	FFPE	Biopsy	250	1493	60	Matched	Metastasis	Paraspinal	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										FAT1 Deletion	0	1
P-0006802	P-0006802-T01-IM5	In-House	FFPE	Resection	250	1043	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.M918T)		BLU-667(RET p.M918T)						LEVEL_1	RET p.M918T;KMT2D p.D3061Qfs*7	2	2
P-0006804	P-0006804-T01-IM5	In-House	FFPE	Biopsy	250	929	40	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0006805	P-0006805-T02-IM5	In-House	FFPE	Resection	250	710	20	Matched	Metastasis	Uterus	Omentum	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										FBXW7 p.R505C;TP53 p.R248Q;PIK3R1 p.E468*;STAG2 p.X373_splice	0	4
P-0006805	P-0006805-T01-IM5	Outside	FFPE	Resection	250	924	10	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										FBXW7 p.R505C;TP53 p.R248Q	0	2
P-0006806	P-0006806-T01-IM5	In-House	FFPE	Biopsy	250	856	40	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R175H;AR Amplification;AURKA Amplification;CCNE1 Amplification;MYC Amplification	0	5
P-0006807	P-0006807-T01-IM5	In-House	FFPE	Cytology	250	762	30	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Everolimus,Temsirolimus(MTOR p.A1459D)				LEVEL_3B	MTOR p.A1459D;FGFR1 Amplification	2	2
P-0006808	P-0006808-T01-IM5	In-House	FFPE	Cytology	250	893	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib(NF1 p.X1870_splice)				LEVEL_4	TP53 p.V173M;NF1 p.X1870_splice;RASA1 p.L830Sfs*8;NFKBIA RPS29-NFKBIA fusion;RPS29 RPS29-NFKBIA fusion	1	5
P-0006809	P-0006809-T01-IM5	Outside	FFPE	Biopsy	250	743	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	TP53 p.X261_splice;NF1 Deletion;MGA MGA-intragenic;KDM6A KDM6A-intragenic	1	4
P-0006810	P-0006810-T01-IM5	Outside	FFPE	Biopsy	141.9	805	30	Matched	Metastasis	Lung	Paraspinal	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.H193D;APC p.T1023Nfs*6;FGFR4 Amplification	1	4
P-0006811	P-0006811-T02-IM5	In-House	FFPE	Biopsy	250	1361	40	Unmatched	Primary	Lung	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MAPK1 p.E322K;PIM1 p.K24N;MAP2K1 p.K57T;TNFRSF14 p.W201*;PIM1 p.G28A;CARD11 p.K215T;NFKBIA p.X113_splice;NFKBIA p.Q112*;B2M p.L7*;KMT2A p.N125Tfs*25;PIM1 p.L2_S4delinsFLF	0	11
P-0006812	P-0006812-T01-IM5	In-House	FFPE	Biopsy	250	802	30	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.C141Y;SMAD4 p.S144Wfs*7;CCND3 Amplification;FGFR3 Amplification	0	4
P-0006813	P-0006813-T01-IM5	Outside	FFPE	Resection	250	933	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12F)	Cetuximab,Panitumumab(KRAS p.G12F)			LEVEL_4	TP53 p.R248Q;APC p.R213*;APC p.E1379*;KRAS p.G12F	1	4
P-0006814	P-0006814-T01-IM5	Outside	FFPE	Biopsy	118.75	604	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.Q37*	0	1
P-0006815	P-0006815-T01-IM5	Outside	FFPE	Biopsy	250	413	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R273L;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0006816	P-0006816-T01-IM5	In-House	FFPE	Resection	250	669	30	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345_V346delinsKG)					LEVEL_3B	TP53 p.R273H;APC p.R283*;APC p.E1353*;ARID1A p.X1067_splice;TCF7L2 p.W259*;PIK3CA p.N345_V346delinsKG	1	6
P-0006817	P-0006817-T01-IM5	In-House	FFPE	Resection	250	243	20	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201C	1	2
P-0006818	P-0006818-T01-IM5	In-House	FFPE	Resection	250	1082	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.D148Ifs*22;MYC Amplification	0	2
P-0006819	P-0006819-T01-IM5	In-House	FFPE	Resection	250	362	10	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R282W;APC p.R805*;GLI1 p.R380Q;TCF7L2 p.X63_splice	0	4
P-0006821	P-0006821-T01-IM5	In-House	FFPE	Resection	250	646	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.S127F;TP53 p.I255N;APC p.E1309Dfs*4	1	4
P-0006822	P-0006822-T01-IM5	In-House	FFPE	Resection	250	642	50	Matched	Metastasis	Descending Colon	Pleura	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C;APC p.E1322Pfs*10;SMAD3 Deletion	0	3
P-0006823	P-0006823-T01-IM5	Outside	FFPE	Resection	250	354	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										TP53 p.R282W;RB1 RB1-intragenic	0	2
P-0006824	P-0006824-T01-IM5	In-House	FFPE	Resection	250	1031	20	Matched	Metastasis	Lung	Brain	Tumor	HDCN	Histiocytosis	Histiocytic and Dendritic Cell Neoplasms			Cobimetinib(KRAS p.K117N);Trametinib,Cobimetinib(MAP2K1 p.F53L)						LEVEL_3A	KRAS p.K117N;TNFRSF14 p.X184_splice;MAP2K1 p.F53L	2	3
P-0006825	P-0006825-T01-IM5	In-House	FFPE	Biopsy	250	987	10	Matched	Metastasis	Transverse Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										MYD88 p.L265P;TP53 p.T253Nfs*11	0	2
P-0006826	P-0006826-T01-IM5	In-House	FFPE	Biopsy	250	822	50	Matched	Metastasis	Oral Cavity	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TTC28 FBXW7-TTC28 fusion;FBXW7 FBXW7-TTC28 fusion	1	3
P-0006827	P-0006827-T01-IM5	In-House	FFPE	Biopsy	250	997	10	Matched	Metastasis	Breast	Ipsilateral Breast	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.E224*;SPEN p.Q921*	0	2
P-0006828	P-0006828-T01-IM5	Outside	FFPE	Biopsy	250	829	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.C238Y;TGFBR2 p.P525T;RNF43 p.R363Gfs*56	1	4
P-0006829	P-0006829-T01-IM5	Outside	FFPE	Resection	250	796	80	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										AKT1 p.D323G;CCND1 Amplification;PAK1 Amplification	0	3
P-0006830	P-0006830-T01-IM5	In-House	FFPE	Biopsy	250	1099	30	Matched	Metastasis	Uterus	Pelvis	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;FBXW7 p.R465C;PIK3R2 p.D557Y;RUNX1 p.S287Cfs*285;PIK3R1 p.L380*;ERBB2 Amplification;EP300 LRRC20-EP300 fusion;LRRC20 LRRC20-EP300 fusion	2	8
P-0006831	P-0006831-T01-IM5	Outside	FFPE	Biopsy	250	939	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	PTEN p.R130Q;FBXW7 p.R689W;TP53 p.V122Dfs*26;EPCAM p.S76*;CIC p.Q994*	1	5
P-0006833	P-0006833-T01-IM5	In-House	FFPE	Cytology	139	332	60	Unmatched	Metastasis	Bone Marrow	Lymph Node	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										ARID1A p.Y215*;KMT2D p.C5133*;CREBBP p.Y1503N;BTK p.C481R;KMT2D p.X5262_splice;FOXO1 p.N204_S205delinsSY;PRKN Deletion;TNFAIP3 Deletion	0	8
P-0006834	P-0006834-T01-IM5	Outside	FFPE	Resection	250	692	10	Matched	Primary	Duodenum-Jejunum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;RNF43 p.D196Mfs*2;TP53 p.X307_splice	1	3
P-0006835	P-0006835-T01-IM5	In-House	FFPE	Resection	250	810	20	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R306*	0	1
P-0006836	P-0006836-T01-IM5	Outside	FFPE	Biopsy	250	855	30	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;FBXW7 p.R465C;RHOA p.L22R;KMT2C p.W4634*;AXIN2 p.M623Sfs*68	1	5
P-0006837	P-0006837-T02-IM5	In-House	FFPE	Biopsy	250	1035	70	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.V53*)				LEVEL_4	TP53 p.S215R;PTEN p.V53*;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0006837	P-0006837-T01-IM5	Outside	FFPE	Resection	250	668	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.S215R;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0006838	P-0006838-T01-IM5	In-House	FFPE	Biopsy	250	975	60	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.I605Yfs*9)	Trametinib,Cobimetinib,Binimetinib(KRAS p.L19F);GSK2636771,AZD8186(PTEN p.X55_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.L19F;BRCA2 p.I605Yfs*9;BMPR1A p.R273*;PTEN p.X55_splice;BCL10 p.I46Nfs*4;CDH1 p.V132Ffs*83;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;PIK3R3 PIK3R3-intragenic	4	11
P-0006839	P-0006839-T01-IM5	In-House	FFPE	Resection	250	1035	70	Matched	Metastasis	Bladder	Adrenal Gland	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(ATM p.Q401*);Olaparib(ATM p.E2744*)					LEVEL_3B	TP53 p.E285K;RB1 p.N472Ifs*6;ARID1A p.W1670*;ATM p.Q401*;ATM p.E2744*;CIC p.Q907*;RPS29 MLL3-RPS29 fusion;KMT2C MLL3-RPS29 fusion	2	8
P-0006840	P-0006840-T01-IM5	In-House	FFPE	Biopsy	250	1001	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ASXL1 p.G646Wfs*12;AXIN1 p.W564Mfs*134;CDKN1B Deletion;PIK3R1 Deletion;DOCK7 JAK1-DOCK7 fusion;JAK1 JAK1-DOCK7 fusion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	8
P-0006841	P-0006841-T01-IM5	In-House	FFPE	Resection	250	662	40	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;GNAS p.R201H;PIK3CA p.Q546P	2	3
P-0006842	P-0006842-T01-IM5	In-House	FFPE	Biopsy	250	961	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.A88Sfs*61;MEF2B Amplification;MYC Amplification;PAK1 Amplification;PIK3R2 Amplification;PPM1D Amplification	2	7
P-0006843	P-0006843-T01-IM5	Outside	FFPE	Resection	250	1131	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(KDM6A p.Q641*)				LEVEL_3B	PIK3CA p.E545K;BAP1 p.S460*;NUP93 p.E14K;KDM6A p.Q641*;ARID1A p.E1385*;EP300 p.X587_splice;ARID1A p.L657Efs*18;FOXA1 p.F254Vfs*39;CCND1 Amplification;CDK8 Amplification;FGF19 Amplification;FLT3 Amplification;MDM2 Amplification;SDHD Deletion	3	14
P-0006844	P-0006844-T02-IM5	In-House	FFPE	Biopsy	250	1028	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.F328Sfs*17	1	2
P-0006844	P-0006844-T01-IM5	In-House	FFPE	Resection	250	868	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.F328Sfs*17	1	2
P-0006845	P-0006845-T01-IM5	In-House	FFPE	Cytology	245	553	10	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Tipifarnib(HRAS p.Q61K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Q50*)				LEVEL_3B	TP53 p.R196*;HRAS p.Q61K;APC p.Q1175*;CDKN2A p.Q50*	2	4
P-0006846	P-0006846-T01-IM5	Outside	FFPE	Biopsy	250	942	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.A289V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.A289V;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	4
P-0006847	P-0006847-T01-IM5	Outside	FFPE	Resection	250	663	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	GATA3 p.T355Qfs*97;ARID1A p.Q575Pfs*49;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MDM2 Amplification	2	6
P-0006848	P-0006848-T01-IM5	In-House	FFPE	Resection	250	902	40	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma					Trametinib,Cobimetinib(NF1 p.R2637*);GSK2636771,AZD8186(PTEN p.G230*)				LEVEL_4	TP53 p.H193R;NF1 p.R2637*;PTEN p.G230*;TP63 p.N87Rfs*16	2	4
P-0006849	P-0006849-T01-IM5	In-House	FFPE	Resection	250	671	40	Matched	Primary	Uterus	Not Applicable	Tumor	UUC	Endometrial Cancer	Uterine Undifferentiated Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	GSK2636771,AZD8186(PTEN p.K267Rfs*9)				LEVEL_3B	JAK1 p.K860Nfs*16;PTEN p.K267Rfs*9;PIK3CA p.N345K;JAK1 p.P430Rfs*2;ARID1A p.R1276*;PPP2R1A p.R183W;MLH1 p.R497Gfs*11;CCND1 p.T286I;SMAD3 p.R93*;CTNNB1 p.D32N;NSD1 p.G574*;CTCF p.K405Sfs*18;BCOR p.G400Afs*42;FAT1 p.R2989Gfs*20;NOTCH4 p.P1306Qfs*3	2	15
P-0006850	P-0006850-T01-IM5	Outside	FFPE	Resection	250	877	30	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209L	0	1
P-0006851	P-0006851-T01-IM5	Outside	FFPE	Resection	250	1228	50	Matched	Primary	Testis	Not Applicable	Tumor	ERMS	Soft Tissue Sarcoma	Embryonal Rhabdomyosarcoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	NRAS p.Q61K;CARD11 Amplification;MDM2 Amplification;YAP1 Amplification	2	4
P-0006852	P-0006852-T01-IM5	Outside	FFPE	Resection	250	842	20	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006853	P-0006853-T01-IM5	In-House	FFPE	Resection	250	792	20	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12V)		Cetuximab,Panitumumab(NRAS p.G12V)			LEVEL_3B	TP53 p.E285K;APC p.Q1367*;NRAS p.G12V	1	3
P-0006854	P-0006854-T01-IM5	In-House	FFPE	Biopsy	250	874	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_1	TP53 p.X307_splice;PIK3CA p.E542K;ESR1 p.Y537S;CCND2 Amplification;GPS2 Deletion;KDM5A Amplification;KRAS Amplification;MAP2K4 Deletion;NCOR1 Deletion;TP53 Deletion;YAP1 Amplification	3	11
P-0006855	P-0006855-T01-IM5	In-House	FFPE	Biopsy	250	978	50	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;STK11 p.G242V;MAX p.E32Nfs*33;FOXA1 Amplification;MDM2 Amplification;NKX2-1 Amplification	2	6
P-0006856	P-0006856-T01-IM5	In-House	FFPE	Biopsy	250	779	40	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CTNNB1 p.S33P;TP53 p.L257V;RB1 p.L326*;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion;MAP3K1 FLJ37543-MAP3K1 fusion;C5orf64 FLJ37543-MAP3K1 fusion	1	8
P-0006857	P-0006857-T01-IM5	In-House	FFPE	Biopsy	250	685	30	Matched	Metastasis	Breast	Brain	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.T304Ifs*41;CCNE1 Amplification;ERBB2 Amplification;FGFR4 Amplification;FOXA1 Amplification;PMAIP1 Deletion	2	6
P-0006858	P-0006858-T01-IM5	In-House	FFPE	Biopsy	250	776	10	Matched	Metastasis	Testis	Pelvis	Tumor	SEM	Germ Cell Tumor	Seminoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;KRAS Amplification	1	2
P-0006859	P-0006859-T01-IM5	In-House	FFPE	Resection	250	642	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;ERBB3 p.D297Y;SMAD2 p.S276L	1	3
P-0006860	P-0006860-T01-IM5	In-House	FFPE	Biopsy	250	763	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345I)					LEVEL_3B	TP53 p.R248W;PIK3CA p.N345I;BRAF p.D594G;FBXW7 p.R465C;SETD2 p.Q1829*;ANKRD11 p.S2496Pfs*6;PBRM1 p.N458Mfs*17;SMAD4 Deletion	1	8
P-0006861	P-0006861-T01-IM5	In-House	FFPE	Resection	250	775	30	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	KRAS p.G12A;TCF7L2 p.C486Vfs*8;STAG2 p.R614*;AXIN2 p.M5Vfs*14;APC p.A1358_K1359delinsS*	1	5
P-0006862	P-0006862-T02-IM5	Outside	FFPE	Resection	250	514	40	Matched	Primary	Pancreas	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	TP53 p.Y163C;KRAS p.Q61R	1	2
P-0006863	P-0006863-T01-IM5	In-House	FFPE	Resection	250	730	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Imatinib(KIT p.R888W);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N986Ifs*5)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;MSH6 p.F1088Lfs*5;PIK3CA p.E545K;FBXW7 p.R465H;APC p.R1450*;APC p.R805*;KIT p.R888W;EGFR p.G724S;TCF7L2 p.K485Sfs*23;BRCA2 p.N986Ifs*5;PTPRS p.R1492W;BMPR1A p.R244*;SOX9 p.R254*;KDM6A p.Q677*;PTPRT p.S1349Pfs*31;APC p.V2194Ffs*5	4	16
P-0006864	P-0006864-T01-IM5	Outside	FFPE	Biopsy	250	838	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C176*;PRKN PARK2-intragenic	0	2
P-0006865	P-0006865-T01-IM5	In-House	FFPE	Resection	250	799	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum										APC p.Q1338*;TP53 p.N131Cfs*27	0	2
P-0006866	P-0006866-T01-IM5	In-House	FFPE	Biopsy	250	912	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.Y537S)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	PIK3CA p.E545K;GATA3 p.P408Afs*99;ESR1 p.Y537S;FGFR1 Amplification;PTEN Deletion	5	5
P-0006867	P-0006867-T01-IM5	In-House	FFPE	Biopsy	250	606	10	Matched	Primary	Rectum	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum										GNAS p.R201H	0	1
P-0006868	P-0006868-T01-IM5	Outside	FFPE	Resection	250	796	30	Matched	Metastasis	Duodenum	Liver	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD3 p.D258N;APC p.R1478Gfs*8;SOX9 p.S449Tfs*22	1	4
P-0006869	P-0006869-T01-IM5	In-House	FFPE	Cytology	250	647	50	Matched	Metastasis	Stomach	Abdomen	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.H233Vfs*8;ARID1A p.KQ2025N*;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0006870	P-0006870-T01-IM5	Outside	FFPE	Resection	250	539	20	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006871	P-0006871-T01-IM5	In-House	FFPE	Biopsy	250	1114	20	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										ERRFI1 p.L182*	0	1
P-0006872	P-0006872-T01-IM5	In-House	FFPE	Resection	250	1052	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.G245S;APC p.R213*;APC p.Q1303*	1	4
P-0006873	P-0006873-T01-IM5	Outside	FFPE	Cytology	250	1106	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										NFKBIA p.C152Vfs*12	0	1
P-0006874	P-0006874-T01-IM5	Outside	FFPE	Resection	250	991	30	Matched	Metastasis	Breast	Lymph Node	Tumor	ADNOS	Cancer of Unknown Primary	Adenocarcinoma, NOS											0	0
P-0006875	P-0006875-T01-IM5	Outside	FFPE	Biopsy	250	878	70	Matched	Primary	Rectum	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Q556_V560delinsRG)								LEVEL_1	KIT p.Q556_V560delinsRG	1	1
P-0006876	P-0006876-T01-IM5	Outside	FFPE	Resection	250	1135	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.R222C;CCND2 Amplification;EGFR Amplification	1	3
P-0006877	P-0006877-T01-IM5	Outside	FFPE	Biopsy	250	895	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	PTPRD p.W57*;SMAD4 p.D351H;TP53 p.C238*;ERBB2 Amplification;FOXA1 Amplification;KRAS Amplification;MYC Amplification	2	7
P-0006878	P-0006878-T01-IM5	In-House	FFPE	Biopsy	250	1065	NA	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.X307_splice;KEAP1 p.G364C	2	3
P-0006879	P-0006879-T01-IM5	Outside	FFPE	Resection	250	668	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	Trametinib,Cobimetinib(NF1 p.D1976Afs*3);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	PTPN11 p.E69K;TP53 p.D281E;RB1 p.L335*;NF1 p.D1976Afs*3;FH Deletion;PTEN Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	4	8
P-0006880	P-0006880-T01-IM5	In-House	FFPE	Biopsy	250	958	10	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R196*;CCND1 Amplification;EGFR Amplification;FGF19 Amplification;FGFR1 Amplification;MYC Amplification	1	6
P-0006881	P-0006881-T01-IM5	In-House	FFPE	Resection	250	837	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R	1	1
P-0006882	P-0006882-T01-IM5	Outside	FFPE	Resection	250	998	60	Matched	Primary	Heart	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;LATS2 Deletion;MDM2 Amplification;PAX5 Deletion;TERT Amplification;YAP1 Amplification;PTPRS ARHGEF18-PTPRS fusion;ARHGEF18 ARHGEF18-PTPRS fusion	3	10
P-0006883	P-0006883-T01-IM5	In-House	FFPE	Biopsy	250	781	10	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)								LEVEL_1	EGFR p.E746_S752delinsV;TP53 p.X331_splice	1	2
P-0006884	P-0006884-T01-IM5	Outside	FFPE	Biopsy	250	1228	20	Matched	Primary	Maxilla	Not Applicable	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma				Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;MEF2B Amplification;MET Amplification	2	3
P-0006885	P-0006885-T01-IM5	In-House	FFPE	Biopsy	250	551	10	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(BICC1 FGFR2-BICC1 fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 FGFR2-BICC1 fusion)					LEVEL_3B	BAP1 p.L294Afs*13;BICC1 FGFR2-BICC1 fusion;FGFR2 FGFR2-BICC1 fusion	2	3
P-0006886	P-0006886-T01-IM5	In-House	FFPE	Cytology	81.9	690	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;SETD2 p.D1334Vfs*39;ARID1A p.Q553Lfs*63;ETV1 Amplification;NKX2-1 Amplification	1	5
P-0006887	P-0006887-T01-IM5	In-House	FFPE	Biopsy	250	1102	30	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12S;TP53 p.P190T;APC p.X216_splice	2	4
P-0006888	P-0006888-T01-IM5	In-House	FFPE	Resection	250	886	50	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S);GSK2636771,AZD8186(PTEN p.R173C)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;PTEN p.R173C;TP53 p.R213*;APC p.Q1193*;APC p.S1581Ffs*70	2	5
P-0006889	P-0006889-T01-IM5	In-House	FFPE	Resection	250	885	30	Matched	Metastasis	Descending Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		Cetuximab,Panitumumab(NRAS p.Q61R)			LEVEL_3B	NRAS p.Q61R;TP53 p.R282W;APC p.Q1367*;APC p.S1298Lfs*7	1	4
P-0006890	P-0006890-T01-IM5	In-House	FFPE	Biopsy	250	1078	10	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;EP300 p.W1466*	1	2
P-0006891	P-0006891-T01-IM5	Outside	FFPE	Resection	250	264	60	Matched	Primary	Ovary	Not Applicable	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W	0	1
P-0006892	P-0006892-T01-IM5	In-House	FFPE	Resection	250	725	50	Matched	Metastasis	Ovary	Peritoneum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R158P	0	1
P-0006893	P-0006893-T01-IM5	In-House	FFPE	Resection	250	1003	60	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										ANKRD11 ANKRD11-intragenic	0	1
P-0006894	P-0006894-T01-IM5	In-House	FFPE	Biopsy	190	406	10	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0006895	P-0006895-T01-IM5	In-House	FFPE	Biopsy	250	882	NA	Matched	Metastasis	Lung	Adrenal	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-intragenic)				LEVEL_4	TP53 p.R175H;ERBB3 p.D297H;KEAP1 p.X511_splice;CIC p.S1105*;SMARCA4 p.D1432Tfs*31;EZH2 p.K99Gfs*3;CDKN2A CDKN2A-intragenic	1	7
P-0006896	P-0006896-T01-IM5	In-House	FFPE	Cytology	160.6	573	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Olaparib(PALB2 p.E384*);Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.R273L;RB1 p.E737*;PALB2 p.E384*;RECQL4 p.X541_splice;ARID1A p.A615Qfs*2;MET Amplification;MCF2L2 TP63-MCF2L2 fusion;TP63 TP63-MCF2L2 fusion	3	8
P-0006897	P-0006897-T01-IM5	In-House	FFPE	Resection	250	1227	50	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma										TP53 p.Y220C;KMT2D p.E4276*	0	2
P-0006898	P-0006898-T01-IM5	Outside	FFPE	Resection	250	959	20	Unmatched	Primary	Lymph node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										TET2 p.N202Ifs*8	0	1
P-0006899	P-0006899-T01-IM5	In-House	FFPE	Cytology	214.4	288	80	Unmatched	Primary	Lymph node	Not Applicable	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms										DNMT3A p.R882H;MYD88 p.L265P;BCOR p.D417Efs*22	0	3
P-0006901	P-0006901-T01-IM5	In-House	FFPE	Resection	250	813	30	Matched	Metastasis	Small Bowel	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A502_Y503dup);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.N822K);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K642E)	Sorafenib(KIT p.N822K)					Imatinib,Sunitinib(KIT p.N822K)		LEVEL_1	KIT p.A502_Y503dup;KIT p.N822K;KIT p.K642E	4	3
P-0006902	P-0006902-T01-IM5	In-House	FFPE	Biopsy	250	698	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	PIK3CA p.H1047R;FGFR3 p.S249C;STAG2 p.E598*;CREBBP p.L243*	3	4
P-0006903	P-0006903-T01-IM5	In-House	FFPE	Resection	250	654	20	Matched	Metastasis	Bile Duct	Lymph Node	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.K57N)					LEVEL_3B	MAP2K1 p.K57N;ARID1A p.Y1055Lfs*50	1	2
P-0006904	P-0006904-T01-IM5	In-House	FFPE	Resection	250	378	20	Matched	Metastasis	Kidney	Brain	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X114_splice;SETD2 p.E2120Nfs*27	0	2
P-0006905	P-0006905-T01-IM5	In-House	FFPE	Biopsy	250	981	10	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.V290Sfs*8)				LEVEL_4	TP53 p.H179R;PTEN p.V290Sfs*8;MGA p.S635Vfs*22;CCNE1 Amplification;NKX2-1 Amplification;ZFHX3 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	8
P-0006906	P-0006906-T01-IM5	In-House	FFPE	Resection	250	877	40	Matched	Metastasis	Cecum	Abdominal Wall	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SMAD4 p.R361C;TP53 p.R337C;RNF43 p.A244Pfs*175	3	4
P-0006907	P-0006907-T01-IM5	In-House	FFPE	Resection	250	689	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.F134L	1	2
P-0006908	P-0006908-T01-IM5	In-House	FFPE	Biopsy	250	874	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FOXP1 p.R525*;ARID1A Deletion;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification;TCF7L2 Deletion	1	7
P-0006909	P-0006909-T01-IM5	In-House	FFPE	Resection	250	780	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248Q;APC p.R499*;BRAF p.N581S;LATS1 PCMT1-LATS1 fusion;PCMT1 PCMT1-LATS1 fusion	0	5
P-0006910	P-0006910-T01-IM5	In-House	FFPE	Resection	250	687	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	ERBB2 p.L755S;GRIN2A p.X336_splice;FOXA1 p.I176V;KMT2C p.R3606*;TBX3 p.A51Gfs*37;CDH1 p.V392Efs*5;ERBB2 Amplification;FGFR1 Amplification;MYC Amplification	5	9
P-0006911	P-0006911-T01-IM5	Outside	FFPE	Biopsy	250	621	40	Matched	Metastasis	Stomach	Lung	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0006911	P-0006911-T02-IM5	Outside	FFPE	Biopsy	250	1096	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										CDH1 p.D290N;ARID1A p.G307Afs*56	0	2
P-0006912	P-0006912-T01-IM5	In-House	FFPE	Resection	250	975	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;KDM5C p.R68Pfs*7;TP53 p.A86Vfs*55;RHEB Amplification	1	4
P-0006913	P-0006913-T01-IM5	Outside	FFPE	Biopsy	250	674	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	ERBB2 p.Y772_A775dup;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;TERT Amplification;GALNT11 MLL3-GALNT11 fusion;KMT2C MLL3-GALNT11 fusion	3	7
P-0006914	P-0006914-T01-IM5	In-House	FFPE	Cytology	250	863	10	Matched	Metastasis	Lung	Trachea	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										FOXO1 Deletion;RB1 Deletion	0	2
P-0006915	P-0006915-T01-IM5	Outside	FFPE	Biopsy	250	809	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q);Afatinib(EGFR p.G719A)				GSK2636771,AZD8186(PTEN p.G132D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.L861Q;EGFR p.G719A;APC p.R216*;PTEN p.G132D;CDKN2A Deletion;CDKN2B Deletion	4	6
P-0006916	P-0006916-T01-IM5	In-House	FFPE	Resection	250	914	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	TP53 p.S241F;NF1 NF1-intragenic	1	2
P-0006917	P-0006917-T01-IM5	In-House	FFPE	Resection	250	830	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma											0	0
P-0006918	P-0006918-T01-IM5	Outside	FFPE	Biopsy	250	1056	40	Matched	Metastasis	Kidney	Lymph Node	Tumor	MRC	Renal Cell Carcinoma	Renal Medullary Carcinoma											0	0
P-0006919	P-0006919-T01-IM5	Outside	FFPE	Biopsy	250	745	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0006920	P-0006920-T01-IM5	In-House	FFPE	Resection	250	876	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)	Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_2	ERBB2 p.Y772_A775dup;PIK3R1 p.D569G;TP53 p.I254L;TP53 p.T256_S260del;CDK4 Amplification	3	5
P-0006921	P-0006921-T01-IM5	In-House	FFPE	Biopsy	250	1005	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 SLC34A2-ROS1 fusion);Crizotinib,Entrectinib(SLC34A2 SLC34A2-ROS1 fusion);Crizotinib,Entrectinib(FAM135B ROS1-FAM135B fusion);Crizotinib,Entrectinib(ROS1 ROS1-FAM135B fusion)								LEVEL_1	ROS1 SLC34A2-ROS1 fusion;SLC34A2 SLC34A2-ROS1 fusion;FAM135B ROS1-FAM135B fusion;ROS1 ROS1-FAM135B fusion	4	4
P-0006922	P-0006922-T02-IM5	Outside	FFPE	Resection	250	541	30	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;NKX2-1 Amplification	1	2
P-0006923	P-0006923-T01-IM5	In-House	FFPE	Resection	250	1022	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.E298*;CCND1 Amplification;FGF19 Amplification	0	3
P-0006924	P-0006924-T01-IM5	In-House	FFPE	Biopsy	250	685	10	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										EGFR p.H773R	0	1
P-0006925	P-0006925-T01-IM5	In-House	FFPE	Resection	250	817	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										ARID2 p.M1633Hfs*8;BAP1 p.N695Tfs*41	0	2
P-0006926	P-0006926-T02-IM5	In-House	FFPE	Biopsy	250	773	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D769H);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S3245*)					LEVEL_3B	PIK3CA p.E545K;ARID1A p.Q840*;ERBB2 p.D769H;CTNNB1 p.S37C;CDKN1A p.R9Pfs*27;VHL p.R79G;TET2 p.E1144K;FAT1 p.S1315*;NOTCH4 p.R1474*;RECQL4 p.E1152*;BRCA2 p.S3245*;RECQL4 LRRC24-RECQL4 fusion;LRRC24 LRRC24-RECQL4 fusion	3	13
P-0006926	P-0006926-T01-IM5	In-House	FFPE	Resection	250	719	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D769H)					LEVEL_3B	PIK3CA p.E545K;ERBB2 p.D769H;CTNNB1 p.S37C;CDKN1A p.R9Pfs*27	2	4
P-0006927	P-0006927-T01-IM5	In-House	FFPE	Biopsy	250	251	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.W91*;RB1 p.E492*;RBM10 p.Q707*;ARID1A p.Q457Kfs*162	0	4
P-0006928	P-0006928-T01-IM5	In-House	FFPE	Resection	250	699	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P408Afs*99;PPM1D Amplification	0	2
P-0006929	P-0006929-T01-IM5	In-House	FFPE	Biopsy	250	1043	40	Unmatched	Primary	Lung	Not Applicable	Tumor	MZL	Mature B-Cell Neoplasms	Marginal Zone Lymphoma										CARD11 p.R337Q;TNFAIP3 Deletion	0	2
P-0006930	P-0006930-T01-IM5	In-House	FFPE	Resection	250	1030	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T79Pfs*67)				LEVEL_4	KRAS p.G12V;MED12 p.K1768Qfs*3;TP53 p.I50Mfs*73;CDKN2A p.T79Pfs*67	2	4
P-0006931	P-0006931-T01-IM5	In-House	FFPE	Biopsy	250	650	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0006932	P-0006932-T01-IM5	In-House	FFPE	Resection	250	835	50	Matched	Metastasis	Intraabdominal	Pelvis	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_E561delinsQ);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.I669_T670delinsMI)				Trametinib,Cobimetinib(NF1 p.F1654Rfs*5);GSK2636771,AZD8186(PTEN Deletion)		Imatinib(KIT p.I669_T670delinsMI)		LEVEL_1	NF1 p.F1654Rfs*5;KIT p.W557_E561delinsQ;KIT p.I669_T670delinsMI;ID3 Deletion;PTEN Deletion	4	5
P-0006933	P-0006933-T01-IM5	Outside	FFPE	Resection	250	659	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.K1165*;APC p.V452Sfs*7	1	3
P-0006934	P-0006934-T01-IM5	In-House	FFPE	Biopsy	250	893	30	Matched	Primary	Urethra	Not Applicable	Tumor	UCU	Bladder Cancer	Urethral Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NFE2L2 p.D29H;KMT2D p.S2935*;ATR p.X1237_splice;CDKN2A Deletion;CDKN2B Deletion	1	5
P-0006935	P-0006935-T01-IM5	Outside	FFPE	Resection	250	914	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X114_splice;KDM5C p.C1190Wfs*13	0	2
P-0006936	P-0006936-T01-IM5	In-House	FFPE	Resection	250	396	10	Matched	Metastasis	Cecum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;CTNNB1 p.S45F	1	2
P-0006937	P-0006937-T01-IM5	In-House	FFPE	Resection	250	329	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.W4*;MCL1 Amplification	0	2
P-0006938	P-0006938-T01-IM5	In-House	FFPE	Resection	250	840	10	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0006939	P-0006939-T01-IM5	In-House	FFPE	Biopsy	250	1015	50	Matched	Primary	Breast	Not Applicable	Tumor	ACBC	Breast Cancer	Adenoid Cystic Breast Cancer										KMT2C p.Q668Rfs*3;NOTCH1 p.T2466Sfs*11	0	2
P-0006940	P-0006940-T01-IM5	In-House	FFPE	Resection	250	540	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice)				LEVEL_4	KRAS p.G12R;RASA1 p.X537_splice;TP53 p.G244Tfs*19;CDKN2A p.X51_splice	2	4
P-0006941	P-0006941-T01-IM5	In-House	FFPE	Resection	250	1068	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1002_F1007del)	Crizotinib(MET p.D1002_F1007del)	Cabozantinib(MET p.D1002_F1007del)	Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	MET p.D1002_F1007del;CDK4 Amplification;GLI1 Amplification;KRAS Amplification	4	4
P-0006942	P-0006942-T01-IM5	In-House	FFPE	Biopsy	193.2	863	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E3071*)	Trametinib,Cobimetinib(NF1 p.Q684*)				LEVEL_3B	TP53 p.R273C;BRCA2 p.E3071*;NF1 p.Q684*;RBM10 p.X168_splice	2	4
P-0006945	P-0006945-T01-IM5	In-House	FFPE	Resection	250	888	40	Matched	Primary	Pancreas	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma											0	0
P-0006946	P-0006946-T01-IM5	Outside	FFPE	Biopsy	110	666	50	Matched	Primary	Skin	Not Applicable	Tumor	ACRM	Melanoma	Acral Melanoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CTNNB1 p.P44_S60del;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification;MITF Amplification	2	5
P-0006947	P-0006947-T01-IM5	In-House	FFPE	Resection	250	448	30	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.R202W;FUBP1 p.P600Rfs*3;CIC p.K899Qfs*32;PIK3R1 p.R461_E462delinsQ;ARID2 Deletion	1	6
P-0006948	P-0006948-T01-IM5	In-House	FFPE	Biopsy	250	965	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R342*	0	1
P-0006949	P-0006949-T01-IM5	In-House	FFPE	Resection	250	968	30	Matched	Metastasis	Cervix	Diaphragm	Tumor	ICEMU	Cervical Cancer	Intestinal Type Mucinous Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.V28_E33del)				LEVEL_3B	KRAS p.G12V;TP53 p.H193Y;ARID2 p.X87_splice;SMARCA4 p.Y1149*;CDKN2A p.V28_E33del;ERBB2 Amplification	3	6
P-0006950	P-0006950-T01-IM5	In-House	FFPE	Resection	250	941	NA	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	CDKN2A Deletion;CDKN2B Deletion;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	3	4
P-0006952	P-0006952-T01-IM5	Outside	FFPE	Resection	250	1130	NA	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_3B	ERBB2 p.S310F;TP53 p.R342*;TGFBR1 p.L180*;CDKN2A p.P114L	2	4
P-0006953	P-0006953-T01-IM5	In-House	FFPE	Biopsy	162.675	864	NA	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.*394Tfs*76	1	2
P-0006954	P-0006954-T01-IM5	In-House	FFPE	Biopsy	128.1	691	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.S335C)	Neratinib(ERBB2 p.S335C)						LEVEL_2	BCOR p.N1459S;ERBB2 p.S335C;STK11 p.W308C;KEAP1 p.W403*	2	4
P-0006958	P-0006958-T01-IM5	Outside	FFPE	Resection	250	898	60	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0006959	P-0006959-T01-IM5	In-House	FFPE	Resection	250	793	40	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.R273H;VHL p.X114_splice	0	2
P-0006960	P-0006960-T01-IM5	In-House	FFPE	Resection	250	812	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Olaparib(PALB2 p.W575*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T);Trametinib,Cobimetinib(NF1 p.X465_splice);GSK2636771,AZD8186(PTEN p.D162Y);Trametinib,Cobimetinib,Binimetinib(KRAS p.Q22H)	Cetuximab,Panitumumab(KRAS p.A146T);Cetuximab,Panitumumab(KRAS p.Q22H)			LEVEL_3B	TP53 p.R175H;KRAS p.A146T;APC p.R1114*;TP53 p.H168R;APC p.S1400*;RB1 p.E323*;GNAS p.R160C;FBXW7 p.R689W;NF1 p.X465_splice;PBRM1 p.R710*;B2M p.E19*;MAP3K1 p.S1330L;LATS1 p.R82*;TGFBR1 p.P83L;B2M p.L12P;LATS1 p.R924*;FOXO1 p.S205N;SPEN p.X545_splice;MSH6 p.E641*;MSH6 p.E1322*;CASP8 p.X102_splice;SETD2 p.E1115*;PBRM1 p.R1185*;INPP4B p.Q40*;FAT1 p.G2960*;EPHA7 p.E643*;EGFR p.D761N;EGFR p.V843I;KMT2C p.R56Q;PTEN p.D162Y;KRAS p.Q22H;RB1 p.K80*;PALB2 p.W575*;NCOR1 p.E843*;SMARCA4 p.Q464*;CIC p.G399*;EP300 p.R2263*;RBM10 p.X811_splice;GATA1 p.R270W;ATR p.H2277Qfs*38;NBN p.M553Wfs*6	5	41
P-0006961	P-0006961-T01-IM5	In-House	FFPE	Resection	250	753	50	Matched	Primary	Chest Wall	Not Applicable	Tumor	MF	Soft Tissue Sarcoma	Myofibroma											0	0
P-0006962	P-0006962-T01-IM5	In-House	FFPE	Resection	250	790	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L	0	1
P-0006963	P-0006963-T01-IM5	In-House	FFPE	Biopsy	250	887	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SPEN p.E805Dfs*3;KMT2A p.K1748*;SPEN p.Q3493Rfs*23;NFE2L2 p.E79del;AURKA Amplification;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	0	8
P-0006964	P-0006964-T01-IM5	In-House	FFPE	Biopsy	250	1012	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.K101*;MCL1 Amplification;NTRK1 Amplification	1	4
P-0006965	P-0006965-T01-IM5	Outside	FFPE	Resection	250	743	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A60V)				LEVEL_2	ERBB2 p.Y772_A775dup;TP53 p.M246I;CDKN2A p.A60V	3	3
P-0006966	P-0006966-T01-IM5	Outside	FFPE	Resection	250	801	40	Matched	Metastasis	Uterus	Pelvis	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	BRCA2 Deletion;CIC Deletion;DIS3 Deletion;FOXO1 Deletion;RB1 Deletion	1	5
P-0006967	P-0006967-T01-IM5	Outside	FFPE	Resection	250	1172	30	Matched	Metastasis	Sigmoid Colon	Ovary	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R273H;APC p.G1312*;FAT1 Deletion;SMAD2 Deletion	0	4
P-0006968	P-0006968-T01-IM5	In-House	FFPE	Resection	250	800	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;BRAF p.D594G;APC p.Q412*;SMAD4 p.C324R;APC Deletion	0	5
P-0006969	P-0006969-T01-IM5	In-House	FFPE	Resection	250	855	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R175H;PAK5 p.T538S	0	2
P-0006970	P-0006970-T02-IM5	In-House	FFPE	Biopsy	250	895	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										ATRX p.W1883*;TP53 p.T256K;RB1 p.S182Yfs*2	0	3
P-0006970	P-0006970-T01-IM5	Outside	FFPE	Resection	250	881	20	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Everolimus(TSC2 p.W257*)					LEVEL_3B	RB1 p.X840_splice;ATRX p.W1883*;TSC2 p.W257*;TP53 p.T256K	1	4
P-0006971	P-0006971-T01-IM5	In-House	FFPE	Biopsy	250	893	50	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;BAP1 p.K25_D34delinsN	0	2
P-0006972	P-0006972-T01-IM5	In-House	FFPE	Resection	250	796	40	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Olaparib(ATM Deletion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PPM1D p.R458*;ATM Deletion;KDR Amplification;KIT Amplification;PDGFRA Amplification	2	6
P-0006973	P-0006973-T01-IM5	In-House	FFPE	Biopsy	250	812	50	Matched	Metastasis	Skin	Pelvis	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;U2AF1 p.S34F;TCF7L2 p.Q325Rfs*26	1	3
P-0006974	P-0006974-T01-IM5	In-House	FFPE	Biopsy	250	955	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1044K)					LEVEL_3B	CTNNB1 p.N387K;PIK3CA p.N1044K;SOX9 p.N301Tfs*68	1	3
P-0006975	P-0006975-T01-IM5	In-House	FFPE	Resection	250	599	50	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										RB1 Deletion;TP53 Deletion;YAP1 Amplification	0	3
P-0006976	P-0006976-T01-IM5	In-House	FFPE	Biopsy	250	1004	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.S166*;ARID1A p.G945*;BCL6 Amplification;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;PIK3CA Amplification;SMAD2 Deletion;SMAD4 Deletion	0	9
P-0006977	P-0006977-T01-IM5	Outside	FFPE	Resection	250	668	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer					Tazemetostat(SMARCB1 p.P383Rfs*100)				LEVEL_4	SMARCB1 p.P383Rfs*100;APC p.R1171Tfs*8;APC p.S982Rfs*23	1	3
P-0006978	P-0006978-T01-IM5	In-House	FFPE	Resection	250	537	40	Matched	Primary	Descending Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	PIK3CA p.E542K;TP53 p.C176F;APC p.E1059*;RBM10 p.X565_splice;FGFR1 Amplification	2	5
P-0006979	P-0006979-T01-IM5	In-House	FFPE	Resection	250	836	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.T125K;STK11 p.Q170*;KEAP1 p.M110V;SMARCA4 p.E419*;ERBB2 Amplification	1	5
P-0006980	P-0006980-T01-IM5	In-House	FFPE	Resection	250	788	30	Matched	Metastasis	Thyroid	Pelvis	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C	2	1
P-0006981	P-0006981-T01-IM5	In-House	FFPE	Biopsy	250	891	10	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V777L);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	APC p.Q1429*;ERBB2 p.V777L;ERBB2 Amplification;FLT3 Amplification	3	4
P-0006982	P-0006982-T01-IM5	In-House	FFPE	Resection	250	628	30	Matched	Metastasis	Abdomen	Lung	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;JUN Amplification;MDM2 Amplification	2	3
P-0006983	P-0006983-T01-IM5	In-House	FFPE	Resection	250	843	20	Matched	Metastasis	Rectum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13R)		Cetuximab,Panitumumab(NRAS p.G13R)			LEVEL_3B	NRAS p.G13R;APC p.R1314Sfs*7	1	2
P-0006984	P-0006984-T01-IM5	In-House	FFPE	Resection	250	727	20	Matched	Metastasis	Ovary	Sigmoid Colon	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R342*	0	1
P-0006985	P-0006985-T01-IM5	In-House	FFPE	Resection	250	802	30	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification;TP53 Deletion	1	4
P-0006986	P-0006986-T01-IM5	In-House	FFPE	Biopsy	250	866	30	Unmatched	Primary	Lung	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										SETD2 p.R53*	0	1
P-0006988	P-0006988-T01-IM5	Outside	FFPE	Resection	250	655	30	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										CBL p.G375Afs*17	0	1
P-0006989	P-0006989-T01-IM5	In-House	FFPE	Resection	250	707	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)		Tazemetostat(KDM6A p.X1336_splice)				LEVEL_1	FOXA1 p.R261C;FGFR3 p.Y373C;KDM6A p.X1336_splice;PPP2R1A p.E297K;KMT2D p.W1422Vfs*79;ARID1A p.P109Efs*3;EP300 p.Y1192*;KMT2D p.V1429Cfs*3	3	8
P-0006990	P-0006990-T01-IM5	Outside	FFPE	Biopsy	250	724	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G266R;MAP3K1 p.G914Dfs*7;RAD21 p.R554Dfs*57;DDX4 MAP3K1-DDX4 fusion;MAP3K1 MAP3K1-DDX4 fusion	0	5
P-0006991	P-0006991-T01-IM5	In-House	FFPE	Resection	250	786	30	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										TNFRSF14 Deletion	0	1
P-0006992	P-0006992-T01-IM5	Outside	FFPE	Biopsy	250	1029	30	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.H434Pfs*73	0	1
P-0006993	P-0006993-T01-IM5	Outside	FFPE	Resection	250	597	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.X125_splice;KEAP1 p.E192*;RBM10 p.R822*;ZFHX3 p.V1393Cfs*32	2	5
P-0006994	P-0006994-T01-IM5	In-House	FFPE	Biopsy	250	852	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	CDKN1B p.E39*;MGA p.G73Vfs*23;TP53 p.X23_splice;BRCA2 Deletion;PTEN Deletion	3	5
P-0006995	P-0006995-T01-IM5	In-House	FFPE	Biopsy	250	811	30	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.S752_I759del)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.P151S;EGFR p.S752_I759del;RBM10 p.X565_splice;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERBB2 Amplification;NKX2-1 Amplification	3	8
P-0006996	P-0006996-T01-IM5	In-House	FFPE	Biopsy	250	1044	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R248W;EPCAM p.X219_splice;ERBB2 Amplification	2	3
P-0006997	P-0006997-T01-IM5	Outside	FFPE	Biopsy	200.3	537	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.C124S)				LEVEL_4	PTEN p.C124S	1	1
P-0006999	P-0006999-T02-IM5	In-House	FFPE	Biopsy	247.85	347	20	Matched	Metastasis	Ascending Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										CTNNB1 p.K335I;APC p.R554*;TP53 p.X33_splice;MYC Amplification	0	4
P-0007000	P-0007000-T01-IM5	In-House	FFPE	Biopsy	250	602	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.X1336_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;TP53 p.R175C;SF3B1 p.E902Q;KDM6A p.X1336_splice;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion;CREBBP CREBBP-intragenic	4	8
P-0007001	P-0007001-T01-IM5	In-House	FFPE	Biopsy	250	997	50	Matched	Metastasis	Uterus	Lung	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111E);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	PIK3CA p.K111E;TP53 p.G245S;FGFR1 Amplification	2	3
P-0007002	P-0007002-T01-IM5	In-House	FFPE	Biopsy	250	889	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;ARID1A p.Q428*;CDKN1A p.P24Tfs*9;RB1 Deletion	1	4
P-0007003	P-0007003-T01-IM5	In-House	FFPE	Resection	250	351	10	Matched	Metastasis	Ovary	Omentum	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;EIF1AX p.N4S	1	2
P-0007004	P-0007004-T01-IM5	In-House	FFPE	Resection	250	775	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;STK11 p.X245_splice;PTPRD p.E442*	1	3
P-0007005	P-0007005-T01-IM5	Outside	FFPE	Resection	250	814	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.H247R;APC p.E2534Dfs*24	0	2
P-0007006	P-0007006-T01-IM5	In-House	FFPE	Biopsy	250	578	20	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.I33del)				LEVEL_4	TP53 p.R273H;PTEN p.I33del	1	2
P-0007007	P-0007007-T01-IM5	In-House	FFPE	Resection	250	1059	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)						LEVEL_3A	TP53 p.R249M;TET2 p.G1370V;BAP1 p.Q280Rfs*55;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	1	6
P-0007009	P-0007009-T01-IM5	In-House	FFPE	Cytology	250	776	60	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM Deletion);Olaparib(CHEK1 Deletion)					LEVEL_3B	CIC p.R274Q;AKT1 p.P68_C77dup;ATM Deletion;BIRC3 Deletion;CBL Deletion;CHEK1 Deletion;KMT2A Deletion;NKX3-1 Deletion;SDHD Deletion	2	9
P-0007009	P-0007009-T02-IM5	In-House	FFPE	Cytology	250	971	50	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM Deletion);Olaparib(CHEK1 Deletion)					LEVEL_3B	CIC p.R274Q;AKT1 p.P68_C77dup;ATM Deletion;BIRC3 Deletion;CBL Deletion;CHEK1 Deletion;KMT2A Deletion;NKX3-1 Deletion;SDHD Deletion	2	9
P-0007010	P-0007010-T01-IM5	In-House	FFPE	Resection	250	908	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.Y2285Tfs*5)				LEVEL_4	NF1 p.Y2285Tfs*5	1	1
P-0007010	P-0007010-T02-IM5	In-House	FFPE	Resection	250	996	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-intragenic)				LEVEL_4	KDR Amplification;KIT Amplification;MYC Amplification;PDGFRA Amplification;CDKN2A CDKN2A-intragenic	1	5
P-0007011	P-0007011-T01-IM5	Outside	FFPE	Resection	250	609	40	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	FOXA1 Amplification;KDR Amplification;KIT Amplification;MDM2 Amplification;NKX2-1 Amplification	1	5
P-0007012	P-0007012-T01-IM5	In-House	FFPE	Biopsy	250	1009	10	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										APC p.E1322*;TP53 p.Y205S;MYCL Amplification	0	3
P-0007013	P-0007013-T01-IM5	In-House	FFPE	Resection	250	794	30	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P124E)					LEVEL_3B	ARID1A p.M1564*;IDH1 p.R132H;ARID1A p.Q766Sfs*67;ARID1A p.Q2176Rfs*48;CIC p.N205S;FUBP1 p.M297Rfs*26;BAP1 p.Y33del;DAXX p.H300Qfs*43;PIK3CA p.P124E	2	9
P-0007014	P-0007014-T01-IM5	In-House	FFPE	Resection	250	521	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ZFP64 RAD51C-ZFP64 fusion);Olaparib(RAD51C RAD51C-ZFP64 fusion)					LEVEL_3B	GATA3 p.D335Gfs*17;TP53 p.X126_splice;FGFR2 Amplification;FOXA1 Amplification;MYC Amplification;ZFP64 RAD51C-ZFP64 fusion;RAD51C RAD51C-ZFP64 fusion	2	7
P-0007015	P-0007015-T01-IM5	In-House	FFPE	Biopsy	250	984	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.P463L)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	PIK3CA p.E545K;TP53 p.R282W;SMARCA4 p.E821K;ERCC2 p.P463L;ARID1A p.P728Lfs*12;CDKN2A Deletion;CDKN2B Deletion	3	7
P-0007016	P-0007016-T01-IM5	Outside	FFPE	Biopsy	250	124	10	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H	1	1
P-0007017	P-0007017-T01-IM5	Outside	FFPE	Biopsy	250	1135	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R273H;RB1 p.X830_splice;RB1 p.A333Ffs*13;ARID1A p.F1750Qfs*5;CCND3 Amplification;EGFR Amplification;FGFR1 Amplification;MAPK1 Amplification	1	8
P-0007018	P-0007018-T01-IM5	Outside	FFPE	Biopsy	250	380	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E120*)				LEVEL_3B	EGFR p.H304Y;PTPN11 p.D61Y;TP53 p.K132E;PIK3R1 p.E458_Y463dup;CDKN2A p.E120*;CDK4 Amplification;MDM2 Amplification	3	7
P-0007020	P-0007020-T01-IM5	In-House	FFPE	Biopsy	250	1126	30	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.D281E;ATRX p.Y2084*;RB1 p.X286_splice;CREBBP p.C1178Afs*72	0	4
P-0007021	P-0007021-T01-IM5	In-House	FFPE	Biopsy	250	871	50	Matched	Metastasis	Cancer of Unknown Primary	Scalp	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PPM1D p.S446*;CDKN2A Deletion;CDKN2B Deletion;NF2 Deletion	1	4
P-0007022	P-0007022-T01-IM5	In-House	FFPE	Biopsy	250	842	40	Matched	Metastasis	Pancreas	Liver	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS											0	0
P-0007023	P-0007023-T01-IM5	Outside	FFPE	Biopsy	250	799	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma											0	0
P-0007024	P-0007024-T01-IM5	In-House	FFPE	Resection	250	847	30	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lapatinib(EGFR p.A289V);GSK2636771,AZD8186(PTEN p.S170N);Lapatinib(EGFR Amplification)				LEVEL_3B	EGFR p.A289V;PTEN p.S170N;CDK4 Amplification;EGFR Amplification;GLI1 Amplification;MDM2 Amplification	5	6
P-0007025	P-0007025-T01-IM5	In-House	FFPE	Cytology	250	981	10	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.N323Kfs*2)				LEVEL_4	PTEN p.N323Kfs*2;APC p.X470_splice;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0007026	P-0007026-T01-IM5	In-House	FFPE	Biopsy	250	1014	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	TP53 p.R175H;KRAS p.G12A;RBM10 p.W217*	1	3
P-0007027	P-0007027-T01-IM5	Outside	FFPE	Resection	250	1059	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.P244Lfs*12);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.P244Lfs*12;PIK3R1 p.N378del;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;GATA3 Deletion;TERT Amplification	2	7
P-0007028	P-0007028-T01-IM5	In-House	FFPE	Resection	250	1346	50	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										CTNNB1 p.T41I	0	1
P-0007029	P-0007029-T01-IM5	Outside	FFPE	Resection	250	841	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.E223*;KEAP1 p.M409*;ATR p.I933Sfs*6;TP53 p.G154Afs*16	0	4
P-0007030	P-0007030-T01-IM5	Outside	FFPE	Resection	250	887	10	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.E339*	1	2
P-0007031	P-0007031-T01-IM5	In-House	FFPE	Resection	250	828	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;MDM2 Amplification	2	2
P-0007032	P-0007032-T01-IM5	In-House	FFPE	Biopsy	250	1035	10	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)		GSK2636771,AZD8186(PTEN p.C124S)				LEVEL_1	PIK3CA p.E545K;TP53 p.E294Sfs*51;PTEN p.C124S;VHL p.R161L;ARID1B ARID1B-intragenic	3	5
P-0007033	P-0007033-T01-IM5	In-House	FFPE	Resection	250	620	40	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer											0	0
P-0007034	P-0007034-T01-IM5	In-House	FFPE	Biopsy	161.2	729	NA	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344G)					LEVEL_3B	IDH1 p.R132H;SETD2 p.V1427Efs*4;PIK3CA p.V344G;CIC p.R1515C;ARID1B p.L1085Rfs*32	2	5
P-0007035	P-0007035-T01-IM5	In-House	FFPE	Resection	250	763	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				AMG-510(KRAS p.G12C);Everolimus(TSC1 p.N891Kfs*13)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.P152L;APC p.P1319Lfs*2;TSC1 p.N891Kfs*13	3	4
P-0007036	P-0007036-T02-IM5	In-House	FFPE	Biopsy	250	977	10	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0007036	P-0007036-T01-IM5	In-House	FFPE	Resection	250	795	30	Matched	Metastasis	Rectum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R282W;APC p.P1319Lfs*2	0	2
P-0007037	P-0007037-T01-IM5	In-House	FFPE	Resection	250	343	20	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Talazoparib,Olaparib(BRCA1 p.G1371Vfs*4)		Niraparib,Rucaparib(BRCA1 p.G1371Vfs*4)					LEVEL_2	TP53 p.E224D;SOX9 p.X139_splice;BRCA1 p.G1371Vfs*4;PBRM1 PBRM1-intragenic	2	4
P-0007039	P-0007039-T01-IM5	In-House	FFPE	Resection	250	810	40	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.C135Afs*35;FBXW7 p.R465C;KRAS p.G13D;APC p.L1489Yfs*27	1	4
P-0007040	P-0007040-T01-IM5	Outside	FFPE	Biopsy	250	906	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 p.T515Ifs*10)		Rucaparib,Niraparib(BRCA2 p.T515Ifs*10)					LEVEL_2	KMT2C p.X3860_splice;TP53 p.Q100Lfs*42;BRCA2 p.T515Ifs*10	2	3
P-0007041	P-0007041-T01-IM5	In-House	FFPE	Cytology	100	147	30	Matched	Metastasis	Liver	Peritoneum	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										TP53 p.C176Y;SMAD4 p.P130L;TP53 p.H178P;PTPRS p.E1182*;FAT1 p.S592Cfs*3	0	5
P-0007042	P-0007042-T01-IM5	In-House	FFPE	Resection	250	759	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0007043	P-0007043-T01-IM5	In-House	FFPE	Biopsy	250	470	30	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	APC p.G2164Afs*10;FOXA1 p.I360Pfs*2;AR Amplification;FOXA1 Deletion;MAP3K1 Deletion;PIK3R1 Deletion;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	9
P-0007044	P-0007044-T01-IM5	In-House	FFPE	Biopsy	250	875	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.G757*);Olaparib(ATM p.C2488Y)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.X332_splice;ATM p.G757*;ATM p.C2488Y	4	4
P-0007045	P-0007045-T01-IM5	In-House	FFPE	Biopsy	250	956	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.E542K;DICER1 p.E707*;CREBBP p.E1054Dfs*4;TP53 p.A83Gfs*65;CDK8 Amplification;ERBB2 Amplification;FGFR3 Amplification;MDM2 Amplification;MYC Amplification	5	9
P-0007046	P-0007046-T01-IM5	In-House	FFPE	Resection	250	823	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas				Olaparib(ATM p.E2139*)	GSK2636771,AZD8186(PTEN p.S229*)				LEVEL_3B	SPEN p.G1994*;SETD2 p.S1442*;PTEN p.S229*;ATM p.E2139*;AXIN1 p.E404*;CDH1 p.E167*;AXIN2 p.C555*;CREBBP CREBBP-intragenic	2	8
P-0007047	P-0007047-T01-IM5	Outside	FFPE	Biopsy	250	948	10	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										MGA p.W795*	0	1
P-0007048	P-0007048-T01-IM5	In-House	FFPE	Biopsy	250	1459	20	Unmatched	Primary	Retroperitoneum	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CREBBP p.S1680del;HLA-A p.W75*;HLA-A p.W84*;KMT2D p.C1024*;ARID1A p.R1833Afs*6	0	5
P-0007049	P-0007049-T01-IM5	Outside	FFPE	Biopsy	250	1037	30	Matched	Metastasis	Oral Cavity	Lymph Node, Regional	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma											0	0
P-0007050	P-0007050-T01-IM5	In-House	FFPE	Resection	250	767	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Larotrectinib,Entrectinib(NTRK1 VANGL2-NTRK1 fusion);Larotrectinib,Entrectinib(VANGL2 VANGL2-NTRK1 fusion)								LEVEL_1	NTRK1 VANGL2-NTRK1 fusion;VANGL2 VANGL2-NTRK1 fusion	2	2
P-0007051	P-0007051-T01-IM5	In-House	FFPE	Biopsy	189.6	715	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	PLX8394(BRAF p.G469A)				LEVEL_3B	PIK3CA p.E542K;BRAF p.G469A;SMAD4 p.Q245*;STK11 p.S216F;KEAP1 p.M110I;TP63 p.W658*;TP53 p.T150Sfs*22	2	7
P-0007052	P-0007052-T01-IM5	Outside	FFPE	Resection	250	631	60	Unmatched	Metastasis	Upper Tract	Lymph Node	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma			Cisplatin(ERCC2 p.F610Cfs*38)	Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Olaparib(BARD1 p.D172Mfs*40);Olaparib(ATM p.R35*);Olaparib(BARD1 p.S558*)					LEVEL_3A	ERBB2 p.S310F;ARID1A p.T294Pfs*69;BARD1 p.D172Mfs*40;AXIN1 p.G508Vfs*197;CIC p.P1248Hfs*54;ATM p.R35*;BARD1 p.S558*;PBRM1 p.E164*;KMT2C p.E2739*;RECQL4 p.X822_splice;KMT2D p.Q3580*;CDK8 p.E66Q;DNMT3B p.R571*;FBXW7 p.S668Efs*26;TBX3 p.C711Rfs*18;ERCC2 p.F610Cfs*38;ZFHX3 p.R2740Sfs*15;MGA p.N416Vfs*7	5	18
P-0007053	P-0007053-T01-IM5	Outside	FFPE	Resection	250	479	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0007054	P-0007054-T01-IM5	In-House	FFPE	Cytology	234.7	514	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.L755A)	Neratinib(ERBB2 p.L755A)						LEVEL_2	TP53 p.F270V;ERBB2 p.L755A	2	2
P-0007055	P-0007055-T01-IM5	In-House	FFPE	Resection	250	653	50	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib(NF1 p.X616_splice)				LEVEL_1	FUBP1 p.I301Yfs*22;BRAF p.V600E;PIK3CA p.H1047R;TP53 p.R282W;CTCF p.T204Nfs*26;CREBBP p.P1423Lfs*36;ARID1A p.P1326Rfs*155;FLCN p.H429Tfs*39;SMARCA4 p.G271Rfs*16;EPHA7 p.X545_splice;NCOR1 p.R2018*;NF1 p.X616_splice;SMARCA4 p.X1128_splice;KMT2C p.K3604Rfs*26;PBRM1 p.N955Kfs*27;KMT2D p.A2119Rfs*36;ANKRD11 p.V873Gfs*42;KMT2A p.N1110Efs*2;KMT2D p.P2392Lfs*34;MSH6 p.K693Nfs*43;RAD50 p.N795Kfs*10	5	21
P-0007056	P-0007056-T01-IM5	Outside	FFPE	Resection	250	822	30	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										NSD1 p.Q1482*	0	1
P-0007057	P-0007057-T01-IM5	Outside	FFPE	Biopsy	250	651	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0007058	P-0007058-T01-IM5	Outside	FFPE	Resection	250	1182	20	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0007059	P-0007059-T01-IM5	Outside	FFPE	Resection	250	710	40	Matched	Primary	Uterus	Not Applicable	Tumor	UPECOMA	Uterine Sarcoma	Uterine Perivascular Epithelioid Cell Tumor				Everolimus(TSC2 p.R1459*)					LEVEL_3B	TSC2 p.R1459*;MCL1 Amplification;NTRK1 Amplification;TP53 Deletion	1	4
P-0007060	P-0007060-T01-IM5	In-House	FFPE	Biopsy	250	962	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E61*)				LEVEL_4	KRAS p.G12D;TP53 p.E286K;CTNNB1 p.W383R;KDM6A p.X944_splice;RBM10 p.X700_splice;CDKN2A p.E61*	2	6
P-0007061	P-0007061-T01-IM5	In-House	FFPE	Biopsy	250	928	20	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209P;BAP1 p.X86_splice	0	2
P-0007062	P-0007062-T01-IM5	In-House	FFPE	Biopsy	250	614	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12D;TP53 p.R213*;ARID1A p.K250Rfs*152;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification	3	6
P-0007063	P-0007063-T01-IM5	Outside	FFPE	Resection	250	1096	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.A86Cfs*63;RNF43 p.G4Pfs*4;ERBB2 Amplification	2	4
P-0007064	P-0007064-T01-IM5	In-House	FFPE	Resection	250	1062	40	Matched	Metastasis	Ovary	Colon	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R273C;CDKN2A Deletion;CDKN2B Deletion;ID3 Deletion	1	4
P-0007065	P-0007065-T01-IM5	In-House	FFPE	Resection	250	933	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Olaparib(PALB2 DCTN5-PALB2 fusion);Olaparib(DCTN5 DCTN5-PALB2 fusion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PALB2 DCTN5-PALB2 fusion;DCTN5 DCTN5-PALB2 fusion;RNF43 RNF43-intragenic	3	4
P-0007066	P-0007066-T01-IM5	In-House	FFPE	Resection	250	814	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.P142Afs*5	0	1
P-0007067	P-0007067-T01-IM5	Outside	FFPE	Cytology	250	993	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R273H;KEAP1 p.E69*;BCL2L1 Amplification;MYC Amplification	0	4
P-0007068	P-0007068-T01-IM5	Outside	FFPE	Cytology	250	931	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										PIK3R3 p.R309*;TP53 p.R267P;SRC Amplification;TERT Amplification	0	4
P-0007069	P-0007069-T01-IM5	Outside	FFPE	Resection	250	1023	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	GSK2636771,AZD8186(PTEN p.N63Kfs*11)				LEVEL_3B	PIK3CA p.E545K;TP53 p.R248Q;PTEN p.N63Kfs*11;ASXL1 p.G646Wfs*12;APC p.Y935*;APC p.N1531Mfs*34	2	6
P-0007070	P-0007070-T01-IM5	In-House	FFPE	Resection	250	580	30	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	APC p.E1397*;TP53 p.X224_splice;ERBB2 Amplification	2	3
P-0007071	P-0007071-T01-IM5	In-House	FFPE	Resection	250	799	20	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.V172F;CARD11 Amplification;RAC1 Amplification	0	3
P-0007072	P-0007072-T01-IM5	Outside	FFPE	Resection	250	524	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 Deletion)		Rucaparib,Niraparib(BRCA2 Deletion)					LEVEL_2	GATA3 p.P408Afs*99;SMAD4 p.T7*;BRCA2 Deletion;FOXA1 Amplification	2	4
P-0007073	P-0007073-T01-IM5	In-House	FFPE	Biopsy	250	745	50	Matched	Primary	Brain	Not Applicable	Tumor	LGGNOS	Glioma	Low-Grade Glioma, NOS											0	0
P-0007074	P-0007074-T01-IM5	In-House	FFPE	Resection	250	819	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PAX5 p.L228Cfs*50;STK11 p.P221Afs*61	2	3
P-0007075	P-0007075-T01-IM5	In-House	FFPE	Resection	250	887	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R	1	1
P-0007076	P-0007076-T03-IM5	In-House	FFPE	Biopsy	250	1255	75	Matched	Metastasis	Pancreas	Liver	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS				Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64);Binimetinib,Binimetinib+Ribociclib(NRAS p.G13S);Everolimus(TSC2 p.E234*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.E63K);GSK2636771,AZD8186(PTEN p.S59*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R175H;PTCH1 p.R1308Efs*64;KRAS p.E63K;RBM10 p.Q742*;MEN1 p.R465*;PTEN p.S59*;NRAS p.G13S;SETD2 p.W1341*;SETD2 p.Q1287*;TET2 p.E1401K;NSD1 p.Q2313*;NOTCH1 p.X481_splice;CBL p.X812_splice;AXIN1 p.X821_splice;TSC2 p.E234*;CDKN1B p.W60_K68delins*;CREBBP p.M784Ifs*17;CDKN2A Deletion;CDKN2B Deletion;EZH2 Amplification	6	20
P-0007076	P-0007076-T02-IM5	Outside	FFPE	Biopsy	250	887	75	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					GSK2636771,AZD8186(PTEN p.S59*);Trametinib,Cobimetinib(NF1 p.E2753*)				LEVEL_4	MEN1 p.R465*;PTEN p.S59*;NF1 p.E2753*	2	3
P-0007078	P-0007078-T02-IM5	Outside	FFPE	Resection	250	1341	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.L265P;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0007079	P-0007079-T01-IM5	In-House	FFPE	Resection	250	952	NA	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V;APC p.R213*;APC p.E1379Gfs*7	2	4
P-0007080	P-0007080-T02-IM5	In-House	FFPE	Resection	250	1286	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R342*;ERBB3 p.A232V;APC p.Q412*;APC p.K1182Nfs*83	0	4
P-0007081	P-0007081-T02-IM5	In-House	FFPE	Biopsy	250	1146	40	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.X331_splice;APC p.K1370Dfs*7;EGFR Amplification	0	3
P-0007082	P-0007082-T01-IM5	In-House	FFPE	Biopsy	135	390	10	Matched	Metastasis	Lung	Spine	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.E746_A750del;CTNNB1 p.S37C;ERBB2 Amplification;MDM2 Amplification;TERT Amplification	3	5
P-0007084	P-0007084-T02-IM5	In-House	FFPE	Biopsy	192.5	263	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	BCOR p.N1459S;TP53 p.C176F;EGFR p.T725M;KRAS p.Q61H	1	4
P-0007085	P-0007085-T02-IM5	In-House	FFPE	Resection	250	1173	NA	Matched	Metastasis	Rectum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										APC p.R213*;APC p.T1487Nfs*27;TP53 p.R156P;FOXP1 p.D441Rfs*20	0	4
P-0007086	P-0007086-T02-IM5	In-House	FFPE	Biopsy	250	1653	70	Unmatched	Primary	Retroperitoneum	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.Q165*;CARD11 p.D401N;BCL2 p.A131D;TP53 p.R249Sfs*96;MGA Deletion;RB1 Deletion	0	6
P-0007087	P-0007087-T01-IM5	Outside	FFPE	Biopsy	250	728	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.D538G)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;ESR1 p.D538G;SF3B1 p.K700E;GATA3 p.P408Afs*99;PBRM1 p.I279Yfs*4;FAT1 p.P3228Lfs*42;HIST1H3B p.L104I;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	4	10
P-0007088	P-0007088-T02-IM5	In-House	FFPE	Biopsy	250	919	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Afatinib(EGFR p.G719A)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.G719A;TP53 p.X307_splice;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification	3	6
P-0007089	P-0007089-T02-IM5	In-House	FFPE	Biopsy	147.6	434	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ARID1A p.Y551Lfs*72;GATA3 p.S413Qfs*94;ERBB2 Amplification;PPM1D Amplification;PRDM1 Deletion	2	5
P-0007090	P-0007090-T02-IM5	In-House	FFPE	Resection	250	758	NA	Matched	Metastasis	Transverse Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	TP53 p.R273H;BRAF p.V600E;PIK3CA p.E545K;APC p.S1465Wfs*3;APC p.R876*;FLT3 Amplification	4	6
P-0007091	P-0007091-T01-IM5	In-House	FFPE	Biopsy	250	1128	90	Matched	Metastasis	Lung	Liver	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.A1708E)					LEVEL_3B	TP53 p.C238F;BCOR p.R1217*;KDR p.L161I;BRCA1 p.A1708E;TGFBR2 Deletion	1	5
P-0007092	P-0007092-T01-IM5	In-House	FFPE	Resection	250	876	35	Matched	Metastasis	Rectum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										SMAD4 p.R361C;TP53 p.R273C;APC p.K1165*;APC p.R216*;NKX3-1 Deletion;PAX5 Amplification;SOX9 Deletion	0	7
P-0007093	P-0007093-T01-IM5	Outside	FFPE	Biopsy	250	1131	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Neratinib(ERBB2 p.S310F)	Ado-Trastuzumab Emtansine(ERBB2 p.S310F);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.X160_splice)				LEVEL_1	PIK3CA p.E545K;ERBB2 p.S310F;TP53 p.L330P;NF1 p.X160_splice;ERBB2 Amplification;RB1 Deletion;SMAD4 Deletion	7	7
P-0007094	P-0007094-T01-IM5	Outside	FFPE	Resection	250	837	10	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R282W;GNAS p.R201C;FBXW7 p.R479Q;ASXL2 p.M1?	1	5
P-0007095	P-0007095-T01-IM5	Outside	FFPE	Resection	250	829	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.X332_splice;BRAF p.D594N;RASA1 p.X566_splice;FANCC p.Q212*;SMAD4 p.Q410*;APC p.P2522Hfs*8;CDKN2A Deletion;CDKN2B Deletion	1	8
P-0007096	P-0007096-T01-IM5	In-House	FFPE	Biopsy	250	731	20	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.Q709L)					LEVEL_3B	TP53 p.R196*;ERBB2 p.Q709L	1	2
P-0007097	P-0007097-T01-IM5	In-House	FFPE	Resection	250	408	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)	Cetuximab,Panitumumab(KRAS p.A146V)			LEVEL_3B	PIK3CA p.H1047R;TP53 p.P278S;KRAS p.A146V;APC p.R876*;APC p.G1412*;CCND3 Amplification;VEGFA Amplification	2	7
P-0007098	P-0007098-T01-IM5	Outside	FFPE	Biopsy	250	487	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion;SOX17 Deletion	1	2
P-0007099	P-0007099-T01-IM5	In-House	FFPE	Biopsy	250	963	30	Matched	Metastasis	Lung	Back	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.R248P;KRAS p.G13D;STK11 p.Q159*;ARID1A p.Q200*;NOTCH4 p.Q142*	1	5
P-0007100	P-0007100-T01-IM5	In-House	FFPE	Biopsy	250	854	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;EGFR p.T1041A;CBL p.Q175*;TBX3 p.S396Pfs*236;CDH1 p.F516Nfs*4	2	5
P-0007101	P-0007101-T02-IM5	In-House	FFPE	Cytology	132.1	513	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.V143M;PTPRD p.R1674S;STK11 p.K78*;BCL2L1 Amplification;MCL1 Amplification;MYC Amplification;NKX2-1 Amplification	1	8
P-0007102	P-0007102-T01-IM5	In-House	FFPE	Resection	250	886	15	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Tipifarnib(HRAS p.G13R)					LEVEL_3B	PIK3CA p.H1047R;HRAS p.G13R;TP53 p.N239D	2	3
P-0007103	P-0007103-T01-IM5	In-House	FFPE	Resection	250	843	NA	Matched	Primary	Mediastinum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										PPM1D Amplification	0	1
P-0007104	P-0007104-T01-IM5	Outside	FFPE	Biopsy	250	1003	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R158H;CDKN2A Deletion;CDKN2B Deletion;PDGFRA Amplification	1	4
P-0007105	P-0007105-T01-IM5	In-House	FFPE	Resection	250	916	10	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix										FBXW7 p.D520V	0	1
P-0007106	P-0007106-T01-IM5	In-House	FFPE	Biopsy	250	924	40	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0007107	P-0007107-T01-IM5	In-House	FFPE	Resection	250	742	30	Matched	Metastasis	Gallbladder	Lymph Node	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3A	PIK3CA p.E545K;IDH1 p.R132C	2	2
P-0007108	P-0007108-T01-IM5	In-House	FFPE	Biopsy	250	1028	45	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	TP53 p.R267W;CTNNB1 p.K292E;MAP2K4 p.Q69*;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	5
P-0007109	P-0007109-T01-IM5	Outside	FFPE	Resection	250	786	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453Q)	Tazemetostat(KDM6A p.E736Rfs*4);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R248Q;PIK3CA p.E453Q;KMT2D p.Q2800*;FOXP1 p.X511_splice;SMAD3 p.Y237S;KDM6A p.E736Rfs*4;AXIN2 p.Q509Rfs*180;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	3	10
P-0007110	P-0007110-T01-IM5	Outside	FFPE	Resection	250	872	40	Matched	Metastasis	Testis	Kidney	Tumor	VYST	Germ Cell Tumor	Yolk Sac Tumor					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	APC p.S457*;CCND2 Amplification;KDM5A Amplification;KRAS Amplification;PTEN Deletion	1	5
P-0007111	P-0007111-T01-IM5	In-House	FFPE	Resection	250	880	50	Matched	Primary	Thigh	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	NF2 p.X173_splice;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;DDR2 Amplification;MCL1 Amplification;MDM2 Amplification;NTRK1 Amplification	3	8
P-0007112	P-0007112-T01-IM5	Outside	FFPE	Resection	250	1077	15	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;APC p.R232*;APC p.E1353*	2	4
P-0007113	P-0007113-T01-IM5	Outside	FFPE	Biopsy	167.8	638	NA	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;SETD2 p.Y2286*;TP53 p.I251F;SMAD4 p.X136_splice	1	4
P-0007114	P-0007114-T01-IM5	In-House	FFPE	Biopsy	250	970	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					PLX8394(BRAF p.G469A);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	BRAF p.G469A;KRAS p.G13C;FAT1 p.E2659*;STK11 p.D176G;KEAP1 p.X511_splice;SMARCA4 p.E1255*;CREBBP CREBBP-intragenic	2	7
P-0007115	P-0007115-T01-IM5	Outside	FFPE	Resection	250	1028	35	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);GSK2636771,AZD8186(PTEN p.E242*)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	APC p.R1450*;PIK3CA p.M1043L;KRAS p.G13D;APC p.E1080*;TP53 p.X33_splice;PTEN p.E242*	3	6
P-0007116	P-0007116-T01-IM5	In-House	FFPE	Resection	250	887	10	Matched	Metastasis	Appendix	Ovary	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201H	1	2
P-0007117	P-0007117-T01-IM5	In-House	FFPE	Biopsy	250	1216	80	Matched	Primary	Abdomen	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EP300 p.Q1931*;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	3
P-0007118	P-0007118-T01-IM5	In-House	FFPE	Biopsy	250	1232	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TET2 p.Q481*;TP53 p.R280*;FBXW7 p.Y310Lfs*7;FAT1 p.D3376Rfs*11;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;FGFR1 Amplification	2	9
P-0007119	P-0007119-T01-IM5	Outside	FFPE	Biopsy	80.35	562	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.E339*;SMARCA4 p.G95*	0	2
P-0007120	P-0007120-T01-IM5	In-House	FFPE	Biopsy	250	1264	60	Matched	Metastasis	Transverse Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.R1450*;APC Deletion;FH Deletion;MAP3K1 Deletion;MYC Amplification;PIK3R1 Deletion;RAD50 Deletion;RAF1 Amplification;RASA1 Deletion;RECQL4 Deletion	0	11
P-0007120	P-0007120-T02-IM5	In-House	FFPE	Biopsy	250	987	60	Matched	Metastasis	Transverse Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.R1450*;MYC Amplification	0	3
P-0007121	P-0007121-T01-IM5	In-House	FFPE	Resection	250	851	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.S215I;SMARCA4 p.E1399Rfs*60	2	3
P-0007123	P-0007123-T01-IM5	Outside	FFPE	Cytology	250	861	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.X245_splice;INPP4B p.X46_splice	2	3
P-0007124	P-0007124-T01-IM5	In-House	FFPE	Biopsy	121.8	311	80	Matched	Primary	Brain	Not Applicable	Tumor	LGGNOS	Glioma	Low-Grade Glioma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib(NF1 p.R816*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	TP53 p.V157F;TP53 p.R342*;NF1 p.R816*;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB3 Amplification;KDR Amplification;KIT Amplification;NF1 Deletion;PDGFRA Amplification	4	11
P-0007125	P-0007125-T01-IM5	Outside	FFPE	Cytology	212.1	988	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK ALK-EML4 fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 ALK-EML4 fusion)								LEVEL_1	SMARCA4 SMARCA4-intragenic;ALK ALK-EML4 fusion;EML4 ALK-EML4 fusion	2	3
P-0007126	P-0007126-T01-IM5	In-House	FFPE	Resection	250	911	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.Q1406*;TP53 p.S215G;PTPN11 p.T468M;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;NKX3-1 Deletion;SRC Amplification	0	8
P-0007127	P-0007127-T01-IM5	Outside	FFPE	Resection	250	601	20	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R110Wfs*12;CCNE1 Amplification;ERBB2 Amplification	2	3
P-0007128	P-0007128-T01-IM5	In-House	FFPE	Resection	250	510	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.H1047R;APC p.R213*;RHEB p.Y35C	2	4
P-0007129	P-0007129-T01-IM5	In-House	FFPE	Biopsy	166.6	281	20	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.A634V;FAT1 p.S1803*;TP53 p.S149Ffs*32;MYC Amplification	0	4
P-0007129	P-0007129-T02-IM5	In-House	FFPE	Cytology	250	1040	90	Matched	Metastasis	Breast	Ascites Fluid	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.A634V;FAT1 p.S1803*;TP53 p.S149Ffs*32;CDKN1B Deletion;FBXW7 Deletion;MYC Amplification	0	6
P-0007130	P-0007130-T01-IM5	In-House	FFPE	Resection	250	782	70	Matched	Metastasis	Ovary	Lymph Node	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W	0	1
P-0007131	P-0007131-T01-IM5	In-House	FFPE	Biopsy	206.8	509	NA	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	KEAP1 p.V155F;SMARCA4 p.W1346Lfs*16;TP53 p.P128Rfs*20;EPHA3 p.X323_splice;ERBB2 Amplification;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	3	7
P-0007131	P-0007131-T02-IM5	In-House	FFPE	Resection	250	500	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;EPHA3 Deletion;TERT Amplification	1	3
P-0007132	P-0007132-T01-IM5	In-House	FFPE	Resection	250	980	20	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.X187_splice;APC p.V569Efs*11;APC p.R1399Lfs*16	0	3
P-0007133	P-0007133-T01-IM5	In-House	FFPE	Biopsy	250	754	20	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545G;APC p.L1488Ffs*23	2	3
P-0007134	P-0007134-T01-IM5	In-House	FFPE	Resection	204	552	10	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R248W	0	1
P-0007135	P-0007135-T01-IM5	In-House	FFPE	Resection	250	785	20	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	APC p.D1486Ifs*21;KRAS p.G13D;TP53 p.X307_splice;PRKN Deletion;SMAD4 Deletion	1	5
P-0007136	P-0007136-T01-IM5	In-House	FFPE	Resection	250	829	10	Matched	Metastasis	Transverse Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)	Cetuximab,Panitumumab(KRAS p.G13C)			LEVEL_4	TP53 p.R213*;KRAS p.G13C;APC p.E1306*;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification;ASXL1 DNMT3B-ASXL1 fusion;DNMT3B DNMT3B-ASXL1 fusion	1	8
P-0007137	P-0007137-T01-IM5	Outside	FFPE	Biopsy	250	788	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										MED12 p.L1224F	0	1
P-0007138	P-0007138-T01-IM5	In-House	FFPE	Biopsy	250	737	30	Matched	Metastasis	Cecum	Retroperitoneum	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.S241T;CCND1 Amplification;FLT3 Amplification;MYCN Amplification	1	5
P-0007139	P-0007139-T01-IM5	In-House	FFPE	Biopsy	250	1049	70	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM Deletion)								LEVEL_1	ATM Deletion;BCL10 Deletion;PIK3R3 Deletion;RB1 Deletion	1	4
P-0007140	P-0007140-T01-IM5	In-House	FFPE	Resection	250	1108	20	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12C)		Cetuximab,Panitumumab(NRAS p.G12C)			LEVEL_3B	APC p.R876*;TP53 p.H179D;APC p.E1464Vfs*8;NRAS p.G12C;SMAD4 p.C324F	1	5
P-0007141	P-0007141-T02-IM5	Outside	FFPE	Resection	250	575	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SETD2 p.K1405*;PBRM1 p.X514_splice;TP53 p.*394Rext*9	0	3
P-0007142	P-0007142-T01-IM5	In-House	FFPE	Cytology	116	368	10	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0007143	P-0007143-T01-IM5	Outside	FFPE	Biopsy	138	756	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0007144	P-0007144-T01-IM5	In-House	FFPE	Resection	250	1032	30	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN p.E43*)				LEVEL_4	BRAF p.D594N;TP53 p.G199V;PBRM1 p.E1331*;APC p.S1104*;APC p.E1451*;PTEN p.E43*;MAP2K4 p.G323*;SMAD2 p.E439*;AMER1 p.E191*;KDM5C p.P55Lfs*17	1	10
P-0007145	P-0007145-T01-IM5	Outside	FFPE	Resection	250	988	60	Matched	Metastasis	Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)					LEVEL_3B	NRAS p.G12D;ARID1B p.R1324*;EP300 p.L1600Nfs*3;PPM1D p.A481Pfs*2;NOTCH1 p.P2445Lfs*23	1	5
P-0007146	P-0007146-T01-IM5	In-House	FFPE	Biopsy	250	1042	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification	2	1
P-0007147	P-0007147-T01-IM5	In-House	FFPE	Resection	250	706	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Cisplatin(ERCC2 p.X272_splice);Olaparib(PALB2 p.A935*);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.Q210Sfs*6);Sonidegib,Vismodegib(PTCH1 p.P1202Lfs*53)	GSK2636771,AZD8186(PTEN p.N323Kfs*2)				LEVEL_3B	RAC1 p.C18Y;PIK3CA p.H1047R;JAK1 p.K860Nfs*16;RNF43 p.G659Vfs*41;KMT2A p.P773Rfs*8;TET1 p.T62Nfs*4;PTEN p.N323Kfs*2;JAK1 p.P430Rfs*2;KMT2D p.P2354Lfs*30;RNF43 p.R132*;BAP1 p.V27Cfs*45;CTCF p.E691Sfs*30;AXIN2 p.A417Rfs*41;TP53 p.H178Pfs*3;PTPRS p.P622Lfs*16;PIK3CA p.R88Q;AXIN2 p.G665Afs*24;PPM1D p.L450*;NSD1 p.M1531Cfs*43;AXIN1 p.G508Vfs*197;CASP8 p.V205Gfs*13;AXIN2 p.G406Rfs*53;BCOR p.G400Afs*42;RASA1 p.X782_splice;KMT2D p.R4960*;ERCC2 p.X272_splice;ATRX p.G859Efs*10;MSH2 p.K567Rfs*3;PBRM1 p.P1518Lfs*21;PIK3R3 p.L181Tfs*13;KMT2D p.A4922Gfs*10;FAT1 p.N126Ifs*20;PTPRS p.L1357Sfs*59;PALB2 p.A935*;ZFHX3 p.L2785Sfs*4;KMT2D p.G1235Wfs*14;BRCA1 p.Q210Sfs*6;PAX5 p.F27Lfs*2;DAXX p.C629Afs*16;FAT1 p.E183Gfs*7;FOXO1 p.N631*;MAP3K1 p.A594Pfs*62;ARID2 p.K600Nfs*47;KDM6A p.A694Lfs*21;EPHA3 p.M847Wfs*10;ASXL1 p.P1377Sfs*3;PIK3R2 p.P126Lfs*4;CIC p.S1191Vfs*3;KMT2A p.K3664Nfs*30;ARID5B p.F1131Lfs*20;ARID1B p.N1782Efs*7;FOXP1 p.K393Tfs*23;DNMT3A p.V60Rfs*13;TNFRSF14 p.T18Pfs*4;PTCH1 p.P1202Lfs*53	7	55
P-0007148	P-0007148-T01-IM5	In-House	FFPE	Biopsy	135.6	762	30	Matched	Metastasis	Breast	Lung	Tumor	MBC	Breast Cancer	Metaplastic Breast Cancer										TP53 p.K132R;CCND1 Amplification;EGFR Amplification;FGF19 Amplification	0	4
P-0007149	P-0007149-T01-IM5	In-House	FFPE	Resection	250	865	80	Unmatched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A502_Y503dup)								LEVEL_1	KIT p.A502_Y503dup;DICER1 Deletion	1	2
P-0007150	P-0007150-T01-IM5	In-House	FFPE	Resection	250	579	30	Matched	Metastasis	Ovary	Peritoneum	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor				Olaparib(CDK12 p.N474Kfs*12)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.N474Kfs*12)				LEVEL_3B	TP53 p.V272M;RB1 p.X240_splice;CDK12 p.N474Kfs*12	2	3
P-0007151	P-0007151-T01-IM5	In-House	FFPE	Biopsy	250	966	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			AZD5363(AKT1 p.E17K);Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	AKT1 p.E17K;BRAF p.V600E	3	2
P-0007152	P-0007152-T01-IM5	Outside	FFPE	Biopsy	250	448	50	Matched	Primary	Sinus	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma											0	0
P-0007153	P-0007153-T01-IM5	In-House	FFPE	Biopsy	250	1269	20	Matched	Primary	Mediastinum	Not Applicable	Tumor	HL	Hodgkin Lymphoma	Hodgkin Lymphoma											0	0
P-0007154	P-0007154-T01-IM5	In-House	FFPE	Biopsy	250	785	70	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CARD11 p.S116P;CREBBP p.Q1941*;BCOR p.Q918Hfs*8;EPHA7 Deletion	0	4
P-0007155	P-0007155-T01-IM5	Outside	FFPE	Resection	250	601	50	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_3B	KRAS p.G12C;SPOP p.S80R;AMER1 p.E277Afs*8;CDKN2A p.W110*;AKT3 Amplification;KDM5A Amplification	3	6
P-0007156	P-0007156-T02-IM5	In-House	FFPE	Biopsy	250	135	10	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0007157	P-0007157-T01-IM5	In-House	FFPE	Resection	250	613	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CTNNB1 p.T41A;CTNNB1 p.D32G;ARID1A p.R2232Gfs*35;CDKN2A Deletion;CDKN2B Deletion;NKX3-1 Deletion	1	6
P-0007158	P-0007158-T01-IM5	Outside	FFPE	Resection	250	990	30	Matched	Primary	Foot	Not Applicable	Tumor	ACRM	Melanoma	Acral Melanoma											0	0
P-0007159	P-0007159-T01-IM5	In-House	FFPE	Resection	250	919	20	Matched	Primary	Stomach	Not Applicable	Tumor	ISTAD	Esophagogastric Cancer	Intestinal Type Stomach Adenocarcinoma										TP53 p.R110Lfs*13	0	1
P-0007160	P-0007160-T01-IM5	Outside	FFPE	Resection	250	755	100	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.S303Afs*42;FAT1 p.P1560Rfs*25;APC Deletion;CDKN2A Deletion;CDKN2B Deletion;FLCN Deletion;FOXA1 Deletion;GPS2 Deletion;MAP2K4 Deletion;KMT2C Deletion;NCOR1 Deletion;TP53 Deletion	1	12
P-0007161	P-0007161-T01-IM5	In-House	FFPE	Cytology	124.6	350	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.F270L	0	1
P-0007162	P-0007162-T01-IM5	In-House	FFPE	Resection	250	897	20	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)		Cetuximab,Panitumumab(NRAS p.G12D)			LEVEL_3B	APC p.Q1406*;APC p.R1114*;NRAS p.G12D;TP53 p.L130F	1	4
P-0007163	P-0007163-T01-IM5	In-House	FFPE	Resection	250	568	30	Matched	Primary	Stomach	Not Applicable	Tumor	SPDAC	Esophagogastric Cancer	Poorly Differentiated Carcinoma of the Stomach				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	PIK3CA p.E545K;ARID1A p.Q1332*;FGFR2 Amplification;MDM2 Amplification	2	4
P-0007164	P-0007164-T01-IM5	In-House	FFPE	Biopsy	250	1070	10	Matched	Primary	GE Junction	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma										TP53 p.R273H;NOTCH1 p.T2371Hfs*132	0	2
P-0007165	P-0007165-T01-IM5	In-House	FFPE	Resection	250	973	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.P151T	1	2
P-0007166	P-0007166-T01-IM5	Outside	FFPE	Resection	250	1096	10	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma										FGFR2 Amplification	0	1
P-0007167	P-0007167-T01-IM5	In-House	FFPE	Resection	250	937	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R196*;EGFR p.E746_A750del;PIK3CA p.E545K;SF3B1 p.K700E;FLT3 p.E800Q;CDKN2A Deletion;CDKN2B Deletion;PAX5 Amplification	3	8
P-0007168	P-0007168-T01-IM5	In-House	FFPE	Resection	250	1079	30	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.G266R;PIK3CB p.E552K;TCF7L2 p.E28*;SMAD4 p.D415Efs*20;APC p.N728Kfs*6	0	5
P-0007169	P-0007169-T01-IM5	In-House	FFPE	Resection	250	1001	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										APC p.L1488Yfs*19;APC p.R876*;ARID2 p.N1317Ifs*5;TET2 Deletion;TP53 TP53-intragenic;PRKN PARK2-intragenic	0	6
P-0007170	P-0007170-T01-IM5	In-House	FFPE	Biopsy	250	971	40	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.G245C;AMER1 p.E939*	2	3
P-0007171	P-0007171-T01-IM5	Outside	FFPE	Resection	250	862	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										FBXW7 p.R465H	0	1
P-0007172	P-0007172-T01-IM5	In-House	FFPE	Biopsy	241.6	757	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.M918T)		BLU-667(RET p.M918T)						LEVEL_1	RET p.M918T	2	1
P-0007173	P-0007173-T01-IM5	In-House	FFPE	Biopsy	250	770	70	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma										TP53 p.X187_splice;KDM5A Amplification	0	2
P-0007174	P-0007174-T01-IM5	In-House	FFPE	Biopsy	250	949	10	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.N2679Sfs*9)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.D53Tfs*11;ATM p.N2679Sfs*9	3	3
P-0007175	P-0007175-T01-IM5	In-House	FFPE	Biopsy	250	886	30	Matched	Metastasis	Descending Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C	0	1
P-0007176	P-0007176-T01-IM5	In-House	FFPE	Biopsy	250	1292	40	Matched	Metastasis	Soft Tissue	Lung	Tumor	MFS	Soft Tissue Sarcoma	Myxofibrosarcoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.H1686Y)					LEVEL_3B	FLT3 p.V624G;BRCA1 p.H1686Y;ATRX p.X2073_splice;ATRX p.X2069_splice;AXL Amplification;CDKN1B Deletion;DICER1 CLMN-DICER1 fusion;CLMN CLMN-DICER1 fusion	1	8
P-0007177	P-0007177-T01-IM5	In-House	FFPE	Resection	250	732	NA	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R337L;PPP6C p.R140Dfs*12;PTEN Deletion;SMAD2 Deletion;SMAD3 Deletion	1	5
P-0007178	P-0007178-T01-IM5	In-House	FFPE	Resection	250	916	20	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Olaparib(CDK12 p.G396*);Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.G396*)				LEVEL_2	TP53 p.R175H;CDK12 p.G396*;FOXP1 p.Q94Rfs*8;CCNE1 Amplification;ERBB2 Amplification	4	5
P-0007179	P-0007179-T01-IM5	In-House	FFPE	Resection	250	829	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	FBXW7 p.R505C;KRAS p.G12D;TP53 p.E326*	1	3
P-0007179	P-0007179-T02-IM5	In-House	FFPE	Resection	250	382	65	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma											0	0
P-0007180	P-0007180-T01-IM5	In-House	FFPE	Resection	250	1091	NA	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	TP53 p.R248W;PIK3CA p.E542K;APC p.R213*;APC p.S1346*;PRKN Deletion	1	5
P-0007181	P-0007181-T01-IM5	In-House	FFPE	Biopsy	250	445	40	Matched	Metastasis	Rectosigmoid Colon	Lung	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I)					LEVEL_3B	TP53 p.P190L;ERBB2 p.V842I;APC p.A1492Cfs*22	1	3
P-0007182	P-0007182-T01-IM5	In-House	FFPE	Cytology	142.9	387	70	Matched	Metastasis	Prostate	Spine	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.V216L;FGFR1 Amplification;GPS2 Deletion;MAP2K4 Deletion;MYC Amplification;NCOR1 Deletion;TP53 Deletion	1	7
P-0007183	P-0007183-T01-IM5	In-House	FFPE	Biopsy	250	853	60	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K;CDKN1B p.X159_splice;CBL p.R149*;SUZ12 p.Q4*;CDKN1B Deletion;RNF43 Deletion	2	6
P-0007184	P-0007184-T01-IM5	In-House	FFPE	Resection	250	700	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CCND1 Amplification;FGF19 Amplification	0	2
P-0007185	P-0007185-T01-IM5	In-House	FFPE	Biopsy	250	1047	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	APC p.K993*;TP53 p.P87Lfs*59;TCF7L2 p.P577Qfs*42;MET Amplification	1	4
P-0007186	P-0007186-T01-IM5	In-House	FFPE	Biopsy	250	1258	90	Matched	Primary	Lymph node	Not Applicable	Tumor	CLLSLL	Mature B-Cell Neoplasms	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma										CREBBP p.G587Kfs*19;NOTCH1 p.L2510Hfs*5;BIRC3 p.K532Nfs*24	0	3
P-0007202	P-0007202-T01-IM5	In-House	FFPE	Biopsy	250	1787	35	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;RBM10 p.R186*	1	2
P-0007203	P-0007203-T01-IM5	Outside	FFPE	Resection	250	1100	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.V173L	1	2
P-0007204	P-0007204-T01-IM5	Outside	FFPE	Resection	250	667	15	Matched	Primary	Ovary	Not Applicable	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R)					LEVEL_3B	TP53 p.Y220C;PIK3CA p.Q546R	1	2
P-0007205	P-0007205-T01-IM5	In-House	FFPE	Biopsy	250	880	50	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;KMT2A p.X1406_splice;BAP1 Deletion;SHBG TP53-SHBG fusion;TP53 TP53-SHBG fusion	1	5
P-0007206	P-0007206-T01-IM5	In-House	FFPE	Biopsy	250	1243	95	Unmatched	Primary	Lymph node	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										ATM p.C790_K792delins*	0	1
P-0007207	P-0007207-T01-IM5	In-House	FFPE	Biopsy	250	696	15	Matched	Metastasis	Rectum	Lung	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R248Q;FBXW7 p.R465H;APC p.Q1429*	1	4
P-0007208	P-0007208-T01-IM5	Outside	FFPE	Resection	250	569	40	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BAP1 p.W196*;BAP1 p.L18Sfs*54;CDKN2A Deletion;CDKN2B Deletion;NF2 Deletion	1	5
P-0007209	P-0007209-T01-IM5	Outside	FFPE	Biopsy	250	875	10	Matched	Primary	Sinus	Not Applicable	Tumor	ARMS	Soft Tissue Sarcoma	Alveolar Rhabdomyosarcoma										MGA p.P1227Qfs*9	0	1
P-0007210	P-0007210-T01-IM5	Outside	FFPE	Resection	250	766	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.R161*	0	1
P-0007211	P-0007211-T01-IM5	Outside	FFPE	Biopsy	250	642	50	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	CDKN2A Deletion;CDKN2B Deletion;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	3	4
P-0007213	P-0007213-T01-IM5	Outside	FFPE	Resection	250	836	20	Matched	Primary	Gallbladder	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib(ATM p.F1445Lfs*5);Olaparib(ATM p.S214Ffs*40);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;ARID1A p.E1783Sfs*8;ATM p.F1445Lfs*5;ATM p.S214Ffs*40;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	5	7
P-0007214	P-0007214-T01-IM5	Outside	FFPE	Cytology	250	1270	25	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)	Cetuximab,Panitumumab(KRAS p.A146V)			LEVEL_4	TP53 p.R306*;APC p.Q1429*;KRAS p.A146V;APC p.R876*	1	4
P-0007215	P-0007215-T01-IM5	Outside	FFPE	Biopsy	122.2	456	15	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A76Pfs*70)				LEVEL_4	KRAS p.G12D;TP53 p.M237I;CDKN2A p.A76Pfs*70	2	3
P-0007216	P-0007216-T01-IM5	In-House	FFPE	Biopsy	250	923	40	Matched	Metastasis	Cecum	Lung	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.E545K;TP53 p.R342*;APC p.Q1429*;APC p.R1114*;KRAS p.G13D	2	5
P-0007217	P-0007217-T01-IM5	In-House	FFPE	Resection	250	734	10	Matched	Primary	Ileum	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0007218	P-0007218-T01-IM5	In-House	FFPE	Resection	250	664	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.P153Afs*28;SMAD2 p.T303R;RASA1 p.R749*;APC p.L453Vfs*17;TCF7L2 p.P262Hfs*23;BCL2L1 Amplification;DNMT3B Amplification;NKX3-1 Deletion;SRC Amplification	0	9
P-0007219	P-0007219-T01-IM5	In-House	FFPE	Biopsy	250	757	15	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R342P	0	1
P-0007220	P-0007220-T01-IM5	In-House	FFPE	Biopsy	250	1013	20	Matched	Metastasis	Maxilla	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.R282W;NOTCH2 p.Q1479*;TET2 p.K1799Ifs*3;TP53 p.Q136Sfs*26;CCND1 Amplification;EGFR Amplification;FGF19 Amplification	0	7
P-0007221	P-0007221-T01-IM5	In-House	FFPE	Resection	250	908	30	Matched	Primary	Ovary	Not Applicable	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor				Olaparib(CDK12 p.K264Sfs*32)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K264Sfs*32)				LEVEL_3B	TP53 p.E204*;CDK12 p.K264Sfs*32;CCNE1 Amplification;MYCL Amplification	2	4
P-0007222	P-0007222-T01-IM5	In-House	FFPE	Resection	250	397	10	Matched	Metastasis	Sigmoid Colon	Abdomen	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	TP53 p.R273H;KRAS p.G12A;APC p.N775Yfs*12;APC p.P1453Hfs*21	1	4
P-0007223	P-0007223-T01-IM5	In-House	FFPE	Biopsy	250	1111	50	Matched	Metastasis	Lung	Liver	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										MEN1 p.Y106Rfs*7	0	1
P-0007224	P-0007224-T01-IM5	In-House	FFPE	Resection	250	595	NA	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.Y373C;STAG2 p.X675_splice;CDKN2A Deletion;CDKN2B Deletion	3	4
P-0007225	P-0007225-T01-IM5	Outside	FFPE	Biopsy	225.6	707	90	Matched	Primary	Stomach	Not Applicable	Tumor	SCUP	Cancer of Unknown Primary	Small Cell Carcinoma of Unknown Primary										TP53 p.R273H;RB1 p.R320*	0	2
P-0007226	P-0007226-T01-IM5	In-House	FFPE	Biopsy	250	933	80	Matched	Metastasis	Sigmoid Colon	Brain	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_4	TP53 p.R175H;KRAS p.Q61H;APC p.L764*;EP300 p.Q190Efs*29;EPHA3 Deletion;KRAS Amplification	1	6
P-0007227	P-0007227-T02-IM5	In-House	FFPE	Biopsy	250	890	50	Matched	Metastasis	Stomach	Peritoneum	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										CDK6 Amplification	0	1
P-0007227	P-0007227-T01-IM5	Outside	FFPE	Biopsy	250	482	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;CDK6 Amplification	1	2
P-0007228	P-0007228-T01-IM5	In-House	FFPE	Biopsy	240	535	30	Matched	Metastasis	Breast	Liver	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.V272Afs*33;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	2	4
P-0007229	P-0007229-T01-IM5	Outside	FFPE	Biopsy	250	872	70	Matched	Metastasis	Lung	Scalp	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	NOTCH1 p.E2061*;RB1 p.X127_splice;TP53 p.R273P;SMARCA4 p.E1376*;AKT1 Amplification;KEAP1 Deletion;PRKN Deletion;PTEN Deletion;SRC Amplification	1	9
P-0007230	P-0007230-T01-IM5	Outside	FFPE	Biopsy	250	882	90	Matched	Metastasis	Intraabdominal	Omentum	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A502_Y503dup)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.A502_Y503dup;MAX p.Q91Hfs*76;AKT2 Amplification;CCNE1 Amplification;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0007231	P-0007231-T01-IM5	Outside	FFPE	Cytology	250	839	90	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	AKT1 p.E17K;GATA3 p.M293K;MAP3K1 p.C1120Sfs*24;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;PAK1 Amplification	2	8
P-0007233	P-0007233-T01-IM5	Outside	FFPE	Biopsy	250	347	50	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 BRCA2-intragenic)					LEVEL_3B	TP53 p.X261_splice;RAD21 p.S40Rfs*9;EGFR Amplification;BRCA2 BRCA2-intragenic	1	4
P-0007234	P-0007234-T01-IM5	In-House	Cell Pellet	Cytology	250	1048	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.Q56P)						LEVEL_3A	MAP2K1 p.Q56P;STK11 p.Q214*;KEAP1 p.R296Afs*9;AKT3 Amplification;DDR2 Amplification;EPHA7 Deletion;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	1	10
P-0007235	P-0007235-T01-IM5	In-House	FFPE	Biopsy	250	924	80	Matched	Primary	Esophagus	Not Applicable	Tumor	ESMM	Melanoma	Mucosal Melanoma of the Esophagus				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K1515*)					LEVEL_3B	FBXW7 p.X329_splice;FBXW7 p.E287D;PIK3R1 p.X475_splice;BRCA2 p.K1515*;MGA p.Q1952*;FAT1 Deletion	1	6
P-0007236	P-0007236-T01-IM5	Outside	FFPE	Biopsy	91.85	534	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;RBM10 p.Q867*;MSH2 p.X669_splice;SMARCA4 p.G1232D;CDK4 Amplification;FOXA1 Amplification;GLI1 Amplification;MDM2 Amplification;NKX2-1 Amplification;PRKN Deletion;PAX5 Deletion;PTPRD Deletion	3	12
P-0007237	P-0007237-T01-IM5	In-House	FFPE	Biopsy	250	913	20	Matched	Metastasis	Testis	Retroperitoneum	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0007238	P-0007238-T01-IM5	Outside	FFPE	Biopsy	250	571	80	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61R;CCND1 Amplification;CDKN2A Deletion;FGF19 Amplification;PAK1 Amplification	2	5
P-0007239	P-0007239-T01-IM5	Outside	FFPE	Biopsy	132.6	380	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.X307_splice;AKT1 Amplification;EPHA7 Deletion;FOXA1 Amplification;KDM5A Amplification;KRAS Amplification;NKX2-1 Amplification;PMAIP1 Deletion	0	8
P-0007240	P-0007240-T01-IM5	In-House	FFPE	Biopsy	250	708	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.N239S;NOTCH3 p.X856_splice;RBM10 p.X355_splice;CCND1 Amplification;FGF19 Amplification;KDM5C KDM5C-intragenic	2	7
P-0007241	P-0007241-T01-IM5	In-House	FFPE	Cytology	250	790	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;KMT2C p.F3951Sfs*36	1	2
P-0007266	P-0007266-T01-IM5	In-House	FFPE	Resection	250	1055	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0007267	P-0007267-T01-IM5	Outside	FFPE	Biopsy	250	874	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E339*	0	1
P-0007268	P-0007268-T02-IM5	In-House	FFPE	Biopsy	250	294	60	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										TP53 p.R248W;TERT Amplification	0	2
P-0007268	P-0007268-T01-IM5	In-House	FFPE	Resection	250	1085	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										RICTOR Amplification;TERT Amplification	0	2
P-0007269	P-0007269-T01-IM5	Outside	FFPE	Biopsy	250	589	40	Matched	Primary	Cervix	Not Applicable	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma										FAT1 p.S1459*;STK11 p.X171_splice	0	2
P-0007270	P-0007270-T01-IM5	Outside	FFPE	Biopsy	216.5	258	75	Unmatched	Primary	Adrenal Gland	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.R248W;SPEN p.R1959*;NSD1 p.E1550*;KMT2C p.G2992Afs*11;TNFAIP3 p.G616Wfs*56	0	5
P-0007271	P-0007271-T01-IM5	In-House	FFPE	Resection	250	852	15	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;TP53 p.Y205H;MAP2K4 p.G22Rfs*18	1	3
P-0007272	P-0007272-T01-IM5	In-House	FFPE	Resection	250	990	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R38C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R357L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN Deletion)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;APC p.R499*;PIK3CA p.R38C;PIK3CA p.R357L;APC p.V1528Ffs*37;PTEN Deletion	4	6
P-0007273	P-0007273-T01-IM5	In-House	FFPE	Biopsy	250	1127	60	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.V173L;BRAF p.G469V;KMT2D p.Y2199Ifs*65;KMT2D p.X1341_splice;TNFRSF14 p.K17Qfs*60	0	5
P-0007274	P-0007274-T01-IM5	In-House	FFPE	Biopsy	250	854	20	Matched	Metastasis	Urethra	Lung	Tumor	UAD	Bladder Cancer	Urethral Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.E286Q	1	2
P-0007275	P-0007275-T01-IM5	Outside	FFPE	Resection	250	899	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D);Trametinib,Cobimetinib(MAP2K1 p.C121S)					LEVEL_3B	SMAD4 p.R445*;NRAS p.G12D;ARID1A p.R750*;MAP2K1 p.C121S;ASXL2 p.E33Ffs*10;ARID1B p.P1478Qfs*3;AXIN1 Deletion	2	7
P-0007276	P-0007276-T01-IM5	In-House	FFPE	Resection	250	739	25	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.R175H	1	2
P-0007277	P-0007277-T01-IM5	In-House	FFPE	Biopsy	250	901	15	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Olaparib(CDK12 p.R1242*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R1242*)				LEVEL_3B	TP53 p.R282W;TP53 p.A138P;CDK12 p.R1242*;NOTCH1 p.G310R;KMT2C p.X4821_splice;KMT2C p.W1671*;KMT2D p.R5086*;PPM1D p.S453*;EP300 p.P1502L;KMT2D p.M1360Sfs*16;NOTCH1 p.C1345*	2	11
P-0007278	P-0007278-T01-IM5	In-House	FFPE	Resection	250	760	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.D2959Tfs*4)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.N181S;ATM p.D2959Tfs*4;CCND1 Amplification;FGF19 Amplification	3	5
P-0007279	P-0007279-T01-IM5	In-House	FFPE	Resection	250	629	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R175H;TP53 p.G245S;APC p.R213*	0	3
P-0007280	P-0007280-T01-IM5	In-House	FFPE	Resection	250	748	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0007281	P-0007281-T01-IM5	In-House	FFPE	Biopsy	250	939	20	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Vemurafenib+Atezolizumab+Cobimetinib(BRAF p.V600R)	Encorafenib+Binimetinib,Dabrafenib+Trametinib,Vemurafenib+Cobimetinib(BRAF p.V600R)							LEVEL_1	BRAF p.V600R;TP53 p.X307_splice	2	2
P-0007282	P-0007282-T01-IM5	In-House	FFPE	Biopsy	250	1134	90	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)		Everolimus,Temsirolimus(MTOR p.A2210P)				LEVEL_3A	ESR1 p.D538G;KMT2C p.R3507*;FGFR4 p.V550M;MTOR p.A2210P;AKT1 p.T65_I75dup;CCND1 Amplification;FGF19 Amplification	2	7
P-0007283	P-0007283-T01-IM5	Outside	FFPE	Resection	250	498	20	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0007284	P-0007284-T01-IM5	Outside	FFPE	Cytology	125.55	594	80	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	KMT2A p.L3094Sfs*15;GPS2 p.V122Sfs*26;FGFR1 Amplification;PIK3R3 Deletion;PRDM1 Deletion	1	5
P-0007285	P-0007285-T01-IM5	In-House	FFPE	Biopsy	250	816	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Everolimus(TSC1 p.W676*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	ERBB3 p.K329E;FGFR3 p.R248C;TSC1 p.W676*;TGFBR1 p.P133Wfs*30;KMT2A p.G2406*;CDKN2A Deletion;CDKN2B Deletion;GATA3 Amplification;PTPRD Deletion	4	9
P-0007286	P-0007286-T01-IM5	In-House	FFPE	Resection	250	883	20	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0007286	P-0007286-T02-IM5	In-House	FFPE	Resection	250	754	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0007287	P-0007287-T01-IM5	In-House	FFPE	Resection	250	438	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111_I112del)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;APC p.Q1429*;APC p.Q1041*;ARID2 p.X572_splice;PIK3CA p.K111_I112del;TGFBR2 GADL1-TGFBR2 fusion;GADL1 GADL1-TGFBR2 fusion	2	7
P-0007288	P-0007288-T01-IM5	In-House	FFPE	Resection	250	453	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		AZD5363(AKT1 p.E17K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	AKT1 p.E17K;PIK3CA p.E545K;CTCF p.Y226C;GPS2 p.E46Nfs*16;MAP3K1 p.P1304Tfs*31	3	5
P-0007289	P-0007289-T02-IM5	Outside	FFPE	Resection	250	657	80	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.X307_splice;ARID1B Deletion;BRCA2 Deletion;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MYC Amplification;PAK1 Amplification;PRKN Deletion;PTPRD Deletion;YAP1 Amplification	3	12
P-0007290	P-0007290-T02-IM5	In-House	FFPE	Resection	250	844	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma											0	0
P-0007291	P-0007291-T01-IM5	In-House	FFPE	Resection	250	676	NA	Unmatched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;SETD2 p.E2215*;CDKN2A Deletion;CDKN2B Deletion;EPHA7 Deletion	3	5
P-0007293	P-0007293-T01-IM5	In-House	FFPE	Biopsy	250	1621	10	Matched	Metastasis	Cervix	Abdominal Wall	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ATRX p.R1803Tfs*7;ERBB2 Amplification;MDM2 Amplification	2	3
P-0007294	P-0007294-T01-IM5	In-House	FFPE	Resection	250	917	NA	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;FBXW7 p.R465C;APC p.R876*;SOX9 p.V486Gfs*92;MYC Amplification	0	5
P-0007295	P-0007295-T01-IM5	In-House	FFPE	Resection	250	850	50	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										AMER1 p.Q10*	0	1
P-0007296	P-0007296-T01-IM5	In-House	FFPE	Resection	250	516	NA	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.H119Y);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(CHEK2 p.R346C);Olaparib(CHEK2 p.D293*)	GSK2636771,AZD8186(PTEN p.N323Mfs*21);GSK2636771,AZD8186(PTEN p.W274Lfs*24)				LEVEL_3B	MAP2K1 p.H119Y;CREBBP p.I1084Sfs*15;PIK3CA p.H1047R;JAK1 p.K860Nfs*16;PTEN p.N323Mfs*21;APC p.S1465Wfs*3;CTCF p.T204Nfs*26;KMT2D p.P2354Lfs*30;HNF1A p.P291Qfs*51;APC p.Y796Wfs*2;ARID5B p.K967Nfs*15;TCF7L2 p.K485Sfs*23;FLCN p.H429Tfs*39;CREBBP p.P1947Tfs*19;MGA p.E1249Rfs*42;MLH1 p.K195*;MLH1 p.K361*;HLA-A p.R99*;NOTCH1 p.X1723_splice;TP53 p.R282L;CHEK2 p.R346C;TCF3 p.A314Gfs*35;PTEN p.W274Lfs*24;ARID1B p.G278Rfs*257;DNMT3B p.N786Tfs*8;NOTCH3 p.P2231Qfs*15;SOX9 p.P346Rfs*37;ARID1B p.P844Qfs*57;FOXL2 p.G40Vfs*110;TCF3 p.R525Gfs*76;CHEK2 p.D293*;INPP4B p.V503Sfs*15;FANCC p.I89Ffs*2;FAT1 p.P4439Qfs*48;APC p.G2250Afs*29	6	35
P-0007297	P-0007297-T01-IM5	In-House	FFPE	Biopsy	250	1039	NA	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R342P	0	1
P-0007298	P-0007298-T01-IM5	Outside	FFPE	Resection	250	826	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma										TP53 p.G245S;ZFHX3 p.X1177_splice	0	2
P-0007299	P-0007299-T02-IM5	Outside	FFPE	Biopsy	250	374	70	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.G528Afs*4)					LEVEL_3B	VHL p.R161*;TSC1 p.G528Afs*4;BAP1 Deletion	1	3
P-0007299	P-0007299-T01-IM5	Outside	FFPE	Resection	250	161	25	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.G528Afs*4)					LEVEL_3B	VHL p.R161*;TSC1 p.G528Afs*4	1	2
P-0007300	P-0007300-T01-IM5	In-House	FFPE	Resection	250	904	NA	Matched	Primary	Pancreas	Not Applicable	Tumor	MCN	Pancreatic Cancer	Mucinous Cystic Neoplasm				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;PIK3CA p.H1047R;SMAD4 p.R361H	2	3
P-0007301	P-0007301-T01-IM5	In-House	FFPE	Biopsy	204.75	112	40	Matched	Primary	Chest Wall	Not Applicable	Tumor	DDCHS	Bone Cancer	Dedifferentiated Chondrosarcoma										TP53 p.G266E;EED p.Y138*	0	2
P-0007302	P-0007302-T01-IM5	In-House	FFPE	Biopsy	250	439	20	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;ARID1A p.D1850Gfs*4;PBRM1 p.L1388Rfs*6	1	3
P-0007303	P-0007303-T01-IM5	In-House	FFPE	Resection	250	1118	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;APC p.T1556Nfs*3;APC p.Q879*;TP53 p.X126_splice;CCND2 Amplification;KDM5A Amplification	1	6
P-0007304	P-0007304-T01-IM5	In-House	FFPE	Biopsy	250	949	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0007305	P-0007305-T01-IM5	In-House	FFPE	Resection	250	532	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										GNAS p.R201H;TP53 p.Y236D;SOX9 p.Q393*;APC p.N436Kfs*8	0	4
P-0007306	P-0007306-T01-IM5	Outside	FFPE	Biopsy	250	432	95	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.R273C;NOTCH2 p.H2293Sfs*3;KMT2D p.A5010Efs*41;NTRK1 Amplification;ARID1A FAF1-ARID1A fusion;FAF1 FAF1-ARID1A fusion;EIF4A2 BCL6-EIF4A2 fusion;BCL6 BCL6-EIF4A2 fusion	0	8
P-0007307	P-0007307-T02-IM5	In-House	FFPE	Biopsy	244	864	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.N311Kfs*34;AR Amplification;ASXL2 Deletion;CDKN2A Deletion;CDKN2B Deletion;NKX3-1 Deletion;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	9
P-0007307	P-0007307-T01-IM5	Outside	FFPE	Resection	250	857	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.N311Kfs*34;CDKN2A Deletion;CDKN2B Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	5
P-0007308	P-0007308-T01-IM5	In-House	FFPE	Biopsy	250	838	90	Matched	Metastasis	Chest Wall	Lung	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion	1	1
P-0007309	P-0007309-T01-IM5	In-House	FFPE	Biopsy	250	563	50	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;KEAP1 p.G332Afs*68;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0007310	P-0007310-T01-IM5	Outside	FFPE	Resection	250	624	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.R273H;SETD2 p.K899*;FUBP1 p.X642_splice;VHL p.Y185*;BAP1 p.X13_splice	0	5
P-0007311	P-0007311-T01-IM5	Outside	FFPE	Biopsy	250	574	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	TP53 p.R248Q;TP53 p.S241F;ERBB2 p.R678Q;DDR2 p.G505C;CDKN2A p.R58*;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	8
P-0007312	P-0007312-T01-IM5	Outside	FFPE	Resection	250	640	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.Q958*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.C238F;KDM6A p.Q958*;STAG2 p.Y384*;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;GATA3 Amplification	2	8
P-0007313	P-0007313-T01-IM5	Outside	FFPE	Biopsy	250	624	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.E204*	0	1
P-0007314	P-0007314-T01-IM5	Outside	FFPE	Biopsy	250	981	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PTEN Deletion	3	4
P-0007315	P-0007315-T01-IM5	In-House	FFPE	Biopsy	250	720	30	Matched	Metastasis	Rectum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.C135F;APC p.Q1175*;CREBBP p.R1173*;EGFR Amplification	0	4
P-0007316	P-0007316-T01-IM5	In-House	FFPE	Biopsy	250	797	50	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0007317	P-0007317-T01-IM5	In-House	FFPE	Biopsy	250	896	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.C242Y	0	1
P-0007318	P-0007318-T01-IM5	Outside	FFPE	Resection	250	960	30	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;HIST1H3B p.E106Q;MAX p.Q91*;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0007319	P-0007319-T01-IM5	Outside	FFPE	Resection	250	985	35	Matched	Primary	Penis	Not Applicable	Tumor	BPSCC	Penile Cancer	Basaloid Penile Squamous Cell Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.R2842C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G);Olaparib(ATM p.R337C);Cisplatin(ERCC2 p.E576K);Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.D820E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1055I);Everolimus(TSC1 p.F158C);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S196R);Trametinib,Cobimetinib(MAP2K1 p.R49C);Olaparib(BRIP1 p.R798*);Olaparib(CDK12 p.S133Kfs*24)	GSK2636771,AZD8186(PTEN p.R130Q);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S133Kfs*24);Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L)				LEVEL_3B	MLH1 p.R265C;PTEN p.R130Q;PTPRD p.S431L;APC p.R1920*;FBXW7 p.R479*;AKT3 p.E17K;BRCA2 p.R2842C;PIK3CA p.E545G;ATM p.R337C;PBRM1 p.R710*;POLE p.V411L;APC p.R2237*;ERCC2 p.E576K;FBXW7 p.R224Q;KIT p.D820E;MSH6 p.E1234*;MSH6 p.R976H;CTNNB1 p.K335T;INPP4B p.E285*;FAT1 p.E2052*;RICTOR p.S1101L;MAP3K1 p.E950*;EPHA7 p.R895*;EPHA7 p.E850*;EZH2 p.E473*;KMT2C p.E4226*;KMT2C p.E1744*;TSC1 p.F158C;KMT2A p.X1525_splice;PTPN11 p.R512Q;FLT3 p.P893L;BRCA2 p.S196R;MGA p.X2380_splice;MAP2K1 p.R49C;CDH1 p.D254N;ZFHX3 p.X1177_splice;ANKRD11 p.E1051*;NCOR1 p.R2422*;SPOP p.K134N;BRIP1 p.R798*;ASXL1 p.E883*;TOP1 p.R95*;CDK12 p.S133Kfs*24;DAXX p.I663Dfs*19;KRAS p.Q61L	14	45
P-0007320	P-0007320-T01-IM5	In-House	FFPE	Cytology	250	922	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.C135F;NOTCH4 p.E589*;KRAS Amplification;MCL1 Amplification	2	5
P-0007321	P-0007321-T01-IM5	In-House	FFPE	Biopsy	250	1353	60	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										MET p.Y1230C;DNMT3B p.R104*	0	2
P-0007322	P-0007322-T01-IM5	In-House	FFPE	Cytology	250	921	10	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0007323	P-0007323-T01-IM5	In-House	FFPE	Resection	181.9	722	40	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0007324	P-0007324-T01-IM5	Outside	FFPE	Resection	250	850	50	Matched	Primary	Breast	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										MYC Amplification	0	1
P-0007325	P-0007325-T01-IM5	In-House	FFPE	Resection	250	821	80	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;BAP1 p.D199Sfs*22;MYC Amplification	0	3
P-0007327	P-0007327-T01-IM5	Outside	FFPE	Resection	250	813	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Olaparib(BRIP1 p.R836*)					LEVEL_1	PIK3CA p.H1047R;BRIP1 p.R836*;MAP3K1 p.L766Wfs*33	3	3
P-0007328	P-0007328-T01-IM5	In-House	FFPE	Resection	250	952	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R24P)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	MAX p.R60Q;SETD2 p.X1715_splice;TP53 p.L264_N268del;MGA p.P725Rfs*19;SMARCA4 p.Q1562Rfs*34;CDKN2A p.R24P;MET Amplification	3	7
P-0007330	P-0007330-T01-IM5	Outside	FFPE	Cytology	100.4	672	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;ARID1A p.K1021Rfs*18;TP53 p.Q192*	2	3
P-0007331	P-0007331-T01-IM5	In-House	FFPE	Biopsy	250	836	90	Unmatched	Primary	Lung	Not Applicable	Tumor	PMBL	Mature B-Cell Neoplasms	Primary Mediastinal (Thymic) Large B-Cell Lymphoma										XPO1 p.E571K;IRF4 p.C99R;CDKN2A p.R80*;PIK3CD p.E1021K;CDKN2B p.A23G;CD274 Amplification;JAK2 Amplification	0	7
P-0007332	P-0007332-T01-IM5	Outside	FFPE	Biopsy	250	231	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.R209Kfs*6;APC p.T1556Nfs*3;FOXA1 Amplification;MDM2 Amplification	1	4
P-0007333	P-0007333-T01-IM5	In-House	FFPE	Resection	250	834	15	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44Lfs*76)				LEVEL_3B	KRAS p.G12D;TP53 p.L194R;CDKN2A p.Y44Lfs*76;MDM2 Amplification	3	4
P-0007334	P-0007334-T01-IM5	In-House	FFPE	Resection	250	658	NA	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										FBXW7 p.W365*;TP53 p.C238_S240del;PIK3R1 p.E462_R465del;MAP2K4 p.F48Lfs*14;APC p.R414Tfs*5	0	5
P-0007335	P-0007335-T02-IM5	In-House	FFPE	Biopsy	250	834	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.C136Mfs*44)				LEVEL_1	PTEN p.C136Mfs*44;TP53 p.X307_splice;ERBB2 Amplification;TERT Amplification	3	4
P-0007335	P-0007335-T01-IM5	Outside	FFPE	Biopsy	250	845	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.C136Mfs*44)				LEVEL_1	PTEN p.C136Mfs*44;TP53 p.X307_splice;ERBB2 Amplification	3	3
P-0007336	P-0007336-T01-IM5	Outside	FFPE	Biopsy	250	515	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SF3B1 p.R625C;TP53 p.Y234C;PBRM1 p.I279Yfs*4	1	4
P-0007337	P-0007337-T01-IM5	Outside	FFPE	Biopsy	250	810	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.Y178*)				LEVEL_3B	PTEN p.Y178*;PTPN11 p.Q510L;CDK4 Amplification;KDR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification	3	7
P-0007338	P-0007338-T01-IM5	In-House	FFPE	Cytology	250	639	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.C238F;STK11 REEP6-STK11 fusion;REEP6 REEP6-STK11 fusion	1	4
P-0007339	P-0007339-T01-IM5	Outside	FFPE	Biopsy	250	716	90	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma										PIK3R1 p.F456_Q457del	0	1
P-0007340	P-0007340-T01-IM5	In-House	FFPE	Biopsy	250	1791	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SH2B3 p.M1?;CCND1 Amplification;FGF19 Amplification	0	3
P-0007341	P-0007341-T01-IM5	In-House	FFPE	Biopsy	76.32	725	NA	Unmatched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0007342	P-0007342-T01-IM5	Outside	FFPE	Biopsy	250	711	50	Matched	Metastasis	Sigmoid Colon	Omentum	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.G245S	0	1
P-0007343	P-0007343-T01-IM5	In-House	FFPE	Resection	250	644	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										GPS2 p.K52Rfs*11;TP53 p.D184Afs*62;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0007344	P-0007344-T01-IM5	Outside	FFPE	Biopsy	134	672	60	Matched	Metastasis	Soft Tissue	Soft Tissue	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CDK4 Amplification;FGFR1 Amplification;GLI1 Amplification	2	3
P-0007345	P-0007345-T01-IM5	In-House	FFPE	Biopsy	195.47	601	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;MRE11 p.X595_splice;NOTCH3 p.E510*;PMS1 p.G138Ffs*6	1	4
P-0007346	P-0007346-T01-IM5	In-House	FFPE	Resection	250	725	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.L123Tfs*4)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L123Tfs*4)				LEVEL_1	CDK12 p.L123Tfs*4	2	1
P-0007347	P-0007347-T01-IM5	In-House	FFPE	Resection	250	603	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PIK3CB p.E1051K;VHL p.T133Lfs*26	0	2
P-0007348	P-0007348-T01-IM5	In-House	FFPE	Biopsy	183	462	50	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.V216L	0	1
P-0007349	P-0007349-T01-IM5	Outside	FFPE	Biopsy	250	691	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.L257R;ARID1A p.S261*;TP53 p.S106Tfs*17;ERBB2 Amplification	2	4
P-0007350	P-0007350-T01-IM5	In-House	FFPE	Resection	250	656	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0007351	P-0007351-T01-IM5	In-House	FFPE	Resection	250	656	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0007352	P-0007352-T01-IM5	In-House	FFPE	Resection	250	649	30	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Everolimus(TSC1 p.X170_splice)					LEVEL_3B	TSC1 p.X170_splice	1	1
P-0007353	P-0007353-T01-IM5	In-House	FFPE	Biopsy	250	1142	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										JAK1 p.L910P	0	1
P-0007354	P-0007354-T01-IM5	Outside	FFPE	Cytology	250	499	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CD79B p.Y196H;PIM1 p.G28D;HLA-A p.Q204*;BRCA1 p.E1451*;KMT2D p.A3689Gfs*24;CDKN2A Deletion	0	6
P-0007355	P-0007355-T01-IM5	In-House	FFPE	Biopsy	250	1164	90	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	MEN1 p.X310_splice;ARID5B Deletion;BMPR1A Deletion;PTEN Deletion;SUFU Deletion;TCF7L2 Deletion;TET1 Deletion	1	7
P-0007356	P-0007356-T01-IM5	In-House	FFPE	Resection	250	628	15	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				AZD5363(AKT1 p.E17K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549S);Tazemetostat(KDM6A p.L624*)				LEVEL_3B	AKT1 p.E17K;FGFR2 p.N549S;STAG2 p.K906*;TP53 p.S116Vfs*23;KMT2D p.Q3821Pfs*191;KDM6A p.L624*	3	6
P-0007357	P-0007357-T01-IM5	In-House	FFPE	Biopsy	250	720	30	Matched	Metastasis	Rectum	Lung	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.X332_splice;APC p.R876*;TET2 p.E1955*;CCND2 Amplification;KRAS Amplification	0	5
P-0007358	P-0007358-T02-IM5	In-House	FFPE	Biopsy	250	1028	90	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R175H;AR Amplification	0	2
P-0007359	P-0007359-T01-IM5	In-House	FFPE	Resection	250	570	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.C141Y;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0007360	P-0007360-T01-IM5	In-House	FFPE	Resection	250	916	30	Matched	Metastasis	Gallbladder	Pelvis	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;BRAF p.L485W;SMAD4 p.T73Nfs*31	1	3
P-0007361	P-0007361-T01-IM5	In-House	FFPE	Resection	250	374	15	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Olaparib(ATM p.R337H);Olaparib(ATM p.R3008C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	KRAS p.G12A;APC p.T1556Nfs*3;CTNNB1 p.K335I;ATM p.R337H;ATM p.R3008C;APC p.S833Afs*9	3	6
P-0007362	P-0007362-T01-IM5	In-House	FFPE	Resection	250	583	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.Q546K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)						LEVEL_1	PIK3CA p.Q546K;NCOR1 p.T525Nfs*11;GATA3 p.R366*;TBX3 p.L319Afs*10;MAP3K1 p.G879Vfs*30;GATA3 p.S437Rfs*38	2	6
P-0007363	P-0007363-T01-IM5	In-House	FFPE	Biopsy	250	789	40	Matched	Metastasis	Buttock	Lung	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										TP53 p.S241F;KDM6A p.H189Qfs*4;RECQL4 ARHGAP39-RECQL4 fusion;ARHGAP39 ARHGAP39-RECQL4 fusion	0	4
P-0007364	P-0007364-T01-IM5	Outside	FFPE	Biopsy	250	762	50	Matched	Metastasis	Breast	Pericardium	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;KDM5C p.R332*	2	2
P-0007365	P-0007365-T01-IM5	In-House	FFPE	Resection	250	390	30	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Lorlatinib,Brigatinib(ALK p.R395H)					LEVEL_3B	ALK p.R395H;TP53 p.R337C;SMAD4 p.H382R;CCND2 Amplification;MYC Amplification	1	5
P-0007366	P-0007366-T01-IM5	In-House	FFPE	Resection	250	656	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.D1054Efs*9)			Talazoparib,Niraparib(BRCA2 p.D1054Efs*9)					LEVEL_1	BRCA2 p.D1054Efs*9;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	3
P-0007368	P-0007368-T01-IM5	In-House	FFPE	Resection	250	589	NA	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)		Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	NRAS p.Q61K;PIK3CA p.N345K;APC p.R1114*;APC p.Q1429Kfs*44;SOX9 p.Q375Rfs*9	2	5
P-0007369	P-0007369-T01-IM5	Outside	FFPE	Resection	250	583	90	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;FAT1 p.D279Mfs*11	1	2
P-0007370	P-0007370-T01-IM5	In-House	FFPE	Resection	250	694	60	Matched	Primary	Ovary	Not Applicable	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor				Olaparib(RAD51B Deletion)					LEVEL_3B	TP53 p.T55Pfs*52;MAP3K1 Deletion;MYCL Amplification;PIK3R1 Deletion;RAD51B Deletion	1	5
P-0007371	P-0007371-T01-IM5	In-House	FFPE	Resection	250	620	50	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C901F)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN p.D92E);GSK2636771,AZD8186(PTEN p.C304*)				LEVEL_3B	KRAS p.G12A;PIK3CA p.C901F;PTEN p.D92E;SOX17 p.A96G;PTEN p.C304*;ARID1A p.Q588Sfs*31;CREBBP p.G1815Pfs*149	4	7
P-0007372	P-0007372-T01-IM5	In-House	FFPE	Biopsy	250	680	90	Unmatched	Metastasis	Lymph node	Kidney	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										TNFRSF14 p.W7*;CARD11 p.S250P	0	2
P-0007373	P-0007373-T01-IM5	In-House	FFPE	Resection	250	505	NA	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;APC p.R232*;BCL2L1 Amplification;DNMT3B Amplification	0	4
P-0007374	P-0007374-T01-IM5	Outside	FFPE	Resection	250	444	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.M552_V555del)								LEVEL_1	KIT p.M552_V555del	1	1
P-0007375	P-0007375-T01-IM5	In-House	FFPE	Resection	250	594	40	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										FH p.L132*;EP300 p.P1458Lfs*16	0	2
P-0007376	P-0007376-T01-IM5	In-House	FFPE	Biopsy	250	721	30	Matched	Metastasis	Soft Tissue	Lung	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	HIST1H2BD p.D52N;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification;PTEN Deletion	3	6
P-0007377	P-0007377-T02-IM5	In-House	FFPE	Biopsy	250	793	90	Matched	Metastasis	Rectum	Bladder	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.D259Y;TCF7L2 p.C486Vfs*8;APC p.L1489Yfs*18;APC p.N436Kfs*8;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SMAD2 Deletion;SMAD4 Deletion;SRC Amplification	0	10
P-0007379	P-0007379-T01-IM5	In-House	FFPE	Biopsy	250	536	90	Unmatched	Metastasis	Lymph node	Soft Tissue	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										BRAF p.G469A;KMT2D p.X280_splice;CREBBP p.L1499R;CREBBP p.Y1460*;KMT2D p.P1920Afs*35	0	5
P-0007380	P-0007380-T01-IM5	In-House	FFPE	Resection	250	421	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										APC p.R564*;TP53 p.L257R	0	2
P-0007381	P-0007381-T01-IM5	In-House	FFPE	Resection	250	792	40	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.E286K;EGFR Amplification;FLT3 Amplification;SMAD4 Deletion	0	4
P-0007382	P-0007382-T01-IM5	In-House	FFPE	Cytology	207.1	407	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0007383	P-0007383-T01-IM5	In-House	FFPE	Biopsy	250	910	60	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209P;KMT2C p.R2403*;MYC Amplification	0	3
P-0007384	P-0007384-T01-IM5	In-House	FFPE	Resection	250	798	20	Matched	Primary	Tongue	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.R342*;KMT2D p.S2910Kfs*2;CCND1 Amplification;FGF19 Amplification	0	4
P-0007385	P-0007385-T01-IM5	In-House	FFPE	Resection	250	731	15	Matched	Primary	Gallbladder	Not Applicable	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;U2AF1 p.S34F;ERBB3 p.V104M;SMAD4 p.Q442*;ARID1A p.Q1430*;KMT2C p.Q3285Pfs*41	1	6
P-0007386	P-0007386-T01-IM5	In-House	FFPE	Biopsy	250	1317	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										RHOA p.Y42C;TP53 p.L145Q;ARID1B p.L2221Gfs*7;EGFR Amplification	0	4
P-0007387	P-0007387-T01-IM5	In-House	FFPE	Biopsy	250	912	80	Unmatched	Primary	Porto-cava mass	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS											0	0
P-0007388	P-0007388-T01-IM5	In-House	FFPE	Biopsy	250	633	20	Matched	Primary	Tongue	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.R213*;TP53 p.A83Cfs*30;CCND1 Amplification;FGF19 Amplification	0	4
P-0007389	P-0007389-T01-IM5	In-House	FFPE	Resection	250	716	40	Matched	Metastasis	Descending Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)	Cetuximab,Panitumumab(KRAS p.G12R)			LEVEL_4	KRAS p.G12R;TP53 p.G245S;APC p.E1408*;APC p.R876*	1	4
P-0007390	P-0007390-T01-IM5	Outside	FFPE	Biopsy	250	860	90	Matched	Primary	Abdomen	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0007391	P-0007391-T01-IM5	In-House	FFPE	Biopsy	250	1176	30	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	TP53 p.R196*;KRAS p.G12D;PIK3CA p.E545K;APC p.R302*;APC p.P1443Hfs*32	2	5
P-0007392	P-0007392-T01-IM5	Outside	FFPE	Biopsy	250	769	90	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Trametinib,Cobimetinib(SCRIB BRAF-SCRIB fusion);Trametinib,Cobimetinib(BRAF BRAF-SCRIB fusion)					LEVEL_3B	SCRIB BRAF-SCRIB fusion;BRAF BRAF-SCRIB fusion	2	2
P-0007393	P-0007393-T01-IM5	In-House	FFPE	Resection	250	853	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.H193L	0	1
P-0007394	P-0007394-T01-IM5	Outside	FFPE	Resection	250	748	60	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;BAP1 p.V24Gfs*38	0	2
P-0007395	P-0007395-T01-IM5	Outside	FFPE	Biopsy	250	792	90	Matched	Primary	Thoracic Spine	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma											0	0
P-0007396	P-0007396-T01-IM5	Outside	FFPE	Biopsy	250	792	50	Matched	Metastasis	Breast	Ipsilateral Breast	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K);Fulvestrant+Alpelisib(PIK3CA p.E970K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E970K)						LEVEL_1	PIK3CA p.N345K;PIK3CA p.E970K;TBX3 p.X309_splice;RAF1 Amplification	4	4
P-0007397	P-0007397-T01-IM5	In-House	FFPE	Biopsy	250	603	NA	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					GSK2636771,AZD8186(PTEN p.F154C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PIK3R1 p.X475_splice;PTEN p.F154C;CDKN2A Deletion;CDKN2B Deletion;NF2 C22orf34-NF2 fusion;C22orf34 C22orf34-NF2 fusion	2	6
P-0007398	P-0007398-T02-IM5	Outside	FFPE	Biopsy	250	1062	80	Matched	Metastasis	Uterus	Lung	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										U2AF1 p.S34F;TP53 p.G245S;MTREX APC-SKIV2L2 fusion;APC APC-SKIV2L2 fusion	0	4
P-0007398	P-0007398-T01-IM5	Outside	FFPE	Resection	250	515	40	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	U2AF1 p.S34F;TP53 p.G245S;FGFR1 Amplification	1	3
P-0007399	P-0007399-T01-IM5	Outside	FFPE	Resection	250	868	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;VHL p.R161*	1	2
P-0007400	P-0007400-T01-IM5	Outside	FFPE	Biopsy	250	778	95	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.L35Ffs*8;FBXW7 p.V87*;RB1 p.E19*	0	3
P-0007401	P-0007401-T01-IM5	In-House	FFPE	Resection	250	810	50	Matched	Metastasis	Breast	Lung	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;GATA3 p.X350_splice;MAP3K1 p.E1293Rfs*16	1	3
P-0007402	P-0007402-T01-IM5	Outside	FFPE	Biopsy	250	763	25	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F125V;KMT2D p.M999*;APC Deletion	0	3
P-0007403	P-0007403-T01-IM5	In-House	FFPE	Resection	250	851	25	Matched	Primary	Lung	Not Applicable	Tumor	BLCLC	Non-Small Cell Lung Cancer	Basaloid Large Cell Carcinoma of the Lung				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.X187_splice;NOTCH1 p.E216*;RB1 p.L832*;FGFR1 Amplification	1	4
P-0007404	P-0007404-T01-IM5	In-House	FFPE	Biopsy	250	762	60	Matched	Primary	Brain	Not Applicable	Tumor	ACPG	Sellar Tumor	Craniopharyngioma, Adamantinomatous Type										CTNNB1 p.S37F;SETD2 p.M1451Nfs*3	0	2
P-0007405	P-0007405-T01-IM5	In-House	FFPE	Resection	250	639	35	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E542K;SMAD4 p.D351Y;APC p.E941*;APC p.C1578Yfs*12	2	5
P-0007406	P-0007406-T01-IM5	In-House	FFPE	Biopsy	250	859	90	Matched	Primary	Spleen	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TNFRSF14 p.R13*;KMT2D p.Q1583*;STAT3 p.S614R;KMT2D p.L4141*	0	4
P-0007407	P-0007407-T01-IM5	Outside	FFPE	Resection	250	544	15	Matched	Primary	Larynx	Not Applicable	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma				Olaparib(PALB2 p.I429Rfs*22)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NOTCH2 p.K1580*;NOTCH1 p.S1150*;PALB2 p.I429Rfs*22;BCL2L1 Amplification;CDKN2A Deletion;CDKN2B Deletion;RAC1 Amplification;VEGFA Amplification	2	8
P-0007408	P-0007408-T01-IM5	In-House	FFPE	Resection	250	949	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;B2M p.M1?	1	2
P-0007409	P-0007409-T01-IM5	Outside	FFPE	Resection	250	931	40	Matched	Primary	Kidney	Not Applicable	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma											0	0
P-0007410	P-0007410-T01-IM5	In-House	FFPE	Resection	250	565	25	Matched	Metastasis	Rectum	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.L257Q;APC p.Q663*;NKX3-1 Deletion	0	3
P-0007411	P-0007411-T02-IM5	In-House	FFPE	Cytology	250	854	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.Y68H)				LEVEL_4	CUL3 p.M299R;PTEN p.Y68H;APC Deletion	1	3
P-0007412	P-0007412-T01-IM5	In-House	FFPE	Resection	250	604	30	Matched	Primary	Stomach	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma										TP53 p.R175H;MYC Amplification	0	2
P-0007413	P-0007413-T01-IM5	In-House	FFPE	Biopsy	250	856	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R273H	0	1
P-0007414	P-0007414-T01-IM5	In-House	FFPE	Resection	250	582	15	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R249W;TP53 p.P152Tfs*30	0	2
P-0007415	P-0007415-T01-IM5	Outside	FFPE	Biopsy	250	684	80	Matched	Primary	Brain	Not Applicable	Tumor	APE	CNS Cancer	Anaplastic Ependymoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Tazemetostat(SMARCB1 p.R377H)				LEVEL_3B	BRAF p.V600E;FBXW7 p.R465H;SMARCB1 p.R377H;RB1 p.X127_splice;BAP1 Deletion;RHOA Amplification	2	6
P-0007416	P-0007416-T01-IM5	In-House	FFPE	Biopsy	250	361	95	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R175H;FOXA1 Amplification;NKX2-1 Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	5
P-0007416	P-0007416-T02-IM5	In-House	FFPE	Biopsy	250	847	65	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma										TP53 p.R175H;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0007417	P-0007417-T01-IM5	In-House	FFPE	Biopsy	250	1068	40	Matched	Primary	Bile Duct	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Enasidenib(IDH2 p.R172K)					LEVEL_3B	IDH2 p.R172K	1	1
P-0007418	P-0007418-T01-IM5	In-House	FFPE	Biopsy	250	519	70	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PTPRT p.Q1169*;EPHA3 p.L455Ffs*33;FAT1 Deletion;TERT Amplification	2	5
P-0007419	P-0007419-T01-IM5	Outside	FFPE	Resection	250	661	50	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;SMAD4 p.R361H;RASA1 p.R789*	1	3
P-0007420	P-0007420-T01-IM5	In-House	FFPE	Biopsy	250	673	NA	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.S2484Nfs*5)				LEVEL_4	TP53 p.D259Y;ARID2 p.X444_splice;NF1 p.S2484Nfs*5	1	3
P-0007421	P-0007421-T01-IM5	In-House	FFPE	Biopsy	250	905	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Tazemetostat(KDM6A p.V1176Sfs*3)				LEVEL_3B	TP53 p.X332_splice;KDM6A p.V1176Sfs*3;FGFR1 Amplification	2	3
P-0007422	P-0007422-T01-IM5	Outside	FFPE	Biopsy	250	773	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0007423	P-0007423-T01-IM5	In-House	FFPE	Biopsy	100.1	101	60	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;GATA3 p.N351Kfs*20;TBX3 p.G448Rfs*244;CBFB p.G51Afs*31;MAP3K1 p.X790_splice	2	5
P-0007424	P-0007424-T01-IM5	In-House	FFPE	Resection	250	938	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)						LEVEL_1	KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	6	2
P-0007424	P-0007424-T02-IM5	In-House	FFPE	Resection	250	835	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0007425	P-0007425-T01-IM5	In-House	FFPE	Cytology	250	628	10	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer										DICER1 p.E1705K;DICER1 p.Y1335*	0	2
P-0007426	P-0007426-T01-IM5	Outside	FFPE	Biopsy	250	572	30	Matched	Metastasis	Bile Duct	Diaphragm	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Olaparib(ATM p.X974_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_3B	KRAS p.Q61H;TP53 p.D259Y;ATM p.X974_splice	2	3
P-0007427	P-0007427-T01-IM5	Outside	FFPE	Biopsy	250	789	90	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										EP300 p.Y1414C;TP53 p.R209*;RB1 p.X500_splice	0	3
P-0007428	P-0007428-T01-IM5	In-House	FFPE	Resection	250	1381	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.X126_splice;NFE2L2 p.G81R;VHL p.I151N;PBRM1 p.V1182Yfs*36	0	4
P-0007483	P-0007483-T01-IM5	In-House	FFPE	Resection	250	854	NA	Matched	Metastasis	Ascending Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.G245S;APC p.Q1444*;KMT2D p.Q2222*	0	3
P-0007484	P-0007484-T01-IM5	In-House	FFPE	Biopsy	250	493	80	Matched	Primary	Bladder	Not Applicable	Tumor	UAD	Bladder Cancer	Urethral Adenocarcinoma										TP53 p.R342*	0	1
P-0007485	P-0007485-T01-IM5	Outside	FFPE	Biopsy	250	715	30	Matched	Metastasis	Cervix	Lymph Node	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma										ERBB3 p.G284R	0	1
P-0007486	P-0007486-T01-IM5	In-House	FFPE	Resection	250	550	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R)					LEVEL_3B	PIK3CA p.G1049R;TP53 p.X126_splice;NCOR1 p.K1313Nfs*48;APC p.S1100Ffs*26	1	4
P-0007487	P-0007487-T01-IM5	In-House	FFPE	Biopsy	215.9	1014	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;U2AF1 p.S34F;TP53 p.S127F;B2M p.Y83Sfs*6	1	4
P-0007488	P-0007488-T01-IM5	In-House	FFPE	Resection	250	637	NA	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V	2	2
P-0007489	P-0007489-T01-IM5	In-House	FFPE	Resection	250	355	NA	Matched	Primary	Descending Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R273H;APC p.R564*;SMAD4 p.H427Sfs*2;BCL2L1 Amplification;FLCN Deletion;MYC Amplification	0	6
P-0007490	P-0007490-T01-IM5	In-House	FFPE	Resection	250	749	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R248Q;APC p.R805*;APC p.L1489Ffs*26;PIK3R1 p.E650Rfs*8	0	4
P-0007491	P-0007491-T01-IM5	In-House	FFPE	Biopsy	250	544	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0007492	P-0007492-T01-IM5	Outside	FFPE	Resection	250	628	NA	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.P38S)				LEVEL_1	BRAF p.V600E;PTEN p.P38S;SMARCA4 p.X1292_splice	3	3
P-0007493	P-0007493-T02-IM5	In-House	FFPE	Biopsy	250	902	40	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_3B	KRAS p.G13C;TP53 p.E224D;CDK4 Amplification;ERBB3 Amplification;FOXA1 Amplification;NKX2-1 Amplification	2	6
P-0007494	P-0007494-T01-IM5	In-House	FFPE	Resection	250	725	10	Matched	Metastasis	Pancreas	Appendix	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;BCOR p.G1596Lfs*7	1	2
P-0007495	P-0007495-T01-IM5	Outside	FFPE	Resection	250	793	25	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;MED12 p.G44S;APC p.Q1367*;FBXW7 p.G423V;B2M p.S31*;SOX9 p.X229_splice;SMAD4 p.X380_splice;MAP2K4 p.T183Nfs*4	2	8
P-0007496	P-0007496-T01-IM5	Outside	FFPE	Biopsy	250	890	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047L;MEN1 p.Q141*;ARID1A p.Q420*;MAP3K1 p.Q977*;FGFR1 Amplification	3	5
P-0007497	P-0007497-T01-IM5	Outside	FFPE	Biopsy	250	392	60	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Palbociclib,Abemaciclib(CDK4 Amplification);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.X261_splice;AXIN1 p.R712*;CDK4 Amplification;ERBB2 Amplification	5	5
P-0007498	P-0007498-T01-IM5	In-House	FFPE	Biopsy	250	999	60	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										BAP1 p.Q392*;NF2 p.Y207Ifs*2	0	2
P-0007499	P-0007499-T01-IM5	Outside	FFPE	Biopsy	250	756	90	Matched	Metastasis	Maxilla	Pleura	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										KDM6A p.Y362*;ARID1B p.R885Efs*16;ARID1A p.S658*	0	3
P-0007500	P-0007500-T01-IM5	In-House	FFPE	Cytology	172.665	834	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D	1	1
P-0007501	P-0007501-T01-IM5	In-House	FFPE	Resection	250	923	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559D)								LEVEL_1	KIT p.V559D	1	1
P-0007502	P-0007502-T01-IM5	Outside	FFPE	Resection	250	825	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.M246T	1	2
P-0007503	P-0007503-T01-IM5	Outside	FFPE	Resection	250	826	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.G638*);Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	PTPN11 p.A461T;NF1 p.G638*;PIK3R1 p.V401_H407del;NF1 NF1-intragenic	2	4
P-0007504	P-0007504-T01-IM5	In-House	FFPE	Biopsy	250	909	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EGFR p.R222C;PTPN11 p.F285S;CDKN2A Deletion;EGFR Amplification;MCL1 Amplification;PTEN Deletion	3	6
P-0007505	P-0007505-T01-IM5	In-House	FFPE	Biopsy	250	890	30	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0007506	P-0007506-T01-IM5	Outside	FFPE	Biopsy	250	818	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										DDR2 p.G253S	0	1
P-0007507	P-0007507-T01-IM5	Outside	FFPE	Cytology	100.9	187	10	Matched	Metastasis	Lung	Pericardium	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.N235D;CTNNB1 p.G34V	1	3
P-0007508	P-0007508-T01-IM5	In-House	FFPE	Cytology	250	942	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.R282W;APC p.S963*;FOXA1 Amplification;NKX2-1 Amplification;TERT Amplification	1	6
P-0007509	P-0007509-T01-IM5	In-House	FFPE	Cytology	250	1154	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;TP53 p.Q192*	1	2
P-0007510	P-0007510-T01-IM5	In-House	FFPE	Biopsy	250	793	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;PBRM1 p.T699Ffs*2	1	2
P-0007511	P-0007511-T01-IM5	In-House	FFPE	Biopsy	250	985	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.G245S;TP53 p.R280G;APC p.R876*;FOXP1 p.L154*;PTPRT p.Q1132*;APC p.T1445Qfs*28;CCND2 Amplification	1	8
P-0007512	P-0007512-T01-IM5	Outside	FFPE	Biopsy	250	1224	60	Matched	Metastasis	Appendix	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;CTNNB1 p.S45F;GNAS p.R201C	1	3
P-0007513	P-0007513-T02-IM5	In-House	FFPE	Biopsy	250	1045	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	ERBB2 p.Y772_A775dup	2	1
P-0007513	P-0007513-T01-IM5	Outside	FFPE	Biopsy	250	736	80	Matched	Metastasis	Small Bowel	Pelvis	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D579del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_1	KRAS p.G12V;PIK3CA p.H1047R;KIT p.D579del	3	3
P-0007513	P-0007513-T03-IM5	Outside	FFPE	Resection	250	747	60	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D579del)								LEVEL_1	KIT p.D579del	1	1
P-0007514	P-0007514-T01-IM5	In-House	FFPE	Biopsy	250	606	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_T751del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	PIK3CA p.H1047R;TP53 p.R110P;EGFR p.L747_T751del;RBM10 p.Q779*;MYC Amplification	2	5
P-0007515	P-0007515-T01-IM5	In-House	FFPE	Biopsy	250	924	95	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ZFHX3 p.Y135*;APC Deletion;MCL1 Amplification;PTPRD Deletion;RAD50 Deletion;RASA1 Deletion;RB1 Deletion;NCOR1 SLFN12-NCOR1 fusion;SLFN12 SLFN12-NCOR1 fusion	0	9
P-0007516	P-0007516-T01-IM5	Outside	FFPE	Resection	250	862	90	Matched	Primary	Uterus	Not Applicable	Tumor	UAS	Uterine Sarcoma	Uterine Adenosarcoma				AZD9496,Fulvestrant(NCOA3 ESR1-NCOA3 fusion);AZD9496,Fulvestrant(ESR1 ESR1-NCOA3 fusion)					LEVEL_3B	AKT3 Amplification;BAP1 Deletion;DDR2 Amplification;FOXP1 Deletion;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;MITF Deletion;NTRK1 Amplification;PBRM1 Deletion;RYBP Deletion;SETD2 Deletion;SHQ1 Deletion;NCOA3 ESR1-NCOA3 fusion;ESR1 ESR1-NCOA3 fusion	2	15
P-0007517	P-0007517-T01-IM5	In-House	FFPE	Biopsy	250	832	90	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	Olaparib(ATM p.K610Nfs*11)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61R;ATM p.K610Nfs*11;BMPR1A Deletion;CDKN2A Deletion	3	4
P-0007518	P-0007518-T01-IM5	In-House	FFPE	Resection	250	830	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.H168Rfs*5;GATA3 Amplification;MCL1 Amplification;SBNO2 STK11-SBNO2 fusion;STK11 STK11-SBNO2 fusion;STK11 STK11-intragenic	0	6
P-0007519	P-0007519-T01-IM5	In-House	FFPE	Resection	250	913	70	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A502_Y503dup)								LEVEL_1	KIT p.A502_Y503dup	1	1
P-0007520	P-0007520-T01-IM5	In-House	FFPE	Biopsy	250	785	95	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Olaparib(ATM p.P178Lfs*16)					LEVEL_3B	ERCC4 p.X405_splice;ATM p.P178Lfs*16;CCND1 Amplification;FGF19 Amplification;GATA3 Amplification	1	5
P-0007521	P-0007521-T01-IM5	In-House	FFPE	Cytology	50	177	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.H179Y;B2M p.G49Ifs*4	1	3
P-0007522	P-0007522-T01-IM5	Outside	FFPE	Resection	250	1094	95	Matched	Metastasis	Soft Tissue	Lung	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										GATA3 Deletion	0	1
P-0007523	P-0007523-T01-IM5	In-House	FFPE	Biopsy	250	863	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										TP53 p.R248Q;TP53 p.G244D;EIF4A2 BCL6-EIF4A2 fusion;BCL6 BCL6-EIF4A2 fusion	0	4
P-0007524	P-0007524-T01-IM5	Outside	FFPE	Biopsy	245.5	591	80	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)	GSK2636771,AZD8186(PTEN p.C296*)				LEVEL_3B	NRAS p.G12D;PTEN p.C296*	2	2
P-0007525	P-0007525-T01-IM5	In-House	FFPE	Biopsy	250	413	15	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	ERBB2 p.Y772_A775dup;TP53 p.G199E;FOXA1 p.A458Dfs*4;PBRM1 p.P1297Rfs*15	2	4
P-0007526	P-0007526-T02-IM5	In-House	FFPE	Biopsy	250	864	40	Matched	Primary	Pelvis	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										MAPK1 Amplification	0	1
P-0007527	P-0007527-T01-IM5	Outside	FFPE	Biopsy	101.145	573	80	Matched	Metastasis	Brain	Skin	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma											0	0
P-0007528	P-0007528-T01-IM5	Outside	FFPE	Biopsy	198.1	437	NA	Matched	Metastasis	Thyroid	Rib	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R	2	1
P-0007529	P-0007529-T01-IM5	In-House	FFPE	Biopsy	250	721	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.W131G	0	1
P-0007530	P-0007530-T01-IM5	In-House	FFPE	Biopsy	250	1153	NA	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Olaparib(PALB2 Deletion)					LEVEL_3B	TP53 p.R175H;KDR Amplification;KIT Amplification;PALB2 Deletion;PDGFRA Amplification;RB1 Deletion;TP63 Deletion	1	7
P-0007531	P-0007531-T01-IM5	In-House	FFPE	Biopsy	162	200	NA	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.Q1998Nfs*4)					LEVEL_3B	DICER1 p.D1400Rfs*2;ARID2 p.P1235Hfs*7;BRCA2 p.Q1998Nfs*4	1	3
P-0007531	P-0007531-T02-IM5	In-House	FFPE	Biopsy	250	1032	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.Q1998Nfs*4)					LEVEL_3B	DICER1 p.D1400Rfs*2;ARID2 p.P1235Hfs*7;KMT2C p.P1962Lfs*8;ARID1A p.Q766Pfs*51;BRCA2 p.Q1998Nfs*4	1	5
P-0007532	P-0007532-T01-IM5	In-House	FFPE	Resection	250	937	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;RBM10 p.S781*;RBM10 p.R684Sfs*20	2	3
P-0007533	P-0007533-T01-IM5	In-House	FFPE	Biopsy	250	811	80	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Trametinib,Cobimetinib(SND1 BRAF-SND1 fusion);Trametinib,Cobimetinib(BRAF BRAF-SND1 fusion)	GSK2636771,AZD8186(PTEN p.T319*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTEN p.T319*;CDKN2A Deletion;SND1 BRAF-SND1 fusion;BRAF BRAF-SND1 fusion	4	4
P-0007534	P-0007534-T01-IM5	Outside	FFPE	Cytology	125.2	93	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)						LEVEL_1	MET p.X1010_splice	3	1
P-0007535	P-0007535-T01-IM5	In-House	FFPE	Biopsy	250	582	30	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.G266R;PPP2R1A p.S219L	0	2
P-0007536	P-0007536-T01-IM5	In-House	FFPE	Biopsy	250	770	60	Matched	Primary	Abdomen	Abdomen	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification;ROS1 Amplification	2	4
P-0007538	P-0007538-T01-IM5	In-House	FFPE	Resection	250	234	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.K164Rfs*3)				LEVEL_4	PIK3R1 p.I571Yfs*31;PTEN p.K164Rfs*3;PIK3R2 p.X337_splice;JAK1 p.S524Rfs*12;ARID2 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	7
P-0007539	P-0007539-T01-IM5	In-House	FFPE	Biopsy	250	315	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.*444Lfs*63;AURKA Amplification;DNMT3B Amplification	0	3
P-0007540	P-0007540-T01-IM5	In-House	FFPE	Resection	250	479	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.T1977K)				LEVEL_4	MTOR p.T1977K;VHL p.S68*;PBRM1 p.S275*;BAP1 p.D552Vfs*19;MCL1 Amplification	1	5
P-0007541	P-0007541-T01-IM5	Outside	FFPE	Resection	250	885	25	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;APC p.R216*;CDKN1B p.P137Rfs*8	0	3
P-0007542	P-0007542-T01-IM5	In-House	FFPE	Resection	250	1020	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.E962*)				LEVEL_4	TP53 p.R158L;NF1 p.E962*;RBM10 p.E125*;ARID5B p.A618Pfs*11	1	4
P-0007543	P-0007543-T01-IM5	Outside	FFPE	Cytology	250	908	70	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;CD274 Amplification;JAK2 Amplification	1	3
P-0007544	P-0007544-T01-IM5	In-House	FFPE	Biopsy	250	958	70	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.E731K);Trametinib,Cobimetinib(NF1 p.W784*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D153N)				LEVEL_4	TP53 p.R342*;PTPRT p.E548K;CREBBP p.R1392*;TP63 p.X193_splice;FGFR2 p.E731K;NF1 p.W784*;CDKN2A p.D153N;YAP1 Amplification	3	8
P-0007545	P-0007545-T01-IM5	In-House	FFPE	Biopsy	250	946	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_T751del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.C420R;EGFR p.L747_T751del;MDM2 Amplification	3	3
P-0007546	P-0007546-T01-IM5	In-House	FFPE	Cytology	250	793	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;STK11 p.V197Rfs*69	1	2
P-0007547	P-0007547-T01-IM5	In-House	FFPE	Biopsy	250	674	80	Matched	Metastasis	Prostate	Pleura	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	MYC Amplification;PTEN Deletion	1	2
P-0007548	P-0007548-T01-IM5	Outside	FFPE	Resection	250	1039	40	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;RB1 p.R467*;TP53 p.R282W;ATR p.X578_splice;AKT2 Amplification;CCNE1 Amplification;SMAD2 Deletion;SMAD4 Deletion	1	8
P-0007549	P-0007549-T01-IM5	In-House	FFPE	Biopsy	250	1062	45	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Y236C;ARID2 p.Q651*;SMARCA4 p.E993*	0	3
P-0007550	P-0007550-T01-IM5	In-House	FFPE	Resection	152.1	182	40	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Olaparib(CDK12 p.R890H);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	CDK12 p.R890H;TP53 p.S106Qfs*43;CCND2 Amplification;ERBB2 Amplification;KDM5A Amplification	3	5
P-0007551	P-0007551-T01-IM5	Outside	FFPE	Biopsy	250	414	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_4	PTEN p.X70_splice;TP53 p.R267W;ARID2 p.P1562Qfs*4	1	3
P-0007552	P-0007552-T01-IM5	Outside	FFPE	Resection	250	1041	50	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor											0	0
P-0007554	P-0007554-T01-IM5	In-House	FFPE	Resection	131	726	NA	Matched	Metastasis	Cecum	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R175H;APC p.R876*;AMER1 p.R626*;TBX3 p.L207Qfs*19;APC p.S1465Rfs*8	1	6
P-0007555	P-0007555-T01-IM5	In-House	FFPE	Resection	250	1011	20	Matched	Metastasis	Rectum	Lung	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146P)	Cetuximab,Panitumumab(KRAS p.A146P)			LEVEL_4	FBXW7 p.R465H;TP53 p.X32_splice;KRAS p.A146P;CCND2 Amplification;KDM5A Amplification	1	5
P-0007556	P-0007556-T01-IM5	In-House	FFPE	Resection	250	731	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.R273C;PBRM1 p.F872Lfs*43;SETD2 p.X2478_splice;VHL p.S72Pfs*87;CCND3 Amplification;LATS2 LATS2-intragenic	0	6
P-0007557	P-0007557-T01-IM5	Outside	FFPE	Resection	250	838	NA	Unmatched	Primary	Skin	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										RB1 p.R7Pfs*24;TNFRSF14 p.W201*;SPEN p.Q2891*;EP300 p.Y1467D;CREBBP p.S1030_K1033delins*;KMT2D p.E524Kfs*406;CDKN2A Deletion;CDKN2B Deletion;TMEM121 MYC-TMEM121 fusion;MYC MYC-TMEM121 fusion	0	10
P-0007558	P-0007558-T01-IM5	In-House	FFPE	Resection	250	924	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma											0	0
P-0007559	P-0007559-T01-IM5	Outside	FFPE	Biopsy	250	426	70	Matched	Metastasis	Breast	Orbit	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537C)						LEVEL_3A	TBX3 p.E100Wfs*40;ESR1 p.Y537C;TBX3 p.W113*;CDH1 p.D221Ifs*29	1	4
P-0007560	P-0007560-T01-IM5	In-House	FFPE	Biopsy	250	1023	60	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E542K;APC p.R554*;APC p.E1464Vfs*8;AXIN2 p.H83Tfs*58	2	5
P-0007561	P-0007561-T01-IM5	In-House	FFPE	Resection	250	759	NA	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Tipifarnib(HRAS p.Q61R)	Trametinib,Cobimetinib(NF1 p.R440*);GSK2636771,AZD8186(PTEN p.P38F);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice)				LEVEL_3B	HRAS p.Q61R;NF1 p.R440*;JAK1 p.X705_splice;AKT2 p.R368C;PTEN p.P38F;CDKN2A p.X51_splice	4	6
P-0007562	P-0007562-T01-IM5	In-House	FFPE	Biopsy	250	998	80	Matched	Metastasis	Soft Tissue	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 p.R273H;RB1 p.R445*;APC p.R2816*;RB1 p.X702_splice;ATRX p.R1504*	0	5
P-0007563	P-0007563-T01-IM5	In-House	FFPE	Biopsy	250	864	30	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										RAD50 p.E922*;PRDM1 p.W158*;B2M p.M1?;PRDM1 p.A525Tfs*25;CDKN2A Deletion;CDKN2B Deletion;KMT2D Deletion;RAF1 Amplification	0	8
P-0007564	P-0007564-T01-IM5	In-House	FFPE	Biopsy	250	686	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_1	PIK3CA p.H1047R;ESR1 p.D538G;MAP3K1 p.L328Pfs*10	3	3
P-0007565	P-0007565-T01-IM5	In-House	FFPE	Cytology	250	921	NA	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;RNF43 p.G659Vfs*41;ARID1A p.A339Lfs*24;STK11 p.P281Rfs*6;CIC p.P1529Lfs*91;ZFHX3 p.A3407Lfs*78;ARID1A p.P1326Rfs*155;PIK3R1 p.M1?;KMT2A p.S2869*;ERCC4 p.R689C;B2M p.S14Ffs*29;BCL2L11 p.S118Kfs*21;MLH1 p.X556_splice;MAP3K1 p.N1079Ifs*3;FANCA p.P1444Rfs*3;RECQL4 p.V155Sfs*25	1	16
P-0007566	P-0007566-T01-IM5	In-House	FFPE	Resection	250	715	90	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.Q171R);GSK2636771,AZD8186(PTEN p.T321Qfs*23)				LEVEL_4	PTEN p.Q171R;PTEN p.T321Qfs*23	2	2
P-0007567	P-0007567-T01-IM5	In-House	FFPE	Cytology	250	741	80	Matched	Metastasis	Transverse Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V;APC p.R1114*;BRAF p.G466V;APC p.Q1067*	2	5
P-0007568	P-0007568-T01-IM5	Outside	FFPE	Resection	250	802	NA	Unmatched	Primary	Lymph Node	Not Applicable	Tumor	ALCL	Mature T and NK Neoplasms	Anaplastic Large Cell Lymphoma										SETD2 p.D2064Efs*84	0	1
P-0007570	P-0007570-T02-IM5	In-House	FFPE	Biopsy	250	840	60	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										RHOA p.T37A;SOCS1 p.H129Pfs*85;CREBBP Deletion	0	3
P-0007571	P-0007571-T01-IM5	In-House	FFPE	Resection	250	829	80	Matched	Primary	Ovary	Not Applicable	Tumor	EOV	Ovarian Cancer	Endometrioid Ovarian Cancer				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.D769H)	GSK2636771,AZD8186(PTEN p.Y27C);GSK2636771,AZD8186(PTEN p.S170N)				LEVEL_3B	PTEN p.Y27C;ERBB2 p.D769H;ARID1A p.P224Rfs*8;PTEN p.S170N;CASP8 p.L123Qfs*6;PIK3R1 p.N453del	3	6
P-0007572	P-0007572-T01-IM5	Outside	FFPE	Biopsy	210.4	682	40	Matched	Primary	Stomach	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_1	PMS2 p.X8_splice;TP53 p.Y163*;CDKN2A p.W110*;ERBB2 Amplification;KRAS Amplification	3	5
P-0007573	P-0007573-T01-IM5	In-House	FFPE	Resection	250	485	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	CCND1 Amplification;FGF19 Amplification;NF1 Deletion;PAK1 Amplification	1	4
P-0007574	P-0007574-T01-IM5	In-House	FFPE	Resection	250	619	NA	Matched	Metastasis	Cheek	Bone	Tumor	SCCNOS	Cancer of Unknown Primary	Squamous Cell Carcinoma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	RHOA p.E40Q;TP53 p.F134I;HLA-A p.X299_splice;CDKN2A p.R80*	1	4
P-0007575	P-0007575-T01-IM5	In-House	FFPE	Biopsy	250	890	70	Matched	Metastasis	Nasopharynx	Liver	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma										TP53 p.Y163C;RASA1 p.Q882*;SPEN p.R2624Lfs*12;CCND2 Amplification;CCND3 Amplification;KDM5A Amplification;MYC Amplification;VEGFA Amplification	0	8
P-0007576	P-0007576-T01-IM5	Outside	FFPE	Resection	250	691	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.S215I;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0007577	P-0007577-T01-IM5	Outside	FFPE	Resection	250	925	70	Matched	Metastasis	Breast	Bowel	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		Trametinib,Cobimetinib(NF1 p.R440*);Trametinib,Cobimetinib(NF1 p.E1333*)				LEVEL_1	PIK3CA p.E542K;SOX9 p.*510Sext*49;NF1 p.R440*;ZFHX3 p.S2421*;NF1 p.E1333*;CDH1 p.R492Sfs*44;TBX3 p.T121Afs*19;DDR2 Amplification	4	8
P-0007578	P-0007578-T01-IM5	Outside	FFPE	Cytology	250	776	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Olaparib(RAD51D p.X246_splice)	PLX8394(BRAF p.G469A)				LEVEL_3B	BRAF p.G469A;TP53 p.R249T;CDK4 p.R24L;RAD51D p.X246_splice;RB1 Deletion	2	5
P-0007579	P-0007579-T01-IM5	In-House	FFPE	Resection	250	787	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P408Afs*99	0	1
P-0007580	P-0007580-T01-IM5	In-House	FFPE	Biopsy	56.87	191	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)								LEVEL_1	EGFR p.L861Q;TP53 p.H193P;AKT1 Amplification	1	3
P-0007581	P-0007581-T01-IM5	In-House	FFPE	Resection	250	585	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.L93Cfs*30;APC p.S1356*;KRAS Amplification	0	3
P-0007582	P-0007582-T01-IM5	In-House	FFPE	Biopsy	229.3	780	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)	Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L861Q;MSH2 p.Q252*;ARID2 p.X1636_splice;CD274 Amplification;EGFR Amplification;MET Amplification	3	6
P-0007583	P-0007583-T01-IM5	In-House	FFPE	Biopsy	250	744	70	Matched	Metastasis	Lung	Soft tissue back	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.Y234C;NF2 p.A381Vfs*45	2	3
P-0007584	P-0007584-T01-IM5	In-House	FFPE	Resection	250	505	30	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	KRAS p.G12A;TP53 p.P153Afs*28;APC p.R876*;FAT1 Deletion	1	4
P-0007585	P-0007585-T01-IM5	In-House	FFPE	Biopsy	109	399	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	AKT1 Amplification;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0007586	P-0007586-T01-IM5	In-House	FFPE	Resection	250	507	15	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R342*;APC p.S1411Rfs*4;APC p.R554*	0	3
P-0007587	P-0007587-T01-IM5	In-House	FFPE	Resection	250	1042	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Olaparib(CDK12 RARA-CDK12 fusion);Olaparib(RARA RARA-CDK12 fusion)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 RARA-CDK12 fusion);Pembrolizumab,Nivolumab,Cemiplimab(RARA RARA-CDK12 fusion)				LEVEL_1	EGFR p.E746_A750del;TP53 p.C242F;CDK12 RARA-CDK12 fusion;RARA RARA-CDK12 fusion	5	4
P-0007588	P-0007588-T01-IM5	In-House	FFPE	Resection	250	774	30	Matched	Metastasis	Sigmoid Colon	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R213*;APC p.E1309Dfs*4;BCL2L1 Amplification	0	3
P-0007589	P-0007589-T01-IM5	In-House	FFPE	Resection	250	412	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;KEAP1 p.R260Q	1	2
P-0007590	P-0007590-T01-IM5	In-House	FFPE	Cytology	250	669	NA	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;TP53 p.F212Sfs*3;APC p.R554*;EPHA7 p.X704_splice;SOX9 p.L142R;SMAD4 p.R496H	1	6
P-0007591	P-0007591-T01-IM5	In-House	FFPE	Resection	250	939	NA	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R213*;APC p.Q1367*;TP53 p.S90Pfs*33	0	3
P-0007592	P-0007592-T01-IM5	Outside	FFPE	Resection	250	856	NA	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AZD5363(AKT1 p.E17K);Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A);Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	AKT1 p.E17K;KRAS p.G12A;NRAS p.Q61K;SMAD4 p.D537G;FBXW7 p.R479Q;APC p.Q789*;TCF7L2 p.Q264*;APC p.C1578Lfs*72	3	8
P-0007593	P-0007593-T01-IM5	In-House	FFPE	Resection	63.46	600	NA	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.E1322*;TP53 p.P152L;BCL6 p.R618C;APC p.R923*;CIC p.G580Vfs*148	1	6
P-0007594	P-0007594-T01-IM5	Outside	FFPE	Biopsy	116.4	291	90	Matched	Primary	Skin	Not Applicable	Tumor	AECA	Skin Cancer, Non-Melanoma	Sweat Gland Carcinoma/Apocrine Eccrine Carcinoma				AZD9496,Fulvestrant(ESR1 p.Y537C)					LEVEL_3B	ESR1 p.Y537C;CDC73 p.N99Mfs*10;KMT2C p.Q3658Pfs*30	1	3
P-0007595	P-0007595-T01-IM5	Outside	FFPE	Resection	250	1101	80	Matched	Metastasis	Kidney	Abdomen	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										NF2 p.Q337*;KEAP1 p.Y584*	0	2
P-0007596	P-0007596-T01-IM5	Outside	FFPE	Resection	250	834	70	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.E864Kfs*39)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.G111Afs*35)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;GNAS p.R201H;CDH1 p.P127Afs*41;TCF7L2 p.K485Sfs*23;FUBP1 p.S11Lfs*43;MEN1 p.R98*;TBX3 p.R310*;FLT3 p.R712K;CDH1 p.M1?;PMS2 p.E109Kfs*3;PTCH1 p.E864Kfs*39;KMT2A p.Q554Sfs*13;APC p.D849Efs*62;NCOR1 p.L1036Sfs*35;CDKN2A p.G111Afs*35	3	15
P-0007597	P-0007597-T01-IM5	In-House	FFPE	Cytology	250	1213	80	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12A;TP53 p.R280G;PTPRD p.X118_splice;KDM6A p.S884*;RBM10 p.Q621*;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;FOXA1 Amplification;KRAS Amplification;NKX2-1 Amplification	2	12
P-0007598	P-0007598-T01-IM5	Outside	FFPE	Biopsy	167.7	534	50	Matched	Metastasis	Stomach	Retroperitoneum	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma										TP53 p.E298*;CDH1 p.X440_splice;PTPRT p.T605M;NCOR1 p.K553Hfs*20;FGFR2 Amplification;SMAD4 Deletion	0	6
P-0007599	P-0007599-T01-IM5	In-House	FFPE	Biopsy	250	126	25	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132L)						LEVEL_3A	IDH1 p.R132L;SOX9 p.S421Kfs*157;FGFR4 p.D127Y	1	3
P-0007600	P-0007600-T01-IM5	Outside	FFPE	Biopsy	250	965	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;TP53 p.R273C	2	3
P-0007601	P-0007601-T01-IM5	In-House	FFPE	Resection	250	989	70	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;ERCC3 p.R109*;CDH1 p.T199Nfs*10	2	3
P-0007602	P-0007602-T01-IM5	In-House	FFPE	Biopsy	250	1211	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;SMAD4 p.A118V;PIK3CA p.E542K;KMT2A p.S774Vfs*12;ASXL1 p.E635Rfs*15;TCF7L2 p.P281Hfs*46;APC p.I1574Yfs*2	2	7
P-0007604	P-0007604-T01-IM5	Outside	FFPE	Cytology	250	1082	25	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L16Pfs*9)				LEVEL_4	KRAS p.G12D;TP53 p.E298Sfs*47;CDKN2A p.L16Pfs*9	2	3
P-0007605	P-0007605-T01-IM5	Outside	FFPE	Biopsy	250	509	70	Matched	Primary	Groin	Not Applicable	Tumor	EPIS	Soft Tissue Sarcoma	Epithelioid Sarcoma	Tazemetostat(SMARCB1 Deletion)								LEVEL_1	SMARCB1 Deletion	1	1
P-0007606	P-0007606-T01-IM5	Outside	FFPE	Resection	250	350	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.T1977K)				LEVEL_4	MTOR p.T1977K;VHL p.L89P;TP53 p.R110H;ARID2 p.M545Cfs*12	1	4
P-0007607	P-0007607-T01-IM5	Outside	FFPE	Resection	250	1088	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;ARID1A p.Q1327Afs*11;RNF43 p.R371*	1	3
P-0007608	P-0007608-T01-IM5	Outside	FFPE	Biopsy	250	802	30	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.R175H;PPP2R1A p.P179R;MYC Amplification	0	3
P-0007619	P-0007619-T01-IM5	In-House	FFPE	Biopsy	185.9	785	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3B	NRAS p.Q61K;TP53 p.C238Y;STK11 p.X155_splice	1	3
P-0007620	P-0007620-T02-IM5	In-House	FFPE	Biopsy	250	924	50	Matched	Metastasis	Oral Cavity	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.W290R)				LEVEL_4	FGFR2 p.W290R;PIK3R1 p.E458_K459del;RICTOR Amplification;TERT Amplification	1	4
P-0007620	P-0007620-T01-IM5	In-House	FFPE	Resection	250	554	NA	Matched	Metastasis	Oral Cavity	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.E542K	2	2
P-0007622	P-0007622-T01-IM5	In-House	FFPE	Biopsy	250	598	30	Matched	Metastasis	Oropharynx	Chest Wall	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.Q214*)				LEVEL_4	PTEN p.Q214*;KDM6A KDM6A-intragenic	1	2
P-0007623	P-0007623-T01-IM5	In-House	FFPE	Resection	250	752	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										CREBBP p.Y1482D	0	1
P-0007624	P-0007624-T01-IM5	In-House	FFPE	Resection	250	788	25	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.C238Y	1	2
P-0007625	P-0007625-T01-IM5	Outside	FFPE	Biopsy	250	451	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0007626	P-0007626-T01-IM5	In-House	FFPE	Biopsy	250	927	60	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P539R);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Crizotinib,Entrectinib(ROS1 GOPC-ROS1 fusion);Crizotinib,Entrectinib(GOPC GOPC-ROS1 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_3B	PIK3CA p.P539R;RHOA p.G17E;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;ETV1 Amplification;NF1 NF1-intragenic;ROS1 GOPC-ROS1 fusion;GOPC GOPC-ROS1 fusion	6	9
P-0007627	P-0007627-T01-IM5	In-House	FFPE	Biopsy	250	984	80	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)	Olaparib(ATM p.X2757_splice)	Trametinib,Cobimetinib(NF1 p.F394*)				LEVEL_3A	AKT1 p.E17K;KMT2C p.X3151_splice;ATM p.X2757_splice;SPOP p.E47*;NF1 p.F394*	3	5
P-0007628	P-0007628-T01-IM5	Outside	FFPE	Resection	250	798	50	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.Q171*)				LEVEL_4	KRAS p.G12V;PTEN p.Q171*;PIK3R1 p.Q572Rfs*33;SOX9 p.L146Tfs*36	2	4
P-0007629	P-0007629-T01-IM5	In-House	FFPE	Biopsy	250	455	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.Q171*)				LEVEL_4	PTEN p.Q171*;TP53 p.P278S;SPOP p.F133L;MYC Amplification	1	4
P-0007630	P-0007630-T01-IM5	In-House	FFPE	Biopsy	250	869	70	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										SMAD4 p.X380_splice	0	1
P-0007631	P-0007631-T01-IM5	In-House	FFPE	Resection	250	740	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R306*;APC p.Q1127*;RAD50 p.Q211*;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	1	7
P-0007632	P-0007632-T01-IM5	In-House	FFPE	Biopsy	250	500	20	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	TP53 p.R273H;KRAS p.G12V;PIK3CA p.H1047R;KMT2D p.P480Lfs*450;RAD50 p.X1020_splice	2	5
P-0007633	P-0007633-T01-IM5	In-House	FFPE	Biopsy	250	719	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										SETD2 p.S2117Ifs*10;SETD2 p.S918Lfs*16	0	2
P-0007634	P-0007634-T01-IM5	In-House	FFPE	Resection	250	696	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.G245V;SMARCA4 p.M76Wfs*18	0	2
P-0007635	P-0007635-T01-IM5	In-House	FFPE	Resection	250	841	NA	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.V272M;SMAD4 p.Q311*;RNF43 p.E318Rfs*101	1	4
P-0007637	P-0007637-T01-IM5	In-House	FFPE	Biopsy	250	857	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.C176G	0	1
P-0007638	P-0007638-T01-IM5	In-House	FFPE	Resection	250	864	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ASXL1 p.Q692*;AMER1 p.W695_R696delins*	1	3
P-0007639	P-0007639-T02-IM5	In-House	FFPE	Biopsy	209	304	60	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Everolimus(TSC1 p.S334*)					LEVEL_3B	VHL p.Q195*;TSC1 p.S334*;BAP1 p.L691Wfs*44;PBRM1 p.G1582Cfs*31	1	4
P-0007640	P-0007640-T01-IM5	Outside	FFPE	Biopsy	250	920	NA	Matched	Primary	Lung	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	GPS2 p.Q152*;CDK4 Amplification;ERBB3 Amplification;GLI1 Amplification;KRAS Amplification;MDM2 Amplification;MET Amplification;TERT Amplification	3	8
P-0007641	P-0007641-T01-IM5	In-House	FFPE	Biopsy	250	211	80	Matched	Metastasis	Soft Tissue	Bone	Tumor	SEF	Soft Tissue Sarcoma	Sclerosing Epithelioid Fibrosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ATRX p.D791*;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0007642	P-0007642-T01-IM5	In-House	FFPE	Biopsy	250	887	50	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										BAP1 p.A496Gfs*73	0	1
P-0007643	P-0007643-T01-IM5	Outside	FFPE	Biopsy	250	778	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R);Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	NRAS p.Q61R;BRAF p.K601E;EP300 p.K1528Nfs*13	3	3
P-0007644	P-0007644-T01-IM5	Outside	FFPE	Resection	250	971	80	Matched	Primary	Maxilla	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS											0	0
P-0007645	P-0007645-T01-IM5	Outside	FFPE	Biopsy	250	378	50	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;APC p.Q1303*;HLA-A p.E43*;PIK3CA p.Q546P;FLCN Deletion;RUNX1 Deletion	2	6
P-0007646	P-0007646-T01-IM5	In-House	FFPE	Resection	250	850	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Y578_D579insEQQLPY)								LEVEL_1	KIT p.Y578_D579insEQQLPY	1	1
P-0007647	P-0007647-T01-IM5	In-House	FFPE	Biopsy	250	875	NA	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TACR3 TET2-TACR3 fusion;TET2 TET2-TACR3 fusion	0	2
P-0007647	P-0007647-T02-IM5	In-House	FFPE	Resection	250	825	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TACR3 TET2-TACR3 fusion;TET2 TET2-TACR3 fusion	0	2
P-0007647	P-0007647-T03-IM5	In-House	FFPE	Resection	250	910	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma										TACR3 TET2-TACR3 fusion;TET2 TET2-TACR3 fusion	0	2
P-0007648	P-0007648-T01-IM5	Outside	FFPE	Biopsy	250	944	70	Matched	Metastasis	Duodenum	Liver	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.Y772_A775dup)					LEVEL_3B	TP53 p.R213*;ERBB2 p.Y772_A775dup;FBXW7 p.Q221*;ARID2 p.Q1112*;FUBP1 p.I443Lfs*49	1	5
P-0007649	P-0007649-T01-IM5	In-House	FFPE	Resection	250	840	90	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;BCOR p.K1256Tfs*20	2	2
P-0007650	P-0007650-T01-IM5	Outside	FFPE	Resection	250	324	70	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										SF3B1 p.R625H;GNAQ p.Q209L	0	2
P-0007651	P-0007651-T01-IM5	In-House	FFPE	Resection	230.8	86	60	Matched	Metastasis	Abdomen	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.H380Qfs*42;RB1 Deletion	0	2
P-0007652	P-0007652-T01-IM5	In-House	FFPE	Resection	250	569	70	Matched	Primary	Kidney	Not Applicable	Tumor	ROCY	Renal Cell Carcinoma	Renal Oncocytoma											0	0
P-0007653	P-0007653-T01-IM5	In-House	FFPE	Resection	250	718	10	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.V173L	0	1
P-0007654	P-0007654-T01-IM5	In-House	FFPE	Resection	250	833	55	Matched	Metastasis	Rectosigmoid Colon	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;APC p.E1397*;APC p.E1353*	0	3
P-0007655	P-0007655-T01-IM5	Outside	FFPE	Resection	250	517	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FUBP1 p.R430C	0	1
P-0007656	P-0007656-T01-IM5	Outside	FFPE	Resection	250	735	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										ERBB3 p.D297Y;CASP8 p.Q465*;RB1 p.X46_splice;CREBBP p.Y1482C;CASP8 p.Q358_A359delins*	0	5
P-0007657	P-0007657-T01-IM5	In-House	FFPE	Resection	250	709	60	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;APC p.R876*;FLCN p.L261Rfs*6;TP53 p.H214Qfs*7	1	4
P-0007658	P-0007658-T01-IM5	Outside	FFPE	Resection	250	1063	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310Y)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R248Q;ERBB2 p.S310Y;FBXW7 p.R505G;MEN1 p.Q591*;EP300 p.X1539_splice;CDKN2A Deletion;CDKN2B Deletion;NKX3-1 Deletion;RAF1 Amplification	2	9
P-0007660	P-0007660-T01-IM5	In-House	FFPE	Resection	250	962	70	Matched	Metastasis	Soft Tissue	Lung	Tumor	OS	Bone Cancer	Osteosarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NOTCH2 p.X2010_splice;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification	2	4
P-0007661	P-0007661-T01-IM5	In-House	FFPE	Resection	250	1184	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.S215N;KMT2D p.Q3826*;KMT2A p.Q2607Rfs*5;CCND1 Amplification;DDR2 Amplification;FGF19 Amplification;RAF1 Amplification;FCER1G SDHC-FCER1G fusion;SDHC SDHC-FCER1G fusion	0	9
P-0007662	P-0007662-T01-IM5	Outside	FFPE	Biopsy	250	898	80	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										BCL2L11 Deletion;DIS3 Deletion;FOXO1 Deletion;RB1 Deletion	0	4
P-0007663	P-0007663-T01-IM5	In-House	FFPE	Biopsy	250	646	20	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)	Crizotinib(MET Amplification)		Milademetan Tosylate,RO5045337(MDM2 Amplification);Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L858R;SMAD4 p.Q248*;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MDM2 Amplification;MET Amplification	5	7
P-0007664	P-0007664-T01-IM5	In-House	FFPE	Resection	250	1089	NA	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.Q1303*;SMAD2 SMAD2-intragenic	1	3
P-0007665	P-0007665-T01-IM5	In-House	FFPE	Resection	120.6	118	30	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										KEAP1 p.T43Sfs*35	0	1
P-0007666	P-0007666-T01-IM5	In-House	FFPE	Biopsy	250	1021	35	Matched	Metastasis	Thyroid	Pleura	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0007667	P-0007667-T01-IM5	Outside	FFPE	Resection	250	774	30	Matched	Primary	Larynx	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										KDM5C p.R198*;FOXO1 p.W295*;NBN p.V153Kfs*17	0	3
P-0007668	P-0007668-T01-IM5	In-House	FFPE	Biopsy	250	1069	80	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;RIT1 p.A77T;BAP1 p.F15Pfs*56;TGFBR2 Deletion	1	4
P-0007669	P-0007669-T01-IM5	In-House	FFPE	Resection	250	1505	NA	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.H380Ifs*42;APC p.E1353Vfs*20;MGA p.A1280*;AKAP11 FH-AKAP11 fusion;FH FH-AKAP11 fusion;COL1A2 FH-COL1A2 fusion;FH FH-COL1A2 fusion	0	7
P-0007670	P-0007670-T01-IM5	In-House	FFPE	Resection	177.66	560	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0007671	P-0007671-T01-IM5	In-House	FFPE	Biopsy	250	1011	15	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);AZD9496,Fulvestrant(ESR1 p.Y537N)		Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K)				LEVEL_1	PIK3CA p.H1047L;ESR1 p.Y537N;FGFR2 p.N549K;GPS2 p.S134Afs*211;MAP2K4 p.W291Gfs*27	4	5
P-0007672	P-0007672-T01-IM5	Outside	FFPE	Biopsy	250	320	90	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma											0	0
P-0007673	P-0007673-T01-IM5	In-House	FFPE	Resection	250	1035	10	Matched	Metastasis	Appendix	Sigmoid Colon	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma											0	0
P-0007675	P-0007675-T01-IM5	In-House	FFPE	Biopsy	250	619	50	Matched	Metastasis	Uterus	Pelvis	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	GSK2636771,AZD8186(PTEN p.S338Qfs*5)				LEVEL_3B	JAK1 p.K860Nfs*16;RNF43 p.G659Vfs*41;ARID1A p.G276Efs*87;PIK3CA p.R88Q;ASXL1 p.T600Pfs*103;ACVR1 p.R206H;ARID1A p.N1183Kfs*10;KMT2D p.K2322Dfs*3;SPEN p.N2053Tfs*11;ASXL1 p.I985Sfs*8;PTEN p.S338Qfs*5;CBFB Deletion	2	12
P-0007676	P-0007676-T01-IM5	In-House	FFPE	Cytology	197.7	533	10	Matched	Metastasis	Sigmoid Colon	Lymph Node	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.D33E)	Cetuximab,Panitumumab(KRAS p.D33E)			LEVEL_4	TP53 p.E294*;KRAS p.D33E	1	2
P-0007677	P-0007677-T01-IM5	In-House	FFPE	Biopsy	250	246	80	Matched	Primary	Lung	Not Applicable	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid											0	0
P-0007678	P-0007678-T01-IM5	In-House	FFPE	Resection	250	684	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.G245D	1	2
P-0007679	P-0007679-T01-IM5	Outside	FFPE	Biopsy	250	710	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum										TP53 p.R196*;APC p.E1408*;APC p.R302*;BCOR p.X1011_splice;RB1 Deletion	0	5
P-0007680	P-0007680-T01-IM5	In-House	FFPE	Biopsy	250	927	NA	Matched	Metastasis	Uterus	Soft Tissue	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Olaparib(ATM p.R2763*);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ERBB3 p.V104L;APC p.S1465Wfs*3;FBXW7 p.R465C;ATM p.R2763*;DNMT3A p.Q402*;TP53 p.C242Lfs*22;FGFR1 Amplification;FGFR3 Amplification;KEAP1 Deletion;PRKN Deletion	2	10
P-0007681	P-0007681-T01-IM5	In-House	FFPE	Biopsy	250	1003	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;PAX5 Deletion;TERT Amplification;VEGFA Amplification	3	8
P-0007682	P-0007682-T01-IM5	In-House	FFPE	Biopsy	250	811	80	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106V)	Tazemetostat(KDM6A p.X1246_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.G106V;FGFR3 p.Y373C;KDM6A p.X1246_splice;CEBPA p.H195Afs*126;CREBBP p.C1311*;CDKN2A Deletion;CDKN2B Deletion	5	7
P-0007683	P-0007683-T01-IM5	In-House	FFPE	Resection	250	789	50	Matched	Primary	Colorectal NOS	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.Q1378*;TP53 p.K132E	1	3
P-0007684	P-0007684-T01-IM5	Outside	FFPE	Biopsy	250	520	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	GATA3 p.N331Efs*21;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification;PPM1D Amplification	2	5
P-0007685	P-0007685-T01-IM5	Outside	FFPE	Biopsy	250	551	60	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma		Olaparib,Talazoparib(BRCA2 p.E837_K838delinsQ*)		Rucaparib,Niraparib(BRCA2 p.E837_K838delinsQ*);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_2	TP53 p.L130_A138dup;BRCA2 p.E837_K838delinsQ*;FGFR1 Amplification	3	3
P-0007685	P-0007685-T02-IM5	Outside	FFPE	Biopsy	250	1115	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification	2	1
P-0007686	P-0007686-T01-IM5	In-House	FFPE	Resection	250	848	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.G245D;APC p.R283*;CDK8 Amplification;FLT3 Amplification	3	5
P-0007688	P-0007688-T01-IM5	In-House	FFPE	Resection	250	722	40	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);BLU-667,Selpercatinib(RET p.M848V);Olaparib(PALB2 p.N280Tfs*8);Olaparib(ATM p.I2701*)					LEVEL_1	BRAF p.V600E;MSH6 p.F1088Lfs*5;SMAD4 p.R361C;PBRM1 p.P1584Lfs*12;RNF43 p.G659Vfs*41;ARID1A p.D1850Gfs*4;EP300 p.H2324Pfs*55;GATA3 p.S237Afs*28;PTPRS p.V1025Sfs*18;RET p.M848V;BLM p.N515Mfs*16;PALB2 p.N280Tfs*8;CASP8 p.F356Lfs*26;SH2B3 p.E523Sfs*25;CASP8 p.R413*;NOTCH4 p.X774_splice;RBM10 p.X144_splice;ATM p.I2701*;PARP1 p.A483Qfs*3;PARP1 p.K352Sfs*29	6	20
P-0007689	P-0007689-T01-IM5	In-House	FFPE	Biopsy	250	731	70	Matched	Metastasis	Cancer of Unknown Primary	Eyelid	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;KMT2C p.N2842Kfs*2;TP53 p.V218G	1	3
P-0007690	P-0007690-T01-IM5	In-House	FFPE	Biopsy	250	748	60	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;BAP1 p.N547Gfs*13	0	2
P-0007691	P-0007691-T01-IM5	Outside	FFPE	Biopsy	250	533	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;PIK3CA p.E542K;APC p.Q1429*;SMAD4 p.P356L;SOX9 p.W143*;SMAD2 p.D158Gfs*2	3	6
P-0007692	P-0007692-T01-IM5	In-House	FFPE	Resection	250	602	80	Matched	Primary	Leg	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0007693	P-0007693-T01-IM5	In-House	FFPE	Resection	250	673	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Y174H);Trametinib,Cobimetinib(NF1 p.X464_splice);Trametinib,Cobimetinib(NF1 p.Q1617*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.C238Y;TP53 p.R337C;PTEN p.Y174H;NF1 p.X464_splice;NF1 p.Q1617*;CDKN2A Deletion;CDKN2B Deletion	4	7
P-0007694	P-0007694-T01-IM5	Outside	FFPE	Cytology	250	686	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.V157F;RB1 p.X776_splice;DDR2 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	0	6
P-0007695	P-0007695-T01-IM5	In-House	FFPE	Biopsy	250	750	20	Matched	Metastasis	Cancer of Unknown Primary	Spine	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;STK11 p.G196V;BBC3 p.X190_splice;KEAP1 p.X511_splice	1	4
P-0007696	P-0007696-T01-IM5	Outside	FFPE	Biopsy	147.2	214	25	Matched	Metastasis	Lung	Bone	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F;TP53 p.E339*;RBM10 p.X355_splice;TRAF7 p.R189L	2	5
P-0007697	P-0007697-T01-IM5	In-House	FFPE	Biopsy	250	1024	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CREBBP p.S1680del;TNFRSF14 p.X23_splice;HRAS Amplification	0	3
P-0007698	P-0007698-T01-IM5	Outside	FFPE	Resection	250	863	80	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Ivosidenib(IDH1 p.R132C)					LEVEL_1	BRAF p.V600E;IDH1 p.R132C;BMPR1A Deletion;SMAD4 Deletion	4	4
P-0007699	P-0007699-T02-IM5	Outside	FFPE	Biopsy	158.5	470	70	Matched	Metastasis	Major Salivary Gland	Liver	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Everolimus(TSC2 Deletion)					LEVEL_3B	TP53 p.R249S;ATRX Deletion;EPHA7 Deletion;ERCC4 Deletion;ROS1 Amplification;TSC2 Deletion;FOXA1 FOXA1-intragenic	1	7
P-0007699	P-0007699-T01-IM5	Outside	FFPE	Resection	250	653	25	Matched	Primary	Major Salivary Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										TP53 p.R249S	0	1
P-0007700	P-0007700-T01-IM5	Outside	FFPE	Biopsy	250	878	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G106_R108del)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106_R108del)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	GATA3 p.D335Gfs*17;PIK3CA p.G106_R108del;CCND1 Amplification;FGF19 Amplification;FGFR3 Amplification;MDM2 Amplification;PAK1 Amplification;SRC Amplification;YAP1 Amplification	3	9
P-0007701	P-0007701-T01-IM5	In-House	FFPE	Resection	250	896	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)								LEVEL_1	EGFR p.L747_A750delinsP	1	1
P-0007702	P-0007702-T01-IM5	In-House	FFPE	Biopsy	250	1031	90	Matched	Metastasis	Stomach	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.W557_K558del;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0007703	P-0007703-T01-IM5	In-House	FFPE	Resection	250	801	60	Matched	Metastasis	Bile Duct	Liver	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										SMAD4 p.Q534Pfs*41	0	1
P-0007705	P-0007705-T01-IM5	Outside	FFPE	Biopsy	250	886	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)	Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	TP53 p.E258*;CDK6 Amplification;MET Amplification;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	4	5
P-0007734	P-0007734-T01-IM5	Outside	FFPE	Biopsy	193.1	131	80	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.P128Lfs*42	0	1
P-0007735	P-0007735-T01-IM5	In-House	FFPE	Biopsy	250	956	NA	Matched	Metastasis	Leg	Soft Tissue	Tumor	PLLS	Soft Tissue Sarcoma	Pleomorphic Liposarcoma			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Olaparib(CHEK1 Deletion)					LEVEL_3A	CDKN1A Deletion;CHEK1 Deletion;MDM2 Amplification;PTPRD Deletion;RB1 Deletion	2	5
P-0007736	P-0007736-T01-IM5	In-House	FFPE	Resection	250	795	90	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_1	BRAF p.V600E;KMT2D p.E1171Nfs*41;CDKN2A p.R80*;ARID5B Deletion;HNF1A Deletion;MITF Amplification;PTPN11 Deletion;SH2B3 Deletion;TBX3 Deletion	3	9
P-0007737	P-0007737-T01-IM5	In-House	FFPE	Resection	250	846	NA	Matched	Metastasis	Duodenum	Liver	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer										ERBB3 p.A232V;APC p.T1556Nfs*3;APC p.R876*;TP53 p.H168R;MYC Amplification;SOX9 Deletion	0	6
P-0007738	P-0007738-T01-IM5	In-House	FFPE	Biopsy	250	895	NA	Matched	Metastasis	Ovary	Muscle	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification	2	3
P-0007739	P-0007739-T01-IM5	In-House	FFPE	Resection	250	893	NA	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma	Larotrectinib,Entrectinib(LMNA NTRK1-LMNA fusion);Larotrectinib,Entrectinib(NTRK1 NTRK1-LMNA fusion)								LEVEL_1	RNF43 p.G659Vfs*41;CTCF p.E691Sfs*30;TP53 p.R337C;FLCN p.H429Tfs*39;CTCF p.T204Qfs*18;PMS2 p.E109Kfs*3;DIS3 p.R467*;BCOR p.K1577Sfs*3;ZFHX3 p.P2011Lfs*22;ARID1B p.G401Afs*29;SMARCA4 p.T296Rfs*7;TCF3 p.R527Gfs*74;TP63 p.P161Ifs*36;TP53 p.V173*;ATR p.R1814Efs*10;LMNA NTRK1-LMNA fusion;NTRK1 NTRK1-LMNA fusion	2	17
P-0007740	P-0007740-T01-IM5	In-House	FFPE	Resection	250	951	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R175H;APC p.R216*;FGFR1 Amplification;MYC Amplification	1	4
P-0007741	P-0007741-T01-IM5	In-House	FFPE	Biopsy	250	699	50	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;PIK3CA p.E545K;FOXA1 p.H247Y;ARID1A p.Q1835*;CDH1 p.X278_splice	3	5
P-0007742	P-0007742-T01-IM5	Outside	FFPE	Resection	250	626	50	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0007744	P-0007744-T01-IM5	In-House	FFPE	Biopsy	250	600	80	Matched	Primary	Brain	Not Applicable	Tumor	APXA	Glioma	Anaplastic Pleomorphic Xanthoastrocytoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0007745	P-0007745-T01-IM5	In-House	FFPE	Cytology	250	765	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.E746_A750del;APC p.Q1477*;PIK3R1 p.D464_Y467del;CDKN2A Deletion;CDKN2B Deletion;TP53 Deletion	2	6
P-0007746	P-0007746-T01-IM5	In-House	FFPE	Biopsy	250	921	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										SMAD4 p.S32*	0	1
P-0007747	P-0007747-T01-IM5	In-House	FFPE	Biopsy	250	365	80	Matched	Primary	Brain	Not Applicable	Tumor	DIPG	Glioma	Diffuse Intrinsic Pontine Glioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;ACVR1 p.R206H	1	2
P-0007748	P-0007748-T01-IM5	In-House	FFPE	Cytology	224.6	337	20	Matched	Metastasis	Esophagus	Peritoneum	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R213*;DDR2 Amplification;KRAS Amplification	0	3
P-0007749	P-0007749-T01-IM5	Outside	FFPE	Biopsy	250	884	40	Matched	Metastasis	Prostate	Omentum	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.G245S;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0007750	P-0007750-T01-IM5	Outside	FFPE	Biopsy	250	511	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R249W;CREBBP p.E72Afs*10;CCND3 Amplification;MYC Amplification;YAP1 Amplification	0	5
P-0007751	P-0007751-T01-IM5	Outside	FFPE	Resection	250	715	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lapatinib(EGFR Amplification)				LEVEL_3B	RB1 p.R552*;EGFR Amplification;MDM2 Amplification	2	3
P-0007752	P-0007752-T01-IM5	In-House	FFPE	Biopsy	250	1095	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										PIM1 p.S97N;SOCS1 p.A3T;SOCS1 p.A3P;STAT3 p.K658N;TET2 p.R918Vfs*5;SOCS1 p.V128Dfs*83;TET2 p.L914Rfs*8;STAT3 p.S614R;ARID5B Deletion;CD274 Amplification;MDM4 Amplification	0	11
P-0007753	P-0007753-T01-IM5	Outside	FFPE	Biopsy	57.824	438	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.A347D;AMER1 p.E387*;STK11 p.E120Kfs*9	2	4
P-0007754	P-0007754-T01-IM5	Outside	FFPE	Cytology	161.8	298	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	EGFR p.L858R;PIK3CA p.E545K;TP53 p.R209Kfs*6;APC p.S1411Vfs*4;RBM10 p.S710Kfs*10	2	5
P-0007755	P-0007755-T01-IM5	In-House	FFPE	Resection	250	970	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.N239S;TP53 p.X126_splice;RYBP p.Q158*;KMT2C p.S1148*;CREBBP p.K68*;EP300 p.X1391_splice;ARID1A p.X911_splice;ERBB2 Amplification	1	8
P-0007756	P-0007756-T01-IM5	Outside	FFPE	Resection	250	839	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	CBL p.C384R;PIK3R1 p.K567del;CDK4 Amplification;TP53 Deletion	1	4
P-0007758	P-0007758-T01-IM5	Outside	FFPE	Resection	250	801	70	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;CDH1 p.E247*;GPS2 p.Q48*;MAP2K4 p.X171_splice	2	4
P-0007759	P-0007759-T01-IM5	In-House	FFPE	Resection	250	1154	20	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										RUNX1 p.S295*	0	1
P-0007770	P-0007770-T01-IM5	In-House	FFPE	Biopsy	250	1170	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification;PIK3CB Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0007771	P-0007771-T01-IM5	In-House	FFPE	Resection	250	646	80	Matched	Metastasis	Rectosigmoid Colon	Adrenal	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R213*;APC p.R554Qfs*4;FAT1 Deletion;INPP4B Deletion;SMAD4 Deletion;SOX9 Deletion	0	6
P-0007772	P-0007772-T01-IM5	In-House	FFPE	Resection	250	696	80	Matched	Metastasis	Thyroid	Neck	Tumor	HNMASC	Salivary Gland Cancer	Mammary Analogue Secretory Carcinoma of Salivary Gland Origin	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	2
P-0007772	P-0007772-T02-IM5	In-House	FFPE	Resection	250	426	80	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	2
P-0007772	P-0007772-T03-IM5	Outside	FFPE	Resection	250	235	80	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	APC p.R640W;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	3
P-0007773	P-0007773-T01-IM5	In-House	FFPE	Biopsy	250	651	70	Matched	Metastasis	Liver	Spine	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.H36P;PPP2R1A p.W257C;PTPRT p.R453C;MEN1 p.T62Sfs*59;CCND1 Amplification;FGF19 Amplification	0	6
P-0007774	P-0007774-T01-IM5	In-House	FFPE	Resection	250	912	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	B2M p.L15Ffs*41;TP53 p.R181P;APC p.E1295*;APC p.Q1175*;MGA p.K937*;KRAS p.G12S;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification	1	10
P-0007775	P-0007775-T01-IM5	In-House	FFPE	Cytology	50	297	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.Q192_H193delinsHY	1	2
P-0007776	P-0007776-T01-IM5	In-House	FFPE	Resection	250	1167	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0007777	P-0007777-T01-IM5	In-House	FFPE	Biopsy	250	1000	60	Matched	Primary	Trachea	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										RBM10 p.R230*;PIK3R1 p.Y334Afs*6;CCNE1 Amplification;MDM4 Amplification	0	4
P-0007778	P-0007778-T01-IM5	In-House	FFPE	Resection	250	388	30	Matched	Metastasis	Testis	Lymph Node	Tumor	BEC	Germ Cell Tumor	Embryonal Carcinoma										MCL1 Amplification	0	1
P-0007779	P-0007779-T01-IM5	In-House	FFPE	Resection	250	1201	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.X246_splice	1	2
P-0007780	P-0007780-T01-IM5	In-House	FFPE	Biopsy	250	897	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.G127E);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.G127E;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MDM4 Amplification	3	5
P-0007781	P-0007781-T01-IM5	In-House	FFPE	Biopsy	250	341	70	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.H168P;APC p.S1415Ifs*5	0	2
P-0007782	P-0007782-T01-IM5	In-House	FFPE	Resection	250	797	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Olaparib(PALB2 p.F816Sfs*35)	GSK2636771,AZD8186(PTEN p.T167Ffs*15)				LEVEL_3B	SMAD4 p.X436_splice;KMT2C p.S122Cfs*9;PTEN p.T167Ffs*15;PALB2 p.F816Sfs*35;CBL p.X478_splice;TP53 p.E221Gfs*25;RUNX1 p.L261Tfs*24;ARID2 p.T1719Lfs*2;RNF43 p.Q488Sfs*12;SMAD3 p.T390*;FOXP1 p.Q153Pfs*17;TP53 p.N239_S240delinsC	2	12
P-0007783	P-0007783-T01-IM5	In-House	FFPE	Resection	250	900	40	Matched	Primary	Thigh	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0007784	P-0007784-T01-IM5	In-House	FFPE	Biopsy	250	911	50	Matched	Metastasis	Bile Duct	Peritoneum	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	SMAD4 p.E526K;TP53 p.S166*;ERBB2 Amplification;FGFR1 Amplification	2	4
P-0007785	P-0007785-T01-IM5	Outside	FFPE	Biopsy	250	422	80	Matched	Primary	Spine	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Olaparib(RAD51B Deletion)					LEVEL_3B	CDKN2C Deletion;CIC Deletion;RAD51B Deletion;ZFHX3 HTA-ZFHX3 fusion;HCCAT5 HTA-ZFHX3 fusion	1	5
P-0007786	P-0007786-T01-IM5	In-House	FFPE	Resection	250	639	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R130*)				LEVEL_4	PTEN p.R130*;CTNNB1 p.S33C;SPOP p.Y87N	1	3
P-0007787	P-0007787-T01-IM5	In-House	FFPE	Biopsy	250	738	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Everolimus(TSC2 p.E96*)					LEVEL_3B	TP53 p.R337C;RB1 p.Q436*;TSC2 p.E96*	1	3
P-0007788	P-0007788-T01-IM5	In-House	FFPE	Biopsy	250	302	60	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)					LEVEL_1	EGFR p.E746_A750del;PIK3CA p.C420R;CTNNB1 p.T41A;MED12 p.K681Sfs*30;TP53 p.S240F	2	5
P-0007788	P-0007788-T02-IM5	In-House	FFPE	Biopsy	111.2	794	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	EGFR p.E746_A750del;PIK3CA p.C420R;MED12 p.K681Sfs*30;SMARCA4 p.M113Ifs*189;TP53 p.S240F;FGFR1 Amplification	3	6
P-0007790	P-0007790-T01-IM5	In-House	FFPE	Biopsy	250	886	50	Matched	Primary	Lung	Not Applicable	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A;TP53 p.K132N;ERBB3 p.E332K;ARID1B p.Q595*;FBXW7 p.R465S;NF2 p.X525_splice;RAF1 p.S259C;RASA1 p.S122*;NOTCH1 p.S2211*	1	9
P-0007791	P-0007791-T01-IM5	In-House	FFPE	Resection	250	717	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0007792	P-0007792-T01-IM5	Outside	FFPE	Biopsy	250	347	90	Matched	Metastasis	Kidney	Liver	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										MET p.V1070A;LATS1 p.A975Vfs*22;CDC73 Deletion;DICER1 Deletion;MED12 Deletion	0	5
P-0007793	P-0007793-T01-IM5	In-House	FFPE	Resection	250	786	70	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;PIK3CA p.H1047R;APC p.S1465Wfs*3;SMAD3 p.C227*;SMAD2 p.R310T;APC p.T621Ifs*9;SMAD3 IQCH-SMAD3 fusion;IQCH IQCH-SMAD3 fusion	2	8
P-0007794	P-0007794-T01-IM5	In-House	FFPE	Biopsy	250	865	80	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	NF2 p.X149_splice;TP53 p.F109Lfs*36;CCNE1 Amplification;PTEN Deletion	1	4
P-0007804	P-0007804-T01-IM5	Outside	FFPE	Biopsy	250	910	25	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;PIK3CA p.Q546K;APC p.R1450*;APC p.Q1065*;EIF1AX p.R13H;SOX9 p.P258Afs*22;PTEN Deletion	5	7
P-0007805	P-0007805-T01-IM5	Outside	FFPE	Resection	250	937	85	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Trametinib,Cobimetinib(NF1 p.R2517*);Tazemetostat(KDM6A p.X219_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G13D;NF1 p.R2517*;KDM6A p.X219_splice;STAG2 p.R1033*;MSH6 p.D913Efs*32;TP53 p.T102Pfs*21;CCND1 Amplification;CDKN2A Deletion;ERBB2 Amplification;FGF19 Amplification;RAF1 Amplification	5	11
P-0007806	P-0007806-T01-IM5	In-House	FFPE	Resection	250	951	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	VHL p.S111P;CDKN2A Deletion;CDKN2B Deletion;PTEN Deletion	2	4
P-0007807	P-0007807-T01-IM5	In-House	FFPE	Resection	250	976	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0007808	P-0007808-T01-IM5	In-House	FFPE	Biopsy	250	922	NA	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		Trametinib,Cobimetinib(NF1 p.W561*)				LEVEL_1	PIK3CA p.E542K;TP53 p.Y205C;NF1 p.W561*;FOXA1 p.T341Pfs*4;AKT3 Amplification;AURKA Amplification;EGFR Amplification;IKBKE Amplification;MDM4 Amplification;ROS1 Amplification;HCK DNMT3B-HCK fusion;DNMT3B DNMT3B-HCK fusion	3	12
P-0007809	P-0007809-T01-IM5	Outside	FFPE	Resection	250	770	60	Matched	Metastasis	Colorectal NOS	Brain	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.R876*;APC p.Q1303*;CDK8 Amplification;FLT3 Amplification	2	5
P-0007810	P-0007810-T02-IM5	Outside	FFPE	Resection	250	836	10	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.R669Q)				LEVEL_4	ARID2 p.S297F;TP53 p.C229*;FUBP1 p.L89*;FGFR3 p.R669Q;KMT2A p.R2379*;ARID2 p.Q1482*;PTPRT p.Q494*	1	7
P-0007811	P-0007811-T01-IM5	Outside	FFPE	Biopsy	250	1044	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										BCL2 p.A131D;ARID1A p.Q30*;TNFAIP3 p.X163_splice;FOXO1 p.MA1_?2;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion	0	7
P-0007813	P-0007813-T01-IM5	In-House	FFPE	Cytology	250	946	60	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Trametinib,Cobimetinib(NF1 p.X196_splice)				LEVEL_3A	KRAS p.G12C;NF1 p.X196_splice;FOXA1 Amplification;KRAS Amplification;NKX2-1 Amplification;RICTOR Amplification	3	6
P-0007814	P-0007814-T01-IM5	Outside	FFPE	Resection	250	639	70	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.E224D;ATRX p.R1425Kfs*5	1	3
P-0007815	P-0007815-T01-IM5	In-House	FFPE	Resection	250	800	55	Matched	Primary	Pancreas	Not Applicable	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;AMER1 Deletion	1	2
P-0007816	P-0007816-T01-IM5	In-House	FFPE	Resection	250	794	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;RBM10 p.X67_splice;MDM2 Amplification	3	3
P-0007821	P-0007821-T02-IM5	In-House	FFPE	Biopsy	250	1129	NA	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MYD88 p.L265P;ETV6 p.X11_splice;CARD11 p.R337Q;CCND3 p.I290K;CD79B p.Y196R;CDKN2B Deletion;EPHA7 Deletion;MGA Deletion;PRKN Deletion	0	9
P-0007831	P-0007831-T01-IM5	Outside	FFPE	Resection	250	497	40	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N812Ifs*13)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D153N)				LEVEL_1	BRAF p.V600E;DNMT3A p.R882H;CIC p.P1597Hfs*23;RUNX1 p.P330Rfs*237;GATA3 p.P135Rfs*60;EPHA3 p.M847Wfs*10;BMPR1A p.C61*;KMT2D p.Q4254*;DIS3 p.L791Wfs*14;NOTCH4 p.H991Pfs*14;BMPR1A p.F147Lfs*18;BRCA2 p.N812Ifs*13;CBFB p.F18Lfs*4;TET1 p.K127Rfs*8;TNFRSF14 p.I223Mfs*10;CDKN2A p.D153N	5	16
P-0007832	P-0007832-T01-IM5	Outside	FFPE	Biopsy	250	657	15	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	NFE2L2 p.R34P;RB1 p.Q217*;TP53 p.A159Hfs*21;NF1 NF1-intragenic	1	4
P-0007833	P-0007833-T01-IM5	Outside	FFPE	Resection	250	924	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.R1769*)				LEVEL_4	PTPN11 p.A72T;TP53 p.T125M;TP53 p.L130H;NF1 p.R1769*	1	4
P-0007834	P-0007834-T01-IM5	Outside	FFPE	Biopsy	250	840	80	Matched	Metastasis	Kidney	Pleura	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.L2220F)				LEVEL_4	MTOR p.L2220F;VHL p.V84E;PBRM1 p.X332_splice	1	3
P-0007835	P-0007835-T01-IM5	Outside	FFPE	Resection	250	791	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lapatinib(EGFR Amplification)				LEVEL_3B	AKT3 Amplification;CDK4 Amplification;EGFR Amplification;ETV1 Amplification;GATA3 Deletion;MDM2 Amplification	3	6
P-0007836	P-0007836-T01-IM5	Outside	FFPE	Resection	250	814	40	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93Q);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E110del);Olaparib(ATM p.R3008H)	GSK2636771,AZD8186(PTEN p.D268Gfs*30);GSK2636771,AZD8186(PTEN p.R233*)				LEVEL_3B	EP300 p.M1470Cfs*26;PIK3CA p.R93Q;PTEN p.D268Gfs*30;CTCF p.T204Nfs*26;B2M p.S16Afs*27;APC p.R283*;PTEN p.R233*;GATA3 p.P135Rfs*60;PIK3CA p.E110del;ATM p.R3008H;PIK3R1 p.R358*;CIC p.P1248Hfs*54;APC p.H298Lfs*28;MRE11 p.N511Ifs*13;NOTCH1 p.S2486Rfs*103;SMARCA4 p.T296Rfs*7;MSH2 p.E56*;MSH2 p.S743*;FAT1 p.R3872*;HNF1A p.X176_splice;KMT2D p.A4594Pfs*23;B2M p.Y46Cfs*10;ZFHX3 p.E3541Gfs*30;PAX5 p.V26Ffs*3;MGA p.T2966Pfs*4	5	25
P-0007837	P-0007837-T01-IM5	Outside	FFPE	Biopsy	250	212	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;TP53 p.R209Kfs*6;SMAD4 p.D537H;RNF43 p.X318_splice;MAP2K4 Deletion;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	1	8
P-0007838	P-0007838-T01-IM5	In-House	FFPE	Biopsy	250	901	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.V157F;HLA-A p.M1?;FOXO1 p.Q595*;BBC3 p.X190_splice;FANCA p.X199_splice	1	6
P-0007839	P-0007839-T02-IM5	In-House	FFPE	Biopsy	250	905	25	Matched	Metastasis	Oropharynx	Chest Wall	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	GSK2636771,AZD8186(PTEN p.Q171*);GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_3B	PIK3CA p.E542K;PTEN p.Q171*;PTEN p.T319*;FBXW7 p.X619_splice	3	4
P-0007839	P-0007839-T01-IM5	Outside	FFPE	Resection	250	867	20	Matched	Metastasis	Tonsil	Periaortic Mass	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K	1	1
P-0007841	P-0007841-T01-IM5	In-House	FFPE	Cytology	250	1073	90	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.E180K	1	2
P-0007842	P-0007842-T01-IM5	In-House	FFPE	Biopsy	250	669	80	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Afatinib(EGFR p.G719A)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E10*)				LEVEL_1	EGFR p.G719A;IL7R p.I241F;TP53 p.Y220Hfs*5;CDKN2A p.E10*;BCL2L1 Amplification	2	5
P-0007843	P-0007843-T01-IM5	In-House	FFPE	Resection	250	605	55	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.H1047R;ARID1A p.D1850Tfs*33;ARID5B p.I497*;CTNNB1 p.T41A;KRAS p.G13D;SMAD2 p.S276L;MLH1 p.X182_splice;SETD2 p.S2382Lfs*47;SETD2 p.T1652Yfs*14;FAT1 p.T1364Yfs*8;ASXL1 p.E719Gfs*54	2	11
P-0007844	P-0007844-T01-IM5	Outside	FFPE	Resection	250	618	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.X342_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PTEN p.X342_splice;CDKN2A Deletion;CDKN2B Deletion;KDR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification	3	7
P-0007845	P-0007845-T01-IM5	In-House	FFPE	Biopsy	250	840	50	Matched	Primary	GE Junction	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma					GSK2636771,AZD8186(PTEN p.A126V)				LEVEL_4	TP53 p.R248Q;PTEN p.A126V	1	2
P-0007846	P-0007846-T01-IM5	In-House	FFPE	Resection	250	851	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;RBM10 p.Q563*	1	2
P-0007847	P-0007847-T01-IM5	In-House	FFPE	Resection	250	900	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0007848	P-0007848-T01-IM5	In-House	FFPE	Resection	250	654	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133V	0	1
P-0007849	P-0007849-T02-IM5	In-House	FFPE	Biopsy	134.3	486	60	Matched	Metastasis	Submandibular Gland	Bone	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;KDM6A p.N1236Tfs*30;MYCL Amplification	1	3
P-0007849	P-0007849-T01-IM5	In-House	FFPE	Resection	250	1850	60	Matched	Metastasis	Submandibular Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0007850	P-0007850-T01-IM5	Outside	FFPE	Resection	250	932	70	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.N329Kfs*14);GSK2636771,AZD8186(PTEN p.S170Vfs*13)				LEVEL_3B	PIK3CA p.H1047R;PTEN p.N329Kfs*14;PTEN p.S170Vfs*13	3	3
P-0007851	P-0007851-T01-IM5	Outside	FFPE	Biopsy	250	775	60	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0007852	P-0007852-T02-IM5	In-House	FFPE	Biopsy	250	1022	70	Matched	Metastasis	Oral Cavity	Liver	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576delinsMITNGSD)					LEVEL_3B	CTNNB1 p.S33F;KIT p.L576delinsMITNGSD;CCND1 Amplification;FGF19 Amplification;KDR Amplification;KIT Amplification;PAK1 Amplification;PDGFRA Amplification	1	8
P-0007852	P-0007852-T01-IM5	In-House	FFPE	Resection	250	608	50	Matched	Metastasis	Oral Cavity	Lymph Node, Regional	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576delinsMITNGSD)					LEVEL_3B	CTNNB1 p.S33F;KIT p.L576delinsMITNGSD;CCND1 Amplification;FGF19 Amplification;KDR Amplification;KIT Amplification;PAK1 Amplification;PDGFRA Amplification	1	8
P-0007853	P-0007853-T01-IM5	In-House	FFPE	Resection	250	880	15	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0007854	P-0007854-T01-IM5	Outside	FFPE	Resection	250	397	45	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.G302Rfs*4;VHL p.K159Rfs*6;BAP1 p.L636Wfs*16	0	3
P-0007855	P-0007855-T01-IM5	In-House	FFPE	Resection	250	672	65	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Y163C;CCND3 Amplification;CCNE1 Amplification;PAK1 Amplification	0	4
P-0007856	P-0007856-T01-IM5	Outside	FFPE	Biopsy	250	724	30	Matched	Metastasis	Prostate	Pelvic Nodule	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.T253A;FOXA1 p.Q263_C268del	0	2
P-0007857	P-0007857-T01-IM5	Outside	FFPE	Resection	250	848	50	Matched	Metastasis	Tonsil	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0007858	P-0007858-T01-IM5	In-House	FFPE	Biopsy	250	956	80	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										SF3B1 p.R625C;TP53 p.C176F;ASXL1 p.R693*;BTK p.C481S;PTPRD Deletion	0	5
P-0007859	P-0007859-T01-IM5	In-House	FFPE	Resection	250	692	85	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.R282W;TP53 p.P151S;KDM5C p.E1024Gfs*31	0	3
P-0007860	P-0007860-T01-IM5	In-House	FFPE	Resection	250	921	NA	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										SOX9 R144fs	0	1
P-0007861	P-0007861-T01-IM5	In-House	FFPE	Biopsy	250	712	75	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Trametinib,Cobimetinib(BRAF AGAP3-BRAF fusion);Trametinib,Cobimetinib(AGAP3 AGAP3-BRAF fusion)					LEVEL_3B	PIK3CA p.H1047R;BRAF AGAP3-BRAF fusion;AGAP3 AGAP3-BRAF fusion	3	3
P-0007862	P-0007862-T01-IM5	In-House	FFPE	Biopsy	250	855	NA	Unmatched	Primary	Skin	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS											0	0
P-0007863	P-0007863-T01-IM5	Outside	FFPE	Resection	250	326	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_2	GRIN2A p.R1443Qfs*9;AURKA Amplification;CDK6 Amplification;ERBB2 Amplification;MET Amplification	3	5
P-0007864	P-0007864-T01-IM5	In-House	FFPE	Biopsy	250	846	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;PIK3CA p.E542K;CTNNB1 p.S33F;TGFBR2 p.K314Rfs*10	3	5
P-0007865	P-0007865-T01-IM5	In-House	FFPE	Biopsy	182	805	10	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R248W	1	2
P-0007866	P-0007866-T01-IM5	In-House	FFPE	Resection	250	752	65	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.L638*);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R175H;APC p.K534*;APC p.E1309Dfs*4;BRCA2 p.L638*;FGFR1 Amplification	2	5
P-0007868	P-0007868-T01-IM5	In-House	FFPE	Resection	250	527	NA	Matched	Metastasis	Rectosigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										SMAD4 p.R361C;TP53 p.P151S;APC p.Y1143*;APC p.R1386*;PTPRT p.R1358*	0	5
P-0007869	P-0007869-T01-IM5	In-House	FFPE	Resection	117.6	622	NA	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.R213*;APC p.T1388Qfs*4;MET Amplification;PMAIP1 Deletion	1	4
P-0007870	P-0007870-T01-IM5	In-House	FFPE	Biopsy	170.4	685	NA	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;PIK3CA p.E542K;TP53 p.V73Rfs*76;MAP2K4 p.R304*;CCNE1 Amplification;EGFR Amplification;RICTOR Amplification	3	8
P-0007871	P-0007871-T01-IM5	Outside	FFPE	Resection	250	529	NA	Matched	Metastasis	Adnexa	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_3B	TP53 p.R306*;BRCA2 Deletion;TOP1 TOP1-intragenic	1	3
P-0007872	P-0007872-T01-IM5	In-House	FFPE	Resection	250	794	20	Matched	Metastasis	Uterus	Lymph Node	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma										TP53 p.R273H;PIK3R1 p.I442Mfs*30;CCNE1 Amplification;KRAS Amplification	0	4
P-0007873	P-0007873-T01-IM5	In-House	FFPE	Biopsy	250	622	50	Matched	Primary	Cervix	Not Applicable	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	PIK3CA p.H1047R;KRAS p.G12A;TP53 p.Q104Afs*18	2	3
P-0007874	P-0007874-T01-IM5	In-House	FFPE	Resection	250	619	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R280G;FOXA1 p.Y259S	0	2
P-0007875	P-0007875-T01-IM5	In-House	FFPE	Resection	250	861	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(PALB2 p.E12*)								LEVEL_1	PALB2 p.E12*	1	1
P-0007876	P-0007876-T01-IM5	Outside	FFPE	Biopsy	250	591	70	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;PPP6C p.R264C;TP63 p.R379S;FLT3 p.D909N;MED12 p.E35K	1	5
P-0007877	P-0007877-T01-IM5	Outside	FFPE	Resection	250	617	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.H178Pfs*69	0	1
P-0007879	P-0007879-T01-IM5	In-House	FFPE	Resection	62.4	827	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	MAX p.R33*;KRAS p.G12A;RBM10 p.X546_splice	1	3
P-0007880	P-0007880-T01-IM5	Outside	FFPE	Resection	250	1264	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R38H)	GSK2636771,AZD8186(PTEN p.X85_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PTEN p.X85_splice;PIK3CA p.R38H;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	4	5
P-0007881	P-0007881-T01-IM5	Outside	FFPE	Biopsy	250	415	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										MED12 p.L1224F	0	1
P-0007882	P-0007882-T01-IM5	Outside	FFPE	Resection	250	991	65	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E2981Rfs*37);Olaparib(CDK12 p.S238Lfs*10)	Trametinib,Cobimetinib(NF1 p.I679Dfs*21);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S238Lfs*10)				LEVEL_3B	FBXW7 p.S668Vfs*39;NCOR1 p.E529Kfs*26;TP53 p.H178Tfs*69;B2M p.M1?;ARID1A p.A339Lfs*24;CTNNB1 p.S37F;ARID1A p.K1072Nfs*21;FBXW7 p.R465C;BRCA2 p.E2981Rfs*37;TP53 p.R267W;NF1 p.I679Dfs*21;B2M p.T93Hfs*2;FOXA1 p.R219C;CARD11 p.T117A;TP53 p.T170M;TNFAIP3 p.P457Lfs*20;NOTCH4 p.G1891Afs*13;SPEN p.P3317Rfs*83;CDK12 p.S238Lfs*10;CREBBP p.P928Rfs*70	4	20
P-0007883	P-0007883-T01-IM5	In-House	FFPE	Biopsy	250	1036	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										TP53 p.R248W;SMAD2 p.S464*;MAP2K4 p.P326L;APC p.D1394Vfs*21;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;FAT1 Deletion;SRC Amplification;FOXP1 FOXP1-intragenic	0	10
P-0007884	P-0007884-T01-IM5	Outside	FFPE	Resection	250	559	70	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12A);Imatinib,Sunitinib,Regorafenib,Sorafenib,Avapritinib,Ripretinib(KIT p.D816V)					LEVEL_3B	NRAS p.G12A;KIT p.D816V	2	2
P-0007885	P-0007885-T01-IM5	In-House	FFPE	Resection	250	975	NA	Matched	Primary	Sinus	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NFE2L2 p.E79Q;TP53 p.X33_splice;NOTCH3 p.P1633Rfs*44;AKT2 Amplification;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;FGF19 Amplification;PDGFRA Amplification;PIK3CA Amplification	2	11
P-0007886	P-0007886-T01-IM5	In-House	FFPE	Resection	250	437	70	Matched	Primary	Abdomen	Abdomen	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;CDK8 Amplification;MDM2 Amplification	2	3
P-0007887	P-0007887-T01-IM5	In-House	FFPE	Resection	250	589	40	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_4	TP53 p.R248Q;KRAS p.Q61H;SMAD4 p.E520*;APC p.E1306*;BCL2L1 Amplification	1	5
P-0007888	P-0007888-T01-IM5	In-House	FFPE	Biopsy	250	617	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										KMT2C p.S279*;ARID2 p.P576Qfs*5;KMT2C MLL3-intragenic	0	3
P-0007889	P-0007889-T01-IM5	In-House	FFPE	Resection	250	614	70	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248W	0	1
P-0007890	P-0007890-T01-IM5	In-House	FFPE	Resection	250	897	85	Matched	Metastasis	Stomach	Pleura	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V560D)	Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.N659S)							LEVEL_1	KIT p.V560D;PDGFRA p.N659S;PDGFRA Amplification;PPM1D Amplification;RBM10 CLCN5-RBM10 fusion;CLCN5 CLCN5-RBM10 fusion	2	6
P-0007891	P-0007891-T01-IM5	Outside	FFPE	Resection	250	536	85	Matched	Primary	Uterus	Not Applicable	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.R156P;TP53 p.G199*;ATRX p.T792Ifs*12;RB1 Deletion	0	4
P-0007893	P-0007893-T01-IM5	In-House	FFPE	Biopsy	250	1060	20	Matched	Metastasis	Sigmoid Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;APC p.S299Cfs*27;SMAD3 Deletion	0	3
P-0007894	P-0007894-T01-IM5	In-House	FFPE	Resection	250	563	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	RECQL4 p.T909Rfs*31;RB1 p.C489Lfs*5;SOX17 p.P276Qfs*111;AKT3 Amplification;AURKA Amplification;AXIN1 Deletion;CDKN2A Deletion;CDKN2B Deletion;IKBKE Amplification;MDM4 Amplification	1	10
P-0007895	P-0007895-T01-IM5	Outside	FFPE	Biopsy	250	791	70	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.C135F;CCNE1 Amplification;ERBB2 Amplification	2	3
P-0007896	P-0007896-T01-IM5	In-House	FFPE	Biopsy	250	824	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.R248W;RB1 p.X406_splice;EGFR Amplification	1	4
P-0007897	P-0007897-T01-IM5	Outside	FFPE	Biopsy	250	718	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Olaparib(CHEK2 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	TP53 p.E56*;EGFR p.A289T;CDKN2A Deletion;CDKN2B Deletion;CHEK2 Deletion;EGFR Amplification;NF2 Deletion	3	7
P-0007898	P-0007898-T01-IM5	In-House	FFPE	Resection	250	941	NA	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R175H;KMT2C p.Q1719*;SMAD4 p.N306Kfs*2;KMT2D p.P3291Hfs*6	1	5
P-0007899	P-0007899-T01-IM5	In-House	FFPE	Resection	250	744	60	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;AMER1 Deletion	1	2
P-0007900	P-0007900-T01-IM5	In-House	FFPE	Biopsy	250	844	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRNE	Prostate Cancer	Prostate Neuroendocrine Carcinoma				Tipifarnib(HRAS p.Q61K)					LEVEL_3B	HRAS p.Q61K;CDH1 p.E490*;TP53 p.P142Gfs*24	1	3
P-0007901	P-0007901-T01-IM5	In-House	FFPE	Resection	250	867	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R213*;EGFR p.L861Q;ERBB2 Amplification;NKX2-1 Amplification	2	4
P-0007902	P-0007902-T01-IM5	Outside	FFPE	Biopsy	250	915	20	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;CDH1 p.E410Gfs*9;CCND1 Amplification;FGF19 Amplification;MCL1 Amplification	2	5
P-0007903	P-0007903-T01-IM5	In-House	FFPE	Resection	250	935	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S8Lfs*15)				LEVEL_4	TP53 p.P250L;JAK3 p.R657Q;CDKN2A p.S8Lfs*15	1	3
P-0007904	P-0007904-T01-IM5	In-House	FFPE	Biopsy	250	902	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_T751del)								LEVEL_1	EGFR p.L747_T751del;TP53 p.N131K;TP53 p.R249Gfs*96;CCNE1 Amplification;EGFR Amplification;PAK1 Amplification	1	6
P-0007905	P-0007905-T01-IM5	Outside	FFPE	Biopsy	109.8	355	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Everolimus(TSC2 p.G1567D)					LEVEL_3B	TP53 p.Y220C;TSC2 p.G1567D;ARID1A p.A2234Pfs*32;ERCC3 p.G31Ffs*9;MYCL Amplification;RB1 Deletion	1	6
P-0007906	P-0007906-T01-IM5	In-House	FFPE	Biopsy	250	598	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.V173G;TGFBR2 p.G509Afs*9;CDK6 Amplification	1	4
P-0007907	P-0007907-T01-IM5	Outside	FFPE	Biopsy	250	862	70	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										KMT2D p.S543*;TP53 p.M243_I255del;CCND1 Amplification;CD274 Amplification;FGF19 Amplification;JAK2 Amplification	0	6
P-0007908	P-0007908-T01-IM5	In-House	FFPE	Resection	250	1044	80	Matched	Primary	Small Intestine	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	ARID1A Deletion;ID3 Deletion;SDHB Deletion;SMARCB1 Deletion;TNFRSF14 Deletion;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	1	7
P-0007909	P-0007909-T01-IM5	In-House	FFPE	Resection	250	236	70	Matched	Metastasis	Rectosigmoid Colon	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Everolimus(TSC1 Deletion)					LEVEL_3B	TP53 p.R175H;APC p.Q1378*;SMAD3 p.Q322*;SMAD2 Deletion;TSC1 Deletion	1	5
P-0007910	P-0007910-T01-IM5	In-House	FFPE	Biopsy	250	810	90	Matched	Metastasis	Stomach	Pelvic Nodule	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.N822K)	Sorafenib(KIT p.N822K)			Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib,Sunitinib(KIT p.N822K)		LEVEL_1	KIT p.W557_K558del;PPP2R1A p.R183Q;KIT p.N822K;CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion;SETD2 Deletion	4	7
P-0007911	P-0007911-T01-IM5	In-House	FFPE	Resection	250	1337	NA	Matched	Metastasis	Lung	Skin	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(PALB2 p.K346*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PALB2 p.K346*;EP300 p.H1377Y	3	3
P-0007911	P-0007911-T02-IM5	In-House	FFPE	Resection	250	587	40	Matched	Metastasis	Thyroid	Skin	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	PPP2R1A p.R182W;ETV6 p.P214L;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	4
P-0007912	P-0007912-T01-IM5	In-House	FFPE	Resection	250	494	50	Matched	Metastasis	Transverse Colon	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.C135R;APC Deletion;FGFR1 Amplification;PTEN Deletion;RNF43 Deletion	2	5
P-0007913	P-0007913-T01-IM5	In-House	FFPE	Resection	250	449	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0007914	P-0007914-T01-IM5	Outside	FFPE	Resection	248.2	152	80	Matched	Primary	Brain	Not Applicable	Tumor	DIPG	Glioma	Diffuse Intrinsic Pontine Glioma				Ivosidenib(IDH1 p.R132S)					LEVEL_3B	TP53 p.G266R;IDH1 p.R132S;ATRX p.N1318Kfs*6	1	3
P-0007915	P-0007915-T01-IM5	In-House	FFPE	Resection	250	668	75	Matched	Primary	Brain	Not Applicable	Tumor	MPE	CNS Cancer	Myxopapillary Ependymoma											0	0
P-0007916	P-0007916-T01-IM5	In-House	FFPE	Resection	250	699	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111Q);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.F3298Afs*27)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;PIK3CA p.K111Q;RBM10 p.X890_splice;BRCA2 p.F3298Afs*27	3	4
P-0007917	P-0007917-T01-IM5	Outside	FFPE	Resection	250	1153	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.M35V)				LEVEL_3B	PTEN p.M35V;ARID2 p.Q1165*;CDK4 Amplification;MDM2 Amplification;CST7 FAM175A-CST7 fusion;ABRAXAS1 FAM175A-CST7 fusion	3	6
P-0007917	P-0007917-T02-IM5	Outside	FFPE	Resection	250	1115	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.M35V)				LEVEL_3B	PTEN p.M35V;ARID2 p.Q1165*;MSH6 p.R240*;MSH6 p.R1035*;CTLA4 p.A66T;CDK4 Amplification;MDM2 Amplification;CST7 FAM175A-CST7 fusion;ABRAXAS1 FAM175A-CST7 fusion	3	9
P-0007918	P-0007918-T01-IM5	In-House	FFPE	Biopsy	250	972	NA	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma		Imatinib(KIT p.L576P)		Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)	PLX8394(BRAF p.G469R);Trametinib,Cobimetinib(NF1 p.R1241*);Trametinib,Cobimetinib(NF1 p.W696_N697delins*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_2	RHOA p.E47K;CTNNB1 p.T41A;KIT p.L576P;KMT2A p.Q814*;BRAF p.G469R;PIK3CD p.E1021K;BAP1 p.S628*;FBXW7 p.G423*;NF1 p.R1241*;BAP1 p.X194_splice;DIS3 p.I185Kfs*14;NF1 p.W696_N697delins*;CDKN2A p.R58*;CDKN2A p.R58*	7	14
P-0007919	P-0007919-T01-IM5	In-House	FFPE	Resection	250	1012	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0007920	P-0007920-T01-IM5	Outside	FFPE	Resection	250	638	40	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										FOXO1 p.X568_splice	0	1
P-0007921	P-0007921-T01-IM5	In-House	FFPE	Resection	250	562	40	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A	1	1
P-0007922	P-0007922-T01-IM5	In-House	FFPE	Resection	250	741	90	Matched	Primary	Cervix	Not Applicable	Tumor	CEAS	Cervical Cancer	Cervical Adenosquamous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93W)					LEVEL_3B	PIK3CA p.R93W;FGFR2 Amplification	1	2
P-0007923	P-0007923-T01-IM5	In-House	FFPE	Resection	250	668	50	Matched	Primary	Appendix	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Everolimus,Temsirolimus(MTOR p.T1977I)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.Y935*;SMAD2 p.R182*;MTOR p.T1977I;APC p.V1414Efs*3	2	5
P-0007924	P-0007924-T01-IM5	In-House	FFPE	Biopsy	250	829	70	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.S303Afs*42;MSH2 p.Y522*;RAD21 p.Q514*;AKT1 Amplification;MET Amplification;MYCL Amplification	2	6
P-0007925	P-0007925-T01-IM5	In-House	FFPE	Resection	250	611	60	Matched	Primary	Skin	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.S241C;TP53 p.X225_splice;CCND1 Amplification;FGF19 Amplification;YAP1 Amplification	0	5
P-0007926	P-0007926-T01-IM5	In-House	FFPE	Biopsy	250	681	NA	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.K320*;EGFR Amplification	0	2
P-0007927	P-0007927-T01-IM5	In-House	FFPE	Resection	250	633	30	Matched	Primary	Skin	Not Applicable	Tumor	ACRM	Melanoma	Acral Melanoma					Trametinib,Cobimetinib(NF1 p.R1769*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.R1769*;ARID1B Deletion;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;MITF Amplification	2	6
P-0007929	P-0007929-T01-IM5	In-House	FFPE	Resection	250	724	40	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.D183Rfs*10;APC p.S1298Ifs*8;TP53 p.P152Afs*14	0	3
P-0007930	P-0007930-T02-IM5	In-House	FFPE	Resection	250	658	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.C124Wfs*25	0	1
P-0007930	P-0007930-T01-IM5	Outside	FFPE	Resection	250	301	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0007931	P-0007931-T01-IM5	In-House	FFPE	Resection	250	281	90	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R181H;MSH2 p.R389*;CDH1 p.G837*;KMT2C p.P2829Qfs*3;MCL1 Amplification	1	6
P-0007932	P-0007932-T01-IM5	Outside	FFPE	Resection	250	1353	70	Matched	Metastasis	Uterus	Colon	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	1	7
P-0007961	P-0007961-T02-IM5	Outside	FFPE	Resection	250	1101	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.C135Y;PBRM1 p.X856_splice;VHL p.L169*;CD274 Amplification;JAK2 Amplification	0	5
P-0007965	P-0007965-T01-IM5	Outside	FFPE	Resection	250	703	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.S215R;TP53 p.L265P;FOXA1 p.S250_Y259del	0	3
P-0007966	P-0007966-T01-IM5	In-House	FFPE	Biopsy	250	851	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;KMT2C p.S279*;KMT2C p.R3612Kfs*18;FAT1 Deletion;RAD21 Deletion;MAP2K1 SMAD3-MAP2K1 fusion;SMAD3 SMAD3-MAP2K1 fusion	2	7
P-0007967	P-0007967-T01-IM5	Outside	FFPE	Resection	250	1064	90	Matched	Primary	Rectum	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del)								LEVEL_1	KIT p.W557_K558del	1	1
P-0007968	P-0007968-T01-IM5	Outside	FFPE	Resection	250	468	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.T1556Nfs*3	0	1
P-0007969	P-0007969-T01-IM5	In-House	FFPE	Resection	250	651	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	JAK1 p.K860Nfs*16;CTCF p.T204Nfs*26;B2M p.L15Ffs*41;B2M p.D96Mfs*7;KRAS p.G13D;PBRM1 p.I279Yfs*4;CIC p.P1248Hfs*54;TNFAIP3 p.E366Gfs*22;ARID1A p.P224Rfs*8;KMT2D p.R4198*;RNF43 p.T542Pfs*158;ARID1A p.P1554Hfs*11;CDC73 p.G416Afs*12	1	13
P-0007970	P-0007970-T01-IM5	In-House	FFPE	Resection	250	806	60	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L97R)				LEVEL_1	BRAF p.V600E;TP53 p.G279E;CDKN2A p.L97R;CCND1 Amplification;FGF19 Amplification	3	5
P-0007971	P-0007971-T01-IM5	In-House	FFPE	Biopsy	250	867	60	Matched	Metastasis	Neck	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	FBXW7 p.X195_splice;TP53 p.K319*;TP53 p.D184Vfs*63;PTPRT p.L668Ifs*16;FAT1 p.Y1893Lfs*15;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;FOXA1 Amplification;NKX2-1 Amplification;PRKN Deletion;PIK3CA Amplification;PTPRD Deletion;YAP1 Amplification;FSCB ARID5B-FSCB fusion;ARID5B ARID5B-FSCB fusion;FANCC FANCC-intragenic	2	17
P-0007971	P-0007971-T02-IM5	In-House	FFPE	Biopsy	250	1010	30	Matched	Metastasis	Neck	Pleura	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	FBXW7 p.X195_splice;TP53 p.K319*;TP53 p.D184Vfs*63;FAT1 p.Y1893Lfs*15;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;YAP1 Amplification;FSCB ARID5B-FSCB fusion;ARID5B ARID5B-FSCB fusion	2	10
P-0007972	P-0007972-T01-IM5	In-House	FFPE	Resection	250	776	65	Matched	Metastasis	Pancreas	Ovary	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0007973	P-0007973-T01-IM5	In-House	FFPE	Biopsy	250	720	60	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;PIK3CA p.H1047R;CTNNB1 p.S33F;MAX p.R60Q	2	4
P-0007974	P-0007974-T01-IM5	Outside	FFPE	Biopsy	250	945	70	Matched	Metastasis	Submandibular Gland	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.Y220C;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;FGF19 Amplification;FLCN Deletion;GPS2 Deletion;MAP2K4 Deletion;MCL1 Amplification;NCOR1 Deletion;TP53 Deletion	2	12
P-0007975	P-0007975-T01-IM5	In-House	FFPE	Biopsy	250	941	25	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;FOXP1 p.N461Rfs*4	1	2
P-0007976	P-0007976-T01-IM5	In-House	FFPE	Resection	250	974	NA	Matched	Metastasis	Intraabdominal	Omentum	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Y823D)	Sorafenib(KIT p.Y823D)			Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib,Sunitinib(KIT p.Y823D)		LEVEL_1	KIT p.W557_K558del;KIT p.Y823D;CDKN2A Deletion;CDKN2B Deletion	4	4
P-0007977	P-0007977-T01-IM5	In-House	FFPE	Cytology	124.1	420	10	Matched	Metastasis	Lung	Liver	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion)				LEVEL_3B	TP53 p.R267P;KEAP1 p.K323Rfs*5;ERBB2 Amplification;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion	3	5
P-0007978	P-0007978-T01-IM5	Outside	FFPE	Biopsy	250	707	10	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.G128V)						LEVEL_3A	TP53 p.S241C;MAP2K1 p.G128V;STK11 p.X307_splice;KEAP1 p.G480V;MYC Amplification	1	5
P-0007979	P-0007979-T01-IM5	Outside	FFPE	Biopsy	250	700	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(ATM p.R337C)					LEVEL_1	BRAF p.V600E;ATM p.R337C	4	2
P-0007980	P-0007980-T01-IM5	In-House	FFPE	Biopsy	250	793	80	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0007981	P-0007981-T01-IM5	In-House	FFPE	Biopsy	250	948	30	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										MET p.Y1230H	0	1
P-0007981	P-0007981-T02-IM5	In-House	FFPE	Biopsy	250	904	70	Matched	Metastasis	Kidney	Liver	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										ARID5B p.S958Ifs*9	0	1
P-0007982	P-0007982-T01-IM5	Outside	FFPE	Biopsy	250	1067	80	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										KMT2C p.A1685S;MTOR p.E1799K;BCL2 p.A131D;PIM1 p.Q37H;BCOR p.Y1698*;B2M p.V102Efs*12;CDKN2A Deletion;CDKN2B Deletion	0	8
P-0007983	P-0007983-T01-IM5	Outside	FFPE	Biopsy	250	566	10	Matched	Metastasis	Soft Tissue	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_3B	NRAS p.Q61R;CDKN2A p.E88*;CDKN2A p.W110*	3	3
P-0007984	P-0007984-T01-IM5	In-House	FFPE	Biopsy	250	1072	75	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MAP3K1 p.Q520*;CBFB p.W73*;GATA3 p.V337Gfs*21	0	3
P-0007985	P-0007985-T01-IM5	In-House	FFPE	Resection	250	569	85	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559D)								LEVEL_1	KIT p.V559D;MGA p.I2540Nfs*17	1	2
P-0007986	P-0007986-T01-IM5	In-House	FFPE	Resection	250	862	15	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;KMT2D p.Q5520*;IKBKE Amplification	1	3
P-0007987	P-0007987-T01-IM5	Outside	FFPE	Resection	250	801	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.P151R;KMT2A p.K1748*;ASXL2 p.R614*	0	3
P-0007988	P-0007988-T01-IM5	In-House	FFPE	Biopsy	250	415	75	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;NCOR1 p.R1326*	2	2
P-0007989	P-0007989-T01-IM5	In-House	FFPE	Resection	250	830	75	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.R189*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.R189*;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;EGFR SEPT14-EGFR fusion;SEPT14 SEPT14-EGFR fusion	3	6
P-0007990	P-0007990-T01-IM5	In-House	FFPE	Biopsy	250	914	75	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_2	KRAS p.G12S;TP53 p.R248Q;APC p.R1450*;TP53 p.R342Efs*3;APC p.R876*;ERBB2 Amplification;KRAS Amplification;MAPK1 Amplification	3	8
P-0007991	P-0007991-T01-IM5	Outside	FFPE	Biopsy	250	678	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;GLI1 Amplification	3	5
P-0007992	P-0007992-T01-IM5	In-House	FFPE	Resection	250	843	85	Matched	Metastasis	Testis	Lymph Node	Tumor	TMT	Germ Cell Tumor	Teratoma with Malignant Transformation										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0007993	P-0007993-T01-IM5	In-House	FFPE	Resection	250	922	75	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MTOR p.V2006F;KMT2D p.Q2044*;KMT2D p.R321Lfs*22;TNFRSF14 p.C121Wfs*114;TP53 p.G266T	0	5
P-0007994	P-0007994-T01-IM5	In-House	FFPE	Biopsy	250	973	30	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.V274A;TP53 p.H193N;CDKN1A p.D7Gfs*29;BCL2L1 Amplification;DNMT3B Amplification;RICTOR Amplification	0	6
P-0007995	P-0007995-T01-IM5	In-House	FFPE	Biopsy	250	896	45	Matched	Metastasis	GE Junction	Lymph Node	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.R273H;RNF43 p.G659Vfs*41;ARID1A p.R1276*;ARID1A p.D1850Gfs*4;TET1 p.K22Rfs*23;CREBBP p.P1423Lfs*36;KRAS p.G13D;ZFHX3 p.E763Sfs*61;KMT2D p.Q2208*;PBRM1 p.E927Sfs*2;MLH1 p.X264_splice;TBX3 p.G496Afs*136;ERCC4 p.M361Wfs*15;TET2 p.T229Hfs*21;MEN1 p.R521Gfs*43	1	15
P-0007995	P-0007995-T02-IM5	In-House	FFPE	Biopsy	250	1067	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.R273H;RNF43 p.G659Vfs*41;ARID1A p.R1276*;ARID1A p.D1850Gfs*4;CTNNB1 p.S37F;B2M p.L15Ffs*41;TET1 p.K22Rfs*23;CTNNB1 p.D32N;KRAS p.G13D;ZFHX3 p.E763Sfs*61;KMT2D p.Q2208*;PBRM1 p.E927Sfs*2;MLH1 p.X264_splice;TBX3 p.G496Afs*136;ERCC4 p.M361Wfs*15;TET2 p.T229Hfs*21;MEN1 p.R521Gfs*43	1	17
P-0007996	P-0007996-T01-IM5	Outside	FFPE	Resection	250	113	30	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G154V;APC p.E1353Vfs*20;SOX9 p.W335*;CDKN1B p.H129Pfs*8	0	4
P-0007997	P-0007997-T01-IM5	In-House	FFPE	Resection	250	600	40	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	BRAF p.V600E;PIK3CA p.H1047R;APC p.S1465Rfs*9;KMT2D p.P2354Lfs*30;PTPRT p.P1075Rfs*6;PMS2 p.Y268Tfs*39;FLCN p.H429Tfs*39;ARID1A p.P224Rfs*8;EPHA3 p.M847Wfs*10;B2M p.S14Ffs*29;NOTCH3 p.X66_splice;ARID1A p.R2116Tfs*33;ARID1A p.G324Afs*39;CASP8 p.K473Nfs*?;ASXL2 p.G697Vfs*102;APC p.T1208Pfs*57	4	16
P-0007998	P-0007998-T02-IM5	In-House	FFPE	Biopsy	250	1023	10	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										BRAF p.T599dup	0	1
P-0007998	P-0007998-T01-IM5	In-House	FFPE	Cytology	250	792	30	Matched	Metastasis	Ascending Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;APC p.R1450*;MAP3K1 p.R1482*;BRAF p.T599dup;TP53 p.V122Dfs*26;APC p.N936Kfs*14	1	6
P-0007999	P-0007999-T01-IM5	Outside	FFPE	Resection	250	868	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106_R108del)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)	Cetuximab,Panitumumab(KRAS p.G12R)			LEVEL_3B	KRAS p.G12R;ERBB3 p.D297Y;RNF43 p.P660Sfs*87;PIK3CA p.G106_R108del;CDH1 p.F98Sfs*19	2	5
P-0008000	P-0008000-T01-IM5	In-House	FFPE	Biopsy	159.7	707	20	Matched	Metastasis	Lung	Liver	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.X307_splice;RB1 G840fs	0	2
P-0008001	P-0008001-T01-IM5	Outside	FFPE	Resection	250	909	85	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Avapritinib,Ripretinib(KIT p.D816V);Olaparib(CDK12 p.Y210*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Y210*)				LEVEL_3B	KIT p.D816V;CDK12 p.Y210*	3	2
P-0008002	P-0008002-T01-IM5	In-House	FFPE	Resection	250	823	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A60Rfs*86)				LEVEL_3B	PIK3CA p.E542K;TP53 p.C242Afs*5;MGA p.W763*;TP53 p.M133I;TP53 p.C135Lfs*14;CDKN2A p.A60Rfs*86	2	6
P-0008003	P-0008003-T01-IM5	Outside	FFPE	Biopsy	250	814	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 TIMP2-NF1 fusion);Trametinib,Cobimetinib(TIMP2 TIMP2-NF1 fusion)				LEVEL_4	TP53 p.L22Yfs*22;NF1 TIMP2-NF1 fusion;TIMP2 TIMP2-NF1 fusion	2	3
P-0008004	P-0008004-T01-IM5	In-House	FFPE	Biopsy	250	911	10	Matched	Metastasis	GE Junction	Lung	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TGFBR2 p.X508_splice;STK11 p.M136Nfs*24;MDM2 Amplification	1	3
P-0008005	P-0008005-T01-IM5	Outside	FFPE	Resection	250	824	60	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.X55_splice)				LEVEL_4	PTEN p.X55_splice;VHL p.R79_S80del	1	2
P-0008006	P-0008006-T01-IM5	In-House	FFPE	Resection	250	723	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_4	PTEN p.X70_splice;MAP2K4 p.S280*	1	2
P-0008007	P-0008007-T01-IM5	Outside	FFPE	Biopsy	250	625	50	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_3A	ERBB2 p.L755S;ERBB3 p.E928G;CDH1 p.X178_splice	2	3
P-0008008	P-0008008-T01-IM5	In-House	FFPE	Biopsy	250	511	20	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma											0	0
P-0008008	P-0008008-T02-IM5	In-House	FFPE	Resection	250	731	25	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma											0	0
P-0008009	P-0008009-T01-IM5	Outside	FFPE	Resection	250	747	50	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61R;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0008010	P-0008010-T01-IM5	In-House	FFPE	Biopsy	250	678	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	KDM6A p.Y890*;ERBB2 Amplification;MAP2K4 Deletion;NCOR1 Deletion	2	4
P-0008011	P-0008011-T01-IM5	Outside	FFPE	Resection	250	655	40	Matched	Metastasis	Uterus	Lymph Node	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;PPP2R1A p.P179R;TP53 p.V216M;PIK3CA p.M1043I	2	4
P-0008012	P-0008012-T01-IM5	Outside	FFPE	Cytology	146.2	579	15	Matched	Primary	Skin	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R248W;PIK3CA p.E542K;RAF1 p.S259F;RBM10 p.G467Afs*52;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0008013	P-0008013-T01-IM5	In-House	FFPE	Resection	250	772	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H	1	2
P-0008014	P-0008014-T01-IM5	In-House	FFPE	Resection	250	653	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	SMAD4 p.D537G;KRAS p.Q61H;TP53 p.A161_I162delinsPS	1	3
P-0008015	P-0008015-T01-IM5	In-House	FFPE	Biopsy	250	812	80	Matched	Metastasis	Ileum	Liver	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS					Trametinib,Cobimetinib(NF1 p.L179*);Trametinib,Cobimetinib(NF1 p.Y1989*)				LEVEL_4	NF1 p.L179*;NF1 p.Y1989*;BCOR p.A320Wfs*57;DIS3 Deletion;SMAD2 Deletion	2	5
P-0008016	P-0008016-T01-IM5	Outside	FFPE	Resection	250	693	75	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;BAP1 p.Q28*	0	2
P-0008017	P-0008017-T01-IM5	Outside	FFPE	Biopsy	226.7	619	20	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0008018	P-0008018-T01-IM5	Outside	FFPE	Resection	250	690	70	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;BAP1 p.R701Hfs*11	0	2
P-0008019	P-0008019-T01-IM5	In-House	FFPE	Resection	250	670	75	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.H179Q;APC p.E1309Dfs*4;FBXW7 p.S562*	0	3
P-0008020	P-0008020-T01-IM5	Outside	FFPE	Biopsy	250	722	50	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;BAP1 p.R146K	1	2
P-0008022	P-0008022-T02-IM5	Outside	FFPE	Resection	250	730	60	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R337H)					LEVEL_3B	TP53 p.R248W;SMAD4 p.D537G;ATM p.R337H;PIK3R1 p.G376R;TP53 p.N131S;ARID1A p.Q1420*;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;MYC Amplification;SRC Amplification	1	11
P-0008023	P-0008023-T01-IM5	In-House	FFPE	Resection	250	597	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(BARD1 p.W629*)					LEVEL_3B	TP53 p.R213*;BARD1 p.W629*;BBC3 p.X126_splice;PTPRT p.M798Tfs*54;ZNF778 ANKRD11-ZNF778 fusion;ANKRD11 ANKRD11-ZNF778 fusion	1	6
P-0008025	P-0008025-T01-IM5	Outside	FFPE	Resection	250	501	35	Matched	Primary	Bile Duct	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										TP53 p.K382Nfs*40;ARID1A p.G838*;KMT2D p.R1702*;PBRM1 p.N258Mfs*25;ARID1B p.Q1183Sfs*15	0	5
P-0008026	P-0008026-T01-IM5	In-House	FFPE	Resection	250	710	90	Matched	Metastasis	Adrenal Gland	Liver	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Tipifarnib(HRAS p.Q61K)					LEVEL_3B	HRAS p.Q61K;MYCN Amplification	1	2
P-0008027	P-0008027-T01-IM5	In-House	FFPE	Biopsy	250	405	25	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.N345K;FOXA1 p.Y259C;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	3	6
P-0008028	P-0008028-T01-IM5	Outside	FFPE	Biopsy	95	127	20	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;BAP1 p.Q456*	2	2
P-0008029	P-0008029-T01-IM5	In-House	FFPE	Resection	250	630	75	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.H2038Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;ATM p.H2038Q	2	2
P-0008030	P-0008030-T01-IM5	Outside	FFPE	Biopsy	250	552	30	Matched	Primary	Leg	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0008031	P-0008031-T01-IM5	Outside	FFPE	Biopsy	250	799	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.Q1406*;APC p.K1192*	0	3
P-0008032	P-0008032-T01-IM5	Outside	FFPE	Resection	250	569	85	Matched	Metastasis	Lung	Brain	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.E271K;STK11 p.X288_splice;SF3B1 p.K666M;SETD2 p.S1763*;TP53 p.E285Q;KMT2C p.P2217Lfs*22;KEAP1 p.V420Gfs*25;ERBB2 Amplification;SMARCA4 Deletion	1	9
P-0008033	P-0008033-T01-IM5	In-House	FFPE	Biopsy	250	760	80	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	BMPR1A Deletion;PTEN Deletion	1	2
P-0008034	P-0008034-T01-IM5	In-House	FFPE	Resection	250	557	35	Matched	Primary	Duodenum	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				Everolimus(TSC2 p.X786_splice)					LEVEL_3B	RNF43 p.G659Vfs*41;ARID1A p.P1115Qfs*46;GNAS p.R201C;PIK3R2 p.G373R;SPEN p.P2495Lfs*4;RHOA p.Y42C;INHA p.L189Cfs*2;HIST1H3H p.T4A;TGFBR1 p.R413*;TSC2 p.X786_splice;PRKN p.G329Afs*106;TNFAIP3 p.K759Sfs*57;RASA1 p.A148Rfs*26	1	13
P-0008035	P-0008035-T01-IM5	In-House	FFPE	Biopsy	103	56	50	Matched	Primary	Brain	Not Applicable	Tumor	LGGNOS	Glioma	Low-Grade Glioma, NOS				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.D281H;IDH1 p.R132H;ATRX p.T684Sfs*2	1	3
P-0008036	P-0008036-T01-IM5	In-House	FFPE	Biopsy	250	768	65	Matched	Metastasis	Hypopharynx	Lung	Tumor	HPHSC	Head and Neck Cancer	Hypopharynx Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.V216M;NFE2L2 p.R34Q;TP53 p.Y220*;CDKN2A Deletion;CDKN2B Deletion;BAP1 PHF7-BAP1 fusion;PHF7 PHF7-BAP1 fusion	1	7
P-0008037	P-0008037-T01-IM5	In-House	FFPE	Resection	250	482	40	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R280S	0	1
P-0008038	P-0008038-T01-IM5	In-House	FFPE	Resection	250	881	50	Matched	Primary	Appendix	Not Applicable	Tumor	GCCAP	Appendiceal Cancer	Goblet Cell Carcinoid of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;INHBA p.R379W	1	2
P-0008039	P-0008039-T01-IM5	In-House	FFPE	Biopsy	250	677	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;ARID1A p.K1938Qfs*7	1	2
P-0008040	P-0008040-T01-IM5	In-House	FFPE	Resection	250	862	20	Matched	Metastasis	Uterus	Ascites	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.C124Yfs*24	2	2
P-0008041	P-0008041-T01-IM5	Outside	FFPE	Cytology	101	134	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L16Pfs*9)				LEVEL_3B	TP53 p.E171*;KRAS p.Q61H;TP53 p.H168_T170dup;CDKN2A p.L16Pfs*9;FGFR1 Amplification	3	5
P-0008042	P-0008042-T01-IM5	In-House	FFPE	Biopsy	250	823	25	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C176Y;APC p.E941*	0	2
P-0008043	P-0008043-T01-IM5	In-House	FFPE	Biopsy	250	705	30	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.E60Sfs*59	0	1
P-0008044	P-0008044-T01-IM5	In-House	FFPE	Resection	250	676	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008045	P-0008045-T01-IM5	Outside	FFPE	Resection	250	298	70	Matched	Primary	Ear Canal	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0008046	P-0008046-T01-IM5	In-House	FFPE	Resection	250	996	45	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0008047	P-0008047-T01-IM5	In-House	FFPE	Resection	250	680	70	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0008048	P-0008048-T01-IM5	In-House	FFPE	Biopsy	250	918	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1044K)					LEVEL_3B	TP53 p.W91*;PIK3CA p.N1044K;FOXA1 p.Q263_D296delinsH;AR Amplification	1	4
P-0008049	P-0008049-T01-IM5	In-House	FFPE	Resection	250	842	35	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 p.X2659_splice)		Rucaparib,Niraparib(BRCA2 p.X2659_splice)					LEVEL_2	BRCA2 p.X2659_splice;CDH1 p.X337_splice;ZFHX3 p.R715*;RB1 p.X314_splice;TBX3 p.M634Afs*254	2	5
P-0008050	P-0008050-T01-IM5	In-House	FFPE	Cytology	135.7	437	25	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0008051	P-0008051-T01-IM5	Outside	FFPE	Biopsy	250	413	70	Matched	Primary	Rectum	Not Applicable	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	CDK6 Amplification;ETV1 Amplification;FGFR4 Amplification;MDM2 Amplification;MET Amplification	2	5
P-0008052	P-0008052-T01-IM5	In-House	FFPE	Resection	250	839	75	Matched	Metastasis	Ovary	Colon	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R306*;MYC Amplification	0	2
P-0008053	P-0008053-T01-IM5	Outside	FFPE	Biopsy	250	768	25	Matched	Metastasis	Kidney	Peritoneum	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.X856_splice;VHL p.N193Kfs*63;SETD2 p.L300*	0	3
P-0008054	P-0008054-T01-IM5	Outside	FFPE	Resection	250	833	25	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;EED FAT3-EED fusion;FAT3 FAT3-EED fusion	1	5
P-0008055	P-0008055-T02-IM5	In-House	FFPE	Biopsy	250	884	40	Matched	Primary	Rectum	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X2659_splice)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.D228*;NFE2L2 p.G31R;NCOR1 p.A1582Efs*28;BRCA2 p.X2659_splice;PTEN Deletion	2	5
P-0008055	P-0008055-T01-IM5	In-House	FFPE	Biopsy	250	205	20	Matched	Primary	Testis	Not Applicable	Tumor	HDCN	Histiocytosis	Histiocytic and Dendritic Cell Neoplasms											0	0
P-0008056	P-0008056-T01-IM5	Outside	FFPE	Biopsy	136.3	105	10	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R	1	1
P-0008057	P-0008057-T01-IM5	In-House	FFPE	Resection	250	846	25	Matched	Metastasis	Prostate	Skull	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ASXL1 p.Q372*;TP53 p.X307_splice;KMT2D p.Y5451Pfs*5;AR Amplification;RB1 Deletion	0	5
P-0008058	P-0008058-T01-IM5	In-House	FFPE	Resection	250	1000	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.X331_splice;HLA-A p.W171*;KMT2D p.Q3821Rfs*9;CCND1 Amplification;EGFR Amplification;FGF19 Amplification	0	6
P-0008059	P-0008059-T01-IM5	Outside	FFPE	Resection	216.3	215	70	Matched	Metastasis	Sigmoid Colon	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.R335*)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;PTEN p.R335*;APC p.E1306*	2	3
P-0008060	P-0008060-T01-IM5	Outside	FFPE	Resection	250	682	90	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Olaparib(RAD51B Deletion)					LEVEL_3B	IDH1 p.R132H;CIC p.R215W;SETD2 p.R2063Tfs*83;FUBP1 p.G171Dfs*20;FUBP1 p.A137Yfs*4;RAD51B Deletion	2	6
P-0008061	P-0008061-T01-IM5	Outside	FFPE	Resection	250	567	80	Matched	Metastasis	Kidney	Brain	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.D24G)				LEVEL_4	PTEN p.D24G;KDM5C p.R198*;PBRM1 p.R434*;ARID1A p.G95Afs*6;VHL p.L158Pfs*16;SETD2 p.Y450Tfs*34;RAB9BP1 APC-RAB9BP1 fusion;APC APC-RAB9BP1 fusion	1	8
P-0008062	P-0008062-T01-IM5	In-House	FFPE	Resection	250	752	70	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Tazemetostat(KDM6A p.S1114Ifs*37)				LEVEL_3B	KMT2D p.S2488*;KDM6A p.S1114Ifs*37;TP53 p.C238Vfs*9;STAG2 p.I375Lfs*4;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	2	7
P-0008063	P-0008063-T01-IM5	In-House	FFPE	Resection	250	605	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN p.X212_splice);Trametinib,Cobimetinib,Binimetinib(KRAS p.K5E)	Cetuximab,Panitumumab(KRAS p.K5E)			LEVEL_4	APC p.R213*;TP53 p.T125M;PTEN p.X212_splice;KRAS p.K5E;APC p.V1414Afs*3	2	5
P-0008064	P-0008064-T01-IM5	In-House	FFPE	Resection	250	735	40	Matched	Primary	Pharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.I547V);Palbociclib,Ribociclib,Abemaciclib(EEA1 CDKN2A-EEA1 fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-EEA1 fusion)				LEVEL_4	TP53 p.C238Y;FGFR2 p.I547V;AKT1 Amplification;FOXA1 Amplification;NKX2-1 Amplification;EEA1 CDKN2A-EEA1 fusion;CDKN2A CDKN2A-EEA1 fusion	3	7
P-0008065	P-0008065-T01-IM5	In-House	FFPE	Resection	250	718	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										APC p.E428*;NCOR1 p.M2226Gfs*8;VHL p.V166Sfs*4	0	3
P-0008066	P-0008066-T01-IM5	In-House	FFPE	Biopsy	250	1108	90	Matched	Metastasis	Salivary Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										ARID1A p.E1733*;RB1 Deletion	0	2
P-0008067	P-0008067-T01-IM5	In-House	FFPE	Resection	250	231	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										MGA p.Y2424*	0	1
P-0008068	P-0008068-T01-IM5	In-House	FFPE	Resection	250	1327	50	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)		Cetuximab,Panitumumab(NRAS p.G12D)			LEVEL_3B	ASXL1 p.G646Wfs*12;APC p.R232*;NRAS p.G12D;CIC p.Q172*;TP53 p.Q144Sfs*26	1	5
P-0008069	P-0008069-T02-IM5	In-House	FFPE	Biopsy	250	1203	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	TP53 p.R175H;KMT2D p.S2431Lfs*53;TP53 p.Y234S;CTCF p.V124Tfs*15;FUBP1 Deletion;SMARCB1 Deletion	1	6
P-0008069	P-0008069-T01-IM5	In-House	FFPE	Cytology	250	895	15	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	SMARCB1 Deletion	1	1
P-0008071	P-0008071-T01-IM5	In-House	FFPE	Biopsy	250	998	80	Unmatched	Primary	Pelvis	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										GPS2 p.E46Nfs*16;KMT2D p.E500*;TP53 p.Y126H;KMT2D p.S892Afs*5;CDKN2A Deletion;CDKN2B Deletion;MYC Amplification;FAM238C APC-NCRNA00202 fusion;APC APC-NCRNA00202 fusion;APC GLRA1-APC fusion;GLRA1 GLRA1-APC fusion;APC DTWD2-APC fusion;DTWD2 DTWD2-APC fusion;APC PRELID2-APC fusion;PRELID2 PRELID2-APC fusion	0	15
P-0008072	P-0008072-T01-IM5	In-House	FFPE	Resection	250	751	70	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0008073	P-0008073-T01-IM5	In-House	FFPE	Biopsy	250	910	70	Matched	Metastasis	Tonsil	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;KMT2C p.L2189Nfs*7;FLT3 Amplification	1	3
P-0008074	P-0008074-T01-IM5	In-House	FFPE	Biopsy	250	862	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R249G;BRD4 Amplification;PTEN Deletion;RHEB Amplification	1	4
P-0008075	P-0008075-T01-IM5	In-House	FFPE	Resection	250	614	70	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.R283*;APC p.F1396Lfs*19;SOX9 p.K106*;TP53 p.D61Vfs*62	0	5
P-0008077	P-0008077-T01-IM5	In-House	FFPE	Resection	209.6	243	40	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 Amplification;MCL1 Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0008077	P-0008077-T02-IM5	In-House	FFPE	Resection	250	303	65	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.V272L;ARID2 p.Q613*	0	2
P-0008078	P-0008078-T01-IM5	Outside	FFPE	Cytology	250	967	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	PIK3CA p.H1047R;EGFR p.E746_A750del;TP53 p.X126_splice;FAT1 p.Y2427*;RB1 p.N328Ifs*4;MCL1 Amplification;NTRK1 Amplification	2	7
P-0008079	P-0008079-T01-IM5	Outside	FFPE	Resection	250	707	40	Matched	Metastasis	Descending Colon	Omentum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.E847*;MGA p.L2167Gfs*27;BCL2L1 Amplification	0	4
P-0008080	P-0008080-T01-IM5	In-House	FFPE	Cytology	250	720	90	Matched	Metastasis	Skin	Stomach	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.T831Rfs*33);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88K)				LEVEL_4	TP53 p.S127F;CREBBP p.S1778L;FAT1 p.Q3192*;APC p.S142*;EPHA7 p.X795_splice;GNAQ p.Q209H;B2M p.X23_splice;NF1 p.T831Rfs*33;CDKN2A p.E88K;SETD2 IP6K1-SETD2 fusion;IP6K1 IP6K1-SETD2 fusion	2	11
P-0008081	P-0008081-T01-IM5	In-House	FFPE	Resection	250	385	70	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K	1	1
P-0008082	P-0008082-T01-IM5	Outside	FFPE	Resection	153	217	60	Matched	Metastasis	Breast	Trachea	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Olaparib,Talazoparib(BRCA2 BRCA2-intragenic)	AZD9496,Fulvestrant(ESR1 p.D538G)	Everolimus(TSC2 p.R120Sfs*53);Rucaparib,Niraparib(BRCA2 BRCA2-intragenic)					LEVEL_2	ESR1 p.D538G;PMS1 p.C101*;PTPRD p.X608_splice;TSC2 p.R120Sfs*53;BRCA2 BRCA2-intragenic	4	5
P-0008083	P-0008083-T01-IM5	In-House	FFPE	Cytology	206	369	35	Matched	Metastasis	Ascending Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(PALB2 p.E545*)					LEVEL_3B	ERBB3 p.G284R;TP53 p.R110L;APC p.W553*;EGFR p.R776H;BRAF p.F247L;PALB2 p.E545*;SMAD4 p.D165Rfs*31;ZFHX3 p.N2855Sfs*3	1	8
P-0008084	P-0008084-T02-IM5	In-House	FFPE	Biopsy	250	942	70	Matched	Metastasis	Small Bowel	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V654A);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559_P573del)				GSK2636771,AZD8186(PTEN p.R130Q)		Imatinib(KIT p.V654A)		LEVEL_1	PTEN p.R130Q;KIT p.V654A;SETD2 p.K2001*;EPHB1 p.N749K;KIT p.V559_P573del	3	5
P-0008084	P-0008084-T01-IM5	In-House	FFPE	Resection	250	510	35	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559_P573del)								LEVEL_1	SETD2 p.K2001*;EPHB1 p.N749K;KIT p.V559_P573del	1	3
P-0008085	P-0008085-T01-IM5	In-House	FFPE	Resection	250	640	80	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										CDKN2C p.D76Sfs*2	0	1
P-0008094	P-0008094-T01-IM5	In-House	FFPE	Resection	250	539	25	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	ERBB2 Amplification	2	1
P-0008095	P-0008095-T01-IM5	Outside	FFPE	Resection	250	246	70	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R213*;APC p.Q1303*;APC p.E578*	1	4
P-0008097	P-0008097-T01-IM5	In-House	FFPE	Resection	250	993	30	Matched	Primary	Oropharynx	Not Applicable	Tumor	HPHSC	Head and Neck Cancer	Hypopharynx Squamous Cell Carcinoma										TP53 p.R175H	0	1
P-0008098	P-0008098-T01-IM5	In-House	FFPE	Biopsy	250	882	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Everolimus(TSC2 p.L81Rfs*26);Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	AR p.H875Y;SPOP p.Y87D;TSC2 p.L81Rfs*26;BRCA2 Deletion;KMT2C Deletion	3	5
P-0008099	P-0008099-T01-IM5	In-House	FFPE	Resection	250	929	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.N310Kfs*27;KDM5A Amplification	1	3
P-0008100	P-0008100-T01-IM5	Outside	FFPE	Resection	250	939	70	Unmatched	Primary	Neck	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.F113S;KMT2D p.R4536*	0	2
P-0008101	P-0008101-T01-IM5	In-House	FFPE	Biopsy	77.58	674	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Crizotinib(MET Amplification);Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)	Cabozantinib(MET Amplification)	Everolimus,Temsirolimus(MTOR p.Y1463F)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	TP53 p.Y163H;MTOR p.Y1463F;MET Amplification;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	9	5
P-0008102	P-0008102-T01-IM5	Outside	FFPE	Resection	250	1268	90	Matched	Metastasis	Bone	Lung	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	TP53 p.G245S;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	3
P-0008103	P-0008103-T01-IM5	In-House	FFPE	Biopsy	250	1195	90	Matched	Metastasis	Thyroid	Mediastinum	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(ATM p.M1714Afs*6)					LEVEL_3B	BRAF p.V600E;ATM p.M1714Afs*6;GATA3 GATA3-intragenic	2	3
P-0008104	P-0008104-T01-IM5	In-House	FFPE	Resection	250	768	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.S463P)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	ESR1 p.S463P;AURKA Amplification;FGFR1 Amplification	2	3
P-0008105	P-0008105-T01-IM5	In-House	FFPE	Biopsy	250	745	40	Matched	Primary	Oropharynx	Not Applicable	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L78Hfs*41)				LEVEL_3B	FBXW7 p.S678*;TP53 p.T125M;FAT1 p.R1627*;FAT1 p.Q600*;TP53 p.A276_E285del;CDKN2A p.L78Hfs*41;FGFR1 Amplification	2	7
P-0008106	P-0008106-T01-IM5	In-House	FFPE	Resection	250	1129	70	Matched	Primary	Bladder	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										TP53 p.E286*	0	1
P-0008123	P-0008123-T01-IM5	Outside	FFPE	Resection	250	192	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer					PLX8394(BRAF p.G469A)				LEVEL_4	BRAF p.G469A	1	1
P-0008124	P-0008124-T01-IM5	In-House	FFPE	Resection	250	489	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0008125	P-0008125-T01-IM5	In-House	FFPE	Biopsy	250	1076	90	Matched	Primary	Bone	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;FGF19 Amplification;APC ADH5-APC fusion;ADH5 ADH5-APC fusion	1	7
P-0008126	P-0008126-T01-IM5	Outside	FFPE	Resection	250	1231	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.Q628Pfs*7);Olaparib(ATM p.Q2684*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;ATM p.Q628Pfs*7;ATM p.Q2684*;STK11 p.E57*	3	4
P-0008127	P-0008127-T02-IM5	In-House	FFPE	Biopsy	239.9	792	60	Matched	Metastasis	Pleura	Lymph Node	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										TP53 p.P142Lfs*28;TP53 p.R156Afs*12;AKT2 Amplification;PIK3R2 Amplification	0	4
P-0008127	P-0008127-T01-IM5	Outside	FFPE	Cytology	250	764	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLBMESO	Mesothelioma	Pleural Mesothelioma, Biphasic Type										TP53 p.P142Lfs*28;TP53 p.R156Afs*12;PIK3R2 Amplification	0	3
P-0008128	P-0008128-T01-IM5	Outside	FFPE	Resection	250	855	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);GSK2636771,AZD8186(PTEN Deletion)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G13D;APC p.M1431Efs*38;APC p.G309Efs*27;PTEN Deletion	3	5
P-0008129	P-0008129-T01-IM5	In-House	FFPE	Biopsy	250	1112	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma										RHOA p.G17V;TET2 p.R1359S;DNMT3A p.Q249*	0	3
P-0008130	P-0008130-T01-IM5	Outside	FFPE	Biopsy	250	1011	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										AKT1 p.E17K;TP53 p.V73Rfs*76;TET2 p.R1516*;TET2 p.C1273R;CDK6 Amplification;MET Amplification	0	6
P-0008131	P-0008131-T01-IM5	Outside	FFPE	Resection	250	1013	90	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)	Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L858R;TP53 p.X224_splice;ARID1B p.Q149*;BRAF Amplification;CDKN2A Deletion;CDKN2B Deletion;EZH2 Amplification;MET Amplification;RHEB Amplification	4	9
P-0008132	P-0008132-T01-IM5	In-House	FFPE	Biopsy	93.275	729	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.P152T	0	1
P-0008133	P-0008133-T01-IM5	In-House	FFPE	Resection	250	1016	70	Matched	Metastasis	Cecum	Brain	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K);Trametinib,Cobimetinib(MAP2K1 p.G128V)		Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	NRAS p.Q61K;FBXW7 p.R367*;APC p.T1487Nfs*27;DICER1 p.D1810N;TP53 p.X33_splice;MAP2K1 p.G128V;CDK8 Amplification;FLT3 Amplification;NKX3-1 Deletion	2	9
P-0008134	P-0008134-T01-IM5	Outside	FFPE	Cytology	250	1185	70	Matched	Metastasis	Lung	pericardial Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_1	MED12 p.X69_splice;CDKN2A p.H83Y;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	3	4
P-0008135	P-0008135-T01-IM5	Outside	FFPE	Resection	250	778	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										TP53 p.X125_splice	0	1
P-0008136	P-0008136-T01-IM5	In-House	FFPE	Resection	250	803	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.A118V;MAP2K4 p.E203*;TP53 p.X206_splice	1	4
P-0008137	P-0008137-T01-IM5	Outside	FFPE	Resection	250	1269	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										ARID1A p.S11Afs*91;VHL p.X114_splice	0	2
P-0008138	P-0008138-T01-IM5	Outside	FFPE	Biopsy	250	1152	80	Matched	Metastasis	Cancer of Unknown Primary	Abdominal Wall	Tumor	MUP	Melanoma	Melanoma of Unknown Primary										SOX9 Deletion	0	1
P-0008139	P-0008139-T02-IM5	In-House	FFPE	Biopsy	214.3	879	15	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification;FGFR3 Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0008139	P-0008139-T01-IM5	In-House	FFPE	Cytology	118	256	10	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM Deletion)								LEVEL_1	ATM Deletion;AXIN2 Deletion;FGFR3 Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	5
P-0008140	P-0008140-T01-IM5	In-House	FFPE	Biopsy	250	843	60	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas				Trametinib,Cobimetinib(SND1 BRAF-SND1 fusion);Trametinib,Cobimetinib(BRAF BRAF-SND1 fusion)					LEVEL_3B	PMS2 Deletion;SND1 BRAF-SND1 fusion;BRAF BRAF-SND1 fusion	2	3
P-0008141	P-0008141-T01-IM5	In-House	FFPE	Resection	250	814	75	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.E1353*;TP53 p.Y107*;VEGFA Amplification	0	3
P-0008142	P-0008142-T02-IM5	Outside	FFPE	Resection	250	855	10	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V;SMAD4 p.R445*;RNF43 p.Q180*;TP53 p.T231Nfs*9	2	5
P-0008143	P-0008143-T01-IM5	In-House	FFPE	Resection	250	794	80	Matched	Metastasis	Cervix	Ovary	Tumor	CEMU	Cervical Cancer	Mucinous Carcinoma										TP53 p.N235D;SMAD4 Deletion;TERT Amplification	0	3
P-0008144	P-0008144-T01-IM5	In-House	FFPE	Biopsy	250	1163	40	Unmatched	Primary	Perineum	Not Applicable	Tumor	MZL	Mature B-Cell Neoplasms	Marginal Zone Lymphoma											0	0
P-0008145	P-0008145-T01-IM5	In-House	FFPE	Biopsy	250	703	85	Matched	Primary	Breast	Not Applicable	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS				Afatinib(EGFR p.G719A)					LEVEL_3B	EGFR p.E709K;EGFR p.G719A;TP53 p.H179Y;NF2 p.X525_splice;CCND3 Amplification	1	5
P-0008145	P-0008145-T02-IM5	In-House	FFPE	Biopsy	250	917	70	Matched	Metastasis	Breast	Soft Tissue	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS				Afatinib(EGFR p.G719A);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	EGFR p.E709K;EGFR p.G719A;TP53 p.H179Y;NF2 p.X525_splice;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;MYC Amplification;VEGFA Amplification	3	10
P-0008146	P-0008146-T01-IM5	Outside	FFPE	Biopsy	250	680	50	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(BICC1 FGFR2-BICC1 fusion);Pemigatinib(FGFR2 FGFR2-BICC1 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(BICC1 FGFR2-BICC1 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-BICC1 fusion)						LEVEL_1	BAP1 p.S492Rfs*6;BICC1 FGFR2-BICC1 fusion;FGFR2 FGFR2-BICC1 fusion	4	3
P-0008147	P-0008147-T01-IM5	In-House	FFPE	Resection	250	730	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0008148	P-0008148-T01-IM5	In-House	FFPE	Resection	250	835	20	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;CDH1 p.R74*	2	2
P-0008149	P-0008149-T01-IM5	Outside	FFPE	Resection	250	675	80	Matched	Primary	Bladder	Not Applicable	Tumor	SCBC	Bladder Cancer	Small Cell Bladder Cancer										TP53 p.R248W;BCL2L1 Amplification;GATA3 Deletion;IKZF1 Deletion;RB1 Deletion	0	5
P-0008150	P-0008150-T01-IM5	In-House	FFPE	Resection	250	992	85	Matched	Primary	Lung	Not Applicable	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										MEN1 p.R532*	0	1
P-0008151	P-0008151-T01-IM5	Outside	FFPE	Resection	250	868	90	Matched	Primary	Soft Palate	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										RIT1 p.Q79E;ARID5B p.D521Rfs*7	0	2
P-0008152	P-0008152-T01-IM5	In-House	FFPE	Biopsy	250	709	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Ivosidenib(IDH1 p.R132C)					LEVEL_1	BRAF p.V600E;IDH1 p.R132C	3	2
P-0008153	P-0008153-T01-IM5	In-House	FFPE	Biopsy	250	743	90	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	GSK2636771,AZD8186(PTEN p.E150Vfs*4)				LEVEL_3B	BCOR p.N1459S;PIK3CA p.H1047R;CTNNB1 p.T41I;PIK3CA p.R88Q;ARID1A p.S11Afs*90;PTEN p.E150Vfs*4;SOX17 p.L167Wfs*213;ARID1A p.X957_splice;MAP3K1 p.K272*;KEAP1 Deletion;SMARCA4 Deletion	3	11
P-0008154	P-0008154-T01-IM5	In-House	FFPE	Resection	250	1012	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.P152L	1	2
P-0008155	P-0008155-T01-IM5	In-House	FFPE	Resection	250	1128	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.V105_N107delinsG)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V105_N107delinsG)						LEVEL_1	SF3B1 p.K700E;TP53 p.R337C;PIK3CA p.V105_N107delinsG	2	3
P-0008156	P-0008156-T01-IM5	Outside	FFPE	Resection	250	1061	40	Matched	Primary	Anal	Not Applicable	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS										ERBB3 p.G284R;TP53 p.Y234H;BCL2L1 Amplification;BRD4 Amplification;MYC Amplification;KREMEN1 SMARCA4-KREMEN1 fusion;SMARCA4 SMARCA4-KREMEN1 fusion	0	7
P-0008157	P-0008157-T01-IM5	In-House	FFPE	Biopsy	250	645	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R249M	1	2
P-0008158	P-0008158-T01-IM5	In-House	FFPE	Resection	250	634	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13V)				LEVEL_4	TP53 p.R248W;SETD2 p.Q872*;ARID1A p.R2233Gfs*34;KRAS p.G13V	1	4
P-0008159	P-0008159-T01-IM5	Outside	FFPE	Biopsy	137.3	140	35	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.V1099Ffs*19;ARID1A p.G1848Wfs*6	0	3
P-0008160	P-0008160-T01-IM5	In-House	FFPE	Biopsy	250	867	50	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)						LEVEL_3A	TP53 p.P152L;EGFR p.E709_T710delinsD	1	2
P-0008160	P-0008160-T02-IM5	In-House	FFPE	Cytology	250	620	90	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)	Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	TP53 p.P152L;EGFR p.E709_T710delinsD;AKT1 Amplification;BRCA2 Deletion;CARD11 Amplification;CCNE1 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;EPHA7 Deletion;ETV1 Amplification;FOXO1 Deletion;NKX2-1 Amplification;NKX3-1 Deletion;RAC1 Amplification;SOX17 Deletion	3	16
P-0008161	P-0008161-T01-IM5	In-House	FFPE	Biopsy	250	1182	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	EPHA3 p.R510*;STK11 p.K191*;NF2 p.Q400Efs*6;KEAP1 p.M550*;NF1 NF1-intragenic	1	5
P-0008161	P-0008161-T02-IM5	In-House	FFPE	Biopsy	250	756	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	STK11 p.K191*;KEAP1 p.M550*;NF1 NF1-intragenic	1	3
P-0008162	P-0008162-T02-IM5	In-House	FFPE	Resection	250	883	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor											0	0
P-0008163	P-0008163-T01-IM5	Outside	FFPE	Resection	250	1087	30	Matched	Metastasis	Thyroid	Neck	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;ZFHX3 p.Q1847*	1	2
P-0008164	P-0008164-T01-IM5	In-House	FFPE	Biopsy	250	797	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.R175H;ARID1A p.L1676Pfs*22	1	3
P-0008165	P-0008165-T01-IM5	In-House	FFPE	Resection	250	543	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R213*	1	2
P-0008166	P-0008166-T01-IM5	In-House	FFPE	Resection	250	583	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	2	6
P-0008167	P-0008167-T02-IM5	In-House	FFPE	Biopsy	250	521	35	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.E224D;CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;KRAS Amplification;NKX2-1 Amplification	2	7
P-0008167	P-0008167-T01-IM5	In-House	FFPE	Resection	250	451	50	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R175H;APC p.Q1367*;FBXW7 p.R689W	1	4
P-0008168	P-0008168-T01-IM5	In-House	FFPE	Resection	250	1067	40	Matched	Metastasis	Upper Tract	Lymph Node	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma					Tazemetostat(KDM6A p.L85Ffs*4)				LEVEL_4	TP53 p.V197M;SPOP p.F102L;KDM6A p.L85Ffs*4;ARID1A p.R2153Tfs*43;RBM10 p.K627Rfs*77;GPS2 TNFSF12-GPS2 fusion;TNFSF12 TNFSF12-GPS2 fusion	1	7
P-0008169	P-0008169-T01-IM5	In-House	FFPE	Biopsy	250	416	50	Matched	Metastasis	Oral Cavity	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.T2125Nfs*4)					LEVEL_3B	PIK3CA p.G118D;TP53 p.R342*;BRCA2 p.T2125Nfs*4;ATRX ATRX-intragenic	2	4
P-0008171	P-0008171-T01-IM5	In-House	FFPE	Resection	250	520	40	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CDH1 p.L714Rfs*33;STAG2 SLC25A14-STAG2 fusion;SLC25A14 SLC25A14-STAG2 fusion	2	4
P-0008172	P-0008172-T01-IM5	In-House	FFPE	Resection	250	1088	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	TP53 p.R273H;KRAS p.G12V	1	2
P-0008173	P-0008173-T01-IM5	In-House	FFPE	Resection	250	1015	50	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R248W;APC p.I1307Nfs*8	0	2
P-0008174	P-0008174-T01-IM5	In-House	FFPE	Biopsy	250	1307	NA	Matched	Metastasis	Cancer of Unknown Primary	Pleura	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.R335*)				LEVEL_4	KRAS p.G12V;SMAD4 p.R445*;SMARCA4 p.R1189Q;PTEN p.R335*;RBM10 p.Q169*	2	5
P-0008175	P-0008175-T01-IM5	In-House	FFPE	Resection	250	740	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.R175H;SMAD4 p.P215Qfs*19	1	3
P-0008176	P-0008176-T01-IM5	In-House	FFPE	Resection	250	698	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;NF2 p.X375_splice	1	2
P-0008177	P-0008177-T01-IM5	In-House	FFPE	Resection	250	714	90	Matched	Metastasis	Kidney	Lymph Node	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										NF2 p.L397Cfs*17	0	1
P-0008178	P-0008178-T01-IM5	Outside	FFPE	Biopsy	250	345	70	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	ERBB3 p.A232V;ERBB2 Amplification;ERBB3 Amplification;ATP1B2 TP53-ATP1B2 fusion;TP53 TP53-ATP1B2 fusion	2	5
P-0008179	P-0008179-T01-IM5	In-House	FFPE	Resection	250	1145	90	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CCND1 Amplification;FGF19 Amplification	0	2
P-0008180	P-0008180-T01-IM5	In-House	FFPE	Resection	250	836	50	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.V1862*);Everolimus(TSC2 p.L448P)					LEVEL_3B	ARID1A p.D1850Tfs*33;TP53 p.R273C;PPP2R1A p.R183W;KMT2D p.P647Hfs*283;BAP1 p.V27Cfs*45;ERCC4 p.M361Nfs*4;BRCA2 p.V1862*;MRE11 p.N511Ifs*13;B2M p.T93Lfs*10;KMT2D p.P998Lfs*2;TCF3 p.R525Gfs*76;MEN1 p.R521Gfs*43;MLH1 p.Q537*;RECQL4 p.Q235*;LATS2 p.X159_splice;TSC2 p.L448P;CDH1 p.W213*;SETD2 p.C805*;RNF43 p.P118Tfs*41;LATS1 p.K1011*;AXIN2 p.K253Nfs*15;PTPRD p.L663Wfs*25;EP300 p.S552Gfs*63;EP300 p.S24Gfs*14;BLM p.D757Rfs*18;DICER1 p.L1323*	2	26
P-0008181	P-0008181-T01-IM5	In-House	FFPE	Resection	250	784	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12L)				LEVEL_4	TP53 p.I254S;SMAD4 p.Y260*;KRAS p.G12L	1	3
P-0008182	P-0008182-T01-IM5	In-House	FFPE	Biopsy	250	952	65	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Enasidenib(IDH2 p.R172W)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3B	IDH2 p.R172W;NF2 p.R57*;KRAS p.G13D	2	3
P-0008184	P-0008184-T01-IM5	In-House	FFPE	Resection	250	611	20	Matched	Metastasis	Duodenum	Peritoneum	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;NCOR1 p.S903*;MYC p.S161L;BRAF p.F595L;TGFBR1 p.T375K	1	5
P-0008185	P-0008185-T01-IM5	In-House	FFPE	Resection	250	1095	90	Matched	Primary	Nasopharynx	Not Applicable	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;EP300 p.H2324Pfs*55;MLH1 p.X264_splice;KMT2D p.E4662*;KMT2D p.Q2416*;CREBBP p.Q963*;NOTCH1 p.G270Vfs*7;CCND1 Amplification;CDKN2B Deletion;FGF19 Amplification	1	10
P-0008186	P-0008186-T01-IM5	In-House	FFPE	Resection	250	639	90	Matched	Primary	Femoral Tendon	Not Applicable	Tumor	GS	Soft Tissue Sarcoma	Glomangiosarcoma											0	0
P-0008187	P-0008187-T01-IM5	Outside	FFPE	Resection	250	860	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 BRCA2-intragenic)					LEVEL_3B	TP53 p.W91*;ERBB3 p.F219L;SMAD4 p.Q28Kfs*17;BRCA2 BRCA2-intragenic	1	4
P-0008188	P-0008188-T01-IM5	Outside	FFPE	Biopsy	180	370	30	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Everolimus(TSC1 p.P603Rfs*26)					LEVEL_3B	PTCH1 p.S1203Afs*52;CREBBP p.I1084Sfs*15;PIK3CA p.H1047R;ARID1B p.R1611*;KMT2D p.R2830*;FBXW7 p.R367*;TSC1 p.P603Rfs*26;ARID1A p.Q372Sfs*19;MRE11 p.N511Ifs*13;DICER1 p.R745*;PTPRS p.X1830_splice;FOXP1 p.N558Kfs*22;KLF4 p.R309Afs*14;NOTCH3 p.A1802Lfs*23;ARID1A p.Q758Rfs*75;KMT2C p.P1543Hfs*20	3	16
P-0008189	P-0008189-T01-IM5	In-House	FFPE	Resection	250	785	90	Matched	Primary	Brain	Not Applicable	Tumor	APXA	Glioma	Anaplastic Pleomorphic Xanthoastrocytoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0008191	P-0008191-T01-IM5	Outside	FFPE	Biopsy	175.5	145	90	Matched	Primary	Abdominal Wall	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.X307_splice;ARID2 p.G964*;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0008192	P-0008192-T01-IM5	In-House	FFPE	Biopsy	250	998	40	Matched	Metastasis	Pleura	Lung	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0008204	P-0008204-T01-IM5	In-House	FFPE	Biopsy	250	828	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;TP53 p.C176R	2	2
P-0008205	P-0008205-T01-IM5	Outside	FFPE	Resection	250	683	50	Matched	Primary	Kidney	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.Y220C;RB1 p.S816Qfs*10;STAG2 p.S377Yfs*4;CCNE1 Amplification;PDGFRA Amplification;TERT Amplification	0	6
P-0008206	P-0008206-T01-IM5	In-House	FFPE	Biopsy	250	1141	70	Matched	Metastasis	Prostate	Neck	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.G245R;PTEN Deletion;RB1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	5
P-0008207	P-0008207-T01-IM5	In-House	FFPE	Biopsy	250	849	80	Matched	Metastasis	Uterus	Diaphragm	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Poziotinib(EGFR p.D770_P772dup)					LEVEL_3B	PIK3R1 p.I571_R574del;EGFR p.D770_P772dup	1	2
P-0008208	P-0008208-T01-IM5	In-House	FFPE	Resection	250	201	25	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma											0	0
P-0008210	P-0008210-T01-IM5	In-House	FFPE	Biopsy	117	158	50	Matched	Metastasis	Minor Salivary Gland	Skull	Tumor	OSACA	Salivary Gland Cancer	Salivary Carcinoma, Other										EWSR1 ATF1-EWSR1 fusion;ATF1 ATF1-EWSR1 fusion	0	2
P-0008211	P-0008211-T02-IM5	In-House	FFPE	Biopsy	250	850	60	Matched	Metastasis	Breast	Bone	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS										FOXA1 p.S242F;CCND1 Amplification;FGF19 Amplification;KRAS Amplification;PAK1 Amplification	0	5
P-0008211	P-0008211-T01-IM5	Outside	FFPE	Resection	250	552	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CCND1 Amplification;FGF19 Amplification;KRAS Amplification;PAK1 Amplification	0	4
P-0008212	P-0008212-T01-IM5	In-House	FFPE	Resection	250	847	70	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma											0	0
P-0008213	P-0008213-T02-IM5	In-House	FFPE	Biopsy	149.4	521	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.E285K;TP53 p.E271Q;CTCF p.H288R;ZFHX3 p.Q1584*;CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;MAP2K4 Deletion	1	9
P-0008213	P-0008213-T01-IM3	Outside	FFPE	Resection	250	710	60	Matched	Primary	Breast	Bone Marrow	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;CCND1 Amplification;FOXA1 Amplification;MAP2K4 Deletion;MCL1 Amplification;MYC Amplification	1	6
P-0008214	P-0008214-T01-IM5	In-House	FFPE	Biopsy	250	676	60	Matched	Metastasis	Oropharynx	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E120*)				LEVEL_4	TP53 p.R273L;NFE2L2 p.E79K;FBXW7 p.R505G;CASP8 p.R432*;FAT1 p.M2698Cfs*25;FAT1 p.E1100Vfs*9;CDKN2A p.E120*;CCND1 Amplification;FGF19 Amplification	1	9
P-0008215	P-0008215-T01-IM5	Outside	FFPE	Biopsy	250	778	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)	Olaparib,Talazoparib(BRCA2 p.K437Ifs*22)		Rucaparib,Niraparib(BRCA2 p.K437Ifs*22);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R248Q;BRCA2 p.K437Ifs*22;PRKN p.Q252*;CCND1 Amplification;ERBB2 Amplification;FOXA1 Amplification	4	6
P-0008224	P-0008224-T01-IM5	Outside	FFPE	Cytology	250	424	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	TP53 p.R273H;KRAS p.G12D;BLM p.L208Cfs*11	1	3
P-0008225	P-0008225-T01-IM5	In-House	FFPE	Resection	250	670	80	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.R280I;ATRX p.X1440_splice	1	3
P-0008226	P-0008226-T02-IM5	In-House	FFPE	Resection	250	854	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(PALB2 p.N280Tfs*8);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.X1663_splice);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.L557*);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.M1728Cfs*2)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	FBXW7 p.S668Vfs*39;PIK3CA p.H1047R;ARID1A p.D1850Tfs*33;APC p.T1556Nfs*3;APC p.R805*;PTPRS p.V608Wfs*30;MLH1 p.R100*;AXIN2 p.G665Afs*24;BCOR p.Q1208Tfs*8;KRAS p.G13D;AMER1 p.R353*;ERBB3 p.R475W;KMT2C p.R3507*;CIC p.S1117Kfs*34;PPM1D p.N512Kfs*16;PALB2 p.N280Tfs*8;SETD2 p.N1396Mfs*16;MGA p.Q1807*;B2M p.X23_splice;CREBBP p.X406_splice;BRCA1 p.X1663_splice;ARID1A p.A339Gfs*61;BRCA2 p.L557*;BRCA1 p.M1728Cfs*2;TET2 p.P410Sfs*33	6	25
P-0008227	P-0008227-T01-IM5	In-House	FFPE	Biopsy	250	822	70	Matched	Metastasis	Submandibular Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0008228	P-0008228-T01-IM5	Outside	FFPE	Resection	250	565	70	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Olaparib(CHEK2 p.R95*)					LEVEL_3B	PTPRT p.E548K;TP53 p.H179Y;PTPRD p.P1720L;KMT2A p.G3123*;PTPRT p.X287_splice;CHEK2 p.R95*;CARD11 Amplification;RAC1 Amplification;RAF1 Amplification	1	9
P-0008229	P-0008229-T01-IM5	In-House	FFPE	Resection	250	764	25	Matched	Metastasis	Larynx	Bone	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.R273L;TET2 p.R1516*;KMT2D p.R1757*;FGF19 Amplification	0	4
P-0008230	P-0008230-T01-IM5	Outside	FFPE	Resection	250	347	45	Matched	Metastasis	Spine	Lung	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0008231	P-0008231-T01-IM5	Outside	FFPE	Biopsy	250	1059	70	Matched	Primary	Mediastinum	Not Applicable	Tumor	TYST	Germ Cell Tumor	Yolk Sac Tumor										ARID1A Deletion;ID3 Deletion;SDHB Deletion	0	3
P-0008232	P-0008232-T01-IM5	Outside	FFPE	Biopsy	250	373	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										RNF43 p.P581Rfs*121;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0008233	P-0008233-T01-IM5	In-House	FFPE	Resection	250	853	80	Matched	Metastasis	Uterus	Pelvis	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252W)				LEVEL_4	FGFR2 p.S252W;CCND3 Amplification;IKBKE Amplification;MDM4 Amplification;SUFU Deletion;TNFRSF14 Deletion;VEGFA Amplification	1	7
P-0008234	P-0008234-T01-IM5	In-House	FFPE	Resection	167.5	555	15	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106V)	Tazemetostat(KDM6A p.Q247Tfs*16)				LEVEL_3B	PIK3CA p.G106V;RBM10 p.S43*;KDM6A p.Q247Tfs*16	2	3
P-0008235	P-0008235-T01-IM5	Outside	FFPE	Biopsy	250	788	35	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.R329*);Olaparib(CDK12 p.K446Sfs*6)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R329*);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K446Sfs*6)				LEVEL_1	CDK12 p.R329*;CTCF p.E691Rfs*5;CDK12 p.K446Sfs*6;FOXA1 p.S472_*473delinsFL	4	4
P-0008236	P-0008236-T01-IM5	In-House	FFPE	Cytology	250	958	30	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0008237	P-0008237-T01-IM5	Outside	FFPE	Biopsy	106	170	60	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132G)						LEVEL_3A	IDH1 p.R132G	1	1
P-0008239	P-0008239-T01-IM5	In-House	FFPE	Biopsy	238.9	465	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.L146*);Trametinib,Cobimetinib(NF1 p.X1066_splice)				LEVEL_4	PTEN p.L146*;TP53 p.Q317*;NF1 p.X1066_splice;SMAD4 p.S138*	2	4
P-0008240	P-0008240-T01-IM5	In-House	FFPE	Resection	250	581	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;KMT2C p.R4549C;KMT2D p.C1471Y;CREBBP p.H408Ifs*26;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0008241	P-0008241-T01-IM5	In-House	FFPE	Biopsy	250	854	40	Matched	Metastasis	Soft Tissue	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.X33_splice;RB1 Deletion	0	2
P-0008242	P-0008242-T01-IM5	Outside	FFPE	Resection	171.6	591	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.R213*;IDH1 p.R132H;TP53 p.Y234H;ATRX p.K1045*;CDK4 Amplification;FGFR3 Amplification	2	6
P-0008243	P-0008243-T01-IM5	In-House	FFPE	Resection	250	655	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	TP53 p.S241Y;KRAS p.Q61H;CDKN2A p.H83Y	2	3
P-0008244	P-0008244-T01-IM5	Outside	FFPE	Biopsy	250	707	90	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.R1512C	1	2
P-0008244	P-0008244-T02-IM5	Outside	FFPE	Resection	250	663	70	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.R1512C;SPEN p.X348_splice;ARID1A p.Q74*	1	4
P-0008245	P-0008245-T01-IM5	In-House	FFPE	Resection	250	722	65	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201S;SOX9 p.E255Gfs*34	1	3
P-0008246	P-0008246-T02-IM5	In-House	FFPE	Biopsy	250	1101	80	Matched	Metastasis	Skin	Colon	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Larotrectinib,Entrectinib(NTRK1 DDR2-NTRK1 fusion);Larotrectinib,Entrectinib(DDR2 DDR2-NTRK1 fusion)			Olaparib(RAD51B p.Y46*)	Trametinib,Cobimetinib(NF1 p.Q2239*)				LEVEL_1	RAC1 p.P29S;TP53 p.K132N;ARID2 p.S297F;TP63 p.Q70*;PPP6C p.R264C;APC p.R2204*;FAT1 p.Q4114*;NOTCH4 p.Q482*;RAD51B p.Y46*;MGA p.R1240*;NF1 p.Q2239*;DICER1 p.X706_splice;NTRK1 DDR2-NTRK1 fusion;DDR2 DDR2-NTRK1 fusion	4	14
P-0008247	P-0008247-T01-IM5	Outside	FFPE	Resection	250	469	70	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										SDHA p.R512*	0	1
P-0008248	P-0008248-T01-IM5	In-House	FFPE	Biopsy	250	778	70	Matched	Primary	Trachea	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_4	TP53 p.R273C;FAT1 p.E821*;NOTCH1 p.Y1716Tfs*82;CDKN2A p.W110*	1	4
P-0008249	P-0008249-T01-IM5	Outside	FFPE	Resection	250	1028	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										KDM5C p.E468*;VHL p.Y175Lfs*81;AKT2 Amplification	0	3
P-0008257	P-0008257-T01-IM5	In-House	FFPE	Resection	250	782	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Poziotinib(EGFR p.Y764_D770dup);Everolimus(TSC1 Deletion)	GSK2636771,AZD8186(PTEN p.G132A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	STAG2 p.D515Gfs*6;PTEN p.G132A;EGFR p.V292L;EGFR p.Y764_D770dup;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERRFI1 Deletion;PPP6C Deletion;TNFRSF14 Deletion;TSC1 Deletion	5	11
P-0008258	P-0008258-T01-IM5	Outside	FFPE	Biopsy	250	1040	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.R222C;PIK3R1 p.Y463*;PIK3R1 p.M326Vfs*6;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;TNFRSF14 Deletion;TP63 Deletion	2	8
P-0008259	P-0008259-T01-IM5	Outside	FFPE	Biopsy	250	926	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R342*;APC p.E1322*	0	2
P-0008260	P-0008260-T01-IM5	In-House	FFPE	Resection	250	912	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H;SMAD4 p.S232Qfs*3	1	3
P-0008261	P-0008261-T01-IM5	Outside	FFPE	Resection	250	837	90	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.E224D;RICTOR Amplification;TERT Amplification	2	4
P-0008262	P-0008262-T01-IM5	Outside	FFPE	Resection	250	880	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)	Lapatinib(EGFR p.A289V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.M1043V;EGFR p.A289V;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	4	5
P-0008263	P-0008263-T01-IM5	In-House	FFPE	Resection	250	997	60	Matched	Primary	Colon	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										TERT Amplification	0	1
P-0008264	P-0008264-T01-IM5	Outside	FFPE	Biopsy	250	669	50	Matched	Primary	Groin	Not Applicable	Tumor	PTES	Soft Tissue Sarcoma	Proximal-Type Epithelioid Sarcoma	Tazemetostat(SMARCB1 Deletion)								LEVEL_1	SMARCB1 Deletion	1	1
P-0008265	P-0008265-T01-IM5	Outside	FFPE	Resection	250	821	50	Matched	Primary	Parotid Gland	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0008266	P-0008266-T01-IM5	In-House	FFPE	Biopsy	250	448	65	Matched	Metastasis	Bone	Pleura	Tumor	DDCHS	Bone Cancer	Dedifferentiated Chondrosarcoma										BCOR DDX3X-BCOR fusion;DDX3X DDX3X-BCOR fusion	0	2
P-0008267	P-0008267-T01-IM5	Outside	FFPE	Resection	250	796	60	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										FBXW7 p.R505C;TP53 p.R248W;APC p.R876*;APC p.S1346*;PBRM1 CACNA1D-PBRM1 fusion;CACNA1D CACNA1D-PBRM1 fusion	0	6
P-0008268	P-0008268-T01-IM5	Outside	FFPE	Biopsy	250	967	60	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.V216E;PIM1 p.S97N;KMT2D p.R1615*;BCL10 p.K146*	0	4
P-0008269	P-0008269-T01-IM5	In-House	FFPE	Resection	250	795	70	Matched	Metastasis	Uterus	Lung	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.H179*;PTEN Deletion;RB1 Deletion	1	3
P-0008270	P-0008270-T01-IM5	In-House	FFPE	Biopsy	250	723	80	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)	Trametinib,Cobimetinib(NF1 p.X1477_splice)				LEVEL_3B	IDH1 p.R132H;NF1 p.X1477_splice;CIC p.X151_splice;CIC p.Q1494*;CIC p.S476Rfs*37	2	5
P-0008271	P-0008271-T01-IM5	In-House	FFPE	Biopsy	250	613	50	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	SMAD4 p.R361C;TP53 p.G245S;CIC p.H260Pfs*55;CCND1 Amplification;FGF19 Amplification;KRAS Amplification;MET Amplification;PMAIP1 Deletion	1	8
P-0008282	P-0008282-T01-IM5	Outside	FFPE	Cytology	250	628	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E61*)				LEVEL_1	TP53 p.N131I;MET p.X963_splice;PIK3R1 p.H706Afs*35;CDKN2A p.E61*;CDKN1A Deletion	4	5
P-0008283	P-0008283-T01-IM5	Outside	FFPE	Biopsy	250	518	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;TP53 p.R273C;MAP2K4 Deletion;PTEN Deletion;SMAD4 RGS17-SMAD4 fusion;RGS17 RGS17-SMAD4 fusion	4	6
P-0008285	P-0008285-T01-IM5	In-House	FFPE	Biopsy	250	889	10	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	EGFR p.L858R;PIK3CA p.H1047R	2	2
P-0008286	P-0008286-T01-IM5	Outside	FFPE	Biopsy	250	702	60	Matched	Primary	Liver	Not Applicable	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										KMT2C p.V2364Ifs*3;ERRFI1 p.P137Lfs*38	0	2
P-0008287	P-0008287-T01-IM5	In-House	FFPE	Biopsy	250	872	25	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;ARID1A p.M1256Wfs*13	1	2
P-0008288	P-0008288-T01-IM5	In-House	FFPE	Biopsy	250	1240	70	Matched	Metastasis	Rectum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.L1488Ffs*19;TP53 p.H214Qfs*7;RAD50 p.E856Rfs*2;APC Deletion;RASA1 Deletion	0	5
P-0008289	P-0008289-T01-IM5	In-House	FFPE	Resection	250	1050	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)						LEVEL_1	KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	6	2
P-0008290	P-0008290-T01-IM5	In-House	FFPE	Biopsy	250	937	80	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Tipifarnib(HRAS p.Q61R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84Y)				LEVEL_3B	HRAS p.Q61R;CDKN1A p.D7Gfs*29;CDKN2A p.D84Y	2	3
P-0008291	P-0008291-T01-IM5	Outside	FFPE	Cytology	250	1006	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Crizotinib(SLC1A2 MET-SLC1A2 fusion);Crizotinib(MET MET-SLC1A2 fusion)				LEVEL_4	SLC1A2 MET-SLC1A2 fusion;MET MET-SLC1A2 fusion	2	2
P-0008292	P-0008292-T01-IM5	In-House	FFPE	Resection	250	1002	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)								LEVEL_1	EGFR p.L747_A750delinsP;MED12 p.I6Sfs*7	1	2
P-0008295	P-0008295-T01-IM5	In-House	FFPE	Biopsy	250	1118	30	Matched	Metastasis	Lung	Spine	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.C277F;KEAP1 p.G480W;MRE11 p.X51_splice;CDKN2A Deletion;CDKN2B Deletion;EPHA7 Deletion;FGFR1 Amplification;FOXA1 Amplification;MYC Amplification;NKX2-1 Amplification;PRDM1 Deletion;TP63 Deletion	2	12
P-0008296	P-0008296-T01-IM5	In-House	FFPE	Biopsy	250	2075	70	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										KMT2D p.Q3471*;KMT2D p.G1850Pfs*2	0	2
P-0008297	P-0008297-T01-IM5	In-House	FFPE	Biopsy	250	844	50	Matched	Metastasis	Lung	Spleen	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										ARID1A p.S103*;RB1 p.X89_splice;TP53 p.I162Sfs*8	0	3
P-0008299	P-0008299-T02-IM5	In-House	FFPE	Biopsy	250	1387	80	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.V216M;TP53 p.Y205H;MYC p.V7M	0	3
P-0008299	P-0008299-T01-IM5	Outside	FFPE	Biopsy	250	805	90	Unmatched	Primary	Colon	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.V216M;TP53 p.Y205H;MYC p.V7M	0	3
P-0008300	P-0008300-T01-IM5	Outside	FFPE	Resection	250	903	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.V157F;MRE11 p.D647Yfs*28;CDK4 Amplification;MDM2 Amplification	3	5
P-0008301	P-0008301-T01-IM5	In-House	FFPE	Biopsy	250	916	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										PBRM1 p.X129_splice;ASXL1 p.T754Pfs*14	0	2
P-0008302	P-0008302-T01-IM5	Outside	FFPE	Resection	250	928	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.D1053*;VHL p.T124Hfs*35	0	2
P-0008303	P-0008303-T01-IM5	In-House	FFPE	Resection	250	769	90	Matched	Metastasis	Thyroid	Brain	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.X224_splice	2	2
P-0008304	P-0008304-T01-IM5	In-House	FFPE	Resection	250	615	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CDH1 p.M316Nfs*5;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0008305	P-0008305-T01-IM5	In-House	FFPE	Biopsy	250	982	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R273H;AURKA Amplification	0	2
P-0008306	P-0008306-T01-IM5	Outside	FFPE	Resection	250	1013	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PIK3R1 p.G446_L449delinsV;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0008307	P-0008307-T01-IM5	In-House	FFPE	Cytology	64.435	577	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)				LEVEL_4	KRAS p.A146V;RBM10 p.E750*;KEAP1 p.M110V;EED p.X89_splice	1	4
P-0008308	P-0008308-T01-IM5	In-House	FFPE	Resection	250	837	NA	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Olaparib(BARD1 BARD1-intragenic)					LEVEL_3B	APC p.R232*;TCF7L2 p.E51*;TP53 p.I195Yfs*14;APC p.E1309Rfs*11;CCND1 Amplification;EGFR Amplification;FGF19 Amplification;BARD1 BARD1-intragenic	1	8
P-0008309	P-0008309-T01-IM5	Outside	FFPE	Resection	250	778	50	Matched	Primary	Mediastinum	Not Applicable	Tumor	BMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.I101T)				LEVEL_4	KRAS p.G12V;TP53 p.Q165*;TP53 p.C277Y;PTEN p.I101T;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	2	7
P-0008310	P-0008310-T01-IM5	In-House	FFPE	Resection	238.08	840	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.R248Q	2	3
P-0008311	P-0008311-T01-IM5	Outside	FFPE	Resection	250	301	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)					LEVEL_3B	PIK3CA p.Q546K;CDKN1A p.Q10*;ARID1A p.Q878*	1	3
P-0008312	P-0008312-T01-IM5	Outside	FFPE	Resection	250	819	80	Matched	Primary	Knee	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										ATRX p.C1107Yfs*5;CARD11 Amplification;ETV1 Amplification;MCL1 Amplification;RAC1 Amplification;RB1 Deletion	0	6
P-0008313	P-0008313-T01-IM5	Outside	FFPE	Biopsy	250	783	80	Matched	Primary	Uterus	Not Applicable	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma				Everolimus(TSC2 p.H597R);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FBXW7 p.R465H;TP53 p.G245S;TSC2 p.H597R;ERBB2 Amplification;FGFR1 Amplification	3	5
P-0008314	P-0008314-T01-IM5	Outside	FFPE	Resection	250	857	60	Matched	Primary	Arm	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0008315	P-0008315-T01-IM5	In-House	FFPE	Biopsy	250	987	60	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM p.X24_splice);Olaparib(ATM p.D639Ifs*10)								LEVEL_1	AR p.L702H;AR p.H875Y;ATM p.X24_splice;ATM p.D639Ifs*10;PAX5 Amplification	2	5
P-0008316	P-0008316-T01-IM5	In-House	FFPE	Biopsy	250	204	35	Matched	Metastasis	Cervix	Muscle	Tumor	CEAS	Cervical Cancer	Cervical Adenosquamous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;FBXW7 p.R505L;KMT2D p.H350Qfs*52;SMO p.V414G	1	4
P-0008317	P-0008317-T01-IM5	In-House	FFPE	Resection	250	373	60	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(PALB2 p.M296*);Olaparib(BARD1 p.D172Rfs*10)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Trametinib,Cobimetinib(NF1 p.X296_splice)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	MSH6 p.F1088Lfs*5;PIK3CA p.H1047R;KRAS p.G12A;APC p.R232*;B2M p.L15Ffs*41;APC p.R216*;FOXP1 p.R514H;ARID1A p.M1564Hfs*8;ZFHX3 p.G3406Rfs*25;PALB2 p.M296*;BARD1 p.D172Rfs*10;NF1 p.X296_splice;DNMT3B p.R840*;APC p.L2144Gfs*9;TCF7L2 p.H255Ifs*3;MSH2 p.D660Ifs*25	5	16
P-0008318	P-0008318-T01-IM5	In-House	FFPE	Resection	250	734	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R282W;CDH1 p.X177_splice	0	2
P-0008319	P-0008319-T01-IM5	In-House	FFPE	Resection	250	829	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCPRC	Renal Cell Carcinoma	Clear Cell Papillary Renal Cell Carcinoma											0	0
P-0008320	P-0008320-T01-IM5	In-House	FFPE	Resection	250	596	40	Matched	Primary	Fibula	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0008321	P-0008321-T01-IM5	In-House	FFPE	Resection	250	800	75	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R1114*;PTPRT p.R470*;TP53 p.G245C	0	3
P-0008322	P-0008322-T01-IM5	In-House	FFPE	Biopsy	159.04	788	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK LOC1720-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(LOC1720 LOC1720-ALK fusion)								LEVEL_1	TP53 p.R175H;SETD2 p.S831*;KDM5C p.E984*;ALK LOC1720-ALK fusion;LOC1720 LOC1720-ALK fusion	2	5
P-0008323	P-0008323-T01-IM5	In-House	FFPE	Cytology	250	789	90	Matched	Metastasis	Nasopharynx	Pancreas	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS										ID3 Deletion;MDM4 Amplification;RHEB Amplification	0	3
P-0008324	P-0008324-T01-IM5	In-House	FFPE	Biopsy	250	1033	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Sorafenib(ARAF p.S214P)						LEVEL_3A	CTNNB1 p.S45del;STAT3 p.E616del;ARAF p.S214P;TP53 p.N131del;TP53 p.V122Dfs*26;BAP1 p.Q280*;NFKBIA p.F310Wfs*30;ARID5B p.E456Kfs*23;TGFBR2 p.S409Wfs*21;CCND3 Amplification;FOXA1 Amplification;HLA-A Deletion;MYC Amplification;NKX2-1 Amplification;TERT Amplification;VEGFA Amplification	1	16
P-0008325	P-0008325-T01-IM5	Outside	FFPE	Resection	250	929	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	ALK Amplification;CDK4 Amplification	1	2
P-0008326	P-0008326-T01-IM5	In-House	FFPE	Resection	250	478	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F102C	0	1
P-0008327	P-0008327-T01-IM5	Outside	FFPE	Biopsy	142.3	503	10	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MAP2K4 p.X347_splice;SPEN p.K2052*;MEN1 p.E491*;NCOR1 p.E1421*;GATA3 p.G431Wfs*76	0	5
P-0008328	P-0008328-T01-IM5	Outside	FFPE	Resection	250	869	30	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	RHOA p.E47K;PIK3CA p.E542K;TP53 p.R273C;SMAD4 p.S154*;NOTCH1 p.Q1845*	1	5
P-0008329	P-0008329-T01-IM5	In-House	FFPE	Biopsy	250	353	80	Matched	Metastasis	Soft Tissue	Pelvis	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma											0	0
P-0008330	P-0008330-T01-IM5	In-House	FFPE	Biopsy	250	961	60	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.S241F	0	1
P-0008330	P-0008330-T02-IM5	In-House	FFPE	Biopsy	250	807	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008331	P-0008331-T01-IM5	Outside	FFPE	Resection	250	473	40	Matched	Metastasis	Kidney	Lymph Node	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.X856_splice;SETD2 p.S1238Lfs*21	0	2
P-0008332	P-0008332-T01-IM5	In-House	FFPE	Biopsy	69.625	509	90	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	SMAD4 p.G352V;CDKN2A Deletion;CDKN2B Deletion;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	3	5
P-0008333	P-0008333-T01-IM5	In-House	FFPE	Resection	202.6	372	80	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0008334	P-0008334-T01-IM5	In-House	FFPE	Biopsy	250	918	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.Y537C)						LEVEL_1	PIK3CA p.E545K;ESR1 p.Y537C;MAP2K4 p.W95*;SMARCA4 SMARCA4-intragenic	3	4
P-0008335	P-0008335-T01-IM5	In-House	FFPE	Resection	250	855	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008336	P-0008336-T01-IM5	In-House	FFPE	Resection	250	822	80	Matched	Metastasis	Bladder	Lung	Tumor	UCU	Bladder Cancer	Urethral Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC2 p.R905W);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	FGFR3 p.S249C;TP53 p.W91*;TSC2 p.R905W;FGFR1 Amplification	4	4
P-0008337	P-0008337-T01-IM5	Outside	FFPE	Resection	250	612	70	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Ivosidenib(IDH1 p.R132H)	Tazemetostat(SMARCB1 p.K364del)				LEVEL_3B	PIK3CA p.H1047R;IDH1 p.R132H;SMARCB1 p.K364del	3	3
P-0008338	P-0008338-T01-IM5	Outside	FFPE	Biopsy	250	1123	30	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										KMT2C p.Q2317*;CBFB p.X55_splice	0	2
P-0008339	P-0008339-T01-IM5	In-House	FFPE	Cytology	250	505	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.M253_N256del	0	1
P-0008340	P-0008340-T02-IM5	In-House	FFPE	Resection	250	875	90	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	PTEN p.T319*;TP53 p.C242F;GPS2 p.X106_splice	1	3
P-0008340	P-0008340-T01-IM5	In-House	FFPE	Resection	250	799	90	Matched	Metastasis	Kidney	Colon	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	TP53 p.R213*;PTEN p.T319*;GPS2 p.X106_splice;RB1 Deletion;YAP1 Amplification	1	5
P-0008341	P-0008341-T01-IM5	In-House	FFPE	Resection	250	801	NA	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	PTPN11 p.D61Y;APC p.Q238Kfs*55;CDKN2A Deletion;CDKN2B Deletion;NF1 Deletion	2	5
P-0008342	P-0008342-T01-IM5	Outside	FFPE	Resection	250	405	60	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822K)					LEVEL_3B	KIT p.N822K	1	1
P-0008343	P-0008343-T01-IM5	Outside	FFPE	Resection	250	332	40	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.H179Y;APC p.T1208Pfs*57	0	2
P-0008344	P-0008344-T01-IM5	In-House	FFPE	Resection	250	1035	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L)				LEVEL_4	KRAS p.Q61L;AR Amplification;PAK1 Amplification	1	3
P-0008345	P-0008345-T01-IM5	In-House	FFPE	Resection	250	964	80	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Olaparib(CDK12 p.G1461Afs*38)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.G1461Afs*38)				LEVEL_1	CREBBP p.I1084Sfs*15;FBXW7 p.R465H;ARID1A p.D1850Tfs*33;XPO1 p.E571K;ARID1A p.P146Qfs*86;FGFR3 p.R248C;CDK12 p.G1461Afs*38;KMT2D p.R4198*;PIK3CD p.E1021K;FAT1 p.R132*;ARID1B p.W1109*;EP300 p.R1312*;MSH2 p.T754Lfs*9;FOXP1 p.L414*;KMT2D p.Q3826Cfs*3	4	15
P-0008346	P-0008346-T01-IM5	In-House	FFPE	Biopsy	250	977	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	AKT1 p.E17K;FOXA1 p.G277Afs*36;RB1 p.L486Ifs*6;NCOR1 p.T882Sfs*27;TP53 p.L93Ffs*53;FGFR1 Amplification;RAF1 Amplification	2	7
P-0008347	P-0008347-T01-IM5	In-House	FFPE	Resection	250	666	60	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										TERT Amplification	0	1
P-0008348	P-0008348-T02-IM5	In-House	FFPE	Biopsy	250	1236	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPEN p.E718*;JAK1 p.X216_splice	0	2
P-0008348	P-0008348-T01-IM5	Outside	FFPE	Resection	250	519	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPEN p.E718*;JAK1 p.X216_splice	0	2
P-0008349	P-0008349-T01-IM5	In-House	FFPE	Resection	250	596	10	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma										TET2 p.I1873T;TET2 p.N1266Mfs*97	0	2
P-0008350	P-0008350-T02-IM5	In-House	FFPE	Resection	250	158	50	Matched	Metastasis	Cecum	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SMAD4 p.D537Y;RNF43 p.P441Lfs*61;CCND1 p.E9D	3	4
P-0008351	P-0008351-T01-IM5	Outside	FFPE	Resection	250	632	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008352	P-0008352-T01-IM5	In-House	FFPE	Resection	250	526	70	Matched	Metastasis	Bone	Skull	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	SMARCA4 p.R1243W;CREBBP p.R386*;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	4
P-0008353	P-0008353-T01-IM5	In-House	FFPE	Biopsy	250	1027	40	Matched	Metastasis	Tonsil	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BIRC3 p.S360*;ARID2 p.S1458*;NOTCH1 p.X1721_splice;TP53 p.S20Qfs*24;CCND1 Amplification;CCND2 Amplification;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;KDM5A Amplification;KRAS Amplification	1	12
P-0008354	P-0008354-T01-IM5	In-House	FFPE	Resection	250	839	80	Matched	Metastasis	Lung	Brain	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor										EIF1AX p.G9V;ARID1A p.G945Afs*61	0	2
P-0008355	P-0008355-T01-IM5	In-House	FFPE	Biopsy	250	365	70	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.X1559_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_3B	KRAS p.G12D;BRCA1 p.X1559_splice;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	4	4
P-0008356	P-0008356-T01-IM5	In-House	FFPE	Resection	250	464	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.F254Sfs*68	0	1
P-0008357	P-0008357-T01-IM5	In-House	FFPE	Resection	250	647	30	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R499*;ATRX p.T1582Nfs*19;APC p.I1287*;EGFR Amplification	0	4
P-0008358	P-0008358-T01-IM5	In-House	FFPE	Resection	250	788	20	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.Q317*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.N39Tfs*14)				LEVEL_3B	TP53 p.L289F;BRCA1 p.Q317*;TP53 p.L289Ffs*56;CDKN2A p.N39Tfs*14	2	4
P-0008359	P-0008359-T01-IM5	Outside	FFPE	Biopsy	73.152	440	30	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(BARD1 p.Q206Afs*8)	Trametinib,Cobimetinib(NF1 p.L276Ffs*15)				LEVEL_3B	TP53 p.G105C;BARD1 p.Q206Afs*8;NF1 p.L276Ffs*15	2	3
P-0008360	P-0008360-T01-IM5	In-House	FFPE	Resection	250	945	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.Q87Lfs*9)				LEVEL_1	BRAF p.V600E;TP53 p.P151H;RB1 p.X203_splice;RB1 p.X830_splice;PTEN p.Q87Lfs*9	3	5
P-0008369	P-0008369-T01-IM5	Outside	FFPE	Resection	250	741	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.I206Tfs*10;CCND1 Amplification;FGF19 Amplification	0	3
P-0008370	P-0008370-T02-IM5	In-House	FFPE	Cytology	224.14	737	50	Matched	Metastasis	Pancreas	Lymph Node	Tumor	UCP	Pancreatic Cancer	Undifferentiated Carcinoma of the Pancreas				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	PIK3CA p.H1047R;KRAS p.G12A;RUNX1 p.P271Qfs*13	2	3
P-0008370	P-0008370-T01-IM5	In-House	FFPE	Resection	250	876	50	Matched	Primary	Pancreas	Not Applicable	Tumor	UCP	Pancreatic Cancer	Undifferentiated Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12A;NFE2L2 p.L30F;ARID1A p.S255Rfs*112;RUNX1 p.P271Qfs*13;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0008371	P-0008371-T01-IM5	Outside	FFPE	Resection	250	643	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;APC p.E1544*;SMAD4 p.L172*	1	3
P-0008372	P-0008372-T01-IM5	In-House	FFPE	Resection	250	822	80	Matched	Primary	Pancreas	Not Applicable	Tumor	SPN	Pancreatic Cancer	Solid Pseudopapillary Neoplasm of the Pancreas										CTNNB1 p.S37F;DNMT3A p.R635Q	0	2
P-0008373	P-0008373-T01-IM5	Outside	FFPE	Biopsy	250	890	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.S99Ffs*55	0	1
P-0008374	P-0008374-T01-IM5	In-House	FFPE	Biopsy	171.8	556	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;TP53 p.I195F	1	2
P-0008375	P-0008375-T01-IM5	In-House	FFPE	Cytology	250	811	70	Matched	Metastasis	Anus	Omentum	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D);Olaparib(CDK12 p.G1441Kfs*72)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.G1441Kfs*72)				LEVEL_3B	NRAS p.G12D;CBL p.W408S;CDK12 p.G1441Kfs*72;MYC Amplification	3	4
P-0008376	P-0008376-T01-IM5	In-House	FFPE	Resection	250	1076	50	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma										KDM5C GPA33-KDM5C fusion;GPA33 GPA33-KDM5C fusion	0	2
P-0008377	P-0008377-T01-IM5	In-House	FFPE	Resection	250	692	60	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106_R108del)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	KRAS p.G13D;PIK3CA p.G106_R108del;APC p.Q1477*;APC p.E761Kfs*4;RASA1 p.V643Lfs*2;CASP8 p.Q462Rfs*8	2	6
P-0008378	P-0008378-T01-IM5	In-House	FFPE	Biopsy	250	835	60	Matched	Metastasis	Lung	Bone	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										APC p.E1521*;TP53 p.D208V;FAT1 p.G3740*;RBM10 p.X301_splice;CCNE1 Amplification;KEAP1 Deletion;MCL1 Amplification;STK11 Deletion	0	8
P-0008380	P-0008380-T02-IM5	In-House	FFPE	Biopsy	250	959	80	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma				Trametinib(BRAF p.L597R)	GSK2636771,AZD8186(PTEN p.W274*);PLX8394(BRAF p.L597R)				LEVEL_3B	TP53 p.R248W;PTEN p.W274*;BRAF p.L597R	3	3
P-0008380	P-0008380-T01-IM5	Outside	FFPE	Resection	250	828	70	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma					GSK2636771,AZD8186(PTEN p.W274*)				LEVEL_4	TP53 p.R248W;PTEN p.W274*;RB1 Deletion	1	3
P-0008381	P-0008381-T01-IM5	In-House	FFPE	Resection	250	1191	80	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										PPM1D Amplification	0	1
P-0008382	P-0008382-T01-IM5	Outside	FFPE	Resection	250	1006	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)	GSK2636771,AZD8186(PTEN p.K60Sfs*39);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R273C;IDH1 p.R132H;FAT1 p.E1206Tfs*4;ATRX p.C1718Mfs*6;PTEN p.K60Sfs*39;CCND2 Amplification;CDKN2A Deletion;CDKN2B Deletion;EED CNTN5-EED fusion;CNTN5 CNTN5-EED fusion	3	10
P-0008383	P-0008383-T01-IM5	In-House	FFPE	Biopsy	250	878	10	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R213*;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0008384	P-0008384-T01-IM5	In-House	FFPE	Resection	250	336	80	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.H193R;CDK6 Amplification;KMT2D NEUROD4-MLL2 fusion;NEUROD4 NEUROD4-MLL2 fusion	1	5
P-0008385	P-0008385-T01-IM5	In-House	FFPE	Biopsy	250	629	90	Matched	Metastasis	Breast	Liver	Tumor	ACBC	Breast Cancer	Adenoid Cystic Breast Cancer										NOTCH1 p.Y550*;ARID1A Deletion;EZH2 Deletion;ID3 Deletion;KMT2C Deletion	0	5
P-0008386	P-0008386-T01-IM5	Outside	FFPE	Biopsy	136.7	142	80	Matched	Metastasis	Breast	Lung	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ARID1A p.E1904*;GATA3 p.A332Gfs*20;FAT1 p.Y2690Lfs*33;MDM2 Amplification	1	4
P-0008387	P-0008387-T01-IM5	In-House	FFPE	Resection	171	188	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										MSH6 p.F1088Lfs*5;SMARCA4 p.T910M;ASXL1 p.E635Rfs*15;MAP3K13 p.X502_splice;FOXA1 p.G251_F254del;FOXA1 Amplification	0	6
P-0008388	P-0008388-T01-IM5	In-House	FFPE	Resection	250	908	80	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;MLH1 p.X182_splice;CIC p.R599Gfs*129	1	3
P-0008389	P-0008389-T01-IM5	In-House	FFPE	Biopsy	250	1025	55	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)					LEVEL_3B	BRAF p.V600E;PIK3CA p.Q546K	2	2
P-0008390	P-0008390-T01-IM5	In-House	FFPE	Biopsy	250	1331	70	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.C176W;FOXA1 p.S250_Y259del;SPEN p.Q385*;ATRX p.G2284Dfs*2;CDC73 Deletion;MYC Amplification;RB1 Deletion	0	7
P-0008391	P-0008391-T01-IM5	In-House	FFPE	Resection	250	1057	85	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559A)								LEVEL_1	KIT p.V559A	1	1
P-0008391	P-0008391-T02-IM5	In-House	FFPE	Resection	250	1050	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)								LEVEL_1	KIT p.L576P;CBL p.H398D	1	2
P-0008392	P-0008392-T01-IM5	In-House	FFPE	Resection	250	895	35	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0008393	P-0008393-T01-IM5	In-House	FFPE	Resection	250	463	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008394	P-0008394-T01-IM5	In-House	FFPE	Resection	250	695	20	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R249M	1	2
P-0008395	P-0008395-T01-IM5	In-House	FFPE	Resection	250	872	80	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0008396	P-0008396-T01-IM5	In-House	FFPE	Biopsy	250	916	40	Matched	Metastasis	Descending Colon	Brain	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R196*;APC p.R213*;ASXL1 p.G646Wfs*12;ERBB4 p.L798R;TET1 p.G724*;SPEN p.E2111*;NKX3-1 Deletion;COP1 Deletion	0	8
P-0008397	P-0008397-T01-IM5	Outside	FFPE	Resection	250	844	90	Matched	Primary	Brain	Not Applicable	Tumor	MBL	Embryonal Tumor	Medulloblastoma										CDK6 Amplification	0	1
P-0008398	P-0008398-T01-IM5	Outside	FFPE	Resection	250	1125	80	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.R335*;KMT2C p.G3007Efs*25	0	2
P-0008399	P-0008399-T01-IM5	Outside	FFPE	Resection	250	664	70	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.V2006F)				LEVEL_4	MTOR p.V2006F;PBRM1 p.X856_splice;VHL p.P97Afs*35	1	3
P-0008400	P-0008400-T01-IM5	In-House	FFPE	Biopsy	250	810	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	GATA3 p.D335Gfs*17;PIK3CA p.N345K	2	2
P-0008401	P-0008401-T01-IM5	In-House	FFPE	Resection	250	894	40	Matched	Metastasis	Neck	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D);Olaparib(ATM p.R337C)					LEVEL_3B	TP53 p.R248Q;NRAS p.G12D;ATM p.R337C;PTPRD p.P421S;NOTCH1 p.R365C;ARID2 p.R314Cfs*14	2	6
P-0008402	P-0008402-T01-IM5	Outside	FFPE	Resection	250	804	70	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;NOTCH1 p.F357del;FUBP1 p.X213_splice;ARID1A p.S11Afs*92;ARID1A p.R356Efs*43;CIC p.T1375Afs*64	1	6
P-0008403	P-0008403-T01-IM5	In-House	FFPE	Cytology	250	718	70	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)	Ivosidenib(IDH1 p.R132C)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	IDH1 p.R132C;NRAS p.Q61L;PTPRT p.Q625*;NF2 p.R57*;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0008404	P-0008404-T01-IM5	In-House	FFPE	Cytology	250	227	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.K57N)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345Y)					LEVEL_3A	MAP2K1 p.K57N;PIK3CA p.N345Y;TP53 p.R156P;TNFAIP3 p.Q737*;STK11 p.G163Afs*124;KEAP1 p.A331Kfs*14	2	6
P-0008404	P-0008404-T02-IM5	In-House	FFPE	Cytology	250	931	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.K57N)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345Y)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	B2M p.Q28*;MAP2K1 p.K57N;PIK3CA p.N345Y;TP53 p.R156P;TNFAIP3 p.Q737*;KEAP1 p.G332Dfs*64;STK11 p.G163Afs*124;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;EPHA3 Deletion;MSH2 MSH2-intragenic	3	12
P-0008405	P-0008405-T01-IM5	In-House	FFPE	Resection	250	394	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0008406	P-0008406-T01-IM5	In-House	FFPE	Biopsy	250	989	70	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 TACC1-FGFR1 fusion);Debio1347,BGJ398,Erdafitinib,AZD4547(TACC1 TACC1-FGFR1 fusion)				LEVEL_3B	PIK3CA p.E545K;HIST1H3B p.E106Q;DNMT3A p.E28*;ZFHX3 p.S1394*;GPS2 p.Q290Sfs*55;TP53 p.R249G;PBRM1 Deletion;FGFR1 TACC1-FGFR1 fusion;TACC1 TACC1-FGFR1 fusion	3	9
P-0008407	P-0008407-T01-IM5	In-House	FFPE	Resection	250	963	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.G266*	0	1
P-0008408	P-0008408-T01-IM5	In-House	FFPE	Biopsy	250	1086	10	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										KMT2D p.L4674Rfs*15	0	1
P-0008416	P-0008416-T01-IM5	Outside	FFPE	Resection	250	757	60	Matched	Primary	Brain	Not Applicable	Tumor	OAST	Glioma	Oligoastrocytoma				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E110del)					LEVEL_3B	IDH1 p.R132H;NOTCH1 p.F357del;MAX p.R60Q;PIK3CA p.E110del;FUBP1 p.Q413*;ASXL1 p.E990Sfs*7	2	6
P-0008417	P-0008417-T01-IM5	Outside	FFPE	Biopsy	250	417	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R282W;CIC p.P651Lfs*39;LATS1 p.Q663Tfs*5;RUNX1 p.X178_splice;EGFR Amplification	0	5
P-0008418	P-0008418-T01-IM5	In-House	FFPE	Biopsy	250	833	30	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										ASXL1 p.Q1063*;ARID1B p.G376Rfs*159;CDKN2A Deletion;CDKN2B Deletion;GPS2 Deletion;TP53 Deletion;TCF3 ZBTB7A-TCF3 fusion;ZBTB7A ZBTB7A-TCF3 fusion	0	8
P-0008419	P-0008419-T01-IM5	In-House	FFPE	Biopsy	250	849	50	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.Q1998*);Everolimus(TSC2 p.E656*)	GSK2636771,AZD8186(PTEN p.Y178*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.X224_splice;APC p.E1554*;PTEN p.Y178*;BRCA2 p.Q1998*;TSC2 p.E656*;CDKN2A Deletion;CDKN2B Deletion;RICTOR Amplification	4	8
P-0008420	P-0008420-T01-IM5	Outside	FFPE	Resection	250	1185	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	3
P-0008421	P-0008421-T01-IM5	Outside	FFPE	Resection	250	880	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	FDCS	Soft Tissue Sarcoma	Follicular Dendritic Cell Sarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	STAT3 p.K658Y;BIRC3 Deletion;CDKN2A Deletion;CDKN2B Deletion;CYHR1 RECQL4-CYHR1 fusion;RECQL4 RECQL4-CYHR1 fusion	1	6
P-0008422	P-0008422-T01-IM5	In-House	FFPE	Cytology	250	1014	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.H214R	0	1
P-0008424	P-0008424-T01-IM5	Outside	FFPE	Biopsy	250	845	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.G31Afs*28	0	1
P-0008425	P-0008425-T01-IM5	Outside	FFPE	Resection	250	842	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										RB1 p.R556*;TP53 p.E285K;KMT2D p.Q2800*;TP53 p.G244D	0	4
P-0008426	P-0008426-T01-IM5	Outside	FFPE	Cytology	250	527	10	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				GSK2636771,AZD8186(PTEN p.H118L);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.E746_A750del;ARID1A p.R2158*;PTEN p.H118L;CDKN2A Deletion;CDKN2B Deletion	3	5
P-0008427	P-0008427-T01-IM5	In-House	FFPE	Biopsy	250	1163	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.P278A;RB1 p.W99Yfs*5;EGFR Amplification	1	4
P-0008428	P-0008428-T01-IM5	Outside	FFPE	Biopsy	250	952	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;PTPRD p.Q461*;RBM10 p.E177*	1	3
P-0008429	P-0008429-T02-IM5	In-House	FFPE	Biopsy	250	1056	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN Deletion)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.E1309Dfs*4;PTEN Deletion;SMAD4 Deletion;PIK3R1 PIK3R1-intragenic	2	5
P-0008429	P-0008429-T01-IM5	Outside	FFPE	Biopsy	149.4	436	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.E1309Dfs*4;PIK3R1 PIK3R1-intragenic	1	3
P-0008430	P-0008430-T01-IM5	In-House	FFPE	Cytology	110	181	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										TP53 p.F270V	0	1
P-0008431	P-0008431-T01-IM5	In-House	FFPE	Biopsy	250	840	10	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0008432	P-0008432-T01-IM5	In-House	FFPE	Resection	250	867	60	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	2	3
P-0008433	P-0008433-T01-IM5	Outside	FFPE	Cytology	132.4	134	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.S2148Yfs*2)	AMG-510(KRAS p.G12C);Talazoparib,Niraparib(BRCA2 p.S2148Yfs*2)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;TP53 p.L130F;BRCA2 p.S2148Yfs*2;CDKN2A Deletion;CDKN2B Deletion;FLCN Deletion;SMAD4 Deletion	5	7
P-0008434	P-0008434-T01-IM5	In-House	FFPE	Biopsy	250	891	60	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.X465_splice);Trametinib,Cobimetinib(NF1 p.W696*)				LEVEL_4	TP53 p.R342*;NF1 p.X465_splice;NF1 p.W696*;ARID2 p.X374_splice;TCF3 p.X389_splice;FAT1 p.R1230*;ATRX ATRX-intragenic	2	7
P-0008435	P-0008435-T01-IM5	Outside	FFPE	Cytology	136	100	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	TP53 p.S215I;KRAS p.G13C;CCND1 Amplification;FGF19 Amplification	1	4
P-0008436	P-0008436-T01-IM5	In-House	FFPE	Biopsy	250	999	30	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0008437	P-0008437-T01-IM5	In-House	FFPE	Resection	250	825	60	Matched	Metastasis	Gallbladder	Liver	Tumor	NETNOS	Cancer of Unknown Primary	Neuroendocrine Tumor, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84N)				LEVEL_4	TP53 p.L130P;CDKN2A p.D84N;CCND3 Amplification;CDK6 Amplification;VEGFA Amplification;SPSB4 ATR-SPSB4 fusion;ATR ATR-SPSB4 fusion	1	7
P-0008438	P-0008438-T01-IM5	Outside	FFPE	Resection	250	737	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S	1	1
P-0008439	P-0008439-T01-IM5	In-House	FFPE	Biopsy	122.1	384	10	Matched	Metastasis	Bladder	Bone	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.S246F)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.E1013Nfs*4)					LEVEL_3A	PIK3CA p.H1047R;TP53 p.P152L;APC p.Q161*;FOXA1 *321fs*;NSD1 p.P1726Cfs*5;ARID1A p.G126Qfs*272;BRCA1 p.E1013Nfs*4;BAP1 p.E148*;BAP1 p.R207Pfs*36;NSD1 p.W1770Sfs*12;ERCC2 p.S246F	3	11
P-0008440	P-0008440-T01-IM5	In-House	FFPE	Resection	250	863	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.Q1189*);Trametinib,Cobimetinib(NF1 p.Q2288*)				LEVEL_4	NF1 p.Q1189*;NF1 p.Q2288*	2	2
P-0008441	P-0008441-T01-IM5	In-House	FFPE	Biopsy	250	960	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.I255S;AR Amplification;BCL2L11 Deletion;CIC Deletion;EPHA7 Deletion;FLCN Deletion;GPS2 Deletion;MAP2K4 Deletion;MYC Amplification;NCOR1 Deletion;PRDM1 Deletion;TP53 Deletion;ZFHX3 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	15
P-0008442	P-0008442-T01-IM5	In-House	FFPE	Biopsy	250	501	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;PIK3CA p.C420R;TP53 p.G266R;RB1 p.Y173Ffs*11;ERBB2 Amplification;FOXA1 Amplification;MDM2 Amplification;MYCL Amplification;NKX2-1 Amplification;RICTOR Amplification	4	10
P-0008443	P-0008443-T01-IM5	Outside	FFPE	Cytology	141.6	380	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.V243Gfs*23;TET1 p.R1780*;TP53 p.D281_R282insP	2	4
P-0008444	P-0008444-T01-IM5	In-House	FFPE	Biopsy	250	639	20	Matched	Metastasis	Uterus	Lung	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)	GSK2636771,AZD8186(PTEN p.G251V)				LEVEL_3B	KMT2D p.P648Tfs*2;EP300 p.M1470Cfs*26;JAK1 p.K860Nfs*16;ERBB2 p.R678Q;CIC p.P1116Qfs*45;AXIN2 p.N666Qfs*41;PTEN p.G251V;ARID1A p.P1468Lfs*13;KMT2D p.C346Sfs*17;PIK3R1 p.D578Pfs*23;ZFHX3 p.N344Kfs*13;ERRFI1 p.H270Lfs*28	2	12
P-0008445	P-0008445-T01-IM5	Outside	FFPE	Resection	250	321	40	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)								LEVEL_1	BRAF p.V600K	1	1
P-0008446	P-0008446-T01-IM5	In-House	FFPE	Resection	250	581	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.H179R	1	2
P-0008447	P-0008447-T01-IM5	Outside	FFPE	Resection	250	387	70	Matched	Metastasis	Soft Tissue	Lung	Tumor	ASPS	Soft Tissue Sarcoma	Alveolar Soft Part Sarcoma											0	0
P-0008448	P-0008448-T01-IM5	In-House	FFPE	Biopsy	250	630	20	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CDH1 p.Q23*;NSD1 p.P2526Hfs*46;CCND1 Amplification;EPHA7 Deletion;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	7
P-0008449	P-0008449-T01-IM5	In-House	FFPE	Resection	250	608	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TBX3 p.A530Rfs*162	1	2
P-0008450	P-0008450-T01-IM5	Outside	FFPE	Biopsy	250	522	50	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma											0	0
P-0008452	P-0008452-T01-IM5	In-House	FFPE	Resection	250	540	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	SMAD4 p.R361C;CTNNB1 p.G34R;FOXA1 p.H247R;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0008453	P-0008453-T01-IM5	Outside	FFPE	Resection	250	556	20	Matched	Metastasis	Oral Cavity	Lymph Node	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.R306*;FAT1 p.Q3968*;KMT2D p.L4134Cfs*29;EGFR Amplification	0	4
P-0008455	P-0008455-T01-IM5	In-House	FFPE	Biopsy	250	438	50	Matched	Metastasis	Abdomen	Liver	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.X187_splice;STK11 Deletion	0	2
P-0008456	P-0008456-T01-IM5	In-House	FFPE	Biopsy	250	661	30	Matched	Metastasis	Ovary	Diaphragm	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	TP53 p.R196*;KRAS p.G12D;BCOR p.N1459S;MAP2K4 p.X171_splice;AKT2 Amplification	1	5
P-0008457	P-0008457-T02-IM5	In-House	FFPE	Resection	250	975	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0008458	P-0008458-T02-IM5	In-House	Cell Pellet	Cytology	250	442	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_3B	KRAS p.G12R;PIK3CA p.H1047R;TP53 p.X125_splice;KMT2C p.W4352*;TGFBR2 p.M450Hfs*13	2	5
P-0008459	P-0008459-T02-IM5	In-House	FFPE	Resection	250	906	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.I151S	0	1
P-0008460	P-0008460-T02-IM5	In-House	FFPE	Resection	250	908	80	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MYC p.T73I;FOXO1 p.T24I;BCL2 p.G33R;SRSF2 p.P95_H99del;FH Deletion	0	5
P-0008461	P-0008461-T01-IM5	In-House	FFPE	Cytology	250	716	40	Matched	Metastasis	Prostate	Retroperitoneum	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	AR p.L702H;PTEN p.R130Q;AR p.H875Y;KMT2C p.P1560Sfs*2;TP53 p.S183*;ZFHX3 p.L274Wfs*29;CDKN1B Deletion;IKZF1 Deletion;PRDM1 Deletion	1	9
P-0008462	P-0008462-T02-IM5	In-House	FFPE	Resection	250	594	80	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T93Gfs*24)				LEVEL_4	CDKN2A p.T93Gfs*24;MCL1 Amplification;MYC Amplification	1	3
P-0008464	P-0008464-T02-IM5	In-House	FFPE	Cytology	250	614	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12V;KRAS p.G12R;CTNNB1 p.N387K	2	3
P-0008465	P-0008465-T02-IM5	In-House	FFPE	Biopsy	250	1015	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;TP53 p.Y236C;DIS3 p.D479Y;EPHA3 p.X783_splice;MAP2K4 p.R239*;TGFBR1 p.G345Efs*8	1	6
P-0008466	P-0008466-T01-IM5	Outside	FFPE	Biopsy	250	840	25	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Olaparib(PALB2 p.L451*);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X2281_splice)					LEVEL_3B	TP53 p.P278L;RAD50 p.Q384*;PDPK1 p.P499L;PALB2 p.L451*;BRCA2 p.X2281_splice;TP53 p.P316Lfs*29;RB1 p.G423_Y424delinsE*;RB1 p.W563*;MYCL Amplification;TERT Amplification	2	10
P-0008467	P-0008467-T01-IM5	Outside	FFPE	Biopsy	250	1142	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;APC p.R657Sfs*18;APC p.E1513Dfs*10;EPHA7 Deletion;PTEN Deletion;TP53 Deletion	4	6
P-0008468	P-0008468-T01-IM5	In-House	FFPE	Resection	250	986	90	Matched	Primary	Intraabdominal	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Q556_D572del)								LEVEL_1	KIT p.Q556_D572del;RB1 Deletion	1	2
P-0008469	P-0008469-T01-IM5	In-House	FFPE	Resection	250	1343	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.R1509Gfs*62)				LEVEL_1	PIK3CA p.E542K;ERBB3 p.D297Y;TP53 p.L111Nfs*14;NF1 p.R1509Gfs*62;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;PAK1 Amplification	5	8
P-0008470	P-0008470-T01-IM5	Outside	FFPE	Biopsy	250	441	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										KMT2C p.Y2759*;RYBP p.X136_splice;DDR2 Amplification;EGFR Amplification;ETV1 Amplification;RB1 Deletion	0	6
P-0008471	P-0008471-T01-IM5	In-House	FFPE	Resection	250	520	60	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										GPS2 p.K99Nfs*10	0	1
P-0008472	P-0008472-T01-IM5	In-House	FFPE	Resection	250	693	80	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)	Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	TP53 p.R196*;ERBB2 p.Y772_A775dup;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;MYC Amplification;RAC1 Amplification	4	7
P-0008473	P-0008473-T02-IM5	In-House	FFPE	Resection	250	631	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM p.E1428*)					LEVEL_3B	TP53 p.R249W;ATM p.E1428*	1	2
P-0008474	P-0008474-T01-IM5	In-House	FFPE	Biopsy	250	1034	70	Matched	Metastasis	Ovary	Soft Tissue	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.M237I;FAT1 Deletion	0	2
P-0008475	P-0008475-T01-IM5	In-House	FFPE	Resection	250	969	NA	Unmatched	Primary	Lymph Node	Not Applicable	Tumor	CHL	Hodgkin Lymphoma	Classical Hodgkin Lymphoma											0	0
P-0008476	P-0008476-T01-IM5	In-House	FFPE	Biopsy	250	943	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719A);Afatinib(EGFR p.S768I)								LEVEL_1	EGFR p.G719A;EGFR p.S768I;TP53 p.C275F;STK11 p.N181T;TERT Amplification	2	5
P-0008477	P-0008477-T01-IM5	In-House	FFPE	Biopsy	250	1055	20	Matched	Metastasis	Anus	Lung	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma											0	0
P-0008478	P-0008478-T01-IM5	In-House	FFPE	Biopsy	250	635	60	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CDH1 p.Q346*	2	2
P-0008479	P-0008479-T01-IM5	In-House	FFPE	Biopsy	250	690	40	Matched	Primary	Brain	Not Applicable	Tumor	HMBL	Miscellaneous Brain Tumor	Hemangioblastoma										VHL p.Y98Sfs*62	0	1
P-0008480	P-0008480-T01-IM5	In-House	FFPE	Biopsy	250	508	60	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Olaparib(BARD1 p.G627*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Q50*)				LEVEL_3B	TP53 p.E286K;BARD1 p.G627*;FAT1 p.E3637*;HIST1H2BD p.E3K;NOTCH1 p.X1723_splice;NOTCH1 p.X635_splice;CBFB p.Q117*;NOTCH3 p.C738*;NOTCH2 p.K1622Gfs*3;ARID2 p.X258_splice;CDKN2A p.Q50*;CARD11 Amplification;EGFR Amplification;ETV1 Amplification;RAC1 Amplification	2	15
P-0008481	P-0008481-T02-IM5	In-House	FFPE	Biopsy	250	301	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	PTEN p.T319*;CDH1 p.T211Qfs*4;FOXA1 Amplification;IKZF1 Deletion	1	4
P-0008482	P-0008482-T01-IM5	Outside	FFPE	Biopsy	250	871	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	RHOA p.G17E;PTPN11 p.E69D;ERBB2 Amplification;MYCN Amplification	2	4
P-0008483	P-0008483-T01-IM5	In-House	FFPE	Biopsy	250	720	60	Matched	Metastasis	Rectosigmoid Colon	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;APC p.T489Lfs*9;KDM5C KDM5C-intragenic	0	3
P-0008484	P-0008484-T02-IM5	Outside	FFPE	Resection	250	966	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R	2	1
P-0008485	P-0008485-T01-IM5	Outside	FFPE	Resection	250	628	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D;STK11 p.Q159*;RBM10 p.K824Sfs*23;KMT2C p.M825Kfs*3	1	4
P-0008486	P-0008486-T01-IM5	In-House	FFPE	Resection	250	630	90	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V560D)								LEVEL_1	KIT p.V560D;CBL p.C384R;ATR p.L108Sfs*14	1	3
P-0008487	P-0008487-T01-IM5	Outside	FFPE	Cytology	239.4	584	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.N771_P772insH)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R115P)		Erlotinib,Gefitinib,Afatinib(EGFR p.N771_P772insH)			LEVEL_3A	PIK3CA p.R115P;EGFR p.N771_P772insH;TP53 p.X224_splice	2	3
P-0008488	P-0008488-T02-IM5	In-House	FFPE	Biopsy	250	989	10	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R175G	0	1
P-0008489	P-0008489-T01-IM5	Outside	FFPE	Biopsy	250	763	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(BARD1 p.H686Ifs*28)					LEVEL_3B	TP53 p.R342*;BARD1 p.H686Ifs*28;CD274 Amplification;JAK2 Amplification	1	4
P-0008490	P-0008490-T01-IM5	In-House	FFPE	Resection	250	754	60	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);PLX8394(BRAF p.G469R)				LEVEL_4	KRAS p.G12D;BRAF p.G469R	2	2
P-0008490	P-0008490-T02-IM5	In-House	FFPE	Resection	250	756	25	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);PLX8394(BRAF p.G469R)				LEVEL_4	KRAS p.G12D;TP53 p.R248W;BRAF p.G469R	2	3
P-0008492	P-0008492-T02-IM5	In-House	FFPE	Resection	250	696	60	Matched	Metastasis	Scalp	Lymph Node	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TERT Amplification	2	2
P-0008493	P-0008493-T02-IM5	Outside	FFPE	Resection	250	663	80	Matched	Primary	Parotid Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0008494	P-0008494-T01-IM5	Outside	FFPE	Resection	250	886	60	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.G245D;PBRM1 p.I279Nfs*8;BAP1 p.E653*;APC p.Q358*	0	4
P-0008514	P-0008514-T01-IM5	In-House	FFPE	Biopsy	250	1119	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)	Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L858R;TP53 p.X332_splice;TP53 p.A189Pfs*58;EGFR Amplification;MET Amplification	3	5
P-0008515	P-0008515-T02-IM5	In-House	FFPE	Biopsy	250	732	50	Matched	Metastasis	Adrenal Gland	Lung	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										BBC3 p.S149Cfs*74	0	1
P-0008515	P-0008515-T01-IM5	In-House	FFPE	Resection	250	1016	60	Matched	Metastasis	Adrenal Gland	Lung	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										BBC3 p.S149Cfs*74;APC p.X45_splice	0	2
P-0008516	P-0008516-T01-IM5	In-House	FFPE	Resection	250	620	40	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)					LEVEL_3B	PIK3CA p.H1047L;ARID5B p.L1124Afs*37;TP53 p.V147Rfs*27;KDM6A KDM6A-intragenic	1	4
P-0008517	P-0008517-T01-IM5	In-House	FFPE	Biopsy	250	1004	80	Matched	Metastasis	Bone	Soft Tissue	Tumor	MCHS	Bone Cancer	Mesenchymal Chondrosarcoma										ATRX p.E1323*	0	1
P-0008518	P-0008518-T01-IM5	Outside	FFPE	Resection	250	708	70	Matched	Metastasis	Tonsil	Brain	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma											0	0
P-0008519	P-0008519-T01-IM5	In-House	FFPE	Resection	250	1117	10	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;SMAD4 p.R361C;TP53 p.M246K	1	3
P-0008520	P-0008520-T01-IM5	Outside	FFPE	Resection	250	757	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification	1	1
P-0008521	P-0008521-T01-IM5	In-House	FFPE	Resection	250	895	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.G154V;APC p.E1397*;FBXW7 p.R465C;KRAS p.G13D;DAXX p.X647_splice;APC p.C1249Wfs*7;FLT3 Amplification	1	7
P-0008522	P-0008522-T01-IM5	Outside	FFPE	Resection	250	784	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Everolimus,Temsirolimus(MTOR p.F1888I)				LEVEL_3B	PIK3CA p.H1047R;MTOR p.F1888I;AKT2 p.R76_I84dup;ARID2 p.R1414Efs*8;VHL p.R64Gfs*66	2	5
P-0008523	P-0008523-T01-IM5	In-House	FFPE	Resection	250	920	60	Matched	Metastasis	Liver	Soft Tissue	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 RIC3-EWSR1 fusion;RIC3 RIC3-EWSR1 fusion	0	2
P-0008524	P-0008524-T01-IM5	In-House	FFPE	Resection	250	959	40	Matched	Primary	Vulva	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)					LEVEL_3B	KIT p.L576P;SF3B1 p.R625L;KIT Amplification;PDGFRA Amplification	1	4
P-0008525	P-0008525-T01-IM5	Outside	FFPE	Biopsy	250	1014	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.L111Q;SPEN p.L3473Cfs*18;MAP2K4 p.F366Lfs*3;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion;CNTRL SETD2-CEP110 fusion;SETD2 SETD2-CEP110 fusion	0	7
P-0008526	P-0008526-T01-IM5	In-House	FFPE	Biopsy	250	878	60	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										CCND3 Amplification;VEGFA Amplification	0	2
P-0008527	P-0008527-T01-IM5	In-House	FFPE	Resection	250	998	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.M52Ifs*68)				LEVEL_4	KRAS p.G12D;TP53 p.R248W;CDKN2A p.M52Ifs*68	2	3
P-0008528	P-0008528-T01-IM5	In-House	FFPE	Biopsy	250	1061	60	Matched	Metastasis	Tongue	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;FBXW7 p.R479P;NSD1 p.X412_splice	1	3
P-0008529	P-0008529-T01-IM5	In-House	FFPE	Biopsy	250	855	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AZD5363(AKT1 p.E17K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Everolimus,Temsirolimus(MTOR p.E1799K)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	AKT1 p.E17K;KRAS p.G12D;APC p.Q1429*;APC p.R876*;MTOR p.E1799K	3	5
P-0008530	P-0008530-T01-IM5	Outside	FFPE	Resection	250	860	20	Matched	Metastasis	Testis	Pelvis	Tumor	TMT	Germ Cell Tumor	Teratoma with Malignant Transformation										KRAS Amplification	0	1
P-0008531	P-0008531-T02-IM5	In-House	FFPE	Biopsy	250	738	40	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;SETD2 p.E1412Vfs*19;CIC p.R1515H;CIC p.R599Gfs*129;PIK3R1 p.L449_H450insQ;PIK3R1 p.G35Efs*4	1	6
P-0008532	P-0008532-T01-IM5	Outside	FFPE	Biopsy	250	842	50	Matched	Metastasis	Upper Tract	Retroperitoneum	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.K978*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;KDM6A p.K978*;CDKN2A Deletion;CDKN2B Deletion;STAG2 Deletion	4	5
P-0008533	P-0008533-T01-IM5	In-House	FFPE	Resection	250	913	60	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0008534	P-0008534-T01-IM5	In-House	FFPE	Resection	250	993	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G60V)		Cetuximab,Panitumumab(NRAS p.G60V)			LEVEL_3B	TP53 p.R248Q;NRAS p.G60V;FOXP1 p.Q542Kfs*57;APC p.S1117Lfs*9;FANCA CLMN-FANCA fusion;CLMN CLMN-FANCA fusion	1	6
P-0008535	P-0008535-T01-IM5	In-House	FFPE	Resection	250	951	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0008536	P-0008536-T02-IM5	In-House	FFPE	Biopsy	250	668	40	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction										TP53 p.Y234H;SMAD4 p.G352R;CCND1 Amplification;CCND3 Amplification;CDK6 Amplification;FGF19 Amplification;KRAS Amplification;VEGFA Amplification;RNF43 RNF43-intragenic	0	9
P-0008537	P-0008537-T01-IM5	In-House	FFPE	Resection	250	915	10	Matched	Metastasis	Kidney	Lymph Node	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										AKAP4 KDM5C-AKAP4 fusion;KDM5C KDM5C-AKAP4 fusion	0	2
P-0008538	P-0008538-T01-IM5	In-House	FFPE	Cytology	166.1	612	10	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y327*;RASA1 p.S817Yfs*12;RB1 RB1-intragenic	0	3
P-0008539	P-0008539-T01-IM5	In-House	FFPE	Resection	250	860	60	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										NOTCH4 p.R1871Sfs*45;PTPRD p.A259Pfs*9	0	2
P-0008540	P-0008540-T01-IM5	In-House	FFPE	Resection	250	440	20	Matched	Metastasis	Colorectal NOS	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;TP53 p.R306*;APC p.P1319Lfs*2;RASA1 p.E166*;APC p.C417Wfs*37;TP53 p.N288Tfs*55;CCND2 Amplification;KDM5A Amplification	1	8
P-0008541	P-0008541-T01-IM5	In-House	FFPE	Resection	250	858	60	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G266E;FBXW7 p.R465H;APC p.P1319Lfs*2	0	3
P-0008542	P-0008542-T01-IM5	In-House	FFPE	Biopsy	250	1108	10	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0008542	P-0008542-T03-IM5	In-House	FFPE	Resection	250	514	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.G251_G257del	0	1
P-0008543	P-0008543-T01-IM5	In-House	FFPE	#N/A	250	1030	60	Matched	Metastasis	Neck	Maxillary Sinus	Tumor	ARMS	Soft Tissue Sarcoma	Alveolar Rhabdomyosarcoma											0	0
P-0008544	P-0008544-T02-IM5	Outside	FFPE	Resection	250	708	60	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0008545	P-0008545-T01-IM5	In-House	FFPE	Biopsy	250	1184	20	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										KRAS p.G13D;BCL2 p.P59S;PIM1 p.S97R;ARID1A p.Q576*;CCND3 p.I290R;FOXO1 p.S22P;PRDM1 p.D149Tfs*14;KMT2D p.Q836Sfs*94;KMT2D p.Q3722Hfs*28;BCL2 p.N172Q;MGA p.I878Tfs*35;CXCR4 p.G332_K333delinsE*;CDKN2A Deletion;CDKN2B Deletion	0	14
P-0008546	P-0008546-T01-IM5	In-House	FFPE	Resection	250	882	60	Matched	Metastasis	Ovary	Pelvis	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	FOXL2 p.C134W;KMT2D p.V4585Afs*7;SMARCB1 Deletion;YAP1 Amplification	1	4
P-0008547	P-0008547-T01-IM5	In-House	FFPE	Resection	250	503	80	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma											0	0
P-0008548	P-0008548-T01-IM5	In-House	FFPE	Resection	250	1050	80	Matched	Primary	Small Bowel	Not available	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D820Y);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Y570_L576del)	Sorafenib(KIT p.D820Y)			GSK2636771,AZD8186(PTEN p.I33del)		Imatinib,Sunitinib(KIT p.D820Y)		LEVEL_1	PTEN p.I33del;KIT p.D820Y;KIT p.Y570_L576del	4	3
P-0008549	P-0008549-T02-IM5	Outside	FFPE	Biopsy	250	916	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Temsirolimus(MTOR p.L2209V)	Everolimus(MTOR p.L2209V)				LEVEL_1	EGFR p.E746_A750del;MTOR p.L2209V	3	2
P-0008551	P-0008551-T01-IM5	Outside	FFPE	Resection	250	793	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.A138P;APC p.S1415Rfs*4;APC p.S770Qfs*7	0	3
P-0008552	P-0008552-T01-IM5	In-House	FFPE	Resection	250	772	80	Matched	Primary	Gallbladder	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										TP53 p.L257R;TP53 p.K321*;AURKA Amplification;CCNE1 Amplification;RB1 Deletion	0	5
P-0008552	P-0008552-T02-IM5	Outside	FFPE	Cytology	108.775	246	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										TP53 p.L257R;TP53 p.K321*;RB1 Deletion;SH2B3 Deletion	0	4
P-0008553	P-0008553-T01-IM5	In-House	FFPE	Resection	250	837	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;TP53 p.H179L;CDKN2C p.X44_splice;ATR p.W102*;CDKN1B p.A121Lfs*24	1	5
P-0008554	P-0008554-T01-IM5	Outside	FFPE	Resection	250	703	40	Matched	Primary	Parotid Gland	Not Applicable	Tumor	MYEC	Salivary Gland Cancer	Myoepithelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KDM5C p.L152*;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0008555	P-0008555-T01-IM5	Outside	FFPE	Resection	250	669	90	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.S33C;MYC Amplification;TERT Amplification	0	3
P-0008556	P-0008556-T01-IM5	Outside	FFPE	Biopsy	250	720	80	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CARD11 p.L251P;CREBBP p.Y1503H;KMT2D p.R1252*;PPM1D p.R458*;TNFRSF14 p.X102_splice;ARID1A p.L2259*;CDKN2A Deletion;SUFU Deletion;TNFAIP3 Deletion	0	9
P-0008557	P-0008557-T02-IM5	Outside	FFPE	Resection	250	948	70	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.T1040Lfs*3)	Trametinib,Cobimetinib(NF1 p.H1460Qfs*9)				LEVEL_3B	RAC1 p.P29S;IKZF1 p.E304K;FH p.G397E;LATS2 p.S1000*;ARID1A p.A707Lfs*36;BRCA2 p.T1040Lfs*3;NF1 p.H1460Qfs*9	2	7
P-0008558	P-0008558-T02-IM5	Outside	FFPE	Resection	250	969	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.S183_G187delinsC;RB1 p.C102Yfs*7;MCL1 Amplification	0	3
P-0008559	P-0008559-T01-IM5	Outside	FFPE	Biopsy	250	704	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;TP53 p.E271*;MYC Amplification	2	3
P-0008560	P-0008560-T01-IM5	In-House	FFPE	Resection	250	711	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 p.R248C)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	TP53 p.X126_splice;FGFR3 p.R248C;RBM10 p.X168_splice;CDKN2A p.R80*	2	4
P-0008561	P-0008561-T01-IM5	In-House	FFPE	Resection	250	697	80	Matched	Metastasis	Thigh	Bone	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma											0	0
P-0008562	P-0008562-T01-IM5	In-House	FFPE	Biopsy	250	935	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R248G;BCL6 Amplification;FAT1 Deletion;MAP2K4 Deletion;PIK3CA Amplification	0	5
P-0008563	P-0008563-T01-IM5	In-House	FFPE	Resection	250	1056	20	Matched	Primary	Kidney	Not Applicable	Tumor	RAML	Renal Cell Carcinoma	Renal Angiomyolipoma										TP53 p.R306*;ATRX p.K910*;APC APC-intragenic	0	3
P-0008563	P-0008563-T02-IM5	Outside	FFPE	Resection	250	1107	30	Matched	Metastasis	Kidney	Retroperitoneum	Tumor	RAML	Renal Cell Carcinoma	Renal Angiomyolipoma				Everolimus(TSC2 p.X740_splice)					LEVEL_3B	TP53 p.R306*;TSC2 p.X740_splice;ATRX p.K910*;APC APC-intragenic	1	4
P-0008564	P-0008564-T01-IM5	In-House	FFPE	Biopsy	250	866	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.K335I;JAK1 p.S703I	0	2
P-0008565	P-0008565-T01-IM5	In-House	FFPE	Resection	250	689	70	Matched	Primary	Rectum	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	APC p.Q1406*;TP53 p.K132R;APC p.R302*;SOX9 p.A472Vfs*51;CDKN2A Deletion;CDKN2B Deletion	1	6
P-0008566	P-0008566-T01-IM5	In-House	FFPE	Resection	250	872	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.R161*;PBRM1 p.Y390Lfs*14	0	2
P-0008567	P-0008567-T01-IM5	Outside	FFPE	Cytology	250	766	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Trametinib,Cobimetinib(PRKAR2B BRAF-PRKAR2B fusion);Trametinib,Cobimetinib(BRAF BRAF-PRKAR2B fusion)					LEVEL_3B	PRKAR2B BRAF-PRKAR2B fusion;BRAF BRAF-PRKAR2B fusion	2	2
P-0008568	P-0008568-T01-IM5	In-House	FFPE	Resection	250	1003	10	Matched	Metastasis	Appendix	Omentum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;SMAD4 p.E526*;ARID2 p.L390*;CDK8 p.V93M;SMAD4 p.L536P;SOX9 p.K141Qfs*111;DICER1 p.K1363Efs*13	1	7
P-0008569	P-0008569-T02-IM5	In-House	FFPE	Resection	250	1001	30	Matched	Metastasis	Testis	Retroperitoneum	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification	0	2
P-0008569	P-0008569-T01-IM5	Outside	FFPE	Biopsy	250	944	20	Matched	Metastasis	Testis	Neck	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0008570	P-0008570-T01-IM5	In-House	FFPE	Biopsy	250	803	70	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.N319Efs*33;BRD4 Amplification;MCL1 Amplification;MEF2B Amplification;PIK3R2 Amplification	0	5
P-0008571	P-0008571-T01-IM5	In-House	FFPE	Biopsy	250	1282	10	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	SMARCA4 p.T910M;FGFR1 Amplification	1	2
P-0008571	P-0008571-T02-IM5	In-House	FFPE	Biopsy	250	1121	10	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	SMARCA4 p.T910M;FGFR1 Amplification	1	2
P-0008572	P-0008572-T01-IM5	In-House	FFPE	Resection	250	721	30	Matched	Metastasis	Breast	Skin	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.Q1987Tfs*22)				LEVEL_1	PIK3CA p.H1047R;NF1 p.Q1987Tfs*22;CDH1 p.P826Cfs*14;ZFHX3 p.Q2258Rfs*22;ERBB2 Amplification	5	5
P-0008573	P-0008573-T01-IM5	In-House	FFPE	Resection	250	573	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.H179D;NF2 p.Q407*	2	3
P-0008574	P-0008574-T01-IM5	Outside	FFPE	Biopsy	250	921	50	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_3A	ESR1 p.Y537S	1	1
P-0008575	P-0008575-T01-IM5	In-House	FFPE	Biopsy	250	876	60	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Everolimus(TSC1 p.X246_splice)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ERBB3 p.V104L;TSC1 p.X246_splice;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;FLCN Deletion;PAX5 Deletion	2	8
P-0008576	P-0008576-T01-IM5	In-House	FFPE	Resection	250	887	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.G154V	2	2
P-0008577	P-0008577-T01-IM5	In-House	FFPE	Cytology	230.02	676	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	EGFR p.L858R;TP53 p.R273H;PIK3CA p.E545K;RBM10 p.E740*;CASP8 p.S375*;RUNX1 p.W79*;EGFR Amplification;ANKRD11 ANKRD11-intragenic	2	8
P-0008577	P-0008577-T02-IM5	In-House	FFPE	Resection	250	876	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	EGFR p.L858R;TP53 p.R273H;PIK3CA p.E545K;RBM10 p.E740*;RUNX1 p.W79*;EGFR Amplification;ANKRD11 ANKRD11-intragenic	2	7
P-0008578	P-0008578-T01-IM5	In-House	FFPE	Resection	250	563	80	Matched	Metastasis	Soft Tissue	Bone	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS											0	0
P-0008579	P-0008579-T01-IM5	In-House	FFPE	Biopsy	250	755	20	Matched	Metastasis	Rectum	Omentum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.K57E)					LEVEL_3B	SMAD4 p.R361H;BRAF p.D594G;MAP2K1 p.K57E;TP53 p.C229_H233del	1	4
P-0008580	P-0008580-T01-IM5	In-House	FFPE	Resection	250	827	10	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										KMT2D p.R2734*;KMT2D p.G1596Hfs*6;CDKN2A Deletion;CDKN2B Deletion	0	4
P-0008581	P-0008581-T01-IM5	Outside	FFPE	Resection	250	660	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008582	P-0008582-T01-IM5	In-House	FFPE	Resection	250	1012	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.R499*;ERBB3 p.R475W;TP53 p.I254N;AKT2 Amplification	1	5
P-0008583	P-0008583-T01-IM5	Outside	FFPE	Resection	250	836	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C;APC p.L629*;CDK8 Amplification;FLT3 Amplification	0	4
P-0008584	P-0008584-T01-IM5	In-House	FFPE	Resection	250	694	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;APC p.R283*	0	2
P-0008586	P-0008586-T01-IM5	In-House	FFPE	Resection	250	886	10	Matched	Metastasis	Cancer of Unknown Primary	Soft Tissue	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	GNAS p.R201H;APC p.R216*;KRAS p.G13D;APC p.S1282*;TCF7L2 p.R407*	1	5
P-0008587	P-0008587-T01-IM5	In-House	FFPE	Resection	250	565	20	Matched	Primary	Testis	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										BCOR p.Q1700*	0	1
P-0008588	P-0008588-T01-IM5	In-House	FFPE	Resection	250	1030	10	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				AMG-510(KRAS p.G12C);Olaparib(ATM p.E2139*);Olaparib(ATM p.Q2637*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Everolimus,Temsirolimus(MTOR p.F1888I)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;MTOR p.F1888I;ATM p.E2139*;ATM p.Q2637*;APC p.V890Sfs*26	5	5
P-0008589	P-0008589-T01-IM5	In-House	FFPE	Biopsy	250	872	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K	1	1
P-0008589	P-0008589-T02-IM5	Outside	FFPE	Biopsy	250	193	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K	1	1
P-0008590	P-0008590-T01-IM5	In-House	FFPE	Resection	250	716	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.W423*	2	2
P-0008591	P-0008591-T01-IM5	In-House	FFPE	Resection	250	794	70	Matched	Metastasis	Prostate	Brain	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.P27Lfs*17;AR Amplification;CARD11 Amplification;ETV1 Amplification;FOXP1 Deletion;RAC1 Amplification;RYBP Deletion;SHQ1 Deletion;ZFHX3 BATF-ZFHX3 fusion;BATF BATF-ZFHX3 fusion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	12
P-0008592	P-0008592-T01-IM5	In-House	FFPE	Resection	250	732	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0008593	P-0008593-T01-IM5	In-House	FFPE	Resection	250	750	40	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										BCL2 p.G33R;BCL2 p.P59L	0	2
P-0008594	P-0008594-T01-IM5	In-House	FFPE	Resection	250	809	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.V73Rfs*76;APC p.Q1367*;APC p.E941*	1	4
P-0008595	P-0008595-T02-IM5	Outside	FFPE	Biopsy	220.8	565	60	Matched	Primary	Breast	Not Applicable	Tumor	SRCBC	Bladder Cancer	Plasmacytoid/Signet Ring Cell Bladder Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;ARID1A p.Q944*;MAP3K1 p.Q1494*;CDH1 p.X766_splice	1	4
P-0008595	P-0008595-T01-IM5	Outside	FFPE	Resection	250	976	40	Matched	Primary	Bladder	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDKN1A p.D87Gfs*2;CDH1 p.Q706*;ERBB3 p.M91I;RB1 p.Q217*;KMT2D p.E499*;CDKN1A p.D52Gfs*2;FAT1 p.L1857Ffs*4;KMT2D p.E1224Gfs*22	0	8
P-0008596	P-0008596-T01-IM5	Outside	FFPE	Resection	250	868	80	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma											0	0
P-0008597	P-0008597-T01-IM5	In-House	FFPE	Resection	250	913	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										BCL2L11 Deletion	0	1
P-0008598	P-0008598-T01-IM5	Outside	FFPE	Resection	250	966	10	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					GSK2636771,AZD8186(PTEN p.X267_splice);Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.I195F;PTEN p.X267_splice;EGFR Amplification	2	3
P-0008599	P-0008599-T01-IM5	In-House	FFPE	Biopsy	250	1089	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)								LEVEL_1	EGFR p.L747_P753delinsS;TP53 p.H179Y	1	2
P-0008600	P-0008600-T01-IM5	In-House	FFPE	Resection	250	910	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.W223*)				LEVEL_4	APC p.R1114*;APC p.R232*;ASXL1 p.E635Rfs*15;NF1 p.W223*;TP53 p.P223Lfs*24	1	5
P-0008601	P-0008601-T01-IM5	In-House	FFPE	Resection	250	955	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.R213*;EGFR p.L62R;CCND1 Amplification;FGF19 Amplification;MYC Amplification	1	6
P-0008602	P-0008602-T01-IM5	In-House	FFPE	Resection	250	894	60	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Erlotinib,Gefitinib(EGFR p.K745_E746insVPVAIK)		Afatinib(EGFR p.K745_E746insVPVAIK);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	TP53 p.R248G;EGFR p.K745_E746insVPVAIK;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MYC Amplification	3	6
P-0008625	P-0008625-T03-IM5	Outside	FFPE	Resection	250	632	20	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma				Enasidenib(IDH2 p.R172G)					LEVEL_3B	BRAF p.K601N;IDH2 p.R172G;TNFAIP3 p.R271*;TET2 p.Q745*;TET2 p.N427Vfs*4	1	5
P-0008643	P-0008643-T01-IM5	Outside	FFPE	Resection	250	867	30	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease	Vemurafenib(BRAF p.V600E)		Cobimetinib(BRAF p.V600E)						LEVEL_1	BRAF p.V600E	2	1
P-0008644	P-0008644-T01-IM5	In-House	FFPE	Biopsy	250	870	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.X187_splice	1	2
P-0008645	P-0008645-T01-IM5	In-House	FFPE	Resection	250	884	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.E746_A750del;CDKN2A Deletion;CDKN2B Deletion;FOXA1 FOXA1-intragenic	2	4
P-0008646	P-0008646-T01-IM5	Outside	FFPE	Biopsy	250	1019	10	Matched	Metastasis	Uterus	Abdomen	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				AMG-510(KRAS p.G12C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93Q);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E2981Rfs*37)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);GSK2636771,AZD8186(PTEN p.G251V)				LEVEL_3B	KRAS p.G12C;PIK3CA p.R93Q;KMT2C p.S2816Ifs*6;ARID1A p.K1072Nfs*21;SMARCA4 p.T910M;BRCA2 p.E2981Rfs*37;PTPRS p.V1025Sfs*18;ARID1A p.P1326Rfs*155;CTCF p.T204Qfs*18;PTEN p.G251V;ARID5B p.E456Mfs*22;CCND1 p.V293del;KMT2A p.K3825Rfs*31	5	13
P-0008647	P-0008647-T01-IM5	In-House	FFPE	Biopsy	250	1109	30	Matched	Metastasis	Breast	Lung	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.R130Q);Trametinib,Cobimetinib(NF1 p.G751*)				LEVEL_4	PTEN p.R130Q;PIK3R1 p.F456_Q457del;PARP1 p.E76*;KMT2C p.Q2301*;CDH1 p.S9*;NF1 p.G751*	2	6
P-0008648	P-0008648-T01-IM5	In-House	FFPE	Biopsy	250	1118	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										ARID1A p.M1497Vfs*5	0	1
P-0008649	P-0008649-T01-IM5	In-House	FFPE	Resection	250	976	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.L436_P449dup);Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.H1047R;PIK3CA p.L436_P449dup;CDKN2A Deletion;CDKN2B Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	5	6
P-0008650	P-0008650-T02-IM5	In-House	FFPE	Biopsy	250	982	80	Matched	Metastasis	Lung	Chest Wall	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	Capmatinib(MET p.X1009_splice)	Crizotinib(MET p.X1009_splice)	Cabozantinib(MET p.X1009_splice)						LEVEL_1	TP53 p.M237I;RBM10 p.X67_splice;MET p.X1009_splice;TERT Amplification	3	4
P-0008650	P-0008650-T01-IM5	Outside	FFPE	Resection	250	776	20	Matched	Primary	Lung	Not Applicable	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer										TP53 p.M237I	0	1
P-0008651	P-0008651-T01-IM5	Outside	FFPE	Resection	250	454	70	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.T1556Nfs*3;TP53 p.X187_splice;APC p.Y935*;APC p.L318Ffs*9	0	4
P-0008652	P-0008652-T01-IM5	In-House	FFPE	Cytology	101	426	40	Matched	Metastasis	Rectum	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R216*;APC p.K1182*;TP53 p.H179P	0	3
P-0008653	P-0008653-T01-IM5	Outside	FFPE	Cytology	250	952	60	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.S241F;ERBB2 Amplification;MYC Amplification;SRC Amplification	2	4
P-0008654	P-0008654-T01-IM5	In-House	FFPE	Resection	250	877	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0008655	P-0008655-T01-IM5	In-House	FFPE	Resection	250	689	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008656	P-0008656-T01-IM5	Outside	FFPE	CUSA	250	676	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	TP53 p.R273C;PTEN p.T319*;RB1 p.Y529Tfs*3	1	3
P-0008657	P-0008657-T01-IM5	In-House	FFPE	Biopsy	250	908	70	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 KLRAQ1-FGFR2 fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(PPP1R21 KLRAQ1-FGFR2 fusion)					LEVEL_3B	BCOR p.G1283Afs*11;FGFR2 KLRAQ1-FGFR2 fusion;PPP1R21 KLRAQ1-FGFR2 fusion	2	3
P-0008658	P-0008658-T01-IM5	In-House	FFPE	Biopsy	250	913	80	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma	Pemigatinib(KIAA1217 FGFR2-KIAA1217 fusion);Pemigatinib(FGFR2 FGFR2-KIAA1217 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(KIAA1217 FGFR2-KIAA1217 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-KIAA1217 fusion)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)					LEVEL_1	PIK3CA p.Q546K;KIAA1217 FGFR2-KIAA1217 fusion;FGFR2 FGFR2-KIAA1217 fusion	5	3
P-0008659	P-0008659-T01-IM5	In-House	FFPE	Resection	250	735	90	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	NRAS p.Q61K;SMAD3 p.R287W;RB1 p.X376_splice;MYC Amplification	1	4
P-0008661	P-0008661-T01-IM5	Outside	FFPE	Biopsy	250	854	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008662	P-0008662-T01-IM5	In-House	FFPE	Resection	250	680	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;SMAD4 p.G386S	1	2
P-0008663	P-0008663-T01-IM5	In-House	FFPE	Resection	250	1098	80	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification);Sonidegib,Vismodegib(PTCH1 GULP1-PTCH1 fusion);Sonidegib,Vismodegib(GULP1 GULP1-PTCH1 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MDM2 Amplification;PAK1 Amplification;VEGFA Amplification;DIS3 FAM155A-DIS3 fusion;FAM155A FAM155A-DIS3 fusion;PTCH1 GULP1-PTCH1 fusion;GULP1 GULP1-PTCH1 fusion	4	11
P-0008663	P-0008663-T02-IM5	In-House	FFPE	Resection	250	897	70	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MDM2 Amplification;PAK1 Amplification;VEGFA Amplification;DIS3 FAM155A-DIS3 fusion;FAM155A FAM155A-DIS3 fusion	2	9
P-0008664	P-0008664-T01-IM5	In-House	FFPE	Resection	250	950	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.R273H;RBM10 p.L363Sfs*115	1	3
P-0008665	P-0008665-T01-IM5	In-House	FFPE	Resection	250	813	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsVA)								LEVEL_1	EGFR p.E746_T751delinsVA	1	1
P-0008666	P-0008666-T01-IM5	In-House	FFPE	Biopsy	250	1323	60	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.A159V;DIS3 Deletion;FGFR1 Amplification;FGFR2 Amplification;PIK3CB Amplification;PTEN Deletion	2	6
P-0008667	P-0008667-T01-IM5	In-House	FFPE	Resection	250	663	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.R219S	0	1
P-0008668	P-0008668-T01-IM5	In-House	FFPE	Resection	250	776	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.V172F	1	2
P-0008669	P-0008669-T01-IM5	In-House	FFPE	Resection	250	1117	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TMPRSS2 ETV1-TMPRSS2 fusion;ETV1 ETV1-TMPRSS2 fusion	0	2
P-0008670	P-0008670-T04-IM5	In-House	FFPE	Resection	250	708	20	Matched	Primary	Testis	Not Applicable	Tumor	VOEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0008671	P-0008671-T01-IM5	In-House	FFPE	Biopsy	105.3	200	10	Matched	Metastasis	Rectum	Soft Tissue	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										APC p.S1465Wfs*3;BRAF p.T599dup;AMER1 p.R358*	0	3
P-0008672	P-0008672-T01-IM5	In-House	FFPE	Resection	250	737	20	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;MEN1 p.I85Sfs*33	1	2
P-0008673	P-0008673-T01-IM5	In-House	FFPE	Resection	250	816	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0008674	P-0008674-T01-IM5	Outside	FFPE	Resection	250	838	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	SMAD4 p.R361C;KRAS p.Q61R;TP53 p.S241C;GNAS p.R201C	1	4
P-0008675	P-0008675-T01-IM5	In-House	FFPE	Resection	250	1059	80	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R273L;APC p.D849Ifs*12;TP53 p.L93Cfs*30;JAK1 p.Q644Hfs*57	0	4
P-0008676	P-0008676-T01-IM5	In-House	FFPE	Resection	250	899	80	Matched	Primary	Eye	Not Applicable	Tumor	RBL	Retinoblastoma	Retinoblastoma										RB1 p.R579*	0	1
P-0008677	P-0008677-T01-IM5	In-House	FFPE	Resection	250	1017	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.E229K);Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.K351_L356del)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PDGFRA p.E229K;TP53 p.P316Lfs*30;PDGFRA p.K351_L356del;CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion;PDGFRA Amplification	3	7
P-0008678	P-0008678-T01-IM5	In-House	FFPE	Cytology	250	1066	60	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010H)	Crizotinib(MET p.D1010H)	Cabozantinib(MET p.D1010H)	Olaparib(CHEK2 Deletion);Tazemetostat(SMARCB1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	MET p.D1010H;MAX p.X58_splice;TP53 p.G244C;RBM10 p.E800*;JAK1 p.I943Sfs*33;CDKN2A Deletion;CDKN2B Deletion;CHEK2 Deletion;NF2 Deletion;RICTOR Amplification;SMARCB1 Deletion;TERT Amplification	6	12
P-0008679	P-0008679-T03-IM5	Outside	FFPE	Biopsy	250	1165	80	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.N345I)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345I)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.N345I;HNF1A p.X590_splice;CCND1 Amplification;EPHA7 Deletion;FGF19 Amplification	4	6
P-0008679	P-0008679-T01-IM5	Outside	FFPE	Resection	250	373	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.N345I)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345I)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.N345I;STK11 p.D194N;HNF1A p.X590_splice;CCND1 Amplification	4	5
P-0008680	P-0008680-T01-IM5	Outside	FFPE	Resection	250	960	30	Matched	Primary	Lung	Not Applicable	Tumor	EHAE	Soft Tissue Sarcoma	Epithelioid Hemangioendothelioma										ATRX p.E2262*;FAT1 FAT1-intragenic	0	2
P-0008682	P-0008682-T01-IM5	Outside	FFPE	Biopsy	250	664	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344M)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);GSK2636771,AZD8186(PTEN PTEN-intragenic)				LEVEL_3B	PTEN p.K267Rfs*9;PIK3CA p.V344M;KMT2C p.S2816Ifs*6;JAK1 p.L346Tfs*4;EP300 p.R2263*;JAK1 p.R549*;ASXL2 p.V779Sfs*25;AXIN2 p.Y804Sfs*56;EPCAM Deletion;MSH2 Deletion;MSH6 Deletion;PTEN PTEN-intragenic	3	12
P-0008683	P-0008683-T01-IM5	In-House	FFPE	Resection	250	676	10	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.K117N)	Cetuximab,Panitumumab(KRAS p.K117N)			LEVEL_3B	PIK3CA p.E545K;MED12 p.G44S;APC p.E1317*;KRAS p.K117N	2	4
P-0008684	P-0008684-T01-IM5	In-House	FFPE	Resection	250	776	80	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										KMT2C p.S3371*	0	1
P-0008685	P-0008685-T01-IM5	In-House	FFPE	Cytology	250	952	20	Matched	Metastasis	Uterus	Ascites	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542Q);Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	PPP2R1A p.P179R;TP53 p.H178D;PIK3CA p.E542Q;ERBB2 Amplification	3	4
P-0008686	P-0008686-T01-IM5	In-House	FFPE	Cytology	119.9	543	80	Matched	Metastasis	Skin	Pancreas	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0008687	P-0008687-T01-IM5	In-House	FFPE	Resection	250	598	80	Matched	Metastasis	Testis	Lymph Node	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0008688	P-0008688-T01-IM5	Outside	FFPE	Resection	105.8	138	60	Matched	Primary	Hard palate	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;RUNX1 p.P417Qfs*157;ANKRD11 p.K683Sfs*2	1	3
P-0008689	P-0008689-T02-IM5	In-House	FFPE	Biopsy	250	1026	90	Unmatched	Primary	Colon	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										ZRSR2 p.P385Lfs*?;KMT2D p.T5429Pfs*27	0	2
P-0008690	P-0008690-T01-IM5	In-House	FFPE	Biopsy	136.3	686	20	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;SMAD4 p.D537V;APC p.T1556Nfs*3;AMER1 p.R358*;APC p.S104Ifs*35	1	5
P-0008691	P-0008691-T01-IM5	In-House	FFPE	Biopsy	250	980	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.W146*;CCND2 Amplification;MYC Amplification;PAX5 Amplification	0	4
P-0008692	P-0008692-T01-IM5	In-House	FFPE	Resection	250	786	60	Matched	Metastasis	Appendix	Soft Tissue	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma										TP53 p.C176F;ARID1B p.A1697Sfs*3;DNMT3B p.L454Sfs*136;SOX9 p.Q496Pfs*82	0	4
P-0008693	P-0008693-T01-IM5	In-House	FFPE	Biopsy	250	835	40	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(NRAP FGFR2-NRAP fusion);Pemigatinib(FGFR2 FGFR2-NRAP fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(NRAP FGFR2-NRAP fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-NRAP fusion)						LEVEL_1	NRAP FGFR2-NRAP fusion;FGFR2 FGFR2-NRAP fusion	4	2
P-0008694	P-0008694-T01-IM5	Outside	FFPE	Resection	250	855	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E453K);Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.E453K;PIK3CA p.E542K;ZRSR2 p.Q477*;ARID1A p.H170Tfs*62;MDM2 Amplification	5	5
P-0008695	P-0008695-T01-IM5	In-House	FFPE	Resection	250	675	90	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	NCOR1 p.X361_splice;CARD11 Amplification;CCND3 Amplification;DAXX Deletion;MDM2 Amplification;RAF1 Amplification;VEGFA Amplification;TP53 EIF5-TP53 fusion;EIF5 EIF5-TP53 fusion;MITF FAM86DP-MITF fusion;FAM86DP FAM86DP-MITF fusion	1	11
P-0008705	P-0008705-T01-IM5	In-House	FFPE	Biopsy	208.8	824	30	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Olaparib(PALB2 SLC1A2-PALB2 fusion);Olaparib(SLC1A2 SLC1A2-PALB2 fusion)					LEVEL_1	EGFR p.L858R;PALB2 SLC1A2-PALB2 fusion;SLC1A2 SLC1A2-PALB2 fusion	3	3
P-0008706	P-0008706-T01-IM5	In-House	FFPE	Resection	250	614	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	TP53 p.R273H;KRAS p.G12R;RNF43 p.W15Lfs*25	1	3
P-0008707	P-0008707-T01-IM5	In-House	FFPE	Biopsy	145	305	60	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	DAXX p.E535*;MEN1 p.I252Lfs*34;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0008708	P-0008708-T01-IM5	In-House	FFPE	Resection	170	181	50	Matched	Primary	Soft Tissue	Soft Tissue	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CCND3 Amplification;CD274 Amplification;CDK4 Amplification;JAK2 Amplification;JUN Amplification;MDM2 Amplification	2	6
P-0008709	P-0008709-T01-IM5	In-House	FFPE	Biopsy	250	833	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Tazemetostat(SMARCB1 p.R374W)				LEVEL_4	TP53 p.C176W;SMARCB1 p.R374W;ERRFI1 p.N135Kfs*41	1	3
P-0008710	P-0008710-T01-IM5	In-House	FFPE	Resection	250	370	20	Matched	Metastasis	Testis	Lymph Node	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0008711	P-0008711-T01-IM5	In-House	FFPE	Resection	250	755	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Olaparib(ATM p.X2862_splice);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	ATM p.X2862_splice;CCND3 Amplification;CDK4 Amplification;ERBB3 Amplification;GLI1 Amplification;KRAS Amplification;PPM1D Amplification;VEGFA Amplification;FOXO1 FOXO1-intragenic	2	9
P-0008712	P-0008712-T01-IM5	In-House	FFPE	Biopsy	250	719	80	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(RAD51D Deletion)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	GATA3 p.P408Afs*99;MDM4 Amplification;MYC Amplification;NF1 Deletion;PPM1D Amplification;RAD51D Deletion;SUZ12 Deletion;MIR873 PAX5-MIR873 fusion;PAX5 PAX5-MIR873 fusion	2	9
P-0008713	P-0008713-T01-IM5	Outside	FFPE	Biopsy	250	358	80	Matched	Metastasis	Uterus	Retroperitoneum	Tumor	USTUMP	Uterine Sarcoma	Uterine Smooth Muscle Tumor of Uncertain Malignant Potential										MEN1 p.Q64*;MEN1 Deletion;NKX3-1 Deletion;NOTCH4 Deletion;TNFRSF14 Deletion	0	5
P-0008714	P-0008714-T01-IM5	Outside	FFPE	Resection	250	413	70	Matched	Primary	Breast	Not Applicable	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										TP53 p.R209Kfs*6	0	1
P-0008715	P-0008715-T01-IM5	In-House	FFPE	Biopsy	236.1	636	35	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.A276S;FAT1 p.S1553Ffs*9;TP53 p.R280Efs*65;CDKN2B Deletion;ARID1A ARID1A-intragenic;STK11 STK11-intragenic	0	6
P-0008716	P-0008716-T01-IM5	Outside	FFPE	Biopsy	163.4	565	60	Matched	Primary	Larynx	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0008717	P-0008717-T01-IM5	In-House	FFPE	Resection	250	877	80	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.E542K;TP53 p.E286*;AKT2 Amplification;CCNE1 Amplification	2	5
P-0008718	P-0008718-T01-IM5	Outside	FFPE	Resection	250	888	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.H380Ifs*42;CDH1 p.W638*;NF2 p.E202*;CDKN1A p.F150Sfs*8	1	5
P-0008719	P-0008719-T01-IM5	Outside	FFPE	Resection	250	793	20	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;NF2 p.R341*	1	2
P-0008720	P-0008720-T01-IM5	In-House	FFPE	Resection	250	855	60	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CD274 Amplification;CDKN2A Deletion;CDKN2B Deletion;DNMT3A Deletion;JAK2 Amplification	1	5
P-0008721	P-0008721-T01-IM5	Outside	FFPE	Resection	250	978	80	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(ATM p.K2811Sfs*46);Tipifarnib(HRAS p.G13S)	GSK2636771,AZD8186(PTEN p.R173H);Trametinib,Cobimetinib(NF1 p.R1870W)				LEVEL_1	BRAF p.V600E;PIK3CA p.H1047R;TP53 p.R342*;RNF43 p.G659Vfs*41;SOX9 p.Q412*;APC p.S1465Rfs*9;ASXL1 p.G646Wfs*12;KMT2D p.P647Hfs*283;FBXW7 p.R465C;TET1 p.K22Rfs*23;ATM p.K2811Sfs*46;PTEN p.R173H;ERBB3 p.V104M;PTPRS p.V1025Sfs*18;RB1 p.R73Sfs*36;PBRM1 p.I279Yfs*4;BLM p.N515Mfs*16;HRAS p.G13S;SMARCA4 p.M272Cfs*31;RAD50 p.R938*;NOTCH3 p.P2231Qfs*15;FBXW7 p.S582P;MGA p.X698_splice;NF1 p.R1870W;SMAD4 p.I383M;HLA-A p.H27Pfs*2;APC p.K212Nfs*7;RBM10 p.N671Ifs*33;PRDM1 p.K18Sfs*7;SOCS1 p.F113Sfs*5;PTPRD p.K679Nfs*9	8	31
P-0008722	P-0008722-T01-IM5	In-House	FFPE	Resection	250	685	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type											0	0
P-0008723	P-0008723-T01-IM5	In-House	FFPE	Biopsy	250	1132	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;MYD88 p.L265P;MEN1 p.E60*;SMARCA4 p.Q1480*	2	4
P-0008724	P-0008724-T01-IM5	Outside	FFPE	Resection	250	915	70	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										ARID1A p.A339Lfs*24;APC p.R1450*;TP53 p.C135Y;AMER1 Deletion;CDK8 Amplification;FLT3 Amplification;MAP3K1 Deletion	0	7
P-0008725	P-0008725-T01-IM5	In-House	FFPE	Resection	250	958	80	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;SETD2 p.R424*;FUBP1 p.X395_splice;SETD2 p.R2109*;CIC p.E57Rfs*20	1	5
P-0008726	P-0008726-T01-IM5	In-House	FFPE	Biopsy	250	757	80	Matched	Metastasis	Ampulla of Vater	Brain	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS				Everolimus(TSC2 p.R751*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R337C;RB1 p.R455*;TSC2 p.R751*;SMAD4 p.E330Q;SMARCA4 p.P109Rfs*194;CDKN1B Deletion;CDKN2A Deletion;CDKN2B Deletion;FOXA1 Amplification;NKX2-1 Amplification	2	10
P-0008727	P-0008727-T01-IM5	In-House	FFPE	Resection	250	325	30	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);GSK2636771,AZD8186(PTEN p.Y16D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	FBXW7 p.R505C;APC p.L1488Ffs*19;APC p.R554*;KRAS p.G13D;PTEN p.Y16D;TP53 p.E28Cfs*63;TCF7L2 p.I19Tfs*22;MCL1 Amplification	2	8
P-0008728	P-0008728-T01-IM5	In-House	FFPE	Resection	120.9	337	10	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.E716*);Trametinib,Cobimetinib(NF1 p.G1406*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	TP53 p.R213*;SETD2 p.Q2480*;TP63 p.K32*;KDR p.E1097K;FAT1 p.Q1483*;FLT3 p.D839N;NF1 p.E716*;NF1 p.G1406*;SETD2 p.E282Rfs*9;CDKN2A p.R80*	3	10
P-0008729	P-0008729-T01-IM5	In-House	FFPE	Resection	250	976	60	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_1	BRAF p.V600E;KRAS p.G12D;EP300 p.M1470Cfs*26;BCOR p.G1622Rfs*7;RNF43 p.G659Vfs*41;PTPRS p.V1025Sfs*18;AXIN2 p.E405Gfs*56;TGFBR2 p.R495*;ARID1A p.E1760*;RNF43 p.R337*;PMS1 p.I654Dfs*21;KMT2A p.P1939Afs*31;TCF3 p.P231Rfs*53;SOX17 p.E264Gfs*101;ARID1A p.Q557Vfs*65	4	15
P-0008730	P-0008730-T01-IM5	Outside	FFPE	Resection	250	901	40	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.H1047R;APC p.R232*;FBXW7 p.R278*;GNAS p.R201S;SMAD2 p.C463*;STK11 p.G251V;FAT1 p.R2539Sfs*4	2	8
P-0008731	P-0008731-T01-IM5	In-House	FFPE	Resection	250	584	40	Matched	Primary	Kidney	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0008732	P-0008732-T01-IM5	In-House	FFPE	Resection	250	984	70	Matched	Metastasis	Uterus	Lymph Node	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										TP53 p.R248W;BCL2L11 p.G156*;CCNE1 Amplification	0	3
P-0008733	P-0008733-T01-IM5	In-House	FFPE	Resection	250	807	90	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;ARID1A p.Q2128*;BRAF p.N581D;RECQL4 p.S1002Cfs*30	1	4
P-0008734	P-0008734-T01-IM5	Outside	FFPE	Resection	250	1262	90	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.E285K;TP53 p.E258Q;BAP1 p.X577_splice;CREBBP p.Q887*;CCND1 Amplification;CDKN2A Deletion;FGF19 Amplification	1	7
P-0008735	P-0008735-T01-IM5	In-House	FFPE	Cytology	250	1163	30	Matched	Metastasis	Cecum	Peritonuem	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.R209Kfs*6;SMAD4 p.R361C;APC p.S1465Wfs*3;APC p.E892*;NKX3-1 Deletion;SOX9 Deletion	2	7
P-0008736	P-0008736-T01-IM5	In-House	FFPE	Resection	250	1068	60	Matched	Metastasis	Pancreas	Ovary	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.Y220C	1	2
P-0008737	P-0008737-T01-IM5	In-House	FFPE	Resection	250	993	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS											0	0
P-0008744	P-0008744-T01-IM5	In-House	FFPE	Biopsy	250	1054	20	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR Amplification;FGFR4 Amplification	1	3
P-0008744	P-0008744-T02-IM5	In-House	FFPE	Biopsy	250	1195	60	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;CARD11 Amplification;EGFR Amplification;ETV1 Amplification;FGFR4 Amplification;PIK3R1 Deletion;RAC1 Amplification	1	7
P-0008745	P-0008745-T01-IM5	In-House	FFPE	Resection	250	1087	80	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Everolimus(TSC1 p.L203Cfs*7)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;TP53 p.R248Q;APC p.R213*;PIK3R1 p.N564D;SOX17 p.P328Rfs*59;NBN p.R466Gfs*18;TP53 p.T125M;HIST1H3C p.A30T;TSC1 p.L203Cfs*7	2	9
P-0008746	P-0008746-T01-IM5	In-House	FFPE	Resection	250	942	80	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R38H);Sonidegib,Vismodegib(PTCH1 p.C454Ffs*2)	GSK2636771,AZD8186(PTEN p.R173C);GSK2636771,AZD8186(PTEN p.K267Rfs*9)				LEVEL_3B	PTEN p.R173C;PTEN p.K267Rfs*9;ARID1A p.D1850Tfs*33;CTNNB1 p.T41A;FBXW7 p.R278*;PBRM1 p.K651Nfs*5;SOX9 p.G263Afs*16;TCF7L2 p.K485Sfs*23;MRE11 p.N511Ifs*13;NOTCH3 p.A1802Gfs*8;CTCF p.T204Qfs*18;SMARCA4 p.M272Cfs*31;PIK3CA p.R38H;ZFHX3 p.L1256Pfs*25;HLA-A p.I308Nfs*32;PTCH1 p.C454Ffs*2;ARID1B p.G721Afs*11	4	17
P-0008747	P-0008747-T01-IM5	Outside	FFPE	Resection	250	933	80	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K)	Cetuximab,Panitumumab(KRAS p.Q61K)			LEVEL_4	TP53 p.R273C;KRAS p.Q61K;CCND1 Amplification;FGF19 Amplification	1	4
P-0008748	P-0008748-T01-IM5	Outside	FFPE	Resection	250	975	70	Matched	Primary	Pancreas	Not Applicable	Tumor	UCP	Pancreatic Cancer	Undifferentiated Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.E286Q	1	2
P-0008749	P-0008749-T01-IM5	In-House	FFPE	Biopsy	250	1184	40	Matched	Metastasis	Bone	Lymph Node	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	STAG2 p.Y414Lfs*27;EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	3
P-0008750	P-0008750-T01-IM5	In-House	FFPE	Biopsy	250	1114	90	Matched	Metastasis	Liver	Mediastinum	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										BAP1 p.X686_splice;TBX3 p.G598*	0	2
P-0008751	P-0008751-T01-IM5	In-House	FFPE	Biopsy	250	808	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CCND1 Amplification;FGF19 Amplification	2	3
P-0008752	P-0008752-T01-IM5	Outside	FFPE	Resection	250	903	90	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.P151H;ATRX p.R1302Kfs*7;OR3A2 RB1-OR3A2 fusion;RB1 RB1-OR3A2 fusion	0	4
P-0008753	P-0008753-T01-IM5	Outside	FFPE	Biopsy	250	1078	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	KRAS p.G13D;SOX9 p.Q175*	1	2
P-0008754	P-0008754-T01-IM5	In-House	FFPE	Biopsy	250	1145	10	Matched	Metastasis	Pancreas	Mesentery	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.R361H;CIC p.P929Lfs*17	1	3
P-0008755	P-0008755-T01-IM5	Outside	FFPE	Biopsy	250	856	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 p.I271Sfs*2	0	1
P-0008756	P-0008756-T01-IM5	Outside	FFPE	Cytology	250	1079	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(ATM p.Q1015*)	GSK2636771,AZD8186(PTEN p.G127E)				LEVEL_1	BRAF p.V600E;KMT2C p.S682*;PTEN p.G127E;SETD2 p.R2399*;ATM p.Q1015*	4	5
P-0008757	P-0008757-T01-IM5	In-House	FFPE	Biopsy	250	1014	80	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)								LEVEL_1	TP53 p.R248Q;EGFR p.L861Q;EGFR p.L747F;AKT1 Amplification;NKX2-1 Amplification	1	5
P-0008758	P-0008758-T02-IM5	Outside	FFPE	Biopsy	120	656	30	Matched	Primary	Skin	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma											0	0
P-0008759	P-0008759-T02-IM5	In-House	FFPE	Biopsy	250	1197	80	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;EIF1AX p.X113_splice;TP53 p.C275F	2	3
P-0008760	P-0008760-T01-IM5	Outside	FFPE	Biopsy	250	802	90	Matched	Metastasis	Breast	Peritoneum	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537S);AZD9496,Fulvestrant(ESR1 p.Y537N)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	ESR1 p.Y537S;ESR1 p.Y537N;CDH1 p.G169Afs*46;CBFB p.Y85*;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MEN1 Deletion;PAK1 Amplification	3	9
P-0008761	P-0008761-T03-IM5	In-House	FFPE	Biopsy	250	1151	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	KRAS p.Q61R;TP53 p.G245S	1	2
P-0008763	P-0008763-T01-IM5	In-House	FFPE	Biopsy	250	985	70	Matched	Metastasis	Cancer of Unknown Primary	Soft Tissue	Tumor	ADNOS	Cancer of Unknown Primary	Adenocarcinoma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.E285K;SMARCA4 p.E512*;U2AF1 p.I24T;STK11 p.Y36Sfs*125;SMARCA4 p.S1371Efs*83;CDKN2A Deletion;CDKN2B Deletion	1	7
P-0008764	P-0008764-T01-IM5	In-House	FFPE	Biopsy	250	1030	70	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(KIF5B ALK-KIF5B fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK ALK-KIF5B fusion)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(NF1 p.X2657_splice)				LEVEL_1	ARID1A p.Q2188*;NF1 p.X2657_splice;ATRX p.E1021*;CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;GLI1 Amplification;KDM5A Amplification;MDM2 Amplification;KIF5B ALK-KIF5B fusion;ALK ALK-KIF5B fusion	5	11
P-0008765	P-0008765-T01-IM5	In-House	FFPE	Cytology	250	1040	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3A	PIK3CA p.H1047R;EGFR p.E709_T710delinsD;EPHB1 p.R767C;CDKN2A p.H83Y;MDM4 Amplification	3	5
P-0008766	P-0008766-T01-IM5	Outside	FFPE	Biopsy	250	1047	90	Matched	Metastasis	Bile Duct	Liver	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;TP53 p.R280K;RNF43 p.R371*;KDM6A p.K768*;ARID1A p.A1239Vfs*30;CDKN2A Deletion;MYC Amplification;SMAD4 Deletion	2	8
P-0008767	P-0008767-T01-IM5	Outside	FFPE	Resection	250	688	90	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										AKT2 p.R67_L78dup;MYC Amplification	0	2
P-0008768	P-0008768-T01-IM5	Outside	FFPE	Biopsy	250	1006	30	Matched	Primary	Maxillary Sinus	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma					Everolimus,Temsirolimus(MTOR p.S2215F)				LEVEL_4	TP53 p.R248W;MTOR p.S2215F;NOTCH1 p.D2442Gfs*4	1	3
P-0008769	P-0008769-T02-IM5	In-House	FFPE	Cytology	250	673	80	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.X3086_splice)			Talazoparib,Niraparib(BRCA2 p.X3086_splice)					LEVEL_1	BRCA2 p.X3086_splice;BLM p.R818Lfs*4;KMT2D p.D2Vfs*122;ZFHX3 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	6
P-0008770	P-0008770-T01-IM5	Outside	FFPE	Biopsy	250	745	90	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					GSK2636771,AZD8186(PTEN p.T78Nfs*5);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.D208E;PTEN p.T78Nfs*5;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;EP300 Deletion;ETV1 Amplification;PAX5 Deletion	3	8
P-0008771	P-0008771-T01-IM5	Outside	FFPE	Biopsy	250	826	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 C4orf48-FGFR3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(C4orf48 C4orf48-FGFR3 fusion)					LEVEL_3B	MGA p.R1053*;FGFR3 C4orf48-FGFR3 fusion;C4orf48 C4orf48-FGFR3 fusion	2	3
P-0008772	P-0008772-T01-IM5	Outside	FFPE	Resection	250	834	70	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										MET p.M1250T;MYC Amplification	0	2
P-0008773	P-0008773-T01-IM5	In-House	FFPE	Resection	250	758	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLSC	Bladder Cancer	Bladder Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	NFE2L2 p.D29H;CDKN2A p.R80*	1	2
P-0008774	P-0008774-T01-IM5	Outside	FFPE	Resection	250	729	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										CREBBP p.E1000*;TP53 p.Y327Lfs*10	0	2
P-0008775	P-0008775-T01-IM5	Outside	FFPE	Resection	250	769	70	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma											0	0
P-0008776	P-0008776-T01-IM5	In-House	FFPE	Resection	250	959	80	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma											0	0
P-0008777	P-0008777-T01-IM5	Outside	FFPE	Resection	250	876	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EGFR p.R222C;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PTEN Deletion	3	5
P-0008778	P-0008778-T01-IM5	In-House	FFPE	Resection	250	860	80	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.X125_splice;SMARCA4 SMARCA4-intragenic	0	2
P-0008779	P-0008779-T01-IM5	In-House	FFPE	Biopsy	250	915	10	Matched	Primary	Periurethra	Not Applicable	Tumor	EMPD	Skin Cancer, Non-Melanoma	Extramammary Paget Disease											0	0
P-0008780	P-0008780-T02-IM5	In-House	Cell Pellet	Cytology	81	142	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.N1066Lfs*10)	Talazoparib,Niraparib(BRCA2 p.N1066Lfs*10)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3A	KRAS p.G12D;TP53 p.A86Vfs*55;MSH6 p.S470*;BRCA2 p.N1066Lfs*10;CDKN2A p.H83Y	4	5
P-0008781	P-0008781-T01-IM5	In-House	FFPE	Biopsy	250	1093	40	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										CREBBP p.S1680del;SRSF2 p.P95R;MAP2K1 p.Y130N;EPHA7 Deletion;FANCA PAX5-FANCA fusion;PAX5 PAX5-FANCA fusion	0	6
P-0008782	P-0008782-T01-IM5	In-House	FFPE	Biopsy	250	913	30	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	TP53 p.G266E;NRAS p.Q61K;APC p.T1556Nfs*3;APC p.R876*;CTNNB1 p.W383R;SMAD3 p.Y384*	1	6
P-0008783	P-0008783-T01-IM5	In-House	FFPE	Resection	250	558	80	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0008784	P-0008784-T02-IM5	In-House	FFPE	Cytology	250	179	NA	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209L;BAP1 p.X146_splice	0	2
P-0008785	P-0008785-T01-IM5	Outside	FFPE	Resection	250	854	80	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma				Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(RAD51AP2 ALK-RAD51AP2 fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK ALK-RAD51AP2 fusion)					LEVEL_3B	TP53 p.D259Y;RAD51AP2 ALK-RAD51AP2 fusion;ALK ALK-RAD51AP2 fusion	2	3
P-0008785	P-0008785-T02-IM5	Outside	FFPE	Resection	250	880	80	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma				Olaparib(ATM p.L807*)					LEVEL_3B	ATM p.L807*	1	1
P-0008786	P-0008786-T01-IM5	In-House	FFPE	Cytology	223.132	1174	30	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.L747_A750delinsP;RB1 p.K96*;MED12 p.D23Mfs*14;CDKN2A Deletion;MDM2 Amplification	3	5
P-0008787	P-0008787-T01-IM5	In-House	FFPE	Resection	250	652	80	Matched	Primary	Ovary	Not Applicable	Tumor	MXOV	Ovarian Cancer	Mixed Ovarian Carcinoma					GSK2636771,AZD8186(PTEN p.I50*)				LEVEL_4	TP53 p.X332_splice;ARID1A p.L771*;ARID1A p.S264Pfs*98;PTEN p.I50*;AXL Amplification;KMT2A PHLDB1-MLL fusion;PHLDB1 PHLDB1-MLL fusion;KEAP1 DNAH1-KEAP1 fusion;DNAH1 DNAH1-KEAP1 fusion	1	9
P-0008788	P-0008788-T01-IM5	In-House	FFPE	Biopsy	250	789	60	Matched	Metastasis	Stomach	Pleura	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	RB1 p.R467*;TP53 p.T253P;KRAS p.G13D;ARID1A p.S740Yfs*76	1	4
P-0008789	P-0008789-T01-IM5	In-House	FFPE	Resection	250	758	40	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(PHTF2 BRAF-PHTF2 fusion);Trametinib,Cobimetinib(BRAF BRAF-PHTF2 fusion)		GSK2636771,AZD8186(PTEN p.L325R)				LEVEL_3A	PTEN p.L325R;PHTF2 BRAF-PHTF2 fusion;BRAF BRAF-PHTF2 fusion	3	3
P-0008790	P-0008790-T01-IM5	In-House	FFPE	Biopsy	250	827	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L32P)				LEVEL_4	KRAS p.G12D;TGFBR2 p.E440*;TP53 p.L32Pfs*11;CDKN2A p.L32P	2	4
P-0008791	P-0008791-T01-IM5	In-House	FFPE	Biopsy	109.2	617	60	Matched	Metastasis	Larynx	Lung	Tumor	SCRMS	Soft Tissue Sarcoma	Spindle Cell Rhabdomyosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R213*;KDM6A p.R165*;FAT1 p.L1755Ffs*4;CDKN2A Deletion;CDKN2B Deletion;NSD1 Deletion;PPM1D Amplification;COP1 Deletion	1	8
P-0008792	P-0008792-T01-IM5	In-House	FFPE	Resection	250	935	80	Matched	Metastasis	Larynx	Brain	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;TP53 p.S127F;TP53 p.E287K;ASXL1 p.R596Gfs*107;CDKN2A Deletion;IKZF1 Deletion;MCL1 Amplification;MDM2 Amplification;RASA1 Deletion	3	9
P-0008794	P-0008794-T01-IM5	In-House	FFPE	Biopsy	136.9	647	50	Unmatched	Primary	Spleen	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										EP300 p.D1399N;TP53 p.R110P;TNFRSF14 p.W12*;SRSF2 p.P95_R117del;KMT2D p.D2066Efs*15;NSD1 p.S1334Ffs*2	0	6
P-0008795	P-0008795-T01-IM5	In-House	FFPE	Biopsy	250	953	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ARID1A p.P1292Efs*2;TP53 p.D61*;FOXA1 Amplification;MYC Amplification;NKX2-1 Amplification;FOXA1 CASZ1-FOXA1 fusion;CASZ1 CASZ1-FOXA1 fusion;FOXA1 NRG1-FOXA1 fusion;NRG1 NRG1-FOXA1 fusion	0	9
P-0008796	P-0008796-T01-IM5	In-House	FFPE	Biopsy	250	1255	50	Matched	Primary	Lung	Not Applicable	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	Lorlatinib,Brigatinib(ALK p.M1166T)			Olaparib(BARD1 p.W146*)	GSK2636771,AZD8186(PTEN p.X212_splice)				LEVEL_1	TP53 p.R158L;DICER1 p.D1810Y;PTEN p.X212_splice;RIT1 p.R122L;ALK p.M1166T;BARD1 p.W146*;SHQ1 p.G70*;GRIN2A p.R1443Gfs*3;ARID1A p.L2053Ffs*46;APC p.R106Lfs*19;SOX9 p.T395Kfs*8;EGFR Amplification	3	12
P-0008797	P-0008797-T01-IM5	Outside	FFPE	Biopsy	250	987	80	Matched	Metastasis	Kidney	Mediastinum	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Tazemetostat(SMARCB1 p.X329_splice)				LEVEL_4	SMARCB1 p.X329_splice;NF2 p.X225_splice	1	2
P-0008798	P-0008798-T01-IM5	In-House	FFPE	Biopsy	250	987	40	Matched	Metastasis	Larynx	Lung	Tumor	OHNCA	Head and Neck Cancer	Head and Neck Carcinoma, Other										ANKRD11 p.E1008_P1015del;TP63 TP63-intragenic	0	2
P-0008799	P-0008799-T01-IM5	In-House	FFPE	Resection	250	893	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										VHL p.R167Q	0	1
P-0008800	P-0008800-T02-IM5	Outside	FFPE	Biopsy	250	816	20	Matched	Metastasis	Larynx	Lung	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma										CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;NKX2-1 Amplification	0	4
P-0008809	P-0008809-T01-IM5	In-House	FFPE	Resection	250	848	60	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.E339*	0	1
P-0008810	P-0008810-T01-IM5	In-House	FFPE	Biopsy	250	877	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ZFHX3 p.P2787Cfs*3;ZFHX3 p.C947Sfs*19	0	2
P-0008811	P-0008811-T01-IM5	In-House	FFPE	Resection	250	1108	90	Matched	Metastasis	Testis	Pelvis	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										TP53 p.R175H	0	1
P-0008812	P-0008812-T01-IM5	Outside	FFPE	Biopsy	250	961	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.H214Ifs*33;CCND1 Amplification;CCNE1 Amplification;MYC Amplification;PAK1 Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	7
P-0008813	P-0008813-T02-IM5	In-House	FFPE	Resection	250	833	90	Matched	Primary	Ovary	Not Applicable	Tumor	OMT	Germ Cell Tumor	Mature Teratoma											0	0
P-0008813	P-0008813-T01-IM5	Outside	FFPE	Resection	250	930	60	Matched	Primary	Ovary	Not Applicable	Tumor	OMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										PIK3CD p.E1021K;BCL2L1 Amplification	0	2
P-0008814	P-0008814-T01-IM5	Outside	FFPE	Biopsy	250	348	50	Matched	Metastasis	Testis	Liver	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										TP53 Deletion	0	1
P-0008815	P-0008815-T01-IM5	In-House	FFPE	Biopsy	250	749	10	Matched	Metastasis	Appendix	Omentum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R342*;EPHA3 p.R274*;SDHAF2 p.E57*;CCND1 Amplification;FGF19 Amplification	1	6
P-0008816	P-0008816-T01-IM5	Outside	FFPE	Resection	250	742	70	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MDM2 Amplification;RAF1 Amplification	1	2
P-0008817	P-0008817-T01-IM5	In-House	FFPE	Resection	250	960	80	Matched	Primary	Skin	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma										WT1 p.W328*;FLT3 p.G622E;KIT Amplification;PDGFRA Amplification;YAP1 Amplification	0	5
P-0008818	P-0008818-T01-IM5	Outside	FFPE	Resection	250	1094	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84V)				LEVEL_4	KRAS p.G12D;TP53 p.C135Y;CDKN2A p.D84V	2	3
P-0008819	P-0008819-T01-IM5	Outside	FFPE	Biopsy	125	77	10	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_4	TP53 p.V73Rfs*76;KRAS p.Q61H;ERRFI1 p.Q88*	1	3
P-0008830	P-0008830-T01-IM5	Outside	FFPE	Resection	250	561	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.N67Kfs*65	0	1
P-0008831	P-0008831-T01-IM5	In-House	FFPE	Resection	250	1079	90	Matched	Metastasis	Adrenal Gland	Soft Tissue	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma					Trametinib,Cobimetinib(NF1 p.Q1447*)				LEVEL_4	NF1 p.Q1447*;TET2 p.K1304Rfs*59	1	2
P-0008832	P-0008832-T01-IM5	Outside	FFPE	Resection	250	641	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008833	P-0008833-T01-IM5	In-House	FFPE	Biopsy	250	967	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ARID2 p.Q920*;MAP2K4 p.K187*;GATA3 p.L396Hfs*107	0	3
P-0008834	P-0008834-T01-IM5	In-House	FFPE	Biopsy	250	603	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Tazemetostat(KDM6A p.H808Qfs*58)				LEVEL_1	PIK3CA p.E545K;FGFR3 p.S249C;BAP1 p.F170L;TP53 p.H193Q;U2AF1 p.S34Y;KDM6A p.H808Qfs*58;RBM10 p.K837Sfs*10;CDKN1A p.F63Tfs*5	4	8
P-0008835	P-0008835-T01-IM5	In-House	FFPE	Biopsy	129	493	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.P551*)				LEVEL_4	TP53 p.R196*;KDM6A p.P551*	1	2
P-0008836	P-0008836-T02-IM5	In-House	Cell Pellet	Cytology	60.5	681	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0008837	P-0008837-T01-IM5	In-House	FFPE	Resection	250	846	80	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Everolimus(TSC1 p.L628Rfs*17)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;TP53 p.V272L;TGFBR1 p.G52V;TSC1 p.L628Rfs*17;AXIN2 p.G597Efs*92;CARD11 Amplification;CDKN2A Deletion;CDKN2B Deletion;FOXA1 Amplification;NKX2-1 Amplification;PTPRD Deletion;RAC1 Amplification;RICTOR Amplification	4	13
P-0008838	P-0008838-T01-IM5	Outside	FFPE	Resection	250	644	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P81R)				LEVEL_4	KRAS p.G12V;TP53 p.S315Pfs*31;CDKN2A p.P81R	2	3
P-0008839	P-0008839-T01-IM5	In-House	FFPE	Resection	250	1014	20	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R337C;ERBB2 Amplification	2	2
P-0008840	P-0008840-T01-IM5	In-House	FFPE	Resection	250	978	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)						LEVEL_1	TP53 p.P278S;MET p.X1010_splice;TP53 p.R158P;MYD88 p.L265P;RB1 p.G304*;SALL1 ANKRD11-SALL1 fusion;ANKRD11 ANKRD11-SALL1 fusion	3	7
P-0008841	P-0008841-T01-IM5	Outside	FFPE	Biopsy	250	1205	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;APC p.R213*;APC p.T1493Rfs*14	1	3
P-0008842	P-0008842-T01-IM5	Outside	FFPE	Resection	250	776	90	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678W)					LEVEL_3B	TCF7L2 p.R522*;ERBB2 p.R678W;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	1	5
P-0008843	P-0008843-T01-IM5	In-House	FFPE	Resection	250	1025	90	Matched	Primary	Soft Tissue	Not Applicable	Tumor	IMT	Soft Tissue Sarcoma	Inflammatory Myofibroblastic Tumor		Crizotinib,Ceritinib(ALK RANBP2-ALK fusion);Crizotinib,Ceritinib(RANBP2 RANBP2-ALK fusion)		Lorlatinib,Brigatinib,Alectinib(ALK RANBP2-ALK fusion);Lorlatinib,Brigatinib,Alectinib(RANBP2 RANBP2-ALK fusion)					LEVEL_2	ALK RANBP2-ALK fusion;RANBP2 RANBP2-ALK fusion	4	2
P-0008844	P-0008844-T01-IM5	Outside	FFPE	Biopsy	250	1012	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K)				LEVEL_4	KRAS p.Q61K	1	1
P-0008845	P-0008845-T01-IM5	In-House	FFPE	Resection	250	883	90	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G118D);Fulvestrant+Alpelisib(PIK3CA p.K111E)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111E)						LEVEL_1	PIK3CA p.G118D;PIK3CA p.K111E;NCOR1 p.T525Nfs*11;NCOR1 p.Q2154*;RUNX1 p.S191Afs*19;RUNX1 p.D96Gfs*11	4	6
P-0008846	P-0008846-T01-IM5	Outside	FFPE	Biopsy	250	788	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R248Q;FGFR1 Amplification;FGFR2 Amplification	1	3
P-0008847	P-0008847-T01-IM5	In-House	FFPE	Biopsy	250	1073	80	Unmatched	Primary	Duodenum	Not Applicable	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms										TP53 p.Y236C;TP53 p.C176G;B2M p.M1?;CCND3 p.I290K;PMS2 p.X301_splice;KMT2D p.Q1893*;CREBBP p.X1203_splice;TP53 p.D184E;MEF2B p.K4E;TNFRSF14 p.T169Dfs*65;PTEN Deletion	0	11
P-0008848	P-0008848-T01-IM5	In-House	FFPE	Biopsy	250	1029	60	Matched	Metastasis	Lung	Peritoneum	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.E180K	2	2
P-0008849	P-0008849-T01-IM5	Outside	FFPE	Biopsy	93.15	583	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)								LEVEL_1	EGFR p.L747_P753delinsS;EGFR p.A755G;TP53 p.S269Tfs*76;BAP1 p.P522Cfs*14;EGFR Amplification;FOXA1 Amplification;NKX2-1 Amplification	1	7
P-0008850	P-0008850-T01-IM5	In-House	FFPE	Biopsy	250	1002	70	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	PTEN p.R130Q;TP53 p.R158Sfs*23	1	2
P-0008851	P-0008851-T01-IM5	Outside	FFPE	Biopsy	250	1102	90	Matched	Primary	Lung	Not Applicable	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TGFBR2 p.Q532*;RBM10 p.Q603Lfs*101	2	3
P-0008852	P-0008852-T01-IM5	Outside	FFPE	Resection	250	507	90	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	SPOP p.F133L;SMAD2 p.P305T;SMAD2 p.Y268Qfs*9;SMAD2 p.V431*;KMT2D p.K5384Qfs*75;FOXA1 Amplification;PTEN Deletion;BMPR1A BMPR1A-intragenic	1	8
P-0008853	P-0008853-T01-IM5	In-House	FFPE	Resection	250	961	90	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.E1309Dfs*4;APC p.L779Ffs*9	0	3
P-0008854	P-0008854-T01-IM5	In-House	FFPE	Resection	250	1064	20	Matched	Primary	Lung	Not Applicable	Tumor	SPCC	Non-Small Cell Lung Cancer	Spindle Cell Carcinoma of the Lung			AMG-510(KRAS p.G12C)	Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.G405*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.C242W;SOX17 p.S397*;BRCA2 p.G405*	3	4
P-0008855	P-0008855-T01-IM5	Outside	FFPE	Biopsy	86.805	684	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)								LEVEL_1	EGFR p.E746_S752delinsV	1	1
P-0008856	P-0008856-T01-IM5	In-House	FFPE	Biopsy	250	1095	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.H1047R;ERBB2 Amplification;MDM2 Amplification;PPM1D Amplification	5	4
P-0008857	P-0008857-T02-IM5	In-House	FFPE	Resection	250	1064	70	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)		Trametinib,Cobimetinib(NF1 p.X355_splice)				LEVEL_3A	ARID2 p.Q1313*;NRAS p.Q61H;FLT3 p.E708K;CARD11 p.E93K;NF1 p.X355_splice;PPP2R1A p.E45*;EZH2 p.X595_splice	2	7
P-0008857	P-0008857-T01-IM5	Outside	FFPE	Resection	250	781	90	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61H)		Trametinib,Cobimetinib(NF1 p.X355_splice)				LEVEL_3A	ARID2 p.Q1313*;NRAS p.Q61H;FLT3 p.E708K;CARD11 p.E93K;NF1 p.X355_splice;EZH2 p.X595_splice;PPP2R1A p.E45*	2	7
P-0008858	P-0008858-T01-IM5	Outside	FFPE	Resection	250	482	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R196*;ZFHX3 p.Q1607*;ARID1A p.T118Rfs*251	0	3
P-0008859	P-0008859-T01-IM5	In-House	FFPE	Resection	250	923	20	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R	1	1
P-0008860	P-0008860-T01-IM5	Outside	FFPE	Resection	250	814	90	Matched	Primary	Vulva	Not Applicable	Tumor	EPIS	Soft Tissue Sarcoma	Epithelioid Sarcoma	Tazemetostat(SMARCB1 Deletion)								LEVEL_1	SMARCB1 Deletion	1	1
P-0008861	P-0008861-T01-IM5	In-House	FFPE	Cytology	250	924	60	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R273H;CCND3 Amplification;RB1 Deletion;TNFRSF14 Deletion;VEGFA Amplification	0	5
P-0008862	P-0008862-T01-IM5	In-House	FFPE	Biopsy	250	1042	70	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.X224_splice;SMAD4 p.Q448Lfs*20;ARID1A p.R2116Cfs*40	1	4
P-0008863	P-0008863-T01-IM5	In-House	FFPE	Biopsy	193.95	908	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										PBRM1 p.T232Pfs*21;TP53 p.L130del	0	2
P-0008864	P-0008864-T01-IM5	Outside	FFPE	Biopsy	250	566	80	Matched	Metastasis	Uterus	Upper Tract	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				AZD9496,Fulvestrant(ESR1 p.Y537S)	GSK2636771,AZD8186(PTEN p.R130G);GSK2636771,AZD8186(PTEN p.R130S)				LEVEL_3B	PTEN p.R130G;BCOR p.N1459S;ESR1 p.Y537S;CTNNB1 p.S33F;PIK3R1 p.Q721*;ARID1A p.P1114Sfs*9;PIK3R1 p.X582_splice;PTEN p.R130S	3	8
P-0008865	P-0008865-T01-IM5	Outside	FFPE	Biopsy	163.7	721	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.L576P;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0008866	P-0008866-T01-IM5	In-House	FFPE	Resection	250	740	80	Matched	Metastasis	Retroperitoneum	Bone	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;JUN Amplification;MDM2 Amplification	2	3
P-0008867	P-0008867-T01-IM5	In-House	FFPE	Biopsy	250	846	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										CTNNB1 p.S33F	0	1
P-0008868	P-0008868-T01-IM5	Outside	FFPE	Resection	250	761	50	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.E102_I103del)					LEVEL_3B	TP53 p.R273H;MAP2K1 p.E102_I103del;MYC Amplification;RNF43 MTMR4-RNF43 fusion;MTMR4 MTMR4-RNF43 fusion	1	5
P-0008869	P-0008869-T01-IM5	Outside	FFPE	Biopsy	250	600	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.S127Y;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0008870	P-0008870-T01-IM5	Outside	FFPE	Resection	250	700	80	Matched	Metastasis	Eye	Soft Tissue	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;MYC Amplification	0	2
P-0008871	P-0008871-T01-IM5	In-House	FFPE	Biopsy	250	724	80	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Everolimus(TSC1 p.G389Efs*51)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;NFE2L2 p.D27del;TSC1 p.G389Efs*51;STK11 p.N226Rfs*39	3	4
P-0008872	P-0008872-T01-IM5	In-House	FFPE	Resection	250	644	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PSC	Pancreatic Cancer	Serous Cystadenoma of the Pancreas										VHL p.E70_R79dup	0	1
P-0008873	P-0008873-T01-IM5	In-House	FFPE	Cytology	228.5	854	90	Matched	Metastasis	Ovary	Pleural Fluid	Tumor	MXOV	Ovarian Cancer	Mixed Ovarian Carcinoma	Niraparib,Olaparib,Rucaparib(BRCA1 Deletion)			Talazoparib(BRCA1 Deletion)					LEVEL_1	TP53 p.X261_splice;RASA1 p.C34Sfs*62;BRCA1 Deletion;FGFR2 Amplification	2	4
P-0008874	P-0008874-T01-IM5	In-House	FFPE	Resection	250	923	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.V274F;PBRM1 p.M731L;TP63 p.S365*;DNMT3B p.V229L;STK11 p.F264Rfs*22	0	5
P-0008875	P-0008875-T01-IM5	In-House	FFPE	Resection	250	628	90	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13D)		Cetuximab,Panitumumab(NRAS p.G13D)			LEVEL_3B	TP53 p.X225_splice;NRAS p.G13D;APC p.R216*;APC p.E1309*	1	4
P-0008876	P-0008876-T01-IM5	In-House	FFPE	Biopsy	250	1093	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(RAD51B p.F147*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ATRX p.G161*;STK11 p.D53Tfs*11;SMARCA4 p.K458Rfs*16;RAD51B p.F147*	3	5
P-0008877	P-0008877-T01-IM5	In-House	FFPE	Biopsy	250	689	80	Matched	Primary	Abdomen	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.P152L;RB1 p.R358*;PTPRT PTPRT-intragenic	0	3
P-0008878	P-0008878-T01-IM5	In-House	FFPE	Biopsy	250	1059	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Trametinib,Cobimetinib(NF1 p.S1355*)				LEVEL_4	TP53 p.X332_splice;KRAS p.G13D;NF1 p.S1355*	2	3
P-0008879	P-0008879-T01-IM5	In-House	FFPE	Resection	250	642	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R248W;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0008880	P-0008880-T01-IM5	In-House	FFPE	Biopsy	250	745	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma			Cisplatin(ERCC2 p.T484M)						LEVEL_3A	POLE p.E18K;FBXW7 p.R479G;CREBBP p.R386*;ERCC2 p.T484M;ARID1A p.Q605*;PMS1 p.M1?;ARID1A p.Q2037Pfs*62	1	7
P-0008881	P-0008881-T01-IM5	Outside	FFPE	Resection	250	781	90	Matched	Metastasis	Parotid Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma					Trametinib,Cobimetinib(NF1 p.X1757_splice)				LEVEL_4	NF1 p.X1757_splice;NCOR1 p.E1288Gfs*8;FOXA1 p.G430Vfs*125	1	3
P-0008882	P-0008882-T01-IM5	Outside	FFPE	Biopsy	250	822	40	Matched	Primary	Stomach	Not Applicable	Tumor	SPDAC	Esophagogastric Cancer	Poorly Differentiated Carcinoma of the Stomach										TP53 p.R306*	0	1
P-0008885	P-0008885-T03-IM5	In-House	FFPE	Resection	250	953	20	Matched	Metastasis	Testis	Muscle	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										TP53 p.E285K;PIK3CD p.G124D	0	2
P-0008885	P-0008885-T04-IM5	In-House	FFPE	Resection	250	688	30	Unmatched	Primary	Spleen	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0008901	P-0008901-T01-IM5	Outside	FFPE	Resection	250	625	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)	Olaparib,Talazoparib(BRCA2 p.S1968*)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Rucaparib,Niraparib(BRCA2 p.S1968*)					LEVEL_1	PIK3CA p.N345K;ZFHX3 p.Q1584*;BRCA2 p.S1968*	4	3
P-0008902	P-0008902-T01-IM5	Outside	FFPE	Resection	250	828	70	Matched	Metastasis	Lung	Groin	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.Y2285Tfs*5)				LEVEL_4	TP53 p.R273C;NF1 p.Y2285Tfs*5;TET1 p.C1376*	1	3
P-0008903	P-0008903-T01-IM5	In-House	FFPE	Biopsy	250	908	50	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0008904	P-0008904-T01-IM5	In-House	FFPE	Biopsy	250	978	30	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.G48L	0	1
P-0008905	P-0008905-T01-IM5	Outside	FFPE	Resection	250	1274	40	Matched	Primary	Lymph node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										TP53 p.R213*	0	1
P-0008906	P-0008906-T01-IM5	Outside	FFPE	Cytology	140	669	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;SMAD4 p.A118V;TP53 p.P278A;CDK6 Amplification	2	4
P-0008907	P-0008907-T01-IM5	In-House	FFPE	Resection	250	996	70	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										CTNNB1 p.D32V;ARID1A p.Q529*;TP53 p.Q52Lfs*68;CCND1 Amplification;FGF19 Amplification	0	5
P-0008908	P-0008908-T01-IM5	Outside	FFPE	Biopsy	93.1	468	80	Matched	Metastasis	Lung	Spine	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.E1346*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13E)				LEVEL_3B	KRAS p.G13E;ATM p.E1346*;MCL1 Amplification;NBN TRPS1-NBN fusion;TRPS1 TRPS1-NBN fusion	2	5
P-0008909	P-0008909-T01-IM5	Outside	FFPE	Biopsy	204.8	428	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.V173_R175delinsGG	1	2
P-0008910	P-0008910-T02-IM5	In-House	FFPE	Biopsy	250	1013	50	Matched	Metastasis	Breast	Liver	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma			AZD9496,Fulvestrant(ESR1 p.L536H)						LEVEL_3A	ESR1 p.L536H;KMT2C p.E4712*;KMT2A p.T3276Lfs*9;MAPK1 Amplification	1	4
P-0008911	P-0008911-T01-IM5	Outside	FFPE	Biopsy	148.6	708	25	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.F212Sfs*3;RNF43 p.I75*;KDM5A Amplification	1	4
P-0008912	P-0008912-T01-IM5	In-House	FFPE	Cytology	250	917	80	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		GSK2636771,AZD8186(PTEN p.I101Sfs*12);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*)				LEVEL_3A	NRAS p.Q61K;NOTCH1 p.Q2398*;PTEN p.I101Sfs*12;TP53 p.R110Cfs*13;CDKN2A p.E88*	3	5
P-0008913	P-0008913-T01-IM5	In-House	FFPE	Resection	250	813	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248Q;APC p.R232*	0	2
P-0008914	P-0008914-T01-IM5	Outside	FFPE	Biopsy	250	911	90	Matched	Metastasis	Brain	Bone	Tumor	PGNG	Miscellaneous Neuroepithelial Tumor	Paraganglioma											0	0
P-0008915	P-0008915-T01-IM5	Outside	FFPE	Biopsy	250	939	20	Matched	Metastasis	Lung	Stomach	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Q50H);Crizotinib(MET PTPRZ1-MET fusion);Crizotinib(PTPRZ1 PTPRZ1-MET fusion)				LEVEL_4	TP53 p.R273S;CDKN2A p.Q50H;MET PTPRZ1-MET fusion;PTPRZ1 PTPRZ1-MET fusion	3	4
P-0008916	P-0008916-T01-IM5	In-House	FFPE	Biopsy	250	1068	20	Unmatched	Primary	Lung	Not Applicable	Tumor	MZL	Mature B-Cell Neoplasms	Marginal Zone Lymphoma										XPO1 p.E571K	0	1
P-0008917	P-0008917-T01-IM5	In-House	FFPE	Resection	250	855	25	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;CTNNB1 p.S37F;EGFR Amplification	2	4
P-0008918	P-0008918-T03-IM5	In-House	FFPE	Biopsy	250	857	50	Matched	Metastasis	Soft Tissue	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										MAPK1 Amplification;TP53 Deletion	0	2
P-0008919	P-0008919-T01-IM5	In-House	FFPE	Biopsy	250	752	30	Matched	Metastasis	Pancreas	Pleura	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;KMT2A p.Q1052*;SMAD4 p.Y430*;ARID2 p.A88Efs*23	1	4
P-0008920	P-0008920-T01-IM5	In-House	FFPE	Resection	250	699	70	Matched	Metastasis	Prostate	Testis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Trametinib,Cobimetinib(ZNF207 BRAF-ZNF207 fusion);Trametinib,Cobimetinib(BRAF BRAF-ZNF207 fusion)					LEVEL_3B	PIK3CA p.E545K;CTNNB1 p.D32Y;FOXA1 p.M253R;EPHA7 Deletion;FOXA1 Amplification;FUBP1 Deletion;IKZF1 Deletion;PARP1 Deletion;ZNF207 BRAF-ZNF207 fusion;BRAF BRAF-ZNF207 fusion	3	10
P-0008922	P-0008922-T01-IM5	In-House	FFPE	Resection	250	832	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;STK11 p.Q37*	1	2
P-0008922	P-0008922-T02-IM5	In-House	FFPE	Resection	250	853	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;STK11 p.Q37*;TP53 p.P278L	1	3
P-0008923	P-0008923-T01-IM5	In-House	FFPE	Biopsy	250	974	90	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification);Everolimus(TSC1 Deletion)	Trametinib,Cobimetinib(NF1 p.W599Gfs*6);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	FANCA p.S478*;ATRX p.Q1848*;NF1 p.W599Gfs*6;BCL10 Deletion;BRCA2 Deletion;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;FOXO1 Deletion;KDR Amplification;KIT Amplification;LATS2 Deletion;MDM2 Amplification;MDM4 Amplification;PDGFRA Amplification;PTPRD Deletion;RB1 Deletion;SMAD2 Deletion;TSC1 Deletion	6	20
P-0008924	P-0008924-T01-IM5	Outside	FFPE	Resection	250	1151	95	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma											0	0
P-0008926	P-0008926-T01-IM5	Outside	FFPE	Biopsy	250	933	10	Matched	Primary	GE Junction	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma										BRAF p.D594E	0	1
P-0008927	P-0008927-T01-IM5	In-House	FFPE	Biopsy	250	757	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.A289D;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	4
P-0008928	P-0008928-T01-IM5	In-House	FFPE	Biopsy	250	1164	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0008929	P-0008929-T01-IM5	In-House	FFPE	Cytology	224.9	1152	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;FLT3 p.D750Y;KMT2C p.X1664_splice;EPHA3 p.L181Ffs*47;EPHA7 Deletion	2	5
P-0008930	P-0008930-T01-IM5	In-House	FFPE	Cytology	88.56	352	90	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ARID1A p.A1687Hfs*2;KMT2C p.M1901Nfs*13;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	6
P-0008931	P-0008931-T01-IM5	In-House	FFPE	Biopsy	250	1097	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.D259Rfs*5;KMT2C p.E713Nfs*5;MYC Amplification	2	4
P-0008932	P-0008932-T01-IM5	In-House	FFPE	Resection	250	938	80	Matched	Metastasis	Oral Cavity	Brain	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)					LEVEL_3B	PIK3CA p.R88Q;FAT1 p.S404Gfs*10;SMAD4 Deletion;TP53 Deletion;NCOR1 CD82-NCOR1 fusion;CD82 CD82-NCOR1 fusion	1	6
P-0008932	P-0008932-T02-IM5	In-House	FFPE	Resection	250	567	20	Matched	Primary	Tongue	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)					LEVEL_3B	PIK3CA p.R88Q;FAT1 p.S404Gfs*10	1	2
P-0008933	P-0008933-T01-IM5	In-House	FFPE	Resection	250	840	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Y16*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R248W;FBXW7 p.R465H;PTEN p.Y16*;APC p.E1309Dfs*4;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0008934	P-0008934-T01-IM5	In-House	FFPE	Biopsy	250	913	50	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.F134L;EGFR p.E746_S752delinsV;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0008935	P-0008935-T01-IM5	Outside	FFPE	Biopsy	53.505	543	80	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										CTNNB1 p.S33F;TP53 p.E294Lfs*12	0	2
P-0008936	P-0008936-T01-IM5	Outside	FFPE	Resection	250	913	60	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma					GSK2636771,AZD8186(PTEN p.R130G)				LEVEL_4	PTEN p.R130G;TP53 p.G245D;PIK3R1 p.Y452_Q457del;FOXP1 p.Q150Tfs*20	1	4
P-0008937	P-0008937-T01-IM5	In-House	FFPE	Resection	250	487	90	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										KDM6A p.Q611*;MCL1 Amplification	0	2
P-0008938	P-0008938-T01-IM5	In-House	FFPE	Biopsy	250	1279	95	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										KMT2D p.Y2199Ifs*65;TNFRSF14 p.X60_splice;CARD11 p.D357V	0	3
P-0008939	P-0008939-T01-IM5	In-House	FFPE	Biopsy	250	1067	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.T165Ffs*12);Trametinib,Cobimetinib(NF1 p.C709Vfs*39)				LEVEL_4	NF1 p.T165Ffs*12;NF1 p.C709Vfs*39	2	2
P-0008940	P-0008940-T01-IM5	Outside	FFPE	Biopsy	250	754	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma											0	0
P-0008941	P-0008941-T01-IM5	Outside	FFPE	Resection	250	905	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.N567Pfs*16)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ERBB2 p.R678Q;SMAD4 p.E330K;TP53 p.Q144Sfs*26;BRCA1 p.N567Pfs*16;BCL2L1 Amplification;CDKN2A Deletion;CDKN2B Deletion	3	7
P-0008942	P-0008942-T01-IM5	In-House	FFPE	Biopsy	250	794	80	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.G13S)	Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S2303F);Sonidegib,Vismodegib(PTCH1 STRN-PTCH1 fusion);Sonidegib,Vismodegib(STRN STRN-PTCH1 fusion)	Trametinib,Cobimetinib(NF1 p.R1241*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3A	KDR p.S1037L;NF1 p.R1241*;NRAS p.G13S;MEN1 p.Q410*;BRCA2 p.S2303F;CDKN2A Deletion;CDKN2B Deletion;PTEN Deletion;PTCH1 STRN-PTCH1 fusion;STRN STRN-PTCH1 fusion	7	10
P-0008943	P-0008943-T01-IM5	Outside	FFPE	Biopsy	250	932	30	Matched	Metastasis	Cancer of Unknown Primary	Neck	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										MET p.M1250T;SH2B3 p.R518*;ARID1A p.V1271Rfs*19	0	3
P-0008944	P-0008944-T01-IM5	In-House	FFPE	Resection	250	718	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)					LEVEL_3B	NRAS p.Q61L;TP53 p.R248L;NF2 p.E106K;CCNE1 Amplification	1	4
P-0008945	P-0008945-T01-IM5	Outside	FFPE	Biopsy	250	621	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P408Afs*99;MAP3K1 p.R273Sfs*27;TP53 p.X331_splice;AURKA Amplification;PPM1D Amplification;PTPRD Deletion;TRPC6 YAP1-TRPC6 fusion;YAP1 YAP1-TRPC6 fusion	0	8
P-0008946	P-0008946-T01-IM5	In-House	FFPE	Cytology	250	758	30	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D;PARP1 p.R340*;PPP6C p.S270L;CCND1 Amplification;ERBB3 Amplification;FGF19 Amplification;MITF Amplification;PAK1 Amplification	1	8
P-0008947	P-0008947-T01-IM5	In-House	FFPE	Cytology	250	955	80	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer				Olaparib(ATM ELOVL4-ATM fusion);Olaparib(ELOVL4 ELOVL4-ATM fusion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;KEAP1 Deletion;ATM ELOVL4-ATM fusion;ELOVL4 ELOVL4-ATM fusion	3	4
P-0008948	P-0008948-T01-IM5	In-House	FFPE	Cytology	134.8	382	50	Matched	Metastasis	Lung	Chest Wall	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.A159V;FBXW7 p.E655*;CDK4 Amplification;ERBB3 Amplification;FOXP1 Deletion;GLI1 Amplification;LATS2 Deletion;MDM2 Amplification;MYC Amplification;PRKN Deletion;STK11 Deletion;APC MCC-APC fusion;MCC MCC-APC fusion	2	13
P-0008949	P-0008949-T01-IM5	In-House	FFPE	Biopsy	250	955	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)		GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_2	ERBB2 p.Y772_A775dup;PTEN p.R130Q;BAP1 p.M1?	3	3
P-0008950	P-0008950-T01-IM5	In-House	FFPE	Cytology	156.3	639	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										CCNE1 Amplification	0	1
P-0008951	P-0008951-T01-IM5	In-House	FFPE	Resection	250	752	10	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN Amplification	0	1
P-0008952	P-0008952-T01-IM5	In-House	FFPE	Resection	250	725	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K	2	1
P-0008953	P-0008953-T01-IM5	In-House	FFPE	Biopsy	250	1000	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.C176G;SMAD4 p.X84_splice;KRAS Amplification	1	4
P-0008954	P-0008954-T01-IM5	In-House	FFPE	Biopsy	250	919	95	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0008955	P-0008955-T03-IM5	In-House	FFPE	Biopsy	94.8	482	20	Matched	Primary	Lung	Not Applicable	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	Selpercatinib(RET CCDC6-RET fusion);Selpercatinib(CCDC6 CCDC6-RET fusion)	Cabozantinib,Vandetanib(RET CCDC6-RET fusion);Cabozantinib,Vandetanib(CCDC6 CCDC6-RET fusion)	BLU-667(RET CCDC6-RET fusion);BLU-667(CCDC6 CCDC6-RET fusion)						LEVEL_1	RET CCDC6-RET fusion;CCDC6 CCDC6-RET fusion	6	2
P-0008956	P-0008956-T01-IM5	Outside	FFPE	Biopsy	250	771	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.F62Lfs*18);Crizotinib,Entrectinib(HS3ST5 ROS1-HS3ST5 fusion);Crizotinib,Entrectinib(ROS1 ROS1-HS3ST5 fusion)					LEVEL_3B	BRCA2 p.F62Lfs*18;PRDM1 p.X635_splice;HS3ST5 ROS1-HS3ST5 fusion;ROS1 ROS1-HS3ST5 fusion	3	4
P-0008957	P-0008957-T01-IM5	In-House	FFPE	Resection	250	743	25	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					GSK2636771,AZD8186(PTEN p.S229_K237delins*)				LEVEL_4	CTNNB1 p.G34R;TP53 p.Y205H;STK11 p.K146*;PTEN p.S229_K237delins*	1	4
P-0008958	P-0008958-T01-IM5	In-House	FFPE	Biopsy	250	1002	90	Matched	Metastasis	Retroperitoneum	Spine	Tumor	TYST	Germ Cell Tumor	Yolk Sac Tumor											0	0
P-0008959	P-0008959-T01-IM5	Outside	FFPE	Resection	250	736	40	Matched	Primary	Chest Wall	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion;MAX Deletion;TERT Amplification	1	5
P-0008960	P-0008960-T01-IM5	In-House	FFPE	Biopsy	250	980	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 HTR1E-CDK12 fusion);Olaparib(HTR1E HTR1E-CDK12 fusion)				GSK2636771,AZD8186(PTEN Deletion);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 HTR1E-CDK12 fusion);Pembrolizumab,Nivolumab,Cemiplimab(HTR1E HTR1E-CDK12 fusion)				LEVEL_1	AR Amplification;PTEN Deletion;CDK12 HTR1E-CDK12 fusion;HTR1E HTR1E-CDK12 fusion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	5	6
P-0008961	P-0008961-T01-IM5	In-House	FFPE	Biopsy	250	1056	90	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.R248Q;PBRM1 p.K1380*;KDM6A p.W632Gfs*59;CCNE1 Amplification;MET Amplification;MYC Amplification	1	6
P-0008962	P-0008962-T02-IM5	In-House	FFPE	Resection	250	812	50	Matched	Primary	Mediastinum	Not Applicable	Tumor	TT	Germ Cell Tumor	Teratoma										TP53 p.X32_splice;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	4
P-0008963	P-0008963-T01-IM5	In-House	FFPE	Resection	250	528	90	Matched	Metastasis	Skin	Small Bowel	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)		Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K);Trametinib,Cobimetinib(MAP2K1 p.G128D)	Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Q50*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;NRAS p.Q61K;PTPRT p.L695F;MAP2K1 p.G128D;CDKN2A p.Q50*;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;MITF Amplification;PAX5 Deletion	6	10
P-0008964	P-0008964-T01-IM5	Outside	FFPE	Resection	250	854	60	Matched	Metastasis	Kidney	Omentum	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma				Trametinib,Cobimetinib(MAP2K1 p.F53V)					LEVEL_3B	MAP2K1 p.F53V	1	1
P-0008965	P-0008965-T01-IM5	In-House	FFPE	Biopsy	250	991	80	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										XPO1 p.E571K;MYD88 p.L265P;CREBBP p.W1502C;ETV6 p.X11_splice;CARD11 p.G123S;EP300 p.X1048_splice;CDKN2A Deletion;CDKN2B Deletion;MGA Deletion;RAD51 Deletion	0	10
P-0008966	P-0008966-T01-IM5	In-House	FFPE	Biopsy	250	876	50	Matched	Metastasis	Prostate	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EPHA3 p.W457*;TP53 p.X187_splice;PTEN Deletion	1	3
P-0008967	P-0008967-T01-IM5	In-House	FFPE	Resection	250	638	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.R361C;SMARCA4 p.T910R	1	3
P-0008968	P-0008968-T01-IM5	In-House	FFPE	Biopsy	250	564	90	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.L1090Yfs*14)				LEVEL_1	FGFR3 p.S249C;KDM6A p.L1090Yfs*14;SUFU Deletion;TCF7L2 Deletion	3	4
P-0008969	P-0008969-T01-IM5	Outside	FFPE	Biopsy	250	236	50	Matched	Metastasis	Retroperitoneum	Neck	Tumor	SEM	Germ Cell Tumor	Seminoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;PPM1D p.K511*;KDM6A p.Q346*;DAXX p.Y198Cfs*19	1	4
P-0008970	P-0008970-T01-IM5	In-House	FFPE	Biopsy	250	906	80	Matched	Metastasis	Breast	Bone	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma				Everolimus(TSC1 p.R190Afs*20)					LEVEL_3B	TP53 p.X332_splice;TSC1 p.R190Afs*20;NCOR1 p.T1991Dfs*8;FGFR2 Amplification;FOXO1 Deletion;LATS2 Deletion;RB1 Deletion	1	7
P-0008971	P-0008971-T01-IM5	Outside	FFPE	Resection	250	520	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.G199E	0	1
P-0008972	P-0008972-T01-IM5	In-House	FFPE	Biopsy	250	905	60	Matched	Metastasis	Skin	Groin	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										TP53 p.Y234N;TP53 p.Y236H;NOTCH1 p.E1583*;BLM p.X628_splice	0	4
P-0008973	P-0008973-T01-IM5	In-House	FFPE	Biopsy	250	924	10	Matched	Metastasis	Cancer of Unknown Primary	Neck	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Capmatinib,Crizotinib,Cabozantinib(MET p.D1010N)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;MET p.D1010N;TP53 p.Q144Hfs*26	2	3
P-0008974	P-0008974-T01-IM5	In-House	FFPE	Resection	250	636	80	Matched	Metastasis	Skin	Bone	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.R416*);Trametinib,Cobimetinib(NF1 p.F406Lfs*22)				LEVEL_4	BRAF p.D594N;NF1 p.R416*;SMARCA4 p.E821K;NSD1 p.Q2260*;DAXX p.E550*;NF1 p.F406Lfs*22;SETD2 p.H1603Y	2	7
P-0008975	P-0008975-T01-IM5	In-House	FFPE	Cytology	250	818	50	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;EIF1AX p.X113_splice	2	2
P-0008976	P-0008976-T01-IM5	In-House	Cell Pellet	Cytology	250	209	90	Matched	Metastasis	Lung	Back	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Trametinib,Cobimetinib(MAP2K1 p.I103M)						LEVEL_3A	MAP2K1 p.I103M;STK11 p.G242V;KDM5C p.S287*;SMARCA4 p.N1516Vfs*30	1	4
P-0008978	P-0008978-T01-IM5	In-House	FFPE	Biopsy	250	929	80	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.R273C;SMAD4 Deletion;APC APC-intragenic	1	4
P-0008994	P-0008994-T01-IM5	Outside	FFPE	Resection	250	1114	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)	Talazoparib,Olaparib(BRCA1 p.R71Kfs*10)	GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Olaparib(ATM p.R2598*);Niraparib,Rucaparib(BRCA1 p.R71Kfs*10)					LEVEL_1	PIK3CA p.H1047R;JAK1 p.P430Rfs*2;TP53 p.Y107D;NOTCH1 p.S2486Rfs*103;ATM p.R2598*;BRCA1 p.R71Kfs*10;CDH1 p.P825Rfs*21;CDH1 CDH1-intragenic	5	8
P-0008995	P-0008995-T02-IM5	In-House	FFPE	Resection	250	964	60	Matched	Primary	Mediastinum	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822Y)					LEVEL_3B	TP53 p.X126_splice;KIT p.N822Y;FAT1 p.Y1948*	1	3
P-0008995	P-0008995-T01-IM5	Outside	FFPE	Biopsy	142.6	689	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	MGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822Y)					LEVEL_3B	TP53 p.X126_splice;KIT p.N822Y	1	2
P-0008996	P-0008996-T01-IM5	Outside	FFPE	Resection	250	1028	10	Matched	Primary	Oral Cavity	Not Applicable	Tumor	SACA	Salivary Gland Cancer	Salivary Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification);Crizotinib,Entrectinib(ROS1 C6orf204-ROS1 fusion);Crizotinib,Entrectinib(CEP85L C6orf204-ROS1 fusion)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification;ROS1 C6orf204-ROS1 fusion;CEP85L C6orf204-ROS1 fusion	4	4
P-0008997	P-0008997-T01-IM5	In-House	FFPE	Biopsy	250	1223	80	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Trametinib,Cobimetinib(NF1 p.L164*)				LEVEL_4	TP53 p.Q317*;TET1 p.P1752S;ERBB4 p.E563K;SH2D1A p.V102F;NF1 p.L164*	1	5
P-0008998	P-0008998-T01-IM5	Outside	FFPE	Resection	250	681	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);GSK2636771,AZD8186(PTEN p.R234Pfs*9);PLX8394(BRAF p.G464V);GSK2636771,AZD8186(PTEN p.E114Dfs*17)				LEVEL_1	KRAS p.G12A;PIK3CA p.C420R;PTEN p.R234Pfs*9;BRAF p.G464V;PTEN p.E114Dfs*17	6	5
P-0008999	P-0008999-T01-IM5	In-House	FFPE	Biopsy	250	881	50	Matched	Metastasis	Skin	Spine	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61K;CDKN2A Deletion	2	2
P-0009000	P-0009000-T01-IM5	In-House	FFPE	Biopsy	250	1139	80	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.Q1367*;TCF7L2 p.E51*	1	3
P-0009001	P-0009001-T01-IM5	Outside	FFPE	Biopsy	181.3	919	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.L452_P458del)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.L452_P458del)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_1	KRAS p.G12D;TP53 p.C135W;PIK3CA p.L452_P458del;RUNX1 p.L226Pfs*2;AKT2 Amplification;CCNE1 Amplification	3	6
P-0009002	P-0009002-T01-IM5	In-House	FFPE	Biopsy	250	1058	20	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.X187_splice;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0009003	P-0009003-T01-IM5	In-House	FFPE	Biopsy	250	1229	90	Matched	Metastasis	Scalp	Lung	Tumor	SEBA	Skin Cancer, Non-Melanoma	Sebaceous Carcinoma			Sonidegib,Vismodegib(PTCH1 p.G288Mfs*35)						LEVEL_3A	MYCN p.P44L;SMARCA4 p.X373_splice;PRDM1 p.T325Nfs*99;NOTCH1 p.G427Sfs*207;PTCH1 p.G288Mfs*35;CCND3 Amplification;VEGFA Amplification	1	7
P-0009004	P-0009004-T01-IM5	In-House	FFPE	Biopsy	250	1079	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D;SF3B1 p.G742D;TP53 p.T284Rfs*19	1	3
P-0009005	P-0009005-T01-IM5	In-House	FFPE	Resection	250	1098	50	Matched	Metastasis	Bladder	Brain	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ARID1A p.A2027Efs*12;DDR2 Amplification;DIS3 Deletion;DNMT3B Amplification;ERBB2 Amplification;MCL1 Amplification;MYCL Amplification;RB1 Deletion;RICTOR Amplification;SRC Amplification;TERT Amplification	1	11
P-0009006	P-0009006-T01-IM5	Outside	FFPE	Resection	250	253	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0009007	P-0009007-T01-IM5	In-House	FFPE	Biopsy	250	940	20	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	NETNOS	Cancer of Unknown Primary	Neuroendocrine Tumor, NOS											0	0
P-0009008	P-0009008-T01-IM5	In-House	FFPE	Biopsy	250	741	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma											0	0
P-0009009	P-0009009-T01-IM5	Outside	FFPE	Resection	250	829	10	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;GNAS p.R201H;MED12 p.G44D;SOX9 p.S450Ffs*128	1	4
P-0009010	P-0009010-T01-IM5	Outside	FFPE	Biopsy	250	891	40	Matched	Metastasis	Kidney	Pleura	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R248W;SETD2 p.X2477_splice	1	3
P-0009011	P-0009011-T01-IM5	Outside	FFPE	Biopsy	250	365	40	Matched	Primary	Small Bowel	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q993R)					LEVEL_3B	CTNNB1 p.S45P;TP53 p.Y234N;FAT1 Deletion	1	3
P-0009012	P-0009012-T01-IM5	In-House	FFPE	Resection	250	891	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X23_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)	Cetuximab,Panitumumab(KRAS p.G12R)			LEVEL_3B	KRAS p.G12R;TP53 p.M237I;BRCA2 p.X23_splice;APC p.S823Hfs*4;APC p.L1488Ffs*26;AURKA Amplification;CCND1 Amplification;FGF19 Amplification	2	8
P-0009013	P-0009013-T02-IM5	In-House	FFPE	Resection	250	697	80	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;GNAS p.R201C	1	2
P-0009014	P-0009014-T01-IM5	In-House	FFPE	Biopsy	250	1053	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	CDK8 Amplification;ERBB2 Amplification	2	2
P-0009015	P-0009015-T01-IM5	In-House	FFPE	Biopsy	250	764	90	Matched	Metastasis	Breast	Brain	Tumor	MBC	Breast Cancer	Metaplastic Breast Cancer				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.C242Afs*5;APC Deletion;ARID5B Deletion;BCL2L11 Deletion;BMPR1A Deletion;CDKN2A Deletion;CDKN2B Deletion;ERCC3 Deletion;FGFR1 Amplification;MAP3K1 Deletion;MYC Amplification;PIK3R1 Deletion;PTEN Deletion;RAD50 Deletion;RASA1 Deletion;TET1 Deletion	3	16
P-0009016	P-0009016-T01-IM5	Outside	FFPE	Biopsy	250	973	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		AZD5363(AKT1 p.E17K);Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	AKT1 p.E17K;BRAF p.V600E;SMAD4 p.R361H;APC p.E1521*	4	4
P-0009017	P-0009017-T01-IM5	In-House	FFPE	Resection	250	1097	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.Y163C;PIK3CA p.N345K;KEAP1 p.Q402*;ARID2 p.Q666Nfs*40;ERBB2 Amplification	2	5
P-0009018	P-0009018-T01-IM5	Outside	FFPE	Biopsy	250	976	40	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.X114_splice;BAP1 p.*730Lext*205;TP53 TP53-intragenic	0	3
P-0009019	P-0009019-T01-IM5	In-House	FFPE	Biopsy	250	950	80	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										SF3B1 p.R625H;GNAQ p.Q209L	0	2
P-0009020	P-0009020-T01-IM5	Outside	FFPE	Biopsy	188.6	449	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.S240G;FAT1 p.I4183Mfs*20	1	3
P-0009021	P-0009021-T01-IM5	In-House	FFPE	Biopsy	250	1206	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	PIK3R1 p.R465*;NOTCH4 p.E317*;ARID2 p.X140_splice;MGA p.S947*;MED12 p.Q2109*;TP53 p.N263Ifs*82;FGFR1 Amplification;FLCN Deletion;MAP2K4 Deletion;NCOR1 Deletion;RB1 Deletion;STK11 Deletion;TCF3 Deletion;TERT Amplification	1	14
P-0009022	P-0009022-T01-IM5	In-House	FFPE	Cytology	122	432	20	Matched	Metastasis	Cervix	Pelvis	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma					GSK2636771,AZD8186(PTEN p.Q17*)				LEVEL_4	PTEN p.Q17*;HLA-A p.Q303Hfs*19	1	2
P-0009023	P-0009023-T01-IM5	In-House	FFPE	Biopsy	250	1119	40	Matched	Metastasis	Duodenum	Liver	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.P60Qfs*63	1	2
P-0009024	P-0009024-T01-IM5	In-House	FFPE	Biopsy	250	938	75	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Trametinib,Cobimetinib(MKRN1 BRAF-MKRN1 fusion);Trametinib,Cobimetinib(BRAF BRAF-MKRN1 fusion)					LEVEL_3B	MKRN1 BRAF-MKRN1 fusion;BRAF BRAF-MKRN1 fusion	2	2
P-0009025	P-0009025-T01-IM5	In-House	FFPE	Resection	250	940	15	Matched	Primary	Skin	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.Q893*)					LEVEL_3B	TP53 p.R342*;MSH2 p.Q344*;EPHA3 p.Q39*;SOX9 p.P70S;BRCA2 p.Q893*;TP53 p.S106Rfs*2	1	6
P-0009026	P-0009026-T01-IM5	In-House	FFPE	Resection	250	927	60	Matched	Primary	Breast	Not Applicable	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS										GATA3 p.T315Kfs*37;AKT2 Amplification;AURKA Amplification;FOXA1 Amplification;PPM1D Amplification	0	5
P-0009027	P-0009027-T01-IM5	Outside	FFPE	Resection	250	940	80	Matched	Primary	Thigh	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Olaparib,Rucaparib,Talazoparib,Niraparib(CRYL1 BRCA2-CRYL1 fusion);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 BRCA2-CRYL1 fusion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.H214R;PTEN Deletion;LATS2 NUP107-LATS2 fusion;NUP107 NUP107-LATS2 fusion;CRYL1 BRCA2-CRYL1 fusion;BRCA2 BRCA2-CRYL1 fusion	3	6
P-0009029	P-0009029-T01-IM5	In-House	FFPE	Biopsy	250	730	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;TP53 p.R156H;ARID2 p.R1272*;CDKN1A p.S15Rfs*15	2	4
P-0009042	P-0009042-T01-IM5	In-House	FFPE	Resection	250	698	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750delinsIP)			Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.A750P;EGFR p.E746_A750delinsIP;MDM2 Amplification	2	3
P-0009043	P-0009043-T01-IM5	In-House	FFPE	Biopsy	250	988	10	Matched	Primary	Stomach	Not Applicable	Tumor	SPDAC	Esophagogastric Cancer	Poorly Differentiated Carcinoma of the Stomach											0	0
P-0009044	P-0009044-T01-IM5	Outside	FFPE	Biopsy	250	936	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.K90*);Olaparib(CDK12 p.E182*)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K90*);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.E182*)				LEVEL_1	TP53 p.P151S;CDK12 p.K90*;CDK12 p.E182*;TP53 ANTXR2-TP53 fusion;ANTXR2 ANTXR2-TP53 fusion	4	5
P-0009045	P-0009045-T01-IM5	In-House	FFPE	Biopsy	250	932	90	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TP53 p.R282W;FGFR1 Amplification;MYC Amplification;RB1 Deletion	2	5
P-0009046	P-0009046-T01-IM5	In-House	FFPE	Biopsy	250	932	50	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ATRX p.L1656*;TP53 p.S185Afs*62;PPM1D Amplification	1	4
P-0009047	P-0009047-T01-IM5	In-House	FFPE	Resection	250	1053	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L130Q)				LEVEL_4	KRAS p.G12V;SMAD4 p.R361_G365del;TP53 p.T150Hfs*20;CDKN2A p.L130Q	2	4
P-0009048	P-0009048-T01-IM5	Outside	FFPE	Resection	250	1250	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.R108K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.R108K;EGFR p.A289T;EGFR p.G588S;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	6
P-0009050	P-0009050-T01-IM5	In-House	FFPE	Resection	250	813	50	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN p.P44L	0	1
P-0009051	P-0009051-T01-IM5	In-House	FFPE	Cytology	203.3	302	80	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										TP53 p.R213*	0	1
P-0009052	P-0009052-T01-IM5	Outside	FFPE	Biopsy	250	846	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.D107E);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.D107E;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	4
P-0009053	P-0009053-T01-IM5	In-House	FFPE	Biopsy	250	1044	15	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;FBXW7 p.R465H;APC p.S1398Ifs*20;PIK3R1 p.D578_M582delinsE	1	4
P-0009054	P-0009054-T01-IM5	In-House	FFPE	Resection	250	802	60	Matched	Primary	Eye	Not Applicable	Tumor	RBL	Retinoblastoma	Retinoblastoma										RB1 p.Q631*	0	1
P-0009055	P-0009055-T01-IM5	Outside	FFPE	Biopsy	250	981	20	Matched	Primary	Esophagus	Not Applicable	Tumor	EPDCA	Esophagogastric Cancer	Esophageal Poorly Differentiated Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.L194R;KRAS p.G13D;IL7R p.K395R;ARID1A p.N1203Tfs*2;SMAD4 p.G336*	1	5
P-0009056	P-0009056-T01-IM5	In-House	FFPE	Cytology	250	1107	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R196*;AR Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0009057	P-0009057-T01-IM5	In-House	FFPE	Resection	250	987	50	Matched	Metastasis	Stomach	Ovary	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										NCOR1 p.R1113*;RNF43 p.G659Vfs*41;KMT2D p.P2354Lfs*30;ARID1A p.G276Efs*87;ASXL2 p.M1?;RNF43 p.R117Afs*41;GRIN2A p.S1341Afs*56;ARID1A p.Q372Sfs*19;NCOR1 p.G639Vfs*2;BLM p.K1217Nfs*62;ARID5B p.I497Nfs*31;PBRM1 p.X272_splice;HLA-A p.X25_splice;CDH1 p.N405Ifs*12;ARID1B p.P1476Lfs*5;PIK3R1 p.L356Wfs*17;SOX9 p.F466Lfs*4;TET2 p.L615Sfs*24	0	18
P-0009058	P-0009058-T01-IM5	Outside	FFPE	Resection	250	953	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;TP53 p.M237I;APC p.S1411Rfs*4;FLT3 Amplification	1	4
P-0009059	P-0009059-T01-IM5	Outside	FFPE	Biopsy	250	937	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	KRAS p.G13D	1	1
P-0009060	P-0009060-T01-IM5	In-House	FFPE	Resection	250	687	60	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										LATS1 p.R148*;TP53 p.P47Rfs*76	0	2
P-0009061	P-0009061-T02-IM5	In-House	FFPE	Resection	250	908	40	Matched	Primary	Gallbladder	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Olaparib(ATM p.X221_splice);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.R175H;TP53 p.Q192*;CTNNB1 p.S45P;ATM p.X221_splice;ERBB3 Amplification;MDM2 Amplification	2	6
P-0009061	P-0009061-T01-IM5	In-House	FFPE	Resection	250	683	20	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R248Q;MLH1 p.X193_splice	0	2
P-0009062	P-0009062-T01-IM5	In-House	FFPE	Resection	250	826	50	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	TP53 p.R273H;KRAS p.G12D;SMAD4 p.D537Y;APC p.E1306*	1	4
P-0009063	P-0009063-T01-IM5	In-House	FFPE	Resection	250	781	15	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.R282W;RNF43 p.Q233*	1	3
P-0009064	P-0009064-T01-IM5	In-House	FFPE	Biopsy	250	826	70	Matched	Metastasis	Adrenal Gland	Brain	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										ALK Amplification;MYCN Amplification	0	2
P-0009065	P-0009065-T02-IM5	In-House	FFPE	Biopsy	250	1136	70	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R175H;CCND3 Amplification;ERBB2 Amplification;FAT1 Deletion;VEGFA Amplification;RHPN1 RECQL4-RHPN1 fusion;RECQL4 RECQL4-RHPN1 fusion	2	7
P-0009065	P-0009065-T01-IM5	Outside	FFPE	Biopsy	250	1043	20	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R175H;BCL2L1 Amplification;CCND3 Amplification;ERBB2 Amplification;VEGFA Amplification;RHPN1 RECQL4-RHPN1 fusion;RECQL4 RECQL4-RHPN1 fusion	2	7
P-0009066	P-0009066-T01-IM5	In-House	FFPE	Biopsy	250	764	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.G245S;CIC p.R599Gfs*129	1	3
P-0009067	P-0009067-T01-IM5	Outside	FFPE	Biopsy	250	946	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	AURKA Amplification;CCND1 Amplification;FGF19 Amplification;MDM2 Amplification	1	4
P-0009068	P-0009068-T01-IM5	In-House	FFPE	Biopsy	250	1030	50	Matched	Metastasis	Lung	Adrenal Gland	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;MLH1 p.X264_splice;FAT1 p.K1488*	1	3
P-0009069	P-0009069-T01-IM5	In-House	FFPE	Biopsy	250	856	30	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.X307_splice;KRAS Amplification	0	2
P-0009070	P-0009070-T01-IM5	Outside	FFPE	Biopsy	135.1	133	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	ERBB2 Amplification	2	1
P-0009071	P-0009071-T01-IM5	In-House	FFPE	Biopsy	250	989	40	Matched	Primary	Sinus	Not Applicable	Tumor	SNA	Head and Neck Cancer	Sinonasal Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	MYCN p.P44L;CDK4 Amplification;EGFR Amplification;GLI1 Amplification;MDM2 Amplification;TMEM127 TSN-TMEM127 fusion;TSN TSN-TMEM127 fusion	2	7
P-0009072	P-0009072-T01-IM5	Outside	FFPE	Biopsy	250	806	100	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;SETD2 p.R441*;CDKN2A Deletion;MYC Amplification;VEGFA Amplification	3	5
P-0009073	P-0009073-T01-IM5	Outside	FFPE	Biopsy	250	597	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0009074	P-0009074-T01-IM5	Outside	FFPE	Biopsy	250	1036	80	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;MYC Amplification	0	2
P-0009075	P-0009075-T01-IM5	Outside	FFPE	Resection	250	568	40	Matched	Primary	Ovary	Not Applicable	Tumor	EOV	Ovarian Cancer	Endometrioid Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	GSK2636771,AZD8186(PTEN p.X343_splice)				LEVEL_3B	PIK3CA p.H1047L;CTNNB1 p.S33F;PTEN p.X343_splice;ARID1A p.S558Lfs*61	2	4
P-0009076	P-0009076-T01-IM5	Outside	FFPE	Biopsy	250	1141	90	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	CBL p.X250_splice;NF1 Deletion	1	2
P-0009077	P-0009077-T01-IM5	Outside	FFPE	Resection	250	634	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0009078	P-0009078-T01-IM5	In-House	FFPE	Resection	250	1065	95	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	BAP1 Deletion;FH Deletion;NF1 Deletion;PPM1D Amplification	1	4
P-0009079	P-0009079-T01-IM5	Outside	FFPE	Resection	250	812	30	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma										FBXW7 p.R465C	0	1
P-0009080	P-0009080-T01-IM5	In-House	FFPE	Resection	250	973	80	Matched	Metastasis	Lung	Brain	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib(NF1 p.Q1841*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.V157F;NF1 p.Q1841*;SETD2 p.X2478_splice;CDKN2A Deletion;CDKN2B Deletion;RASA1 Deletion	2	6
P-0009081	P-0009081-T01-IM5	In-House	FFPE	Resection	250	738	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type											0	0
P-0009082	P-0009082-T01-IM5	In-House	FFPE	Biopsy	250	838	90	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification;NKX3-1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0009083	P-0009083-T01-IM5	In-House	FFPE	Biopsy	250	1093	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(BARD1 p.X72_splice)					LEVEL_3B	TP53 p.E298*;FAT1 p.E821*;BARD1 p.X72_splice;KLF4 p.Y266*;KEAP1 p.C518_Y520delinsGV*	1	5
P-0009084	P-0009084-T02-IM5	In-House	FFPE	Biopsy	250	926	60	Matched	Metastasis	Anus	Liver	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822K)					LEVEL_3B	KIT p.N822K;SF3B1 p.R625H	1	2
P-0009084	P-0009084-T01-IM5	In-House	FFPE	Resection	250	778	20	Matched	Metastasis	Anus	Lymph Node, Regional	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Sorafenib,Ripretinib(KIT p.N822K)					LEVEL_3B	KIT p.N822K;SF3B1 p.R625H;APC p.S1400*	1	3
P-0009085	P-0009085-T01-IM5	Outside	FFPE	Resection	250	842	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										KMT2C p.Q1719*;FOXA1 p.H247L	0	2
P-0009086	P-0009086-T01-IM5	In-House	FFPE	Resection	250	720	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Tipifarnib(HRAS p.Q61R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	HRAS p.Q61R;ARID1A p.W1844*;BRAF p.K499E;CDKN2A Deletion;CDKN2B Deletion;CREBBP Deletion	2	6
P-0009087	P-0009087-T01-IM5	Outside	FFPE	Biopsy	250	1097	90	Matched	Metastasis	Cancer of Unknown Primary	Vagina	Tumor	NETNOS	Cancer of Unknown Primary	Neuroendocrine Tumor, NOS				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)					LEVEL_3B	PIK3CA p.C420R;ARID1A p.D1850Tfs*33;JAK1 p.L431Vfs*22;NSD1 p.A1837Lfs*12;JAK1 p.N339Ifs*3;CREBBP p.P1423Lfs*36;CTNNB1 p.G34R;ARID1A p.Q372Sfs*19;STAG2 p.R614*;DIS3 p.I678Ffs*59;ZFHX3 p.P2775Qfs*14;ARID5B p.P461Afs*26;MED12 p.R1735Afs*23;XRCC2 p.K267Nfs*30;STAG2 p.F927Lfs*4;KMT2D p.R845Gfs*85;PTPRD p.S1845delinsM*VTVQEC	1	17
P-0009088	P-0009088-T01-IM5	In-House	FFPE	Biopsy	250	971	60	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction										TP53 p.R196*	0	1
P-0009089	P-0009089-T01-IM5	In-House	FFPE	Resection	250	1125	90	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast					Trametinib,Cobimetinib(NF1 p.I679Dfs*21);Trametinib,Cobimetinib(NF1 p.Q2324*)				LEVEL_4	NF1 p.I679Dfs*21;NF1 p.Q2324*;MED12 p.V41_S52del;BCOR p.S1310Qfs*56	2	4
P-0009090	P-0009090-T01-IM5	In-House	FFPE	Resection	250	801	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	BRAF p.K601E	2	1
P-0009091	P-0009091-T01-IM5	Outside	FFPE	Biopsy	250	430	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;KMT2C p.R4549H;TP53 p.X187_splice	1	3
P-0009092	P-0009092-T01-IM5	In-House	FFPE	Resection	250	992	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.S1455I);Everolimus(TSC2 p.Q1118*)					LEVEL_3B	TP53 p.X187_splice;ATM p.S1455I;TSC2 p.Q1118*;ARID2 p.E427Kfs*13	2	4
P-0009093	P-0009093-T01-IM5	In-House	FFPE	Resection	250	816	15	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;RB1 p.X776_splice;AKT2 Amplification	1	3
P-0009094	P-0009094-T01-IM5	In-House	FFPE	Resection	250	1145	70	Matched	Metastasis	Stomach	Ovary	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach										TP53 p.R175H;TGFBR1 p.S241L;ARID2 p.V872Dfs*17	0	3
P-0009095	P-0009095-T01-IM5	Outside	FFPE	Resection	250	961	40	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma											0	0
P-0009096	P-0009096-T01-IM5	In-House	FFPE	Biopsy	250	1143	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;RBM10 p.X785_splice	1	2
P-0009097	P-0009097-T01-IM5	Outside	FFPE	Biopsy	250	997	60	Matched	Primary	Brain	Not Applicable	Tumor	PAST	Glioma	Pilocytic Astrocytoma				Trametinib,Cobimetinib(KIAA1549 BRAF-KIAA1549 fusion);Trametinib,Cobimetinib(BRAF BRAF-KIAA1549 fusion)					LEVEL_3B	KIAA1549 BRAF-KIAA1549 fusion;BRAF BRAF-KIAA1549 fusion	2	2
P-0009098	P-0009098-T01-IM5	In-House	FFPE	Resection	250	920	15	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TP53 p.R248W;MDM2 Amplification	2	3
P-0009099	P-0009099-T01-IM5	In-House	FFPE	Biopsy	250	774	80	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma					Tazemetostat(KDM6A p.X901_splice)				LEVEL_4	TP53 p.D281H;ARID5B p.E527*;RB1 p.S391*;KDM6A p.X901_splice;RBM10 p.Q674*;ARID5B Deletion;EPHA7 Deletion;GATA3 Amplification;RB1 Deletion;RICTOR Amplification;TERT Amplification;TNFAIP3 Deletion	1	12
P-0009100	P-0009100-T01-IM5	In-House	FFPE	Biopsy	250	1066	30	Matched	Primary	Esophagus	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K)				LEVEL_3B	FGFR2 p.N549K;SMAD4 p.G386V;TP53 p.I251N;CDK4 Amplification;ERBB3 Amplification;GLI1 Amplification;MDM2 Amplification	3	7
P-0009101	P-0009101-T01-IM5	In-House	FFPE	Biopsy	250	1138	15	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_1	PIK3CA p.E545K;FGFR3 p.S249C;PIK3CA p.E542K	4	3
P-0009102	P-0009102-T01-IM5	In-House	FFPE	Resection	250	604	60	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	RAC1 p.C18S;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	3
P-0009103	P-0009103-T01-IM5	In-House	FFPE	Resection	250	717	20	Unmatched	Metastasis	Leg	Lung	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS					Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	TP53 p.Q167*;NF1 NF1-intragenic	1	2
P-0009104	P-0009104-T01-IM5	In-House	FFPE	Resection	250	259	30	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0009105	P-0009105-T01-IM5	In-House	FFPE	Resection	250	778	30	Matched	Metastasis	Cancer of Unknown Primary	Omentum	Tumor	MUP	Melanoma	Melanoma of Unknown Primary				Olaparib(ATM p.L2890P)	Trametinib,Cobimetinib(NF1 p.X2273_splice);Trametinib,Cobimetinib(SH3BGRL NF1-SH3BGRL fusion);Trametinib,Cobimetinib(NF1 NF1-SH3BGRL fusion)				LEVEL_3B	RAF1 p.S257L;ATM p.L2890P;DNMT3A p.Q606*;APC p.Q1244*;PTPRD p.R189*;RB1 p.C553Vfs*58;FOXO1 p.E242Rfs*91;NF1 p.X2273_splice;SH3BGRL NF1-SH3BGRL fusion;NF1 NF1-SH3BGRL fusion	4	10
P-0009106	P-0009106-T01-IM5	In-House	FFPE	Biopsy	250	894	60	Matched	Metastasis	Anus	Liver	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.D579del);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.Q1063*)	Trametinib,Cobimetinib(NF1 p.N78Kfs*29);Trametinib,Cobimetinib(NF1 p.G629R)				LEVEL_3B	NF1 p.N78Kfs*29;NF1 p.G629R;SF3B1 p.R625H;KIT p.D579del;BRCA2 p.Q1063*;EGFR Amplification;FGFR2 Amplification;KIT Amplification	4	8
P-0009107	P-0009107-T01-IM5	Outside	FFPE	Resection	250	201	25	Matched	Primary	Pancreas	Not Applicable	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.I195T;SMAD4 p.A118V;SMAD4 p.T349Lfs*35	1	4
P-0009108	P-0009108-T01-IM5	Outside	FFPE	Biopsy	250	1098	90	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Trametinib(BRAF p.K601E)		PLX8394(BRAF p.K601E);Trametinib,Cobimetinib(NF1 p.R304*)				LEVEL_3A	BRAF p.K601E;PAK5 p.M173I;PTPRT p.Q625*;KMT2A p.R745*;NOTCH3 p.C749*;ASXL1 p.Q1517*;NF1 p.R304*	3	7
P-0009109	P-0009109-T01-IM5	In-House	FFPE	Cytology	95.4	458	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;U2AF1 p.S34F;IRF1 RAD50-IRF1 fusion;RAD50 RAD50-IRF1 fusion	1	4
P-0009110	P-0009110-T01-IM5	In-House	FFPE	Biopsy	250	1102	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.R1634_E1635delinsS*)					LEVEL_3B	TP53 p.Q331H;SMARCA4 p.E740*;BRCA1 p.R1634_E1635delinsS*	1	3
P-0009111	P-0009111-T01-IM5	Outside	FFPE	Cytology	100	457	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H);Palbociclib,Ribociclib,Abemaciclib(MIR548H2 CDKN2A-MIR548H2 fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-MIR548H2 fusion);Palbociclib,Ribociclib,Abemaciclib(MIR548H2 CDKN2A-MIR548H2 fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-MIR548H2 fusion)				LEVEL_3B	TP53 p.K132R;KRAS p.Q61H;SMAD4 p.R496H;ERBB2 Amplification;MIR548H2 CDKN2A-MIR548H2 fusion;CDKN2A CDKN2A-MIR548H2 fusion;MIR548H2 CDKN2A-MIR548H2 fusion;CDKN2A CDKN2A-MIR548H2 fusion	6	8
P-0009112	P-0009112-T01-IM5	Outside	FFPE	Biopsy	120.9	350	10	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	TP53 p.R273H;AKT1 p.E17K	1	2
P-0009113	P-0009113-T01-IM5	Outside	FFPE	Resection	250	1298	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.E40Kfs*14)				LEVEL_4	TP53 p.R342Efs*3;TP53 p.Y234D;MED12 p.C1488*;RB1 p.N803Tfs*7;MED12 p.L571Cfs*11;PTEN p.E40Kfs*14	1	6
P-0009114	P-0009114-T01-IM5	In-House	FFPE	Resection	250	480	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C;APC p.F1354Efs*16;APC p.L592*	0	3
P-0009115	P-0009115-T01-IM5	Outside	FFPE	Biopsy	250	769	10	Unmatched	Metastasis	Kidney	Lymph Node	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma										TP53 p.C135F	0	1
P-0009116	P-0009116-T01-IM5	In-House	FFPE	Resection	250	930	60	Unmatched	Primary	Femoral Vein	Not Applicable	Tumor	EHAE	Soft Tissue Sarcoma	Epithelioid Hemangioendothelioma										TFE3 YAP1-TFE3 fusion;YAP1 YAP1-TFE3 fusion	0	2
P-0009117	P-0009117-T01-IM5	In-House	FNA	Cytology	250	269	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.R175H;MGA p.Q1977*;SMARCA4 p.T894_Q895delins*	1	4
P-0009118	P-0009118-T01-IM5	Outside	FFPE	Biopsy	250	535	80	Matched	Primary	Ascending Colon	Not Applicable	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.G245S;APC p.E1464Vfs*8;ERCC3 p.V458Afs*7;RB1 Deletion	1	5
P-0009119	P-0009119-T01-IM5	In-House	FFPE	Biopsy	250	937	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib(NF1 p.E1735Kfs*4)				LEVEL_3B	PIK3CA p.E542K;TP53 p.P190Sfs*12;NF1 p.E1735Kfs*4	2	3
P-0009120	P-0009120-T01-IM5	In-House	FFPE	Biopsy	250	568	50	Matched	Metastasis	Breast	Epidural Mass	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS											0	0
P-0009121	P-0009121-T01-IM5	In-House	FFPE	Resection	250	851	60	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H	0	1
P-0009122	P-0009122-T01-IM5	In-House	FFPE	Biopsy	250	895	80	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.X225_splice;MAP2K4 p.X171_splice	0	2
P-0009132	P-0009132-T02-IM5	In-House	FFPE	Resection	250	861	40	Matched	Primary	Skin	Not Applicable	Tumor	SKAC	Skin Cancer, Non-Melanoma	Skin Adnexal Carcinoma										ASXL2 p.X20_splice	0	1
P-0009137	P-0009137-T01-IM5	Outside	FFPE	Biopsy	250	673	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0009138	P-0009138-T01-IM5	In-House	FFPE	Resection	250	924	20	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201H;TP53 p.R273C;BMPR1A p.X290_splice	1	4
P-0009139	P-0009139-T01-IM5	In-House	FFPE	Resection	250	629	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.Y205C;APC p.K534*	0	2
P-0009141	P-0009141-T01-IM5	Outside	FFPE	Biopsy	250	788	15	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H	1	2
P-0009142	P-0009142-T01-IM5	In-House	FFPE	Resection	250	1083	25	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										FBXW7 p.R505C;TP53 p.R248Q;APC p.E1309Dfs*4;APC p.N436Kfs*8;TP53 p.L35*	0	5
P-0009143	P-0009143-T01-IM5	In-House	FFPE	Biopsy	250	1288	80	Matched	Metastasis	Uterus	Abdomen	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	GSK2636771,AZD8186(PTEN p.R130G)				LEVEL_3B	PTEN p.R130G;TP53 p.Y220*;PIK3CA p.R88Q;ARID1A p.Y471*;ZFHX3 p.D1165Ifs*22;CCND1 Amplification;FGF19 Amplification	2	7
P-0009144	P-0009144-T01-IM5	In-House	FFPE	Resection	250	719	70	Matched	Primary	Chest Wall	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0009145	P-0009145-T01-IM5	In-House	FFPE	Resection	250	909	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.Y236C;APC p.C1410*;APC p.R194Gfs*11	0	3
P-0009145	P-0009145-T02-IM5	In-House	FFPE	Resection	250	962	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.Y236C;APC p.R194Gfs*11	0	2
P-0009146	P-0009146-T01-IM5	Outside	FFPE	Biopsy	94	301	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44Lfs*76)				LEVEL_3B	PIK3CA p.E545K;KRAS p.G12R;TP53 p.R282W;KMT2D p.S4669*;CDKN2A p.Y44Lfs*76	3	5
P-0009147	P-0009147-T01-IM5	In-House	FFPE	Biopsy	103	428	40	Matched	Metastasis	Kidney	Abdomen	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)							LEVEL_2	CDK4 Amplification;DNMT3A Deletion;GLI1 Amplification;KDM5A Amplification;ANXA6 NSD1-ANXA6 fusion;NSD1 NSD1-ANXA6 fusion	1	6
P-0009148	P-0009148-T01-IM5	In-House	FFPE	Biopsy	250	593	90	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)		Trametinib,Cobimetinib(MAP2K1 p.E203K)	Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E);Olaparib(RAD51C p.L117*)	GSK2636771,AZD8186(PTEN p.V166Sfs*14);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;MAP2K1 p.E203K;PTEN p.V166Sfs*14;RAD51C p.L117*;CDKN2A Deletion;CDKN2B Deletion	6	6
P-0009149	P-0009149-T01-IM5	In-House	FFPE	Resection	250	838	30	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G266E;ARID1A p.R1276*;SMAD3 p.R287W;APC p.S1344*	0	4
P-0009151	P-0009151-T01-IM5	In-House	FFPE	Resection	250	339	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.T41I;SPOP p.F133V	0	2
P-0009152	P-0009152-T01-IM5	In-House	FFPE	Resection	250	972	60	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										CREBBP p.I1084Sfs*15;SF3B1 p.R625C;PPP2R1A p.R183Q;NSD1 p.F1799Lfs*22;ARID1A p.A339Lfs*24;CTCF p.T204Nfs*26;CREBBP p.L524Wfs*6;RAD50 p.N795Ifs*6;CIC p.P509Hfs*14;KMT2D p.R1903*;TCF7L2 p.K485Sfs*23;FLCN p.H429Tfs*39;ARID1A p.P1468Lfs*13;DIS3 p.I678Ffs*59;KMT2D p.R3321*;ATRX p.N1318Ifs*28;LATS1 p.D881Gfs*40;MSH2 p.G410Vfs*2	0	18
P-0009153	P-0009153-T01-IM5	Outside	FFPE	Biopsy	62.9	77	70	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										DAXX p.E454*;MEN1 p.X267_splice	0	2
P-0009155	P-0009155-T01-IM5	Outside	FFPE	Biopsy	250	1074	80	Matched	Metastasis	Breast	Liver	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;GATA3 p.S390Rfs*112;IKBKE Amplification;MDM4 Amplification;PPM1D Amplification	1	5
P-0009156	P-0009156-T01-IM5	In-House	FFPE	Resection	250	1135	40	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559D)								LEVEL_1	KIT p.V559D	1	1
P-0009158	P-0009158-T01-IM5	In-House	FFPE	Biopsy	250	1040	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.C238Y;KMT2D p.E4805*;MAP2K4 p.R110L;SMARCA4 p.E1496*;PTPRT p.X962_splice	0	5
P-0009159	P-0009159-T02-IM5	Outside	FFPE	Biopsy	250	882	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.R181C;RHOA p.L69R	0	2
P-0009160	P-0009160-T01-IM5	In-House	FFPE	Biopsy	250	1397	50	Matched	Metastasis	Breast	Lung	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 p.R248C);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.E545K;FGFR3 p.R248C;GATA3 p.N331Efs*21;CCND1 Amplification;MDM2 Amplification	4	5
P-0009161	P-0009161-T01-IM5	In-House	FFPE	Cytology	250	912	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3CA p.E545K;TP53 p.R280T;TP53 p.D228H;SMAD4 p.Q224*	3	5
P-0009162	P-0009162-T01-IM5	In-House	FFPE	Resection	250	883	20	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Olaparib(CDK12 p.E173*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.E173*)				LEVEL_3B	TP53 p.Y205S;EP300 p.Q2023*;KMT2D p.S2927*;CDK12 p.E173*;STK11 p.D23Sfs*25	2	5
P-0009163	P-0009163-T01-IM5	In-House	FFPE	Biopsy	250	956	30	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.F2827C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	KRAS p.G12A;APC p.Y1376*;ATM p.F2827C	2	3
P-0009164	P-0009164-T01-IM5	In-House	FFPE	Biopsy	250	1021	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.C176S	1	2
P-0009166	P-0009166-T01-IM5	In-House	FFPE	Biopsy	250	1231	50	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CREBBP p.R1341*;TP53 p.G244V;ID3 p.L64F	0	3
P-0009167	P-0009167-T01-IM5	Outside	FFPE	Resection	250	835	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;SOX9 p.S403Efs*175	1	2
P-0009168	P-0009168-T01-IM5	In-House	FFPE	Biopsy	250	1044	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(CDK12 p.E431*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.E431*)				LEVEL_3B	BCOR p.N1459S;RBM10 p.X6_splice;ARID1A p.Q520*;KMT2D p.X59_splice;CDK12 p.E431*;TP53 p.N268Tfs*77	2	6
P-0009169	P-0009169-T01-IM5	Outside	FFPE	Resection	250	829	40	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R248W;RNF43 p.R145*;TCF7L2 p.X440_splice	1	4
P-0009170	P-0009170-T01-IM5	Outside	FFPE	Biopsy	142.3	481	90	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;APC p.T1556Nfs*3	3	2
P-0009171	P-0009171-T01-IM5	Outside	FFPE	Cytology	183.2	869	80	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(CHEK2 p.R346C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;STK11 p.Q220*;SETD2 p.S512*;CHEK2 p.R346C;KMT2C p.E1640*;SMARCA4 p.E1342*;MGA p.Q972Rfs*22;CDKN2A Deletion;CDKN2B Deletion	4	9
P-0009172	P-0009172-T01-IM5	Outside	FFPE	Resection	250	975	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.P278L	1	2
P-0009173	P-0009173-T01-IM5	In-House	FFPE	Resection	250	909	10	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	FBXW7 p.R505C;KRAS p.G12D;GNAS p.R201H;APC p.Q1529*;SOX9 p.F69*	1	5
P-0009174	P-0009174-T01-IM5	In-House	FFPE	Biopsy	250	1018	80	Matched	Metastasis	Oropharynx	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										ARID2 p.S184*;BCOR p.A1453Efs*16	0	2
P-0009175	P-0009175-T02-IM5	Outside	FFPE	Resection	250	171	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.N252_S408del	0	1
P-0009176	P-0009176-T01-IM5	In-House	FFPE	Cytology	250	997	20	Matched	Metastasis	Breast	Pleural Fluid	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma											0	0
P-0009177	P-0009177-T01-IM5	In-House	FFPE	Biopsy	250	1217	70	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	NRAS p.Q61K;TP53 p.T125Afs*46;MEN1 p.S606Ffs*77	1	3
P-0009178	P-0009178-T01-IM5	In-House	FFPE	Resection	250	678	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Everolimus,Temsirolimus(MTOR p.S2215Y);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A4Hfs*14)				LEVEL_4	TP53 p.V157F;MAX p.E96*;MTOR p.S2215Y;APC p.S583*;TP53 p.X367_splice;SMARCA4 p.Y834*;CDKN2A p.A4Hfs*14	2	7
P-0009179	P-0009179-T01-IM5	Outside	FFPE	Resection	250	657	40	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Olaparib(CDK12 p.N894Kfs*14)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13V);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.N894Kfs*14)				LEVEL_3B	KRAS p.G13V;CDK12 p.N894Kfs*14	3	2
P-0009180	P-0009180-T01-IM5	In-House	FFPE	Resection	250	750	10	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_1	BRAF p.V600E;PTEN p.R130Q	3	2
P-0009181	P-0009181-T02-IM5	In-House	FFPE	Biopsy	250	745	70	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y236C;CBFB p.X55_splice	0	2
P-0009181	P-0009181-T01-IM5	In-House	FFPE	Resection	117.3	519	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y236C;CBFB p.X55_splice	0	2
P-0009182	P-0009182-T01-IM5	In-House	FFPE	Resection	250	997	60	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;SPEN p.Q1926*;ARID2 p.A664Ffs*38	2	3
P-0009183	P-0009183-T01-IM5	In-House	FFPE	Biopsy	250	1036	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCC	Esophagogastric Cancer	Esophageal Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion)				LEVEL_4	TP53 p.C275Y;KMT2D p.P643Lfs*287;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion	2	4
P-0009184	P-0009184-T01-IM5	Outside	FFPE	Cytology	250	1136	95	Matched	Metastasis	Lung	Liver	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R65*;NOTCH1 p.E1929*;EP300 p.X48_splice;APC Deletion;BAP1 Deletion;MAP3K1 Deletion;NPM1 Deletion;NSD1 Deletion;PBRM1 Deletion;PIK3R1 Deletion;RASA1 Deletion	0	11
P-0009185	P-0009185-T01-IM5	In-House	FFPE	Resection	250	967	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	KRAS p.G13D;TP53 p.X307_splice;APC p.T1332Nfs*10	1	3
P-0009186	P-0009186-T01-IM5	Outside	FFPE	Resection	250	1057	25	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.V73Rfs*76;TGFBR1 p.Q275*	1	3
P-0009187	P-0009187-T01-IM5	In-House	FFPE	Biopsy	250	1055	50	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										TP53 p.X331_splice;PIK3CB Amplification	0	2
P-0009188	P-0009188-T01-IM5	In-House	FFPE	Cytology	250	242	60	Matched	Metastasis	Tongue	Lymph Node	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										AKT2 Amplification	0	1
P-0009189	P-0009189-T01-IM5	In-House	FFPE	Biopsy	160.9	254	80	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	TP53 p.E285K;TP53 p.G187D;KMT2D p.R5432W;HIST1H3B p.E106K;CBL p.W60*;TP53 p.F113Sfs*10;CDKN2A p.R58*;MYC Amplification	1	8
P-0009190	P-0009190-T01-IM5	In-House	FFPE	Resection	250	975	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0009191	P-0009191-T01-IM5	Outside	FFPE	Resection	250	867	35	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SF3B1 p.K700E;SMAD4 p.X263_splice;TP53 p.M237Vfs*9	1	4
P-0009192	P-0009192-T01-IM5	In-House	FFPE	Resection	250	991	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	KRAS p.G12A;APC p.E1379*;SOX9 p.S279*;PRKN p.Y147Mfs*30;SOX9 p.Y477Lfs*101	1	5
P-0009193	P-0009193-T01-IM5	In-House	FFPE	Biopsy	202.8	204	80	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.X307_splice;IDH1 p.R132H;ATRX p.Y341*	1	3
P-0009194	P-0009194-T01-IM5	In-House	FFPE	Resection	250	710	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	KRAS p.G13C;KEAP1 p.E542*	1	2
P-0009195	P-0009195-T01-IM5	Outside	FFPE	Resection	250	551	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0009196	P-0009196-T01-IM5	In-House	FFPE	Cytology	250	726	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)				LEVEL_4	TP53 p.Q100*;KRAS p.A146T;STK11 p.X245_splice;KEAP1 p.W591*;AMER1 p.L652*	1	5
P-0009197	P-0009197-T01-IM5	In-House	FFPE	Resection	250	816	90	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Lorlatinib,Brigatinib(ALK p.F1245I)					LEVEL_3B	ALK p.F1245I;B2M Deletion;MGA Deletion;RAD51 Deletion	1	4
P-0009198	P-0009198-T01-IM5	Outside	FFPE	Biopsy	250	638	35	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;ARID1A p.Q2039*;SETD2 p.E1200*;SETD2 p.R395*	2	4
P-0009199	P-0009199-T02-IM5	Outside	FFPE	Resection	250	881	60	Matched	Primary	Ovary	Not Applicable	Tumor	UCCA	Gestational Trophoblastic Disease	Choriocarcinoma											0	0
P-0009200	P-0009200-T01-IM5	In-House	FFPE	Biopsy	250	830	40	Matched	Metastasis	Transverse Colon	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_4	TP53 p.R282W;KRAS p.Q61H;ASXL1 p.R693*;MYC Amplification;SMAD4 Deletion	1	5
P-0009201	P-0009201-T01-IM5	Outside	FFPE	Biopsy	250	549	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345T);Olaparib(PALB2 p.I76Mfs*4)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.N345T;PALB2 p.I76Mfs*4;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	4	5
P-0009202	P-0009202-T01-IM5	In-House	FFPE	Biopsy	250	649	30	Matched	Primary	Trachea	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.Y220C;NOTCH1 p.Q184Rfs*93;EPHA3 Deletion;FBXW7 Deletion;KDR Amplification;KIT Amplification;PDGFRA Amplification	0	7
P-0009203	P-0009203-T01-IM5	In-House	FFPE	Resection	250	686	25	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H	1	2
P-0009204	P-0009204-T01-IM5	Outside	FFPE	Resection	250	631	80	Matched	Primary	Testis	Not Applicable	Tumor	PLLS	Soft Tissue Sarcoma	Pleomorphic Liposarcoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.R248W;FGFR1 Amplification;PTEN Deletion	2	3
P-0009205	P-0009205-T01-IM5	Outside	FFPE	Biopsy	250	600	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma					Trametinib,Cobimetinib(NF1 p.T2335Vfs*49);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.T2335Vfs*49;TP53 p.Y103_G108del;NF2 p.N286Afs*4;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0009206	P-0009206-T01-IM5	Outside	FFPE	Resection	250	801	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H	1	1
P-0009207	P-0009207-T02-IM5	Outside	FFPE	Biopsy	250	832	90	Unmatched	Primary	Neck	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0009214	P-0009214-T01-IM5	In-House	FFPE	Cytology	250	1006	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R273L;KEAP1 p.G333Lfs*16	0	2
P-0009215	P-0009215-T01-IM5	In-House	FFPE	Resection	250	872	25	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0009216	P-0009216-T02-IM5	In-House	FFPE	Resection	250	1049	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.R249T;ATRX p.K319*	1	3
P-0009216	P-0009216-T01-IM5	Outside	FFPE	Biopsy	250	951	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.R249T;ATRX p.K319*;RB1 Deletion	1	4
P-0009217	P-0009217-T01-IM5	In-House	FFPE	Resection	250	583	40	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	NBL	Peripheral Nervous System	Neuroblastoma											0	0
P-0009218	P-0009218-T01-IM5	Outside	FFPE	Biopsy	94.7	320	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										PRDM1 Deletion	0	1
P-0009219	P-0009219-T01-IM5	In-House	FFPE	Biopsy	250	876	80	Matched	Primary	Brain	Not Applicable	Tumor	OAST	Glioma	Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.R1415Kfs*25;CIC p.K1428Efs*12	1	3
P-0009220	P-0009220-T01-IM5	Outside	FFPE	Resection	250	907	25	Matched	Metastasis	Soft Tissue	Lung	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13D)					LEVEL_3B	NRAS p.G13D	1	1
P-0009221	P-0009221-T01-IM5	In-House	FFPE	Resection	250	873	30	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										TP53 p.E343*;ZFHX3 ZFHX3-intragenic	0	2
P-0009223	P-0009223-T01-IM5	In-House	FFPE	Cytology	250	881	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.R273S;MGA p.K1201*;SMARCA4 p.X1511_splice;KMT2C p.G4387Afs*26;TET2 p.E1323*;MET Amplification	2	6
P-0009224	P-0009224-T02-IM5	In-House	FFPE	Resection	250	638	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R);GSK2636771,AZD8186(PTEN p.M35I)	Cetuximab,Panitumumab(KRAS p.Q61R)			LEVEL_4	KRAS p.Q61R;APC p.R1450*;TP53 p.Q167*;PTEN p.M35I;AMER1 p.E282*;APC p.Y622*	2	6
P-0009225	P-0009225-T01-IM5	In-House	FFPE	Resection	107.6	320	20	Matched	Primary	Pancreas	Not Applicable	Tumor	MCN	Pancreatic Cancer	Mucinous Cystic Neoplasm					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0009226	P-0009226-T02-IM5	Outside	FFPE	Biopsy	250	1224	NA	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.G154V;ARID1A p.P224Rfs*8;SMARCA4 p.E1326*;STK11 p.R39Pfs*8	0	4
P-0009228	P-0009228-T01-IM5	In-House	FFPE	Cytology	250	959	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12R;TP53 p.A39Qfs*5;AKT2 Amplification;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0009238	P-0009238-T01-IM5	In-House	FFPE	Resection	250	814	95	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms										BRAF p.V600E;NFKBIA p.Q44*;TET2 p.Y1255*	0	3
P-0009239	P-0009239-T01-IM5	In-House	FFPE	Resection	250	946	50	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P48L)				LEVEL_4	TET2 p.Q1546*;MEN1 p.Q266*;CBL p.Q282*;KMT2D p.S4359*;HOXB13 p.W195*;TP53 p.P151F;CDKN2A p.P48L;FAT1 FAT1-intragenic	1	8
P-0009240	P-0009240-T01-IM5	In-House	FFPE	Cytology	250	1050	80	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										INPP4B p.A435Rfs*43;TP53 p.K132_C141delinsT;FOXA1 Amplification;PIK3CB Amplification;SH2D1A SH2D1A-intragenic	0	5
P-0009241	P-0009241-T01-IM5	Outside	FFPE	Biopsy	96.8	52	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0009242	P-0009242-T01-IM5	Outside	FFPE	Cytology	250	679	80	Matched	Primary	Pancreas	Not Applicable	Tumor	SPN	Pancreatic Cancer	Solid Pseudopapillary Neoplasm of the Pancreas										CTNNB1 p.D32G	0	1
P-0009243	P-0009243-T01-IM5	In-House	FFPE	Cytology	184.1	515	90	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.A293P)	Neratinib(ERBB2 p.A293P)						LEVEL_2	TP53 p.G266V;ARID2 p.G1226*;ERBB2 p.A293P;CCNE1 Amplification;MCL1 Amplification	2	5
P-0009244	P-0009244-T01-IM5	Outside	FFPE	Biopsy	250	889	70	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ATRX p.F2113Sfs*9;TP53 p.N131del	1	3
P-0009245	P-0009245-T01-IM5	In-House	FFPE	Biopsy	145.6	610	90	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)	Ivosidenib(IDH1 p.R132C);Olaparib(ATM p.D2889_L2890delinsEI)	Trametinib,Cobimetinib(NF1 p.R440*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	IDH1 p.R132C;NRAS p.Q61L;NF1 p.R440*;BRAF p.K483E;ATM p.D2889_L2890delinsEI;CDKN2A Deletion;CDKN2B Deletion	5	7
P-0009246	P-0009246-T01-IM5	In-House	FFPE	Resection	250	821	80	Matched	Metastasis	Abdomen	Colon	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(BRAF RBM33-BRAF fusion);Trametinib,Cobimetinib(RBM33 RBM33-BRAF fusion)					LEVEL_2	CDK4 Amplification;MDM2 Amplification;BRAF RBM33-BRAF fusion;RBM33 RBM33-BRAF fusion	4	4
P-0009248	P-0009248-T01-IM5	In-House	FFPE	Resection	250	962	40	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;FLT3 p.S753L	1	2
P-0009249	P-0009249-T01-IM5	In-House	FFPE	Resection	250	855	30	Matched	Metastasis	Breast	Lung	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.E198*;NUP93 p.E14K;ERBB2 Amplification;FOXA1 Amplification;TMCO5A MGA-TMCO5A fusion;MGA MGA-TMCO5A fusion	2	6
P-0009250	P-0009250-T02-IM5	In-House	FFPE	Resection	250	788	90	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor		Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.H845_D846delinsPN)							LEVEL_2	PDGFRA p.H845_D846delinsPN	1	1
P-0009251	P-0009251-T01-IM5	Outside	FFPE	Cytology	250	1008	80	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor											0	0
P-0009252	P-0009252-T01-IM5	Outside	FFPE	Resection	250	808	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V173M;KRAS Amplification	0	2
P-0009253	P-0009253-T01-IM5	In-House	FFPE	Resection	201.066	905	80	Matched	Metastasis	Lung	Adrenal	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										KMT2D p.E914*;TP53 p.I195K	0	2
P-0009254	P-0009254-T01-IM5	In-House	FFPE	Resection	250	836	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	KRAS p.G12D;TP53 p.R175H;KDM6A p.P1269Tfs*22;CDKN2A p.H83Y	2	4
P-0009255	P-0009255-T01-IM5	Outside	FFPE	Resection	250	648	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										SETD2 p.R2109*	0	1
P-0009256	P-0009256-T01-IM5	In-House	FFPE	Biopsy	250	828	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.I2888T);Olaparib(ATM p.G2369*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.E165*;ATM p.I2888T;ATM p.G2369*	4	4
P-0009257	P-0009257-T01-IM5	In-House	FFPE	Biopsy	250	1613	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	PBRM1 p.F1406Lfs*15;MET Amplification	1	2
P-0009258	P-0009258-T01-IM5	In-House	FFPE	Resection	250	936	30	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64)	Olaparib(PALB2 p.N280Tfs*8)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E61*)				LEVEL_3A	TP53 p.W53*;TP53 p.W53*;PTCH1 p.R1308Efs*64;KMT2C p.F4496Lfs*21;PALB2 p.N280Tfs*8;PGR p.P906L;HNF1A p.Q176*;NOTCH1 p.G1196Afs*249;MSH2 p.X554_splice;FAT1 p.P3798Lfs*35;CDKN2A p.E61*	3	11
P-0009260	P-0009260-T01-IM5	In-House	FFPE	Resection	250	1004	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion)				LEVEL_1	EGFR p.L858R;EGFR p.R776C;MDM2 Amplification;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion	4	5
P-0009261	P-0009261-T01-IM5	In-House	FFPE	Resection	250	774	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.S310F);Ado-Trastuzumab Emtansine(ERBB2 p.D277Y)	Neratinib(ERBB2 p.S310F);Neratinib(ERBB2 p.D277Y)	Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	ERBB2 p.S310F;TP53 p.S127Y;ERBB2 p.D277Y;ERBB2 Amplification	5	4
P-0009262	P-0009262-T01-IM5	Outside	FFPE	Resection	250	987	10	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R280K;SMAD4 p.V539_A546del	0	2
P-0009263	P-0009263-T01-IM5	In-House	FFPE	Biopsy	250	1150	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A57Gfs*51)				LEVEL_1	FGFR3 p.S249C;PIK3CA p.E542K;KMT2C p.Q448*;KMT2D p.S2438*;DICER1 p.X146_splice;NOTCH1 p.X376_splice;BCL2L11 p.Y96*;KMT2C p.E4008Rfs*6;CDKN2A p.A57Gfs*51	4	9
P-0009264	P-0009264-T01-IM5	Outside	FFPE	Biopsy	247.4	638	70	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.M1414Rfs*40	1	2
P-0009265	P-0009265-T01-IM5	In-House	FFPE	Biopsy	78.585	433	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F;DIS3 p.D488Y	2	3
P-0009266	P-0009266-T01-IM5	In-House	FFPE	Biopsy	250	841	60	Matched	Metastasis	Lung	Pleura	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R273H;TP53 p.R196P;CDKN2A Deletion;CDKN2B Deletion;PIK3CA Amplification	1	5
P-0009267	P-0009267-T01-IM5	Outside	FFPE	Resection	250	1429	40	Matched	Metastasis	Uterus	Omentum	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	KRAS p.G12V;PPP2R1A p.R183W;ARID1A p.E1777*;CDKN2A p.R80*	2	4
P-0009268	P-0009268-T01-IM5	In-House	FFPE	Cytology	235.4	1347	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.X331_splice;RB1 p.Q217*;KEAP1 p.E121*;RBM10 p.E638Rfs*66	1	5
P-0009269	P-0009269-T01-IM5	Outside	FFPE	Biopsy	227.2	984	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0009270	P-0009270-T01-IM5	Outside	FFPE	Cytology	139.9	937	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.N239dup	1	2
P-0009271	P-0009271-T01-IM5	Outside	FFPE	Biopsy	250	985	60	Matched	Metastasis	Pancreas	Arm	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion)				LEVEL_3B	KRAS p.Q61K;ARID1A p.V1427Dfs*54;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;MYC Amplification;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion	5	8
P-0009272	P-0009272-T01-IM5	Outside	FFPE	Biopsy	250	728	NA	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.G154V;BRAF p.G466A;SMARCA4 p.S297Afs*6	0	3
P-0009273	P-0009273-T01-IM5	Outside	FFPE	Resection	250	784	NA	Matched	Primary	Cervix	Not Applicable	Tumor	MCCE	Cervical Cancer	Mixed Cervical Carcinoma										KEAP1 p.R260*	0	1
P-0009274	P-0009274-T01-IM5	In-House	FFPE	Resection	250	1002	NA	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;EPHA7 Deletion;PRDM1 Deletion	2	3
P-0009275	P-0009275-T01-IM5	Outside	FFPE	Biopsy	250	934	20	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	TP53 p.R248W;KRAS p.G13C;STK11 p.E165*	1	3
P-0009277	P-0009277-T01-IM5	In-House	FFPE	Biopsy	250	1149	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A	1	1
P-0009288	P-0009288-T01-IM5	In-House	FFPE	Resection	250	998	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.X331_splice;KDM6A p.L1296Sfs*36	1	3
P-0009289	P-0009289-T01-IM5	In-House	FFPE	Resection	250	998	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.X125_splice;RUNX1 p.R444Pfs*128	1	3
P-0009290	P-0009290-T01-IM5	In-House	FFPE	Biopsy	250	755	50	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										INHBA p.R377H;SETD2 p.K712Afs*53;KDM6A p.P618Tfs*3;CREBBP p.T163Afs*13	0	4
P-0009291	P-0009291-T01-IM5	Outside	FFPE	Resection	250	559	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma		Cabozantinib(MET Amplification)		Crizotinib(MET Amplification)					LEVEL_2	TP53 p.K132N;VHL p.E55Gfs*7;MET Amplification	2	3
P-0009292	P-0009292-T01-IM5	In-House	FFPE	Biopsy	250	1020	70	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;RB1 p.K640*;TP53 p.P71Lfs*52	2	3
P-0009293	P-0009293-T01-IM5	In-House	FFPE	Cytology	61.8	558	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										CTNNB1 p.S37F;TP53 p.E285V;BRAF p.G596R;SMAD2 p.T197Sfs*8	0	4
P-0009294	P-0009294-T01-IM5	In-House	FFPE	Resection	250	1222	40	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Everolimus,Temsirolimus(MTOR p.A1459D)				LEVEL_4	TP53 p.R273H;MTOR p.A1459D;APC p.R805*;APC p.S1415Kfs*8	1	4
P-0009295	P-0009295-T01-IM5	In-House	FFPE	Biopsy	250	1036	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.R249S;PBRM1 p.E913*;ATR p.W2177*;KMT2D p.E3237*;AKT1 Amplification;FGFR1 Amplification;FOXA1 Amplification;MDM2 Amplification;MYC Amplification;NKX2-1 Amplification;PAK1 Amplification	2	11
P-0009296	P-0009296-T01-IM5	Outside	FFPE	Resection	250	405	60	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0009297	P-0009297-T01-IM5	In-House	FFPE	Biopsy	129.9	670	50	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	TP53 p.C135Afs*35;NOTCH2 p.T1754Sfs*11;CDKN2A p.H83Y	1	3
P-0009297	P-0009297-T02-IM5	In-House	FFPE	Biopsy	250	986	50	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	TP53 p.C135Afs*35;NOTCH2 p.T1754Sfs*11;CDKN2A p.H83Y;MYC Amplification;PIK3CB Amplification;MED12 MED12-intragenic	1	6
P-0009299	P-0009299-T01-IM5	In-House	FFPE	Resection	250	1095	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.H61R)				LEVEL_4	KRAS p.G12D;PTEN p.H61R;RNF43 p.S262*;TP53 p.P153Sfs*13	2	4
P-0009300	P-0009300-T01-IM5	In-House	FFPE	Resection	250	1008	50	Matched	Metastasis	Lung	Lymph Node	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										EPHA7 Deletion	0	1
P-0009301	P-0009301-T01-IM5	In-House	FFPE	Biopsy	250	841	50	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	TRIB2 MSH6-TRIB2 fusion;MSH6 MSH6-TRIB2 fusion;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	4
P-0009302	P-0009302-T01-IM5	Outside	FFPE	Biopsy	161.7	286	50	Matched	Metastasis	Sigmoid Colon	Peritoneal Implant	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.E1309Dfs*4;PPM1D p.N512Ifs*2;APC p.K1359*;MYCL Amplification;RICTOR Amplification	0	5
P-0009303	P-0009303-T01-IM5	Outside	FFPE	Resection	250	825	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;SMAD4 p.A532D;ARID2 p.Y1584Cfs*24;TP53 TP53-intragenic	3	4
P-0009304	P-0009304-T01-IM5	Outside	FFPE	Biopsy	250	1124	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.D77Tfs*22)				LEVEL_3B	PIK3CA p.H1047R;PTEN p.D77Tfs*22	2	2
P-0009305	P-0009305-T01-IM5	Outside	FFPE	Resection	250	815	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;TP53 p.C176F;APC p.R876*;MAX p.R60Q;APC p.E1464Vfs*8	2	6
P-0009306	P-0009306-T01-IM5	In-House	FFPE	Biopsy	193.6	883	40	Matched	Metastasis	Bile Duct	Gallbladder	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3A	PIK3CA p.E545K;IDH1 p.R132C;ERBB2 Amplification;MDM2 Amplification	4	4
P-0009307	P-0009307-T01-IM5	In-House	FFPE	Cytology	250	916	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R248Q	0	1
P-0009308	P-0009308-T01-IM5	Outside	FFPE	Biopsy	250	1046	60	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	NRAS p.Q61K	1	1
P-0009309	P-0009309-T01-IM5	Outside	FFPE	Biopsy	250	917	60	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3B	TP53 p.R248W;IDH1 p.R132H;CDKN2A p.H83Y	2	3
P-0009310	P-0009310-T01-IM5	In-House	Cell Pellet	Cytology	90	523	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib(BRCA1 Deletion)	Niraparib,Rucaparib,Talazoparib(BRCA1 Deletion);Olaparib(RAD51D Deletion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E119*)				LEVEL_3A	KRAS p.G12D;TP53 p.P128Lfs*42;ERCC3 p.Q710*;KDM6A p.Q541*;CDKN2A p.E119*;BRCA1 Deletion;CASP8 Deletion;CBL Deletion;FUBP1 Deletion;GATA3 Deletion;MYC Amplification;RAD51D Deletion	5	12
P-0009311	P-0009311-T01-IM5	Outside	FFPE	Biopsy	250	905	70	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)	Olaparib(BRIP1 p.Q689*)	Trametinib,Cobimetinib(NF1 p.W9_V10delins*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3A	RAC1 p.P29S;NRAS p.Q61L;CTNNB1 p.G34E;ARID2 p.Q1128*;BRIP1 p.Q689*;NF1 p.W9_V10delins*;CDKN2A p.H83Y;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	4	10
P-0009312	P-0009312-T01-IM5	In-House	FFPE	Resection	250	959	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										RASA1 p.X829_splice;APC p.X278_splice;TP53 p.G154_T155del	0	3
P-0009313	P-0009313-T01-IM5	In-House	FFPE	Resection	250	906	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	TP53 p.V157F;BRAF p.G466V;ARID2 p.G642*;ATRX p.K1030*;CDK4 Amplification	1	5
P-0009314	P-0009314-T01-IM5	In-House	FFPE	Resection	250	1050	80	Matched	Metastasis	Uterus	Muscle	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0009315	P-0009315-T01-IM5	In-House	FFPE	Resection	250	893	30	Matched	Primary	Oropharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										CASP8 p.E200*;CASP8 p.R432*;TP53 p.R249W;SMAD4 Deletion	0	4
P-0009316	P-0009316-T01-IM5	In-House	FFPE	Resection	250	621	50	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y)	GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_3B	PIK3CA p.E545K;PTEN p.T319*;SPOP p.E50K;SOX17 p.S403I;PIK3CA p.H1047Y;ARID1A p.S1558Cfs*11;ACVR1 p.R206H;RASA1 p.P145Lfs*29	3	8
P-0009317	P-0009317-T02-IM5	In-House	FFPE	Resection	250	572	50	Matched	Primary	Oropharynx	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	PIK3CA p.C420R;KMT2C p.Q1791*;MDM2 Amplification	2	3
P-0009318	P-0009318-T01-IM5	In-House	FFPE	Biopsy	250	1016	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										ATM p.R3008H;BIRC3 Deletion;CDKN2A Deletion;CDKN2B Deletion	0	4
P-0009319	P-0009319-T01-IM5	In-House	FFPE	Cytology	250	919	60	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										KMT2C p.R4690*	0	1
P-0009320	P-0009320-T01-IM5	In-House	FFPE	Biopsy	250	884	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.S59*)				LEVEL_4	TP53 p.H193Y;PTEN p.S59*;RB1 p.L809Rfs*17	1	3
P-0009321	P-0009321-T01-IM5	Outside	FFPE	Resection	250	798	20	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D;SMAD2 p.C463*	1	2
P-0009322	P-0009322-T01-IM5	In-House	FFPE	Resection	250	1110	50	Matched	Primary	Eyelid	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										TP53 p.R280T;TP53 p.E287Q	0	2
P-0009323	P-0009323-T01-IM5	Outside	FFPE	Resection	250	744	NA	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.D631_L633delinsA)		BLU-667(RET p.D631_L633delinsA)						LEVEL_1	MGA p.E410*;RET p.D631_L633delinsA	2	2
P-0009324	P-0009324-T02-IM5	Outside	FFPE	Biopsy	250	699	80	Matched	Metastasis	Cancer of Unknown Primary	Soft Tissue	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.N42Y);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.E285K;FAT1 p.R191*;ASXL1 p.L542Rfs*7;NOTCH1 p.P460L;CDKN2A p.N42Y;BMPR1A Deletion;CDH1 Deletion;PTEN Deletion;ZFHX3 Deletion	2	9
P-0009325	P-0009325-T02-IM5	In-House	FFPE	Biopsy	250	1165	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Olaparib(RAD51C DHX40-RAD51C fusion);Olaparib(DHX40 DHX40-RAD51C fusion)					LEVEL_3B	GATA3 p.H434Pfs*73;KMT2C p.S2494Rfs*28;RAD51C DHX40-RAD51C fusion;DHX40 DHX40-RAD51C fusion	2	4
P-0009326	P-0009326-T01-IM5	Outside	FFPE	Resection	250	979	80	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma				Enasidenib(IDH2 p.R172M)					LEVEL_3B	RHOA p.G17V;IDH2 p.R172M;DNMT3A p.X519_splice;TET2 p.R1167K	1	4
P-0009327	P-0009327-T01-IM5	Outside	FFPE	Resection	250	973	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	EGFR p.A289T;NSD1 p.K683Rfs*2;ARID1A p.N957Ffs*49;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;GLI1 Amplification	2	8
P-0009328	P-0009328-T01-IM5	Outside	FFPE	Resection	250	1073	50	Matched	Primary	Vulva	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina					Trametinib,Cobimetinib(NF1 p.L1505*)				LEVEL_4	TP53 p.X125_splice;ATRX p.Q1785*;NF1 p.L1505*;EPCAM NRXN1-EPCAM fusion;NRXN1 NRXN1-EPCAM fusion	1	5
P-0009330	P-0009330-T01-IM5	In-House	FFPE	Biopsy	250	953	40	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.N345K;TP53 p.R306*;TBX3 p.X219_splice;ERBB2 Amplification	4	4
P-0009331	P-0009331-T01-IM5	Outside	FFPE	Biopsy	250	906	30	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.V143M	0	1
P-0009333	P-0009333-T01-IM5	In-House	FFPE	Biopsy	250	1061	70	Matched	Metastasis	Breast	Chest Wall	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);AZD9496,Fulvestrant(ESR1 p.D538G)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.E545K;ESR1 p.D538G;MCL1 Amplification;MDM2 Amplification;MYC Amplification	4	5
P-0009334	P-0009334-T01-IM5	Outside	FFPE	Biopsy	250	940	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma					Trametinib,Cobimetinib(NF1 p.E1768*)				LEVEL_4	NBN p.X690_splice;NOTCH1 p.Q885*;NF1 p.E1768*;TP53 p.M66Ifs*76	1	4
P-0009335	P-0009335-T01-IM5	In-House	FFPE	Biopsy	250	830	10	Matched	Metastasis	Pancreas	Omentum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.H193R	1	2
P-0009336	P-0009336-T01-IM5	Outside	FFPE	Biopsy	122	256	10	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;STK11 p.A76Gfs*21	2	2
P-0009337	P-0009337-T01-IM5	Outside	FFPE	Biopsy	250	711	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.X225_splice;JAK1 p.E1147Ffs*6;CCNE1 Amplification	0	3
P-0009338	P-0009338-T01-IM5	In-House	FFPE	Resection	250	908	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0009339	P-0009339-T01-IM5	Outside	FFPE	Biopsy	250	999	90	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Lorlatinib,Brigatinib(ALK p.F1174L);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	TP53 p.R248W;ALK p.F1174L;CCNE1 Amplification;DIS3 Deletion;FOXO1 Deletion;MYC Amplification;RB1 Deletion;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	3	9
P-0009339	P-0009339-T02-IM5	Outside	FFPE	Biopsy	250	1016	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	TP53 p.R248W;MYC Amplification;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	4
P-0009341	P-0009341-T01-IM5	In-House	FFPE	Resection	250	1215	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;SMAD4 p.R361H;MAP2K4 p.R134W;KMT2A p.A1030Gfs*9	0	4
P-0009343	P-0009343-T01-IM5	In-House	FFPE	Biopsy	250	1034	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	TP53 p.H178Tfs*69;ARID1A p.Q404*;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	4
P-0009344	P-0009344-T01-IM5	Outside	FFPE	Biopsy	250	939	40	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.L194R;ATR p.E386*;NCOR1 p.S1099*;AURKA Amplification;FGFR1 Amplification;MYC Amplification;PIK3CA Amplification	3	8
P-0009345	P-0009345-T01-IM5	In-House	FFPE	Resection	250	798	10	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)								LEVEL_1	BRAF p.V600K	1	1
P-0009345	P-0009345-T02-IM5	In-House	FFPE	Resection	250	603	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R	2	1
P-0009346	P-0009346-T01-IM5	In-House	FFPE	Biopsy	250	868	90	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsVP)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;ERRFI1 p.S372Ifs*4;EGFR p.E746_T751delinsVP;AURKA Amplification;CARD11 Amplification;EGFR Amplification;ETV1 Amplification;RAC1 Amplification;MAFB ARID2-MAFB fusion;ARID2 ARID2-MAFB fusion	2	10
P-0009347	P-0009347-T01-IM5	Outside	FFPE	Resection	250	1440	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.F91Lfs*68;TP53 p.X187_splice;CDKN2B CDKN2BAS-CDKN2B fusion;CDKN2B-AS1 CDKN2BAS-CDKN2B fusion	0	4
P-0009348	P-0009348-T01-IM5	In-House	FFPE	Resection	250	727	80	Matched	Metastasis	Kidney	Soft Tissue	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.S80N;SETD2 p.X1529_splice;PBRM1 p.F786Lfs*5;TGFBR1 p.N478Rfs*4	0	4
P-0009349	P-0009349-T01-IM5	In-House	FFPE	Cytology	250	671	50	Matched	Metastasis	Skin	Abdomen	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib(BRAF p.L597R)	Ivosidenib(IDH1 p.R132C);Tipifarnib(HRAS p.A146T)	PLX8394(BRAF p.L597R);Trametinib,Cobimetinib(NF1 p.R440*);GSK2636771,AZD8186(PTEN p.X268_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	IDH1 p.R132C;BRAF p.L597R;NF1 p.R440*;PTEN p.X268_splice;HRAS p.A146T;ZFHX3 p.K1069*;PTPRT p.X995_splice;RAC1 p.P29F;CDKN2A Deletion;CDKN2B Deletion;TNFAIP3 Deletion	7	11
P-0009350	P-0009350-T01-IM5	In-House	FFPE	Resection	250	1101	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010H)	Crizotinib(MET p.D1010H);Crizotinib(MET Amplification)	Cabozantinib(MET p.D1010H)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification);Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	MET p.D1010H;RBM10 p.X890_splice;CDK4 Amplification;MDM2 Amplification;MET Amplification;TERT Amplification	7	6
P-0009351	P-0009351-T02-IM5	Outside	FFPE	Cytology	165	257	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.R213*;KRAS p.Q61H	1	2
P-0009352	P-0009352-T01-IM5	Outside	FFPE	Biopsy	250	998	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.R248Q	1	2
P-0009353	P-0009353-T01-IM5	Outside	FFPE	Biopsy	141	185	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0009355	P-0009355-T01-IM5	Outside	FFPE	Resection	250	858	10	Matched	Metastasis	Sigmoid Colon	Omentum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.C176F	3	2
P-0009356	P-0009356-T01-IM5	Outside	FFPE	Biopsy	250	542	80	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.P408Afs*99;TP53 p.S94Pfs*24;ARID1A p.G127Afs*265;ERBB2 Amplification;FGFR4 Amplification	2	5
P-0009357	P-0009357-T01-IM5	In-House	FFPE	Resection	250	892	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	EGFR p.L858R;PIK3CA p.H1047R;TP53 p.C135Y;EGFR p.A289T	2	4
P-0009358	P-0009358-T01-IM5	In-House	FFPE	Resection	250	885	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(NF1 p.X1066_splice)				LEVEL_3B	NF1 p.X1066_splice;STK11 p.X307_splice;BCL2L1 Amplification;CDK4 Amplification;CDKN1B Deletion;ERBB3 Amplification;GLI1 Amplification;MDM2 Amplification	3	8
P-0009359	P-0009359-T01-IM5	Outside	FFPE	Biopsy	250	848	80	Matched	Primary	Brain	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0009360	P-0009360-T01-IM5	In-House	FFPE	Resection	250	941	70	Matched	Metastasis	Retroperitoneum	Lung	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										RB1 p.L335*	0	1
P-0009361	P-0009361-T01-IM5	Outside	FFPE	Biopsy	250	816	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F102C;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0009362	P-0009362-T01-IM5	In-House	FFPE	Resection	250	762	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.Q1338*;TP53 p.I255del;APC p.R213*;SMAD4 p.Y260*	0	4
P-0009363	P-0009363-T01-IM5	In-House	FFPE	Resection	250	886	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.G245S;APC p.Y935*;APC p.A1492Cfs*22;TCF7L2 p.S334*;NKX3-1 Deletion;SMAD2 Deletion;SMAD3 Deletion	1	8
P-0009364	P-0009364-T01-IM5	In-House	FFPE	Biopsy	250	1086	60	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;RUNX1 p.D96Gfs*15;FGFR4 p.V550M;SPEN p.E2260*;MGA p.S300*;TP53 p.N29Kfs*14;CD274 Amplification;JAK2 Amplification;MYC Amplification;FOXP1 FOXP1-intragenic	2	10
P-0009365	P-0009365-T01-IM5	In-House	FFPE	Biopsy	250	913	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.W111R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.X332_splice;TP53 p.A159P;PTEN p.W111R;CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion	2	6
P-0009366	P-0009366-T01-IM5	Outside	FFPE	Resection	250	943	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.I97Sfs*5	0	1
P-0009367	P-0009367-T02-IM5	In-House	FFPE	Biopsy	250	991	80	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		Trametinib,Cobimetinib(NF1 p.W2075*)				LEVEL_1	PIK3CA p.H1047R;NF1 p.W2075*;CDH1 p.F810Lfs*6;MAP3K1 p.K188Nfs*2;TBX3 p.Q84Rfs*4	3	5
P-0009367	P-0009367-T01-IM5	Outside	FFPE	Biopsy	99.4	341	80	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		Trametinib,Cobimetinib(NF1 p.W2075*)				LEVEL_1	PIK3CA p.H1047R;NF1 p.W2075*;CDH1 p.F810Lfs*6;MAP3K1 p.K188Nfs*2;TBX3 p.Q84Rfs*4;BIRC3 Deletion	3	6
P-0009368	P-0009368-T01-IM5	Outside	FFPE	Biopsy	250	261	25	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.T1052K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D	2	1
P-0009369	P-0009369-T01-IM5	In-House	FFPE	Biopsy	250	1205	60	Matched	Metastasis	Breast	Liver	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	1	4
P-0009370	P-0009370-T01-IM5	Outside	FFPE	Cytology	76.45	827	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.E165*;KEAP1 p.W352*;SMARCA4 p.X1057_splice;MEN1 p.S560Rfs*2	1	5
P-0009371	P-0009371-T01-IM5	In-House	FFPE	Biopsy	176	398	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.R559Lfs*34)				LEVEL_1	CTNNB1 p.S45F;RHOA p.E47K;FGFR3 p.S249C;TP53 p.A159V;KDM6A p.R559Lfs*34	3	5
P-0009372	P-0009372-T01-IM5	In-House	FFPE	Resection	250	1136	10	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(CDK12 p.H818Tfs*2)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.H818Tfs*2)				LEVEL_3B	TP53 p.R273H;CDK12 p.H818Tfs*2	2	2
P-0009373	P-0009373-T01-IM5	In-House	FFPE	Resection	250	806	20	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification;MEF2B Amplification	2	3
P-0009374	P-0009374-T02-IM5	In-House	FFPE	Biopsy	250	943	60	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	AR Amplification;BMPR1A Deletion;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	5
P-0009375	P-0009375-T01-IM5	In-House	FFPE	Biopsy	143	770	20	Matched	Metastasis	Breast	Pleura	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										TP53 p.R273H;TERT Amplification;ZFHX3 ZFHX3-intragenic	0	3
P-0009376	P-0009376-T01-IM5	In-House	FFPE	Resection	250	965	20	Matched	Metastasis	Lung	Lung	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;AURKA Amplification;CDK8 Amplification;CDKN1B Deletion;FLT3 Amplification	2	5
P-0009377	P-0009377-T01-IM5	In-House	FFPE	Biopsy	250	1023	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R213*;APC p.Q1367*;PIK3R1 p.K567E;TP53 p.L252dup;CCND3 Amplification;VEGFA Amplification	0	6
P-0009378	P-0009378-T02-IM5	In-House	FFPE	Biopsy	250	1036	30	Matched	Metastasis	Sinus	Epidural	Tumor	SNUC	Head and Neck Cancer	Sinonasal Undifferentiated Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	GATA3 Deletion;PTEN Deletion	1	2
P-0009379	P-0009379-T01-IM5	In-House	FFPE	Biopsy	250	1224	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A60Rfs*86)				LEVEL_4	KRAS p.G12V;KEAP1 p.R320L;STK11 p.E33*;SMARCA4 p.A843Vfs*8;RBM10 p.X353_splice;CDKN2A p.A60Rfs*86	2	6
P-0009393	P-0009393-T01-IM5	Outside	FFPE	Biopsy	120	201	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.D268Gfs*30)				LEVEL_4	PTEN p.D268Gfs*30;CREBBP CREBBP-intragenic	1	2
P-0009394	P-0009394-T01-IM5	In-House	FFPE	Resection	250	744	30	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R175H;MEF2B Amplification;PIK3R2 Amplification;YAP1 Amplification	0	4
P-0009395	P-0009395-T01-IM5	In-House	FFPE	Resection	236	674	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.H214R	1	2
P-0009396	P-0009396-T01-IM5	In-House	FFPE	Resection	250	1172	10	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMAD4 p.Q534*	1	2
P-0009398	P-0009398-T01-IM5	In-House	FFPE	Biopsy	250	807	80	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R273H;IDH1 p.R132H;ATRX p.X1856_splice	1	3
P-0009399	P-0009399-T01-IM5	In-House	FFPE	Biopsy	250	1211	80	Matched	Metastasis	Prostate	Pleura	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	CTNNB1 p.T41I;TP53 p.Y103*;BRCA2 Deletion;DIS3 Deletion;FOXO1 Deletion;MYC Amplification;NKX3-1 Deletion;RB1 Deletion	2	8
P-0009400	P-0009400-T01-IM5	Outside	FFPE	Resection	250	361	30	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	0	3
P-0009401	P-0009401-T01-IM5	In-House	FFPE	Biopsy	108	184	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.H224Pfs*6)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.H224Pfs*6)				LEVEL_1	CDK12 p.H224Pfs*6;MCL1 Amplification	2	2
P-0009403	P-0009403-T01-IM5	In-House	FFPE	Biopsy	225.85	822	20	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AZD5363(AKT1 p.E17K);AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	AKT1 p.E17K;KRAS p.G12C;RBM10 p.E47*	3	3
P-0009404	P-0009404-T01-IM5	In-House	FFPE	Resection	250	566	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	KRAS p.G12R;TP53 p.G245V;SMAD4 p.H530Tfs*47;CDKN2A p.H83Y	2	4
P-0009405	P-0009405-T01-IM5	Outside	FFPE	Biopsy	250	916	80	Matched	Metastasis	Breast	Chest Wall	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma		Olaparib,Talazoparib(BRCA2 Deletion)		Rucaparib,Niraparib(BRCA2 Deletion);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_2	TP53 p.W91*;ARID1A p.E1964*;BRCA2 Deletion;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MAPK1 Amplification;MYC Amplification	3	8
P-0009406	P-0009406-T02-IM5	In-House	FFPE	Biopsy	250	884	20	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;RB1 p.W195*;TP53 p.C277F;KMT2C p.S2542Yfs*20;TERT Amplification	2	5
P-0009406	P-0009406-T01-IM3	In-House	FFPE	Resection	250	568	50	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;RB1 p.W195*;TP53 p.C277F;KMT2C p.S2542Yfs*20	2	4
P-0009408	P-0009408-T01-IM5	In-House	FFPE	Resection	250	734	60	Matched	Metastasis	Adrenal Gland	Retroperitoneum	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN p.P44L;ATRX p.P663Yfs*10;MYCN Amplification	0	3
P-0009408	P-0009408-T02-IM5	In-House	FFPE	Resection	250	1187	80	Matched	Metastasis	Adrenal Gland	Sacrum	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										MYCN p.P44L;ATRX p.P663Yfs*10	0	2
P-0009409	P-0009409-T01-IM5	Outside	FFPE	Resection	250	511	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0009410	P-0009410-T01-IM5	In-House	FFPE	Biopsy	250	755	60	Matched	Primary	Brain	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma										ARID1B Deletion;MYCN Amplification	0	2
P-0009411	P-0009411-T01-IM5	In-House	FFPE	Biopsy	250	770	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)	Tazemetostat(SMARCB1 p.R374Q)				LEVEL_3B	IDH1 p.R132H;PIK3R1 p.N564D;TP53 p.R267W;TP53 p.G244D;NOTCH1 p.Y550*;CIC p.S1117Kfs*34;SMARCB1 p.R374Q;NF2 p.X225_splice;EPHA3 p.W808*;SMAD4 p.X142_splice;PMS1 p.K655Nfs*14;NOTCH2 p.K849Rfs*6	2	12
P-0009412	P-0009412-T01-IM5	Outside	FFPE	Resection	250	907	50	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.E7Rfs*6)				LEVEL_1	BRAF p.V600E;PTEN p.E7Rfs*6	3	2
P-0009413	P-0009413-T01-IM5	In-House	FFPE	Cytology	88.38	356	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0009414	P-0009414-T01-IM5	In-House	FFPE	Biopsy	250	753	20	Matched	Metastasis	Bladder	Pleura	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										RB1 p.E184*;CDH1 p.C28*	0	2
P-0009415	P-0009415-T01-IM5	Outside	FFPE	Resection	250	924	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN p.Y27*);Lapatinib(EGFR Amplification)				LEVEL_3B	PTEN p.Y27*;RB1 p.D479Efs*16;TP53 p.M133Lfs*42;BRCA2 Deletion;EGFR Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	3	8
P-0009416	P-0009416-T01-IM5	In-House	FFPE	Resection	250	714	50	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Olaparib(CDK12 Deletion);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Olaparib(RAD51D Deletion)					LEVEL_1	TP53 p.S227Hfs*9;ARID1A Deletion;CDK12 Deletion;DDR2 Amplification;ERBB2 Amplification;FLCN Deletion;MYC Amplification;RAD51D Deletion;TP53 Deletion	4	9
P-0009417	P-0009417-T01-IM5	Outside	FFPE	Biopsy	135.8	503	20	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0009418	P-0009418-T01-IM5	In-House	FFPE	Resection	250	646	30	Matched	Metastasis	Ascending Colon	Sigmoid Colon	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	APC p.R554*;KRAS p.G13D;APC p.A1492Cfs*22	1	3
P-0009419	P-0009419-T01-IM5	In-House	FFPE	Biopsy	65.376	606	NA	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E120*)				LEVEL_4	TP53 p.C277F;KEAP1 p.G570*;TP53 p.S106I;GNAS p.Q227H;CDKN2A p.E120*	1	5
P-0009420	P-0009420-T01-IM5	In-House	FFPE	Resection	250	630	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM p.S2812Vfs*3)								LEVEL_1	CUL3 p.M299R;ATM p.S2812Vfs*3	1	2
P-0009421	P-0009421-T01-IM5	In-House	FFPE	Resection	250	711	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAASC	Pancreatic Cancer	Adenosquamous Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.R213*;KRAS p.Q61H	1	2
P-0009422	P-0009422-T01-IM5	In-House	FFPE	Resection	250	809	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A	1	1
P-0009423	P-0009423-T01-IM5	In-House	Cell Pellet	Cytology	250	878	30	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_P753delinsS)			Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	EGFR p.L747_P753delinsS;TP53 p.Y163D;CDK4 Amplification;EGFR Amplification;NKX2-1 Amplification	2	5
P-0009425	P-0009425-T01-IM5	In-House	FFPE	Resection	250	634	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0009426	P-0009426-T01-IM5	In-House	FFPE	Biopsy	250	227	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TET2 p.S1107*;STK11 p.X155_splice	1	3
P-0009427	P-0009427-T01-IM5	In-House	FFPE	Resection	250	986	50	Matched	Primary	Testis	Not Applicable	Tumor	NSGCT	Germ Cell Tumor	Non-Seminomatous Germ Cell Tumor										NPM1 FGF18-NPM1 fusion;FGF18 FGF18-NPM1 fusion	0	2
P-0009428	P-0009428-T01-IM5	In-House	FFPE	Biopsy	158.6	605	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.H214R;PIK3R2 p.D557N	0	2
P-0009430	P-0009430-T01-IM5	Outside	FFPE	Biopsy	100	387	10	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										MED12 p.L36R	0	1
P-0009431	P-0009431-T01-IM5	Outside	FFPE	Resection	250	638	70	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93W)	GSK2636771,AZD8186(PTEN p.R130G);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K)				LEVEL_3B	PTEN p.R130G;TP53 p.R175H;TP53 p.R213*;PIK3CA p.R93W;FGFR2 p.N549K;ZFHX3 p.Q3197Pfs*42;ARID5B p.I497Nfs*31;GATA3 LOC100128811-GATA3 fusion;LOC100128811 LOC100128811-GATA3 fusion	3	9
P-0009432	P-0009432-T01-IM5	Outside	FFPE	Resection	250	1166	60	Matched	Metastasis	Breast	Lung	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										GATA3 p.A441Pfs*34;AURKA Amplification;MAP2K4 Deletion	0	3
P-0009433	P-0009433-T01-IM5	In-House	FFPE	Resection	250	544	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.E847*;TP53 p.V197M	1	3
P-0009434	P-0009434-T01-IM5	Outside	FFPE	Resection	250	560	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.A276G;PTPRS p.R238*;MCL1 Amplification	2	4
P-0009435	P-0009435-T01-IM5	Outside	FFPE	Biopsy	250	904	30	Matched	Primary	Vagina	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina										CBL p.F418L;YAP1 Amplification	0	2
P-0009436	P-0009436-T01-IM5	Outside	FFPE	Resection	250	1007	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R306*;PTEN Deletion	1	2
P-0009437	P-0009437-T01-IM5	Outside	FFPE	Resection	250	854	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R158L;TP53 p.E198*	0	2
P-0009438	P-0009438-T01-IM5	In-House	FFPE	Biopsy	250	824	30	Matched	Metastasis	Kidney	Muscle	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.P86S;PBRM1 p.K1293Nfs*20	0	2
P-0009439	P-0009439-T01-IM5	Outside	FFPE	Biopsy	250	940	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	CDK4 Amplification;MDM2 Amplification;PTEN Deletion	3	3
P-0009440	P-0009440-T01-IM5	In-House	FFPE	Cytology	250	711	20	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0009441	P-0009441-T01-IM5	Outside	FFPE	Biopsy	250	874	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;TP53 p.Y205C	2	2
P-0009442	P-0009442-T01-IM5	Outside	FFPE	Resection	250	928	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;RBM10 p.E513*	2	2
P-0009443	P-0009443-T01-IM5	Outside	FFPE	Biopsy	250	620	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				AZD5363(AKT1 p.E17K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S43Ifs*10)				LEVEL_3B	AKT1 p.E17K;KRAS p.Q61R;TP53 p.N263Kfs*8;CDKN2A p.S43Ifs*10;BRD4 Amplification	3	5
P-0009444	P-0009444-T01-IM5	In-House	FFPE	Biopsy	250	933	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										AURKA Amplification	0	1
P-0009445	P-0009445-T01-IM5	In-House	FFPE	Biopsy	250	970	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.G1357*;TP53 p.V73Gfs*50	0	2
P-0009446	P-0009446-T01-IM5	In-House	FFPE	Resection	250	852	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R248Q	1	2
P-0009447	P-0009447-T01-IM5	Outside	FFPE	Resection	250	661	30	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.E1222Lfs*81	1	2
P-0009448	P-0009448-T01-IM5	In-House	FFPE	Cytology	250	650	10	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.*394Gext*9;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0009449	P-0009449-T01-IM5	Outside	FFPE	Resection	250	590	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EGFR p.G598V;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PTEN Deletion	3	5
P-0009450	P-0009450-T01-IM5	In-House	FFPE	Biopsy	250	778	40	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.Q144P	0	1
P-0009451	P-0009451-T01-IM5	Outside	FFPE	Biopsy	250	834	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.R108K);GSK2636771,AZD8186(PTEN p.X212_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.R108K;EGFR p.E114K;PTEN p.X212_splice;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	4	6
P-0009452	P-0009452-T01-IM5	Outside	FFPE	Biopsy	250	717	80	Matched	Metastasis	Abdomen	Liver	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor										EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	0	2
P-0009453	P-0009453-T01-IM5	In-House	FFPE	Biopsy	250	769	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lapatinib(EGFR Amplification)				LEVEL_3B	CDK4 Amplification;EGFR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification	3	5
P-0009454	P-0009454-T01-IM5	In-House	FFPE	Biopsy	250	693	70	Matched	Metastasis	Pharynx	Parotid	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P48L)				LEVEL_4	TP53 p.P177_C182del;CDKN2A p.P48L	1	2
P-0009455	P-0009455-T01-IM5	Outside	FFPE	Resection	250	810	60	Unmatched	Primary	Leg	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma										MUTYH p.R179H	0	1
P-0009456	P-0009456-T01-IM5	Outside	FFPE	Biopsy	206	583	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma					Palbociclib,Ribociclib,Abemaciclib(MTAP CDKN2A-MTAP fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-MTAP fusion)				LEVEL_4	ATRX p.E886Lfs*18;MTAP CDKN2A-MTAP fusion;CDKN2A CDKN2A-MTAP fusion	2	3
P-0009457	P-0009457-T01-IM5	Outside	FFPE	Cytology	250	666	60	Matched	Primary	Submandibular Gland	Not Applicable	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										TBX3 p.Q510*;BCOR p.R1547Dfs*21	0	2
P-0009458	P-0009458-T01-IM5	In-House	FFPE	Biopsy	250	806	80	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R175H;RIT1 p.F82L;RB1 p.H281Sfs*2;PTEN Deletion	1	4
P-0009459	P-0009459-T01-IM5	In-House	FFPE	Resection	250	824	10	Matched	Metastasis	Testis	Lymph Node	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0009460	P-0009460-T01-IM5	Outside	FFPE	Biopsy	250	831	30	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.P408Afs*99;AURKA Amplification;ERBB2 Amplification;PPM1D Amplification	2	4
P-0009462	P-0009462-T01-IM5	In-House	FFPE	Resection	250	718	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.V243Sfs*44	2	2
P-0009463	P-0009463-T01-IM5	In-House	FFPE	Biopsy	250	758	20	Matched	Metastasis	Prostate	Soft Tissue	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-intragenic)				LEVEL_4	PIK3R1 PIK3R1-intragenic;CDKN2A CDKN2A-intragenic	1	2
P-0009464	P-0009464-T01-IM5	Outside	FFPE	Resection	250	497	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_3B	KRAS p.G12S;PIK3CA p.Q546K;RBM10 p.A631Tfs*41;SMAD4 p.P356S	2	4
P-0009465	P-0009465-T01-IM5	In-House	FFPE	Resection	250	805	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.S215R;KRAS p.Q61H;MAP2K4 Deletion	1	3
P-0009466	P-0009466-T01-IM5	In-House	FFPE	Biopsy	250	1116	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.E285K;KEAP1 p.G430C	0	2
P-0009467	P-0009467-T01-IM5	In-House	Cell Pellet	Cytology	250	842	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)					LEVEL_3B	TP53 p.X187_splice;NRAS p.Q61L;NKX2-1 Amplification	1	3
P-0009468	P-0009468-T01-IM5	In-House	FFPE	Cytology	250	1160	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.V51Sfs*2);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	TP53 p.P278S;KMT2D p.R5432W;ARID1A p.R1335*;TP53 p.R267P;STAG2 p.Q245*;CDKN2A p.V51Sfs*2;CDKN2A p.R58*;MDM2 Amplification	3	8
P-0009469	P-0009469-T01-IM5	Outside	FFPE	Biopsy	250	696	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.N771_H773dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.N771_H773dup)			LEVEL_3A	TP53 p.C277F;EGFR p.N771_H773dup;CDH1 CDH1-intragenic	1	3
P-0009470	P-0009470-T01-IM5	In-House	FFPE	Biopsy	250	1024	20	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.E287*	2	2
P-0009471	P-0009471-T01-IM5	Outside	FFPE	Resection	250	676	50	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	2	3
P-0009472	P-0009472-T01-IM5	Outside	FFPE	Biopsy	250	947	50	Matched	Primary	Brain	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma											0	0
P-0009473	P-0009473-T01-IM5	Outside	FFPE	Resection	250	709	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAS	Non-Small Cell Lung Cancer	Lung Adenosquamous Carcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.X2543_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.N42H)				LEVEL_3A	KRAS p.G12C;TP53 p.E285K;ATM p.X2543_splice;CDKN2A p.N42H;ERBB3 Amplification	4	5
P-0009474	P-0009474-T01-IM5	Outside	FFPE	Biopsy	250	968	20	Matched	Metastasis	Breast	Skin	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS				Olaparib(BARD1 Deletion)	GSK2636771,AZD8186(PTEN p.R233*)				LEVEL_3B	TP53 p.R273H;PTEN p.R233*;BARD1 Deletion;DDR2 Amplification;EPHA7 Deletion;MCL1 Amplification;NTRK1 Amplification	2	7
P-0009475	P-0009475-T01-IM5	In-House	FFPE	Resection	250	733	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.H168R;RB1 p.X180_splice;ARID5B Deletion;CDKN1B Deletion;EGFR Amplification	1	5
P-0009476	P-0009476-T01-IM5	In-House	FFPE	Resection	250	717	60	Matched	Metastasis	Lung	Spine	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ARID2 p.D242Mfs*50;TP53 p.V73Afs*51	2	3
P-0009477	P-0009477-T01-IM5	Outside	FFPE	Biopsy	250	927	80	Matched	Metastasis	Lung	Omentum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;STK11 p.L282Afs*3;BRAF p.W604L;RBM10 p.W187*;CDKN2A Deletion;CDKN2B Deletion;KEAP1 Deletion;SMAD4 Deletion	2	8
P-0009478	P-0009478-T01-IM5	Outside	FFPE	Biopsy	250	736	50	Matched	Primary	Vagina	Not Applicable	Tumor	VSC	Vaginal Cancer	Squamous Cell Carcinoma of the Vulva/Vagina				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;KMT2D p.K1301Tfs*23;KMT2C p.F3304Tfs*21	1	3
P-0009479	P-0009479-T01-IM5	Outside	FFPE	Resection	250	734	80	Matched	Metastasis	Ovary	Uterus	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer											0	0
P-0009480	P-0009480-T01-IM5	Outside	FFPE	Biopsy	250	931	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.X125_splice;ERBB2 Amplification;GATA3 Amplification	2	3
P-0009481	P-0009481-T01-IM5	In-House	FFPE	Biopsy	250	979	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Afatinib(EGFR p.E709_T710delinsD)	Olaparib(ATM p.E2039K)					LEVEL_3A	EGFR p.E709_T710delinsD;ATM p.E2039K;TGFBR1 p.V466Efs*6;ATRX p.X1405_splice	2	4
P-0009482	P-0009482-T01-IM5	In-House	FFPE	Resection	250	777	70	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma					Palbociclib,Ribociclib,Abemaciclib(GFRA1 CDKN2A-GFRA1 fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-GFRA1 fusion)				LEVEL_4	KMT2A p.E1497*;GFRA1 CDKN2A-GFRA1 fusion;CDKN2A CDKN2A-GFRA1 fusion;ANKRD11 DLAT-ANKRD11 fusion;DLAT DLAT-ANKRD11 fusion	2	5
P-0009483	P-0009483-T01-IM5	In-House	FFPE	Biopsy	201.6	802	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Ivosidenib(IDH1 p.R132C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);PLX8394(BRAF p.G464R);Trametinib,Cobimetinib(NF1 p.A1506Yfs*67)				LEVEL_3B	KRAS p.G12V;IDH1 p.R132C;BRAF p.G464R;KEAP1 p.R272H;NF1 p.A1506Yfs*67	4	5
P-0009484	P-0009484-T01-IM5	In-House	FFPE	Biopsy	250	1044	20	Matched	Primary	Duodenum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.N1784Tfs*7);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K3416Nfs*11);Olaparib(ATM p.L1814Wfs*14)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	FUBP1 p.I301Yfs*22;KRAS p.G12D;BRCA2 p.N1784Tfs*7;HNF1A p.P379Lfs*5;CREBBP p.P1946Hfs*30;PTPRS p.P622Lfs*16;SOX9 p.Q312*;PTPRS p.V1025Sfs*18;PPM1D p.L450*;BRCA2 p.K3416Nfs*11;HLA-A p.R7Efs*13;CDKN1B p.R93Afs*32;ARID1A p.Q758Rfs*75;CREBBP p.A1782V;PIK3R2 p.X139_splice;CIC p.Q1054*;ARID1A p.S536Lfs*87;BBC3 p.R243Qfs*7;DIS3 p.F775Lfs*30;KMT2D p.P886Lfs*44;KMT2D p.T1195Hfs*17;PMS2 p.Y149Lfs*23;ATM p.L1814Wfs*14;PMS1 p.N593Kfs*3;NOTCH4 p.W1482Afs*39;GPS2 p.I316Nfs*28	4	26
P-0009486	P-0009486-T01-IM5	In-House	FFPE	Resection	250	829	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;RAC1 p.P29S	2	2
P-0009487	P-0009487-T01-IM5	In-House	FFPE	Resection	250	828	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R158H;SMARCA4 p.R1192C	1	3
P-0009488	P-0009488-T01-IM5	In-House	FFPE	Resection	250	713	40	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.C238Y;TP53 p.R337C;APC p.S1072Rfs*11;KRAS Amplification	1	5
P-0009490	P-0009490-T01-IM5	In-House	FFPE	Resection	250	877	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y126C;CCNE1 Amplification;KDM4C PTPRD-KDM4C fusion;PTPRD PTPRD-KDM4C fusion	0	4
P-0009491	P-0009491-T01-IM5	In-House	FFPE	Biopsy	250	892	40	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.R273L;KEAP1 p.Y396*;STK11 p.E223V;NF2 *8fs*	2	5
P-0009492	P-0009492-T01-IM5	In-House	FFPE	Resection	250	902	10	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H	1	2
P-0009497	P-0009497-T01-IM5	Outside	FFPE	Resection	250	599	80	Matched	Primary	Anus	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma										GNA11 p.Q209L;EIF1AX p.X6_splice	0	2
P-0009498	P-0009498-T01-IM5	In-House	FFPE	Biopsy	250	945	40	Matched	Metastasis	Breast	Pleura	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS					GSK2636771,AZD8186(PTEN p.D24Rfs*20)				LEVEL_4	PTEN p.D24Rfs*20;MAP2K4 p.P325Lfs*4;SMAD4 Deletion	1	3
P-0009499	P-0009499-T01-IM5	In-House	FFPE	Biopsy	250	868	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)	Trametinib,Cobimetinib(NF1 p.W1236*);Trametinib,Cobimetinib(NF1 p.X997_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	IDH1 p.R132H;NF1 p.W1236*;SPEN p.Q2946*;MSH6 p.T1219I;ATR p.Q996*;RASA1 p.X592_splice;NF1 p.X997_splice;RNF43 p.S766*;ATRX p.N428Yfs*5;ARID2 p.L182Pfs*4;TP53 p.V218Gfs*4;CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion;FBXW7 Deletion;INPP4B Deletion	4	16
P-0009500	P-0009500-T01-IM5	In-House	FFPE	Resection	250	730	30	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.S37P	0	1
P-0009501	P-0009501-T01-IM5	In-House	FFPE	Biopsy	250	777	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;TP53 p.S241F;RASA1 p.L902Ffs*9;AKT1 Amplification	1	4
P-0009503	P-0009503-T01-IM5	Outside	FFPE	Biopsy	250	894	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R248Q;ERBB3 p.S846I;CCNE1 Amplification;BRD4 RSL1D1-BRD4 fusion;RSL1D1 RSL1D1-BRD4 fusion;PPP2R1A ZNF236-PPP2R1A fusion;ZNF236 ZNF236-PPP2R1A fusion	0	7
P-0009505	P-0009505-T01-IM5	Outside	FFPE	Biopsy	250	1088	30	Matched	Metastasis	Lung	Chest Wall	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;STK11 p.C132Wfs*29;MYC Amplification	1	3
P-0009506	P-0009506-T01-IM5	In-House	FFPE	Biopsy	250	870	40	Matched	Metastasis	Thyroid	Chest Wall	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;TP53 p.M246I;NF2 Deletion	2	3
P-0009507	P-0009507-T01-IM5	Outside	FFPE	Biopsy	200.5	344	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.H168R;ATRX p.R444*;FAT1 p.E1925Rfs*20	1	4
P-0009508	P-0009508-T01-IM5	In-House	FFPE	Biopsy	250	861	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.L130F;ARID2 p.X63_splice;ARID2 p.V465*	0	3
P-0009509	P-0009509-T01-IM5	In-House	FFPE	Resection	250	589	80	Matched	Metastasis	Ovary	Abdominal Wall	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W;KMT2D p.D1100Tfs*19	0	2
P-0009510	P-0009510-T01-IM5	In-House	FFPE	Biopsy	250	1060	10	Matched	Metastasis	Thyroid	Bone	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;DNMT3A p.D438Efs*213	2	2
P-0009511	P-0009511-T02-IM5	In-House	FFPE	Resection	250	976	80	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;FUBP1 p.S147Wfs*15;ARID1B p.R842Qfs*6	1	3
P-0009512	P-0009512-T01-IM5	In-House	FFPE	Biopsy	250	956	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(BICC1 FGFR2-BICC1 fusion);Pemigatinib(FGFR2 FGFR2-BICC1 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(BICC1 FGFR2-BICC1 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-BICC1 fusion)						LEVEL_1	BICC1 FGFR2-BICC1 fusion;FGFR2 FGFR2-BICC1 fusion	4	2
P-0009513	P-0009513-T01-IM5	In-House	FFPE	Resection	250	539	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										BAP1 p.X126_splice	0	1
P-0009514	P-0009514-T01-IM5	Outside	FFPE	Biopsy	250	1081	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)						LEVEL_1	CTNNB1 p.S33C;SMAD4 p.R361H;CTNNB1 p.S37F;TP53 p.F134L;KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	6	6
P-0009515	P-0009515-T01-IM5	In-House	FFPE	Resection	250	973	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	TP53 p.R248W;KRAS p.G12R;RB1 p.R556*	1	3
P-0009516	P-0009516-T01-IM5	In-House	FFPE	Resection	250	240	60	Matched	Primary	Brain	Not Applicable	Tumor	SFTCNS	CNS Cancer	Solitary Fibrous Tumor of the Central Nervous System										FBXW7 p.R689W	0	1
P-0009517	P-0009517-T01-IM5	In-House	FFPE	Resection	250	446	50	Matched	Metastasis	Kidney	Stomach	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1065Y)					LEVEL_3B	NFE2L2 p.D77G;TP53 p.G245C;PBRM1 p.R472*	1	3
P-0009518	P-0009518-T01-IM5	In-House	FFPE	Resection	250	1171	80	Matched	Metastasis	Uterus	Muscle	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma										BCOR p.N1459S;CCND1 p.T286I;CTNNB1 p.S37P;PIK3R1 p.D569Tfs*34	0	4
P-0009519	P-0009519-T01-IM5	In-House	FFPE	Resection	250	579	10	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;GNAS p.R201C;CTNNB1 p.S33F;SOX9 p.G263Afs*16	1	4
P-0009520	P-0009520-T01-IM5	Outside	FFPE	Biopsy	187.6	219	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	PTEN p.T319*	1	1
P-0009521	P-0009521-T01-IM5	Outside	FFPE	Biopsy	173	403	50	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	MAP2K2 p.K61T;NF2 p.W60*;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0009523	P-0009523-T01-IM5	In-House	FFPE	Resection	250	911	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										TP53 p.G266E;SMAD4 p.C115Y;CDK6 Amplification;FGFR3 Amplification	0	4
P-0009524	P-0009524-T01-IM5	In-House	FFPE	Biopsy	250	913	40	Matched	Metastasis	Ovary	Muscle	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	PIK3R1 p.I442_N453del;ARID1A p.Q1493Hfs*6;ERBB2 Amplification;PTPRD PTPRD-intragenic	1	4
P-0009525	P-0009525-T01-IM5	In-House	FFPE	Biopsy	250	825	50	Matched	Metastasis	Soft Tissue	Chest Wall	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.D281N;RB1 p.L277Pfs*9;ATRX Deletion;PAX5 Deletion;SH2D1A Deletion;STAG2 Deletion	0	6
P-0009526	P-0009526-T01-IM5	In-House	FFPE	Biopsy	250	697	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R282W;EP300 p.D1399N;FBXW7 p.S426L;TCF3 p.Y153*;NFE2L2 p.L74_Q87del	0	5
P-0009527	P-0009527-T01-IM5	In-House	FFPE	Resection	250	1062	80	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;MGA p.S924*;PTEN Deletion	3	3
P-0009528	P-0009528-T01-IM5	In-House	FFPE	Biopsy	250	1024	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0009529	P-0009529-T01-IM5	In-House	FFPE	Biopsy	250	702	50	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0009530	P-0009530-T01-IM5	In-House	FFPE	Resection	250	825	10	Matched	Metastasis	Pancreas	Diaphragm	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.N131I;CCNE1 Amplification	1	3
P-0009531	P-0009531-T01-IM5	Outside	FFPE	Resection	250	463	30	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFS	Soft Tissue Sarcoma	Myxofibrosarcoma											0	0
P-0009532	P-0009532-T01-IM5	In-House	FFPE	Cytology	250	1032	80	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.E224D;STAG2 p.X787_splice	1	3
P-0009533	P-0009533-T01-IM5	In-House	FFPE	Resection	250	1066	80	Matched	Metastasis	Ovary	Small Bowel	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor											0	0
P-0009534	P-0009534-T01-IM5	Outside	FFPE	Resection	250	906	30	Matched	Metastasis	Salivary Gland	Liver	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K	1	1
P-0009535	P-0009535-T01-IM5	In-House	FFPE	Cytology	55.55	289	25	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsA)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_T751delinsA;CDK4 Amplification;EGFR Amplification;FOXA1 Amplification;MDM2 Amplification;NKX2-1 Amplification	4	7
P-0009536	P-0009536-T01-IM5	Outside	FFPE	Resection	250	771	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0009537	P-0009537-T01-IM5	In-House	FFPE	Resection	250	878	70	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;FUBP1 p.K209*;CIC p.X379_splice;CIC p.E641*;CIC p.P911Rfs*15;CIC p.L727Vfs*34;CIC p.F1359Lfs*56;CIC p.T872Pfs*52	1	8
P-0009538	P-0009538-T01-IM5	In-House	FFPE	Biopsy	250	1021	50	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.R181C	2	2
P-0009539	P-0009539-T01-IM5	Outside	FFPE	Cytology	250	1065	60	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0009540	P-0009540-T01-IM5	In-House	FFPE	Biopsy	171.4	598	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.S45F;TP53 p.H193R	0	2
P-0009541	P-0009541-T01-IM5	Outside	FFPE	Resection	250	470	60	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										CCND2 Amplification;KDM5A Amplification;KRAS Amplification;MCL1 Amplification	0	4
P-0009542	P-0009542-T01-IM5	In-House	FFPE	Biopsy	250	1112	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F;GRIN2A p.E1264*;MDM2 Amplification;SH2B3 TMEM116-SH2B3 fusion;TMEM116 TMEM116-SH2B3 fusion	3	6
P-0009543	P-0009543-T01-IM5	In-House	FFPE	Biopsy	250	1069	40	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CHEK1 Deletion);Olaparib(CHEK2 Deletion)				GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	SOX17 p.R61*;CHEK1 Deletion;CHEK2 Deletion;DIS3 Deletion;PTEN Deletion;RB1 Deletion;SUFU Deletion;TP53 Deletion	3	8
P-0009543	P-0009543-T02-IM5	In-House	FFPE	Resection	250	744	80	Matched	Metastasis	Prostate	Brain	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	AR Amplification;BMPR1A Deletion;PTEN Deletion;TP53 Deletion	1	4
P-0009544	P-0009544-T01-IM5	Outside	FFPE	Resection	250	652	30	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;ETV1 Amplification;FOXA1 Amplification;KDM5A Amplification;KRAS Amplification	0	5
P-0009546	P-0009546-T01-IM5	In-House	FFPE	Resection	250	599	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.G1122Efs*28);Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 p.G1122Efs*28);Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	BRCA2 p.G1122Efs*28;BRCA2 Deletion;PRDM1 PRDM1-intragenic	4	3
P-0009547	P-0009547-T01-IM5	In-House	FFPE	Biopsy	250	985	60	Unmatched	Metastasis	Mediastinum	Liver	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.N239Kfs*22;RB1 Deletion	0	2
P-0009555	P-0009555-T01-IM5	Outside	FFPE	Biopsy	250	138	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.L755P)	Neratinib(ERBB2 p.L755P)						LEVEL_2	ERBB2 p.L755P	2	1
P-0009556	P-0009556-T01-IM5	Outside	FFPE	Resection	250	1013	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.L123Kfs*3);Olaparib(CDK12 p.R219_S220delins*)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L123Kfs*3);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R219_S220delins*)				LEVEL_1	CDK12 p.L123Kfs*3;CDK12 p.R219_S220delins*	4	2
P-0009557	P-0009557-T01-IM5	Outside	FFPE	Cytology	94	309	70	Matched	Metastasis	Breast	Bone	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)	Talazoparib,Olaparib(BRCA1 Deletion)		Niraparib,Rucaparib(BRCA1 Deletion);Olaparib(CDK12 Deletion);Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_1	PTEN p.T319*;TP53 p.S183*;BRCA1 Deletion;CCNE1 Amplification;CD274 Amplification;CDK12 Deletion;CDKN1B Deletion;ERBB2 Amplification;EZH2 Deletion;JAK2 Amplification;NOTCH1 Deletion;SETD2 Deletion;STK11 Deletion;TCF3 Deletion	6	14
P-0009558	P-0009558-T01-IM5	Outside	FFPE	Resection	250	865	40	Matched	Primary	Ovary	Not Applicable	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0009559	P-0009559-T01-IM5	Outside	FFPE	Cytology	229.4	1062	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12A;STK11 p.X307_splice;KEAP1 p.R272L;STAG2 p.R259*;CDKN2A Deletion;CDKN2B Deletion	2	6
P-0009560	P-0009560-T01-IM5	In-House	FFPE	Biopsy	250	709	90	Matched	Metastasis	Lung	Brain	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.E294*;NOTCH1 p.G270Vfs*7;FLT3 p.P888T;CCND2 Amplification;KDM5A Amplification;RB1 Deletion	0	6
P-0009561	P-0009561-T01-IM5	Outside	FFPE	Resection	250	873	50	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(CDK12 p.Q1149*)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q1149*)				LEVEL_1	BRAF p.V600E;CDK12 p.Q1149*;RNF43 p.R113*;TP53 p.I255dup;AKT1 Amplification	5	5
P-0009562	P-0009562-T01-IM5	In-House	FFPE	Biopsy	250	961	80	Matched	Primary	Brain	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma											0	0
P-0009563	P-0009563-T01-IM5	Outside	FFPE	Biopsy	250	893	50	Matched	Primary	Esophagus	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84Y)				LEVEL_3B	PIK3CA p.E542K;TP53 p.P151H;AXIN1 p.E715*;CDKN2A p.D84Y;KRAS Amplification;SMAD4 Deletion;AKT2 C19orf47-AKT2 fusion;C19orf47 C19orf47-AKT2 fusion	2	8
P-0009564	P-0009564-T01-IM5	Outside	FFPE	Biopsy	250	1054	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.X70_splice);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.N549K)				LEVEL_4	PTEN p.X70_splice;FGFR2 p.N549K;FOXA1 Amplification;NKX2-1 Amplification	2	4
P-0009565	P-0009565-T01-IM5	In-House	FFPE	Resection	250	1000	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.D32V;TET1 p.Q617*;FOXA1 p.S250_F254del	0	3
P-0009565	P-0009565-T02-IM5	Outside	FFPE	Biopsy	250	1014	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.D32V;TET1 p.Q617*;FOXA1 p.S250_F254del;FOXA1 p.M253_Y259del	0	4
P-0009583	P-0009583-T01-IM5	Outside	FFPE	Resection	250	869	40	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0009584	P-0009584-T01-IM5	In-House	FFPE	Resection	250	754	70	Matched	Metastasis	Ileum	Liver	Tumor	NETNOS	Cancer of Unknown Primary	Neuroendocrine Tumor, NOS										STAG2 p.X845_splice;CDKN1B p.G97Rfs*28;CDKN1B Deletion	0	3
P-0009585	P-0009585-T01-IM5	Outside	FFPE	Biopsy	168	299	30	Matched	Metastasis	Uterus	Liver	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.R130G);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252W)				LEVEL_4	PTEN p.R130G;TP53 p.R248Q;FGFR2 p.S252W;JAK1 p.K142Rfs*26;CTCF p.R377C;KMT2D p.G1235Vfs*95;ARID1A p.R1989*;LATS1 p.F1010Lfs*10;FAT1 p.G3155*;PIK3R1 p.D440_E451del;NOTCH1 p.T1379Rfs*66;TBX3 p.L473Rfs*160;KDM5C p.L1305Wfs*53;KMT2C p.S1557Hfs*6;KMT2C p.C417Lfs*30;EP300 p.H2324Tfs*29;EP300 p.M1470Nfs*3	2	17
P-0009586	P-0009586-T01-IM5	In-House	FFPE	Cytology	250	1196	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Ivosidenib(IDH1 p.R132C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;IDH1 p.R132C;TP53 p.V272L;RB1 p.V654L;MGA p.G1205Efs*15;RBM10 p.R42Ffs*92;BCL2L1 Amplification;MYC Amplification	3	8
P-0009587	P-0009587-T01-IM5	Outside	FFPE	Resection	250	1007	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.A289V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.A289V;EGFR p.A289T;DNMT3A p.X59_splice;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERRFI1 Deletion;GATA3 Deletion	3	8
P-0009588	P-0009588-T01-IM5	Outside	FFPE	Biopsy	87.78	399	60	Matched	Metastasis	Nasopharynx	Esophagus	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0009589	P-0009589-T01-IM5	In-House	FFPE	Resection	250	1000	60	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T79Nfs*41)				LEVEL_4	CDKN2A p.T79Nfs*41	1	1
P-0009590	P-0009590-T01-IM5	In-House	FFPE	Resection	250	829	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ARID2 p.G16Dfs*42;STK11 p.T249Gfs*37;ARID2 NUP107-ARID2 fusion;NUP107 NUP107-ARID2 fusion	2	5
P-0009590	P-0009590-T02-IM5	In-House	FFPE	Resection	250	881	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.G251V	0	1
P-0009591	P-0009591-T01-IM5	In-House	FFPE	Biopsy	250	948	30	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.S1893*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.R110L;SETD2 p.R1598*;ARID1A p.X807_splice;ATM p.S1893*;SETD2 p.E1901Dfs*12	3	6
P-0009592	P-0009592-T01-IM5	In-House	FFPE	Resection	250	945	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer	Selpercatinib(RET NCOA4-RET fusion);Selpercatinib(NCOA4 NCOA4-RET fusion)			BLU-667,Cabozantinib,Vandetanib(RET NCOA4-RET fusion);BLU-667,Cabozantinib,Vandetanib(NCOA4 NCOA4-RET fusion)					LEVEL_1	RET NCOA4-RET fusion;NCOA4 NCOA4-RET fusion	4	2
P-0009593	P-0009593-T01-IM5	In-House	FFPE	Resection	250	734	60	Matched	Metastasis	Kidney	Brain	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Sorafenib(ARAF p.S214F)					LEVEL_3B	SETD2 p.Q2484*;VHL p.F148Lfs*11;NFE2L2 p.W24R;ARAF p.S214F;PBRM1 p.N671Kfs*15	1	5
P-0009594	P-0009594-T01-IM5	Outside	FFPE	Resection	250	919	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	GATA3 p.P408Afs*99;TP53 p.C242R;ERBB2 Amplification	2	3
P-0009595	P-0009595-T01-IM5	Outside	FFPE	Resection	250	771	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Olaparib(ATM p.Q1839*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;ARID1A p.S261*;ATM p.Q1839*;ARID1A Deletion;ID3 Deletion;SDHB Deletion	2	6
P-0009596	P-0009596-T01-IM5	Outside	FFPE	Biopsy	250	772	NA	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)		Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.W290R)				LEVEL_3A	IDH1 p.R132C;FGFR2 p.W290R;KRAS Amplification;PBRM1 PBRM1-intragenic	2	4
P-0009597	P-0009597-T01-IM5	In-House	FFPE	Biopsy	250	999	50	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										CCND2 Amplification	0	1
P-0009598	P-0009598-T01-IM5	Outside	FFPE	Resection	250	645	30	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib(NF1 p.E1796*)				LEVEL_4	TP53 p.H214R;NF2 p.R262*;NF1 p.E1796*	1	3
P-0009599	P-0009599-T01-IM5	Outside	FFPE	Resection	250	898	50	Matched	Primary	Brain	Not Applicable	Tumor	PNET	Embryonal Tumor	Primitive Neuroectodermal Tumor					GSK2636771,AZD8186(PTEN p.X342_splice)				LEVEL_4	RB1 p.R455*;PTEN p.X342_splice;TP53 p.X33_splice	1	3
P-0009600	P-0009600-T01-IM5	Outside	FFPE	Resection	250	726	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.Y236C;IDH1 p.R132H;ATRX p.K1081Rfs*37	1	3
P-0009601	P-0009601-T01-IM5	In-House	FFPE	Biopsy	250	938	50	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Sonidegib,Vismodegib(PTCH1 p.S719Tfs*25)					LEVEL_3B	TP53 p.R248W;RB1 p.X89_splice;PTCH1 p.S719Tfs*25;MYC Amplification	1	4
P-0009602	P-0009602-T01-IM5	In-House	FFPE	Biopsy	250	909	50	Matched	Metastasis	Breast	Liver	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C378F)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C378F)		Trametinib,Cobimetinib(NF1 p.S749*);Trametinib,Cobimetinib(NF1 p.Q2492*)				LEVEL_1	PIK3CA p.C378F;FGFR4 p.N535K;ATR p.E1659*;NF1 p.S749*;NF1 p.Q2492*;ATRX p.S750*;ARID1A p.G1396Lfs*81;PIK3CB Amplification;PIK3R1 PIK3R1-intragenic	4	9
P-0009603	P-0009603-T01-IM5	Outside	FFPE	Resection	250	849	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.P248_N256delinsR	0	1
P-0009604	P-0009604-T01-IM5	Outside	FFPE	Biopsy	250	818	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0009605	P-0009605-T01-IM5	Outside	FFPE	Resection	250	856	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma										ARID1A p.Q553Tfs*70	0	1
P-0009606	P-0009606-T01-IM5	In-House	FFPE	Biopsy	116	526	10	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Olaparib(ATM p.Y1844*)					LEVEL_3B	SETD2 p.G1644*;BAP1 p.X220_splice;FBXW7 p.R479L;ATM p.Y1844*	1	4
P-0009607	P-0009607-T01-IM5	In-House	FFPE	Resection	250	887	20	Matched	Metastasis	Stomach	Ovary	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.Y2503*)				LEVEL_4	FBXW7 p.R505C;TP53 p.R273C;NF1 p.Y2503*;CCNE1 Amplification;MYC Amplification	1	5
P-0009608	P-0009608-T01-IM5	Outside	FFPE	Biopsy	250	773	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;SMAD4 p.R361H	1	2
P-0009609	P-0009609-T01-IM5	In-House	FFPE	Biopsy	250	1093	10	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0009610	P-0009610-T01-IM5	In-House	FFPE	Cytology	174	657	80	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0009610	P-0009610-T02-IM5	Outside	FFPE	Biopsy	250	724	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0009611	P-0009611-T01-IM5	In-House	FFPE	Biopsy	250	819	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										PBRM1 p.R146*	0	1
P-0009612	P-0009612-T01-IM5	Outside	FFPE	Biopsy	105.2	665	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.G165R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CREBBP p.S1680del;PTEN p.G165R;CDKN2A Deletion;CDKN2B Deletion;TP53 Deletion	2	5
P-0009613	P-0009613-T01-IM5	Outside	FFPE	Cytology	250	1282	30	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Olaparib(PALB2 p.R37Cfs*5)					LEVEL_3B	TP53 p.V157F;PBRM1 p.I279Nfs*8;EPHA3 p.X833_splice;RAD21 p.R590*;RB1 p.L44Rfs*4;MLH1 p.D450Gfs*29;BMPR1A p.N367Tfs*32;PALB2 p.R37Cfs*5;KMT2D p.Q773Sfs*157	1	9
P-0009614	P-0009614-T01-IM5	Outside	FFPE	Cytology	151.42	562	NA	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D74N)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.V157F;ARID1A p.E1924*;ATRX p.E1639*;PTPRT p.P855Lfs*4;NFKBIA p.I120Dfs*9;CDKN2A p.D74N;MET Amplification	3	7
P-0009615	P-0009615-T01-IM5	Outside	FFPE	Resection	250	856	70	Matched	Metastasis	Small Bowel	Mesentery	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.A502_Y503dup)								LEVEL_1	KIT p.A502_Y503dup	1	1
P-0009617	P-0009617-T01-IM5	In-House	FFPE	Resection	250	802	70	Matched	Metastasis	Cecum	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13D)		Cetuximab,Panitumumab(NRAS p.G13D)			LEVEL_3B	TP53 p.R273C;BRAF p.D594N;NRAS p.G13D;APC p.R876*;RAF1 p.S257L;APC p.D1562Gfs*5;CDK8 Amplification;FLT3 Amplification	1	8
P-0009618	P-0009618-T01-IM5	In-House	FFPE	Biopsy	250	829	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.R280T	0	1
P-0009619	P-0009619-T01-IM5	Outside	FFPE	Biopsy	250	1065	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Trametinib,Cobimetinib(SND1 BRAF-SND1 fusion);Trametinib,Cobimetinib(BRAF BRAF-SND1 fusion)					LEVEL_3B	BRAF p.V600E;TP53 p.C141Y;SMAD4 p.S178*;SND1 BRAF-SND1 fusion;BRAF BRAF-SND1 fusion	3	5
P-0009621	P-0009621-T01-IM5	In-House	FFPE	Biopsy	250	680	10	Matched	Metastasis	Cancer of Unknown Primary	Omentum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*)				LEVEL_4	KRAS p.G12V;TP53 p.R280K;CDKN2A p.E88*	2	3
P-0009622	P-0009622-T01-IM5	Outside	FFPE	Resection	250	942	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										BRAF p.D594N;RPS6KA4 p.S236L;GRIN2A p.E962*;DNMT3B p.X69_splice;KDM6A p.S1284*;BAP1 PBRM1-BAP1 fusion;PBRM1 PBRM1-BAP1 fusion	0	7
P-0009623	P-0009623-T01-IM5	Outside	FFPE	Resection	250	974	NA	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	EGFR p.L858R;SETD2 p.D1519Ifs*8;TP53 p.Q167_H168delins*;CARD11 Amplification;EGFR Amplification;ERBB2 Amplification;FGFR4 Amplification;RAC1 Amplification;RB1 Deletion	2	9
P-0009624	P-0009624-T01-IM5	Outside	FFPE	Resection	250	1170	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.G154V;ARID1B p.G814*;STK11 p.A206Rfs*81	2	4
P-0009625	P-0009625-T01-IM5	Outside	FFPE	Resection	250	853	30	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Sonidegib,Vismodegib(PTCH1 p.G1093*)					LEVEL_3B	TP53 p.R196*;TP53 p.R248Q;PPP6C p.P186S;FLT3 p.R931K;PTCH1 p.G1093*;EIF1AX p.P2L	1	6
P-0009626	P-0009626-T01-IM5	Outside	FFPE	Resection	250	1046	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R248Q;RB1 RB1-intragenic	0	2
P-0009627	P-0009627-T01-IM5	In-House	FFPE	Resection	250	810	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)						LEVEL_2	ERBB2 p.Y772_A775dup;NF2 p.R198*;APC p.S1587*	2	3
P-0009629	P-0009629-T01-IM5	Outside	FFPE	Resection	250	887	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132G)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.V157F;IDH1 p.R132G;PIK3R1 p.K459del;ATRX p.R781*;NOTCH1 p.D338del;CDKN2A Deletion;CDKN2B Deletion	2	7
P-0009630	P-0009630-T01-IM5	Outside	FFPE	Biopsy	250	995	10	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										TP53 p.X187_splice;CDH1 p.Q23*;FOXA1 p.G322Rfs*10;NCOR1 p.V706Kfs*49;NCOR1 p.E526Kfs*9	0	5
P-0009631	P-0009631-T01-IM5	Outside	FFPE	Biopsy	250	930	20	Matched	Primary	Esophagus	Not Applicable	Tumor	EGC	Esophagogastric Cancer	Esophagogastric Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	SMAD4 p.D351N;TP53 p.Y220Mfs*27;ERBB2 Amplification	2	3
P-0009632	P-0009632-T01-IM5	Outside	FFPE	Resection	250	762	30	Unmatched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_1	PIK3CA p.H1047R;KRAS p.G12A;MAP2K4 p.S184L;KMT2C p.E78Nfs*17;FGFR1 Amplification	4	5
P-0009633	P-0009633-T01-IM5	In-House	FFPE	Resection	250	985	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.L105*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;BRCA2 p.L105*	2	2
P-0009634	P-0009634-T01-IM5	In-House	FFPE	Biopsy	250	1102	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.N329Kfs*14);Lapatinib(EGFR Amplification);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	PTEN p.N329Kfs*14;EGFR Amplification;NF1 Deletion	3	3
P-0009635	P-0009635-T01-IM5	In-House	FFPE	Biopsy	250	1097	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PB	Pancreatic Cancer	Pancreatoblastoma										CTNNB1 p.S37F	0	1
P-0009636	P-0009636-T01-IM5	Outside	FFPE	Biopsy	250	1178	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(ATM p.T2947N);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(SMARCB1 p.R377C)				LEVEL_3B	SMARCB1 p.R377C;ATM p.T2947N;FLT3 p.S762C;ARID1A p.L192Pfs*201;GATA3 p.R330Mfs*24;CCND1 Amplification;FGF19 Amplification;MDM2 Amplification	3	8
P-0009637	P-0009637-T01-IM5	Outside	FFPE	Biopsy	250	191	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R306*	0	1
P-0009638	P-0009638-T01-IM5	Outside	FFPE	Resection	250	1002	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D92Gfs*28)				LEVEL_4	TP53 p.S241F;CTNNB1 p.S37F;STK11 p.Q159*;SMARCA4 p.K1091*;RECQL4 p.V767Wfs*76;KEAP1 p.I500Mfs*3;CDKN2A p.D92Gfs*28	1	7
P-0009639	P-0009639-T01-IM5	Outside	FFPE	Biopsy	250	1007	70	Matched	Primary	Pleura	Not Applicable	Tumor	PLSMESO	Mesothelioma	Pleural Mesothelioma, Sarcomatoid Type										CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;CDKN2B CDKN2BAS-CDKN2B fusion;CDKN2B-AS1 CDKN2BAS-CDKN2B fusion	0	5
P-0009640	P-0009640-T01-IM5	Outside	FFPE	Resection	250	815	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R158H;TMPRSS2 ETV1-TMPRSS2 fusion;ETV1 ETV1-TMPRSS2 fusion	0	3
P-0009641	P-0009641-T01-IM5	In-House	FFPE	Biopsy	250	1141	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		AZD9496,Fulvestrant(ESR1 p.D538G);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	ESR1 p.D538G;PIK3CA p.N345K;RHOA p.G17E;TP53 p.Y205F;CDKN1B p.K165*;FGFR1 Amplification	4	6
P-0009642	P-0009642-T01-IM5	In-House	FFPE	Biopsy	250	1313	30	Matched	Metastasis	Cancer of Unknown Primary	Adrenal Gland	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;NF2 p.R262*;STK11 p.Y60*;KEAP1 p.Y396*	1	4
P-0009643	P-0009643-T01-IM5	In-House	FFPE	Resection	250	164	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0009644	P-0009644-T01-IM5	In-House	FFPE	Biopsy	250	866	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.E343Gfs*2;CDKN1A p.R83Gfs*2;CTNNB1 p.Q28_D32delinsH;LATS1 p.E689Rfs*3;CCND3 Amplification;VEGFA Amplification	0	6
P-0009645	P-0009645-T01-IM5	In-House	FFPE	Resection	250	980	50	Matched	Metastasis	Cecum	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R3008C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;AMER1 p.R531*;ATM p.R3008C;APC p.L1511Hfs*9;SMAD4 p.N64Kfs*6	2	5
P-0009646	P-0009646-T01-IM5	In-House	FFPE	Resection	250	1011	70	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor					Trametinib,Cobimetinib(NF1 p.C93*)				LEVEL_4	NF1 p.C93*	1	1
P-0009647	P-0009647-T01-IM5	Outside	FFPE	Resection	250	894	20	Matched	Metastasis	Pancreas	Omentum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.C1365Mfs*3);Olaparib,Rucaparib(BRCA2 TUBGCP3-BRCA2 fusion);Olaparib,Rucaparib(TUBGCP3 TUBGCP3-BRCA2 fusion)	Talazoparib,Niraparib(BRCA2 p.C1365Mfs*3);Talazoparib,Niraparib(BRCA2 TUBGCP3-BRCA2 fusion);Talazoparib,Niraparib(TUBGCP3 TUBGCP3-BRCA2 fusion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.X55_splice)				LEVEL_3A	KRAS p.G12V;TP53 p.C176Y;BRCA2 p.C1365Mfs*3;PTEN p.X55_splice;TGFBR2 Deletion;BRCA2 TUBGCP3-BRCA2 fusion;TUBGCP3 TUBGCP3-BRCA2 fusion;TP63 LEPREL1-TP63 fusion;P3H2 LEPREL1-TP63 fusion	8	9
P-0009648	P-0009648-T01-IM5	Outside	FFPE	Resection	250	863	80	Matched	Primary	Anus	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559A)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KIT p.V559A;CDKN2A Deletion;CDKN2B Deletion;GATA3 Deletion;KDR Amplification;KIT Amplification;NKX3-1 Deletion;PDGFRA Amplification;MUC16 RARA-MUC16 fusion;RARA RARA-MUC16 fusion	2	10
P-0009649	P-0009649-T01-IM5	Outside	FFPE	Resection	250	842	60	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma					GSK2636771,AZD8186(PTEN p.R130*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.R130*;BRAF p.G466E;SUZ12 p.T596Nfs*6;CDKN2A Deletion;CDKN2B Deletion;PRKN Deletion	2	6
P-0009650	P-0009650-T01-IM5	In-House	FFPE	Biopsy	111.6	558	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R175H;TP53 p.R282W;APC p.I1008Nfs*3	0	3
P-0009651	P-0009651-T01-IM5	In-House	FFPE	Resection	250	463	80	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64)					LEVEL_3B	TP53 p.R273C;PIK3R1 p.W583del;PPP2R1A p.S256F;PTCH1 p.R1308Efs*64	1	4
P-0009652	P-0009652-T01-IM5	In-House	FFPE	Resection	250	754	80	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0009653	P-0009653-T01-IM5	In-House	FFPE	Resection	250	1120	70	Matched	Primary	Soft Tissue	Mediastinum	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	2	3
P-0009654	P-0009654-T01-IM5	In-House	FFPE	Biopsy	250	1449	40	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.P655Qfs*5)			Talazoparib,Niraparib(BRCA2 p.P655Qfs*5)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	APC p.T1556Nfs*3;BRCA2 p.P655Qfs*5;PTEN Deletion	3	3
P-0009655	P-0009655-T01-IM5	In-House	FFPE	Biopsy	157.3	948	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.T125K;EGFR Amplification	2	4
P-0009656	P-0009656-T01-IM5	Outside	FFPE	Biopsy	250	762	30	Matched	Metastasis	Prostate	Kidney	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.N323Kfs*2);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN p.N323Kfs*2;TP53 p.P190T;AR Amplification;PTEN Deletion	2	4
P-0009657	P-0009657-T01-IM5	In-House	FFPE	Resection	250	315	50	Matched	Metastasis	Kidney	Lymph Node	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Everolimus,Temsirolimus(MTOR p.A1971T)				LEVEL_4	BAP1 p.S513*;MTOR p.A1971T;VHL p.P86S	1	3
P-0009658	P-0009658-T01-IM5	In-House	FFPE	Biopsy	212.4	819	10	Matched	Primary	Skin	Not Applicable	Tumor	LCH	Histiocytosis	Langerhans Cell Histiocytosis			Cobimetinib(BRAF p.V600E)						LEVEL_3A	BRAF p.V600E	1	1
P-0009660	P-0009660-T01-IM5	In-House	FFPE	Biopsy	250	606	70	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Binimetinib,Binimetinib+Ribociclib(NRAS p.P34R);Everolimus(TSC1 p.S836*);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.E848*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;NFE2L2 p.G31A;TP53 p.A276P;NRAS p.P34R;NOTCH2 p.Q1677*;TSC1 p.S836*;KMT2D p.X2789_splice;BRCA1 p.E848*;SMARCA4 p.E520*;CDKN2A Deletion;CDKN2B Deletion	6	11
P-0009661	P-0009661-T01-IM5	In-House	FFPE	Biopsy	247.41	1109	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.G245S;EGFR p.L62R;TP53 p.N200Ifs*47;BCL2L11 p.*199Cext*70	1	5
P-0009662	P-0009662-T01-IM5	Outside	FFPE	Biopsy	250	504	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma											0	0
P-0009663	P-0009663-T01-IM5	Outside	FFPE	Resection	250	320	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;PTPRD p.A1716T	1	2
P-0009664	P-0009664-T01-IM5	In-House	FFPE	Biopsy	250	847	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.G34V;ARID2 p.Q1005*;ARID2 p.K361*	0	3
P-0009680	P-0009680-T01-IM5	In-House	FFPE	Biopsy	171.8	448	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										BRAF p.D594G;STK11 p.E291*	0	2
P-0009682	P-0009682-T01-IM5	In-House	FFPE	Resection	250	1098	20	Matched	Primary	Cervix	Not Applicable	Tumor	GCEMU	Cervical Cancer	Gastric Type Mucinous Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D;STK11 p.X245_splice	1	2
P-0009683	P-0009683-T01-IM5	In-House	FFPE	Resection	250	915	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.E70*	0	1
P-0009684	P-0009684-T01-IM5	In-House	FFPE	Resection	250	1024	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Cabozantinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88Rfs*58)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.Q38*;STK11 p.D53Gfs*110;KEAP1 p.X511_splice;ARID1A p.H1581Pfs*31;CDKN2A p.E88Rfs*58;MET Amplification;MYC Amplification	3	7
P-0009685	P-0009685-T01-IM5	In-House	FFPE	Resection	160.3	296	80	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.Q1110Lfs*49	1	2
P-0009686	P-0009686-T01-IM5	In-House	FFPE	Biopsy	250	985	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TET1 p.Q1504*;TP53 p.T102_G105delinsS	0	2
P-0009687	P-0009687-T01-IM5	Outside	FFPE	Biopsy	217.7	610	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	NKX3-1 Deletion;PTEN Deletion;TCF7L2 Deletion;TP53 SPG11-TP53 fusion;SPG11 SPG11-TP53 fusion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	7
P-0009688	P-0009688-T01-IM5	In-House	FFPE	Cytology	182.3	457	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.D335Gfs*17;EZH2 Amplification;MDM4 Amplification;MYC Amplification;PPM1D Amplification	0	5
P-0009689	P-0009689-T01-IM5	In-House	FFPE	Resection	250	921	70	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E27Rfs*26)				LEVEL_4	TP53 p.R158L;ARID1A p.Q605*;NFE2L2 p.G31R;CDKN2A p.E27Rfs*26	1	4
P-0009690	P-0009690-T01-IM5	In-House	FFPE	Resection	250	1085	70	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.R216*;APC p.E1306*;PMS1 p.E640*;FBXW7 p.G437V	0	5
P-0009691	P-0009691-T01-IM5	In-House	FFPE	Resection	250	1005	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R273L;STK11 p.D194V	0	2
P-0009692	P-0009692-T01-IM5	In-House	FFPE	Resection	250	763	80	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.S241F;PTPRS p.X1308_splice	1	3
P-0009693	P-0009693-T01-IM5	In-House	FFPE	Resection	250	938	20	Matched	Metastasis	Appendix	Diaphragm	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201H	1	2
P-0009694	P-0009694-T01-IM5	In-House	FFPE	Resection	250	870	20	Matched	Primary	Bile Duct	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Olaparib(RAD54L p.G325R);Trametinib,Cobimetinib(PRKAR1B BRAF-PRKAR1B fusion);Trametinib,Cobimetinib(BRAF BRAF-PRKAR1B fusion)					LEVEL_3B	TP53 p.R273H;RAD54L p.G325R;MYC Amplification;PRKAR1B BRAF-PRKAR1B fusion;BRAF BRAF-PRKAR1B fusion	3	5
P-0009695	P-0009695-T01-IM5	In-House	FFPE	Resection	250	986	70	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor		Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.S566_E571delinsR)							LEVEL_2	PDGFRA p.S566_E571delinsR	1	1
P-0009696	P-0009696-T01-IM5	In-House	FFPE	Biopsy	250	1239	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										PIK3CD p.E1021K;BCL2 p.A131D;TNFAIP3 p.P457Lfs*20;SMARCA4 p.K546del;CREBBP p.S1598Kfs*19;FOXO1 p.T24M;EPCAM Deletion;MSH2 Deletion;MSH6 Deletion;MYC Amplification	0	10
P-0009697	P-0009697-T01-IM5	Outside	FFPE	Resection	250	1092	60	Matched	Metastasis	Cancer of Unknown Primary	Testis	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_1	BRAF p.V600E;MET Amplification;TERT Amplification	3	3
P-0009698	P-0009698-T01-IM5	Outside	FFPE	Resection	250	958	30	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D	1	1
P-0009699	P-0009699-T01-IM5	In-House	FFPE	Resection	250	714	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.E659Nfs*94);Olaparib(CDK12 p.K126Ifs*31)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.E659Nfs*94);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K126Ifs*31)				LEVEL_1	CDK12 p.E659Nfs*94;CDK12 p.K126Ifs*31;FOXA1 p.Q263Lfs*55	4	3
P-0009700	P-0009700-T01-IM5	In-House	FFPE	Resection	250	1029	60	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	TP53 p.R248Q;PIK3CA p.H1047R;NCOR1 p.R414*;KMT2C p.L527*;ANKRD11 p.S2051*;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;PAK1 Amplification	3	9
P-0009701	P-0009701-T01-IM5	In-House	FFPE	Resection	250	1398	30	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(FGFR2 KCNH7-FGFR2 fusion);Debio1347,Erdafitinib,Pemigatinib,BGJ398,AZD4547(KCNH7 KCNH7-FGFR2 fusion)					LEVEL_3B	ARID1A p.N1571Tfs*40;FGFR2 KCNH7-FGFR2 fusion;KCNH7 KCNH7-FGFR2 fusion	2	3
P-0009702	P-0009702-T01-IM5	In-House	FFPE	Resection	250	1055	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X1066_splice)				LEVEL_4	NF1 p.X1066_splice;NF2 p.X525_splice;EGFR Amplification;TP53 PSMD14-TP53 fusion;PSMD14 PSMD14-TP53 fusion	1	5
P-0009703	P-0009703-T01-IM5	In-House	FFPE	Biopsy	250	1260	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.K117N)	Cetuximab,Panitumumab(KRAS p.K117N)			LEVEL_4	TP53 p.R248Q;KRAS p.K117N;CDH3 CDH1-CDH3 fusion;CDH1 CDH1-CDH3 fusion	1	4
P-0009704	P-0009704-T01-IM5	In-House	FFPE	Biopsy	250	1229	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_S752del)								LEVEL_1	TP53 p.E286K;EGFR p.L747_S752del	1	2
P-0009705	P-0009705-T01-IM5	Outside	FFPE	Biopsy	145	214	60	Matched	Metastasis	Cancer of Unknown Primary	Soft Tissue	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0009706	P-0009706-T01-IM5	Outside	FFPE	Resection	224.7	554	20	Matched	Metastasis	Kidney	Bone	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.N323Mfs*21)				LEVEL_4	SETD2 p.R1407Gfs*5;PTEN p.N323Mfs*21;TP53 p.S215I;PPP2R1A p.X331_splice;ARID1B p.A415Pfs*15;KDM5C p.E691Gfs*2	1	6
P-0009707	P-0009707-T01-IM5	In-House	FFPE	Resection	250	700	40	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.H179R;APC p.N1473Mfs*34;ERBB2 Amplification	2	3
P-0009708	P-0009708-T01-IM5	In-House	FFPE	Biopsy	250	910	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_T751del)								LEVEL_1	EGFR p.L747_T751del;TP53 p.V274F;FOXP1 p.M1?;MET p.H1094Y;TERT Amplification	1	5
P-0009709	P-0009709-T01-IM5	Outside	FFPE	Resection	250	877	40	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor										TP53 p.C238Y;DPP9 PTPRS-DPP9 fusion;PTPRS PTPRS-DPP9 fusion	0	3
P-0009710	P-0009710-T01-IM5	In-House	Cell Pellet	Cytology	222.145	1266	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.G244C;RBM10 p.X565_splice	1	3
P-0009711	P-0009711-T01-IM5	In-House	FFPE	Resection	250	1232	20	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.A289V);Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.Y163C;EGFR p.A289V;EGFR Amplification	2	3
P-0009712	P-0009712-T01-IM5	In-House	FFPE	Resection	250	971	50	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	TP53 p.R273H;KRAS p.A146T;KMT2C p.R2066*;APC p.Q264*;SMAD4 p.E538Ffs*12;CCND2 Amplification;KDM5A Amplification	1	7
P-0009713	P-0009713-T01-IM5	Outside	FFPE	Cytology	190	793	40	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ARID1A Deletion;AXIN1 Deletion;CCND1 Amplification;CDK4 Amplification;CDKN2A Deletion;EGFR Amplification;ERBB3 Amplification;FGF19 Amplification;GLI1 Amplification;MDM2 Amplification;MYC Amplification	3	11
P-0009714	P-0009714-T01-IM5	In-House	FFPE	Cytology	250	1544	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Crizotinib(MET Amplification)		Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.E75Kfs*13);Cabozantinib(MET Amplification)	Trametinib,Cobimetinib(NF1 p.X421_splice)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	TP53 p.Y236C;STK11 p.G188Afs*99;NF1 p.X421_splice;KDM5C p.E1441*;RASA1 R231fs;BRCA1 p.E75Kfs*13;MET Amplification;MYC Amplification;KEAP1 KEAP1-intragenic	4	9
P-0009715	P-0009715-T01-IM5	In-House	FFPE	Resection	250	1008	65	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A59T);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E149*)				LEVEL_4	KRAS p.A59T;JAK1 p.X1086_splice;TP53 p.A276D;PTPRT p.X771_splice;RNF43 p.L155Wfs*3;CDKN2A p.E149*;AKT2 Amplification;FOXA1 Amplification;NKX2-1 Amplification;RICTOR Amplification;TERT Amplification;RB1 RB1-intragenic	2	12
P-0009716	P-0009716-T01-IM5	In-House	FFPE	Resection	250	893	40	Matched	Metastasis	Cecum	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)	Cetuximab,Panitumumab(KRAS p.A146V)			LEVEL_4	APC p.Y935*;APC p.E1408*;KRAS p.A146V;SMAD3 p.R373C;NBN p.E505*	1	5
P-0009717	P-0009717-T01-IM5	In-House	FFPE	Resection	250	833	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.G244C;VHL p.V87Dfs*72	0	2
P-0009725	P-0009725-T01-IM5	Outside	FFPE	Biopsy	250	1021	20	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K;TP53 p.Y220C	2	2
P-0009726	P-0009726-T01-IM5	Outside	FFPE	Biopsy	250	1010	40	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P424Rfs*51;KMT2A MLL-intragenic	0	2
P-0009727	P-0009727-T01-IM5	Outside	FFPE	Resection	250	616	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G199*	0	1
P-0009728	P-0009728-T01-IM5	Outside	FFPE	Biopsy	250	957	30	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.X307_splice;PIK3R1 p.V661Afs*3;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0009729	P-0009729-T01-IM5	Outside	FFPE	Resection	250	843	60	Matched	Metastasis	Soft Tissue	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										TP53 p.P191del	0	1
P-0009730	P-0009730-T01-IM5	Outside	FFPE	Biopsy	250	1627	60	Matched	Metastasis	Lung	Mediastinum	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.G154V;KMT2D p.Q4412*;RB1 p.X776_splice;AXIN1 p.E671*	0	4
P-0009731	P-0009731-T01-IM5	Outside	FFPE	Resection	250	896	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.S310F)	Ado-Trastuzumab Emtansine(ERBB2 p.S310F)	Trametinib,Cobimetinib(NF1 p.W1997Rfs*15)				LEVEL_3A	ERBB2 p.S310F;ERBB3 p.S846I;ERBB3 p.K329E;CDH1 p.V157Gfs*11;NF1 p.W1997Rfs*15	3	5
P-0009732	P-0009732-T01-IM5	Outside	FFPE	Biopsy	250	823	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										STK11 p.K84*;BAP1 p.S395*	0	2
P-0009733	P-0009733-T01-IM5	Outside	FFPE	Resection	250	721	60	Matched	Primary	Small Bowel	Not Applicable	Tumor	DSRCT	Soft Tissue Sarcoma	Desmoplastic Small-Round-Cell Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EWSR1 WT1-EWSR1 fusion;WT1 WT1-EWSR1 fusion	1	4
P-0009734	P-0009734-T01-IM5	Outside	FFPE	Resection	250	916	40	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										CCND2 Amplification;KDM5A Amplification	0	2
P-0009735	P-0009735-T01-IM5	Outside	FFPE	Resection	250	850	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer				Olaparib(ATM p.R2832C)					LEVEL_3B	TP53 p.G245S;ATM p.R2832C;KMT2C p.R4478*;GPS2 p.R102*;BCOR p.Q1414*;EZH2 p.N152Ifs*15	1	6
P-0009736	P-0009736-T01-IM5	In-House	FFPE	Biopsy	250	837	80	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;ATRX p.R250*;PTPRD p.W57*;CDKN2A Deletion;CDKN2B Deletion;GATA3 Deletion;PRKN Deletion;SRC Amplification	3	8
P-0009737	P-0009737-T01-IM5	Outside	FFPE	Cytology	226.1	684	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0009738	P-0009738-T01-IM5	In-House	FFPE	Resection	250	961	10	Matched	Metastasis	Breast	Ovary	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K	2	1
P-0009739	P-0009739-T01-IM5	In-House	FFPE	Resection	250	667	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R209Kfs*6;MYCL Amplification;PAX5 Amplification	0	3
P-0009740	P-0009740-T01-IM5	Outside	FFPE	Biopsy	250	916	60	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;GATA3 p.N331Efs*21;PPP2R1A p.E297D;BLM p.T1074Rfs*4;IKZF1 Deletion;PPM1D Amplification;RB1 Deletion;ARID1B ARID1B-intragenic	2	8
P-0009741	P-0009741-T01-IM5	In-House	FFPE	Resection	250	740	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248Q;APC p.R302*;SMAD4 p.Q224*;SOX9 p.S337Pfs*46;TP53 Deletion;APC APC-intragenic	0	6
P-0009742	P-0009742-T01-IM5	In-House	FFPE	Resection	250	1195	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)						LEVEL_1	MET p.X963_splice	3	1
P-0009743	P-0009743-T01-IM5	In-House	FFPE	Biopsy	250	1108	50	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										DDR2 Amplification;EGFR Amplification;MCL1 Amplification;TP53 TP53-intragenic	0	4
P-0009744	P-0009744-T01-IM5	In-House	FFPE	Biopsy	232.95	1013	80	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	NRAS p.Q61K;TP63 p.E609K;PBRM1 p.W1183*	1	3
P-0009745	P-0009745-T01-IM5	In-House	FFPE	Biopsy	250	1291	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C420R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.G380R)					LEVEL_1	PIK3CA p.C420R;FGFR3 p.G380R	3	2
P-0009746	P-0009746-T02-IM5	In-House	FFPE	Biopsy	250	1286	40	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0009747	P-0009747-T01-IM5	In-House	FFPE	Resection	250	1035	30	Matched	Primary	Scalp	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S372F);Trametinib,Cobimetinib(NF1 p.R1362*)				LEVEL_4	ARID2 p.Q1411*;FGFR2 p.S372F;NF1 p.R1362*;FUBP1 p.R363Vfs*29	2	4
P-0009748	P-0009748-T01-IM5	In-House	FFPE	Biopsy	250	1412	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	GSK2636771,AZD8186(PTEN p.I253Qfs*44);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E27del)				LEVEL_3B	RBM10 p.X168_splice;PTEN p.I253Qfs*44;CDKN2A p.E27del;ERBB2 Amplification;MCL1 Amplification	3	5
P-0009749	P-0009749-T01-IM5	In-House	FFPE	Resection	250	787	40	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Sonidegib,Vismodegib(PTCH1 p.C92Lfs*48)					LEVEL_3B	IDH1 p.R132H;CDH1 p.X522_splice;ARID1B p.Y1135*;CIC p.G787Wfs*144;PTCH1 p.C92Lfs*48;SMAD2 Deletion	2	6
P-0009750	P-0009750-T01-IM5	In-House	FFPE	Biopsy	250	579	50	Matched	Metastasis	Ovary	Sigmoid Colon	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.E171*;CIC Deletion	0	2
P-0009751	P-0009751-T01-IM5	In-House	FFPE	Biopsy	250	923	20	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;APC p.S1495Vfs*12;TP53 p.C124G;APC p.G871Efs*45	1	4
P-0009752	P-0009752-T01-IM5	Outside	FFPE	Biopsy	250	969	50	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.E731K);Trametinib,Cobimetinib(NF1 p.Q912*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E27Afs*16)				LEVEL_4	TP53 p.R273L;PAK5 p.M173I;KMT2C p.R4549C;EGFR p.E114K;EPHA3 p.R136*;PGR p.R836Q;ERBB4 p.E452K;EPHA7 p.X725_splice;FGFR2 p.E731K;ASXL2 p.Q181*;ERBB4 p.R544W;KDR p.S1100F;MGA p.Q1603*;NCOR1 p.R744*;NF1 p.Q912*;RNF43 p.X229_splice;PTPRT p.W230*;CDKN2A p.E27Afs*16	3	18
P-0009753	P-0009753-T01-IM5	Outside	FFPE	Biopsy	250	955	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R280I;FGFR1 Amplification	1	2
P-0009754	P-0009754-T01-IM5	Outside	FFPE	Biopsy	250	463	20	Matched	Primary	Tongue	Not Applicable	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										TP53 p.G245S;NOTCH1 p.R2087Gfs*177	0	2
P-0009755	P-0009755-T01-IM5	Outside	FFPE	Biopsy	250	900	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;TP53 p.V272L	1	2
P-0009756	P-0009756-T01-IM5	In-House	FFPE	Biopsy	209.055	870	30	Matched	Metastasis	Cancer of Unknown Primary	Rib	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										APC p.T1556Nfs*3;HIST1H3B p.E51K;STK11 p.Y60*;KEAP1 p.E307*;SMARCA4 p.E1512*;NOTCH4 NOTCH4-intragenic	0	6
P-0009757	P-0009757-T01-IM5	Outside	FFPE	Biopsy	250	856	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(BRAF AGAP3-BRAF fusion);Trametinib,Cobimetinib(AGAP3 AGAP3-BRAF fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T93M)				LEVEL_3B	TP53 p.X126_splice;RNF43 p.P361Lfs*58;CDKN2A p.T93M;SMAD4 Deletion;BRAF AGAP3-BRAF fusion;AGAP3 AGAP3-BRAF fusion	3	6
P-0009758	P-0009758-T01-IM5	In-House	FFPE	Resection	250	661	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.G245V	1	2
P-0009759	P-0009759-T01-IM5	In-House	FFPE	Biopsy	250	839	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 SHISA9-NF1 fusion);Trametinib,Cobimetinib(SHISA9 SHISA9-NF1 fusion)				LEVEL_1	TP53 p.C176W;CD274 Amplification;ERBB2 Amplification;JAK2 Amplification;NF1 SHISA9-NF1 fusion;SHISA9 SHISA9-NF1 fusion	4	6
P-0009760	P-0009760-T01-IM5	Outside	FFPE	Resection	250	855	60	Matched	Metastasis	Colorectal NOS	Ovary	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P449_L456del)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;RNF43 p.E453*;BAP1 p.K529Qfs*8;PIK3CA p.P449_L456del;APC p.E1540Afs*3	2	5
P-0009761	P-0009761-T01-IM5	Outside	FFPE	Biopsy	250	1012	40	Matched	Metastasis	Oropharynx	Lung	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E579K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.E565Q)				LEVEL_3B	PIK3CA p.E545K;KDM6A p.Q271*;PIK3CA p.E579K;TET2 p.Q1445*;FGFR2 p.E565Q	3	5
P-0009762	P-0009762-T01-IM5	In-House	FFPE	Biopsy	250	963	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X1773_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.T58I)				LEVEL_3B	SMARCA4 p.T910M;ATM p.X1773_splice;KRAS p.T58I;SMARCA4 p.M781L;STK11 p.R40Afs*11;KEAP1 p.R296Afs*21	2	6
P-0009763	P-0009763-T01-IM5	Outside	FFPE	Biopsy	250	803	10	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Y163H;LATS1 p.Q225Sfs*4;FGFR3 Amplification	0	3
P-0009764	P-0009764-T01-IM5	In-House	FFPE	Biopsy	250	893	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										ERBB3 p.E928G;MGA p.E2432*;TP53 p.P85Lfs*38;HOXB13 p.E118Kfs*161;EGFR Amplification	0	5
P-0009765	P-0009765-T01-IM5	Outside	FFPE	Resection	250	687	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R282W;AKT2 Amplification	1	3
P-0009785	P-0009785-T01-IM5	In-House	FFPE	Resection	250	803	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										STK11 p.E265*	0	1
P-0009786	P-0009786-T02-IM5	In-House	FFPE	Resection	250	888	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0009786	P-0009786-T01-IM5	Outside	FFPE	Biopsy	250	760	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 KCNJ3-TP53 fusion;KCNJ3 KCNJ3-TP53 fusion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0009787	P-0009787-T01-IM5	Outside	FFPE	Biopsy	213.9	642	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.H179Q;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0009788	P-0009788-T01-IM5	In-House	FFPE	Biopsy	104	395	20	Matched	Metastasis	Kidney	Bone	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;NF2 p.K284*	1	2
P-0009789	P-0009789-T01-IM5	Outside	FFPE	Resection	250	784	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;EPHA7 p.X642_splice;MGA p.G1205*;TP53 p.C141R	2	4
P-0009790	P-0009790-T01-IM5	In-House	FFPE	Resection	250	864	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Y27N);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.Y27N;ARID1B p.X1229_splice;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0009791	P-0009791-T01-IM5	Outside	FFPE	Biopsy	250	851	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Sonidegib,Vismodegib(PTCH1 p.Y812*)					LEVEL_1	PIK3CA p.N345K;TP53 p.H193R;PTCH1 p.Y812*;MAP2K4 Deletion;MYC Amplification;NCOR1 Deletion;PCDH10 INPP4B-PCDH10 fusion;INPP4B INPP4B-PCDH10 fusion;PPP6C LOC100272217-PPP6C fusion;LOC100272217 LOC100272217-PPP6C fusion	3	10
P-0009792	P-0009792-T01-IM5	Outside	FFPE	Resection	250	929	60	Matched	Primary	Brain	Not Applicable	Tumor	MBL	Embryonal Tumor	Medulloblastoma										SMO p.W535L;KDM6A p.X1048_splice	0	2
P-0009793	P-0009793-T01-IM5	In-House	FFPE	Resection	250	773	NA	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.D259Y;MYC Amplification	1	3
P-0009794	P-0009794-T01-IM5	Outside	FFPE	Resection	250	892	50	Matched	Metastasis	Appendix	Ovary	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H;CDK6 Amplification;DIS3 Deletion;MYC Amplification	1	5
P-0009795	P-0009795-T01-IM5	Outside	FFPE	Resection	250	745	30	Matched	Primary	Scalp	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P104L)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	TP53 p.E286K;TP53 p.X307_splice;PIK3CA p.P104L;ERBB4 p.E872K;KMT2D p.M1?;CDKN2A p.R58*;TERT Amplification	2	7
P-0009796	P-0009796-T02-IM5	In-House	FFPE	Resection	250	776	80	Matched	Primary	Kidney	Not Applicable	Tumor	WT	Wilms Tumor	Wilms' Tumor										MAX Deletion	0	1
P-0009797	P-0009797-T01-IM5	Outside	FFPE	Resection	250	933	40	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor				Olaparib(CDK12 ITPR2-CDK12 fusion);Olaparib(ITPR2 ITPR2-CDK12 fusion)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 ITPR2-CDK12 fusion);Pembrolizumab,Nivolumab,Cemiplimab(ITPR2 ITPR2-CDK12 fusion)				LEVEL_3B	KRAS Amplification;CDK12 ITPR2-CDK12 fusion;ITPR2 ITPR2-CDK12 fusion	4	3
P-0009798	P-0009798-T01-IM5	In-House	FFPE	Resection	250	825	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	KRAS p.G13D;TCF7L2 p.W259*;CDKN2A Deletion;CDKN2B Deletion;SMAD2 Deletion;SMAD3 Deletion	2	6
P-0009799	P-0009799-T01-IM5	In-House	FFPE	Biopsy	250	999	30	Matched	Primary	Bone	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										H3F3A p.G35W	0	1
P-0009813	P-0009813-T01-IM5	In-House	FFPE	Cytology	250	1006	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.R175H;KRAS p.Q61H;MEN1 MEN1-intragenic	1	3
P-0009814	P-0009814-T01-IM5	In-House	FFPE	Biopsy	250	1038	50	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										ARID1A p.Q200*;FOXO1 p.S22P;TMEM127 p.Y220*;PRDM1 p.C58*;KMT2D p.Q4220*;EP300 p.W1466G;KMT2D p.N1493Kfs*13;EIF4A2 BCL6-EIF4A2 fusion;BCL6 BCL6-EIF4A2 fusion	0	9
P-0009815	P-0009815-T01-IM5	In-House	FFPE	Resection	250	742	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.X195_splice)				LEVEL_1	FOXP1 p.E242*;NF1 p.X195_splice;TP53 p.D186Gfs*61;ERBB2 Amplification	3	4
P-0009816	P-0009816-T01-IM5	Outside	FFPE	Biopsy	250	992	30	Matched	Metastasis	Intrahepatic Bile Duct	Lymph Node	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0009817	P-0009817-T01-IM5	Outside	FFPE	Biopsy	231.7	520	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.S37F;SPOP p.S119N;FOXA1 Amplification	0	3
P-0009818	P-0009818-T01-IM5	Outside	FFPE	Biopsy	250	864	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.C135*;FOXA1 p.R261Afs*32;AR Amplification;CDK4 Amplification;MDM2 Amplification	2	5
P-0009819	P-0009819-T01-IM5	In-House	FFPE	Resection	250	665	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0009821	P-0009821-T01-IM5	In-House	FFPE	Biopsy	250	1309	20	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.Y537C)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.H1047R;ESR1 p.Y537C;TP53 p.X307_splice;CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;MDM2 Amplification	5	7
P-0009822	P-0009822-T01-IM5	In-House	FFPE	Resection	250	697	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.V777L)	Ado-Trastuzumab Emtansine(ERBB2 p.V777L);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3A	TP53 p.E285K;ERBB2 p.V777L;CDH1 p.Q677Hfs*3;FGFR1 Amplification	3	4
P-0009823	P-0009823-T01-IM5	In-House	FFPE	Resection	250	659	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;NKX2-1 Amplification	1	2
P-0009824	P-0009824-T01-IM5	In-House	FFPE	Biopsy	250	921	20	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.R175G;MGA p.S2127*;RB1 p.D571Lfs*41	2	5
P-0009825	P-0009825-T01-IM5	In-House	FFPE	Biopsy	250	1006	20	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;KEAP1 p.V420Sfs*38;ARID2 p.Q694*;DNMT3A p.T691Hfs*14	1	4
P-0009826	P-0009826-T01-IM5	In-House	FFPE	Resection	250	943	10	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R196*;APC p.I1311Mfs*10	0	2
P-0009827	P-0009827-T01-IM5	In-House	FFPE	Resection	250	1088	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.E221*;CASP8 p.W420*;TCF3 p.X100_splice	1	4
P-0009828	P-0009828-T02-IM5	In-House	FFPE	Biopsy	250	842	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Tazemetostat(SMARCB1 SMARCB1-intragenic)				LEVEL_4	TP53 p.G266R;GATA3 p.R366*;SMARCB1 SMARCB1-intragenic	1	3
P-0009828	P-0009828-T01-IM5	Outside	FFPE	Biopsy	103.2	87	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G266R;GATA3 p.R366*	0	2
P-0009829	P-0009829-T01-IM5	Outside	FFPE	Biopsy	50	460	30	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);Neratinib(ERBB2 p.Y772_A775dup)	Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)					LEVEL_1	PIK3CA p.H1047L;ERBB2 p.Y772_A775dup;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	4	5
P-0009830	P-0009830-T01-IM5	In-House	FFPE	Biopsy	108.2	633	20	Matched	Metastasis	Descending Colon	Lymph Node	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.V726Sfs*25);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.K654Sfs*47)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Trametinib,Cobimetinib(NF1 p.X2486_splice)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	FBXW7 p.R465H;APC p.S1465Wfs*3;SMAD4 p.R361H;SETD2 p.T305Nfs*4;PTPRS p.P622Lfs*16;RHOA p.G17E;BRCA2 p.V726Sfs*25;EGFR p.R252H;KRAS p.G13D;PPM1D p.L450*;BRCA1 p.K654Sfs*47;TCF7L2 p.L200Sfs*25;FAT1 p.K1225Nfs*9;APC p.T1208Pfs*57;MLH1 p.T117M;APC p.N1026K;NF1 p.X2486_splice;ZFHX3 p.P2044Lfs*57;CREBBP p.Q232Rfs*12;CASP8 p.K461Nfs*10;KMT2C p.P4302Lfs*24;KMT2D p.G2265Efs*21	4	22
P-0009831	P-0009831-T01-IM5	In-House	FFPE	Resection	250	790	70	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209P;BAP1 p.R60*	0	2
P-0009832	P-0009832-T01-IM5	In-House	FFPE	Biopsy	250	1209	50	Matched	Metastasis	Larynx	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma											0	0
P-0009833	P-0009833-T01-IM5	In-House	FFPE	Biopsy	250	972	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13F)					LEVEL_3B	TP53 p.R273L;RB1 p.N803Tfs*7;BRAF p.S467L;NRAS p.G13F;MCL1 Amplification;KMT2C MLL3-intragenic	1	6
P-0009834	P-0009834-T01-IM5	Outside	FFPE	Biopsy	250	1246	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.M133K;SMARCA4 p.R1243P;MAP3K1 p.L707Cfs*19;ERBB2 Amplification;MYC Amplification	4	6
P-0009835	P-0009835-T01-IM5	Outside	FFPE	Resection	250	885	40	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Olaparib(CDK12 RECQL4-CDK12 fusion);Olaparib(RECQL4 RECQL4-CDK12 fusion)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 RECQL4-CDK12 fusion);Pembrolizumab,Nivolumab,Cemiplimab(RECQL4 RECQL4-CDK12 fusion)				LEVEL_2	TP53 p.H193R;ERBB2 Amplification;ERBB3 Amplification;MYC Amplification;CDK12 RECQL4-CDK12 fusion;RECQL4 RECQL4-CDK12 fusion	6	6
P-0009836	P-0009836-T01-IM5	In-House	FFPE	Resection	250	1036	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_4	KRAS p.G12V;RNF43 p.E110*;CDKN2A p.W110*	2	3
P-0009837	P-0009837-T01-IM5	In-House	FFPE	Resection	250	1067	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Trametinib,Cobimetinib,Binimetinib(KRAS p.G12F)				LEVEL_3A	KRAS p.G12C;KRAS p.G12F;RBM10 p.Q573*;ASXL1 p.T1298Rfs*153	3	4
P-0009838	P-0009838-T01-IM5	Outside	FFPE	Resection	250	884	40	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R248G;APC p.Q1291*;FGFR1 Amplification	1	3
P-0009839	P-0009839-T01-IM5	In-House	FFPE	Resection	250	868	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	HIST1H3H p.K37M;NCOR1 p.N1500Efs*21;MDM2 Amplification	1	3
P-0009840	P-0009840-T01-IM5	Outside	FFPE	Resection	250	719	20	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.G244D	0	1
P-0009841	P-0009841-T01-IM5	Outside	FFPE	Resection	250	621	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.S149Pfs*21;ERBB2 Amplification	4	3
P-0009842	P-0009842-T01-IM5	In-House	FFPE	Resection	250	636	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.F2799Kfs*4)					LEVEL_3B	TP53 p.R273H;ARID1A p.S645*;APC p.E1286*;ATM p.F2799Kfs*4;APC APC-intragenic	1	5
P-0009843	P-0009843-T01-IM5	Outside	FFPE	Resection	250	223	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.S420Wfs*15);Olaparib(CDK12 p.I782Sfs*8)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S420Wfs*15);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.I782Sfs*8)				LEVEL_1	CDK12 p.S420Wfs*15;FOXA1 p.E255Tfs*62;CDK12 p.I782Sfs*8;GRIN2A p.I533Nfs*9	4	4
P-0009844	P-0009844-T01-IM5	Outside	FFPE	Resection	108	246	50	Matched	Primary	Skin	Not Applicable	Tumor	SKAC	Skin Cancer, Non-Melanoma	Skin Adnexal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;NF2 Deletion	1	3
P-0009845	P-0009845-T01-IM5	In-House	FFPE	Resection	250	822	40	Matched	Metastasis	Pancreas	Ovary	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	KRAS p.Q61R;SMAD4 p.R135*;KDM6A p.E226*;SMAD3 p.N165*	1	4
P-0009846	P-0009846-T01-IM5	In-House	FFPE	Resection	250	1199	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310Y);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.E285K;ERBB2 p.S310Y;ASXL2 p.E330K;KMT2D p.G3819Afs*8;ARID1A p.N756Efs*61;CASP8 p.V410Ffs*28;ERBB2 Amplification	2	7
P-0009847	P-0009847-T01-IM5	In-House	FFPE	Resection	250	957	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.Y163C	0	1
P-0009848	P-0009848-T01-IM5	In-House	FFPE	Resection	250	972	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201C	1	2
P-0009849	P-0009849-T01-IM5	In-House	FFPE	Resection	250	1013	40	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification	2	2
P-0009850	P-0009850-T01-IM5	In-House	FFPE	Resection	250	766	70	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.R283*;APC p.E1309Dfs*4;TP53 p.N239*	0	3
P-0009851	P-0009851-T01-IM5	In-House	FFPE	Resection	250	992	60	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V274A;MGA p.S1911Afs*12;APC p.S1392*	0	3
P-0009852	P-0009852-T01-IM5	Outside	FFPE	Biopsy	250	973	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.C275Y;EGFR p.A289D;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	6
P-0009853	P-0009853-T02-IM5	In-House	FFPE	Biopsy	250	722	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0009853	P-0009853-T01-IM5	Outside	FFPE	Resection	250	932	50	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Everolimus(TSC2 p.R462H);Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	TSC2 p.R462H;BRCA2 Deletion;PIK3CB Amplification	3	3
P-0009854	P-0009854-T01-IM5	Outside	FFPE	Biopsy	250	958	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	KRAS p.Q61R;SMAD4 p.P514Kfs*12	1	2
P-0009855	P-0009855-T01-IM5	Outside	FFPE	Biopsy	250	925	70	Matched	Metastasis	Skin	Duodenum	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Larotrectinib,Entrectinib(GON4L NTRK1-GON4L fusion);Larotrectinib,Entrectinib(NTRK1 NTRK1-GON4L fusion)		Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	NRAS p.Q61R;CDKN2A Deletion;CDKN2B Deletion;DDR2 Amplification;MYC Amplification;NTRK1 Amplification;GON4L NTRK1-GON4L fusion;NTRK1 NTRK1-GON4L fusion	4	8
P-0009856	P-0009856-T01-IM5	In-House	FFPE	Cytology	250	1061	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.R337C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ATM p.R337C;KEAP1 p.A95Pfs*62;PIK3R2 Deletion;STK11 C19orf26-STK11 fusion;CBARP C19orf26-STK11 fusion	3	6
P-0009857	P-0009857-T01-IM5	In-House	FFPE	Resection	250	899	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.Y236S	0	1
P-0009858	P-0009858-T01-IM5	In-House	Cell Pellet	Cytology	55	174	50	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.W1692Mfs*3)	Ivosidenib(IDH1 p.R132H);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R103Q);Olaparib(CDK12 p.G1461Afs*38);Talazoparib,Niraparib(BRCA2 p.W1692Mfs*3)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.G1461Afs*38);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3A	KRAS p.G12D;GNAS p.R201H;ARID1A p.Q1519Pfs*13;RNF43 p.G659Vfs*41;IDH1 p.R132H;ARID1A p.Q802Sfs*15;MAX p.R60Q;ERBB2 p.R103Q;CDK12 p.G1461Afs*38;RNF43 p.R371*;HLA-A p.Y31*;KMT2C p.R4806*;AXIN2 p.R399*;SETD2 p.E282Kfs*19;BRCA2 p.W1692Mfs*3;KMT2C p.S2293Ifs*5;BCOR p.S830Cfs*6;CDKN2A p.R80*	8	18
P-0009859	P-0009859-T01-IM5	In-House	FFPE	Biopsy	250	1045	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	RB1 p.Q471*;PIK3CA p.E542K;FOXP1 p.X511_splice;NCOR1 p.W2371*;NCOR1 p.Q698*	2	5
P-0009860	P-0009860-T01-IM5	Outside	FFPE	Resection	250	922	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.K132R;SMAD4 p.D351N	1	3
P-0009861	P-0009861-T01-IM5	In-House	FFPE	Biopsy	250	926	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.H193R;TERT Amplification	1	3
P-0009862	P-0009862-T01-IM5	In-House	FFPE	Biopsy	250	879	80	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3CA p.E545K;TP53 p.E285K;SETD2 p.L339Sfs*4	3	4
P-0009863	P-0009863-T01-IM5	Outside	FFPE	Biopsy	250	813	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(ATM p.X1249_splice)					LEVEL_1	BRAF p.V600E;MAX p.R60Q;ATM p.X1249_splice;NF2 p.K525*;CDKN1B p.Q104Rfs*19;TP53 p.G293Rfs*13;AKT2 Amplification;AXL Amplification	4	8
P-0009864	P-0009864-T01-IM5	In-House	FFPE	Biopsy	194.56	439	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;RB1 p.Q471*;TP53 p.V122Dfs*26;EGFR Amplification;FOXA1 Amplification;NKX2-1 Amplification	1	6
P-0009865	P-0009865-T01-IM5	Outside	FFPE	Resection	250	1165	60	Matched	Primary	Eye	Not Applicable	Tumor	RBL	Retinoblastoma	Retinoblastoma										RB1 p.R255*;RB1 p.N623Qfs*15	0	2
P-0009867	P-0009867-T01-IM5	Outside	FFPE	Resection	250	1130	60	Matched	Primary	Vagina	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K558delinsNP)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KIT p.K558delinsNP;CDKN2A Deletion;CDKN2B Deletion;KDR Amplification;KIT Amplification;PDGFRA Amplification;PTPRD Deletion;GPS2 NEURL4-GPS2 fusion;NEURL4 NEURL4-GPS2 fusion	2	9
P-0009868	P-0009868-T01-IM5	Outside	FFPE	Biopsy	250	1358	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R273S;APC p.S1436Rfs*2;AURKA Amplification;CDK6 Amplification;ERBB2 Amplification	2	5
P-0009869	P-0009869-T01-IM5	In-House	FFPE	Biopsy	250	1053	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0009870	P-0009870-T01-IM5	In-House	FFPE	Resection	250	1057	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A86Gfs*54)				LEVEL_4	TP53 p.R273H;KRAS p.G12D;ARID1A p.Q372Afs*28;ARID1A p.G2087E;CDKN2A p.A86Gfs*54;AKT2 Amplification	2	6
P-0009871	P-0009871-T01-IM5	Outside	FFPE	Resection	250	978	10	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										AMER1 p.R353*;APC p.E868Dfs*45;TCF7L2 p.I309Hfs*19	0	3
P-0009872	P-0009872-T02-IM5	In-House	FFPE	Biopsy	250	1275	40	Matched	Metastasis	Esophagus	Lung	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R282W;ERBB2 Amplification	2	2
P-0009872	P-0009872-T01-IM5	Outside	FFPE	Biopsy	250	1135	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	SMAD4 p.R361C;TP53 p.R282W;ERBB2 Amplification	2	3
P-0009873	P-0009873-T01-IM5	Outside	FFPE	Resection	250	1024	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Lapatinib(EGFR p.A289V);Lapatinib(EGFR Amplification)				LEVEL_3B	EGFR p.A289V;CDK4 Amplification;EGFR Amplification	3	3
P-0009874	P-0009874-T02-IM5	Outside	FFPE	Resection	250	729	65	Matched	Metastasis	Breast	Ovary	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	1	4
P-0009875	P-0009875-T01-IM5	In-House	FFPE	Resection	250	1009	70	Matched	Primary	Duodenum	Not Applicable	Tumor	DA	Small Bowel Cancer	Duodenal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L755S);Olaparib(CHEK1 p.T226Hfs*14);Olaparib(PALB2 p.M296*);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.T733I);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.I332Ffs*17)					LEVEL_3B	PIK3CA p.H1047R;ERBB2 p.L755S;PBRM1 p.N258Kfs*6;APC p.R564*;CHEK1 p.T226Hfs*14;ASXL1 p.G646Wfs*12;CIC p.P1597Hfs*23;ASXL1 p.R693*;ZFHX3 p.R1893Gfs*35;AXIN1 p.G508Vfs*197;PALB2 p.M296*;KDM6A p.R519Hfs*29;ERBB2 p.T733I;MED12 p.V24G;CDH1 p.X54_splice;BRCA2 p.I332Ffs*17;CALR p.Q356Rfs*73;BLM p.F194Lfs*11;APC p.E1538Ifs*5;ZFHX3 p.E763Gfs*26;ARID2 p.I199Sfs*16;HLA-A p.R38Pfs*61;CIC p.A652Pfs*76;NOTCH4 p.Q177Rfs*75	6	24
P-0009876	P-0009876-T01-IM5	Outside	FFPE	Biopsy	250	820	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.Y373C)		Debio1347,BGJ398,AZD4547(FGFR3 p.Y373C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q)					LEVEL_1	PIK3CA p.E545Q;FGFR3 p.Y373C;CDKN1A p.V25Sfs*11;ARID2 p.Q1578*;GATA3 p.H434Tfs*42;CCND1 Amplification;FGF19 Amplification;RAF1 Amplification;THRB TGFBR2-THRB fusion;TGFBR2 TGFBR2-THRB fusion	3	10
P-0009878	P-0009878-T01-IM5	Outside	FFPE	Biopsy	250	1076	30	Matched	Metastasis	Breast	Peritoneum	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_1	PIK3CA p.H1047R;RHOA p.G17E;CDH1 p.L15Cfs*41;GATA3 p.K387Rfs*17;ESR1 p.Y537S	3	5
P-0009879	P-0009879-T01-IM5	In-House	FFPE	Resection	250	1032	70	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K550_P551delinsI)								LEVEL_1	KIT p.K550_P551delinsI	1	1
P-0009892	P-0009892-T01-IM5	Outside	FFPE	Resection	250	987	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R130*);GSK2636771,AZD8186(PTEN p.T319Kfs*24)				LEVEL_4	PTEN p.R130*;PTEN p.T319Kfs*24;TP53 p.R158H;SPEN p.R1470*;ASXL1 p.G646Wfs*12;RB1 p.X405_splice;ZFHX3 p.D1894Gfs*21;LATS1 p.R148*;ARID2 p.R1677*;FLT3 p.A680T;EP300 p.R2180*;KDM6A p.X189_splice;JAK1 p.S333Cfs*2;MSH6 p.G93Efs*56;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	16
P-0009893	P-0009893-T01-IM5	Outside	FFPE	Resection	250	945	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLAD	Bladder Cancer	Bladder Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.R361H;TP53 p.P152Afs*14;CCND1 Amplification;FGF19 Amplification;MAP3K1 Deletion;PIK3R1 Deletion;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	1	10
P-0009894	P-0009894-T01-IM5	In-House	FFPE	Resection	250	910	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R280I;STK11 p.G279Rfs*6	0	2
P-0009895	P-0009895-T01-IM5	In-House	FFPE	Resection	250	854	60	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;KEAP1 p.E441*;STK11 p.E165*;SMARCA4 p.R1189G;RBM10 p.Q509*;PTPRT p.P117Qfs*4;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	2	11
P-0009896	P-0009896-T01-IM5	In-House	FFPE	Resection	250	703	70	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										NF2 p.S288*	0	1
P-0009897	P-0009897-T01-IM5	Outside	FFPE	Biopsy	250	1077	20	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12*)				LEVEL_1	PIK3CA p.E545K;TP53 p.G266E;JAK1 p.R174*;ARID1A p.Q1212*;CDH1 p.S111Rfs*2;CDKN2A p.S12*	3	6
P-0009898	P-0009898-T01-IM5	In-House	FFPE	Biopsy	250	1142	80	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib(ATM p.S2058*);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	PIK3CA p.E545K;ATM p.S2058*;SMARCA4 p.E1083*;CCND1 Amplification;DDR2 Amplification;FGF19 Amplification;GATA3 Amplification;MDM2 Amplification;RAF1 Amplification	3	9
P-0009899	P-0009899-T01-IM5	Outside	FFPE	Resection	250	1000	30	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0009900	P-0009900-T01-IM5	In-House	FFPE	Biopsy	250	1015	10	Matched	Metastasis	Appendix	Peritoneum	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0009901	P-0009901-T01-IM5	In-House	FFPE	Biopsy	250	1116	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification	1	1
P-0009902	P-0009902-T01-IM5	In-House	FFPE	Resection	250	579	50	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	APC p.R1114*;KRAS p.G13D;APC p.M1413Wfs*2	1	3
P-0009903	P-0009903-T01-IM5	In-House	FFPE	Biopsy	93.6	530	NA	Matched	Metastasis	Colorectal NOS	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C242Y;APC p.R232*;APC p.Q1244*	0	3
P-0009904	P-0009904-T01-IM5	In-House	FFPE	Resection	250	527	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM p.P1382Hfs*4)			Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I)					LEVEL_1	ERBB2 p.V842I;ATM p.P1382Hfs*4	2	2
P-0009905	P-0009905-T01-IM5	Outside	FFPE	Biopsy	226.9	717	30	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.R1450*;TP53 p.R333Vfs*12;CCNE1 Amplification;KDM5A Amplification;KRAS Amplification	1	6
P-0009906	P-0009906-T01-IM5	In-House	FFPE	Resection	250	672	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.K320Efs*17;ARID1B p.V1503Afs*63;PBRM1 p.F1389Efs*5	0	3
P-0009907	P-0009907-T01-IM5	Outside	FFPE	Biopsy	250	590	60	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L;MAP3K1 p.S1077*;FOXA1 p.D226G;ARID2 p.N807Hfs*12;CDH1 p.I521Nfs*16;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	8
P-0009908	P-0009908-T01-IM5	In-House	FFPE	Resection	250	872	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.L70Cfs*20)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.L70Cfs*20)				LEVEL_1	CDK12 p.L70Cfs*20	2	1
P-0009909	P-0009909-T01-IM5	In-House	FFPE	Resection	250	574	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAASC	Pancreatic Cancer	Adenosquamous Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R342*;CDK6 Amplification	1	3
P-0009910	P-0009910-T01-IM5	In-House	FFPE	Biopsy	250	1064	80	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	SF3B1 p.E902Q;ARID1A p.Q524*;MLH1 p.E358*;ZFHX3 p.K3689*;AKT2 Amplification;CCND1 Amplification;CCNE1 Amplification;FGF19 Amplification;MCL1 Amplification;MDM2 Amplification;MYCL Amplification;SRC Amplification	1	12
P-0009911	P-0009911-T01-IM5	In-House	FFPE	Biopsy	143.4	617	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;RB1 p.G617Rfs*36;TP53 p.Q144Gfs*2	1	3
P-0009912	P-0009912-T01-IM5	Outside	FFPE	Biopsy	108.5	429	10	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease	Vemurafenib(BRAF p.V600E)		Cobimetinib(BRAF p.V600E)						LEVEL_1	BRAF p.V600E	2	1
P-0009913	P-0009913-T01-IM5	In-House	FFPE	Resection	250	660	30	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Olaparib(ATM p.S2394L)					LEVEL_3B	SMAD4 p.R361H;RIT1 p.M90I;ATM p.S2394L;ARID1A p.Q708*;RASA1 p.R679*;ARID1B p.R1062*;KMT2C p.Q2539*;ERBB3 p.T355I;AXIN1 p.E407*;SMAD4 p.E526Q;AMER1 p.E138*	1	11
P-0009914	P-0009914-T01-IM5	In-House	FFPE	Resection	250	738	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.Q1447*;SPOP p.K129E;KMT2C p.P3976Qfs*11;RAD21 FGF12-RAD21 fusion;FGF12 FGF12-RAD21 fusion	0	5
P-0009915	P-0009915-T01-IM5	Outside	FFPE	Resection	250	882	60	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	TP53 p.H179L;ZFHX3 p.K2190*;NSD1 p.L1356Wfs*16;NOTCH3 p.P2247Hfs*82;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;TGFBR2 Deletion	2	8
P-0009916	P-0009916-T01-IM5	In-House	FFPE	Resection	250	460	80	Matched	Metastasis	Bile Duct	Liver	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;ARID1A p.F1750Lfs*20	1	2
P-0009917	P-0009917-T01-IM5	In-House	FFPE	Resection	250	722	80	Matched	Metastasis	Liver	Brain	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	2
P-0009918	P-0009918-T01-IM5	In-House	FFPE	Resection	250	858	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111N);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.V344M)	GSK2636771,AZD8186(PTEN p.K267Rfs*9)				LEVEL_3B	PTCH1 p.S1203Afs*52;PIK3CA p.H1047R;TP53 p.R175H;JAK1 p.K860Nfs*16;PTEN p.K267Rfs*9;PIK3CA p.K111N;PIK3CA p.V344M;KMT2A p.S774Vfs*12;KMT2D p.P2354Lfs*30;TGFBR2 p.K128Afs*3;B2M p.L15Ffs*41;ARID1A p.Q766Sfs*67;PPM1D p.N512Ifs*2;ARID1A p.Q372Sfs*19;KDM5C p.P1508Lfs*36;ARID1B p.G507Dfs*16;BCL10 p.S167Lfs*6;MGA p.E1249Rfs*42;SMARCA4 p.W284Cfs*19;ARID1B p.G384Afs*46	5	20
P-0009919	P-0009919-T01-IM5	Outside	FFPE	Resection	250	538	80	Matched	Primary	Ileum	Not Applicable	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0009920	P-0009920-T01-IM5	In-House	FFPE	Resection	250	852	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	U2AF1 p.S34F;KRAS p.G13C	1	2
P-0009921	P-0009921-T01-IM5	In-House	FFPE	Resection	250	678	30	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib(NF1 HDAC5-NF1 fusion);Trametinib,Cobimetinib(HDAC5 HDAC5-NF1 fusion)				LEVEL_3B	TP53 p.R248Q;PIK3R1 p.Q455_S460dup;CDK4 Amplification;NF1 HDAC5-NF1 fusion;HDAC5 HDAC5-NF1 fusion	3	5
P-0009922	P-0009922-T01-IM5	In-House	FFPE	Biopsy	250	1025	70	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.P128Lfs*42;BCL6 Amplification;EGFR Amplification;PIK3CA Amplification	0	4
P-0009923	P-0009923-T01-IM5	In-House	FFPE	Cytology	250	826	60	Matched	Metastasis	Breast	Lung	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.E294*;RB1 p.K4*;CDKN2A Deletion;PIK3CA Amplification	1	4
P-0009924	P-0009924-T01-IM5	In-House	FFPE	Biopsy	250	982	70	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R158C;SETD2 p.K509*	1	3
P-0009925	P-0009925-T01-IM5	In-House	FFPE	Biopsy	250	1019	10	Unmatched	Primary	Lymph node	Not Applicable	Tumor	CHL	Hodgkin Lymphoma	Classical Hodgkin Lymphoma										IRF4 p.C99R;ARID1A p.S261*;SOCS1 p.Q131Pfs*122;CTCF p.E584Gfs*12;B2M p.S4*	0	5
P-0009926	P-0009926-T01-IM5	Outside	FFPE	Biopsy	250	888	60	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										ARID5B Deletion	0	1
P-0009927	P-0009927-T01-IM5	Outside	FFPE	Resection	250	765	40	Matched	Primary	Rectum	Not Applicable	Tumor	MIXED	Cancer of Unknown Primary	Mixed Cancer Types				Trametinib,Cobimetinib(MAP2K1 p.K57N)					LEVEL_3B	GNAS p.R201H;MAP2K1 p.K57N	1	2
P-0009928	P-0009928-T01-IM5	In-House	FFPE	Biopsy	250	1182	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.V659E)	Neratinib(ERBB2 p.V659E)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_2	PIK3CA p.E542K;STK11 p.P314Lfs*22;ERBB2 p.V659E;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	5	6
P-0009930	P-0009930-T01-IM5	Outside	FFPE	Resection	250	872	20	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	ACRM	Melanoma	Acral Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)					LEVEL_1	BRAF p.V600E	2	1
P-0009931	P-0009931-T01-IM5	In-House	FFPE	Biopsy	250	863	30	Matched	Metastasis	Breast	Bone	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma										ARID1A p.E1718_Y1719delinsA*;FGFR2 Amplification	0	2
P-0009932	P-0009932-T01-IM5	Outside	FFPE	Resection	250	715	70	Matched	Metastasis	Sinonasal	Brain	Tumor	SNA	Head and Neck Cancer	Sinonasal Adenocarcinoma				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	SMARCB1 Deletion	1	1
P-0009933	P-0009933-T01-IM5	Outside	FFPE	Resection	250	609	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252L)				LEVEL_4	FGFR2 p.S252L;GATA3 p.H411Pfs*96	1	2
P-0009934	P-0009934-T01-IM5	In-House	FFPE	Biopsy	250	790	70	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	GSK2636771,AZD8186(PTEN p.H196Rfs*22);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	PIK3CA p.E545K;TP53 p.E271V;PTEN p.H196Rfs*22;RASA1 p.L497_S500delins*;CDKN2A Deletion;CDKN2B Deletion;NF1 Deletion	4	7
P-0009935	P-0009935-T01-IM5	In-House	FFPE	Resection	250	894	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K	1	1
P-0009936	P-0009936-T01-IM5	Outside	FFPE	Resection	250	684	20	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;NCOR1 p.E1005Kfs*10;MAP2K4 Deletion;ZFHX3 Deletion	2	4
P-0009937	P-0009937-T01-IM5	In-House	FFPE	Resection	250	871	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										BCOR p.N1459S;RBM10 p.R5Dfs*129	0	2
P-0009938	P-0009938-T01-IM5	In-House	FFPE	Resection	250	832	60	Matched	Metastasis	Small Bowel	Peritoneum	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.N822K);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559_G565del)	Sorafenib(KIT p.N822K)					Imatinib,Sunitinib(KIT p.N822K)		LEVEL_1	KIT p.N822K;KIT p.V559_G565del	3	2
P-0009939	P-0009939-T01-IM5	In-House	FFPE	Resection	250	417	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F102V	0	1
P-0009940	P-0009940-T01-IM5	In-House	FFPE	Biopsy	250	1035	80	Matched	Metastasis	Eyelid	Liver	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma			Sonidegib,Vismodegib(PTCH1 p.F585Ifs*42)						LEVEL_3A	IKZF1 p.E304K;PPP6C p.R264C;APC p.Q1123*;KMT2C p.Q873Hfs*40;PTCH1 p.F585Ifs*42;CREBBP p.R1446C	1	6
P-0009941	P-0009941-T01-IM5	In-House	FFPE	Resection	250	1035	70	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;RUNX1 p.D96Gfs*15	2	2
P-0009942	P-0009942-T01-IM5	In-House	FFPE	Resection	250	274	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0009943	P-0009943-T01-IM5	Outside	FFPE	Cytology	97	587	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_4	TP53 p.P301Qfs*44;KRAS p.Q61R;KMT2D MLL2-intragenic	1	3
P-0009944	P-0009944-T01-IM5	In-House	FFPE	Biopsy	250	1073	80	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209L	0	1
P-0009945	P-0009945-T01-IM5	Outside	FFPE	Resection	250	361	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G1049R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R)						LEVEL_1	PIK3CA p.G1049R;TP53 p.F270V	2	2
P-0009946	P-0009946-T01-IM5	Outside	FFPE	Biopsy	250	868	50	Matched	Metastasis	Breast	Chest Wall	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										TP53 p.P71Gfs*75	0	1
P-0009947	P-0009947-T01-IM5	In-House	FFPE	Resection	250	771	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0009947	P-0009947-T02-IM5	In-House	FFPE	Resection	250	816	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma											0	0
P-0009948	P-0009948-T01-IM5	In-House	FFPE	Biopsy	250	1030	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)								LEVEL_1	TP53 p.R158L;EGFR p.L861Q;FOXA1 Amplification;NKX2-1 Amplification	1	4
P-0009948	P-0009948-T02-IM5	In-House	FFPE	Resection	250	429	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)								LEVEL_1	TP53 p.R158L;EGFR p.L861Q	1	2
P-0009949	P-0009949-T01-IM5	Outside	FFPE	Resection	99.63	212	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R499*;TP53 p.E198*;APC p.S1327*;TCF7L2 p.X127_splice	0	4
P-0009950	P-0009950-T01-IM5	Outside	FFPE	Resection	250	858	80	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib(NF1 p.K810*);Trametinib,Cobimetinib(NF1 p.E1334*)				LEVEL_3B	RAC1 p.P29S;PIK3CA p.E542K;TP53 p.P151S;PTPRD p.R1674C;PTPN11 p.P33S;NF1 p.K810*;NF1 p.E1334*;SMARCA4 p.Q498*	3	8
P-0009951	P-0009951-T01-IM5	In-House	FFPE	Resection	250	776	40	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.Y220S;SMAD4 p.X84_splice;EPHA3 p.P787Qfs*10;PTPRT p.F498Lfs*103;FANCA p.X951_splice;MYC Amplification	0	6
P-0009952	P-0009952-T01-IM5	In-House	FFPE	Cytology	250	1101	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0009953	P-0009953-T01-IM5	In-House	FFPE	Resection	250	966	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ARID1A p.Q1327*	1	2
P-0009954	P-0009954-T01-IM5	Outside	FFPE	Resection	250	1296	50	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)	Cetuximab,Panitumumab(KRAS p.A146V)			LEVEL_4	TP53 p.R342*;TP53 p.R175H;KRAS p.A146V;EPHA7 p.R231*;APC p.L456Sfs*6;APC p.T1487Nfs*20	1	6
P-0009955	P-0009955-T01-IM5	Outside	FFPE	Cytology	250	1160	20	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer										TP53 p.G245D	0	1
P-0009956	P-0009956-T01-IM5	Outside	FFPE	Resection	250	797	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.I49N)				LEVEL_4	KRAS p.G12V;TP53 p.E336*;CDKN2A p.I49N	2	3
P-0009957	P-0009957-T01-IM5	In-House	FFPE	Resection	250	781	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.G105D;TP53 p.L194R;CDK4 Amplification	2	4
P-0009958	P-0009958-T01-IM5	In-House	FFPE	Resection	250	963	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010N)	Crizotinib(MET p.D1010N)	Cabozantinib(MET p.D1010N)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-intragenic)				LEVEL_1	MET p.D1010N;SMAD4 p.E526K;CDKN2A CDKN2A-intragenic	4	3
P-0009959	P-0009959-T01-IM5	In-House	FFPE	Biopsy	250	1367	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.X245_splice	2	2
P-0009960	P-0009960-T01-IM5	In-House	FFPE	Resection	250	775	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;GNAS p.Q227K;STK11 p.G279Vfs*8	2	3
P-0009961	P-0009961-T01-IM5	In-House	FFPE	Resection	250	782	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;BAP1 p.S595Pfs*22	1	2
P-0009962	P-0009962-T01-IM5	In-House	FFPE	Biopsy	250	1105	60	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.Q2823*)					LEVEL_3B	PIK3CA p.E545K;HIST1H2BD p.P9A;BRCA2 p.Q2823*;CREBBP p.Q540*;CDH1 p.S851*;AKT2 Amplification;CD274 Amplification;RAD50 Deletion	2	8
P-0009963	P-0009963-T01-IM5	In-House	FFPE	Resection	250	918	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.X307_splice;ERBB2 Amplification	1	2
P-0009964	P-0009964-T01-IM5	In-House	FFPE	Resection	250	982	60	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(CDK12 p.T1463Nfs*50);Olaparib(ATM p.K1170Nfs*11)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.T1463Nfs*50)				LEVEL_1	BRAF p.V600E;PIK3CA p.H1047R;HLA-A p.A16Pfs*4;CDK12 p.T1463Nfs*50;RNF43 p.R330*;KMT2C p.N2842Mfs*21;NOTCH1 p.G446Afs*185;ARID1A p.P224Rfs*8;XRCC2 p.K267Nfs*30;TGFBR2 p.X508_splice;RNF43 p.W726*;ATM p.K1170Nfs*11	7	12
P-0009964	P-0009964-T02-IM5	Outside	FFPE	Biopsy	250	739	20	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(ATM p.S214Pfs*16);Olaparib(ATM p.F357Lfs*33)	GSK2636771,AZD8186(PTEN p.C218*);Trametinib,Cobimetinib(NF1 p.N78Ifs*7)				LEVEL_1	BRAF p.V600E;ATM p.S214Pfs*16;FBXW7 p.R505H;HNF1A p.P291Qfs*51;PTEN p.C218*;ANKRD11 p.K1461del;KMT2C p.S143Vfs*3;MEN1 p.R521Pfs*15;SPEN p.X465_splice;MAP2K4 p.X73_splice;RNF43 p.T58Qfs*4;ATM p.F357Lfs*33;NF1 p.N78Ifs*7;MGA p.D2578Tfs*10;RNF43 p.V205Gfs*53;NOTCH4 p.T350Hfs*4	7	16
P-0009965	P-0009965-T01-IM5	In-House	FFPE	Resection	250	880	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	KRAS p.G12V;TP53 p.G245V;CDKN2A p.R80*	2	3
P-0009966	P-0009966-T01-IM5	Outside	FFPE	Biopsy	250	951	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CDH1 p.X278_splice	2	2
P-0009967	P-0009967-T01-IM5	In-House	FFPE	Biopsy	250	1125	10	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	ARID1A p.Y551Lfs*72;KRAS p.Q61H	1	2
P-0009968	P-0009968-T01-IM5	In-House	FFPE	Resection	250	786	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)	Olaparib(ATM Deletion);Olaparib(RAD51B Deletion)					LEVEL_2	ATM Deletion;ATRX Deletion;CBL Deletion;CDK4 Amplification;DICER1 Deletion;JUN Amplification;MAX Deletion;MDM2 Amplification;KMT2A Deletion;MRE11 Deletion;RAD51B Deletion;YAP1 Amplification	4	12
P-0009969	P-0009969-T01-IM5	In-House	FFPE	Resection	250	792	40	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma			Tipifarnib(HRAS p.Q61K)						LEVEL_3A	HRAS p.Q61K;TP53 p.X225_splice;TGFBR2 p.E428*	1	3
P-0009970	P-0009970-T01-IM5	In-House	FFPE	Biopsy	250	1112	50	Matched	Metastasis	Lung	Liver	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer											0	0
P-0009971	P-0009971-T01-IM5	In-House	FFPE	Biopsy	138	337	40	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					GSK2636771,AZD8186(PTEN p.V343*)				LEVEL_4	TP53 p.R282W;APC p.S1315*;PIK3R1 p.E218*;APC p.F773Lfs*4;PTEN p.V343*;ARID1A p.S862Lfs*10	1	6
P-0009972	P-0009972-T01-IM5	In-House	FFPE	Resection	250	753	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R282W;APC p.G1339Ifs*12	0	2
P-0009973	P-0009973-T01-IM5	In-House	FFPE	Resection	56.154	499	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)	GSK2636771,AZD8186(PTEN p.H185Ifs*14)				LEVEL_3B	NRAS p.Q61L;TP53 p.Y220D;PTEN p.H185Ifs*14	2	3
P-0009974	P-0009974-T01-IM5	In-House	FFPE	Resection	250	792	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.K292Nfs*7	1	2
P-0009975	P-0009975-T01-IM5	In-House	FFPE	Resection	250	937	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;RAD50 p.L402Afs*7	1	2
P-0009981	P-0009981-T01-IM5	In-House	FFPE	Biopsy	250	1054	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.P152R	1	2
P-0009982	P-0009982-T01-IM5	In-House	FFPE	Biopsy	250	1017	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CTNNB1 p.S45P;PIK3R1 p.X475_splice	0	2
P-0009984	P-0009984-T01-IM5	In-House	FFPE	Biopsy	250	1167	10	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Y205C;FAT1 p.S3268*;STK11 p.D194G;SMARCA4 p.S662*;NOTCH1 p.D1849Lfs*36	0	5
P-0009985	P-0009985-T01-IM5	In-House	FFPE	Resection	250	772	50	Matched	Metastasis	Uterus	Vagina	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Olaparib(CHEK1 p.T226Hfs*14);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.V1713A)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.E288*)				LEVEL_3B	KRAS p.G12D;BCOR p.N1459S;JAK1 p.K860Nfs*16;NFE2L2 p.G31E;JAK1 p.L431Vfs*22;CHEK1 p.T226Hfs*14;PIK3CA p.E545G;INPP4B p.R818Efs*4;ATRX p.R2407*;PTEN p.E288*;FOXP1 p.L414*;DIS3 p.I678Ffs*59;AXIN1 p.R533*;BRCA1 p.V1713A;KMT2C p.P2947Hfs*12;KMT2D p.P1855Qfs*21;LOC100134259 MSH6-LOC100134259 fusion;MSH6 MSH6-LOC100134259 fusion	5	18
P-0009986	P-0009986-T01-IM5	In-House	FFPE	Cytology	238.8	1004	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.C135_L137delinsW;FBXW7 p.Q428Sfs*64;AKT2 Amplification;CDKN2A Deletion;CDKN2B Deletion	1	5
P-0009987	P-0009987-T01-IM5	In-House	FFPE	Biopsy	250	1292	80	Matched	Primary	Peritoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma			Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_3A	CCNE1 Amplification;MDM2 Amplification;SMARCA4 Deletion;TERT Amplification	1	4
P-0009988	P-0009988-T01-IM5	In-House	FFPE	Biopsy	250	1075	40	Matched	Metastasis	Breast	Liver	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma			AZD9496,Fulvestrant(ESR1 p.Y537N)		GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3A	ESR1 p.Y537N;ARID1A p.A139Pfs*93;CDH1 p.Q23Rfs*31;BMPR1A Deletion;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;PTEN Deletion	2	8
P-0009989	P-0009989-T01-IM5	In-House	FFPE	Biopsy	250	1140	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.A119G;GPS2 p.E47Nfs*16	0	2
P-0009990	P-0009990-T01-IM5	In-House	FFPE	Biopsy	250	876	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R233Tfs*10)				LEVEL_4	PTEN p.R233Tfs*10	1	1
P-0009991	P-0009991-T01-IM5	Outside	FFPE	Cytology	208.1	467	30	Matched	Metastasis	Parotid Gland	Liver	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										CBFB p.X27_splice;ARID1A p.X1368_splice;MYC p.S298del;FAT1 FAT1-intragenic	0	4
P-0009992	P-0009992-T01-IM5	In-House	FFPE	Resection	250	512	80	Matched	Metastasis	Thyroid	Chest Wall	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R	2	1
P-0009993	P-0009993-T01-IM3	In-House	FFPE	Biopsy	250	739	15	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.P278S;APC p.R1114*;APC p.X470_splice	0	3
P-0009993	P-0009993-T01-IM5	In-House	FFPE	Resection	250	733	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.P278S;APC p.R1114*;APC p.X470_splice	0	3
P-0009995	P-0009995-T01-IM5	In-House	FFPE	Resection	250	995	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;PIK3CA p.E545K	3	2
P-0009996	P-0009996-T01-IM5	In-House	FFPE	Resection	250	935	20	Matched	Primary	Duodenum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer										CD274 Amplification;EGFR Amplification;JAK2 Amplification;MYC Amplification	0	4
P-0009997	P-0009997-T01-IM5	Outside	FFPE	Resection	250	822	80	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										TP53 p.H193L;AKT2 Amplification;CCNE1 Amplification;MCL1 Amplification;NTRK1 Amplification	0	5
P-0009998	P-0009998-T01-IM5	Outside	FFPE	Resection	250	653	30	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Trametinib,Cobimetinib(NF1 Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	STAG2 p.X892_splice;ARID1A p.T894Pfs*25;NF1 Deletion;PTEN Deletion	2	4
P-0010001	P-0010001-T01-IM5	In-House	FFPE	Biopsy	250	1410	30	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma										TET2 p.R550*;SPEN p.E2025*;NOTCH1 p.V2421Gfs*14;TET2 p.F381Lfs*9	0	4
P-0010002	P-0010002-T01-IM5	In-House	FFPE	Resection	250	807	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G1049R);Fulvestrant+Alpelisib(PIK3CA p.Q546P)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)						LEVEL_1	PIK3CA p.G1049R;PIK3CA p.Q546P;CBFB p.R90Kfs*7	4	3
P-0010003	P-0010003-T01-IM5	In-House	FFPE	Resection	250	954	50	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0010004	P-0010004-T01-IM5	Outside	FFPE	Resection	250	1194	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.R108K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	EGFR p.R108K;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;GATA3 Deletion;PTEN Deletion;PTPRD Deletion	4	8
P-0010005	P-0010005-T01-IM5	Outside	FFPE	Resection	250	938	30	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma										CTNNB1 p.S45P	0	1
P-0010006	P-0010006-T01-IM5	Outside	FFPE	Biopsy	121	249	70	Matched	Primary	Bone	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma										MGA p.E1345Kfs*7	0	1
P-0010007	P-0010007-T01-IM5	Outside	FFPE	Biopsy	250	1020	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12V);Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V;KRAS p.G12A;APC p.S1465Rfs*9;SMAD4 p.D537G;SOX9 p.Q296*	3	6
P-0010008	P-0010008-T01-IM5	In-House	FFPE	Biopsy	126	742	70	Matched	Metastasis	Skin	Liver	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	NRAS p.Q61K;CTNNB1 p.S45Y	1	2
P-0010009	P-0010009-T01-IM5	In-House	FFPE	Biopsy	224.5	1178	40	Matched	Metastasis	Colorectal NOS	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										BRAF p.D594G;TP53 p.K132R	0	2
P-0010010	P-0010010-T01-IM5	Outside	FFPE	Resection	250	684	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.H1047R;RUNX1 p.Q370Kfs*197;RUNX1 p.A107Gfs*4;CDH1 p.Y827_D828delins*;MDM2 Amplification	3	5
P-0010011	P-0010011-T01-IM5	In-House	FFPE	Resection	250	1217	60	Matched	Metastasis	Ovary	Lung	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R213*;PRKN Deletion;PIK3CA Amplification;SMAD4 Deletion	0	4
P-0010012	P-0010012-T01-IM5	In-House	FFPE	Resection	250	972	50	Matched	Primary	Pancreas	Not Applicable	Tumor	IPMN	Pancreatic Cancer	Intraductal Papillary Mucinous Neoplasm					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A30Gfs*23)				LEVEL_4	KRAS p.G12D;GNAS p.R201C;RNF43 p.L285Pfs*9;RNF43 p.X283_splice;CDKN2A p.A30Gfs*23	2	5
P-0010013	P-0010013-T01-IM5	In-House	Cell Pellet	Cytology	99.96	269	10	Matched	Primary	Lung	Not Applicable	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	KRAS p.G13D;RBM10 p.A631Hfs*73	1	2
P-0010014	P-0010014-T01-IM5	In-House	FFPE	Resection	250	717	50	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.W53*;SMAD4 p.R496H;APC p.L1511Rfs*2	0	3
P-0010015	P-0010015-T01-IM5	In-House	FFPE	Biopsy	250	1199	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(RAD51B Deletion)				GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	EPHB1 p.R743W;TP53 p.G266V;AR Amplification;CCND2 Amplification;KDM5A Amplification;MAX Deletion;PTEN Deletion;RAD51B Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	10
P-0010016	P-0010016-T01-IM5	In-House	FFPE	Resection	250	773	20	Matched	Metastasis	Liver	Soft Tissue	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma											0	0
P-0010017	P-0010017-T01-IM5	In-House	FFPE	Resection	250	891	60	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.E632_L633del)		BLU-667(RET p.E632_L633del)						LEVEL_1	RET p.E632_L633del	2	1
P-0010018	P-0010018-T01-IM5	In-House	FFPE	Resection	250	866	50	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C;ARID1A p.R1335*;ARID1B p.X629_splice	0	3
P-0010019	P-0010019-T01-IM5	In-House	FFPE	Resection	250	948	70	Matched	Metastasis	Duodenum	Brain	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.R213*;ERBB3 p.S846I;TGFBR1 p.S241L;RNF43 p.F69Lfs*7;AKT1 p.R23Q;ANKRD11 p.E1927Gfs*23;MET Amplification	1	7
P-0010020	P-0010020-T01-IM5	In-House	FFPE	Resection	250	515	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Everolimus,Temsirolimus(MTOR p.Y1450_W1456del)				LEVEL_4	TP53 p.R273H;LATS2 p.P479_A480dup;APC p.E1345*;APC p.R1158*;MTOR p.Y1450_W1456del	1	5
P-0010021	P-0010021-T01-IM5	In-House	FFPE	Resection	250	827	10	Matched	Primary	Uterus	Not Applicable	Tumor	MIXED	Cancer of Unknown Primary	Mixed Cancer Types											0	0
P-0010022	P-0010022-T01-IM5	In-House	FFPE	Resection	250	1170	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(ATM p.R337C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_3B	PIK3CA p.H1047R;KRAS p.G12A;APC p.R216*;ATM p.R337C;APC p.R1314Sfs*7;GATA1 p.R270Q	3	6
P-0010023	P-0010023-T01-IM5	In-House	FFPE	Resection	250	882	70	Matched	Primary	Prostate	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										ATRX Deletion;RB1 Deletion;TP53 Deletion	0	3
P-0010024	P-0010024-T01-IM5	Outside	FFPE	Cytology	250	1238	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)						LEVEL_3A	TP53 p.V157F;KEAP1 p.D422H;KMT2D p.P2206Lfs*58;FGFR1 Amplification	1	4
P-0010025	P-0010025-T01-IM5	In-House	FFPE	Biopsy	250	1025	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R273L;BRAF p.G596R	0	2
P-0010026	P-0010026-T01-IM5	In-House	FFPE	Resection	250	712	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										CDK6 Amplification	0	1
P-0010027	P-0010027-T01-IM5	In-House	FFPE	Biopsy	250	1150	70	Matched	Metastasis	Lung	Soft Tissue	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.C277F;PPP2R1A p.E297K;RASA1 p.E734*;NOTCH1 p.E531*;KMT2D p.X5471_splice;BCL6 Amplification;RB1 Deletion	0	7
P-0010028	P-0010028-T01-IM5	In-House	FFPE	Resection	250	878	60	Matched	Metastasis	Ovary	Peritoneum	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12D;PIK3CA p.E542K;SPEN p.Q743*;TP53 p.X307_splice;CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification	3	7
P-0010029	P-0010029-T01-IM5	In-House	FFPE	Resection	250	1013	20	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification	0	1
P-0010030	P-0010030-T01-IM5	In-House	FFPE	Resection	250	906	70	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.R925Gfs*4)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;STK11 p.P281Rfs*6;PTPRS p.R235*;ATM p.R925Gfs*4;MCL1 Amplification;PAX5 Deletion	2	6
P-0010031	P-0010031-T01-IM5	Outside	FFPE	Resection	250	815	40	Matched	Primary	Appendix	Not Applicable	Tumor	GCCAP	Appendiceal Cancer	Goblet Cell Carcinoid of the Appendix				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R273C;APC p.R1435*;FGFR1 Amplification	1	3
P-0010032	P-0010032-T02-IM5	In-House	FFPE	Resection	250	1065	NA	Matched	Metastasis	Appendix	Ascending Colon	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										SDHAF2 SDHAF2-intragenic	0	1
P-0010033	P-0010033-T01-IM5	In-House	FFPE	Resection	250	873	70	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;KMT2D p.R4960*;NSD1 p.G408*;KMT2C p.R1481*;KMT2D p.E2989*	2	5
P-0010034	P-0010034-T01-IM5	Outside	FFPE	Biopsy	250	689	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R130*)				LEVEL_4	NCOR1 p.E529Kfs*26;TP53 p.R175H;PTEN p.R130*;RNF43 p.G659Vfs*41;TP53 p.R273C;GNAS p.R201C;PIK3CB p.E470K;ZFHX3 p.E763Sfs*61;ATR p.F2243Lfs*8	1	9
P-0010035	P-0010035-T01-IM5	Outside	FFPE	Cytology	250	1062	50	Matched	Primary	Breast	Not available	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS		Talazoparib,Olaparib(BRCA1 p.G911Efs*89)		Niraparib,Rucaparib(BRCA1 p.G911Efs*89)					LEVEL_2	BRCA1 p.G911Efs*89;TP53 p.R110Pfs*14	2	2
P-0010041	P-0010041-T01-IM5	Outside	FFPE	Resection	250	763	70	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0010042	P-0010042-T01-IM5	Outside	FFPE	Biopsy	155.5	252	50	Matched	Metastasis	Appendix	Omentum	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N996S)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)				LEVEL_3B	KRAS p.A146T;SMAD4 p.X142_splice;TP53 p.H214Ifs*33	2	3
P-0010043	P-0010043-T01-IM5	In-House	FFPE	Biopsy	195.7	811	20	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Fulvestrant+Alpelisib(PIK3CA p.P539R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P539R);AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_1	PIK3CA p.H1047R;PIK3CA p.P539R;ESR1 p.Y537S;CCND1 Amplification;FGF19 Amplification	5	5
P-0010044	P-0010044-T01-IM5	In-House	FFPE	Resection	250	685	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.K164E	0	1
P-0010046	P-0010046-T01-IM5	In-House	FFPE	Biopsy	250	1046	70	Matched	Metastasis	Kidney	Adrenal Gland	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										MED12 p.R1716*	0	1
P-0010048	P-0010048-T01-IM5	In-House	FFPE	Biopsy	108.7	522	70	Matched	Metastasis	Soft Tissue	Lung	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	NF1 Deletion;TP53 Deletion	1	2
P-0010049	P-0010049-T01-IM5	Outside	FFPE	Resection	250	812	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.A161T;SOX9 p.F69Lfs*182	0	2
P-0010050	P-0010050-T01-IM5	Outside	FFPE	Resection	250	889	80	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	2
P-0010051	P-0010051-T01-IM5	Outside	FFPE	Resection	250	683	80	Matched	Primary	Ovary	Not Applicable	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor										TP53 p.R248Q;AKT2 Amplification;CCND2 Amplification;CCNE1 Amplification;KDM5A Amplification;KRAS Amplification;MAP3K1 Deletion;PIK3R1 Deletion	0	8
P-0010052	P-0010052-T01-IM5	Outside	FFPE	Resection	250	547	80	Matched	Primary	Ovary	Not Applicable	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W;TP53 p.R267W	0	2
P-0010053	P-0010053-T01-IM5	In-House	FFPE	Biopsy	250	1176	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.L861Q)								LEVEL_1	TP53 p.Q100*;EGFR p.L861Q;EGFR Amplification	1	3
P-0010054	P-0010054-T01-IM5	In-House	FFPE	Resection	250	1120	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.G245C;ARID1A p.Q515*;MAP3K1 p.W1449*;ARID2 p.X236_splice;ARID2 p.Q614*;ARID2 p.E1287*;STK11 p.E65*	0	7
P-0010055	P-0010055-T01-IM5	Outside	FFPE	Biopsy	210.4	909	30	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	NECNOS	Cancer of Unknown Primary	Neuroendocrine Carcinoma, NOS					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R209Kfs*6;RB1 p.X654_splice;AKT2 Amplification;CCNE1 Amplification;MYCL Amplification;PTEN Deletion	1	6
P-0010056	P-0010056-T01-IM5	In-House	FFPE	Cytology	250	1004	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;PIK3CA p.H1047L;KDM5C p.E693*	2	3
P-0010057	P-0010057-T01-IM5	In-House	FFPE	Biopsy	200.4	1058	30	Matched	Metastasis	Cancer of Unknown Primary	Abdomen	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS					Tazemetostat(SMARCB1 p.X167_splice)				LEVEL_4	SMARCB1 p.X167_splice;SPOP p.E50K;TP53 p.X225_splice;ARID1A p.E1033*;ARID5B p.X467_splice;RB1 p.K240*;TCF3 p.E51*;ARID5B p.G919Afs*25;MLH1 p.Q409Rfs*82	1	9
P-0010058	P-0010058-T01-IM5	Outside	FFPE	Biopsy	250	972	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 p.Q1017*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	GATA3 p.D335Gfs*17;NF1 p.Q1017*;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;PPM1D Amplification	2	7
P-0010059	P-0010059-T01-IM5	Outside	FFPE	Resection	250	636	40	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Temsirolimus(MTOR p.L1460P)	Everolimus(MTOR p.L1460P)				LEVEL_3B	BRAF p.V600E;MTOR p.L1460P	3	2
P-0010060	P-0010060-T01-IM5	In-House	FFPE	Resection	250	864	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(CHEK2 p.R95*)	GSK2636771,AZD8186(PTEN p.R130*);Trametinib,Cobimetinib(NF1 p.Q1841*);Trametinib,Cobimetinib(NF1 p.R192*)				LEVEL_3B	PTEN p.R130*;CHEK2 p.R95*;NF1 p.Q1841*;NF1 p.R192*	4	4
P-0010061	P-0010061-T01-IM5	In-House	FFPE	Biopsy	250	1271	20	Matched	Metastasis	Lung	Pleura	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.E180K;RBM10 p.X42_splice;RBM10 p.G727*;DNMT3A p.K397Rfs*10	2	5
P-0010062	P-0010062-T01-IM5	In-House	FFPE	Biopsy	250	1189	40	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R213L;APC p.I1580Ffs*70;KRAS p.G13D;FOXO1 p.S22W;APC p.E696*	1	5
P-0010063	P-0010063-T01-IM5	In-House	FFPE	Resection	250	1157	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	KRAS p.G12V;TP53 p.R175H;SMAD4 p.Y95C;CDKN2A p.H83Y	2	4
P-0010064	P-0010064-T01-IM5	Outside	FFPE	Resection	250	770	80	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0010065	P-0010065-T01-IM5	Outside	FFPE	Biopsy	250	589	10	Matched	Metastasis	Lung	Pleura	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer										TP53 p.H193R	0	1
P-0010066	P-0010066-T01-IM5	Outside	FFPE	Biopsy	250	1099	80	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.X225_splice;MAP2K4 p.X272_splice;RB1 p.G449Efs*8;ATR p.A747Pfs*12;CDKN2A Deletion;CDKN2B Deletion;MGA PLA2G4F-MGA fusion;PLA2G4F PLA2G4F-MGA fusion;BBC3 BBC3-intragenic	1	9
P-0010067	P-0010067-T01-IM5	Outside	FFPE	Biopsy	211.9	842	30	Matched	Metastasis	Pancreas	Diaphragm	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Olaparib(ATM p.R3008H)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_3B	KRAS p.Q61H;ATM p.R3008H	2	2
P-0010068	P-0010068-T01-IM5	In-House	FFPE	Resection	250	664	60	Matched	Metastasis	Breast	Lung	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0010069	P-0010069-T01-IM5	In-House	FFPE	Biopsy	250	1061	40	Matched	Metastasis	Breast	Soft Tissue	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);AZD9496,Fulvestrant(ESR1 p.L536R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047L;ESR1 p.L536R;CDH1 p.W526*;RUNX1 p.V54Gfs*57;ERBB2 Amplification	5	5
P-0010070	P-0010070-T01-IM5	In-House	FFPE	Biopsy	250	1122	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										PPM1D p.L546*;PBRM1 p.E1335Dfs*43	0	2
P-0010071	P-0010071-T01-IM5	In-House	FFPE	Resection	250	773	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Everolimus(MIR548H3 TSC1-MIR548H3 fusion);Everolimus(TSC1 TSC1-MIR548H3 fusion)					LEVEL_3B	TP53 p.M246V;ERBB3 p.N126K;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion;MIR548H3 TSC1-MIR548H3 fusion;TSC1 TSC1-MIR548H3 fusion	2	6
P-0010072	P-0010072-T01-IM5	Outside	FFPE	Resection	250	855	30	Matched	Primary	Jejunum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Olaparib(CDK12 p.K721Nfs*32)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.K721Nfs*32)				LEVEL_3B	RAF1 p.S257L;RB1 p.G617Rfs*36;KRAS p.G13D;BCOR p.P1621Qfs*53;FBXW7 p.R473Efs*25;CTCF p.N587Mfs*44;RB1 p.M825*;CDK12 p.K721Nfs*32	3	8
P-0010073	P-0010073-T01-IM5	In-House	FFPE	Biopsy	250	919	40	Matched	Primary	Nasopharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.X165_splice)				LEVEL_4	PTEN p.X165_splice	1	1
P-0010074	P-0010074-T01-IM5	In-House	FFPE	Biopsy	250	991	NA	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R196*;APC p.L1488Yfs*19;FBXW7 p.R465C	0	3
P-0010075	P-0010075-T01-IM5	In-House	FFPE	Resection	250	498	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.Y27*)				LEVEL_4	PTEN p.Y27*;ZFHX3 Deletion;TNFRSF19 RB1-TNFRSF19 fusion;RB1 RB1-TNFRSF19 fusion	1	4
P-0010076	P-0010076-T01-IM5	In-House	FFPE	Resection	221.7	286	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0010077	P-0010077-T01-IM5	Outside	FFPE	Resection	159.9	834	NA	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	MAP3K1 p.Q1259*;MAP3K1 p.E839Rfs*24;BRD4 Amplification;ERBB2 Amplification	2	4
P-0010078	P-0010078-T01-IM5	In-House	FFPE	Biopsy	140.5	617	30	Matched	Metastasis	Prostate	Adrenal Gland	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.G262V;SPOP p.F133C;AR Amplification;CDK6 Amplification;MYC Amplification	0	5
P-0010079	P-0010079-T01-IM5	In-House	FFPE	Biopsy	250	945	10	Matched	Metastasis	Bladder	Lymph Node	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;NCOR1 p.S875*	1	2
P-0010080	P-0010080-T01-IM5	In-House	FFPE	Resection	250	962	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.T319*);GSK2636771,AZD8186(PTEN p.R14Nfs*9)				LEVEL_4	PTEN p.T319*;CBFB p.P70Sfs*13;PTEN p.R14Nfs*9	2	3
P-0010081	P-0010081-T01-IM5	In-House	FFPE	Biopsy	250	1038	60	Matched	Metastasis	Cancer of Unknown Primary	Peritoneum	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0010082	P-0010082-T01-IM5	In-House	FFPE	Biopsy	250	1161	80	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.Y205C;TNFAIP3 p.Q8*;ARID1A Deletion;ERBB2 Amplification	1	4
P-0010083	P-0010083-T01-IM5	In-House	FFPE	Cytology	250	851	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Trametinib,Cobimetinib(PARP12 PARP12-BRAF fusion);Trametinib,Cobimetinib(BRAF PARP12-BRAF fusion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;ARID1A p.D1850Tfs*33;U2AF1 p.S34F;TP53 p.S215N;TOP1 p.K82Rfs*30;PARP12 PARP12-BRAF fusion;BRAF PARP12-BRAF fusion	3	7
P-0010084	P-0010084-T01-IM5	Outside	FFPE	Resection	250	205	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MEN1 p.I85Yfs*32;KMT2C p.R1890*;ARID1A p.R1046*;AATF SOX9-AATF fusion;SOX9 SOX9-AATF fusion	0	5
P-0010085	P-0010085-T01-IM5	Outside	FFPE	Resection	250	1053	70	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0010086	P-0010086-T01-IM5	In-House	FFPE	Biopsy	250	1110	60	Matched	Metastasis	Soft Tissue	Lung	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS	Larotrectinib,Entrectinib(LMNA NTRK1-LMNA fusion);Larotrectinib,Entrectinib(NTRK1 NTRK1-LMNA fusion)								LEVEL_1	TERT Amplification;LMNA NTRK1-LMNA fusion;NTRK1 NTRK1-LMNA fusion	2	3
P-0010087	P-0010087-T01-IM5	In-House	FFPE	Biopsy	250	1029	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										ARID1A p.Q1519*;ATR p.E1388*;TP53 Deletion;NBN C8orf38-NBN fusion;NDUFAF6 C8orf38-NBN fusion	0	5
P-0010088	P-0010088-T01-IM5	In-House	FFPE	Resection	250	983	40	Matched	Metastasis	Tonsil	Small Bowel	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;KEAP1 p.X214_splice	1	2
P-0010089	P-0010089-T01-IM5	Outside	FFPE	Biopsy	250	758	70	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MYC Amplification	4	5
P-0010090	P-0010090-T01-IM5	Outside	FFPE	Biopsy	151.2	608	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MGA p.S1778*;ATRX p.K1725Mfs*10;MEN1 p.D70Tfs*49	0	3
P-0010091	P-0010091-T01-IM5	In-House	FFPE	Resection	250	374	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.Y234C;MYC Amplification	1	3
P-0010092	P-0010092-T01-IM5	In-House	FFPE	Biopsy	250	1346	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Tazemetostat(SMARCB1 p.E98Dfs*7);Tazemetostat(SMARCB1 p.D196Mfs*13)				LEVEL_4	SMARCB1 p.E98Dfs*7;SMARCB1 p.D196Mfs*13	2	2
P-0010093	P-0010093-T01-IM5	In-House	FFPE	Biopsy	250	991	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;TP53 p.X261_splice;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0010094	P-0010094-T01-IM5	Outside	FFPE	Resection	250	832	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	ERBB2 p.S310F;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;MDM2 Amplification	3	6
P-0010095	P-0010095-T01-IM5	Outside	FFPE	Resection	250	696	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H419_C420del)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H419_C420del)						LEVEL_1	TP53 p.R342*;PIK3CA p.H419_C420del;CBFB p.Q45*;GATA3 p.D335Vfs*35;MYC Amplification	2	5
P-0010097	P-0010097-T01-IM5	In-House	FFPE	Resection	250	913	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.C136R)				LEVEL_4	PTEN p.C136R;PBRM1 p.R1185*;SETD2 p.X1639_splice;BAP1 p.M80Nfs*46	1	4
P-0010098	P-0010098-T01-IM5	Outside	FFPE	Resection	250	710	30	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	PIK3CA p.G118D;BRAF p.V600E;TP53 p.W146*;APC p.Q1367*;APC p.R216*;FOXO1 p.Q428*	4	6
P-0010099	P-0010099-T01-IM5	In-House	FFPE	Biopsy	250	1053	20	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										CDH1 CMIP-CDH1 fusion;CMIP CMIP-CDH1 fusion	0	2
P-0010100	P-0010100-T01-IM5	In-House	FFPE	Biopsy	250	907	NA	Matched	Metastasis	Cancer of Unknown Primary	Soft Tissue	Tumor	ADNOS	Cancer of Unknown Primary	Adenocarcinoma, NOS					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.S127F;STK11 p.P221L;BRAF p.G466E;PTPRT p.Y412*	1	5
P-0010101	P-0010101-T01-IM5	In-House	FFPE	Resection	250	930	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	PECOMA	Soft Tissue Sarcoma	Perivascular Epithelioid Cell Tumor				Palbociclib,Abemaciclib(CDK4 Amplification);Crizotinib,Entrectinib(NETO1 ROS1-NETO1 fusion);Crizotinib,Entrectinib(ROS1 ROS1-NETO1 fusion);Crizotinib,Entrectinib(ROS1 SLC4A10-ROS1 fusion);Crizotinib,Entrectinib(SLC4A10 SLC4A10-ROS1 fusion)					LEVEL_3B	CDK4 Amplification;MEF2B Amplification;TERT Amplification;NETO1 ROS1-NETO1 fusion;ROS1 ROS1-NETO1 fusion;ROS1 SLC4A10-ROS1 fusion;SLC4A10 SLC4A10-ROS1 fusion	5	7
P-0010102	P-0010102-T01-IM5	In-House	FFPE	Biopsy	246.9	1250	40	Matched	Metastasis	Bile Duct	Omentum	Tumor	EHCH	Hepatobiliary Cancer	Extrahepatic Cholangiocarcinoma				Olaparib(BRIP1 p.Y1131Lfs*18)	GSK2636771,AZD8186(PTEN p.R173C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3B	PTEN p.R173C;BRIP1 p.Y1131Lfs*18;TP53 p.R337C;CDKN2A p.H83Y;KDM5A Amplification;SMAD4 Deletion	3	6
P-0010103	P-0010103-T01-IM5	In-House	FFPE	Biopsy	250	1090	80	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)						LEVEL_1	FGFR3 p.S249C;KMT2C p.K1346*;CREBBP p.W1472R;KMT2D p.G3669Afs*29;KMT2C p.R2609Hfs*38;CDKN1A p.L71Qfs*14	2	6
P-0010104	P-0010104-T01-IM5	In-House	FFPE	Biopsy	250	1039	40	Matched	Primary	Pharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R282W;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;TERT Amplification	1	6
P-0010105	P-0010105-T01-IM5	Outside	FFPE	Cytology	250	767	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	TP53 p.R273H;KRAS p.G12D;APC p.Q222*;TGFBR2 p.P174Hfs*24	1	4
P-0010106	P-0010106-T01-IM5	In-House	FFPE	Biopsy	250	1020	70	Unmatched	Primary	Retroperitoneum	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										B2M p.M1?;NOTCH2 p.Q2341*;KMT2D p.Q3518*;B2M p.X5_splice;TNFAIP3 p.L171Qfs*81;TNFRSF14 Deletion	0	6
P-0010107	P-0010107-T01-IM5	In-House	FFPE	Biopsy	250	917	60	Matched	Metastasis	Soft Tissue	Lymph Node	Tumor	VYST	Germ Cell Tumor	Yolk Sac Tumor											0	0
P-0010108	P-0010108-T01-IM5	Outside	FFPE	Resection	250	673	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0010109	P-0010109-T01-IM5	In-House	FFPE	Resection	250	831	60	Matched	Primary	Vulva	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576_H580dup)					LEVEL_3B	SF3B1 p.R625H;KIT p.L576_H580dup	1	2
P-0010110	P-0010110-T01-IM5	In-House	FFPE	Biopsy	250	1063	80	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										CDH1 p.X320_splice;PRKN p.X288_splice;IKBKE Amplification;MDM4 Amplification;ROS1 Amplification	0	5
P-0010111	P-0010111-T01-IM5	Outside	FFPE	Resection	250	835	70	Matched	Primary	Vagina	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina				Palbociclib,Abemaciclib(CDK4 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	ARID1B Deletion;CDK4 Amplification;KRAS Amplification;LATS1 Deletion;MCL1 Amplification;PRKN Deletion;PTEN Deletion	2	7
P-0010112	P-0010112-T01-IM5	In-House	FFPE	Resection	250	782	40	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	TP53 p.R248W;KRAS p.G12V;APC p.M1583Tfs*68	1	3
P-0010113	P-0010113-T01-IM5	Outside	FFPE	Cytology	157.1	833	70	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS					Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-intragenic)				LEVEL_4	TP53 p.R213Q;EGFR Amplification;CDKN2A CDKN2A-intragenic	1	3
P-0010114	P-0010114-T01-IM5	Outside	FFPE	Biopsy	102.7	373	20	Matched	Primary	Cervix	Not Applicable	Tumor	GCEMU	Cervical Cancer	Gastric Type Mucinous Carcinoma										TP53 p.R213*;RB1 p.W99Lfs*11;MDM4 Amplification	0	3
P-0010115	P-0010115-T01-IM5	In-House	FFPE	Biopsy	250	879	50	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	MUP	Melanoma	Melanoma of Unknown Primary			Trametinib,Cobimetinib(MAP2K1 p.P124M)		Trametinib,Cobimetinib(NF1 p.R440*);Trametinib,Cobimetinib(NF1 p.Q803*)				LEVEL_3A	TP53 p.Q317*;ARID2 p.Q288*;NF1 p.R440*;ARID2 p.S297F;TET2 p.G1145S;PTPRD p.R1496*;ARID2 p.Q658*;GRIN2A p.X593_splice;NF1 p.Q803*;MAP2K1 p.P124M;TP53 p.G266R	3	11
P-0010116	P-0010116-T01-IM5	In-House	FFPE	Biopsy	250	1001	30	Matched	Primary	Duodenum	Not available	Tumor	DA	Small Bowel Cancer	Duodenal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64)	PLX8394(BRAF p.G469A)				LEVEL_3B	PIK3CA p.H1047R;BRAF p.G469A;FUBP1 p.I301Nfs*4;MAX p.R60Q;SMAD3 p.P182Lfs*4;PTCH1 p.R1308Efs*64;APC p.Q1447*;FAT1 p.P1877Lfs*20;APC p.Q1244*;NSD1 p.K1604*;BRAF p.T241M;TOP1 p.N277Ifs*10;ARID1A p.E49Gfs*62;SMAD2 p.K157Rfs*6	3	14
P-0010117	P-0010117-T01-IM5	In-House	FFPE	Resection	250	872	70	Matched	Primary	Breast	Not Applicable	Tumor	BA	Breast Sarcoma	Breast Angiosarcoma										TP53 p.G245S;MYC Amplification	0	2
P-0010118	P-0010118-T01-IM5	Outside	FFPE	Resection	250	814	20	Matched	Primary	Descending Colon	Not Applicable	Tumor	SRCCR	Colorectal Cancer	Signet Ring Cell Adenocarcinoma of the Colon and Rectum										TP53 p.R175H;ERBB4 p.F1102C;SMAD4 p.E330K	0	3
P-0010119	P-0010119-T01-IM5	In-House	FFPE	Biopsy	250	982	20	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma					Tazemetostat(SMARCB1 p.R377H)				LEVEL_4	SMARCB1 p.R377H;CTNNB1 p.T41A	1	2
P-0010124	P-0010124-T01-IM5	Outside	FFPE	Biopsy	197.5	766	40	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.X126_splice;MAP3K1 p.N749Lfs*5;ERBB2 Amplification	4	4
P-0010125	P-0010125-T01-IM5	In-House	FFPE	Biopsy	250	1073	50	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G364R)					LEVEL_1	TP53 p.R273H;BRAF p.V600E;PIK3CA p.G364R;B2M p.Y46Wfs*8	4	4
P-0010126	P-0010126-T01-IM5	Outside	FFPE	Cytology	190.3	1289	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.K41*);Olaparib(ATM p.Q2730L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ATM p.K41*;ATM p.Q2730L;RBM10 p.X301_splice;FOXA1 Amplification;NKX2-1 Amplification;NOCT FAT1-CCRN4L fusion;FAT1 FAT1-CCRN4L fusion	4	8
P-0010127	P-0010127-T01-IM5	In-House	FFPE	Biopsy	250	925	80	Matched	Primary	Brain	Not Applicable	Tumor	PPTID	Pineal Tumor	Pineal Parenchymal Tumor of Intermediate Differentiation											0	0
P-0010128	P-0010128-T01-IM5	Outside	FFPE	Resection	250	844	70	Matched	Metastasis	Adrenal Gland	Liver	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										TP53 p.R213L;SETD2 p.E1921*;SETD2 p.E608*;KMT2A p.X3688_splice	0	4
P-0010129	P-0010129-T01-IM5	In-House	FFPE	Biopsy	250	1235	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	TP53 p.P60Qfs*63;AXIN1 Deletion;CCND2 Amplification;KDM5A Amplification;MET Amplification;RB1 Deletion	1	6
P-0010130	P-0010130-T01-IM5	In-House	FFPE	Resection	250	1046	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.E298*;CDK4 p.R24L;RBM10 p.R98Efs*36	1	4
P-0010130	P-0010130-T02-IM5	In-House	FFPE	Resection	250	988	80	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;RB1 p.Q471*;TP53 p.E298*;CDK4 p.R24L;RBM10 p.R98Efs*36;SMAD4 p.E175*;VEGFA Amplification	1	7
P-0010131	P-0010131-T01-IM5	In-House	FFPE	Resection	250	1068	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;RBM10 p.Q169Efs*10	1	2
P-0010132	P-0010132-T01-IM5	Outside	FFPE	Biopsy	250	936	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	KRAS p.G12V;TP53 p.R342*;CDKN2A p.R58*	2	3
P-0010133	P-0010133-T01-IM5	In-House	FFPE	Resection	250	808	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	EGFR p.E746_A750del;TP53 p.C242Y;CDK4 Amplification;GLI1 Amplification;NKX2-1 Amplification	2	5
P-0010134	P-0010134-T01-IM5	In-House	FFPE	Biopsy	250	871	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										RBM10 p.R230*;TP53 p.M133Rfs*38	0	2
P-0010135	P-0010135-T01-IM5	In-House	FFPE	Resection	250	510	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAASC	Pancreatic Cancer	Adenosquamous Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.T155P;TP53 p.R156L	1	3
P-0010136	P-0010136-T01-IM5	In-House	FFPE	Biopsy	250	1162	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)						LEVEL_3A	TP53 p.R248W;NSD1 p.N576Kfs*8;FGFR1 Amplification	1	3
P-0010137	P-0010137-T01-IM5	In-House	FFPE	Biopsy	250	1067	50	Unmatched	Primary	Skin	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										EP300 p.Y1467D;PIK3R1 p.D560G;KMT2D p.Y5070Lfs*2;TNFRSF14 p.C75*	0	4
P-0010138	P-0010138-T01-IM5	In-House	FFPE	Resection	250	834	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L)	Cetuximab,Panitumumab(KRAS p.Q61L)			LEVEL_4	KRAS p.Q61L;TP53 p.Q104*;APC p.R216*;APC p.E1309Dfs*4	1	4
P-0010139	P-0010139-T01-IM5	In-House	FFPE	Biopsy	153.2	890	60	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	KRAS p.A146T;PIK3CA p.R88Q;FBXW7 p.G423V;SMAD4 p.D355G;TP53 p.A189Gfs*20;APC p.N1455Kfs*2	2	6
P-0010141	P-0010141-T01-IM5	Outside	FFPE	Resection	250	202	60	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.A347D	0	1
P-0010142	P-0010142-T01-IM5	Outside	FFPE	Resection	250	1217	NA	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0010143	P-0010143-T01-IM5	In-House	FFPE	Resection	250	889	80	Matched	Metastasis	Ovary	Pelvis	Tumor	SLCT	Sex Cord Stromal Tumor	Sertoli-Leydig Cell Tumor										FOXL2 p.C134W	0	1
P-0010144	P-0010144-T01-IM5	In-House	FFPE	Cytology	250	910	10	Matched	Metastasis	Breast	Pleural Fluid	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R273C	0	1
P-0010145	P-0010145-T01-IM5	In-House	FFPE	Biopsy	250	1007	70	Matched	Metastasis	Skin	Lung	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma										RB1 p.X500_splice;ARID1A p.Q467*;FAT1 p.Q3450*;PBRM1 p.S32Ifs*5;TP53 p.K351Gfs*27;JAK1 p.A1006*;CCNE1 Amplification	0	7
P-0010146	P-0010146-T01-IM5	In-House	FFPE	Biopsy	250	1177	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R209Kfs*6;APC p.I1307Nfs*8;SMAD4 p.G419W	1	4
P-0010147	P-0010147-T01-IM5	In-House	FFPE	Resection	250	915	70	Matched	Metastasis	Colorectal NOS	Ovary	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13R)		Cetuximab,Panitumumab(NRAS p.G13R)			LEVEL_3B	TP53 p.R196*;NRAS p.G13R;APC p.R213*;AMER1 p.R641*;DNMT3B p.L454Sfs*136;APC p.I1418Nfs*5;FLT3 Amplification;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	1	10
P-0010148	P-0010148-T01-IM5	In-House	FFPE	Biopsy	250	1488	60	Matched	Metastasis	Liver	Abdomen	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.X26_splice;CCND1 Amplification;FGF19 Amplification;RECQL4 Deletion;TET2 Deletion	0	5
P-0010149	P-0010149-T01-IM5	In-House	FFPE	Resection	250	616	70	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										SMARCA4 p.R1192H;PBRM1 p.V215Cfs*9;SETD2 p.E423Dfs*61	0	3
P-0010158	P-0010158-T01-IM5	Outside	FFPE	Resection	250	469	70	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0010159	P-0010159-T01-IM5	In-House	FFPE	Resection	250	820	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										FBXW7 p.R505C;APC p.E1379*;TP53 p.L265del;TOP1 p.X11_splice;FBXW7 p.Q303*;ARID1B p.Q604*;AURKA Amplification;BCL2L1 Amplification;DNMT3B Amplification;SRC Amplification;RBM10 PHIP-RBM10 fusion;PHIP PHIP-RBM10 fusion	0	12
P-0010160	P-0010160-T01-IM5	In-House	FFPE	Resection	250	463	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;APC p.R1399Ffs*9;PPP2R1A p.X434_splice	0	3
P-0010161	P-0010161-T01-IM5	Outside	FFPE	Biopsy	250	1026	60	Matched	Metastasis	Tongue	Liver	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										CASP8 Deletion	0	1
P-0010162	P-0010162-T01-IM5	Outside	FFPE	Cytology	250	862	80	Matched	Metastasis	Pancreas	Lymph Node	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;SETD2 p.E1200*;KMT2D p.K3551*;CDKN2A Deletion	2	4
P-0010163	P-0010163-T01-IM5	Outside	FFPE	Cytology	228.9	641	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;SMAD4 Deletion	1	2
P-0010164	P-0010164-T01-IM5	Outside	FFPE	Resection	250	476	40	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma											0	0
P-0010165	P-0010165-T01-IM5	Outside	FFPE	Biopsy	250	1273	30	Matched	Metastasis	Cancer of Unknown Primary	Lacrimal Gland	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12*)				LEVEL_3B	TP53 p.C135F;CDKN2A p.S12*;ERBB2 Amplification;SMAD4 Deletion	2	4
P-0010166	P-0010166-T01-IM5	In-House	FFPE	Biopsy	250	1220	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y44*)				LEVEL_4	KRAS p.G12V;TP53 p.H193R;FLT3 p.V894I;AXIN2 p.E231Gfs*36;CDKN2A p.Y44*;KRAS Amplification	2	6
P-0010167	P-0010167-T01-IM5	In-House	FFPE	Resection	250	692	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Olaparib(BRIP1 p.N1147Mfs*3)					LEVEL_3B	FUBP1 p.I301Yfs*22;MSH6 p.F1088Lfs*5;PIK3CA p.H1047R;BRIP1 p.N1147Mfs*3;PTPRT p.P1075Rfs*6;CDH1 p.A634V;PPM1D p.L450*;ARID1A p.R2158*;B2M p.S14Ffs*29;NSD1 p.N1488Mfs*15;BCOR p.N529Tfs*60;FBXW7 p.S182Ffs*74	2	12
P-0010168	P-0010168-T01-IM5	In-House	FFPE	Biopsy	250	879	30	Matched	Metastasis	Cervix	Pleural Fluid	Tumor	CEEN	Cervical Cancer	Cervical Endometrioid Carcinoma											0	0
P-0010169	P-0010169-T01-IM5	In-House	FFPE	Resection	250	990	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H	1	1
P-0010170	P-0010170-T01-IM5	In-House	FFPE	Resection	250	852	70	Matched	Primary	Brain	Not Applicable	Tumor	ATM	CNS Cancer	Atypical Meningioma											0	0
P-0010171	P-0010171-T01-IM5	In-House	FFPE	Biopsy	250	1080	60	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.Y225Ifs*28)				LEVEL_4	TP53 p.X332_splice;NOTCH2 p.C937*;PTEN p.Y225Ifs*28;KDM5A Amplification;KANSL1L ARID1A-C2orf67 fusion;ARID1A ARID1A-C2orf67 fusion	1	6
P-0010172	P-0010172-T01-IM5	In-House	FFPE	Resection	250	1011	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.X187_splice;SMARCA4 p.E1542*;CCND1 Amplification;FGF19 Amplification;PIK3CA Amplification;CREBBP TSG1-CREBBP fusion;TSG1 TSG1-CREBBP fusion	0	7
P-0010173	P-0010173-T01-IM5	In-House	FFPE	Resection	250	815	20	Unmatched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	TP53 p.R248L;BRAF p.G466V;KRAS p.G12C;PTPRT p.L708F;TGFBR2 p.K128Nfs*4	2	5
P-0010174	P-0010174-T01-IM5	In-House	FFPE	Resection	250	950	40	Matched	Primary	Ethmoid Sinus	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.K120N;NOTCH1 p.S25Cfs*7	0	2
P-0010175	P-0010175-T02-IM5	Outside	FFPE	Resection	202.4	392	15	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor		Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.N659Y)							LEVEL_2	PDGFRA p.N659Y	1	1
P-0010176	P-0010176-T01-IM5	In-House	FFPE	Resection	250	1031	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Olaparib(ATM p.Q2433Rfs*7)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;ATM p.Q2433Rfs*7	2	2
P-0010177	P-0010177-T01-IM5	In-House	FFPE	Resection	250	1016	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	U2AF1 p.S34F;SMAD4 p.D493G;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	4
P-0010178	P-0010178-T01-IM5	In-House	FFPE	Biopsy	250	1063	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TBX3 p.X219_splice	0	1
P-0010179	P-0010179-T01-IM5	In-House	FFPE	Resection	250	660	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0010180	P-0010180-T01-IM5	In-House	FFPE	Biopsy	250	1232	NA	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Afatinib(EGFR p.L861Q)	GSK2636771,AZD8186(PTEN p.E242*)				LEVEL_3B	EGFR p.L861Q;PTEN p.E242*	2	2
P-0010181	P-0010181-T01-IM5	In-House	FFPE	Biopsy	250	1105	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				GSK2636771,AZD8186(PTEN p.R130*)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;PTEN p.R130*;TP53 p.P278S;CCND3 Amplification	3	5
P-0010182	P-0010182-T01-IM5	In-House	FFPE	Resection	250	855	40	Matched	Metastasis	Uterus	Lymph Node	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma											0	0
P-0010183	P-0010183-T01-IM5	In-House	FFPE	Biopsy	250	1107	60	Matched	Metastasis	Stomach	Pelvis	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.Q556_D572del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	ARID1A p.R110Efs*3;KIT p.Q556_D572del;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0010184	P-0010184-T01-IM5	In-House	FFPE	Resection	109	230	50	Matched	Metastasis	Kidney	Lung	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma										TFE3 FUBP1-TFE3 fusion;FUBP1 FUBP1-TFE3 fusion	0	2
P-0010185	P-0010185-T01-IM5	In-House	FFPE	Resection	250	800	50	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Ivosidenib(IDH1 p.R132H)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Trametinib,Cobimetinib(NF1 p.W223*);Trametinib,Cobimetinib(NF1 p.R1968*)				LEVEL_3B	KRAS p.G12D;PIK3CA p.H1047R;PTPN11 p.E69K;IDH1 p.R132H;NF1 p.W223*;PTPN11 p.P491L;NF1 p.R1968*;AMER1 p.R641*;DNMT3A p.R635W;MSH2 p.Q545*;MLH1 p.Q86*;SETD2 p.W1640*;PBRM1 p.X128_splice;MAP3K1 p.X211_splice	5	14
P-0010195	P-0010195-T01-IM5	In-House	FFPE	Cytology	90.2	236	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;TP53 p.S241P;RNF43 p.N297*;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0010196	P-0010196-T01-IM5	Outside	FFPE	Resection	250	770	30	Matched	Primary	Jejunum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer					Trametinib,Cobimetinib(NF1 p.F945Lfs*9);Trametinib,Cobimetinib(NF1 p.R2258*)				LEVEL_4	CTNNB1 p.S37F;KMT2D p.P2354Lfs*30;FBXW7 p.R465C;ERBB3 p.V104M;NF1 p.F945Lfs*9;HLA-A p.A16Pfs*4;FLCN p.H429Tfs*39;BLM p.K1217Nfs*62;MAP3K1 p.Y338*;NF1 p.R2258*;TNFRSF14 p.N116Rfs*117;CTCF p.T317Rfs*91;SPEN p.L1407Yfs*2	2	13
P-0010197	P-0010197-T01-IM5	In-House	FFPE	Biopsy	250	892	20	Matched	Metastasis	Stomach	Peritoneum	Tumor	SPDAC	Esophagogastric Cancer	Poorly Differentiated Carcinoma of the Stomach										TP53 p.R273H;KMT2D p.R2410*;CDH1 p.X441_splice;SPEN p.L1531Ffs*7;FGFR2 Amplification	0	5
P-0010198	P-0010198-T01-IM5	In-House	FFPE	Biopsy	250	863	20	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0010199	P-0010199-T01-IM5	Outside	FFPE	Resection	250	821	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma										TP53 p.R248Q;TP53 p.G266*;EZH2 p.X209_splice;CCND3 Amplification;RAF1 Amplification;VEGFA Amplification	0	6
P-0010200	P-0010200-T01-IM5	In-House	FFPE	Cytology	250	888	40	Unmatched	Metastasis	Lung	Pleural Fluid	Tumor	ECD	Histiocytosis	Erdheim-Chester Disease											0	0
P-0010201	P-0010201-T01-IM5	In-House	FFPE	Biopsy	250	930	50	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_3A	ERBB2 p.L755S;KMT2C p.R2066*;NCOR1 p.R350*;RUNX1 p.Y328Lfs*245;TBX3 p.E122Lfs*14;CDH1 p.R108Tfs*61	2	6
P-0010202	P-0010202-T01-IM5	Outside	FFPE	Biopsy	250	839	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106C);Sonidegib,Vismodegib(PTCH1 PPP3R2-PTCH1 fusion);Sonidegib,Vismodegib(PPP3R2 PPP3R2-PTCH1 fusion)					LEVEL_3B	TP53 p.S183*;RYBP p.E111*;PIK3CA p.G106C;EED p.W331*;PTCH1 PPP3R2-PTCH1 fusion;PPP3R2 PPP3R2-PTCH1 fusion	3	6
P-0010203	P-0010203-T01-IM5	Outside	FFPE	Biopsy	250	848	60	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.G245S;APC p.Y935*;APC p.E1397*;KRAS p.G13D;SOX9 p.Y297*;SMAD4 p.T62Nfs*8;TCF7L2 p.S586Pfs*41	1	7
P-0010205	P-0010205-T01-IM5	In-House	FFPE	Resection	250	761	70	Matched	Primary	Pubic Mass	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										SETD2 p.E1997*;TGFBR2 Deletion	0	2
P-0010206	P-0010206-T01-IM5	Outside	FFPE	Resection	250	619	80	Matched	Metastasis	Soft Tissue	Lung	Tumor	OS	Bone Cancer	Osteosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	ATRX Deletion;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0010207	P-0010207-T01-IM5	Outside	FFPE	Resection	250	911	20	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.R216*;AMER1 p.Q335*	0	3
P-0010208	P-0010208-T01-IM5	In-House	FFPE	Resection	250	806	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R248W;ARID1A p.S103*;UBAC1 NOTCH1-UBAC1 fusion;NOTCH1 NOTCH1-UBAC1 fusion	1	5
P-0010209	P-0010209-T01-IM5	Outside	FFPE	Biopsy	250	630	20	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R273H;NOTCH3 p.Q2139*;AKT2 Amplification;AXL Amplification	0	4
P-0010210	P-0010210-T01-IM5	In-House	FFPE	Biopsy	250	1085	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.X1010_splice;ARID1A p.A1789Tfs*13;CDK4 Amplification;KRAS Amplification;MDM2 Amplification	5	5
P-0010210	P-0010210-T02-IM5	In-House	FFPE	Resection	250	630	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.X1010_splice;ARID1A p.A1789Tfs*13;CDK4 Amplification;MDM2 Amplification	5	4
P-0010211	P-0010211-T01-IM5	Outside	FFPE	Biopsy	100.9	196	60	Unmatched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.H1047R;FGFR1 Amplification	3	2
P-0010212	P-0010212-T01-IM5	Outside	FFPE	Resection	250	900	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.L89H;TET2 p.K1338T	0	2
P-0010213	P-0010213-T01-IM5	Outside	FFPE	Resection	250	631	80	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.P75Lfs*48;ZFHX3 p.Q149*;DNMT3B p.X219_splice;BCOR p.L7Pfs*29;CDKN2A Deletion;CDKN2B Deletion;KDR Amplification;KIT Amplification	2	9
P-0010214	P-0010214-T01-IM5	In-House	FFPE	Biopsy	250	885	70	Matched	Metastasis	Ovary	Peritoneum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R342*;TOP1 HADHB-TOP1 fusion;HADHB HADHB-TOP1 fusion	0	3
P-0010215	P-0010215-T01-IM5	In-House	FFPE	Resection	122.4	856	20	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)	Neratinib(ERBB2 p.G778_P780dup)						LEVEL_2	ERBB2 p.G778_P780dup;TP53 p.V143M;ERCC4 p.K753*	2	3
P-0010216	P-0010216-T01-IM5	Outside	FFPE	Resection	113	150	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.D335Gfs*17	0	1
P-0010217	P-0010217-T01-IM5	In-House	FFPE	Resection	250	874	20	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);AZD9496,Fulvestrant(ESR1 p.Y537S)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R);GSK2636771,AZD8186(PTEN p.P248Tfs*5)				LEVEL_3B	PIK3CA p.H1047R;FGFR2 p.C382R;ESR1 p.Y537S;CTNNB1 p.S33C;PTEN p.P248Tfs*5	4	5
P-0010218	P-0010218-T01-IM5	Outside	FFPE	Resection	250	602	80	Matched	Primary	Brain	Not Applicable	Tumor	EPM	CNS Cancer	Ependymoma											0	0
P-0010219	P-0010219-T01-IM5	In-House	FFPE	Biopsy	250	1130	40	Matched	Metastasis	Sigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.L1194*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);GSK2636771,AZD8186(PTEN p.L320Ffs*5)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;APC p.I1311Lfs*10;PTEN p.L320Ffs*5;ARID2 p.L269Ifs*10;ATM p.L1194*	3	5
P-0010220	P-0010220-T01-IM5	Outside	FFPE	Biopsy	200.4	713	40	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_1	TP53 p.S241F;NOTCH1 p.C456R;CDKN2A p.H83Y;ERBB2 Amplification;KRAS Amplification	3	5
P-0010221	P-0010221-T01-IM5	Outside	FFPE	Resection	250	545	60	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P449_L452del);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.E198*;PIK3CA p.P449_L452del;MDM2 Amplification;MYC Amplification	2	4
P-0010222	P-0010222-T01-IM5	In-House	FFPE	Biopsy	250	1090	20	Matched	Metastasis	Oral Cavity	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion)				LEVEL_4	TP53 p.P278S;RB1 p.X472_splice;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion	2	4
P-0010222	P-0010222-T02-IM5	Outside	FFPE	Biopsy	250	342	60	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.R282W;TP53 p.X261_splice	0	2
P-0010223	P-0010223-T01-IM5	Outside	FFPE	Cytology	90	157	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.R342*;CDKN2A Deletion;CDKN2B Deletion;FGFR4 Amplification;RICTOR Amplification;TERT Amplification;VEGFA Amplification	2	8
P-0010224	P-0010224-T01-IM5	Outside	FFPE	Resection	250	975	70	Matched	Primary	Thigh	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										EPHA3 p.Y505*;TP53 p.V143_P153del;RB1 p.R828Kfs*10	0	3
P-0010225	P-0010225-T01-IM5	Outside	FFPE	Resection	250	780	40	Matched	Primary	Ovary	Not Applicable	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer										ARID1A p.S11Afs*90;LATS1 p.S342*	0	2
P-0010226	P-0010226-T01-IM5	In-House	FFPE	Biopsy	250	1098	60	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.P75Lfs*48;ARID5B Deletion;DIS3 Deletion;FBXW7 Deletion;INPP4B Deletion;NBN Deletion;PTEN Deletion;PTPRD Deletion;RB1 Deletion;TET2 Deletion;TGFBR2 Deletion;VEGFA Amplification	1	12
P-0010227	P-0010227-T01-IM5	In-House	FFPE	Resection	250	825	10	Matched	Primary	Lung	Not Applicable	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid										ARID1A p.C884*	0	1
P-0010228	P-0010228-T01-IM5	In-House	FFPE	Resection	250	1019	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0010229	P-0010229-T01-IM5	In-House	FFPE	Resection	250	878	40	Matched	Primary	Pancreas	Not Applicable	Tumor	IPMN	Pancreatic Cancer	Intraductal Papillary Mucinous Neoplasm				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;GNAS p.R201C;RNF43 p.X318_splice	2	3
P-0010231	P-0010231-T01-IM5	Outside	FFPE	Resection	250	1055	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.E293*;AURKA Amplification;CCND3 Amplification;VEGFA Amplification	0	4
P-0010232	P-0010232-T01-IM5	In-House	FFPE	Biopsy	250	1044	80	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	NRAS p.Q61K;TP53 p.R249T;PBRM1 p.E104*;DDR2 Amplification	1	4
P-0010234	P-0010234-T01-IM5	In-House	FFPE	Biopsy	250	604	NA	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS			AZD9496,Fulvestrant(ESR1 p.D538G)	Olaparib(RAD51B p.Q371*)					LEVEL_3A	ESR1 p.D538G;KMT2C p.R4549C;GATA3 p.S407Afs*99;RAD51B p.Q371*	2	4
P-0010235	P-0010235-T01-IM5	Outside	FFPE	Resection	216.7	194	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84G)				LEVEL_1	PIK3CA p.H1047R;PMS2 p.E77*;TP53 p.V218Gfs*30;CDKN2A p.D84G;AKT2 Amplification	3	5
P-0010236	P-0010236-T01-IM5	In-House	FFPE	Biopsy	250	1310	70	Matched	Metastasis	Bladder	Pelvis	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.W110*)				LEVEL_4	MED12 p.G44S;CREBBP p.R1446H;FAT1 p.D3086Ifs*30;STAG2 p.Q275*;KMT2D p.Q2087*;EP300 p.R580*;KMT2D p.P2059Cfs*33;CDKN2A p.W110*	1	8
P-0010237	P-0010237-T01-IM5	Outside	FFPE	Resection	250	873	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	APC p.Q1204*;SPOP p.F133L;CARD11 Amplification;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;RAC1 Amplification	1	7
P-0010238	P-0010238-T01-IM5	In-House	FFPE	Resection	250	896	50	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.S215I;CCND3 Amplification;PMAIP1 Deletion;TET2 Deletion;APC APC-intragenic	0	5
P-0010239	P-0010239-T01-IM5	In-House	FFPE	Resection	250	481	70	Matched	Primary	Brain	Not Applicable	Tumor	ATM	CNS Cancer	Atypical Meningioma										ARID2 p.F34Lfs*24;NF2 p.E445Gfs*9;DNMT3A Deletion	0	3
P-0010240	P-0010240-T01-IM5	In-House	FFPE	Resection	250	655	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)					LEVEL_3B	PIK3CA p.Q546P;KDM6A Q475fs;TP53 p.Q317Sfs*28	1	3
P-0010241	P-0010241-T01-IM5	In-House	FFPE	Biopsy	250	1109	40	Matched	Metastasis	Nasopharynx	Skull	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Olaparib(PALB2 p.M296*)					LEVEL_3B	PTCH1 p.S1203Afs*52;PIK3CA p.E545K;PPM1D p.L450*;KMT2D p.A2119Lfs*25;PALB2 p.M296*;TGFBR1 p.R157*;BLM p.K1217Nfs*62;MGA p.E1249Rfs*42;ETV6 p.P214L;MEN1 p.R521Gfs*43;RASA1 p.L902Ffs*9;NOTCH4 p.X1380_splice;KMT2D p.X4882_splice;CIC p.X1003_splice;KDM6A p.G526E;PTPRT p.S1349Lfs*20;EPHA3 p.R580Kfs*19	3	17
P-0010242	P-0010242-T01-IM5	In-House	FFPE	Biopsy	139.9	178	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.V130Gfs*2	0	1
P-0010243	P-0010243-T01-IM5	Outside	FFPE	Resection	192.6	566	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)	Cetuximab,Panitumumab(KRAS p.G12A)			LEVEL_4	KRAS p.G12A;TP53 p.V216M;APC p.S1421Vfs*52;EP300 p.X541_splice;TERT Amplification;TP53 TP53-intragenic	1	6
P-0010244	P-0010244-T01-IM5	Outside	FFPE	Biopsy	250	1119	20	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;MYD88 p.S243N	2	2
P-0010245	P-0010245-T01-IM5	In-House	FFPE	Cytology	90	418	20	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;FGFR4 p.N535K;CDH1 p.L742Tfs*6	2	3
P-0010246	P-0010246-T01-IM5	In-House	FFPE	Resection	250	805	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	TP53 p.R273H;KRAS p.G12V;SMAD4 p.S178*	1	3
P-0010247	P-0010247-T01-IM5	In-House	FFPE	Biopsy	250	1001	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;FANCA CDCA8-FANCA fusion;CDCA8 CDCA8-FANCA fusion	2	4
P-0010249	P-0010249-T01-IM5	In-House	FFPE	Resection	250	954	80	Matched	Metastasis	Skin	Muscle	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.G13C)	Ivosidenib(IDH1 p.R132C);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.Q1408*)	Trametinib,Cobimetinib(NF1 p.R416*);Trametinib,Cobimetinib(NF1 p.W2075*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.X51_splice)				LEVEL_3A	IDH1 p.R132C;CTNNB1 p.D32V;NF1 p.R416*;NRAS p.G13C;NF1 p.W2075*;BRCA1 p.Q1408*;CDKN2A p.X51_splice	6	7
P-0010250	P-0010250-T01-IM5	In-House	FFPE	Resection	250	892	50	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.R282W;HLA-A p.G342Cfs*4;ERBB2 Amplification;ERBB3 Amplification;PPM1D Amplification	1	5
P-0010251	P-0010251-T01-IM5	Outside	FFPE	Resection	250	964	60	Matched	Primary	Liver	Not Applicable	Tumor	HCCIHCH	Hepatobiliary Cancer	Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma										BAP1 p.A258Gfs*26	0	1
P-0010252	P-0010252-T01-IM5	In-House	FFPE	Resection	250	839	80	Matched	Metastasis	Breast	Brain	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS										TP53 p.R248Q;EPHA3 p.X566_splice;CELF2 APC-CELF2 fusion;APC APC-CELF2 fusion	0	4
P-0010253	P-0010253-T01-IM5	In-House	FFPE	Resection	250	802	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0010255	P-0010255-T01-IM5	In-House	FFPE	Biopsy	250	869	40	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.I195T;KDM6A p.E206*	1	3
P-0010256	P-0010256-T01-IM5	In-House	FFPE	Resection	250	556	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.D194V;MYC Amplification	2	3
P-0010257	P-0010257-T01-IM5	In-House	FFPE	Cytology	250	961	30	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.V272L;SETD2 p.E1692*;SETD2 p.X1485_splice	2	4
P-0010258	P-0010258-T01-IM5	In-House	Cell Pellet	Cytology	250	1389	10	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A	1	1
P-0010259	P-0010259-T01-IM5	In-House	FFPE	Resection	250	911	60	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Enasidenib(IDH2 p.R172G)					LEVEL_3B	TP53 p.R273C;IDH2 p.R172G;ATRX p.R1504*	1	3
P-0010260	P-0010260-T01-IM5	Outside	FFPE	Resection	250	549	30	Matched	Metastasis	Cancer of Unknown Primary	Abdominal wall	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										CTNNB1 p.S45F;SF3B1 p.K666T;TGFBR2 p.G253Vfs*11;NRG1 CD74-NRG1 fusion;CD74 CD74-NRG1 fusion	0	5
P-0010261	P-0010261-T01-IM5	In-House	FFPE	Biopsy	250	751	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.V216L;KRAS Amplification	1	3
P-0010261	P-0010261-T02-IM5	In-House	FFPE	Cytology	242.2	684	50	Matched	Metastasis	Lung	Duodenum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.V216L;CARD11 Amplification;CDKN2A Deletion;CDKN2B Deletion;KDM5A Amplification;KRAS Amplification;RAC1 Amplification	2	8
P-0010262	P-0010262-T01-IM5	Outside	FFPE	Cytology	250	1036	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61_S65dup)				LEVEL_4	TP53 p.R209Kfs*6;KRAS p.Q61_S65dup	1	2
P-0010264	P-0010264-T01-IM5	Outside	FFPE	Biopsy	95	539	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	KMT2D p.P648Tfs*2;GNAS p.R201H;SOX9 p.S414*;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	5
P-0010265	P-0010265-T01-IM5	Outside	FFPE	Resection	250	599	40	Matched	Primary	Ileum	Not Applicable	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0010266	P-0010266-T01-IM5	Outside	FFPE	Resection	250	652	30	Matched	Primary	Liver	Not Applicable	Tumor	FLC	Hepatobiliary Cancer	Fibrolamellar Carcinoma										PRKACA DNAJB1-PRKACA fusion;DNAJB1 DNAJB1-PRKACA fusion	0	2
P-0010267	P-0010267-T01-IM5	Outside	FFPE	Cytology	250	915	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.L858R;TP53 p.V216M;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification	3	5
P-0010268	P-0010268-T01-IM5	In-House	FFPE	Biopsy	250	1165	50	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;APC p.E1397*;TP53 p.P151S;APC p.X653_splice;FAT1 p.R3098Kfs*24;NSD1 p.S920Kfs*2;GATA3 Deletion;NKX3-1 Deletion	1	8
P-0010269	P-0010269-T01-IM5	Outside	FFPE	Biopsy	250	797	10	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0010270	P-0010270-T01-IM5	Outside	FFPE	Resection	250	820	50	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma				Everolimus(TSC2 p.P1309Lfs*16)					LEVEL_3B	TP53 p.X225_splice;TSC2 p.P1309Lfs*16	1	2
P-0010271	P-0010271-T01-IM5	Outside	FFPE	Resection	250	898	80	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Olaparib(ATM Deletion);Olaparib(CHEK1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-intragenic)				LEVEL_3B	TP53 p.R280G;KMT2D p.Q4200*;KMT2D p.Q3892Hfs*118;ATM Deletion;BIRC3 Deletion;CBL Deletion;CHEK1 Deletion;FOXA1 Deletion;KMT2A Deletion;MRE11 Deletion;NFKBIA Deletion;RAF1 Amplification;SDHD Deletion;CDKN2A CDKN2A-intragenic	3	14
P-0010272	P-0010272-T01-IM5	In-House	FFPE	Biopsy	250	889	60	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.D259del;AR Amplification	0	2
P-0010273	P-0010273-T01-IM5	In-House	FFPE	Resection	250	810	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.X1010_splice;MDM2 Amplification	4	2
P-0010275	P-0010275-T01-IM5	In-House	FFPE	Resection	250	751	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					GSK2636771,AZD8186(PTEN p.R233*);GSK2636771,AZD8186(PTEN p.Y68H);Tazemetostat(SMARCB1 p.R377C)				LEVEL_4	FBXW7 p.R465H;NOTCH3 p.P695Rfs*165;ARID1A p.A339Lfs*24;APC p.R499*;HNF1A p.P291Qfs*51;PTEN p.R233*;PTEN p.Y68H;SMARCB1 p.R377C;NSD1 p.M1531Cfs*43;TCF7L2 p.K485Sfs*23;TP53 p.T125M;MRE11 p.N511Ifs*13;APC p.V452Sfs*7;NOTCH3 p.P2231Qfs*15;FANCC p.I89Ffs*2;ARID1A p.Q2207*;FOXP1 p.X574_splice;SUFU p.P16Rfs*80;SOX9 p.V306Cfs*77;SOX17 p.P263Rfs*124;MLH1 p.K196Nfs*6;KMT2C p.S143Vfs*3;SPEN p.I1052Nfs*7	3	23
P-0010276	P-0010276-T01-IM5	In-House	FFPE	Biopsy	250	896	80	Matched	Metastasis	Thyroid	Lung	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61R;CDKN2A Deletion	3	2
P-0010277	P-0010277-T01-IM5	In-House	FFPE	Biopsy	250	1018	20	Matched	Metastasis	Breast	Lung	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										GATA3 p.C320Wfs*18	0	1
P-0010278	P-0010278-T01-IM5	In-House	FFPE	Biopsy	250	985	40	Matched	Metastasis	Parotid	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V777L)					LEVEL_3B	ERBB2 p.V777L;CDH1 p.F601Ifs*4;TP53 p.S96Yfs*53;ARID1A p.E1864Afs*36;NCOR1 p.T525Rfs*10	1	5
P-0010279	P-0010279-T01-IM5	In-House	FFPE	Cytology	197.9	609	20	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	SF3B1 p.K700E;FGFR1 Amplification	1	2
P-0010281	P-0010281-T01-IM5	In-House	FFPE	Biopsy	230.3	929	60	Matched	Metastasis	Adrenal Gland	Lung	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	1	3
P-0010283	P-0010283-T01-IM5	Outside	FFPE	Resection	250	825	30	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	FBXW7 p.R505C;TP53 p.R248Q;KRAS p.G13D;AMER1 p.Q733*;CCNE1 Amplification	1	5
P-0010296	P-0010296-T01-IM5	In-House	FFPE	Biopsy	250	1088	20	Matched	Metastasis	Breast	Bone	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047Y)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y)						LEVEL_1	PIK3CA p.H1047Y;FOXA1 p.S242_Y243delinsCS	2	2
P-0010297	P-0010297-T01-IM5	Outside	FFPE	Resection	250	68	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0010298	P-0010298-T02-IM5	Outside	FFPE	Resection	250	619	60	Matched	Primary	Duodenum	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor											0	0
P-0010299	P-0010299-T01-IM5	In-House	FFPE	Biopsy	250	1047	20	Matched	Primary	Cancer of Unknown Primary	Not available	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;PTPRS p.G1871Wfs*24	1	2
P-0010300	P-0010300-T01-IM5	In-House	FFPE	Resection	250	882	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.L755P)	Neratinib(ERBB2 p.L755P)	Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	TP53 p.C275W;TP53 p.W53*;ERBB2 p.L755P;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification	4	6
P-0010301	P-0010301-T01-IM5	In-House	FFPE	Biopsy	250	1055	70	Matched	Primary	Knee	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										TP53 Deletion	0	1
P-0010302	P-0010302-T01-IM5	In-House	FFPE	Resection	250	1070	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A TEK-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(TEK TEK-CDKN2A fusion)				LEVEL_4	ARID5B Deletion;FGFR3 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification;CDKN2A TEK-CDKN2A fusion;TEK TEK-CDKN2A fusion	2	7
P-0010303	P-0010303-T01-IM5	Outside	FFPE	Biopsy	250	980	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;SMAD4 p.W302*;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0010304	P-0010304-T01-IM5	Outside	FFPE	Resection	250	681	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma										TP53 p.L194R	0	1
P-0010305	P-0010305-T01-IM5	Outside	FFPE	Resection	250	649	20	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										FBXW7 p.E177Rfs*62	0	1
P-0010306	P-0010306-T01-IM5	Outside	FFPE	Biopsy	131.6	487	60	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R342Efs*3	0	1
P-0010307	P-0010307-T01-IM5	In-House	FFPE	Resection	250	584	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;DIS3 p.L767F;GRIN2A p.G873*;NCOR1 p.C994Lfs*24;STK11 p.G242V	2	5
P-0010308	P-0010308-T01-IM5	In-House	FFPE	Resection	250	861	50	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	GSK2636771,AZD8186(PTEN p.K267Rfs*9)				LEVEL_1	BRAF p.V600E;PTCH1 p.S1203Afs*52;PIK3CA p.E545K;PTEN p.K267Rfs*9;TP53 p.I255T;B2M p.L15Ffs*41;CASP8 p.I357Yfs*8;ARID1A p.R1721*;NFKBIA p.L148Yfs*16;ARID1A p.N2059Tfs*76;KDM6A p.A694Lfs*21;MAP2K4 p.V321M;FAT1 p.E2820Kfs*7;BCOR p.P602Rfs*67;SOX9 p.K167del	6	15
P-0010309	P-0010309-T01-IM5	In-House	FFPE	Biopsy	250	1175	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				AZD5363(AKT1 p.E17K)	Everolimus,Temsirolimus(MTOR p.A1971P)				LEVEL_3B	AKT1 p.E17K;CTNNB1 p.T41I;TP53 p.N239S;MTOR p.A1971P;AR Amplification;CIC Deletion	2	6
P-0010310	P-0010310-T01-IM5	Outside	FFPE	Resection	250	857	50	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.T733I)	GSK2636771,AZD8186(PTEN p.C136Mfs*44)				LEVEL_3B	CCND1 p.T286I;SPOP p.E50K;PTEN p.C136Mfs*44;CTNNB1 p.S37P;ERBB2 p.T733I;ARID1A p.E2034*;ARID1B p.P857Gfs*43;PIK3R1 p.E558_R562del	2	8
P-0010311	P-0010311-T01-IM5	In-House	FFPE	Resection	250	937	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.H115N;KDM5C p.X76_splice;SETD2 p.X1672_splice	0	3
P-0010312	P-0010312-T01-IM5	In-House	FFPE	Biopsy	250	970	20	Matched	Metastasis	Tongue	Lung	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K	1	1
P-0010313	P-0010313-T01-IM5	Outside	FFPE	Biopsy	250	705	40	Matched	Primary	GE Junction	Not Applicable	Tumor	GEJ	Esophagogastric Cancer	Adenocarcinoma of the Gastroesophageal Junction										TP53 p.R273C;ARID1A p.D1850Gfs*4;FGFR2 Amplification;RICTOR Amplification	0	4
P-0010314	P-0010314-T01-IM5	In-House	FFPE	Resection	250	859	50	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	AKT2 Amplification;AXL Amplification;CDK4 Amplification;JUN Amplification;MDM2 Amplification;TERT Amplification	2	6
P-0010316	P-0010316-T01-IM5	In-House	FFPE	Resection	250	863	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma											0	0
P-0010317	P-0010317-T01-IM5	Outside	FFPE	Biopsy	250	1005	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.H193R;SMAD4 p.Y353D;PMAIP1 Deletion;PTPRD Deletion;RB1 Deletion;SMAD2 Deletion;SMAD4 Deletion	0	7
P-0010318	P-0010318-T01-IM5	Outside	FFPE	Biopsy	250	310	60	Matched	Primary	Duodenum	Not Applicable	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma										CTNNB1 p.S45F;RBM10 p.Q225*;TP53 p.D21Tfs*23	0	3
P-0010319	P-0010319-T01-IM5	In-House	FFPE	Resection	250	804	30	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										TP53 p.V173M;RB1 Deletion	0	2
P-0010320	P-0010320-T01-IM5	In-House	FFPE	Biopsy	250	993	40	Matched	Primary	Testis	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										TGFBR2 p.E526K;STK11 STK11-intragenic	0	2
P-0010321	P-0010321-T01-IM5	Outside	FFPE	Biopsy	250	1037	40	Matched	Metastasis	Breast	Liver	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.G778_P780dup)	Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)					LEVEL_3A	ERBB2 p.G778_P780dup;CDH1 p.N431Kfs*15	2	2
P-0010326	P-0010326-T01-IM5	Outside	FFPE	Biopsy	250	772	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										ERBB3 p.E928G;TP53 p.H193Y	0	2
P-0010327	P-0010327-T01-IM5	Outside	FFPE	Biopsy	250	906	20	Matched	Primary	Esophagus	Not Applicable	Tumor	ESMM	Melanoma	Mucosal Melanoma of the Esophagus										CIC Deletion	0	1
P-0010328	P-0010328-T01-IM5	In-House	FFPE	Resection	250	844	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ARID5B p.L478*	1	2
P-0010329	P-0010329-T01-IM5	Outside	FFPE	Biopsy	75.2	619	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.S241Y	2	2
P-0010330	P-0010330-T01-IM5	Outside	FFPE	Biopsy	214.7	818	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;SMAD4 p.R361H;APC p.R216*;APC p.E1309*;EZH2 p.X298_splice;SMAD3 p.E383*;MED12 p.K42_N46del	1	7
P-0010331	P-0010331-T01-IM5	In-House	FFPE	Biopsy	250	898	70	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										ARID1A p.K1072Nfs*21;AXIN2 p.N666Qfs*41;SOX9 p.K167del;JAK1 p.E883*;ZFHX3 p.R2322*;TP53 p.H115Y;SMARCA4 p.E717*	0	7
P-0010332	P-0010332-T01-IM5	In-House	FFPE	Resection	250	812	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R110P;BAP1 p.F81L;ATRX p.X7_splice;STK11 p.X155_splice;KEAP1 p.G186F;MED12 p.A534Efs*3	0	6
P-0010333	P-0010333-T01-IM5	Outside	FFPE	Cytology	250	800	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.N771_H773dup)	Milademetan Tosylate,RO5045337(MDM2 Amplification)		Erlotinib,Gefitinib,Afatinib(EGFR p.N771_H773dup)			LEVEL_3A	EGFR p.N771_H773dup;CDKN1B Deletion;EGFR Amplification;FLT3 Amplification;MCL1 Amplification;MDM2 Amplification;PTPN11 Deletion;PTPRD Deletion;RB1 Deletion;RICTOR Amplification;SH2B3 Deletion;TERT Amplification	2	12
P-0010334	P-0010334-T01-IM5	In-House	FFPE	Biopsy	250	893	60	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S12*)				LEVEL_3B	TP53 p.E339*;CDKN2A p.S12*;AMER1 Deletion;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification	2	6
P-0010335	P-0010335-T01-IM5	Outside	FFPE	Biopsy	95.4	490	70	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	NETNOS	Cancer of Unknown Primary	Neuroendocrine Tumor, NOS										AURKA Amplification;CDH1 Deletion;GATA3 Deletion	0	3
P-0010336	P-0010336-T01-IM5	In-House	FFPE	Biopsy	250	943	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(MYO18A NF1-MYO18A fusion);Trametinib,Cobimetinib(NF1 NF1-MYO18A fusion)				LEVEL_3B	ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;ERRFI1 Deletion;GATA3 Deletion;MET Amplification;TNFAIP3 Deletion;MYO18A NF1-MYO18A fusion;NF1 NF1-MYO18A fusion	4	9
P-0010337	P-0010337-T01-IM5	In-House	FFPE	Biopsy	250	897	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)	Crizotinib(MET Amplification)		Palbociclib,Abemaciclib(CDK4 Amplification);Cabozantinib(MET Amplification)	Trametinib,Cobimetinib(NF1 p.X297_splice)		Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	EGFR p.L858R;TP53 p.R248L;ARID1A p.L1688*;NF1 p.X297_splice;RBM10 p.E292*;CDK4 Amplification;MET Amplification;MYC Amplification;TERT Amplification	5	9
P-0010338	P-0010338-T01-IM5	In-House	FFPE	Biopsy	250	919	30	Matched	Metastasis	Lung	Rib	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										FOXA1 Amplification;NKX2-1 Amplification;RICTOR Amplification;TERT Amplification;ATRX C14orf176-ATRX fusion;TMEM253 C14orf176-ATRX fusion	0	6
P-0010339	P-0010339-T01-IM5	In-House	FFPE	Resection	250	859	30	Matched	Primary	Chest Wall	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 p.X13_splice	0	1
P-0010340	P-0010340-T01-IM5	In-House	FFPE	Resection	250	795	60	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Trametinib,Cobimetinib(NF1 p.X1445_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.Q100*;PTPRT p.R364Q;EZH2 p.R207*;ARID2 p.Q1100*;NF1 p.X1445_splice;ZRSR2 p.R68Afs*5;CDKN2A Deletion;CDKN2B Deletion;MITF Amplification	2	9
P-0010341	P-0010341-T01-IM5	In-House	FFPE	Resection	250	870	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);Olaparib(ATM p.R1875*)					LEVEL_3B	PIK3CA p.G118D;TP53 p.R273H;ATM p.R1875*;AKT2 Amplification;CCNE1 Amplification	2	5
P-0010342	P-0010342-T01-IM5	In-House	FFPE	Biopsy	134.2	753	30	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	NRAS p.Q61K;ASXL1 p.G646Wfs*12;APC p.S932*;APC p.H791Qfs*7;APC p.L235Yfs*58	1	5
P-0010343	P-0010343-T01-IM5	Outside	FFPE	Biopsy	250	886	40	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.H214R;SETD2 p.Q1619Rfs*7;SMAD4 p.K507*	0	3
P-0010344	P-0010344-T01-IM5	In-House	FFPE	Biopsy	161.28	781	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PTEN Deletion;SH2B3 Deletion	3	5
P-0010345	P-0010345-T02-IM5	In-House	FFPE	Resection	250	848	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR p.L833_V834delinsFL	1	2
P-0010345	P-0010345-T01-IM5	In-House	FFPE	Resection	250	641	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719C);Afatinib(EGFR p.S768I)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546P)					LEVEL_1	PIK3CA p.Q546P;EGFR p.G719C;EGFR p.S768I;SETD2 p.K1795*	3	4
P-0010346	P-0010346-T01-IM5	In-House	FFPE	Biopsy	122	435	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										TP53 p.I255T;RB1 p.X500_splice;NTRK1 Amplification	0	3
P-0010347	P-0010347-T01-IM5	In-House	FFPE	Biopsy	250	829	80	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma										TET2 p.C1378F;TET2 p.Q909Lfs*14	0	2
P-0010348	P-0010348-T01-IM5	Outside	FFPE	Resection	250	625	70	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Cisplatin(ERCC2 p.H659Q)					LEVEL_3B	TP53 p.R175H;ERCC2 p.H659Q;MIR1281 EP300-MIR1281 fusion;EP300 EP300-MIR1281 fusion;AMER1 ASB12-FAM123B fusion;ASB12 ASB12-FAM123B fusion	1	6
P-0010349	P-0010349-T01-IM5	Outside	FFPE	Biopsy	250	607	20	Matched	Primary	Breast	Not Applicable	Tumor	DCIS	Breast Cancer	Breast Ductal Carcinoma In Situ	Fulvestrant+Alpelisib(PIK3CA p.H1047L);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 p.Q2636*)				LEVEL_1	TP53 p.R196*;PIK3CA p.H1047L;NF1 p.Q2636*;ERBB2 Amplification;FGFR1 Amplification	6	5
P-0010350	P-0010350-T01-IM5	Outside	FFPE	Resection	250	741	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;CTNNB1 p.S45F;TP53 p.R282W;TP53 p.H179Y;EIF1AX p.N4I	1	5
P-0010351	P-0010351-T01-IM5	In-House	FFPE	Biopsy	250	773	60	Matched	Metastasis	Lung	Mediastinum	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.G266V;RB1 p.X703_splice;IKZF1 Deletion;KDR Amplification;KIT Amplification;PDGFRA Amplification	0	6
P-0010352	P-0010352-T01-IM5	In-House	FFPE	Biopsy	250	957	40	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.G245S;APC p.R213*;APC p.E1309Dfs*4;SMAD4 p.D537_E538dup;FLT3 Amplification	1	6
P-0010353	P-0010353-T01-IM5	Outside	FFPE	Biopsy	250	646	50	Matched	Primary	Thigh	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										TERT Amplification;TGFBR2 Deletion	0	2
P-0010354	P-0010354-T01-IM5	In-House	FFPE	Resection	250	814	60	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ATRX p.R1426*;TP53 p.G244D;ARID2 p.P970Lfs*12;EPHA7 Deletion	1	5
P-0010355	P-0010355-T01-IM5	In-House	FFPE	Biopsy	250	825	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.N239D;NFE2L2 p.W24R	2	3
P-0010356	P-0010356-T01-IM5	Outside	FFPE	Biopsy	250	1030	30	Matched	Primary	Bone	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma											0	0
P-0010357	P-0010357-T01-IM5	In-House	FFPE	Cytology	210.7	763	70	Matched	Metastasis	Ovary	Pleural Fluid	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.Q317*;LATS2 p.Y742*	1	3
P-0010358	P-0010358-T01-IM5	In-House	FFPE	Resection	250	835	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Trametinib,Cobimetinib(NF1 p.R440*);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	RB1 p.N258Efs*11;TP53 p.H179Y;NF1 p.R440*;ARID5B Deletion;FOXA1 Deletion;PTEN Deletion	2	6
P-0010359	P-0010359-T01-IM5	In-House	FFPE	Resection	250	716	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	PIK3CA p.H1047R;EGFR p.E746_A750del	2	2
P-0010360	P-0010360-T01-IM5	Outside	FFPE	Biopsy	250	993	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R3008C)					LEVEL_3B	ATM p.R3008C;APC p.G1428Dfs*45;APC p.Q260_N261delins*	1	3
P-0010361	P-0010361-T01-IM5	Outside	FFPE	Resection	250	755	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.H1047R;TP53 p.R175H;KMT2C p.S2953Rfs*23;MAP2K4 p.G249Afs*27;CDK8 Amplification;DDR2 Amplification;FGFR1 Amplification;MDM2 Amplification	4	8
P-0010362	P-0010362-T01-IM5	In-House	FFPE	Biopsy	250	784	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.G242W	1	2
P-0010363	P-0010363-T01-IM5	In-House	FFPE	Resection	250	711	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;PIK3CA p.E542K;APC p.R805*;APC p.E1464Vfs*8;EPHA7 p.X442_splice;SOX9 p.I275Mfs*4	2	6
P-0010364	P-0010364-T01-IM5	In-House	FFPE	Biopsy	250	919	60	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.H168R;APC p.S1032*	0	2
P-0010365	P-0010365-T01-IM5	In-House	FFPE	Biopsy	250	1102	50	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;TP53 p.V73Rfs*76;APC p.R1114*	1	3
P-0010367	P-0010367-T01-IM5	In-House	FFPE	Resection	250	708	30	Matched	Metastasis	Colorectal NOS	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.Y234C;APC p.E1379*;APC p.Q1096*;NCOR1 p.R507*;SMAD4 Deletion	0	5
P-0010368	P-0010368-T01-IM5	In-House	FFPE	Cytology	250	866	80	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.Y220H;RB1 p.L779*;ATRX p.Q42*;KMT2D p.V1244Sfs*86;ARID5B Deletion;GATA3 Deletion;MYCL Amplification;RICTOR Amplification;TERT Amplification;TNFRSF14 Deletion	0	10
P-0010369	P-0010369-T01-IM5	Outside	FFPE	Resection	250	507	50	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.Y205C;IDH1 p.R132H;ATRX p.E1365Rfs*13	1	3
P-0010372	P-0010372-T01-IM5	In-House	FFPE	Biopsy	250	1177	30	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;TP53 p.H179R;EPHA3 p.X630_splice;CCNE1 Amplification	2	5
P-0010373	P-0010373-T01-IM5	In-House	FFPE	Biopsy	250	1140	10	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	TP53 p.R196*;KRAS p.G12D;CDKN2A p.R58*;MYC Amplification	2	4
P-0010374	P-0010374-T01-IM5	In-House	FFPE	Resection	250	1047	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.R233*);Trametinib,Cobimetinib(NF1 p.Q985*)				LEVEL_4	PTEN p.R233*;RB1 p.L523*;NF1 p.Q985*;STAG2 p.R451Kfs*10	2	4
P-0010375	P-0010375-T01-IM5	Outside	FFPE	Resection	250	1092	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_4	KRAS p.G12A;TP53 p.D281E;RBM10 p.N787Tfs*15	1	3
P-0010376	P-0010376-T01-IM5	Outside	FFPE	Resection	250	726	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.R710*;PBRM1 p.E1132Rfs*11;VHL p.F76del;MLH1 p.E199Dfs*4	0	4
P-0010378	P-0010378-T01-IM5	In-House	FFPE	Biopsy	250	1131	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.X331_splice;NOTCH2 p.P2303Hfs*9;DICER1 Deletion;FH Deletion;PTPRD Deletion;RAD51C Deletion	0	6
P-0010380	P-0010380-T01-IM5	In-House	FFPE	Biopsy	250	1058	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Q261*)				LEVEL_4	TP53 p.R248W;PTEN p.Q261*;RB1 p.X830_splice	1	3
P-0010381	P-0010381-T01-IM5	Outside	FFPE	Biopsy	250	1194	20	Matched	Metastasis	Cancer of Unknown Primary	Left Scapula	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										SETD2 p.K347Nfs*2	0	1
P-0010382	P-0010382-T01-IM5	Outside	FFPE	Biopsy	124.3	489	60	Matched	Metastasis	Prostate	Adrenal	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	PIK3CA p.C420R;PPP2R1A p.R183Q;TP53 p.R273C;AR p.W742C;AR p.T878A;ASXL1 p.G646Wfs*12;EIF1AX p.X6_splice;PTPRS p.V1025Sfs*18;VHL p.R167W;SPOP p.K129E;TP53 p.G108S;MED12 p.X808_splice;ZFHX3 p.Q3197Sfs*44;ASXL2 p.K535Nfs*3;KMT2C p.L3425Cfs*16;BRCA2 Deletion;FOXA1 Amplification;FOXO1 Deletion;RB1 Deletion;TOP1 TOP1-intragenic	3	20
P-0010383	P-0010383-T01-IM5	In-House	FFPE	Cytology	250	1068	30	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201H;TP53 p.I251F;EPHA3 p.X463_splice	1	4
P-0010385	P-0010385-T01-IM5	Outside	FFPE	Biopsy	250	1185	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.M246V;TP53 p.K139Rfs*31	2	3
P-0010386	P-0010386-T01-IM5	In-House	FFPE	Resection	250	696	10	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;SPEN p.Q3450*;ARID2 p.Q1575*	1	3
P-0010387	P-0010387-T01-IM5	Outside	FFPE	Resection	250	406	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Olaparib(ATM p.S378Vfs*12)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;ATM p.S378Vfs*12	2	2
P-0010388	P-0010388-T01-IM5	Outside	FFPE	Resection	250	303	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										SMAD2 p.E288_T289ins*	0	1
P-0010389	P-0010389-T01-IM5	In-House	FFPE	Biopsy	250	1039	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0010391	P-0010391-T01-IM5	Outside	FFPE	Biopsy	144.5	601	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										TP53 p.K132M;TP53 p.T231_I232insTDCTT	0	2
P-0010392	P-0010392-T01-IM5	Outside	FFPE	Biopsy	250	1417	20	Matched	Metastasis	Liver	Pleura	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Enasidenib(IDH2 p.R172W)					LEVEL_3B	IDH2 p.R172W;KMT2C p.Q3983*;BAP1 p.R179Sfs*7	1	3
P-0010393	P-0010393-T01-IM5	In-House	FFPE	Resection	250	570	50	Matched	Metastasis	Rectosigmoid Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R273C;KDM5C p.P480S;ERBB2 Amplification	2	3
P-0010394	P-0010394-T01-IM5	In-House	FFPE	Resection	250	781	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;ARID1A p.Q199Pfs*201;FOXA1 p.G3Efs*3	1	3
P-0010397	P-0010397-T01-IM5	In-House	FFPE	Cytology	250	867	80	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										STK11 p.R304W;ARID1A Deletion	0	2
P-0010398	P-0010398-T01-IM5	Outside	FFPE	Resection	250	766	90	Matched	Metastasis	Soft Tissue	Colon	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Trametinib,Cobimetinib(BRAF OSBPL9-BRAF fusion);Trametinib,Cobimetinib(OSBPL9 OSBPL9-BRAF fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	EIF1AX p.P2L;KMT2A p.R3280Qfs*7;CDKN2A Deletion;BRAF OSBPL9-BRAF fusion;OSBPL9 OSBPL9-BRAF fusion	3	5
P-0010400	P-0010400-T01-IM5	In-House	FFPE	Resection	250	627	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.G245V;CCND1 Amplification;FGF19 Amplification	0	3
P-0010401	P-0010401-T01-IM5	In-House	FFPE	Resection	250	789	80	Matched	Metastasis	Ovary	Pelvis	Tumor	GRCT	Sex Cord Stromal Tumor	Granulosa Cell Tumor										FOXL2 p.C134W;ASXL2 p.T1164Yfs*4	0	2
P-0010402	P-0010402-T01-IM5	In-House	FFPE	Biopsy	126.5	458	50	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)					LEVEL_3B	TP53 p.P191del;PIK3CA p.M1043V;KMT2D p.Q3826Cfs*3;ATRX p.G124Vfs*3	1	4
P-0010403	P-0010403-T01-IM5	In-House	FFPE	Resection	250	742	30	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MYXO	Soft Tissue Sarcoma	Myxoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.K117N)				LEVEL_4	KRAS p.K117N	1	1
P-0010404	P-0010404-T01-IM5	In-House	FFPE	Resection	250	882	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_S752delinsV)								LEVEL_1	EGFR p.E746_S752delinsV	1	1
P-0010405	P-0010405-T01-IM5	In-House	FFPE	Cytology	250	1103	50	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										CBFB p.X55_splice;NOTCH1 p.Y813*;GRIN2A p.G819Afs*69;RB1 Deletion;TGFBR2 Deletion	0	5
P-0010406	P-0010406-T01-IM5	Outside	FFPE	Resection	250	840	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R282W;APC p.N1548Sfs*28;RASA1 RASA1-intragenic	0	3
P-0010407	P-0010407-T01-IM5	In-House	FFPE	Resection	137.8	495	20	Matched	Metastasis	Rectosigmoid Colon	Spine	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R342*;APC p.P1319Lfs*2;AURKA Amplification;SRC Amplification	0	4
P-0010420	P-0010420-T01-IM5	Outside	FFPE	Biopsy	250	834	60	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.K650E);Olaparib(ATM p.K2266Qfs*7)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	KMT2D p.P648Tfs*2;TP53 p.G245S;FGFR3 p.K650E;STAT3 p.E616del;ANKRD11 p.K1461del;ANKRD11 p.A2265Rfs*8;MSH2 p.Q545*;FAT1 p.E2855*;FAT1 p.R1795*;ATRX p.Q2421*;ATM p.K2266Qfs*7;TP53 p.K373Rfs*49;APC p.P1043Ffs*4;NOTCH1 p.T1213Hfs*7;MSH2 Q462fs;PBRM1 p.X1042_splice;CDKN2A p.R80*;CDKN2A p.R58*	4	18
P-0010421	P-0010421-T01-IM5	In-House	FFPE	Resection	250	705	40	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S7Hfs*6)				LEVEL_4	TP53 p.R280K;TP53 p.G117V;CDKN2A p.S7Hfs*6;CD274 Amplification;JAK2 Amplification	1	5
P-0010422	P-0010422-T01-IM5	In-House	FFPE	Biopsy	90.6	1256	20	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.W91*;APC p.E1322*;CDKN2B p.R60Pfs*105;TCF7L2 p.S32Pfs*10	0	4
P-0010423	P-0010423-T01-IM5	In-House	FFPE	Biopsy	250	905	10	Unmatched	Primary	Scalp	Not Applicable	Tumor	LCH	Histiocytosis	Langerhans Cell Histiocytosis										STAG2 p.X607_splice	0	1
P-0010424	P-0010424-T01-IM5	In-House	FFPE	Resection	250	737	10	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.P278S	0	1
P-0010425	P-0010425-T01-IM5	In-House	FFPE	Resection	250	808	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R209Kfs*6;APC p.E1322*;KRAS p.G13D	1	3
P-0010426	P-0010426-T01-IM5	Outside	FFPE	Biopsy	97.4	1123	30	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma					Trametinib,Cobimetinib(NF1 p.Q83*)				LEVEL_4	TP53 p.X32_splice;NF1 p.Q83*;BAP1 p.S460*;RHOA p.E40K;TBX3 TBX3-intragenic	1	5
P-0010427	P-0010427-T01-IM5	In-House	FFPE	Biopsy	250	893	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TBX3 p.X314_splice;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	1	4
P-0010428	P-0010428-T01-IM5	Outside	FFPE	Resection	250	849	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Everolimus,Temsirolimus(MTOR p.S2215Y)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V;AMER1 p.R353*;MTOR p.S2215Y;APC p.N1455Kfs*2	3	5
P-0010429	P-0010429-T01-IM5	In-House	FFPE	Resection	250	990	10	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R175H;PTPN11 p.E69K;DNAJC11 ARID1A-DNAJC11 fusion;ARID1A ARID1A-DNAJC11 fusion	0	4
P-0010431	P-0010431-T01-IM5	In-House	FFPE	Biopsy	250	778	40	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.Y772_A775dup)	Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)					LEVEL_3A	ERBB2 p.Y772_A775dup;ARID1A p.Q372*;CBFB p.X133_splice;CDH1 p.E497Rfs*25	2	4
P-0010432	P-0010432-T01-IM5	In-House	FFPE	Biopsy	250	822	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;PIK3CA p.C420R;SMAD4 p.R361H;ETV6 p.P214L;KDM6A p.S1114Ifs*37;RNF43 p.X84_splice	2	6
P-0010441	P-0010441-T01-IM5	In-House	FFPE	Resection	250	769	70	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0010442	P-0010442-T01-IM5	In-House	FFPE	Resection	250	859	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;PTPRD p.E558*;ARID2 p.S139*	1	3
P-0010443	P-0010443-T01-IM5	In-House	FFPE	Biopsy	250	1001	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R175H;TP53 p.R282W;IDH1 p.R132H;DNMT3A p.X285_splice;ARID2 p.Q68Lfs*6;ATRX p.S784Lfs*13;KIT Amplification;PDGFRA Amplification	1	8
P-0010445	P-0010445-T01-IM5	In-House	FFPE	Biopsy	250	912	50	Matched	Metastasis	Pancreas	Liver	Tumor	NETNOS	Cancer of Unknown Primary	Neuroendocrine Tumor, NOS				Everolimus(TSC2 p.L48Qfs*18)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	DAXX p.S737*;TSC2 p.L48Qfs*18;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0010449	P-0010449-T01-IM5	Outside	FFPE	Resection	250	835	90	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.Q209P;EIF1AX p.N4Y	0	2
P-0010450	P-0010450-T01-IM5	In-House	FFPE	Biopsy	250	845	40	Matched	Metastasis	Cancer of Unknown Primary	Soft Tissue	Tumor	HNSCUP	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545_Q546delinsDK)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP63 p.X194_splice;TP53 p.C176S;PRKN p.E426*;PIK3CA p.E545_Q546delinsDK;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;FGF19 Amplification	2	9
P-0010451	P-0010451-T01-IM5	In-House	FFPE	Resection	250	489	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0010452	P-0010452-T01-IM5	In-House	FFPE	Resection	250	924	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12V;TP53 p.V274D;CARD11 Amplification;CDKN2A Deletion;FGFR1 Amplification;FOXA1 Amplification;NKX2-1 Amplification;PRKN Deletion;PTPRD Deletion;RAC1 Amplification	3	10
P-0010453	P-0010453-T01-IM5	In-House	FFPE	Biopsy	92.6	238	20	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;FOXA1 p.S250F;GATA3 p.R364S;MAP3K1 p.E1159Afs*4;MAP3K1 p.E1294Kfs*13	2	5
P-0010454	P-0010454-T01-IM5	In-House	FFPE	Biopsy	250	1317	30	Matched	Primary	Lung	Not available	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	PIK3CA p.G118D;KRAS p.G12C;TP53 p.Q331*	3	3
P-0010455	P-0010455-T01-IM5	Outside	FFPE	Resection	250	661	30	Matched	Metastasis	Testis	Pelvis	Tumor	VOEC	Germ Cell Tumor	Embryonal Carcinoma										ARID5B Deletion;CCND2 Amplification;KDM5A Amplification	0	3
P-0010456	P-0010456-T01-IM5	In-House	FFPE	Biopsy	250	699	50	Matched	Metastasis	Kidney	Liver	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	EP300 p.H844Ifs*6;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;VEGFA Amplification	1	5
P-0010457	P-0010457-T01-IM5	Outside	FFPE	Biopsy	250	823	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma		Talazoparib,Olaparib(BRCA1 p.K1724*)		Niraparib,Rucaparib(BRCA1 p.K1724*)					LEVEL_2	TP53 p.T125R;BRCA1 p.K1724*	2	2
P-0010458	P-0010458-T01-IM5	Outside	FFPE	Cytology	250	660	80	Matched	Primary	Breast	Not Applicable	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	TP53 p.R342*;PIK3CA p.E542K;KMT2C p.Q3185Rfs*55;MYC Amplification;PTEN Deletion	3	5
P-0010459	P-0010459-T01-IM5	Outside	FFPE	Biopsy	250	677	30	Matched	Primary	Nasopharynx	Not Applicable	Tumor	NPC	Head and Neck Cancer	Nasopharyngeal Carcinoma											0	0
P-0010460	P-0010460-T01-IM5	Outside	FFPE	Biopsy	250	632	30	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										STAT3 p.E616del;NOTCH2 p.R2400*;CREBBP p.I1084Nfs*3;FUBP1 p.X499_splice;SPEN p.A2763Gfs*18;KMT2D p.E2320Dfs*3;TNFAIP3 p.G101Afs*22;DNASE1 CREBBP-DNASE1 fusion;CREBBP CREBBP-DNASE1 fusion	0	9
P-0010462	P-0010462-T01-IM5	Outside	FFPE	Resection	250	556	60	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.Q1756*);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.X198_splice)					LEVEL_3B	TP53 p.R248W;DICER1 p.S1344L;PTPRD p.H1843Y;KMT2D p.Q791*;FLT3 p.S618L;RB1 p.E667*;CTCF p.K144*;ASXL1 p.Q708*;STAG2 p.R1012*;TP53 p.DR281EW;BRCA1 p.Q1756*;BRCA1 p.X198_splice	2	12
P-0010463	P-0010463-T01-IM5	In-House	FFPE	Biopsy	250	884	60	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										TP53 p.Q136*;FBXW7 p.W673Cfs*34;RB1 p.S842*;SETD2 p.W1640_T1641delins*;BAP1 Deletion;FOXP1 Deletion;GATA3 Amplification;MCL1 Amplification;MITF Deletion;NTRK1 Amplification;RYBP Deletion;SHQ1 Deletion;KDM6A KDM6A-intragenic	0	13
P-0010464	P-0010464-T01-IM5	In-House	FFPE	Biopsy	250	730	20	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS		Olaparib,Talazoparib(BRCA2 p.M408Afs*24)		Rucaparib,Niraparib(BRCA2 p.M408Afs*24)					LEVEL_2	MUTYH p.E192*;FAT1 p.K1422*;SETD2 p.X1760_splice;BRCA2 p.M408Afs*24	2	4
P-0010465	P-0010465-T01-IM5	Outside	FFPE	Resection	250	662	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 WHSC1-FGFR3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(NSD2 WHSC1-FGFR3 fusion)					LEVEL_3B	TP53 p.E271*;PIK3R2 p.L712Afs*86;CREBBP Deletion;HLA-A Deletion;FGFR3 WHSC1-FGFR3 fusion;NSD2 WHSC1-FGFR3 fusion	2	6
P-0010466	P-0010466-T01-IM5	In-House	FFPE	Cytology	123.75	610	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0010467	P-0010467-T01-IM5	Outside	FFPE	Resection	250	581	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.V2406Ffs*12)				LEVEL_4	TP53 p.A159V;RASA1 p.P886Yfs*11;NF1 p.V2406Ffs*12	1	3
P-0010483	P-0010483-T01-IM5	In-House	FFPE	Resection	250	975	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	PIK3CA p.E545K;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	4
P-0010484	P-0010484-T01-IM5	Outside	FFPE	Resection	250	928	30	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R175H;CTNNB1 p.S45P;DAXX p.K378*;EED p.N86Vfs*25;CDKN2A Deletion;CDKN2B Deletion	1	6
P-0010485	P-0010485-T01-IM5	In-House	FFPE	Resection	250	876	30	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor		Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.V561D)							LEVEL_2	PDGFRA p.V561D	1	1
P-0010486	P-0010486-T01-IM5	In-House	FFPE	Cytology	70.453	355	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;MGA p.K1978*	1	2
P-0010487	P-0010487-T01-IM5	Outside	FFPE	Resection	250	1177	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.S768_D770dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.S768_D770dup)			LEVEL_3A	TP53 p.E285V;EGFR p.S768_D770dup	1	2
P-0010488	P-0010488-T01-IM5	Outside	FFPE	Resection	250	827	60	Matched	Metastasis	Breast	Bone	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.P151A;BCL2L1 Amplification;CCND1 Amplification;FGFR1 Amplification;MYC Amplification;PAK1 Amplification	1	6
P-0010489	P-0010489-T01-IM5	Outside	FFPE	Resection	250	825	60	Unmatched	Primary	Lymph node	Not Applicable	Tumor	NHL	Non-Hodgkin Lymphoma	Non-Hodgkin Lymphoma										RHOA p.G17V;STAT3 p.E616del;EP300 p.Q476*;TET2 p.K1785Rfs*35	0	4
P-0010490	P-0010490-T01-IM5	In-House	FFPE	Biopsy	250	1164	60	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Olaparib(CHEK2 Deletion);Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	MEN1 p.L285*;ARID5B Deletion;CHEK2 Deletion;NF2 Deletion;SMARCB1 Deletion	2	5
P-0010491	P-0010491-T01-IM5	Outside	FFPE	Resection	250	687	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.Q346*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84N)				LEVEL_4	STAG2 p.Q1029*;TP53 p.S241F;NCOR1 p.Q120*;KDM6A p.Q346*;CDKN2A p.D84N	2	5
P-0010492	P-0010492-T01-IM5	In-House	FFPE	Resection	250	933	20	Matched	Primary	Stomach	Not Applicable	Tumor	SSRCC	Esophagogastric Cancer	Signet Ring Cell Carcinoma of the Stomach					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S	1	1
P-0010493	P-0010493-T01-IM5	Outside	FFPE	Resection	250	891	70	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0010494	P-0010494-T01-IM5	Outside	FFPE	Cytology	250	1480	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas				Trametinib,Cobimetinib(BRAF GIPC2-BRAF fusion);Trametinib,Cobimetinib(GIPC2 GIPC2-BRAF fusion)					LEVEL_3B	FAT1 Deletion;BRAF GIPC2-BRAF fusion;GIPC2 GIPC2-BRAF fusion	2	3
P-0010495	P-0010495-T01-IM5	In-House	FFPE	Resection	250	709	80	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		GSK2636771,AZD8186(PTEN p.R173H)				LEVEL_3A	NRAS p.Q61K;PTEN p.R173H;PBRM1 Deletion;RAD50 Deletion	2	4
P-0010496	P-0010496-T01-IM5	Outside	FFPE	Resection	250	734	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										ATRX p.N1321Kfs*3	0	1
P-0010497	P-0010497-T01-IM5	In-House	FFPE	Resection	250	762	50	Matched	Primary	Colorectal NOS	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	TP53 p.R175H;PIK3CA p.E542K;FBXW7 p.Y291Lfs*26;EP300 ZC3H7B-EP300 fusion;ZC3H7B ZC3H7B-EP300 fusion	1	5
P-0010498	P-0010498-T01-IM5	Outside	FFPE	Biopsy	250	778	30	Matched	Primary	Tonsil	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										BCL2L1 Amplification;DNMT3B Amplification	0	2
P-0010499	P-0010499-T01-IM5	In-House	FFPE	Biopsy	250	895	20	Matched	Primary	Transverse Colon	Not Applicable	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N1044K);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.S309Ffs*6)	GSK2636771,AZD8186(PTEN p.R130Q);GSK2636771,AZD8186(PTEN p.E7*)				LEVEL_3B	ERBB3 p.A232V;PTEN p.R130Q;APC p.R1114*;APC p.R1920*;ATR p.E148*;ARID1A p.R1989*;ATR p.X98_splice;PIK3CA p.N1044K;RICTOR p.S1101L;PMS1 p.L518*;SETD2 p.E1901*;PBRM1 p.X79_splice;PIK3R1 p.R461*;RASA1 p.R1010*;APC p.S1196*;EPHA7 p.E930*;PTEN p.E7*;ARID2 p.E245*;POLE p.V411L;BLM p.S718*;NCOR1 p.X2057_splice;NCOR1 p.E1077*;PTPRT p.Q965*;BRCA2 p.S309Ffs*6	4	24
P-0010500	P-0010500-T01-IM5	In-House	FFPE	Resection	250	769	70	Matched	Primary	Mediastinum	Not Applicable	Tumor	NSGCT	Germ Cell Tumor	Non-Seminomatous Germ Cell Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);GSK2636771,AZD8186(PTEN p.K60Sfs*39)				LEVEL_4	TP53 p.P191del;KRAS p.G13D;PTEN p.K60Sfs*39	2	3
P-0010501	P-0010501-T01-IM5	In-House	FFPE	Biopsy	250	969	20	Matched	Metastasis	Stomach	Peritoneum	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	TP53 p.R248Q;ERBB2 p.S310F;FBXW7 p.S582L;FBXW7 p.X195_splice;CDH1 p.X337_splice	1	5
P-0010503	P-0010503-T01-IM5	In-House	FFPE	Resection	250	522	20	Matched	Primary	Larynx	Not Applicable	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma										NFE2L2 p.R34P;TP53 p.H193N;EP300 p.Y1467K	0	3
P-0010504	P-0010504-T01-IM5	In-House	FFPE	Resection	250	478	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	CMC	Colorectal Cancer	Medullary Carcinoma of the Colon				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R38H);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X2602_splice)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);GSK2636771,AZD8186(PTEN p.E242*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3B	MSH6 p.F1088Lfs*5;FBXW7 p.R465H;JAK1 p.K860Nfs*16;PTEN p.K267Rfs*9;RNF43 p.G659Vfs*41;SMARCA4 p.L1161Sfs*3;RPTOR p.R139H;TP53 p.P152L;CDH1 p.X522_splice;ERBB3 p.V104M;TP53 p.R110C;APC p.Q1328*;ARID5B p.K967Nfs*15;RB1 p.X180_splice;PBRM1 p.I279Yfs*4;TCF7L2 p.K485Sfs*23;KMT2C p.F4496Lfs*21;ARID1A p.Y551Tfs*68;PARP1 p.S507Afs*17;ARID1B p.P174Rfs*6;PTEN p.E242*;MGA p.E1249Rfs*42;FAT1 p.P3228Lfs*42;PIK3CA p.R38H;ARID1B p.G721Afs*11;FUBP1 p.Q122*;BRCA2 p.X2602_splice;MAP2K4 p.S251T;AXIN2 p.S809Mfs*51;KMT2C p.P3901Lfs*33;APC p.P1993Lfs*51;KMT2D p.V4188Gfs*146;ATRX p.N2483Ifs*17;NOTCH3 p.E1711*;CDKN2C p.D17Gfs*7;ARID1A p.P121Afs*110;MITF p.M477Wfs*9;CDKN2A p.R80*;SDCCAG8 AKT3-SDCCAG8 fusion;AKT3 AKT3-SDCCAG8 fusion	5	40
P-0010505	P-0010505-T01-IM5	In-House	FFPE	Biopsy	88.2	686	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;MRE11 p.S586*	2	2
P-0010506	P-0010506-T01-IM5	In-House	FFPE	Resection	250	778	30	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Olaparib(CDK12 p.F1405Lfs*6);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.F1405Lfs*6)				LEVEL_2	APC p.R283*;PBRM1 p.R1185*;ERBB3 p.D297A;SMAD4 p.L536R;TP53 p.P390Lfs*79;CDK12 p.F1405Lfs*6;ERBB2 Amplification	4	7
P-0010507	P-0010507-T01-IM5	In-House	FFPE	Resection	250	632	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	CTNNB1 p.N387K;FGFR1 Amplification;STK11 STK11-intragenic	1	3
P-0010508	P-0010508-T01-IM5	In-House	FFPE	Biopsy	250	1041	40	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CBFB p.Q74*;GATA3 p.T322Rfs*34;CCND1 Amplification;FGF19 Amplification;MYCL Amplification;PIK3CA Amplification	2	7
P-0010509	P-0010509-T01-IM5	In-House	FFPE	Resection	250	571	40	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		AZD5363(AKT1 p.E17K);Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	AKT1 p.E17K;BRAF p.V600E;APC p.T1556Nfs*3;SMAD4 p.D537G;APC p.Y1183*;SOX9 p.W143*	4	6
P-0010510	P-0010510-T01-IM5	In-House	FFPE	Biopsy	250	900	60	Matched	Metastasis	Ovary	Chest Wall	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.P104L)					LEVEL_3B	PPP2R1A p.S256F;TP53 p.C141W;PIK3CA p.P104L	1	3
P-0010511	P-0010511-T01-IM5	Outside	FFPE	Resection	250	757	20	Matched	Metastasis	Cancer of Unknown Primary	Skin	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS				Olaparib(ATM p.X947_splice);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ATM p.X947_splice;ERBB2 Amplification	2	2
P-0010512	P-0010512-T01-IM5	Outside	FFPE	Resection	250	1136	20	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma										APC p.S1346*;TCF7L2 p.S46*;APC p.P950Yfs*14;JAK1 ASB17-JAK1 fusion;ASB17 ASB17-JAK1 fusion;YTHDC1 JAK1-YTHDC1 fusion;JAK1 JAK1-YTHDC1 fusion	0	7
P-0010513	P-0010513-T01-IM5	In-House	FFPE	Resection	250	667	50	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.S215R;APC p.Q195*;AURKA Amplification;BCL2L1 Amplification;CDK8 Amplification;DNMT3B Amplification;FLT3 Amplification;MYC Amplification;SRC Amplification	0	9
P-0010514	P-0010514-T01-IM5	Outside	FFPE	Biopsy	129.4	80	50	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;BAP1 p.G109*;DIS3 p.X274_splice	2	3
P-0010515	P-0010515-T01-IM5	In-House	FFPE	Resection	250	786	50	Matched	Metastasis	Abdominal Wall	Lung	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma										ARID2 p.R274*;AMER1 Deletion	0	2
P-0010516	P-0010516-T01-IM5	In-House	FFPE	Biopsy	250	680	60	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	TP53 p.R273H;IDH1 p.R132H;ATRX p.W222*	1	3
P-0010517	P-0010517-T01-IM5	In-House	FFPE	Biopsy	101	193	30	Matched	Metastasis	Kidney	Abdominal wall	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	GSK2636771,AZD8186(PTEN p.P38L)				LEVEL_3B	PIK3CA p.E542K;PTEN p.P38L;VHL p.F76del;SETD2 p.W1562*	2	4
P-0010518	P-0010518-T01-IM5	In-House	FFPE	Biopsy	250	1080	50	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	RB1 p.R556*;PTEN p.T319*;TP53 p.V274A;APC p.N1797Kfs*2;EPHA7 Deletion	1	5
P-0010519	P-0010519-T01-IM5	In-House	FFPE	Biopsy	250	1075	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;PBRM1 p.R921*;TP63 p.Q99*;PMS2 p.Q25*;CD274 Amplification;JAK2 Amplification	1	6
P-0010520	P-0010520-T01-IM5	In-House	FFPE	Resection	250	608	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;VHL p.V137Lfs*23	1	2
P-0010521	P-0010521-T01-IM5	Outside	FFPE	Resection	250	1302	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS					GSK2636771,AZD8186(PTEN p.N329Kfs*14)				LEVEL_4	PTEN p.N329Kfs*14;TP53 p.H193R;RB1 Deletion	1	3
P-0010522	P-0010522-T01-IM5	In-House	FFPE	Resection	151	749	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.R248W;KRAS p.Q61H;ARID2 p.X31_splice	1	3
P-0010523	P-0010523-T01-IM5	In-House	FFPE	Biopsy	114	1336	30	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.M44Afs*7	0	1
P-0010524	P-0010524-T01-IM5	In-House	FFPE	Cytology	250	986	60	Matched	Metastasis	Ovary	Retroperitoneum	Tumor	SBMOV	Ovarian Cancer	Serous Borderline Ovarian Tumor, Micropapillary				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.Y772_A775dup);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ERBB2 p.Y772_A775dup;ERBB2 Amplification;ID3 Deletion	2	3
P-0010525	P-0010525-T01-IM5	In-House	FFPE	Biopsy	250	987	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	KRAS p.G13C	1	1
P-0010526	P-0010526-T01-IM5	In-House	FFPE	Resection	250	1059	70	Matched	Metastasis	Adrenal Gland	Small Intestine	Tumor	ACC	Adrenocortical Carcinoma	Adrenocortical Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EP300 Deletion	1	3
P-0010527	P-0010527-T01-IM5	Outside	FFPE	Biopsy	250	828	60	Matched	Primary	Cervix	Not Applicable	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E545K;PIK3CA p.E542K;BAP1 p.S460*;BAP1 p.E566*	2	4
P-0010528	P-0010528-T01-IM5	Outside	FFPE	Biopsy	250	617	70	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										TP53 p.R213*;TP53 p.E286*;CREBBP Deletion;MCL1 Amplification	0	4
P-0010529	P-0010529-T01-IM5	Outside	FFPE	Resection	250	904	60	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	TP53 p.E298*;ARID1B Deletion;BRCA2 Deletion;PTPRD Deletion	2	4
P-0010530	P-0010530-T01-IM5	Outside	FFPE	Biopsy	108.3	310	90	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H);Cabozantinib,Crizotinib(MET Amplification)					LEVEL_3B	IDH1 p.R132H;TP53 p.Y236S;ATRX p.V1347Efs*2;MET Amplification;PDGFRA Amplification	2	5
P-0010531	P-0010531-T01-IM5	In-House	FFPE	Biopsy	250	775	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);Olaparib(ATM p.S2394*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T);Trametinib,Cobimetinib(NF1 p.S2670*);Tazemetostat(KDM6A p.E206*)				LEVEL_3B	KRAS p.A146T;PIK3CA p.E453K;BAP1 p.X126_splice;NF1 p.S2670*;ARID1A p.Q1366*;ATM p.S2394*;MGA p.S526*;ZFHX3 p.Q2526*;KDM6A p.E206*;NOTCH3 p.D1898Afs*9	5	10
P-0010532	P-0010532-T01-IM5	In-House	FFPE	Biopsy	250	1056	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;TP53 p.P318Rfs*17	1	2
P-0010533	P-0010533-T01-IM5	In-House	FFPE	Biopsy	250	1023	30	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										ARID1A p.P1568Lfs*44	0	1
P-0010534	P-0010534-T01-IM5	Outside	FFPE	Biopsy	250	871	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3R1 p.N453_D464dup;CDKN2A Deletion;CDKN2B Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	3	5
P-0010535	P-0010535-T01-IM5	In-House	FFPE	Resection	250	851	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.Q546K;APC p.P1319Lfs*2;SOX9 p.P374Rfs*9;FUBP1 p.R344*;PBRM1 p.E924*;CARD11 p.R423Q;APC p.S1276Tfs*6	2	8
P-0010537	P-0010537-T01-IM5	In-House	FFPE	Cytology	250	866	30	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R248Q;RB1 p.X165_splice;PPP2R1A MYOF-PPP2R1A fusion;MYOF MYOF-PPP2R1A fusion	0	4
P-0010538	P-0010538-T01-IM5	Outside	FFPE	Biopsy	116.7	450	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.Q1338*;APC p.R1450*;SPOP p.F133V;KMT2C p.Q2128*;MGA p.S1849Ifs*2;SMAD4 p.A532Pfs*5	0	6
P-0010553	P-0010553-T01-IM5	In-House	FFPE	Biopsy	203.5	913	70	Matched	Metastasis	Breast	Soft Tissue	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										TP53 p.P128Lfs*42	0	1
P-0010554	P-0010554-T01-IM5	In-House	FFPE	Resection	250	789	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L858R;PIK3CA p.C420R;CCND2 Amplification;KDM5A Amplification;MDM2 Amplification	3	5
P-0010555	P-0010555-T01-IM5	Outside	FFPE	Biopsy	90	388	20	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.E56*;TET2 p.S1059*	0	2
P-0010555	P-0010555-T02-IM5	Outside	FFPE	Biopsy	250	968	70	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	BRAF p.V600E;TP53 p.C275R;APC p.R876*;SMAD4 p.D351N;APC p.L1488*;FGFR1 Amplification;RICTOR Amplification	4	7
P-0010556	P-0010556-T01-IM5	Outside	FFPE	Resection	250	1041	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme	Larotrectinib,Entrectinib(NTRK3 ZNF710-NTRK3 fusion);Larotrectinib,Entrectinib(ZNF710 ZNF710-NTRK3 fusion)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	ARID5B Deletion;CDK4 Amplification;CDKN1B Deletion;FBXW7 Deletion;KDR Amplification;KIT Amplification;KRAS Amplification;MDM2 Amplification;PDGFRA Amplification;PTEN Deletion;RUNX1 Amplification;TERT Amplification;NTRK3 ZNF710-NTRK3 fusion;ZNF710 ZNF710-NTRK3 fusion	5	14
P-0010557	P-0010557-T01-IM5	In-House	FFPE	Cytology	250	915	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)						LEVEL_3A	TP53 p.G266*;STK11 p.X199_splice;FGFR1 Amplification;HNF1A Deletion	1	4
P-0010558	P-0010558-T01-IM5	In-House	FFPE	Biopsy	250	913	50	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R342*;BRAF p.G466E;ARID1A p.A348Pfs*15;STK11 p.S216Rfs*43;FOXA1 Amplification;MYCL Amplification;NKX2-1 Amplification	0	7
P-0010559	P-0010559-T01-IM5	Outside	FFPE	Resection	250	681	50	Matched	Primary	Eye	Not Applicable	Tumor	GCT	Sellar Tumor	Granular Cell Tumor											0	0
P-0010560	P-0010560-T01-IM5	In-House	FFPE	Resection	250	873	30	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	PIK3R2 p.D557Y;GATA3 p.H423Afs*84;FGFR1 Amplification	1	3
P-0010561	P-0010561-T01-IM5	Outside	FFPE	Resection	250	853	50	Matched	Metastasis	Lung	Spine	Tumor	LUCA	Non-Small Cell Lung Cancer	Lung Carcinoid					Tazemetostat(SMARCB1 p.R377C)				LEVEL_4	PBRM1 p.E1214Rfs*6;SMARCB1 p.R377C;VHL p.L89P;PBRM1 p.P1584Rfs*31	1	4
P-0010562	P-0010562-T01-IM5	Outside	FFPE	Biopsy	250	1012	40	Matched	Metastasis	Salivary Gland	Pleura	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)				Trametinib,Cobimetinib(NF1 THRB-NF1 fusion);Trametinib,Cobimetinib(THRB THRB-NF1 fusion)				LEVEL_1	NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion;NF1 THRB-NF1 fusion;THRB THRB-NF1 fusion	4	4
P-0010563	P-0010563-T01-IM5	Outside	FFPE	Biopsy	250	1030	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_A750delinsP)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.L747_A750delinsP;TP53 p.L43*;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	5
P-0010564	P-0010564-T01-IM5	Outside	FFPE	Resection	250	855	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer											0	0
P-0010565	P-0010565-T01-IM5	In-House	FFPE	Biopsy	250	1066	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FAT1 p.F2751Lfs*2;CDKN1B p.S83Lfs*37;RB1 Deletion	0	3
P-0010566	P-0010566-T01-IM5	In-House	FFPE	Biopsy	90	528	50	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.R342*;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification	3	9
P-0010567	P-0010567-T01-IM5	Outside	FFPE	Resection	250	789	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma											0	0
P-0010568	P-0010568-T01-IM5	In-House	FFPE	Biopsy	250	1067	NA	Unmatched	Primary	Lymph node	Not Applicable	Tumor	CHL	Hodgkin Lymphoma	Classical Hodgkin Lymphoma										TP53 p.Y163N	0	1
P-0010569	P-0010569-T01-IM5	In-House	FFPE	Biopsy	250	669	60	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C);Sonidegib,Vismodegib(PTCH1 p.G492*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;STK11 p.P281Rfs*6;TP53 p.G244C;SMARCA4 p.E1083*;INPP4B p.X124_splice;PTCH1 p.G492*;FLT3 p.M837I;CREBBP p.X1576_splice	3	8
P-0010570	P-0010570-T01-IM5	In-House	FFPE	Resection	250	1127	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Cisplatin(ERCC2 Deletion)	GSK2636771,AZD8186(PTEN p.D162V)				LEVEL_3B	TP53 p.L252P;PTEN p.D162V;STAG2 p.E383Dfs*9;RB1 p.S318Nfs*13;ERCC2 Deletion;ERCC4 Deletion;GRIN2A Deletion;SOCS1 Deletion	2	8
P-0010571	P-0010571-T01-IM5	In-House	FFPE	Resection	250	764	50	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.E294*;CBL p.X410_splice;STK11 p.K44*;RASA1 p.D455Mfs*28;KEAP1 p.V547Rfs*27	2	6
P-0010572	P-0010572-T01-IM5	In-House	FFPE	Resection	250	661	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.S376Vfs*60);Olaparib(CDK12 p.R112Vfs*12)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.S376Vfs*60);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R112Vfs*12)				LEVEL_1	CDK12 p.S376Vfs*60;CDK12 p.R112Vfs*12	4	2
P-0010573	P-0010573-T01-IM5	Outside	FFPE	Resection	250	303	40	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Everolimus(TSC2 p.X454_splice)					LEVEL_3B	TP53 p.H178Tfs*69;TSC2 p.X454_splice;ARID1A p.Q321Gfs*70;SMAD4 p.S232Afs*10;TERT Amplification	1	5
P-0010574	P-0010574-T01-IM5	In-House	FFPE	Biopsy	198.5	932	40	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										ARID1A p.D130Mfs*102;ERRFI1 p.P290Yfs*6	0	2
P-0010575	P-0010575-T02-IM5	In-House	FFPE	Biopsy	250	743	80	Matched	Metastasis	Breast	Skin	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS			AZD5363(AKT1 p.E17K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 p.Y2285Tfs*5);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	AKT1 p.E17K;NF1 p.Y2285Tfs*5;MAP2K4 p.X229_splice;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification	4	6
P-0010576	P-0010576-T01-IM5	Outside	FFPE	Resection	250	553	60	Matched	Metastasis	Thymus	Pericardium	Tumor	THYM	Thymic Tumor	Thymoma											0	0
P-0010577	P-0010577-T01-IM5	In-House	FFPE	Biopsy	250	974	50	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma											0	0
P-0010578	P-0010578-T01-IM5	Outside	FFPE	Resection	250	959	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;NOTCH1 p.Q300*;PIK3R2 p.X272_splice;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0010579	P-0010579-T01-IM5	Outside	FFPE	Biopsy	250	820	70	Matched	Primary	Abdominal Wall	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										ARID1B p.X515_splice;BAP1 Deletion;PBRM1 Deletion	0	3
P-0010580	P-0010580-T01-IM5	Outside	FFPE	Biopsy	250	1108	50	Unmatched	Primary	Mesentery	Not Applicable	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms										ARID1A p.R1989*;PIM1 p.K24N;CREBBP p.Y1503H;BCL2 p.A131D;TNFRSF14 p.M1_?4;TNFRSF14 p.W7Pfs*8	0	6
P-0010581	P-0010581-T01-IM5	In-House	FFPE	Resection	250	806	40	Matched	Metastasis	Cecum	Adrenal Gland	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma	Larotrectinib,Entrectinib(LMNA NTRK1-LMNA fusion);Larotrectinib,Entrectinib(NTRK1 NTRK1-LMNA fusion)			Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)					LEVEL_1	PTCH1 p.S1203Afs*52;EP300 p.M1470Cfs*26;TP53 p.R342*;ARID1A p.G276Efs*87;HNF1A p.P291Qfs*51;CREBBP p.S1680del;KMT2D p.P647Hfs*283;ARID1A p.F2141Sfs*59;PTPRS p.V1025Sfs*18;EIF1AX p.G9D;RNF43 p.R225Afs*194;ARID1B p.Q452*;MGA p.L2182*;GPS2 p.Q80*;PIK3R2 p.X370_splice;EP300 p.R648*;KDM5C p.R828*;KMT2D p.A3416Cfs*7;SUFU p.P24Rfs*72;SPEN p.A2251Qfs*102;KMT2D p.A2133Pfs*11;LMNA NTRK1-LMNA fusion;NTRK1 NTRK1-LMNA fusion	3	23
P-0010582	P-0010582-T01-IM5	In-House	FFPE	Biopsy	250	1073	60	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C);Cisplatin(ERCC2 p.D609E)						LEVEL_1	FGFR3 p.S249C;MED12 p.G44S;JAK1 p.R724H;SF3B1 p.E902K;FBXW7 p.S546L;ARID1B p.W490*;NCOR1 p.Q60*;ERCC2 p.D609E;CDH1 p.P27Tfs*27;TGFBR1 Deletion	3	10
P-0010584	P-0010584-T01-IM5	In-House	FFPE	Biopsy	250	1133	20	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0010585	P-0010585-T01-IM5	In-House	FFPE	Biopsy	250	1016	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.F270C;CCND1 Amplification;FGF19 Amplification;GATA3 Amplification;PAK1 Amplification;TERT Amplification	0	6
P-0010587	P-0010587-T01-IM5	In-House	FFPE	Resection	250	1019	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G);Sonidegib,Vismodegib(PTCH1 p.R621Sfs*5)					LEVEL_3B	MSH6 p.F1088Lfs*5;PTCH1 p.S1203Afs*52;B2M p.V69Wfs*34;RNF43 p.G659Vfs*41;JAK1 p.P430Rfs*2;B2M p.L15Ffs*41;AXIN2 p.A417Rfs*41;RNF43 p.R145*;PIK3CA p.E545G;CIC p.P1529Lfs*91;SOX9 p.G263Afs*16;NOTCH3 p.G2035Vfs*50;PIK3R1 p.R358*;RASA1 p.R903*;SOX9 p.S23Afs*38;MSH2 p.R680*;ARID1A p.P1175Hfs*5;SPEN p.P3317Rfs*83;RNF43 p.P441Lfs*61;SOX9 p.V306Cfs*77;ZFHX3 p.Q3197Sfs*44;MSH2 p.R406*;RAD50 p.X916_splice;CDKN1A p.W65*;FLT3 p.N847D;ZFHX3 p.W3617*;STK11 p.G163S;KMT2C p.L2870Cfs*36;PTCH1 p.R621Sfs*5;MEN1 p.R521Pfs*15;KMT2D p.P2400Lfs*26;RASA1 p.P139Lfs*35;ASXL2 p.V206Tfs*13;PBRM1 p.K702Sfs*12	3	34
P-0010588	P-0010588-T01-IM5	Outside	FFPE	Biopsy	203.8	753	20	Matched	Primary	Oropharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.R175H;FAT1 p.D2434Rfs*3;ZFHX3 ZFHX3-intragenic	0	3
P-0010589	P-0010589-T01-IM5	Outside	FFPE	Resection	250	846	60	Matched	Primary	Soft Tissue	Soft Tissue	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	2	3
P-0010590	P-0010590-T01-IM5	In-House	FFPE	Biopsy	250	688	15	Matched	Primary	Lymph node	Not Applicable	Tumor	HL	Hodgkin Lymphoma	Hodgkin Lymphoma											0	0
P-0010591	P-0010591-T01-IM5	In-House	FFPE	Resection	250	894	60	Matched	Metastasis	Anus	Kidney	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma										STK11 p.Q100*;FAT1 p.R1262*;KMT2D p.X5471_splice;NF2 p.E434*;EP300 p.E1706*;NOTCH1 p.D1348Efs*97;NOTCH2 p.C691Sfs*51;CASP8 Deletion	0	8
P-0010592	P-0010592-T01-IM5	In-House	FFPE	Resection	250	733	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12F)				LEVEL_4	KRAS p.G12F;NOTCH2 p.K1725*	1	2
P-0010594	P-0010594-T01-IM5	In-House	FFPE	Resection	250	670	40	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib(NF1 p.R816*)				LEVEL_4	TP53 p.S149Pfs*21;NF1 p.R816*	1	2
P-0010595	P-0010595-T01-IM5	In-House	FFPE	Resection	183.3	490	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma											0	0
P-0010596	P-0010596-T01-IM5	In-House	FFPE	Resection	250	756	50	Matched	Metastasis	Skin	Pancreas	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)		Trametinib,Cobimetinib(MAP2K1 p.G128D)						LEVEL_1	BRAF p.V600K;MAP2K1 p.G128D;ARID1A p.G82Vfs*19;KMT2C p.F1556Cfs*7	2	4
P-0010597	P-0010597-T01-IM5	In-House	FFPE	Resection	250	932	60	Matched	Primary	Thymus	Not Applicable	Tumor	THYC	Thymic Tumor	Thymic Carcinoma										TP53 p.R110P	0	1
P-0010598	P-0010598-T01-IM5	In-House	FFPE	Biopsy	192.7	639	60	Matched	Metastasis	Ovary	Lymph Node	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Y163C	0	1
P-0010599	P-0010599-T01-IM5	In-House	FFPE	Resection	250	926	60	Matched	Metastasis	Descending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.K132N	2	2
P-0010600	P-0010600-T01-IM5	In-House	FFPE	Biopsy	250	1281	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.C141Y;CCND3 Amplification;EGFR Amplification	0	3
P-0010601	P-0010601-T01-IM5	In-House	FFPE	Resection	250	1046	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F;TP53 p.X125_splice;B2M p.E19*	2	4
P-0010602	P-0010602-T01-IM5	In-House	Cell Pellet	Cytology	250	1089	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										TP53 p.R213*;KEAP1 p.G417V;EPHA7 p.E210*;PTPN11 p.G60R;RB1 p.X654_splice;TNFAIP3 p.G429Afs*47;STK11 p.D229Tfs*58;ERCC3 Deletion	0	8
P-0010603	P-0010603-T01-IM5	Outside	FFPE	Resection	250	849	70	Matched	Metastasis	Kidney	Liver	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										TP53 p.C135F;VHL p.S183*;SETD2 p.S2082*;STAG2 p.R450*	0	4
P-0010604	P-0010604-T01-IM5	Outside	FFPE	Resection	250	875	60	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										TP53 p.R342*;SPEN p.R702*;NOTCH1 p.G2420Pfs*10;KMT2C MLL3-intragenic	0	4
P-0010605	P-0010605-T01-IM5	Outside	FFPE	Biopsy	250	996	10	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Non-Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma										BRAF p.D594N	0	1
P-0010606	P-0010606-T01-IM5	Outside	FFPE	Biopsy	250	822	30	Matched	Metastasis	Cervix	Vagina	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	ERBB2 Amplification	1	1
P-0010607	P-0010607-T01-IM5	Outside	FFPE	Resection	250	577	20	Matched	Primary	Soft Tissue	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma											0	0
P-0010608	P-0010608-T01-IM5	In-House	FFPE	Cytology	87.55	1226	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;SMAD4 p.D537G	1	2
P-0010609	P-0010609-T01-IM5	Outside	FFPE	Resection	250	743	60	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.Q37*;FAT1 p.Y1144Ifs*60	2	3
P-0010610	P-0010610-T01-IM5	In-House	FFPE	Biopsy	159.6	614	60	Matched	Primary	Lung	Not Applicable	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;KEAP1 p.G523V;TP53 p.D208Ffs*35;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification;EPHA3 EPHA3-intragenic	3	7
P-0010611	P-0010611-T01-IM5	In-House	FFPE	Resection	250	979	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0010612	P-0010612-T01-IM5	In-House	FFPE	Cytology	236.94	1180	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.V157F;GNAS p.Q227L;SMARCA4 p.G1128*;CCND3 Amplification;MYC Amplification;VEGFA Amplification	0	6
P-0010613	P-0010613-T01-IM5	Outside	FFPE	Resection	105.3	669	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E409*);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.G561*);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 CLYBL-BRCA2 fusion);Olaparib,Rucaparib,Talazoparib,Niraparib(CLYBL CLYBL-BRCA2 fusion)	Lapatinib(EGFR Amplification)				LEVEL_3B	EGFR p.A289T;BRCA2 p.E409*;BRCA2 p.G561*;TP53 p.C124*;BRAF Amplification;EGFR Amplification;EZH2 Amplification;GPS2 Deletion;RHEB Amplification;SOX9 Deletion;TP53 Deletion;BRCA2 CLYBL-BRCA2 fusion;CLYBL CLYBL-BRCA2 fusion	5	13
P-0010614	P-0010614-T01-IM5	In-House	FFPE	Biopsy	250	988	70	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L;BAP1 p.V171Afs*15;ARID1A Deletion;ID3 Deletion;MYC Amplification	0	5
P-0010615	P-0010615-T01-IM5	In-House	FFPE	Biopsy	250	1029	20	Matched	Primary	Bile Duct	Not available	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3A	PIK3CA p.E545K;IDH1 p.R132C	2	2
P-0010627	P-0010627-T01-IM5	Outside	FFPE	Biopsy	250	1208	30	Matched	Metastasis	Sigmoid Colon	Soft Tissue	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83R)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R248Q;APC p.V1323Afs*8;CDKN2A p.H83R;SMAD4 Deletion	2	5
P-0010628	P-0010628-T01-IM5	In-House	FFPE	Biopsy	250	1056	20	Matched	Metastasis	Cancer of Unknown Primary	Axilla	Tumor	PDC	Cancer of Unknown Primary	Poorly Differentiated Carcinoma, NOS	Larotrectinib,Entrectinib(NTRK1 IRF2BP2-NTRK1 fusion);Larotrectinib,Entrectinib(IRF2BP2 IRF2BP2-NTRK1 fusion)								LEVEL_1	NTRK1 IRF2BP2-NTRK1 fusion;IRF2BP2 IRF2BP2-NTRK1 fusion	2	2
P-0010629	P-0010629-T01-IM5	In-House	FFPE	Resection	250	834	50	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)				Imatinib(PDGFRA p.D842V)			LEVEL_1	PDGFRA p.D842V	2	1
P-0010630	P-0010630-T01-IM5	Outside	FFPE	Resection	250	647	20	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0010631	P-0010631-T01-IM5	Outside	FFPE	Resection	250	1049	20	Matched	Primary	Appendix	Not Applicable	Tumor	SRAP	Appendiceal Cancer	Signet Ring Cell Type of the Appendix										TP53 p.S215N	0	1
P-0010632	P-0010632-T01-IM5	In-House	FFPE	Resection	250	620	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;MYC Amplification	2	2
P-0010633	P-0010633-T01-IM5	Outside	FFPE	Resection	250	693	40	Matched	Primary	Ovary	Not Applicable	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0010634	P-0010634-T01-IM5	In-House	FFPE	Resection	250	814	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D846V)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	PIK3CA p.E542K;NFE2L2 p.E79Q;TP53 p.R158P;PDGFRA p.D846V;SPEN p.T2496Yfs*2;CDKN2A p.R58*	3	6
P-0010635	P-0010635-T01-IM5	In-House	FFPE	Resection	250	664	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0010636	P-0010636-T01-IM5	In-House	FFPE	Biopsy	250	1073	70	Matched	Metastasis	Lung	Bone	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_3A	KRAS p.G12C;TP53 p.R158P;CDKN2A p.R80*;DNMT3B Amplification;FGFR4 Amplification	3	5
P-0010637	P-0010637-T01-IM5	In-House	FFPE	Biopsy	250	1018	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0010638	P-0010638-T01-IM5	In-House	FFPE	Resection	250	1023	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FOXA1 p.D226G;RNF43 p.Q577*;GPS2 p.R50Kfs*46;MAP2K4 p.E360Afs*11;CDH1 p.P461Tfs*3;FGFR1 Amplification	1	6
P-0010639	P-0010639-T01-IM5	In-House	FFPE	Biopsy	250	1030	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0010640	P-0010640-T01-IM5	In-House	FFPE	Biopsy	250	995	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_S752del)								LEVEL_1	TP53 p.R273C;EGFR p.L747_S752del;NKX2-1 Amplification	1	3
P-0010641	P-0010641-T01-IM5	In-House	FFPE	Resection	250	783	50	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	PIK3CA p.E545K;STAG2 p.S853Lfs*17;VHL p.S139Cfs*2;BAP1 p.L570Gfs*69;CCNE1 Amplification	1	5
P-0010642	P-0010642-T01-IM5	In-House	FFPE	Resection	250	787	40	Unmatched	Primary	Brain	Not Applicable	Tumor	HDCN	Histiocytosis	Histiocytic and Dendritic Cell Neoplasms			Trametinib,Cobimetinib(MAP2K1 p.E203K)						LEVEL_3A	MAP2K1 p.E203K	1	1
P-0010643	P-0010643-T01-IM5	In-House	FFPE	Resection	250	891	60	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast					Trametinib,Cobimetinib(NF1 p.P2310Afs*17);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PIK3R1 p.L396Vfs*6;PIK3R1 p.K448_N453del;NF1 p.P2310Afs*17;CDKN2A Deletion;CDKN2B Deletion;SUFU Deletion	2	6
P-0010643	P-0010643-T02-IM5	In-House	FFPE	Resection	250	835	20	Matched	Metastasis	Cancer of Unknown Primary	Breast	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R	1	1
P-0010644	P-0010644-T01-IM5	In-House	FFPE	Biopsy	250	1058	70	Matched	Metastasis	Eye	Liver	Tumor	UM	Melanoma	Uveal Melanoma										GNAQ p.R183Q;BAP1 Deletion;ERRFI1 Deletion;TNFRSF14 Deletion	0	4
P-0010645	P-0010645-T01-IM5	Outside	FFPE	Resection	250	699	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.E286_E287del;TET2 p.G1282C	0	2
P-0010646	P-0010646-T01-IM5	Outside	FFPE	Resection	250	910	30	Matched	Primary	Testis	Not Applicable	Tumor	VOEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0010647	P-0010647-T01-IM5	Outside	FFPE	Resection	250	996	60	Unmatched	Primary	Neck	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										KMT2A p.R478*;KMT2D p.Q2796*;TNFAIP3 p.L236Sfs*18;KMT2D p.R2068Gfs*26;GPS2 Deletion;TNFRSF14 Deletion;TP53 Deletion	0	7
P-0010648	P-0010648-T01-IM5	In-House	FFPE	Biopsy	119	553	40	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_4	KRAS p.G12S;STK11 p.H174R;MYC Amplification	1	3
P-0010649	P-0010649-T01-IM5	Outside	FFPE	Resection	250	852	70	Matched	Metastasis	Skin	Lymph Node	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_3B	MSH6 p.F1088Lfs*5;PIK3CA p.E545K;FOXL2 p.E118K;RB1 p.R467*;TP53 p.P278F;KMT2D p.P998Lfs*2;ATR p.Q1073*;MGA p.R627*;RNF43 p.W15*;NOTCH1 p.G1893Afs*88;NOTCH1 p.L1531Cfs*49;FAT1 p.R2726*;KMT2D p.P2053Sfs*3;NOTCH3 p.W1750*	1	14
P-0010650	P-0010650-T01-IM5	In-House	FFPE	Resection	250	732	30	Matched	Primary	Pancreas	Not Applicable	Tumor	IPMN	Pancreatic Cancer	Intraductal Papillary Mucinous Neoplasm					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	TP53 p.R248Q;KRAS p.Q61H	1	2
P-0010651	P-0010651-T01-IM5	In-House	FFPE	Resection	250	913	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										TP53 p.K132R;BAP1 p.I445Sfs*112	0	2
P-0010652	P-0010652-T01-IM5	In-House	FFPE	Resection	250	814	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.X456_splice;DAXX p.M470_Q471delinsI*	0	2
P-0010653	P-0010653-T01-IM5	In-House	FFPE	Biopsy	98	796	70	Matched	Metastasis	Pancreas	Retroperitoneum	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas										CTNNB1 p.S45F;CTNNB1 p.S45C	0	2
P-0010654	P-0010654-T01-IM5	Outside	FFPE	Cytology	250	1405	60	Matched	Metastasis	Parotid Gland	Lymph Node	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.R68S)				LEVEL_4	KRAS p.R68S;JAK1 p.R755*;BCOR p.Q918Lfs*29;IKZF1 Deletion;TET2 Deletion	1	5
P-0010655	P-0010655-T01-IM5	Outside	FFPE	Resection	250	933	50	Matched	Metastasis	Breast	Chest Wall	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma			Neratinib(ERBB2 p.L869R)	Ado-Trastuzumab Emtansine(ERBB2 p.L869R)					LEVEL_3A	ERBB3 p.E928G;ERBB2 p.L869R;CDH1 p.G81Vfs*2;TBX3 p.R436Tfs*3	2	4
P-0010656	P-0010656-T01-IM5	Outside	FFPE	Biopsy	190	748	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133V;PIK3R3 p.F342Lfs*40	0	2
P-0010657	P-0010657-T01-IM5	Outside	FFPE	Resection	250	937	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	SOX9 p.K167E;PTEN Deletion	1	2
P-0010658	P-0010658-T01-IM5	In-House	FFPE	Biopsy	189.7	681	60	Matched	Metastasis	Kidney	Pelvis	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0010659	P-0010659-T01-IM5	In-House	FFPE	Resection	250	820	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										MED12 p.L1224F;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0010660	P-0010660-T01-IM5	In-House	FFPE	Biopsy	250	960	50	Matched	Metastasis	Uterus	Lymph Node	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Everolimus,Temsirolimus(MTOR p.S2215F);GSK2636771,AZD8186(PTEN p.D187Afs*7)				LEVEL_4	MTOR p.S2215F;CTNNB1 p.G34V;EP300 p.L931Cfs*15;ARID1A p.V1082Gfs*22;PIK3R1 p.K448_Y452del;PTEN p.D187Afs*7;MGA MAPKBP1-MGA fusion;MAPKBP1 MAPKBP1-MGA fusion	2	8
P-0010661	P-0010661-T01-IM5	In-House	FFPE	Resection	250	884	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										BCOR p.R1268Kfs*8	0	1
P-0010662	P-0010662-T01-IM5	Outside	FFPE	Resection	250	886	60	Matched	Primary	Pancreas	Not Applicable	Tumor	UCP	Pancreatic Cancer	Undifferentiated Carcinoma of the Pancreas					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;KRAS Amplification;NTRK1 Amplification;TERT Amplification	1	4
P-0010663	P-0010663-T01-IM5	In-House	FFPE	Resection	250	887	80	Matched	Metastasis	Parotid Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma										TP53 p.C238Y;EP300 p.Q1736*	0	2
P-0010664	P-0010664-T01-IM5	In-House	FFPE	Resection	250	636	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.C634R)		BLU-667(RET p.C634R)	Ivosidenib(IDH1 p.R132L)					LEVEL_1	RET p.C634R;IDH1 p.R132L	3	2
P-0010665	P-0010665-T01-IM5	In-House	FFPE	Resection	180	231	20	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R213*;APC p.E1353*;ARID1A p.R2158*;TCF7L2 p.M1?;APC p.A762Gfs*13;SMAD4 p.L529Ffs*48	0	6
P-0010668	P-0010668-T01-IM5	In-House	FFPE	Biopsy	250	657	40	Matched	Metastasis	Parotid Gland	Lung	Tumor	HNMASC	Salivary Gland Cancer	Mammary Analogue Secretory Carcinoma of Salivary Gland Origin	Larotrectinib,Entrectinib(NTRK3 ETV6-NTRK3 fusion);Larotrectinib,Entrectinib(ETV6 ETV6-NTRK3 fusion)								LEVEL_1	KDM5C p.C14Lfs*54;NTRK3 ETV6-NTRK3 fusion;ETV6 ETV6-NTRK3 fusion	2	3
P-0010669	P-0010669-T01-IM5	In-House	FFPE	Biopsy	250	748	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.X307_splice	0	1
P-0010670	P-0010670-T01-IM5	In-House	FFPE	Biopsy	250	697	40	Matched	Primary	Cancer of Unknown Primary	Not available	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;ATR p.X878_splice;CDKN2A p.R80*;ARID5B Deletion;EPHA7 Deletion;FAT1 Deletion;FBXW7 Deletion;INPP4B Deletion;PTEN Deletion	4	9
P-0010671	P-0010671-T01-IM5	Outside	FFPE	Resection	250	630	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R);Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_3B	CTNNB1 p.S45F;PIK3CA p.H1047R;JAK1 p.K860Nfs*16;PTEN p.K267Rfs*9;ARID1A p.A339Lfs*24;ARID1A p.Q802Sfs*15;CTCF p.T204Nfs*26;CTCF p.R377C;PTCH1 p.R1308Efs*64;PTEN p.X70_splice;BCOR p.K1207Nfs*31;JAK1 p.N339Kfs*2;MED12 p.R605*;KMT2D p.K3140Rfs*2;NOTCH3 p.G1692Afs*13	4	15
P-0010672	P-0010672-T02-IM5	In-House	FFPE	Biopsy	250	1069	85	Matched	Primary	Lung	Not Applicable	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor										TP53 p.G105C;TBX3 p.X130_splice;SMARCA4 p.Q205*;TOP1 p.X682_splice;DICER1 p.K923Nfs*2;ARID1A p.A333Pfs*30;BCL2L1 Amplification;TCF7L2 Deletion;TERT Amplification	0	9
P-0010672	P-0010672-T01-IM5	Outside	FFPE	Cytology	250	485	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor										TP53 p.G105C;TBX3 p.X130_splice;SMARCA4 p.Q205*;TOP1 p.X682_splice;DICER1 p.K923Nfs*2;ARID1A p.A333Pfs*30	0	6
P-0010673	P-0010673-T01-IM5	Outside	FFPE	Resection	250	520	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C141Y;APC p.S1356*;SMAD3 p.X291_splice;SMAD2 p.A272Tfs*10;TET1 p.S1155Ifs*18	0	5
P-0010674	P-0010674-T01-IM5	In-House	FFPE	Biopsy	140.1	499	20	Matched	Metastasis	Kidney	Lung	Tumor	TRCC	Renal Cell Carcinoma	Translocation-Associated Renal Cell Carcinoma										TFE3 ASPSCR1-TFE3 fusion;ASPSCR1 ASPSCR1-TFE3 fusion	0	2
P-0010675	P-0010675-T01-IM5	In-House	FFPE	Resection	250	978	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.H773dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.H773dup)			LEVEL_3A	EGFR p.H773dup;TERT Amplification	1	2
P-0010676	P-0010676-T01-IM5	Outside	FFPE	Biopsy	250	669	40	Unmatched	Primary	Bone	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.E171G;ARID5B Deletion;BRCA2 Deletion;PTEN Deletion;RB1 Deletion	2	5
P-0010677	P-0010677-T01-IM5	In-House	FFPE	Biopsy	250	795	70	Matched	Primary	Tonsil	Not Applicable	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma										FBXW7 p.R689W	0	1
P-0010678	P-0010678-T01-IM5	In-House	FFPE	Biopsy	250	730	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 p.S464Gfs*99	0	1
P-0010679	P-0010679-T01-IM5	In-House	FFPE	Biopsy	250	653	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLBMESO	Mesothelioma	Pleural Mesothelioma, Biphasic Type										BAP1 p.X177_splice;BAP1 p.S319Yfs*16;MRE11 p.I93Ffs*17;NF2 p.L239Wfs*12	0	4
P-0010680	P-0010680-T01-IM5	In-House	FFPE	Resection	250	854	50	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108H);Olaparib(ATM p.R805*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	KRAS p.A146T;APC p.R213*;PIK3CA p.R108H;EP300 p.H2324Pfs*55;MAX p.R60Q;ATM p.R805*;APC p.V1452Yfs*21;CCND2 Amplification;KDM5A Amplification	3	9
P-0010681	P-0010681-T01-IM5	In-House	FFPE	Biopsy	250	1240	10	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;TP53 p.C242F;SMARCA4 p.R1093*	1	3
P-0010682	P-0010682-T01-IM5	Outside	FFPE	Biopsy	250	840	30	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.V173L;CDK6 Amplification;KMT2C MLL3-intragenic	0	3
P-0010683	P-0010683-T01-IM5	In-House	FFPE	Biopsy	59.34	493	20	Unmatched	Primary	Skin	Not Applicable	Tumor	MF	Soft Tissue Sarcoma	Myofibroma											0	0
P-0010684	P-0010684-T01-IM5	In-House	FFPE	Biopsy	250	1014	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			AZD9496,Fulvestrant(ESR1 p.D538G)						LEVEL_3A	ESR1 p.D538G;TP53 p.H179Y;MAP2K4 Deletion	1	3
P-0010685	P-0010685-T01-IM5	Outside	FFPE	Resection	250	893	80	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										SF3B1 p.R625C;GNAQ p.Q209P;EIF1AX p.X6_splice	0	3
P-0010686	P-0010686-T01-IM5	Outside	FFPE	Resection	250	893	50	Unmatched	Primary	Pelvis	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MEF2B p.K4E;BCL2L11 Deletion	0	2
P-0010687	P-0010687-T01-IM5	Outside	FFPE	Resection	250	1035	40	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0010688	P-0010688-T01-IM5	In-House	FFPE	Biopsy	250	1105	70	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PIK3R1 p.K567_L570del;FAT1 p.L3512*;EPHA7 p.G753Dfs*31;TP53 p.R213Yfs*34;CDKN2A Deletion;CDKN2B Deletion;PIK3CA Amplification	1	7
P-0010689	P-0010689-T01-IM5	In-House	FFPE	Biopsy	250	1182	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.L188Q;PBRM1 PBRM1-intragenic	1	3
P-0010690	P-0010690-T01-IM5	In-House	FFPE	Resection	250	1118	50	Matched	Primary	Ovary	Not Applicable	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.R273C	0	1
P-0010691	P-0010691-T01-IM5	Outside	FFPE	Resection	250	1067	20	Matched	Metastasis	Pancreas	Soft Tissue	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R248Q	1	2
P-0010692	P-0010692-T01-IM5	In-House	FFPE	Resection	250	772	70	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Everolimus(TSC1 p.R484Efs*48)					LEVEL_3B	TSC1 p.R484Efs*48	1	1
P-0010700	P-0010700-T01-IM5	In-House	FFPE	Biopsy	159.1	1095	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.S768_D770dup)			Erlotinib,Gefitinib,Afatinib(EGFR p.S768_D770dup)			LEVEL_3A	EGFR p.S768_D770dup;APC p.I224Kfs*26	1	2
P-0010701	P-0010701-T01-IM5	In-House	FFPE	Biopsy	250	1056	60	Matched	Metastasis	Gallbladder	Liver	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer				Everolimus(TSC2 p.S1454Kfs*69)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	TP53 p.G266E;TP53 p.R267Tfs*5;TSC2 p.S1454Kfs*69;AURKA Amplification;CDKN2A Deletion;CDKN2B Deletion;FANCC Deletion;NF1 Deletion;RASA1 Deletion;SRC Amplification;BCL2L11 BCL2L11-intragenic	3	11
P-0010702	P-0010702-T01-IM5	Outside	FFPE	Resection	250	587	30	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix											0	0
P-0010703	P-0010703-T01-IM5	In-House	FFPE	Resection	233.9	683	20	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047L)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L)						LEVEL_1	PIK3CA p.H1047L	2	1
P-0010704	P-0010704-T01-IM5	Outside	FFPE	Biopsy	250	905	60	Matched	Metastasis	Oral Cavity	Soft Tissue	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma			Tipifarnib(HRAS p.Q61K)						LEVEL_3A	HRAS p.Q61K;MAPK1 p.E322K;SETD2 p.R2077*;FBXW7 p.E531*;ARID2 p.X62_splice;FAT1 p.V623Gfs*53;ARID2 ARID2-intragenic	1	7
P-0010705	P-0010705-T01-IM5	In-House	FFPE	Resection	250	941	40	Matched	Metastasis	Ovary	Small Bowel	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.V272M	0	1
P-0010706	P-0010706-T01-IM5	In-House	FFPE	Resection	250	875	70	Matched	Metastasis	Breast	Brain	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma			Neratinib(ERBB2 p.L755S);Neratinib(ERBB2 p.S310Y)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S);Ado-Trastuzumab Emtansine(ERBB2 p.S310Y);Olaparib(PALB2 p.E12*);Olaparib(ATM Deletion)					LEVEL_3A	XPO1 p.E571K;U2AF1 p.S34F;ERBB2 p.L755S;ERBB2 p.S310Y;PPM1D p.S446*;PALB2 p.E12*;ZFHX3 p.S924*;CDH1 p.N174Kfs*25;ATM Deletion;BIRC3 Deletion;CCND1 Amplification;EED Deletion;FGF19 Amplification;MRE11 Deletion;SDHAF2 Deletion;SDHD Deletion	6	16
P-0010707	P-0010707-T01-IM5	In-House	FFPE	Biopsy	250	1039	70	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E542K;PTPRD p.G1868*;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0010708	P-0010708-T01-IM5	In-House	FFPE	Biopsy	250	1009	40	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Enasidenib(IDH2 p.R172G)					LEVEL_3B	IDH2 p.R172G;BAP1 p.N89Tfs*9	1	2
P-0010709	P-0010709-T01-IM5	In-House	FFPE	Biopsy	250	1210	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MAP3K1 p.Q951*	0	1
P-0010710	P-0010710-T01-IM5	In-House	FFPE	Biopsy	250	1136	40	Unmatched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.W91*;SMAD4 p.R361C;APC p.S1465Wfs*3;APC p.T1556Lfs*9;SMAD2 p.V160Yfs*3	3	6
P-0010711	P-0010711-T01-IM5	Outside	FFPE	Biopsy	250	957	60	Matched	Primary	Pharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.S94*;NOTCH3 p.R113*;CCND1 Amplification;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;FOXA1 Amplification;NKX2-1 Amplification;NOTCH1 Deletion;N4BP1 MAP3K1-N4BP1 fusion;MAP3K1 MAP3K1-N4BP1 fusion	1	12
P-0010712	P-0010712-T01-IM5	Outside	FFPE	Resection	250	855	40	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	MIXED	Cancer of Unknown Primary	Mixed Cancer Types				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;TP53 p.E271*;CTNNB1 p.S37F;SMARCA4 p.T910M;AXIN2 AXIN2-intragenic	1	5
P-0010713	P-0010713-T01-IM5	Outside	FFPE	Resection	250	973	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.R233*)				LEVEL_3B	PTEN p.R233*;CDK4 Amplification;GLI1 Amplification;KRAS Amplification;MDM2 Amplification	3	5
P-0010714	P-0010714-T01-IM5	Outside	FFPE	Resection	250	901	30	Matched	Primary	Soft Tissue	Not Applicable	Tumor	PLRMS	Soft Tissue Sarcoma	Pleomorphic Rhabdomyosarcoma											0	0
P-0010715	P-0010715-T01-IM5	In-House	FFPE	Biopsy	250	1357	50	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R273L;SMARCA4 p.T910M;B2M p.S40*;MAX p.E96*;CDKN2C p.E99*;IL7R p.I241V;CBL p.X197_splice;ZFHX3 p.E583*;NOTCH3 p.X227_splice;PPP2R1A p.W140R;KMT2D p.Q395Sfs*7;RECQL4 p.R370Afs*35;CCNE1 Amplification;FGFR1 Amplification	1	14
P-0010716	P-0010716-T01-IM5	In-House	FFPE	Resection	250	822	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	TP53 p.R248W;KRAS p.G12V;TGFBR2 p.R495*;BIRC3 p.T175Lfs*7	1	4
P-0010717	P-0010717-T01-IM5	Outside	FFPE	Biopsy	250	1197	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	THYC	Thymic Tumor	Thymic Carcinoma										KMT2D p.Q3717*	0	1
P-0010718	P-0010718-T01-IM5	Outside	FFPE	Resection	250	738	70	Matched	Primary	Maxilla	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										BCOR p.T1176*;TP53 p.T150Nfs*20;CCND2 Amplification;KDM5A Amplification	0	4
P-0010719	P-0010719-T01-IM5	In-House	FFPE	Resection	250	881	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.R248W	2	2
P-0010720	P-0010720-T01-IM5	In-House	FFPE	Biopsy	250	1012	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	GSK2636771,AZD8186(PTEN p.L247*)				LEVEL_3B	PIK3CA p.E545K;PTEN p.L247*;MYC Amplification	2	3
P-0010721	P-0010721-T01-IM5	Outside	FFPE	Resection	250	987	20	Matched	Primary	Lung	Not Applicable	Tumor	CMPT	Non-Small Cell Lung Cancer	Ciliated Muconodular Papillary Tumor of the Lung											0	0
P-0010722	P-0010722-T01-IM5	In-House	FFPE	Cytology	250	1146	30	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)		Trametinib,Cobimetinib(NF1 p.F1275Pfs*8);Trametinib,Cobimetinib(NF1 p.W561*)				LEVEL_1	NF1 p.F1275Pfs*8;NF1 p.W561*;MET p.X963_splice	5	3
P-0010723	P-0010723-T01-IM5	Outside	FFPE	Biopsy	95.7	665	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										KDM5C p.R198*	0	1
P-0010724	P-0010724-T01-IM5	Outside	FFPE	Biopsy	250	994	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0010725	P-0010725-T01-IM5	In-House	FFPE	Resection	250	723	70	Matched	Metastasis	Anus	Lymph Node, Regional	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma					Trametinib,Cobimetinib(NF1 p.X1612_splice)				LEVEL_4	NF1 p.X1612_splice	1	1
P-0010726	P-0010726-T01-IM5	Outside	FFPE	Resection	250	976	30	Matched	Metastasis	Unknown	Soft Tissue	Tumor	MUP	Melanoma	Melanoma of Unknown Primary					Trametinib,Cobimetinib(NF1 p.R440*);Trametinib,Cobimetinib(NF1 p.E1436K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.R440*;GRIN2A p.W771*;TP53 p.A86Vfs*55;NF1 p.E1436K;CIC p.W24*;ATRX p.E1268*;GRIN2A p.K1339Efs*27;GRIN2A p.W1014_K1015delins*;CDKN2A Deletion;CDKN2B Deletion	3	10
P-0010728	P-0010728-T02-IM5	In-House	FFPE	Cytology	250	858	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0010728	P-0010728-T01-IM5	Outside	FFPE	Biopsy	250	809	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0010729	P-0010729-T01-IM5	Outside	FFPE	Resection	250	688	80	Unmatched	Primary	Testis	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MYD88 p.L265P;PRDM1 p.X222_splice;CDKN2A Deletion;CDKN2B Deletion;NOTCH4 Deletion;PAX5 Amplification	0	6
P-0010730	P-0010730-T01-IM5	In-House	FFPE	Resection	250	782	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	STMYEC	Soft Tissue Sarcoma	Soft Tissue Myoepithelial Carcinoma										CDKN1B Deletion	0	1
P-0010731	P-0010731-T01-IM5	In-House	FFPE	Resection	250	529	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.M270Cfs*6)				LEVEL_4	PTEN p.M270Cfs*6;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	3
P-0010732	P-0010732-T01-IM5	Outside	FFPE	Biopsy	250	423	60	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										FOXO1 p.M1?;BCL2 p.A131T;KMT2D p.L5084Rfs*6	0	3
P-0010733	P-0010733-T01-IM5	In-House	FFPE	Biopsy	250	902	10	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;ARID1A p.Q1584*;PBRM1 p.R710*	1	3
P-0010734	P-0010734-T01-IM5	In-House	FFPE	Resection	250	845	50	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.G245S;APC p.S1465Wfs*3;APC p.R876*;AMER1 p.K92Rfs*8	0	4
P-0010735	P-0010735-T01-IM5	In-House	FFPE	Biopsy	250	970	20	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS											0	0
P-0010736	P-0010736-T01-IM5	In-House	FFPE	Biopsy	175	733	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.H179R;ARID1A p.E2078*;EP300 p.Q259*;NCOR1 p.N484Mfs*31;MSH2 p.L223Tfs*10;DDR2 Amplification	0	6
P-0010737	P-0010737-T01-IM5	In-House	FFPE	Biopsy	250	957	50	Matched	Metastasis	Skin	Foot	Tumor	ACRM	Melanoma	Acral Melanoma				Tipifarnib(HRAS p.G13R)					LEVEL_3B	HRAS p.G13R;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification;TERT Amplification	1	5
P-0010738	P-0010738-T01-IM5	Outside	FFPE	Resection	250	647	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R342*;CCNE1 Amplification;FGFR1 Amplification;MYC Amplification	1	4
P-0010739	P-0010739-T01-IM5	In-House	FFPE	Resection	250	741	70	Matched	Metastasis	Parotid Gland	Lung	Tumor	OSACA	Salivary Gland Cancer	Salivary Carcinoma, Other				Enasidenib(IDH2 p.R172W)					LEVEL_3B	IDH2 p.R172W;FLCN p.F150Cfs*49	1	2
P-0010740	P-0010740-T01-IM5	In-House	FFPE	Biopsy	250	829	60	Matched	Metastasis	Lung	Bone	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										RB1 p.X500_splice;TP53 p.H179Y;KMT2D KCNC2-MLL2 fusion;KCNC2 KCNC2-MLL2 fusion;CREBBP CREBBP-intragenic	0	5
P-0010741	P-0010741-T01-IM5	In-House	FFPE	Resection	250	790	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;RBM10 p.X145_splice;SETD2 p.H1762Lfs*26	1	3
P-0010742	P-0010742-T01-IM5	In-House	FFPE	Biopsy	250	1002	30	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12D)		Cetuximab,Panitumumab(NRAS p.G12D)			LEVEL_3B	TP53 p.R209Kfs*6;APC p.E1309Dfs*4;NRAS p.G12D;CDK8 Amplification;FLT3 Amplification;PRMT8 APC-PRMT8 fusion;APC APC-PRMT8 fusion	1	7
P-0010743	P-0010743-T01-IM5	In-House	FFPE	Resection	250	1028	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.G127R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.G127R;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	5
P-0010744	P-0010744-T01-IM5	In-House	FFPE	Resection	250	787	60	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Everolimus(TSC1 p.R509*)					LEVEL_3B	IDH1 p.R132H;NOTCH1 p.A465T;TSC1 p.R509*;CREBBP p.X406_splice;CIC p.R202W;PBRM1 p.X363_splice;TET2 p.Q640*;HGF p.G229D;KMT2C p.X541_splice;ARID2 p.X572_splice;TP53 p.P153L;TP53 p.T140I;VHL p.Y98Lfs*34	2	13
P-0010745	P-0010745-T01-IM5	In-House	FFPE	Resection	250	716	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	FGFR1 Amplification;MYC Amplification;PTEN Deletion;RB1 Deletion	2	4
P-0010746	P-0010746-T01-IM5	In-House	FFPE	Biopsy	250	1191	30	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106_N107delinsVS)					LEVEL_3B	CTNNB1 p.D32A;PIK3CA p.G106_N107delinsVS;AR Amplification	1	3
P-0010747	P-0010747-T01-IM5	In-House	FFPE	Biopsy	250	966	40	Matched	Metastasis	Appendix	Abdomen	Tumor	SRAP	Appendiceal Cancer	Signet Ring Cell Type of the Appendix										CDH1 p.D254N;TP53 p.X187_splice	0	2
P-0010748	P-0010748-T01-IM5	Outside	FFPE	Resection	250	889	60	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L	0	1
P-0010749	P-0010749-T01-IM5	In-House	FFPE	Resection	250	840	20	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.C141Y;APC p.E1353Vfs*19	0	2
P-0010750	P-0010750-T01-IM5	In-House	FFPE	Biopsy	250	916	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.E51*;SMAD4 p.D351V;ARID2 p.Q1620*;EGFR Amplification	2	6
P-0010751	P-0010751-T01-IM5	In-House	FFPE	Resection	250	727	20	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.G245S;APC p.R216*;APC p.Q1294*;SOX9 p.Y451*	0	4
P-0010752	P-0010752-T01-IM5	In-House	FFPE	Resection	250	597	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.G251_F254del	0	1
P-0010753	P-0010753-T01-IM5	Outside	FFPE	Resection	250	908	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Olaparib(RAD51B Deletion)					LEVEL_3B	ARID1B Deletion;CDKN2C Deletion;DICER1 Deletion;MAX Deletion;MYCL Amplification;NTRK1 Amplification;PRDM1 Deletion;RAD51B Deletion;TNFAIP3 Deletion	1	9
P-0010754	P-0010754-T01-IM5	Outside	FFPE	Resection	250	607	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SF3B1 p.K700E;ARID1A p.E2145*;GATA3 p.R330Mfs*20	0	3
P-0010755	P-0010755-T01-IM5	In-House	FFPE	Biopsy	250	1086	30	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	HNSCUP	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma of Unknown Primary										RB1 p.R251*	0	1
P-0010756	P-0010756-T01-IM5	In-House	FFPE	Resection	250	830	70	Matched	Primary	Pancreas	Not Applicable	Tumor	IPMN	Pancreatic Cancer	Intraductal Papillary Mucinous Neoplasm				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0010757	P-0010757-T01-IM5	Outside	FFPE	Biopsy	140.4	631	60	Matched	Primary	Sacral Mass	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma										KMT2A p.X1406_splice	0	1
P-0010758	P-0010758-T01-IM5	In-House	FFPE	Biopsy	250	1066	60	Matched	Metastasis	Breast	Soft Tissue	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS		Talazoparib,Olaparib(BRCA1 p.V1654Cfs*4)		Niraparib,Rucaparib(BRCA1 p.V1654Cfs*4)					LEVEL_2	BRCA1 p.V1654Cfs*4;TP53 p.P85Vfs*35;BCL2L1 Amplification;DNMT3B Amplification;ERRFI1 Deletion;MYC Amplification;PHOX2B Deletion;EP300 EP300-intragenic	2	8
P-0010759	P-0010759-T01-IM5	In-House	FFPE	Cytology	107	724	60	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SYNS	Soft Tissue Sarcoma	Synovial Sarcoma											0	0
P-0010760	P-0010760-T01-IM5	In-House	FFPE	Biopsy	250	1001	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	TP53 p.R175H;CASP8 p.S386*;CASP8 p.R435*;MYC Amplification;ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	6
P-0010761	P-0010761-T01-IM5	In-House	FFPE	Resection	250	740	20	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma	Pemigatinib(PHC1 FGFR2-PHC1 fusion);Pemigatinib(FGFR2 FGFR2-PHC1 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(PHC1 FGFR2-PHC1 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-PHC1 fusion)						LEVEL_1	PHC1 FGFR2-PHC1 fusion;FGFR2 FGFR2-PHC1 fusion	4	2
P-0010762	P-0010762-T01-IM5	Outside	FFPE	Resection	171.9	172	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer											0	0
P-0010763	P-0010763-T01-IM5	In-House	FFPE	Resection	250	1049	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.V157F;MGA p.E1130*	0	2
P-0010764	P-0010764-T01-IM5	Outside	FFPE	Biopsy	250	593	60	Matched	Metastasis	Salivary Gland	Lung	Tumor	EMYOCA	Head and Neck Cancer	Epithelial-Myoepithelial Carcinoma											0	0
P-0010765	P-0010765-T01-IM5	In-House	FFPE	Biopsy	59.67	672	20	Matched	Metastasis	Lung	Neck	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Everolimus(TSC2 p.Q883*)		Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.E746_A750del;TP53 p.H179Y;MGA p.S2127*;MSH6 p.Q572*;TSC2 p.Q883*	3	6
P-0010779	P-0010779-T01-IM5	Outside	FFPE	Resection	250	800	20	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma										DNMT3A p.R882C;CREBBP p.C1783Afs*16;TP53 p.X261_splice	0	3
P-0010780	P-0010780-T01-IM5	Outside	FFPE	Resection	250	928	40	Matched	Primary	Spine	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma											0	0
P-0010781	P-0010781-T01-IM5	Outside	FFPE	Biopsy	250	973	20	Matched	Metastasis	Cecum	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										SMAD4 p.R361C;SMAD4 p.R445*;RHOA p.G17E;EP300 p.M2239Ifs*35	0	4
P-0010782	P-0010782-T01-IM5	In-House	FFPE	Resection	250	742	30	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma		Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)		Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Capecitabine+Trastuzumab+Tucatinib,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_2	TP53 p.R273H;KRAS p.G12D;PIK3CA p.R88Q;AKT1 Amplification;ERBB2 Amplification;MYC Amplification;NBN TMEM64-NBN fusion;TMEM64 TMEM64-NBN fusion	4	8
P-0010783	P-0010783-T01-IM5	Outside	FFPE	Resection	250	1020	50	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.K654Sfs*47)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KMT2D p.V3089Wfs*30;KRAS p.G12D;TP53 p.R248W;JAK1 p.K860Nfs*16;RNF43 p.G659Vfs*41;PAX5 p.V26G;JAK1 p.P430Rfs*2;KMT2D p.P2354Lfs*30;NBN p.R551Gfs*8;KMT2D p.G1235Vfs*95;ASXL1 p.G645Vfs*58;SETD2 p.S2382Lfs*29;BRCA1 p.K654Sfs*47;TCF7L2 p.K485Sfs*23;CIC p.S1117Kfs*34;FAT1 p.P1877Lfs*20;NCOR1 p.E529Rfs*7;NOTCH4 p.P1306Qfs*3;TP53 p.F134L;CIC p.T1541Lfs*79;SPEN p.R1371*;RAC1 p.A159V;CREBBP p.R1446S;CREBBP p.S1065*;JAK1 p.G673Vfs*30;TNFAIP3 p.V288Ffs*4	2	26
P-0010784	P-0010784-T01-IM5	In-House	FFPE	Biopsy	250	1161	30	Matched	Metastasis	Cervix	Lung	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma										RAD21 p.Q568*;RAD21 p.Q561*;RB1 p.R544*;YAP1 Amplification	0	4
P-0010785	P-0010785-T01-IM5	In-House	FFPE	Resection	250	896	NA	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Q709L)	Neratinib(ERBB2 p.Q709L)						LEVEL_2	TP53 p.T155N;ERBB2 p.Q709L	2	2
P-0010786	P-0010786-T01-IM5	Outside	FFPE	Biopsy	250	996	60	Matched	Primary	Cervix	Not Applicable	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma										LATS1 p.R148*;FBXW7 p.X243_splice;HLA-A p.E288*	0	3
P-0010787	P-0010787-T01-IM5	Outside	FFPE	Biopsy	250	990	40	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma					Trametinib,Cobimetinib(NF1 p.Y2285Tfs*5);Trametinib,Cobimetinib(NF1 p.C167Qfs*10)				LEVEL_4	NF1 p.Y2285Tfs*5;NF1 p.C167Qfs*10	2	2
P-0010788	P-0010788-T01-IM5	Outside	FFPE	Resection	250	751	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.H179Y;SMAD4 p.P130S;RNF43 p.P192Rfs*11	1	4
P-0010789	P-0010789-T01-IM5	In-House	FFPE	Resection	250	777	65	Matched	Metastasis	Gallbladder	Lymph Node	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										TP53 p.V216G;KEAP1 p.Y567*	0	2
P-0010790	P-0010790-T01-IM5	In-House	FFPE	Resection	250	838	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R282W	1	2
P-0010791	P-0010791-T01-IM5	In-House	FFPE	Biopsy	157.6	879	75	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Everolimus(TSC1 p.X170_splice)					LEVEL_3B	TP53 p.X225_splice;TSC1 p.X170_splice;VHL p.G123Hfs*35	1	3
P-0010792	P-0010792-T01-IM5	In-House	FFPE	Resection	109	106	75	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C;TP53 p.V172F;ATRX p.K2096Sfs*12	1	3
P-0010793	P-0010793-T01-IM5	In-House	FFPE	Biopsy	250	1060	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)					Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;EGFR p.L858R;RB1 p.W681*;TP53 p.X331_splice;EGFR Amplification;EZH2 Amplification;TGFBR2 Deletion	2	7
P-0010794	P-0010794-T01-IM5	Outside	FFPE	Resection	250	671	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0010795	P-0010795-T01-IM5	Outside	FFPE	Resection	250	497	50	Matched	Metastasis	Ovary	Soft Tissue	Tumor	VYST	Germ Cell Tumor	Yolk Sac Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0010796	P-0010796-T01-IM5	In-House	FFPE	Biopsy	250	930	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										CDKN1B Deletion;GPS2 Deletion;PTPRD Deletion;TBX3 Deletion;TP53 Deletion;ZFHX3 Deletion;MGA MGA-intragenic;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	9
P-0010797	P-0010797-T01-IM5	Outside	FFPE	Resection	250	929	85	Matched	Metastasis	Thyroid	Lung	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer										DNMT3A p.R736H;TP53 p.F134Lfs*14	0	2
P-0010798	P-0010798-T01-IM5	In-House	FFPE	Resection	250	859	45	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	FBXW7 p.S668Vfs*39;B2M p.V69Wfs*34;ARID1A p.D1850Tfs*33;RNF43 p.G659Vfs*41;ASXL1 p.G646Wfs*12;B2M p.L15Ffs*41;PIK3CA p.Q546R;KRAS p.G13D;TCF7L2 p.K485Sfs*23;APC p.Q260*;NOTCH2 p.N1999Mfs*32;APC p.K581Rfs*9	2	12
P-0010799	P-0010799-T01-IM5	In-House	FFPE	Biopsy	250	1167	50	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS											0	0
P-0010800	P-0010800-T01-IM5	Outside	FFPE	Resection	250	706	30	Matched	Metastasis	Breast	Lymph Node	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;CDH1 p.G62Rfs*32	2	2
P-0010801	P-0010801-T01-IM5	Outside	FFPE	Resection	250	840	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.Q144*	1	2
P-0010802	P-0010802-T01-IM5	In-House	FFPE	Resection	250	817	65	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion;ERRFI1 Deletion;KDR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification;PTEN Deletion	3	10
P-0010803	P-0010803-T01-IM5	In-House	FFPE	Resection	250	764	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.G380R);Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542V);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.K339Rfs*2);Everolimus(TSC2 p.E929Rfs*19)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);Tazemetostat(KDM6A p.S637Tfs*53)				LEVEL_1	PTEN p.K267Rfs*9;ARID1A p.D1850Tfs*33;NOTCH3 p.P695Rfs*165;JAK1 p.K142Rfs*26;CTCF p.T204Nfs*26;FGFR3 p.G380R;ARID1A p.G276Efs*87;FGFR3 p.R248C;BRAF p.G466E;PIK3CA p.H1047Y;TCF7L2 p.K485Sfs*23;SMARCA4 p.R1157W;TET2 p.R1452*;SMARCA4 p.M272Cfs*31;SMAD2 p.S276L;ZFHX3 p.E763Gfs*26;PIK3CA p.E542V;ARID1B p.Q1980*;RAB35 p.A151T;CREBBP p.R2004*;STK11 p.X125_splice;MED12 p.X659_splice;ARID1B p.G1071Lfs*33;ARID1A p.G314Afs*49;MSH2 p.C176Vfs*38;BRCA1 p.K339Rfs*2;ARID1A p.N209Kfs*191;TSC2 p.E929Rfs*19;CDKN1B p.Q65Sfs*60;FBXW7 p.D300Rfs*17;STAG2 p.K1074Nfs*31;KMT2D p.V2510Rfs*34;KDM6A p.S637Tfs*53	9	33
P-0010804	P-0010804-T01-IM5	In-House	FFPE	Resection	250	738	15	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R248W	1	2
P-0010805	P-0010805-T01-IM5	Outside	FFPE	Resection	250	812	75	Matched	Metastasis	Skin	Lymph Node, Non-Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)						LEVEL_3A	NRAS p.Q61L;ARID1A p.Q1342*	1	2
P-0010806	P-0010806-T01-IM5	In-House	FFPE	Resection	250	766	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma											0	0
P-0010807	P-0010807-T01-IM5	Outside	FFPE	Resection	250	869	35	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CDH1 p.X278_splice;CCND1 Amplification;FGF19 Amplification	2	4
P-0010808	P-0010808-T01-IM5	Outside	FFPE	Cytology	250	889	80	Matched	Metastasis	Breast	Pleural Fluid	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma											0	0
P-0010809	P-0010809-T01-IM5	Outside	FFPE	Biopsy	250	828	65	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.E545K;TP53 p.E56*;KMT2D p.R5179P;CDH1 p.D768*;STAG2 p.T395Lfs*29;ERBB2 Amplification	4	6
P-0010810	P-0010810-T01-IM5	In-House	FFPE	Resection	250	843	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										RHOA p.Y42S	0	1
P-0010811	P-0010811-T01-IM5	In-House	FFPE	Resection	250	733	65	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0010812	P-0010812-T01-IM5	Outside	FFPE	Resection	250	783	75	Matched	Metastasis	Colon	Peritoneum	Tumor	HGNEC	Gastrointestinal Neuroendocrine Tumor	High-Grade Neuroendocrine Carcinoma of the Colon and Rectum				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Everolimus(TSC2 PKD1-TSC2 fusion);Everolimus(PKD1 PKD1-TSC2 fusion)					LEVEL_3B	TP53 p.R196*;BRAF p.V600E;ARID2 p.R1769*;RNF43 p.R117Pfs*8;MYC Amplification;SMAD4 Deletion;TSC2 PKD1-TSC2 fusion;PKD1 PKD1-TSC2 fusion	3	8
P-0010813	P-0010813-T01-IM5	In-House	FFPE	Biopsy	250	1045	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)						LEVEL_3A	BAP1 p.R356Pfs*63;TP53 p.A83Gfs*66;FAT1 p.A3923Wfs*3;FAT1 p.M1149_E1150delinsI*;FGFR1 Amplification	1	5
P-0010814	P-0010814-T01-IM5	In-House	FFPE	Biopsy	250	1115	75	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;TP53 p.V216G;SMAD4 p.G510E;AMER1 Deletion;CDK6 Amplification;CDKN2A Deletion;CDKN2B Deletion	2	7
P-0010815	P-0010815-T01-IM5	Outside	FFPE	Biopsy	250	747	85	Unmatched	Primary	Lymph node	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										TP53 p.R196*;KMT2D p.R2771*	0	2
P-0010816	P-0010816-T01-IM5	In-House	FFPE	Biopsy	250	1233	85	Matched	Primary	Palate	Not Applicable	Tumor	OPHSC	Head and Neck Cancer	Oropharynx Squamous Cell Carcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.S90Lfs*59;KMT2D p.X170_splice;ANKRD11 p.E1687Kfs*10;CDKN2A Deletion;CDKN2B Deletion;ERBB2 Amplification;RB1 Deletion;RICTOR Amplification;TGFBR2 Deletion;YAP1 Amplification	2	10
P-0010817	P-0010817-T01-IM5	In-House	FFPE	Resection	250	760	25	Matched	Primary	Larynx	Not Applicable	Tumor	LXSC	Head and Neck Cancer	Larynx Squamous Cell Carcinoma				Olaparib(PALB2 PALB2-intragenic)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NFE2L2 p.G31E;TP53 p.S149Pfs*21;NOTCH1 p.C440W;KMT2D p.P3893Rfs*120;KMT2D p.Q4239Dfs*94;TP53 p.C124Lfs*25;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;PALB2 PALB2-intragenic	2	11
P-0010818	P-0010818-T01-IM5	In-House	FFPE	Biopsy	250	1137	25	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Trametinib,Cobimetinib(MAP2K1 p.N109_R113del)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D153N)				LEVEL_3A	MAP2K1 p.N109_R113del;SRSF2 p.P95L;NOTCH2 p.C842*;CDKN2A p.D153N	2	4
P-0010819	P-0010819-T01-IM5	In-House	FFPE	Resection	250	810	75	Matched	Primary	Epidural	Not Applicable	Tumor	CHDM	Bone Cancer	Chordoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C901F)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.C901F;NBN p.X691_splice;CDKN2A Deletion	2	3
P-0010820	P-0010820-T01-IM5	In-House	FFPE	Resection	250	813	70	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer					Trametinib,Cobimetinib(NF1 p.Q347*)				LEVEL_4	NF1 p.Q347*	1	1
P-0010821	P-0010821-T01-IM5	In-House	FFPE	Resection	250	632	55	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.X221_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;ATM p.X221_splice	3	2
P-0010822	P-0010822-T01-IM5	In-House	FFPE	Biopsy	250	1246	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification);Olaparib(CDK12 CDK12-intragenic)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 CDK12-intragenic)				LEVEL_3B	CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;MDM2 Amplification;MYC Amplification;PAK1 Amplification;SRC Amplification;CDK12 CDK12-intragenic	4	8
P-0010823	P-0010823-T01-IM5	In-House	FFPE	Biopsy	250	1009	30	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.F266C;TP53 p.C275G;AR Amplification;CCNE1 Amplification;MYC Amplification;RHEB Amplification	0	6
P-0010824	P-0010824-T01-IM5	Outside	FFPE	Biopsy	250	972	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(RB1 CDKN2A-RB1 fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2A-RB1 fusion)				LEVEL_4	KRAS p.G12V;MAP2K4 Deletion;RB1 CDKN2A-RB1 fusion;CDKN2A CDKN2A-RB1 fusion;KDM6A HHIP-KDM6A fusion;HHIP HHIP-KDM6A fusion	3	6
P-0010825	P-0010825-T01-IM5	In-House	FFPE	Biopsy	250	945	20	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma											0	0
P-0010826	P-0010826-T01-IM5	In-House	FFPE	Resection	250	767	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Poziotinib(EGFR p.P772_H773insTPNP)	Tazemetostat(KDM6A p.Q301*)				LEVEL_3B	PIK3CA p.E542K;KDM6A p.Q301*;FOXP1 p.R514H;EGFR p.P772_H773insTPNP	3	4
P-0010827	P-0010827-T01-IM5	Outside	FFPE	Resection	250	1016	30	Matched	Metastasis	Esophagus	Lung	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.E294*;AR p.Q876K;ARID1A p.Y454Mfs*165;ERBB2 Amplification;VEGFA Amplification	2	5
P-0010828	P-0010828-T01-IM5	In-House	FFPE	Resection	250	999	25	Matched	Metastasis	Uterus	Lymph Node	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252W);GSK2636771,AZD8186(PTEN p.Q298Kfs*9)				LEVEL_3B	JAK1 p.K860Nfs*16;FGFR2 p.S252W;CTCF p.T204Nfs*26;ARID1A p.Q1519Rfs*8;PIK3CA p.R88Q;ANKRD11 p.K1461del;BLM p.F194Lfs*11;PTEN p.Q298Kfs*9;ARID1A p.M2166Tfs*27;MED12 p.K1771Nfs*44	3	10
P-0010829	P-0010829-T01-IM5	In-House	FFPE	Biopsy	250	1260	35	Matched	Metastasis	Pelvis	Lung	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										BCOR Deletion	0	1
P-0010830	P-0010830-T01-IM5	Outside	FFPE	Biopsy	105.1	487	70	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										CREBBP p.Q203*;MEN1 p.M239Gfs*14;CDKN1A Deletion	0	3
P-0010831	P-0010831-T01-IM5	In-House	FFPE	Resection	250	625	30	Unmatched	Primary	Lymph node	Not Applicable	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms											0	0
P-0010832	P-0010832-T01-IM5	Outside	FFPE	Resection	250	440	35	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;SMAD4 p.R361C;TP53 p.R213Dfs*34	2	3
P-0010833	P-0010833-T01-IM5	In-House	FFPE	Biopsy	250	975	25	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3B	SUFU p.A25Gfs*23;FBXW7 p.S668Vfs*39;PIK3CA p.E545K;KMT2A p.P773Rfs*8;APC p.R1450*;CTCF p.T204Nfs*26;KRAS p.G13D;PAX5 p.A322Rfs*19;APC p.E1059*	2	9
P-0010834	P-0010834-T01-IM5	Outside	FFPE	Resection	250	609	80	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G)					LEVEL_3B	PIK3CA p.E545G;TGFBR2 Deletion	1	2
P-0010835	P-0010835-T01-IM5	Outside	FFPE	Biopsy	250	1051	60	Matched	Primary	Cervix	Not Applicable	Tumor	CESC	Cervical Cancer	Cervical Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310Y)					LEVEL_3B	PIK3CA p.E453K;ERBB2 p.S310F;ERBB2 p.S310Y	3	3
P-0010836	P-0010836-T01-IM5	In-House	FFPE	Resection	250	956	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R	1	1
P-0010837	P-0010837-T02-IM5	Outside	FFPE	Cytology	102.2	383	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.N71Kfs*49)				LEVEL_4	KRAS p.G12V;TP53 p.Y220C;CDKN2A p.N71Kfs*49	2	3
P-0010838	P-0010838-T01-IM5	Outside	FFPE	Resection	250	1165	85	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)		Tazemetostat(KDM6A p.G722*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;PMS2 p.Q567*;MED12 p.E33Q;KDM6A p.G722*;CDKN2A Deletion;CDKN2B Deletion;PAX5 Deletion;PTPRD Deletion	4	8
P-0010839	P-0010839-T01-IM5	Outside	FFPE	Cytology	191	875	10	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;TP53 p.R209Kfs*6;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0010840	P-0010840-T02-IM5	In-House	FFPE	Cytology	250	313	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12A;RBM10 p.X565_splice;STK11 p.E120*;CDKN2A Deletion;CDKN2B Deletion;EPHA7 Deletion;SMARCA4 Deletion	2	7
P-0010841	P-0010841-T01-IM5	In-House	FFPE	Resection	250	817	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G776delinsVV)	Neratinib(ERBB2 p.G776delinsVV)						LEVEL_2	ERBB2 p.G776delinsVV;TERT Amplification	2	2
P-0010842	P-0010842-T01-IM5	Outside	FFPE	Biopsy	250	1031	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0010843	P-0010843-T01-IM5	Outside	FFPE	Resection	250	827	75	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;DNMT3B p.V229M;FGFR3 Amplification	2	3
P-0010844	P-0010844-T01-IM5	Outside	FFPE	Biopsy	250	1091	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	TP53 p.M246V;KRAS p.G13C	1	2
P-0010845	P-0010845-T01-IM5	In-House	FFPE	Resection	250	721	65	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										ARID1A p.H203Rfs*196	0	1
P-0010846	P-0010846-T01-IM5	In-House	FFPE	Biopsy	250	1320	15	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										SMARCA4 SMARCA4-intragenic	0	1
P-0010847	P-0010847-T01-IM5	Outside	FFPE	Biopsy	250	621	80	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Olaparib(ATM p.R337C)	Trametinib,Cobimetinib(NF1 p.R440*);Trametinib,Cobimetinib(NF1 p.R1241*)				LEVEL_3B	ATM p.R337C;NF1 p.R440*;NF1 p.R1241*;FAT1 Deletion;GATA3 Deletion;MITF Amplification;PAX5 Deletion	3	7
P-0010848	P-0010848-T01-IM5	Outside	FFPE	Resection	250	621	70	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	GSK2636771,AZD8186(PTEN p.T319*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;PTEN p.T319*;JAK1 p.T1100Qfs*6;ARID1A p.Q2212*;CDKN2A Deletion;CDKN2B Deletion	4	6
P-0010849	P-0010849-T01-IM5	In-House	FFPE	Resection	250	784	75	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Q136*;RB1 p.X350_splice;EP300 p.Q341*	0	3
P-0010850	P-0010850-T01-IM5	In-House	FFPE	Resection	250	963	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;EGFR Amplification;PTEN Deletion;RB1 Deletion	3	6
P-0010851	P-0010851-T01-IM5	Outside	FFPE	Biopsy	203	769	50	Matched	Primary	Cancer of Unknown Primary	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132L)						LEVEL_3A	IDH1 p.R132L	1	1
P-0010852	P-0010852-T01-IM5	Outside	FFPE	Cytology	250	1353	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12R;TP53 p.C238*;SMAD4 p.K122Nfs*4;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0010853	P-0010853-T01-IM5	Outside	FFPE	Biopsy	250	877	15	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P81L)				LEVEL_1	CDKN2A p.P81L;ERBB2 Amplification	3	2
P-0010854	P-0010854-T01-IM5	In-House	FFPE	Cytology	132	769	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R);Trametinib,Cobimetinib,Binimetinib(KRAS p.S65N)				LEVEL_4	KRAS p.Q61R;TP53 p.R213L;KRAS p.S65N	2	3
P-0010855	P-0010855-T01-IM5	In-House	FFPE	Biopsy	53.775	817	40	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TGFBR1 p.R487W;TP53 p.S240G;WT1 p.S325*	0	3
P-0010856	P-0010856-T01-IM5	Outside	FFPE	Resection	250	832	20	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification	2	2
P-0010857	P-0010857-T01-IM5	Outside	FFPE	Biopsy	250	1145	15	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.N310Tfs*35;KMT2D p.A3427Pfs*6;RECQL4 p.N352Qfs*20;IKZF1 Deletion;TGFBR2 Deletion	0	5
P-0010858	P-0010858-T01-IM5	In-House	FFPE	Resection	250	792	20	Matched	Primary	Stomach	Not Applicable	Tumor	TSTAD	Esophagogastric Cancer	Tubular Stomach Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64)					LEVEL_3B	GNAS p.R201C;CTCF p.T204Nfs*26;KMT2D p.P2354Lfs*30;TP53 p.H168R;TP53 p.R267W;PTCH1 p.R1308Efs*64;DNMT3B p.R380*;ASXL1 p.P229Rfs*3;KMT2D p.L4463_K4465delins*;ARID1A p.Y1055Cfs*49	1	10
P-0010859	P-0010859-T01-IM5	Outside	FFPE	Resection	250	561	40	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;KMT2D p.V1033Ffs*23	1	2
P-0010860	P-0010860-T02-IM5	In-House	FFPE	Biopsy	250	840	20	Matched	Metastasis	Parotid Gland	Lymph Node	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E);Trametinib,Cobimetinib(NF1 p.S168*)				LEVEL_3B	BRAF p.K601E;MAP3K1 p.Q965*;MGA p.S2613*;NF1 p.S168*;PIK3CB Amplification	3	5
P-0010860	P-0010860-T01-IM5	In-House	FFPE	Resection	250	872	NA	Matched	Primary	Parotid Gland	Not Applicable	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3B	BRAF p.K601E	2	1
P-0010861	P-0010861-T01-IM5	In-House	FFPE	Biopsy	250	991	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Everolimus(TSC2 p.K821*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	FBXW7 p.R505C;NCOR1 p.E529Kfs*26;KRAS p.G12V;TP53 p.R282W;CTCF p.R377C;TSC2 p.K821*;MGA p.P2257Lfs*78;PRDM1 p.K8Nfs*17;KMT2D p.F2494Sfs*49	2	9
P-0010862	P-0010862-T01-IM5	Outside	FFPE	Resection	250	742	50	Matched	Primary	Thyroid	Not Applicable	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer										ASXL1 p.T880Nfs*2	0	1
P-0010863	P-0010863-T01-IM5	In-House	FFPE	Biopsy	250	1333	40	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice);Crizotinib(MET Amplification)	Cabozantinib(MET p.X1010_splice)	Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_1	MET p.X1010_splice;MET Amplification	5	2
P-0010864	P-0010864-T01-IM5	Outside	FFPE	Resection	250	1253	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.T319*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.T319*;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0010865	P-0010865-T01-IM5	Outside	FFPE	Biopsy	250	682	80	Matched	Primary	Pharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										NOTCH1 p.I471T	0	1
P-0010866	P-0010866-T01-IM5	In-House	FFPE	Resection	250	914	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib,Rucaparib(BRCA2 p.D1199Vfs*9)	Talazoparib,Niraparib(BRCA2 p.D1199Vfs*9)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3A	KRAS p.G12V;SMAD4 p.X380_splice;BRCA2 p.D1199Vfs*9	3	3
P-0010867	P-0010867-T01-IM5	Outside	FFPE	Biopsy	243.6	957	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas										CTNNB1 p.S37C	0	1
P-0010868	P-0010868-T01-IM5	Outside	FFPE	Resection	250	832	50	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;FGFR1 Amplification	2	2
P-0010869	P-0010869-T01-IM5	In-House	FFPE	Resection	250	840	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R	2	1
P-0010870	P-0010870-T01-IM5	In-House	FFPE	Resection	250	742	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0010890	P-0010890-T01-IM5	In-House	FFPE	Resection	250	662	75	Matched	Primary	Kidney	Not Applicable	Tumor	RAML	Renal Cell Carcinoma	Renal Angiomyolipoma				Everolimus(TSC2 p.E1366Rfs*17)					LEVEL_3B	TSC2 p.E1366Rfs*17	1	1
P-0010891	P-0010891-T01-IM5	Outside	FFPE	Cytology	250	881	15	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.D770_N771insY)			Erlotinib,Gefitinib,Afatinib(EGFR p.D770_N771insY)			LEVEL_3A	EGFR p.D770_N771insY	1	1
P-0010892	P-0010892-T01-IM5	In-House	FFPE	Cytology	231	1020	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.G1090*)				LEVEL_4	TP53 p.R248L;APC p.G502*;NF1 p.G1090*	1	3
P-0010893	P-0010893-T01-IM5	Outside	FFPE	Resection	250	940	50	Matched	Primary	Testis	Not Applicable	Tumor	NSGCT	Germ Cell Tumor	Non-Seminomatous Germ Cell Tumor										TERT Amplification	0	1
P-0010894	P-0010894-T01-IM5	In-House	FFPE	Cytology	226.1	989	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1007_splice)	Crizotinib(MET p.X1007_splice)	Cabozantinib(MET p.X1007_splice)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	PIK3CA p.E545K;RB1 p.Y239Lfs*25;MET p.X1007_splice;TP53 Deletion	4	4
P-0010895	P-0010895-T01-IM5	In-House	FFPE	Resection	250	1229	65	Matched	Metastasis	Breast	Lung	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	AMER1 p.R871*;AURKA Amplification;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;FGFR3 Amplification	2	6
P-0010896	P-0010896-T01-IM5	Outside	FFPE	Biopsy	95.4	435	70	Matched	Metastasis	Lung	Liver	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor										ARID1A p.Q450*	0	1
P-0010897	P-0010897-T01-IM5	Outside	FFPE	Resection	250	815	80	Matched	Primary	Brain	Not Applicable	Tumor	HGGNOS	Glioma	High-Grade Glioma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CCND2 Amplification;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;GLI1 Amplification;KRAS Amplification;MDM2 Amplification	3	8
P-0010898	P-0010898-T01-IM5	In-House	FFPE	Biopsy	250	1197	20	Unmatched	Metastasis	Ascending Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R342*;FBXW7 p.R278*;KRAS p.G13D;RAD50 p.S514*;ASXL1 p.R1415*;APC p.S1042Lfs*2;APC p.K1468*	1	7
P-0010899	P-0010899-T01-IM5	In-House	FFPE	Biopsy	250	1073	80	Matched	Metastasis	Pancreas	liver	Tumor	PAAC	Pancreatic Cancer	Acinar Cell Carcinoma of the Pancreas				Ivosidenib(IDH1 p.R132C);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	IDH1 p.R132C;GNAS p.R201H;CTNNB1 p.G34R;PBRM1 p.I279Yfs*4;KMT2D p.Q3333*;SPOP p.X280_splice;FGFR1 Amplification	2	7
P-0010900	P-0010900-T01-IM5	Outside	FFPE	Resection	250	426	70	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R	1	1
P-0010901	P-0010901-T01-IM5	In-House	FFPE	Biopsy	250	938	75	Matched	Metastasis	Lung	Adrenal Gland	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.Y220C;PTPRD p.E721*;NOTCH1 p.X1171_splice;RB1 p.Q266*;MYCL Amplification	0	5
P-0010902	P-0010902-T01-IM5	Outside	FFPE	Resection	250	1058	40	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R	1	1
P-0010903	P-0010903-T01-IM5	Outside	FFPE	Biopsy	250	1164	60	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer				Olaparib(ATM p.E2366Dfs*6)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108H)				LEVEL_3B	TP53 p.R273H;TP53 p.E294*;KMT2C p.E2231*;ATM p.E2366Dfs*6;CDKN2A p.D108H;BCL2L1 Amplification;CCND1 Amplification;DNMT3B Amplification;FGF19 Amplification;FOXA1 Amplification;KDR Amplification;KIT Amplification;NKX2-1 Amplification	2	13
P-0010904	P-0010904-T01-IM5	In-House	FFPE	Biopsy	250	1184	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3B	MGA p.L754Ffs*6;KDM5C p.M1119Sfs*25;CDK4 Amplification;KRAS Amplification;NKX2-1 Amplification;TERT Amplification	1	6
P-0010911	P-0010911-T01-IM5	Outside	FFPE	Resection	250	773	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.G165R)				LEVEL_4	DDR2 p.G505S;PTEN p.G165R;MDM4 Amplification	1	3
P-0010912	P-0010912-T01-IM5	Outside	FFPE	Biopsy	250	1104	60	Matched	Metastasis	Breast	Liver	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										HIST1H1C p.E115K;CCND1 Amplification;DNMT3B Amplification;FGF19 Amplification;PAK1 Amplification	0	5
P-0010914	P-0010914-T01-IM5	In-House	FFPE	Resection	250	879	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										TP53 p.E204*;CTNNB1 p.N387K	0	2
P-0010915	P-0010915-T01-IM5	Outside	FFPE	Resection	250	889	60	Matched	Primary	Leg	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	EPHB1 p.R743W;SMAD3 p.Q358*;FUBP1 p.L67*;BRAF p.G469S;CDKN2A Deletion;MAPK1 Amplification;STK11 Deletion	1	7
P-0010916	P-0010916-T01-IM5	Outside	FFPE	Biopsy	250	1024	65	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84Y)				LEVEL_4	TP53 p.R249S;KRAS p.G13D;PTPRD p.G446E;CBL p.P417A;DIS3 p.D479V;B2M p.S72*;ARID1A p.D2178Tfs*22;CDKN2A p.D84Y	2	8
P-0010917	P-0010917-T01-IM5	Outside	FFPE	Resection	250	881	55	Matched	Metastasis	Breast	Bowel	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;ANKRD11 p.X2603_splice;CDH1 p.G500Wfs*37;TBX3 p.I125Gfs*14	2	4
P-0010918	P-0010918-T01-IM5	Outside	FFPE	Resection	250	554	40	Matched	Primary	Soft Tissue	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Tazemetostat(SMARCB1 Deletion)					LEVEL_3B	HNF1A p.E329*;SMARCB1 Deletion	1	2
P-0010919	P-0010919-T01-IM5	Outside	FFPE	Biopsy	250	838	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P408Afs*99;CCND1 Amplification;FGF19 Amplification;PPM1D Amplification	0	4
P-0010920	P-0010920-T01-IM5	Outside	FFPE	Biopsy	151.4	266	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0010921	P-0010921-T01-IM5	Outside	FFPE	Biopsy	250	544	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453Q);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1065Y)	GSK2636771,AZD8186(PTEN p.Q171*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E542K;PTEN p.Q171*;TET1 p.N1611Tfs*13;PIK3CA p.E453Q;NFE2L2 p.E79Q;SPEN p.E2267*;FBXW7 p.Q306*;NSD1 p.Q2274*;KMT2D p.Q3949*;SH2B3 p.Q379*;EP300 p.Q65*;SPEN p.T2586Nfs*10;CDKN2A Deletion;CDKN2B Deletion	5	14
P-0010922	P-0010922-T01-IM5	Outside	FFPE	Resection	250	659	80	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS										GATA3 p.P408Afs*99;PRDM1 Deletion	0	2
P-0010923	P-0010923-T01-IM5	Outside	FFPE	Biopsy	107.4	760	15	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.D281V;RASA1 p.S247Lfs*6	1	3
P-0010924	P-0010924-T01-IM5	In-House	FFPE	Resection	250	846	45	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.D252G);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2C p.X44_splice;PTEN p.D252G;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	5
P-0010925	P-0010925-T01-IM5	In-House	FFPE	Cytology	250	833	10	Matched	Metastasis	Breast	Bone	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma			AZD9496,Fulvestrant(ESR1 p.E380Q)						LEVEL_3A	ESR1 p.E380Q;ARID1A p.N833Kfs*39;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	1	5
P-0010926	P-0010926-T01-IM5	Outside	FFPE	Resection	250	825	60	Matched	Primary	Pancreas	Not Applicable	Tumor	SPN	Pancreatic Cancer	Solid Pseudopapillary Neoplasm of the Pancreas										CTNNB1 p.S37F	0	1
P-0010927	P-0010927-T01-IM5	In-House	FFPE	Resection	250	826	70	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.L755P)	Neratinib(ERBB2 p.L755P)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	ERBB2 p.L755P;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	3	4
P-0010927	P-0010927-T02-IM5	In-House	FFPE	Resection	250	719	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.L755P)	Neratinib(ERBB2 p.L755P)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	ERBB2 p.L755P;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification	3	4
P-0010928	P-0010928-T01-IM5	In-House	FFPE	Biopsy	96.25	766	35	Matched	Metastasis	Lung	Liver	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor				Olaparib(ATM p.G587Vfs*3)					LEVEL_3B	ARID1A p.W2091*;ATM p.G587Vfs*3	1	2
P-0010929	P-0010929-T01-IM5	In-House	FFPE	Resection	250	759	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;NCOR1 p.E529Kfs*26;RNF43 p.G659Vfs*41;KMT2A p.P773Rfs*8;CASP8 p.L474Tfs*6;KMT2D p.P647Hfs*283;TP53 p.R267L;KMT2C p.I4036Sfs*47;SMAD2 p.T298*;AMER1 p.G76Dfs*24;KMT2D p.G4154Afs*7;LATS2 p.Y191Tfs*49	3	12
P-0010930	P-0010930-T01-IM5	In-House	FFPE	Biopsy	250	1099	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										GATA3 p.P408Afs*99;PPM1D Amplification	0	2
P-0010931	P-0010931-T01-IM5	Outside	FFPE	Resection	250	686	90	Matched	Primary	Retroperitoneum	Retroperitoneum	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0010932	P-0010932-T01-IM5	In-House	FFPE	Resection	250	879	15	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	PIK3CA p.C420R;TP53 p.R282W;KRAS p.G13D	2	3
P-0010933	P-0010933-T01-IM5	In-House	FFPE	Biopsy	250	940	65	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K);AZD9496,Fulvestrant(ESR1 p.Y537S)						LEVEL_1	PIK3CA p.N345K;ESR1 p.Y537S;TP53 p.H179Y;BCL2L11 p.Y172Gfs*83	3	4
P-0010934	P-0010934-T01-IM5	In-House	FFPE	Biopsy	86.25	799	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										ERBB3 p.S846I	0	1
P-0010935	P-0010935-T01-IM5	Outside	FFPE	Resection	201.1	254	70	Matched	Primary	Adrenal Gland	Not Applicable	Tumor	PHC	Pheochromocytoma	Pheochromocytoma				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R	1	1
P-0010936	P-0010936-T01-IM5	In-House	FFPE	Resection	94	69	35	Matched	Primary	Pelvis	Not Applicable	Tumor	CHS	Bone Cancer	Chondrosarcoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0010937	P-0010937-T01-IM5	Outside	FFPE	Resection	250	961	25	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Tipifarnib(HRAS p.Q61K)	GSK2636771,AZD8186(PTEN p.R173Afs*7);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	HRAS p.Q61K;PTPRT p.R364Q;PIK3R1 p.Q432*;PTEN p.R173Afs*7;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;DNMT3B Amplification;FGF19 Amplification	3	9
P-0010938	P-0010938-T01-IM5	In-House	Cell Pellet	Cytology	250	710	15	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Everolimus(TSC2 p.Q1525*)					LEVEL_3B	TP53 p.F113V;KMT2A p.R849*;FLT3 p.I674L;TSC2 p.Q1525*;KDM6A p.G850Vfs*6	1	5
P-0010939	P-0010939-T01-IM5	In-House	FFPE	Biopsy	250	1363	60	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;DICER1 Deletion;DIS3 Deletion;RB1 Deletion	2	4
P-0010940	P-0010940-T01-IM5	In-House	FFPE	Resection	250	1012	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R306*;KRAS Amplification;RICTOR Amplification	0	3
P-0010941	P-0010941-T01-IM5	In-House	FFPE	Resection	250	821	85	Matched	Metastasis	Intraabdominal	Peritoneum	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V559_N566delinsD)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TET2 p.T1393I;KIT p.V559_N566delinsD;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0010942	P-0010942-T01-IM5	In-House	FFPE	Biopsy	250	1208	25	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										NCOR1 p.K965*;GATA3 p.R69Qfs*234;MAP2K4 Deletion	0	3
P-0010943	P-0010943-T01-IM5	Outside	FFPE	Resection	250	603	75	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61R)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3A	NRAS p.Q61R;TNFRSF14 Deletion	2	2
P-0010945	P-0010945-T01-IM5	In-House	FFPE	Cytology	85.15	745	15	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Trametinib,Cobimetinib(BRAF AGK-BRAF fusion);Trametinib,Cobimetinib(AGK AGK-BRAF fusion)					LEVEL_3B	BRAF AGK-BRAF fusion;AGK AGK-BRAF fusion	2	2
P-0010946	P-0010946-T01-IM5	Outside	FFPE	Biopsy	250	714	35	Matched	Metastasis	Ovary	Pelvis	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.Y220C;ASXL2 p.X42_splice;RB1 Deletion	0	3
P-0010947	P-0010947-T01-IM5	In-House	FFPE	Biopsy	250	826	60	Matched	Metastasis	Lung	Adrenal	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										CBL p.X366_splice;KEAP1 p.G379D;SMARCA4 p.E1083K;GRIN2A p.E352_E353delinsD*	0	4
P-0010948	P-0010948-T01-IM5	In-House	FFPE	Biopsy	250	1091	15	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Trametinib,Cobimetinib(NF1 p.X418_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion)				LEVEL_4	KRAS p.G12R;SMARCA4 p.R1189Q;SMAD4 p.S357_G365del;TP53 p.S269Cfs*32;NF1 p.X418_splice;CCND1 Amplification;CDKN2B Deletion;FGF19 Amplification;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion	4	10
P-0010949	P-0010949-T01-IM5	In-House	FFPE	Resection	250	755	85	Matched	Metastasis	Small Bowel	Pancreas	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K550_W557delinsIR)								LEVEL_1	KIT p.K550_W557delinsIR;RB1 Deletion;TERT Amplification	1	3
P-0010950	P-0010950-T01-IM5	Outside	FFPE	Resection	250	644	35	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L	0	1
P-0010951	P-0010951-T01-IM5	Outside	FFPE	Resection	250	886	20	Matched	Primary	Ileum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer										TP53 p.G245S;APC p.R332*	0	2
P-0010952	P-0010952-T01-IM5	In-House	FFPE	Resection	250	769	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.T514Lfs*96)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.T514Lfs*96)				LEVEL_1	CDK12 p.T514Lfs*96	2	1
P-0010953	P-0010953-T01-IM5	In-House	FFPE	Biopsy	250	1163	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.Q165*;AR Amplification;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0010954	P-0010954-T01-IM5	In-House	FFPE	Biopsy	250	744	25	Matched	Primary	Sinus	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										SPEN p.A3213Rfs*5	0	1
P-0010955	P-0010955-T01-IM5	In-House	FFPE	Resection	250	548	75	Matched	Metastasis	Testis	Lymph Node	Tumor	VOEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0010957	P-0010957-T01-IM5	Outside	FFPE	Resection	250	788	30	Matched	Primary	Vulva	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina											0	0
P-0010958	P-0010958-T01-IM5	In-House	FFPE	Resection	250	699	70	Matched	Primary	Bladder	Not Applicable	Tumor	SFT	Soft Tissue Sarcoma	Solitary Fibrous Tumor/Hemangiopericytoma					Trametinib,Cobimetinib(NF1 p.A1767Gfs*9)				LEVEL_4	SUZ12 p.X480_splice;NF1 p.A1767Gfs*9	1	2
P-0010959	P-0010959-T01-IM5	In-House	FFPE	Resection	250	614	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.P190L	0	1
P-0010960	P-0010960-T01-IM5	In-House	FFPE	Biopsy	250	1077	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	TP53 p.R196*;KRAS p.G12C;APC p.Q879*;FBXW7 p.E51*;APC p.L1488Ffs*25	2	5
P-0010961	P-0010961-T01-IM5	In-House	FFPE	Cytology	171.9	724	40	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0010962	P-0010962-T01-IM5	Outside	FFPE	Resection	250	882	85	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0010963	P-0010963-T01-IM5	In-House	FFPE	Cytology	109	462	40	Matched	Metastasis	Kidney	Bone	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0010965	P-0010965-T01-IM5	In-House	FFPE	Resection	250	957	50	Matched	Primary	Rectum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_4	KRAS p.A146T;APC p.D849Efs*11;APC p.E1494Kfs*13	1	3
P-0010966	P-0010966-T01-IM5	Outside	FFPE	Resection	195.1	543	10	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V	2	2
P-0010967	P-0010967-T01-IM5	In-House	FFPE	Resection	250	673	85	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Olaparib(ATM p.R250*);Olaparib(CHEK1 p.E183*)	Tazemetostat(SMARCB1 p.R53*);GSK2636771,AZD8186(PTEN p.E7*);GSK2636771,AZD8186(PTEN p.E114*);Trametinib,Cobimetinib(NF1 p.E924*);Trametinib,Cobimetinib(NF1 p.S2549*)				LEVEL_3B	POLE p.P286R;PIK3CA p.R88Q;ARID1A p.R1989*;SMARCB1 p.R53*;CTCF p.R339W;ATM p.R250*;KMT2C p.R56Q;AMER1 p.E939*;FAT1 p.R1627*;PTEN p.E7*;ARID1A p.S607*;MSH2 p.E859*;RASA1 p.E429*;RASA1 p.E725*;NSD1 p.E95*;LATS1 p.R626*;KMT2C p.E4030*;BMPR1A p.L59*;PTEN p.E114*;SUFU p.X433_splice;CHEK1 p.E183*;FLT3 p.G875V;MGA p.X2380_splice;NF1 p.E924*;NF1 p.S2549*;PPM1D p.E525*;DNMT1 p.E51K	8	27
P-0010968	P-0010968-T01-IM5	In-House	FFPE	Resection	250	951	60	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										FBXW7 p.R658*;TP53 p.H193R;APC p.S583*;APC p.T1487Ifs*25	0	4
P-0010969	P-0010969-T01-IM5	In-House	FFPE	Biopsy	250	1330	70	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										MED12 p.V41G;CREBBP p.I1189Lfs*61	0	2
P-0010970	P-0010970-T01-IM5	Outside	FFPE	Resection	250	989	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	STAG2 p.R213Sfs*25;CDKN2A Deletion;EGFR Amplification	2	3
P-0010971	P-0010971-T01-IM5	Outside	FFPE	Biopsy	250	1183	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										FBXW7 p.R465C	0	1
P-0010972	P-0010972-T01-IM5	Outside	FFPE	Resection	250	1225	30	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										KDM5A Amplification;ASXL1 ASXL1-intragenic;MYC PVT1-MYC fusion;PVT1 PVT1-MYC fusion	0	4
P-0010973	P-0010973-T01-IM5	In-House	FFPE	Biopsy	250	1365	10	Matched	Metastasis	Breast	Soft Tissue	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.H1047R);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.L2330Cfs*16);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.T79Pfs*67)				LEVEL_1	PIK3CA p.H1047R;TP53 p.P153_G154del;NF1 p.L2330Cfs*16;CDKN2A p.T79Pfs*67;CCND1 Amplification;ERBB2 Amplification	6	6
P-0010974	P-0010974-T01-IM5	Outside	FFPE	Resection	250	825	20	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E;ARID2 p.Q1318*;ARID2 p.Q1462*	1	3
P-0010975	P-0010975-T01-IM5	In-House	FFPE	Biopsy	250	1121	20	Matched	Metastasis	Skin	Lung	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)						LEVEL_3A	FBXW7 p.R505C;NRAS p.Q61K;RB1 p.E693Dfs*3	1	3
P-0010976	P-0010976-T01-IM5	In-House	FFPE	Resection	250	862	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0010977	P-0010977-T01-IM5	In-House	FFPE	Resection	250	947	80	Matched	Metastasis	Soft Tissue	Lung	Tumor	ASPS	Soft Tissue Sarcoma	Alveolar Soft Part Sarcoma				Sorafenib(ARAF p.P216L)					LEVEL_3B	ARAF p.P216L;TFE3 ASPSCR1-TFE3 fusion;ASPSCR1 ASPSCR1-TFE3 fusion	1	3
P-0010978	P-0010978-T01-IM5	Outside	FFPE	Biopsy	50	644	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	CCND1 Amplification;NKX2-1 Amplification;YAP1 Amplification;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	5
P-0010978	P-0010978-T02-IM5	Outside	FFPE	Resection	250	303	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	2
P-0010979	P-0010979-T02-IM5	In-House	FFPE	Biopsy	250	949	70	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		Trametinib,Cobimetinib(NF1 p.Y628Lfs*6);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.H1047R;FGFR4 p.V550L;TBX3 p.K476Qfs*216;CDH1 p.D805Cfs*5;KLF4 p.P221Lfs*88;NF1 p.Y628Lfs*6;NOTCH2 p.I2304Hfs*9;RB1 p.Y771Cfs*23;CDKN2A Deletion;CDKN2B Deletion;TBX3 TBX3-intragenic	4	11
P-0010979	P-0010979-T01-IM5	Outside	FFPE	Resection	250	639	25	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;FOXP1 p.X511_splice;TBX3 p.K476Qfs*216;CDH1 p.D805Cfs*5	2	4
P-0010980	P-0010980-T01-IM5	In-House	FFPE	Resection	250	987	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D84Y)				LEVEL_3A	KRAS p.G12C;STK11 p.W308C;SMARCA4 p.X373_splice;ZFHX3 p.P1205Sfs*11;CDKN2A p.D84Y	3	5
P-0010981	P-0010981-T01-IM5	Outside	FFPE	Resection	250	966	30	Matched	Primary	Breast	Not Applicable	Tumor	MPT	Breast Sarcoma	Malignant Phyllodes Tumor of the Breast				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.Q546K);Tipifarnib(HRAS p.G12D);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.Q546K;HRAS p.G12D;CDKN2A Deletion;CDKN2B Deletion;MDM2 Amplification;YAP1 Amplification	4	6
P-0010982	P-0010982-T01-IM5	Outside	FFPE	Biopsy	250	1184	75	Matched	Primary	Cervix	Not Applicable	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_3B	PIK3CA p.E545K;KRAS p.G12S;CCND2 Amplification;KDM5A Amplification;KRAS Amplification	2	5
P-0010983	P-0010983-T01-IM5	Outside	FFPE	Biopsy	250	1351	20	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.X1010_splice;MDM2 Amplification	4	2
P-0010984	P-0010984-T01-IM5	Outside	FFPE	Biopsy	250	1064	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Olaparib(ATM p.X2717_splice);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.I13_P18delinsH);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Crizotinib,Entrectinib(ROS1 SLC4A4-ROS1 fusion);Crizotinib,Entrectinib(SLC4A4 SLC4A4-ROS1 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_3B	ATM p.X2717_splice;BCOR p.A1014_Y1015insT*MEGLQEDSILCLPAA;PIK3CA p.I13_P18delinsH;CDKN2A p.H83Y;ERBB2 Amplification;KMT2A MLL-intragenic;ROS1 SLC4A4-ROS1 fusion;SLC4A4 SLC4A4-ROS1 fusion	6	8
P-0010985	P-0010985-T01-IM5	In-House	FFPE	Resection	250	889	70	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;APC p.T1556Nfs*3;ERBB3 p.V104M;SMAD2 p.S467P;PIK3R1 p.D440_K448del;APC p.Y935*;SMAD3 p.C89Wfs*22;AMER1 p.H269Ifs*9	1	8
P-0010986	P-0010986-T01-IM5	In-House	FFPE	Biopsy	250	1215	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;CTNNB1 p.I35S;EIF1AX p.P2L;ARID1A p.Q595*	1	4
P-0010987	P-0010987-T01-IM5	In-House	FFPE	Biopsy	250	1459	65	Matched	Primary	Eyelid	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0010988	P-0010988-T01-IM5	In-House	FFPE	Biopsy	119.5	810	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;SMAD4 p.R361H;TP53 p.I255F	1	3
P-0010989	P-0010989-T01-IM5	Outside	FFPE	Resection	250	806	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 EZR-ROS1 fusion);Crizotinib,Entrectinib(EZR EZR-ROS1 fusion)								LEVEL_1	TP53 p.E271*;CDK4 p.R24H;ROS1 EZR-ROS1 fusion;EZR EZR-ROS1 fusion	2	4
P-0010990	P-0010990-T01-IM5	In-House	FFPE	Resection	250	944	65	Matched	Primary	Eye	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										NF2 p.A313Pfs*9	0	1
P-0010991	P-0010991-T01-IM5	Outside	FFPE	Resection	250	1164	35	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.P318Efs*16;PAX5 p.P320Wfs*18;YAP1 Amplification	0	3
P-0010992	P-0010992-T01-IM5	In-House	FFPE	Resection	250	1110	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.H61R);PLX8394(BRAF p.G469R);Trametinib,Cobimetinib(NF1 p.X1166_splice);GSK2636771,AZD8186(PTEN p.C250Sfs*43);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_4	PTEN p.H61R;BRAF p.G469R;NF1 p.X1166_splice;PTEN p.C250Sfs*43;CDKN2A Deletion;CDKN2B Deletion;PXMP2 ERBB4-PXMP2 fusion;ERBB4 ERBB4-PXMP2 fusion;CRLF3 RARA-CRLF3 fusion;RARA RARA-CRLF3 fusion;NF1 NF1-intragenic	6	11
P-0010993	P-0010993-T01-IM5	In-House	FFPE	Resection	250	1979	75	Matched	Metastasis	Breast	Bone	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.D281Y;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MAP2K4 Deletion;NCOR1 Deletion;PPM1D Amplification	2	7
P-0010994	P-0010994-T01-IM5	In-House	FFPE	Biopsy	250	1010	30	Matched	Metastasis	Breast	Skin	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.G245V;EWSR1 MTMR3-EWSR1 fusion;MTMR3 MTMR3-EWSR1 fusion	0	3
P-0010995	P-0010995-T01-IM5	In-House	FFPE	Biopsy	234	936	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.V272L;EGFR p.H773_V774delinsLM;RAD21 RAD21-intragenic	0	3
P-0010996	P-0010996-T01-IM5	Outside	FFPE	Biopsy	228.8	1010	40	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.R248Q;KMT2C p.Q1211*;ERBB2 Amplification	2	3
P-0010997	P-0010997-T01-IM5	In-House	FFPE	Biopsy	92.34	459	10	Matched	Primary	Eye	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma											0	0
P-0010998	P-0010998-T01-IM5	Outside	FFPE	Resection	250	607	80	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0010999	P-0010999-T01-IM5	In-House	FFPE	Biopsy	250	1099	80	Matched	Primary	Sacral Mass	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma										NOTCH2 p.E1302Vfs*17	0	1
P-0011001	P-0011001-T01-IM5	Outside	FFPE	Biopsy	250	532	35	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C420R);Enasidenib(IDH2 p.R172K)					LEVEL_3B	PIK3CA p.C420R;IDH2 p.R172K;NOTCH1 p.F357del;CIC p.R1515H;CIC p.V1122Gfs*28	2	5
P-0011002	P-0011002-T01-IM5	In-House	FFPE	Biopsy	250	1147	65	Matched	Metastasis	Forearm	Axilla	Tumor	IMT	Soft Tissue Sarcoma	Inflammatory Myofibroblastic Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;LATS2 LATS2-intragenic	1	2
P-0011003	P-0011003-T01-IM5	In-House	FFPE	Biopsy	250	1267	25	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.R663Pfs*36)			Tipifarnib(HRAS p.Q61K)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R663Pfs*36)				LEVEL_1	HRAS p.Q61K;CDK12 p.R663Pfs*36;AR Amplification;CCND1 Amplification;FGF19 Amplification;PPM1D Amplification	3	6
P-0011004	P-0011004-T01-IM5	Outside	FFPE	Resection	250	1191	50	Matched	Primary	Cervix	Not Applicable	Tumor	ECAD	Cervical Cancer	Endocervical Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CTNNB1 p.S33F;PTEN Deletion;SMAD4 Deletion	1	3
P-0011005	P-0011005-T01-IM5	In-House	FFPE	Resection	250	886	85	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;RBM10 p.Q649*;STK11 p.P314Lfs*22;PTPRT p.W1001*;KEAP1 p.M550Ifs*24;TBX3 p.A526Pfs*106	2	6
P-0011006	P-0011006-T01-IM5	In-House	FFPE	Resection	250	953	85	Matched	Metastasis	Adrenal Gland	Lymph Node	Tumor	NBL	Peripheral Nervous System	Neuroblastoma										FUBP1 Deletion	0	1
P-0011007	P-0011007-T01-IM5	Outside	FFPE	Resection	250	1116	85	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.V173M;BCL2 p.K22R;KMT2D p.K2096Pfs*27;SMAD3 p.Q322Rfs*18	0	4
P-0011008	P-0011008-T01-IM5	Outside	FFPE	Resection	232.3	808	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CBL p.X410_splice;CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion;PPM1D Amplification	1	5
P-0011009	P-0011009-T01-IM5	In-House	FFPE	Resection	250	866	85	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Ivosidenib(IDH1 p.R132H)					LEVEL_3B	PIK3CA p.E545K;IDH1 p.R132H;CIC p.R202W;CIC p.N205S;FUBP1 p.H543Qfs*24;ATRX p.A23Hfs*18;PIK3R1 p.K575_L581delinsM	2	7
P-0011010	P-0011010-T01-IM5	Outside	FFPE	Resection	250	842	40	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Lapatinib(EGFR Amplification)				LEVEL_3B	DIS3 Deletion;EGFR Amplification;KRAS Amplification;MDM2 Amplification;RB1 Deletion	2	5
P-0011011	P-0011011-T01-IM5	Outside	FFPE	Resection	250	993	60	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Tipifarnib(HRAS p.Q61R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	RHOA p.E47K;HRAS p.Q61R;AKT2 Amplification;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification	2	7
P-0011012	P-0011012-T01-IM5	In-House	Cell Pellet	Cytology	250	448	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)				LEVEL_3A	KRAS p.G12C;KRAS p.G12S	3	2
P-0011013	P-0011013-T01-IM5	In-House	FFPE	Biopsy	250	1227	45	Matched	Metastasis	Uterus	Peritoneum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN p.R130G);GSK2636771,AZD8186(PTEN p.I50Lfs*4)				LEVEL_4	KRAS p.G12V;PTEN p.R130G;SMAD4 p.G231Afs*10;NSD1 p.R1031*;NFE2L2 p.E82D;CTCF p.T204Qfs*18;SPEN p.P3317Rfs*83;SOX9 p.V306Cfs*77;MGA p.Q2200*;PIK3R1 p.D464_E468dup;SOX9 p.P260Afs*36;ARID1A p.G314Afs*49;BCOR p.K839Qfs*5;NKX3-1 p.L210Wfs*76;PTEN p.I50Lfs*4	3	15
P-0011014	P-0011014-T01-IM5	Outside	FFPE	Biopsy	250	1169	40	Matched	Metastasis	Colorectal NOS	Peritoneum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_3B	KRAS p.G12V;KDM5A Amplification;MDM2 Amplification	2	3
P-0011015	P-0011015-T01-IM5	In-House	FFPE	Biopsy	250	1018	70	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;TP53 p.R273C	2	2
P-0011016	P-0011016-T01-IM5	In-House	FFPE	Biopsy	250	1041	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.G244C;CARD11 p.E626Q;PTPRD p.X823_splice;KDM6A p.X1095_splice;RB1 p.Y453*;SRC Amplification;TERT Amplification	0	7
P-0011017	P-0011017-T01-IM5	In-House	FFPE	Resection	250	962	80	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.C275F;GPS2 p.E46Nfs*16	0	2
P-0011018	P-0011018-T01-IM5	In-House	FFPE	Resection	250	923	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)								LEVEL_1	FAT1 p.S3760*;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	3
P-0011019	P-0011019-T01-IM5	In-House	FFPE	Resection	250	973	20	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0011025	P-0011025-T01-IM5	Outside	FFPE	Biopsy	250	1259	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 CD74-ROS1 fusion);Crizotinib,Entrectinib(CD74 CD74-ROS1 fusion)								LEVEL_1	ROS1 CD74-ROS1 fusion;CD74 CD74-ROS1 fusion	2	2
P-0011026	P-0011026-T01-IM5	Outside	FFPE	Resection	250	1515	70	Matched	Primary	Brain	Not Applicable	Tumor	GSARC	Glioma	Gliosarcoma					GSK2636771,AZD8186(PTEN p.S229*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.R282W;PTEN p.S229*;CDKN2A Deletion;CDKN2B Deletion;MYCL Amplification	2	5
P-0011027	P-0011027-T01-IM5	In-House	FFPE	Resection	250	819	65	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273C;APC p.E1309Dfs*4;SOX9 p.Y127Cfs*17	0	3
P-0011028	P-0011028-T01-IM5	Outside	FFPE	Resection	250	1121	85	Matched	Metastasis	Uterus	Abdomen	Tumor	UAS	Uterine Sarcoma	Uterine Adenosarcoma				AZD5363(AKT1 p.E17K);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 Deletion);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	AKT1 p.E17K;ATRX p.D1126Rfs*3;BRCA2 Deletion;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;MDM2 Amplification;RB1 Deletion	4	8
P-0011029	P-0011029-T01-IM5	In-House	FFPE	Biopsy	250	1111	50	Matched	Metastasis	Vagina	Liver	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	TP53 p.R110P;ATRX p.K2233_D2234ins*;CD274 Amplification;NF1 Deletion;MRE11 ST6GALNAC3-MRE11A fusion;ST6GALNAC3 ST6GALNAC3-MRE11A fusion	1	6
P-0011029	P-0011029-T02-IM5	Outside	FFPE	Biopsy	250	864	80	Matched	Primary	Vagina	Not Applicable	Tumor	VMM	Melanoma	Mucosal Melanoma of the Vulva/Vagina					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R110P;ATRX p.K2233_D2234ins*;BMPR1A Deletion;CD274 Amplification;PTEN Deletion;MRE11 ST6GALNAC3-MRE11A fusion;ST6GALNAC3 ST6GALNAC3-MRE11A fusion	1	7
P-0011030	P-0011030-T01-IM5	In-House	FFPE	Cytology	108	430	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.G105V;CCNE1 Amplification;FANCA Deletion;FOXA1 Amplification;MYC Amplification;NKX2-1 Amplification;PTEN Deletion	1	7
P-0011031	P-0011031-T01-IM5	Outside	FFPE	Biopsy	250	1206	20	Matched	Metastasis	Lung	Esophagus	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0011032	P-0011032-T01-IM5	Outside	FFPE	Cytology	117.4	612	40	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Olaparib(ATM p.E2304Gfs*69)					LEVEL_3A	IDH1 p.R132C;ARID1A p.S1948Dfs*9;ATM p.E2304Gfs*69	2	3
P-0011033	P-0011033-T01-IM5	Outside	FFPE	Biopsy	250	806	75	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)	Neratinib(ERBB2 p.G778_P780dup)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_2	ERBB2 p.G778_P780dup;CDKN2A Deletion;CDKN2B Deletion;FOXA1 Amplification;NKX2-1 Amplification	3	5
P-0011034	P-0011034-T01-IM5	In-House	FFPE	Biopsy	250	1112	15	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.H179L;RB1 p.R544*;CREBBP p.Q919*	0	3
P-0011035	P-0011035-T01-IM5	In-House	FFPE	Resection	250	751	70	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Selpercatinib(KIF5B RET-KIF5B fusion);Selpercatinib(RET RET-KIF5B fusion)	Cabozantinib,Vandetanib(KIF5B RET-KIF5B fusion);Cabozantinib,Vandetanib(RET RET-KIF5B fusion)	BLU-667(KIF5B RET-KIF5B fusion);BLU-667(RET RET-KIF5B fusion)						LEVEL_1	KIF5B RET-KIF5B fusion;RET RET-KIF5B fusion	6	2
P-0011036	P-0011036-T01-IM5	In-House	FFPE	Biopsy	250	1170	30	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;RBM10 p.E705*;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0011037	P-0011037-T01-IM5	Outside	FFPE	Cytology	250	1056	70	Matched	Primary	Pancreas	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS											0	0
P-0011038	P-0011038-T01-IM5	In-House	FFPE	Resection	250	906	60	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	EGFR p.L858R;TP53 p.V147G;CARD11 Amplification;EGFR Amplification;FGFR1 Amplification;RAC1 Amplification;RICTOR Amplification;TERT Amplification	2	8
P-0011039	P-0011039-T01-IM5	Outside	FFPE	Biopsy	250	1166	65	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453K);Olaparib(ATM p.R3008C);Olaparib(CHEK2 KIAA1984-CHEK2 fusion);Olaparib(CCDC183 KIAA1984-CHEK2 fusion)					LEVEL_3B	PIK3CA p.E453K;APC p.R805*;ATM p.R3008C;APC p.L1489Pfs*15;CCND2 Amplification;KDM5A Amplification;NF2 Deletion;PMAIP1 Deletion;SMAD4 Deletion;CHEK2 KIAA1984-CHEK2 fusion;CCDC183 KIAA1984-CHEK2 fusion	4	11
P-0011040	P-0011040-T01-IM5	In-House	FFPE	Resection	250	979	10	Matched	Primary	Breast	Not Applicable	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS			Neratinib(ERBB2 p.L755S)	Ado-Trastuzumab Emtansine(ERBB2 p.L755S)					LEVEL_3A	ERBB2 p.L755S;TP53 p.G245S;CDH1 p.W4*;NCOR1 p.E693*	2	4
P-0011041	P-0011041-T01-IM5	In-House	FFPE	Resection	250	832	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.E1313Gfs*36)					LEVEL_3B	STK11 p.A206Rfs*81;ATM p.E1313Gfs*36;NKX3-1 p.R115Gfs*22	1	3
P-0011042	P-0011042-T01-IM5	In-House	FFPE	Biopsy	250	1094	80	Matched	Metastasis	Breast	Pleura	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS			AZD9496,Fulvestrant(ESR1 p.L536H)						LEVEL_3A	ARID1A p.Q2207*;MAP3K1 p.N1279Kfs*5;MAP3K1 p.R516Kfs*25;ESR1 p.L536H	1	4
P-0011043	P-0011043-T01-IM5	In-House	FFPE	Biopsy	250	1074	NA	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TP53 p.X126_splice	1	2
P-0011043	P-0011043-T02-IM5	In-House	FFPE	Biopsy	93.3	266	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Trametinib,Cobimetinib,Binimetinib(KRAS p.F28L)				LEVEL_4	KRAS p.G12R;TP53 p.H214R;CASP8 p.Y380*;KRAS p.F28L;KMT2C p.P2093Hfs*13;AKT2 Amplification;MCL1 Amplification	2	7
P-0011044	P-0011044-T01-IM5	In-House	FFPE	Biopsy	155.1	642	10	Matched	Metastasis	Pancreas	Omentum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib(BRCA1 p.E1258*);Olaparib,Rucaparib(BRCA2 p.L659*)	Niraparib,Rucaparib,Talazoparib(BRCA1 p.E1258*);Talazoparib,Niraparib(BRCA2 p.L659*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3A	KRAS p.G12D;TP53 p.V272L;BRCA1 p.E1258*;BRCA2 p.L659*;FOXO1 p.A97Tfs*224	5	5
P-0011046	P-0011046-T01-IM5	Outside	FFPE	Resection	250	582	35	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										EIF1AX p.R13L;FOXA1 p.M253K;ZFHX3 p.S2324*	0	3
P-0011047	P-0011047-T01-IM5	In-House	FFPE	Resection	250	845	80	Matched	Metastasis	Skin	Parotid	Tumor	SKCM	Melanoma	Cutaneous Melanoma		Imatinib(KIT p.L576del)		Sunitinib,Regorafenib,Ripretinib(KIT p.L576del)					LEVEL_2	EPHA7 p.G656E;ARID1A p.Q1452*;CBL p.E366*;KIT p.L576del	2	4
P-0011050	P-0011050-T01-IM5	In-House	FFPE	Biopsy	250	1098	30	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Sorafenib(ARAF p.P216R)					LEVEL_3B	ARAF p.P216R	1	1
P-0011060	P-0011060-T01-IM5	In-House	FFPE	Resection	250	447	65	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.R306*;TMEM127 p.Q168*;NOTCH3 p.P2188Sfs*54	0	3
P-0011061	P-0011061-T01-IM5	In-House	FFPE	Biopsy	250	1111	60	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma			Neratinib(ERBB2 p.V777L)	Ado-Trastuzumab Emtansine(ERBB2 p.V777L)					LEVEL_3A	ERBB2 p.V777L;RB1 p.E464*;CBFB p.M1?	2	3
P-0011062	P-0011062-T01-IM5	In-House	FFPE	Biopsy	221	651	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0011063	P-0011063-T01-IM5	In-House	FFPE	Resection	250	859	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K;MAP3K1 p.L380S;CBFB p.X55_splice	2	3
P-0011064	P-0011064-T01-IM5	In-House	FFPE	Resection	250	793	30	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	ARID1A p.T1892Kfs*31;AURKA Amplification;FGFR1 Amplification;SRC Amplification	1	4
P-0011065	P-0011065-T01-IM5	In-House	FFPE	Resection	250	382	30	Matched	Primary	Liver	Not Applicable	Tumor	PHCH	Hepatobiliary Cancer	Perihilar Cholangiocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R342*;SMAD4 p.Y353N;CCNE1 Amplification	1	4
P-0011066	P-0011066-T01-IM5	Outside	FFPE	Resection	250	931	30	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.L130V;CCNE1 Amplification;AMER1 FAM123B-intragenic	1	4
P-0011067	P-0011067-T01-IM5	In-House	FFPE	Resection	250	451	40	Matched	Primary	Bone	Not Applicable	Tumor	EMCHS	Bone Cancer	Extraskeletal Myxoid Chondrosarcoma										ARID1A p.Q1142*;ANKRD11 Deletion;GPS2 Deletion;TP53 Deletion	0	4
P-0011068	P-0011068-T01-IM5	Outside	FFPE	Resection	250	404	40	Matched	Primary	Descending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.K2811Sfs*46);Olaparib(BARD1 p.D172Mfs*40);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.A1232Lfs*70)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;GNAS p.R201H;RNF43 p.G659Vfs*41;TP53 p.R273C;ATM p.K2811Sfs*46;HNF1A p.P291Qfs*51;BARD1 p.D172Mfs*40;FLCN p.H429Tfs*39;ERBB2 p.A1232Lfs*70;RNF43 p.R371*;ARID5B p.I497Nfs*31;CTCF p.E691Rfs*5;APC p.K581Rfs*9;MLH1 p.N38S;PTPRD p.A1846T;BBC3 p.G242Afs*48;APC p.S587Afs*3;PTPRS p.P548Rfs*37;PBRM1 p.K1129Rfs*30;INHA p.G66Afs*61	4	20
P-0011069	P-0011069-T01-IM5	In-House	FFPE	Resection	250	812	20	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.S68P;SETD2 p.Q2250*	0	2
P-0011070	P-0011070-T01-IM5	In-House	FFPE	Resection	250	743	70	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor											0	0
P-0011071	P-0011071-T01-IM5	In-House	FFPE	Resection	250	445	40	Matched	Metastasis	Transverse Colon	Small Bowel	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L755S);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R108S);Sonidegib,Vismodegib(PTCH1 p.L39Afs*51)	GSK2636771,AZD8186(PTEN p.N323Mfs*21);Trametinib,Cobimetinib(NF1 p.Y628Tfs*3);Tazemetostat(SMARCB1 p.T72Nfs*4);Trametinib,Cobimetinib(NF1 p.Y580Lfs*8)				LEVEL_3B	SETD2 p.R1407Gfs*5;PTCH1 p.S1203Afs*52;CTNNB1 p.S45F;PTEN p.N323Mfs*21;PIK3CA p.E542K;ERBB2 p.L755S;NF1 p.Y628Tfs*3;ARID1A p.R693*;PAX5 p.V26Gfs*49;ERBB3 p.V104M;TCF7L2 p.K485Sfs*23;XRCC2 p.H268Tfs*11;FOXP1 p.L414*;APC p.T1556Lfs*9;ZFHX3 p.Q3197Sfs*44;MLH1 p.Q689*;PIK3CA p.R108S;NCOR1 p.X2056_splice;EP300 p.X1485_splice;NBN p.N30Tfs*5;SMARCB1 p.T72Nfs*4;PPP2R1A p.E191Sfs*39;PTCH1 p.L39Afs*51;NF1 p.Y580Lfs*8;KMT2D p.C232*;MSH6 p.E205Kfs*5	9	26
P-0011072	P-0011072-T01-IM5	Outside	FFPE	Resection	250	414	60	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	GATA3 p.N331Gfs*17;CCND1 Amplification;DDR2 Amplification;FGF19 Amplification;FGFR1 Amplification;MDM2 Amplification	2	6
P-0011073	P-0011073-T01-IM5	Outside	FFPE	Resection	250	703	30	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R342*;SMAD4 p.P91Lfs*3;MYC Amplification	1	4
P-0011074	P-0011074-T01-IM5	In-House	FFPE	Resection	250	810	80	Matched	Metastasis	Rectum	Lung	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G13D)		Cetuximab,Panitumumab(NRAS p.G13D)			LEVEL_3B	TP53 p.R175H;NRAS p.G13D;APC p.S895*;AMER1 p.R631*;AURKA Amplification;KDM5A Amplification	1	6
P-0011075	P-0011075-T01-IM5	In-House	FFPE	Resection	250	794	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCPRC	Renal Cell Carcinoma	Clear Cell Papillary Renal Cell Carcinoma											0	0
P-0011076	P-0011076-T01-IM5	Outside	FFPE	Biopsy	91	232	10	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										ARID1A p.E1444*;BAP1 p.X373_splice;FOXP1 p.Q202*;SOX9 p.Q505Hfs*74;EPHA7 Deletion	0	5
P-0011077	P-0011077-T01-IM5	Outside	FFPE	Biopsy	250	578	80	Unmatched	Primary	Lymph node	Not Applicable	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms										TP53 p.R175H;RHOA p.L69P;PIK3CA p.E1037K;PTEN p.W111G;TP53 p.C135S;MSH6 MSH6-intragenic	0	6
P-0011078	P-0011078-T01-IM5	In-House	FFPE	Biopsy	250	988	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R273L	0	1
P-0011079	P-0011079-T01-IM5	In-House	FFPE	Resection	250	719	65	Matched	Metastasis	Thyroid	Skull	Tumor	THHC	Thyroid Cancer	Hurthle Cell Thyroid Cancer											0	0
P-0011080	P-0011080-T01-IM5	Outside	FFPE	Biopsy	250	1195	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.K254Rfs*42);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_3B	STAG2 p.Q517*;PTEN p.K254Rfs*42;CDKN2A p.R80*;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MDM2 Amplification	5	7
P-0011081	P-0011081-T01-IM5	In-House	FFPE	Biopsy	250	960	50	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3A	PIK3CA p.H1047R;NRAS p.Q61K;RB1 p.Q639*;ARID1B Deletion;CCND3 Amplification;NTRK1 Amplification;PRKN Deletion;RBM10 Deletion;TOP1 Deletion;VEGFA Amplification	2	10
P-0011082	P-0011082-T01-IM5	In-House	FFPE	Resection	250	1017	20	Matched	Primary	Pancreas	Not Applicable	Tumor	IPMN	Pancreatic Cancer	Intraductal Papillary Mucinous Neoplasm										MYCN p.P44L;GNAS p.R201C	0	2
P-0011083	P-0011083-T01-IM5	In-House	FFPE	Biopsy	250	843	20	Matched	Metastasis	Appendix	Peritoneum	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R248Q;GNAS p.R201H;TP53 p.R267W	1	4
P-0011085	P-0011085-T01-IM5	In-House	FFPE	Biopsy	167.2	719	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										AXIN1 p.X652_splice;AXIN1 p.E384*;ANKRD11 Deletion;PRDM1 Deletion;ZFHX3 Deletion	0	5
P-0011086	P-0011086-T01-IM5	In-House	FFPE	Resection	250	750	25	Matched	Metastasis	Ovary	Omentum	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.P58Qfs*65;MCL1 Amplification;PAK1 Amplification	0	3
P-0011087	P-0011087-T01-IM5	Outside	FFPE	Biopsy	250	1004	60	Unmatched	Primary	Cecum	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										TP53 p.E68Rfs*55	0	1
P-0011088	P-0011088-T01-IM5	In-House	FFPE	Biopsy	250	1544	40	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.T131N)				LEVEL_4	PTEN p.T131N	1	1
P-0011089	P-0011089-T01-IM5	In-House	FFPE	Resection	250	698	90	Matched	Primary	Epidural	Not Applicable	Tumor	FIBS	Soft Tissue Sarcoma	Fibrosarcoma										EWSR1 CREB3L2-EWSR1 fusion;CREB3L2 CREB3L2-EWSR1 fusion	0	2
P-0011090	P-0011090-T01-IM5	In-House	FFPE	Biopsy	250	1492	25	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	PIK3CA p.E542K;TP53 p.X126_splice;AR Amplification;PTEN Deletion	2	4
P-0011091	P-0011091-T01-IM5	In-House	FFPE	Resection	250	1052	60	Matched	Metastasis	Thyroid	Trachea	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer					GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_4	PTEN p.X70_splice;STK11 p.N90Tfs*6;RBM10 p.S50Tfs*84	1	3
P-0011092	P-0011092-T01-IM5	In-House	FFPE	Resection	250	437	10	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0011092	P-0011092-T02-IM5	In-House	FFPE	Resection	250	728	80	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C	1	1
P-0011093	P-0011093-T01-IM5	In-House	FFPE	Cytology	250	911	10	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.G245S;CIC p.A900Pfs*24	0	2
P-0011094	P-0011094-T01-IM5	In-House	FFPE	Biopsy	250	1238	50	Matched	Primary	Soft Tissue	Not Applicable	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification	2	2
P-0011094	P-0011094-T02-IM5	In-House	FFPE	Biopsy	250	1361	70	Matched	Primary	Groin	Groin	Tumor	DDLS	Soft Tissue Sarcoma	Dedifferentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;MDM2 Amplification	2	4
P-0011095	P-0011095-T01-IM5	In-House	FFPE	Resection	250	697	80	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0011095	P-0011095-T02-IM5	In-House	FFPE	Resection	250	503	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.Y175*;SETD2 p.K2525*	0	2
P-0011096	P-0011096-T01-IM5	In-House	FFPE	Biopsy	250	1269	20	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	SPOP p.F102C;TP53 p.E286K;CTNNB1 p.S33A;AR Amplification;FGFR1 Amplification;PIK3CB Amplification;PTEN Deletion;RAF1 Amplification	2	8
P-0011097	P-0011097-T01-IM5	In-House	FFPE	Resection	250	565	80	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.R472*;KDM5C p.E792*	0	2
P-0011098	P-0011098-T01-IM5	In-House	FFPE	Biopsy	250	1339	65	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.G1049R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R)						LEVEL_1	PIK3CA p.G1049R;TP53 p.R175H;CDKN2C Deletion;MYC Amplification;PAK1 Amplification;RASA1 Deletion;MMP16 SPEN-MMP16 fusion;SPEN SPEN-MMP16 fusion	2	8
P-0011099	P-0011099-T01-IM5	In-House	FFPE	Biopsy	250	1017	20	Matched	Metastasis	Kidney	Skull	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.S80R	0	1
P-0011100	P-0011100-T01-IM5	In-House	Cell Pellet	Cytology	250	145	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsA)								LEVEL_1	EGFR p.E746_T751delinsA	1	1
P-0011101	P-0011101-T01-IM5	Outside	FFPE	Resection	250	755	40	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G118D);Trametinib,Cobimetinib(MAP2K1 p.Q56P);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	PIK3CA p.G118D;MAP2K1 p.Q56P;FBXW7 p.R479Q;PPP2R1A p.S256F;TP53 p.G266V;ZFHX3 p.R2693*;ERBB2 Amplification	3	7
P-0011102	P-0011102-T01-IM5	Outside	FFPE	Biopsy	250	974	75	Matched	Primary	Anus	Not Applicable	Tumor	ANSC	Anal Cancer	Anal Squamous Cell Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)	GSK2636771,AZD8186(PTEN p.R130*)				LEVEL_3B	PTEN p.R130*;ERBB2 p.R678Q;BCL6 Amplification	2	3
P-0011103	P-0011103-T01-IM5	In-House	FFPE	Cytology	250	890	60	Matched	Metastasis	Gallbladder	Pleural Fluid	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.R306*;KRAS p.G13D;ARID1A Deletion	1	3
P-0011104	P-0011104-T01-IM5	Outside	FFPE	Resection	250	886	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Trametinib(BRAF p.K601E)	PLX8394(BRAF p.K601E)				LEVEL_3A	IDH1 p.R132C;BRAF p.K601E;ARID1A p.G801Vfs*32	3	3
P-0011105	P-0011105-T01-IM5	Outside	FFPE	Resection	250	1088	75	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										SF3B1 p.R625C;GNAQ p.Q209P	0	2
P-0011106	P-0011106-T01-IM5	Outside	FFPE	Resection	250	792	80	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0011107	P-0011107-T01-IM5	In-House	FFPE	Resection	250	1026	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719S)								LEVEL_1	EGFR p.G719S;TP53 p.X225_splice;EGFR p.G598V;MGA p.E829*	1	4
P-0011108	P-0011108-T01-IM5	In-House	FFPE	Biopsy	250	1107	40	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.X1052_splice);Olaparib(ATM p.Q1531*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;TP53 p.R248Q;APC p.L180*;ATM p.X1052_splice;ATM p.Q1531*;CDK8 Amplification;FLT3 Amplification;PMAIP1 Deletion;SMAD2 Deletion;SMAD4 Deletion	3	10
P-0011109	P-0011109-T01-IM5	Outside	FFPE	Resection	250	877	70	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.R175H;KRAS p.G13D;ARID2 p.S1137*;APC p.T1388Ifs*2	1	4
P-0011110	P-0011110-T01-IM5	In-House	FFPE	Biopsy	250	1147	60	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R209Kfs*6;APC p.E1295*;ERBB2 Amplification	2	3
P-0011111	P-0011111-T01-IM5	In-House	FFPE	Resection	250	379	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Trametinib,Cobimetinib(KDM7A BRAF-JHDM1D fusion);Trametinib,Cobimetinib(BRAF BRAF-JHDM1D fusion)					LEVEL_3B	SMAD4 p.R361H;TP53 p.E286K;KDM7A BRAF-JHDM1D fusion;BRAF BRAF-JHDM1D fusion	2	4
P-0011112	P-0011112-T01-IM5	Outside	FFPE	Resection	250	889	50	Matched	Metastasis	Uterus	Omentum	Tumor	ULMS	Uterine Sarcoma	Uterine Leiomyosarcoma										TP53 p.R213Q;DAXX p.V694Afs*70;PTPRD Deletion	0	3
P-0011113	P-0011113-T01-IM5	In-House	FFPE	Cytology	250	1021	10	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.F270L	0	1
P-0011114	P-0011114-T01-IM5	In-House	FFPE	Biopsy	250	1076	50	Matched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.V143M;TP53 p.V218G;MDM2 Amplification;CRLF2 DHRSX-CRLF2 fusion;DHRSX DHRSX-CRLF2 fusion	0	5
P-0011115	P-0011115-T01-IM5	Outside	FFPE	Resection	250	872	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L)				LEVEL_4	TP53 p.L130R;KRAS p.Q61L	1	2
P-0011117	P-0011117-T01-IM5	In-House	FFPE	Resection	250	309	25	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.S215I;KEAP1 p.R272C	0	2
P-0011119	P-0011119-T01-IM5	Outside	FFPE	Resection	250	963	85	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;ERRFI1 Deletion	2	4
P-0011120	P-0011120-T01-IM5	In-House	FFPE	Resection	250	822	75	Matched	Metastasis	Descending Colon	Omentum	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R273H;APC p.S1315*	0	2
P-0011123	P-0011123-T01-IM5	In-House	FFPE	Biopsy	239.7	753	20	Matched	Primary	Muscle	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification	2	2
P-0011124	P-0011124-T01-IM5	In-House	FFPE	Resection	250	611	60	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.R273C;APC p.Q1291*;ARID2 p.S635*	2	4
P-0011125	P-0011125-T01-IM5	In-House	FFPE	Biopsy	250	896	80	Matched	Metastasis	Lung	Chest Wall	Tumor	SPCC	Non-Small Cell Lung Cancer	Spindle Cell Carcinoma of the Lung			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);GSK2636771,AZD8186(PTEN p.R159Gfs*8);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	KRAS p.G12C;NSD1 p.Q1598*;PTEN p.R159Gfs*8;MGA p.P1260Hfs*31;CDKN2A Deletion;CDKN2B Deletion;PTPRD Deletion	4	7
P-0011126	P-0011126-T01-IM5	In-House	FFPE	Cytology	80.28	402	20	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	KRAS p.Q61H;TP53 p.G154Afs*16	1	2
P-0011127	P-0011127-T01-IM5	Outside	FFPE	Biopsy	250	1130	65	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type					GSK2636771,AZD8186(PTEN p.R130*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.R130*;TP53 p.F341C;CDKN2A Deletion	2	3
P-0011128	P-0011128-T01-IM5	In-House	FFPE	Biopsy	250	982	70	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Olaparib(ATM p.N109Sfs*3)					LEVEL_3B	CTNNB1 p.S33F;TP53 p.G245R;TP53 p.L130F;ATM p.N109Sfs*3;FUBP1 p.Y618Tfs*62	1	5
P-0011129	P-0011129-T01-IM5	Outside	FFPE	Biopsy	250	904	80	Matched	Primary	Lung	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS				AMG-510(KRAS p.G12C);Cisplatin(ERCC2 p.X611_splice);Olaparib(ATM p.I818Ffs*4)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12C;RAC1 p.A159V;ERCC2 p.X611_splice;ATM p.I818Ffs*4;CDKN2A Deletion;CDKN2B Deletion	5	6
P-0011130	P-0011130-T01-IM5	In-House	FFPE	Resection	250	796	20	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung										TP53 p.A161D;PMAIP1 p.K4Rfs*33	0	2
P-0011131	P-0011131-T01-IM5	In-House	FFPE	Biopsy	250	1205	35	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;TP53 p.R282W;APC p.L1488Yfs*19;APC p.E1156*;TP53 p.L130Sfs*40;CDKN2A Deletion;CDKN2B Deletion	2	7
P-0011132	P-0011132-T01-IM5	In-House	FFPE	Biopsy	250	1248	65	Matched	Metastasis	Lung	Bone	Tumor	NSCLC	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;KEAP1 p.E449*;SMARCA4 p.X1072_splice;PTPRT p.A1121Gfs*35;STK11 p.P281Gfs*3	1	5
P-0011133	P-0011133-T01-IM5	Outside	FFPE	Biopsy	206.9	1339	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;RB1 p.R7Efs*58	1	2
P-0011134	P-0011134-T01-IM5	In-House	FFPE	Biopsy	185.9	733	30	Matched	Metastasis	Breast	Liver	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	BRD4 Amplification;ERBB2 Amplification;FLCN Deletion;MAP2K4 Deletion;MYC Amplification;NCOR1 NCOR1-intragenic	2	6
P-0011135	P-0011135-T01-IM5	In-House	FFPE	Biopsy	250	925	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_3B	KRAS p.G12V;TP53 p.T211_H214del;CDKN2A p.R58*;CDK4 Amplification	3	4
P-0011136	P-0011136-T01-IM5	In-House	FFPE	Biopsy	250	1383	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.X1537_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;CREBBP p.R1360*;ATM p.X1537_splice;CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;NKX2-1 Amplification	3	7
P-0011137	P-0011137-T01-IM5	Outside	FFPE	Cytology	250	1082	50	Matched	Primary	Mediastinum	Not Applicable	Tumor	VYST	Germ Cell Tumor	Yolk Sac Tumor					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.T125M;TP53 p.Y220N;PIK3CA Amplification	1	4
P-0011138	P-0011138-T01-IM5	Outside	FFPE	Cytology	135.09	820	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)	Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	ERBB2 p.Y772_A775dup;TP53 p.R110P;WT1 p.C303*;ERBB2 Amplification	3	4
P-0011139	P-0011139-T01-IM5	Outside	FFPE	Biopsy	250	1175	20	Unmatched	Primary	Lymph node	Not Applicable	Tumor	AITL	Mature T and NK Neoplasms	Angioimmunoblastic T-Cell Lymphoma										DNMT3A p.R882H;ATM p.R2034*;TET2 p.R1134Mfs*7	0	3
P-0011140	P-0011140-T01-IM5	In-House	FFPE	Biopsy	250	810	60	Matched	Metastasis	Liver	Peritoneum	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)						LEVEL_3A	IDH1 p.R132C;PBRM1 p.S429Ifs*15	1	2
P-0011141	P-0011141-T01-IM5	In-House	FFPE	Biopsy	250	1029	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;TP53 p.R209K;TP53 p.K132N;CCND1 Amplification;FGF19 Amplification	1	5
P-0011141	P-0011141-T02-IM5	In-House	FFPE	Resection	250	785	20	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;CCND1 Amplification;FGF19 Amplification	1	3
P-0011142	P-0011142-T01-IM5	In-House	FFPE	Resection	250	988	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	TP53 p.A159P;KRAS p.G13D;EGFR Amplification	1	3
P-0011143	P-0011143-T01-IM5	In-House	FFPE	Biopsy	250	1291	80	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	KRAS p.G12C;STK11 p.L85*;NF2 p.E372*;RBM10 p.D854Tfs*32	2	4
P-0011144	P-0011144-T01-IM5	In-House	FFPE	Resection	250	945	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.L130V;APC p.E1047*;APC p.S1415Nfs*5	1	4
P-0011145	P-0011145-T01-IM5	In-House	FFPE	Resection	250	921	60	Matched	Primary	Uterus	Not Applicable	Tumor	USC	Endometrial Cancer	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R)					LEVEL_3B	PIK3CA p.G1049R;TP53 p.Q167*;PPP2R1A p.S256F;AKT2 Amplification;CCNE1 Amplification	1	5
P-0011146	P-0011146-T01-IM5	Outside	FFPE	Biopsy	250	1167	75	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										SPEN p.K1114*;TP53 p.R267G;BBC3 p.R233Sfs*45;BBC3 p.T216Gfs*20	0	4
P-0011147	P-0011147-T01-IM5	In-House	FFPE	Biopsy	250	976	40	Matched	Primary	Lung	Not Applicable	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Y)				LEVEL_4	TP53 p.R273S;KMT2D p.R4282*;ARID2 p.Q834*;CDKN2A p.D108Y;AKT2 Amplification;ANKRD11 Deletion;CDKN2B Deletion;SUZ12 Deletion;CUL1 EZH2-CUL1 fusion;EZH2 EZH2-CUL1 fusion	1	10
P-0011148	P-0011148-T01-IM5	Outside	FFPE	Resection	250	850	35	Matched	Primary	Lung	Not Applicable	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;CDKN2B Deletion;ETV1 Amplification;MDM2 Amplification;RAC1 Amplification;TERT Amplification;ARID2 MRPS30-ARID2 fusion;MRPS30 MRPS30-ARID2 fusion	2	8
P-0011149	P-0011149-T01-IM5	In-House	FFPE	Biopsy	167.65	732	80	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_4	KRAS p.G13C;EGFR p.Q787L;STK11 p.X97_splice;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification;MGA SPTBN5-MGA fusion;SPTBN5 SPTBN5-MGA fusion	1	8
P-0011150	P-0011150-T01-IM5	In-House	FFPE	Resection	250	787	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Trametinib,Cobimetinib(NF1 p.Q1188*)				LEVEL_3A	KRAS p.G12C;TP53 p.E298*;NF1 p.Q1188*;SH2D1A p.X116_splice	3	4
P-0011151	P-0011151-T01-IM5	In-House	FFPE	Resection	250	719	60	Matched	Primary	Chest Wall	Not Applicable	Tumor	MPNST	Nerve Sheath Tumor	Malignant Peripheral Nerve Sheath Tumor					Trametinib,Cobimetinib(NF1 p.X509_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	SUZ12 p.X275_splice;NF1 p.X509_splice;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0011152	P-0011152-T01-IM5	In-House	FFPE	Resection	250	796	70	Matched	Metastasis	Skin	Lymph Node	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	PTEN Deletion	1	1
P-0011153	P-0011153-T01-IM5	In-House	FFPE	Biopsy	250	786	25	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										RB1 p.Q770*;TP53 p.X307_splice	0	2
P-0011154	P-0011154-T01-IM5	In-House	FFPE	Biopsy	250	612	15	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(ATM p.P2699L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;U2AF1 p.S34F;STAG2 p.Q275*;ATM p.P2699L;AKT2 Amplification	3	5
P-0011155	P-0011155-T01-IM5	In-House	FFPE	Biopsy	250	1081	70	Matched	Metastasis	Prostate	Adrenal Gland	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ASXL1 p.G646Wfs*12;AR p.H875Y;INHA p.L189Cfs*2;MEN1 p.R420*;ZFHX3 p.S3606Pfs*88;ANKRD11 p.K1464Tfs*89;CDKN1B Deletion;PRDM1 Deletion	0	8
P-0011156	P-0011156-T01-IM5	In-House	FFPE	Biopsy	250	1069	50	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										RB1 p.A15Pfs*3;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0011157	P-0011157-T01-IM5	In-House	FFPE	Resection	250	899	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib(CHEK2 p.X303_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;NOTCH1 p.E1624*;CHEK2 p.X303_splice;RBM10 p.Q51*	3	4
P-0011158	P-0011158-T01-IM5	In-House	FFPE	Resection	250	935	40	Matched	Metastasis	Ascending Colon	Diaphragm	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D350V)					LEVEL_3B	TP53 p.R175H;BRAF p.D594G;RAF1 p.P261R;APC p.R554*;APC p.Q1477*;PIK3CA p.D350V;EPHA7 Deletion	1	7
P-0011159	P-0011159-T01-IM5	In-House	FFPE	Resection	250	795	60	Matched	Metastasis	Thyroid	Bone	Tumor	THFO	Thyroid Cancer	Follicular Thyroid Cancer										EIF1AX p.X113_splice;BRAF p.I592_A598dup;NOTCH1 p.X635_splice;CREBBP p.X266_splice;TGFBR2 Deletion	0	5
P-0011160	P-0011160-T01-IM5	In-House	FFPE	Resection	250	870	65	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer			Selumetinib+Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol(NRAS p.Q61K)	Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3A	NRAS p.Q61K	2	1
P-0011161	P-0011161-T01-IM5	In-House	FFPE	Cytology	250	1052	40	Matched	Metastasis	Lung	Pericardium	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	EGFR p.E746_A750del;TP53 p.C275S;CDK4 Amplification;GLI1 Amplification;KRAS Amplification	2	5
P-0011162	P-0011162-T01-IM5	In-House	FFPE	Resection	250	454	85	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PIK3R1 p.Q586*;PBRM1 p.A222Dfs*3;VHL p.E134Ifs*9	0	3
P-0011162	P-0011162-T02-IM5	In-House	FFPE	Resection	250	964	85	Matched	Metastasis	Kidney	Stomach	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PIK3R1 p.Q586*;PBRM1 p.A222Dfs*3;VHL p.E134Ifs*9;CDKN2A Deletion	1	4
P-0011163	P-0011163-T01-IM5	In-House	FFPE	Resection	250	857	35	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor											0	0
P-0011174	P-0011174-T01-IM5	In-House	FFPE	Biopsy	250	771	80	Matched	Metastasis	Uterus	Bone	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.X70_splice)				LEVEL_4	CTNNB1 p.I35S;PTEN p.X70_splice;PPM1D p.E540Qfs*10;PIK3R1 p.E462_Y463delinsD	1	4
P-0011175	P-0011175-T01-IM5	Outside	FFPE	Biopsy	250	1084	10	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma										TP53 p.K139*;CBL CBL-intragenic;MSH2 MSH2-intragenic	0	3
P-0011176	P-0011176-T01-IM5	In-House	FFPE	Resection	250	874	30	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)						LEVEL_1	PIK3CA p.E542K;CBFB p.X55_splice;CDH1 p.X720_splice	2	3
P-0011177	P-0011177-T01-IM5	In-House	FFPE	Biopsy	250	1030	50	Matched	Metastasis	Maxilla	Lymph Node	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K	1	1
P-0011178	P-0011178-T01-IM5	In-House	FFPE	Resection	250	944	50	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Avapritinib(PDGFRA p.D842V)	Dasatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)				Imatinib(PDGFRA p.D842V)			LEVEL_1	PDGFRA p.D842V;NOTCH2 p.T932Ffs*13	2	2
P-0011179	P-0011179-T01-IM5	Outside	FFPE	Biopsy	250	981	85	Unmatched	Primary	Stomach	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MAP2K1 p.K57E;DNMT3A p.X477_splice;TET2 p.Q557*;TET2 p.Y1245Lfs*22;MCL1 Amplification;MYC Amplification;TP53 Deletion	0	7
P-0011180	P-0011180-T01-IM5	In-House	FFPE	Biopsy	250	913	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										CTNNB1 p.D32V;TP53 p.I251F;MYC Amplification;NRG1 CD74-NRG1 fusion;CD74 CD74-NRG1 fusion	0	5
P-0011181	P-0011181-T01-IM5	In-House	FFPE	Resection	250	1306	65	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.H179R;RB1 p.L343Sfs*3;PRKN p.X179_splice	0	3
P-0011182	P-0011182-T01-IM5	In-House	FFPE	Biopsy	250	955	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R337C;SMAD4 p.X72_splice;APC p.S1213*;APC p.S1436Vfs*37	0	4
P-0011183	P-0011183-T01-IM5	In-House	FFPE	Biopsy	250	1052	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.R3008L)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;TP53 p.P278S;ATM p.R3008L;EP300 p.H828Ifs*22;ARID2 p.X140_splice;SETD2 MAP4-SETD2 fusion;MAP4 MAP4-SETD2 fusion	2	7
P-0011184	P-0011184-T01-IM5	Outside	FFPE	Biopsy	250	980	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V777L);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)	Cetuximab,Panitumumab(KRAS p.A146V)			LEVEL_2	KRAS p.A146V;ERBB2 p.V777L;ERBB2 Amplification	4	3
P-0011185	P-0011185-T01-IM5	Outside	FFPE	Cytology	250	870	15	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.T3033Nfs*11)	GSK2636771,AZD8186(PTEN p.E235Vfs*5)				LEVEL_3B	BRCA2 p.T3033Nfs*11;PTEN p.E235Vfs*5;TP53 p.G266Dfs*79;KMT2D p.L1155Wfs*9;GATA3 Deletion;MYCL Amplification;RB1 Deletion;SMAD3 Deletion;TNFRSF14 Deletion	2	9
P-0011186	P-0011186-T01-IM5	Outside	FFPE	Biopsy	250	1000	60	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.Q2762*)					LEVEL_3B	CTNNB1 p.S45F;TP53 p.V73Wfs*50;ATM p.Q2762*;KEAP1 p.G509A;STK11 p.R211Lfs*76	1	5
P-0011187	P-0011187-T01-IM5	In-House	FFPE	Biopsy	250	910	80	Matched	Metastasis	Bladder	Lung	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.N891Kfs*13)	Tazemetostat(KDM6A p.X207_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;TSC1 p.N891Kfs*13;KDM6A p.X207_splice;RBM10 p.X596_splice;KMT2D p.S4411Gfs*69;CDKN2A Deletion;CDKN2B Deletion;TGFBR1 Deletion	5	8
P-0011188	P-0011188-T01-IM5	Outside	FFPE	Resection	250	524	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.L260Sfs*62	0	1
P-0011189	P-0011189-T01-IM5	In-House	FFPE	Biopsy	250	986	55	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Osimertinib(EGFR p.T790M);Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_T751del)				GSK2636771,AZD8186(PTEN p.N329Kfs*14)	Erlotinib,Gefitinib,Afatinib(EGFR p.T790M)			LEVEL_1	EGFR p.T790M;PTEN p.N329Kfs*14;EGFR p.L747_T751del;SMAD4 p.Q534*	3	4
P-0011190	P-0011190-T01-IM5	In-House	FFPE	Resection	247.2	296	20	Matched	Primary	Soft Tissue	Not Applicable	Tumor	PGNG	Miscellaneous Neuroepithelial Tumor	Paraganglioma											0	0
P-0011191	P-0011191-T01-IM5	Outside	FFPE	Biopsy	250	856	65	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A86Gfs*31);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A86Wfs*31)				LEVEL_4	KRAS p.G12D;TP53 p.H193Y;CDKN2A p.A86Gfs*31;CDKN2A p.A86Wfs*31;AMER1 Deletion;EP300 Deletion;KDM5C Deletion;PTPRD Deletion	3	8
P-0011192	P-0011192-T01-IM5	In-House	Cell Pellet	Cytology	250	920	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)					LEVEL_3B	NRAS p.Q61K;NFE2L2 p.R34Q;TP53 p.M246L;BRAF p.N581S;PTPRD Deletion	1	5
P-0011193	P-0011193-T01-IM5	Outside	FFPE	Cytology	225.5	764	10	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.C901F)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.C901F)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.C901F;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;NKX3-1 Deletion	3	5
P-0011194	P-0011194-T01-IM5	In-House	FFPE	Biopsy	158.2	700	40	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma											0	0
P-0011195	P-0011195-T01-IM5	In-House	FFPE	Biopsy	250	883	10	Matched	Metastasis	Rectum	Paraspinal Mass	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	APC p.R564*;APC p.E1353*;TP53 p.X307_splice;ERBB2 Amplification	2	4
P-0011196	P-0011196-T01-IM5	In-House	FFPE	Resection	250	398	30	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										TP53 p.Y234*;TP53 DLEU7-TP53 fusion;DLEU7 DLEU7-TP53 fusion;TP53 TP53-intragenic	0	4
P-0011197	P-0011197-T01-IM5	In-House	FFPE	Biopsy	250	992	30	Matched	Metastasis	Lung	Pleura	Tumor	ALUCA	Non-Small Cell Lung Cancer	Atypical Lung Carcinoid										ARID1B p.R1611*;CCND1 Amplification;FGF19 Amplification	0	3
P-0011198	P-0011198-T01-IM5	Outside	FFPE	Resection	250	711	65	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TMPRSS2 ETV5-TMPRSS2 fusion;ETV5 ETV5-TMPRSS2 fusion	0	2
P-0011199	P-0011199-T01-IM5	In-House	FFPE	Resection	250	815	75	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.R130*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.R130*;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	4
P-0011200	P-0011200-T01-IM5	Outside	FFPE	Biopsy	250	796	20	Matched	Metastasis	Testis	Liver	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0011201	P-0011201-T01-IM5	In-House	FFPE	Cytology	250	1128	80	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.X173_splice)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.K319*;BRCA2 p.X173_splice;NCOR1 p.K1366*;EP300 p.G2160*;AURKA Amplification;CDKN2A Deletion;NKX3-1 Deletion;RGS2 CDC73-RGS2 fusion;CDC73 CDC73-RGS2 fusion	2	9
P-0011202	P-0011202-T01-IM5	Outside	FFPE	Resection	250	895	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion;PTEN Deletion	2	4
P-0011203	P-0011203-T01-IM5	Outside	FFPE	Cytology	250	933	10	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	SDCA	Salivary Gland Cancer	Salivary Duct Carcinoma				Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(ALK EML4-ALK fusion);Crizotinib,Lorlatinib,Brigatinib,Ceritinib,Alectinib(EML4 EML4-ALK fusion)					LEVEL_3B	FOXA1 p.P272Rfs*26;KMT2D MLL2-intragenic;ALK EML4-ALK fusion;EML4 EML4-ALK fusion	2	4
P-0011204	P-0011204-T01-IM5	In-House	FFPE	Biopsy	250	751	85	Unmatched	Primary	Lymph node	Not Applicable	Tumor	MCL	Mature B-Cell Neoplasms	Mantle Cell Lymphoma										TP53 p.R273C;CREBBP p.Q1148*;CCND1 p.K46_C47delinsNG;ATM Deletion;FOXP1 Deletion;LATS2 Deletion;PTPRD Deletion;SDHD Deletion	0	8
P-0011205	P-0011205-T01-IM5	In-House	FFPE	Biopsy	250	846	40	Matched	Primary	Liver	Not Applicable	Tumor	LIHB	Hepatobiliary Cancer	Hepatoblastoma										NFE2L2 p.D77Y	0	1
P-0011206	P-0011206-T01-IM5	Outside	FFPE	Biopsy	250	765	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;CCND1 Amplification;FGF19 Amplification	2	3
P-0011207	P-0011207-T01-IM5	In-House	FFPE	Biopsy	145.7	289	90	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					GSK2636771,AZD8186(PTEN p.N323Kfs*2);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.N323Kfs*2;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0011208	P-0011208-T01-IM5	Outside	FFPE	Cytology	250	1097	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R209*;SMAD4 p.X68_splice	1	3
P-0011210	P-0011210-T01-IM5	Outside	FFPE	Biopsy	250	972	30	Matched	Metastasis	Kidney	Peritoneum	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0011211	P-0011211-T01-IM5	In-House	FFPE	Resection	250	542	70	Matched	Metastasis	Cancer of Unknown Primary	Axilla	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Olaparib(ATM p.R337C)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_3B	TP53 p.R213*;TP53 p.Q317*;NOTCH1 p.X481_splice;TP53 p.E286K;ATM p.R337C;NF2 p.Q389*;NOTCH3 p.X398_splice;CDKN2A p.P114L	2	8
P-0011212	P-0011212-T01-IM5	Outside	FFPE	Resection	250	932	20	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201C	1	2
P-0011213	P-0011213-T01-IM5	Outside	FFPE	Biopsy	211.3	758	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR Amplification)				LEVEL_4	TP53 p.R273C;ATRX p.L513*;CARD11 Amplification;EGFR Amplification	1	4
P-0011214	P-0011214-T01-IM5	In-House	FFPE	Biopsy	250	1137	70	Matched	Metastasis	Skin	Retroperitoneum	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma										BCL2L1 Amplification	0	1
P-0011215	P-0011215-T01-IM5	Outside	FFPE	Cytology	250	1148	60	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Tazemetostat(DRICH1 SMARCB1-C22orf43 fusion);Tazemetostat(SMARCB1 SMARCB1-C22orf43 fusion)				LEVEL_3B	BRAF p.V600E;SMAD4 p.R361C;RNF43 p.X260_splice;DRICH1 SMARCB1-C22orf43 fusion;SMARCB1 SMARCB1-C22orf43 fusion	3	5
P-0011216	P-0011216-T01-IM5	Outside	FFPE	Resection	250	1059	50	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node, Regional	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	BRAF p.V600E;TP53 p.S241F;MED12 p.E55K;CDKN2A p.E88*;CCND1 Amplification;FGF19 Amplification;GATA3 Deletion;PTEN Deletion	4	8
P-0011217	P-0011217-T01-IM5	In-House	FFPE	Resection	250	916	20	Matched	Primary	Pancreas	Not Applicable	Tumor	IPMN	Pancreatic Cancer	Intraductal Papillary Mucinous Neoplasm										GNAS p.R201H;ARID1A p.P225Afs*175;BRAF p.N486_P490del;KMT2D p.X371_splice	0	4
P-0011218	P-0011218-T01-IM5	Outside	FFPE	Resection	250	669	80	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma										STAG2 p.X699_splice;FH p.A102Lfs*5	0	2
P-0011219	P-0011219-T01-IM5	Outside	FFPE	Resection	250	823	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	EGFR p.S229C;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;PRKN Deletion;CDKN2C RNF11-CDKN2C fusion;RNF11 RNF11-CDKN2C fusion	2	7
P-0011220	P-0011220-T01-IM5	In-House	FFPE	Biopsy	250	1059	30	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	ATRX p.R1514*;CCND3 Amplification;CDK4 Amplification;FAT1 Deletion;MDM2 Amplification;VEGFA Amplification	2	6
P-0011221	P-0011221-T01-IM5	In-House	FFPE	Biopsy	250	739	40	Matched	Primary	Thyroid	Not Applicable	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer					GSK2636771,AZD8186(PTEN p.R233*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.R233*;MAX p.X99_splice;MAP2K4 p.X297_splice;SETD2 p.G2211Yfs*32;CDKN2A Deletion	2	5
P-0011222	P-0011222-T01-IM5	In-House	FFPE	Resection	250	695	80	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma			AZD5363(AKT1 p.E17K)		Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252W);Everolimus,Temsirolimus(MTOR p.A1459_D1468del)				LEVEL_3A	AKT1 p.E17K;FGFR2 p.S252W;ARID1A p.D1850Gfs*4;LATS1 p.F1010Lfs*10;NBN p.L654Afs*5;SMAD2 p.R310T;NFE2L2 p.E82D;CTCF p.E87*;MTOR p.A1459_D1468del;PIK3R1 p.I405_L420del;KMT2D p.T2123Pfs*21;RB1 p.A74Efs*4	3	12
P-0011223	P-0011223-T01-IM5	Outside	FFPE	Biopsy	250	847	10	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;TP53 p.V73Lfs*43	1	2
P-0011224	P-0011224-T01-IM5	In-House	FFPE	Resection	250	815	60	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	MYCN p.P44L;PTEN p.R130Q;ARID1A p.Q633*;KMT2D p.C69*;PIK3R1 p.R577_L581delinsSI	1	5
P-0011225	P-0011225-T01-IM5	In-House	FFPE	Biopsy	250	894	15	Matched	Metastasis	Breast	Soft Tissue	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma											0	0
P-0011225	P-0011225-T02-IM5	Outside	FFPE	Resection	250	576	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										KMT2C p.E87Rfs*9	0	1
P-0011226	P-0011226-T01-IM5	In-House	FFPE	Resection	250	983	25	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Sonidegib,Vismodegib(PTCH1 p.L39Cfs*41);Olaparib(CHEK2 p.Y329Lfs*12)	GSK2636771,AZD8186(PTEN p.D268Gfs*30);Trametinib,Cobimetinib,Binimetinib(KRAS p.A59T);GSK2636771,AZD8186(PTEN p.C105Lfs*2)	Cetuximab,Panitumumab(KRAS p.A59T)			LEVEL_3B	PIK3CA p.E542K;PTEN p.D268Gfs*30;APC p.R1450*;KMT2D p.P2354Lfs*30;JAK1 p.N339Ifs*3;TP53 p.P250L;APC p.R876*;KRAS p.A59T;ZFHX3 p.R1893Gfs*35;BCOR p.K1207Nfs*31;PTCH1 p.L39Cfs*41;PAX5 p.V26Ffs*3;KMT2D p.P886Lfs*44;HLA-A p.X25_splice;RAD21 p.Q607*;PIK3R2 p.A171S;CHEK2 p.Y329Lfs*12;ZFHX3 p.D2766*;KMT2D p.V2551Sfs*32;RYBP p.R103Dfs*33;ASXL2 p.E1287Sfs*37;PTEN p.C105Lfs*2;ASXL2 p.E1009Dfs*35;SOX9 p.P267Lfs*12;MSH2 p.T234Kfs*12;MSH2 p.E48Wfs*16	6	26
P-0011234	P-0011234-T01-IM5	In-House	FFPE	Biopsy	250	758	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.E746_A750del;TP53 p.H214Rfs*25;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0011234	P-0011234-T02-IM5	In-House	FFPE	Resection	250	1038	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del	1	1
P-0011235	P-0011235-T01-IM5	In-House	FFPE	Biopsy	250	1064	65	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Everolimus(TSC1 p.N891Kfs*13)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	HIST1H1C p.K23del;KRAS p.G13D;TSC1 p.N891Kfs*13;KMT2C p.Q2385*;SOX9 p.Q401*;CBL p.L272Ffs*4	2	6
P-0011236	P-0011236-T01-IM5	In-House	FFPE	Resection	250	828	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.X1921_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_3B	KRAS p.G12A;U2AF1 p.S34F;ATM p.X1921_splice	2	3
P-0011237	P-0011237-T01-IM5	In-House	FFPE	Cytology	181.1	687	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	SDHAF2 p.S10*;CCND3 Amplification;EGFR Amplification;MDM2 Amplification	1	4
P-0011238	P-0011238-T01-IM5	Outside	FFPE	Biopsy	250	1028	25	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BAP1 p.Q483*;BAP1 p.N645Gfs*12;CDKN2A Deletion;CDKN2B Deletion	1	4
P-0011239	P-0011239-T01-IM5	In-House	FFPE	Resection	250	918	25	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R	1	1
P-0011239	P-0011239-T02-IM5	Outside	FFPE	Resection	250	938	30	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.I679Dfs*21);Trametinib,Cobimetinib(NF1 p.N39Kfs*28)				LEVEL_4	CREBBP p.I1084Sfs*15;GNAS p.R201H;RIT1 p.A77T;HNF1A p.P379Lfs*5;APC p.T1556Nfs*3;CTCF p.T204Nfs*26;PPP2R1A p.R183W;KMT2D p.P2354Lfs*30;FBXW7 p.R465C;CTCF p.R457*;SMAD4 p.S32*;NF1 p.I679Dfs*21;KMT2D p.G1235Vfs*95;FLCN p.H429Tfs*39;AXIN2 p.E405Gfs*56;TNFAIP3 p.K759Sfs*57;CIC p.A900Pfs*24;RASA1 p.X418_splice;RASA1 p.X592_splice;TCF3 p.X49_splice;TP63 p.M107Cfs*11;SOX9 p.V306Gfs*272;PIK3R1 p.S460Vfs*20;NF1 p.N39Kfs*28;MGA p.K1136Rfs*6;PIK3R1 p.I82Sfs*32	2	26
P-0011240	P-0011240-T01-IM5	Outside	FFPE	Resection	250	1023	50	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.E271*;ERBB2 Amplification;FGFR3 Amplification	1	3
P-0011241	P-0011241-T01-IM5	In-House	FFPE	Resection	250	793	70	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										NF2 Deletion	0	1
P-0011242	P-0011242-T01-IM5	Outside	FFPE	Biopsy	250	1145	35	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;STK11 p.E256*;PBRM1 p.X239_splice;KEAP1 p.E446*;MED12 p.Q2132*;ARID1A p.Y2254*;CDH15 ANKRD11-CDH15 fusion;ANKRD11 ANKRD11-CDH15 fusion	1	8
P-0011244	P-0011244-T01-IM5	In-House	FFPE	Biopsy	250	1071	10	Matched	Metastasis	Lung	Pleura	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0011245	P-0011245-T01-IM5	In-House	FFPE	Resection	250	818	10	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)						LEVEL_1	FGFR3 p.R248C;FBXW7 p.R505G	2	2
P-0011246	P-0011246-T01-IM5	Outside	FFPE	Resection	250	603	70	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.P151Rfs*27	0	1
P-0011247	P-0011247-T01-IM5	In-House	FFPE	Biopsy	250	1318	70	Matched	Metastasis	Breast	Lung	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.E453_P466del)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453_P466del)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.E453_P466del;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;FGF19 Amplification;PAK1 Amplification;SMAD4 Deletion	3	7
P-0011248	P-0011248-T01-IM5	In-House	FFPE	Resection	250	1471	30	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043V)					LEVEL_3B	IDH1 p.R132H;PIK3CA p.M1043V;CIC p.R215W;CIC p.R202W;FUBP1 p.X41_splice;TET2 p.S1330F;ASXL1 p.T822Nfs*11	2	7
P-0011249	P-0011249-T01-IM5	In-House	FFPE	Resection	250	911	25	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0011250	P-0011250-T01-IM5	Outside	FFPE	Resection	250	702	35	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K	2	1
P-0011251	P-0011251-T01-IM5	In-House	FFPE	Resection	250	1265	80	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma											0	0
P-0011252	P-0011252-T01-IM5	In-House	FFPE	Resection	250	1022	80	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma					Tazemetostat(SMARCB1 p.R377H);GSK2636771,AZD8186(PTEN RNLS-PTEN fusion);GSK2636771,AZD8186(RNLS RNLS-PTEN fusion)				LEVEL_4	TP53 p.R175H;SMARCB1 p.R377H;FOXP1 p.R514H;RB1 p.R455*;ATRX p.R250*;PTEN RNLS-PTEN fusion;RNLS RNLS-PTEN fusion	3	7
P-0011253	P-0011253-T01-IM5	In-House	FFPE	Resection	250	948	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0011254	P-0011254-T01-IM5	In-House	FFPE	Biopsy	250	1053	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Trametinib,Cobimetinib(NF1 p.Q2531*);Trametinib,Cobimetinib(NF1 p.S2013Kfs*17)				LEVEL_3A	KRAS p.G12C;NF1 p.Q2531*;NF1 p.S2013Kfs*17;DDR2 Amplification;NTRK1 Amplification	4	5
P-0011255	P-0011255-T01-IM5	In-House	FFPE	Biopsy	250	985	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.V157_R158del;APC p.R283*;APC p.Q1378*	0	3
P-0011256	P-0011256-T01-IM5	In-House	FFPE	Resection	250	939	15	Matched	Metastasis	Bone	Rib	Tumor	OS	Bone Cancer	Osteosarcoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CCND3 Amplification;CDK4 Amplification;MDM2 Amplification;TERT Amplification;VEGFA Amplification	2	5
P-0011257	P-0011257-T01-IM5	In-House	FFPE	Resection	250	1261	80	Matched	Primary	Brain	Not Applicable	Tumor	ASTR	Glioma	Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.R213Q;ATRX p.L359Tfs*3;TP53 p.S240G;BCOR p.X1080_splice	1	5
P-0011258	P-0011258-T01-IM5	In-House	FFPE	Resection	250	534	60	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Olaparib(CDK12 p.G9Afs*48)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.G9Afs*48)				LEVEL_3B	APC p.D170Vfs*4;ARID1A p.Y948*;ARID1A p.Q1493*;FAT1 p.E2149*;CDK12 p.G9Afs*48;SOX9 p.H413Lfs*57	2	6
P-0011260	P-0011260-T01-IM5	In-House	FFPE	Cytology	250	1035	80	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib(NF1 p.G675*);Trametinib,Cobimetinib(NF1 p.E1210*)				LEVEL_3B	TP53 p.X307_splice;NF1 p.G675*;NF1 p.E1210*;PBRM1 p.Q235Rfs*18;FGFR1 Amplification	3	5
P-0011261	P-0011261-T01-IM5	In-House	FFPE	Biopsy	250	847	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Neratinib(ERBB2 p.D769Y)	Ado-Trastuzumab Emtansine(ERBB2 p.D769Y)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A)				LEVEL_1	KRAS p.G12A;PIK3CA p.E542K;ERBB2 p.D769Y;MAP3K1 p.W1325*;KMT2C p.C4465Vfs*52	5	5
P-0011262	P-0011262-T01-IM5	In-House	FFPE	Resection	250	841	75	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);GSK2636771,AZD8186(PTEN p.N323Kfs*2);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A36Rfs*17)				LEVEL_3B	NCOR1 p.E529Kfs*26;PTEN p.K267Rfs*9;TP53 p.P301Qfs*44;ARID1A p.P1115Qfs*46;PTEN p.N323Kfs*2;ARID1A p.G276Efs*87;ERBB2 p.V842I;PPP2R1A p.R221W;TP53 p.K382Nfs*40;SETD2 p.S2382Lfs*29;FAT1 p.R2989Gfs*20;TET2 p.R1440W;FAT1 p.Q1494*;NOTCH4 p.X504_splice;PPP6C p.R111*;SPOP p.R121Q;KMT2D p.V1670Sfs*52;MSH2 p.Q409Rfs*3;CDKN2A p.A36Rfs*17	4	19
P-0011263	P-0011263-T01-IM5	In-House	FFPE	Resection	250	640	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										KDM6A p.E1337*	0	1
P-0011264	P-0011264-T01-IM5	Outside	FFPE	Resection	250	1012	30	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61K)	Cetuximab,Panitumumab(KRAS p.Q61K)			LEVEL_4	SMAD4 p.C363F;KRAS p.Q61K;TP53 p.L35Pfs*10;RNF43 p.A193Gfs*6	1	4
P-0011265	P-0011265-T01-IM5	In-House	FFPE	Resection	250	492	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P81Rfs*38)				LEVEL_4	TP53 p.R248Q;KRAS p.G12R;SMAD4 p.L529Yfs*8;CDKN2A p.P81Rfs*38	2	4
P-0011266	P-0011266-T01-IM5	In-House	FFPE	Biopsy	250	1096	80	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THPD	Thyroid Cancer	Poorly Differentiated Thyroid Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.C135Y;RB1 p.W563*;CDKN1B p.G72A;PTEN Deletion	1	4
P-0011267	P-0011267-T01-IM5	Outside	FFPE	Resection	250	877	85	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0011268	P-0011268-T01-IM5	In-House	FFPE	Resection	250	728	70	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P3Rfs*23)				LEVEL_3A	KRAS p.G12C;TP53 p.R158L;STAG2 p.W1103*;EPHA3 p.M847Nfs*26;CDKN2A p.P3Rfs*23;B2M TRIM69-B2M fusion;TRIM69 TRIM69-B2M fusion	3	7
P-0011269	P-0011269-T01-IM5	In-House	FFPE	Resection	250	835	20	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)		Trametinib,Cobimetinib(MAP2K1 p.P124S)	Ivosidenib(IDH1 p.R132C)					LEVEL_1	RAC1 p.P29S;IDH1 p.R132C;EGFR p.E709K;TET2 p.R1440Q;PTPRD p.R1674C;BRAF p.V600K;MUTYH p.Q169*;ASXL2 p.Q192*;MAP2K1 p.P124S;GRIN2A p.W843*	3	10
P-0011270	P-0011270-T01-IM5	In-House	FFPE	Biopsy	250	957	60	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma										JAK1 p.L431Vfs*22	0	1
P-0011271	P-0011271-T01-IM5	Outside	FFPE	Resection	250	988	85	Matched	Primary	Appendix	Not Applicable	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.S138*;TET1 p.R1646*;TP53 p.X187_splice;AMER1 Deletion;SRC Amplification	1	6
P-0011276	P-0011276-T01-IM5	In-House	FFPE	Biopsy	250	1479	60	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.L114Ffs*35;ASXL1 ASXL1-intragenic	0	2
P-0011278	P-0011278-T01-IM5	In-House	FFPE	Resection	250	650	85	Matched	Primary	Pleura	Not Applicable	Tumor	PLMESO	Mesothelioma	Pleural Mesothelioma										DIS3 p.X326_splice;TP53 p.N239Kfs*15	0	2
P-0011279	P-0011279-T01-IM5	In-House	FFPE	Resection	250	759	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;TP53 p.L188Rfs*59;ATRX p.V1579Efs*21;EPHA7 Deletion	1	4
P-0011280	P-0011280-T01-IM5	In-House	FFPE	Biopsy	185.1	643	10	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;MAP3K1 p.X790_splice	2	2
P-0011281	P-0011281-T01-IM5	In-House	FFPE	Biopsy	136.9	735	30	Matched	Metastasis	Breast	Lung	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.N345K;TP53 p.E286*;NOTCH1 p.C312*;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MYC Amplification;PPM1D Amplification;ELP4 WT1-ELP4 fusion;WT1 WT1-ELP4 fusion	4	10
P-0011282	P-0011282-T01-IM5	Outside	FFPE	Biopsy	250	1028	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R273H	0	1
P-0011283	P-0011283-T01-IM5	Outside	FFPE	Resection	250	731	45	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.R273C;TCF7L2 p.X424_splice;APC p.E1306*;ERBB4 p.R544W;FGFR1 Amplification;MYC Amplification	1	6
P-0011284	P-0011284-T01-IM5	In-House	FFPE	Biopsy	250	1012	80	Matched	Primary	Esophagus	Not Applicable	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma				Olaparib(BRIP1 p.I983Nfs*19)	Trametinib,Cobimetinib(NF1 NF1-intragenic)				LEVEL_3B	TP53 p.P36Rfs*8;PIK3R1 p.E451_Y452del;BRIP1 p.I983Nfs*19;MSH6 p.R361H;MAP3K1 p.R179Vfs*6;NF1 NF1-intragenic	2	6
P-0011285	P-0011285-T01-IM5	Outside	FFPE	Biopsy	250	851	70	Matched	Metastasis	Pancreas	Stomach	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;TP53 p.S149Pfs*21;FGFR1 Amplification;RB1 RB1-intragenic	2	4
P-0011287	P-0011287-T01-IM5	Outside	FFPE	Biopsy	250	841	25	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;TP53 p.R175H;APC p.R1450*;SMAD4 p.D537G;APC p.R876*	1	5
P-0011288	P-0011288-T01-IM5	Outside	FFPE	Resection	250	292	50	Matched	Primary	Transverse Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)					LEVEL_3B	TP53 p.R273C;PIK3CA p.R88Q;APC p.E1379*;APC p.R302*	1	4
P-0011289	P-0011289-T01-IM5	In-House	FFPE	Resection	250	792	75	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma											0	0
P-0011290	P-0011290-T01-IM5	In-House	FFPE	Biopsy	250	753	15	Matched	Metastasis	Prostate	Sacral Mass	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L;AR p.W742C;SETD2 p.K2519Rfs*3;APC Deletion;KMT2D C7orf60-MLL2 fusion;BMT2 C7orf60-MLL2 fusion	0	6
P-0011291	P-0011291-T01-IM5	In-House	FFPE	Resection	250	618	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	KRAS p.G13D	1	1
P-0011292	P-0011292-T01-IM5	In-House	FFPE	Resection	250	768	85	Matched	Primary	Hip	Not Applicable	Tumor	PLRMS	Soft Tissue Sarcoma	Pleomorphic Rhabdomyosarcoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion	1	2
P-0011293	P-0011293-T01-IM5	In-House	FFPE	Resection	250	598	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Y234C;TP53 p.E285Q;CIC p.X151_splice;B2M p.W80Sfs*6;EGFR Amplification	0	5
P-0011294	P-0011294-T01-IM5	In-House	FFPE	Resection	250	120	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										BCOR p.Q1441*	0	1
P-0011295	P-0011295-T01-IM5	In-House	FFPE	Resection	152.5	289	90	Matched	Primary	Abdomen	Abdomen	Tumor	WDLS	Soft Tissue Sarcoma	Well-Differentiated Liposarcoma		Palbociclib,Abemaciclib(CDK4 Amplification)	Milademetan Tosylate,RO5045337(MDM2 Amplification)						LEVEL_2	CDK4 Amplification;MDM2 Amplification;PDGFRA Amplification	2	3
P-0011296	P-0011296-T01-IM5	Outside	FFPE	Resection	250	1126	80	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										KMT2C p.R2139*;PPM1D p.N512Ifs*2;SOX9 p.Q230Nfs*23	0	3
P-0011297	P-0011297-T01-IM5	In-House	FFPE	Resection	250	994	70	Matched	Metastasis	Skin	Small bowel	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)						LEVEL_3A	NRAS p.Q61R;MITF Amplification	1	2
P-0011298	P-0011298-T01-IM5	In-House	FFPE	Resection	250	954	20	Matched	Metastasis	Lung	Epidural	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Kfs*12)				LEVEL_3A	KRAS p.G12C;KEAP1 p.E138*;STK11 p.G196Afs*91;SMARCA4 p.F1052Sfs*54;CDKN2A p.D108Kfs*12	3	5
P-0011299	P-0011299-T01-IM5	In-House	FFPE	Biopsy	243.9	814	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification	0	1
P-0011300	P-0011300-T01-IM5	Outside	FFPE	Resection	250	969	80	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.R248Q;APC p.G1039*;PIK3CB Amplification;TET2 Deletion	0	4
P-0011302	P-0011302-T01-IM5	Outside	FFPE	Cytology	250	1222	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.M528I)				LEVEL_4	TP53 p.Q104*;SMAD4 p.Q289*;FGFR3 p.M528I;SETD2 p.S381*	1	4
P-0011303	P-0011303-T01-IM5	In-House	FFPE	Biopsy	250	1444	30	Matched	Metastasis	Lung	Scapula	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E453Q)					LEVEL_3B	PIK3CA p.E453Q;TP53 p.Q144P;RB1 p.X738_splice;STK11 p.M1?;SMARCA4 p.E1254*;KMT2D p.Q827Pfs*3;CCNE1 Amplification;STK11 STK11-intragenic	1	8
P-0011304	P-0011304-T01-IM5	Outside	FFPE	Resection	250	851	80	Matched	Primary	Heart	Not Applicable	Tumor	INTS	Soft Tissue Sarcoma	Intimal Sarcoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	NSD1 p.Q2274*;EIF1AX p.G6R;SETD2 p.V1070Lfs*44;KIT Amplification;MDM2 Amplification;PDGFRA Amplification	1	6
P-0011305	P-0011305-T01-IM5	In-House	FFPE	Biopsy	250	933	10	Matched	Metastasis	Breast	Bone	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;GATA3 p.M293K;HIST1H1C p.E115K;CDKN1B p.X159_splice;ASXL1 p.R1270Sfs*6	2	5
P-0011306	P-0011306-T01-IM5	Outside	FFPE	Biopsy	250	874	70	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R248Q;APC p.I1307Nfs*8;APC p.S583*;BCL2L1 Amplification;MYC Amplification;SRC Amplification	0	6
P-0011307	P-0011307-T01-IM5	Outside	FFPE	Resection	250	702	60	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)					LEVEL_3B	PIK3CA p.E542K;PIK3R1 p.M326Vfs*6;PBRM1 p.M704Wfs*10;SETD2 p.S1108Ffs*3;VHL p.V181Afs*72	1	5
P-0011308	P-0011308-T01-IM5	In-House	FFPE	Resection	250	1103	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.G154delinsAR;EGFR Amplification	1	3
P-0011309	P-0011309-T01-IM5	In-House	FFPE	Biopsy	127.764	535	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.V274Cfs*32	1	2
P-0011310	P-0011310-T01-IM5	In-House	FFPE	Resection	250	742	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0011311	P-0011311-T01-IM5	Outside	FFPE	Resection	250	876	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0011312	P-0011312-T01-IM5	Outside	FFPE	Resection	250	940	20	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.K164*;NF2 p.E386*	2	3
P-0011319	P-0011319-T01-IM5	Outside	FFPE	Biopsy	250	987	30	Matched	Metastasis	Cancer of Unknown Primary	Diaphragm	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.T256_S260del;ARID2 p.S930Cfs*11	0	2
P-0011320	P-0011320-T01-IM5	Outside	FFPE	Resection	153.3	146	70	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H	1	1
P-0011321	P-0011321-T01-IM5	In-House	FFPE	Biopsy	250	952	65	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.M552_Y570del);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	KIT p.M552_Y570del;GATA3 p.R329Gfs*17;BAP1 Deletion;MDM2 Amplification;MYC Amplification;PAK1 Amplification;PBRM1 Deletion;TGFBR2 Deletion;PIK3R2 ZNF714-PIK3R2 fusion;ZNF714 ZNF714-PIK3R2 fusion	2	10
P-0011322	P-0011322-T01-IM5	In-House	FFPE	Resection	250	814	30	Unmatched	Primary	Tonsil	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										RHOA p.G17V;TET2 p.N275Ifs*18;TET2 p.C1273Y	0	3
P-0011323	P-0011323-T01-IM5	In-House	FFPE	Cytology	133.84	911	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0011324	P-0011324-T01-IM5	In-House	FFPE	Resection	250	730	50	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I);Olaparib(ATM p.R2832H);Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	PTEN p.K267Rfs*9;KRAS p.A146T;RNF43 p.G659Vfs*41;HNF1A p.P291Qfs*51;ERBB2 p.V842I;ETV6 p.R369W;AXIN2 p.N666Qfs*41;ATM p.R2832H;PTCH1 p.R1308Efs*64;ARID1A p.R1721*;KMT2D p.R1903*;ATR p.R1814Efs*10;DNMT3A p.R635W;PTPRS p.R188*;XRCC2 p.I271Yfs*8;MSH2 p.Q518Vfs*10	5	16
P-0011325	P-0011325-T01-IM5	In-House	FFPE	Biopsy	245	503	65	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma											0	0
P-0011326	P-0011326-T01-IM5	In-House	FFPE	Biopsy	250	1205	20	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsVS)								LEVEL_1	TP53 p.C176F;CTNNB1 p.S37F;NUP93 p.E14K;EGFR p.E746_T751delinsVS	1	4
P-0011328	P-0011328-T01-IM5	In-House	FFPE	Biopsy	250	987	75	Matched	Metastasis	Esophagus	Adrenal Gland	Tumor	ESCA	Esophagogastric Cancer	Esophageal Adenocarcinoma										TP53 p.R175H;PIK3R3 p.W65*;ARID1A p.Q449Afs*173;ARID1A p.D1738Gfs*2	0	4
P-0011329	P-0011329-T01-IM5	In-House	FFPE	Resection	250	767	30	Matched	Metastasis	Liver	Bone	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma	Pemigatinib(REEP3 FGFR2-REEP3 fusion);Pemigatinib(FGFR2 FGFR2-REEP3 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(REEP3 FGFR2-REEP3 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-REEP3 fusion)						LEVEL_1	TP53 p.W53Yfs*2;REEP3 FGFR2-REEP3 fusion;FGFR2 FGFR2-REEP3 fusion	4	3
P-0011330	P-0011330-T01-IM5	Outside	FFPE	Biopsy	250	1104	20	Matched	Metastasis	Uterus	Cervix	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.R15Ifs*28)				LEVEL_4	BCOR p.N1459S;CTNNB1 p.T41I;ARID1A p.S90Pfs*11;RHEB p.Y35S;ERBB3 p.F219C;SOX17 p.H132Pfs*30;PIK3R1 p.I566_P568delinsT;SOX17 p.Q380Pfs*4;ZFHX3 p.E1888Kfs*26;PTEN p.R15Ifs*28	1	10
P-0011331	P-0011331-T01-IM5	Outside	FFPE	Biopsy	250	805	70	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Olaparib(BRIP1 BRIP1-intragenic)					LEVEL_3B	TP53 p.E349*;STK11 p.E145*;KEAP1 p.R296Qfs*52;CDK4 Amplification;GLI1 Amplification;KRAS Amplification;RICTOR Amplification;BRIP1 BRIP1-intragenic	2	8
P-0011332	P-0011332-T01-IM5	In-House	FFPE	Resection	250	566	75	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.N292Kfs*6);Trametinib,Cobimetinib(NF1 p.V14Qfs*23)				LEVEL_4	PTEN p.N292Kfs*6;NF1 p.V14Qfs*23;PIK3R1 p.D440del	2	3
P-0011333	P-0011333-T01-IM5	In-House	FFPE	Resection	250	777	60	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)	Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E2959*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;SMARCA4 p.E371*;ATR p.X1502_splice;BRCA2 p.E2959*;TP53 p.Q144L;STK11 p.G251C	3	6
P-0011334	P-0011334-T01-IM5	In-House	FFPE	Cytology	250	721	60	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer				Everolimus(TSC1 p.E232*)					LEVEL_3B	TP53 p.R342*;TP53 p.C176F;STK11 p.S216F;DNMT3A p.Q402*;TSC1 p.E232*;WT1 p.W146*;SMARCA4 K1511fs;DICER1 p.G465Afs*15;SETD2 p.P778Qfs*20;CCNE1 Amplification;RIPK2 NBN-RIPK2 fusion;NBN NBN-RIPK2 fusion	1	12
P-0011334	P-0011334-T02-IM5	Outside	FFPE	Cytology	171.5	830	30	Matched	Primary	Lung	Not Applicable	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer				Everolimus(TSC1 p.E232*)					LEVEL_3B	TP53 p.R342*;TP53 p.C176F;STK11 p.S216F;DNMT3A p.Q402*;TSC1 p.E232*;WT1 p.W146*;SMARCA4 K1511fs;DICER1 p.G465Afs*15;SETD2 p.P778Qfs*20;CCNE1 Amplification	1	10
P-0011335	P-0011335-T01-IM5	Outside	FFPE	Resection	250	713	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VPS35 CDH1-VPS35 fusion;CDH1 CDH1-VPS35 fusion	0	2
P-0011336	P-0011336-T01-IM5	Outside	FFPE	Resection	250	954	70	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0011337	P-0011337-T01-IM5	In-House	FFPE	Resection	250	755	70	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										BAP1 p.X194_splice;PTPRT p.G369Vfs*28	0	2
P-0011338	P-0011338-T01-IM5	In-House	FFPE	Biopsy	250	908	20	Matched	Metastasis	Breast	Lymph Node	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Trametinib,Cobimetinib(NF1 p.X1757_splice)				LEVEL_1	TP53 p.I255T;SMAD4 p.Q289*;CDH1 p.S9*;NF1 p.X1757_splice;APC p.E2074*;ERBB2 Amplification	3	6
P-0011339	P-0011339-T01-IM5	Outside	FFPE	Biopsy	250	848	70	Matched	Metastasis	Pancreas	Omentum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_4	KRAS p.G12D;TP53 p.A161T;ARID1A p.Q1212*;ARID1A p.S350*;CDKN2A p.P114L;SMAD4 Deletion	2	6
P-0011341	P-0011341-T01-IM5	In-House	FFPE	Resection	250	821	15	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R175H	1	2
P-0011342	P-0011342-T01-IM5	In-House	FFPE	Biopsy	250	786	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Y129C)				LEVEL_4	KRAS p.G12S;KEAP1 p.R596*;STK11 p.L201Pfs*63;CDKN2A p.Y129C	2	4
P-0011343	P-0011343-T01-IM5	In-House	FFPE	Resection	250	754	80	Matched	Primary	Lung	Not Applicable	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor					Trametinib,Cobimetinib(NF1 p.S1150*)				LEVEL_4	NF1 p.S1150*;TP53 p.X225_splice;SMARCA4 SMARCA4-intragenic;RAD21 RAD21-intragenic	1	4
P-0011344	P-0011344-T01-IM5	Outside	FFPE	Resection	250	840	80	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H419_C420del)					LEVEL_3B	TP53 p.R248W;FBXW7 p.R479Q;PIK3CA p.H419_C420del;RB1 p.L199Ffs*4;KDM5A Amplification	1	5
P-0011345	P-0011345-T01-IM5	In-House	FFPE	Biopsy	250	777	80	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.R248C)		Debio1347,BGJ398,AZD4547(FGFR3 p.R248C)	Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_1	FBXW7 p.R465H;ERBB2 p.S310F;KMT2D p.P2354Lfs*30;ARID1A p.K1072Nfs*21;FGFR3 p.R248C;KMT2D p.R3982*;ZFHX3 p.R3429Vfs*56;KMT2A p.R1264*;FAT1 p.R1070*;ARID1A p.P1175Hfs*5;CREBBP p.R1173*;FOXP1 p.Q59*;KMT2C p.R3850*;SMARCA4 p.R1135Q;NCOA3 p.R80H;NOTCH4 p.G349Afs*49;NOTCH1 p.Y85Cfs*57;CTCF p.T204Kfs*19;MSH2 p.A54Pfs*10;NSD1 p.M2250Cfs*44;KMT2D p.T4629Pfs*11;SMARCA4 p.E952Kfs*5;TGFBR2 p.C396Vfs*35	3	23
P-0011346	P-0011346-T01-IM5	In-House	FFPE	Resection	250	645	80	Matched	Primary	Kidney	Not Applicable	Tumor	RAML	Renal Cell Carcinoma	Renal Angiomyolipoma				Everolimus(TSC2 p.Q443*);Everolimus(TSC2 p.T317Ifs*20)					LEVEL_3B	TSC2 p.Q443*;TSC2 p.T317Ifs*20	2	2
P-0011347	P-0011347-T01-IM5	In-House	FFPE	Resection	250	749	50	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										APC p.Q1071*;TP53 p.I254F	0	2
P-0011348	P-0011348-T01-IM5	In-House	FFPE	Resection	250	661	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	GATA3 p.P408Afs*99;ERBB2 Amplification;FGFR1 Amplification;PPM1D Amplification;TET2 NR3C2-TET2 fusion;NR3C2 NR3C2-TET2 fusion	3	6
P-0011349	P-0011349-T01-IM5	Outside	FFPE	Biopsy	250	603	25	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										BAP1 p.Q410*	0	1
P-0011350	P-0011350-T01-IM5	Outside	FFPE	Resection	250	644	20	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.Y163C;SMAD4 p.R361H;MYC Amplification;APC REEP5-APC fusion;REEP5 REEP5-APC fusion	1	6
P-0011351	P-0011351-T01-IM5	Outside	FFPE	Biopsy	205.6	441	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Y346D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PIK3R1 p.R557*;PTEN p.Y346D;PIK3R1 p.A486Hfs*6;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0011352	P-0011352-T01-IM5	Outside	FFPE	Biopsy	250	799	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.E258G;FGFR1 Amplification	1	2
P-0011353	P-0011353-T01-IM5	Outside	FFPE	Biopsy	250	525	50	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma											0	0
P-0011354	P-0011354-T01-IM5	Outside	FFPE	Biopsy	250	838	80	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	3
P-0011355	P-0011355-T01-IM5	In-House	FFPE	Resection	250	865	60	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)		Trametinib,Cobimetinib(NF1 p.X297_splice)				LEVEL_1	PIK3CA p.H1047R;SOX9 p.*510Sext*49;TP53 p.E336*;RB1 p.X406_splice;RUNX1 p.Q237*;TET2 p.W1291C;NF1 p.X297_splice	3	7
P-0011356	P-0011356-T01-IM5	In-House	FFPE	Resection	250	705	50	Matched	Metastasis	Testis	Lymph Node	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0011357	P-0011357-T01-IM5	In-House	FFPE	Resection	250	737	20	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111N);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E2129*);Sonidegib,Vismodegib(PTCH1 p.Y1021*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.A146T);Trametinib,Cobimetinib(NF1 p.E1583*)	Cetuximab,Panitumumab(KRAS p.A146T)			LEVEL_3B	KRAS p.A146T;PIK3CA p.K111N;APC p.R332*;APC p.R1114*;APC p.R1920*;SMAD3 p.R268H;APC p.E1536*;SMAD4 p.E520*;BRCA2 p.E2129*;LATS1 p.R744*;RB1 p.R451C;B2M p.E64*;APC p.R2204*;APC p.R2237*;TP53 p.Y236D;FBXW7 p.S582L;TNFAIP3 p.E633*;MSH6 p.E1234*;POLE p.S459F;EPHA7 p.E643*;PIK3R1 p.R557*;ERRFI1 p.K409N;SPEN p.E390*;RIT1 p.F82C;ATR p.R2606*;FAT1 p.E2684*;FAT1 p.R1627Q;RAD50 p.R954*;EPHA7 p.G737*;BRAF p.S602Y;EZH2 p.E59*;PTCH1 p.Y1021*;KMT2D p.E551*;MGA p.R2396*;B2M p.Y87*;MAP2K4 p.E107*;NF1 p.E1583*;CIC p.X963_splice;BBC3 p.M1?	5	39
P-0011358	P-0011358-T01-IM5	In-House	FFPE	Resection	250	889	40	Matched	Primary	Bone	Not Applicable	Tumor	DDCHS	Bone Cancer	Dedifferentiated Chondrosarcoma				Ivosidenib(IDH1 p.R132L)					LEVEL_3B	TP53 p.G266R;JAK1 p.L431Vfs*22;IDH1 p.R132L;ARID1A p.Q354*;KIT Amplification;PDGFRA Amplification	1	6
P-0011359	P-0011359-T01-IM5	In-House	FFPE	Biopsy	250	1070	50	Unmatched	Primary	Pleura	Not Applicable	Tumor	PCM	Mature B-Cell Neoplasms	Plasma Cell Myeloma										BRAF p.V600E;CDH1 Deletion;CDKN2C Deletion	0	3
P-0011360	P-0011360-T01-IM5	In-House	FFPE	Biopsy	250	1136	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										MEF2B p.K4E;TNFRSF14 p.C111Y;PTEN p.V166E;KMT2D p.K3062Rfs*9	0	4
P-0011361	P-0011361-T01-IM5	In-House	FFPE	Biopsy	250	685	15	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.Q100*;SMAD4 p.D415Efs*20;AKT2 Amplification;CCNE1 Amplification;CDKN2B Deletion	1	6
P-0011362	P-0011362-T01-IM5	In-House	FFPE	Biopsy	250	1021	30	Unmatched	Primary	Bone	Not Applicable	Tumor	LCH	Histiocytosis	Langerhans Cell Histiocytosis			Cobimetinib(BRAF p.V600E)						LEVEL_3A	BRAF p.V600E	1	1
P-0011363	P-0011363-T01-IM5	Outside	FFPE	Resection	250	822	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.H543Tfs*17)			Talazoparib,Niraparib(BRCA2 p.H543Tfs*17)					LEVEL_1	BRCA2 p.H543Tfs*17	2	1
P-0011364	P-0011364-T01-IM5	Outside	FFPE	Biopsy	159.6	384	25	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.L344P;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0011365	P-0011365-T01-IM5	Outside	FFPE	Cytology	250	967	50	Matched	Metastasis	Breast	Pleural Fluid	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										FOXA1 Amplification;NKX2-1 Amplification;PPM1D Amplification;RARA COPZ2-RARA fusion;COPZ2 COPZ2-RARA fusion	0	5
P-0011366	P-0011366-T01-IM5	In-House	FFPE	Biopsy	250	1171	60	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Trametinib,Cobimetinib,Binimetinib(KRAS p.D33E)	Cetuximab,Panitumumab(KRAS p.G12V);Cetuximab,Panitumumab(KRAS p.D33E)			LEVEL_3B	KRAS p.G12V;APC p.E1309*;PIK3CA p.E545G;KRAS p.D33E;TCF7L2 p.R407*;SOX9 p.S228*;SMAD4 p.H287Tfs*46;SMAD4 p.H530Tfs*7;SOX9 p.Y451Sfs*128	3	9
P-0011367	P-0011367-T01-IM5	In-House	FFPE	Biopsy	250	1042	80	Matched	Metastasis	Prostate	Bone	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										MAP3K1 Deletion;KMT2D ZNF804A-MLL2 fusion;ZNF804A ZNF804A-MLL2 fusion;KDM6A KDM6A-intragenic	0	4
P-0011368	P-0011368-T01-IM5	In-House	FFPE	Biopsy	250	1195	30	Matched	Metastasis	Prostate	Pelvis	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										RB1 p.R455*;AR p.W742C	0	2
P-0011369	P-0011369-T01-IM5	In-House	FFPE	Biopsy	250	1014	70	Matched	Metastasis	Breast	Liver	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma		Talazoparib,Olaparib(BRCA1 p.E686*)		Niraparib,Rucaparib(BRCA1 p.E686*)					LEVEL_2	TP53 p.R196*;PRDM1 p.X73_splice;BRCA1 p.E686*;ASCC3 PRDM1-ASCC3 fusion;PRDM1 PRDM1-ASCC3 fusion	2	5
P-0011370	P-0011370-T01-IM5	In-House	FFPE	Biopsy	250	1001	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.C275Y;AKT2 Amplification;AR Amplification;BCL2L1 Amplification	0	4
P-0011371	P-0011371-T01-IM5	In-House	FFPE	Resection	250	846	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;MAP2K2 p.L46F	1	2
P-0011372	P-0011372-T01-IM5	Outside	FFPE	Biopsy	250	536	90	Matched	Primary	Spinal Cord	Not Applicable	Tumor	EPMT	CNS Cancer	Ependymomal Tumor										NF2 p.E445Gfs*9	0	1
P-0011373	P-0011373-T01-IM5	In-House	FFPE	Biopsy	250	1216	50	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										KDM6A p.X944_splice;ARID1A Deletion;DIS3 Deletion;FOXP1 Deletion;GATA3 Deletion;ID3 Deletion;IKBKE Amplification;MDM4 Amplification;TET2 Deletion	0	9
P-0011374	P-0011374-T01-IM5	In-House	FFPE	Resection	250	878	70	Matched	Metastasis	Rectum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;TP53 p.V73Rfs*76;APC p.Q767*	2	3
P-0011375	P-0011375-T01-IM5	Outside	FFPE	Resection	250	922	40	Matched	Primary	Testis	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0011376	P-0011376-T01-IM5	In-House	FFPE	Biopsy	250	1006	80	Matched	Metastasis	Breast	Brain	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.C176F;CDKN2A Deletion;CDKN2B Deletion;RUNX1 Deletion	1	4
P-0011377	P-0011377-T01-IM5	Outside	FFPE	Biopsy	250	894	70	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R213*;FOXA1 p.A342Pfs*4;PTEN Deletion;MGA MGA-intragenic;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0011378	P-0011378-T01-IM5	Outside	FFPE	Biopsy	250	904	30	Matched	Metastasis	Lung	Lymph Node	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer		Crizotinib(MET Amplification)		Everolimus(TSC2 p.A614S);Cabozantinib(MET Amplification)			Erlotinib,Gefitinib,Osimertinib(MET Amplification)		LEVEL_2	CBL p.R420Q;TP53 p.Y107*;TSC2 p.A614S;RBM10 p.Q767*;CCNE1 Amplification;MET Amplification	3	6
P-0011379	P-0011379-T01-IM5	Outside	FFPE	Cytology	250	731	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.S127F	1	2
P-0011380	P-0011380-T01-IM5	Outside	FFPE	Biopsy	250	971	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Trametinib,Cobimetinib(MAP2K1 p.Y130C)	GSK2636771,AZD8186(PTEN p.Y68H);Trametinib,Cobimetinib,Binimetinib(KRAS p.K117N)	Cetuximab,Panitumumab(KRAS p.K117N)			LEVEL_3B	APC p.T1556Nfs*3;PTEN p.Y68H;KRAS p.K117N;MAP2K1 p.Y130C;FLCN p.E303Gfs*20;FOXP1 p.F502Lfs*16	3	6
P-0011381	P-0011381-T01-IM5	Outside	FFPE	Resection	250	905	70	Matched	Primary	Small Bowel	Small Bowel	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.W557_K558del);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V654A)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib(KIT p.V654A)		LEVEL_1	KIT p.W557_K558del;KIT p.V654A;CDKN2A Deletion;CDKN2B Deletion	3	4
P-0011382	P-0011382-T01-IM5	In-House	FFPE	Biopsy	250	1005	80	Matched	Primary	Lung	Not Applicable	Tumor	LNET	Non-Small Cell Lung Cancer	Lung Neuroendocrine Tumor										CBL Deletion;KMT2A Deletion;SDHD Deletion	0	3
P-0011383	P-0011383-T01-IM5	In-House	FFPE	Biopsy	250	824	40	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification)	Lapatinib(EGFR p.R108K);Lapatinib(EGFR Amplification)				LEVEL_3B	TP53 p.R273H;EGFR p.R108K;CDK4 Amplification;EGFR Amplification;GLI1 Amplification;PIK3R1 Deletion	3	6
P-0011384	P-0011384-T01-IM5	In-House	FFPE	Biopsy	250	951	25	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.S1465Wfs*3;TP53 p.P75Lfs*48	0	2
P-0011385	P-0011385-T01-IM5	In-House	FFPE	Resection	250	1006	20	Matched	Primary	Uterus	Not Applicable	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.L755S);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043T);Olaparib(ATM p.R337C);Olaparib(ATM p.G2536*)					LEVEL_3B	EPHB1 p.D762N;ERBB2 p.L755S;PPP2R1A p.R183W;ERBB2 p.V842I;FBXW7 p.R465C;MLH1 p.R100*;ERBB3 p.V104M;B2M p.M1?;PIK3CA p.M1043T;TGFBR1 p.R487Q;ATM p.R337C;TP53 p.H115Y;MGA p.R627*;KMT2C p.R3850*;ARID1B p.G732*;ATM p.G2536*;HNF1A p.R114H;B2M p.M1?;B2M p.X116_splice;ARID1A p.Y2031*	5	20
P-0011386	P-0011386-T01-IM5	Outside	FFPE	Resection	250	813	70	Matched	Metastasis	Breast	Chest Wall	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108N)				LEVEL_4	TP53 p.Y236C;SMAD2 p.R120*;CDKN2A p.D108N	1	3
P-0011387	P-0011387-T01-IM5	In-House	FFPE	Resection	250	650	50	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R);Trametinib,Cobimetinib(MAP2K1 p.E203K)					LEVEL_3B	NRAS p.Q61R;MAP2K1 p.E203K;CREBBP p.I1431N;ARID1A p.G1137Dfs*24	2	4
P-0011388	P-0011388-T01-IM5	In-House	FFPE	Resection	250	817	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D1029H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E982Q);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D1045N);Everolimus(TSC1 p.F216S)					LEVEL_3B	PIK3CA p.D1029H;TP53 p.Y126D;TSC1 p.F216S;KMT2D p.Q3340*;PIK3CA Amplification	4	5
P-0011389	P-0011389-T01-IM5	In-House	FFPE	Biopsy	250	797	40	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;EGFR p.A289V;TP53 p.E285V	1	3
P-0011390	P-0011390-T01-IM5	In-House	FFPE	Biopsy	250	887	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Lapatinib(EGFR Amplification)				LEVEL_4	ARID5B Deletion;CDK6 Amplification;EGFR Amplification;MDM4 Amplification	1	4
P-0011391	P-0011391-T01-IM5	Outside	FFPE	Biopsy	250	1150	20	Matched	Metastasis	Gallbladder	Soft Tissue	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					GSK2636771,AZD8186(PTEN p.R130Q);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D);GSK2636771,AZD8186(PTEN p.D19Gfs*25)				LEVEL_4	PTEN p.R130Q;KRAS p.G13D;ARID1A p.Q1172*;SMAD4 p.L536Kfs*14;PTEN p.D19Gfs*25	3	5
P-0011392	P-0011392-T01-IM5	Outside	FFPE	Biopsy	250	1128	80	Matched	Metastasis	Breast	Liver	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	ARID1A p.G623Kfs*3;DDR2 Amplification;IKBKE Amplification;MAPK1 Amplification;MDM4 Amplification;PTEN Deletion	1	6
P-0011393	P-0011393-T01-IM5	Outside	FFPE	Biopsy	250	878	80	Matched	Metastasis	Major Salivary Gland	Pleura	Tumor	SACA	Salivary Gland Cancer	Salivary Carcinoma										KDM6A p.R393*;CREBBP p.X525_splice;CREBBP p.G77Afs*9	0	3
P-0011394	P-0011394-T01-IM5	Outside	FFPE	Biopsy	250	1125	15	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma	Pemigatinib(FGFR2 LAMC1-FGFR2 fusion);Pemigatinib(LAMC1 LAMC1-FGFR2 fusion);Pemigatinib(FGFR2 RABGAP1L-FGFR2 fusion);Pemigatinib(RABGAP1L RABGAP1L-FGFR2 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 LAMC1-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(LAMC1 LAMC1-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 RABGAP1L-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(RABGAP1L RABGAP1L-FGFR2 fusion)						LEVEL_1	MEN1 p.X154_splice;FGFR2 LAMC1-FGFR2 fusion;LAMC1 LAMC1-FGFR2 fusion;FGFR2 RABGAP1L-FGFR2 fusion;RABGAP1L RABGAP1L-FGFR2 fusion	8	5
P-0011395	P-0011395-T02-IM5	In-House	FFPE	Biopsy	250	1070	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)						LEVEL_1	PTPRT p.T605K;MET p.X963_splice;ARID1B ARID1B-intragenic	3	3
P-0011395	P-0011395-T01-IM5	Outside	FFPE	Biopsy	245.9	907	25	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X963_splice)	Crizotinib(MET p.X963_splice)	Cabozantinib(MET p.X963_splice)						LEVEL_1	PTPRT p.T605K;MET p.X963_splice;ARID1B ARID1B-intragenic	3	3
P-0011396	P-0011396-T01-IM5	In-House	FFPE	Resection	250	977	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q)					LEVEL_3B	TP53 p.R282W;ERBB2 p.R678Q;APC p.Q532*	1	3
P-0011397	P-0011397-T01-IM5	Outside	FFPE	Biopsy	250	1159	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma											0	0
P-0011398	P-0011398-T01-IM5	Outside	FFPE	Cytology	250	1096	50	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										TP53 p.Y220C;RB1 p.R251*;MYC Amplification	0	3
P-0011399	P-0011399-T01-IM5	In-House	FFPE	Resection	250	1210	10	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L	0	1
P-0011400	P-0011400-T01-IM5	In-House	FFPE	Biopsy	250	1259	60	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma					GSK2636771,AZD8186(PTEN p.E256*)				LEVEL_4	TP53 p.R213*;ERBB3 p.E928G;CTNNB1 p.S37C;TBX3 p.W113*;KMT2C p.Q2054*;PTEN p.E256*;ZFHX3 p.S1519*	1	7
P-0011401	P-0011401-T01-IM5	Outside	FFPE	Resection	250	994	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.K332*)				LEVEL_3B	PTEN p.K332*;ATRX p.R666*;CD274 Amplification;CDK4 Amplification;JAK2 Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification	3	8
P-0011402	P-0011402-T01-IM5	Outside	FFPE	Biopsy	177.6	633	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										FBXW7 p.D520N;FAT1 p.Q3204*;RASA1 p.X180_splice	0	3
P-0011403	P-0011403-T01-IM5	In-House	FFPE	Cytology	250	1338	90	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.K139*;RB1 p.X654_splice	0	2
P-0011404	P-0011404-T01-IM5	In-House	FFPE	Biopsy	250	904	90	Matched	Metastasis	Lung	Lymph Node	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer				Lorlatinib,Brigatinib(ALK p.R395C)	GSK2636771,AZD8186(PTEN p.W111*)				LEVEL_3B	PTEN p.W111*;TP53 p.R181P;ALK p.R395C;RB1 p.Q504*	2	4
P-0011405	P-0011405-T01-IM5	Outside	FFPE	Resection	250	874	70	Matched	Primary	Pancreas	Not Applicable	Tumor	MIXED	Cancer of Unknown Primary	Mixed Cancer Types										MEN1 Deletion;DNMT3A DNMT3A-intragenic	0	2
P-0011412	P-0011412-T01-IM5	In-House	FFPE	Cytology	250	1079	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.Q61L;EPHA3 p.R104*;STK11 p.P280Lfs*7;CDKN2A Deletion;FOXA1 Amplification;NKX2-1 Amplification;RICTOR Amplification	2	7
P-0011413	P-0011413-T01-IM5	In-House	FFPE	Resection	250	976	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L747_T751del)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.L747_T751del;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification	3	4
P-0011414	P-0011414-T01-IM5	In-House	FFPE	Biopsy	250	465	60	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma										TP53 p.Q165*;KMT2D p.X3481_splice;KMT2D p.S1555Lfs*47	0	3
P-0011415	P-0011415-T01-IM5	Outside	FFPE	Resection	250	1112	60	Matched	Metastasis	Breast	Skin	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS			AZD9496,Fulvestrant(ESR1 p.Y537C)						LEVEL_3A	ESR1 p.Y537C;GATA3 p.X350_splice	1	2
P-0011416	P-0011416-T01-IM5	In-House	FFPE	Cytology	169.7	655	10	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K437Ifs*22)	GSK2636771,AZD8186(PTEN p.M35V)				LEVEL_3B	PTEN p.M35V;BRCA2 p.K437Ifs*22	2	2
P-0011418	P-0011418-T01-IM5	In-House	FFPE	Resection	250	593	80	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.H115N;NBN p.G206Lfs*26;SETD2 p.S2180Afs*68	0	3
P-0011419	P-0011419-T01-IM5	In-House	FFPE	Biopsy	250	469	50	Matched	Metastasis	Testis	Lymph Node	Tumor	VOEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0011420	P-0011420-T01-IM5	In-House	FFPE	Biopsy	250	1237	40	Matched	Metastasis	Breast	Lymph Node	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.E545K);Fulvestrant+Alpelisib(PIK3CA p.A1066V)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.A1066V)						LEVEL_1	PIK3CA p.E545K;PIK3CA p.A1066V	4	2
P-0011421	P-0011421-T01-IM5	In-House	FFPE	Resection	250	1109	20	Matched	Metastasis	Retroperitoneum	Para caval mass	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor											0	0
P-0011422	P-0011422-T01-IM5	In-House	FFPE	Biopsy	250	1070	15	Matched	Primary	Tongue	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma											0	0
P-0011423	P-0011423-T01-IM5	Outside	FFPE	Biopsy	250	1008	90	Matched	Metastasis	Testis	Lymph Node	Tumor	CCS	Soft Tissue Sarcoma	Clear Cell Sarcoma										EWSR1 ATF1-EWSR1 fusion;ATF1 ATF1-EWSR1 fusion	0	2
P-0011424	P-0011424-T01-IM5	In-House	FFPE	Biopsy	250	1062	90	Matched	Primary	Brain	Not Applicable	Tumor	PPTID	Pineal Tumor	Pineal Parenchymal Tumor of Intermediate Differentiation											0	0
P-0011425	P-0011425-T01-IM5	Outside	FFPE	Resection	250	1553	80	Unmatched	Primary	Testis	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										MYD88 p.L265P;PIM1 p.L2F;PIM1 p.E79D;PIM1 p.L193F;HLA-A p.W191*;ARID5B p.Q941Hfs*16	0	6
P-0011426	P-0011426-T01-IM5	In-House	FFPE	Resection	250	991	30	Matched	Metastasis	Ovary	Soft Tissue	Tumor	CCOV	Ovarian Cancer	Clear Cell Ovarian Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	ARID1A p.S138*;PIK3CA p.H1047R;SPOP p.E50K;ARID1A p.S711*;ARID1B p.Q641*;PBRM1 p.Q90*;MAP3K1 p.Q535*	1	7
P-0011427	P-0011427-T01-IM5	In-House	FFPE	Biopsy	250	1217	15	Matched	Metastasis	Cancer of Unknown Primary	Lung	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.Q534*;KMT2D p.R1702*	1	3
P-0011428	P-0011428-T01-IM5	Outside	FFPE	Resection	250	854	50	Matched	Primary	Skin	Not Applicable	Tumor	DFSP	Skin Cancer, Non-Melanoma	Dermatofibrosarcoma Protuberans										PPM1D Amplification	0	1
P-0011429	P-0011429-T01-IM5	Outside	FFPE	Biopsy	205.5	224	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AKT2 p.L78_Q79insHANTFVIRCL;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0011430	P-0011430-T01-IM5	Outside	FFPE	Resection	250	1338	30	Matched	Primary	Mediastinum	Not Applicable	Tumor	VMGCT	Germ Cell Tumor	Mixed Germ Cell Tumor										TP53 p.R248L	0	1
P-0011431	P-0011431-T01-IM5	Outside	FFPE	Biopsy	250	998	50	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_1	BRAF p.V600E;PIK3CA p.H1047R;NF2 p.Q453*	3	3
P-0011432	P-0011432-T01-IM5	In-House	FFPE	Biopsy	250	861	40	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	HNSCUP	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E88*)				LEVEL_4	TP53 p.R213*;KMT2D p.N2517Ifs*26;HNF1A p.P291Qfs*51;ASXL2 p.Q39*;MLH1 p.E679*;KMT2D p.K4345Nfs*39;ASXL2 p.P778Qfs*21;CREBBP p.I1493Yfs*57;GATA3 p.C284Afs*10;CASP8 p.N458Tfs*13;LATS1 p.G717Wfs*2;EP300 p.T1021Lfs*3;BLM p.I243Lfs*6;TP53 p.I251N;CDKN2A p.E88*	1	15
P-0011433	P-0011433-T01-IM5	In-House	FFPE	Resection	250	1026	50	Matched	Primary	Uterus	Not Applicable	Tumor	UCS	Endometrial Cancer	Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;TP53 p.P47Rfs*76;AKT2 Amplification;AXL Amplification;PIK3CA Amplification;MSH6 FBXO11-MSH6 fusion;FBXO11 FBXO11-MSH6 fusion	1	7
P-0011434	P-0011434-T01-IM5	Outside	FFPE	Resection	250	874	40	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	GATA3 p.P408Afs*99;AURKA Amplification;FGFR1 Amplification;PTEN Deletion	2	4
P-0011435	P-0011435-T01-IM5	In-House	FFPE	Resection	250	881	50	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12D;TP53 p.R342*;CDKN2A Deletion;CDKN2B Deletion;FAT1 Deletion	2	5
P-0011438	P-0011438-T01-IM5	In-House	FFPE	Biopsy	250	1165	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										ARID1A p.L2279Ffs*104;CDKN2A Deletion	0	2
P-0011439	P-0011439-T01-IM5	In-House	FFPE	Cytology	250	1337	NA	Matched	Metastasis	Bladder	Liver	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);Olaparib(CHEK1 CDON-CHEK1 fusion);Olaparib(CDON CDON-CHEK1 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	FGFR3 p.S249C;PIK3CA p.H1047L;KMT2C p.S2816Ifs*6;KMT2D p.P1460Hfs*46;KMT2D p.R1702*;KMT2C p.Q2539*;CREBBP p.Q357*;MEN1 p.E371Mfs*8;CDKN2A Deletion;CDKN2B Deletion;TERT Amplification;CHEK1 CDON-CHEK1 fusion;CDON CDON-CHEK1 fusion	6	13
P-0011440	P-0011440-T01-IM5	In-House	FFPE	Biopsy	250	761	90	Matched	Metastasis	Upper Tract	Liver	Tumor	SCBC	Bladder Cancer	Small Cell Bladder Cancer				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G364R)	Tazemetostat(KDM6A p.Q1302*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	TP53 p.R249S;PIK3CA p.G364R;MUTYH p.X503_splice;NOTCH2 p.C1034*;KDM6A p.Q1302*;ARID5B p.G1042Lfs*66;BRAF Amplification;CCND1 Amplification;CDKN2A Deletion;CDKN2B Deletion;EZH2 Amplification;FGF19 Amplification;RHEB Amplification	3	13
P-0011441	P-0011441-T01-IM5	In-House	FFPE	Biopsy	250	1245	50	Unmatched	Primary	Mesentery	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CREBBP p.R1498*;BCL2 p.A131D;CARD11 p.D357V;KDM5C p.X622_splice	0	4
P-0011442	P-0011442-T01-IM5	In-House	FFPE	Biopsy	184.5	506	80	Matched	Metastasis	Breast	Soft Tissue	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS										ARID1A p.Q372Afs*28;PAK1 Amplification	0	2
P-0011443	P-0011443-T01-IM5	In-House	FFPE	Resection	250	912	20	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma				Olaparib(CHEK2 p.L280*)					LEVEL_3B	VHL p.E160*;CHEK2 p.L280*;BAP1 BAP1-intragenic	1	3
P-0011444	P-0011444-T01-IM5	In-House	FFPE	Resection	250	737	40	Matched	Metastasis	Appendix	Soft Tissue	Tumor	APAD	Appendiceal Cancer	Appendiceal Adenocarcinoma											0	0
P-0011445	P-0011445-T01-IM5	In-House	FFPE	Resection	250	906	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					GSK2636771,AZD8186(PTEN p.L320*)				LEVEL_4	TP53 p.G245S;SMAD3 p.R93*;PTEN p.L320*	1	3
P-0011446	P-0011446-T01-IM5	In-House	FFPE	Resection	250	830	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Olaparib(ATM p.R2993*);Everolimus(TSC1 p.V128del)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;FBXW7 p.S668Vfs*39;GNAS p.R201H;ARID1A p.G276Efs*87;CTNNB1 p.T41A;TCF7L2 p.K485Sfs*23;FLCN p.H429Tfs*39;CASP8 p.F356Lfs*26;ARID1B p.E1053*;CCND1 p.T286A;ATM p.R2993*;PPM1D p.R572*;FAT1 p.Y2102Cfs*23;TSC1 p.V128del;BBC3 p.H97Tfs*132	3	15
P-0011447	P-0011447-T01-IM5	Outside	FFPE	Resection	250	925	80	Matched	Primary	Skin	Not Applicable	Tumor	ANGS	Soft Tissue Sarcoma	Angiosarcoma				Tipifarnib(HRAS p.Q61R)					LEVEL_3B	HRAS p.Q61R;MYC Amplification;PRDM1 Deletion	1	3
P-0011448	P-0011448-T01-IM5	In-House	FFPE	Resection	250	948	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				AZD9496,Fulvestrant(ESR1 p.S463P)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R);GSK2636771,AZD8186(PTEN p.N323Kfs*2);GSK2636771,AZD8186(PTEN p.L108*)				LEVEL_3B	BCOR p.N1459S;FGFR2 p.C382R;EIF1AX p.R13L;CTNNB1 p.S33C;PTEN p.N323Kfs*2;ESR1 p.S463P;ARID1A p.R1722*;PTEN p.L108*;PIK3R1 p.I405del	4	9
P-0011449	P-0011449-T01-IM5	In-House	FFPE	Biopsy	250	1011	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					GSK2636771,AZD8186(PTEN p.F341*)				LEVEL_4	TP53 p.R273H;FAT1 p.S3373*;PIK3R3 p.X396_splice;PTEN p.F341*;FGFR2 Amplification;MYC Amplification;PIK3CB Amplification	1	7
P-0011450	P-0011450-T01-IM5	In-House	FFPE	Biopsy	250	797	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)					LEVEL_1	BRAF p.V600E;PIK3CA p.E545K;SETD2 p.X1672_splice	3	3
P-0011451	P-0011451-T01-IM5	Outside	FFPE	Biopsy	250	891	80	Matched	Metastasis	Stomach	Liver	Tumor	GINET	Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumors										TP53 p.C275S;FAT1 Deletion;RB1 Deletion	0	3
P-0011452	P-0011452-T01-IM5	In-House	FFPE	Resection	250	848	30	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.Y236C;PTPRD p.E905Rfs*4	0	2
P-0011453	P-0011453-T01-IM5	Outside	FFPE	Biopsy	250	818	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;BAP1 p.K457*	2	2
P-0011454	P-0011454-T01-IM5	In-House	FFPE	Biopsy	250	989	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.E298*;ERBB2 Amplification	2	2
P-0011455	P-0011455-T01-IM5	Outside	FFPE	Resection	250	1027	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.E271*;APC p.R805*;MAP2K4 p.K143Ifs*9;PRKN PARK2-intragenic	0	4
P-0011456	P-0011456-T01-IM5	In-House	FFPE	Biopsy	250	1041	80	Matched	Metastasis	Lung	Pancreas	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R267G;GATA2 p.C352R;PTPRT p.V648G;ERRFI1 Deletion;FOXP1 Deletion;MITF Deletion;RYBP Deletion;SHQ1 Deletion;TNFRSF14 Deletion;RB1 PTPRG-RB1 fusion;PTPRG PTPRG-RB1 fusion	0	11
P-0011457	P-0011457-T01-IM5	In-House	FFPE	Resection	250	927	15	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	TP53 p.N239S;ARID1A p.Q2128*;EED p.G98Efs*14;KMT2D p.P2118Lfs*26;CDKN2A p.H83Y	1	5
P-0011458	P-0011458-T01-IM5	Outside	FFPE	Biopsy	250	1017	70	Matched	Primary	Retroperitoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										SUFU p.G218Afs*17;BAP1 Deletion;SETD2 Deletion	0	3
P-0011459	P-0011459-T01-IM5	In-House	FFPE	Resection	250	1222	80	Matched	Primary	Thymus	Not Applicable	Tumor	THYM	Thymic Tumor	Thymoma											0	0
P-0011461	P-0011461-T01-IM5	In-House	FFPE	Resection	250	843	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12A);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.D108Y);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E120*)				LEVEL_4	KRAS p.G12A;TP53 p.T211I;CDKN2A p.D108Y;CDKN2A p.E120*	3	4
P-0011462	P-0011462-T01-IM5	In-House	FFPE	Resection	250	1010	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										AKT1 p.L52R	0	1
P-0011463	P-0011463-T01-IM5	In-House	FFPE	Biopsy	250	785	50	Matched	Metastasis	Breast	Lymph Node	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.P177_C182del;SMAD4 p.Q224*;KDM5C p.S1173Vfs*91;CDKN2A Deletion;CDKN2B Deletion;PPM1D Amplification	1	6
P-0011464	P-0011464-T01-IM5	Outside	FFPE	Resection	250	585	80	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										MEN1 p.X309_splice;ETV1 Amplification;FOXA1 Amplification	0	3
P-0011465	P-0011465-T01-IM5	Outside	FFPE	Biopsy	250	611	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0011466	P-0011466-T01-IM5	Outside	FFPE	Biopsy	250	615	30	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										DGKG BCL6-DGKG fusion;BCL6 BCL6-DGKG fusion	0	2
P-0011467	P-0011467-T01-IM5	Outside	FFPE	Biopsy	250	785	10	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Olaparib(ATM p.R2598*)	Trametinib,Cobimetinib(NF1 p.R1241*)				LEVEL_3B	PGR p.R836Q;SETD2 p.R1625C;ATM p.R2598*;NF1 p.R1241*;PIK3R2 p.Q549*;TP53 p.S261Vfs*84	2	6
P-0011468	P-0011468-T01-IM5	In-House	FFPE	Biopsy	250	1172	40	Matched	Metastasis	Transverse Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);GSK2636771,AZD8186(PTEN Deletion)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;TP53 p.R175H;APC p.R790Tfs*8;CDKN1B Deletion;PTEN Deletion;SMAD4 Deletion	2	6
P-0011469	P-0011469-T01-IM5	In-House	FFPE	Resection	250	841	20	Matched	Metastasis	Pancreas	Appendix	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.Q144*;SMAD4 p.X302_splice	1	3
P-0011470	P-0011470-T01-IM5	In-House	FFPE	Resection	250	818	70	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.X332_splice;RB1 p.E72Vfs*34;FGFR1 Amplification	1	3
P-0011471	P-0011471-T01-IM5	In-House	FFPE	Biopsy	250	976	60	Matched	Metastasis	Lung	Peritoneum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.X307_splice;RNF43 p.Q597*;SMARCA4 p.R1369Vfs*15;RB1 p.L487Ffs*6;ERBB2 Amplification	1	5
P-0011472	P-0011472-T01-IM5	In-House	FFPE	Resection	250	514	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0011473	P-0011473-T01-IM5	Outside	FFPE	Resection	250	1149	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Avapritinib,Dasatinib,Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.D842V)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PDGFRA p.D842V;PIK3R1 p.F456_K459del;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0011474	P-0011474-T01-IM5	In-House	FFPE	Biopsy	250	806	40	Matched	Metastasis	Parotid Gland	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Olaparib(ATM p.R337H)					LEVEL_3B	ATM p.R337H;BCOR p.E518*;NOTCH1 p.P1907Gfs*35;ARID2 p.Y423Ifs*38;KMT2D p.G1967Vfs*80	1	5
P-0011475	P-0011475-T01-IM5	In-House	FFPE	Cytology	250	859	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										AR Amplification	0	1
P-0011476	P-0011476-T01-IM5	In-House	FFPE	Biopsy	250	783	40	Matched	Metastasis	Skin	Lymph Node, Regional	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;CDKN2A Deletion	3	2
P-0011479	P-0011479-T01-IM5	In-House	FFPE	Resection	250	830	60	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor											0	0
P-0011480	P-0011480-T01-IM5	In-House	FFPE	Resection	250	917	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.V74D;PBRM1 p.M1383*;PBRM1 p.G939Lfs*16	0	3
P-0011481	P-0011481-T01-IM5	In-House	FFPE	Resection	250	966	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.L194F	1	2
P-0011482	P-0011482-T01-IM5	Outside	FFPE	Resection	250	407	20	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix				Olaparib(ATM p.R337C);Olaparib(ATM p.R248*);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E1037Q)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_3B	KRAS p.G12V;ATM p.R337C;ATM p.R248*;PIK3CA p.E1037Q;CTCF p.E182*;TCF7L2 p.I350Tfs*2	4	6
P-0011483	P-0011483-T01-IM5	Outside	FFPE	Resection	250	962	60	Matched	Metastasis	Prostate	Lung	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	SPOP p.F102C;MDM2 Amplification;PTEN Deletion	2	3
P-0011484	P-0011484-T01-IM5	Outside	FFPE	Biopsy	250	696	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										TP53 p.P250L;APC p.L1302Pfs*13	0	2
P-0011486	P-0011486-T01-IM5	Outside	FFPE	Biopsy	250	966	90	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.D478Afs*21	1	2
P-0011499	P-0011499-T01-IM5	In-House	FFPE	Cytology	250	884	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;KEAP1 p.R601L;RNF43 p.E170*;STK11 p.A198Pfs*89	1	4
P-0011500	P-0011500-T01-IM5	In-House	FFPE	Biopsy	250	1042	50	Matched	Metastasis	Thyroid	Lung	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	BRAF p.V600E;RBM10 p.Q285*;CDKN2A Deletion;CDKN2B Deletion	2	4
P-0011501	P-0011501-T01-IM5	In-House	FFPE	Biopsy	250	1166	75	Matched	Primary	Skin	Not Applicable	Tumor	MCC	Skin Cancer, Non-Melanoma	Merkel Cell Carcinoma											0	0
P-0011502	P-0011502-T01-IM5	In-House	FFPE	Biopsy	250	1093	20	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma					GSK2636771,AZD8186(PTEN p.N329Kfs*14)				LEVEL_4	TP53 p.R342*;PTEN p.N329Kfs*14;MAP2K4 p.Q282*	1	3
P-0011503	P-0011503-T01-IM5	In-House	FFPE	Biopsy	250	922	80	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion;EGFR Amplification;PTEN Deletion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	5	7
P-0011504	P-0011504-T01-IM5	Outside	FFPE	Biopsy	250	951	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;U2AF1 p.S34F;TP53 p.C135Y	1	3
P-0011505	P-0011505-T01-IM5	In-House	FFPE	Biopsy	250	958	80	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	SETD2 p.X1715_splice;CDK4 Amplification;KDR Amplification;KIT Amplification;MDM2 Amplification;PDGFRA Amplification	2	6
P-0011506	P-0011506-T01-IM5	Outside	FFPE	Biopsy	250	1074	10	Matched	Primary	Tongue	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				AZD5363(AKT1 p.E17K)					LEVEL_3B	AKT1 p.E17K;ETV6 CDKN1B-ETV6 fusion;CDKN1B CDKN1B-ETV6 fusion	1	3
P-0011507	P-0011507-T01-IM5	In-House	FFPE	Biopsy	250	1008	80	Matched	Metastasis	Thyroid	Liver	Tumor	THME	Thyroid Cancer	Medullary Thyroid Cancer	Selpercatinib(RET p.M918T)		BLU-667(RET p.M918T)						LEVEL_1	RET p.M918T	2	1
P-0011508	P-0011508-T01-IM5	In-House	FFPE	Biopsy	250	954	60	Matched	Metastasis	Lung	Liver	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										RB1 p.Y454*;GRIN2A p.Q661*;TP53 p.V73Lfs*76	0	3
P-0011509	P-0011509-T01-IM5	In-House	FFPE	Resection	250	1009	20	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.L57Ffs*6)				LEVEL_4	ARID1A p.Q507*;EP300 p.R1627W;PTEN p.L57Ffs*6	1	3
P-0011510	P-0011510-T01-IM5	Outside	FFPE	Biopsy	250	937	25	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.K117N)	Cetuximab,Panitumumab(KRAS p.K117N)			LEVEL_3B	PIK3CA p.E542K;APC p.R876*;APC p.E1374*;TP53 p.R283P;KRAS p.K117N;RUNX1 p.A371Lfs*200	2	6
P-0011511	P-0011511-T01-IM5	Outside	FFPE	Biopsy	250	738	10	Matched	Metastasis	Cecum	Skin	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)	Cetuximab,Panitumumab(KRAS p.Q61H)			LEVEL_4	KRAS p.Q61H;CDH1 p.X522_splice;ZFHX3 p.A3407Lfs*78;TP53 p.T125M	1	4
P-0011512	P-0011512-T01-IM5	Outside	FFPE	Biopsy	250	964	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R248Q;APC p.S1346_E1353delins*;ERBB2 Amplification	2	3
P-0011513	P-0011513-T01-IM5	In-House	FFPE	Resection	250	731	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.S90Pfs*33;SMAD4 p.Q410*	1	3
P-0011514	P-0011514-T01-IM5	In-House	FFPE	Biopsy	250	989	20	Matched	Primary	Omentum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										BAP1 Deletion	0	1
P-0011515	P-0011515-T01-IM5	Outside	FFPE	Biopsy	250	846	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0011516	P-0011516-T01-IM5	In-House	FFPE	Resection	250	1020	30	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma	Pemigatinib(CTNNA3 FGFR2-CTNNA3 fusion);Pemigatinib(FGFR2 FGFR2-CTNNA3 fusion);Pemigatinib(SHC2 FGFR2-SHC2 fusion);Pemigatinib(FGFR2 FGFR2-SHC2 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(CTNNA3 FGFR2-CTNNA3 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-CTNNA3 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(SHC2 FGFR2-SHC2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-SHC2 fusion)						LEVEL_1	KMT2D p.Q4387*;MED12 p.G44D;CTNNB1 p.K292E;SETD2 p.Q68*;CTNNA3 FGFR2-CTNNA3 fusion;FGFR2 FGFR2-CTNNA3 fusion;SHC2 FGFR2-SHC2 fusion;FGFR2 FGFR2-SHC2 fusion	8	8
P-0011517	P-0011517-T01-IM5	In-House	FFPE	Biopsy	250	1037	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib(NF1 p.X509_splice)				LEVEL_4	TP53 p.C275Y;CTNNB1 p.S37C;SMAD4 p.E526Q;NF1 p.X509_splice;RBM10 p.R32*	1	5
P-0011518	P-0011518-T01-IM5	Outside	FFPE	Biopsy	115	115	60	Matched	Primary	Mediastinum	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma				Imatinib(KIT p.D572G)					LEVEL_3B	KIT p.D572G;PMAIP1 p.V23Sfs*65	1	2
P-0011519	P-0011519-T01-IM5	In-House	FFPE	Biopsy	250	905	20	Matched	Primary	Oral Cavity	Not Applicable	Tumor	OCSC	Head and Neck Cancer	Oral Cavity Squamous Cell Carcinoma										TP53 p.C275W	0	1
P-0011520	P-0011520-T01-IM5	In-House	FFPE	Resection	250	732	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	FBXW7 p.R479P;TP53 p.M237I;APC p.R564*;KRAS p.G13D;NBN p.X13_splice;AMER1 p.L454*;APC p.S1501Lfs*6	1	7
P-0011521	P-0011521-T01-IM5	Outside	FFPE	Biopsy	250	982	70	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Imatinib,Regorafenib,Ripretinib,Sunitinib(PDGFRA p.N659K);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G106V)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E542K;PDGFRA p.N659K;PIK3CA p.G106V;PTPN11 p.A72G;PTPN11 p.A72S;BCOR p.E1281*;CDKN2A Deletion;CDKN2B Deletion	4	8
P-0011522	P-0011522-T01-IM5	In-House	FFPE	Biopsy	250	1143	30	Matched	Metastasis	Kidney	Lung	Tumor	SCCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma with Sarcomatoid Features										VHL p.E189Afs*61;PBRM1 p.T821Nfs*2	0	2
P-0011523	P-0011523-T01-IM5	Outside	FFPE	Resection	250	786	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Tazemetostat(KDM6A p.X1336_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KMT2D p.R2635*;KDM6A p.X1336_splice;EP300 p.X711_splice;ARID1A p.D1122Vfs*67;CCND1 Amplification;CCND3 Amplification;CDKN2A Deletion;CDKN2B Deletion;MCL1 Amplification;MDM2 Amplification;MYC Amplification;MYCL Amplification;VEGFA Amplification	3	13
P-0011524	P-0011524-T01-IM5	In-House	FFPE	Biopsy	250	897	40	Matched	Metastasis	Bladder	Soft Tissue	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	RB1 p.R251*;CDH1 p.S9*;MDM2 Amplification	1	3
P-0011525	P-0011525-T01-IM5	Outside	FFPE	Resection	250	1104	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0011526	P-0011526-T01-IM5	In-House	FFPE	Resection	250	800	70	Matched	Metastasis	Bone	Soft Tissue	Tumor	OS	Bone Cancer	Osteosarcoma										ATRX p.Q1890*;ASXL2 Deletion;KMT2C Deletion;RB1 Deletion;TP53 Deletion	0	5
P-0011527	P-0011527-T01-IM5	In-House	FFPE	Biopsy	250	964	20	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R58*)				LEVEL_4	KRAS p.G12D;TP53 p.P151H;CDKN2A p.R58*	2	3
P-0011528	P-0011528-T01-IM5	In-House	FFPE	Biopsy	250	773	20	Matched	Primary	Omentum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma											0	0
P-0011529	P-0011529-T01-IM5	Outside	FFPE	Biopsy	250	657	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.E1581*)			Talazoparib,Niraparib(BRCA2 p.E1581*)					LEVEL_1	APC p.T1556Nfs*3;BRCA2 p.E1581*;FLT3 p.Q640H;ARID2 p.V627Ffs*72;AR Amplification;BIRC3 Deletion;MGA Deletion	2	7
P-0011530	P-0011530-T01-IM5	Outside	FFPE	Resection	250	794	90	Matched	Primary	Ectopic Embryonic Rest	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										CTNNB1 p.S33C	0	1
P-0011531	P-0011531-T01-IM5	In-House	FFPE	Resection	250	727	40	Matched	Primary	Stomach	Not Applicable	Tumor	STAD	Esophagogastric Cancer	Stomach Adenocarcinoma	Trastuzumab(ERBB2 Amplification)			Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_1	TP53 p.R175H;ARID1A p.Q1519Pfs*13;RHOA p.G17E;ERBB2 Amplification	2	4
P-0011532	P-0011532-T01-IM5	In-House	FFPE	Biopsy	250	622	80	Matched	Primary	Brain	Not Applicable	Tumor	AOAST	Glioma	Anaplastic Oligoastrocytoma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.S231N;DIS3 p.M667Vfs*13	1	3
P-0011533	P-0011533-T01-IM5	In-House	FFPE	Biopsy	250	786	30	Matched	Metastasis	Ascending Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PIK3CA p.E545K;APC p.E1379*;APC p.V1320Afs*3	2	4
P-0011534	P-0011534-T01-IM5	In-House	FFPE	Biopsy	250	799	30	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0011535	P-0011535-T01-IM5	In-House	FFPE	Biopsy	250	993	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.Y220S;RBM10 p.X890_splice;NKX2-1 Amplification	1	4
P-0011536	P-0011536-T01-IM5	In-House	FFPE	Biopsy	250	813	60	Matched	Primary	Vagina	Not Applicable	Tumor	VYST	Germ Cell Tumor	Yolk Sac Tumor										MAP3K1 Deletion;MAPK1 Amplification	0	2
P-0011537	P-0011537-T01-IM5	In-House	FFPE	Cytology	250	882	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma										TP53 p.A159P;RB1 p.X738_splice;EPHA3 Deletion;FGFR3 Amplification;FOXP1 Deletion;MITF Deletion;MYC Amplification;NKX3-1 Deletion;RYBP Deletion;SHQ1 Deletion;TERT Amplification;TGFBR2 Deletion	0	12
P-0011538	P-0011538-T01-IM5	Outside	FFPE	Biopsy	218.6	715	80	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	CDKN2A Deletion;CDKN2B Deletion;FOXP1 Deletion	1	3
P-0011539	P-0011539-T01-IM5	In-House	FFPE	Resection	250	571	50	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										TP53 p.A159P;CCNE1 Amplification;MCL1 Amplification	0	3
P-0011540	P-0011540-T01-IM5	Outside	FFPE	Resection	250	729	10	Matched	Primary	Ileum	Not Applicable	Tumor	SBC	Small Bowel Cancer	Small Bowel Cancer				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q);Olaparib(ATM p.H2554Ifs*10)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_3B	MSH6 p.F1088Lfs*5;TP53 p.R175H;B2M p.R117*;ERBB2 p.R678Q;CASP8 p.L474Tfs*6;CTCF p.T204Nfs*26;APC p.R1114*;KRAS p.G13D;APC p.D802*;ARID1A p.F2141Lfs*9;ERRFI1 p.N135Tfs*40;ATR p.R1503*;ATM p.H2554Ifs*10;NOTCH3 p.A2233Gfs*9;EP300 p.R2330Kfs*49;ASXL1 p.R596Pfs*23	3	16
P-0011541	P-0011541-T01-IM5	In-House	FFPE	Biopsy	174.6	353	20	Matched	Metastasis	Lung	Spinal Cord	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.G187R	1	2
P-0011542	P-0011542-T01-IM5	In-House	FFPE	Biopsy	250	896	20	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.K111E);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.K111E)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.K111E;TP53 p.I195S;ERBB2 Amplification;MDM2 Amplification;SRC Amplification;CNTN1 MLL2-CNTN1 fusion;KMT2D MLL2-CNTN1 fusion	5	7
P-0011543	P-0011543-T01-IM5	In-House	FFPE	Biopsy	141.33	818	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										CDK4 p.R24L;EGFR p.H773_V774delinsLM;B2M p.D54Afs*5	0	3
P-0011544	P-0011544-T01-IM5	In-House	FFPE	Resection	250	972	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.K267Rfs*9);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	PTEN p.K267Rfs*9;TP53 p.G279E;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	3	5
P-0011545	P-0011545-T01-IM5	Outside	FFPE	Resection	250	604	20	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.G1803V)					LEVEL_1	BRAF p.V600E;BRCA1 p.G1803V;TP53 p.V217_V218insDSVV	4	3
P-0011546	P-0011546-T01-IM5	In-House	FFPE	Biopsy	250	872	60	Matched	Metastasis	Lung	Liver	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma				Sonidegib,Vismodegib(PTCH1 p.E604*)					LEVEL_3B	STK11 p.E223*;PTCH1 p.E604*;RB1 p.X405_splice;TP53 p.X261_splice;BAP1 Deletion;RICTOR Amplification;RUNX1 Amplification	1	7
P-0011547	P-0011547-T01-IM5	In-House	FFPE	Biopsy	250	826	30	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0011548	P-0011548-T01-IM5	In-House	FFPE	Resection	250	847	50	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0011549	P-0011549-T01-IM5	In-House	FFPE	Resection	250	735	50	Matched	Metastasis	Arm	Liver	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										TP53 p.E326Dfs*19;ATRX p.Y343Gfs*5;RB1 Deletion	0	3
P-0011550	P-0011550-T01-IM5	In-House	FFPE	Resection	250	782	90	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma										CCNE1 Amplification;GATA3 Deletion;MCL1 Amplification;NTRK1 Amplification;RB1 Deletion;TP53 TP53-intragenic	0	6
P-0011551	P-0011551-T01-IM5	In-House	FFPE	Biopsy	250	735	80	Matched	Primary	Pituitary Gland	Not Applicable	Tumor	PTAD	Sellar Tumor	Pituitary Adenoma										TP53 p.Y220C;TP53 p.H179R	0	2
P-0011552	P-0011552-T01-IM5	In-House	FFPE	Biopsy	250	913	10	Matched	Metastasis	Breast	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AZD9496,Fulvestrant(ESR1 p.D538G)					LEVEL_3B	ESR1 p.D538G;RHOA p.G17E;CDH1 p.Q346*;KMT2D p.P3665Lfs*84;KMT2C p.M2475*;CBFB p.X55_splice	1	6
P-0011553	P-0011553-T01-IM5	Outside	FFPE	Biopsy	250	816	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0011554	P-0011554-T01-IM5	In-House	FFPE	Biopsy	250	936	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma			Olaparib(BRCA1 p.Q1388*)	Niraparib,Rucaparib,Talazoparib(BRCA1 p.Q1388*);Olaparib(CWF19L2 CHEK1-CWF19L2 fusion);Olaparib(CHEK1 CHEK1-CWF19L2 fusion)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3A	KRAS p.G12D;TP53 p.Q192*;BRCA1 p.Q1388*;RNF43 p.M18Yfs*20;CWF19L2 CHEK1-CWF19L2 fusion;CHEK1 CHEK1-CWF19L2 fusion	5	6
P-0011555	P-0011555-T01-IM5	Outside	FFPE	Biopsy	220.3	323	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Olaparib(BARD1 p.D226Afs*6);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12D;TP53 p.R175H;KMT2C p.Q1796*;BARD1 p.D226Afs*6;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;ERBB3 Amplification;GLI1 Amplification;MDM2 Amplification;TGFBR2 Deletion;SDHAF2 SDHAF2-intragenic;SDHAF2 FAM65B-SDHAF2 fusion;RIPOR2 FAM65B-SDHAF2 fusion	5	14
P-0011556	P-0011556-T01-IM5	In-House	FFPE	Biopsy	250	933	70	Matched	Primary	Liver	Not Applicable	Tumor	IHCH	Hepatobiliary Cancer	Intrahepatic Cholangiocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	NRAS p.Q61R;BAP1 p.X146_splice;AKT3 Amplification;DDR2 Amplification;IKBKE Amplification;MCL1 Amplification;MDM4 Amplification;NTRK1 Amplification	1	8
P-0011557	P-0011557-T01-IM5	In-House	FFPE	Cytology	250	838	20	Matched	Metastasis	Ovary	Lung	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.C141R;CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification;MCL1 Amplification;MYC Amplification	1	6
P-0011558	P-0011558-T01-IM5	Outside	FFPE	Resection	250	601	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.T1556Nfs*3;SPOP p.F133L;SPOP p.F133V;VGLL3 EPHA3-VGLL3 fusion;EPHA3 EPHA3-VGLL3 fusion	0	5
P-0011559	P-0011559-T01-IM5	Outside	FFPE	Biopsy	250	883	10	Matched	Metastasis	Lung	Pericardium	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.G245D	0	1
P-0011560	P-0011560-T01-IM5	Outside	FFPE	Resection	250	495	50	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.S1390Rfs*4;SETD2 p.X21_splice	0	2
P-0011560	P-0011560-T02-IM5	Outside	FFPE	Resection	250	715	50	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma										KMT2A p.G1065*	0	1
P-0011560	P-0011560-T03-IM5	Outside	FFPE	Resection	250	935	20	Matched	Primary	Kidney	Not Applicable	Tumor	ROCY	Renal Cell Carcinoma	Renal Oncocytoma											0	0
P-0011561	P-0011561-T01-IM5	Outside	FFPE	Cytology	250	951	50	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	HNSCUP	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma of Unknown Primary					GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_4	PTEN p.R130Q;KEAP1 p.D422N;NSD1 p.S759*;BCL6 Amplification;PIK3CA Amplification;PIK3CB Amplification	1	6
P-0011562	P-0011562-T01-IM5	In-House	FFPE	Resection	250	909	60	Matched	Primary	Uterus	Not Applicable	Tumor	UELMS	Uterine Sarcoma	Uterine Epithelioid Leiomyosarcoma										PDGFRB p.N666K;MED12 p.G44V;TP53 p.H214P	0	3
P-0011563	P-0011563-T01-IM5	Outside	FFPE	Biopsy	250	927	30	Matched	Metastasis	Rectum	Omentum	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.L111Ffs*40;KRAS p.G13D	1	2
P-0011564	P-0011564-T01-IM5	In-House	FFPE	Biopsy	250	874	60	Unmatched	Primary	Duodenum	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CREBBP p.W1158*;CREBBP p.X1378_splice;FOXO1 p.S22P;RHOA p.F39L;MGA p.C355*	0	5
P-0011566	P-0011566-T01-IM5	Outside	FFPE	Biopsy	250	1136	40	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma			Ivosidenib(IDH1 p.R132C)	Binimetinib,Binimetinib+Ribociclib(NRAS p.G13S)					LEVEL_3A	IDH1 p.R132C;NRAS p.G13S	2	2
P-0011568	P-0011568-T01-IM5	In-House	FFPE	Resection	250	887	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.L78Rfs*46);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83D)				LEVEL_1	PIK3CA p.E542K;TP53 p.L111P;PIK3R3 p.R309*;CDKN2A p.L78Rfs*46;CDKN2A p.H83D;CCND1 Amplification;ERBB2 Amplification;FGF19 Amplification;MDM4 Amplification;MEF2B Amplification	6	10
P-0011569	P-0011569-T01-IM5	In-House	FFPE	Resection	250	774	20	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R93Q);Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.R678Q);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R);GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_3B	FGFR2 p.C382R;PIK3CA p.R93Q;ERBB2 p.R678Q;PTEN p.R130Q;NSD1 p.C1435*;DICER1 p.E1813G;PIK3R2 p.G373R;ERBB3 p.V104M;PIK3CA p.R88Q;CCND1 p.P287S;TP53 p.D208V;ARID1A p.Q1327*;PPP2R1A p.R182W;NSD1 p.C1562*;RAD21 p.R478*;KMT2A p.X168_splice;FAT1 p.Y4256Lfs*8;KMT2D p.A4594Gfs*12	5	18
P-0011570	P-0011570-T01-IM5	In-House	FFPE	Resection	250	888	25	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				AZD9496,Fulvestrant(ESR1 p.L536H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.D549N);Olaparib(ATM p.R1730*);Olaparib(ATM p.R35*);Olaparib(ATM p.E1133*)	GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_3B	ESR1 p.L536H;XPO1 p.E571K;PIK3CA p.D549N;PTEN p.R130Q;FBXW7 p.R658*;CDK8 p.S62L;ATRX p.R1426*;ARID1A p.R1989*;ATM p.R1730*;FAT1 p.R2597*;MAP2K4 p.E221*;MGA p.R1242*;POLE p.V411L;MAP3K1 p.S1330L;ATM p.R35*;PPM1D p.E525*;SPEN p.R3011*;JAK1 p.E1133*;INPP4B p.X712_splice;RASA1 p.E641*;ARID5B p.E519*;ARID5B p.E851*;ATM p.E1133*;KMT2A p.R2146*;ERBB3 p.M91I;ATRX p.R2079*	6	26
P-0011571	P-0011571-T01-IM5	Outside	FFPE	Resection	250	575	10	Matched	Metastasis	Ovary	Omentum	Tumor	MXOV	Ovarian Cancer	Mixed Ovarian Carcinoma	Niraparib,Olaparib,Rucaparib(BRCA1 p.L290Yfs*8)			Talazoparib(BRCA1 p.L290Yfs*8)	Trametinib,Cobimetinib(NF1 p.X2235_splice)				LEVEL_1	TP53 p.R248Q;NSD1 p.S1679*;NF1 p.X2235_splice;BRCA1 p.L290Yfs*8;KMT2C MLL3-intragenic	3	5
P-0011573	P-0011573-T01-IM5	In-House	FFPE	Biopsy	250	989	70	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										TP53 p.R248W;CARD11 p.L251P;B2M p.S14Ffs*29;CREBBP p.W1502C;CREBBP p.X1465_splice;SOCS1 p.V155Afs*59;SOCS1 p.G122Efs*7;GPS2 p.Q290Pfs*?	0	8
P-0011574	P-0011574-T01-IM5	In-House	FFPE	Biopsy	250	732	30	Matched	Primary	Brain	Not Applicable	Tumor	MNG	CNS Cancer	Meningioma										NF2 p.X39_splice;SUZ12 p.E578*	0	2
P-0011575	P-0011575-T01-IM5	In-House	FFPE	Resection	250	819	60	Unmatched	Primary	Liver	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										TP53 p.X126_splice;PDGFRA Amplification	0	2
P-0011576	P-0011576-T01-IM5	In-House	FFPE	Resection	250	615	40	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma		Cabozantinib(MET Amplification)		Crizotinib(MET Amplification)					LEVEL_2	MET Amplification	2	1
P-0011577	P-0011577-T01-IM5	Outside	FFPE	Biopsy	250	884	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.A83Cfs*63;TP53 p.N310Kfs*26;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0011578	P-0011578-T01-IM5	In-House	FFPE	Biopsy	250	909	90	Matched	Metastasis	Thymus	Pleura	Tumor	THYM	Thymic Tumor	Thymoma											0	0
P-0011579	P-0011579-T01-IM5	In-House	FFPE	Resection	250	814	50	Matched	Primary	Kidney	Not Applicable	Tumor	CHRCC	Renal Cell Carcinoma	Chromophobe Renal Cell Carcinoma											0	0
P-0011580	P-0011580-T01-IM5	In-House	FFPE	Resection	250	823	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Trametinib,Cobimetinib(MAP2K1 p.E203K)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	MAP2K1 p.E203K;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0011581	P-0011581-T01-IM5	In-House	FFPE	Resection	250	880	10	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma										PPP2R1A p.R183W	0	1
P-0011582	P-0011582-T01-IM5	In-House	FFPE	Biopsy	250	779	90	Unmatched	Primary	Skin	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										TNFAIP3 p.W448*;CREBBP p.W1472G;KMT2D p.F195Sfs*13;ARID1A Deletion;ERRFI1 Deletion;TNFRSF14 Deletion	0	6
P-0011585	P-0011585-T01-IM5	In-House	FFPE	Biopsy	250	855	90	Unmatched	Primary	Lung	Not Applicable	Tumor	EMALT	Mature B-Cell Neoplasms	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT lymphoma)										NOTCH1 p.Q2503*	0	1
P-0011587	P-0011587-T01-IM5	Outside	FFPE	Biopsy	250	841	80	Matched	Primary	Brain	Not Applicable	Tumor	CNC	Miscellaneous Neuroepithelial Tumor	Central Neurocytoma											0	0
P-0011589	P-0011589-T01-IM5	In-House	FFPE	Biopsy	250	633	50	Matched	Metastasis	Ovary	Liver	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer										TP53 p.D259Y;SPEN SPEN-intragenic	0	2
P-0011590	P-0011590-T01-IM5	In-House	FFPE	Resection	250	346	40	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.Y523*	0	1
P-0011592	P-0011592-T01-IM5	In-House	FFPE	Biopsy	250	914	50	Matched	Metastasis	Breast	Soft Tissue	Tumor	MDLC	Breast Cancer	Breast Mixed Ductal and Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib(NF1 p.K1283Sfs*22)				LEVEL_3B	KMT2D p.C1083*;CDH1 p.I158Yfs*10;NF1 p.K1283Sfs*22;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification;MDM2 Amplification;PAK1 Amplification;RAF1 Amplification	3	9
P-0011593	P-0011593-T01-IM5	In-House	FFPE	Resection	250	775	20	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CDH1 p.D291Hfs*11;ANKRD11 p.E2499Sfs*3	2	3
P-0011594	P-0011594-T01-IM5	Outside	FFPE	Biopsy	250	730	50	Matched	Metastasis	Skin	In-transit	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;APC p.R2204*;CDKN2A Deletion;CDKN2B Deletion	3	4
P-0012000	P-0012000-T01-IM5	Outside	FFPE	Cytology	250	927	30	Matched	Metastasis	Lung	Rib	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Olaparib(ATM p.Q1015*)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12F)				LEVEL_3B	KRAS p.G12F;ATM p.Q1015*	2	2
P-0012001	P-0012001-T01-IM5	In-House	FFPE	Biopsy	250	1164	20	Matched	Metastasis	Lung	Adrenal	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Everolimus(TSC1 p.D546Hfs*17)	PLX8394(BRAF p.G469A)				LEVEL_3B	BRAF p.G469A;TP53 p.G105V;NF2 p.X39_splice;EP300 p.E1063*;TSC1 p.D546Hfs*17	2	5
P-0012002	P-0012002-T01-IM5	Outside	FFPE	Biopsy	250	1101	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.N329Kfs*14);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	PTEN p.N329Kfs*14;PTPN11 p.E139D;ARID1A p.E2250Vfs*27;CDKN2A Deletion;CDKN2B Deletion;GATA3 Deletion;NF1 Deletion	3	7
P-0012003	P-0012003-T01-IM5	Outside	FFPE	Biopsy	250	1160	50	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma					Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.C382R)				LEVEL_4	FGFR2 p.C382R;BAP1 Deletion	1	2
P-0012004	P-0012004-T01-IM5	In-House	FFPE	Biopsy	250	911	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	RMS	Soft Tissue Sarcoma	Rhabdomyosarcoma										MYCN Amplification	0	1
P-0012005	P-0012005-T01-IM5	Outside	FFPE	Resection	250	911	25	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma										MEN1 p.Q513*;GATA3 p.D335Pfs*16;CCND1 Amplification;FGF19 Amplification	0	4
P-0012006	P-0012006-T01-IM5	In-House	FFPE	Resection	250	1007	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047_H1048delinsRR)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047_H1048delinsRR)						LEVEL_1	PIK3CA p.H1047_H1048delinsRR	2	1
P-0012007	P-0012007-T01-IM5	Outside	FFPE	Resection	250	776	50	Matched	Primary	Small Bowel	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor										GLI1 Amplification	0	1
P-0012008	P-0012008-T01-IM5	In-House	FFPE	Biopsy	250	847	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(SDC4 ROS1-SDC4 fusion);Crizotinib,Entrectinib(ROS1 ROS1-SDC4 fusion)								LEVEL_1	SDC4 ROS1-SDC4 fusion;ROS1 ROS1-SDC4 fusion	2	2
P-0012009	P-0012009-T01-IM5	In-House	FFPE	Resection	250	854	10	Matched	Primary	Ampulla of Vater	Not Applicable	Tumor	PAMPCA	Ampullary Carcinoma	Pancreatobiliary Ampullary Carcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0012010	P-0012010-T01-IM5	In-House	FFPE	Resection	250	854	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61H)				LEVEL_4	SMARCA4 p.T910M;ARID1A p.Q372Afs*28;KRAS p.Q61H;TP53 p.V122Dfs*26;TGFBR2 p.N154Ifs*10	1	5
P-0012025	P-0012025-T01-IM5	Outside	FFPE	Biopsy	250	986	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ZFHX3 p.R1114*;RB1 p.I723Nfs*28;SOX9 Deletion	0	3
P-0012026	P-0012026-T01-IM5	In-House	FFPE	Resection	250	794	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.S298Lfs*23;ZFHX3 ZFHX3-intragenic	0	2
P-0012027	P-0012027-T01-IM5	In-House	FFPE	Cytology	250	925	10	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.X225_splice;FGFR1 Amplification;RICTOR Amplification;TERT Amplification	1	4
P-0012028	P-0012028-T01-IM5	Outside	FFPE	Biopsy	133.4	518	10	Matched	Primary	Oral Cavity	Not Applicable	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.L576P)					LEVEL_3B	KIT p.L576P;CCND1 Amplification;FGF19 Amplification	1	3
P-0012029	P-0012029-T01-IM5	Outside	FFPE	Biopsy	250	862	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0012030	P-0012030-T01-IM5	Outside	FFPE	Biopsy	250	815	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	FOXA1 p.K264dup;CDKN1B Deletion;PTEN Deletion	1	3
P-0012031	P-0012031-T01-IM5	Outside	FFPE	Biopsy	169.3	440	90	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification;GPS2 Deletion;MYC Amplification;PAX5 Deletion;PTPRT Deletion;TOP1 Deletion;TP53 Deletion	1	7
P-0012032	P-0012032-T01-IM5	Outside	FFPE	Biopsy	250	891	40	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.R175H;APC p.T1493Rfs*14;RBM10 p.L195Sfs*71;APC p.Q1062*;FLT3 Amplification;KRAS Amplification	0	6
P-0012033	P-0012033-T01-IM5	In-House	FFPE	Resection	250	840	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.P151S;APC p.E1309Dfs*4;KMT2C p.R2884*;APC p.T916Kfs*39	0	4
P-0012034	P-0012034-T01-IM5	Outside	FFPE	Resection	250	931	70	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma											0	0
P-0012035	P-0012035-T01-IM5	In-House	FFPE	Biopsy	250	875	10	Matched	Metastasis	Transverse Colon	Peritoneum	Tumor	MACR	Colorectal Cancer	Mucinous Adenocarcinoma of the Colon and Rectum				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_3B	GNAS p.R201H;PIK3CA p.E542K;KRAS p.G13D	2	3
P-0012036	P-0012036-T01-IM5	Outside	FFPE	Biopsy	250	914	90	Matched	Metastasis	Lung	Liver	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.L114*;DNMT3A p.S337*;EPHA3 Deletion;NKX2-1 Amplification;TGFBR2 Deletion	0	5
P-0012037	P-0012037-T01-IM5	In-House	FFPE	Biopsy	250	727	30	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.P301Qfs*44;RB1 p.X445_splice;KMT2D p.G4596Efs*21;NCOR1 p.N746Kfs*7;MYCL Amplification	0	5
P-0012038	P-0012038-T01-IM5	Outside	FFPE	Biopsy	250	709	10	Matched	Metastasis	Ovary	Peritoneum	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor										TP53 p.R175H;CCNE1 Amplification;KRAS Amplification	0	3
P-0012039	P-0012039-T01-IM5	In-House	FFPE	Resection	250	519	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0012040	P-0012040-T01-IM5	In-House	FFPE	Resection	250	758	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										BAP1 p.K419*;VHL p.S168Tfs*2	0	2
P-0012041	P-0012041-T01-IM5	In-House	FFPE	Biopsy	250	1030	30	Matched	Metastasis	Pancreas	Abdominal wall	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047Y);Olaparib(ATM p.X1331_splice)	Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61R)				LEVEL_3B	KRAS p.Q61R;TP53 p.C238Y;PIK3CA p.H1047Y;RB1 p.W516*;ATM p.X1331_splice;RNF43 p.F562Sfs*138;CCNE1 Amplification;DDR2 Amplification;NTRK1 Amplification;TERT Amplification	3	10
P-0012042	P-0012042-T01-IM5	In-House	FFPE	Biopsy	250	908	70	Matched	Metastasis	Cancer of Unknown Primary	Liver	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	BCOR p.S259Ifs*42;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0012043	P-0012043-T01-IM5	In-House	FFPE	Biopsy	250	929	40	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.G719C);Afatinib(EGFR p.S768I)			Palbociclib,Abemaciclib(CDK4 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	TP53 p.R248Q;EGFR p.G719C;EGFR p.S768I;CARD11 Amplification;CD274 Amplification;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;GLI1 Amplification;JAK2 Amplification;NKX2-1 Amplification	4	12
P-0012046	P-0012046-T01-IM5	Outside	FFPE	Biopsy	250	906	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 Deletion)			Talazoparib,Niraparib(BRCA2 Deletion)					LEVEL_1	BRCA2 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	3
P-0012047	P-0012047-T01-IM5	In-House	FFPE	Cytology	250	1270	20	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E110K);Sonidegib,Vismodegib(PTCH1 p.X356_splice)					LEVEL_3B	TP53 p.R342*;EPHA3 p.R136*;TP53 p.X307_splice;PIK3CA p.E110K;PIK3R1 p.Q475*;ARID1B p.Q1407*;PTCH1 p.X356_splice;BLM p.N82_Q83delinsI*	2	8
P-0012048	P-0012048-T01-IM5	In-House	FFPE	Resection	250	729	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	MGA p.R2466*;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	4
P-0012049	P-0012049-T01-IM5	In-House	FFPE	Cytology	250	889	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	PIK3CA p.E545K;KRAS p.G12V;TP53 p.G245D;MAX p.E10*;CDKN2A Deletion;CDKN2B Deletion	3	6
P-0012050	P-0012050-T01-IM5	Outside	FFPE	Resection	250	703	40	Matched	Primary	Testis	Not Applicable	Tumor	VOEC	Germ Cell Tumor	Embryonal Carcinoma											0	0
P-0012051	P-0012051-T01-IM5	In-House	FFPE	Biopsy	250	1052	50	Matched	Metastasis	Trachea	Lung	Tumor	ACYC	Salivary Gland Cancer	Adenoid Cystic Carcinoma				Olaparib(ATM p.K296Nfs*4)					LEVEL_3B	ARID1A p.Q386*;ATM p.K296Nfs*4	1	2
P-0012054	P-0012054-T01-IM5	Outside	FFPE	Resection	250	797	10	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201H;SMAD4 p.R445*;SMAD4 p.R361S;SOX9 p.K205*	1	5
P-0012055	P-0012055-T01-IM5	In-House	FFPE	Cytology	250	1244	20	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	FH p.X412_splice;RBM10 p.W187*;AR Amplification;ARID1A Deletion;CCNE1 Amplification;CDK4 Amplification;ID3 Deletion;MAPK1 Amplification;MDM2 Amplification;MITF Amplification;RICTOR Amplification;TERT Amplification;ZFHX3 Deletion;SOX17 SOX17-intragenic	2	14
P-0012056	P-0012056-T01-IM5	In-House	FFPE	Resection	250	943	60	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	TP53 p.R282G;ERBB2 Amplification;MDM2 Amplification;MYCL Amplification	2	4
P-0012057	P-0012057-T01-IM5	In-House	FFPE	Resection	250	832	20	Matched	Primary	Lung	Not Applicable	Tumor	SARCL	Non-Small Cell Lung Cancer	Sarcomatoid Carcinoma of the Lung			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;STK11 p.Y60*	2	2
P-0012058	P-0012058-T01-IM5	Outside	FFPE	Biopsy	250	926	50	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.F241Lfs*6)				LEVEL_4	KMT2D p.V1554Lfs*48;CTNNB1 p.S37A;ARID1A p.Q1148*;JAK1 p.C481*;MYC p.P74T;CCND1 p.E275*;TOP1 p.E526*;PTEN p.F241Lfs*6	1	8
P-0012059	P-0012059-T01-IM5	In-House	FFPE	Cytology	250	970	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C;TP53 p.V173L;GPS2 p.V93Ffs*16;PTPRD p.L1721Wfs*19	2	4
P-0012060	P-0012060-T01-IM5	Outside	FFPE	Resection	250	569	50	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma											0	0
P-0012061	P-0012061-T01-IM5	In-House	FFPE	Biopsy	250	959	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.Y1003C)	Crizotinib(MET p.Y1003C)	AMG-510(KRAS p.G12C);Cabozantinib(MET p.Y1003C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_1	KRAS p.G12C;PIK3CA p.E545K;MET p.Y1003C	6	3
P-0012062	P-0012062-T01-IM5	In-House	FFPE	Resection	250	1174	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma											0	0
P-0012063	P-0012063-T01-IM5	Outside	FFPE	Resection	250	866	60	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.R248L;RAF1 p.S259P;KEAP1 p.F546*	0	3
P-0012064	P-0012064-T01-IM5	In-House	FFPE	Cytology	198	743	40	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C)				LEVEL_3B	KRAS p.G13C;SMARCA4 p.E535*;KEAP1 p.E117*;STK11 p.A218Gfs*48;MDM2 Amplification	2	5
P-0012065	P-0012065-T01-IM5	In-House	FFPE	Resection	250	1032	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;STK11 p.Y60*	1	2
P-0012066	P-0012066-T01-IM5	Outside	FFPE	Biopsy	250	779	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma										SMAD4 p.S232Qfs*3;TP53 p.C135Y	0	2
P-0012067	P-0012067-T01-IM5	In-House	FFPE	Biopsy	129.1	216	20	Matched	Primary	Peritoneum	Not Applicable	Tumor	PEMESO	Mesothelioma	Peritoneal Mesothelioma										KMT2C p.S2638Lfs*9	0	1
P-0012068	P-0012068-T01-IM5	Outside	FFPE	Resection	250	766	20	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Olaparib(ATM p.E1832*)					LEVEL_3B	ATM p.E1832*;CTNNB1 p.L31_S33del	1	2
P-0012069	P-0012069-T01-IM5	In-House	FFPE	Biopsy	250	1196	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	FL	Mature B-Cell Neoplasms	Follicular Lymphoma										BCL2 p.A131T;KMT2D p.Q2237*;KMT2D p.P4949Lfs*10	0	3
P-0012070	P-0012070-T01-IM5	Outside	FFPE	Biopsy	105.2	610	60	Matched	Metastasis	Breast	Liver	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.R88Q);Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	PIK3CA p.R88Q;SMAD4 p.E538*;ERBB2 Amplification;PPM1D Amplification	4	4
P-0012071	P-0012071-T01-IM5	In-House	FFPE	Biopsy	250	1128	50	Matched	Metastasis	Oral Cavity	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										TP53 p.G245C;FAT1 p.Q301*;RB1 p.X566_splice;PPP2R1A p.R134P;BCL2L1 Amplification	0	5
P-0012072	P-0012072-T01-IM5	In-House	FFPE	Biopsy	250	1142	80	Unmatched	Primary	Soft Tissue	Not Applicable	Tumor	PTCL	Mature T and NK Neoplasms	Peripheral T-Cell lymphoma, NOS										RHOA p.A161V;TP53 p.Y234del	0	2
P-0012073	P-0012073-T01-IM5	Outside	FFPE	Biopsy	250	907	20	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										ARID2 ARID2-intragenic	0	1
P-0012074	P-0012074-T01-IM5	In-House	FFPE	Biopsy	250	887	40	Matched	Metastasis	Rectosigmoid Colon	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.C124Wfs*25;APC p.S1315*;FBXW7 p.R224*	0	3
P-0012075	P-0012075-T01-IM5	In-House	FFPE	Resection	250	877	20	Matched	Primary	Pancreas	Not Applicable	Tumor	IPMN	Pancreatic Cancer	Intraductal Papillary Mucinous Neoplasm					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201H;KLF4 p.K409Q	1	3
P-0012076	P-0012076-T01-IM5	In-House	FFPE	Biopsy	250	1021	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;RB1 p.S834*;TP53 p.A159P;EGFR Amplification	1	4
P-0012077	P-0012077-T01-IM5	Outside	FFPE	Resection	193.7	556	30	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme										TP53 p.X125_splice;CCNE1 Amplification	0	2
P-0012079	P-0012079-T01-IM5	In-House	FFPE	Resection	250	739	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.K132M	1	2
P-0012080	P-0012080-T01-IM5	In-House	FFPE	Biopsy	250	946	50	Matched	Metastasis	Skin	Soft Tissue	Tumor	SKCM	Melanoma	Cutaneous Melanoma			Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	NRAS p.Q61R;TP53 p.P278L;ERBB4 p.R544Q;CDKN2A Deletion	2	4
P-0012081	P-0012081-T01-IM5	Outside	FFPE	Biopsy	250	809	30	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma			Neratinib(ERBB2 p.G778_P780dup)	Ado-Trastuzumab Emtansine(ERBB2 p.G778_P780dup)					LEVEL_3A	RUNX1 p.R142Kfs*44;TP53 p.E56*;ERBB2 p.G778_P780dup;MAP3K1 p.R273Sfs*27;KRAS Amplification	2	5
P-0012082	P-0012082-T01-IM5	Outside	FFPE	Biopsy	250	754	50	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.A146V)				LEVEL_4	KRAS p.A146V;TP53 p.F54Lfs*69;RB1 p.R579*;ZFHX3 p.Q528*;EP300 p.K654*;APC Deletion;DDR2 Amplification;MAP3K1 Deletion;MCL1 Amplification;MYC Amplification;NTRK1 Amplification;PIK3R1 Deletion;PMAIP1 Deletion;RASA1 Deletion;SMAD4 Deletion;STK11 Deletion;TERT Amplification	1	17
P-0012083	P-0012083-T01-IM5	Outside	FFPE	Cytology	72	218	80	Matched	Metastasis	Lung	Pleural Fluid	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.L858R)								LEVEL_1	EGFR p.L858R;TP53 p.S215R	1	2
P-0012084	P-0012084-T01-IM5	In-House	FFPE	Cytology	106	577	50	Matched	Metastasis	Lung	Lymph Node	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.M1043I)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	PIK3CA p.M1043I;CASP8 p.Q49*;KEAP1 p.R470C;FAT1 p.E2045*;KDM6A p.S666Lfs*19;TP53 p.I254Sfs*91;TP53 p.T230Pfs*17;AKT2 Amplification;AXL Amplification;CDKN2A Deletion;CDKN2B Deletion;FGFR1 Amplification;NKX3-1 Deletion	3	13
P-0012086	P-0012086-T01-IM5	In-House	FFPE	Biopsy	250	991	50	Matched	Metastasis	Lung	Adrenal	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma										TP53 p.R273L;KMT2D p.K3540Rfs*118;MEF2B Amplification;MYCL Amplification;PIK3R2 Amplification	0	5
P-0012087	P-0012087-T01-IM5	Outside	FFPE	Biopsy	250	1029	90	Matched	Metastasis	Cancer of Unknown Primary	Abdomen	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary										TP53 p.R273H;RB1 p.X474_splice;AXIN1 p.E128*;AURKA Amplification;DNMT3B Amplification;GATA3 Deletion;SRC Amplification;ERBB2 RARA-ERBB2 fusion;RARA RARA-ERBB2 fusion	0	9
P-0012088	P-0012088-T01-IM5	In-House	FFPE	Resection	250	818	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.Q331*;U2AF1 p.S34F;TP53 p.R280T;KMT2D p.Q1402*;MGA p.X2398_splice;RBM10 p.Q277*;SPEN p.E1964*;EGFR Amplification	0	8
P-0012089	P-0012089-T01-IM5	In-House	FFPE	Resection	250	795	80	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)								LEVEL_1	EGFR p.E746_A750del;TP53 p.E51Nfs*72	1	2
P-0012090	P-0012090-T01-IM5	In-House	FFPE	Resection	250	988	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma		Ado-Trastuzumab Emtansine(ERBB2 p.Y772_A775dup)	Neratinib(ERBB2 p.Y772_A775dup)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_2	PIK3CA p.H1047R;ERBB2 p.Y772_A775dup;TP53 p.G105Afs*18	3	3
P-0012091	P-0012091-T01-IM5	In-House	FFPE	Biopsy	250	1157	10	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer										TP53 p.R196*;APC p.Y1183*;GRIN2A p.W284*	0	3
P-0012092	P-0012092-T01-IM5	In-House	FFPE	Biopsy	250	903	70	Matched	Metastasis	Lung	Brain	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R175H;AKT2 Amplification;FOXA1 Amplification;NKX2-1 Amplification;PTEN Deletion;RB1 Deletion;RICTOR Amplification;TERT Amplification	1	8
P-0012093	P-0012093-T01-IM5	Outside	FFPE	Resection	250	1027	40	Matched	Metastasis	Nasopharynx	Lymph Node	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.S310F)					LEVEL_3B	ERBB2 p.S310F;EPHA3 p.X832_splice;AKT2 Amplification	1	3
P-0012094	P-0012094-T01-IM5	In-House	FFPE	Resection	250	869	50	Matched	Primary	Testis	Not Applicable	Tumor	SEM	Germ Cell Tumor	Seminoma										CCND2 Amplification;KDM5A Amplification;KRAS Amplification	0	3
P-0012095	P-0012095-T01-IM5	Outside	FFPE	Biopsy	103.5	276	10	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Encorafenib+Binimetinib,Vemurafenib+Atezolizumab+Cobimetinib,Dabrafenib+Trametinib,Vemurafenib+Cobimetinib(BRAF p.V600R)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.M52*)				LEVEL_3B	FBXW7 p.R465H;GNAS p.R201C;BRAF p.V600R;TP53 p.C124L;CDKN2A p.M52*	2	5
P-0012096	P-0012096-T01-IM5	In-House	FFPE	Biopsy	250	1048	70	Matched	Metastasis	Small Bowel	Liver	Tumor	SBWDNET	Gastrointestinal Neuroendocrine Tumor	Small Bowel Well-Differentiated Neuroendocrine Tumor											0	0
P-0012098	P-0012098-T01-IM5	Outside	FFPE	Biopsy	250	1026	15	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_T751delinsI)								LEVEL_1	EGFR p.E746_T751delinsI	1	1
P-0012099	P-0012099-T01-IM5	Outside	FFPE	Biopsy	250	874	80	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										BCL2L1 Amplification;FGFR3 Amplification	0	2
P-0012100	P-0012100-T01-IM5	In-House	FFPE	Resection	250	590	15	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S)	Cetuximab,Panitumumab(KRAS p.G12S)			LEVEL_4	KRAS p.G12S;APC p.R232*;TCF7L2 p.E84Kfs*24;APC p.Q222_Q223delinsH*	1	4
P-0012101	P-0012101-T01-IM5	In-House	FFPE	Resection	250	533	40	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma										TP53 p.R175H;STK11 p.S216F	0	2
P-0012102	P-0012102-T01-IM5	Outside	FFPE	Resection	250	643	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SF3B1 p.K741E;VHL p.W117Gfs*42;PBRM1 p.I1288Ffs*25;FGFR4 Amplification	0	4
P-0012102	P-0012102-T02-IM5	Outside	FFPE	Resection	250	691	30	Matched	Metastasis	Kidney	Adrenal	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										SF3B1 p.K741E;VHL p.W117Gfs*42;PBRM1 p.I1288Ffs*25;FGFR4 Amplification	0	4
P-0012104	P-0012104-T01-IM5	In-House	FFPE	Resection	250	632	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0012105	P-0012105-T01-IM5	In-House	FFPE	Resection	250	836	50	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Everolimus(TSC2 TSC2-intragenic)					LEVEL_3B	TP53 p.R175H;TSC2 TSC2-intragenic;PIK3R2 PIK3R2-intragenic	1	3
P-0012106	P-0012106-T01-IM5	In-House	FFPE	Biopsy	250	1146	30	Matched	Metastasis	Pancreas	Soft Tissue	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;TP53 p.R249W;KDM5A Amplification	1	3
P-0012107	P-0012107-T01-IM5	In-House	FFPE	Biopsy	250	816	40	Matched	Metastasis	Tonsil	Parotid	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma										ARID1A p.Q758*;CDH1 p.R54*;EP300 EP300-intragenic;ARID1B ARID1B-intragenic	0	4
P-0012108	P-0012108-T01-IM5	In-House	FFPE	Resection	250	816	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0012109	P-0012109-T01-IM5	In-House	FFPE	Biopsy	250	1001	60	Matched	Metastasis	Prostate	Liver	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.Y76*)				LEVEL_4	TP53 p.R213Sfs*3;PIK3R1 p.K567_L570del;PTEN p.Y76*;FOXP1 Deletion;MITF Deletion;RYBP Deletion;SHQ1 Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	9
P-0012110	P-0012110-T01-IM5	In-House	FFPE	Biopsy	250	991	30	Matched	Metastasis	Rectum	Liver	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma										TP53 p.Y220C;APC p.S1198*;PBRM1 PBRM1-intragenic	0	3
P-0012111	P-0012111-T01-IM5	In-House	FFPE	Resection	250	818	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			AMG-510(KRAS p.G12C)		Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3A	KRAS p.G12C	2	1
P-0012112	P-0012112-T01-IM5	In-House	FFPE	Resection	250	531	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.E258Q;MAP3K1 Deletion	1	3
P-0012113	P-0012113-T01-IM5	In-House	FFPE	Resection	250	900	NA	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.T1025A);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Olaparib(ATM p.R2691C);Sonidegib,Vismodegib(PTCH1 p.R1394Lfs*10)	GSK2636771,AZD8186(PTEN p.R130Q)				LEVEL_3B	RNF43 p.G659Vfs*41;PIK3CA p.T1025A;FBXW7 p.R479Q;PTEN p.R130Q;PIK3CA p.R88Q;PGR p.R836Q;ARID1A p.R1721*;POLE p.V411L;MRE11 p.N511Ifs*13;ATM p.R2691C;XPO1 p.R749Q;MSH6 p.E1322*;PMS2 p.E109Kfs*3;EPHA3 p.X630_splice;TET2 p.S1284P;NOTCH4 p.Q115*;NBN p.R714*;FLT3 p.A813T;DIS3 p.X557_splice;CREBBP p.R424*;ZFHX3 p.R2668*;TP53 p.T231N;SMAD2 p.G27*;ZFHX3 p.L995Pfs*53;APC p.T2736Lfs*3;HOXB13 p.W195Gfs*84;PTCH1 p.R1394Lfs*10	5	27
P-0012114	P-0012114-T01-IM5	In-House	FFPE	Biopsy	250	683	20	Matched	Metastasis	Lung	Pleura	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.H214L	0	1
P-0012115	P-0012115-T01-IM5	Outside	FFPE	Biopsy	250	924	10	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52);Olaparib(BARD1 p.G700Afs*14);Olaparib(BRIP1 p.N1241Kfs*2)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.A76Pfs*70)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_3B	KRAS p.G12D;PTCH1 p.S1203Afs*52;NCOR1 p.R572Efs*18;KMT2D p.G1960Afs*87;ARID1A p.R1276*;CTCF p.T204Nfs*26;HLA-A p.A16Pfs*4;KMT2C p.K4647Sfs*12;SPEN p.P2495Lfs*4;FUBP1 p.S11Lfs*43;RNF43 p.W159*;ARID1B p.L2221Gfs*7;NOTCH4 p.G1891Afs*13;RNF43 p.R117Pfs*8;TOP1 p.X52_splice;BCOR p.R1547*;MLH1 p.P300Hfs*40;BARD1 p.G700Afs*14;ARID1B p.N1106Kfs*6;BRIP1 p.N1241Kfs*2;CIC p.E1288Gfs*56;KMT2D p.E1287Rfs*43;KMT2D p.I2093Sfs*3;AXIN2 p.E405Afs*52;PIK3R3 p.M295*;CDKN2A p.A76Pfs*70	5	26
P-0012116	P-0012116-T01-IM5	In-House	FFPE	Resection	250	740	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;TP53 p.X261_splice;CCND1 Amplification;FGF19 Amplification;NBN CWH43-NBN fusion;CWH43 CWH43-NBN fusion	2	6
P-0012117	P-0012117-T01-IM5	In-House	FFPE	Biopsy	250	922	50	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	DAXX p.L538Wfs*6;CDKN2A Deletion;CDKN2B Deletion	1	3
P-0012118	P-0012118-T01-IM5	Outside	FFPE	Biopsy	137.2	185	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R342Efs*3	1	2
P-0012119	P-0012119-T01-IM5	Outside	FFPE	Biopsy	250	546	30	Matched	Primary	Axilla	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61R)					LEVEL_3B	TP53 p.R342*;NRAS p.Q61R;ARID2 p.R542*;SUFU p.X228_splice	1	4
P-0012120	P-0012120-T01-IM5	In-House	FFPE	Resection	250	652	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K;CBFB p.X133_splice;GATA3 p.I361Rfs*11	2	3
P-0012121	P-0012121-T01-IM5	In-House	FFPE	Resection	250	1108	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										CTNNB1 p.D32Y;DICER1 p.G1809R;DICER1 p.G1809W	0	3
P-0012122	P-0012122-T01-IM5	In-House	FFPE	Resection	250	932	10	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Olaparib(RAD51C BCAS3-RAD51C fusion);Olaparib(BCAS3 BCAS3-RAD51C fusion)					LEVEL_3B	MAP2K2 p.F57L;GATA3 p.A313Sfs*39;RAD51C BCAS3-RAD51C fusion;BCAS3 BCAS3-RAD51C fusion	2	4
P-0012124	P-0012124-T01-IM5	Outside	FFPE	Resection	250	519	20	Matched	Primary	Eyelid	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.Q50R)				LEVEL_4	TP53 p.X32_splice;CDKN2A p.Q50R	1	2
P-0012125	P-0012125-T01-IM5	Outside	FFPE	Resection	250	632	10	Matched	Primary	Eye	Not Applicable	Tumor	UM	Melanoma	Uveal Melanoma										GNA11 p.Q209L	0	1
P-0012126	P-0012126-T01-IM5	In-House	FFPE	Resection	250	601	50	Matched	Primary	Bone	Not Applicable	Tumor	OS	Bone Cancer	Osteosarcoma										TP53 p.R248Q;RB1 p.K577Rfs*34;ETV1 Amplification;KDR Amplification;KIT Amplification;PDGFRA Amplification;RAC1 Amplification	0	7
P-0012127	P-0012127-T01-IM5	In-House	FFPE	Biopsy	250	760	60	Matched	Metastasis	Breast	Bone	Tumor	BRCANOS	Breast Cancer	Breast Invasive Cancer, NOS	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K;SMARCA4 p.A723Pfs*51;NKX3-1 Deletion	2	3
P-0012128	P-0012128-T01-IM5	Outside	FFPE	Biopsy	250	611	70	Matched	Metastasis	Cancer of Unknown Primary	Scalp	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V697L)					LEVEL_3B	ERBB2 p.V697L;NOTCH2 p.S856Lfs*17;SMAD4 Deletion	1	3
P-0012129	P-0012129-T01-IM5	Outside	FFPE	Biopsy	250	847	50	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma				Olaparib(CDK12 p.R1067*)	Trametinib,Cobimetinib(NF1 p.X2143_splice);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.R1067*)				LEVEL_3B	TP53 p.W146*;TP53 p.F113C;ARID2 p.Q1676*;MYC p.S161L;ARID2 p.Q1100*;FAT1 p.E3848*;NF1 p.X2143_splice;CDK12 p.R1067*	3	8
P-0012130	P-0012130-T01-IM5	In-House	FFPE	Resection	250	741	50	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.P200Hfs*16	0	1
P-0012131	P-0012131-T01-IM5	In-House	FFPE	Biopsy	250	868	80	Matched	Primary	Kidney	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0012132	P-0012132-T01-IM5	Outside	FFPE	Biopsy	250	754	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC p.T1556Nfs*3;RB1 p.X203_splice;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	4
P-0012133	P-0012133-T01-IM5	Outside	FFPE	Biopsy	91	354	10	Matched	Metastasis	Cecum	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;SMAD4 p.Q534*;TP53 p.X33_splice;MYCL Amplification	1	4
P-0012134	P-0012134-T01-IM5	In-House	FFPE	Biopsy	250	859	50	Matched	Metastasis	Breast	Liver	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.G1049R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.G1049R)						LEVEL_1	PIK3CA p.G1049R;TP53 p.G244V;SPEN p.X28_splice;ASXL2 p.E345*;CCND1 Amplification;FGF19 Amplification;MYC ADCY8-MYC fusion;ADCY8 ADCY8-MYC fusion	2	8
P-0012135	P-0012135-T01-IM5	In-House	FFPE	Resection	250	609	20	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma		Lapatinib+Trastuzumab,Trastuzumab+Pertuzumab(ERBB2 Amplification)		Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_2	TP53 p.R175H;APC p.E1309*;ERBB2 Amplification	2	3
P-0012136	P-0012136-T01-IM5	Outside	FFPE	Biopsy	156.9	171	60	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0012137	P-0012137-T01-IM5	Outside	FFPE	Resection	250	545	30	Matched	Primary	Kidney	Not Applicable	Tumor	RCC	Renal Cell Carcinoma	Renal Cell Carcinoma											0	0
P-0012138	P-0012138-T01-IM5	In-House	FFPE	Biopsy	250	938	20	Matched	Primary	Pleura	Not Applicable	Tumor	PLEMESO	Mesothelioma	Pleural Mesothelioma, Epithelioid Type										TP53 p.E285K;TP53 p.E287D	0	2
P-0012139	P-0012139-T01-IM5	Outside	FFPE	Resection	250	593	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.R306*	1	2
P-0012140	P-0012140-T01-IM5	Outside	FFPE	Resection	250	569	20	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	GSK2636771,AZD8186(PTEN p.K267Rfs*9)				LEVEL_3B	PIK3CA p.H1047R;FBXW7 p.R465H;PTEN p.K267Rfs*9;ERBB3 p.V104M;ARID1A p.D2178Tfs*22;RUNX1 p.X296_splice	2	6
P-0012141	P-0012141-T01-IM5	In-House	FFPE	Resection	250	649	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM Deletion)				GSK2636771,AZD8186(PTEN Deletion)				LEVEL_1	ATM Deletion;BMPR1A Deletion;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion;PIK3R1 PIK3R1-intragenic	2	6
P-0012142	P-0012142-T01-IM5	In-House	FFPE	Resection	250	668	80	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_4	TP53 p.D281N;MGA p.D2578Rfs*45;NF1 Deletion;ZFAND1 PIK3R1-ZFAND1 fusion;PIK3R1 PIK3R1-ZFAND1 fusion	1	5
P-0012143	P-0012143-T01-IM5	In-House	FFPE	Biopsy	250	875	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.V274L;ARID1A p.X641_splice	1	3
P-0012144	P-0012144-T01-IM5	In-House	FFPE	Biopsy	250	737	70	Matched	Primary	Anus	Not Applicable	Tumor	ARMM	Melanoma	Anorectal Mucosal Melanoma					Trametinib,Cobimetinib(NF1 p.X775_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	NF1 p.X775_splice;CDKN2A Deletion	2	2
P-0012145	P-0012145-T01-IM5	In-House	FFPE	Resection	250	609	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib,Rucaparib(BRCA2 p.S1099*)			Talazoparib,Niraparib(BRCA2 p.S1099*)					LEVEL_1	BRCA2 p.S1099*;KMT2C p.H636Ifs*5;RNF43 p.H683Ifs*17;RNF43 ALDH4A1-RNF43 fusion;ALDH4A1 ALDH4A1-RNF43 fusion	2	5
P-0012147	P-0012147-T01-IM5	In-House	FFPE	Biopsy	250	964	60	Matched	Metastasis	Rectum	Lung	Tumor	COADREAD	Colorectal Cancer	Colorectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Tazemetostat(SMARCB1 p.L356Dfs*4)	Cetuximab,Panitumumab(KRAS p.G12V)			LEVEL_4	KRAS p.G12V;APC p.S1465Wfs*3;SMARCB1 p.L356Dfs*4;APC p.L235*;AMER1 p.E543*;SOX9 p.L382Rfs*2	2	6
P-0012148	P-0012148-T01-IM5	In-House	FFPE	Biopsy	250	1141	50	Matched	Metastasis	Breast	Liver	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS				Everolimus(TSC1 p.X221_splice);Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.C242Afs*5;TSC1 p.X221_splice;PIK3R1 p.V402_L413del;FGFR1 Amplification	2	4
P-0012149	P-0012149-T01-IM5	In-House	FFPE	Biopsy	250	970	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.X1010_splice)	Crizotinib(MET p.X1010_splice)	Cabozantinib(MET p.X1010_splice)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	MET p.X1010_splice;CDK4 Amplification;MDM2 Amplification	5	3
P-0012150	P-0012150-T01-IM5	In-House	FFPE	Biopsy	250	894	10	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma					GSK2636771,AZD8186(PTEN p.G127E)				LEVEL_4	TP53 p.Y107*;PTEN p.G127E;ARID2 p.X342_splice	1	3
P-0012151	P-0012151-T01-IM5	In-House	FFPE	Resection	250	736	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										KEAP1 KEAP1-intragenic	0	1
P-0012152	P-0012152-T01-IM5	Outside	FFPE	Biopsy	185.4	378	40	Matched	Metastasis	Uterus	Peritoneum	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545G)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR2 p.S252W);GSK2636771,AZD8186(PTEN p.K62*)				LEVEL_3B	BCOR p.N1459S;KMT2A p.P773Rfs*8;FGFR2 p.S252W;NBN p.R466Gfs*18;NFE2L2 p.E82D;PIK3CA p.E545G;ZFHX3 p.E763Sfs*61;ARID1A p.M1564Hfs*8;MRE11 p.N511Ifs*13;CTCF p.T204Qfs*18;ACVR1 p.R206H;SETD2 p.E282Kfs*19;PTEN p.K62*;CCND1 p.L283_D294del;KMT2D p.V1153Cfs*31;ARID1A p.A360Efs*37;MITF p.N376Tfs*43	3	17
P-0012153	P-0012153-T01-IM5	Outside	FFPE	Biopsy	250	897	60	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K;TP53 p.W146*;DDR2 Amplification;FGFR2 Amplification;NAP1L2 ATRX-NAP1L2 fusion;ATRX ATRX-NAP1L2 fusion	2	6
P-0012154	P-0012154-T01-IM5	Outside	FFPE	Biopsy	250	849	10	Matched	Primary	Oropharynx	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma											0	0
P-0012155	P-0012155-T01-IM5	Outside	FFPE	Biopsy	250	1536	60	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	TP53 p.E286K;AURKA Amplification;BCL2L1 Amplification;CDKN2A Deletion;CDKN2B Deletion;DNMT3B Amplification;KDM5A Amplification;MYCN Amplification	1	8
P-0012156	P-0012156-T01-IM5	Outside	FFPE	Resection	250	654	70	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.R130*);Trametinib,Cobimetinib(NF1 p.P1990Hfs*22)				LEVEL_4	PTEN p.R130*;RB1 p.X405_splice;ATRX p.R840Efs*29;ASXL2 p.V779Sfs*25;TP53 p.X25_splice;NF1 p.P1990Hfs*22	2	6
P-0012157	P-0012157-T01-IM5	In-House	FFPE	Biopsy	250	763	50	Matched	Primary	Tongue	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545Q);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 p.R248C)					LEVEL_3B	PIK3CA p.E545Q;RB1 p.Q736*;FGFR3 p.R248C;FBXW7 p.R505G;RB1 p.S807*;PIK3CD p.E525Q;ATR p.W2450*;BCL2L1 Amplification;DNMT3B Amplification	2	9
P-0012158	P-0012158-T01-IM5	Outside	FFPE	Biopsy	250	731	50	Matched	Metastasis	Lung	Adrenal Gland	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;HIST1H3B p.E106K;ARID1A p.Q1430*	1	3
P-0012159	P-0012159-T01-IM5	Outside	FFPE	Biopsy	136.2	291	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	CDK4 Amplification;MDM2 Amplification	2	2
P-0012160	P-0012160-T01-IM5	In-House	FFPE	Biopsy	250	875	60	Matched	Metastasis	Lung	Brain	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.E746_A750del;AKT1 Amplification;CCNE1 Amplification;CDK4 Amplification;CDKN2A Deletion;CDKN2B Deletion;KRAS Amplification;MDM2 Amplification;PTPRD Deletion;TERT Amplification	4	10
P-0012161	P-0012161-T01-IM5	In-House	FFPE	Resection	250	669	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										TP53 p.I162S;ARID2 p.K522*	0	2
P-0012173	P-0012173-T01-IM5	In-House	FFPE	Biopsy	250	835	50	Matched	Metastasis	Ovary	Bowel	Tumor	LGSOC	Ovarian Cancer	Low-Grade Serous Ovarian Cancer										NF2 p.X149_splice	0	1
P-0012175	P-0012175-T01-IM5	Outside	FFPE	Biopsy	250	837	40	Matched	Primary	Sinus	Not Applicable	Tumor	SNA	Head and Neck Cancer	Sinonasal Adenocarcinoma										ARID1A p.E193*;DDR2 Amplification;NTRK1 Amplification	0	3
P-0012176	P-0012176-T01-IM5	Outside	FFPE	Biopsy	250	778	40	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma					Trametinib,Cobimetinib(GOSR1 NF1-GOSR1 fusion);Trametinib,Cobimetinib(NF1 NF1-GOSR1 fusion)				LEVEL_4	TP53 p.D208V;RUNX1 p.A39Cfs*72;GOSR1 NF1-GOSR1 fusion;NF1 NF1-GOSR1 fusion	2	4
P-0012177	P-0012177-T01-IM5	Outside	FFPE	Resection	250	736	30	Unmatched	Primary	Retroperitoneum	Not Applicable	Tumor	LIPO	Soft Tissue Sarcoma	Liposarcoma			Milademetan Tosylate,RO5045337(MDM2 Amplification)	Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_3A	AKT1 Amplification;CDK4 Amplification;GLI1 Amplification;MDM2 Amplification;ABCD2 MLL2-ABCD2 fusion;KMT2D MLL2-ABCD2 fusion	2	6
P-0012178	P-0012178-T01-IM5	Outside	FFPE	Resection	250	920	50	Matched	Metastasis	Small Bowel	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V654A)						Imatinib(KIT p.V654A)		LEVEL_1	KIT p.V654A	1	1
P-0012179	P-0012179-T01-IM5	In-House	FFPE	Resection	250	794	50	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Ado-Trastuzumab Emtansine,Neratinib(ERBB2 p.V842I)	GSK2636771,AZD8186(PTEN p.K267Rfs*9);GSK2636771,AZD8186(PTEN p.R130*)				LEVEL_3B	KMT2D p.V3089Wfs*30;PTEN p.K267Rfs*9;PTEN p.R130*;RNF43 p.G659Vfs*41;HNF1A p.P291Qfs*51;B2M p.L15Ffs*41;ERBB2 p.V842I;NBN p.R466Gfs*18;PTPRS p.P622Lfs*16;TP53 p.R283C;AXIN2 p.N666Qfs*41;PAX5 p.A322Rfs*19;SETD2 p.R1625C;FLCN p.H429Tfs*39;CIC p.P1248Hfs*54;BLM p.N515Mfs*16;MSH2 p.R680*;CIC p.G580Vfs*148;CBFB p.F18Lfs*4;APC p.Q1904*;NBN p.Q216*;ARID5B p.E454Kfs*24;MSH2 p.G247Afs*7;SPEN p.W1467Lfs*14;MAP2K4 MAP2K4-intragenic	3	25
P-0012180	P-0012180-T01-IM5	In-House	FFPE	Resection	250	681	10	Matched	Metastasis	Thyroid	Lymph Node	Tumor	THAP	Thyroid Cancer	Anaplastic Thyroid Cancer	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.R280T;AKT2 p.E17K	2	3
P-0012182	P-0012182-T01-IM5	In-House	FFPE	Biopsy	250	675	50	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										AXIN1 p.E291*;CTNNB1 p.D32_I35delinsV;EPHA7 Deletion	0	3
P-0012183	P-0012183-T01-IM5	In-House	FFPE	Biopsy	250	768	80	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Tazemetostat(KDM6A p.X1392_splice);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.E545K;FGFR3 p.S249C;DAXX p.Q565*;KDM6A p.X1392_splice;STAG2 p.L473Ffs*20;CDKN2A Deletion;CDKN2B Deletion;TGFBR1 Deletion	5	8
P-0012184	P-0012184-T01-IM5	Outside	FFPE	Resection	250	628	70	Matched	Metastasis	Prostate	Bladder	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										APC Deletion;AR Amplification;EPHA7 Deletion;FOXO1 Deletion;RB1 Deletion	0	5
P-0012186	P-0012186-T01-IM5	In-House	FFPE	Biopsy	250	674	40	Matched	Metastasis	Breast	Soft Tissue	Tumor	BRCNOS	Breast Cancer	Breast Invasive Carcinoma, NOS	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_1	PIK3CA p.E545K;TP53 p.V157F;RUNX1 p.L192Gfs*20;FGFR1 Amplification;MYC Amplification	3	5
P-0012187	P-0012187-T01-IM5	Outside	FFPE	Resection	250	823	20	Matched	Metastasis	Appendix	Bladder	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;GNAS p.R201C;SMAD4 p.R361H;SMAD4 p.G510*	1	4
P-0012188	P-0012188-T01-IM5	Outside	FFPE	Resection	250	787	60	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				BLU-667,Selpercatinib(RET p.M848I)					LEVEL_3B	TP53 p.R249S;FUBP1 p.X158_splice;SETD2 p.E978*;RET p.M848I	1	4
P-0012189	P-0012189-T01-IM5	In-House	FFPE	Cytology	250	989	40	Matched	Metastasis	Oropharynx	Neck	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.S7Efs*8)				LEVEL_4	TP53 p.R342*;TP53 p.E286K;MSH6 p.G54Wfs*21;FAT1 p.C3738Rfs*12;CDKN2A p.S7Efs*8;ARID1B Deletion;CCND1 Amplification;FGF19 Amplification;FOXA1 Amplification;FUBP1 Deletion;MYC Amplification;PHOX2B Deletion;PIK3CA Amplification;TGFBR2 Deletion	1	14
P-0012190	P-0012190-T01-IM5	In-House	FFPE	Resection	250	529	30	Matched	Primary	Kidney	Not Applicable	Tumor	PRCC	Renal Cell Carcinoma	Papillary Renal Cell Carcinoma											0	0
P-0012191	P-0012191-T01-IM5	In-House	FFPE	Biopsy	139.7	398	10	Matched	Primary	Bone	Not Applicable	Tumor	MYCHS	Bone Cancer	Myxoid Chondrosarcoma				Ivosidenib(IDH1 p.R132C)					LEVEL_3B	IDH1 p.R132C;TP53 p.D281E	1	2
P-0012193	P-0012193-T01-IM5	Outside	FFPE	Biopsy	250	748	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	CLLSLL	Mature B-Cell Neoplasms	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma										KRAS p.A146V;ATM p.G733Cfs*4	0	2
P-0012194	P-0012194-T01-IM5	Outside	FFPE	Resection	250	764	30	Matched	Primary	Skin	Not Applicable	Tumor	SKCM	Melanoma	Cutaneous Melanoma				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_3B	RAC1 p.P29L;RAF1 p.R391W;B2M p.L7*;CDK4 Amplification;MDM2 Amplification;RAF1 Amplification	2	6
P-0012195	P-0012195-T01-IM5	In-House	FFPE	Resection	250	689	40	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0012196	P-0012196-T01-IM5	Outside	FFPE	Biopsy	127	415	20	Matched	Metastasis	Lung	Bone	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma			Poziotinib(EGFR p.D770delinsGTH)			Erlotinib,Gefitinib,Afatinib(EGFR p.D770delinsGTH)			LEVEL_3A	EGFR p.D770delinsGTH	1	1
P-0012197	P-0012197-T01-IM5	Outside	FFPE	Cytology	250	272	60	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)	GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	TP53 p.G245D;AR Amplification;FGFR1 Amplification;PTEN Deletion;PTPRD Deletion	2	5
P-0012198	P-0012198-T01-IM5	In-House	FFPE	Biopsy	250	945	50	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma										SMAD3 p.N276S;AXIN1 p.Q678*;AXIN1 p.E288*	0	3
P-0012198	P-0012198-T02-IM5	In-House	FFPE	Biopsy	250	706	50	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Everolimus(TSC2 p.S1418*)					LEVEL_3B	TSC2 p.S1418*;AXIN1 p.L592Pfs*113	1	2
P-0012199	P-0012199-T01-IM5	In-House	FFPE	Biopsy	250	1121	50	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Capecitabine+Trastuzumab+Tucatinib,Pertuzumab+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Ado-Trastuzumab Emtansine,Lapatinib,Trastuzumab+Lapatinib,Neratinib(ERBB2 Amplification)			Carboplatin-Taxol Regimen+Trastuzumab(ERBB2 Amplification)					LEVEL_1	TP53 p.I254S;ERBB2 Amplification;KMT2C MLL3-intragenic	2	3
P-0012200	P-0012200-T01-IM5	In-House	FFPE	Biopsy	250	943	20	Matched	Metastasis	Cancer of Unknown Primary	Bone	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0012201	P-0012201-T01-IM5	Outside	FFPE	Biopsy	250	763	90	Unmatched	Primary	Small Bowel	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										CREBBP p.S1680del;BRAF p.G464V;MYD88 p.L265P;ETV6 p.X11_splice;PIM1 p.P81S;ARID2 p.G735Efs*23;CDKN2A Deletion;CDKN2B Deletion;PAX5 Amplification	0	9
P-0012202	P-0012202-T01-IM5	In-House	FFPE	Resection	250	716	20	Matched	Primary	Skin	Not Applicable	Tumor	CSCC	Skin Cancer, Non-Melanoma	Cutaneous Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_4	TP53 p.M133R;NOTCH1 p.X736_splice;PTPRT p.X190_splice;NF2 p.Q212*;ASXL1 p.E558Kfs*145;NOTCH2 p.P1469Hfs*84;CDKN2A p.P114L	1	7
P-0012205	P-0012205-T01-IM5	In-House	FFPE	Biopsy	250	933	50	Matched	Metastasis	Upper Tract	Lung	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma			Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR3 p.S371C)	Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Tazemetostat(KDM6A p.S295*);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3A	PIK3CA p.H1047R;FGFR3 p.S371C;TP53 p.V173M;TP53 p.D281Y;CDKN1A p.C117Lfs*12;ARID1A p.E1783*;CREBBP p.K1051*;KDM6A p.S295*;CDKN2A Deletion;CDKN2B Deletion	4	10
P-0012206	P-0012206-T01-IM5	In-House	FFPE	Biopsy	250	995	20	Matched	Primary	Lung	Not available	Tumor	NSCLCPD	Non-Small Cell Lung Cancer	Poorly Differentiated Non-Small Cell Lung Cancer				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	TP53 p.Q331*;KDM5C p.X1100_splice;FGFR1 Amplification;MYC Amplification	1	4
P-0012207	P-0012207-T01-IM5	In-House	FFPE	Resection	250	672	30	Matched	Primary	Upper Tract	Not Applicable	Tumor	UTUC	Bladder Cancer	Upper Tract Urothelial Carcinoma	Erdafitinib(FGFR3 p.S249C)		Debio1347,BGJ398,AZD4547(FGFR3 p.S249C)	Everolimus(TSC1 p.Q654*)					LEVEL_1	FGFR3 p.S249C;CDKN1A p.E108Gfs*21;CDKN1A p.K75Qfs*14;TSC1 p.Q654*;NCOR1 p.R627*	3	5
P-0012208	P-0012208-T01-IM5	Outside	FFPE	Resection	250	721	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V	1	1
P-0012209	P-0012209-T01-IM5	In-House	FFPE	Biopsy	250	431	80	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;PIK3R1 p.G376R;CIC p.R202W;CIC p.L926Gfs*4	1	4
P-0012210	P-0012210-T01-IM5	In-House	FFPE	Resection	250	500	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0012213	P-0012213-T01-IM5	Outside	FFPE	Resection	250	209	10	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma											0	0
P-0012214	P-0012214-T01-IM5	Outside	FFPE	Biopsy	108	176	50	Matched	Metastasis	Breast	Lung	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma										TP53 p.H193Y;STAG2 p.S941*;LATS1 p.A758Vfs*8;RUNX1 p.T104Nfs*7	0	4
P-0012215	P-0012215-T01-IM5	In-House	FFPE	Resection	250	424	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;SMAD4 p.T349Nfs*3	1	2
P-0012221	P-0012221-T01-IM5	Outside	FFPE	Resection	250	375	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										PBRM1 p.R434*;BAP1 p.S489Qfs*3;BAP1 p.S697Pfs*39;VHL p.V87Yfs*72	0	4
P-0012222	P-0012222-T01-IM5	Outside	FFPE	Biopsy	170.9	243	70	Matched	Metastasis	Breast	Skin	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.N345K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.N345K)						LEVEL_1	PIK3CA p.N345K;CCND1 Amplification;FGF19 Amplification;PAK1 Amplification	2	4
P-0012224	P-0012224-T01-IM5	In-House	FFPE	Resection	250	604	20	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.R273C	1	2
P-0012225	P-0012225-T01-IM5	In-House	FFPE	Resection	250	823	50	Matched	Primary	Soft Tissue	Not Applicable	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;TP53 p.R110P;B2M Deletion;BLM Deletion;MGA Deletion;RAD51 Deletion;SMAD3 Deletion	1	7
P-0012226	P-0012226-T01-IM5	Outside	FFPE	Resection	250	305	50	Matched	Primary	Kidney	Not Applicable	Tumor	URCC	Renal Cell Carcinoma	Unclassified Renal Cell Carcinoma											0	0
P-0012227	P-0012227-T01-IM5	In-House	FFPE	Biopsy	250	659	80	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;ARID1A p.W1844*;ARID1A p.I1943Lfs*13;ARID1A p.V1814Afs*43	1	4
P-0012228	P-0012228-T01-IM5	Outside	FFPE	Resection	250	1017	50	Matched	Primary	Rectum	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.V654A);Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.M552_W557del)			Everolimus(TSC1 p.P231Tfs*11)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)		Imatinib(KIT p.V654A)		LEVEL_1	KIT p.V654A;TSC1 p.P231Tfs*11;KIT p.M552_W557del;KMT2C p.F2313Wfs*8;CDKN2A Deletion;CDKN2B Deletion	4	6
P-0012230	P-0012230-T01-IM5	Outside	FFPE	Biopsy	250	863	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN p.F341V)				LEVEL_4	XPO1 p.E571K;PTEN p.F341V;POLE p.P286R;ASXL2 p.R357*;DIS3 p.R382Q;PBRM1 p.R1185*;ASXL2 p.R302*;SETD2 p.E581*;FLT3 p.A629T;ZFHX3 p.E1884*;PTPRT p.X521_splice	1	11
P-0012231	P-0012231-T01-IM5	In-House	FFPE	Resection	250	671	40	Matched	Primary	Pancreas	Not Applicable	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor										VHL p.F136Lfs*20	0	1
P-0012233	P-0012233-T01-IM5	In-House	FFPE	Biopsy	250	917	30	Matched	Primary	Rectosigmoid Colon	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61K)		Cetuximab,Panitumumab(NRAS p.Q61K)			LEVEL_3B	TP53 p.R248Q;NRAS p.Q61K;APC p.Q1328*	1	3
P-0012239	P-0012239-T01-IM5	Outside	FFPE	Biopsy	250	922	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Capmatinib(MET p.D1010N)	Crizotinib(MET p.D1010N)	Cabozantinib(MET p.D1010N)		Trametinib,Cobimetinib(NF1 p.G1090Rfs*16)				LEVEL_1	TP53 p.Y234C;MET p.D1010N;ARID1B p.Q819*;NF1 p.G1090Rfs*16	4	4
P-0012241	P-0012241-T01-IM5	In-House	FFPE	Biopsy	250	1039	20	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.V95Afs*22)				LEVEL_4	RPS6KA4 p.R629H;TP53 p.E336*;NFE2L2 p.S33_R34del;CDKN2A p.V95Afs*22;AKT2 Amplification;BCL6 Amplification;CCND1 Amplification;CCNE1 Amplification;FGF19 Amplification;PIK3CA Amplification;PAX5 PAX5-intragenic	1	11
P-0012241	P-0012241-T02-IM5	In-House	FFPE	Cytology	191.5	628	50	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K2392*)					LEVEL_3B	BRCA2 p.K2392*;RB1 p.K329*;TP53 p.X33_splice;BCL6 Amplification;PIK3CA Amplification	1	5
P-0012242	P-0012242-T01-IM5	In-House	FFPE	Resection	250	782	30	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma					GSK2636771,AZD8186(PTEN p.X55_splice)				LEVEL_4	PTEN p.X55_splice	1	1
P-0012243	P-0012243-T01-IM5	In-House	FFPE	Biopsy	250	825	10	Matched	Metastasis	Breast	Bone	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	MAP3K1 p.Q1020*;CDH1 p.V17Gfs*17;CCND1 Amplification;FGF19 Amplification;FGFR1 Amplification	1	5
P-0012244	P-0012244-T01-IM5	Outside	FFPE	Biopsy	250	856	50	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)	GSK2636771,AZD8186(PTEN p.E235Kfs*21)				LEVEL_3B	PTEN p.E235Kfs*21;CDK4 Amplification;ERRFI1 Deletion;GLI1 Amplification;MDM2 Amplification;KMT2D RGMB-MLL2 fusion;RGMB RGMB-MLL2 fusion	3	7
P-0012245	P-0012245-T01-IM5	Outside	FFPE	Biopsy	250	720	90	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										ARID1A p.W2049*;MYC p.T73A;EP300 p.X793_splice;TNFRSF14 p.W203Ffs*29	0	4
P-0012246	P-0012246-T01-IM5	In-House	FFPE	Biopsy	250	1052	40	Matched	Metastasis	Pancreas	Liver	Tumor	PANET	Pancreatic Cancer	Pancreatic Neuroendocrine Tumor				Everolimus(TSC1 p.S282*);Olaparib(CDKL5 ATM-CDKL5 fusion);Olaparib(ATM ATM-CDKL5 fusion)					LEVEL_3B	TP53 p.E258K;TSC1 p.S282*;ARID1A p.S334*;CDKL5 ATM-CDKL5 fusion;ATM ATM-CDKL5 fusion	3	5
P-0012247	P-0012247-T01-IM5	Outside	FFPE	Biopsy	250	153	20	Matched	Primary	Maxilla	Not Applicable	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	TP53 p.X332_splice;TP53 p.R213Q;CASP8 p.Q465*;PTPRT p.R1040W;CDKN2A p.R80*;CD274 Amplification;EGFR Amplification;JAK2 Amplification	1	8
P-0012248	P-0012248-T01-IM5	Outside	FFPE	Biopsy	195.3	481	80	Matched	Primary	Stomach	Not Applicable	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.K558delinsNP)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	KIT p.K558delinsNP;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0012249	P-0012249-T01-IM5	Outside	FFPE	Biopsy	250	868	20	Matched	Metastasis	Ascending Colon	Kidney	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.T3033Lfs*29);Olaparib(ATM p.Q2896*);Olaparib(CDK12 p.Q1291Pfs*19)	Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.Q1291Pfs*19)				LEVEL_3B	RNF43 p.G659Vfs*41;ARID1A p.Q766Sfs*67;BRCA2 p.T3033Lfs*29;PTPRT p.R453H;TP63 p.R379H;ATM p.Q2896*;CDK12 p.Q1291Pfs*19;FAT1 p.F3697Lfs*2;MAP2K4 p.V24*	4	9
P-0012250	P-0012250-T01-IM5	Outside	FFPE	Resection	250	839	60	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					GSK2636771,AZD8186(PTEN p.Q17Rfs*26);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	PTEN p.Q17Rfs*26;CDKN2A Deletion;CDKN2B Deletion;PDGFRA Amplification	2	4
P-0012251	P-0012251-T01-IM5	In-House	FFPE	Biopsy	250	1112	20	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.E746_A750del;TP53 p.Y163C;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification	2	5
P-0012252	P-0012252-T01-IM5	In-House	FFPE	Biopsy	250	994	20	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.R80*)				LEVEL_4	KRAS p.G12D;TP53 p.R175H;CDKN2A p.R80*	2	3
P-0012253	P-0012253-T01-IM5	In-House	FFPE	Resection	250	732	10	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.F76del;PBRM1 p.E583D;KDM6A p.G526V;ARID1B ARID1B-intragenic	0	4
P-0012254	P-0012254-T01-IM5	In-House	FFPE	Biopsy	250	943	50	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K);Capecitabine+Trastuzumab+Tucatinib,Carboplatin-Taxol Regimen+Trastuzumab,Lapatinib+Trastuzumab,Trastuzumab,Trastuzumab Deruxtecan,Trastuzumab+Pertuzumab,Ado-Trastuzumab Emtansine,Lapatinib(ERBB2 Amplification)					LEVEL_3B	TP53 p.R273H;PIK3CA p.E542K;TP53 p.E285K;FBXW7 p.G437V;CCNE1 Amplification;ERBB2 Amplification;FGFR3 Amplification	2	7
P-0012255	P-0012255-T01-IM5	Outside	FFPE	Biopsy	250	701	90	Matched	Metastasis	Nasopharynx	Lung	Tumor	SNA	Head and Neck Cancer	Sinonasal Adenocarcinoma				Olaparib(CHEK1 Deletion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	NOTCH1 p.I1680N;ATRX p.Q2368*;CBL Deletion;CDKN2A Deletion;CDKN2B Deletion;CHEK1 Deletion;HRAS Amplification;KMT2A Deletion;PIK3R3 Deletion;RUNX1 Amplification;SDHD Deletion;TNFRSF14 Deletion	2	12
P-0012256	P-0012256-T01-IM5	In-House	FFPE	Biopsy	250	839	30	Matched	Metastasis	Kidney	Rib	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma					GSK2636771,AZD8186(PTEN p.D24V)				LEVEL_4	SETD2 p.E978*;PBRM1 p.R324*;PTEN p.D24V;NBN p.A713Gfs*29;VHL p.E55Afs*72	1	5
P-0012257	P-0012257-T01-IM5	Outside	FFPE	Resection	250	659	60	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer										PTPRT p.E438*;NOTCH1 p.X419_splice;CCNE1 Amplification;FGFR3 Amplification	0	4
P-0012258	P-0012258-T01-IM5	In-House	FFPE	Biopsy	250	566	50	Matched	Metastasis	Prostate	Lymph Node	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(CDK12 p.H664_L665ins*);Olaparib(CDK12 p.T611Sfs*29)				Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.H664_L665ins*);Pembrolizumab,Nivolumab,Cemiplimab(CDK12 p.T611Sfs*29)				LEVEL_1	CDK12 p.H664_L665ins*;CDK12 p.T611Sfs*29;CCND1 Amplification;FGF19 Amplification;MDM4 Amplification	4	5
P-0012259	P-0012259-T01-IM5	Outside	FFPE	Resection	250	627	80	Matched	Primary	Brain	Not Applicable	Tumor	AODG	Glioma	Anaplastic Oligodendroglioma				Ivosidenib(IDH1 p.R132H);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Everolimus,Temsirolimus(MTOR p.V2006F)				LEVEL_3B	IDH1 p.R132H;PIK3CA p.R88Q;SMARCA4 p.M781I;MTOR p.V2006F;NOTCH1 p.D338del;FUBP1 p.P494Rfs*30;CIC p.L981Efs*169;NOTCH1 p.M2093Gfs*174;NOTCH1 p.C359del;CIC p.G563Sfs*126	3	10
P-0012260	P-0012260-T01-IM5	In-House	FFPE	Biopsy	250	888	50	Matched	Metastasis	Breast	Bone	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)	Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	PIK3CA p.H1047R;RAC1 p.P29T;CDK4 Amplification;MDM2 Amplification;RB1 RB1-intragenic	4	5
P-0012261	P-0012261-T01-IM5	In-House	FFPE	Biopsy	250	996	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				Milademetan Tosylate,RO5045337(MDM2 Amplification)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_3B	KRAS p.G12D;TGFBR2 p.E480*;STK11 p.F148Sfs*13;MDM2 Amplification;MYC Amplification	2	5
P-0012262	P-0012262-T01-IM5	Outside	FFPE	Biopsy	250	591	50	Matched	Metastasis	Major Salivary Gland	Lung	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma				Sonidegib,Vismodegib(PTCH1 p.W197*)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.P114L)				LEVEL_3B	TP53 p.Q317*;EPHA3 p.R684*;PPP6C p.S270L;TP53 p.G266R;ERBB3 p.P262L;ASXL1 p.R417*;PTCH1 p.W197*;CDKN2A p.P114L	2	8
P-0012263	P-0012263-T01-IM5	Outside	FFPE	Biopsy	250	824	50	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary											0	0
P-0012264	P-0012264-T01-IM5	In-House	FFPE	Resection	250	553	50	Matched	Metastasis	Bone	Lung	Tumor	OS	Bone Cancer	Osteosarcoma											0	0
P-0012265	P-0012265-T01-IM5	Outside	FFPE	Resection	250	624	20	Matched	Metastasis	Cancer of Unknown Primary	Chest wall	Tumor	MBN	Mature B-Cell Neoplasms	Mature B-Cell Neoplasms										MYD88 p.L265P;CXCR4 p.S338Lfs*27	0	2
P-0012266	P-0012266-T01-IM5	In-House	FFPE	Resection	250	759	10	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)	Cetuximab,Panitumumab(KRAS p.G13D)			LEVEL_4	TP53 p.Y126C;APC p.R232*;KRAS p.G13D	1	3
P-0012268	P-0012268-T01-IM5	In-House	FFPE	Resection	250	877	20	Matched	Metastasis	Descending Colon	Lung	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				AMG-510(KRAS p.G12C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Olaparib(ATM p.R337C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);GSK2636771,AZD8186(PTEN p.R15G)	Cetuximab,Panitumumab(KRAS p.G12C)			LEVEL_3B	KRAS p.G12C;APC p.L954*;PIK3CA p.R88Q;ATM p.R337C;EP300 p.Q824*;PTEN p.R15G;APC p.E1306Kfs*9	5	7
P-0012269	P-0012269-T01-IM5	Outside	FFPE	Resection	250	729	10	Matched	Primary	Appendix	Not Applicable	Tumor	MAAP	Appendiceal Cancer	Mucinous Adenocarcinoma of the Appendix					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;GNAS p.R201H;PPP6C p.X26_splice	1	3
P-0012270	P-0012270-T01-IM5	In-House	FFPE	Resection	250	562	50	Matched	Metastasis	Thyroid	Bone	Tumor	THPA	Thyroid Cancer	Papillary Thyroid Cancer				Dabrafenib,Dabrafenib+Trametinib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_3B	BRAF p.V600E	1	1
P-0012271	P-0012271-T01-IM5	Outside	FFPE	Biopsy	250	726	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0012272	P-0012272-T01-IM5	In-House	FFPE	Biopsy	112.9	321	60	Matched	Metastasis	Pancreas	Liver	Tumor	PAASC	Pancreatic Cancer	Adenosquamous Carcinoma of the Pancreas				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C)				LEVEL_3B	TP53 p.W91*;KRAS p.G12C;KMT2D p.W339*;MAP2K2 p.P128L;TGFBR2 p.P472Afs*44;AURKA Amplification;BCL2L1 Amplification;CCND2 Amplification;DNMT3B Amplification;KDM5A Amplification;KRAS Amplification;RICTOR Amplification;SRC Amplification;TERT Amplification	2	14
P-0012273	P-0012273-T01-IM5	In-House	FFPE	Biopsy	250	755	30	Matched	Metastasis	Lung	Lymph Node	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Crizotinib,Entrectinib(ROS1 SLC6A17-ROS1 fusion);Crizotinib,Entrectinib(SLC6A17 SLC6A17-ROS1 fusion)			Palbociclib,Abemaciclib(CDK4 Amplification)	Trametinib,Cobimetinib(NF1 p.E1121*)				LEVEL_1	TP53 p.G245D;NF1 p.E1121*;SMAD4 p.S32Ffs*11;NOTCH4 p.G242Afs*10;CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;KDR Amplification;KIT Amplification;NKX2-1 Amplification;ANKRD11 SLC46A3-ANKRD11 fusion;SLC46A3 SLC46A3-ANKRD11 fusion;ROS1 SLC6A17-ROS1 fusion;SLC6A17 SLC6A17-ROS1 fusion	4	14
P-0012274	P-0012274-T01-IM5	In-House	FFPE	Biopsy	250	557	40	Matched	Metastasis	Kidney	Epidural	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.R273C;VHL p.Y175*;SETD2 p.E2542*;PBRM1 p.K516Rfs*3	0	4
P-0012275	P-0012275-T01-IM5	In-House	FFPE	Biopsy	240.8	512	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma											0	0
P-0012276	P-0012276-T01-IM5	Outside	FFPE	Resection	250	561	30	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma											0	0
P-0012277	P-0012277-T01-IM5	Outside	FFPE	Biopsy	250	560	30	Matched	Primary	Rectum	Not Applicable	Tumor	READ	Colorectal Cancer	Rectal Adenocarcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12C)		Cetuximab,Panitumumab(NRAS p.G12C)			LEVEL_3B	FBXW7 p.R505C;TP53 p.R175H;NRAS p.G12C;SOX9 p.S228*;APC p.S794Kfs*5	1	5
P-0012279	P-0012279-T01-IM5	In-House	FFPE	Cytology	176.9	503	40	Matched	Metastasis	Kidney	Lung	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										TP53 p.S241C;VHL p.Y98*;SETD2 p.K2525*;KDM5C p.E1152Rfs*112;PBRM1 p.C138Nfs*35	0	5
P-0012280	P-0012280-T01-IM5	In-House	FFPE	Biopsy	250	1134	90	Matched	Primary	Lung	Not Applicable	Tumor	SCLC	Small Cell Lung Cancer	Small Cell Lung Cancer					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.V157F;TP53 p.P152S;RB1 p.X474_splice;AKT2 Amplification;AXL Amplification;BCL2L1 Amplification;DNMT3B Amplification;PTEN Deletion	1	8
P-0012282	P-0012282-T01-IM5	Outside	FFPE	Biopsy	250	1057	60	Matched	Primary	Esophagus	Not Applicable	Tumor	ESMM	Melanoma	Mucosal Melanoma of the Esophagus				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047L);Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)					LEVEL_3B	PIK3CA p.H1047L;BRAF p.V600K	2	2
P-0012282	P-0012282-T02-IM5	Outside	FFPE	Biopsy	250	597	70	Matched	Metastasis	Esophagus	Liver	Tumor	ESMM	Melanoma	Mucosal Melanoma of the Esophagus				Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600K)					LEVEL_3B	BRAF p.V600K;GALNT11 MLL3-GALNT11 fusion;KMT2C MLL3-GALNT11 fusion	1	3
P-0012283	P-0012283-T01-IM5	In-House	FFPE	Resection	250	1242	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D;TP53 p.Y126*	1	2
P-0012284	P-0012284-T01-IM5	In-House	FFPE	Biopsy	250	978	70	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.F133L	0	1
P-0012285	P-0012285-T01-IM5	Outside	FFPE	Resection	250	500	50	Matched	Primary	Thymus	Not Applicable	Tumor	THYM	Thymic Tumor	Thymoma										CREBBP p.E594Dfs*11;CRIM1 ERCC3-CRIM1 fusion;ERCC3 ERCC3-CRIM1 fusion	0	3
P-0012287	P-0012287-T01-IM5	In-House	FFPE	Cytology	225.9	692	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G13C);Trametinib,Cobimetinib(NF1 p.W267*)				LEVEL_4	KRAS p.G13C;SPEN p.R1371*;NF1 p.W267*;TP53 p.R175Pfs*72	2	4
P-0012288	P-0012288-T01-IM5	In-House	FFPE	Biopsy	250	1068	70	Matched	Metastasis	Breast	Bone	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma			AZD5363(AKT1 p.E17K)						LEVEL_3A	AKT1 p.E17K;GRK5 NSD1-GRK5 fusion;NSD1 NSD1-GRK5 fusion	1	3
P-0012289	P-0012289-T01-IM5	In-House	FFPE	Biopsy	250	941	30	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.Q61L)				LEVEL_4	KRAS p.Q61L	1	1
P-0012290	P-0012290-T01-IM5	In-House	FFPE	Resection	250	1015	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma				Debio1347,BGJ398,Erdafitinib,AZD4547(FGFR1 Amplification)					LEVEL_3B	FGFR1 Amplification	1	1
P-0012302	P-0012302-T01-IM5	Outside	FFPE	Resection	250	789	30	Matched	Primary	Pancreas	Not Applicable	Tumor	AMPCA	Ampullary Cancer	Ampullary Carcinoma											0	0
P-0012303	P-0012303-T01-IM5	In-House	FFPE	Biopsy	250	921	90	Matched	Primary	Brain	Not Applicable	Tumor	AASTR	Glioma	Anaplastic Astrocytoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification)				LEVEL_4	BLM p.E598Dfs*19;CDKN2A Deletion;CDKN2B Deletion;DIS3 Deletion;EGFR Amplification;EP300 Deletion;GATA3 Deletion;MYC Amplification;RB1 Deletion;TNFRSF14 Deletion	2	10
P-0012304	P-0012304-T01-IM5	Outside	FFPE	Biopsy	250	895	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.F266L	0	1
P-0012305	P-0012305-T01-IM5	In-House	FFPE	Resection	250	869	30	Matched	Primary	Uterus	Not Applicable	Tumor	UMEC	Endometrial Cancer	Uterine Mixed Endometrial Carcinoma										TP53 p.C141W;PPP2R1A p.R182W;PIK3R1 p.R574del	0	3
P-0012306	P-0012306-T01-IM5	In-House	FFPE	Biopsy	171.215	750	30	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2A CDKN2BAS-CDKN2A fusion);Palbociclib,Ribociclib,Abemaciclib(CDKN2B-AS1 CDKN2BAS-CDKN2A fusion)				LEVEL_1	EGFR p.E746_A750del;TP53 p.G245S;CTNNB1 p.G34R;CCND3 Amplification;VEGFA Amplification;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion;CDKN2A CDKN2BAS-CDKN2A fusion;CDKN2B-AS1 CDKN2BAS-CDKN2A fusion	5	9
P-0012307	P-0012307-T01-IM5	In-House	FFPE	Resection	250	886	30	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)		Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	PIK3CA p.E545K;GATA3 p.A441Rfs*66;TET2 p.G1288V;CDKN2A Deletion;CDKN2B Deletion;KMT2C MLL3-intragenic	3	6
P-0012308	P-0012308-T01-IM5	In-House	FFPE	Resection	250	871	10	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma										BRAF p.N581S;STK11 p.X307_splice;PTPRD p.H1843Ifs*13	0	3
P-0012310	P-0012310-T01-IM5	In-House	FFPE	Cytology	146.8	706	50	Matched	Metastasis	Ovary	Ascites	Tumor	MOV	Ovarian Cancer	Mucinous Ovarian Cancer					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12S);Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.H83Y)				LEVEL_4	KRAS p.G12S;TP53 p.X261_splice;STK11 p.X307_splice;KEAP1 p.L56Wfs*12;CDKN2A p.H83Y	2	5
P-0012311	P-0012311-T01-IM5	Outside	FFPE	Biopsy	250	1037	60	Matched	Primary	Nasopharynx	Not Applicable	Tumor	HNMUCM	Melanoma	Head and Neck Mucosal Melanoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.G12C)	Trametinib,Cobimetinib(NF1 p.V1753Ffs*12)				LEVEL_3B	NRAS p.G12C;NF1 p.V1753Ffs*12;MYC Amplification	2	3
P-0012312	P-0012312-T01-IM5	Outside	FFPE	Biopsy	250	391	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme				Poziotinib(EGFR p.A767_V769dup);Cabozantinib,Crizotinib(MET Amplification)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_3B	EGFR p.A767_V769dup;CDKN2A Deletion;CDKN2B Deletion;EGFR Amplification;MET Amplification;PMAIP1 Deletion;PTEN Deletion	5	7
P-0012313	P-0012313-T01-IM5	In-House	FFPE	Resection	250	679	30	Matched	Primary	Ascending Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma	Encorafenib+Cetuximab(BRAF p.V600E)	Encorafenib+Panitumumab(BRAF p.V600E)		Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E);Olaparib(ATM p.R184Sfs*5)					LEVEL_1	BRAF p.V600E;RNF43 p.G659Vfs*41;NOTCH3 p.P695Rfs*165;CIC p.P1116Qfs*45;TP53 p.S90Lfs*59;TP53 p.K382Nfs*40;ATRX p.L359Tfs*3;TNFAIP3 p.P457Lfs*20;RNF43 p.R113*;HLA-A p.W75*;LATS1 p.Q430*;ATM p.R184Sfs*5;NOTCH3 p.C720*;ZFHX3 p.N344Tfs*8;PTPRS p.N261Qfs*30;TCF3 p.Q634Rfs*11	4	16
P-0012314	P-0012314-T01-IM5	In-House	FFPE	Biopsy	250	941	20	Matched	Primary	Uterus	Not Applicable	Tumor	UCCC	Endometrial Cancer	Uterine Clear Cell Carcinoma										TP53 p.E339Sfs*4;CCNE1 Amplification;TET1 TET1-intragenic	0	3
P-0012315	P-0012315-T01-IM5	In-House	FFPE	Biopsy	250	964	80	Matched	Metastasis	Cancer of Unknown Primary	Brain	Tumor	MUP	Melanoma	Melanoma of Unknown Primary	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	BRAF p.V600E;KMT2A p.V2310Cfs*2;CDKN2A Deletion	3	3
P-0012316	P-0012316-T01-IM5	In-House	FFPE	Resection	250	1119	80	Matched	Primary	Chest Wall	Not Applicable	Tumor	ES	Bone Cancer	Ewing Sarcoma					TK216(EWSR1 FLI1-EWSR1 fusion);TK216(FLI1 FLI1-EWSR1 fusion)				LEVEL_4	EWSR1 FLI1-EWSR1 fusion;FLI1 FLI1-EWSR1 fusion	2	2
P-0012317	P-0012317-T01-IM5	In-House	FFPE	Biopsy	250	1055	40	Matched	Primary	Liver	Not Applicable	Tumor	HCC	Hepatobiliary Cancer	Hepatocellular Carcinoma				Everolimus(TSC2 p.X534_splice)					LEVEL_3B	AMER1 p.L489Afs*19;TP53 p.X224_splice;TSC2 p.X534_splice	1	3
P-0012318	P-0012318-T01-IM5	Outside	FFPE	Biopsy	117.9	303	40	Matched	Metastasis	Breast	Liver	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E545K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)						LEVEL_1	PIK3CA p.E545K	2	1
P-0012320	P-0012320-T01-IM5	In-House	FFPE	Resection	250	773	40	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma										TP53 p.E271Q;ATR p.Q2173*;CCNE1 Amplification	0	3
P-0012321	P-0012321-T01-IM5	Outside	FFPE	Biopsy	250	859	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H419_L422del)	GSK2636771,AZD8186(PTEN p.X55_splice)				LEVEL_3B	TP53 p.K132R;TP53 p.V216L;PIK3CA p.H419_L422del;PTEN p.X55_splice;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	2	6
P-0012322	P-0012322-T01-IM5	In-House	FFPE	Resection	250	761	40	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	2
P-0012323	P-0012323-T01-IM5	In-House	FFPE	Biopsy	250	878	70	Matched	Metastasis	Kidney	Bone	Tumor	RCC	Renal Cell Carcinoma	Renal Cell Carcinoma										NF2 p.K401*;SETD2 p.T896Nfs*20;BAP1 p.E198Gfs*45	0	3
P-0012324	P-0012324-T01-IM5	Outside	FFPE	Biopsy	250	864	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										SPOP p.Y87N	0	1
P-0012325	P-0012325-T01-IM5	In-House	FFPE	Resection	250	788	20	Matched	Primary	Bladder	Not Applicable	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Niraparib,Olaparib,Rucaparib,Talazoparib(BRCA1 p.Q544*)					LEVEL_3B	PIK3CA p.E545K;KMT2D p.E491*;KMT2D p.W141*;BRCA1 p.Q544*	2	4
P-0012326	P-0012326-T01-IM5	Outside	FFPE	Biopsy	250	615	50	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										FOXA1 p.R261G;PPP6C p.R85Wfs*10	0	2
P-0012327	P-0012327-T01-IM5	Outside	FFPE	Biopsy	250	789	30	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										TP53 p.R213Q;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	0	3
P-0012328	P-0012328-T01-IM5	Outside	FFPE	Biopsy	250	837	15	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_4	KRAS p.G12R;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	3
P-0012329	P-0012329-T01-IM5	Outside	FFPE	Biopsy	147.6	414	50	Matched	Metastasis	Pancreas	Liver	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_4	KRAS p.G12V;TP53 p.G245V;SMAD4 p.E175_G176delinsK*;CDKN2A Deletion;CDKN2B Deletion	2	5
P-0012332	P-0012332-T01-IM5	Outside	FFPE	Biopsy	250	473	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma										ZFHX3 p.K996*;KDM6A p.Y944Lfs*5	0	2
P-0012337	P-0012337-T01-IM5	Outside	FFPE	Biopsy	250	719	90	Matched	Primary	Brain	Not Applicable	Tumor	PNET	Embryonal Tumor	Primitive Neuroectodermal Tumor											0	0
P-0012338	P-0012338-T01-IM5	In-House	FFPE	Biopsy	250	305	50	Matched	Metastasis	Ovary	Rectum	Tumor	OCS	Ovarian Cancer	Ovarian Carcinosarcoma/Malignant Mixed Mesodermal Tumor										TP53 p.K164E;ANKRD11 Deletion;CCNE1 Amplification;FANCA Deletion;FGFR3 Amplification	0	5
P-0012341	P-0012341-T01-IM5	Outside	FFPE	Biopsy	250	885	30	Matched	Metastasis	Lung	Omentum	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Dabrafenib+Trametinib(BRAF p.V600E)			Dabrafenib,Encorafenib+Cetuximab,Encorafenib+Panitumumab,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)					LEVEL_1	BRAF p.V600E;TP53 p.P278T;ARID1A p.Q354*;MYC Amplification	2	4
P-0012357	P-0012357-T01-IM5	In-House	FFPE	Cytology	250	916	10	Matched	Primary	Lung	Not Applicable	Tumor	LUSC	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma					GSK2636771,AZD8186(PTEN p.T319*)				LEVEL_4	TP53 p.R248Q;PTEN p.T319*	1	2
P-0012358	P-0012358-T01-IM5	In-House	FFPE	Biopsy	196.4	453	60	Matched	Metastasis	Uterus	Vagina	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q);Olaparib(ATM p.R250*);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R115Q);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.L997I);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.E97*)	GSK2636771,AZD8186(PTEN p.R173C);GSK2636771,AZD8186(PTEN p.F341V);Trametinib,Cobimetinib(NF1 p.R2450*);Trametinib,Cobimetinib(NF1 p.R1241*);Trametinib,Cobimetinib(NF1 p.E1436K)				LEVEL_3B	PTEN p.R173C;TP53 p.R213*;B2M p.R117*;RPTOR p.R139H;APC p.E1544*;PTPRD p.S431L;ASXL2 p.R312*;BCL6 p.R594Q;PTEN p.F341V;RUNX1 p.R293*;PIK3CA p.R88Q;TP63 p.E609K;SMARCD1 p.R183Q;ATRX p.R2131*;APC p.R302*;FUBP1 p.R430C;POLE p.V411L;RB1 p.R451C;APC p.R2237*;NF1 p.R2450*;ATM p.R250*;TP53 p.E287D;MGA p.R1818*;MED12 p.R605*;XPO1 p.R749Q;KMT2C p.R56Q;TGFBR1 p.W458*;INPP4B p.E285*;NF1 p.R1241*;FAT1 p.R1627*;SETD2 p.R2109*;EPHA3 p.R580Kfs*19;NF1 p.E1436K;DNMT1 p.E51K;ARID2 p.I37Nfs*29;MSH2 p.E483*;PMS1 p.L524*;PIK3CA p.R115Q;INPP4B p.X46_splice;APC p.S1503*;RAD50 p.E894*;NSD1 p.E294*;NSD1 p.R2187*;CARD11 p.S250Y;KMT2C p.S1733*;PTPRD p.E106*;ARID5B p.E456*;ARID5B p.E592*;TET1 p.R1690*;KMT2A p.R862*;CBL p.R206*;CDKN1B p.E172*;SH2B3 p.X413_splice;LATS2 p.R1054*;FLT3 p.Y865H;FLT3 p.N676S;BRCA2 p.E97*;DICER1 p.R1895*;ZFHX3 p.E3001*;ZFHX3 p.R1309*;PTPRT p.Y690*;EP300 p.R86*;ATRX p.E1119*	10	63
P-0012359	P-0012359-T01-IM5	In-House	FFPE	Biopsy	250	736	80	Matched	Metastasis	Small Bowel	Liver	Tumor	NETNOS	Cancer of Unknown Primary	Neuroendocrine Tumor, NOS					Trametinib,Cobimetinib(NF1 p.V961Cfs*14)				LEVEL_4	NF1 p.V961Cfs*14	1	1
P-0012360	P-0012360-T01-IM5	Outside	FFPE	Biopsy	250	822	90	Matched	Primary	Brain	Not Applicable	Tumor	GBM	Glioma	Glioblastoma Multiforme					Lapatinib(EGFR p.R108K);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion);Lapatinib(EGFR Amplification);GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.R175H;EGFR p.R108K;ARID5B Deletion;CDKN2A Deletion;CDKN2B Deletion;CDKN2C Deletion;EGFR Amplification;GATA3 Deletion;PTEN Deletion;TCF7L2 Deletion;TNFRSF14 Deletion;TP63 Deletion	4	12
P-0012361	P-0012361-T01-IM5	In-House	FFPE	Biopsy	250	773	60	Matched	Metastasis	Skin	Brain	Tumor	SKCM	Melanoma	Cutaneous Melanoma	Dabrafenib,Dabrafenib+Trametinib,Vemurafenib+Atezolizumab+Cobimetinib,Trametinib,Vemurafenib,Vemurafenib+Cobimetinib,Encorafenib+Binimetinib(BRAF p.V600E)			Encorafenib+Cetuximab,Encorafenib+Panitumumab(BRAF p.V600E);Palbociclib,Abemaciclib(CDK4 Amplification)					LEVEL_1	BRAF p.V600E;PTPRD p.X1292_splice;CBL p.X409_splice;NCOR1 p.X2179_splice;FAT1 p.S3807*;CCND1 Amplification;CDK4 Amplification;FGF19 Amplification;MITF Amplification;PAK1 Amplification;PTPRD Deletion;YAP1 Amplification	3	12
P-0012362	P-0012362-T01-IM5	In-House	FFPE	Resection	250	776	70	Matched	Primary	Breast	Not Applicable	Tumor	ILC	Breast Cancer	Breast Invasive Lobular Carcinoma										CDH1 p.T515_F516ins*;TBX3 p.Y271*	0	2
P-0012363	P-0012363-T01-IM5	In-House	FFPE	Biopsy	250	501	20	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Binimetinib,Binimetinib+Ribociclib(NRAS p.Q61L)					LEVEL_3B	NRAS p.Q61L;CTCF p.T204Nfs*26;PMS2 p.L162*	1	3
P-0012364	P-0012364-T01-IM5	In-House	FFPE	Resection	250	475	30	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.N78K	0	1
P-0012365	P-0012365-T01-IM5	In-House	FFPE	Resection	250	777	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	TP53 p.R196*;KRAS p.G12V	1	2
P-0012366	P-0012366-T01-IM5	In-House	FFPE	Biopsy	250	951	20	Matched	Primary	Sigmoid Colon	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)	Cetuximab,Panitumumab(KRAS p.G12D)			LEVEL_4	KRAS p.G12D;FBXW7 p.R465H;SMAD2 p.D300H;APC p.H1490Pfs*15;SOX9 p.Q376Rfs*4;APC p.Q247Efs*4	1	6
P-0012367	P-0012367-T01-IM5	Outside	FFPE	Biopsy	250	462	50	Matched	Metastasis	Ovary	Brain	Tumor	HGSOC	Ovarian Cancer	High-Grade Serous Ovarian Cancer				Olaparib(RAD51D Deletion)	Trametinib,Cobimetinib(NF1 Deletion)				LEVEL_3B	TP53 p.R273H;MYC Amplification;NF1 Deletion;NKX3-1 Deletion;PAK1 Amplification;RAD51D Deletion	2	6
P-0012368	P-0012368-T01-IM5	In-House	FFPE	Biopsy	250	772	20	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma					GSK2636771,AZD8186(PTEN Deletion)				LEVEL_4	TP53 p.A159V;RB1 p.E492Lfs*4;ASXL2 Deletion;PTEN Deletion;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	6
P-0012370	P-0012370-T01-IM5	In-House	FFPE	Biopsy	250	938	30	Matched	Metastasis	Tongue	Rib	Tumor	HNSC	Head and Neck Cancer	Head and Neck Squamous Cell Carcinoma											0	0
P-0012371	P-0012371-T01-IM5	In-House	FFPE	Biopsy	250	872	10	Matched	Metastasis	Pancreas	Peritoneum	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.V172D	1	2
P-0012372	P-0012372-T01-IM5	Outside	FFPE	Biopsy	250	821	50	Matched	Metastasis	Breast	Pleura	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E542K)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E542K)		GSK2636771,AZD8186(PTEN p.Y174D);GSK2636771,AZD8186(PTEN p.C250Sfs*4)				LEVEL_1	PIK3CA p.E542K;PTEN p.Y174D;PTEN p.C250Sfs*4	4	3
P-0012373	P-0012373-T01-IM5	In-House	FFPE	Biopsy	221.1	634	60	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma				BLU-667,Selpercatinib(RET p.C611S);Debio1347,Erdafitinib,BGJ398,AZD4547(TACC3 FGFR3-TACC3 fusion);Debio1347,Erdafitinib,BGJ398,AZD4547(FGFR3 FGFR3-TACC3 fusion)					LEVEL_3B	TP53 p.C176S;FAT1 p.G3179*;RET p.C611S;STK11 p.X155_splice;MBD3 TCF3-MBD3 fusion;TCF3 TCF3-MBD3 fusion;TACC3 FGFR3-TACC3 fusion;FGFR3 FGFR3-TACC3 fusion	3	8
P-0012374	P-0012374-T01-IM5	Outside	FFPE	Resection	250	840	20	Matched	Primary	Gallbladder	Not Applicable	Tumor	GBC	Hepatobiliary Cancer	Gallbladder Cancer					Trametinib,Cobimetinib(NF1 p.R304*);Trametinib,Cobimetinib,Binimetinib(KRAS p.G13D)				LEVEL_4	NF1 p.R304*;KRAS p.G13D;ARID1A p.E1032*;ARID1B p.Q892Hfs*6	2	4
P-0012375	P-0012375-T01-IM5	Outside	FFPE	Biopsy	250	629	80	Matched	Primary	Prostate	Not Applicable	Tumor	PRAD	Prostate Cancer	Prostate Adenocarcinoma	Olaparib(ATM p.L2659*)								LEVEL_1	FOXA1 p.H247Y;ATM p.L2659*;ZFHX3 p.Q1965*;ERG TMPRSS2-ERG fusion;TMPRSS2 TMPRSS2-ERG fusion	1	5
P-0012376	P-0012376-T01-IM5	Outside	FFPE	Biopsy	250	754	70	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma	Pemigatinib(FGFR2 RAB7L1-FGFR2 fusion);Pemigatinib(RAB29 RAB7L1-FGFR2 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 RAB7L1-FGFR2 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(RAB29 RAB7L1-FGFR2 fusion)						LEVEL_1	FGFR2 RAB7L1-FGFR2 fusion;RAB29 RAB7L1-FGFR2 fusion	4	2
P-0012377	P-0012377-T01-IM5	In-House	FFPE	Biopsy	250	904	80	Matched	Metastasis	Soft Tissue	Thigh	Tumor	LMS	Soft Tissue Sarcoma	Leiomyosarcoma										TP53 p.R282W;EWSR1 AP1B1-EWSR1 fusion;AP1B1 AP1B1-EWSR1 fusion	0	3
P-0012378	P-0012378-T01-IM5	In-House	FFPE	Resection	250	797	40	Matched	Primary	Kidney	Not Applicable	Tumor	CCRCC	Renal Cell Carcinoma	Renal Clear Cell Carcinoma										VHL p.S80R	0	1
P-0012379	P-0012379-T01-IM5	In-House	FFPE	Resection	250	942	50	Matched	Primary	Kidney	Not Applicable	Tumor	MTSCC	Renal Cell Carcinoma	Renal Mucinous Tubular Spindle Cell Carcinoma										NF2 p.X121_splice	0	1
P-0012380	P-0012380-T01-IM5	In-House	FFPE	Resection	250	1039	30	Matched	Primary	Pancreas	Not Applicable	Tumor	IPMN	Pancreatic Cancer	Intraductal Papillary Mucinous Neoplasm				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12R)				LEVEL_3B	PIK3CA p.E545K;KRAS p.G12R;GNAS p.R201C;FBXW7 p.R689Q;SF3B1 p.E622D	2	5
P-0012381	P-0012381-T01-IM5	In-House	FFPE	Resection	250	750	90	Unmatched	Metastasis	Soft Tissue	Pelvis	Tumor	MRLS	Soft Tissue Sarcoma	Myxoid/Round-Cell Liposarcoma										APC p.I1307K	0	1
P-0012393	P-0012393-T01-IM5	Outside	FFPE	Biopsy	250	950	70	Matched	Metastasis	Lung	Liver	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Erlotinib,Afatinib,Gefitinib,Osimertinib,Dacomitinib(EGFR p.E746_A750del)			Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E545K);Palbociclib,Abemaciclib(CDK4 Amplification);Milademetan Tosylate,RO5045337(MDM2 Amplification)					LEVEL_1	EGFR p.E746_A750del;PIK3CA p.E545K;ASXL1 p.R965*;CARD11 Amplification;CDK4 Amplification;EGFR Amplification;ETV1 Amplification;GLI1 Amplification;MDM2 Amplification;RAC1 Amplification	4	10
P-0012394	P-0012394-T01-IM5	In-House	FFPE	Biopsy	250	1057	80	Matched	Metastasis	Cancer of Unknown Primary	Lymph Node	Tumor	CUP	Cancer of Unknown Primary	Cancer of Unknown Primary				AMG-510(KRAS p.G12C)	Trametinib,Cobimetinib,Binimetinib(KRAS p.G12C);Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	KRAS p.G12C;STK11 p.E256*;ATRX p.S1944Vfs*11;SMARCA4 p.A314Rfs*12;CDKN2A Deletion	3	5
P-0012395	P-0012395-T01-IM5	Outside	FFPE	Resection	250	925	70	Matched	Metastasis	Pancreas	Lung	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma				Trametinib,Cobimetinib(SND1 BRAF-SND1 fusion);Trametinib,Cobimetinib(BRAF BRAF-SND1 fusion)	Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_3B	CDKN2A Deletion;CDKN2B Deletion;SND1 BRAF-SND1 fusion;BRAF BRAF-SND1 fusion	3	4
P-0012396	P-0012396-T01-IM5	In-House	FFPE	Resection	250	766	50	Matched	Primary	Breast	Not Applicable	Tumor	IDC	Breast Cancer	Breast Invasive Ductal Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.E110del)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.E110del)		GSK2636771,AZD8186(PTEN p.Q171*);GSK2636771,AZD8186(PTEN p.H123Y)				LEVEL_1	PTEN p.Q171*;PIK3CA p.E110del;PTEN p.H123Y;MAP2K4 p.Q316*	4	4
P-0012397	P-0012397-T01-IM5	In-House	FFPE	Resection	250	911	40	Matched	Primary	Uterus	Not Applicable	Tumor	UEC	Endometrial Cancer	Uterine Endometrioid Carcinoma				Olaparib(ATM p.R1875*);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R88Q)	Trametinib,Cobimetinib(NF1 p.C383*);Trametinib,Cobimetinib(NF1 p.R1769*)				LEVEL_3B	ATM p.R1875*;FBXW7 p.R479Q;AXL p.A273V;PIK3CA p.R88Q;FLT3 p.E800K;POLE p.V411L;NF1 p.C383*;MAP2K4 p.A279T;EP300 p.Y1467H;ARID1A p.W1545*;NF1 p.R1769*;TET2 p.R544*;FH p.W141*;BCL2L11 p.X166_splice;PIK3R1 p.R503W;RASA1 p.E312*;TBX3 p.W230*;MGA p.Q217*;NCOR1 p.R2308*;NCOR1 p.X2227_splice;RNF43 p.X283_splice;STK11 p.A205T;ATRX p.E2101*;STAG2 p.E950*	4	24
P-0012398	P-0012398-T01-IM5	In-House	FFPE	Biopsy	250	929	30	Matched	Primary	Thigh	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma				Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)					LEVEL_3B	PIK3CA p.H1047R;TERT Amplification	1	2
P-0012399	P-0012399-T01-IM5	In-House	FFPE	Resection	250	1039	30	Matched	Metastasis	Sigmoid Colon	Liver	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										ARID1A p.R1461*;APC p.Q1328*;APC p.Q625*;TCF7L2 p.E84*;TP53 p.S185Tfs*62;ARID1A p.P870Qfs*62	0	6
P-0012400	P-0012400-T01-IM5	In-House	FFPE	Resection	250	1041	20	Matched	Primary	Lung	Not Applicable	Tumor	LUNE	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma					Palbociclib,Ribociclib,Abemaciclib(CDKN2A p.E69*)				LEVEL_4	TP53 p.W146*;KDM5C p.E297*;KDM5C p.V272Wfs*2;KEAP1 p.G364F;CDKN2A p.E69*;CDK6 Amplification;SMARCA4 SMARCA4-intragenic;GLIS3 LATS1-GLIS3 fusion;LATS1 LATS1-GLIS3 fusion	1	9
P-0012401	P-0012401-T01-IM5	In-House	FFPE	Resection	250	971	80	Matched	Primary	Thigh	Not Applicable	Tumor	MFH	Soft Tissue Sarcoma	Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma										DIS3 Deletion;RAD21 Deletion;RB1 Deletion;TP53 Deletion	0	4
P-0012402	P-0012402-T01-IM5	In-House	FFPE	Resection	250	788	40	Matched	Primary	Cecum	Not Applicable	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma				Olaparib(ATM p.R250*);Olaparib(ATM p.R3008C);Fulvestrant+Alpelisib,GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.R38H);Everolimus(TSC1 p.E218*);Olaparib,Rucaparib,Talazoparib,Niraparib(BRCA2 p.K3032*);Olaparib(BRIP1 p.S956*)	GSK2636771,AZD8186(PTEN p.R130Q);Trametinib,Cobimetinib,Binimetinib(KRAS p.K117N);Everolimus,Temsirolimus(MTOR p.S2215Y);GSK2636771,AZD8186(PTEN p.M134I)	Cetuximab,Panitumumab(KRAS p.K117N)			LEVEL_3B	B2M p.R117*;APC p.R1450*;PTEN p.R130Q;FBXW7 p.R658*;APC p.R805*;TGFBR1 p.S241L;PIK3CB p.R321Q;ARID1A p.E896*;APC p.Q1291*;KRAS p.K117N;ASXL2 p.R357*;ATM p.R250*;MTOR p.S2215Y;MSH2 p.E580*;KMT2C p.R2403*;XPO1 p.R749Q;TOP1 p.R31*;ATM p.R3008C;PIK3CA p.R38H;ARID2 p.R1677*;POLE p.V411L;CASP8 p.E180*;SETD2 p.E1478*;INPP4B p.E494*;FBXW7 p.R441Q;RASA1 p.X368_splice;RAD50 p.E810*;KMT2C p.S2641*;TGFBR1 p.W458*;TSC1 p.E218*;NOTCH1 p.D2020N;PTEN p.M134I;BIRC3 p.E440*;BRCA2 p.K3032*;B2M p.E89*;CREBBP p.X961_splice;BRIP1 p.S956*;BCOR p.S214*;APC p.K2051Efs*9	10	39
P-0012403	P-0012403-T01-IM5	Outside	FFPE	Biopsy	106.9	474	70	Matched	Metastasis	Intraabdominal	Liver	Tumor	GIST	Gastrointestinal Stromal Tumor	Gastrointestinal Stromal Tumor	Imatinib,Sunitinib,Regorafenib,Ripretinib(KIT p.N566_P573del)								LEVEL_1	TP53 p.F109V;KIT p.N566_P573del;RB1 Deletion	1	3
P-0012404	P-0012404-T01-IM5	In-House	FFPE	Resection	250	951	40	Matched	Primary	Lung	Not Applicable	Tumor	LUAD	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Afatinib(EGFR p.S768_V769delinsIL)				Palbociclib,Ribociclib,Abemaciclib(CDKN2A Deletion)				LEVEL_1	EGFR p.S768_V769delinsIL;CDKN2A Deletion;CDKN2B Deletion	2	3
P-0012405	P-0012405-T01-IM5	In-House	FFPE	Resection	250	832	10	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12D)				LEVEL_4	KRAS p.G12D	1	1
P-0012406	P-0012406-T01-IM5	In-House	FFPE	Biopsy	104.995	304	30	Matched	Metastasis	Descending Colon	Pelvis	Tumor	COAD	Colorectal Cancer	Colon Adenocarcinoma										APC p.R876*;KMT2A p.Q3170*;TP53 p.R110delinsQS	0	3
P-0012423	P-0012423-T01-IM5	Outside	FFPE	Biopsy	250	667	30	Matched	Primary	Liver	Not Applicable	Tumor	CHOL	Hepatobiliary Cancer	Cholangiocarcinoma	Pemigatinib(NOL4 FGFR2-NOL4 fusion);Pemigatinib(FGFR2 FGFR2-NOL4 fusion)		Debio1347,BGJ398,AZD4547,Erdafitinib(NOL4 FGFR2-NOL4 fusion);Debio1347,BGJ398,AZD4547,Erdafitinib(FGFR2 FGFR2-NOL4 fusion)						LEVEL_1	CTNNB1 p.K335I;GRIN2A p.W55*;EP300 p.H78Qfs*11;NTRK1 Amplification;NOL4 FGFR2-NOL4 fusion;FGFR2 FGFR2-NOL4 fusion	4	6
P-0012434	P-0012434-T01-IM5	Outside	FFPE	Biopsy	250	769	70	Matched	Primary	Brain	Not Applicable	Tumor	ODG	Glioma	Oligodendroglioma				Ivosidenib(IDH1 p.R132H)					LEVEL_3B	IDH1 p.R132H;CIC p.P1248Hfs*54;CIC p.K899Qfs*32	1	3
P-0012442	P-0012442-T01-IM5	In-House	FFPE	Resection	250	815	30	Matched	Primary	Pancreas	Not Applicable	Tumor	PAAD	Pancreatic Cancer	Pancreatic Adenocarcinoma					Trametinib,Cobimetinib,Binimetinib(KRAS p.G12V)				LEVEL_4	KRAS p.G12V;TP53 p.Y220C	1	2
P-0012500	P-0012500-T01-IM5	In-House	FFPE	Resection	250	812	50	Matched	Primary	Breast	Not Applicable	Tumor	BRCA	Breast Cancer	Invasive Breast Carcinoma	Fulvestrant+Alpelisib(PIK3CA p.H1047R)		GDC-0077,Copanlisib+Fulvestrant(PIK3CA p.H1047R)						LEVEL_1	PIK3CA p.H1047R;CBFB p.R148Efs*19	2	2
P-0012524	P-0012524-T01-IM5	In-House	FFPE	Biopsy	250	995	70	Unmatched	Primary	Lymph node	Not Applicable	Tumor	DLBCLNOS	Mature B-Cell Neoplasms	Diffuse Large B-Cell Lymphoma, NOS										B2M p.L7*;CREBBP p.Y1503N;TNFAIP3 p.X99_splice;TNFRSF14 p.G60Sfs*18;TNFAIP3 p.P180Hfs*73;KMT2D p.K1466Qfs*25	0	6
P-0012557	P-0012557-T01-IM5	Outside	FFPE	Biopsy	90	297	40	Matched	Metastasis	Bladder	Soft Tissue	Tumor	BLCA	Bladder Cancer	Bladder Urothelial Carcinoma					Tazemetostat(KDM6A p.Q555*)				LEVEL_4	KDM6A p.Q555*;RB1 p.X841_splice;TP53 p.T211Ifs*33;TP63 TP63-intragenic	1	4
P-0012622	P-0012622-T01-IM5	Outside	FFPE	Resection	250	843	80	Matched	Primary	Mesentery	Not Applicable	Tumor	SARCNOS	Soft Tissue Sarcoma	Sarcoma, NOS										ATRX p.K1896*;FOXP1 FOXP1-intragenic	0	2
